Citrus Sinensis ID: 011331
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 488 | 2.2.26 [Sep-21-2011] | |||||||
| Q8L4H0 | 500 | Wee1-like protein kinase | yes | no | 0.971 | 0.948 | 0.631 | 1e-171 | |
| Q6Z829 | 520 | Wee1-like protein kinase | yes | no | 0.827 | 0.776 | 0.614 | 1e-143 | |
| Q8QGV2 | 595 | Wee1-like protein kinase | N/A | no | 0.526 | 0.431 | 0.396 | 2e-55 | |
| Q8AYK6 | 571 | Wee1-like protein kinase | N/A | no | 0.526 | 0.450 | 0.396 | 8e-55 | |
| P30291 | 646 | Wee1-like protein kinase | no | no | 0.528 | 0.399 | 0.388 | 7e-54 | |
| Q63802 | 646 | Wee1-like protein kinase | yes | no | 0.528 | 0.399 | 0.391 | 8e-54 | |
| P54350 | 609 | Wee1-like protein kinase | yes | no | 0.530 | 0.425 | 0.362 | 4e-53 | |
| P47810 | 646 | Wee1-like protein kinase | yes | no | 0.528 | 0.399 | 0.388 | 4e-53 | |
| Q1LX51 | 532 | Wee1-like protein kinase | no | no | 0.516 | 0.473 | 0.404 | 4e-53 | |
| A4QNA8 | 562 | Wee1-like protein kinase | no | no | 0.518 | 0.450 | 0.399 | 6e-52 |
| >sp|Q8L4H0|WEE1_ARATH Wee1-like protein kinase OS=Arabidopsis thaliana GN=WEE1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 601 bits (1550), Expect = e-171, Method: Compositional matrix adjust.
Identities = 308/488 (63%), Positives = 367/488 (75%), Gaps = 14/488 (2%)
Query: 5 RKTQKKSKREESQ----MKGTLARHFQVQLGYSSSIQHQSF-SSTSSSSRLQNHLESVSQ 59
RKTQ K S+ M+GTL RH +Q G S I ++ SS +SS Q L+S S
Sbjct: 13 RKTQGTIKTRASKKIRKMEGTLERHSLLQFGQLSKISFENRPSSNVASSAFQGLLDSDSS 72
Query: 60 DAT--LSAADVD----DKDLILTQDFFCTPDYITPVNQNSMSGFDCNRENIPCPKSPEKL 113
+ L +AD D +KD IL+QDFFCTPDYITP NQN MSG D ++++ PCP+SP KL
Sbjct: 73 ELRNQLGSADSDANCGEKDFILSQDFFCTPDYITPDNQNLMSGLDISKDHSPCPRSPVKL 132
Query: 114 NTVKSKKLRQDGFLVNPLDPTSYDYQDTVDLAKDSFSTDEVQLTKTIGYTTQKTHNYVPQ 173
NTVKSK+ RQ+ F N + T + D TDEV K T++T YV Q
Sbjct: 133 NTVKSKRCRQESFTGNHSNSTWSSKHRVDEQENDDIDTDEVMGDKLQANQTERT-GYVSQ 191
Query: 174 SAVALRCRVMPPPCIKNPYQKDASEMDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDFHE 233
+AVALRCR MPPPC+KNPY + SE D FG+Q +KCA PV T GDGLSRY TDFHE
Sbjct: 192 AAVALRCRAMPPPCLKNPYVLNQSETATDPFGHQRSKCASFLPVSTSGDGLSRYLTDFHE 251
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
I QIGAG+FS VFKVLKR+DGC YAVKHS R+L+ D+ERRKA++EVQALAALG HENIVG
Sbjct: 252 IRQIGAGHFSRVFKVLKRMDGCLYAVKHSTRKLYLDSERRKAMMEVQALAALGFHENIVG 311
Query: 294 YYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
YYSSWFENEQLYIQ+ELCDHSLS KK+S +E E+L +HQIA+AL F+HEKGIAHL
Sbjct: 312 YYSSWFENEQLYIQLELCDHSLSALPKKSSLKVSEREILVIMHQIAKALHFVHEKGIAHL 371
Query: 352 DVKPDNIYVKNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLG 411
DVKPDNIY+KNGV KLGDFG AT L+KSLP+EEGDARYMPQEILNEDY+HLDKVDIFSLG
Sbjct: 372 DVKPDNIYIKNGVCKLGDFGCATRLDKSLPVEEGDARYMPQEILNEDYEHLDKVDIFSLG 431
Query: 412 ATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471
T+YELIKGSPL+ES Q LN+++GKLPLLPGHSLQ Q LLK M+D DP +RPSA+EL++
Sbjct: 432 VTVYELIKGSPLTESRNQSLNIKEGKLPLLPGHSLQLQQLLKTMMDRDPKRRPSARELLD 491
Query: 472 NPIFDKIQ 479
+P+FD+I+
Sbjct: 492 HPMFDRIR 499
|
Cell cycle regulatory kinase that is not rate-limiting for cycle progression under normal growth conditions. Transcriptionally activated upon DNA stress or damage in an ATR-or ATM-dependent manner. Once activated, inhibits plant growth by arresting dividing cells in the G2 phase before proceeding into mitosis. Down-regulates CDKA-1 and CDKD-2 by tyrosine phosphorylation. May target principally CDKA-1. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2 |
| >sp|Q6Z829|WEE1_ORYSJ Wee1-like protein kinase OS=Oryza sativa subsp. japonica GN=WEE1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 509 bits (1311), Expect = e-143, Method: Compositional matrix adjust.
Identities = 257/418 (61%), Positives = 321/418 (76%), Gaps = 14/418 (3%)
Query: 68 VDDKDL-ILTQDFFCTPDYITPVNQNSMSGFDCNRENIPCPKSPEKLNTVKSKKLRQDGF 126
V++KD IL+QDFFCTPDYITP SGFD N+ENIPCP SPEK + +SK+ ++D
Sbjct: 107 VEEKDSGILSQDFFCTPDYITPDAPQLGSGFDANKENIPCPNSPEK-SVCRSKRYKRD-- 163
Query: 127 LVNPLDPTSYDYQDTVDLAKDSFS----TDEVQLTKTIGYTTQKTHNYVPQSAVALRCRV 182
+P S D D+ +A F ++E QL ++ ++ K +YV QSAVALRCRV
Sbjct: 164 -CSPKGLGSNDIFDSQWIAPVQFEGLDDSEEEQLKES---SSHKRGSYVSQSAVALRCRV 219
Query: 183 MPPPCIKNPYQKDASEMDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDFHEIEQIGAGNF 242
MPPPCI+NPY ++D + FG + K +G P + G DGLSRY TDFHEIEQIG GNF
Sbjct: 220 MPPPCIRNPYLNTDHQIDDNVFGGRQCKSSGFSPSVDG-DGLSRYRTDFHEIEQIGRGNF 278
Query: 243 SHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302
S VFKVLKRIDGC YAVK S RQLH+D ERR+A+ EVQALAALG HENIVGY++SWFEN+
Sbjct: 279 SVVFKVLKRIDGCLYAVKRSIRQLHNDRERRQAVKEVQALAALGCHENIVGYFTSWFENK 338
Query: 303 QLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKN 362
QL+IQMELCD LS + +Q GE L+ L+QI + L FIHE+GIAHLDVKPDNIYV+N
Sbjct: 339 QLFIQMELCDRCLSMDR-NQPLKCGEALELLYQICKGLDFIHERGIAHLDVKPDNIYVRN 397
Query: 363 GVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSP 422
GVYKLGDFG ATL+++SL IE+GD+RYMP E+LN+ Y+HLDKVDIFSLGA +YELI+G+
Sbjct: 398 GVYKLGDFGCATLIDRSLAIEDGDSRYMPPEMLNDKYEHLDKVDIFSLGAAIYELIRGTQ 457
Query: 423 LSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
L +SGPQF +LR+GK+ LLPG +QFQ+L+K M+DPDPV+RPSAKE++ +PIFDK+ K
Sbjct: 458 LPDSGPQFTSLREGKIALLPGCPMQFQSLIKSMMDPDPVRRPSAKEVLRHPIFDKLHK 515
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q8QGV2|WEE1B_XENLA Wee1-like protein kinase 1-B OS=Xenopus laevis GN=wee1-b PE=1 SV=1 | Back alignment and function description |
|---|
Score = 217 bits (553), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 113/285 (39%), Positives = 170/285 (59%), Gaps = 28/285 (9%)
Query: 218 ITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL 277
IT + SRY T+FHE+E+IG+G F VFK +KR+DGC YA+K SK+ L + + AL
Sbjct: 235 ITESNMKSRYATEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR 294
Query: 278 EVQALAALGSHENIVGYYSSWFENEQLYIQMELCD-HSLSDK-----KASQFFAEGEVLK 331
EV A A LG H ++V YYS+W E++ + IQ E C+ SLSD + Q+F E E+
Sbjct: 295 EVYAHAVLGQHPHVVRYYSAWAEDDHMLIQNEYCNGGSLSDVISENYRTMQYFTEPELKD 354
Query: 332 ALHQIAQALQFIHEKGIAHLDVKPDNIYVKNG--------------------VYKLGDFG 371
L Q+A+ L++IH + H+D+KP NI++ +YK+GD G
Sbjct: 355 LLLQVARGLKYIHSMSLVHMDIKPSNIFISRTTLPNTAVEEADDEECGSGKVIYKIGDLG 414
Query: 372 RATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL 431
T ++ S +EEGD+R++ E+L E+Y HL K DIF+L T++ P +G Q+
Sbjct: 415 HVTRVS-SPQVEEGDSRFLANEVLQENYTHLAKADIFALALTVWSAAGAEPFPTNGDQWH 473
Query: 432 NLRDGKLPLLPG-HSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
+R GKLP +P S +F +L+K+M+ PDP +RPS+ LV++ +
Sbjct: 474 EIRQGKLPRVPQLLSQEFVDLIKLMISPDPEKRPSSVALVKHSVL 518
|
Acts as a zygotic negative regulator of entry into mitosis (G2 to M transition) by protecting the nucleus from cytoplasmically activated cyclin B1-complexed cdk1 before the onset of mitosis by mediating phosphorylation of cdk1 on 'Tyr-15'. Specifically phosphorylates and inactivates cyclin B1-complexed cdk1 reaching a maximum during G2 phase and a minimum as cells enter M phase. Phosphorylation of cyclin B1-cdk1 occurs exclusively on 'Tyr-15' and phosphorylation of monomeric cdk1 does not occur. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q8AYK6|WEE1A_XENLA Wee1-like protein kinase 1-A OS=Xenopus laevis GN=wee1-a PE=2 SV=1 | Back alignment and function description |
|---|
Score = 215 bits (547), Expect = 8e-55, Method: Compositional matrix adjust.
Identities = 113/285 (39%), Positives = 170/285 (59%), Gaps = 28/285 (9%)
Query: 218 ITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL 277
IT + SRY T+FHE+E+IG+G F VFK +KR+DGC YA+K SK+ + + + AL
Sbjct: 211 ITESNMKSRYATEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPMAGSVDEQNALR 270
Query: 278 EVQALAALGSHENIVGYYSSWFENEQLYIQMELCD-HSLSDK-----KASQFFAEGEVLK 331
EV A A LG H ++V YYS+W E++ + IQ E C+ SL+D + Q+F E E+
Sbjct: 271 EVYAHAVLGQHPHVVRYYSAWAEDDHMLIQNEYCNGGSLADAISENYRTMQYFTEPELKD 330
Query: 332 ALHQIAQALQFIHEKGIAHLDVKPDNIYVK--------------------NGVYKLGDFG 371
L Q+A+ L++IH + H+D+KP NI++ N VYK+GD G
Sbjct: 331 LLLQVARGLKYIHSMSLVHMDIKPSNIFISRITVPNTGVEEGDDEDCGSGNVVYKIGDLG 390
Query: 372 RATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL 431
T ++ S +EEGD+R++ E+L EDY HL K DIF+L T++ P +G Q+
Sbjct: 391 HVTRVS-SPQVEEGDSRFLANEVLQEDYTHLAKADIFALALTVWCAAGAEPFPTNGDQWH 449
Query: 432 NLRDGKLPLLPG-HSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
+R GKLP +P S +F +L+K+M+ PD +RPS+ LV++ +
Sbjct: 450 EIRQGKLPRVPQLLSQEFVDLIKLMISPDSEKRPSSMALVKHSVL 494
|
Acts as a zygotic negative regulator of entry into mitosis (G2 to M transition) by protecting the nucleus from cytoplasmically activated cyclin B1-complexed cdk1 before the onset of mitosis by mediating phosphorylation of cdk1 on 'Tyr-15'. Specifically phosphorylates and inactivates cyclin B1-complexed cdk1 reaching a maximum during G2 phase and a minimum as cells enter M phase. Phosphorylation of cyclin B1-cdk1 occurs exclusively on 'Tyr-15' and phosphorylation of monomeric cdk1 does not occur. Involved in convergent extension of the paraxial mesoderm during neurulation by inhibiting the cell cycle. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P30291|WEE1_HUMAN Wee1-like protein kinase OS=Homo sapiens GN=WEE1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 212 bits (539), Expect = 7e-54, Method: Compositional matrix adjust.
Identities = 111/286 (38%), Positives = 167/286 (58%), Gaps = 28/286 (9%)
Query: 217 VITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKAL 276
IT + SRY T+FHE+E+IG+G F VFK +KR+DGC YA+K SK+ L + + AL
Sbjct: 285 TITESNMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL 344
Query: 277 LEVQALAALGSHENIVGYYSSWFENEQLYIQMELCD-HSLSDK-----KASQFFAEGEVL 330
EV A A LG H ++V Y+S+W E++ + IQ E C+ SL+D + +F E E+
Sbjct: 345 REVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK 404
Query: 331 KALHQIAQALQFIHEKGIAHLDVKPDNIYVKNG--------------------VYKLGDF 370
L Q+ + L++IH + H+D+KP NI++ ++K+GD
Sbjct: 405 DLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 464
Query: 371 GRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF 430
G T ++ S +EEGD+R++ E+L E+Y HL K DIF+L T+ PL +G Q+
Sbjct: 465 GHVTRIS-SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 523
Query: 431 LNLRDGKLPLLPG-HSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
+R G+LP +P S +F LLKVM+ PDP +RPSA LV++ +
Sbjct: 524 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 569
|
Acts as a negative regulator of entry into mitosis (G2 to M transition) by protecting the nucleus from cytoplasmically activated cyclin B1-complexed CDK1 before the onset of mitosis by mediating phosphorylation of CDK1 on 'Tyr-15'. Specifically phosphorylates and inactivates cyclin B1-complexed CDK1 reaching a maximum during G2 phase and a minimum as cells enter M phase. Phosphorylation of cyclin B1-CDK1 occurs exclusively on 'Tyr-15' and phosphorylation of monomeric CDK1 does not occur. Its activity increases during S and G2 phases and decreases at M phase when it is hyperphosphorylated. A correlated decrease in protein level occurs at M/G1 phase, probably due to its degradation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q63802|WEE1_RAT Wee1-like protein kinase OS=Rattus norvegicus GN=Wee1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (538), Expect = 8e-54, Method: Compositional matrix adjust.
Identities = 112/286 (39%), Positives = 167/286 (58%), Gaps = 28/286 (9%)
Query: 217 VITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKAL 276
IT + SRY T+FHE+E+IG+G F VFK +KR+DGC YA+K SK+ L + + AL
Sbjct: 284 TITESNMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL 343
Query: 277 LEVQALAALGSHENIVGYYSSWFENEQLYIQMELCD-HSLSDK-----KASQFFAEGEVL 330
EV A A LG H ++V Y+S+W E++ + IQ E C+ SL+D + +F E E+
Sbjct: 344 REVYAHAVLGQHPHVVRYFSAWAEDDHMLIQNEYCNGGSLADAVSENYRVMSYFTEAELK 403
Query: 331 KALHQIAQALQFIHEKGIAHLDVKPDNIYVK-----NGV---------------YKLGDF 370
L Q+ + L++IH + H+D+KP NI++ N V +K+GD
Sbjct: 404 DLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAVSEEGDEDDWISNKVMFKIGDL 463
Query: 371 GRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF 430
G T ++ S +EEGD+R++ E+L E+Y HL K DIF+L T+ PL +G Q+
Sbjct: 464 GHVTRIS-SPQVEEGDSRFLANEVLQENYSHLPKADIFALALTVVCAAGAEPLPRNGDQW 522
Query: 431 LNLRDGKLPLLPG-HSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
+R G+LP +P S + LLKVM+ PDP +RPSA LV++ +
Sbjct: 523 HEIRQGRLPRIPQVLSQELTELLKVMIHPDPERRPSAMVLVKHSVL 568
|
Acts as a negative regulator of entry into mitosis (G2 to M transition) by protecting the nucleus from cytoplasmically activated cyclin B1-complexed CDK1 before the onset of mitosis by mediating phosphorylation of CDK1 on 'Tyr-15'. Specifically phosphorylates and inactivates cyclin B1-complexed CDK1 reaching a maximum during G2 phase and a minimum as cells enter M phase. Phosphorylation of cyclin B1-CDK1 occurs exclusively on 'Tyr-15' and phosphorylation of monomeric CDK1 does not occur. Its activity increases during S and G2 phases and decreases at M phase when it is hyperphosphorylated. A correlated decrease in protein level occurs at M/G1 phase, probably due to its degradation. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P54350|WEE1_DROME Wee1-like protein kinase OS=Drosophila melanogaster GN=wee PE=1 SV=2 | Back alignment and function description |
|---|
Score = 209 bits (532), Expect = 4e-53, Method: Compositional matrix adjust.
Identities = 107/295 (36%), Positives = 163/295 (55%), Gaps = 36/295 (12%)
Query: 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALA 283
+SR+ +F ++ IG G F VF+ + R+DGC YA+K SK+ + + ++AL EV A A
Sbjct: 232 ISRFKREFMQVNVIGVGEFGVVFQCVNRLDGCIYAIKKSKKPVAGSSFEKRALNEVWAHA 291
Query: 284 ALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQF 342
LG H+N+V YYS+W E++ + IQ E CD SL + E E+ L + + L++
Sbjct: 292 VLGKHDNVVRYYSAWAEDDHMLIQNEFCDGGSLHARIQDHCLGEAELKIVLMHVIEGLRY 351
Query: 343 IHEKGIAHLDVKPDNIYVKNG----------------------------------VYKLG 368
IH + H+D+KP+NI+ YK+G
Sbjct: 352 IHSNDLVHMDLKPENIFSTMNPNAHKLVEVQPQQTKDDDGMDSVYEELRHSENLVTYKIG 411
Query: 369 DFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP 428
D G T + + +EEGD RY+P+EIL+EDY +L K DIFSLG T++E G PL ++GP
Sbjct: 412 DLGHVTSVKEPY-VEEGDCRYLPKEILHEDYSNLFKADIFSLGITLFEAAGGGPLPKNGP 470
Query: 429 QFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRK 483
++ NLRDGK+P+LP S F L+ M+ P P +RP+++ + +PI + K
Sbjct: 471 EWHNLRDGKVPILPSLSRDFNELIAQMMHPYPDKRPTSQSIFSHPILSAVDSKSK 525
|
Could act as a negative regulator of entry into mitosis (G2 to M transition). This kinase specifically phosphorylates and inactivates cyclin B1-complexed CDC2. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P47810|WEE1_MOUSE Wee1-like protein kinase OS=Mus musculus GN=Wee1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 209 bits (532), Expect = 4e-53, Method: Compositional matrix adjust.
Identities = 111/286 (38%), Positives = 167/286 (58%), Gaps = 28/286 (9%)
Query: 217 VITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKAL 276
IT + SRY T+FHE+E+IG+G F VFK +KR+DGC YA+K SK+ L + + AL
Sbjct: 284 TITESNMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL 343
Query: 277 LEVQALAALGSHENIVGYYSSWFENEQLYIQMELCD-HSLSDK-----KASQFFAEGEVL 330
EV A A LG H ++V Y+S+W E++ + IQ E C+ SL+D + + E E+
Sbjct: 344 REVYAHAVLGQHPHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRVMSYLTEVELK 403
Query: 331 KALHQIAQALQFIHEKGIAHLDVKPDNIYVK-----NGV---------------YKLGDF 370
L Q+ + L++IH + H+D+KP NI++ N V +K+GD
Sbjct: 404 DLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAVSEEGDEDDWISNKVMFKIGDL 463
Query: 371 GRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF 430
G T ++ S +EEGD+R++ E+L E+Y HL K DIF+L T+ PL +G Q+
Sbjct: 464 GHVTRIS-SPQVEEGDSRFLANEVLQENYSHLPKADIFALALTVVCAAGAEPLPRNGEQW 522
Query: 431 LNLRDGKLPLLPG-HSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
+R G+LP +P S + LL+VM+ PDP +RPSA ELV++ +
Sbjct: 523 HEIRQGRLPRIPQVLSQEVTELLRVMIHPDPERRPSAMELVKHSVL 568
|
Acts as a negative regulator of entry into mitosis (G2 to M transition) by protecting the nucleus from cytoplasmically activated cyclin B1-complexed CDK1 before the onset of mitosis by mediating phosphorylation of CDK1 on 'Tyr-15'. Specifically phosphorylates and inactivates cyclin B1-complexed CDK1 reaching a maximum during G2 phase and a minimum as cells enter M phase. Phosphorylation of cyclin B1-CDK1 occurs exclusively on 'Tyr-15' and phosphorylation of monomeric CDK1 does not occur. Its activity increases during S and G2 phases and decreases at M phase when it is hyperphosphorylated. A correlated decrease in protein level occurs at M/G1 phase, probably due to its degradation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q1LX51|WEE2_DANRE Wee1-like protein kinase 2 OS=Danio rerio GN=wee2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 209 bits (532), Expect = 4e-53, Method: Compositional matrix adjust.
Identities = 115/284 (40%), Positives = 165/284 (58%), Gaps = 32/284 (11%)
Query: 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALA 283
LSRY ++F E+ IG G F V++ +KR+DGC YA+K S+R + A + AL EV A A
Sbjct: 181 LSRYESEFLELACIGVGEFGSVYRCVKRLDGCMYAIKRSRRPIAGSANEQLALKEVYAHA 240
Query: 284 ALGSHENIVGYYSSWFENEQLYIQMELCD-HSLSD-----KKASQFFAEGEVLKALHQIA 337
LG H ++V YYS+W E++ + IQ E CD SL D ++ +FF+ E+ L Q++
Sbjct: 241 VLGHHPHVVRYYSAWAEDDHMIIQNEYCDGGSLHDAITEKREQGEFFSVPELRDLLLQVS 300
Query: 338 QALQFIHEKGIAHLDVKPDNIYV----------------------KNGVYKLGDFGRATL 375
L++IH G+ HLD+KP NI++ VYK+GD G T
Sbjct: 301 MGLKYIHNSGLVHLDIKPSNIFICRRSTLSAGGEGDSEEEDESHSSGVVYKIGDLGHVTS 360
Query: 376 LNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD 435
++ S +EEGD+R++ E+L EDY HL K DIF+LG T+ SPL ++G + LR
Sbjct: 361 IS-SPQVEEGDSRFLAYEVLREDYTHLPKADIFALGLTVLLAAGASPLPQNGDDWHRLRQ 419
Query: 436 GKLPLLPGHSLQ--FQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
G+LP LP H L F++LLK ++DPDP RPSA L + + K
Sbjct: 420 GELPNLP-HELPALFKDLLKSLLDPDPTARPSATALCRHDVLCK 462
|
Oocyte-specific protein tyrosine kinase that phosphorylates and inhibits cdk1 and acts as a key regulator of meiosis. Required to maintain meiotic arrest in oocytes by phosphorylating cdk1 at 'Tyr-15', leading to inhibit cdk1 activity and prevent meiotic reentry. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|A4QNA8|WEE2_XENTR Wee1-like protein kinase 2 OS=Xenopus tropicalis GN=wee2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 205 bits (522), Expect = 6e-52, Method: Compositional matrix adjust.
Identities = 113/283 (39%), Positives = 163/283 (57%), Gaps = 30/283 (10%)
Query: 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALA 283
+SRY T+F EIE+IGAG F VFK +KR+DGCFYA+K SK+ L + + AL EV A A
Sbjct: 210 VSRYKTEFLEIEKIGAGEFGSVFKCVKRLDGCFYAIKRSKKPLAGSTDEQLALREVYAHA 269
Query: 284 ALGSHENIVGYYSSWFENEQLYIQMELC------DHSLSDKKASQFFAEGEVLKALHQIA 337
LG H ++V YYS+W E++ + IQ E C D + +KK +F E E+ + L Q++
Sbjct: 270 VLGHHPHVVRYYSAWAEDDHMIIQNEYCNGGSLQDLIMENKKEGRFVPEQELKEILLQVS 329
Query: 338 QALQFIHEKGIAHLDVKPDNIYV--------------------KNGVYKLGDFGRAT-LL 376
L++IH G+ H+D+KP NI++ + +YK+GD G T +L
Sbjct: 330 MGLKYIHSSGLVHMDIKPSNIFICRKQTEVGQDESDGEDDLSSASVLYKIGDLGHVTSIL 389
Query: 377 NKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDG 436
N +EEGD+R++ EIL EDY L K DIF+LG T+ PL + + ++R G
Sbjct: 390 NPQ--VEEGDSRFLANEILQEDYRQLPKADIFALGLTITLAAGAGPLPCNEDSWHHIRKG 447
Query: 437 KLPLLPGH-SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478
LP +P + F LLK++V PDPV RP A L +N + +
Sbjct: 448 NLPHIPQPLTPAFLALLKLLVHPDPVMRPPAVSLAKNSLLRRC 490
|
Oocyte-specific protein tyrosine kinase that phosphorylates and inhibits cdk1 and acts as a regulator of meiosis. Required to maintain meiotic arrest in oocytes by phosphorylating cdk1 at 'Tyr-15', leading to inhibit cdk1 activity and prevent meiotic reentry. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 488 | ||||||
| 255582138 | 500 | ATP binding protein, putative [Ricinus c | 0.981 | 0.958 | 0.684 | 0.0 | |
| 359479814 | 452 | PREDICTED: wee1-like protein kinase-like | 0.924 | 0.997 | 0.713 | 0.0 | |
| 351728095 | 502 | wee1 [Glycine max] gi|42362341|gb|AAS133 | 0.979 | 0.952 | 0.672 | 0.0 | |
| 449498453 | 489 | PREDICTED: wee1-like protein kinase-like | 0.983 | 0.981 | 0.620 | 1e-177 | |
| 449436531 | 489 | PREDICTED: wee1-like protein kinase-like | 0.983 | 0.981 | 0.620 | 1e-177 | |
| 357511217 | 490 | Wee1-like protein kinase [Medicago trunc | 0.979 | 0.975 | 0.626 | 1e-176 | |
| 224129646 | 486 | hypothetical protein POPTRDRAFT_573439 [ | 0.918 | 0.921 | 0.673 | 1e-172 | |
| 209968968 | 508 | putative WEE1 kinase [Nicotiana tabacum] | 0.844 | 0.811 | 0.688 | 1e-171 | |
| 6056405 | 519 | Similar to Wee1 protein kinase [Arabidop | 0.975 | 0.917 | 0.630 | 1e-170 | |
| 224128526 | 473 | hypothetical protein POPTRDRAFT_572724 [ | 0.879 | 0.906 | 0.695 | 1e-170 |
| >gi|255582138|ref|XP_002531863.1| ATP binding protein, putative [Ricinus communis] gi|223528471|gb|EEF30500.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 686 bits (1770), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/497 (68%), Positives = 393/497 (79%), Gaps = 18/497 (3%)
Query: 5 RKTQKKSKR---EESQMKGTLARHFQVQLGYSSSIQHQSFSS---TSSSSRLQNHLESVS 58
RKT K+S R E +MKGTLARH QVQLG S Q+Q S + S+ LQN L+S +
Sbjct: 3 RKTLKRSNRKRKESDKMKGTLARHLQVQLGQVSVHQYQQQPSSLDSKPSTVLQNLLDSEA 62
Query: 59 QDATLSAA-----------DVDDKDLILTQDFFCTPDYITPVNQNSMSGFDCNRENIPCP 107
D L + +VDDKD IL+QDFFCTPDYITPV+QN ++ FDCN+ENI CP
Sbjct: 63 TDPQLQPSFGNPSIGDFDINVDDKDFILSQDFFCTPDYITPVDQNLLNSFDCNKENISCP 122
Query: 108 KSPEKLNTVKSKKLRQDGFLVNPLDPTSYDYQDTVDLAKDSFSTDEVQLTKTIGYTTQKT 167
+SPEKLNT+K+KKLR+DG NPL PT + Q +++ KD DEV + KT TQ++
Sbjct: 123 ESPEKLNTIKTKKLRRDGISSNPLSPTLSNQQHNLEIVKDFVGMDEVIIEKTTVPGTQRS 182
Query: 168 HNYVPQSAVALRCRVMPPPCIKNPYQKDASEMDIDRFG-NQWAKCAGLFPVITGGDGLSR 226
NYV QSAVALRCRVMPPPCIKNPY +ASE+++ F N C G F I GGDGLSR
Sbjct: 183 QNYVSQSAVALRCRVMPPPCIKNPYLVEASEVEVLEFSFNSIMLCTGFFSAIVGGDGLSR 242
Query: 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG 286
Y+TDFHEI+QIG GNFS VFKVLKRIDGC YAVK S R+LH DAERRKAL+EVQALAALG
Sbjct: 243 YHTDFHEIQQIGTGNFSRVFKVLKRIDGCLYAVKLSTRKLHQDAERRKALMEVQALAALG 302
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEK 346
H+NIVGYYSSWFENEQLYIQMELCD SLS K S+ F E +VL+ LHQIA+ALQFIHE+
Sbjct: 303 CHKNIVGYYSSWFENEQLYIQMELCDCSLSINKFSKPFTEAKVLEVLHQIAKALQFIHEQ 362
Query: 347 GIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVD 406
GIAHLDVKP+NIYVKNGVYKLGDFG ATLLN+SLPIEEGDARYMPQEILNE+Y HLDKVD
Sbjct: 363 GIAHLDVKPENIYVKNGVYKLGDFGCATLLNQSLPIEEGDARYMPQEILNENYSHLDKVD 422
Query: 407 IFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSA 466
IFSLGA +YELIKGSPL +SG QF NLR+GKL LLPGHSLQFQNLLK+MVDPDP+ RPSA
Sbjct: 423 IFSLGAAIYELIKGSPLPQSGSQFFNLREGKLLLLPGHSLQFQNLLKIMVDPDPLNRPSA 482
Query: 467 KELVENPIFDKIQKHRK 483
KE+VENPIF+K+Q++ +
Sbjct: 483 KEVVENPIFEKVQRNLR 499
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359479814|ref|XP_002268578.2| PREDICTED: wee1-like protein kinase-like [Vitis vinifera] gi|296086593|emb|CBI32228.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 684 bits (1764), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/467 (71%), Positives = 384/467 (82%), Gaps = 16/467 (3%)
Query: 18 MKGTLARHFQVQLGYSSSIQHQSFSSTSSSSRLQNHLESVSQDATLSAADVDDKDLILTQ 77
MKGTLARH VQLG SR QN LES S + A DVDDKD IL+Q
Sbjct: 1 MKGTLARHLTVQLG--------------QVSRCQNLLESESTVDNIDA-DVDDKDFILSQ 45
Query: 78 DFFCTPDYITPVNQNSMSGFDCNRENIPCPKSPEKLNTVKSKKLRQDGFLVNPLDPTSYD 137
DFFCTPDYITP QN ++G DCN++NIPCPKSPEKL T + K+ R+D L++ + T +D
Sbjct: 46 DFFCTPDYITPDGQNILNGLDCNKDNIPCPKSPEKLKTSRIKRKREDDTLLDSPNSTLFD 105
Query: 138 YQDTVDLAKDSFSTDEVQLTKTIGYTTQKTHNYVPQSAVALRCRVMPPPCIKNPYQKDAS 197
Q ++L KD+F TDEV++ K I +QK +YV QSAVALRCRVMPPPC+KNPY K+AS
Sbjct: 106 -QPILELEKDTFGTDEVKVEKAIVTGSQKNQSYVSQSAVALRCRVMPPPCLKNPYLKNAS 164
Query: 198 EMDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFY 257
E DID FGN+ +K +G FP + GGDGLSRY+TDFHEIEQIG GNFS VFKVLKRIDGC Y
Sbjct: 165 ETDIDPFGNRRSKYSGFFPALIGGDGLSRYHTDFHEIEQIGDGNFSRVFKVLKRIDGCMY 224
Query: 258 AVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSLSD 317
AVKHS R LH D ERRKAL+EVQALA LGSHENIVGYY+SWFENE+LYIQMELCDHSLS
Sbjct: 225 AVKHSTRPLHQDTERRKALMEVQALAVLGSHENIVGYYTSWFENEKLYIQMELCDHSLSI 284
Query: 318 KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLN 377
K++S F EGEVL+A+HQIA+ALQF HEKGIAHLDVKPDNIYVK+GVYKLGDFG ATLL+
Sbjct: 285 KRSSHLFTEGEVLEAMHQIAKALQFTHEKGIAHLDVKPDNIYVKDGVYKLGDFGCATLLD 344
Query: 378 KSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGK 437
+SLPI+EGDARYMPQEILN++YDHLDKVD+FSLGA +YELI+GS L ESG QFLNLR+GK
Sbjct: 345 RSLPIDEGDARYMPQEILNDNYDHLDKVDMFSLGAAIYELIRGSHLPESGYQFLNLREGK 404
Query: 438 LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKT 484
LPLLPG+SLQFQNLLK M+DPDPVQRPSAKELVENPIFD++Q++ KT
Sbjct: 405 LPLLPGYSLQFQNLLKAMLDPDPVQRPSAKELVENPIFDRLQRNAKT 451
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351728095|ref|NP_001237183.1| wee1 [Glycine max] gi|42362341|gb|AAS13373.1| wee1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1708), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/501 (67%), Positives = 384/501 (76%), Gaps = 23/501 (4%)
Query: 1 MKRSRKTQKKSKREESQMKGTL------ARHFQVQLGYSSSIQHQ-----SFSSTSSSSR 49
MK ++Q+ K+ +MKG L RH Q+QLG S I Q + +++S+ S
Sbjct: 1 MKGKSQSQRIGKKSR-KMKGALNTHTNTTRHLQLQLGQVSLIPLQQPSSTTATTSSAVSC 59
Query: 50 LQNHLESVSQDATLSAADV---------DDKDLILTQDFFCTPDYITPVNQNSMSGFDCN 100
QN L++ + +A+ S + DD+D IL+QDFFCTPDYITP NQN +GFDC+
Sbjct: 60 FQNLLDAEAPNASSSRVALIDNAAAAAADDRDCILSQDFFCTPDYITPDNQNVFNGFDCD 119
Query: 101 RENIPCPKSPEKLNTVKSKKLRQDGFLVNPLDPT-SYDYQDTVDLAKDSFSTDEVQLTKT 159
REN PCPKSPEKLNT KSK+ R D V+PL PT D+Q V+L KDS T+E+ L KT
Sbjct: 120 RENTPCPKSPEKLNTTKSKRCRPDAMSVHPLSPTFCSDHQPVVELGKDS-GTEELALEKT 178
Query: 160 IGYTTQKTHNYVPQSAVALRCRVMPPPCIKNPYQKDASEMDIDRFGNQWAKCAGLFPVIT 219
I K NYV SAVALRCRVMPPPC +NPY KD S+ D+D FGNQ KCAGLFP T
Sbjct: 179 IAPGKPKAQNYVSHSAVALRCRVMPPPCFRNPYLKDVSDKDLDPFGNQRLKCAGLFPAFT 238
Query: 220 GGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEV 279
GGDGLSRY DFHEIEQIG GNFS VFKVLKRIDGC YAVKHS R L + ER KAL+EV
Sbjct: 239 GGDGLSRYRADFHEIEQIGRGNFSSVFKVLKRIDGCLYAVKHSTRPLRLETERTKALMEV 298
Query: 280 QALAALGSHENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQA 339
QALAALG HENIVGYYSSWFENEQLYIQMELCDHSLS +K S F EG+VL AL Q+A A
Sbjct: 299 QALAALGLHENIVGYYSSWFENEQLYIQMELCDHSLSIRKYSALFTEGQVLDALFQVANA 358
Query: 340 LQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDY 399
LQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFG ATLL+ SLPIEEGDARYMPQEILNE+Y
Sbjct: 359 LQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGCATLLDSSLPIEEGDARYMPQEILNENY 418
Query: 400 DHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPD 459
DHLDKVDIFSLGA++YELI+ PL ESG QF NL++GK PLLPGHSLQ QNLLKVM+DPD
Sbjct: 419 DHLDKVDIFSLGASIYELIRRLPLPESGCQFFNLKEGKFPLLPGHSLQLQNLLKVMMDPD 478
Query: 460 PVQRPSAKELVENPIFDKIQK 480
PV+RPSAKEL+ENPIF +IQ+
Sbjct: 479 PVKRPSAKELIENPIFCRIQR 499
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449498453|ref|XP_004160541.1| PREDICTED: wee1-like protein kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 627 bits (1618), Expect = e-177, Method: Compositional matrix adjust.
Identities = 306/493 (62%), Positives = 377/493 (76%), Gaps = 13/493 (2%)
Query: 1 MKRSRKTQKKSK-REESQMKGTLARHFQVQLGYSSSIQHQSFSSTSSSSRLQNHLESVSQ 59
M+R KT + + +MKGT+ RH QVQLG S+ + +SSS+ L
Sbjct: 1 MRRKSKTLRTTMGARRKKMKGTVTRHLQVQLG-KVSLAPLHLNRSSSSALCFPSLPESEP 59
Query: 60 DATLSAAD--------VDDKDLILTQDFFCTPDYITPVNQNSMSGFDCNRENIPCPKSPE 111
+T++ +D +D+D IL+QDFFCTPDYITP NQN ++G D N+E IPCPKSPE
Sbjct: 60 PSTVNFSDPLPSSSHNFEDRDFILSQDFFCTPDYITPDNQNLLNGVDSNKECIPCPKSPE 119
Query: 112 KLNTVKSKKLRQDGFLVNPLDPTSYDYQDTVDLAKDSFSTDEVQLTKTIGYTTQKTHNYV 171
K+NTVK+K+ + LV PL P+ + V+L D F +D+V + K +K NYV
Sbjct: 120 KINTVKTKRKIHENVLVRPLSPSLSGCEQVVELGNDIFGSDDVDMEKETTAMPKK-ENYV 178
Query: 172 PQSAVALRCRVMPPPCIKNPYQKDASEMDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDF 231
QSAVALRCRVMPPPC+KNPY KDAS++ +D FGNQ KCAG FP + GDGLSRY+TDF
Sbjct: 179 SQSAVALRCRVMPPPCMKNPYLKDASDVGVDPFGNQRTKCAGFFPALFSGDGLSRYHTDF 238
Query: 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENI 291
HEI+ IG GNFS VFKVLKRIDGC YAVK S R L+ D ERR+AL+EVQALAALG+HENI
Sbjct: 239 HEIKLIGTGNFSRVFKVLKRIDGCLYAVKQSTRPLNQDTERRRALMEVQALAALGAHENI 298
Query: 292 VGYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
VGYY+SWFENEQLYIQMELCD SLS + S F+E + L+AL+QIA+AL F+HEKGIAHL
Sbjct: 299 VGYYTSWFENEQLYIQMELCDCSLSMGRYSHPFSEVDALRALYQIAKALLFVHEKGIAHL 358
Query: 352 DVKPDNIYVKNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLG 411
DVKPDNIY+K+GVYKLGDFG TLL+KSLPIEEGDARYMPQEILNE YD+LDKVDIFSLG
Sbjct: 359 DVKPDNIYIKDGVYKLGDFGCVTLLDKSLPIEEGDARYMPQEILNERYDYLDKVDIFSLG 418
Query: 412 ATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471
A +YE+++G L E+ F+NL++GKLPLLPGHSLQFQNL+K MVDPDP +RPSA+E++E
Sbjct: 419 AAIYEIVRGFTLPET--HFMNLKEGKLPLLPGHSLQFQNLIKAMVDPDPTRRPSAREVIE 476
Query: 472 NPIFDKIQKHRKT 484
NPIFDK++ H+++
Sbjct: 477 NPIFDKVRTHKQS 489
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449436531|ref|XP_004136046.1| PREDICTED: wee1-like protein kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 627 bits (1617), Expect = e-177, Method: Compositional matrix adjust.
Identities = 306/493 (62%), Positives = 377/493 (76%), Gaps = 13/493 (2%)
Query: 1 MKRSRKTQKKSK-REESQMKGTLARHFQVQLGYSSSIQHQSFSSTSSSSRLQNHLESVSQ 59
M+R KT + + +MKGT+ RH QVQLG S+ + +SSS+ L
Sbjct: 1 MRRKSKTLRTTMGARRKKMKGTVTRHLQVQLG-KVSLAPLHLNRSSSSALCFPSLPESEP 59
Query: 60 DATLSAAD--------VDDKDLILTQDFFCTPDYITPVNQNSMSGFDCNRENIPCPKSPE 111
+T++ +D +D+D IL+QDFFCTPDYITP NQN ++G D N+E IPCPKSPE
Sbjct: 60 PSTVNFSDPLPSSSHNFEDRDFILSQDFFCTPDYITPDNQNLLNGVDSNKECIPCPKSPE 119
Query: 112 KLNTVKSKKLRQDGFLVNPLDPTSYDYQDTVDLAKDSFSTDEVQLTKTIGYTTQKTHNYV 171
K+NTVK+K+ + LV PL P+ + V+L D F +D+V + K +K NYV
Sbjct: 120 KVNTVKTKRKIHENVLVRPLSPSLSGCEQVVELGNDIFGSDDVDMEKETTAMPKK-ENYV 178
Query: 172 PQSAVALRCRVMPPPCIKNPYQKDASEMDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDF 231
QSAVALRCRVMPPPC+KNPY KDAS++ +D FGNQ KCAG FP + GDGLSRY+TDF
Sbjct: 179 SQSAVALRCRVMPPPCMKNPYLKDASDVGVDPFGNQRTKCAGFFPALFSGDGLSRYHTDF 238
Query: 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENI 291
HEI+ IG GNFS VFKVLKRIDGC YAVK S R L+ D ERR+AL+EVQALAALG+HENI
Sbjct: 239 HEIKLIGTGNFSRVFKVLKRIDGCLYAVKQSTRPLNQDTERRRALMEVQALAALGAHENI 298
Query: 292 VGYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
VGYY+SWFENEQLYIQMELCD SLS + S F+E + L+AL+QIA+AL F+HEKGIAHL
Sbjct: 299 VGYYTSWFENEQLYIQMELCDCSLSMGRYSHPFSEVDALRALYQIAKALLFVHEKGIAHL 358
Query: 352 DVKPDNIYVKNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLG 411
DVKPDNIY+K+GVYKLGDFG TLL+KSLPIEEGDARYMPQEILNE YD+LDKVDIFSLG
Sbjct: 359 DVKPDNIYIKDGVYKLGDFGCVTLLDKSLPIEEGDARYMPQEILNERYDYLDKVDIFSLG 418
Query: 412 ATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471
A +YE+++G L E+ F+NL++GKLPLLPGHSLQFQNL+K MVDPDP +RPSA+E++E
Sbjct: 419 AAIYEIVRGFTLPET--HFMNLKEGKLPLLPGHSLQFQNLIKAMVDPDPSRRPSAREVIE 476
Query: 472 NPIFDKIQKHRKT 484
NPIFDK++ H+++
Sbjct: 477 NPIFDKVRTHKQS 489
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357511217|ref|XP_003625897.1| Wee1-like protein kinase [Medicago truncatula] gi|355500912|gb|AES82115.1| Wee1-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 622 bits (1605), Expect = e-176, Method: Compositional matrix adjust.
Identities = 307/490 (62%), Positives = 366/490 (74%), Gaps = 12/490 (2%)
Query: 4 SRKTQKKSKREESQMKGTLARHFQVQLGYSSSIQHQSFSSTSSSSRLQNHLESV------ 57
+RKT K R+++ + + R Q+QL S Q++ +T+ +S +H +++
Sbjct: 2 TRKTPKSRGRKKAPLGASNTRQLQLQLSKFSLKQYKPLPTTTITSSALSHFQNLIDSEAN 61
Query: 58 ---SQDATLSAADVDDKDLILTQDFFCTPDYITPVNQNSMSGFDCNRENIPCPKSPEKLN 114
S T A D D KD IL+QDFFCTPDYITP NQ ++G D N++N PCPKSPEKLN
Sbjct: 62 QNPSIRVTNDATDADSKDGILSQDFFCTPDYITPDNQRILNGVDFNKDNSPCPKSPEKLN 121
Query: 115 TVKSKKLRQDGFLVNPLDPT-SYDYQDTVDLAKDSFSTDEVQLTKTIGYTTQKTHNYVPQ 173
T KSK+ R DG NPL PT S D+Q V+L KDS + +EV + T+ K NYV
Sbjct: 122 TTKSKRCRLDGVSANPLSPTFSGDHQQVVELGKDSVA-EEVAVDITVAAGKPKAQNYVSH 180
Query: 174 SAVALRCRVMPPPCIKNPYQKDASEMDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDFHE 233
SA LRCR +PPPC NPY KD S+ + D + NQ +KCAG FP T DGLSRY TDFHE
Sbjct: 181 SAATLRCRAIPPPCFSNPYLKDLSQKETDPYANQRSKCAGFFPKFTAYDGLSRYRTDFHE 240
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
IEQIG G FS VFKVLKRIDGC YAVK S Q D ERRKAL+EVQALAALG HENIVG
Sbjct: 241 IEQIGRGYFSCVFKVLKRIDGCLYAVKRST-QFQLDTERRKALMEVQALAALGYHENIVG 299
Query: 294 YYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDV 353
YY+SWFENEQLYIQME+CDHSLS K S+ AEG+VL+ L+Q+A AL+FIH+KGIAHLD+
Sbjct: 300 YYTSWFENEQLYIQMEICDHSLSVNKGSELLAEGQVLEVLYQVANALRFIHDKGIAHLDL 359
Query: 354 KPDNIYVKNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGAT 413
KPDNIYVKNGVYKLGDFG ATL + SLPIEEGDARYMPQEILNE+YDHLDKVDIFSLG +
Sbjct: 360 KPDNIYVKNGVYKLGDFGCATLTDSSLPIEEGDARYMPQEILNENYDHLDKVDIFSLGVS 419
Query: 414 MYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENP 473
+Y+L++ SP+ ESG FLNL++GKLPLLPGHSLQFQNLLK M+DPDPV+RPSA+ELVENP
Sbjct: 420 IYQLVRKSPMPESGCHFLNLKEGKLPLLPGHSLQFQNLLKAMIDPDPVKRPSARELVENP 479
Query: 474 IFDKIQKHRK 483
IFD+ + K
Sbjct: 480 IFDRALRTAK 489
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224129646|ref|XP_002320637.1| hypothetical protein POPTRDRAFT_573439 [Populus trichocarpa] gi|222861410|gb|EEE98952.1| hypothetical protein POPTRDRAFT_573439 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1577), Expect = e-172, Method: Compositional matrix adjust.
Identities = 311/462 (67%), Positives = 359/462 (77%), Gaps = 14/462 (3%)
Query: 1 MKRS----RKTQKKSKREES----QMKGTLARHFQVQLGYSSSIQHQSFSSTSSSSRLQN 52
MKR+ R +K ++R ES +MK L H +Q G IQ S +S +SSSR QN
Sbjct: 1 MKRNTLTKRSYRKSNRRRESSSTAKMKRPLVSH--LQQGQHHQIQSSSSTSAASSSRFQN 58
Query: 53 HLESVSQDATLSAADVDDKDLILTQDFFCTPDYITPVNQNSMSGFDCNRENIPCPKSPEK 112
L+S D L A DVD++D IL+QDFFCTPDYITP NQN + DCN+ENI CPKSPEK
Sbjct: 59 LLDSELTDPQLVAEDVDERDFILSQDFFCTPDYITPDNQNLLCSSDCNKENIQCPKSPEK 118
Query: 113 LNTVKSKKLRQDGFLVNPLDPTSYDYQDTVDLAKDSFSTDEVQLTKTIGYTTQKTHNYVP 172
+NT K KKLRQ V+PL PT D Q VD+ KD+ +++E+ + KT +K NYV
Sbjct: 119 VNTAKIKKLRQ----VHPLSPTLSDQQQIVDIGKDNINSEEMMIEKTSTAEIKKPQNYVS 174
Query: 173 QSAVALRCRVMPPPCIKNPYQKDASEMDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDFH 232
QSAV LRCRVMPPPCIKNPY DASE+ ID FGNQ +KCA P GDGLSRY+ DFH
Sbjct: 175 QSAVYLRCRVMPPPCIKNPYLMDASEVGIDPFGNQRSKCAEFLPAFVHGDGLSRYHIDFH 234
Query: 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIV 292
EI+QIG GNFS FKVLKRIDGCFYAVKHS RQLH + ERRKAL+EVQALAALG HENIV
Sbjct: 235 EIQQIGTGNFSCAFKVLKRIDGCFYAVKHSTRQLHQEPERRKALMEVQALAALGCHENIV 294
Query: 293 GYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLD 352
GYYSSWFENEQLYIQMELCD SLS ++S+ EGE L+ L QIA+AL+FIHE+GIAHLD
Sbjct: 295 GYYSSWFENEQLYIQMELCDCSLSVNRSSKSLTEGEALQVLFQIAKALRFIHERGIAHLD 354
Query: 353 VKPDNIYVKNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGA 412
VKPDNIYVKNGVYKLGDFG ATLL++SLP+EEGDARYMPQEILNE+Y++LDKVDIFSLGA
Sbjct: 355 VKPDNIYVKNGVYKLGDFGCATLLDQSLPVEEGDARYMPQEILNENYNYLDKVDIFSLGA 414
Query: 413 TMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKV 454
+YELI+GS L +SG QF+NLR+GKLPLLPGHSLQ QNLLKV
Sbjct: 415 AIYELIRGSTLPQSGYQFMNLREGKLPLLPGHSLQLQNLLKV 456
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|209968968|emb|CAL64061.1| putative WEE1 kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1567), Expect = e-171, Method: Compositional matrix adjust.
Identities = 290/421 (68%), Positives = 347/421 (82%), Gaps = 9/421 (2%)
Query: 65 AADVDDKDLILTQDFFCTPDYITPVNQNSMSGFDCNREN-IPCPKSPEKLNTVKSKKLRQ 123
AAD D+KD IL+QDFFCTPDY+TP +G D N+++ +PCPKSPEKL TV K+ R
Sbjct: 90 AADGDNKDFILSQDFFCTPDYLTPDAPAICNGLDGNKDDCMPCPKSPEKLQTVARKRQR- 148
Query: 124 DGFLVNPLDPTSYDY---QDTVDLAKDSFSTDEVQLTKTIGYTTQKTHNYVPQSAVALRC 180
V S D+ Q D+ +D+F +DE + K ++K H+YV QSA+ALR
Sbjct: 149 --LAVKSATSLSSDFPGQQQLADIPEDAFGSDETKSEKIT--ESEKGHSYVSQSAIALRY 204
Query: 181 RVMPPPCIKNPYQKDASEMDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDFHEIEQIGAG 240
RVMPPPCI+NPY +DASE+D+D FGN+ +KCAG PVI G DGLSRY +DFHEIEQIG G
Sbjct: 205 RVMPPPCIRNPYLRDASEIDVDPFGNRRSKCAGFNPVIFGNDGLSRYRSDFHEIEQIGTG 264
Query: 241 NFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300
NFS VFKVLKRIDGC YAVKHS +QLH D +RRKAL+EVQALAALG HEN+VGYYSSWFE
Sbjct: 265 NFSRVFKVLKRIDGCMYAVKHSTKQLHQDTDRRKALMEVQALAALGPHENVVGYYSSWFE 324
Query: 301 NEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV 360
NE LYIQMELCDHSLS+KK S+ +E VL+A++Q+A+ALQ+IH++G+AHLDVKPDNIYV
Sbjct: 325 NEHLYIQMELCDHSLSNKKYSKLSSEVAVLEAMYQVAKALQYIHQRGVAHLDVKPDNIYV 384
Query: 361 KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKG 420
K+GVYKLGDFG ATLL+KS PIEEGDARYMPQEILNE+YDHLDKVD+FSLGA +YELI+G
Sbjct: 385 KSGVYKLGDFGCATLLDKSQPIEEGDARYMPQEILNENYDHLDKVDVFSLGAAIYELIRG 444
Query: 421 SPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
SPL ESGP FLNLR+GKLPLLPGHSLQFQNLLKVM+DPDP +RPSAK+LV+NPIF++ Q+
Sbjct: 445 SPLPESGPHFLNLREGKLPLLPGHSLQFQNLLKVMMDPDPTRRPSAKDLVDNPIFERCQR 504
Query: 481 H 481
+
Sbjct: 505 N 505
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|6056405|gb|AAF02869.1|AC009525_3 Similar to Wee1 protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 603 bits (1556), Expect = e-170, Method: Compositional matrix adjust.
Identities = 309/490 (63%), Positives = 368/490 (75%), Gaps = 14/490 (2%)
Query: 5 RKTQKKSKREESQ----MKGTLARHFQVQLGYSSSIQHQSF-SSTSSSSRLQNHLESVSQ 59
RKTQ K S+ M+GTL RH +Q G S I ++ SS +SS Q L+S S
Sbjct: 13 RKTQGTIKTRASKKIRKMEGTLERHSLLQFGQLSKISFENRPSSNVASSAFQGLLDSDSS 72
Query: 60 DAT--LSAADVD----DKDLILTQDFFCTPDYITPVNQNSMSGFDCNRENIPCPKSPEKL 113
+ L +AD D +KD IL+QDFFCTPDYITP NQN MSG D ++++ PCP+SP KL
Sbjct: 73 ELRNQLGSADSDANCGEKDFILSQDFFCTPDYITPDNQNLMSGLDISKDHSPCPRSPVKL 132
Query: 114 NTVKSKKLRQDGFLVNPLDPTSYDYQDTVDLAKDSFSTDEVQLTKTIGYTTQKTHNYVPQ 173
NTVKSK+ RQ+ F N + T + D TDEV K T++T YV Q
Sbjct: 133 NTVKSKRCRQESFTGNHSNSTWSSKHRVDEQENDDIDTDEVMGDKLQANQTERT-GYVSQ 191
Query: 174 SAVALRCRVMPPPCIKNPYQKDASEMDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDFHE 233
+AVALRCR MPPPC+KNPY + SE D FG+Q +KCA PV T GDGLSRY TDFHE
Sbjct: 192 AAVALRCRAMPPPCLKNPYVLNQSETATDPFGHQRSKCASFLPVSTSGDGLSRYLTDFHE 251
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
I QIGAG+FS VFKVLKR+DGC YAVKHS R+L+ D+ERRKA++EVQALAALG HENIVG
Sbjct: 252 IRQIGAGHFSRVFKVLKRMDGCLYAVKHSTRKLYLDSERRKAMMEVQALAALGFHENIVG 311
Query: 294 YYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
YYSSWFENEQLYIQ+ELCDHSLS KK+S +E E+L +HQIA+AL F+HEKGIAHL
Sbjct: 312 YYSSWFENEQLYIQLELCDHSLSALPKKSSLKVSEREILVIMHQIAKALHFVHEKGIAHL 371
Query: 352 DVKPDNIYVKNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLG 411
DVKPDNIY+KNGV KLGDFG AT L+KSLP+EEGDARYMPQEILNEDY+HLDKVDIFSLG
Sbjct: 372 DVKPDNIYIKNGVCKLGDFGCATRLDKSLPVEEGDARYMPQEILNEDYEHLDKVDIFSLG 431
Query: 412 ATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471
T+YELIKGSPL+ES Q LN+++GKLPLLPGHSLQ Q LLK M+D DP +RPSA+EL++
Sbjct: 432 VTVYELIKGSPLTESRNQSLNIKEGKLPLLPGHSLQLQQLLKTMMDRDPKRRPSARELLD 491
Query: 472 NPIFDKIQKH 481
+P+FD+I+ H
Sbjct: 492 HPMFDRIRGH 501
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128526|ref|XP_002320354.1| hypothetical protein POPTRDRAFT_572724 [Populus trichocarpa] gi|222861127|gb|EEE98669.1| hypothetical protein POPTRDRAFT_572724 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 603 bits (1555), Expect = e-170, Method: Compositional matrix adjust.
Identities = 304/437 (69%), Positives = 345/437 (78%), Gaps = 8/437 (1%)
Query: 19 KGTLARHFQVQLGYSSSIQHQSFSSTSSSSRLQNHLESVSQDATLSAADVDDKDLILTQD 78
KGTL H Q + + ++ +SSSR QN L+S D L A DVD+KD IL+QD
Sbjct: 3 KGTLITHSQQVQHHQIQSSSATSAAAASSSRFQNVLDSDLIDPQLLAEDVDEKDFILSQD 62
Query: 79 FFCTPDYITPVNQNSMSGFDCNRENIPCPKSPEKLNTVKSKKLRQDGFLVNPLDPTSYDY 138
FFCTPDYITP NQN + FDCN+ENIPCPKSPEK+NTV SKKLRQ V+PL PT D
Sbjct: 63 FFCTPDYITPDNQNLLYSFDCNKENIPCPKSPEKVNTVISKKLRQ----VHPLSPTLSDQ 118
Query: 139 QDTVDLAKDSFSTDEVQLTKTIGYTTQKTHNYVPQSAVALRCRVMPPPCIKNPYQKDASE 198
Q VD+ KD+ S +E+ + K T+K NYV QSAV LRCRVMPPPCIKNPY DASE
Sbjct: 119 QPIVDIGKDNISAEEMLIEKPSTLETKKPQNYVSQSAVFLRCRVMPPPCIKNPYLTDASE 178
Query: 199 MDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYA 258
+ ID FGNQ +KCA GGDGLSRY+TDFHEI+QIG GNFS VFKVLKRIDGC YA
Sbjct: 179 VGIDPFGNQRSKCAAF----AGGDGLSRYHTDFHEIQQIGTGNFSCVFKVLKRIDGCLYA 234
Query: 259 VKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSLSDK 318
VKHS RQLH DAERRKAL+EVQALAALG HENIVGYYSSWFENEQLYIQMELCD SLS
Sbjct: 235 VKHSTRQLHQDAERRKALMEVQALAALGYHENIVGYYSSWFENEQLYIQMELCDGSLSIN 294
Query: 319 KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNK 378
++S+ EGE L+ L QIA+AL+FIHE+GIAHLDVKPDNIY KNGVYKLGDFG ATLL++
Sbjct: 295 RSSESITEGEALQVLLQIAKALKFIHERGIAHLDVKPDNIYFKNGVYKLGDFGCATLLDQ 354
Query: 379 SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKL 438
SLP+EEGDARYMPQEILNE+Y++LDKVDIFSLGA +YELI+GS L +SG NLR+GKL
Sbjct: 355 SLPVEEGDARYMPQEILNENYNYLDKVDIFSLGAAIYELIRGSTLPQSGSHLFNLREGKL 414
Query: 439 PLLPGHSLQFQNLLKVM 455
PLLPGHSLQ QNLLKV+
Sbjct: 415 PLLPGHSLQLQNLLKVL 431
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 488 | ||||||
| TAIR|locus:2024780 | 500 | WEE1 "WEE1 kinase homolog" [Ar | 0.942 | 0.92 | 0.631 | 3.2e-152 | |
| UNIPROTKB|A7E332 | 422 | WEE1 "Uncharacterized protein" | 0.293 | 0.338 | 0.422 | 2.6e-53 | |
| UNIPROTKB|E2RIU0 | 665 | WEE1 "Uncharacterized protein" | 0.293 | 0.215 | 0.422 | 2e-50 | |
| RGD|1307895 | 646 | Wee1 "wee 1 homolog (S. pombe) | 0.370 | 0.280 | 0.378 | 3.4e-50 | |
| UNIPROTKB|A7MBC3 | 646 | WEE1 "Uncharacterized protein" | 0.293 | 0.221 | 0.422 | 4.2e-50 | |
| UNIPROTKB|F1S6U8 | 646 | WEE1 "Uncharacterized protein" | 0.293 | 0.221 | 0.422 | 7.1e-50 | |
| UNIPROTKB|P30291 | 646 | WEE1 "Wee1-like protein kinase | 0.293 | 0.221 | 0.422 | 1.4e-49 | |
| ZFIN|ZDB-GENE-030131-5682 | 532 | wee2 "WEE1 homolog 2 (S. pombe | 0.280 | 0.257 | 0.426 | 5e-49 | |
| FB|FBgn0011737 | 609 | wee "wee" [Drosophila melanoga | 0.241 | 0.193 | 0.453 | 8.5e-49 | |
| MGI|MGI:103075 | 646 | Wee1 "WEE 1 homolog 1 (S. pomb | 0.370 | 0.280 | 0.373 | 2.1e-48 |
| TAIR|locus:2024780 WEE1 "WEE1 kinase homolog" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1485 (527.8 bits), Expect = 3.2e-152, P = 3.2e-152
Identities = 298/472 (63%), Positives = 355/472 (75%)
Query: 18 MKGTLARHFQVQLGYXXXXXXXXX-XXXXXXXRLQNHLESVSQDAT--LSAADVD----D 70
M+GTL RH +Q G Q L+S S + L +AD D +
Sbjct: 30 MEGTLERHSLLQFGQLSKISFENRPSSNVASSAFQGLLDSDSSELRNQLGSADSDANCGE 89
Query: 71 KDLILTQDFFCTPDYITPVNQNSMSGFDCNRENIPCPKSPEKLNTVKSKKLRQDGFLVNP 130
KD IL+QDFFCTPDYITP NQN MSG D ++++ PCP+SP KLNTVKSK+ RQ+ F N
Sbjct: 90 KDFILSQDFFCTPDYITPDNQNLMSGLDISKDHSPCPRSPVKLNTVKSKRCRQESFTGNH 149
Query: 131 LDPTSYDYQDTVDLAK-DSFSTDEVQLTKTIGYTTQKTHNYVPQSAVALRCRVMPPPCIK 189
+ T + + VD + D TDEV K T++T YV Q+AVALRCR MPPPC+K
Sbjct: 150 SNST-WSSKHRVDEQENDDIDTDEVMGDKLQANQTERT-GYVSQAAVALRCRAMPPPCLK 207
Query: 190 NPYQKDASEMDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVL 249
NPY + SE D FG+Q +KCA PV T GDGLSRY TDFHEI QIGAG+FS VFKVL
Sbjct: 208 NPYVLNQSETATDPFGHQRSKCASFLPVSTSGDGLSRYLTDFHEIRQIGAGHFSRVFKVL 267
Query: 250 KRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309
KR+DGC YAVKHS R+L+ D+ERRKA++EVQALAALG HENIVGYYSSWFENEQLYIQ+E
Sbjct: 268 KRMDGCLYAVKHSTRKLYLDSERRKAMMEVQALAALGFHENIVGYYSSWFENEQLYIQLE 327
Query: 310 LCDHSLS--DKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKL 367
LCDHSLS KK+S +E E+L +HQIA+AL F+HEKGIAHLDVKPDNIY+KNGV KL
Sbjct: 328 LCDHSLSALPKKSSLKVSEREILVIMHQIAKALHFVHEKGIAHLDVKPDNIYIKNGVCKL 387
Query: 368 GDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESG 427
GDFG AT L+KSLP+EEGDARYMPQEILNEDY+HLDKVDIFSLG T+YELIKGSPL+ES
Sbjct: 388 GDFGCATRLDKSLPVEEGDARYMPQEILNEDYEHLDKVDIFSLGVTVYELIKGSPLTESR 447
Query: 428 PQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479
Q LN+++GKLPLLPGHSLQ Q LLK M+D DP +RPSA+EL+++P+FD+I+
Sbjct: 448 NQSLNIKEGKLPLLPGHSLQLQQLLKTMMDRDPKRRPSARELLDHPMFDRIR 499
|
|
| UNIPROTKB|A7E332 WEE1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 331 (121.6 bits), Expect = 2.6e-53, Sum P(2) = 2.6e-53
Identities = 63/149 (42%), Positives = 96/149 (64%)
Query: 218 ITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL 277
IT + SRY T+FHE+E+IG+G F VFK +KR+DGC YA+K SK+ L + + AL
Sbjct: 72 ITESNMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCVYAIKRSKKPLAGSVDEQNALR 131
Query: 278 EVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSDK-----KASQFFAEGEVLK 331
EV A A LG H ++V Y+S+W E++ + IQ E C+ SL+D ++ +F E E+
Sbjct: 132 EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRSMSYFTEAELKD 191
Query: 332 ALHQIAQALQFIHEKGIAHLDVKPDNIYV 360
L Q+ + L++IH + H+D+KP NI++
Sbjct: 192 LLLQVGRGLRYIHSMSLVHMDIKPSNIFI 220
|
|
| UNIPROTKB|E2RIU0 WEE1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 332 (121.9 bits), Expect = 2.0e-50, Sum P(2) = 2.0e-50
Identities = 63/149 (42%), Positives = 96/149 (64%)
Query: 218 ITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL 277
IT + SRY T+FHE+E+IG+G F VFK +KR+DGC YA+K SK+ L + + AL
Sbjct: 287 ITESNMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR 346
Query: 278 EVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSDK-----KASQFFAEGEVLK 331
EV A A LG H ++V Y+S+W E++ + IQ E C+ SL+D ++ +F E E+
Sbjct: 347 EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRSMSYFTEAELKD 406
Query: 332 ALHQIAQALQFIHEKGIAHLDVKPDNIYV 360
L Q+ + L++IH + H+D+KP NI++
Sbjct: 407 LLLQVGRGLRYIHSMSLVHMDIKPSNIFI 435
|
|
| RGD|1307895 Wee1 "wee 1 homolog (S. pombe)" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 332 (121.9 bits), Expect = 3.4e-50, Sum P(2) = 3.4e-50
Identities = 73/193 (37%), Positives = 110/193 (56%)
Query: 189 KNPYQKDASE-MDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFK 247
K Y D+SE M+ + + IT + SRY T+FHE+E+IG+G F VFK
Sbjct: 255 KRAYFNDSSEDMEASDYEFEDETRPAKRITITESNMKSRYTTEFHELEKIGSGEFGSVFK 314
Query: 248 VLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307
+KR+DGC YA+K SK+ L + + AL EV A A LG H ++V Y+S+W E++ + IQ
Sbjct: 315 CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHPHVVRYFSAWAEDDHMLIQ 374
Query: 308 MELCDH-SLSDK-----KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK 361
E C+ SL+D + +F E E+ L Q+ + L++IH + H+D+KP NI++
Sbjct: 375 NEYCNGGSLADAVSENYRVMSYFTEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFIS 434
Query: 362 -----NGVYKLGD 369
N V + GD
Sbjct: 435 RTSIPNAVSEEGD 447
|
|
| UNIPROTKB|A7MBC3 WEE1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 331 (121.6 bits), Expect = 4.2e-50, Sum P(2) = 4.2e-50
Identities = 63/149 (42%), Positives = 96/149 (64%)
Query: 218 ITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL 277
IT + SRY T+FHE+E+IG+G F VFK +KR+DGC YA+K SK+ L + + AL
Sbjct: 286 ITESNMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCVYAIKRSKKPLAGSVDEQNALR 345
Query: 278 EVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSDK-----KASQFFAEGEVLK 331
EV A A LG H ++V Y+S+W E++ + IQ E C+ SL+D ++ +F E E+
Sbjct: 346 EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRSMSYFTEAELKD 405
Query: 332 ALHQIAQALQFIHEKGIAHLDVKPDNIYV 360
L Q+ + L++IH + H+D+KP NI++
Sbjct: 406 LLLQVGRGLRYIHSMSLVHMDIKPSNIFI 434
|
|
| UNIPROTKB|F1S6U8 WEE1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 330 (121.2 bits), Expect = 7.1e-50, Sum P(2) = 7.1e-50
Identities = 63/149 (42%), Positives = 95/149 (63%)
Query: 218 ITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL 277
IT + SRY T+FHE+E+IG+G F VFK +KR+DGC YA+K SK+ L + + AL
Sbjct: 286 ITESNMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR 345
Query: 278 EVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSDK-----KASQFFAEGEVLK 331
EV A A LG H ++V Y+S+W E++ + IQ E C+ SL+D + +F E E+
Sbjct: 346 EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRRMSYFTEAELKD 405
Query: 332 ALHQIAQALQFIHEKGIAHLDVKPDNIYV 360
L Q+ + L++IH + H+D+KP NI++
Sbjct: 406 LLLQVGRGLRYIHSMSLVHMDIKPSNIFI 434
|
|
| UNIPROTKB|P30291 WEE1 "Wee1-like protein kinase" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 329 (120.9 bits), Expect = 1.4e-49, Sum P(2) = 1.4e-49
Identities = 63/149 (42%), Positives = 95/149 (63%)
Query: 218 ITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL 277
IT + SRY T+FHE+E+IG+G F VFK +KR+DGC YA+K SK+ L + + AL
Sbjct: 286 ITESNMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR 345
Query: 278 EVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSDK-----KASQFFAEGEVLK 331
EV A A LG H ++V Y+S+W E++ + IQ E C+ SL+D + +F E E+
Sbjct: 346 EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 405
Query: 332 ALHQIAQALQFIHEKGIAHLDVKPDNIYV 360
L Q+ + L++IH + H+D+KP NI++
Sbjct: 406 LLLQVGRGLRYIHSMSLVHMDIKPSNIFI 434
|
|
| ZFIN|ZDB-GENE-030131-5682 wee2 "WEE1 homolog 2 (S. pombe)" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 311 (114.5 bits), Expect = 5.0e-49, Sum P(2) = 5.0e-49
Identities = 61/143 (42%), Positives = 91/143 (63%)
Query: 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALA 283
LSRY ++F E+ IG G F V++ +KR+DGC YA+K S+R + A + AL EV A A
Sbjct: 181 LSRYESEFLELACIGVGEFGSVYRCVKRLDGCMYAIKRSRRPIAGSANEQLALKEVYAHA 240
Query: 284 ALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSD-----KKASQFFAEGEVLKALHQIA 337
LG H ++V YYS+W E++ + IQ E CD SL D ++ +FF+ E+ L Q++
Sbjct: 241 VLGHHPHVVRYYSAWAEDDHMIIQNEYCDGGSLHDAITEKREQGEFFSVPELRDLLLQVS 300
Query: 338 QALQFIHEKGIAHLDVKPDNIYV 360
L++IH G+ HLD+KP NI++
Sbjct: 301 MGLKYIHNSGLVHLDIKPSNIFI 323
|
|
| FB|FBgn0011737 wee "wee" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 291 (107.5 bits), Expect = 8.5e-49, Sum P(2) = 8.5e-49
Identities = 54/119 (45%), Positives = 79/119 (66%)
Query: 365 YKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLS 424
YK+GD G T + + +EEGD RY+P+EIL+EDY +L K DIFSLG T++E G PL
Sbjct: 408 YKIGDLGHVTSVKEPY-VEEGDCRYLPKEILHEDYSNLFKADIFSLGITLFEAAGGGPLP 466
Query: 425 ESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRK 483
++GP++ NLRDGK+P+LP S F L+ M+ P P +RP+++ + +PI + K
Sbjct: 467 KNGPEWHNLRDGKVPILPSLSRDFNELIAQMMHPYPDKRPTSQSIFSHPILSAVDSKSK 525
|
|
| MGI|MGI:103075 Wee1 "WEE 1 homolog 1 (S. pombe)" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 323 (118.8 bits), Expect = 2.1e-48, Sum P(2) = 2.1e-48
Identities = 72/193 (37%), Positives = 109/193 (56%)
Query: 189 KNPYQKDASE-MDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFK 247
K Y D+SE M+ + + IT + SRY T+FHE+E+IG+G F VFK
Sbjct: 255 KRAYFNDSSEDMEASDYEFEDETRPAKRITITESNMKSRYTTEFHELEKIGSGEFGSVFK 314
Query: 248 VLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307
+KR+DGC YA+K SK+ L + + AL EV A A LG H ++V Y+S+W E++ + IQ
Sbjct: 315 CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHPHVVRYFSAWAEDDHMLIQ 374
Query: 308 MELCDH-SLSDK-----KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK 361
E C+ SL+D + + E E+ L Q+ + L++IH + H+D+KP NI++
Sbjct: 375 NEYCNGGSLADAISENYRVMSYLTEVELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFIS 434
Query: 362 -----NGVYKLGD 369
N V + GD
Sbjct: 435 RTSIPNAVSEEGD 447
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8L4H0 | WEE1_ARATH | 2, ., 7, ., 1, 0, ., 2 | 0.6311 | 0.9713 | 0.948 | yes | no |
| Q6Z829 | WEE1_ORYSJ | 2, ., 7, ., 1, 0, ., 2 | 0.6148 | 0.8278 | 0.7769 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 488 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-55 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-50 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-49 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-45 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-38 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-36 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-32 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-32 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-30 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-29 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-28 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-24 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-22 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-22 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-21 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-21 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-21 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-20 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-09 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.001 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.002 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 0.002 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 3e-55
Identities = 82/261 (31%), Positives = 131/261 (50%), Gaps = 17/261 (6%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ + ++G+G+F V+K + G AVK K++ + + A E++ L L SH N
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59
Query: 291 IVGYYSSWFENEQLYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGI 348
IV ++ + + LY+ ME C+ L D +E E K QI + L+++H GI
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 349 AHLDVKPDNI-YVKNGVYKLGDFGRATLLNKS---LPIEEGDARYMPQEILNEDYDHLDK 404
H D+KP+NI +NGV K+ DFG A L KS L G YM E+L + K
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 405 VDIFSLGATMYELIKGSPLSESGPQ------FLNLRDGKL----PLLPGHSLQFQNLLKV 454
VD++SLG +YEL+ G P + L P S + ++L+K
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239
Query: 455 MVDPDPVQRPSAKELVENPIF 475
++ DP +RP+A+E++++P F
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 1e-51
Identities = 82/258 (31%), Positives = 131/258 (50%), Gaps = 17/258 (6%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ +E++G G+F V+ + G A+K K++ +R + L E++ L L H N
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK-KIKKDRERILREIKILKKLK-HPN 58
Query: 291 IVGYYSSWFENEQLYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGI 348
IV Y + + ++LY+ ME C+ L D K +E E L QI AL+++H KGI
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 349 AHLDVKPDNI-YVKNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEILNED-YDHLDK 404
H D+KP+NI ++G KL DFG A L+ + G YM E+L Y
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGK--A 176
Query: 405 VDIFSLGATMYELIKGSPL----SESGPQFLNLRDGKLPLLPGH---SLQFQNLLKVMVD 457
VDI+SLG +YEL+ G P + F + K P P S + ++L++ ++
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236
Query: 458 PDPVQRPSAKELVENPIF 475
DP +R +A+E +++P F
Sbjct: 237 KDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 1e-50
Identities = 76/245 (31%), Positives = 119/245 (48%), Gaps = 38/245 (15%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYS 296
+G G F V+ + G A+K K++ + L E++ L L +H NIV Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKL-NHPNIVKLYG 58
Query: 297 SWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDV 353
+ + LY+ ME C+ SL D K+ +E E+L+ L QI + L+++H GI H D+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 354 KPDNIYVK--NGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEILNEDYDHLDKVDIF 408
KP+NI + NG KL DFG + LL + + G YM E+L + +K DI+
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178
Query: 409 SLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKE 468
SLG +YEL + ++L++ M+ DP +RPSAKE
Sbjct: 179 SLGVILYELP----------------------------ELKDLIRKMLQKDPEKRPSAKE 210
Query: 469 LVENP 473
++E+
Sbjct: 211 ILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 4e-49
Identities = 85/261 (32%), Positives = 140/261 (53%), Gaps = 18/261 (6%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+ I+QIG G+F V+ V ++ DG Y +K + ER AL EV+ L L +H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59
Query: 290 NIVGYYSSWFENEQLYIQMELCD------HSLSDKKASQFFAEGEVLKALHQIAQALQFI 343
NI+ YY S+ E +L I ME D KK + F E ++L Q+ AL+++
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEIL-NED 398
H + I H D+KP NI++ NG+ KLGDFG + +L+ ++ + + G Y+ E+ N+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP 179
Query: 399 YDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKLPLLPGH-SLQFQNLLKV 454
Y++ K DI+SLG +YEL E+ + L + G+ P +P S + +NL+
Sbjct: 180 YNY--KSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSS 237
Query: 455 MVDPDPVQRPSAKELVENPIF 475
++ DP +RPS +++++P
Sbjct: 238 LLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 8e-45
Identities = 83/260 (31%), Positives = 132/260 (50%), Gaps = 24/260 (9%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH--DAERRKALLEVQALAALGS 287
F +E+IG G F V+K + G A+K + ++ K + E+Q L
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIK----VIKLESKEKKEKIINEIQILKKC-K 55
Query: 288 HENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIH 344
H NIV YY S+ + ++L+I ME C SL D K +Q E ++ ++ + L+++H
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 345 EKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE--GDARYM-PQEILNEDYD 400
GI H D+K NI + +G KL DFG + L+ + G +M P+ I + YD
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 401 HLDKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGKLPLLPG---HSLQFQNLLK 453
+ K DI+SLG T EL +G P SE P F +G P L S +F++ LK
Sbjct: 176 Y--KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG-PPGLRNPEKWSDEFKDFLK 232
Query: 454 VMVDPDPVQRPSAKELVENP 473
+ +P +RP+A++L+++P
Sbjct: 233 KCLQKNPEKRPTAEQLLKHP 252
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 91/272 (33%), Positives = 131/272 (48%), Gaps = 35/272 (12%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD--AERRKALL--EVQALAAL 285
D+ +E IG G+F V KV ++ DG K ++ + E+ K L EV L L
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWK----EIDYGNMTEKEKQQLVSEVNILREL 56
Query: 286 GSHENIVGYYSSWF--ENEQLYIQMELCDH-SLSD-----KKASQFFAEGEVLKALHQIA 337
H NIV YY N+ LYI ME C+ L+ KK ++ E + + L Q+
Sbjct: 57 -KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115
Query: 338 QALQFIHEKG-----IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDAR 388
AL H + + H D+KP NI++ N KLGDFG A +L + G
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY 175
Query: 389 YMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL----RDGKLPLLPG 443
YM E LN YD +K DI+SLG +YEL SP L L ++GK +P
Sbjct: 176 YMSPEQLNHMSYD--EKSDIWSLGCLIYELCALSPPFT-ARNQLQLASKIKEGKFRRIPY 232
Query: 444 H-SLQFQNLLKVMVDPDPVQRPSAKELVENPI 474
S + ++K M++ DP +RPS +EL++ P+
Sbjct: 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 3e-38
Identities = 91/261 (34%), Positives = 129/261 (49%), Gaps = 26/261 (9%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERR-KALL-EVQALAALGSHENIV 292
E +G G+F V+ L + G AVK + L D+E +AL E++ L++L H NIV
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVE--LSGDSEEELEALEREIRILSSL-QHPNIV 62
Query: 293 GYYSSWFENEQ--LYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKG 347
YY S + E+ L I +E SLS KK + E + K QI + L ++H G
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKL-PEPVIRKYTRQILEGLAYLHSNG 121
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE-----GDARYMPQE-ILNEDYD 400
I H D+K NI V +GV KL DFG A L E G +M E I E+Y
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 401 HLDKVDIFSLGATMYELIKGS-PLSESGPQFLNL----RDGKLPLLPGH-SLQFQNLLKV 454
DI+SLG T+ E+ G P SE G L G+ P +P H S + ++ L+
Sbjct: 182 R--AADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239
Query: 455 MVDPDPVQRPSAKELVENPIF 475
+ DP +RP+A EL+++P
Sbjct: 240 CLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 77/259 (29%), Positives = 130/259 (50%), Gaps = 20/259 (7%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
DF ++++G G++ V+KV + D FYA+K ER A+ E++ LA++ +H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHP 59
Query: 290 NIVGYYSSWFENEQLYIQMELCDHSLSD--------KKASQFFAEGEVLKALHQIAQALQ 341
NI+ Y ++ + +L I ME D KK + E E+ + Q+ + LQ
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAP--FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 342 FIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP-IEEGDARYMPQEIL-NED 398
+HE+ I H D+K NI + N + K+GD G + +L K++ + G YM E+
Sbjct: 118 ALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRP 177
Query: 399 YDHLDKVDIFSLGATMYELIKGS-PLSESGPQFLNLR--DGKLPLLPG-HSLQFQNLLKV 454
Y + K DI+SLG +YE+ + P Q L + GK P +P +S QN ++
Sbjct: 178 YSY--KSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS 235
Query: 455 MVDPDPVQRPSAKELVENP 473
M+ P RP+ +++ +P
Sbjct: 236 MLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 9e-36
Identities = 79/262 (30%), Positives = 128/262 (48%), Gaps = 22/262 (8%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSHE 289
+ +E+IG G V+K R G A+K ++ + ++ ++ E+ + H
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIK----KMRLRKQNKELIINEILIMKDC-KHP 75
Query: 290 NIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEK 346
NIV YY S+ ++L++ ME D SL+D + E ++ ++ Q L+++H +
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQE-ILNEDYDH 401
+ H D+K DNI + K+G KL DFG A L K G +M E I +DY
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 402 LDKVDIFSLGATMYELIKGSP--LSESGPQFLNL-RDGKLPLLP-GHSL--QFQNLLKVM 455
KVDI+SLG E+ +G P L E + L L +P L +F++ L
Sbjct: 196 --KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKC 253
Query: 456 VDPDPVQRPSAKELVENPIFDK 477
+ DP +RPSA+EL+++P K
Sbjct: 254 LVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 81/282 (28%), Positives = 128/282 (45%), Gaps = 43/282 (15%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
+ +IG G FS V K R G +YA+K K + E+ L E+QAL L H NI+
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 294 YYSSWFENE--QLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIA 349
F+ + +L + EL D +L + K + E V ++Q+ ++L +H GI
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF 122
Query: 350 HLDVKPDNIYVKNGVYKLGDFGRATLLNKSLPIEEGDAR--YMPQEILNED--YDHLDKV 405
H D+KP+NI +K+ + KL DFG + P E + Y E L D Y K+
Sbjct: 123 HRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGP--KM 180
Query: 406 DIFSLGATMYEL---------------------IKGSPLSESGPQFLNLRD--------- 435
DI+++G +E+ + G+P +E +F R
Sbjct: 181 DIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKK 240
Query: 436 --GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
G LLP S + +LLK ++ DP +R +AK+ + +P F
Sbjct: 241 GTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 82/256 (32%), Positives = 125/256 (48%), Gaps = 12/256 (4%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
++ + IG G F V+K L G F A+K + + + + E+ L L H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHP 59
Query: 290 NIVGYYSSWFENEQLYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKG 347
NIV Y S ++ LYI +E ++ SL K F E V ++Q+ Q L ++HE+G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEILNEDYDHLD 403
+ H D+K NI K+GV KL DFG AT LN + G +M E++
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS-GAST 178
Query: 404 KVDIFSLGATMYELIKGSP----LSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPD 459
DI+SLG T+ EL+ G+P L+ F ++D PL G S + ++ L D
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD 238
Query: 460 PVQRPSAKELVENPIF 475
P RP+AK+L+++P
Sbjct: 239 PNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 83/268 (30%), Positives = 129/268 (48%), Gaps = 22/268 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSH 288
D ++ +G G+ V+KV + G YA+K K + D E RK LL E++ L +
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALK--KIHVDGDEEFRKQLLRELKTLRS-CES 58
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSD-KKASQFFAEGEVLKALHQIAQALQFIH-E 345
+V Y ++++ ++ I +E D SL+D K E + QI + L ++H +
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIE---EGDARYM-PQEILNEDYD 400
+ I H D+KP N+ + G K+ DFG + +L +L G YM P+ I E Y
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYS 178
Query: 401 HLDKVDIFSLGATMYELIKGS-PLSESG-PQFLNLR----DGKLPLLP--GHSLQFQNLL 452
+ DI+SLG T+ E G P G P F L DG P LP S +F++ +
Sbjct: 179 Y--AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236
Query: 453 KVMVDPDPVQRPSAKELVENPIFDKIQK 480
+ DP +RPSA EL+++P K
Sbjct: 237 SACLQKDPKKRPSAAELLQHPFIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 7e-32
Identities = 82/260 (31%), Positives = 121/260 (46%), Gaps = 28/260 (10%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL----EVQALAALGSHENIV 292
IG G F V+ + G AVK + Q K + E++ L L H N+V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQ----DNDPKTIKEIADEMKVLELL-KHPNLV 62
Query: 293 GYYSSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKAL-HQIAQALQFIHEKGIAH 350
YY E++YI ME C +L + + V++ Q+ + L ++H GI H
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 351 LDVKPDNIY-VKNGVYKLGDFGRATLL--NKSLPIEE-----GDARYM-PQEILNEDYD- 400
D+KP NI+ NGV KLGDFG A L N + EE G YM P+ I
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 401 HLDKVDIFSLGATMYELIKGS-PLSESGPQF---LNLRDGKLPLLPGH---SLQFQNLLK 453
H DI+SLG + E+ G P SE +F ++ G P +P S + ++ L
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLD 242
Query: 454 VMVDPDPVQRPSAKELVENP 473
++ DP +RP+A EL+++P
Sbjct: 243 RCLESDPKKRPTASELLQHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 79/257 (30%), Positives = 127/257 (49%), Gaps = 16/257 (6%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ ++++IG G+F V + DG Y +K ER ++ EV L+ + H N
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPN 60
Query: 291 IVGYYSSWFENEQLYIQMELCD----HSLSDKKASQFFAEGEVLKALHQIAQALQFIHEK 346
IV Y S+ EN LYI M+ C+ + + + F E ++L QI AL+ +H++
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEIL-NEDYDH 401
I H D+K NI++ K+G KLGDFG A +LN ++ + G Y+ EI N Y+
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYN- 179
Query: 402 LDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGH-SLQFQNLLKVMVD 457
+K DI++LG +YE+ E+G L + G P + H S +NL+ +
Sbjct: 180 -NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK 238
Query: 458 PDPVQRPSAKELVENPI 474
+P RPS ++E
Sbjct: 239 RNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 85/271 (31%), Positives = 134/271 (49%), Gaps = 30/271 (11%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-----HSKRQLHHDAERRKALLEVQALAAL 285
F +E IG G+F V+K + + A+K ++ ++ D ++ E+Q L+
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQ-----EIQFLSQC 56
Query: 286 GSHENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIH 344
S I YY S+ + +L+I ME C S D E + L ++ L+++H
Sbjct: 57 RS-PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYM-PQEILNEDY 399
E+G H D+K NI + + G KL DFG + L ++ G +M P+ I Y
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 400 DHLDKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGKLPLLPGH--SLQFQNLLK 453
D K DI+SLG T EL KG PLS+ P FL + P L G+ S F++ +
Sbjct: 176 DE--KADIWSLGITAIELAKGEPPLSDLHPMRVLFL-IPKNNPPSLEGNKFSKPFKDFVS 232
Query: 454 VMVDPDPVQRPSAKELVENPIFDKIQKHRKT 484
+ ++ DP +RPSAKEL+++ I+K +KT
Sbjct: 233 LCLNKDPKERPSAKELLKHKF---IKKAKKT 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-30
Identities = 78/256 (30%), Positives = 121/256 (47%), Gaps = 14/256 (5%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
DF + +IG G+F VFKV+++ D YA+K + ER +A+ E + LA L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSS 59
Query: 290 NIVGYYSSWFENEQLYIQMELCD----HSLSDKKASQFFAEGEVLKALHQIAQALQFIHE 345
I+ YY S+ + +L I ME + H L + + E +V + QI L +H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 346 KGIAHLDVKPDNIYVKNGV-YKLGDFGRATLLNKSLPIEE---GDARYMPQEILNEDYDH 401
K I H D+K N+++ K+GD G A LL+ + G Y+ E L ED +
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-LCEDKPY 178
Query: 402 LDKVDIFSLGATMYELIKGS-PL--SESGPQFLNLRDGKLPLLPG-HSLQFQNLLKVMVD 457
+K D+++LG +YE G P + G L + G P + +S Q L+ +
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238
Query: 458 PDPVQRPSAKELVENP 473
D QRP +L+ NP
Sbjct: 239 KDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 6e-30
Identities = 81/286 (28%), Positives = 125/286 (43%), Gaps = 44/286 (15%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ I+Q+G G F V+ + G A+K K++ + E L EV++L L H N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59
Query: 291 IVGYYSSWFENEQLYIQMELCDHSLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKG 347
IV + EN++LY E + +L + + F+E + ++QI Q L IH+ G
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 348 IAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEE--GDARYMPQEIL--NEDYDHL 402
H D+KP+N+ V V K+ DFG A + P + Y EIL + Y
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSS- 178
Query: 403 DKVDIFSLGATMYELIKGSPL----SES-------------GPQF----------LNLRD 435
VDI++LG M EL PL SE Q L R
Sbjct: 179 -PVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237
Query: 436 GKLP------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
+ L+P S + +L+K M+ DP +RP+A + +++P F
Sbjct: 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 7e-30
Identities = 74/293 (25%), Positives = 129/293 (44%), Gaps = 56/293 (19%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALAALGSH 288
DF + IG G+FS V ++ YA+K KRQL + + + +E + L L H
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-----------SLSDKKASQFFAEGEVLKALHQIA 337
I+ Y ++ + E LY +E + SL +K ++F+A +I
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK-CTRFYA--------AEIL 112
Query: 338 QALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE------------ 384
AL+++H KGI H D+KP+NI + K+ K+ DFG A +L+ + E
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 385 -----------GDARYMPQEILNEDYDHLDK-VDIFSLGATMYELIKGSPLSESGPQFL- 431
G A Y+ E+LNE K D+++LG +Y+++ G P ++L
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230
Query: 432 --NLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHR 482
+ + P ++L++ ++ DP R N +D+++ H
Sbjct: 231 FQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV-----NEGYDELKAHP 278
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 81/263 (30%), Positives = 122/263 (46%), Gaps = 36/263 (13%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSK------------RQLHHDAERRKALLEVQAL 282
E +G+G+F V++ L DG F+AVK +QL E+ L
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQ---------EIALL 56
Query: 283 AALGSHENIVGYYSSWFENEQLYIQMELCD----HSLSDKKASQFFAEGEVLKALHQIAQ 338
+ L H NIV Y + E + LYI +EL L K S F E + QI
Sbjct: 57 SKL-QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILL 113
Query: 339 ALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIE--EGDARYMPQEIL 395
L+++H++ H D+K NI V NGV KL DFG A + + + +G +M E++
Sbjct: 114 GLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVI 173
Query: 396 NEDYDHLDKVDIFSLGATMYELIKGSP----LSESGPQFLNLRDGKLPLLPGH-SLQFQN 450
+ + DI+SLG T+ E+ G P L F R +LP +P H S + ++
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233
Query: 451 LLKVMVDPDPVQRPSAKELVENP 473
+ + DP RP+A EL+E+P
Sbjct: 234 FILKCLQRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 76/284 (26%), Positives = 117/284 (41%), Gaps = 40/284 (14%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ ++ +IG G + V+K ++ G A+K K + + + AL E++ L L +H N
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59
Query: 291 IVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGI 348
I+ + LY+ E D L K + E + L+Q+ Q L F H GI
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 349 AHLDVKPDNIYVK-NGVYKLGDFGRATLLN-KSLPIEEGDAR--YMPQEILNEDYDHLDK 404
H D+KP+N+ + GV KL DFG A P Y E+L D +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 405 VDIFSLGATMYELIKGSPL---------------------SESGPQFLNLRDGKLP---- 439
VDI+S+G EL+ PL E P+F +L
Sbjct: 180 VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239
Query: 440 --------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
L P S Q +LL M+ DP +R +A++ + +P F
Sbjct: 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 118 bits (295), Expect = 3e-29
Identities = 79/291 (27%), Positives = 116/291 (39%), Gaps = 38/291 (13%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAALGSH 288
+ + ++G G+F V+ R A+K ++L E + L E+Q LA+L
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 289 ENIVGYYSSWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIAQALQFI 343
NIV Y + + LY+ ME D L +E E L L QI AL+++
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 344 HEKGIAHLDVKPDNIYV--KNGVYKLGDFGRATLLNKS---------LPIEEGDARYMPQ 392
H KGI H D+KP+NI + V KL DFG A LL G YM
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 393 EILNEDYDHLD--KVDIFSLGATMYELIKGSPLSESGPQFL-------NLRDGKLPLLPG 443
E+L DI+SLG T+YEL+ G P E + + P L
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 444 H---------SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTY 485
S +LLK ++ DP R S+ + + + ++
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDL 288
|
Length = 384 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 89/265 (33%), Positives = 129/265 (48%), Gaps = 21/265 (7%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
D + ++GAGN V KVL R G AVK + +++ +A +++ L E+ L +
Sbjct: 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKC-NSP 59
Query: 290 NIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEK 346
IVG+Y +++ N + I ME D SL K+ E + K + + L ++HEK
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 347 -GIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEE-GDARYM-PQEILNEDYDHL 402
I H DVKP NI V + G KL DFG + L SL G + YM P+ I DY
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYS-- 177
Query: 403 DKVDIFSLGATMYELIKG-----SPLSESGPQFLNLR---DGKLPLLPGH--SLQFQNLL 452
K DI+SLG ++ EL G F L+ + P LP S FQ+ +
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV 237
Query: 453 KVMVDPDPVQRPSAKELVENPIFDK 477
+ + DP +RPS KEL+E+P K
Sbjct: 238 NLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 82/257 (31%), Positives = 129/257 (50%), Gaps = 17/257 (6%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ I++IG G+F ++ + D +K E+ + EV LA + H N
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPN 60
Query: 291 IVGYYSSWFENEQLYIQMELCDHSLSDKKASQ----FFAEGEVLKALHQIAQALQFIHEK 346
IV +++S+ EN +L+I ME CD K+ ++ F+E ++L QI+ L+ IH++
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 347 GIAHLDVKPDNIYV-KNG-VYKLGDFGRATLLNKSLPIEE---GDARYMPQEIL-NEDYD 400
I H D+K NI++ KNG V KLGDFG A LN S+ + G Y+ EI N Y+
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYN 180
Query: 401 HLDKVDIFSLGATMYELIK-GSPLSESGPQFLNLR--DGKL-PLLPGHSLQFQNLLKVMV 456
+K DI+SLG +YEL P + L L+ G P+ P S ++L+ +
Sbjct: 181 --NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238
Query: 457 DPDPVQRPSAKELVENP 473
P RPS +++ P
Sbjct: 239 KVSPRDRPSITSILKRP 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 81/252 (32%), Positives = 126/252 (50%), Gaps = 19/252 (7%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYS 296
+G G++ V V R DG Y +K + ER+ A E Q L+ L H NIV Y
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRE 66
Query: 297 SW-FENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAH 350
SW E+ LYI M C+ H L ++K + E +V++ QIA ALQ++HEK I H
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKHILH 125
Query: 351 LDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEIL-NEDYDHLDKV 405
D+K N+++ + + K+GD G A +L + G YM E+ N+ Y++ K
Sbjct: 126 RDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY--KS 183
Query: 406 DIFSLGATMYE---LIKGSPLSESGPQFLNLRDGKLPLLPG-HSLQFQNLLKVMVDPDPV 461
D+++LG +YE L + + +GKLP +P +S + L+ M+ P
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPE 243
Query: 462 QRPSAKELVENP 473
+RPS K ++ P
Sbjct: 244 KRPSVKSILRQP 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 80/287 (27%), Positives = 121/287 (42%), Gaps = 47/287 (16%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE--RRKALLEVQALAALGSH 288
+ ++E++G G + V+K + G A+K K +L ++ E AL E+ L L H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALK--KIRLDNEEEGIPSTALREISLLKEL-KH 57
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEK 346
NIV +LY+ E CD L K + + ++Q+ + L + H
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR-----YMPQEILNEDYD 400
I H D+KP NI + ++GV KL DFG A +P+ Y EIL
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLGSKH 175
Query: 401 HLDKVDIFSLGATMYELIKGSPL---------------------SESGPQFLNLRDGK-- 437
+ VDI+S+G E+I G PL ES P L D K
Sbjct: 176 YSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235
Query: 438 LP---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
P +LP + +LL M+ +P +R SAKE +++P F
Sbjct: 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 74/218 (33%), Positives = 116/218 (53%), Gaps = 18/218 (8%)
Query: 271 ERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQ---FFAE 326
ERR AL E+ L+ L H NI+ YY+ + ++ L I+ME + +L DK Q F E
Sbjct: 42 ERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE 100
Query: 327 GEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE- 384
VL L QI A+ +IH+ GI H D+K NI++ K G+ KLGDFG + +L + E
Sbjct: 101 EMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160
Query: 385 --GDARYMPQEILN-EDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKL--- 438
G YM E+ Y+ K DI++LG +YEL+ + LNL +
Sbjct: 161 VVGTPYYMSPELCQGVKYN--FKSDIWALGCVLYELLTLKRTFD-ATNPLNLVVKIVQGN 217
Query: 439 --PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPI 474
P++ +S + +L+ ++ DP +RP+A E+++ P+
Sbjct: 218 YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 82/258 (31%), Positives = 123/258 (47%), Gaps = 28/258 (10%)
Query: 236 QIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE-RRKALLEVQALAALGSHENIVGY 294
+IG G FS V+K + +DG A+K + DA+ R+ L E+ L L H N++ Y
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKY 67
Query: 295 YSSWFENEQLYIQMELCDH-SLSD-----KKASQFFAEGEVLKALHQIAQALQFIHEKGI 348
+S+ EN +L I +EL D LS KK + E + K Q+ AL+ +H K I
Sbjct: 68 LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127
Query: 349 AHLDVKPDNIYVK-NGVYKLGDFG------RATLLNKSLPIEEGDARYM-PQEILNEDYD 400
H D+KP N+++ GV KLGD G T SL G YM P+ I Y+
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIHENGYN 184
Query: 401 HLDKVDIFSLGATMYELIK-GSPLSESGPQ----FLNLRDGKLPLLPG--HSLQFQNLLK 453
K DI+SLG +YE+ SP + P LP +S + ++L+
Sbjct: 185 F--KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVS 242
Query: 454 VMVDPDPVQRPSAKELVE 471
++PDP +RP +++
Sbjct: 243 RCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 74/275 (26%), Positives = 120/275 (43%), Gaps = 46/275 (16%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
D+ I++IG+G + V+K G A+K K L + E+ L H
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKEC-RH 59
Query: 289 ENIVGYYSSWFENEQLYIQMELCD-HSLSDKKASQFFAEGEVLKALH------QIA---- 337
NIV Y+ S+ ++L+I ME C SL D + + QIA
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-----------IYQVTRGPLSELQIAYVCR 108
Query: 338 ---QALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYM 390
+ L ++HE G H D+K NI + ++G KL DFG + L ++ + G +M
Sbjct: 109 ETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWM 168
Query: 391 PQEILNE----DYDHLDKVDIFSLGATMYELIKGS-PLSESGP----QFLNLRDGKLPLL 441
E+ YD K DI++LG T EL + P+ + P ++ + P L
Sbjct: 169 APEVAAVERKGGYDG--KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKL 226
Query: 442 PGH---SLQFQNLLKVMVDPDPVQRPSAKELVENP 473
S F + +K + DP +RP+A +L+++P
Sbjct: 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 70/278 (25%), Positives = 121/278 (43%), Gaps = 44/278 (15%)
Query: 230 DFHEIEQIGAGNFSHVFKV----------LKRIDGCFYAVKHSKRQLHHDAERRKALLEV 279
D+ IE IG G + V+ +KRID K Q D R+ EV
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRID-------LEKCQTSVDELRK----EV 50
Query: 280 QALAALGSHENIVGYYSSWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALH 334
QA++ +H N+V YY+S+ ++L++ M + E + L
Sbjct: 51 QAMSQC-NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK 109
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE-------GD 386
++ + L+++H G H D+K NI + ++G K+ DFG + L G
Sbjct: 110 EVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
Query: 387 ARYMPQEILNEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ--FLNLRDGKLPLLP- 442
+M E++ + + + K DI+S G T EL G +P S+ P + P L
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLET 229
Query: 443 -----GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
+S F+ ++ + + DP +RP+A+EL+++ F
Sbjct: 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 78/267 (29%), Positives = 131/267 (49%), Gaps = 33/267 (12%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
F +E++G G++ V+K + + G A+K + + + ++ + E+ L S
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIK----VVPVEEDLQEIIKEISILKQCDS- 57
Query: 289 ENIVGYYSSWFENEQLYIQMELCD-HSLSD--KKASQFFAEGEVLKALHQIAQALQFIHE 345
IV YY S+F+N L+I ME C S+SD K ++ E E+ L+Q + L+++H
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEILNE-DYD 400
H D+K NI + + G KL DFG + L ++ G +M E++ E Y+
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 401 HLDKVDIFSLGATMYELIKGS-PLSESGPQ---FL-------NLRDGKLPLLPGH-SLQF 448
+ K DI+SLG T E+ +G P S+ P F+ L D P S +F
Sbjct: 178 N--KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD------PEKWSPEF 229
Query: 449 QNLLKVMVDPDPVQRPSAKELVENPIF 475
+ +K + DP +RPSA +L+++P
Sbjct: 230 NDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 77/281 (27%), Positives = 122/281 (43%), Gaps = 57/281 (20%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVK-------HSKRQLHHDAERRKALLEVQALAALGSHE 289
I G + VF K+ G YA+K K Q+ R L + Q
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-------SP 53
Query: 290 NIVGYYSSWFENEQLYIQME---------LCDH--SLSDKKASQFFAEGEVLKALHQIAQ 338
+V Y S+ + LY+ ME L ++ SL + A + A +I
Sbjct: 54 YVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA---------EIVL 104
Query: 339 ALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFG--RATLLNKSLPIEEGDAR------- 388
AL+++H GI H D+KPDNI + NG KL DFG + L+ + + + + +
Sbjct: 105 ALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
Query: 389 --YMPQE-ILNEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ--FLNLRDGKL--PL 440
Y+ E IL + + VD +SLG +YE + G P P+ F N+ +GK+ P
Sbjct: 165 PDYIAPEVILGQGHSK--TVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE 222
Query: 441 LPGHSLQFQNLLKVMVDPDPVQRP---SAKELVENPIFDKI 478
S + +L+ ++ PDP +R S +E+ +P F I
Sbjct: 223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 8e-25
Identities = 70/218 (32%), Positives = 113/218 (51%), Gaps = 19/218 (8%)
Query: 271 ERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELC-DHSLSDK-----KASQFF 324
E +A E Q L+ L H IV +++S+ E + I E C L K +
Sbjct: 45 ETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL 103
Query: 325 AEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSLPIE- 383
+E +V + Q+ + ++H++ I H D+K NI++KN + K+GDFG + LL S +
Sbjct: 104 SENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLAT 163
Query: 384 --EGDARYM-PQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL----NLRDG 436
G YM P+ + ++ YD K DI+SLG +YE+ + E G FL + +G
Sbjct: 164 TFTGTPYYMSPEALKHQGYD--SKSDIWSLGCILYEMCCLAHAFE-GQNFLSVVLRIVEG 220
Query: 437 KLPLLPG-HSLQFQNLLKVMVDPDPVQRPSAKELVENP 473
P LP +S Q ++++ M++ DP RPSA E++ NP
Sbjct: 221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 29/261 (11%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAER-RKALLEVQALAALGSHENIVGYY 295
IG G F V V KR +A+K+ +Q + R L E + L L +H +V +
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLW 66
Query: 296 SSWFENEQLYIQMEL-----CDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAH 350
S+ + E +Y+ ++L + LS K F+E +V + +I AL+++H KGI H
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVK---FSEEQVKFWICEIVLALEYLHSKGIIH 123
Query: 351 LDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEILN-EDYDHLDKVD 406
D+KPDNI + + G + DF AT + G YM E+L + Y VD
Sbjct: 124 RDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVA--VD 181
Query: 407 IFSLGATMYELIKGS-P----LSESGPQFLNLRDGKLPLLP-GHSLQFQNLLKVMVDPDP 460
+SLG T YE ++G P Q ++ L P S + + + +++ DP
Sbjct: 182 WWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDP 241
Query: 461 VQRPSAKELVENPIFDKIQKH 481
+R L +N ++ H
Sbjct: 242 QKR-----LGDNL--KDLKNH 255
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 73/276 (26%), Positives = 116/276 (42%), Gaps = 53/276 (19%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE--RRKALLEVQALAALGSH 288
+ +I QIG G + V+K + G A+K K ++ ++ E A+ E++ L L H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK--KIRMENEKEGFPITAIREIKLLQKL-RH 57
Query: 289 ENIVGYYSSWFENEQ--LYIQMELCDHSLS---DKKASQFFAEGEVLKALHQIAQALQFI 343
NIV + +Y+ E DH L+ D +F E ++ + Q+ + LQ++
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKF-TESQIKCYMKQLLEGLQYL 116
Query: 344 HEKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEEGDAR---------YMPQE 393
H GI H D+K NI + N GV KL DFG A K A Y P E
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTK-----RNSADYTNRVITLWYRPPE 171
Query: 394 IL--NEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHS--LQFQ 449
+L Y +VD++S+G + EL G P+ G + Q +
Sbjct: 172 LLLGATRYG--PEVDMWSVGCILAELFLGK-----------------PIFQGSTELEQLE 212
Query: 450 NLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTY 485
+ ++ P P +L P F+ + K +K Y
Sbjct: 213 KIFELCGSPTDENWPGVSKL---PWFENL-KPKKPY 244
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 80/275 (29%), Positives = 126/275 (45%), Gaps = 25/275 (9%)
Query: 229 TDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGS 287
D EI ++G G F V+K + G F A K Q+ + E ++E+ L+
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII--QIESEEELEDFMVEIDILSEC-K 60
Query: 288 HENIVGYYSSWFENEQLYIQMELCDHSLSDK---KASQFFAEGEVLKALHQIAQALQFIH 344
H NIVG Y ++F +L+I +E CD D + + E ++ Q+ +AL F+H
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEILN---- 396
+ H D+K NI + +G KL DFG + +L + G +M E++
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 397 --EDYDHLDKVDIFSLGATMYELIKGSPL-SESGPQ--FLNLRDGKLPLL--PGH-SLQF 448
YD+ K DI+SLG T+ EL + P E P L + + P L P S F
Sbjct: 181 KDNPYDY--KADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238
Query: 449 QNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRK 483
+ LK + DP RP+A EL+++P ++
Sbjct: 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKA 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 74/290 (25%), Positives = 120/290 (41%), Gaps = 49/290 (16%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK--HSKRQLHHDAERRKALLEVQALAALGS 287
+ + +IG G VFK R G A+K +R +AL E++AL A
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQAC-Q 57
Query: 288 HENIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHE 345
H +V + + ME LS+ + + E +V + + + + ++H
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPI----EEGDARYMPQEIL--NED 398
GI H D+KP N+ + +GV K+ DFG A L ++ P + Y E+L
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 399 YDHLDKVDIFSLGATMYELIKGSPL---------------------SESGPQFLNLRD-G 436
YD VD++++G EL+ GSPL E+ P +L D
Sbjct: 178 YDPG--VDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 437 KL-----------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
K+ + P S + +LLK ++ DP +R SA E + +P F
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-23
Identities = 81/257 (31%), Positives = 125/257 (48%), Gaps = 23/257 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSK-RQLHHDAE--RRKALLEVQALAALG 286
++ + +G G+F V YA+K + + E R++A+L LA +
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL----LAKM- 55
Query: 287 SHENIVGYYSSWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIAQALQ 341
H NIV + S+ + LYI ME CD + ++ + F E +L+ Q+ +Q
Sbjct: 56 KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQ 114
Query: 342 FIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIE---EGDARYMPQEILNE 397
IHEK + H D+K NI++ +NG KLGDFG A LL G Y+P EI E
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW-E 173
Query: 398 DYDHLDKVDIFSLGATMYELIK-GSPLSESGPQFLNLR--DGKLPLLPGH-SLQFQNLLK 453
+ + +K DI+SLG +YEL P + + L L+ G LP H S + ++L+K
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIK 233
Query: 454 VMVDPDPVQRPSAKELV 470
M +P RPSA ++
Sbjct: 234 QMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 78/284 (27%), Positives = 126/284 (44%), Gaps = 43/284 (15%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
+ +G G + V K + G A+K K + ++ AL EV+ L L HENIV
Sbjct: 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVN 64
Query: 294 YYSSWFENEQLYIQMELCDHSLSDK-KASQFFAEGEVLKAL-HQIAQALQFIHEKGIAHL 351
++ +LY+ E + +L + +AS + +++ Q+ QA+ + H I H
Sbjct: 65 LKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHR 124
Query: 352 DVKPDNIYVK-NGVYKLGDFGRATLL--NKSLPIEEGDAR--YMPQEILNEDYDHLDKVD 406
D+KP+NI V +GV KL DFG A L + P+ + A Y E+L D ++ VD
Sbjct: 125 DIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVD 184
Query: 407 IFSLGATMYELIKGSPL----SE-----------------------SGPQFLNLR----D 435
++++G M EL+ G PL S+ S P+F +
Sbjct: 185 VWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPS 244
Query: 436 GKLPL---LPG-HSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
L PG S + LK + DP +R + EL+++P F
Sbjct: 245 QPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (240), Expect = 1e-22
Identities = 68/270 (25%), Positives = 117/270 (43%), Gaps = 46/270 (17%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
+G G+F V V K+ G YA+K K+++ E L E L+ + +H IV +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLH 59
Query: 296 SSWFENEQLYIQMELCD-----------HSLSDKKASQFFAEGEVLKALHQIAQALQFIH 344
++ E+LY+ +E S+++A + AE I AL+++H
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAE---------IVLALEYLH 110
Query: 345 EKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEEGDAR-------YMPQEIL- 395
GI + D+KP+NI + G KL DFG L K L E Y+ E+L
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFG----LAKELSSEGSRTNTFCGTPEYLAPEVLL 166
Query: 396 NEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLL 452
+ Y VD +SLG +YE++ G P + + + + L S + ++L+
Sbjct: 167 GKGYGK--AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLI 224
Query: 453 KVMVDPDPVQRPSAKELVENPIFDKIQKHR 482
++ DP +R + ++I+ H
Sbjct: 225 SGLLQKDPTKRLGSGG------AEEIKAHP 248
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 72/273 (26%), Positives = 120/273 (43%), Gaps = 35/273 (12%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKAL-LEVQALAALGSH 288
F +E IG G + V+K + G A+K + + + + E L +H
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIK----IMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 289 ENIVGYYSSWFEN------EQLYIQMELCDH-SLSD-----KKASQFFAEGEVLKALHQI 336
NI +Y ++ + +QL++ MELC S++D +K + E + L +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 337 AQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQ 392
+ L ++HE + H D+K NI + KN KL DFG + L+ +L G +M
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182
Query: 393 EI------LNEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGKLPLLP 442
E+ + YD + D++SLG T EL G PL + P F R+ L
Sbjct: 183 EVIACDEQPDASYDA--RSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240
Query: 443 GH--SLQFQNLLKVMVDPDPVQRPSAKELVENP 473
S +F + + + + QRP +EL+E+P
Sbjct: 241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHP 273
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 80/275 (29%), Positives = 134/275 (48%), Gaps = 22/275 (8%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
D IE++G G + V K+ G AVK + ++ E+++ L+++
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQKRLLMDLDISMRSVDC 59
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLK--ALHQIA----QALQF 342
V +Y + F ++I ME+ D SL DK + + +G + L +IA +AL++
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 343 IHEK-GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP--IEEGDARYMPQEILNED 398
+H K + H DVKP N+ + +NG KL DFG + L S+ I+ G YM E +N +
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPE 178
Query: 399 YD--HLD-KVDIFSLGATMYELIKGS-PLSESGPQFLNLR---DGKLPLLP--GHSLQFQ 449
+ D K D++SLG TM EL G P F L+ + P LP S +FQ
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQ 238
Query: 450 NLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKT 484
+ + + + +RP+ EL+++P F ++ + T
Sbjct: 239 DFVNKCLKKNYKERPNYPELLQHP-FFELHLSKNT 272
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 4e-22
Identities = 83/288 (28%), Positives = 131/288 (45%), Gaps = 33/288 (11%)
Query: 212 AGLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH---- 267
A L V+ GD S Y +F +IG G+ V C K + RQ+
Sbjct: 6 AALQLVVDPGDPRS-YLDNF---VKIGEGSTGIV---------CIATDKSTGRQVAVKKM 52
Query: 268 --HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME-LCDHSLSDKKASQFF 324
+RR+ L + H NIV YSS+ ++L++ ME L +L+D
Sbjct: 53 DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRM 112
Query: 325 AEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIE 383
E ++ + +AL F+H +G+ H D+K D+I + +G KL DFG ++K +P
Sbjct: 113 NEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172
Query: 384 E---GDARYM-PQEILNEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQFL-NLRDG 436
+ G +M P+ I Y +VDI+SLG + E++ G P +E Q + +RD
Sbjct: 173 KSLVGTPYWMAPEVISRLPYG--TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230
Query: 437 KLPLLPGH---SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481
P L S + ++ L M+ DP QR +A EL+ +P K
Sbjct: 231 LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 1e-21
Identities = 71/264 (26%), Positives = 109/264 (41%), Gaps = 38/264 (14%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY---AVKHSKRQLHHDAERRKALL-EVQALAALGSH 288
+++G G F V+K LK G AVK K ++ + L E + + L H
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE--DASEQQIEEFLREARIMRKL-DH 60
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHE 345
N+V E E LYI ME + L +K + ++L QIA+ ++++
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRA---------TLLNKSLPIEEGDARYMPQEIL 395
K H D+ N V +N V K+ DFG + LPI R+M E L
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI-----RWMAPESL 175
Query: 396 NED-YDHLDKVDIFSLGATMYELIK--GSPLSE-SGPQFLN-LRDGKLPLLPGHSLQFQN 450
E + K D++S G ++E+ P S + L L++G P +
Sbjct: 176 KEGKFTS--KSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCP--PE 231
Query: 451 LLKVMVD---PDPVQRPSAKELVE 471
L +M+ DP RP+ ELVE
Sbjct: 232 LYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 72/265 (27%), Positives = 108/265 (40%), Gaps = 39/265 (14%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY---AVKHSKRQLHHDAERRKALL-EVQALAALGSH 288
+++G G F V+K LK AVK K ++ + L E + + L H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE--DASEQQIEEFLREARIMRKL-DH 60
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIAQALQFIH 344
NIV E E L I ME L D K + + ++L QIA+ ++++
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRA---------TLLNKSLPIEEGDARYMPQEI 394
K H D+ N V +N V K+ DFG + + LPI R+M E
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI-----RWMAPES 175
Query: 395 LNED-YDHLDKVDIFSLGATMYELIK--GSPLSE-SGPQFLN-LRDGKLPLLPGHSLQFQ 449
L E + K D++S G ++E+ P S + L L+ G P +
Sbjct: 176 LKEGKFTS--KSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCP--P 231
Query: 450 NLLKVMVD---PDPVQRPSAKELVE 471
L K+M+ DP RP+ ELVE
Sbjct: 232 ELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-21
Identities = 75/256 (29%), Positives = 118/256 (46%), Gaps = 14/256 (5%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ +I +G G F V ++ D +K + ER A E Q L L SH N
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPN 60
Query: 291 IVGYYSSWFENEQLYIQMELCD----HSLSDKKASQFFAEGEVLKALHQIAQALQFIHEK 346
I+ YY ++ E++ L I ME K+ + E +L QI AL +H K
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 347 GIAHLDVKPDNIYV--KNGVYKLGDFGRATLL-NKSLPIEE-GDARYMPQEILNEDYDHL 402
I H D+K NI + V K+GDFG + +L +KS G Y+ E+ E +
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC-EGKPYN 179
Query: 403 DKVDIFSLGATMYEL--IKGSPLSESGPQF-LNLRDGKL-PLLPGHSLQFQNLLKVMVDP 458
K DI++LG +YEL +K + + + P L + G P+ +S + L+ M++
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL 239
Query: 459 DPVQRPSAKELVENPI 474
DP +RP +++ PI
Sbjct: 240 DPSKRPQLSQIMAQPI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 80/270 (29%), Positives = 129/270 (47%), Gaps = 24/270 (8%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD--AERRKALLEVQALAAL--G 286
+ +E IG G + V++ G A+K D ++ ++ EV L+ L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR---EVALLSQLRQS 59
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIHE 345
NI YY S+ + +L+I ME + S+ + AE + + ++ AL++IH+
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 346 KGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEE---GDARYMPQEILNEDYDH 401
G+ H D+K NI V N G KL DFG A LLN++ G +M E++ E +
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 402 LDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLPLLPGHSLQFQNLLKVMV-- 456
K DI+SLG T+YE+ G+P F + + K P L + + LL+ V
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNG--YSKLLREFVAA 237
Query: 457 --DPDPVQRPSAKELVENPIFDKIQKHRKT 484
D +P +R SA+EL+++ I+ H KT
Sbjct: 238 CLDEEPKERLSAEELLKSKW---IKAHSKT 264
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 5e-21
Identities = 74/254 (29%), Positives = 117/254 (46%), Gaps = 20/254 (7%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+F ++IG G FS V++ +D A+K + DA+ R+ ++ L +H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSD-----KKASQFFAEGEVLKALHQIAQALQF 342
N++ Y S+ E+ +L I +EL D LS KK + E V K Q+ A++
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 343 IHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE---GDARYM-PQEILNE 397
+H + + H D+KP N+++ GV KLGD G + G YM P+ I
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 398 DYDHLDKVDIFSLGATMYEL-IKGSPLSESGPQFLNL----RDGKLPLLPG--HSLQFQN 450
Y+ K DI+SLG +YE+ SP +L P LP +S + +
Sbjct: 182 GYNF--KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239
Query: 451 LLKVMVDPDPVQRP 464
L+ + + PDP QRP
Sbjct: 240 LVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 5e-21
Identities = 77/249 (30%), Positives = 120/249 (48%), Gaps = 22/249 (8%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE-RRKALLEVQALAALGSHENIVG 293
++IG G FS V++ +DG A+K + DA+ R + E+ L L +H N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIK 66
Query: 294 YYSSWFENEQLYIQMELCDH-SLSD-----KKASQFFAEGEVLKALHQIAQALQFIHEKG 347
YY+S+ E+ +L I +EL D LS KK + E V K Q+ AL+ +H +
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 348 IAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE---GDARYM-PQEILNEDYDHL 402
+ H D+KP N+++ GV KLGD G + G YM P+ I Y+
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF- 185
Query: 403 DKVDIFSLGATMYELIK-GSPLSESGPQFLNL----RDGKLPLLPG--HSLQFQNLLKVM 455
K DI+SLG +YE+ SP +L P LP +S + + L+ +
Sbjct: 186 -KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 244
Query: 456 VDPDPVQRP 464
++PDP +RP
Sbjct: 245 INPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 6e-21
Identities = 72/266 (27%), Positives = 109/266 (40%), Gaps = 35/266 (13%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFY----AVKHSKRQLHHDAERRKALL-EVQALAAL 285
+++G G F V+K + DG AVK K E R+ L E + L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKE--GASEEEREEFLEEASIMKKL 58
Query: 286 GSHENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQF 342
SH NIV + E LYI E L D +K + ++L+ QIA+ +++
Sbjct: 59 -SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----------LPIEEGDARYMP 391
+ K H D+ N V +N V K+ DFG + + + LPI ++M
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI-----KWMA 172
Query: 392 QEILNED-YDHLDKVDIFSLGATMYELIKG--SPLSE-SGPQFLN-LRDGK-LPLLPGHS 445
E L + + K D++S G ++E+ P S + L L DG LP
Sbjct: 173 PESLKDGKFTS--KSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCP 230
Query: 446 LQFQNLLKVMVDPDPVQRPSAKELVE 471
+ L+ DP RP+ ELVE
Sbjct: 231 DELYELMLQCWAYDPEDRPTFSELVE 256
|
Length = 258 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 8e-21
Identities = 78/266 (29%), Positives = 124/266 (46%), Gaps = 27/266 (10%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
D + +IG+G V+K+ + G AVK +R + E ++ L+++ + L SH
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT-GNKEENKRILMDLDVV--LKSH 71
Query: 289 E--NIVGYYSSWFENEQLYIQMEL---CDHSLSDKKASQFFAEGEVLKALHQIAQALQFI 343
+ IV Y + + ++I MEL C L K+ E + K I +AL ++
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMSTCLDKLL-KRIQGPIPEDILGKMTVAIVKALHYL 130
Query: 344 HEK-GIAHLDVKPDNIYV-KNGVYKLGDFGRATLL--NKSLPIEEGDARYMPQEIL---- 395
EK G+ H DVKP NI + +G KL DFG + L +K+ G A YM E +
Sbjct: 131 KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPD 190
Query: 396 -NEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQF------LNLRDGKLPLLPGHSLQ 447
N YD + D++SLG ++ EL G P +F L LP G S
Sbjct: 191 PNPKYD--IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248
Query: 448 FQNLLKVMVDPDPVQRPSAKELVENP 473
F + + + + D +RP +EL+++P
Sbjct: 249 FCSFVDLCLTKDHRKRPKYRELLQHP 274
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 80/290 (27%), Positives = 124/290 (42%), Gaps = 51/290 (17%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ ++ +IG G++ VFK R G A+K ++ AL E++ L L H N
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPN 61
Query: 291 IVGYYSSWFENEQLYIQMELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIHEKGI 348
+V + +L++ E CDH++ ++ K + E + K + Q QA+ F H+
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 349 AHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR--------YMPQEILNEDY 399
H DVKP+NI + K G KL DFG A +L GD Y E+L D
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGP-----GDDYTDYVATRWYRAPELLVGDT 176
Query: 400 DHLDKVDIFSLGATMYELIKGSPL----SESGPQFLNLRD-GKL---------------- 438
+ VD++++G EL+ G PL S+ +L + G L
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236
Query: 439 ----------PL---LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
PL P S + LK + DP +R S +EL+E+P F
Sbjct: 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 69/236 (29%), Positives = 120/236 (50%), Gaps = 18/236 (7%)
Query: 255 CFYAVKHSKRQLH------HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308
C KHS RQ+ +RR+ L + H+N+V Y S+ E+L++ M
Sbjct: 38 CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97
Query: 309 E-LCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NGVYK 366
E L +L+D + E ++ + QAL ++H +G+ H D+K D+I + +G K
Sbjct: 98 EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVK 157
Query: 367 LGDFGRATLLNKSLPIEE---GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSP- 422
L DFG ++K +P + G +M E+++ + +VDI+SLG + E++ G P
Sbjct: 158 LSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPP 216
Query: 423 -LSESGPQFLN-LRDGKLPLLPGH---SLQFQNLLKVMVDPDPVQRPSAKELVENP 473
S+S Q + LRD P L S ++ L+ M+ +P +R +A+EL+++P
Sbjct: 217 YFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHP 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 7e-20
Identities = 81/280 (28%), Positives = 123/280 (43%), Gaps = 36/280 (12%)
Query: 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGS 287
D ++ +IG G F V K+L + G AVK R + E+++ L+++ +
Sbjct: 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSD 61
Query: 288 HENIVGYYSSWFENEQLYIQMELCDHSLSDK-------KASQFFAE---GEV----LKAL 333
IV +Y + F +I MEL D SL DK E G++ +KAL
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDISL-DKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 334 HQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP--IEEGDARYM 390
+ + + L+ IH DVKP NI + +NG KL DFG + L S+ + G YM
Sbjct: 121 NYLKEELKIIHR------DVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYM 174
Query: 391 -PQEILNEDYDHLD-KVDIFSLGATMYELIKGS-PLSESGPQFLNLR---DGKLP-LLPG 443
P+ I D D + D++SLG T+YE+ G P + F L G P L
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNS 234
Query: 444 HSLQFQNLLKVMVD----PDPVQRPSAKELVENPIFDKIQ 479
+F ++ D +RP KEL+E+P +
Sbjct: 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 9e-20
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 28/202 (13%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
+G G F V V + +A+K KR + ++ E + L +H IV Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLY 59
Query: 296 SSWFENEQLYIQMELC----------DHSLSDKKASQFFAEGEVLKALHQIAQALQFIHE 345
++ + + +Y+ ME C D L D+ ++F+ + A +++H
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIA--------CVVLAFEYLHN 111
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL---NKSLPIEEGDARYM-PQEILNEDYD 400
+GI + D+KP+N+ + NG KL DFG A L K+ G Y+ P+ ILN+ YD
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF-CGTPEYVAPEIILNKGYD 170
Query: 401 HLDKVDIFSLGATMYELIKGSP 422
VD +SLG +YEL+ G P
Sbjct: 171 FS--VDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 2e-19
Identities = 73/272 (26%), Positives = 113/272 (41%), Gaps = 48/272 (17%)
Query: 235 EQIGAGNFSHVFK-VLKRIDGCFY--AVKHSKRQLHHDA---ERRKALLEVQALAALGSH 288
+++G G F V+K LK DG AVK L DA ER+ L E + + LG H
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVK----TLKEDASEEERKDFLKEARVMKKLG-H 55
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-----------SLSDKKASQFFAEGEVLKALHQIA 337
N+V E E LY+ +E + + + ++L QIA
Sbjct: 56 PNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 338 QALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----------LPIEEGD 386
+ ++++ K H D+ N V ++ V K+ DFG + + LPI
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI---- 171
Query: 387 ARYMPQEILNEDYDHLDKVDIFSLGATMYELIK--GSPLSE-SGPQFLN-LRDGKLPLLP 442
R+M E L +D K D++S G ++E+ +P S + L LR G P
Sbjct: 172 -RWMAPESL-KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP 229
Query: 443 GHSLQFQNLLKVMV---DPDPVQRPSAKELVE 471
+ L ++M+ DP RP+ ELVE
Sbjct: 230 EYCPDE--LYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 84/276 (30%), Positives = 133/276 (48%), Gaps = 39/276 (14%)
Query: 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAAL 285
+ YT F E+IG G V+ + G A+K Q++ + +K L+ + L
Sbjct: 19 KKYTRF---EKIGQGASGTVYTAIDVATGQEVAIK----QMNLQQQPKKELIINEILVMR 71
Query: 286 -GSHENIVGYYSSWFENEQLYIQME-LCDHSLSDKKASQFFAEGEVLKALHQIAQALQFI 343
H NIV Y S+ ++L++ ME L SL+D EG++ + QAL+F+
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 131
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFG-----------RATLLNKSLPIEEGDARYMP 391
H + H D+K DNI + +G KL DFG R+T++ G +M
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--------GTPYWMA 183
Query: 392 QEILNEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQFLNL--RDGKLPLLPGH--- 444
E++ + KVDI+SLG E+++G P L+E+ + L L +G P L
Sbjct: 184 PEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKL 241
Query: 445 SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
S F++ L ++ D +R SAKEL+++P F KI K
Sbjct: 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHP-FLKIAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 74/268 (27%), Positives = 128/268 (47%), Gaps = 24/268 (8%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
I ++G G F V+K + G A K + + + E ++E++ LA +H IV
Sbjct: 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATC-NHPYIVK 73
Query: 294 YYSSWFENEQLYIQMELCDHSLSDKKASQF---FAEGEVLKALHQIAQALQFIHEKGIAH 350
+++ + +L+I +E C D + E ++ Q+ +ALQ++H I H
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 351 LDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEIL------NEDYD 400
D+K N+ + +G KL DFG + K+L + G +M E++ + YD
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 401 HLDKVDIFSLGATMYELIK-GSPLSESGPQ--FLNLRDGKLPLL--PGH-SLQFQNLLKV 454
+ K DI+SLG T+ E+ + P E P L + + P L P S++F++ LK
Sbjct: 194 Y--KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKT 251
Query: 455 MVDPDPVQRPSAKELVENPIFDKIQKHR 482
+D P RPSA +L+E+P + +R
Sbjct: 252 ALDKHPETRPSAAQLLEHPFVSSVTSNR 279
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 63/238 (26%), Positives = 117/238 (49%), Gaps = 18/238 (7%)
Query: 255 CFYAVKHSKRQLH------HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308
C KH+ +Q+ +RR+ L + HEN+V Y+S+ ++L++ M
Sbjct: 39 CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98
Query: 309 ELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYK 366
E + +L+D E ++ + +AL ++H +G+ H D+K D+I + +G K
Sbjct: 99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIK 158
Query: 367 LGDFGRATLLNKSLPIEE---GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPL 423
L DFG ++K +P + G +M E+++ + +VDI+SLG + E+I G P
Sbjct: 159 LSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPP 217
Query: 424 SESGPQFLNLRDGKLPLLP----GHSLQ--FQNLLKVMVDPDPVQRPSAKELVENPIF 475
+ P +R + L P H + + L +M+ +P QR +A+EL+++P
Sbjct: 218 YFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 9e-19
Identities = 73/264 (27%), Positives = 123/264 (46%), Gaps = 33/264 (12%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDA------ERRKALL-----EVQALAAL 285
IG+G+F V+ + G AVK Q+ + +R++++L E+ L L
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVK----QVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 286 GSHENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQF--FAEGEVLKALHQIAQALQFI 343
HENIV Y S + + L I +E + + F E V + QI + L ++
Sbjct: 64 -QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYL 122
Query: 344 HEKGIAHLDVKPDNIYVKN-GVYKLGDFG---------RATLLNKSLPIEEGDARYMPQE 393
H +GI H D+K NI V N G K+ DFG +T N + P +G +M E
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 394 ILNEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQFLNLRDGK--LPLLPGH-SLQFQ 449
++ + + K DI+SLG + E++ G P + + G+ P +P + S +
Sbjct: 183 VVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAI 241
Query: 450 NLLKVMVDPDPVQRPSAKELVENP 473
+ L+ + D +RP+A EL+++P
Sbjct: 242 DFLEKTFEIDHNKRPTAAELLKHP 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 71/222 (31%), Positives = 109/222 (49%), Gaps = 17/222 (7%)
Query: 269 DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME-LCDHSLSDKKASQF---- 323
D+ + L E AL + H NIV Y S EN I ME + SLS S++
Sbjct: 45 DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLK 104
Query: 324 FAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDFGRATLLNKSLP 381
E ++ QI + L+++H+ I H D+K DN+ V +GV K+ DFG + L P
Sbjct: 105 DNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164
Query: 382 IEE---GDARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGS-PLSESG-PQFLNLRD 435
E G +YM E++++ + DI+SLG T+ E+ G P E G PQ +
Sbjct: 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV 224
Query: 436 G---KLPLLPGH-SLQFQNLLKVMVDPDPVQRPSAKELVENP 473
G P +P S + +N + +PDP +R SA +L+++P
Sbjct: 225 GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 78/266 (29%), Positives = 132/266 (49%), Gaps = 22/266 (8%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
++++G GN+ V+KVL R G A+K + +L +++ + ++E+ L S IV
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPY-IVD 63
Query: 294 YYSSWFENEQLYIQMELCDHSLSDK-----KASQFFAEGEVLKALHQIAQALQFIHEK-G 347
+Y ++F +Y+ ME D DK A++ E + + + + + L+F+ E+
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 348 IAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE-GDARYM-PQEI----LNEDYD 400
I H DVKP N+ V NG KL DFG + L SL G YM P+ I N++
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPT 183
Query: 401 HLDKVDIFSLGATMYELIKGS---PLSESGPQFLNLR---DGKLPLLP-GHSLQFQNLLK 453
+ + D++SLG ++ E+ G P F L DG P LP G+S Q+ +
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVA 243
Query: 454 VMVDPDPVQRPSAKELVENPIFDKIQ 479
++ P +RP+ +L+E+P K +
Sbjct: 244 KCLNKIPNRRPTYAQLLEHPWLVKYK 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 31/282 (10%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
E+ ++G G V K + G +A+K + + +K +L +
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD--PNPDLQKQILRELEINKSCKSPY 60
Query: 291 IVGYYSSWFENEQ--LYIQMELCDHSLSD------KKASQFFAEGEVLKALHQIAQALQF 342
IV YY ++ + + I ME C+ D KK E + K + + L +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFG-RATLLNKSLPIEEGDARYM-PQEILNEDY 399
+H + I H D+KP NI + + G KL DFG L+N G + YM P+ I + Y
Sbjct: 121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPY 180
Query: 400 DHLDKVDIFSLGATMYELIKGS-PLSESGPQFL----------NLRDGKLPLLPGH---- 444
D++SLG T+ E+ + P G L N+ + +L PG+
Sbjct: 181 S--ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238
Query: 445 SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYM 486
S +F++ +K ++ DP +RP+ +++E+P + K Q +K M
Sbjct: 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHP-WIKAQMKKKVNM 279
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 69/264 (26%), Positives = 116/264 (43%), Gaps = 43/264 (16%)
Query: 234 IEQIGAGNFSHVFKVLKRIDG-CFYAVKH--------SKRQLHHDAERRKALLEVQALAA 284
+E +G+G F V+KV K+ +G A+K K + D + EV +
Sbjct: 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 285 LGSHENIVGYYSSWFENEQLYIQMELC------DHSLSDKKASQFFAEGEVLKALHQIAQ 338
H NIV YY ++ EN++LYI M+L +H S K+ Q F E + Q+
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 339 ALQFIH-EKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSLPIEEGDARYM------- 390
AL+++H EK I H D+ P+NI LG+ + T+ + L ++ +
Sbjct: 125 ALRYLHKEKRIVHRDLTPNNIM-------LGEDDKVTITDFGLAKQKQPESKLTSVVGTI 177
Query: 391 ----PQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR----DGKLPLLP 442
P+ + NE Y +K D+++ G +Y++ P S L+L + LP
Sbjct: 178 LYSCPEIVKNEPYG--EKADVWAFGCILYQMCTLQPPFYST-NMLSLATKIVEAVYEPLP 234
Query: 443 G--HSLQFQNLLKVMVDPDPVQRP 464
+S +++ + PD RP
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 74/271 (27%), Positives = 124/271 (45%), Gaps = 38/271 (14%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
DF + Q+G G + VF K+ G A+K K+ L + +L + + E
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 290 NIVGYYSSWFENEQLYIQME----------LCD-HSLSDKKASQFFAEGEVLKALHQIAQ 338
+V ++ ++E LY+ ME L + LS+ A + AE + +
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAE---------MFE 112
Query: 339 ALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRAT-LLNKSLPIEEGDARYMPQEILN 396
A+ +HE G H D+KP+N + +G KL DFG + ++ + + G YM E+L
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-VGSPDYMAPEVLR 171
Query: 397 -EDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ--FLNLRDGKLPL------LPGHSL 446
+ YD VD +SLG +YE + G P S S P + NL+ K L P +L
Sbjct: 172 GKGYDF--TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNL 229
Query: 447 QFQ--NLLKVMVDPDPVQRPSAKELVENPIF 475
+ +L+ +++ DP +R + E ++N F
Sbjct: 230 SDEAWDLITKLIN-DPSRRFGSLEDIKNHPF 259
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 80/277 (28%), Positives = 132/277 (47%), Gaps = 19/277 (6%)
Query: 212 AGLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE 271
A L V+ GD R Y D + I +IG G+ V + G AVK K L +
Sbjct: 7 AALQMVVDPGD--PRTYLD-NFI-KIGEGSTGIVCIATVKSSGKLVAVK--KMDLRKQ-Q 59
Query: 272 RRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVL 330
RR+ L + HEN+V Y+S+ ++L++ ME + +L+D E ++
Sbjct: 60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA 119
Query: 331 KALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE---GD 386
+ +AL +H +G+ H D+K D+I + +G KL DFG ++K +P + G
Sbjct: 120 AVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179
Query: 387 ARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RDG---KLPL 440
+M E+++ + +VDI+SLG + E++ G P + P + RD KL
Sbjct: 180 PYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKN 238
Query: 441 LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
L S + L ++ DP QR +A EL+++P K
Sbjct: 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 70/261 (26%), Positives = 112/261 (42%), Gaps = 25/261 (9%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVK----HSKRQLHHDAERRKALLEVQALAALGSHEN 290
E +G G + V+ L G AVK + L + E K EV L +L H N
Sbjct: 6 EVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVN 63
Query: 291 IVGYYSSWFENEQLYIQMELCDHSLSDKKASQF--FAEGEVLKALHQIAQALQFIHEKGI 348
IV Y + ++ + I ME ++F E K QI + ++H +
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 349 AHLDVKPDNIYV-KNGVYKLGDFGRATLL---------NKSLPIEEGDARYMPQEILNED 398
H D+K +N+ + NG+ KL DFG A L + L G +M E++NE
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 399 YDHLDKVDIFSLGATMYELIKGSPLSESGPQ-----FLNLRDGKLPLLPGH-SLQFQNLL 452
+ K DI+S+G T++E+ G P S + ++ G +P LP S + +
Sbjct: 184 -GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFV 242
Query: 453 KVMVDPDPVQRPSAKELVENP 473
+ D +RPSA +L+ +
Sbjct: 243 TSCLTRDQHERPSALQLLRHD 263
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 77/290 (26%), Positives = 120/290 (41%), Gaps = 57/290 (19%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
+ +G G++ V K + G A+K ++ A+ E++ L L HEN+V
Sbjct: 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVN 64
Query: 294 YYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
+ ++LY+ E DH++ D +K E V K L QI + ++F H I H
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHR 124
Query: 352 DVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR--------YMPQEILNEDYDHL 402
D+KP+NI V ++GV KL DFG A L G+ Y E+L D +
Sbjct: 125 DIKPENILVSQSGVVKLCDFGFARTLAAP-----GEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 403 DKVDIFSLGATMYELIKGSPL--SES-------------------------GPQFLNLRD 435
VDI+++G + E++ G PL +S P F +R
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR- 238
Query: 436 GKLP----------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
LP P S +L K + DP RPS+ +L+ + F
Sbjct: 239 --LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 63/239 (26%), Positives = 99/239 (41%), Gaps = 50/239 (20%)
Query: 215 FPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRK 274
FP D +S+Y ++ +IG G F VFK + A+K E K
Sbjct: 5 FPFC---DEVSKY----EKLAKIGQGTFGEVFKARHKKTKQIVALKKVL------MENEK 51
Query: 275 ------ALLEVQALAALGSHENIVGYY------SSWFENE--QLYIQMELCDHSL----S 316
AL E++ L L HEN+V ++ + Y+ E C+H L S
Sbjct: 52 EGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLS 110
Query: 317 DKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATL 375
+K F E+ K + + L +IH I H D+K NI + K+G+ KL DFG
Sbjct: 111 NKNVK--FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG---- 164
Query: 376 LNKSLPIEEGDAR-----------YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPL 423
L ++ + + Y P E+L + D+ +D++ G M E+ SP+
Sbjct: 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 81/288 (28%), Positives = 119/288 (41%), Gaps = 48/288 (16%)
Query: 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALG 286
+TD EI G G+F V+ A+K E+ + ++ EV+ L L
Sbjct: 17 FTDLREI---GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL- 72
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDHSLSD-----KKASQFFAEGEVLKALHQIAQALQ 341
H N + Y + ++ ME C S SD KK Q E E+ H Q L
Sbjct: 73 RHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQ---EVEIAAICHGALQGLA 129
Query: 342 FIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE--GDARYM-PQEILNE 397
++H H D+K NI + + G KL DFG A+L++ P G +M P+ IL
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS---PANSFVGTPYWMAPEVILAM 186
Query: 398 DYDHLD-KVDIFSLGATMYELIKGSPLSESGPQFLNLR---------DGKLPLLP--GHS 445
D D KVD++SLG T E L+E P N+ P L S
Sbjct: 187 DEGQYDGKVDVWSLGITCIE------LAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWS 240
Query: 446 LQFQNLLKVMVDPDPVQRPSAKELVENP----------IFDKIQKHRK 483
F+N + + P RPS++EL+++ I D IQ+ +
Sbjct: 241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKD 288
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 75/260 (28%), Positives = 120/260 (46%), Gaps = 25/260 (9%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAER-RKALLEVQALAALGSH 288
D+ I+++G+G + V+K G AVK K + D ++ + V+ H
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC----KH 65
Query: 289 ENIVGYYSSWFENEQLYIQMELC-DHSLSD-KKASQFFAEGEVLKALHQIAQALQFIHEK 346
NIV Y+ S+ E+L+I ME C SL D + +E ++ + Q L ++H K
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 347 GIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEIL----NED 398
G H D+K NI + NG KL DFG A + ++ + G +M E+ N
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 399 YDHLDKVDIFSLGATMYELIKGSP----LSESGPQFL----NLRDGKLPLLPGHSLQFQN 450
Y+ L DI+++G T EL + P L FL N + KL S F N
Sbjct: 186 YNQL--CDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243
Query: 451 LLKVMVDPDPVQRPSAKELV 470
+K+ + +P +RP+A+ L+
Sbjct: 244 FVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 73/292 (25%), Positives = 116/292 (39%), Gaps = 56/292 (19%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAER---RKALLEVQALAALGS 287
F ++E++G G ++ V+K R G A+K ++H DAE A+ E+ + L
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALK----EIHLDAEEGTPSTAIREISLMKEL-K 56
Query: 288 HENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKA------LHQIAQALQ 341
HENIV + +L + E D L KK L +Q+ + +
Sbjct: 57 HENIVRLHDVIHTENKLMLVFEYMDKDL--KKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 342 FIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR-----YMPQEIL 395
F HE + H D+KP N+ + K G KL DFG A +P+ Y ++L
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVL 172
Query: 396 NEDYDHLDKVDIFSLGATMYELIKGSPL---------------------SESGPQFLNLR 434
+ +DI+S+G M E+I G PL + P L
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232
Query: 435 D--GKLPLLPGHSLQFQ---------NLLKVMVDPDPVQRPSAKELVENPIF 475
+ P P LQ +LL ++ +P R SA + +++P F
Sbjct: 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 69/259 (26%), Positives = 113/259 (43%), Gaps = 37/259 (14%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE--RRKALLEVQALAALGSH 288
+ ++E+IG G + VFK R A+K + +L D E AL E+ L L H
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALK--RVRLDDDDEGVPSSALREICLLKEL-KH 58
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLSDKK---ASQFFAEGEVLKA-LHQIAQALQFIH 344
+NIV Y +++L + E CD L KK + + E++K+ + Q+ + L F H
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQDL--KKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR-----YMPQEILNED 398
+ H D+KP N+ + KNG KL DFG A +P+ A Y P ++L
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTLWYRPPDVL--- 171
Query: 399 YDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSL--QFQNLLKVMV 456
GA +Y + +G F L + PL PG+ + Q + + +++
Sbjct: 172 -----------FGAKLYS--TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 218
Query: 457 DPDPVQRPSAKELVENPIF 475
P P +L + +
Sbjct: 219 TPTEESWPGVSKLPDYKPY 237
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSK-------RQLHHDAERRKALLEVQAL 282
D I+ +G G F V V RI +YA+K +Q H ++ L EV
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV--- 58
Query: 283 AALGSHENIVGYYSSWFENEQLYIQME-LCDHSL-SDKKASQFFAEGEVLKALHQIAQAL 340
SH I+ + + + LY+ ME + L S + S F+ L +I AL
Sbjct: 59 ----SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL 114
Query: 341 QFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDY 399
+++H K I + D+KP+NI + K G KL DFG A L G Y+ E++ +
Sbjct: 115 EYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVI-QSK 173
Query: 400 DHLDKVDIFSLGATMYELIKGSP 422
H VD ++LG +YE++ G P
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 9e-17
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SK------RQLHHDAERRKALLEVQA 281
DF I+ +G G+F V V + G +YA+K SK +Q+ H ++ L ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR- 59
Query: 282 LAALGSHENIVGYYSSWFENEQLYIQMELC-----------DHSLSDKKASQFFAEGEVL 330
H +V Y S+ ++ LY+ ME + A +F+A
Sbjct: 60 ------HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAA---- 108
Query: 331 KALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARY 389
Q+ AL+++H I + D+KP+N+ + +G K+ DFG A + G Y
Sbjct: 109 ----QVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEY 164
Query: 390 MPQE-ILNEDYDHLDKVDIFSLGATMYELIKGSP 422
+ E IL++ Y VD ++LG +YE++ G P
Sbjct: 165 LAPEIILSKGYGKA--VDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.2 bits (197), Expect = 1e-16
Identities = 84/279 (30%), Positives = 133/279 (47%), Gaps = 22/279 (7%)
Query: 214 LFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERR 273
L +++ GD + YT F E+IG G V+ + G A+ RQ++ + +
Sbjct: 9 LRSIVSVGDP-KKKYTRF---EKIGQGASGTVYTAMDVATGQEVAI----RQMNLQQQPK 60
Query: 274 KALLEVQALAAL-GSHENIVGYYSSWFENEQLYIQME-LCDHSLSDKKASQFFAEGEVLK 331
K L+ + L + NIV Y S+ ++L++ ME L SL+D EG++
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA 120
Query: 332 ALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDA 387
+ QAL+F+H + H D+K DNI + +G KL DFG + G
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
Query: 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQFLNL--RDGKLPLLPG 443
+M E++ + KVDI+SLG E+I+G P L+E+ + L L +G L
Sbjct: 181 YWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239
Query: 444 HSLQ--FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
L F++ L +D D +R SAKEL+++ F KI K
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ-FLKIAK 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 79/263 (30%), Positives = 122/263 (46%), Gaps = 17/263 (6%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
F ++E+IG G+F VFK + A+K + D E E+ L+ S
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEITVLSQCDS-PY 63
Query: 291 IVGYYSSWFENEQLYIQME-LCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIA 349
+ YY S+ + +L+I ME L S D + F E ++ L +I + L ++H +
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 123
Query: 350 HLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEILNED-YDHLDK 404
H D+K N+ + + G KL DFG A L + G +M E++ + YD K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD--SK 181
Query: 405 VDIFSLGATMYELIKGSPL-SESGPQ--FLNLRDGKLPLLPGH-SLQFQNLLKVMVDPDP 460
DI+SLG T EL KG P S+ P + P L G S F+ + ++ DP
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDP 241
Query: 461 VQRPSAKELVENPIFDKIQKHRK 483
RP+AKEL+++ I K+ K
Sbjct: 242 SFRPTAKELLKHKF---IVKNAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 38/269 (14%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
IE IG G + VFKVL + +G AVK +H E +A E L AL H N+V
Sbjct: 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEA--EYNILKALSDHPNVVK 79
Query: 294 YYSSWFEN-----EQLYIQMELCDHSLSDKKASQFFAEGEVLKA------LHQIAQALQF 342
+Y +++ +QL++ +ELC+ F GE ++ LH+ LQ
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 343 IHEKGIAHLDVKPDNIYVKN-GVYKLGDFG-RATLLNKSL--PIEEGDARYMPQEI---- 394
+H H DVK +NI + G KL DFG A L + L G +M E+
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 395 --LNEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQFLNLRDGKLPLLPGHSLQ---- 447
L+ YD + D++SLG T EL G PL++ P K+P P +L
Sbjct: 200 QQLDSTYD--ARCDVWSLGITAIELGDGDPPLADLHPMRALF---KIPRNPPPTLHQPEL 254
Query: 448 ----FQNLLKVMVDPDPVQRPSAKELVEN 472
F + ++ + D +RP+ +L+++
Sbjct: 255 WSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 79/299 (26%), Positives = 122/299 (40%), Gaps = 67/299 (22%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
D+ +IE+IG G + V+K + G A+K + + + A+ E+ L L H
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHP 59
Query: 290 NIVGYYSSWFENEQLYIQMELCDHSLS---DKKASQFFAEGEVLKA-LHQIAQALQFIHE 345
NIV + +LY+ E L D + + E++K+ L+QI Q + F H
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRA---------------TLLNKSLPIEEGDARY 389
+ + H D+KP N+ + GV KL DFG A TL ++ + G RY
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179
Query: 390 -MPQEILNEDYDHLDKVDIFSLGATMYEL---------------------IKGSPLSESG 427
P VDI+S+G E+ I G+P +
Sbjct: 180 STP-------------VDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226
Query: 428 PQFLNLRDGK--LPLLPGHSL--QFQN-------LLKVMVDPDPVQRPSAKELVENPIF 475
P +L D K P SL +N LL+ M+ DP +R SAK+ + +P F
Sbjct: 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 2e-16
Identities = 83/279 (29%), Positives = 134/279 (48%), Gaps = 22/279 (7%)
Query: 214 LFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERR 273
L +++ GD + YT F E+IG G V+ + G A+K Q++ + +
Sbjct: 8 LRSIVSVGDP-KKKYTRF---EKIGQGASGTVYTAIDIATGQEVAIK----QMNLQQQPK 59
Query: 274 KALLEVQALAAL-GSHENIVGYYSSWFENEQLYIQME-LCDHSLSDKKASQFFAEGEVLK 331
K L+ + L + NIV Y S+ ++L++ ME L SL+D EG++
Sbjct: 60 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA 119
Query: 332 ALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFG---RATLLNKSLPIEEGDA 387
+ QAL F+H + H D+K DNI + +G KL DFG + T G
Sbjct: 120 VCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 179
Query: 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQFLNL--RDGKLPLLPG 443
+M E++ + KVDI+SLG E+++G P L+E+ + L L +G L
Sbjct: 180 YWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238
Query: 444 HSLQ--FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
L F++ L ++ D +R SAKEL+++P F K+ K
Sbjct: 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP-FLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-16
Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 52/290 (17%)
Query: 222 DGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQA 281
DG SR ++ I++IG G F VF V + F+ K + + E+ + ++EV
Sbjct: 7 DGESRL-NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNV 65
Query: 282 LAALGSHENIVGYYSSWFE--NEQLYIQMELCDH---SLSDKKASQFFA---EGEVLKAL 333
+ L H+NIV Y + N++LYI ME CD S + +K + F E ++
Sbjct: 66 MREL-KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124
Query: 334 HQIAQALQFIHE-------KGIAHLDVKPDNIYVKNGVY------------------KLG 368
Q+ AL + H + + H D+KP NI++ G+ K+G
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 369 DFGRATLLNKSLPIEE------GDARYM-PQEILNEDYDHLDKVDIFSLGATMYELIKGS 421
DFG L+K++ IE G Y P+ +L+E + DK D+++LG +YEL G
Sbjct: 185 DFG----LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
Query: 422 PLSESGPQFLNL-----RDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSA 466
F L R LP + G S + L+K +++ +RPSA
Sbjct: 241 TPFHKANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSA 289
|
Length = 1021 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 73/263 (27%), Positives = 126/263 (47%), Gaps = 25/263 (9%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAALGSH 288
DF I++IG+G + V+K G A+K K + D A ++ ++ ++ H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC----KH 65
Query: 289 ENIVGYYSSWFENEQLYIQMELC-DHSLSD-KKASQFFAEGEVLKALHQIAQALQFIHEK 346
NIV Y+ S+ ++L+I ME C SL D + +E ++ + Q L ++H K
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 347 GIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEILNED---- 398
G H D+K NI + NG KL DFG + + ++ + G +M E+ +
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 399 YDHLDKVDIFSLGATMYELIKGSP----LSESGPQFL----NLRDGKLPLLPGHSLQFQN 450
Y+ L DI+++G T EL + P L FL N + KL S F +
Sbjct: 186 YNQL--CDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243
Query: 451 LLKVMVDPDPVQRPSAKELVENP 473
+K+ + +P +RP+A++L+++P
Sbjct: 244 FVKMALTKNPKKRPTAEKLLQHP 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 74/288 (25%), Positives = 116/288 (40%), Gaps = 48/288 (16%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE--RRKALLEVQALAALGSH 288
+ ++E+IG G + V+K ++ G A+K K +L + E A+ E+ L L +H
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALK--KIRLETEDEGVPSTAIREISLLKEL-NH 57
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLS---DKKASQFFAEGEVLKALHQIAQALQFIHE 345
NIV +LY+ E D L D + L+Q+ Q + + H
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPI-----EEGDARYMPQEILNEDY 399
+ H D+KP N+ + + G KL DFG A +P+ E Y EIL
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGSR 175
Query: 400 DHLDKVDIFSLGATMYELIKGSPL----SE-----------------SGPQFLNLRDGKL 438
+ VDI+S+G E++ PL SE P +L D K
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235
Query: 439 -----------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
++P +LL M+ DP +R SAK +++P F
Sbjct: 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 68/304 (22%), Positives = 120/304 (39%), Gaps = 74/304 (24%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
++ ++ +I G + V++ + G A+K K + + +L E+ L L H
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHP 64
Query: 290 NIVGYYSSWFENE--------QLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQA 339
NIV E ++Y+ ME +H L + Q F + EV + Q+
Sbjct: 65 NIVTV------KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSG 118
Query: 340 LQFIHEKGIAHLDVKPDNIYVKN-GVYKLGDFGRA----------TLLNKSLPIEEGDAR 388
+ +H+ I H D+K N+ + N G+ K+ DFG A T L +L
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL-------W 171
Query: 389 YMPQEIL--NEDYDHLDKVDIFSLGATMYELIK---------------------GSPLSE 425
Y E+L ++Y +D++S+G EL+ G+P +
Sbjct: 172 YRAPELLLGAKEYST--AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229
Query: 426 SGPQFLNL---RDGKLPLLPGHSL--QFQN---------LLKVMVDPDPVQRPSAKELVE 471
P F L + P + L +F LL ++ DP +R SA++ ++
Sbjct: 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289
Query: 472 NPIF 475
+P F
Sbjct: 290 HPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 76/260 (29%), Positives = 120/260 (46%), Gaps = 14/260 (5%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
F ++E+IG G+F V+K + A+K + D E E+ L+ S
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-EIEDIQQEITVLSQCDS-PY 63
Query: 291 IVGYYSSWFENEQLYIQME-LCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIA 349
I YY S+ + +L+I ME L S D E + L +I + L ++H +
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI 123
Query: 350 HLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEILNED-YDHLDK 404
H D+K N+ + + G KL DFG A L + G +M E++ + YD K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF--K 181
Query: 405 VDIFSLGATMYELIKGSP-LSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDP 460
DI+SLG T EL KG P S+ P FL ++ L +S F+ ++ ++ DP
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDP 241
Query: 461 VQRPSAKELVENPIFDKIQK 480
RP+AKEL+++ + K
Sbjct: 242 RFRPTAKELLKHKFITRYTK 261
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 75/267 (28%), Positives = 124/267 (46%), Gaps = 37/267 (13%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVK--------HSKRQLHHDAERRKALLEVQALAALGSH 288
IG G+F V +++DG YAVK + K Q H AER L V+ H
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-------H 55
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHS--LSDKKASQFFAEGEVLKALHQIAQALQFIHEK 346
+VG + S+ E+LY ++ + + + F E +IA AL ++H
Sbjct: 56 PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 347 GIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEE------GDARYMPQEIL-NED 398
I + D+KP+NI + + G L DFG L + + + G Y+ E++ +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFG---LCKEGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 399 YDHLDKVDIFSLGATMYELIKGSP---LSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVM 455
YD+ VD + LGA +YE++ G P + + N+ L L PG SL ++L+ +
Sbjct: 173 YDN--TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEEL 230
Query: 456 VDPDPVQRPSAK----ELVENPIFDKI 478
++ D +R AK E+ E+P F+ +
Sbjct: 231 LEKDRQRRLGAKEDFLEIQEHPFFESL 257
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 9e-15
Identities = 73/307 (23%), Positives = 122/307 (39%), Gaps = 78/307 (25%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
++ IG+G + V + + G A+K + ++ L E++ L L HENI+G
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR-HENIIG 63
Query: 294 -----YYSSWFENEQLYIQMELCD----------HSLSDKKASQFFAEGEVLKALHQIAQ 338
S + +YI EL + L+D Q+F L+QI +
Sbjct: 64 LLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHI-QYF--------LYQILR 114
Query: 339 ALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM------- 390
L+++H + H D+KP NI V N K+ DFG L + + +E + ++
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFG----LARGVDPDEDEKGFLTEYVVTR 170
Query: 391 ---PQEIL--NEDYDHLDKVDIFSLGATMYELIKGSPL---------------------- 423
E+L + Y +DI+S+G EL+ PL
Sbjct: 171 WYRAPELLLSSSRYT--KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228
Query: 424 -------SESGPQFLNLR--DGKLPL---LPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471
SE +L K PL PG S + +LL+ M+ DP +R +A E +
Sbjct: 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288
Query: 472 NPIFDKI 478
+P ++
Sbjct: 289 HPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 76/304 (25%), Positives = 119/304 (39%), Gaps = 67/304 (22%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
DF I+ IG G F V+ V + G YA+K K + + E LA S
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS- 60
Query: 289 ENIVGYYSSWFENEQLYIQME----------LCDHSLSDKKASQFFAEGEVLKALHQIAQ 338
IV Y S+ + E LY+ ME L + ++ ++F+ E++ AL
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYI-AELVLALDS--- 116
Query: 339 ALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR--------- 388
+H+ G H D+KPDNI + +G KL DFG +NK+ E
Sbjct: 117 ----VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 389 -----------------------YMPQEIL-NEDYDHLDKVDIFSLGATMYELIKG-SPL 423
Y+ E+L Y D +SLG +YE++ G P
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE--CDWWSLGVILYEMLYGFPPF 230
Query: 424 SESGPQ--FLNLRDGK----LPLLPGHSLQFQNLL-KVMVDPDPVQR-PSAKELVENPIF 475
Q + + + K P P S + +L+ +++ DP+ R S +E+ +P F
Sbjct: 231 YSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPE--DRLGSFEEIKSHPFF 288
Query: 476 DKIQ 479
I
Sbjct: 289 KGID 292
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 69/294 (23%), Positives = 124/294 (42%), Gaps = 58/294 (19%)
Query: 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKR--QLHHDAERRKALLEVQALAALGSHEN 290
+ +G+G + V G A+K R Q A+R E++ L + HEN
Sbjct: 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKR--TYRELRLLKHM-DHEN 75
Query: 291 IVGYY-----SSWFEN-EQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIH 344
++G +S E+ + +Y+ L L++ Q ++ + ++QI + L++IH
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH 135
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM-PQEILNEDYDHL 402
GI H D+KP NI V ++ K+ DFG A + + Y P+ +LN + H
Sbjct: 136 SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLN--WMHY 193
Query: 403 DK-VDIFSLGATMYELIKGSPL-----------------------------SESGPQFL- 431
++ VDI+S+G M EL+ G L SES ++
Sbjct: 194 NQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQ 253
Query: 432 --------NLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
+ ++ + G + +LL+ M+ DP +R +A E + +P +
Sbjct: 254 SLPQMPKKDFKE----VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 1e-14
Identities = 79/277 (28%), Positives = 133/277 (48%), Gaps = 24/277 (8%)
Query: 217 VITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKAL 276
+++ GD +Y E+IG G VF + G A+K Q++ + +K L
Sbjct: 11 IVSIGDPKKKYT----RYEKIGQGASGTVFTAIDVATGQEVAIK----QINLQKQPKKEL 62
Query: 277 L--EVQALAALGSHENIVGYYSSWFENEQLYIQME-LCDHSLSDKKASQFFAEGEVLKAL 333
+ E+ + L + NIV + S+ ++L++ ME L SL+D E ++
Sbjct: 63 IINEILVMKEL-KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVC 121
Query: 334 HQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFG---RATLLNKSLPIEEGDARY 389
+ QAL+F+H + H D+K DN+ + +G KL DFG + T G +
Sbjct: 122 RECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 390 MPQEILNEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQFLNL--RDGKLPLLPGHS 445
M E++ + KVDI+SLG E+++G P L+E+ + L L +G L
Sbjct: 182 MAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240
Query: 446 LQ--FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
L F++ L ++ D +R SAKEL+++P F K+ K
Sbjct: 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHP-FLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 278 EVQALAALGSHENIVGYYSSWFENEQLYIQME-LCDHSLSDK-KASQFFAEGEVLKALHQ 335
E+Q L L HE IV YY ++E L I ME + S+ D+ KA E K Q
Sbjct: 54 EIQLLKNL-QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ 112
Query: 336 IAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---------KSLPIEEG 385
I + ++++H I H D+K NI G KLGDFG + L KS+ G
Sbjct: 113 ILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV---TG 169
Query: 386 DARYM-PQEILNEDYDHLDKVDIFSLGATMYELIKGSP----LSESGPQFLNLRDGKLPL 440
+M P+ I E Y K D++S+G T+ E++ P F P
Sbjct: 170 TPYWMSPEVISGEGYGR--KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ 227
Query: 441 LPGH-SLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
LP H S +N L+ + +RPSA+EL+ +
Sbjct: 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 74/252 (29%), Positives = 120/252 (47%), Gaps = 14/252 (5%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
F ++E+IG G+F VFK + A+K + D E E+ L+ S
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIEDIQQEITVLSQCDS-PY 63
Query: 291 IVGYYSSWFENEQLYIQME-LCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIA 349
+ YY S+ ++ +L+I ME L S D E ++ L +I + L ++H +
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 123
Query: 350 HLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEILNED-YDHLDK 404
H D+K N+ + ++G KL DFG A L + G +M E++ + YD K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD--SK 181
Query: 405 VDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDP 460
DI+SLG T EL KG P SE P FL ++ L +S + ++ ++ +P
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 241
Query: 461 VQRPSAKELVEN 472
RP+AKEL+++
Sbjct: 242 SFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 83/294 (28%), Positives = 128/294 (43%), Gaps = 41/294 (13%)
Query: 213 GLFP---VITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD 269
GLFP + G + L + IE IG G + V+KV + DG AVK D
Sbjct: 3 GLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD 62
Query: 270 AERRKALLEVQALAALGSHENIVGYYSSWFENE-----QLYIQMELCD-HSLSD-----K 318
E E L +L +H N+V +Y +++ + QL++ +ELC+ S+++
Sbjct: 63 EEIEA---EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLL 119
Query: 319 KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NGVYKLGDFG-----R 372
Q E + L+ LQ +H I H DVK +NI + G KL DFG
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179
Query: 373 ATLLNKSLPIEEGDARYMPQEIL----NEDYDHLDKVDIFSLGATMYELIKGS-PLSESG 427
+T L ++ + G +M E++ DY + + D++SLG T EL G PL +
Sbjct: 180 STRLRRNTSV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237
Query: 428 PQFLNLRDGKLPLLPGHSL--------QFQNLLKVMVDPDPVQRPSAKELVENP 473
P K+P P +L F + + + D RPS L+E+P
Sbjct: 238 PVKTLF---KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP 288
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 70/299 (23%), Positives = 127/299 (42%), Gaps = 51/299 (17%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALAALGS 287
F +I+ +G G+ VF V + G +A+K K+++ + ++ L E + LA L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-D 59
Query: 288 HENIVGYYSSWFENEQLYIQMELCD----HSLSDKKASQFFAEGEVLKALHQIAQALQFI 343
H + Y+S+ L + M+ C L ++ + +E ++ AL+++
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 344 HEKGIAHLDVKPDNIYVK-NGVYKLGDF-------------------GRATLLNKSLPIE 383
H GI + D+KP+NI + +G L DF G S+P E
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 384 ----EGDAR---------YMPQEILNEDYDHLDKVDIFSLGATMYELI------KGSPLS 424
E R Y+ E+++ D H VD ++LG +YE++ KGS
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238
Query: 425 ESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQR----PSAKELVENPIFDKIQ 479
E+ L ++ P P S ++L++ ++ DP +R A E+ ++P F +
Sbjct: 239 ETFSNILK-KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 65/234 (27%), Positives = 111/234 (47%), Gaps = 28/234 (11%)
Query: 258 AVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH---- 313
AVK K H ER + E++ ++ LG+HENIV + + + E C +
Sbjct: 69 AVKMLKPTAHSS-EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127
Query: 314 SLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNG-VYKLGDFGR 372
+ +K F ++L +Q+A+ + F+ K H D+ N+ + +G + K+ DFG
Sbjct: 128 NFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187
Query: 373 A-TLLNKSLPIEEGDAR----YM-PQEILNEDYDHLDKV--------DIFSLGATMYELI 418
A ++N S + +G+AR +M P+ I N Y V +IFSLG+ Y
Sbjct: 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY--- 244
Query: 419 KGSPLSESGPQFLNL-RDGKLPLLPGHSLQ-FQNLLKVMVDPDPVQRPSAKELV 470
G P+ F L ++G P H+ +++K D DP++RP+ K++V
Sbjct: 245 PGMPVDSK---FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIV 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 69/293 (23%), Positives = 114/293 (38%), Gaps = 47/293 (16%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ ++E+IG G + V+K + G A+K ++ ++ + AL E+ L L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 291 IVGYYSSWFENE-----QLYIQMELCDHSLSD------KKASQFFAEGEVLKALHQIAQA 339
IV E LY+ E D L + + + ++Q+ +
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 340 LQFIHEKGIAHLDVKPDNIYVKN--GVYKLGDFG--RA-TLLNKSLPIEEGDARYMPQEI 394
+ H+ G+ H D+KP N+ V G+ K+ D G RA ++ KS E Y E+
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEV 182
Query: 395 LNEDYDHLDKVDIFSLGATMYELIKGSPL---------------------SESGPQFLNL 433
L + VDI+S+G E+ + PL + P L
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL 242
Query: 434 RD-GKLPLLPGHSLQFQ---------NLLKVMVDPDPVQRPSAKELVENPIFD 476
RD + P L +LL+ M+ DP +R SAK + +P FD
Sbjct: 243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 68/295 (23%), Positives = 116/295 (39%), Gaps = 67/295 (22%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSK---RQLHHDAERRKALLEVQALAALGSHEN 290
+++G G ++ V+K + G A+K K R+ D AL E++ L L H N
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPN 63
Query: 291 IVGYYSSWFENEQLYIQMELCDHSLS----DKKASQFFAEGEVLKALHQIAQALQFIHEK 346
I+G + + + E + L DK S ++ + + L+++H
Sbjct: 64 IIGLLDVFGHKSNINLVFEFMETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSN 121
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR-----------YMPQEI 394
I H D+KP+N+ + +GV KL DFG A G Y E+
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSF--------GSPNRKMTHQVVTRWYRAPEL 173
Query: 395 L--NEDYDHLDKVDIFSLGATMYELIK---------------------GSPLSESGPQFL 431
L Y VD++S+G EL+ G+P E+ P
Sbjct: 174 LFGARHYGV--GVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231
Query: 432 NLRD----GKLPLLPGHSLQF-------QNLLKVMVDPDPVQRPSAKELVENPIF 475
+L D P P + F +LL+ ++ +P +R +A++ +E+P F
Sbjct: 232 SLPDYVEFKPFPPTPLKQI-FPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 77/310 (24%), Positives = 122/310 (39%), Gaps = 73/310 (23%)
Query: 225 SRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERR--KALLEVQAL 282
R F I QIG G + V+K + G A+K K +L ++ E A+ E++ L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALK--KVRLDNEKEGFPITAIREIKIL 60
Query: 283 AALGSHENIVGYY--------SSWF--ENEQLYIQMELCDHSLSDKKASQF--FAEGEVL 330
L +H NIV + F + Y+ E DH L S F+E +
Sbjct: 61 RQL-NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 331 KALHQIAQALQFIHEKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEEGDAR- 388
+ Q+ + L + H+K H D+K NI + N G KL DFG A L N ++R
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS------EESRP 173
Query: 389 ---------YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD---- 435
Y P E+L + + +D++S G + EL P+ ++ + L
Sbjct: 174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233
Query: 436 ------------GKLPL--------------------LPGHSLQFQNLLKVMVDPDPVQR 463
KLP +P +L +LL M+ DP +R
Sbjct: 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPAL---DLLDHMLTLDPSKR 290
Query: 464 PSAKELVENP 473
+A+E + +P
Sbjct: 291 CTAEEALNSP 300
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 68/269 (25%), Positives = 120/269 (44%), Gaps = 35/269 (13%)
Query: 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGS 287
++ + +IG+G V+KV+ R G YA+K H D RR+ E++ L + +
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-HEDTVRRQICREIEILRDV-N 130
Query: 288 HENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIHEK 346
H N+V + + N ++ + +E D SL + E + QI + ++H +
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD---EQFLADVARQILSGIAYLHRR 187
Query: 347 GIAHLDVKPDNIYVKNGV-YKLGDFGRATLLNKSL-PIEE--GDARYMPQEILNEDYDH- 401
I H D+KP N+ + + K+ DFG + +L +++ P G YM E +N D +H
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247
Query: 402 -LDKV--DIFSLGATMYELIKGS-PLSESGPQFLNLRDGKLPLL-------------PGH 444
D DI+SLG ++ E G P R G L
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPFGVG-------RQGDWASLMCAICMSQPPEAPATA 300
Query: 445 SLQFQNLLKVMVDPDPVQRPSAKELVENP 473
S +F++ + + +P +R SA +L+++P
Sbjct: 301 SREFRHFISCCLQREPAKRWSAMQLLQHP 329
|
Length = 353 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 31/274 (11%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
DF +G G+F V V ++ G YA+K K+ + E E + + ++ +
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 290 NIVGYYSSWFENEQLYIQMELCDH----SLSDKKASQFFAEGEVLKALHQIAQALQFIHE 345
I ++ + + LY+ ME SL ++ QF E L ++ A+ +H+
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF-DEDMAQFYLAELVLAIHSVHQ 120
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS------LPIEEGDARYMPQEIL--- 395
G H D+KP+N+ + + G KL DFG A L + LP+ G Y+ E+L
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV--GTPDYIAPEVLTTM 178
Query: 396 ----NEDYDHLDKVDIFSLGATMYELIKG-SPLSE--SGPQFLNL----RDGKLPLLPGH 444
Y + D +SLG YE+I G SP E S + N+ R K P P
Sbjct: 179 NGDGKGTYG--VECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236
Query: 445 SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478
S F +L++ ++ +R + L +P F KI
Sbjct: 237 SSDFLDLIQSLL-CGQKERLGYEGLCCHPFFSKI 269
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 74/282 (26%), Positives = 120/282 (42%), Gaps = 43/282 (15%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRI---DGCFYAVKHSKR----QLHHDAERRKALLEVQAL 282
+F + +G G + VF V K G YA+K K+ Q AE + E Q L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT--ERQVL 58
Query: 283 AALGSHENIVGYYSSWFENEQLYIQM------ELCDHSLSDKKASQFFAEGEVLKALHQI 336
A+ +V + ++ + +L++ + EL H + F E EV + +I
Sbjct: 59 EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEI 114
Query: 337 AQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGD--------A 387
AL +H+ GI + D+K +NI + G L DFG L+K EE +
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFG----LSKEFLAEEEERAYSFCGTI 170
Query: 388 RYMPQEILNE-DYDHLDKVDIFSLGATMYELIKG-SPLSESGPQFLN------LRDGKLP 439
YM E++ H VD +SLG +EL+ G SP + G Q + K P
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP 230
Query: 440 LLPGHSLQFQNLLKVMVDPDPVQR---PSAKELVENPIFDKI 478
S + ++ ++ +++ DP +R A E+ +P F I
Sbjct: 231 FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 74/268 (27%), Positives = 123/268 (45%), Gaps = 42/268 (15%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
IG G+F V + DG FYAVK K+ + E++ + E L H +VG +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 296 SSWFENEQLYIQM------ELCDH-----SLSDKKASQFFAEGEVLKALHQIAQALQFIH 344
S+ ++LY + EL H S + +A + AE IA AL ++H
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE---------IASALGYLH 113
Query: 345 EKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEE------GDARYM-PQEILN 396
I + D+KP+NI + + G L DFG L + + + G Y+ P+ +
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFG---LCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170
Query: 397 EDYDHLDKVDIFSLGATMYELIKGSP---LSESGPQFLNLRDGKLPLLPGHSLQFQNLLK 453
+ YD VD + LGA +YE++ G P ++ + N+ + L L P S+ ++LL+
Sbjct: 171 QPYDR--TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLE 228
Query: 454 VMVDPDPVQRPSAKELVENPIFDKIQKH 481
++ D +R AK+ F +I+ H
Sbjct: 229 GLLQKDRTKRLGAKD-----DFLEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 75/274 (27%), Positives = 114/274 (41%), Gaps = 45/274 (16%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKH---SKRQLHHDAERRKALL-----EVQALAALG 286
E IG G + V+ L G AVK R+K ++ E++ L L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL- 65
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQF-----FAEGEVLKALHQIAQALQ 341
H NIV Y FE + Y+ + L ++ S F E V Q+ + L
Sbjct: 66 DHLNIVQYLG--FETTEEYLSIFL-EYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122
Query: 342 FIHEKGIAHLDVKPDNIYVK-NGVYKLGDFG--------RATLLNKSLPIEEGDARYM-P 391
++H KGI H D+K DN+ V +G+ K+ DFG N S+ +G +M P
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM---QGSVFWMAP 179
Query: 392 QEILNEDYDHLDKVDIFSLGATMYELIKG----SPLSESGPQFLNLRDGKLPLLPGH--- 444
+ I + + KVDI+SLG + E+ G S F P +P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239
Query: 445 -----SLQFQNLLKVMVDPDPVQRPSAKELVENP 473
+L F N ++PD RP+A+EL+++P
Sbjct: 240 NLSPVALDFLN-ACFTINPD--NRPTARELLQHP 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 52/277 (18%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKH-------SKRQLHH-DAERRKALLEVQALAAL 285
++ I G F V+ KR G ++A+K +K Q+ + AER A++ +Q
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAER--AIMMIQ----- 53
Query: 286 GSHENIVGYYSSWFENEQLYIQMELCDHS-----------LSDKKASQFFAEGEVLKALH 334
G + Y S+ + LY+ ME + L + A Q+ AE
Sbjct: 54 GESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAE-------- 105
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFG--RATLLNKSLPIEEGDARYMP 391
+ ++ +H++GI H D+KP+N+ + + G KL DFG R L NK G Y+
Sbjct: 106 -VVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF---VGTPDYLA 161
Query: 392 QEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESG-PQ--FLNLRDGKL----PLLPGH 444
E + D +SLG ++E + G P + P F N+ ++ +
Sbjct: 162 PETIL-GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFC 220
Query: 445 SLQFQNLLKVMVDPDPVQRPSAK---ELVENPIFDKI 478
S + +L+ ++ DP +R A E+ +P F I
Sbjct: 221 SPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 4e-13
Identities = 68/267 (25%), Positives = 124/267 (46%), Gaps = 28/267 (10%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
F +E +G G + V+K G A+K + E ++ E+ L H N
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRN 64
Query: 291 IVGYYSSWFE------NEQLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIAQAL 340
I YY ++ + ++QL++ ME C S++D E + +I + L
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 341 QFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEIL- 395
+H+ + H D+K N+ + +N KL DFG + L++++ G +M E++
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 396 ---NEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGKLPLLPGH--SL 446
N D + K D++SLG T E+ +G+ PL + P FL R+ P L S
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PAPRLKSKKWSK 243
Query: 447 QFQNLLKVMVDPDPVQRPSAKELVENP 473
+FQ+ ++ + + QRP+ ++L+++P
Sbjct: 244 KFQSFIESCLVKNHSQRPTTEQLMKHP 270
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-13
Identities = 81/276 (29%), Positives = 117/276 (42%), Gaps = 42/276 (15%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE---RRKALLEVQALAALG 286
D I +GAGN V KV G A K+ +H A+ R++ L E+Q +
Sbjct: 6 DLETISDLGAGNGGSVSKVKHIPTGTVMA----KKVVHIGAKSSVRKQILRELQIMHECR 61
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDHSLSD---KKASQFFAE--GEVLKALHQIAQALQ 341
S IV +Y ++ + + ME D D KK E G++ A+ + L
Sbjct: 62 S-PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 342 FIHEKGIAHLDVKPDNIYVKN-GVYKLGDFG-RATLLNKSLPIEEGDARYM-PQEILNED 398
+H I H D+KP NI V + G KL DFG L+N G + YM P+ I
Sbjct: 121 NVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGK 178
Query: 399 YDHLDKVDIFSLGATMYELIKGS-PLSESGPQFLNLRDGKL--------------PLLPG 443
Y K D++SLG ++ EL G P + S + +D + P LP
Sbjct: 179 YTV--KSDVWSLGISIIELALGKFPFAFS-NIDDDGQDDPMGILDLLQQIVQEPPPRLP- 234
Query: 444 HSLQFQNLLKVMVD----PDPVQRPSAKELVENPIF 475
S F L+ VD DP +RP+ ++L P F
Sbjct: 235 -SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 71/296 (23%), Positives = 121/296 (40%), Gaps = 46/296 (15%)
Query: 223 GLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQAL 282
G R T+F ++ +IG G + V++ G A+K + D +L E+ L
Sbjct: 1 GRCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLL 60
Query: 283 AALGSHENIVGYYSSWFEN--EQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQ 338
L H NIV + +++ ME C+ L+ F+E +V + Q+ +
Sbjct: 61 LNL-RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLR 119
Query: 339 ALQFIHEKGIAHLDVKPDN-IYVKNGVYKLGDFGRATLLNKSLPIEEGDAR-----YMPQ 392
LQ++HE I H D+K N + G K+ DFG A LP + + Y
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY--GLPAKPMTPKVVTLWYRAP 177
Query: 393 EILNEDYDHLDKVDIFSLGATMYELIKGSPL--SESGPQFLNLRDG-------------- 436
E+L + +D++++G + EL+ PL +S + L+L
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237
Query: 437 KLPLLPGHSLQFQ-----------------NLLKVMVDPDPVQRPSAKELVENPIF 475
LPL+ +L Q LL ++ DP +R +A+E +E+ F
Sbjct: 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 71/261 (27%), Positives = 112/261 (42%), Gaps = 29/261 (11%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSHE 289
F ++ +IG G+F V+ + A+K E+ + ++ EV+ L L H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHP 75
Query: 290 NIVGYYSSWFENEQLYIQMELCDHSLSD-----KKASQFFAEGEVLKALHQIAQALQFIH 344
N + Y + ++ ME C S SD KK Q E E+ H Q L ++H
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ---EVEIAAVTHGALQGLAYLH 132
Query: 345 EKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLD 403
+ H DVK NI + G+ KLGDFG A+++ + P+ IL D D
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 404 -KVDIFSLGATMYELIKGSPLSESGPQFLNLR---------DGKLPLLPGH--SLQFQNL 451
KVD++SLG T E L+E P N+ + P L S F+N
Sbjct: 193 GKVDVWSLGITCIE------LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246
Query: 452 LKVMVDPDPVQRPSAKELVEN 472
+ + P RP+++ L+++
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKH 267
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 69/277 (24%), Positives = 107/277 (38%), Gaps = 34/277 (12%)
Query: 231 FHEIEQIGAGNFSHVFKV--LKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGS 287
+ IG G + V+K DG YA+K K + A E+ L L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-K 60
Query: 288 HENIVGYYSSWFENEQ--LYIQMELCDHSL-------SDKKASQFFAEGEVLKALHQIAQ 338
HEN+V + E+ +Y+ + +H L K V L QI
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSI-PPSMVKSLLWQILN 119
Query: 339 ALQFIHEKGIAHLDVKPDNIYV-----KNGVYKLGDFGRATLLNKSL-PIEEGDAR---- 388
+ ++H + H D+KP NI V + GV K+GD G A L N L P+ + D
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 389 -YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQ 447
Y E+L + +DI+++G EL+ P+ F P Q
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI------FKGREAKIKKSNPFQRDQ 233
Query: 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKT 484
+ + +V+ P P K++ P +D + K KT
Sbjct: 234 LERIFEVLGTPTEKDWPDIKKM---PEYDTLMKDFKT 267
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 14/206 (6%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGS--H 288
+ E+ +IG G + V+K G F A+K + L + L E+ L L S H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 289 ENIVGYYS----SWFENE-QLYIQMELCDHSLSD--KKASQFFAEGEVLKAL-HQIAQAL 340
NIV + E +L + E D L+ K + E +K L Q+ + +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 341 QFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR--YMPQEILNE 397
F+H I H D+KP NI V +G K+ DFG A + + + + Y E+L +
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQ 180
Query: 398 DYDHLDKVDIFSLGATMYELIKGSPL 423
+ VD++S+G EL + PL
Sbjct: 181 SS-YATPVDMWSVGCIFAELFRRRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 70/290 (24%), Positives = 120/290 (41%), Gaps = 42/290 (14%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ +++Q+G+G + V L R G A+K R + ++A E++ L + HEN
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHEN 75
Query: 291 IVGYYSSWFENEQL------YIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIH 344
++G + + L Y+ M L + +E + ++Q+ + L++IH
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH 135
Query: 345 EKGIAHLDVKPDNIYVKNGV-YKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLD 403
GI H D+KP N+ V K+ DFG A + + Y E++ +
Sbjct: 136 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQ 195
Query: 404 KVDIFSLGATMYELIKGSPL--------------------SESGPQFLNLRDGK-----L 438
VDI+S+G M E++ G PL S+ Q L D K L
Sbjct: 196 TVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKL 255
Query: 439 P---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479
P LLP + N+L+ M+ D R +A E + +P F++
Sbjct: 256 PRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 75/256 (29%), Positives = 112/256 (43%), Gaps = 41/256 (16%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVK--------HSKRQLHHDAERRKALLEVQALAALGSH 288
IG G+F V ++ DG FYAVK K Q H AER L ++ H
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-------H 55
Query: 289 ENIVGYYSSWFENEQLYIQM------ELCDHSLSDKKASQFFAEGEVLKALHQIAQALQF 342
+VG + S+ E+LY + EL H ++ F E ++A A+ +
Sbjct: 56 PFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC----FLEPRARFYAAEVASAIGY 111
Query: 343 IHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE------GDARYMPQEIL 395
+H I + D+KP+NI + G L DFG L + + EE G Y+ E+L
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFG---LCKEGVEPEETTSTFCGTPEYLAPEVL 168
Query: 396 -NEDYDHLDKVDIFSLGATMYELIKGSPLSES---GPQFLNLRDGKLPLLPGHSLQFQNL 451
E YD VD + LGA +YE++ G P S + N+ L L G ++ +L
Sbjct: 169 RKEPYDR--TVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDL 226
Query: 452 LKVMVDPDPVQRPSAK 467
L ++ D +R AK
Sbjct: 227 LVGLLHKDQRRRLGAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 70/278 (25%), Positives = 116/278 (41%), Gaps = 40/278 (14%)
Query: 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQAL--- 282
+Y+ +G+G V + DG +AVK + +A++ +A EV L
Sbjct: 33 KYWIS----RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC 88
Query: 283 ---AALGSHENIVGYYSSWFENEQLYIQM-----------ELCDHSLSDKKASQFFAEGE 328
+ + HE+ + M +L S K ++ F E E
Sbjct: 89 DFFSIVKCHEDFA--KKD--PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHE 144
Query: 329 VLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDA 387
Q+ A+ +H K + H D+K NI + NG+ KLGDFG + + ++ + G
Sbjct: 145 AGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204
Query: 388 -----RYMPQEILNEDYDHLDKVDIFSLGATMYELIK------GSPLSESGPQFLNLRDG 436
Y+ EI + K D+FSLG +YEL+ G + E + L R
Sbjct: 205 FCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD 263
Query: 437 KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPI 474
LP P S + Q ++ ++ DP +RPS+ +L+ PI
Sbjct: 264 PLP--PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPI 299
|
Length = 496 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 62/277 (22%), Positives = 109/277 (39%), Gaps = 51/277 (18%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRK---ALLEVQALAALGSHENI 291
+Q+G G FS ++ G AVK + +E+ + AL + L A +H +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 292 VGYYSSWFENEQLYIQMEL-----CDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEK 346
+ + E+ + +E H LS A F E ++ Q+ + L ++HE
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLHEN 122
Query: 347 GIAHLDVKPDNIYVKNG--VYKLGDFGRATLLNKSLPIEE-------GDARYMPQEIL-N 396
I H DVK N+ + + ++ DFG A L G +M E+L
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 397 EDYDHLDKVDIFSLGATMYELIKGSP-----------------LSESGPQFLNLRDGKLP 439
E Y D++S+G + E+ P S + P
Sbjct: 183 EQYGR--SCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA----------P 230
Query: 440 LLPGH-SLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
+P H S +++ ++ P RP ++EL+++P+F
Sbjct: 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 77/286 (26%), Positives = 124/286 (43%), Gaps = 20/286 (6%)
Query: 213 GLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAER 272
F + D + +++ IG+G V + G AVK R +
Sbjct: 5 SQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA 64
Query: 273 RKALLEVQALAALGSHENIVGYYS------SWFENEQLYIQMELCDHSLSDKKASQFFAE 326
++A E+ L + +H+NI+ + S E + +Y+ MEL D +L + E
Sbjct: 65 KRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHE 123
Query: 327 GEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNG-VYKLGDFGRA-TLLNKSLPIEE 384
+ L+Q+ ++ +H GI H D+KP NI VK+ K+ DFG A T +
Sbjct: 124 -RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY 182
Query: 385 GDARY--MPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLP 442
RY P+ IL Y + VDI+S+G M EL+KGS + + G ++ + + L
Sbjct: 183 VVTRYYRAPEVILGMGYK--ENVDIWSVGCIMGELVKGSVIFQ-GTDHIDQWNKVIEQLG 239
Query: 443 GHSLQFQNLLKVMVDPDPVQRP-----SAKELVENPIFDKIQKHRK 483
S +F N L+ V RP S +EL + IF + K
Sbjct: 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDK 285
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKR-------QLHHDAERRKALLEVQAL 282
DF E +G G+F V + G +YA+K K+ Q+ H A+ + L+E+
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL--- 75
Query: 283 AALGSHENIVGYYSSWFENEQLYIQME------LCDHSLSDKKASQFFAEGEVLKALH-Q 335
SH IV S+ + ++Y +E L H +KA +F +V K H +
Sbjct: 76 ----SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRF--PNDVAKFYHAE 126
Query: 336 IAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEI 394
+ A +++H K I + D+KP+N+ + G K+ DFG A + G Y+ E+
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEV 186
Query: 395 LNEDYDHLDKVDIFSLGATMYELIKGSP 422
+ + H VD +++G +YE I G P
Sbjct: 187 I-QSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 72/272 (26%), Positives = 111/272 (40%), Gaps = 36/272 (13%)
Query: 222 DGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK---HSKRQLHHDAERRKALLE 278
D + HEI G G+F V+ AVK +S +Q + + + + E
Sbjct: 17 DDPEEIFVGLHEI---GHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE--KWQDIIKE 71
Query: 279 VQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSLSD-----KKASQFFAEGEVLKAL 333
V+ L L H N + Y + + ++ ME C S SD KK Q E E+
Sbjct: 72 VKFLQQL-KHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQ---EVEIAAIT 127
Query: 334 HQIAQALQFIHEKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEEGDARYMPQ 392
H Q L ++H + H D+K NI + G KL DFG A+ + + P+
Sbjct: 128 HGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPE 187
Query: 393 EILNEDYDHLD-KVDIFSLGATMYELIKGSPLSESGPQFLNLR---------DGKLPLLP 442
IL D D KVD++SLG T E L+E P N+ P L
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIE------LAERKPPLFNMNAMSALYHIAQNDSPTLQ 241
Query: 443 GH--SLQFQNLLKVMVDPDPVQRPSAKELVEN 472
+ + F+ + + P +RP++ EL+ +
Sbjct: 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 67/201 (33%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH----DAERRKALLEVQALAAL 285
DF +I ++GAGN VFKV + G A R+L H A R + + E+Q L
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMA-----RKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 286 GSHENIVGYYSSWFENEQLYIQMELCDHSLSD---KKASQFFAEGEVLKALHQIAQALQF 342
S IVG+Y +++ + ++ I ME D D KKA + E + K + + L +
Sbjct: 61 NS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 118
Query: 343 IHEK-GIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIE-EGDARYMPQEILNEDY 399
+ EK I H DVKP NI V + G KL DFG + L S+ G YM E L +
Sbjct: 119 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH 178
Query: 400 DHLDKVDIFSLGATMYELIKG 420
+ + DI+S+G ++ E+ G
Sbjct: 179 YSV-QSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 84/283 (29%), Positives = 121/283 (42%), Gaps = 62/283 (21%)
Query: 234 IEQIGAGNFSHV----FKVLKRIDGCFYAVK---HSKRQLHHDAERRKALLEVQALAALG 286
I+Q+G GNF V + L+ G AVK HS + D ER E++ L +L
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER-----EIEILKSL- 62
Query: 287 SHENIVGY----YSSWFENEQLYIQME-LCDHSLSD---KKASQFFAEGEVLKALHQIAQ 338
H+NIV Y YS+ N L + ME L SL D K + +L A QI +
Sbjct: 63 QHDNIVKYKGVCYSAGRRN--LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA-SQICK 119
Query: 339 ALQFIHEKGIAHLDVKPDNIYVKNGVY-KLGDFGRATLLNKSLPI--------EEGDAR- 388
++++ K H D+ NI V++ K+GDFG L K LP E G++
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESENRVKIGDFG----LTKVLPQDKEYYKVREPGESPI 175
Query: 389 --YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP------------------ 428
Y P+ + + D++S G +YEL S S S P
Sbjct: 176 FWYAPESLTESKFSV--ASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY 233
Query: 429 QFLNL--RDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKEL 469
+ L +G+LP PG + ++K + DP QRPS EL
Sbjct: 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 68/264 (25%), Positives = 122/264 (46%), Gaps = 25/264 (9%)
Query: 230 DFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+F EI ++G G F V+K + G A K + + E ++E+ LA+ H
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASC-DH 61
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLSDK---KASQFFAEGEVLKALHQIAQALQFIHE 345
NIV +++ L+I +E C D + + E ++ Q +AL ++HE
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 346 KGIAHLDVKPDNI-YVKNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEIL------ 395
I H D+K NI + +G KL DFG + +++ + G +M E++
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 396 NEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ--FLNLRDGKLPLL--PGH-SLQFQ 449
+ YD+ K D++SLG T+ E+ + P E P L + + P L P S +F+
Sbjct: 182 DRPYDY--KADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239
Query: 450 NLLKVMVDPDPVQRPSAKELVENP 473
+ LK ++ + R + +L+++P
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHP 263
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 69/263 (26%), Positives = 115/263 (43%), Gaps = 24/263 (9%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
+G G F V + G YA K K++L + AL E + L + S IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLA 59
Query: 296 SSWFENEQLYIQMELCD----HSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
++ + L + M L + F E + QI L+ +H++ I +
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 352 DVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEE--GDARYMPQEIL-NEDYDHLDKVDI 407
D+KP+N+ + + G ++ D G A L I+ G YM E+L E YD VD
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDF--SVDW 177
Query: 408 FSLGATMYELIKG-SPLSESGPQF----LNLRDGKLPLLPGHSL--QFQNLLKVMVDPDP 460
F+LG T+YE+I G SP + + L R ++ + + ++L + ++ DP
Sbjct: 178 FALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP 237
Query: 461 VQR-----PSAKELVENPIFDKI 478
+R SA E+ E+P+F +
Sbjct: 238 EKRLGCRGGSADEVREHPLFKDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYY 295
+G G+F V + YAVK K+ + D + + E + LA G H + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 296 SSWFENEQLYIQMELCD------HSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIA 349
S + ++L+ ME + H + F E +I LQF+HE+GI
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHERGII 118
Query: 350 HLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDA--------RYMPQEILNE-DY 399
+ D+K DN+ + G K+ DFG + K I G Y+ EIL+ Y
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFG----MCKE-GILGGVTTSTFCGTPDYIAPEILSYQPY 173
Query: 400 DHLDKVDIFSLGATMYELIKGSP 422
VD ++LG +YE++ G
Sbjct: 174 GP--AVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 62/242 (25%), Positives = 100/242 (41%), Gaps = 45/242 (18%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERR---KALLEVQALAAL 285
T + +E++G G+++ V+K + RI+G A+K + E A+ E L L
Sbjct: 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALK----VISMKTEEGVPFTAIREASLLKGL 60
Query: 286 GSHENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEG-------EVLKALHQIAQ 338
H NIV + E L E L+ Q+ + V + Q+ +
Sbjct: 61 -KHANIVLLHDIIHTKETLTFVFEYMHTDLA-----QYMIQHPGGLHPYNVRLFMFQLLR 114
Query: 339 ALQFIHEKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEEGDAR-----YMPQ 392
L +IH + I H D+KP N+ + G KL DFG A KS+P + + Y P
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPP 172
Query: 393 EILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLL 452
++L D+ +DI+ G E+++G P PG S F+ L
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQ-----------------PAFPGVSDVFEQLE 215
Query: 453 KV 454
K+
Sbjct: 216 KI 217
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 68/267 (25%), Positives = 122/267 (45%), Gaps = 28/267 (10%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
F +E +G G + V+K G A+K + E + LE+ L H N
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRN 74
Query: 291 IVGYYSSWFE------NEQLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIAQAL 340
I YY ++ + ++QL++ ME C S++D E + +I + L
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134
Query: 341 QFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEIL- 395
+H + H D+K N+ + +N KL DFG + L++++ G +M E++
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 396 ---NEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGKLPLLPGH--SL 446
N D + + DI+SLG T E+ +G+ PL + P FL R+ P L S
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP-PKLKSKKWSK 253
Query: 447 QFQNLLKVMVDPDPVQRPSAKELVENP 473
+F + ++ + + + RPS ++L+++P
Sbjct: 254 KFIDFIEGCLVKNYLSRPSTEQLLKHP 280
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 50/299 (16%)
Query: 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALA 283
L YT Q+G+G + V + + G A+K R + ++A E+ L
Sbjct: 13 LPERYTSLK---QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLK 69
Query: 284 ALGSHENIVGYY------SSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIA 337
+ HEN++G S E + Y+ M L K +E +V ++Q+
Sbjct: 70 HM-QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQ-KIMGHPLSEDKVQYLVYQML 127
Query: 338 QALQFIHEKGIAHLDVKPDNIYVKNGV-YKLGDFGRATLLNKSLPIEEGDARY-MPQEIL 395
L++IH GI H D+KP N+ V K+ DFG A + + Y P+ IL
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVIL 187
Query: 396 NEDYDHLDK-VDIFSLGATMYELIKGSPLSES-----------------GPQFLNLRDGK 437
N + H ++ VDI+S+G M E++ G L + GP+F+ + K
Sbjct: 188 N--WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245
Query: 438 --------LP---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479
LP L P S Q +LL+ M++ D +R +A E +E+P FD +
Sbjct: 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 67/255 (26%), Positives = 111/255 (43%), Gaps = 17/255 (6%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSHE 289
F ++ +IG G+F V+ A+K E+ + ++ EV+ L + H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHP 85
Query: 290 NIVGYYSSWFENEQLYIQMELCDHSLSD-----KKASQFFAEGEVLKALHQIAQALQFIH 344
N + Y + ++ ME C S SD KK Q E E+ H Q L ++H
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ---EVEIAAITHGALQGLAYLH 142
Query: 345 EKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLD 403
+ H D+K NI + G KL DFG A++ + + P+ IL D D
Sbjct: 143 SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYD 202
Query: 404 -KVDIFSLGATMYELIKGSPL---SESGPQFLNLRDGKLPLLPGH--SLQFQNLLKVMVD 457
KVD++SLG T EL + P + ++ + P L + S F+N + +
Sbjct: 203 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ 262
Query: 458 PDPVQRPSAKELVEN 472
P RP+++EL+++
Sbjct: 263 KIPQDRPTSEELLKH 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 31/245 (12%)
Query: 266 LHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQF-- 323
L+ + + A E+ LAA H IV ++ + +++L + ME +K+ Q
Sbjct: 103 LNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK 161
Query: 324 ----FAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378
F E EV +QI AL +H + + H D+K NI++ G+ KLGDFG + +
Sbjct: 162 EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221
Query: 379 SLPIEEGDA-----RYMPQEILNEDYDHLDKVDIFSLGATMYELI------KGSPLSESG 427
S+ ++ + Y+ E+ E + K D++SLG +YEL+ KG E
Sbjct: 222 SVSLDVASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM 280
Query: 428 PQFLNLRDGKLPLLP-GHSLQFQNLLKVMVDPDPVQRPSAKELVENP-------IFDKIQ 479
Q L GK P S + LL ++ +P RP+ ++L+ +F I
Sbjct: 281 QQVLY---GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIV 337
Query: 480 KHRKT 484
+H +T
Sbjct: 338 RHSET 342
|
Length = 478 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 50/168 (29%), Positives = 70/168 (41%), Gaps = 33/168 (19%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-------HSKRQLHHDAERRKALLEVQAL 282
DF I+ IG G F V V K+ G YA+K K Q+ H R L E
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA--- 58
Query: 283 AALGSHENIVGYYSSWFENEQLYIQME----------LCDHSLSDKKASQFFAEGEVLKA 332
+ +V Y S+ + LY+ ME L ++ ++F+ +L
Sbjct: 59 ----DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL-- 112
Query: 333 LHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379
A+ IH+ G H D+KPDN+ + G KL DFG T L KS
Sbjct: 113 ------AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 72/267 (26%), Positives = 119/267 (44%), Gaps = 33/267 (12%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKH-------SKRQLHHDAERRKALLEVQALAALGSHE 289
IG G F V++V K+ YA+K +K+++ H R L+ L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVR----TLLDESP 56
Query: 290 NIVGYYSSWFENEQLYIQM------ELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFI 343
IVG S+ + LY+ EL H + + F+E + ++ AL+ +
Sbjct: 57 FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR----FSEDRAKFYIAELVLALEHL 112
Query: 344 HEKGIAHLDVKPDNIYVK-NGVYKLGDFG--RATLL-NKSLPIEEGDARYMPQEILNEDY 399
H+ I + D+KP+NI + G L DFG +A L NK+ G Y+ E+L ++
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 400 DHLDKVDIFSLGATMYELIKG-SPLSESGPQ--FLNLRDGKLPLLPGH-SLQFQNLLKVM 455
+ VD +SLG ++E+ G SP Q + N+ GK+ S + + +K +
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGL 232
Query: 456 VDPDPVQR----PSAKELVENPIFDKI 478
++ +P R A EL E+P F I
Sbjct: 233 LNRNPQHRLGAHRDAVELKEHPFFADI 259
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 72/284 (25%), Positives = 109/284 (38%), Gaps = 40/284 (14%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
F ++E+IG G + V+K ++ G A+K + + A+ E+ L L +H N
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPN 60
Query: 291 IVGYYSSWFENEQLYIQMELCDHSLS---DKKASQFFAEGEVLKALHQIAQALQFIHEKG 347
IV +LY+ E L D + L Q+ Q L F H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSLPIEEGDARYMPQEILNEDYDHLD 403
+ H D+KP N+ + G KL DFG A ++ E Y EIL +
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 404 KVDIFSLGATMYELIK---------------------GSPLSESGPQFLNLRDGK--LP- 439
VDI+SLG E++ G+P P +L D K P
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240
Query: 440 --------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
++P ++LL M+ DP +R SAK + +P F
Sbjct: 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 65/307 (21%), Positives = 121/307 (39%), Gaps = 80/307 (26%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
IE IG+G + V + G A+K ++ L E++ L H+NI+
Sbjct: 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIA 68
Query: 294 ----YYSSWFENEQLYIQMEL----------CDHSLSDKKASQFFAEGEVLKALHQIAQA 339
+ + +Y+ M+L D L+++ F L+Q+ +
Sbjct: 69 IRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYF---------LYQLLRG 119
Query: 340 LQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQ------ 392
L++IH + H D+KP N+ V ++ ++GDFG A L+ S P E +M +
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS-PTEHK--YFMTEYVATRW 176
Query: 393 ----EILNEDYDHLDKVDIFSLGATMYELIK---------------------GSPLSESG 427
E+L ++ +D++S+G E++ GSP
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP----S 232
Query: 428 PQFLN------LRD--GKLP---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELV 470
+ LN +R LP + P S + +LL M+ DP +R + ++ +
Sbjct: 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292
Query: 471 ENPIFDK 477
++P +
Sbjct: 293 QHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIV 292
++E++G G ++ VFK ++ A+K + + H + A+ EV L L H NIV
Sbjct: 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLE-HEEGAPCTAIREVSLLKDL-KHANIV 67
Query: 293 GYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAH 350
+ ++ L + E D L + V L+QI + L + H + + H
Sbjct: 68 TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127
Query: 351 LDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR-----YMPQEILNEDYDHLDK 404
D+KP N+ + + G KL DFG A KS+P + Y P ++L ++ +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185
Query: 405 VDIFSLGATMYELIKGSPL 423
+D++ +G +E+ G PL
Sbjct: 186 IDMWGVGCIFFEMASGRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 32/226 (14%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
D IG G F V+ V DG A+K + ++ E++ L H+
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHD 59
Query: 290 NIVGY-------YSSWFENEQLYIQMELCDHSLSDKKAS-QFFAEGEVLKALHQIAQALQ 341
N++ + FE ++Y+ EL L S Q + V L+QI + L+
Sbjct: 60 NVLSALDILQPPHIDPFE--EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLK 117
Query: 342 FIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEEGD-ARYMPQEILNEDY 399
++H GI H D+KP N+ V N V K+ DFG A + EE D +++M QE++ + Y
Sbjct: 118 YLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV-------EEPDESKHMTQEVVTQYY 170
Query: 400 ----------DHLDKVDIFSLGATMYELIKGSPLSE-SGP-QFLNL 433
+ VDI+S+G EL+ L + P Q L+L
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL 216
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH----DAERRKALLEVQALAA 284
DF ++ ++GAGN V KVL R G A R+L H A R + + E++ L
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMA-----RKLIHLEIKPAIRNQIIRELKVL-- 53
Query: 285 LGSHE----NIVGYYSSWFENEQLYIQMELCDHSLSD---KKASQFFAE--GEVLKALHQ 335
HE IVG+Y +++ + ++ I ME D D KKA + G++ A
Sbjct: 54 ---HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA--- 107
Query: 336 IAQALQFIHEK-GIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIE-EGDARYM-P 391
+ + L ++ EK I H DVKP NI V G KL DFG + L S+ G YM P
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 167
Query: 392 QEILNEDYDHLDKVDIFSLGATMYELIKG 420
+ + Y DI+SLG ++ E+ G
Sbjct: 168 ERLQGTHYTVQS--DIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 13/243 (5%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
IG G+F V + + FYAVK K+ + E + + E L H +VG +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 296 SSWFENEQLYIQMELCDHS--LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDV 353
S+ ++LY ++ + + + F E +IA AL ++H I + D+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 354 KPDNIYVKN-GVYKLGDFG---RATLLNKSLPIEEGDARYMPQEILNED-YDHLDKVDIF 408
KP+NI + + G L DFG N + G Y+ E+L++ YD VD +
Sbjct: 123 KPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR--TVDWW 180
Query: 409 SLGATMYELIKGSP---LSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPS 465
LGA +YE++ G P + + N+ + L L P + ++LL+ ++ D +R
Sbjct: 181 CLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLG 240
Query: 466 AKE 468
AK+
Sbjct: 241 AKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 34/224 (15%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK----HSKRQLHHDAERRKALLEVQALAA 284
D+ + ++G G F V+K + G A+K H+++ AL E++ L
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPIT----ALREIKILKK 63
Query: 285 LGSHENIVG----YYS----SWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALH 334
L H N+V S + +Y+ DH LS + S E ++ +
Sbjct: 64 L-KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML 122
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP-----IEEGDAR 388
Q+ + + ++HE I H D+K NI + G+ K+ DFG A + P G +
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 389 YM---------PQEILNEDYDHLDKVDIFSLGATMYELIKGSPL 423
Y P E+L + + VDI+ +G E+ P+
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 16/220 (7%)
Query: 215 FPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRK 274
F + GD + ++ IG+G V I A+K R + ++
Sbjct: 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR 69
Query: 275 ALLEVQALAALGSHENIVGYYS------SWFENEQLYIQMELCDHSLSDKKASQFFAEGE 328
A E+ + + +H+NI+G + S E + +YI MEL D +L + Q + E
Sbjct: 70 AYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC--QVIQMELDHE 126
Query: 329 VLK-ALHQIAQALQFIHEKGIAHLDVKPDNIYVKNG-VYKLGDFGRATLLNKSLPIE-EG 385
+ L+Q+ ++ +H GI H D+KP NI VK+ K+ DFG A S +
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 386 DARY--MPQEILNEDYDHLDKVDIFSLGATMYELIKGSPL 423
RY P+ IL Y + VDI+S+G M E+IKG L
Sbjct: 187 VTRYYRAPEVILGMGYK--ENVDIWSVGCIMGEMIKGGVL 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIV 292
+++++G G ++ VFK ++ A+K + + H + A+ EV L L H NIV
Sbjct: 9 KLDKLGEGTYATVFKGRSKLTENLVALKEIRLE-HEEGAPCTAIREVSLLKNL-KHANIV 66
Query: 293 GYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALH-------QIAQALQFIHE 345
+ L + E D L Q+ L ++H Q+ + L + H+
Sbjct: 67 TLHDIIHTERCLTLVFEYLDSDLK-----QYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 346 KGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEEGDAR-----YMPQEILNEDY 399
+ I H D+KP N+ + G KL DFG A KS+P + Y P ++L
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 400 DHLDKVDIFSLGATMYELIKGSPL 423
++ +D++ +G +YE+ G P+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPM 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 65/200 (32%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH----DAERRKALLEVQALAAL 285
DF I ++GAGN V KV + G A R+L H A R + + E+Q L
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMA-----RKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 286 GSHENIVGYYSSWFENEQLYIQMELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFI 343
S IVG+Y +++ + ++ I ME D D+ K ++ E + K + + L ++
Sbjct: 61 NS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119
Query: 344 HEK-GIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIE-EGDARYMPQEILNEDYD 400
EK I H DVKP NI V + G KL DFG + L S+ G YM E L +
Sbjct: 120 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 401 HLDKVDIFSLGATMYELIKG 420
+ + DI+S+G ++ EL G
Sbjct: 180 SV-QSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIV 292
+++++G G ++ V+K ++ A+K + + H + A+ EV L L H NIV
Sbjct: 10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLE-HEEGAPCTAIREVSLLKDL-KHANIV 67
Query: 293 GYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAH 350
+ + L + E D L V L Q+ + L + H + + H
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLH 127
Query: 351 LDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEEGDAR-----YMPQEILNEDYDHLDK 404
D+KP N+ + G KL DFG A KS+P + Y P +IL D+ +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 405 VDIFSLGATMYELIKGSPL 423
+D++ +G YE+ G PL
Sbjct: 186 IDMWGVGCIFYEMSTGRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 67/289 (23%), Positives = 116/289 (40%), Gaps = 41/289 (14%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ ++E+IG G + V+K R+ A+K + + + A+ E+ L + H N
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGN 62
Query: 291 IVGYYSSWFENEQLYIQMELCDHSLSDK--KASQFFAEGEVLKA-LHQIAQALQFIHEKG 347
IV ++LY+ E D L + F ++K L+QI + + + H
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR 122
Query: 348 IAHLDVKPDNIYV--KNGVYKLGDFGRATLLN---KSLPIEEGDARYMPQEILNEDYDHL 402
+ H D+KP N+ + + KL DFG A ++ E Y EIL +
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182
Query: 403 DKVDIFSLGATMYELIK---------------------GSPLSESGPQFLNLRDGK--LP 439
VDI+S+G E++ G+P E+ P +L D K P
Sbjct: 183 TPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFP 242
Query: 440 ---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479
++P +LL M+ DP +R +A+ +E+ F +
Sbjct: 243 KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291
|
Length = 294 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ ++E++G G+++ V+K +++G A+K + Q + A+ E L L H N
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ-EEEGTPFTAIREASLLKGL-KHAN 64
Query: 291 IVGYYSSWFENEQL-----YIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHE 345
IV + E L Y+ +LC + DK E L L Q+ + L +IH+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKL-FLFQLLRGLSYIHQ 121
Query: 346 KGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPI-----EEGDARYMPQEILNEDY 399
+ I H D+KP N+ + + G KL DFG A KS+P E Y P ++L
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLLGST 179
Query: 400 DHLDKVDIFSLGATMYELIKG 420
++ +D++ +G E+I+G
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 58/192 (30%), Positives = 89/192 (46%), Gaps = 38/192 (19%)
Query: 249 LKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYY------SSWFENE 302
+K++ F V H+KR A R L++ L +H+NI+G S E +
Sbjct: 46 IKKLSRPFQNVTHAKR-----AYRELVLMK------LVNHKNIIGLLNVFTPQKSLEEFQ 94
Query: 303 QLYIQMELCDHSLS-------DKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKP 355
+Y+ MEL D +L D + + L+Q+ ++ +H GI H D+KP
Sbjct: 95 DVYLVMELMDANLCQVIQMDLDHERMSYL--------LYQMLCGIKHLHSAGIIHRDLKP 146
Query: 356 DNIYVKNG-VYKLGDFGRATLLNKSLPIE-EGDARY--MPQEILNEDYDHLDKVDIFSLG 411
NI VK+ K+ DFG A S + RY P+ IL Y + VDI+S+G
Sbjct: 147 SNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK--ENVDIWSVG 204
Query: 412 ATMYELIKGSPL 423
M E+I+G+ L
Sbjct: 205 CIMGEMIRGTVL 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 50/143 (34%), Positives = 79/143 (55%), Gaps = 18/143 (12%)
Query: 333 LHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDA---- 387
L +I+ AL+ +H++GI + D+KP+NI + G KL DFG L +S I EG
Sbjct: 106 LSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFG---LCKES--IHEGTVTHTF 160
Query: 388 ----RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQFLN-LRDGKLPL 440
YM EIL H VD +SLGA MY+++ G+P +E+ + ++ + GKL L
Sbjct: 161 CGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
Query: 441 LPGHSLQFQNLLKVMVDPDPVQR 463
P + + ++LLK ++ +P R
Sbjct: 220 PPYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 29/206 (14%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQ-LHHDAERRKALLEVQALAALGSHENIVGYY 295
+G G+F V + F+A+K K+ + D + ++E + LA H + +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 296 SSWFENEQLYIQMELCD-----------HSLSDKKASQFFAEGEVLKALHQIAQALQFIH 344
++ E L+ ME + + +A + AE I LQF+H
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE---------IICGLQFLH 113
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRA---TLLNKSLPIEEGDARYMPQEIL-NEDY 399
+KGI + D+K DN+ + K+G K+ DFG G Y+ EIL + Y
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 400 DHLDKVDIFSLGATMYELIKG-SPLS 424
+ VD +S G +YE++ G SP
Sbjct: 174 NE--SVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 55/194 (28%), Positives = 89/194 (45%), Gaps = 15/194 (7%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
+G G F V R G YA K +K++L A++E + LA + S IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIVSLA 59
Query: 296 SSWFENEQLYIQMELCD------HSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIA 349
++ L + M + + H + + + F E QI L+ +H++ I
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 350 HLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEEGDA---RYMPQEIL-NEDYDHLDK 404
+ D+KP+N+ + N G ++ D G A L +G A +M E+L E+YD
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF--S 177
Query: 405 VDIFSLGATMYELI 418
VD F+LG T+YE+I
Sbjct: 178 VDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQ-LHHDAERRKALLEVQALAALGSHENIVGYY 295
+G G+F V + YA+K K+ + D + + E + LA H + +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 296 SSWFENEQLYIQMELC---DHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLD 352
+ ++L+ ME D +++ +F A ++ AL F+H G+ + D
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAA-EVTLALMFLHRHGVIYRD 121
Query: 353 VKPDNIYV-KNGVYKLGDFG---RATLLNKSLPIEEGDARYMPQEILNE-DYDHLDKVDI 407
+K DNI + G KL DFG L + G Y+ EIL E +Y VD
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP--SVDW 179
Query: 408 FSLGATMYELIKGSPLSES 426
++LG MYE++ G P E+
Sbjct: 180 WALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 33/167 (19%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-------HSKRQLHHDAERRKALLEVQAL 282
DFH ++ IG G F V V K+ G YA+K K QL H R L E +
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS- 60
Query: 283 AALGSHENIVGYYSSWFENEQLYIQME----------LCDHSLSDKKASQFFAEGEVLKA 332
+V Y S+ + + LY+ ME L + + ++F+ VL
Sbjct: 61 ------PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVL-- 112
Query: 333 LHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378
A++ +H+ G H D+KPDNI + + G KL DFG +T +K
Sbjct: 113 ------AIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 51/200 (25%), Positives = 83/200 (41%), Gaps = 8/200 (4%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ + +G+G + V G AVK R ++ E++ L + HEN
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHEN 77
Query: 291 IVGYY------SSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIH 344
++G S E +Y+ L L++ Q + V ++QI + L++IH
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 137
Query: 345 EKGIAHLDVKPDNIYVKNGV-YKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLD 403
I H D+KP N+ V K+ DFG A + + Y EI+ +
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 197
Query: 404 KVDIFSLGATMYELIKGSPL 423
VDI+S+G M EL+ G L
Sbjct: 198 TVDIWSVGCIMAELLTGRTL 217
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 74/265 (27%), Positives = 120/265 (45%), Gaps = 31/265 (11%)
Query: 237 IGAGNFSHVF---KVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
+G G+F VF K+ G YA+K K+ +R + +E LA + H IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIVK 62
Query: 294 YYSSWFENEQLYIQMELCDHSLSDKKASQ--FFAEGEVLKALHQIAQALQFIHEKGIAHL 351
+ ++ +LY+ ++ + S+ F E +V L ++A AL +H GI +
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR 122
Query: 352 DVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE------GDARYMPQEILNEDYDHLDK 404
D+KP+NI + + G KL DFG L +S+ E+ G YM E++N H
Sbjct: 123 DLKPENILLDEEGHIKLTDFG---LSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQS 178
Query: 405 VDIFSLGATMYELIKGS-PL-----SESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDP 458
D +S G M+E++ GS P E+ L + G L S + Q+LL+ +
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFL---SPEAQSLLRALFKR 235
Query: 459 DPVQRPSA-----KELVENPIFDKI 478
+P R A +E+ +P F I
Sbjct: 236 NPANRLGAGPDGVEEIKRHPFFSTI 260
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+ +++ +G G F V ++ G A+K + ++ E++ L L H
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RH 68
Query: 289 ENIVGYYSSWFE-NEQLYIQMELCDHSLS--------DKKASQFFAEGEVLKALHQIAQA 339
ENI+ + E +Y EL L +K+ Q+F L+QI +
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYF--------LYQILRG 120
Query: 340 LQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNED 398
L+++H G+ H D+KP NI + +N K+ DFG A + + + Y EI+
Sbjct: 121 LKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTW 180
Query: 399 YDHLDKVDIFSLGATMYELIKGSPL 423
+ +VDI+S G E+++G PL
Sbjct: 181 QKYDVEVDIWSAGCIFAEMLEGKPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 278 EVQALAALGSHENIVGYYSSWFENEQ--LYIQME-LCDHSLSDK-KASQFFAEGEVLKAL 333
E+Q L L HE IV YY + + L I ME + S+ D+ KA E K
Sbjct: 54 EIQLLKNL-QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT 112
Query: 334 HQIAQALQFIHEKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLN------KSLPIEEGD 386
QI + + ++H I H D+K NI + G KLGDFG + L + G
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 387 ARYM-PQEILNEDYDHLDKVDIFSLGATMYELIKGSP----LSESGPQFLNLRDGKLPLL 441
+M P+ I E Y K D++SLG T+ E++ P F P L
Sbjct: 173 PYWMSPEVISGEGYGR--KADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQL 230
Query: 442 PGH-SLQFQNLLKVMVDPDPVQRPSAKELVENP 473
P H S ++ L + + RPSA+EL+ +P
Sbjct: 231 PSHISEHARDFLGCIF-VEARHRPSAEELLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 45/215 (20%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVG 293
+ +G G+F VF + F+A+K K+ + D + ++E + L+ H +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 294 YYSSWFENEQLYIQMELCD-----------HSLSDKKASQFFAEGEVLKALHQIAQALQF 342
Y ++ E L+ ME + H +A+ + AE I LQF
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE---------IICGLQF 111
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFG--RATLLNKSLPIEEGDAR---------YM 390
+H KGI + D+K DNI + +G K+ DFG + +L GDA+ Y+
Sbjct: 112 LHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--------GDAKTCTFCGTPDYI 163
Query: 391 PQEI-LNEDYDHLDKVDIFSLGATMYELIKG-SPL 423
EI L + Y+ VD +S G +YE++ G SP
Sbjct: 164 APEILLGQKYNT--SVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 68/240 (28%), Positives = 102/240 (42%), Gaps = 25/240 (10%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
D E +G GN V+K + AVK + + ++ + + E++ L S
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK-QIMSELEILYKCDS-P 59
Query: 290 NIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGI 348
I+G+Y ++F ++ I E D SL + G + A + + L ++ I
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA---VVKGLTYLWSLKI 116
Query: 349 AHLDVKPDNIYVKN-GVYKLGDFGRAT-LLNKSLPIEEGDARYM-PQEILNEDYDHLDKV 405
H DVKP N+ V G KL DFG +T L+N G YM P+ I E Y
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHS-- 174
Query: 406 DIFSLGATMYELIKGS-PLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRP 464
D++SLG + EL G P PQ + +PL LL+ +VD DP P
Sbjct: 175 DVWSLGISFMELALGRFPY----PQIQKNQGSLMPL---------QLLQCIVDEDPPVLP 221
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
DF I+ IG G F V V + YA+K SK ++ ++ E + + A +
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS-AFFWEERDIMAHANS 102
Query: 289 ENIVGYYSSWFENEQLYIQME----------LCDHSLSDKKASQFFAEGEVLKALHQIAQ 338
E IV + ++ +++ LY+ ME + ++ + +K A + AE +
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAE---------VVL 153
Query: 339 ALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE----GDARYMPQE 393
AL IH G H DVKPDN+ + K+G KL DFG ++ + + G Y+ E
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE 213
Query: 394 ILNE---DYDHLDKVDIFSLGATMYELIKGSP 422
+L D + + D +S+G +YE++ G
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 52/175 (29%), Positives = 77/175 (44%), Gaps = 25/175 (14%)
Query: 322 QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380
F+E EV +I AL+ +H+ GI + D+K +NI + G L DFG L+K
Sbjct: 100 DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFG----LSKEF 155
Query: 381 PIEE--------GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQFL 431
EE G YM EI+ H VD +SLG ++EL+ G SP + G +
Sbjct: 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215
Query: 432 NLRDGKL------PLLPGHSLQFQNLLKVMVDPDPVQR-----PSAKELVENPIF 475
+ P + Q+LL ++ DP +R A E+ E+P F
Sbjct: 216 QSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 71/296 (23%), Positives = 126/296 (42%), Gaps = 50/296 (16%)
Query: 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFY--AVKHSKRQLHHDAERRKALLEVQALAAL 285
+ D + IG GNF V K + DG A+K K D R A E++ L L
Sbjct: 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG-ELEVLCKL 64
Query: 286 GSHENIVGYYSSWFENEQLYIQMELCDH-------------------SLSDKKASQFFAE 326
G H NI+ + LY+ +E H ++++ AS ++
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124
Query: 327 GEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDF----GRATLLNKS-- 379
++L +A+ + ++ +K H D+ NI V +N V K+ DF G+ + K+
Sbjct: 125 -QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 183
Query: 380 -LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKL 438
LP+ R+M E LN + D++S G ++E++ G L + KL
Sbjct: 184 RLPV-----RWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-KL 236
Query: 439 PLLPGHSL--------QFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYM 486
P G+ L + +L++ P +RPS +++ + +++ + RKTY+
Sbjct: 237 PQ--GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS--LNRMLEERKTYV 288
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 76/292 (26%), Positives = 109/292 (37%), Gaps = 64/292 (21%)
Query: 234 IEQIGAGNFSHVFKVLKRID------GCFYAVKHSKRQLHHDAE---RRKALLEVQALAA 284
I+Q+G G+F V L R D G AVK L+H E R E++ L
Sbjct: 9 IKQLGEGHFGKVE--LCRYDPLGDNTGEQVAVK----SLNHSGEEQHRSDFEREIEILRT 62
Query: 285 LGSHENIVGY--YSSWFENEQLYIQME-LCDHSLSD--KKASQFFAEGEVLKALHQIAQA 339
L HENIV Y L + ME L SL D ++ +L QI +
Sbjct: 63 L-DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKG 121
Query: 340 LQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-----------LPIEEGDA 387
+ ++ + H D+ NI V + K+ DFG A +L + PI
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF---- 177
Query: 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQFLNLRDGKLPLLPGHSL 446
Y P E L D++S G T+YEL G P +FL + G
Sbjct: 178 WYAP-ECLRTSKFSS-ASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI-GIAQGQMIV-T 233
Query: 447 QFQNLLK-----------------VMV---DPDPVQRPSAKELVENPIFDKI 478
+ LLK +M + +P RPS +L+ I D++
Sbjct: 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI--LIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYA---VKHSKRQLHHDAERRK---------ALLEVQALAA 284
+G G + V K + G A VK + +R+ L E++ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 285 LGSHENIVGYYSSWFENEQLYIQMELCDHSLS---DKKASQFFAEGEVLKALHQIAQALQ 341
+ HENI+G + E + + + M++ L D+K E +V L QI L
Sbjct: 77 I-KHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI--RLTESQVKCILLQILNGLN 133
Query: 342 FIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRAT-----LLNKSLPIEEGDAR------- 388
+H+ H D+ P NI++ G+ K+ DFG A + +L +E R
Sbjct: 134 VLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193
Query: 389 -----YMPQEIL--NEDYDHLDKVDIFSLGATMYELIKGSPL 423
Y E+L E Y VD++S+G EL+ G PL
Sbjct: 194 VVTLWYRAPELLMGAEKYHF--AVDMWSVGCIFAELLTGKPL 233
|
Length = 335 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 47/208 (22%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 231 FHEIEQIGAGNFSHVFKV--LKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+ I+++G G + V + + A+K ++AL E++ L H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 289 ENIVGYYSS---WFEN-EQLYIQMELCDHSLSDK-KASQFFAEGEVLKALHQIAQALQFI 343
+NI Y + N +LY+ EL + L ++ Q + ++QI L++I
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121
Query: 344 HEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEEGDAR-------YMPQEIL 395
H + H D+KP N+ V + K+ DFG A +++ G Y EI+
Sbjct: 122 HSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181
Query: 396 NEDYDHLDKVDIFSLGATMYELIKGSPL 423
+ +D++S+G + EL+ P+
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 67/250 (26%), Positives = 97/250 (38%), Gaps = 74/250 (29%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-------HSKRQLHHDAERRKALLEVQAL 282
DF ++ IG G F V V K+ G YA+K K Q+ H R L+E +L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 283 AALGSHENIVGYYSSWFENEQLYIQME----------LCDHSLSDKKASQFFAEGEVLKA 332
+V + S+ + LY+ ME L ++ +QF+ VL
Sbjct: 62 W-------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL-- 112
Query: 333 LHQIAQALQFIHEKGIAHLDVKPDNIYVKN-GVYKLGDFGRAT------------LLNKS 379
A+ IH+ G H D+KPDN+ + + G KL DFG T LN S
Sbjct: 113 ------AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 380 LPIE--------------------------EGDARYM-PQEILNEDYDHLDKVDIFSLGA 412
LP + G Y+ P+ + Y+ L D +SLG
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL--CDWWSLGV 224
Query: 413 TMYELIKGSP 422
MYE++ G P
Sbjct: 225 IMYEMLIGYP 234
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 8/173 (4%)
Query: 258 AVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYY------SSWFENEQLYIQMELC 311
AVK R R+ E++ L + HEN++G +S ++Y+ L
Sbjct: 44 AVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIENFNEVYLVTNLM 102
Query: 312 DHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGV-YKLGDF 370
L++ Q ++ V ++Q+ + L++IH GI H D+KP N+ V ++ DF
Sbjct: 103 GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDF 162
Query: 371 GRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPL 423
G A + + Y EI+ + VDI+S+G M EL+KG L
Sbjct: 163 GLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL 215
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 70/282 (24%), Positives = 102/282 (36%), Gaps = 54/282 (19%)
Query: 228 YTDFHEIEQIGAGNFSHVFKV-LKRID----GCFYAVK---HSKRQLHHDAERRKALLEV 279
++ EI +G G F VF K I+ VK +K + RR E+
Sbjct: 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRR----EL 59
Query: 280 QALAALGSHENIVGYYSSWFENEQLYIQMELCD-----------HSLSDKKASQFFAEGE 328
L SH+N+V E E Y+ +E D S +K + +
Sbjct: 60 DMFRKL-SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQ 118
Query: 329 VLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-------------NGVYKLGDFGRATL 375
+ QIA + + H D+ N V VY + L
Sbjct: 119 KVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY---KL 175
Query: 376 LNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESG---PQFLN 432
N +P+ R++ E + ED D K D++S G M+E+ L G + LN
Sbjct: 176 RNALIPL-----RWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN 229
Query: 433 -LRDGKLPLLPGHSLQFQNLLKVMV---DPDPVQRPSAKELV 470
L+ GKL LP L K+M +P RPS ELV
Sbjct: 230 RLQAGKLE-LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
++++G G+++ V+K ++ G A+K + + H + A+ E L L H NIV
Sbjct: 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLE-HEEGAPFTAIREASLLKDL-KHANIVT 67
Query: 294 YYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
+ + L + E D L + V L Q+ + L + H++ + H
Sbjct: 68 LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127
Query: 352 DVKPDNIYVKN-GVYKLGDFG--RATLLNKSLPI-----EEGDARYMPQEILNEDYDHLD 403
D+KP N+ + G KL DFG RA KS+P E Y P ++L ++
Sbjct: 128 DLKPQNLLISERGELKLADFGLARA----KSVPSKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 404 KVDIFSLGATMYELIKGSPL 423
+D++ +G YE+ G PL
Sbjct: 184 SLDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 66/257 (25%), Positives = 117/257 (45%), Gaps = 18/257 (7%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLE--VQALAALGSHENIVG 293
IG G F V+ K G YA+K K+++ AL E + +L + G IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 294 YYSSWFENEQLYIQMELCDHSLSDKKASQ--FFAEGEVLKALHQIAQALQFIHEKGIAHL 351
++ ++L ++L + SQ F+E E+ +I L+ +H + + +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 352 DVKPDNIYV-KNGVYKLGDFGRATLLNKSLP-IEEGDARYMPQEILNEDYDHLDKVDIFS 409
D+KP NI + ++G ++ D G A +K P G YM E+L + + D FS
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFS 181
Query: 410 LGATMYELIKG-SPLSESGPQFLNLRDGKL----PLLPGH-SLQFQNLLKVMVDPDPVQR 463
LG +++L++G SP + + + D LP S + ++LL+ ++ D +R
Sbjct: 182 LGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 241
Query: 464 -----PSAKELVENPIF 475
A+E+ E+P F
Sbjct: 242 LGCLGRGAQEVKEHPFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 56/195 (28%), Positives = 87/195 (44%), Gaps = 16/195 (8%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
+G G F V V + G YA K K++L + + ALLE + L + S IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLA 59
Query: 296 SSWFENEQLYIQMELCDHSLSDKKASQFFAEGE-------VLKALHQIAQALQFIHEKGI 348
++ L + M L + D K + GE V+ QI + +H I
Sbjct: 60 YAFESKTHLCLVMSLM--NGGDLK-YHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116
Query: 349 AHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEILNEDYDHLDKV 405
+ D+KP+N+ + G +L D G A L I + G YM EIL E+ + V
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEE-PYSYPV 175
Query: 406 DIFSLGATMYELIKG 420
D F++G ++YE++ G
Sbjct: 176 DWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 76/260 (29%), Positives = 107/260 (41%), Gaps = 32/260 (12%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGS------HEN 290
+G G F V+ G AVK Q+ D E + EV AL HE
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVK----QVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 291 IVGYYSSWFENEQ--LYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHEK 346
IV YY + + L I ME S+ D+ K+ E K QI + + ++H
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 347 GIAHLDVKPDNIYVKN-GVYKLGDFGRATLLN------KSLPIEEGDARYM-PQEILNED 398
I H D+K NI + G KLGDFG + L + G +M P+ I E
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185
Query: 399 YDHLDKVDIFSLGATMYELIKGSP----LSESGPQFLNLRDGKLPLLPGH-SLQFQNLLK 453
Y K DI+S+G T+ E++ P F P+LP H S ++ LK
Sbjct: 186 YGR--KADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLK 243
Query: 454 -VMVDPDPVQRPSAKELVEN 472
+ V+ RPSA EL+ +
Sbjct: 244 RIFVEAK--LRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKAL-LEVQALAALGSHENIVGYY 295
IG G+++ V V + + YA+K K++L HD E + E S+ +VG +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 296 SSWFENEQLYIQMELCD------HSLSDKKA----SQFFAEGEVLKALHQIAQALQFIHE 345
S + +L++ +E + H +K ++F+A +I AL F+HE
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAA--------EICIALNFLHE 114
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFG---RATLLNKSLPIEEGDARYMPQEIL-NEDYD 400
+GI + D+K DN+ + +G KL D+G + G Y+ EIL E+Y
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 401 HLDKVDIFSLGATMYELIKG-SPL 423
VD ++LG M+E++ G SP
Sbjct: 175 F--SVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 21/200 (10%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYS 296
+G G + V K + A+K K ++ + L E++ L L ENIV
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKE 67
Query: 297 SWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVK 354
++ +LY+ E + ++ + ++ +V ++Q+ +A+ + H+ I H D+K
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127
Query: 355 PDNIYVK-NGVYKLGDFGRATLLNKSLPIEEGDARYM----------PQEILNEDYDHLD 403
P+N+ + N V KL DFG A L+ E +A Y P+ +L Y
Sbjct: 128 PENLLISHNDVLKLCDFGFARNLS-----EGSNANYTEYVATRWYRSPELLLGAPYG--K 180
Query: 404 KVDIFSLGATMYELIKGSPL 423
VD++S+G + EL G PL
Sbjct: 181 AVDMWSVGCILGELSDGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 28/275 (10%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSHE 289
F + +G G F V R G YA K K+++ AL E Q L + S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS-R 60
Query: 290 NIVGYYSSWFENEQLYIQMELCD------HSLSDKKASQFFAEGEVLKALHQIAQALQFI 343
+V ++ + L + + L + H +A F EG + +I L+ +
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDL 118
Query: 344 HEKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEE--GDARYM-PQEILNEDY 399
H++ I + D+KP+NI + + G ++ D G A + + I+ G YM P+ + NE Y
Sbjct: 119 HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 178
Query: 400 DHLDKVDIFSLGATMYELIKG-SPLSESGPQFLN------LRDGKLPLLPGHSLQFQNLL 452
D ++LG +YE+I G SP + + +++ + S ++L
Sbjct: 179 TF--SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236
Query: 453 KVMVDPDPVQR-----PSAKELVENPIFDKIQKHR 482
K+++ DP +R A+E+ E+P+F +I R
Sbjct: 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKR 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 8/191 (4%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQ-LHHDAERRKALLEVQALAALGSHENIVGYY 295
+G G+F V + G YAVK K+ + D + + E + L+ +H + Y
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 296 SSWFENEQLYIQMELCDHS--LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDV 353
+ ++L+ ME + + + S+ F E +I AL F+H+KGI + D+
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 354 KPDNIYV-KNGVYKLGDFG--RATLLN-KSLPIEEGDARYMPQEILNEDYDHLDKVDIFS 409
K DN+ + G KL DFG + + N K+ G Y+ EIL E VD ++
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPS-VDWWA 181
Query: 410 LGATMYELIKG 420
+G +YE++ G
Sbjct: 182 MGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 37/215 (17%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKAL-LEVQALAALGSHENIVGYY 295
IG G+++ V V + YA+K K++L +D E + E +H +VG +
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 296 SSWFENEQLYIQME------LCDHSLSDKKA----SQFFAEGEVLKALHQIAQALQFIHE 345
S + +L+ +E L H +K ++F++ +I+ AL F+HE
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA--------EISLALNFLHE 114
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDA--------RYMPQEIL- 395
+GI + D+K DN+ + G KL D+G I GD Y+ EIL
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMC-----KEGIRPGDTTSTFCGTPNYIAPEILR 169
Query: 396 NEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ 429
EDY VD ++LG M+E++ G SP G
Sbjct: 170 GEDYGF--SVDWWALGVLMFEMMAGRSPFDIVGMS 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 68/277 (24%), Positives = 112/277 (40%), Gaps = 41/277 (14%)
Query: 236 QIGAGNFSHVFKVLKRIDGCF---YAVKHSKRQLHHDAERRKALLEVQALAALGSHENIV 292
++G G + HV+K KR DG YA+K Q+ A E+ L L H N++
Sbjct: 8 KVGRGTYGHVYKA-KRKDGKDDRDYALK----QIEGTGISMSACREIALLREL-KHPNVI 61
Query: 293 GYYSSWFE--NEQLYIQMELCDHSL-----------SDKKASQFFAEGEVLKALHQIAQA 339
+ + ++++ + +H L ++KK Q G V L+QI
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL-PRGMVKSLLYQILDG 120
Query: 340 LQFIHEKGIAHLDVKPDNIYV-----KNGVYKLGDFGRATLLNKSL-PIEEGDAR----- 388
+ ++H + H D+KP NI V + G K+ D G A L N L P+ + D
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 389 YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQF 448
Y E+L + +DI+++G EL+ P+ + + + P H Q
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN------PYHHDQL 234
Query: 449 QNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTY 485
+ VM P K++ E+ K R TY
Sbjct: 235 DRIFNVMGFPADKDWEDIKKMPEHSTLMK-DFRRNTY 270
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 55/255 (21%), Positives = 96/255 (37%), Gaps = 71/255 (27%)
Query: 288 HENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQF---FAEGEVLKALHQIAQALQFI 343
H NI+ Y +S+ + +LY+ L + S D + F E + L + AL +I
Sbjct: 58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYI 117
Query: 344 HEKGIAHLDVKPDNIYVKNGVYKLGDFGRATL--LNKSLPIEEGDARYMP---------- 391
H KG H VK +I + GD G+ L L S+ + + R
Sbjct: 118 HSKGFIHRSVKASHILLS------GD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170
Query: 392 ------QEILNED---YDHLDKVDIFSLGATMYEL-------------------IKGSP- 422
E+L ++ Y+ +K DI+S+G T EL ++G+
Sbjct: 171 NLPWLSPEVLQQNLQGYN--EKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVP 228
Query: 423 --------------LSESGPQFLNLRDGKLPLLPGH---SLQFQNLLKVMVDPDPVQRPS 465
+S+S + + P S F +++ + DP RPS
Sbjct: 229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288
Query: 466 AKELVENPIFDKIQK 480
A +L+ + F + ++
Sbjct: 289 ASQLLNHSFFKQCKR 303
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 42/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 273 RKALLEVQALAALGSHENIVGYY--------------SSWFENEQLYIQMELCDHSLSDK 318
+ AL E++ + L H+NIV Y S E +YI E + L++
Sbjct: 47 KHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANV 105
Query: 319 KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV--KNGVYKLGDFGRATLL 376
+E ++Q+ + L++IH + H D+KP N+++ ++ V K+GDFG A ++
Sbjct: 106 LEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165
Query: 377 NKSLP----IEEGDAR--YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPL 423
+ + EG Y +L ++ +D+++ G E++ G PL
Sbjct: 166 DPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL 218
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 9e-08
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 49/228 (21%)
Query: 224 LSRYYTDFHEIEQ-IGAGNFSHVFKVLKRIDGCFYAVKH-----SKRQLHHDAER--RKA 275
L +Y EI Q +G G + V+K + R A+K DA+R R
Sbjct: 6 LRKY-----EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT---DAQRTFR-- 55
Query: 276 LLEVQALAALGSHENIVGYYSSW--FENEQLYIQMELCDHSLSD--KKASQFFAEGEVLK 331
E+ L LG H NIV + ++ +Y+ E + L + +L+
Sbjct: 56 --EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRA--------NILE 105
Query: 332 ALH------QIAQALQFIHEKGIAHLDVKPDNIYVKNGVY-KLGDFGRATLLNKSLPIEE 384
+H Q+ +AL++IH + H D+KP NI + + KL DFG A L+ L
Sbjct: 106 DVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS-ELEENP 164
Query: 385 GDA--------R-YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPL 423
+ R Y EIL + VD++S+G + E++ G PL
Sbjct: 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 64/274 (23%), Positives = 111/274 (40%), Gaps = 35/274 (12%)
Query: 236 QIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
++G G + HV+K KR DG +++ +Q+ A E+ L L H N++
Sbjct: 8 KVGRGTYGHVYKA-KRKDGK-DEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQ 64
Query: 296 SSWFE--NEQLYIQMELCDHSL-----------SDKKASQFFAEGEVLKALHQIAQALQF 342
+ + ++++ + +H L ++KK Q V L+QI + +
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQL-PRSMVKSLLYQILDGIHY 123
Query: 343 IHEKGIAHLDVKPDNIYV-----KNGVYKLGDFGRATLLNKSL-PIEEGDAR-----YMP 391
+H + H D+KP NI V + G K+ D G A L N L P+ + D Y
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 392 QEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNL 451
E+L + +DI+++G EL+ P+ + + + P H Q +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN------PFHHDQLDRI 237
Query: 452 LKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTY 485
VM P +++ E P K R TY
Sbjct: 238 FSVMGFPADKDWEDIRKMPEYPTLQK-DFRRTTY 270
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGS--H 288
+ + +IG G + V+K G F A+K + Q + D + EV L L + H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 289 ENIVGYY----SSWFENE-QLYIQMELCDHSLS---DKKASQFFAEGEVLKALHQIAQAL 340
NIV +S + E ++ + E D L DK + + Q + L
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 341 QFIHEKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSL---PIEEGDARYMPQEILN 396
F+H I H D+KP+NI V + G KL DFG A + + + P+ P+ +L
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 397 EDYDHLDKVDIFSLGATMYELIKGSPL 423
Y VD++S+G E+ + PL
Sbjct: 182 STY--ATPVDMWSVGCIFAEMFRRKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 78/284 (27%), Positives = 128/284 (45%), Gaps = 45/284 (15%)
Query: 230 DFHEIEQIGAGNFSHVF---KVLKRIDGCFYAVKHSKR----QLHHDAERRKALLEVQAL 282
+F ++ +G G + VF KV G YA+K K+ Q E + E Q L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT--ERQVL 58
Query: 283 AALGSHENIVGYYSSWFENEQLYIQM------ELCDHSLSDKKASQFFAEGEVLKALHQI 336
+ +V + ++ + +L++ + EL H LS ++ F E EV +I
Sbjct: 59 EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTH-LSQRER---FKEQEVQIYSGEI 114
Query: 337 AQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE--------GDA 387
AL+ +H+ GI + D+K +NI + NG L DFG L+K +E G
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG----LSKEFHEDEVERAYSFCGTI 170
Query: 388 RYMPQEIL-NEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ------FLNLRDGKLP 439
YM +I+ D H VD +S+G MYEL+ G SP + G + + + P
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 230
Query: 440 LLPGHSLQFQNLLKVMVDPDPVQR----PS-AKELVENPIFDKI 478
S +++++ ++ DP +R PS A E+ ++P F KI
Sbjct: 231 YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 50/168 (29%), Positives = 71/168 (42%), Gaps = 33/168 (19%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-------HSKRQLHHDAERRKALLEVQAL 282
DF ++ IG G F V V K+ G YA+K K Q+ H R L+E
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 283 AALGSHENIVGYYSSWFENEQLYIQME----------LCDHSLSDKKASQFFAEGEVLKA 332
+V + S+ + LY+ ME L ++A+QF+ VL
Sbjct: 62 W-------VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-- 112
Query: 333 LHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379
A+ IH+ G H D+KPDN+ + G KL DFG T L K+
Sbjct: 113 ------AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 231 FHEIEQIGAGNFSHVFKV--LKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGS- 287
+ + +IG G + VFK LK G F A+K + Q + + EV L L +
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKN-GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 288 -HENIVGYY-----SSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLK-ALHQIAQ 338
H N+V + S +L + E D L+ K + E +K + Q+ +
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 339 ALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATL--LNKSLPIEEGDARYMPQEIL 395
L F+H + H D+KP NI V +G KL DFG A + +L Y E+L
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 181
Query: 396 NEDYDHLDKVDIFSLGATMYELIKGSPL 423
+ + VD++S+G E+ + PL
Sbjct: 182 LQS-SYATPVDLWSVGCIFAEMFRRKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 67/257 (26%), Positives = 117/257 (45%), Gaps = 42/257 (16%)
Query: 237 IGAGNFSHVFKV-LKRIDGCFYAVKHSKRQLHHDAERRKAL-LEVQALAALGSHENIVGY 294
IG G+++ V V LK+ + YA+K K++L +D E + E +H +VG
Sbjct: 3 IGRGSYAKVLLVRLKKTER-IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 295 YSSWFENEQLYIQMELCD-----------HSLSDKKASQFFAEGEVLKALHQIAQALQFI 343
+S + +L+ +E + L ++ A + AE I+ AL ++
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE---------ISLALNYL 112
Query: 344 HEKGIAHLDVKPDNIYVKN-GVYKLGDFG---RATLLNKSLPIEEGDARYMPQEIL-NED 398
HE+GI + D+K DN+ + + G KL D+G + G Y+ EIL ED
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 399 YDHLDKVDIFSLGATMYELIKG-SPL----SESGPQ-------FLNLRDGKLPLLPGHSL 446
Y VD ++LG M+E++ G SP S P F + + ++ + S+
Sbjct: 173 YGF--SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 230
Query: 447 QFQNLLKVMVDPDPVQR 463
+ ++LK ++ DP +R
Sbjct: 231 KAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 48/154 (31%), Positives = 69/154 (44%), Gaps = 21/154 (13%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-------SKRQLHHDAERRKALLEVQAL 282
+F ++ I G F V+ K+ + YAVK +K +H R AL
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL------ 58
Query: 283 AALGSHENIVGYYSSWFENEQLYIQMELCDHSLSDKKA----SQFFAEGEVLKALHQIAQ 338
AL IV Y S +Y+ ME D K+ +F E +K + ++A
Sbjct: 59 -ALSKSPFIVHLYYSLQSANNVYLVMEYLIGG--DVKSLLHIYGYFDEEMAVKYISEVAL 115
Query: 339 ALQFIHEKGIAHLDVKPDNIYVKN-GVYKLGDFG 371
AL ++H GI H D+KPDN+ + N G KL DFG
Sbjct: 116 ALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFG 149
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 64/254 (25%), Positives = 105/254 (41%), Gaps = 53/254 (20%)
Query: 269 DAERRKALLEVQALAALGSHENIVGY-------YSSWFENEQLYIQMELCDHSLSD-KKA 320
DA+R L E++ L L HEN++ + F + +YI EL D L ++
Sbjct: 47 DAKR--TLREIKLLRHL-DHENVIAIKDIMPPPHREAFND--VYIVYELMDTDLHQIIRS 101
Query: 321 SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NGVYKLGDFG--RATLLN 377
SQ ++ L+Q+ + L++IH + H D+KP N+ + N K+ DFG R T
Sbjct: 102 SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161
Query: 378 KSLPIEEGDAR--YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPL------------ 423
E R P+ +LN ++ +D++S+G EL+ PL
Sbjct: 162 GDFMTEYVVTRWYRAPELLLNCS-EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKL 220
Query: 424 --------SESGPQFLNLRDGK-----LPLLPGHSLQ--FQN-------LLKVMVDPDPV 461
SE F+ + LP P S F + LL+ M+ DP
Sbjct: 221 ITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPS 280
Query: 462 QRPSAKELVENPIF 475
+R + +E + +P
Sbjct: 281 KRITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 38/269 (14%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYS 296
+G G F V V ++ G +YA+K K+++ + L + H +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 297 SWFENEQLYIQMELC-----------DHSLSDKKASQFFAEGEVLKALHQIAQALQFIH- 344
S+ +++L ME + S+ +A + AE I AL ++H
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE---------IVSALDYLHS 113
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFG---RATLLNKSLPIEEGDARYMPQEILNEDYD 400
EK + + D+K +N+ + K+G K+ DFG ++ G Y+ E+L ED D
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL-EDND 172
Query: 401 HLDKVDIFSLGATMYELIKGS-PL----SESGPQFLNLRDGKLPLLPGHSLQFQNLLKVM 455
+ VD + LG MYE++ G P E + + + + + P + ++LL +
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSP--EAKSLLSGL 230
Query: 456 VDPDPVQR-----PSAKELVENPIFDKIQ 479
+ DP QR AKE++++ F I
Sbjct: 231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 56/239 (23%), Positives = 104/239 (43%), Gaps = 33/239 (13%)
Query: 200 DIDRFGNQWAKCAGLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAV 259
+ID F N++ K ++ L D+ ++ IG G F V V + YA+
Sbjct: 20 NIDNFLNRYEK------IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAM 73
Query: 260 KHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME---------- 309
K + E + + A + +V + ++ +++ LY+ ME
Sbjct: 74 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL 133
Query: 310 LCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLG 368
+ ++ + +K A + AE + AL IH G+ H DVKPDN+ + K+G KL
Sbjct: 134 MSNYDVPEKWAKFYTAE---------VVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLA 184
Query: 369 DFGRATLLNKSLPIE----EGDARYMPQEILNE---DYDHLDKVDIFSLGATMYELIKG 420
DFG ++++ + G Y+ E+L D + + D +S+G ++E++ G
Sbjct: 185 DFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 39/156 (25%), Positives = 63/156 (40%), Gaps = 19/156 (12%)
Query: 330 LKALHQIAQALQFIHEKGIAHLDVKPDNIYV----KNGVY----KLGDFG-RATLLNKSL 380
L Q+A AL ++ +K + H +V NI V N Y KL D G T+L++
Sbjct: 104 LDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE 163
Query: 381 PIEEGDARYMPQEILNEDYDHLDK-VDIFSLGATMYELIKGS--PLSESGPQFLNLR--- 434
+E ++ E + L D +S G T+ E+ PLS
Sbjct: 164 RVE--RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD 221
Query: 435 DGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELV 470
+LP+ + NL+ DP +RPS + ++
Sbjct: 222 QHRLPMP--DCAELANLINQCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
D+ ++ IG G F V V + YA+K + E + + A +
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 290 NIVGYYSSWFENEQLYIQME----------LCDHSLSDKKASQFFAEGEVLKALHQIAQA 339
+V + ++ ++ LY+ ME + ++ + +K A + AE + A
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAE---------VVLA 154
Query: 340 LQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIE----EGDARYMPQEI 394
L IH G H DVKPDN+ + K+G KL DFG +NK + G Y+ E+
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 214
Query: 395 LNE---DYDHLDKVDIFSLGATMYELIKG 420
L D + + D +S+G +YE++ G
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 50/154 (32%), Positives = 79/154 (51%), Gaps = 24/154 (15%)
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDFGRATLLN---KSLPIEEGDA-- 387
QIA+ + ++ EK + H D+ N+ VK V K+ DFG A LL+ K E G
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHV-KITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 388 RYM-PQEILNEDYDHLDKVDIFSLGATMYELI-------KGSPLSESGPQFLNLRDGKLP 439
++M + IL+ Y H K D++S G T++EL+ +G P E P L + +LP
Sbjct: 176 KWMALESILHRIYTH--KSDVWSYGVTVWELMTFGAKPYEGIPAVEI-PDLLE-KGERLP 231
Query: 440 LLPGHSLQ-FQNLLKV-MVDPDPVQRPSAKELVE 471
P ++ + L+K M+D + RP+ KEL+
Sbjct: 232 QPPICTIDVYMVLVKCWMIDAE--SRPTFKELIN 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 8/197 (4%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLE--VQALAALGSHENIVG 293
IG G F V+ K G YA+K K+++ AL E + +L + G IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 294 YYSSWFENEQLYIQMELCDHSLSDKKASQ--FFAEGEVLKALHQIAQALQFIHEKGIAHL 351
++ ++L ++L + SQ F+E E+ +I L+ +H + + +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 352 DVKPDNIYV-KNGVYKLGDFGRATLLNKSLP-IEEGDARYMPQEILNEDYDHLDKVDIFS 409
D+KP NI + ++G ++ D G A +K P G YM E+L + + D FS
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFS 181
Query: 410 LGATMYELIKG-SPLSE 425
LG +++L++G SP +
Sbjct: 182 LGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 44/225 (19%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
DF I+ I G + V+ V + +A+K +K+ L + ++ +E L +
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAEN 60
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-----------SLSDKKASQFFAEGEVLKALHQIA 337
+V + S+ L + ME + +L A +FAE VL
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAE-TVL------- 112
Query: 338 QALQFIHEKGIAHLDVKPDNIYVKN-GVYKLGDFG--RATLLNKSLPIEEG----DAR-- 388
AL+++H GI H D+KPDN+ + + G KL DFG + L++ + + EG D R
Sbjct: 113 -ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 389 ----------YM-PQEILNEDYDHLDKVDIFSLGATMYELIKGSP 422
Y+ P+ IL + Y VD +++G +YE + G
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGK--PVDWWAMGIILYEFLVGCV 214
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 71/313 (22%), Positives = 116/313 (37%), Gaps = 87/313 (27%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGY 294
E IG G++ V + G A+K H ++ + L E++ L L H +IV
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEI 64
Query: 295 Y-----SSWFENEQLYIQMELCDHSLSD---------KKASQFFAEGEVLKALHQIAQAL 340
S E + +Y+ EL + L + QFF L+Q+ +AL
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFF--------LYQLLRAL 116
Query: 341 QFIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATL-LNKSLPIEEGDARYMPQEILNED 398
++IH + H D+KP NI + K+ DFG A + N + P I D
Sbjct: 117 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT-----------PTAIFWTD 165
Query: 399 Y-----------------DHLDKVDIFSLGATMYELIKGSPL------------------ 423
Y + +DI+S+G E++ G PL
Sbjct: 166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG 225
Query: 424 -----------SESGPQFLNLRDGKLPL-----LPGHSLQFQNLLKVMVDPDPVQRPSAK 467
+E ++L+ K P+ P LL+ ++ DP RP+A+
Sbjct: 226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAE 285
Query: 468 ELVENPIFDKIQK 480
E + +P F + K
Sbjct: 286 EALADPYFKGLAK 298
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 45/220 (20%)
Query: 237 IGAGNFSHVFKVLKRIDGC-FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
IG GNF V + + + DG A ++ + + R E++ L LG H NI+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 296 SSWFENEQLYIQMELC-----------------------DHSLSDKKASQFFAEGEVLKA 332
+ LYI +E +H + SQ ++L+
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ-----QLLQF 124
Query: 333 LHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDF----GRATLLNKS---LPIEE 384
+A +Q++ EK H D+ N+ V +N K+ DF G + K+ LP+
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPV-- 182
Query: 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK--GSP 422
R+M E LN + K D++S G ++E++ G+P
Sbjct: 183 ---RWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 10/201 (4%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ-LHHDAERRKALLEVQALAALGSH 288
DF+ + +G G+F V ++ YA+K K+ + D + ++E + LA G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQF--FAEGEVLKALHQIAQALQFIHEK 346
+ +S + ++LY ME + Q F E + +IA L F+H K
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFG---RATLLNKSLPIEEGDARYM-PQEILNEDYDH 401
GI + D+K DN+ + G K+ DFG K+ G Y+ P+ I + Y
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGK 180
Query: 402 LDKVDIFSLGATMYELIKGSP 422
VD ++ G +YE++ G P
Sbjct: 181 --SVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 23/155 (14%)
Query: 334 HQIAQALQFIHEKGIAHLDVKPDNIYVKNG-VYKLGDFGRA-TLLNKSLPIEEGDAR--- 388
+Q+A+ + F+ K H D+ NI + +G + K+ DFG A + N S + +G+AR
Sbjct: 221 YQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 389 -YM-PQEILNEDYDHLDKV--------DIFSLGATMYELIKGSPLSESGPQFLNL-RDGK 437
+M P+ I N Y V +IFSLG++ Y G P+ +F + ++G
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY---PGMPVDS---KFYKMIKEGY 334
Query: 438 LPLLPGHS-LQFQNLLKVMVDPDPVQRPSAKELVE 471
L P + + +++K D DP++RP+ K++V+
Sbjct: 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 7e-07
Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 35/215 (16%)
Query: 237 IGAGNFSHVFKVLKRIDGC-FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
IG GNF V K + DG A ++ + R E++ L LG H NI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 296 SSWFENEQLYIQMELCDHS------------------LSDKKASQFFAEGEVLKALHQIA 337
+ LY+ +E H + + ++L +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 338 QALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDF----GRATLLNKS---LPIEEGDARY 389
+ + ++ +K H D+ NI V +N V K+ DF G+ + K+ LP+ R+
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV-----RW 177
Query: 390 MPQEILNEDYDHLDKVDIFSLGATMYELIK--GSP 422
M E LN + D++S G ++E++ G+P
Sbjct: 178 MAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 7e-07
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 14/215 (6%)
Query: 215 FPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRK 274
F + GD + ++ IG+G V + A+K R + ++
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 275 ALLEVQALAALGSHENIVGYYSSWF------ENEQLYIQMELCDHSLSDKKASQFFAEGE 328
A E+ + + +H+NI+ + + E + +Y+ MEL D +L + E
Sbjct: 63 AYRELVLMKCV-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHE-R 120
Query: 329 VLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNG-VYKLGDFGRATLLNKSL---PIEE 384
+ L+Q+ ++ +H GI H D+KP NI VK+ K+ DFG A S P
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 180
Query: 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK 419
P+ IL Y + VDI+S+G M E+++
Sbjct: 181 TRYYRAPEVILGMGYK--ENVDIWSVGCIMGEMVR 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 35/207 (16%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ--LHHDAERRKALLEVQALAALGS 287
+F ++G+G F V++ L + + A+K K L EVQAL L
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWK-NRVRVAIKILKSDDLLKQQ----DFQKEVQALKRL-R 60
Query: 288 HENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALH------QIAQAL 340
H++++ ++ E +YI EL + SL S EG+VL Q+A+ +
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS---PEGQVLPVASLIDMACQVAEGM 117
Query: 341 QFIHEKGIAHLDVKPDNIYVKNG-VYKLGDFGRATLL--------NKSLPIEEGDARYMP 391
++ E+ H D+ NI V V K+ DFG A L+ +K +P ++
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPY-----KWTA 172
Query: 392 QEILNEDYDHLD-KVDIFSLGATMYEL 417
E + + K D++S G +YE+
Sbjct: 173 PEAAS--HGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 24/204 (11%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAA------LGSHEN 290
+G G F V+ G AVK Q+ D + ++ EV AL H+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVK----QVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 291 IVGYYSSWFENEQ--LYIQME-LCDHSLSDK-KASQFFAEGEVLKALHQIAQALQFIHEK 346
IV YY + E+ L I +E + S+ D+ KA E + QI Q + ++H
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 347 GIAHLDVKPDNIYVKN-GVYKLGDFGRA----TLLNKSLPIEE--GDARYMPQEILN-ED 398
I H D+K NI + G KLGDFG + T+ I+ G +M E+++ E
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG 185
Query: 399 YDHLDKVDIFSLGATMYELIKGSP 422
Y K D++S+ T+ E++ P
Sbjct: 186 YGR--KADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 9/97 (9%)
Query: 333 LHQIAQALQFIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE----GDA 387
+ ++ A+ IH+ H D+KPDN+ + NG +L DFG +N+ ++ G
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
Query: 388 RYMPQEILNEDYDHLDK----VDIFSLGATMYELIKG 420
Y+ EIL D + K D +SLG MYE++ G
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 65/261 (24%), Positives = 99/261 (37%), Gaps = 35/261 (13%)
Query: 235 EQIGAGNFSHVFK-VLKRIDGCFY--AVKHSKRQLHHDAERRKALLEVQALAALGSHENI 291
+++G GNF V K V G AVK K Q H A +++ L E +A L H I
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQL-DHPCI 58
Query: 292 VGYYSSWFENEQLYIQMELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIHEKGIA 349
V + E L + MEL K K + ++ + HQ+A + ++ K
Sbjct: 59 VRLIGV-CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 350 HLDVKPDNIYVKNGVY-KLGDFG--RATLLNKSLPIEEGDAR-----YMPQEILNEDYDH 401
H D+ N+ + N K+ DFG RA R Y P+ I +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177
Query: 402 LDKVDIFSLGATMYELIK--GSPLSE-SGPQFL-----NLRDGKLPLLPGHSLQFQNLLK 453
K D++S G T++E P E G + + R + P Q +
Sbjct: 178 --KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECP------QEIYS 229
Query: 454 VMVD---PDPVQRPSAKELVE 471
+M+ P RP+ EL
Sbjct: 230 IMLSCWKYRPEDRPTFSELES 250
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 58/213 (27%), Positives = 88/213 (41%), Gaps = 39/213 (18%)
Query: 237 IGAGNFSHVFK-VLKRIDGCF-----YAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+G+G F V++ I G AVK + R+ D E+++ L E ++ +H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVK-TLRKGATDQEKKEFLKEAHLMSNF-NHPN 60
Query: 291 IVGYYSSWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIA-------- 337
IV NE YI MEL + L D + +F LK L I
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 338 --QALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKS----------LPIEEG 385
+ + FIH A + + Y + V K+GDFG A + KS LP+
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV--- 177
Query: 386 DARYMPQEILNEDYDHLDKVDIFSLGATMYELI 418
R+M E L D + D++S G M+E++
Sbjct: 178 --RWMAPESL-LDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 51/191 (26%), Positives = 80/191 (41%), Gaps = 12/191 (6%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGY 294
E+IG GNF VF R D AVK + L D + K L E + L SH NIV
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL-KAKFLQEARILKQY-SHPNIVRL 58
Query: 295 YSSWFENEQLYIQMELC---DHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
+ + +YI MEL D + E+++ + A ++++ K H
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHR 118
Query: 352 DVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMP-----QEILNEDYDHLDKV 405
D+ N V + V K+ DFG + + G + +P E LN + +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG-RYSSES 177
Query: 406 DIFSLGATMYE 416
D++S G ++E
Sbjct: 178 DVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 69/277 (24%), Positives = 107/277 (38%), Gaps = 48/277 (17%)
Query: 234 IEQIGAGNFSHVFKVLKRID------GCFYAVKHSKRQLHHDAERRKALLEVQALAALGS 287
I +G G+F V L D G AVK KR+ E+ L L
Sbjct: 9 IRVLGEGHFGKV--SLYCYDPANDGTGEMVAVKTLKRE-CGQQNTSGWKKEINILKTL-Y 64
Query: 288 HENIVGYYSSWFE--NEQLYIQMELCD-HSLSDKKASQFFAEGEVLKALHQIAQALQFIH 344
HENIV Y E + L + ME SL D ++L QI + + ++H
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 345 EKGIAHLDVKPDNIYVKNG-VYKLGDFGRATLLNKSLPI--------EEGDAR--YMPQE 393
+ H D+ N+ + N + K+GDFG L K++P E+GD+ + E
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFG----LAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 394 ILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP-QFLNL------------------R 434
L E D++S G T+YEL+ +S P +F + R
Sbjct: 181 CLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239
Query: 435 DGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471
+LP + L+K + + RP+ + L+
Sbjct: 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 69/281 (24%), Positives = 111/281 (39%), Gaps = 60/281 (21%)
Query: 237 IGAGNFSHVFK-----VLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENI 291
+G G F V K + + AVK K + + + E++ + +G H+NI
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 292 VGYYSSWFENEQLYIQMELCDH-SLSD-------------KKASQFFAEGEVLKAL---- 333
+ + LY+ +E H +L D + E K L
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 334 HQIAQALQFIHEKGIAHLDVKPDNIYVKNG-VYKLGDFGRATLL----------NKSLPI 382
+Q+A+ ++F+ K H D+ N+ V V K+ DFG A + N LP+
Sbjct: 139 YQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPV 198
Query: 383 EEGDARYMPQEILNED-YDHLDKV--------DIFSLGATMYELIKGSPLSESGPQFLNL 433
++M E L + Y H V +IF+LG + Y G P+ E F L
Sbjct: 199 -----KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY---PGIPVEE---LFKLL 247
Query: 434 RDGKLPLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
++G + + Q L +M D P QRP+ K+LVE
Sbjct: 248 KEGY-RMEKPQNCT-QELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 13/152 (8%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQA---LAALGS 287
F +I+ IG G F V V K YA+K ++ D R V+A + A
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKA---DVLMRNQAAHVKAERDILAEAD 59
Query: 288 HENIVGYYSSWFENEQLYIQMELCD----HSLSDKKASQFFAEGEVLKALHQIAQALQFI 343
+E +V Y S+ + + LY M+ SL + F E + ++ A++ +
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESV 117
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRAT 374
H+ G H D+KPDNI + ++G KL DFG T
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 50/209 (23%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 228 YTDFHEIEQIGAGNFSHVF-----------KVLKRIDGCFYAVKHSKRQLHHDAERRKAL 276
Y DF+ I +G G+F V +KR + ++Q+ H RK L
Sbjct: 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII---KQKQVDHVFSERKIL 85
Query: 277 LEVQALAALGSHENIVGYYSSWFENEQLYIQMELC--DHSLSDKKASQFFAEGEVLKALH 334
+ H V Y S+ + LY+ +E + + ++ F
Sbjct: 86 NYIN-------HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA 138
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQE 393
QI +++ I + D+KP+N+ + K+G K+ DFG A +++ G Y+ E
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPE 198
Query: 394 ILNEDYDHLDKVDIFSLGATMYELIKGSP 422
IL + H D ++LG +YE++ G P
Sbjct: 199 IL-LNVGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQA---LAALGS 287
F +I+ +G G F V K YA+K +++ D R + V+A + A
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKK---DVLNRNQVAHVKAERDILAEAD 59
Query: 288 HENIVGYYSSWFENEQLYIQMELCDHS--LSDKKASQFFAEGEVLKALHQIAQALQFIHE 345
+E +V Y S+ + + LY M+ +S + F E + ++ A++ +H+
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK 119
Query: 346 KGIAHLDVKPDNIYVK-NGVYKLGDFGRAT 374
G H D+KPDNI + +G KL DFG T
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCT 149
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 26/169 (15%)
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYVKNGVY-KLGDFGRATLLNKSLPIEEGDARYMP-- 391
QIA+ + ++ E+ + H D+ N+ VK + K+ DFG A LL + +P
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 392 ----QEILNEDYDHLDKVDIFSLGATMYELIK-------GSPLSESGPQFLNLRDG-KLP 439
+ IL+ Y H + D++S G T++EL+ G P SE L G +LP
Sbjct: 177 WMALESILHRIYTH--QSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERLP 231
Query: 440 LLPGHSLQ-FQNLLKV-MVDPDPVQRPSAKELVENPIFDKIQKHRKTYM 486
P ++ + ++K M+D D RP +EL+ F K+ + + Y+
Sbjct: 232 QPPICTIDVYMIMVKCWMIDAD--SRPKFRELIIE--FSKMARDPQRYL 276
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 46/142 (32%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 235 EQIGAGNFSHVFK-VLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
E+IG GNF V+K VLK AVK + L D +RK L E + L H NIV
Sbjct: 1 EKIGKGNFGDVYKGVLK--GNTEVAVKTCRSTLPPD-LKRKFLQEAEILKQY-DHPNIVK 56
Query: 294 YYSSWFENEQLYIQMELC-DHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAH 350
+ + +YI MEL SL +K ++L+ A ++++ K H
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 351 LDVKPDNIYV-KNGVYKLGDFG 371
D+ N V +N V K+ DFG
Sbjct: 117 RDLAARNCLVGENNVLKISDFG 138
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 33/154 (21%), Positives = 54/154 (35%), Gaps = 26/154 (16%)
Query: 326 EGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSLPIEEG 385
E E+ Q AL+ +H + + + + +K G K+
Sbjct: 16 EEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL-------DGSVAF--KTPEQSRP 66
Query: 386 DARYM-PQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGH 444
D +M P+ I + Y K DI+SLG T+YE + P + L
Sbjct: 67 DPYFMAPEVIQGQSYTE--KADIYSLGITLYEALDYEL-----PYNE-----EREL---- 110
Query: 445 SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478
S + LL M DP R + + + F+
Sbjct: 111 SAILEILLNGMPADDPRDRSNLEGVSAARSFEDF 144
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 65/258 (25%), Positives = 100/258 (38%), Gaps = 38/258 (14%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSHE 289
++GAG F V+ AVK L +A L E Q + L H+
Sbjct: 8 LKLERKLGAGQFGEVWMGTWN-GTTKVAVK----TLKPGTMSPEAFLQEAQIMKKL-RHD 61
Query: 290 NIVGYYSSWFENEQLYIQMEL-CDHSLSDKKASQFFAEGEVLKALH---------QIAQA 339
+V Y+ E E +YI E SL D F GE K L QIA+
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLD-----FLKSGEG-KKLRLPQLVDMAAQIAEG 115
Query: 340 LQFIHEKGIAHLDVKPDNIYVKNG-VYKLGDFGRATLLNKSLPIEEGDARY-----MPQE 393
+ ++ + H D+ NI V V K+ DFG A L+ A++ P+
Sbjct: 116 MAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEA 175
Query: 394 ILNEDYDHLD-KVDIFSLGATMYELI-KG-SPL-SESGPQFL-NLRDG-KLPLLPGHSLQ 447
Y K D++S G + E++ G P + + L + G ++P P +
Sbjct: 176 AN---YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEE 232
Query: 448 FQNLLKVMVDPDPVQRPS 465
+L+ D DP +RP+
Sbjct: 233 LYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 40/217 (18%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALAALGSH 288
DF ++ IG G F V V + G YA+K +K ++ AE E + + G
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET-ACFREERDVLVNGDR 60
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALH-------------- 334
I + ++ + LY+ M+ ++ G++L L
Sbjct: 61 RWITNLHYAFQDENNLYLVMD-------------YYVGGDLLTLLSKFEDRLPEDMARFY 107
Query: 335 --QIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE----GDA 387
++ A+ +H+ G H D+KPDN+ + KNG +L DFG L ++ G
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167
Query: 388 RYMPQEILNEDYDHLDK----VDIFSLGATMYELIKG 420
Y+ EIL D + D +SLG MYE++ G
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 48/194 (24%), Positives = 77/194 (39%), Gaps = 14/194 (7%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+ IG G F V R G AVK K + L E + L H
Sbjct: 7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKD---DSTAAQAFLAEASVMTTL-RHP 60
Query: 290 NIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQFFA----EGEVLKALHQIAQALQFIH 344
N+V + LYI E SL D S+ A ++ AL + + ++++
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD-VCEGMEYLE 119
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLD 403
EK H D+ N+ V ++ V K+ DFG A ++ + ++ E L E
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREK-KFST 178
Query: 404 KVDIFSLGATMYEL 417
K D++S G ++E+
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 31/100 (31%), Positives = 44/100 (44%), Gaps = 22/100 (22%)
Query: 338 QALQFIHEKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEEGDARYMPQ---- 392
+AL ++H +GI H DVK +NI++ LGDFG A L PQ
Sbjct: 196 EALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL--------DAHPDTPQCYGW 247
Query: 393 ----EILNEDYDHLD----KVDIFSLGATMYE-LIKGSPL 423
E + + LD K DI+S G ++E +K L
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 7e-06
Identities = 64/261 (24%), Positives = 112/261 (42%), Gaps = 25/261 (9%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYS 296
+G G F V V ++ G +YA+K K+++ + L + H +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 297 SWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
S+ ++L ME + LS ++ F+E +I AL ++H I +
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERV---FSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 352 DVKPDNIYV-KNGVYKLGDFG---RATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDI 407
D+K +N+ + K+G K+ DFG ++ G Y+ E+L ED D+ VD
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL-EDNDYGRAVDW 178
Query: 408 FSLGATMYELIKGS-PL----SESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQ 462
+ LG MYE++ G P E + + + D K P S ++LL ++ DP +
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT--LSADAKSLLSGLLIKDPNK 236
Query: 463 R-----PSAKELVENPIFDKI 478
R AKE++ + F +
Sbjct: 237 RLGGGPDDAKEIMRHSFFTGV 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 67/282 (23%), Positives = 116/282 (41%), Gaps = 46/282 (16%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKH-------SKRQLHHDAERRKALLEVQALAALGSHE 289
IG G+F V +V KR YA+K S+ ++ H R L +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNC-------P 53
Query: 290 NIVGYYSSWFENEQLYIQMELCD-----HSLS-----DKKASQFFAEGEVLKALHQIAQA 339
IV S+ E+LY+ + + H L D ++F+ ++ A
Sbjct: 54 FIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA--------ELLCA 105
Query: 340 LQFIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEIL 395
L+ +H+ + + D+KP+NI + G L DFG L K G Y+ E+L
Sbjct: 106 LENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELL 165
Query: 396 NEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKLPLLPGHSLQFQNLL 452
+ + VD ++LG +YE++ G P E+ + + + L G ++LL
Sbjct: 166 L-GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLL 224
Query: 453 KVMVDPDPVQR---PSAKELVENPIFDKIQKHR---KTYMKP 488
++ DP +R A+E+ +P F ++ + K P
Sbjct: 225 IGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPP 266
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQA---LAALGS 287
F +I+ +G G F V K YA+K +++ D R + V+A + A
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK---DVLLRNQVAHVKAERDILAEAD 59
Query: 288 HENIVGYYSSWFENEQLYIQMELCDHS--LSDKKASQFFAEGEVLKALHQIAQALQFIHE 345
+E +V Y S+ + + LY M+ +S F E + ++ A++ +H+
Sbjct: 60 NEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK 119
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRAT 374
G H D+KPDNI + ++G KL DFG T
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 37/168 (22%)
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDA------ 387
+I AL ++H + + D+K +N+ + K+G K+ DFG L K I +G
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFG----LCKE-GISDGATMKTFCG 157
Query: 388 --RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQFLNLRDGKL-PLLPG 443
Y+ E+L ED D+ VD + LG MYE++ G P F N KL L+
Sbjct: 158 TPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLP-------FYNQDHEKLFELILM 209
Query: 444 HSLQF--------QNLLKVMVDPDPVQR-----PSAKELVENPIFDKI 478
++F ++LL ++ DP QR AKE++E+ F I
Sbjct: 210 EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 334 HQIAQALQFIHEKGIAHLDVKPDNIYVKNGVY--KLGDFGRA-TLLNKSLPIEEGDAR-Y 389
+Q+ +AL +IH K I H D+KP N+ + + KL DFG A LL + +R Y
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFY 236
Query: 390 MPQEILNEDYDHLDKVDIFSLGATMYELIKGSPL 423
E++ ++ +D++SLG + E+I G P+
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGYPI 270
|
Length = 440 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 42/149 (28%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 287 SHENIVGYY----SSWFEN-EQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQ 341
HENI+G FE+ +YI EL + L +Q + + L+QI + L+
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLK 120
Query: 342 FIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL-----NKSLPIEEGDAR-YMPQEI 394
+IH + H D+KP N+ + N K+ DFG A + + E R Y EI
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 395 LNEDYDHLDKVDIFSLGATMYELIKGSPL 423
+ + +DI+S+G + E++ PL
Sbjct: 181 MLNSKGYTKAIDIWSVGCILAEMLSNRPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 51/225 (22%), Positives = 82/225 (36%), Gaps = 50/225 (22%)
Query: 230 DFHEIEQIGAGNFSHVFK----VLKRIDGC-FYAVKHSK----RQLHHDAERRKALLEVQ 280
++G G F VF L+ + AVK K D ER E +
Sbjct: 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER-----EAE 60
Query: 281 ALAALGSHENIVGYYSSWFENEQLYIQMELCDH----------------SLSDKKASQFF 324
L HENIV +Y E + + E +H S
Sbjct: 61 LLTNFQ-HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 325 AEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL------- 376
++L+ QIA + ++ + H D+ N V + V K+GDFG + +
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 377 ---NKSLPIEEGDARYMPQE-ILNEDYDHLDKVDIFSLGATMYEL 417
+ LPI R+MP E I+ + + D++S G ++E+
Sbjct: 180 VGGHTMLPI-----RWMPPESIMYRKFT--TESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 230 DFHEIEQIGAGNFSHVFKV-LKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
DF ++ IG G F V V LK D F +K ++ AE E + + G +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET-ACFREERDVLVNGDN 60
Query: 289 ENIVGYYSSWFENEQLYIQMELC---DHSLSDKKASQFFAEGEVLKALHQIAQALQFIHE 345
+ I + ++ + LY+ M+ D K E L ++ A+ +H+
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 346 KGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE----GDARYMPQEILNEDYD 400
H D+KPDNI + NG +L DFG L + ++ G Y+ EIL D
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 401 ----HLDKVDIFSLGATMYELIKG 420
+ + D +SLG MYE++ G
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 62/252 (24%), Positives = 112/252 (44%), Gaps = 40/252 (15%)
Query: 240 GNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF 299
GN S+ + + CF ++ + E ++ + Q L ++ S ++ S +
Sbjct: 97 GNLSNYLRSKRE---CFSPYRNKSTRKR---EMKQKEGKKQRLDSVSSSQS--SASSGFI 148
Query: 300 ENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIY 359
E++ L E D + E +++ Q+A+ ++F+ + H D+ NI
Sbjct: 149 EDKSLSDVEE--DEEGDELYKEPLTLE-DLISYSFQVARGMEFLASRKCIHRDLAARNIL 205
Query: 360 V-KNGVYKLGDFGRATLLNKSLP--IEEGDAR----YM-PQEILNEDYDHLDKV------ 405
+ +N V K+ DFG A + K P + +GDAR +M P+ I ++ Y V
Sbjct: 206 LSENNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVL 264
Query: 406 --DIFSLGATMYELIKGSPLSESGPQFLN-LRDGKLPLLPGHSLQFQNLLKVMVD---PD 459
+IFSLGA+ Y G + E +F L++G P ++ + +M+D +
Sbjct: 265 LWEIFSLGASPY---PGVQIDE---EFCRRLKEGTRMRAPEYATP--EIYSIMLDCWHNN 316
Query: 460 PVQRPSAKELVE 471
P RP+ ELVE
Sbjct: 317 PEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 31/139 (22%), Positives = 61/139 (43%), Gaps = 9/139 (6%)
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFI 343
SH N+V Y + ++I E + L + ++ +L + +A++++
Sbjct: 57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL 116
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRAT-LLNKSLPIEEGD---ARYMPQEILNED 398
G H D+ N V ++ V K+ DFG A +L+ +G ++ P E+ +
Sbjct: 117 ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYS 176
Query: 399 YDHLDKVDIFSLGATMYEL 417
K D++S G M+E+
Sbjct: 177 -RFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSHE 289
F + +G G F V R G YA K K+++ AL E Q L + S +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS-Q 60
Query: 290 NIVGYYSSWFENEQLYIQMELCDHSLSDKKASQF------FAEGEVLKALHQIAQALQFI 343
+V ++ + L + + + + D K + F E L +I L+ +
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGG--DLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 344 HEKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEE--GDARYMPQEILNEDYD 400
H + + D+KP+NI + + G ++ D G A + + I G YM E+LN
Sbjct: 119 HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY 178
Query: 401 HLDKVDIFSLGATMYELIKG-SPL 423
L D + LG +YE+I+G SP
Sbjct: 179 TLSP-DYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSH 288
DF+ + +G G+F V ++ YA+K K+ + D + ++E + LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQF--FAEGEVLKALHQIAQALQFIHEK 346
+ +S + ++LY ME + Q F E + + +I+ L F+H +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 347 GIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEE-------GDARYMPQEILNED 398
GI + D+K DN+ + + G K+ DFG + K ++ G Y+ EI+
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFG----MCKEHMVDGVTTRTFCGTPDYIAPEIIA-- 174
Query: 399 YDHLDK-VDIFSLGATMYELIKGSP 422
Y K VD ++ G +YE++ G P
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSH 288
DF+ + +G G+F V ++ YA+K K+ + D + ++E + LA G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQF--FAEGEVLKALHQIAQALQFIHEK 346
+ +S + ++LY ME + + Q F E + +IA L F+H K
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 347 GIAHLDVKPDNIYVKN-GVYKLGDFGRAT------LLNKSLPIEEGDARYMPQEILNEDY 399
GI + D+K DN+ + + G K+ DFG + K+ G Y+ EI+ Y
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC---GTPDYIAPEIIA--Y 175
Query: 400 DHLDK-VDIFSLGATMYELIKGSP 422
K VD ++ G +YE++ G
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 66/272 (24%), Positives = 120/272 (44%), Gaps = 45/272 (16%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKH-------SKRQLHHDAERRKALLEVQALAALGSHE 289
+G G F V V ++ G +YA+K +K ++ H + L + H
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-------HP 55
Query: 290 NIVGYYSSWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIAQALQFIH 344
+ ++ +++L ME + LS ++ F E +I AL+++H
Sbjct: 56 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLH 112
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE------GDARYMPQEILNE 397
+ + + D+K +N+ + K+G K+ DFG L + + G Y+ E+L E
Sbjct: 113 SRDVVYRDIKLENLMLDKDGHIKITDFG---LCKEGISDGATMKTFCGTPEYLAPEVL-E 168
Query: 398 DYDHLDKVDIFSLGATMYELIKG-----SPLSESGPQFLNLRDGKLPLLPGHSLQFQNLL 452
D D+ VD + LG MYE++ G + E + + + + + P S + ++LL
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLL 226
Query: 453 KVMVDPDPVQR----PS-AKELVENPIFDKIQ 479
++ DP QR PS AKE++E+ F I
Sbjct: 227 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 41/211 (19%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYY 295
+G G+F V + G ++AVK K+ + D + ++E + LA + + Y
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 296 SSWFENEQLYIQMELCD-----HSLSDK------KASQFFAEGEVLKALHQIAQALQFIH 344
++ E L+ ME + + DK +A+ + AE I LQF+H
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAE---------IVCGLQFLH 113
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFG----------RATLLNKSLPIEEGDARYMPQE 393
KGI + D+K DN+ + ++G K+ DFG RA+ G Y+ E
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-------GTPDYIAPE 166
Query: 394 ILNEDYDHLDKVDIFSLGATMYELIKG-SPL 423
IL + + VD +S G +YE++ G SP
Sbjct: 167 IL-QGLKYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 22/153 (14%)
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYVKNGVY-KLGDFGRATLLNKSLPIEEGDARYMP-- 391
QIA+ + ++ E + H D+ N+ VK+ + K+ DFG A LL+ D +P
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176
Query: 392 ----QEILNEDYDHLDKVDIFSLGATMYELI-------KGSPLSESGPQFLNLRDGKLPL 440
+ IL+ + H + D++S G T++EL+ G P E P L + +LP
Sbjct: 177 WMALESILHRRFTH--QSDVWSYGVTVWELMTFGAKPYDGIPAREI-PDLLE-KGERLPQ 232
Query: 441 LPGHSLQ-FQNLLKV-MVDPDPVQRPSAKELVE 471
P ++ + ++K M+D + RP +ELV+
Sbjct: 233 PPICTIDVYMIMVKCWMIDSE--CRPRFRELVD 263
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 29/158 (18%)
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP--IEEGDAR--- 388
Q+A+ ++F+ + H D+ NI + +N V K+ DFG A + K P + +GDAR
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD-PDYVRKGDARLPL 245
Query: 389 -YM-PQEILNEDYDHLDKV--------DIFSLGATMYELIKGSPLSESGPQFL-NLRDGK 437
+M P+ I + Y V +IFSLGA+ Y G + E +F L++G
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDE---EFCRRLKEGT 299
Query: 438 LPLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVEN 472
P ++ + + M+D +P QRP+ ELVE+
Sbjct: 300 RMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 64/259 (24%), Positives = 115/259 (44%), Gaps = 24/259 (9%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERR---KALLEVQALAALGSHEN 290
E +G G F+ +FK ++R G + + ++ L D R ++ E ++ + SH++
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 291 IVGYYSSWFENEQLYIQMELCDHSLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKG 347
+V Y ++ + E D KK L+ Q+A AL F+ +KG
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 348 IAHLDVKPDNIYV------KNG---VYKLGDFGRA-TLLNKSLPIEEGDARYMPQEILNE 397
+ H +V N+ + K G KL D G + T+L K + +E ++P E + E
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER--IPWVPPECI-E 177
Query: 398 DYDHLD-KVDIFSLGATMYELIKGS--PLSESGPQF-LNLRDGKLPLLPGHSLQFQNLLK 453
+ +L D +S G T++E+ G PLS Q L + + L + NL+
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLIN 237
Query: 454 VMVDPDPVQRPSAKELVEN 472
+D +P RPS + ++ +
Sbjct: 238 QCMDYEPDFRPSFRAIIRD 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 55/219 (25%), Positives = 85/219 (38%), Gaps = 32/219 (14%)
Query: 276 LLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCD-HSLSD---KKASQFFAEGEVLK 331
L E + +L HEN++ Y + + + EL SL D K A F +
Sbjct: 44 LKEAAIMHSL-DHENLIRLYGVVLTHPLMMV-TELAPLGSLLDRLRKDALGHFLISTLCD 101
Query: 332 ALHQIAQALQFIHEKGIAHLDVKPDNI--YVKNGVYKLGDFGRATLLNKSLPIEEGDAR- 388
QIA ++++ K H D+ NI + V K+GDFG L ++LP E
Sbjct: 102 YAVQIANGMRYLESKRFIHRDLAARNILLASDDKV-KIGDFG----LMRALPQNEDHYVM 156
Query: 389 ---------YMPQEILNE-DYDHLDKVDIFSLGATMYELIK--GSP-LSESGPQFLNLRD 435
+ E L + H D++ G T++E+ P SG Q L D
Sbjct: 157 EEHLKVPFAWCAPESLRTRTFSH--ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID 214
Query: 436 GKLPLLPGHSLQFQNLLKVMV---DPDPVQRPSAKELVE 471
+ L Q++ VM+ +P RP+ L E
Sbjct: 215 KEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 4e-05
Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 20/166 (12%)
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYVKNGVY-KLGDFGRATLLNKSLPIEEGDARYMPQE 393
QIA+ + ++ E+ + H D+ N+ VK+ + K+ DFG A LL D MP +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176
Query: 394 ILNEDYDHLDKV----DIFSLGATMYELIK-------GSPLSESGPQFLNLRDGKLPLLP 442
+ + H K D++S G T++EL+ G P E P L + +LP P
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLE-KGERLPQPP 234
Query: 443 GHSLQ-FQNLLKV-MVDPDPVQRPSAKELVENPIFDKIQKHRKTYM 486
++ + ++K M+D D RP KEL F ++ + + Y+
Sbjct: 235 ICTIDVYMVMVKCWMIDAD--SRPKFKELAAE--FSRMARDPQRYL 276
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 31/151 (20%), Positives = 55/151 (36%), Gaps = 20/151 (13%)
Query: 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENI 291
I+ + G + V+ + Y +K + + R EV L L
Sbjct: 1 SSIKLLKGGLTNRVYLL--GTKDEDYVLKINPSREKGADRER----EVAILQLLARKGLP 54
Query: 292 V--GYYSSWFENEQLYIQMELCD-HSLSDKKASQFFAEGEVLKALHQIAQALQFIHE--- 345
V S + Y+ ME + +L + +E E Q+A+ L +H+
Sbjct: 55 VPKVLASGESDGWS-YLLMEWIEGETLDE------VSEEEKEDIAEQLAELLAKLHQLPL 107
Query: 346 KGIAHLDVKPDNIYVKNG-VYKLGDFGRATL 375
+ H D+ P NI V +G + + D+ A
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 15/111 (13%)
Query: 317 DKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKN-GVYKLGDFGRATL 375
D++ + F+A +I L+ +H + I + D+KP+NI + + G ++ D G A
Sbjct: 100 DEERAVFYAA--------EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVE 151
Query: 376 LNKSLPIEE--GDARYMPQEIL-NEDYDHLDKVDIFSLGATMYELIKG-SP 422
+ + I G YM E++ NE Y D + LG +YE+I+G SP
Sbjct: 152 IPEGETIRGRVGTVGYMAPEVVKNERYTF--SPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 53/216 (24%), Positives = 80/216 (37%), Gaps = 34/216 (15%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
I IG G V+ + A+K + L + +K L +AA H IV
Sbjct: 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 294 YYSSWFENEQLYIQM---------ELCDHSLSDKKASQFFAEGEVLKAL----HQIAQAL 340
YS + + +Y M L + S+ AE + A H+I +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 341 QFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSLPI-------EEGDARYMPQE 393
+++H KG+ H D+KPDNI LG FG +L+ I + D +
Sbjct: 127 EYVHSKGVLHRDLKPDNIL-------LGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 394 ILNEDYDHLDKVDIFSLGATMY---ELIKGSPLSES 426
I K+ +G Y E + G P SES
Sbjct: 180 ICYSSMTIPGKI----VGTPDYMAPERLLGVPASES 211
|
Length = 932 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 15/103 (14%)
Query: 328 EVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNG-VYKLGDFGRA-TLLNKSLPIEEG 385
++L+ Q+AQ + F+ K H DV N+ + +G V K+ DFG A ++N S + +G
Sbjct: 213 DLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 386 DAR----YM-PQEILNEDYDHLDKV--------DIFSLGATMY 415
+AR +M P+ I + Y V +IFSLG + Y
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 52/237 (21%), Positives = 101/237 (42%), Gaps = 56/237 (23%)
Query: 278 EVQALAALGSHENIVGYYSSWFENEQLYI--------------------QMELCDHSLSD 317
E++ + +G H+NI+ + ++ LY+ ME C +
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNP--T 130
Query: 318 KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRA--- 373
+ + + +++ +Q+A+ ++++ K H D+ N+ V ++ V K+ DFG A
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 374 -------TLLNKSLPIEEGDARYM-PQEILNEDYDHLDKVDIFSLGATMYELIK------ 419
N LP+ ++M P+ + + Y H + D++S G ++E+
Sbjct: 191 HHIDYYKKTTNGRLPV-----KWMAPEALFDRIYTH--QSDVWSFGVLLWEIFTLGGSPY 243
Query: 420 -GSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVEN 472
G P+ E F L++G P + L +M D P QRP+ K+LVE+
Sbjct: 244 PGVPVEE---LFKLLKEGHRMDKPSNCTN--ELYMMMRDCWHAVPSQRPTFKQLVED 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 61/283 (21%), Positives = 113/283 (39%), Gaps = 61/283 (21%)
Query: 237 IGAGNFSHVFKVLK-RIDG----CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENI 291
+G G F V K R+ G AVK K +E R L E L + +H ++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQV-NHPHV 65
Query: 292 VGYYSSWFENEQLYIQMELCDH-------------------SLSDKKASQFFAEGE---- 328
+ Y + ++ L + +E + S ++ +S E
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 329 ---VLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNG-VYKLGDFGRATLLNKSLPIEE 384
++ QI++ +Q++ E + H D+ N+ V G K+ DFG S + E
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGL------SRDVYE 179
Query: 385 GDA-----------RYMPQEILNEDYDHL--DKVDIFSLGATMYELIK--GSPLSESGPQ 429
D+ ++M E L +DH+ + D++S G ++E++ G+P P+
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESL---FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
Query: 430 --FLNLRDGKLPLLPGH-SLQFQNLLKVMVDPDPVQRPSAKEL 469
F L+ G P + S + NL+ +P +RP+ ++
Sbjct: 237 RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 23/198 (11%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFY--AVKHSKRQLHHDAERRKALLEVQALAALGSHENI 291
++++GAG F V+ +Y + K + + L +A LE L H+ +
Sbjct: 11 VKKLGAGQFGEVWM-------GYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 63
Query: 292 VGYYSSWFENEQLYIQME-LCDHSLSDKKASQFFAEGEVLKALH---QIAQALQFIHEKG 347
V Y+ + E +YI E + SL D S + + K + QIA+ + +I K
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 348 IAHLDVKPDNIYVKNGVY-KLGDFGRATLLNKSLPIEEGDARY-----MPQEILNEDYDH 401
H D++ N+ V + K+ DFG A ++ + A++ P+ I ++
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI---NFGS 180
Query: 402 LD-KVDIFSLGATMYELI 418
K D++S G +YE++
Sbjct: 181 FTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 53/238 (22%), Positives = 105/238 (44%), Gaps = 48/238 (20%)
Query: 278 EVQALAALGSHENIVGYYSSWFENEQLYIQMELC-----------------DHSLSDKKA 320
E++ + +G H+NI+ + ++ LY+ +E ++S +
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 321 S-QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378
+ +++ +Q+A+ ++++ + H D+ N+ V +N V K+ DFG A +N
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN 189
Query: 379 ----------SLPIEEGDARYM-PQEILNEDYDHLDKVDIFSLGATMYEL--IKGSPLSE 425
LP+ ++M P+ + + Y H + D++S G M+E+ + GSP
Sbjct: 190 IDYYKKTTNGRLPV-----KWMAPEALFDRVYTH--QSDVWSFGVLMWEIFTLGGSPYPG 242
Query: 426 SGPQ--FLNLRDGKLPLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVENPIFDKI 478
+ F L++G P + L +M D P RP+ K+LVE+ D+I
Sbjct: 243 IPVEELFKLLKEGHRMDKPANCTN--ELYMMMRDCWHAIPSHRPTFKQLVED--LDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 64/236 (27%), Positives = 94/236 (39%), Gaps = 33/236 (13%)
Query: 264 RQLHHDAERRKALL--EVQALAALGSHENIVGYYSSW-FENEQLYIQMELCD-HSLSDKK 319
R + E ++A E A L H NIV S L+ E +L +
Sbjct: 12 RTDAPEEEHQRARFRRETALCARL-YHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL 70
Query: 320 ASQ-FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGV---YKLGDFGRAT 374
A+ GE + + Q+ AL H +GI H D+KP NI V + GV K+ DFG T
Sbjct: 71 AADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGT 130
Query: 375 LLNKSLPIEE----------GDARY-MPQEILNEDYDHLDKVDIFSLGATMYELIKGSPL 423
LL + G Y P+++ E D+++ G E + G +
Sbjct: 131 LLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT--PNSDLYAWGLIFLECLTGQRV 188
Query: 424 SESGP------QFLNLRDGKLP-LLPGHSLQFQNLLKVMVDPDPVQRP-SAKELVE 471
+ Q L+ D LP + GH L +L+ ++ DP QR SA L E
Sbjct: 189 VQGASVAEILYQQLSPVDVSLPPWIAGHPL--GQVLRKALNKDPRQRAASAPALAE 242
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 28/104 (26%), Positives = 50/104 (48%), Gaps = 18/104 (17%)
Query: 328 EVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEEGD 386
++L + +A+Q++HE I H D+K +NI++ + G LGDFG A P++
Sbjct: 183 DILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC-----FPVDINA 237
Query: 387 ARYM----------PQEILNEDYDHLDKVDIFSLGATMYELIKG 420
+Y P+ + + Y VDI+S G ++E+
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYG--PAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 41/158 (25%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 326 EGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEE 384
E V + ++ AL +H +GI D+ P+NI + + G +L F R + + S E
Sbjct: 84 EECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEA 143
Query: 385 GDARYMPQEI--LNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLP 442
+ Y E+ ++E+ + D +SLGA ++EL+ G L E P +N L +
Sbjct: 144 VENMYCAPEVGGISEE---TEACDWWSLGAILFELLTGKTLVECHPSGIN-THTTLNIPE 199
Query: 443 GHSLQFQNLLKVMVDPDPVQRPSA-----KELVENPIF 475
S + ++LL+ ++ +P +R A +++ +P F
Sbjct: 200 WVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 36/203 (17%)
Query: 236 QIGAGNF----SHVFKVLKR-IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
++G+GNF V+K+ K+ ID A+K K + + + R + + E + + L +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQID---VAIKVLKNE-NEKSVRDEMMREAEIMHQL-DNPY 56
Query: 291 IVGYYSSWFENEQLYIQMELC-----DHSLSDKKASQFFAEGEVLKALHQIAQALQFIHE 345
IV E E L + ME+ + LS KK V++ +HQ++ ++++
Sbjct: 57 IVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEG 113
Query: 346 KGIAHLDVKPDNIYVKNGVY-KLGDFGRATLLNKSLPIEEG--DAR---------YMPQE 393
K H D+ N+ + N Y K+ DFG L+K+L ++ AR Y P+
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFG----LSKALGADDSYYKARSAGKWPLKWYAPEC 169
Query: 394 ILNEDYDHLDKVDIFSLGATMYE 416
I + + D++S G TM+E
Sbjct: 170 INFRKFS--SRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 27/156 (17%)
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP--IEEGDAR--- 388
Q+A+ ++F+ + H D+ NI + +N V K+ DFG A + K P + +G AR
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD-PDYVRKGSARLPL 240
Query: 389 -YM-PQEILNEDYDHLDKV--------DIFSLGATMYELIKGSPLSESGPQFLNLRDGKL 438
+M P+ I ++ Y V +IFSLGA+ Y G ++E Q L+DG
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY---PGVQINEEFCQ--RLKDGTR 295
Query: 439 PLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
P + ++M+ DP +RP+ LVE
Sbjct: 296 MRAP--ENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 24/155 (15%)
Query: 334 HQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRA----------TLLNKSLPI 382
+Q+A+ ++++ + H D+ N+ V ++ V K+ DFG A N LP+
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPV 200
Query: 383 EEGDARYM-PQEILNEDYDHLDKVDIFSLGATMYEL--IKGSPLSESGPQ--FLNLRDG- 436
++M P+ + + Y H + D++S G M+E+ + GSP + F LR+G
Sbjct: 201 -----KWMAPEALFDRVYTH--QSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH 253
Query: 437 KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471
++ + + L++ P QRP+ K+LVE
Sbjct: 254 RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 44/218 (20%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ--LHHD------AERRKALLEVQAL 282
F + +G G+F V + G YA+K K+ + D E+R + E
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKR--IFET--- 55
Query: 283 AALGSHENIVGYYSSWFENEQLYIQME------LCDHSLSD---KKASQFFAEGEVLKAL 333
A H +V ++ + + + ME L H +D + + F+A VL
Sbjct: 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL--- 112
Query: 334 HQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE------GD 386
LQ++HE I + D+K DN+ + G K+ DFG L + + + G
Sbjct: 113 -----GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFG---LCKEGMGFGDRTSTFCGT 164
Query: 387 ARYMPQEILNED-YDHLDKVDIFSLGATMYELIKG-SP 422
++ E+L E Y VD + LG +YE++ G SP
Sbjct: 165 PEFLAPEVLTETSYTR--AVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 40/178 (22%), Positives = 76/178 (42%), Gaps = 41/178 (23%)
Query: 330 LKALH----QIAQALQFIHEKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEE 384
LK QI + + ++ + H D+ N+ V++ K+GDFG L K++ ++
Sbjct: 108 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG----LTKAIETDK 163
Query: 385 G-----DAR------YMPQEILNEDYDHLDKVDIFSLGATMYELI-----KGSPLSE--- 425
D Y P+ ++ + D++S G T+YEL+ + SP++
Sbjct: 164 EYYTVKDDLDSPVFWYAPECLIQSKF--YIASDVWSFGVTLYELLTYCDSESSPMTLFLK 221
Query: 426 -SGP--------QFLN-LRDGK-LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472
GP + + L +GK LP P + L++ + P +R + + L+E
Sbjct: 222 MIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 49/233 (21%), Positives = 102/233 (43%), Gaps = 48/233 (20%)
Query: 278 EVQALAALGSHENIVGYYSSWFENEQLYIQMELC-----------------DHSLSD-KK 319
E++ + +G H+NI+ + ++ LY+ +E D+S K
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 320 ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRA----- 373
+ +++ +Q+A+ ++++ + H D+ N+ V ++ V K+ DFG A
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN 186
Query: 374 -----TLLNKSLPIEEGDARYM-PQEILNEDYDHLDKVDIFSLGATMYELIK-------G 420
N LP+ ++M P+ + + Y H + D++S G ++E+ G
Sbjct: 187 IDYYKKTTNGRLPV-----KWMAPEALFDRVYTH--QSDVWSFGVLLWEIFTLGGSPYPG 239
Query: 421 SPLSESGPQFLNLRDGKLPLLPGH-SLQFQNLLKVMVDPDPVQRPSAKELVEN 472
P+ E F L++G P + + + +++ P QRP+ K+LVE+
Sbjct: 240 IPVEE---LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYVKNGVYK--LGDFGRATLL--NKSLPIEEGDARYM 390
Q+ A+ +IH +GI H D+K +N+ V NG LGDFG A + S P G A +
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLV-NGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 391 ---PQEILNEDYDHLDKVDIFSLGATMYE 416
E+L D + VDI+S G ++E
Sbjct: 327 DTNAPEVLAGD-PYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 48/192 (25%), Positives = 82/192 (42%), Gaps = 22/192 (11%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGY 294
E IG G F V + G + K + + + D + L E + L H+N+V
Sbjct: 12 EIIGEGEFGAVLQ------GEYTGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNLVRL 64
Query: 295 YSSWFENEQLYIQMELCDHSLSDKKASQFF-AEGEVLKALHQ-------IAQALQFIHEK 346
N LYI MEL +S F G L ++ Q +A+ ++++ K
Sbjct: 65 LGVILHN-GLYIVMEL----MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKV 405
+ H D+ NI V ++GV K+ DFG A + + + + ++ E L K
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHK-KFSSKS 178
Query: 406 DIFSLGATMYEL 417
D++S G ++E+
Sbjct: 179 DVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 42/214 (19%)
Query: 236 QIGAGNFSHVF-----KVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
++G G F VF + D AVK K D R+ E + L L HE+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNL-QHEH 68
Query: 291 IVGYYSSWFENEQLYIQMELCDHSLSDK------KASQFFAEG---------EVLKALHQ 335
IV +Y E + L + E H +K + AEG ++L Q
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 336 IAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----------LPIEE 384
IA + ++ + H D+ N V +N + K+GDFG + + + LPI
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI-- 186
Query: 385 GDARYMPQE-ILNEDYDHLDKVDIFSLGATMYEL 417
R+MP E I+ + + D++SLG ++E+
Sbjct: 187 ---RWMPPESIMYRKFT--TESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 57/257 (22%), Positives = 108/257 (42%), Gaps = 34/257 (13%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
+ ++GAG F V++ L + AVK K + + L E Q + L H ++
Sbjct: 11 LRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPG---TMDPKDFLAEAQIMKKL-RHPKLIQ 65
Query: 294 YYSSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALH---------QIAQALQFI 343
Y+ E +YI EL + SL + + +G +AL Q+A + ++
Sbjct: 66 LYAVCTLEEPIYIVTELMKYGSLLE------YLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARY-----MPQEILNE 397
+ H D+ N+ V +N + K+ DFG A ++ + + A++ P+ L
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYN 179
Query: 398 DYDHLDKVDIFSLGATMYELIKGSPLSESG---PQFLNLRDG--KLPLLPGHSLQFQNLL 452
+ K D++S G + E++ + G + L D ++P PG + +++
Sbjct: 180 RFS--IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237
Query: 453 KVMVDPDPVQRPSAKEL 469
DP RP+ + L
Sbjct: 238 LDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 37/231 (16%)
Query: 271 ERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSLSDKKA---------S 321
E+ L EVQ L +H N++ E+ + +E C L D K +
Sbjct: 38 EQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFCP--LGDLKNYLRSNRGMVA 94
Query: 322 QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380
Q + + + ++A L ++H+ H D+ N + + K+GD+G A
Sbjct: 95 QMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154
Query: 381 PIEEGDARYMP-----QEILNEDYDHLDKVD------IFSLGATMYELIKGS--PLSE-S 426
D +P E++ L D I+SLG TM+EL + P + S
Sbjct: 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214
Query: 427 GPQFLNL----RDGKLPL----LPGHSLQFQNLLKVMVDPDPVQRPSAKEL 469
Q L +D KLP L ++ + +DP+ RP+A+E+
Sbjct: 215 DEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWLDPE--TRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 64/283 (22%), Positives = 102/283 (36%), Gaps = 63/283 (22%)
Query: 237 IGAGNFSHVFK-----VLKRIDGCFYAVKHSKR----QLHHDAERRKALLEVQALAALGS 287
IG G F VF+ +L AVK K + D +R AL+ A
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALM------AEFD 66
Query: 288 HENIVGYYSSWFENEQLYIQME------------------LCDHSLSDKKASQFFAEGEV 329
H NIV + + + E C S S A +
Sbjct: 67 HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 330 LKALHQIAQALQ------FIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL------ 376
L Q+ A Q ++ E+ H D+ N V +N V K+ DFG + +
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 377 ----NKSLPIEEGDARYMPQE-ILNEDYDHLDKVDIFSLGATMYELIKGS--P-LSESGP 428
N ++PI R+MP E I Y + D+++ G ++E+ P +
Sbjct: 187 KASENDAIPI-----RWMPPESIFYNRYT--TESDVWAYGVVLWEIFSYGMQPYYGMAHE 239
Query: 429 QFL-NLRDGKLPLLP-GHSLQFQNLLKVMVDPDPVQRPSAKEL 469
+ + +RDG + P L+ NL+++ P RPS +
Sbjct: 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 10/154 (6%)
Query: 234 IEQ-IGAGNFSHVFKVLKRIDG---CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
IE+ IG G F V + ++ G A+K K D +R L E + H
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQF-DHP 65
Query: 290 NIVGYYSSWFENEQLYIQMELCDHSLSDK---KASQFFAEGEVLKALHQIAQALQFIHEK 346
NI+ ++ + I E ++ DK + F G+++ L IA ++++ E
Sbjct: 66 NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379
H D+ NI V N V K+ DFG + L S
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 65/268 (24%), Positives = 115/268 (42%), Gaps = 38/268 (14%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDA---ERRKALLEVQALAALGSHENI 291
++IG G F V L ++ + + ++L A E+ K L E Q +L H N+
Sbjct: 1 KEIGNGWFGKVI--LGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNL 57
Query: 292 VGYYSSWFENEQLYIQMELCD------HSLSDKKASQFFAEGEVLKAL-HQIAQALQFIH 344
+ E + ME C + S +KA + L+ + +IA L +H
Sbjct: 58 LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 345 EKGIAHLDVKPDN-IYVKNGVYKLGDFGRATLLNKSLPIEEGDARYMP-----QEILNED 398
+ H D+ N + + K+GD+G + K D ++P E+++E
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 399 YDHLDKVD------IFSLGATMYELIK-GSP----LSESGPQFLNLRDGKLPL------L 441
+ +L VD ++SLG T++EL + GS LS+ +R+ +L L L
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237
Query: 442 PGHSLQFQNLLKVMVDPDPVQRPSAKEL 469
P ++ + + P+ QRPSA+E+
Sbjct: 238 PLSDRWYEVMQFCWLQPE--QRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 27/91 (29%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 333 LHQIAQALQFIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE----GDA 387
+ Q+ A+++IH+K + H D+K +NI++ +G LGDFG A K + G
Sbjct: 273 MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTV 332
Query: 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELI 418
EIL D + + DI+S G + +++
Sbjct: 333 ATNSPEILAGD-GYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 28/179 (15%)
Query: 312 DHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNG-VYKLGDF 370
+ LSD S+ ++L +Q+A+ ++F+ K H D+ N+ + G + K+ DF
Sbjct: 223 KNLLSDD-GSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDF 281
Query: 371 GRA-TLLNKSLPIEEGDA----RYM-PQEILNEDYDHLDKV--------DIFSLGATMYE 416
G A +++ S + +G ++M P+ I + Y L V +IFSLG T Y
Sbjct: 282 GLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY- 340
Query: 417 LIKGSPLSESGPQFLN-LRDGKLPLLPGHSLQFQNLLKVMV---DPDPVQRPSAKELVE 471
P F N ++ G P H+ Q + +MV + +P +RPS L +
Sbjct: 341 -----PGMIVDSTFYNKIKSGYRMAKPDHAT--QEVYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 45/224 (20%), Positives = 92/224 (41%), Gaps = 33/224 (14%)
Query: 264 RQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQF 323
L H + +L + + V Y + N +L++Q L + Q
Sbjct: 63 YGLSH-----QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQ----QCRLGEANNPQA 113
Query: 324 FAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVY-KLGDFGRATLL------ 376
+ +++ QIA + ++H++G+ H D+ N + + K+ D + L
Sbjct: 114 LSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173
Query: 377 ----NKSLPIEEGDARYM-PQEILNEDYDHLDKVDIFSLGATMYELIK--GSPLSESGPQ 429
N++ P+ ++M + ++N++Y D++S G ++EL+ +P E P
Sbjct: 174 CLGDNENRPV-----KWMALESLVNKEYSS--ASDVWSFGVLLWELMTLGQTPYVEIDPF 226
Query: 430 FLN--LRDGK-LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELV 470
+ L+DG L + ++ DP +RPS +LV
Sbjct: 227 EMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLV 270
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 24/65 (36%), Positives = 32/65 (49%), Gaps = 9/65 (13%)
Query: 333 LHQIAQALQFIHEKGIAHLDVKPDNIYV--KNGVYKLGDFGRATLLNKSLPIEEGDARYM 390
+ QI AL +H GI H DVKP NI +G +K+ D G A L + Y+
Sbjct: 261 MRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-------NYI 313
Query: 391 PQEIL 395
P+E L
Sbjct: 314 PKEFL 318
|
Length = 566 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 57/273 (20%), Positives = 96/273 (35%), Gaps = 83/273 (30%)
Query: 282 LAALGSHENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQ--- 338
++ L +H NIV Y +++ + +L++ + + F +G A+ I Q
Sbjct: 52 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVL 111
Query: 339 -ALQFIHEKGIAHLDVKPDNIY--VKNGVYKLG------------------DFGRATLLN 377
AL +IH G H VK +I V VY G DF + ++
Sbjct: 112 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSV-- 169
Query: 378 KSLPIEEGDARYMPQEILNEDYDHLD-KVDIFSLGATMYELIKGS--------------- 421
K LP ++ E+L ++ D K DI+S+G T EL G
Sbjct: 170 KVLP-------WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 222
Query: 422 --------------PLSE---------------SGPQFLNLR--DGKLPLLPGH---SLQ 447
P E R +G+ P + S
Sbjct: 223 LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPH 282
Query: 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
F + ++ + +P RPSA L+ + F +I++
Sbjct: 283 FHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 315
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 488 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.58 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.84 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.8 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.65 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.6 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.52 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.48 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.38 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.34 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.31 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.3 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.24 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.21 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.07 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.99 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.94 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.9 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.89 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.87 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.8 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.75 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.74 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.63 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.46 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.39 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.33 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.17 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.1 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.1 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.08 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.85 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.85 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.73 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.66 | |
| PLN02236 | 344 | choline kinase | 96.58 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.41 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.27 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.12 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.99 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.85 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.67 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.65 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.44 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 95.02 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.81 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.37 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.86 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.68 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.54 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 93.43 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 92.46 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 91.83 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-51 Score=427.17 Aligned_cols=245 Identities=30% Similarity=0.522 Sum_probs=222.5
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccC-CCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ-LHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~-~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.+|...+.||+|||++||.+.+..+|+.||+|++.+. ......+++..+||++.+.+ +|||||+++++|++.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEE
Confidence 5689999999999999999999999999999999654 44556677899999999999 999999999999999999999
Q ss_pred EecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CCeEEEEeecCceecC---CCCC
Q 011331 308 MELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLN---KSLP 381 (488)
Q Consensus 308 ~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g~vkL~DFGlA~~~~---~~~~ 381 (488)
+|+|..+.+. ..+...++|.+++.+++||+.||.|||+++|||||||..|+|++ +-++||+|||||+.+. +...
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~ 176 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK 176 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence 9999876444 33457799999999999999999999999999999999999995 5699999999999886 4456
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch---hhhhhhcCCCCCCCCCcHHHHHHHHHcccC
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP---QFLNLRDGKLPLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~---~~~~i~~~~~~~~~~~s~~l~~lI~k~L~~ 458 (488)
+.+|||-|+|||++... .++..+||||+||+||.|+.|+|||+... .+..+.......|..++.++.+||.+||+.
T Consensus 177 TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~ 255 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRP 255 (592)
T ss_pred eecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcC
Confidence 78999999999999865 78889999999999999999999998763 466778888888889999999999999999
Q ss_pred CCCCCCCHHHHHhChhh
Q 011331 459 DPVQRPSAKELVENPIF 475 (488)
Q Consensus 459 dP~~RpTa~elL~HP~f 475 (488)
||.+|||+++||.|+||
T Consensus 256 ~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 256 NPSERPSLDEVLDHPFF 272 (592)
T ss_pred CcccCCCHHHHhcCHhh
Confidence 99999999999999999
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-52 Score=414.79 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=214.0
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchH-----HHHHHHHHHHHHHHhCCCCCeeEeeeeeccc
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDA-----ERRKALLEVQALAALGSHENIVGYYSSWFEN 301 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~-----~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~ 301 (488)
+.+.|.+.+.||+|+||.|-+|.++.+|+.||||++.+...... ......+|+++|++| +|||||+++++|...
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecC
Confidence 34457888999999999999999999999999999976533321 123357899999999 999999999999999
Q ss_pred ceEEEEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeC----CeEEEEeecCcee
Q 011331 302 EQLYIQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKN----GVYKLGDFGRATL 375 (488)
Q Consensus 302 ~~l~IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~----g~vkL~DFGlA~~ 375 (488)
+..||||||++|+ |.+ ...++.+.+..-..+++|++.||.|||++||+||||||+|||+++ -.+||+|||+|+.
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999886 444 566778999999999999999999999999999999999999943 4799999999998
Q ss_pred cCC--CCCCCCCCCCccChhhhccc-CCC-CchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcCCCCCC----CC
Q 011331 376 LNK--SLPIEEGDARYMPQEILNED-YDH-LDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDGKLPLL----PG 443 (488)
Q Consensus 376 ~~~--~~~~~~Gt~~Y~APEvl~~~-~~~-~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~~~~~~----~~ 443 (488)
.++ -..+.+||+.|.|||++... +.+ ..++||||+||+||-+++|.+||.+... ...+..+.+++- ..
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~ 408 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR 408 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence 853 35678999999999998643 222 2489999999999999999999976432 345667776654 35
Q ss_pred CcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 444 HSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 444 ~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
++++..+||.+||..||++|||++|+|+||||+.+.
T Consensus 409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 789999999999999999999999999999999654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-51 Score=404.86 Aligned_cols=250 Identities=30% Similarity=0.454 Sum_probs=217.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce-EEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ-LYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~-l~I 306 (488)
..+++.++.||+|..|+||+|+++.+++.+|+|++.. ......+++..+|++++... +|||||.+|++|..++. ++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEe
Confidence 4467888999999999999999999999999999943 34566778899999999999 99999999999999995 999
Q ss_pred EEecCCCCchhh--hhcccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-CC
Q 011331 307 QMELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-LP 381 (488)
Q Consensus 307 V~E~~~~~l~~~--~~~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-~~ 381 (488)
+||||+++.++. ...+.++|..+..++.+|+.||.|||+ ++||||||||+|||| ..|.+||||||.++.+.++ ..
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~ 235 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIAN 235 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhcc
Confidence 999999986663 333679999999999999999999995 999999999999999 7899999999999877554 46
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCc----h----hhhhhhcCCCC-CCCC-CcHHHHHH
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESG----P----QFLNLRDGKLP-LLPG-HSLQFQNL 451 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~----~----~~~~i~~~~~~-~~~~-~s~~l~~l 451 (488)
+.+||..|||||.+.+. .|+.++||||||++++|+++|+.|+... . .+..+..+..| +|.+ .|++|++|
T Consensus 236 tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~F 314 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSF 314 (364)
T ss_pred cccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 77899999999999887 6888999999999999999999876553 1 13344554444 4444 89999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
|..||++||.+|||++||++|||+++...
T Consensus 315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 315 VSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 99999999999999999999999986543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=402.77 Aligned_cols=253 Identities=33% Similarity=0.467 Sum_probs=222.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+++.+.+++.||+|++++...- ..+......|..+|..+ +||+||.++..|++.+++|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEE
Confidence 45899999999999999999999999999999999766333 34567788899999998 99999999999999999999
Q ss_pred EEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCC
Q 011331 307 QMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSL 380 (488)
Q Consensus 307 V~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~ 380 (488)
|+||+.|+ |.. ....+.+++..++.++..|+.||.|||++|||||||||+|||+ .+|+++|+|||+++..- ...
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t 182 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT 182 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc
Confidence 99999886 444 4556789999999999999999999999999999999999999 68999999999998542 234
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCC-CcHHHHHHHHHcc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPG-HSLQFQNLLKVMV 456 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~-~s~~l~~lI~k~L 456 (488)
.+.+||+.|||||++.+. .|+..+|+||||+++|||++|.+||...+. ...+..+..+.++. .+.+.+++|+++|
T Consensus 183 ~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL 261 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLL 261 (357)
T ss_pred ccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHh
Confidence 456899999999999876 688899999999999999999999987654 45667777677776 7999999999999
Q ss_pred cCCCCCCC----CHHHHHhChhhhhhHHhh
Q 011331 457 DPDPVQRP----SAKELVENPIFDKIQKHR 482 (488)
Q Consensus 457 ~~dP~~Rp----Ta~elL~HP~f~~i~~~~ 482 (488)
..||.+|. ++.++-+||||.++.+..
T Consensus 262 ~rdp~~RLg~~~d~~~ik~HpfF~~inW~~ 291 (357)
T KOG0598|consen 262 KRDPRQRLGGPGDAEEIKRHPFFKGINWEK 291 (357)
T ss_pred ccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence 99999995 699999999999997644
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=390.68 Aligned_cols=250 Identities=29% Similarity=0.455 Sum_probs=214.7
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
+.|+.+.++|+|+||+||+|+++.||+.||||++........-.+-+++|+.+|+++ .|+|+|.++++|..+..+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEEe
Confidence 467889999999999999999999999999999976655455556799999999999 9999999999999999999999
Q ss_pred ecCCCCchhh--hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCC
Q 011331 309 ELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPI 382 (488)
Q Consensus 309 E~~~~~l~~~--~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~ 382 (488)
|||++++++. .....+++..+..+++|++.|+.|+|++++|||||||+|||| .+|.+||||||+|+.+.. ..+.
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence 9999987773 333469999999999999999999999999999999999999 689999999999998863 2344
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc---------------------CCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD---------------------GKL 438 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~---------------------~~~ 438 (488)
.+.|.+|+|||.+.+...|+.++||||+||++.||++|.++|.+...... |+. ..+
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 56899999999999888899999999999999999999999887544221 110 011
Q ss_pred CC----------CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 439 PL----------LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 439 ~~----------~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
|. .|..+.-+.+|+++||+.||.+|++-+|+|+||||+++.
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 21 234566789999999999999999999999999998764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=409.92 Aligned_cols=254 Identities=27% Similarity=0.456 Sum_probs=225.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..||..++.||.|+|++|++|+++.+++.||||++.+.... +.......+|-.+|.+|.+||.|++||..|++...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 46899999999999999999999999999999998766332 23334567788999999999999999999999999999
Q ss_pred EEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----
Q 011331 307 QMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---- 379 (488)
Q Consensus 307 V~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---- 379 (488)
|+||+.++ |+. ..+.+.|.+..++.++.+|+.||+|||++|||||||||+|||+ .|++++|.|||.|+.++..
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence 99999765 544 4445779999999999999999999999999999999999999 7899999999999877421
Q ss_pred ------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCC
Q 011331 380 ------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGH 444 (488)
Q Consensus 380 ------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~ 444 (488)
....+||..|.+||+|..+ ..++.+|||+|||+||.|+.|.+||.+..+ +++|....+.++++.
T Consensus 232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~f 310 (604)
T KOG0592|consen 232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGF 310 (604)
T ss_pred cCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCC
Confidence 1346799999999999887 567899999999999999999999998766 567888999999999
Q ss_pred cHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhh
Q 011331 445 SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHR 482 (488)
Q Consensus 445 s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~ 482 (488)
++.+++||+++|..||.+|+|++||.+||||.++.+..
T Consensus 311 p~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 311 PEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred CHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 99999999999999999999999999999999876543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=409.55 Aligned_cols=253 Identities=28% Similarity=0.449 Sum_probs=220.1
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc-eEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE-QLY 305 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~-~l~ 305 (488)
+.++|.++++||.|.||.||+|....+|..||||.+++.... .+.-.-++|+..|+++..|||||+|.+++.+++ .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 456789999999999999999999999999999999877544 555667899999999966999999999999988 999
Q ss_pred EEEecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CCeEEEEeecCceecCCCCC-
Q 011331 306 IQMELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLP- 381 (488)
Q Consensus 306 IV~E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g~vkL~DFGlA~~~~~~~~- 381 (488)
+|||||+.+|.+..+ ...+++..++.||.||+.||+|+|++|+.|||+||+||||. ...+||+|||+|+.+.+..+
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY 166 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCc
Confidence 999999999887433 55799999999999999999999999999999999999996 89999999999998876543
Q ss_pred -CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh------------------------cC
Q 011331 382 -IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR------------------------DG 436 (488)
Q Consensus 382 -~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~------------------------~~ 436 (488)
-.+.|.+|+|||+|.....|+.++|||++||+++|+.+-+++|.+..+..++- +.
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf 246 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF 246 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence 45699999999999988889999999999999999999999998765543321 11
Q ss_pred CCC---------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 437 KLP---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 437 ~~~---------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
.+| +.+..+.++.++|.+||.|||.+||||+|+|+||||+.-..
T Consensus 247 ~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 247 RFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred CCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 122 23447889999999999999999999999999999986544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=378.29 Aligned_cols=252 Identities=26% Similarity=0.423 Sum_probs=228.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccC-CCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ-LHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~-~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..+|+.++.||.|+||+|.+++.+.+|..||+|++.+. .......+....|..+|+.+ .||+++++++.|.+...+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCCeEEE
Confidence 46899999999999999999999999999999998754 33344556788899999999 79999999999999999999
Q ss_pred EEecCCCC--chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCC
Q 011331 307 QMELCDHS--LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIE 383 (488)
Q Consensus 307 V~E~~~~~--l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~ 383 (488)
||||++|+ +...++.+.+++..++.++.||+.||+|||+++|++|||||+|||+ .+|.+||+|||+|+.+....-+.
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~Tl 201 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWTL 201 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcEEEe
Confidence 99999886 3446667889999999999999999999999999999999999999 68999999999999998877788
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDP 460 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP 460 (488)
+||+.|+|||++..+ .++.++|+|||||++|||+.|.+||....+ +.+|..+.+.+|+-.+.++++||.++|+.|-
T Consensus 202 CGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~ 280 (355)
T KOG0616|consen 202 CGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDL 280 (355)
T ss_pred cCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhh
Confidence 999999999999876 688899999999999999999999988765 5678899999999999999999999999999
Q ss_pred CCC-----CCHHHHHhChhhhhhHHh
Q 011331 461 VQR-----PSAKELVENPIFDKIQKH 481 (488)
Q Consensus 461 ~~R-----pTa~elL~HP~f~~i~~~ 481 (488)
.+| ....++.+||||+++.+.
T Consensus 281 t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 281 TKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred HhhhcCcCCCccccccCcccccccHH
Confidence 999 357899999999988653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=405.32 Aligned_cols=254 Identities=22% Similarity=0.356 Sum_probs=229.7
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccC-CCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ-LHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~-~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..+|.+++.||+|+||+|++|..+.+++.||||++++. ...+.+.+..+.|..|+....+||.++.++..|++++++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 56899999999999999999999999999999999876 45566778899999999999889999999999999999999
Q ss_pred EEecCCCCchh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceec---CCCCC
Q 011331 307 QMELCDHSLSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL---NKSLP 381 (488)
Q Consensus 307 V~E~~~~~l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~---~~~~~ 381 (488)
||||+.|+... ......+++..+..|++.|+.||.|||++||||||||.+|||+ .+|.+||+|||+++.. ++...
T Consensus 447 vmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~Ts 526 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTS 526 (694)
T ss_pred EEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccc
Confidence 99999887544 3444789999999999999999999999999999999999999 6899999999999754 45567
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccC
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~ 458 (488)
+.+||+.|||||++.+. .|+.++|+|||||+||||+.|.+||.+.++ +..|.......|..++.++.++|+++|.+
T Consensus 527 TfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k 605 (694)
T KOG0694|consen 527 TFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRK 605 (694)
T ss_pred cccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhcc
Confidence 88999999999999887 788999999999999999999999986554 56788888889999999999999999999
Q ss_pred CCCCCCC-----HHHHHhChhhhhhHHhh
Q 011331 459 DPVQRPS-----AKELVENPIFDKIQKHR 482 (488)
Q Consensus 459 dP~~RpT-----a~elL~HP~f~~i~~~~ 482 (488)
+|++|.. +++|..||||+.|.+..
T Consensus 606 ~p~kRLG~~e~d~~~i~~hpFFr~i~w~~ 634 (694)
T KOG0694|consen 606 NPEKRLGSGERDAEDIKKHPFFRSIDWDD 634 (694)
T ss_pred CcccccCCCCCCchhhhhCCccccCCHHH
Confidence 9999975 78999999999987644
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=396.09 Aligned_cols=257 Identities=28% Similarity=0.368 Sum_probs=216.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||.||+|+.+.||..||+|++++.... .........|-.+|... ++|+||+||..|++.+.+||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEE
Confidence 56899999999999999999999999999999999876333 23345677788888885 99999999999999999999
Q ss_pred EEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC-----
Q 011331 307 QMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK----- 378 (488)
Q Consensus 307 V~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~----- 378 (488)
||||++||-.. ....+.|++.+++.++.+++.|++.||+.|||||||||+|+|| ..|++||+||||++.+..
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 99999887433 4556789999999999999999999999999999999999999 689999999999853311
Q ss_pred ------------------CCC---------------------------CCCCCCCccChhhhcccCCCCchhHHHHHHHH
Q 011331 379 ------------------SLP---------------------------IEEGDARYMPQEILNEDYDHLDKVDIFSLGAT 413 (488)
Q Consensus 379 ------------------~~~---------------------------~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvl 413 (488)
..+ ..+|||.|||||++.+. .|+..+|+||||||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-gY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-GYGKECDWWSLGCI 377 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-CCCccccHHHHHHH
Confidence 000 12499999999999887 58889999999999
Q ss_pred HHHHHcCCCCCCCchhh---hhhhcCC--C--CCCCCCcHHHHHHHHHcccCCCCCCC---CHHHHHhChhhhhhHHhhh
Q 011331 414 MYELIKGSPLSESGPQF---LNLRDGK--L--PLLPGHSLQFQNLLKVMVDPDPVQRP---SAKELVENPIFDKIQKHRK 483 (488)
Q Consensus 414 L~eLltG~~p~~~~~~~---~~i~~~~--~--~~~~~~s~~l~~lI~k~L~~dP~~Rp---Ta~elL~HP~f~~i~~~~~ 483 (488)
+|||+.|.+||.+..+. .++.... + |.-...+.++++||.+||. ||++|. .++||..||||+++.+.+.
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l 456 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHL 456 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchh
Confidence 99999999999987663 3444322 3 3334568999999999999 999996 4999999999999987765
Q ss_pred hcCC
Q 011331 484 TYMK 487 (488)
Q Consensus 484 ~~~~ 487 (488)
-.+.
T Consensus 457 ~~~~ 460 (550)
T KOG0605|consen 457 REMP 460 (550)
T ss_pred hcCC
Confidence 5443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=389.74 Aligned_cols=250 Identities=28% Similarity=0.422 Sum_probs=218.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc---hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH---DAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~---~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.+.|.+.+.||+|+||+|++|.+..+|..||+|++.+.... ........+|+.+++.+..||||+++++++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 45789999999999999999999999999999987664211 123445668999999995599999999999999999
Q ss_pred EEEEecCCC-Cchhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eC-CeEEEEeecCceec---C
Q 011331 305 YIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KN-GVYKLGDFGRATLL---N 377 (488)
Q Consensus 305 ~IV~E~~~~-~l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~-g~vkL~DFGlA~~~---~ 377 (488)
|||||||.+ .|.+. ...+.+.|.++..+++||+.|++|||++||+||||||+|||+ .+ +.+||+|||++... .
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~ 175 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGED 175 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCC
Confidence 999999987 45553 335789999999999999999999999999999999999999 45 89999999999977 2
Q ss_pred CCCCCCCCCCCccChhhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCC-cHHHHHHH
Q 011331 378 KSLPIEEGDARYMPQEILNEDY-DHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGH-SLQFQNLL 452 (488)
Q Consensus 378 ~~~~~~~Gt~~Y~APEvl~~~~-~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~-s~~l~~lI 452 (488)
....+.+||+.|+|||++.+.. ..+.++||||+||+||.|++|..||+.... +..+..+...++..+ +.++..+|
T Consensus 176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li 255 (370)
T KOG0583|consen 176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSLI 255 (370)
T ss_pred CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHHH
Confidence 4556788999999999998865 446799999999999999999999987543 445778888899888 99999999
Q ss_pred HHcccCCCCCCCCHHHHHhChhhhh
Q 011331 453 KVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
.+||..||.+|+|+.++++||||+.
T Consensus 256 ~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 256 EKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999996
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=391.52 Aligned_cols=250 Identities=28% Similarity=0.434 Sum_probs=217.1
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc--ce
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN--EQ 303 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~--~~ 303 (488)
+..+.|+.+++||+|.||.||+|++..+|+.||+|+++.....+.....+.+||.||++| +||||++|.+..... +.
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCce
Confidence 445678999999999999999999999999999999987766666678899999999999 999999999988876 78
Q ss_pred EEEEEecCCCCchhhhhcc--cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 304 LYIQMELCDHSLSDKKASQ--FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 304 l~IV~E~~~~~l~~~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
+|||+|||++.|..+..+. .|++.++.-+|+||+.||+|||.+||+|||||.+|||| .+|.+||+|||||+.+...
T Consensus 193 iYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 193 IYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 9999999999988877665 69999999999999999999999999999999999999 6799999999999977532
Q ss_pred ---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh------c---------CCCCC-
Q 011331 380 ---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR------D---------GKLPL- 440 (488)
Q Consensus 380 ---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~------~---------~~~~~- 440 (488)
.+..+-|.+|+|||+|.+...|+.++|+||.||||.||++|++.+.+..+..++. . ..+|.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 4456689999999999998899999999999999999999999998765543321 1 01110
Q ss_pred ----------------CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhh
Q 011331 441 ----------------LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFD 476 (488)
Q Consensus 441 ----------------~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~ 476 (488)
....+....+|+..||..||.+|.||.++|+|+||.
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 112466788999999999999999999999999993
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=376.70 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=213.6
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
-..+|.+.+.||.|+||+||+|+++.++..||||.+.+........+.+..|+.+|+.+ +|||||++++++...+.+||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCeEEE
Confidence 34578999999999999999999999999999999987755677778899999999999 89999999999999999999
Q ss_pred EEecCCCCch-h-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeC-------CeEEEEeecCceecC
Q 011331 307 QMELCDHSLS-D-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKN-------GVYKLGDFGRATLLN 377 (488)
Q Consensus 307 V~E~~~~~l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~-------g~vkL~DFGlA~~~~ 377 (488)
|||||+|+.+ . ....+.+++..++.++.||+.||++||+++||||||||+||||+. -.+||+|||+|+.+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999997644 3 444558999999999999999999999999999999999999932 258999999999886
Q ss_pred CC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcC--CCCC-CCCCcHHHH
Q 011331 378 KS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDG--KLPL-LPGHSLQFQ 449 (488)
Q Consensus 378 ~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~--~~~~-~~~~s~~l~ 449 (488)
.. ..+.+|++.|||||++... .|.-|+|+||+|++||+|++|++||..... +..+..+ ..+. +...+..+.
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~ 245 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLR 245 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchh
Confidence 43 4567899999999999654 466699999999999999999999986543 2222222 2232 334577788
Q ss_pred HHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 450 NLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+++...++.+|..|.++.+-+.|+++..-.
T Consensus 246 ~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 246 ELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 999999999999999999999999997543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=371.68 Aligned_cols=246 Identities=34% Similarity=0.538 Sum_probs=211.7
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeee-eecccce-EE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYS-SWFENEQ-LY 305 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~-~~~~~~~-l~ 305 (488)
..+|+++++||+|+||+||+|.+..+|..||.|.+.-......+++....|+.+|++| +|||||++++ .|.+++. ++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhH
Confidence 3478999999999999999999999999999999987777788899999999999999 9999999998 5555554 99
Q ss_pred EEEecCCCCchh------hhhcccCCHHHHHHHHHHHHHHHHHHHH--cC--cccCCCCCCcEEE-eCCeEEEEeecCce
Q 011331 306 IQMELCDHSLSD------KKASQFFAEGEVLKALHQIAQALQFIHE--KG--IAHLDVKPDNIYV-KNGVYKLGDFGRAT 374 (488)
Q Consensus 306 IV~E~~~~~l~~------~~~~~~l~~~~~~~i~~qI~~gL~yLH~--~g--IiHrDLKp~NILv-~~g~vkL~DFGlA~ 374 (488)
||||||+++-+. +...+.++|..+|+++.|+|.||.++|. .. |+||||||.||++ .+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999876433 2334569999999999999999999998 44 9999999999999 68999999999999
Q ss_pred ecCCCC---CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCC--CCcH
Q 011331 375 LLNKSL---PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLP--GHSL 446 (488)
Q Consensus 375 ~~~~~~---~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~--~~s~ 446 (488)
.+.+.. ...+|||+||+||++.+. .|+.++||||+||++|||..-.+||.+..- ..+|.++..+..| .+|.
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~ 255 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYST 255 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhh
Confidence 886542 346799999999999876 688899999999999999999999988643 2356777776443 5699
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 447 QFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
++..+|..|+..||+.||+. +|+++++..
T Consensus 256 ~l~~li~~ci~vd~~~RP~t-----~~~v~di~~ 284 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRPDT-----VPYVQDIQS 284 (375)
T ss_pred HHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence 99999999999999999986 666665543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=358.68 Aligned_cols=248 Identities=24% Similarity=0.400 Sum_probs=215.3
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|..++.||+|.||.||+|++..+|+.||||+++.....+.-...+++|+..|+.+ +|+||+.++++|.+.+.+.||+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhccCCCceEEEEE
Confidence 57788999999999999999999999999999987755555567899999999999 89999999999999999999999
Q ss_pred cCCCCchhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCC
Q 011331 310 LCDHSLSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIE 383 (488)
Q Consensus 310 ~~~~~l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~ 383 (488)
|++..|....+. ..++...+..++.++++||+|||++.|+||||||.|+|| .+|.+||+|||+|+.+... ....
T Consensus 82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~ 161 (318)
T KOG0659|consen 82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ 161 (318)
T ss_pred eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc
Confidence 999988775443 458999999999999999999999999999999999999 7899999999999988643 3334
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc-----C--------------------CC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD-----G--------------------KL 438 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~-----~--------------------~~ 438 (488)
+.|.+|+|||++.+...|+..+||||.||++.||+.|.+.+.+.....++.. | ..
T Consensus 162 V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~ 241 (318)
T KOG0659|consen 162 VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQF 241 (318)
T ss_pred eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcC
Confidence 6899999999999988899999999999999999999988876544332210 0 01
Q ss_pred C------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 439 P------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 439 ~------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
| ..+..+.++.+|+.+||..||.+|+|+.|+|+|+||...
T Consensus 242 P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 242 PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 1 234457788999999999999999999999999999854
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=392.88 Aligned_cols=252 Identities=22% Similarity=0.345 Sum_probs=223.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccC-CCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ-LHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~-~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.+-|++++.||.|+.|.|-+|++..||+.+|||++.+. ...+.......+|+.+|+-+ .||||+++|++|+++.++|+
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEE
Confidence 34579999999999999999999999999999998655 34444456677899888888 99999999999999999999
Q ss_pred EEecCCCC-ch-hhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC--CCCC
Q 011331 307 QMELCDHS-LS-DKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN--KSLP 381 (488)
Q Consensus 307 V~E~~~~~-l~-~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~--~~~~ 381 (488)
|.||+++| |. .....+.+++.++.+++.||+.|+.|+|..+|+||||||+|+|+ ..+++||+|||+|..-. .-..
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE 169 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence 99999775 43 36777889999999999999999999999999999999999999 45679999999997653 3456
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccC
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~ 458 (488)
+.||++.|+|||++.+..+.+.++||||.||+||.|++|..||++... +.++..|.+..|..++.++++||.+||..
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~V 249 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDV 249 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhcc
Confidence 779999999999999876778899999999999999999999986543 45677899999999999999999999999
Q ss_pred CCCCCCCHHHHHhChhhhhhHH
Q 011331 459 DPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 459 dP~~RpTa~elL~HP~f~~i~~ 480 (488)
||++|+|.+||++|||+.+-..
T Consensus 250 Dp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 250 DPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred CccccccHHHHhhCchhhcCCC
Confidence 9999999999999999987543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=369.54 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=215.9
Q ss_pred cccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec--ccc
Q 011331 225 SRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF--ENE 302 (488)
Q Consensus 225 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~--~~~ 302 (488)
.+..++|+.++.|++|.||.||+|+++.|++.||+|.++.....+..-...++||.+|.++ +|||||.+-.+.. +.+
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccc
Confidence 4556789999999999999999999999999999999986654444456789999999999 8999999988766 455
Q ss_pred eEEEEEecCCCCchhh--hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 303 QLYIQMELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~~--~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
.+|||||||++.+... ...+.+...++..++.|++.||+|||.+.|+|||||++|+|+ +.|.+||+|||+|+.+++.
T Consensus 151 ~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 151 KIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 7999999999976553 233579999999999999999999999999999999999999 7799999999999999876
Q ss_pred ---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc-----CC-----------CC-
Q 011331 380 ---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD-----GK-----------LP- 439 (488)
Q Consensus 380 ---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~-----~~-----------~~- 439 (488)
.+..+-|.+|+|||++.+...|++++|+||+||++.||++++++|.+..++.++.. |. ++
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 45567899999999999988999999999999999999999999987654332210 00 00
Q ss_pred -----C-----------CC--CCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 440 -----L-----------LP--GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 440 -----~-----------~~--~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+ .+ .+++...+|+..+|.+||.+|.||.|.|+|+||.+..
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 0 01 1457888999999999999999999999999998843
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=389.71 Aligned_cols=245 Identities=28% Similarity=0.437 Sum_probs=214.9
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
..|....+||+|..|.||.|+...++..||||.+... ....++-.+.|+.+|+.. +|+|||.+++.|...+.+|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhc-cchHHHHHHHHhcccceeEEEE
Confidence 3567888999999999999999999999999998754 334456689999999998 9999999999999999999999
Q ss_pred ecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCC
Q 011331 309 ELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIE 383 (488)
Q Consensus 309 E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~ 383 (488)
||++++ |.+......|+|.++..+++.++.||+|||.+||||||||.+|||+ .+|.+||+|||++..+... ..+.
T Consensus 350 Eym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~Tm 429 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTM 429 (550)
T ss_pred eecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccc
Confidence 999886 4445555679999999999999999999999999999999999999 7899999999999887543 3466
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh----c--CCCCCCCCCcHHHHHHHHHccc
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR----D--GKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~----~--~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
+||++|||||++... .|++++||||||++++||+.|.+||....++..+- + ..+..+..+|.+|++|+.+||+
T Consensus 430 VGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~ 508 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLV 508 (550)
T ss_pred cCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhh
Confidence 899999999999876 68889999999999999999999998766654332 2 2345667789999999999999
Q ss_pred CCCCCCCCHHHHHhChhhhh
Q 011331 458 PDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f~~ 477 (488)
.|+++|++|.|||+||||+.
T Consensus 509 ~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 509 VDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred cchhcCCCHHHHhcChhhhh
Confidence 99999999999999999964
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=387.76 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=223.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++.+.||+|+||.||+|+.+.+.+.||||.+.+....+.+.+...+|+++++.+ +|||||.+++.|+...++|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEEe
Confidence 578999999999999999999999999999999988777788888999999999999 9999999999999999999999
Q ss_pred ecCCCCchh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---CCC
Q 011331 309 ELCDHSLSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---PIE 383 (488)
Q Consensus 309 E~~~~~l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---~~~ 383 (488)
|||.|.|.. ....+.++|+.+..+..+++.||.|||+.+|+|||+||.|||+ ..|.+|+||||+|+...... ...
T Consensus 81 e~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi 160 (808)
T KOG0597|consen 81 EYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI 160 (808)
T ss_pred hhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence 999997766 4445679999999999999999999999999999999999999 78899999999999876542 334
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCCCCCCCcHHHHHHHHHcccCCC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLPLLPGHSLQFQNLLKVMVDPDP 460 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP 460 (488)
.||+.|||||++.+. .|+..+|+|||||+||||++|.+||....-. ..|.....+.++..+..|.+|++.+|.+||
T Consensus 161 kGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP 239 (808)
T KOG0597|consen 161 KGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDP 239 (808)
T ss_pred cCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcCh
Confidence 699999999999865 6778999999999999999999999876543 234556667777899999999999999999
Q ss_pred CCCCCHHHHHhChhhhhh
Q 011331 461 VQRPSAKELVENPIFDKI 478 (488)
Q Consensus 461 ~~RpTa~elL~HP~f~~i 478 (488)
.+|.|..+++.|||.++-
T Consensus 240 ~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 240 AQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hhcccHHHHhcChHHhhh
Confidence 999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=367.59 Aligned_cols=249 Identities=27% Similarity=0.391 Sum_probs=214.0
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
+|++++.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.++..+ +||||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEEE
Confidence 68999999999999999999999999999999864321 123345677899999999 9999999999999999999999
Q ss_pred ecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCCC
Q 011331 309 ELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEG 385 (488)
Q Consensus 309 E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~G 385 (488)
||+.++ |.. ......+++..++.++.||+.||.|||++||+||||||+|||+ .+|.+||+|||++...........|
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~g 160 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG 160 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccccC
Confidence 999875 433 2334568999999999999999999999999999999999999 6789999999999877655555679
Q ss_pred CCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCC
Q 011331 386 DARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQ 462 (488)
Q Consensus 386 t~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~ 462 (488)
++.|+|||++... .++.++|||||||++|+|++|..||..... ...+..+...++...+..+.++|++||+.||.+
T Consensus 161 t~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 239 (291)
T cd05612 161 TPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTR 239 (291)
T ss_pred ChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHH
Confidence 9999999998765 567899999999999999999999876543 344556666777778999999999999999999
Q ss_pred CCC-----HHHHHhChhhhhhHH
Q 011331 463 RPS-----AKELVENPIFDKIQK 480 (488)
Q Consensus 463 RpT-----a~elL~HP~f~~i~~ 480 (488)
||+ ++++++||||+.+..
T Consensus 240 R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 240 RLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred ccCCccCCHHHHhcCccccCCCH
Confidence 995 999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=373.28 Aligned_cols=250 Identities=23% Similarity=0.372 Sum_probs=215.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++.+.||+|+||+||+|.+..+|+.||||++..... .......+..|+.++..+ +||||+++++++.+++.+|+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEE
Confidence 5689999999999999999999999999999999864321 122345678899999999 99999999999999999999
Q ss_pred EEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCC
Q 011331 307 QMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIE 383 (488)
Q Consensus 307 V~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~ 383 (488)
||||+.++ +.. ......+++..+..++.||+.||.|||++||+||||||+|||| .++.+||+|||++..........
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 175 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL 175 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCccee
Confidence 99999875 333 3334568999999999999999999999999999999999999 67899999999998876655566
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDP 460 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP 460 (488)
.||+.|+|||++... .++.++|||||||++|||++|..||..... ...+..+....+..++..+.+||.+||+.||
T Consensus 176 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP 254 (329)
T PTZ00263 176 CGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDH 254 (329)
T ss_pred cCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCH
Confidence 799999999998765 567899999999999999999999876543 3345566677777789999999999999999
Q ss_pred CCCCC-----HHHHHhChhhhhhH
Q 011331 461 VQRPS-----AKELVENPIFDKIQ 479 (488)
Q Consensus 461 ~~RpT-----a~elL~HP~f~~i~ 479 (488)
.+|++ ++++++||||....
T Consensus 255 ~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 255 TKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred HHcCCCCCCCHHHHhcCCccCCCC
Confidence 99997 89999999998753
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=368.18 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=215.9
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-----cceE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE-----NEQL 304 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-----~~~l 304 (488)
.|..++.||+|+||.|+.|.+..+|+.||||++..........+..++|+.+|+.+ +|+||+.+++++.. -+.+
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeeccccccccccee
Confidence 45668999999999999999999999999999987777778888999999999999 79999999998875 4568
Q ss_pred EEEEecCCCCchhhhhccc-CCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC----
Q 011331 305 YIQMELCDHSLSDKKASQF-FAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---- 378 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~~~~~-l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---- 378 (488)
|+|+|+|+..|......+. +++..+..+++||+.||.|+|+.||+||||||.|+|+ .+..+||||||+|+..+.
T Consensus 102 YiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred EEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 9999999988888776666 9999999999999999999999999999999999999 678899999999998853
Q ss_pred -CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc----------------------
Q 011331 379 -SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD---------------------- 435 (488)
Q Consensus 379 -~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~---------------------- 435 (488)
..+-.+.|.+|+|||++.....|+.++||||+||+|.||++|++.|.+.+....+..
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 223456799999999998777899999999999999999999999987644322110
Q ss_pred ------CC---C---CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 436 ------GK---L---PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 436 ------~~---~---~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.. . ...++.++.+.+|+.+||..||.+|+|++|+|.||||...+
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 00 0 13457788999999999999999999999999999998765
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=359.27 Aligned_cols=245 Identities=22% Similarity=0.344 Sum_probs=201.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||.|+||+||+|.+..++..||+|++..... ......+.+|+.++..+ +||||+++++++.+.+.+|+||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEE
Confidence 468999999999999999999999999999999864321 12234567899999999 9999999999999999999999
Q ss_pred ecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 309 ELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 309 E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
||+++++..... ...+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++..... ...
T Consensus 83 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~ 162 (288)
T cd07871 83 EYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162 (288)
T ss_pred eCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence 999987665332 2347899999999999999999999999999999999999 6789999999999765322 223
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---h---------------------cCCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---R---------------------DGKL 438 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~---------------------~~~~ 438 (488)
..|++.|+|||++.+...++.++|||||||++|+|++|.+||........+ . ....
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence 458899999999876546778999999999999999999998654321110 0 0000
Q ss_pred ---------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 439 ---------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 439 ---------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
...+..+.++++||.+||.+||.+|||++|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=363.46 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=203.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||.|+||+||+|.+..+|+.||||++...... .....+.+|+.+++.+ +||||+++++++.+...+|+||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEEEE
Confidence 4789999999999999999999999999999998644221 2234567899999999 9999999999999999999999
Q ss_pred ecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCC
Q 011331 309 ELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPI 382 (488)
Q Consensus 309 E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~ 382 (488)
||+.+++..... ...+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||++..... ....
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence 999988766433 2458999999999999999999999999999999999999 678999999999976532 2233
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh----hhhc--CC-------------------
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL----NLRD--GK------------------- 437 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~----~i~~--~~------------------- 437 (488)
..|++.|+|||++.+...++.++|||||||++|||++|..||....... .+.. +.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence 4688999999998765457779999999999999999999987532211 1100 00
Q ss_pred CC--C---------CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 438 LP--L---------LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 438 ~~--~---------~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.. . ....+.++.+||.+||+.||.+|||+.|+++||||+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00 0 002346789999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=357.56 Aligned_cols=250 Identities=20% Similarity=0.328 Sum_probs=208.7
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
|++++.||+|+||+||+|.+..+|..||||++...... ......+..|+.++..+ +|+||+.+++++.+++.+++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEE
Confidence 78899999999999999999999999999998643222 22234577899999999 99999999999999999999999
Q ss_pred cCCCCchh-hh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CCC
Q 011331 310 LCDHSLSD-KK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LPI 382 (488)
Q Consensus 310 ~~~~~l~~-~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~~ 382 (488)
|+.++.+. .. ....+++..++.++.||+.||.|||++||+||||||+|||+ +++.++|+|||++...... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 99876443 21 22358999999999999999999999999999999999999 6789999999999876432 233
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-------hhhhhcCCCCCCCCCcHHHHHHHHHc
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-------FLNLRDGKLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~~~i~~~~~~~~~~~s~~l~~lI~k~ 455 (488)
..||..|+|||++.+. .++.++|||||||++|||++|..||..... ...+.......+..++.++.+||.+|
T Consensus 161 ~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 239 (285)
T cd05631 161 RVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239 (285)
T ss_pred CCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHH
Confidence 4689999999999765 577899999999999999999999876432 11223344456667899999999999
Q ss_pred ccCCCCCCCC-----HHHHHhChhhhhhHHhh
Q 011331 456 VDPDPVQRPS-----AKELVENPIFDKIQKHR 482 (488)
Q Consensus 456 L~~dP~~RpT-----a~elL~HP~f~~i~~~~ 482 (488)
|..||.+||+ ++++++||||+.+...+
T Consensus 240 l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~ 271 (285)
T cd05631 240 LTKNPKERLGCRGNGAAGVKQHPIFKNINFKR 271 (285)
T ss_pred hhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHH
Confidence 9999999997 99999999999986533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=366.83 Aligned_cols=247 Identities=30% Similarity=0.434 Sum_probs=202.8
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc--eEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE--QLYIQ 307 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~--~l~IV 307 (488)
+|...+.||+|+||+||++.+..+|..+|||.+... .......+.+|+.+|.++ +|||||++++.....+ .++|.
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEee
Confidence 467889999999999999999999999999988644 222256688999999999 6999999999755444 68999
Q ss_pred EecCCCCchh-hhhc-c-cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--CCeEEEEeecCceecCC----
Q 011331 308 MELCDHSLSD-KKAS-Q-FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDFGRATLLNK---- 378 (488)
Q Consensus 308 ~E~~~~~l~~-~~~~-~-~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~g~vkL~DFGlA~~~~~---- 378 (488)
|||+.++.+. .... + .+++..+..+.+||+.||+|||++||||+||||+||||+ ++.+||+|||++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 9999876444 3222 2 599999999999999999999999999999999999994 47999999999987652
Q ss_pred --CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCc----hhhhhh-hcC-CCCCCCCCcHHHHH
Q 011331 379 --SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESG----PQFLNL-RDG-KLPLLPGHSLQFQN 450 (488)
Q Consensus 379 --~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~----~~~~~i-~~~-~~~~~~~~s~~l~~ 450 (488)
......||+.|||||++..+.....++|||||||++.||+||.+||... .....+ ... ...++..++.++++
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~ 254 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKD 254 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHH
Confidence 1223569999999999985433335899999999999999999998762 112222 222 23566678999999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
||.+||..||++||||.++|+|||++...
T Consensus 255 Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 255 FLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 99999999999999999999999997643
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=357.08 Aligned_cols=245 Identities=24% Similarity=0.393 Sum_probs=203.6
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||+||+|.+..++..||||++............+..|+.++..+ +||||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEEE
Confidence 368999999999999999999999999999999875544444456678899999998 9999999999999999999999
Q ss_pred ecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----CC
Q 011331 309 ELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----LP 381 (488)
Q Consensus 309 E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----~~ 381 (488)
||+.++++.... ...+++..++.++.||+.||.|||+.||+|+||||+||++ .++.+||+|||++...... ..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 999988666332 3468999999999999999999999999999999999999 6789999999999876432 12
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc--C-------------------C
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD--G-------------------K 437 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~--~-------------------~ 437 (488)
...|+..|+|||++.+. .++.++|||||||++|||++|.+||........ +.. + .
T Consensus 160 ~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 160 EYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred ccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 34589999999998765 467899999999999999999999875432111 100 0 0
Q ss_pred CC-----------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 438 LP-----------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 438 ~~-----------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
.+ .....+.++.+||.+||++||++|||++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 011257789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=368.00 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=206.8
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||+|+||+||+|.+..+|+.||||++..... .......+..|+.++..+ +||||+++++++..++.+||||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 369999999999999999999999999875422 223445678899999998 999999999999999999999999987
Q ss_pred Cchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCCCCCCCCC
Q 011331 314 SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSLPIEEGDA 387 (488)
Q Consensus 314 ~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~~~~~Gt~ 387 (488)
+.+. ......+++..+..++.||+.||+|||++||+||||||+|||+ .++.+||+|||+++... .......||+
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 159 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence 6443 3334568999999999999999999999999999999999999 67899999999987542 2223456999
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRP 464 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~Rp 464 (488)
.|+|||++.+. .++.++|||||||++|||++|..||..... ...+......++..++.++.+||.+||..||++||
T Consensus 160 ~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05571 160 EYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred cccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 99999998765 577899999999999999999999876543 23344556667778899999999999999999999
Q ss_pred -----CHHHHHhChhhhhhHH
Q 011331 465 -----SAKELVENPIFDKIQK 480 (488)
Q Consensus 465 -----Ta~elL~HP~f~~i~~ 480 (488)
++.++++||||..+..
T Consensus 239 ~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 239 GGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred CCCCCCHHHHHcCCCcCCCCH
Confidence 8999999999988644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=369.39 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=214.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCC-eEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDG-CFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.++|++++.||+|+||+||+|.+..++ ..||+|++.... ........+..|+.++..+ +||||+++++++.+.+.+|
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEE
Confidence 457999999999999999999876554 789999885432 1223345678899999999 8999999999999999999
Q ss_pred EEEecCCCCc-hhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCC
Q 011331 306 IQMELCDHSL-SDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPI 382 (488)
Q Consensus 306 IV~E~~~~~l-~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~ 382 (488)
|||||+.++. ... .....+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||++.........
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~~ 187 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT 187 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCcce
Confidence 9999997754 332 334568999999999999999999999999999999999999 6789999999999887665556
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
..||+.|+|||++.+. .++.++|||||||++|||++|.+||..... ...+..+....++..+.++.++|++||+.|
T Consensus 188 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~d 266 (340)
T PTZ00426 188 LCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHD 266 (340)
T ss_pred ecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccC
Confidence 6799999999998765 567799999999999999999999987554 345556666677788999999999999999
Q ss_pred CCCCC-----CHHHHHhChhhhhhHH
Q 011331 460 PVQRP-----SAKELVENPIFDKIQK 480 (488)
Q Consensus 460 P~~Rp-----Ta~elL~HP~f~~i~~ 480 (488)
|++|+ +++++++||||+.+.+
T Consensus 267 p~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 267 LTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred HHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 99995 8999999999997643
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=362.40 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=202.5
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc-----ceE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN-----EQL 304 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~-----~~l 304 (488)
+|++.+.||+|+||.||+|.+..+|..||||++............+.+|+.+++.+ +||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence 48899999999999999999999999999999875433334455688999999999 899999999887543 358
Q ss_pred EEEEecCCCCchhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---
Q 011331 305 YIQMELCDHSLSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--- 379 (488)
|+|||||++++.... ....+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.....
T Consensus 80 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 80 YVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 999999988776643 34469999999999999999999999999999999999999 6789999999999754321
Q ss_pred ---CCCCCCCCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh------------------hh---
Q 011331 380 ---LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN------------------LR--- 434 (488)
Q Consensus 380 ---~~~~~Gt~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~------------------i~--- 434 (488)
.....||..|+|||++... ..++.++|||||||++|||++|.+||........ +.
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 1234689999999998652 3567799999999999999999999865432110 00
Q ss_pred --------cCCCC-----CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 435 --------DGKLP-----LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 435 --------~~~~~-----~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
....+ ..+..+..+.++|.+||..||++|||++|+++||||+.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00001 12356788999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=369.59 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=212.8
Q ss_pred ccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch------------HHHHHHHHHHHHHHHhCCCCCe
Q 011331 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD------------AERRKALLEVQALAALGSHENI 291 (488)
Q Consensus 224 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~------------~~~~~~~~Ei~iL~~l~~HpnI 291 (488)
-....+.|.+++.||+|.||.|.+|++..+++.||||++.+..... ...++..+||.+|+++ .||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nV 170 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNV 170 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCe
Confidence 3456788999999999999999999999999999999986532111 1235788999999999 99999
Q ss_pred eEeeeeecc--cceEEEEEecCCCC-chhhhhccc-CCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEE
Q 011331 292 VGYYSSWFE--NEQLYIQMELCDHS-LSDKKASQF-FAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYK 366 (488)
Q Consensus 292 v~l~~~~~~--~~~l~IV~E~~~~~-l~~~~~~~~-l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vk 366 (488)
|+|+++..+ .+.+|||+|||..+ +.+...... +++.+++.|+.+++.||+|||.+|||||||||+|+|| ++|.+|
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 999999886 55799999999865 444444444 8999999999999999999999999999999999999 789999
Q ss_pred EEeecCceecCCC--------CCCCCCCCCccChhhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhh
Q 011331 367 LGDFGRATLLNKS--------LPIEEGDARYMPQEILNE---DYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLN 432 (488)
Q Consensus 367 L~DFGlA~~~~~~--------~~~~~Gt~~Y~APEvl~~---~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~ 432 (488)
|+|||.+...... ....+||+.|+|||.+.+ ....+.+.||||+||+||.|+.|..||.+... +..
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 9999998765221 233579999999999876 33455799999999999999999999987654 445
Q ss_pred hhcCCCCCCC--CCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 433 LRDGKLPLLP--GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 433 i~~~~~~~~~--~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
|.+..+.++. ...+.++++|.+||.+||++|+++.+|..|||...-
T Consensus 331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 6666555544 479999999999999999999999999999998653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=361.54 Aligned_cols=252 Identities=27% Similarity=0.369 Sum_probs=211.4
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
...++|++.+.||.|..++||+|+...+++.||||++.....+. +...+.+|++.+..+ +||||+.++..|..+..+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhc-CCCCcceEEEEEEecceeE
Confidence 34568999999999999999999999999999999997654333 367788999999998 9999999999999999999
Q ss_pred EEEecCCCCc-hh---hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 306 IQMELCDHSL-SD---KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 306 IV~E~~~~~l-~~---~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
+||.||.++. ++ ......|+|..+..+++++++||.|||++|.||||||+.|||| ++|.|||+|||....+..+
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999998763 33 2223459999999999999999999999999999999999999 7899999999976544321
Q ss_pred ------CCCCCCCCCccChhhhc-ccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh---cCCCCCC--------
Q 011331 380 ------LPIEEGDARYMPQEILN-EDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR---DGKLPLL-------- 441 (488)
Q Consensus 380 ------~~~~~Gt~~Y~APEvl~-~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~---~~~~~~~-------- 441 (488)
..+.+||++|||||++. .-..|+.|+||||||++..||.+|..||....++..+. ++..|.+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d 260 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKD 260 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChH
Confidence 14557999999999954 33456679999999999999999999999877765443 3333311
Q ss_pred --CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 442 --PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 442 --~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
...+..|+++|..||++||.+||||.++|+|+||+...
T Consensus 261 ~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 261 EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 12456799999999999999999999999999998754
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=362.67 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=209.2
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++++.||+|+||.||+|.+..+|+.||||++...... ......+..|+.++..+ +||||+++++++...+.+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEE
Confidence 3689999999999999999999999999999998754222 23345678899999998 799999999999999999999
Q ss_pred EecCCCCchh-hh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCC
Q 011331 308 MELCDHSLSD-KK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE 384 (488)
Q Consensus 308 ~E~~~~~l~~-~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~ 384 (488)
|||++++.+. .. ....+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++...........
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~ 159 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV 159 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCcc
Confidence 9999876444 32 34568999999999999999999999999999999999999 678999999999987765555567
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcC----CCCCC----CCCcHHHHHHHH
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDG----KLPLL----PGHSLQFQNLLK 453 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~----~~~~~----~~~s~~l~~lI~ 453 (488)
||+.|+|||++.+. .++.++|||||||++|||++|..||...... ..+... ..+.. ..++.++.+||.
T Consensus 160 gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~ 238 (333)
T cd05600 160 GSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT 238 (333)
T ss_pred cCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHH
Confidence 99999999998766 6778999999999999999999998764332 122211 11111 145899999999
Q ss_pred HcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 454 VMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+||..+|.+||+++++++||||..+..
T Consensus 239 ~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 239 KLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 999999999999999999999998744
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=351.40 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=218.2
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.+.+.|++-+.||+|.|+.|+++.+..+|+.+|+|++..........+++.+|+.|-..| +|||||+|++.+...+..|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcccceeE
Confidence 445568888899999999999999999999999999876656666778899999999998 9999999999999999999
Q ss_pred EEEecCCCCch--hhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-e---CCeEEEEeecCceecCCC
Q 011331 306 IQMELCDHSLS--DKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-K---NGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 306 IV~E~~~~~l~--~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~---~g~vkL~DFGlA~~~~~~ 379 (488)
||+|+++|+-+ +......++|..+..+++||+.+|.|+|.+||||||+||+|+++ + ..-+||+|||+|..++..
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 99999998632 24444668999999999999999999999999999999999999 2 247999999999988743
Q ss_pred C--CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCC----CCCCCcHHHHH
Q 011331 380 L--PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLP----LLPGHSLQFQN 450 (488)
Q Consensus 380 ~--~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~----~~~~~s~~l~~ 450 (488)
. ....|||.|||||++... .++..+|||+-||+||-|+.|.+||.+.+. +..+..+... .++.++++.++
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred cccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 2 235699999999999877 688899999999999999999999987433 5667766654 45567999999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
||++||..||.+|+|+.|+|+|||++.-.
T Consensus 246 LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 246 LIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred HHHHHhccChhhhccHHHHhCCchhcchH
Confidence 99999999999999999999999997643
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=358.96 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=209.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
+|++++.||+|+||+||+|.+..+++.||||++..... .......+..|+.++..+..|++|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58899999999999999999999999999999875422 23345567889999998855667999999999999999999
Q ss_pred ecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCCCC
Q 011331 309 ELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSLPI 382 (488)
Q Consensus 309 E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~~~ 382 (488)
||++++.+. ......+++..++.++.||+.||.|||++||+||||||+|||+ .++.++|+|||++.... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 999876443 2334568999999999999999999999999999999999999 67899999999987532 12233
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
..||+.|+|||++.+. .++.++|||||||++|||++|..||..... ...+.......+..++.++.++|.+||..|
T Consensus 161 ~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (324)
T cd05587 161 FCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH 239 (324)
T ss_pred ecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 4699999999998765 567899999999999999999999876543 334555666677788999999999999999
Q ss_pred CCCCCCH-----HHHHhChhhhhhHH
Q 011331 460 PVQRPSA-----KELVENPIFDKIQK 480 (488)
Q Consensus 460 P~~RpTa-----~elL~HP~f~~i~~ 480 (488)
|.+|+++ +++++||||+.+..
T Consensus 240 P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 240 PAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9999976 89999999988644
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=376.55 Aligned_cols=246 Identities=27% Similarity=0.383 Sum_probs=207.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCC-----CeeEeeeeecccceE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE-----NIVGYYSSWFENEQL 304 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hp-----nIv~l~~~~~~~~~l 304 (488)
+|.+++.||+|.||+|.+|.+..|++.||||++++. .....+...|+.+|..+..|. |+|+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 789999999999999999999999999999999853 455677889999999996343 799999999999999
Q ss_pred EEEEecCCCCchhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe---CCeEEEEeecCceecCC
Q 011331 305 YIQMELCDHSLSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK---NGVYKLGDFGRATLLNK 378 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~---~g~vkL~DFGlA~~~~~ 378 (488)
|||+|+++.+|.+..+. ..++...++.++.||+.||.+||+.||||+||||+|||+. ...+||+|||.|+....
T Consensus 264 ciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 264 CIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred eeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 99999999987774443 4588999999999999999999999999999999999992 35899999999998887
Q ss_pred CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh------c-----------------
Q 011331 379 SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR------D----------------- 435 (488)
Q Consensus 379 ~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~------~----------------- 435 (488)
..-+...+..|+|||++.+- .|+.++|||||||+++||++|.++|.+..++..+. +
T Consensus 344 ~vytYiQSRfYRAPEVILGl-pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff 422 (586)
T KOG0667|consen 344 RVYTYIQSRFYRAPEVILGL-PYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFF 422 (586)
T ss_pred cceeeeeccccccchhhccC-CCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceeh
Confidence 76677889999999999886 68889999999999999999998887653321110 0
Q ss_pred --------------------------------CCCCCCC-----------CCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 436 --------------------------------GKLPLLP-----------GHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 436 --------------------------------~~~~~~~-----------~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
.....++ .....|.+||++||.+||.+|+|+.|+|+|
T Consensus 423 ~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 423 TSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred hccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000110 112358999999999999999999999999
Q ss_pred hhhhhhH
Q 011331 473 PIFDKIQ 479 (488)
Q Consensus 473 P~f~~i~ 479 (488)
|||....
T Consensus 503 pfl~~~~ 509 (586)
T KOG0667|consen 503 PFLTGTS 509 (586)
T ss_pred ccccccc
Confidence 9998554
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=364.05 Aligned_cols=250 Identities=28% Similarity=0.396 Sum_probs=208.4
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++++.||+|+||+||+|.+..+|+.||||++....... .....+..|+.++..+ +|+||+++++++.+++.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEE
Confidence 36899999999999999999999999999999986542222 3345677899999998 899999999999999999999
Q ss_pred EecCCCC-chhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC----
Q 011331 308 MELCDHS-LSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---- 380 (488)
Q Consensus 308 ~E~~~~~-l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---- 380 (488)
|||+.++ |.... ....+++..++.++.||+.||.|||++||+||||||+|||| .++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 9999775 44332 23579999999999999999999999999999999999999 67899999999997654322
Q ss_pred ----------------------------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh--
Q 011331 381 ----------------------------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF-- 430 (488)
Q Consensus 381 ----------------------------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~-- 430 (488)
....||+.|+|||++... .++.++|||||||+||||++|..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 234589999999999776 6778999999999999999999998765432
Q ss_pred -hhhhc----CCCCCCCCCcHHHHHHHHHcccCCCCCCCC-HHHHHhChhhhhhHHh
Q 011331 431 -LNLRD----GKLPLLPGHSLQFQNLLKVMVDPDPVQRPS-AKELVENPIFDKIQKH 481 (488)
Q Consensus 431 -~~i~~----~~~~~~~~~s~~l~~lI~k~L~~dP~~RpT-a~elL~HP~f~~i~~~ 481 (488)
..+.. ...+....++.++.+||.+||. ||.+|++ ++++++||||+.+...
T Consensus 239 ~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~ 294 (350)
T cd05573 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWE 294 (350)
T ss_pred HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHH
Confidence 22322 2233344569999999999997 9999999 9999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=359.48 Aligned_cols=250 Identities=24% Similarity=0.314 Sum_probs=206.5
Q ss_pred ceeEEEEecccCcEEEEEEEEc---CCCeEEEEEEeccCCC--chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKR---IDGCFYAVKHSKRQLH--HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~l~~~~~--~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
+|++++.||+|+||+||+|++. .+|..||+|++.+... ..........|+.++..+.+|+||+.+++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4789999999999999999874 4789999999864321 1223345778999999997899999999999999999
Q ss_pred EEEEecCCCCch-h-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--
Q 011331 305 YIQMELCDHSLS-D-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 305 ~IV~E~~~~~l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-- 379 (488)
|+||||+.++.+ . ......+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 999999987643 3 2334569999999999999999999999999999999999999 6789999999999765321
Q ss_pred --CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-------hhhhhcCCCCCCCCCcHHHHH
Q 011331 380 --LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-------FLNLRDGKLPLLPGHSLQFQN 450 (488)
Q Consensus 380 --~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~~~i~~~~~~~~~~~s~~l~~ 450 (488)
.....||+.|+|||++.+...++.++|||||||++|||++|..||..... ...+.....+.+..++..+.+
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 12346999999999987654567799999999999999999999863211 122334455666778999999
Q ss_pred HHHHcccCCCCCCC-----CHHHHHhChhhhhhH
Q 011331 451 LLKVMVDPDPVQRP-----SAKELVENPIFDKIQ 479 (488)
Q Consensus 451 lI~k~L~~dP~~Rp-----Ta~elL~HP~f~~i~ 479 (488)
+|.+||..||++|| +++++++||||+...
T Consensus 241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 99999999999999 899999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=360.00 Aligned_cols=249 Identities=25% Similarity=0.351 Sum_probs=203.8
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc---
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE--- 302 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~--- 302 (488)
...++|++++.||+|+||+||+|.+..+|..||||++............+.+|+.++..+ +||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCcc
Confidence 356789999999999999999999999999999999876544445556788899999998 8999999999886543
Q ss_pred ---eEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 303 ---QLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 303 ---~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
.+|+||||+++++..... ..+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++....
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 97 EFQDVYLVMELMDANLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ccceeEEEEeCCCcCHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 579999999988766432 458899999999999999999999999999999999999 688999999999976533
Q ss_pred C--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh-----------------------
Q 011331 379 S--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL----------------------- 433 (488)
Q Consensus 379 ~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i----------------------- 433 (488)
. .....||..|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 176 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (359)
T cd07876 176 NFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254 (359)
T ss_pred CccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 2 2334689999999998765 5778999999999999999999998754321100
Q ss_pred --hcC--CCC------------------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 434 --RDG--KLP------------------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 434 --~~~--~~~------------------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
... ..+ .....+.++.+||.+||..||++|||+.|+|+||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000 000 01123567899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=364.00 Aligned_cols=249 Identities=27% Similarity=0.365 Sum_probs=204.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++++.||+|+||+||+|.+..+|+.||||++.... ........+..|+.++..+ +|+||+++++++.+++.+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEE
Confidence 36899999999999999999999999999999986432 1223345577899999999 899999999999999999999
Q ss_pred EecCCCCch-hh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC----
Q 011331 308 MELCDHSLS-DK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---- 380 (488)
Q Consensus 308 ~E~~~~~l~-~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---- 380 (488)
|||+.++.+ .. .....+++..+..++.||+.||.|||++||+||||||+|||+ .++.++|+|||++..+....
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 999987633 32 334568999999999999999999999999999999999999 67899999999987542110
Q ss_pred -------------------------------------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCC
Q 011331 381 -------------------------------------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPL 423 (488)
Q Consensus 381 -------------------------------------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p 423 (488)
...+||+.|+|||++... .++.++|||||||++|||++|.+|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCCCC
Confidence 123589999999998765 577899999999999999999999
Q ss_pred CCCchhhh---hhhcC--CCCC--CCCCcHHHHHHHHHcccCCCCCCCC---HHHHHhChhhhhhHH
Q 011331 424 SESGPQFL---NLRDG--KLPL--LPGHSLQFQNLLKVMVDPDPVQRPS---AKELVENPIFDKIQK 480 (488)
Q Consensus 424 ~~~~~~~~---~i~~~--~~~~--~~~~s~~l~~lI~k~L~~dP~~RpT---a~elL~HP~f~~i~~ 480 (488)
|....... .+... .... ...++.++.++|.+||. +|.+|++ ++|++.||||+.+..
T Consensus 239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred CCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 97654432 22221 1222 22468999999999997 9999997 999999999987643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=362.35 Aligned_cols=249 Identities=25% Similarity=0.332 Sum_probs=202.5
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++++.||+|+||+||+|.+..+|+.||||++.+... .......+..|+.++..+ +|+||+++++.+.+...+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEE
Confidence 368999999999999999999999999999999865322 222335577799999998 899999999999999999999
Q ss_pred EecCCCCch-hh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-----
Q 011331 308 MELCDHSLS-DK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----- 379 (488)
Q Consensus 308 ~E~~~~~l~-~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----- 379 (488)
||||.++.+ .. .....+++..+..++.||+.||.|||++||+||||||+|||| .++.+||+|||+++.+...
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 999987643 32 334679999999999999999999999999999999999999 6789999999998754321
Q ss_pred ---------------------------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 011331 380 ---------------------------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSES 426 (488)
Q Consensus 380 ---------------------------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~ 426 (488)
....+||+.|+|||++.+. .++.++|||||||++|||++|..||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 0124699999999998765 577899999999999999999999976
Q ss_pred chhh---hhhhc--CCCCCC--CCCcHHHHHHHHHcccCCCC---CCCCHHHHHhChhhhhhHH
Q 011331 427 GPQF---LNLRD--GKLPLL--PGHSLQFQNLLKVMVDPDPV---QRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 427 ~~~~---~~i~~--~~~~~~--~~~s~~l~~lI~k~L~~dP~---~RpTa~elL~HP~f~~i~~ 480 (488)
.... ..+.. .....+ ..++.++.++|.+|+. +|. .||+++|+++||||+++.+
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDW 301 (363)
T ss_pred CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCH
Confidence 5432 23332 222233 2468999999999775 444 4689999999999998744
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=350.65 Aligned_cols=245 Identities=25% Similarity=0.377 Sum_probs=196.1
Q ss_pred ceeEEEEecccCcEEEEEEEEcC-CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC--CCCCeeEeeeeec-----cc
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRI-DGCFYAVKHSKRQLHHDAERRKALLEVQALAALG--SHENIVGYYSSWF-----EN 301 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~--~HpnIv~l~~~~~-----~~ 301 (488)
+|++++.||+|+||+||+|.+.. +|..||||++..............+|+.++..+. +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 68899999999999999999854 4789999998654333333344566777777663 6999999999875 34
Q ss_pred ceEEEEEecCCCCchhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC
Q 011331 302 EQLYIQMELCDHSLSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN 377 (488)
Q Consensus 302 ~~l~IV~E~~~~~l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~ 377 (488)
..+++||||+++++..... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++...
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence 5689999999987655332 2458999999999999999999999999999999999999 67899999999998764
Q ss_pred CC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcC-CC-------------
Q 011331 378 KS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDG-KL------------- 438 (488)
Q Consensus 378 ~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~-~~------------- 438 (488)
.. .....|++.|+|||++... .++.++|||||||++|||++|.+||........ +... ..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (290)
T cd07862 162 FQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 240 (290)
T ss_pred CCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhccc
Confidence 33 2334689999999998665 577799999999999999999999876543211 1100 00
Q ss_pred -------------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 439 -------------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 439 -------------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
...+.++..+.++|.+||+.||++|||+.|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 241 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=356.86 Aligned_cols=241 Identities=25% Similarity=0.352 Sum_probs=204.4
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCCc
Q 011331 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSL 315 (488)
Q Consensus 237 LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~l 315 (488)
||+|+||+||+|.+..+++.||+|++.... ........+..|+.++..+ +||||+++++++...+.+|+||||+.++.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999999999999999986432 2233455678899999998 99999999999999999999999998764
Q ss_pred hh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCCCCCCCCc
Q 011331 316 SD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPIEEGDARY 389 (488)
Q Consensus 316 ~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~~~Gt~~Y 389 (488)
+. ......+++..+..++.||+.||.|||++||+||||||+|||+ .++.++|+|||+++.... ......||+.|
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 159 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence 43 2334568999999999999999999999999999999999999 678999999999975422 12334699999
Q ss_pred cChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCC--
Q 011331 390 MPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRP-- 464 (488)
Q Consensus 390 ~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~Rp-- 464 (488)
+|||++.+. .++.++|||||||++|||++|..||..... +..+.......+..++.++.+||.+||..||.+||
T Consensus 160 ~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 160 LAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGY 238 (312)
T ss_pred CCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCC
Confidence 999998765 577899999999999999999999876433 23445566677778899999999999999999997
Q ss_pred -CHHHHHhChhhhhhH
Q 011331 465 -SAKELVENPIFDKIQ 479 (488)
Q Consensus 465 -Ta~elL~HP~f~~i~ 479 (488)
++.|+++||||....
T Consensus 239 ~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 239 NGAQEIKNHPFFSQLS 254 (312)
T ss_pred CCHHHHHcCCCcCCCC
Confidence 589999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=356.70 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=210.5
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
+|++++.||+|+||+||+|.+..++..||||++.+... ..........|..++..+..|++|+.+++++...+.+||||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 57899999999999999999999999999999875422 22334456778888888878999999999999999999999
Q ss_pred ecCCCCch-h-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCC
Q 011331 309 ELCDHSLS-D-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPI 382 (488)
Q Consensus 309 E~~~~~l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~ 382 (488)
||++++.+ . ......+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 99987543 3 2334568999999999999999999999999999999999999 678999999999975421 2234
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
..||+.|+|||++... .++.++|||||||++|||++|..||..... ...+.......+...+.++.++|.+||+.|
T Consensus 161 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~ 239 (323)
T cd05616 161 FCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 239 (323)
T ss_pred CCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccC
Confidence 5699999999999765 577899999999999999999999976543 334555666677788999999999999999
Q ss_pred CCCCCC-----HHHHHhChhhhhhHH
Q 011331 460 PVQRPS-----AKELVENPIFDKIQK 480 (488)
Q Consensus 460 P~~RpT-----a~elL~HP~f~~i~~ 480 (488)
|.+|++ ..++++||||+.+.+
T Consensus 240 p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 240 PGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred HHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999998 589999999987643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=358.66 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=206.3
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||+|+||+||+|.+..+++.||||++.+.. ........+..|+.++..+.+||||+++++++...+.+||||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999986532 12233456778888888877899999999999999999999999987
Q ss_pred Cchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCCCCCCCCC
Q 011331 314 SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSLPIEEGDA 387 (488)
Q Consensus 314 ~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~~~~~Gt~ 387 (488)
+.+. ......+++..++.++.||+.||.|||++||+||||||+|||+ .++.++|+|||++.... .......||+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 6443 2334569999999999999999999999999999999999999 67899999999987542 1223446999
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRP 464 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~Rp 464 (488)
.|+|||++... .++.++|||||||++|||++|..||..... ...+.......+..++.++.++|.+||+.||.+||
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 239 (320)
T cd05590 161 DYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239 (320)
T ss_pred cccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 99999998765 577799999999999999999999876543 23445566667777899999999999999999999
Q ss_pred CH------HHHHhChhhhhhHH
Q 011331 465 SA------KELVENPIFDKIQK 480 (488)
Q Consensus 465 Ta------~elL~HP~f~~i~~ 480 (488)
++ +++++||||+.+..
T Consensus 240 ~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 240 GSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred CCCCCCCHHHHHcCCCcCCCCH
Confidence 98 99999999988643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=364.29 Aligned_cols=248 Identities=27% Similarity=0.360 Sum_probs=205.9
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc-----eE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE-----QL 304 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~-----~l 304 (488)
+|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.++..+ +|+||+++++++...+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence 47889999999999999999999999999999865443444556788999999999 8999999999998776 78
Q ss_pred EEEEecCCCCchhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---
Q 011331 305 YIQMELCDHSLSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--- 379 (488)
|+||||+.+++.... ....+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.....
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 80 YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 999999998776643 34568999999999999999999999999999999999999 6789999999999865322
Q ss_pred -CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh------------------------
Q 011331 380 -LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR------------------------ 434 (488)
Q Consensus 380 -~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~------------------------ 434 (488)
.....++..|+|||++.+...++.++|||||||++|||++|++||........+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 2234578999999998775456789999999999999999999987543221100
Q ss_pred --cCC---------CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 435 --DGK---------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 435 --~~~---------~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
... .......+.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 000 11233457899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=359.43 Aligned_cols=243 Identities=24% Similarity=0.340 Sum_probs=205.2
Q ss_pred EecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCC
Q 011331 236 QIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHS 314 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~ 314 (488)
.||+|+||+||+|.+..+|..||||++.+... .......+.+|+.++..+ +||||+++++++...+.+||||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 68999999999999999999999999875422 223445678899999998 9999999999999999999999999876
Q ss_pred chh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCCCCCCCC
Q 011331 315 LSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPIEEGDAR 388 (488)
Q Consensus 315 l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~~~Gt~~ 388 (488)
.+. ......+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.... ......||+.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 443 2334568999999999999999999999999999999999999 678999999999875422 2233469999
Q ss_pred ccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCC-
Q 011331 389 YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRP- 464 (488)
Q Consensus 389 Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~Rp- 464 (488)
|+|||++... .++.++|||||||++|+|++|..||..... ...+......++..++.++.+||.+||.+||.+|+
T Consensus 161 y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 161 YLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred ccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999998765 567899999999999999999999875433 22334455667778899999999999999999997
Q ss_pred ----CHHHHHhChhhhhhHH
Q 011331 465 ----SAKELVENPIFDKIQK 480 (488)
Q Consensus 465 ----Ta~elL~HP~f~~i~~ 480 (488)
++.|+++||||.....
T Consensus 240 ~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 240 GGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred CCCCCHHHHhcCCCcCCCCH
Confidence 8999999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=356.44 Aligned_cols=243 Identities=25% Similarity=0.348 Sum_probs=205.3
Q ss_pred EecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCC
Q 011331 236 QIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHS 314 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~ 314 (488)
.||+|+||+||+|.+..+|+.||||++..... .......+..|+.++..+.+||||+++++++...+.+||||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 58999999999999999999999999865422 23344567788888888778999999999999999999999999876
Q ss_pred chh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCCCCCCCC
Q 011331 315 LSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPIEEGDAR 388 (488)
Q Consensus 315 l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~~~Gt~~ 388 (488)
.+. ......+++..+..++.||+.||.|||++||+||||||+|||+ .++.++|+|||++..... ......||+.
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 161 (321)
T cd05591 82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD 161 (321)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCcc
Confidence 443 2344568999999999999999999999999999999999999 678999999999875422 2233468999
Q ss_pred ccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCC-
Q 011331 389 YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRP- 464 (488)
Q Consensus 389 Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~Rp- 464 (488)
|+|||++... .++.++|||||||++|||++|..||..... ...+.......+..++.++.++|.+||..||++|+
T Consensus 162 y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~ 240 (321)
T cd05591 162 YIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLG 240 (321)
T ss_pred ccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence 9999998765 577899999999999999999999976543 33445556666677899999999999999999999
Q ss_pred ------CHHHHHhChhhhhhH
Q 011331 465 ------SAKELVENPIFDKIQ 479 (488)
Q Consensus 465 ------Ta~elL~HP~f~~i~ 479 (488)
+++++++||||..+.
T Consensus 241 ~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 241 CVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred CCCCCCCHHHHhcCCccCCCC
Confidence 999999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=357.65 Aligned_cols=244 Identities=24% Similarity=0.349 Sum_probs=205.2
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||+|+||+||+|.+..+|..||+|++..... .......+..|+.++..+ +||||++++++|..++.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 369999999999999999999999999875422 223445677899999998 999999999999999999999999987
Q ss_pred Cchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCCCCCCC
Q 011331 314 SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPIEEGDA 387 (488)
Q Consensus 314 ~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~~~Gt~ 387 (488)
+.+. ......+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++..... ......||+
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 159 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence 6443 2334568999999999999999999999999999999999999 678999999999875422 123356999
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRP 464 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~Rp 464 (488)
.|+|||++... .++.++|||||||++|||++|..||..... ...+.......+..++.++.++|.+||..||.+|+
T Consensus 160 ~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 160 EYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred CcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhC
Confidence 99999998765 567899999999999999999999876543 22334455566778899999999999999999998
Q ss_pred -----CHHHHHhChhhhhhHH
Q 011331 465 -----SAKELVENPIFDKIQK 480 (488)
Q Consensus 465 -----Ta~elL~HP~f~~i~~ 480 (488)
++.++++||||..+..
T Consensus 239 ~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 239 GGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred CCCCCCHHHHHcCCCcCCCCH
Confidence 8999999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=357.80 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=204.9
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc----
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN---- 301 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~---- 301 (488)
...++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeecccccc
Confidence 356789999999999999999999999999999999876554555567788899999998 899999999988643
Q ss_pred --ceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 302 --EQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 302 --~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
..+|+||||+++++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++....
T Consensus 93 ~~~~~~lv~e~~~~~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 93 EFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ccceeEEEhhhhcccHHHHHh-hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 3579999999988766443 458899999999999999999999999999999999999 678999999999987654
Q ss_pred CC--CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh----------------------
Q 011331 379 SL--PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR---------------------- 434 (488)
Q Consensus 379 ~~--~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~---------------------- 434 (488)
.. ....||..|+|||++.+. .++.++|||||||++|+|++|..||..........
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 172 SFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred ccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 32 334689999999998765 57789999999999999999999987543211000
Q ss_pred ---cC-------C---------CC----CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 435 ---DG-------K---------LP----LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 435 ---~~-------~---------~~----~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.. . .+ .....+.++.+||.+||..||++|||+.|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00 0 00 111235678999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=351.27 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=205.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|.+++.||+|+||+||+|.+..++..||+|++..... ......+.+|+.++..+ +|+||+++++++..++..|+||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEEE
Confidence 568999999999999999999999999999999864422 22234567899999998 8999999999999999999999
Q ss_pred ecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 309 ELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 309 E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
||+++++..... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++...... ...
T Consensus 84 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 84 EYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence 999987766332 2348899999999999999999999999999999999999 6789999999999765322 223
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhh---c------------------CC-
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLR---D------------------GK- 437 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~---~------------------~~- 437 (488)
..+++.|+|||++.+...++.++|||||||++|+|++|.+||....... .+. . ..
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 4578999999998765567789999999999999999999986543211 000 0 00
Q ss_pred --------CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 438 --------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 438 --------~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
....+.++.++.++|.+||..||.+|||++|+++||||+.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 0112346789999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=359.48 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=208.6
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc-----
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN----- 301 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~----- 301 (488)
..++|++++.||.|+||+||+|.+..++..||||++............+.+|+.+++.+ +|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccccc
Confidence 34578999999999999999999999999999999875433334455677899999999 899999999887643
Q ss_pred -ceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 302 -EQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 302 -~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
..+|++||++++.+........+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.....
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred cCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 35799999998887776666779999999999999999999999999999999999999 6789999999999887666
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhc---------------------
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRD--------------------- 435 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~--------------------- 435 (488)
.....||..|+|||++.+...++.++|||||||++|+|++|..||....... .+..
T Consensus 172 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (343)
T cd07878 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKY 251 (343)
T ss_pred cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHH
Confidence 5566799999999998764467789999999999999999999886543211 1100
Q ss_pred -CCCC---------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 436 -GKLP---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 436 -~~~~---------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
...+ ...+.+..+.+||.+||..||.+|||+.|+|+||||....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 252 IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0000 1123566788999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=339.94 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=219.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|.+++.||+|.||.||+|+.+.++-.||+|++.+.. ....-..++.+|++|.+.| +||||+++|++|.+...+|+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheeccceeEE
Confidence 468999999999999999999999999999999986542 2222345688899999999 99999999999999999999
Q ss_pred EEecCCCC-chhh-h--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC-CCC
Q 011331 307 QMELCDHS-LSDK-K--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN-KSL 380 (488)
Q Consensus 307 V~E~~~~~-l~~~-~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~-~~~ 380 (488)
++||...+ +... . ....+++..++.+++|++.||.|+|.+++|||||||+|+|+ ..|.+||+|||.+.... +..
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR 179 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKR 179 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCCc
Confidence 99999765 3332 2 44569999999999999999999999999999999999999 78999999999997764 345
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch---hhhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP---QFLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~---~~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
.+.+||..|.+||...+. .++..+|+|++|++.||++.|.+||++.. .+.++....+..+..++.++.++|.+||.
T Consensus 180 ~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~ 258 (281)
T KOG0580|consen 180 KTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLV 258 (281)
T ss_pred eeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhc
Confidence 677899999999998765 67789999999999999999999998754 36678888888889999999999999999
Q ss_pred CCCCCCCCHHHHHhChhhhhh
Q 011331 458 PDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f~~i 478 (488)
++|.+|.+..|++.|||+...
T Consensus 259 ~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 259 KNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred cCccccccHHHHhhhHHHHhc
Confidence 999999999999999999753
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=364.10 Aligned_cols=249 Identities=27% Similarity=0.375 Sum_probs=201.7
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++++.||+|+||+||+|.+..+|+.||||++.+.. ........+..|+.++..+ +||||++++++|.+.+.+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEE
Confidence 36899999999999999999999999999999986432 1223345677899999998 999999999999999999999
Q ss_pred EecCCCCch-hh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-----
Q 011331 308 MELCDHSLS-DK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----- 379 (488)
Q Consensus 308 ~E~~~~~l~-~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----- 379 (488)
|||+.++.+ .. .....+++..++.++.||+.||+|||++||+||||||+|||+ .++.++|+|||+++.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 999977533 32 334568999999999999999999999999999999999999 6789999999998632110
Q ss_pred ---------------------------------------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHH
Q 011331 380 ---------------------------------------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATM 414 (488)
Q Consensus 380 ---------------------------------------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL 414 (488)
.....||+.|+|||++... .++.++|||||||+|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil 238 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAIM 238 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecchhh
Confidence 0013599999999998765 577899999999999
Q ss_pred HHHHcCCCCCCCchhh---hhhhc--CCCCCC--CCCcHHHHHHHHHcccCCCCCC---CCHHHHHhChhhhhhHH
Q 011331 415 YELIKGSPLSESGPQF---LNLRD--GKLPLL--PGHSLQFQNLLKVMVDPDPVQR---PSAKELVENPIFDKIQK 480 (488)
Q Consensus 415 ~eLltG~~p~~~~~~~---~~i~~--~~~~~~--~~~s~~l~~lI~k~L~~dP~~R---pTa~elL~HP~f~~i~~ 480 (488)
|||++|.+||...... ..+.. .....+ ..++.++.+||.+||. +|.+| +|+.|++.||||+++..
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9999999999765432 22222 122222 3468999999999998 67665 69999999999987643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=371.77 Aligned_cols=245 Identities=23% Similarity=0.299 Sum_probs=197.7
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc--------
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE-------- 300 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-------- 300 (488)
.+|++++.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.+ +||||+++++++..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhc-CCCCCcceeeeEeecccccCCC
Confidence 46899999999999999999999999999999875321 1234689999998 99999999887643
Q ss_pred cceEEEEEecCCCCchhhh-----hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-C-CeEEEEeecCc
Q 011331 301 NEQLYIQMELCDHSLSDKK-----ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-N-GVYKLGDFGRA 373 (488)
Q Consensus 301 ~~~l~IV~E~~~~~l~~~~-----~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~-g~vkL~DFGlA 373 (488)
...+++||||+++++.... ....+++..++.++.||+.||.|||++||+||||||+||||+ + +.+||+|||+|
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 2247799999998765422 235689999999999999999999999999999999999994 4 47999999999
Q ss_pred eecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhc-------------
Q 011331 374 TLLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRD------------- 435 (488)
Q Consensus 374 ~~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~------------- 435 (488)
+..... .....||+.|+|||++.+...++.++|||||||+||||++|.+||.+..... .+..
T Consensus 219 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred hhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 866432 2334689999999998765467789999999999999999999987643211 1110
Q ss_pred ------CCC----------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 436 ------GKL----------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 436 ------~~~----------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
... .++...+.++.+||.+||.+||.+|||+.|+|.||||+.+..
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 000 123346789999999999999999999999999999988754
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=354.42 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=206.3
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHh--CCCCCeeEeeeeecccceEEEE
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAAL--GSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l--~~HpnIv~l~~~~~~~~~l~IV 307 (488)
|++++.||+|+||+||+|.+..+|..||||++..... .......+..|+.++..+ .+||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 6789999999999999999999999999999864321 122334566666665432 2799999999999999999999
Q ss_pred EecCCCCch-hhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCCCC
Q 011331 308 MELCDHSLS-DKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSLPI 382 (488)
Q Consensus 308 ~E~~~~~l~-~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~~~ 382 (488)
|||+.++.+ .......+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++.... .....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST 160 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccc
Confidence 999987644 34445679999999999999999999999999999999999999 67899999999987532 22234
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
..|++.|+|||++.+. .++.++|||||||++|||++|..||..... ...+.......+..++.++.++|.+||..|
T Consensus 161 ~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d 239 (324)
T cd05589 161 FCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRN 239 (324)
T ss_pred cccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 5699999999998765 567799999999999999999999876543 234455556667778999999999999999
Q ss_pred CCCCC-----CHHHHHhChhhhhhH
Q 011331 460 PVQRP-----SAKELVENPIFDKIQ 479 (488)
Q Consensus 460 P~~Rp-----Ta~elL~HP~f~~i~ 479 (488)
|.+|| ++.++++||||+.+.
T Consensus 240 P~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 240 PERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred HhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 99999 799999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=361.92 Aligned_cols=249 Identities=23% Similarity=0.343 Sum_probs=202.2
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.|++++.||+|+||+||+|.+..+++.||||++.... ........+..|+.++..+ +|+||+++++++.+.+.+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEE
Confidence 5889999999999999999999999999999986532 2233456688899999998 9999999999999999999999
Q ss_pred ecCCCCch-h-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC------
Q 011331 309 ELCDHSLS-D-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS------ 379 (488)
Q Consensus 309 E~~~~~l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~------ 379 (488)
||+.++.+ . ......+++..+..++.||+.||.|||+.||+||||||+|||| .++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99987543 3 2334568999999999999999999999999999999999999 6789999999997532100
Q ss_pred --------------------------------------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHH
Q 011331 380 --------------------------------------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMY 415 (488)
Q Consensus 380 --------------------------------------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~ 415 (488)
.....||+.|+|||++... .++.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhhHHH
Confidence 0123699999999998765 5778999999999999
Q ss_pred HHHcCCCCCCCchhh---hhhhc--CC--CCCCCCCcHHHHHHHHHccc--CCCCCCCCHHHHHhChhhhhhHH
Q 011331 416 ELIKGSPLSESGPQF---LNLRD--GK--LPLLPGHSLQFQNLLKVMVD--PDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 416 eLltG~~p~~~~~~~---~~i~~--~~--~~~~~~~s~~l~~lI~k~L~--~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
||++|.+||...... ..+.. .. .+....++.++.+||.+|+. .++..|++++++++||||+.+.+
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 999999999765432 22221 12 23333578999999999664 45556999999999999987643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=356.29 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=214.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
...|++++.||+|.-|+||+|..+.+++.+|+|++.+.... .....++..|-+||..+ +||.++.||..|+.+...|+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEE
Confidence 34678999999999999999999999999999999765333 34456788899999998 99999999999999999999
Q ss_pred EEecCCCCch----hhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---
Q 011331 307 QMELCDHSLS----DKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK--- 378 (488)
Q Consensus 307 V~E~~~~~l~----~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~--- 378 (488)
+||||.|+-+ +......+++..++.++..|+.||+|||-.|||+|||||+|||| .+|++.|+||.|+.....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 9999988733 34455679999999999999999999999999999999999999 899999999998743210
Q ss_pred ------------------------------C-C-------------------------CCCCCCCCccChhhhcccCCCC
Q 011331 379 ------------------------------S-L-------------------------PIEEGDARYMPQEILNEDYDHL 402 (488)
Q Consensus 379 ------------------------------~-~-------------------------~~~~Gt~~Y~APEvl~~~~~~~ 402 (488)
. . ...+||-.|+|||++.+. .++
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~-GHg 313 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE-GHG 313 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC-CCC
Confidence 0 0 012489999999999887 688
Q ss_pred chhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCC--CCCCCcHHHHHHHHHcccCCCCCCCC----HHHHHhCh
Q 011331 403 DKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLP--LLPGHSLQFQNLLKVMVDPDPVQRPS----AKELVENP 473 (488)
Q Consensus 403 ~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~--~~~~~s~~l~~lI~k~L~~dP~~RpT----a~elL~HP 473 (488)
.++|||+|||+||||+.|..||.+... +.++....+. ..+.++..+++||+++|.+||.+|.. |.||.+||
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHP 393 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCc
Confidence 899999999999999999999987654 4455544443 34466899999999999999999998 99999999
Q ss_pred hhhhhHHh
Q 011331 474 IFDKIQKH 481 (488)
Q Consensus 474 ~f~~i~~~ 481 (488)
||+++++.
T Consensus 394 FF~gVnWa 401 (459)
T KOG0610|consen 394 FFEGVNWA 401 (459)
T ss_pred cccCCChh
Confidence 99999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=358.31 Aligned_cols=239 Identities=28% Similarity=0.366 Sum_probs=201.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeE-EEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc-eEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCF-YAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE-QLYIQ 307 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~-vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~-~l~IV 307 (488)
++.+.+.||.|+||+||++.+. |.. ||||++............+.+|+.+|.++ +|||||+++|++.... .++||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCceEEE
Confidence 4456667999999999999985 666 99999976654555577899999999998 9999999999999888 79999
Q ss_pred EecCCCCchhhhh----cccCCHHHHHHHHHHHHHHHHHHHHcC-cccCCCCCCcEEE-eCC-eEEEEeecCceecCC--
Q 011331 308 MELCDHSLSDKKA----SQFFAEGEVLKALHQIAQALQFIHEKG-IAHLDVKPDNIYV-KNG-VYKLGDFGRATLLNK-- 378 (488)
Q Consensus 308 ~E~~~~~l~~~~~----~~~l~~~~~~~i~~qI~~gL~yLH~~g-IiHrDLKp~NILv-~~g-~vkL~DFGlA~~~~~-- 378 (488)
|||+.++.+.... ...++...++.++.||+.||.|||+++ ||||||||+|||| .++ ++||||||+++....
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999887555222 467999999999999999999999999 9999999999999 455 999999999987753
Q ss_pred -CCCCCCCCCCccChhhhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh----hhhcCCCC-CCCCCcHHHHHH
Q 011331 379 -SLPIEEGDARYMPQEILNE-DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL----NLRDGKLP-LLPGHSLQFQNL 451 (488)
Q Consensus 379 -~~~~~~Gt~~Y~APEvl~~-~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~----~i~~~~~~-~~~~~s~~l~~l 451 (488)
......||..|||||++.+ ...++.|+||||||++||||+||..||....... ...++..+ .+...+..+..+
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l 278 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSL 278 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence 3333679999999999985 2467889999999999999999999998766422 22344444 455589999999
Q ss_pred HHHcccCCCCCCCCHHHHHh
Q 011331 452 LKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~ 471 (488)
|..||..||..||++.+++.
T Consensus 279 ~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 279 MERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999986
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.24 Aligned_cols=242 Identities=23% Similarity=0.300 Sum_probs=198.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
..+|++++.||+|+||.||+|.+..+++.||||... ...+.+|+.+++.+ +||||++++++|..+...++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeEEE
Confidence 347999999999999999999999999999999643 23467899999999 999999999999999999999
Q ss_pred EecCCCCchhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC----CCC
Q 011331 308 MELCDHSLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK----SLP 381 (488)
Q Consensus 308 ~E~~~~~l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~----~~~ 381 (488)
||++.+.+... .....+++..++.++.||+.||.|||++|||||||||+|||| .++.+||+|||+|+.... ...
T Consensus 162 ~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 162 LPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 99998876653 334568999999999999999999999999999999999999 678999999999975422 122
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----------hhhhh-----------------
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----------FLNLR----------------- 434 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----------~~~i~----------------- 434 (488)
...||+.|+|||++... .++.++|||||||++|||++|..|+..... +..+.
T Consensus 242 ~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 242 GWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred cccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 34699999999998765 577899999999999999999876543210 00000
Q ss_pred ---------cCC--CC----C---CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 435 ---------DGK--LP----L---LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 435 ---------~~~--~~----~---~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
... .+ . ...++.++.+||.+||++||.+|||++|+|+||||+.+.
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 000 00 0 012456789999999999999999999999999998864
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=356.07 Aligned_cols=245 Identities=24% Similarity=0.352 Sum_probs=204.9
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||+|+||+||+|.+..+++.||||++++.... ......+..|+.++..+.+||||+++++++.+.+.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999999999999999999754322 233455778999999987899999999999999999999999987
Q ss_pred Cchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCCCCCCCCC
Q 011331 314 SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSLPIEEGDA 387 (488)
Q Consensus 314 ~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~~~~~Gt~ 387 (488)
+.+. ......+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++.... .......||.
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 6443 2344579999999999999999999999999999999999999 67899999999987431 2223456999
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch------------hhhhhhcCCCCCCCCCcHHHHHHHHHc
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP------------QFLNLRDGKLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~------------~~~~i~~~~~~~~~~~s~~l~~lI~k~ 455 (488)
.|+|||++.+. .++.++|||||||++|+|++|..||.... ....+.......+..++.++.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 239 (329)
T cd05588 161 NYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239 (329)
T ss_pred cccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 99999998765 57779999999999999999999985211 122344555667778899999999999
Q ss_pred ccCCCCCCCC------HHHHHhChhhhhhHH
Q 011331 456 VDPDPVQRPS------AKELVENPIFDKIQK 480 (488)
Q Consensus 456 L~~dP~~RpT------a~elL~HP~f~~i~~ 480 (488)
|..||.+|+| ++++++||||..+..
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 240 LNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred hccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 9999999987 799999999987644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=361.29 Aligned_cols=252 Identities=26% Similarity=0.458 Sum_probs=215.5
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.+...|.+.+.||+|.||+||+|..+.+|..||+|++.+.... ........+|+.+|.++..|||||.++++|++...+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 3445688999999999999999999999999999999765433 234567899999999996699999999999999999
Q ss_pred EEEEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-----CCeEEEEeecCceecCC
Q 011331 305 YIQMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-----NGVYKLGDFGRATLLNK 378 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-----~g~vkL~DFGlA~~~~~ 378 (488)
++|||+|.|+ |.+......+++..+..++.||+.|+.|||+.||+||||||+|+|+. ++.+|++|||+|.....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 9999999876 33322222499999999999999999999999999999999999992 24799999999998865
Q ss_pred --CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCC----CCCCCCcHHHH
Q 011331 379 --SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKL----PLLPGHSLQFQ 449 (488)
Q Consensus 379 --~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~----~~~~~~s~~l~ 449 (488)
.....+||+.|+|||++... .++..+||||+||++|.|++|.+||..... +..+..+.+ +.++.++..+.
T Consensus 192 ~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ak 270 (382)
T KOG0032|consen 192 GERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAK 270 (382)
T ss_pred CceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHH
Confidence 34556899999999999854 577899999999999999999999987654 334554433 45567799999
Q ss_pred HHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 450 NLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+||.+||..||.+|+|+.++|.|||++..
T Consensus 271 d~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 271 DFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=350.48 Aligned_cols=248 Identities=28% Similarity=0.367 Sum_probs=204.4
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||+||+|.+..+|..||+|++.... .......+.+|+.++..+ +||||+++++++..++.+++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEe
Confidence 57899999999999999999999999999999987542 334456788999999999 8999999999999999999999
Q ss_pred ecCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-CCCC
Q 011331 309 ELCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEK-GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-LPIE 383 (488)
Q Consensus 309 E~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~-gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-~~~~ 383 (488)
||++++.+. . .....+++..+..++.||+.||.|||+. +|+|+||||+|||+ .++.++|+|||++...... ....
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccC
Confidence 999876444 2 2335689999999999999999999986 69999999999999 6789999999999765432 2345
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh--hhhhh---------------------------
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ--FLNLR--------------------------- 434 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~--~~~i~--------------------------- 434 (488)
.|+..|+|||++.+. .++.++|||||||++|||++|..||..... +..+.
T Consensus 163 ~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (331)
T cd06649 163 VGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVS 241 (331)
T ss_pred CCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccccc
Confidence 689999999998765 577899999999999999999999864321 10000
Q ss_pred --------------------cCCCCC--CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 435 --------------------DGKLPL--LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 435 --------------------~~~~~~--~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
....+. ...++.++.+||.+||++||++|||++||++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 242 GHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 000111 113578999999999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=363.46 Aligned_cols=246 Identities=29% Similarity=0.446 Sum_probs=210.3
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
.|+.++.||+|+||.||+|.+..+++.||+|++.... ...+..+...|+.+|..+ +++||.++|+.+..+..+||+||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~-~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHHHHHH
Confidence 4677799999999999999999999999999997653 334567788999999999 89999999999999999999999
Q ss_pred cCCCC-chhhhhcc-cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCC
Q 011331 310 LCDHS-LSDKKASQ-FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIE 383 (488)
Q Consensus 310 ~~~~~-l~~~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~ 383 (488)
||+++ .+.....+ .+.+.++.-++++++.||.|||..+.||||||+.|||+ .+|.+||+|||.+..+... ..+.
T Consensus 92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tf 171 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTF 171 (467)
T ss_pred HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccc
Confidence 99886 34433333 45889999999999999999999999999999999999 6699999999999877543 2467
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hcCCCCCCC-CCcHHHHHHHHHcccCC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RDGKLPLLP-GHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~~~~~~~~-~~s~~l~~lI~k~L~~d 459 (488)
+||+.|||||++... .|..++||||||++.+||++|.+|+..-.++..+ .+...|... .++..+++||..||.+|
T Consensus 172 vGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~ 250 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKN 250 (467)
T ss_pred cccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcC
Confidence 899999999999864 6778999999999999999999998876664333 233333332 45888999999999999
Q ss_pred CCCCCCHHHHHhChhhhhh
Q 011331 460 PVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 460 P~~RpTa~elL~HP~f~~i 478 (488)
|+.||||.+||+|+|++..
T Consensus 251 P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 251 PEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred cccCcCHHHHhhhHHHHhc
Confidence 9999999999999999873
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=345.61 Aligned_cols=245 Identities=26% Similarity=0.382 Sum_probs=195.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC--CCCCeeEeeeeecc-----cc
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG--SHENIVGYYSSWFE-----NE 302 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~--~HpnIv~l~~~~~~-----~~ 302 (488)
+|++++.||+|+||+||+|.+..+|..||+|.+..............+|+.++..+. +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 478999999999999999999999999999998754332222234556777766653 69999999998764 34
Q ss_pred eEEEEEecCCCCchhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 303 QLYIQMELCDHSLSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
.++++|||+.+++..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 589999999987655332 2348999999999999999999999999999999999999 678999999999987643
Q ss_pred CC--CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhc------------------
Q 011331 379 SL--PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRD------------------ 435 (488)
Q Consensus 379 ~~--~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~------------------ 435 (488)
.. ....|+..|+|||++... .++.++|||||||++|+|++|.+||....... .+..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07863 161 QMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239 (288)
T ss_pred cccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence 22 234588999999998765 57789999999999999999999886543211 1100
Q ss_pred CC---------CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 436 GK---------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 436 ~~---------~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
.. ....+.++..+.++|.+||++||++|||+.|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 01224567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=357.93 Aligned_cols=247 Identities=24% Similarity=0.392 Sum_probs=203.7
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
..+|+.++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.++..+ +|+||+++++++..++.+|+|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEEE
Confidence 456788999999999999999999999999999986432 334456788999999999 899999999999999999999
Q ss_pred EecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCC
Q 011331 308 MELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIE 383 (488)
Q Consensus 308 ~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~ 383 (488)
|||++++.+.. .....+..+..++.||+.||.|||++||+||||||+|||| .++.+||+|||++..+... ....
T Consensus 151 ~e~~~~~~L~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 228 (353)
T PLN00034 151 LEFMDGGSLEG--THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228 (353)
T ss_pred EecCCCCcccc--cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccccc
Confidence 99998865432 2346678889999999999999999999999999999999 6789999999999876432 2345
Q ss_pred CCCCCccChhhhccc----CCCCchhHHHHHHHHHHHHHcCCCCCCCchh--hhh----h-hcCCCCCCCCCcHHHHHHH
Q 011331 384 EGDARYMPQEILNED----YDHLDKVDIFSLGATMYELIKGSPLSESGPQ--FLN----L-RDGKLPLLPGHSLQFQNLL 452 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~----~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~--~~~----i-~~~~~~~~~~~s~~l~~lI 452 (488)
.||..|+|||++... ...+.++|||||||++|||++|..||..... ... + .......+..++.++.+||
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 308 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFI 308 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHH
Confidence 699999999987432 2234589999999999999999999863221 111 1 1222334556789999999
Q ss_pred HHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 453 KVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.+||..||++|||+.|+|+||||.+-
T Consensus 309 ~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 309 SCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHccCChhhCcCHHHHhcCcccccC
Confidence 99999999999999999999999875
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=353.55 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=202.8
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||+|+||+||+|.+..+|..||||+++.... ..........|+.++..+.+||||+++++++.+++.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 369999999999999999999999999875421 1233455677888888776999999999999999999999999987
Q ss_pred Cchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCCCCCCCCC
Q 011331 314 SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSLPIEEGDA 387 (488)
Q Consensus 314 ~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~~~~~Gt~ 387 (488)
+.+. ......+++.++..++.||+.||+|||++||+||||||+|||+ .++.++|+|||+++... .......||+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 5433 2234568999999999999999999999999999999999999 67899999999987532 2233456999
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRP 464 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~Rp 464 (488)
.|+|||++.+. .++.++|||||||++|||++|..||..... ...+.......+..++.++.++|.+||+.||++||
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (316)
T cd05620 161 DYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRL 239 (316)
T ss_pred CccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 99999998765 577899999999999999999999876543 22334444555667899999999999999999999
Q ss_pred CH-HHHHhChhhhhhHH
Q 011331 465 SA-KELVENPIFDKIQK 480 (488)
Q Consensus 465 Ta-~elL~HP~f~~i~~ 480 (488)
++ +++++||||+.+..
T Consensus 240 ~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 240 GVVGNIRGHPFFKTINW 256 (316)
T ss_pred CChHHHHcCCCcCCCCH
Confidence 97 58999999988643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=352.62 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=202.6
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||+|+||+||+|.+..+++.||||+++.... ..........|..++..+.+||||+++++++..++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999875422 2233445667777887777999999999999999999999999987
Q ss_pred Cchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCCCCCCC
Q 011331 314 SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPIEEGDA 387 (488)
Q Consensus 314 ~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~~~Gt~ 387 (488)
+.+. ......+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.... ......||+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 6443 2234569999999999999999999999999999999999999 678999999999976422 223346899
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRP 464 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~Rp 464 (488)
.|+|||++.+. .++.++|||||||++|||++|..||..... ...+.......+..++.++.++|.+||..||.+||
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~ 239 (316)
T cd05592 161 DYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRL 239 (316)
T ss_pred cccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 99999998765 577899999999999999999999876543 22334444556667899999999999999999999
Q ss_pred CH-HHHHhChhhhhhHH
Q 011331 465 SA-KELVENPIFDKIQK 480 (488)
Q Consensus 465 Ta-~elL~HP~f~~i~~ 480 (488)
++ .++++||||..+.+
T Consensus 240 ~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 240 GVDGDIRQHPFFRGIDW 256 (316)
T ss_pred CChHHHHcCcccCCCCH
Confidence 86 58999999988753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=362.04 Aligned_cols=247 Identities=24% Similarity=0.366 Sum_probs=202.4
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
+|.+++.||+|+||+||+|.+..+++.||||++..... .......+..|+.+++.+ +|+||+++++.|.+++.+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEE
Confidence 58999999999999999999999999999999864321 223345678899999998 9999999999999999999999
Q ss_pred ecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC-------
Q 011331 309 ELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK------- 378 (488)
Q Consensus 309 E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~------- 378 (488)
|||.++ +... .....+++..+..++.||+.||.|||++||+||||||+|||+ .+|.+||+|||+|+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999876 3332 233568999999999999999999999999999999999999 679999999999753210
Q ss_pred -------------------------------------------CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHH
Q 011331 379 -------------------------------------------SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMY 415 (488)
Q Consensus 379 -------------------------------------------~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~ 415 (488)
......||+.|+|||++... .++.++|||||||+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEechHHHH
Confidence 00123589999999998765 5778999999999999
Q ss_pred HHHcCCCCCCCchhhh---hhhc--C--CCCCCCCCcHHHHHHHHHcccCCCCCCCC---HHHHHhChhhhhhH
Q 011331 416 ELIKGSPLSESGPQFL---NLRD--G--KLPLLPGHSLQFQNLLKVMVDPDPVQRPS---AKELVENPIFDKIQ 479 (488)
Q Consensus 416 eLltG~~p~~~~~~~~---~i~~--~--~~~~~~~~s~~l~~lI~k~L~~dP~~RpT---a~elL~HP~f~~i~ 479 (488)
||++|.+||....... .+.. . ..+....++.++.++|.+|+ .+|.+|++ ++|+++||||+.+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 9999999998654422 2222 1 22333457899999999976 59999987 99999999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=356.57 Aligned_cols=243 Identities=26% Similarity=0.363 Sum_probs=204.0
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||+|+||+||+|.+..+|..||+|++..... ..........|+.++..+ +||||+++++++..++.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 369999999999999999999999999875422 223345677889989888 899999999999999999999999987
Q ss_pred Cchh--hhhcccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCCCCCC
Q 011331 314 SLSD--KKASQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPIEEGD 386 (488)
Q Consensus 314 ~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~~~Gt 386 (488)
+.+. ......+++..++.++.||+.||.|||+ .||+||||||+|||+ .++.+||+|||++..... ......||
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 159 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence 6443 2234568999999999999999999997 799999999999999 678999999999875422 22334699
Q ss_pred CCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCC
Q 011331 387 ARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQR 463 (488)
Q Consensus 387 ~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~R 463 (488)
+.|+|||++.+. .++.++|||||||++|||++|..||..... ...+.......+..++.++.+||.+||+.||++|
T Consensus 160 ~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 238 (325)
T cd05594 160 PEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQR 238 (325)
T ss_pred cccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHh
Confidence 999999998765 577899999999999999999999876543 2333445566677889999999999999999999
Q ss_pred C-----CHHHHHhChhhhhhH
Q 011331 464 P-----SAKELVENPIFDKIQ 479 (488)
Q Consensus 464 p-----Ta~elL~HP~f~~i~ 479 (488)
+ ++.++++||||..+.
T Consensus 239 ~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 239 LGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred CCCCCCCHHHHhcCCCcCCCC
Confidence 7 999999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=362.56 Aligned_cols=247 Identities=25% Similarity=0.342 Sum_probs=202.3
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
+|++++.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.++..+ +|+||+++++.|.+++.+||||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999864321 122345577899999998 9999999999999999999999
Q ss_pred ecCCCCch-hh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC-------
Q 011331 309 ELCDHSLS-DK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK------- 378 (488)
Q Consensus 309 E~~~~~l~-~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~------- 378 (488)
|||+++.+ .. .....+++..++.++.||+.||+|||++||+||||||+|||+ .++.++|+|||+|..+..
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99987643 33 334568899999999999999999999999999999999999 678999999999753210
Q ss_pred ---------------------------------------CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc
Q 011331 379 ---------------------------------------SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK 419 (488)
Q Consensus 379 ---------------------------------------~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt 419 (488)
......||+.|+|||++... .++.++|||||||+||||++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceeeehhh
Confidence 00123699999999998765 57789999999999999999
Q ss_pred CCCCCCCchhhh---hhhcC----CCCCCCCCcHHHHHHHHHcccCCCCCCC---CHHHHHhChhhhhhH
Q 011331 420 GSPLSESGPQFL---NLRDG----KLPLLPGHSLQFQNLLKVMVDPDPVQRP---SAKELVENPIFDKIQ 479 (488)
Q Consensus 420 G~~p~~~~~~~~---~i~~~----~~~~~~~~s~~l~~lI~k~L~~dP~~Rp---Ta~elL~HP~f~~i~ 479 (488)
|..||....... .+... ..+....++.++.++|.+|+ .+|.+|+ |+.|+++||||+.+.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 999997654422 22211 22333467899999999976 5999999 999999999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=351.68 Aligned_cols=251 Identities=29% Similarity=0.447 Sum_probs=208.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCC-eeEeeeeecccc----
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN-IVGYYSSWFENE---- 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hpn-Iv~l~~~~~~~~---- 302 (488)
...|..+++||+|.||+||+|+.+.+|..||+|+++.....+.-...+.+|+.+|..+ +|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccc
Confidence 3457778889999999999999999999999999875433222345688999999999 8999 999999998877
Q ss_pred --eEEEEEecCCCCchhhhhc-----ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCce
Q 011331 303 --QLYIQMELCDHSLSDKKAS-----QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRAT 374 (488)
Q Consensus 303 --~l~IV~E~~~~~l~~~~~~-----~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~ 374 (488)
.+++||||++..+...... ..++...+..++.||+.||+|||++||+||||||+|||| .+|.+||+|||+|+
T Consensus 89 ~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 89 IGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred cceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 8999999999876652221 357788999999999999999999999999999999999 67999999999998
Q ss_pred ecC---CCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc----------------
Q 011331 375 LLN---KSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD---------------- 435 (488)
Q Consensus 375 ~~~---~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~---------------- 435 (488)
... ......++|.+|+|||++.+...|++.+||||+||+++||+++.++|.+......+..
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 664 2345667999999999999887788999999999999999999999887654332210
Q ss_pred -----CCCCCC------------CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 436 -----GKLPLL------------PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 436 -----~~~~~~------------~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
...+++ +..+.+..+++.+||+.+|.+|.||+.+|+||||+.+.
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 011111 12234788999999999999999999999999999874
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.57 Aligned_cols=245 Identities=27% Similarity=0.402 Sum_probs=203.5
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc-----eE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE-----QL 304 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~-----~l 304 (488)
.|...+.+|.|+||.||.|....+++.||||.+-.. . +-..+|+++|..+ .|||||+|..+|.... .+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~--r~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----K--RYKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC----C--CcCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHH
Confidence 578899999999999999999999999999987422 1 1234689999987 9999999988876422 34
Q ss_pred EEEEecCCCCchhhhh-----cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE--eCCeEEEEeecCceecC
Q 011331 305 YIQMELCDHSLSDKKA-----SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV--KNGVYKLGDFGRATLLN 377 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv--~~g~vkL~DFGlA~~~~ 377 (488)
.+||||++.++....+ +..++.-.++-++.||++||.|||+.||+||||||.|||| +.|.+||||||.|+.+.
T Consensus 98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 5899999999887554 5679999999999999999999999999999999999999 46999999999999886
Q ss_pred CCCCCC--CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhc--------------C--
Q 011331 378 KSLPIE--EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRD--------------G-- 436 (488)
Q Consensus 378 ~~~~~~--~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~--------------~-- 436 (488)
...+.. .-|..|+|||.+.+...|+.+.||||.||++.||+.|.+.|.+.... ..+.+ .
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 554432 35789999999998888999999999999999999999998865331 11110 0
Q ss_pred ---CCC----------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHh
Q 011331 437 ---KLP----------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481 (488)
Q Consensus 437 ---~~~----------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~ 481 (488)
..+ .....+.++.+|+.++|.++|.+|.++.|++.||||+.++..
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 000 233467899999999999999999999999999999998753
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=343.38 Aligned_cols=248 Identities=21% Similarity=0.315 Sum_probs=206.4
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.|++++.||+|+||+||++.+..+++.||||++....... .....+..|+.+++.+ +|+||+.+++.+...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEE
Confidence 3789999999999999999999899999999986432222 2234567899999999 8999999999999999999999
Q ss_pred ecCCCCchh-hh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CC
Q 011331 309 ELCDHSLSD-KK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LP 381 (488)
Q Consensus 309 E~~~~~l~~-~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~ 381 (488)
||+.++.+. .. ....+++..+..++.||+.||.|||+.||+|+||||+||++ +++.++|+|||++...... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence 999876443 22 22458999999999999999999999999999999999999 5689999999999876432 22
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh-------hhhhcCCCCCCCCCcHHHHHHHHH
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF-------LNLRDGKLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~-------~~i~~~~~~~~~~~s~~l~~lI~k 454 (488)
...|+..|+|||++... .++.++||||+||++|||++|..||...... ..+.......+..++..+.+||.+
T Consensus 160 ~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 160 GRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred cccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHH
Confidence 34689999999998765 5778999999999999999999999764321 122333444556789999999999
Q ss_pred cccCCCCCCC-----CHHHHHhChhhhhhH
Q 011331 455 MVDPDPVQRP-----SAKELVENPIFDKIQ 479 (488)
Q Consensus 455 ~L~~dP~~Rp-----Ta~elL~HP~f~~i~ 479 (488)
||..||.+|| +++++++||||....
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 9999999999 999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=355.89 Aligned_cols=250 Identities=26% Similarity=0.344 Sum_probs=205.0
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++.+.||+|+||+||+|.+..+|+.||||+++.... .......+..|+.++..+ +|+||+++++++.+.+.+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEE
Confidence 368999999999999999999999999999999875432 122334566788888777 999999999999999999999
Q ss_pred EecCCCCchh-hhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---
Q 011331 308 MELCDHSLSD-KKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL--- 380 (488)
Q Consensus 308 ~E~~~~~l~~-~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~--- 380 (488)
|||++++.+. .... ..+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999775443 3222 468999999999999999999999999999999999999 67899999999998764322
Q ss_pred -CCCCCCCCccChhhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcC----CCCCCCCCcHH
Q 011331 381 -PIEEGDARYMPQEILNE-----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDG----KLPLLPGHSLQ 447 (488)
Q Consensus 381 -~~~~Gt~~Y~APEvl~~-----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~----~~~~~~~~s~~ 447 (488)
....||+.|+|||++.. ...++.++|||||||++|||++|..||...... ..+... ..+..+.++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 22368999999999863 234667999999999999999999999765432 222221 23344467899
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+.+||.+||. +|.+|||+++++.||||+.+..
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 9999999998 9999999999999999998654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=351.35 Aligned_cols=245 Identities=25% Similarity=0.363 Sum_probs=205.0
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||+|+||+||+|.+..++..||||++.+... ..........|+.++..+.+||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999875422 2233455678888888887899999999999999999999999987
Q ss_pred Cchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCCCCCCCCC
Q 011331 314 SLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSLPIEEGDA 387 (488)
Q Consensus 314 ~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~~~~~Gt~ 387 (488)
+.+. . .....+++..+..++.||+.||.|||++||+|+||||+|||+ .++.++|+|||+++... .......|++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 6443 2 233469999999999999999999999999999999999999 67899999999987532 1223346899
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRP 464 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~Rp 464 (488)
.|+|||++.+. .++.++|||||||++|+|++|..||..... ...+.......+..++.++.+||.+||..||.+||
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (318)
T cd05570 161 DYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239 (318)
T ss_pred cccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcC
Confidence 99999998765 577899999999999999999999875443 23344455556667899999999999999999999
Q ss_pred CH-----HHHHhChhhhhhHH
Q 011331 465 SA-----KELVENPIFDKIQK 480 (488)
Q Consensus 465 Ta-----~elL~HP~f~~i~~ 480 (488)
|+ .++++||||+.+.+
T Consensus 240 s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 240 GCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CCCCCCHHHHhcCCCcCCCCH
Confidence 99 99999999988643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=355.60 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=203.5
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc-----
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN----- 301 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~----- 301 (488)
..++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.+ +||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccc
Confidence 45789999999999999999999999999999999876544445566788899999998 899999999887643
Q ss_pred -ceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 302 -EQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 302 -~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
..+|+||||+++++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++..+..
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 3579999999988766443 458889999999999999999999999999999999999 6789999999999876543
Q ss_pred C--CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hc-------------------
Q 011331 380 L--PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RD------------------- 435 (488)
Q Consensus 380 ~--~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~------------------- 435 (488)
. ....||..|+|||++.+. .++.++|||||||++|+|++|..||........+ ..
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258 (364)
T ss_pred CcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence 2 334689999999998765 5778999999999999999999998754321110 00
Q ss_pred ---CC----------------CC----CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 436 ---GK----------------LP----LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 436 ---~~----------------~~----~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
.. .+ .....+.++++||.+||+.||.+|||++|+|+||||+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00 00 00112467899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=360.62 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=196.0
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHh-----CCCCCeeEeeeeecc
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAAL-----GSHENIVGYYSSWFE 300 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l-----~~HpnIv~l~~~~~~ 300 (488)
....+|++++.||+|+||+||+|.+..+++.||||+++.. .........|++++..+ ..|.+|+.++++|..
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3456899999999999999999999999999999998642 12223345566666665 134568899888875
Q ss_pred c-ceEEEEEecCCCCchhh-hhcccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEe-CC-------------
Q 011331 301 N-EQLYIQMELCDHSLSDK-KASQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYVK-NG------------- 363 (488)
Q Consensus 301 ~-~~l~IV~E~~~~~l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv~-~g------------- 363 (488)
. +++|||||++++.+... ...+.+++..++.++.||+.||.|||+ .|||||||||+|||++ ++
T Consensus 203 ~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 203 ETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 4 57899999998877663 344579999999999999999999997 5999999999999994 33
Q ss_pred ---eEEEEeecCceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc--
Q 011331 364 ---VYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD-- 435 (488)
Q Consensus 364 ---~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~-- 435 (488)
.+||+|||++...........||+.|+|||++.+. .++.++|||||||+||||++|++||........ +..
T Consensus 283 ~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361 (467)
T ss_pred CCceEEECCCCccccCccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence 49999999987655555567899999999998765 577899999999999999999999976433111 000
Q ss_pred CCCC------------------------C-C---------------CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 436 GKLP------------------------L-L---------------PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 436 ~~~~------------------------~-~---------------~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
+.++ . . ......+.+||.+||++||.+|||++|+|+||||
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~ 441 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV 441 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence 0000 0 0 0013557899999999999999999999999999
Q ss_pred hhhH
Q 011331 476 DKIQ 479 (488)
Q Consensus 476 ~~i~ 479 (488)
+...
T Consensus 442 ~~~~ 445 (467)
T PTZ00284 442 LKYY 445 (467)
T ss_pred cccC
Confidence 8753
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=350.61 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=209.4
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
+|+..+.||+|+||+||+|.+..+|+.||||++.+... ..........|+.++..+.+|++|+.+++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47889999999999999999999999999999865322 22334567788888888867788999999999999999999
Q ss_pred ecCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCC
Q 011331 309 ELCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPI 382 (488)
Q Consensus 309 E~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~ 382 (488)
||++++.+. . .....+++..++.++.||+.||.|||++||+||||||+|||+ .++.++|+|||++..... ....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 999876433 2 233569999999999999999999999999999999999999 678999999999875422 1223
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
..||+.|+|||++... .++.++|||||||++|||++|.+||..... ...+.......+...+.++.+++.+||+.+
T Consensus 161 ~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 239 (323)
T cd05615 161 FCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKH 239 (323)
T ss_pred ccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccC
Confidence 4589999999998765 577899999999999999999999876543 234455566677788999999999999999
Q ss_pred CCCCCC-----HHHHHhChhhhhhHH
Q 011331 460 PVQRPS-----AKELVENPIFDKIQK 480 (488)
Q Consensus 460 P~~RpT-----a~elL~HP~f~~i~~ 480 (488)
|.+|++ .+++++||||+.+..
T Consensus 240 p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 240 PSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred HhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 999997 589999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=353.91 Aligned_cols=244 Identities=23% Similarity=0.353 Sum_probs=203.9
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||+|+||+||+|.+..+++.||+|++.+.... ......+..|+.++..+.+||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999999999999999998764322 234455778888888887899999999999999999999999987
Q ss_pred Cchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCCCCCCCCC
Q 011331 314 SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSLPIEEGDA 387 (488)
Q Consensus 314 ~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~~~~~Gt~ 387 (488)
+.+. ......+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++... .......||.
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 6443 2334579999999999999999999999999999999999999 67899999999987532 1223456999
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch------------hhhhhhcCCCCCCCCCcHHHHHHHHHc
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP------------QFLNLRDGKLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~------------~~~~i~~~~~~~~~~~s~~l~~lI~k~ 455 (488)
.|+|||++.+. .++.++|||||||++|||++|..||.... ....+.......+...+.++.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~ 239 (329)
T cd05618 161 NYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239 (329)
T ss_pred cccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 99999998765 57789999999999999999999985210 112234455667778899999999999
Q ss_pred ccCCCCCCCC------HHHHHhChhhhhhH
Q 011331 456 VDPDPVQRPS------AKELVENPIFDKIQ 479 (488)
Q Consensus 456 L~~dP~~RpT------a~elL~HP~f~~i~ 479 (488)
|..||.+||+ +.++++||||+.+.
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 240 LNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred hcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 9999999998 58999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=341.60 Aligned_cols=243 Identities=22% Similarity=0.324 Sum_probs=201.1
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCCc
Q 011331 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSL 315 (488)
Q Consensus 237 LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~l 315 (488)
||+|+||+||+|.+..+|+.||+|++...... ......+..|+.++..+ +|+||+++++++..+..+|+||||++++.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 79999999999999999999999998643221 12334567899999998 99999999999999999999999998764
Q ss_pred hh-hh-----hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---CCCCC
Q 011331 316 SD-KK-----ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---PIEEG 385 (488)
Q Consensus 316 ~~-~~-----~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---~~~~G 385 (488)
+. .. ....+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++....... ....|
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence 43 21 23468999999999999999999999999999999999999 67899999999997664322 23468
Q ss_pred CCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-------hhhhhcCCCCCCCCCcHHHHHHHHHcccC
Q 011331 386 DARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-------FLNLRDGKLPLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 386 t~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~~~i~~~~~~~~~~~s~~l~~lI~k~L~~ 458 (488)
|+.|+|||++.+. .++.++|||||||++|||++|..||..... ...+.......++.++.++.+++.+||+.
T Consensus 160 ~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 160 TPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred CcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcC
Confidence 9999999999765 577899999999999999999999865322 11222334455667899999999999999
Q ss_pred CCCCCC-----CHHHHHhChhhhhhHHh
Q 011331 459 DPVQRP-----SAKELVENPIFDKIQKH 481 (488)
Q Consensus 459 dP~~Rp-----Ta~elL~HP~f~~i~~~ 481 (488)
||++|| +++++++||||+.+.+.
T Consensus 239 ~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred CHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 999999 88999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=357.79 Aligned_cols=251 Identities=25% Similarity=0.326 Sum_probs=207.7
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..++..||+|++.+.. ........+..|+.++..+ +||||+++++++.+.+.+||
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEE
Confidence 458999999999999999999999999999999986431 1222334567789999988 99999999999999999999
Q ss_pred EEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----C
Q 011331 307 QMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----L 380 (488)
Q Consensus 307 V~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----~ 380 (488)
||||+.++ |........+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||++...... .
T Consensus 121 v~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~ 200 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccC
Confidence 99999775 4445555568999999999999999999999999999999999999 6799999999999876432 1
Q ss_pred CCCCCCCCccChhhhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcC--CC--CCCCCCcHHHHH
Q 011331 381 PIEEGDARYMPQEILNED---YDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDG--KL--PLLPGHSLQFQN 450 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~---~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~--~~--~~~~~~s~~l~~ 450 (488)
....||+.|+|||++... ..++.++|||||||++|||++|.+||..... +..+... .. +....++.++.+
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 280 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKD 280 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHH
Confidence 235699999999998643 2366799999999999999999999876543 2333322 22 233357999999
Q ss_pred HHHHcccCCCCC--CCCHHHHHhChhhhhhH
Q 011331 451 LLKVMVDPDPVQ--RPSAKELVENPIFDKIQ 479 (488)
Q Consensus 451 lI~k~L~~dP~~--RpTa~elL~HP~f~~i~ 479 (488)
||.+||..+|.+ |+|++|+++||||+...
T Consensus 281 li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 281 LICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred HHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 999999999988 99999999999998643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=350.86 Aligned_cols=242 Identities=29% Similarity=0.423 Sum_probs=202.7
Q ss_pred EEecccCcEEEEEEEEc---CCCeEEEEEEeccCCC--chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 235 EQIGAGNFSHVFKVLKR---IDGCFYAVKHSKRQLH--HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~---~~g~~vAvK~l~~~~~--~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+.||+|+||+||+|.+. .+++.||||++..... .......+..|+.++..+ +||||+++++++..++.+|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEEe
Confidence 57999999999999864 4689999999864321 122334567899999999 89999999999999999999999
Q ss_pred cCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCCC
Q 011331 310 LCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPIE 383 (488)
Q Consensus 310 ~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~~ 383 (488)
|+.++.+. ......+.+..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.... .....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 99876443 2334568889999999999999999999999999999999999 678999999999875422 12234
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDP 460 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP 460 (488)
.|++.|+|||++... .++.++|||||||++|||++|..||..... ...+..+....++.++.++.+||.+||+.||
T Consensus 161 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 239 (323)
T cd05584 161 CGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNP 239 (323)
T ss_pred CCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 699999999998765 567799999999999999999999876543 3345566777788889999999999999999
Q ss_pred CCCC-----CHHHHHhChhhhhh
Q 011331 461 VQRP-----SAKELVENPIFDKI 478 (488)
Q Consensus 461 ~~Rp-----Ta~elL~HP~f~~i 478 (488)
++|| +++++++||||...
T Consensus 240 ~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 240 SSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred hHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999 89999999999765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=338.80 Aligned_cols=245 Identities=29% Similarity=0.411 Sum_probs=201.4
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++++.||.|++|+||+|.+..+|..||||++............+..|+.++..+ +||||+++++++.+++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEEe
Confidence 47899999999999999999999999999999865433333345677899999999 89999999999999999999999
Q ss_pred cCCCCchhhhh----cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CC
Q 011331 310 LCDHSLSDKKA----SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LP 381 (488)
Q Consensus 310 ~~~~~l~~~~~----~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~ 381 (488)
|+.+++..... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++...... ..
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 99876654322 2468999999999999999999999999999999999999 6789999999999765432 12
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh---------------------c-----
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR---------------------D----- 435 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~---------------------~----- 435 (488)
...+++.|+|||++.+...++.++|||||||++|+|++|.+||.......... .
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 34578899999998765456779999999999999999999987543211100 0
Q ss_pred -----C-CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 436 -----G-KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 436 -----~-~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
. .......++.++.++|.+||..||.+|||+.+|++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 001123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=349.77 Aligned_cols=245 Identities=24% Similarity=0.333 Sum_probs=202.3
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||+|+||+||+|.+..+++.||||++..... ..........|..++..+.+||||+++++++.+.+.+||||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999999999999999875421 1233445677888888767999999999999999999999999987
Q ss_pred Cch-hhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCCCCCCCCC
Q 011331 314 SLS-DKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSLPIEEGDA 387 (488)
Q Consensus 314 ~l~-~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~~~~~Gt~ 387 (488)
+.+ ... ....+++..+..++.||+.||.|||++||+||||||+|||+ .++.++|+|||++.... .......||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 544 332 23468999999999999999999999999999999999999 67899999999987532 1223346899
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRP 464 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~Rp 464 (488)
.|+|||++.+. .++.++|||||||++|||++|..||..... ...+.......+..++.++.++|.+||+.||.+||
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 239 (316)
T cd05619 161 DYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRL 239 (316)
T ss_pred cccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcC
Confidence 99999998765 577899999999999999999999876543 22333444445567899999999999999999999
Q ss_pred CHH-HHHhChhhhhhHH
Q 011331 465 SAK-ELVENPIFDKIQK 480 (488)
Q Consensus 465 Ta~-elL~HP~f~~i~~ 480 (488)
++. +++.||||+.+..
T Consensus 240 ~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 240 GVKGDIRQHPFFREIDW 256 (316)
T ss_pred CChHHHHcCcccCCCCH
Confidence 996 9999999988643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=351.85 Aligned_cols=244 Identities=27% Similarity=0.387 Sum_probs=201.5
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||+|+||+||+|.+..+|+.||||++..... .......++.|+.++.+..+||||+++++.+...+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 369999999999999999999999999864321 2223345566666554434999999999999999999999999987
Q ss_pred Cchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCCCCCCC
Q 011331 314 SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPIEEGDA 387 (488)
Q Consensus 314 ~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~~~Gt~ 387 (488)
+.+. ......+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||++..... ......||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 6443 2334568999999999999999999999999999999999999 678999999999875422 223346899
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRP 464 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~Rp 464 (488)
.|+|||++.+. .++.++|||||||++|||++|..||..... ...+.......++..+.++.++|.+||+.||.+||
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (323)
T cd05575 161 EYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL 239 (323)
T ss_pred hhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCC
Confidence 99999998765 577899999999999999999999876533 33455566677778899999999999999999999
Q ss_pred CH----HHHHhChhhhhhH
Q 011331 465 SA----KELVENPIFDKIQ 479 (488)
Q Consensus 465 Ta----~elL~HP~f~~i~ 479 (488)
++ .++++||||..+.
T Consensus 240 ~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 240 GAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred CCCCCHHHHHcCCCcCCCC
Confidence 87 6999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=355.73 Aligned_cols=249 Identities=25% Similarity=0.357 Sum_probs=203.5
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++++.||+|+||+||+|.+..+|+.||||++.... ........+..|+.++..+ +|+||+++++.+.+.+.+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 36899999999999999999999999999999986432 1222345577799999998 999999999999999999999
Q ss_pred EecCCCCch-hh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-----
Q 011331 308 MELCDHSLS-DK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----- 379 (488)
Q Consensus 308 ~E~~~~~l~-~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----- 379 (488)
|||+.++.+ .. .....+++..++.++.||+.||.|||++||+||||||+|||| .+|.++|+|||++..+...
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 999987643 33 334568999999999999999999999999999999999999 6799999999998654211
Q ss_pred ---------------------------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 011331 380 ---------------------------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSES 426 (488)
Q Consensus 380 ---------------------------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~ 426 (488)
....+||+.|+|||++.+. .++.++|||||||++|||++|.+||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccCCCCCCC
Confidence 0123699999999998765 577899999999999999999999976
Q ss_pred chhh---hhhhc--CCCCCCC--CCcHHHHHHHHHcccCCCCCCC---CHHHHHhChhhhhhHH
Q 011331 427 GPQF---LNLRD--GKLPLLP--GHSLQFQNLLKVMVDPDPVQRP---SAKELVENPIFDKIQK 480 (488)
Q Consensus 427 ~~~~---~~i~~--~~~~~~~--~~s~~l~~lI~k~L~~dP~~Rp---Ta~elL~HP~f~~i~~ 480 (488)
.... ..+.. .....++ ..+.++.++|.+|+ .||.+|+ +++|+++||||+++.+
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 239 ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 5442 22332 1222333 36889999999987 4999998 5899999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=340.78 Aligned_cols=245 Identities=27% Similarity=0.409 Sum_probs=200.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++++.||+|+||+||+|.+..+|..||+|++............+..|+.+++.+ +|+||+++++++.+.+.+|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEEe
Confidence 47899999999999999999999999999999865433333334567799999999 89999999999999999999999
Q ss_pred cCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCC
Q 011331 310 LCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIE 383 (488)
Q Consensus 310 ~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~ 383 (488)
|+++++..... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++...... ....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 99988766432 3568999999999999999999999999999999999999 6789999999999765432 2234
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh----hhhh------------------c-CC---
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF----LNLR------------------D-GK--- 437 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~----~~i~------------------~-~~--- 437 (488)
.++..|+|||++.+...++.++|||||||++|+|++|..|+...... ..+. . ..
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence 57889999999876545678999999999999999998775432211 0000 0 00
Q ss_pred -------CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 438 -------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 438 -------~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
....+.++.++.++|.+||+.||.+|||++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 01123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=355.99 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=204.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+..|+.++..+ +||||+++++++.+++.+|+
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEE
Confidence 457999999999999999999999999999999986421 1222334566788888887 99999999999999999999
Q ss_pred EEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC----
Q 011331 307 QMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---- 380 (488)
Q Consensus 307 V~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---- 380 (488)
||||+.++ |........+++..+..++.||+.||+|||++||+||||||+|||+ .++.+||+|||+|.......
T Consensus 121 v~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~ 200 (370)
T cd05621 121 VMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceec
Confidence 99999775 5555555578999999999999999999999999999999999999 67999999999998764321
Q ss_pred CCCCCCCCccChhhhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcC--CCCCC--CCCcHHHHH
Q 011331 381 PIEEGDARYMPQEILNED---YDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDG--KLPLL--PGHSLQFQN 450 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~---~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~--~~~~~--~~~s~~l~~ 450 (488)
....||+.|+|||++... ..++.++|||||||+||||++|..||..... +..+... ....+ ..++..+.+
T Consensus 201 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~ 280 (370)
T cd05621 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKN 280 (370)
T ss_pred ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHH
Confidence 245699999999998653 1366799999999999999999999976543 2233321 22333 346899999
Q ss_pred HHHHcccCCCCC--CCCHHHHHhChhhhhh
Q 011331 451 LLKVMVDPDPVQ--RPSAKELVENPIFDKI 478 (488)
Q Consensus 451 lI~k~L~~dP~~--RpTa~elL~HP~f~~i 478 (488)
+|.+||..++.+ |+|+.|+++||||+..
T Consensus 281 li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 281 LICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999865544 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.63 Aligned_cols=243 Identities=28% Similarity=0.409 Sum_probs=203.8
Q ss_pred EEecccCcEEEEEEEEc---CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecC
Q 011331 235 EQIGAGNFSHVFKVLKR---IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELC 311 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~---~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~ 311 (488)
+.||+|+||+||++.+. .+|..||+|++...............|+.++.++ +||||+++++++..++.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcCC
Confidence 57999999999999763 5789999999875433333445677899999999 8999999999999999999999999
Q ss_pred CCCch-hh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCCCC
Q 011331 312 DHSLS-DK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIEEG 385 (488)
Q Consensus 312 ~~~l~-~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~~G 385 (488)
.++.+ .. .....+++..++.++.||+.||.|||++||+||||||+|||+ .++.++|+|||++...... .....|
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 87543 32 234568999999999999999999999999999999999999 6789999999999765332 223468
Q ss_pred CCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCC
Q 011331 386 DARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQ 462 (488)
Q Consensus 386 t~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~ 462 (488)
++.|+|||++... .++.++|||||||++|||++|..||..... ...+.......+..++.++.++|.+||+.||++
T Consensus 161 ~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~ 239 (318)
T cd05582 161 TVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPAN 239 (318)
T ss_pred ChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhH
Confidence 9999999998765 567799999999999999999999876543 233445566677788999999999999999999
Q ss_pred CCC-----HHHHHhChhhhhhH
Q 011331 463 RPS-----AKELVENPIFDKIQ 479 (488)
Q Consensus 463 RpT-----a~elL~HP~f~~i~ 479 (488)
||+ +.+++.||||+.+.
T Consensus 240 R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 240 RLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred cCCCCCCCHHHHhCCCCcCCCC
Confidence 999 78899999998763
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=347.88 Aligned_cols=245 Identities=24% Similarity=0.336 Sum_probs=204.5
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||+|+||+||+|.+..+++.||+|++.+.... ......+..|+.++.++.+||||+.+++++...+.+||||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999999999999999998754322 233456778999999987899999999999999999999999987
Q ss_pred Cchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCCCCCCCCC
Q 011331 314 SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSLPIEEGDA 387 (488)
Q Consensus 314 ~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~~~~~Gt~ 387 (488)
+.+. ......+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++.... .......||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 6443 2334579999999999999999999999999999999999999 67899999999987532 2233456999
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch----------hhhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP----------QFLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~----------~~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
.|+|||++.+. .++.++|||||||+||||++|..||.... ....+.......+..++..+.++|.+||.
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 239 (327)
T cd05617 161 NYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239 (327)
T ss_pred ccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 99999998765 57789999999999999999999985311 12233444556677789999999999999
Q ss_pred CCCCCCCC------HHHHHhChhhhhhHH
Q 011331 458 PDPVQRPS------AKELVENPIFDKIQK 480 (488)
Q Consensus 458 ~dP~~RpT------a~elL~HP~f~~i~~ 480 (488)
.||.+|++ +.++++||||+.+.+
T Consensus 240 ~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 240 KDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred cCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 99999998 579999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=341.61 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=205.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||.|+||.||+|.+..++..||+|.+..... ......+..|+.+++.+ +|+||+++++++...+.+|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEEE
Confidence 4578999999999999999999999999999999864322 12234567899999999 999999999999999999999
Q ss_pred EecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CC
Q 011331 308 MELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LP 381 (488)
Q Consensus 308 ~E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~ 381 (488)
|||+++++..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.++|+|||++...... ..
T Consensus 83 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (301)
T cd07873 83 FEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162 (301)
T ss_pred EeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence 9999987665332 3458899999999999999999999999999999999999 6789999999998765322 22
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh------h------------------cCC
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL------R------------------DGK 437 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i------~------------------~~~ 437 (488)
...+++.|+|||++.+...++.++|||||||++|||++|.+||........+ . ...
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence 3457889999999876556778999999999999999999998754321100 0 000
Q ss_pred CC---------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 438 LP---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 438 ~~---------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
.+ ..+.++.++.+||.+||..||.+|||++|+++||||+.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 01 12346788999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=332.06 Aligned_cols=244 Identities=35% Similarity=0.550 Sum_probs=203.4
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEec
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMEL 310 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~ 310 (488)
|++++.||+|+||+||+|.+..+++.||+|++...............|+.++..+ +||||+++++++.+...++++||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccccccccccccc
Confidence 7899999999999999999999999999999986644444444556799999999 999999999999999999999999
Q ss_pred CCC-Cchhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceec---CCCCCCCC
Q 011331 311 CDH-SLSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL---NKSLPIEE 384 (488)
Q Consensus 311 ~~~-~l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~---~~~~~~~~ 384 (488)
+.+ .+.... ....+++..++.++.||+.||.+||+.||+|+||||+||++ .++.++|+|||.+... ........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 998 455433 36779999999999999999999999999999999999999 5899999999999763 22234456
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCc---hhhhhh---hcC----CCCCCCCCcHHHHHHHHH
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESG---PQFLNL---RDG----KLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~---~~~~~i---~~~----~~~~~~~~s~~l~~lI~k 454 (488)
++..|+|||++......+.++||||||+++|+|++|..|+... .....+ ... ........+.++.++|.+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 239 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK 239 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence 8999999999873335778999999999999999999998875 221111 111 111112234899999999
Q ss_pred cccCCCCCCCCHHHHHhChhh
Q 011331 455 MVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~HP~f 475 (488)
||+.||++|||+.++++||||
T Consensus 240 ~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 240 MLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HSSSSGGGSTTHHHHHTSGGG
T ss_pred HccCChhHCcCHHHHhcCCCC
Confidence 999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=351.10 Aligned_cols=244 Identities=27% Similarity=0.412 Sum_probs=201.7
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||+|+||+||+|.+..+|..||||++..... .......+..|+.++.+..+||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 368999999999999999999999999865422 2233345566666555444999999999999999999999999987
Q ss_pred Cchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCCCCCCCCC
Q 011331 314 SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSLPIEEGDA 387 (488)
Q Consensus 314 ~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~~~~~Gt~ 387 (488)
+.+. ......+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||++.... .......||.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 6443 3344568999999999999999999999999999999999999 67899999999987532 2223456999
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRP 464 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~Rp 464 (488)
.|+|||++.+. .++.++|||||||++|||++|.+||..... +..+........+..+..+.++|.+||..+|.+||
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~ 239 (325)
T cd05604 161 EYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRL 239 (325)
T ss_pred hhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcC
Confidence 99999998765 567799999999999999999999876543 33445566667778899999999999999999999
Q ss_pred CH----HHHHhChhhhhhH
Q 011331 465 SA----KELVENPIFDKIQ 479 (488)
Q Consensus 465 Ta----~elL~HP~f~~i~ 479 (488)
++ .++++||||..+.
T Consensus 240 ~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 240 GAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred CCCCCHHHHhcCCCcCCCC
Confidence 75 6999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=354.35 Aligned_cols=254 Identities=28% Similarity=0.372 Sum_probs=225.6
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
++-.=|.+.+.||+|.|++|.+|++.-+|..||||++.+....+.....++.|+..++.+ +|||||+||++......+|
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcccceEE
Confidence 334457888999999999999999999999999999988777777777899999999988 9999999999999999999
Q ss_pred EEEecCCCC-chh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE--eCCeEEEEeecCceecC--C
Q 011331 306 IQMELCDHS-LSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV--KNGVYKLGDFGRATLLN--K 378 (488)
Q Consensus 306 IV~E~~~~~-l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv--~~g~vkL~DFGlA~~~~--~ 378 (488)
||+|+-+++ +.+ ......+.|..+.+|+.||+.|+.|+|+..+|||||||+||.+ .-|.+||.|||++..+. .
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999875 443 2334569999999999999999999999999999999999988 56999999999987663 4
Q ss_pred CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch---hhhhhhcCCCCCCCCCcHHHHHHHHHc
Q 011331 379 SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP---QFLNLRDGKLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 379 ~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~---~~~~i~~~~~~~~~~~s~~l~~lI~k~ 455 (488)
...+.+|+..|-|||++.+....-+++||||||||||.|++|.+||.... .+..|++.++..|..++.++++||..|
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sM 253 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSM 253 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHH
Confidence 46678999999999999877445579999999999999999999998654 356788999999999999999999999
Q ss_pred ccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 456 VDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 456 L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
|..||.+|.+.+|+..|+|++.+.+
T Consensus 254 LvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 254 LVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HhcCchhhccHHHHhccccccCCCC
Confidence 9999999999999999999998755
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=357.11 Aligned_cols=249 Identities=33% Similarity=0.512 Sum_probs=221.5
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce-EEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ-LYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~-l~IV 307 (488)
++|..++.+|+|+||.+++++++.++..|++|.+......+.+++.++.|+.+++++ .|||||.+.+.|..++. ++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEEEE
Confidence 468899999999999999999999999999999988878888888999999999998 99999999999999998 9999
Q ss_pred EecCCCCchh----hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---
Q 011331 308 MELCDHSLSD----KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 308 ~E~~~~~l~~----~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--- 379 (488)
|+||+|+.+. ..+...+++..+..|+.||+.|+.|||+++|+|||||+.|||+ .++.|+|+|||+|+.++..
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 9999997555 2223469999999999999999999999999999999999999 6788899999999988654
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCC-CCCCCCCcHHHHHHHHHc
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGK-LPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~-~~~~~~~s~~l~~lI~k~ 455 (488)
..+.+||+.||+||++.+. .|..|+|||||||++|||++-++.|...+. ..++..+. .|.+..++.+++.+|..|
T Consensus 163 a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~ 241 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSM 241 (426)
T ss_pred hheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHH
Confidence 3456799999999999876 688899999999999999999999987544 22344444 678888999999999999
Q ss_pred ccCCCCCCCCHHHHHhChhhhhhH
Q 011331 456 VDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 456 L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
|..+|..||++.+||.+|.++...
T Consensus 242 l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 242 LRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred hhcCCccCCCHHHHhhChhhhhHH
Confidence 999999999999999999998654
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=347.67 Aligned_cols=244 Identities=26% Similarity=0.372 Sum_probs=199.9
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||+|+||+||+|.+..++..||+|++..... .......+..|+..+.+..+|+||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 369999999999999999999999999864321 1223344555665544434999999999999999999999999988
Q ss_pred Cchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCCCCCCC
Q 011331 314 SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPIEEGDA 387 (488)
Q Consensus 314 ~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~~~Gt~ 387 (488)
+.+. ......+.+..+..++.||+.||.|||++||+||||||+|||+ .++.++|+|||+++.... ......||+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 6443 2334568899999999999999999999999999999999999 678999999999875421 223456999
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRP 464 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~Rp 464 (488)
.|+|||++.+. .++.++|||||||++|||++|.+||..... +..+........+.++..+.++|.+||+.||.+|+
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (325)
T cd05602 161 EYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 239 (325)
T ss_pred cccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 99999998765 577799999999999999999999876543 23445556667778899999999999999999999
Q ss_pred CHH----HHHhChhhhhhH
Q 011331 465 SAK----ELVENPIFDKIQ 479 (488)
Q Consensus 465 Ta~----elL~HP~f~~i~ 479 (488)
++. ++++|+||..+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 240 GAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred CCCCCHHHHhcCcccCCCC
Confidence 865 999999997764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=351.80 Aligned_cols=250 Identities=23% Similarity=0.310 Sum_probs=204.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ........+..|+.++..+ +||||+++++.+.+++.+|+
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEE
Confidence 468999999999999999999999999999999986421 1222334466788888877 99999999999999999999
Q ss_pred EEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----C
Q 011331 307 QMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----L 380 (488)
Q Consensus 307 V~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----~ 380 (488)
||||++++ |........+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||++...... .
T Consensus 121 v~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~ 200 (371)
T cd05622 121 VMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200 (371)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccc
Confidence 99999765 5445555678999999999999999999999999999999999999 6789999999999876432 1
Q ss_pred CCCCCCCCccChhhhcccC---CCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcC----CCCCCCCCcHHHHH
Q 011331 381 PIEEGDARYMPQEILNEDY---DHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDG----KLPLLPGHSLQFQN 450 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~---~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~----~~~~~~~~s~~l~~ 450 (488)
....||+.|+|||++.... .++.++|||||||++|||++|.+||..... +..+... ..+....++.++.+
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 280 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 280 (371)
T ss_pred cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHH
Confidence 2456999999999986431 366799999999999999999999986543 2333322 23334468999999
Q ss_pred HHHHcccCCCCC--CCCHHHHHhChhhhhh
Q 011331 451 LLKVMVDPDPVQ--RPSAKELVENPIFDKI 478 (488)
Q Consensus 451 lI~k~L~~dP~~--RpTa~elL~HP~f~~i 478 (488)
+|.+||..++.+ |++++|+++||||+..
T Consensus 281 li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 281 LICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999999844443 7899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=346.55 Aligned_cols=245 Identities=26% Similarity=0.366 Sum_probs=200.8
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||+|+||+||+|.+..+|..||+|++.+... .......+..|+..+.+..+||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999864322 2233445666665544434999999999999999999999999987
Q ss_pred Cchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCCCCCCC
Q 011331 314 SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPIEEGDA 387 (488)
Q Consensus 314 ~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~~~Gt~ 387 (488)
+.+. ......+++..+..++.||+.||.|||++||+||||||+|||| .+|.+||+|||+++.... ......||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 6443 2334568999999999999999999999999999999999999 678999999999875322 123346899
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRP 464 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~Rp 464 (488)
.|+|||++... .++.++|||||||++|||++|..||..... ...+.......++..+.++.++|.+||+.||.+|+
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (321)
T cd05603 161 EYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL 239 (321)
T ss_pred ccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcC
Confidence 99999998765 577799999999999999999999876543 33445566677778899999999999999999998
Q ss_pred CH----HHHHhChhhhhhHH
Q 011331 465 SA----KELVENPIFDKIQK 480 (488)
Q Consensus 465 Ta----~elL~HP~f~~i~~ 480 (488)
++ .|+++||||..+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 240 GAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred CCCCCHHHHhCCCCcCCCCH
Confidence 74 69999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=341.70 Aligned_cols=237 Identities=24% Similarity=0.405 Sum_probs=186.7
Q ss_pred EEEecccCcEEEEEEEEc--CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc--cceEEEEEe
Q 011331 234 IEQIGAGNFSHVFKVLKR--IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE--NEQLYIQME 309 (488)
Q Consensus 234 ~~~LG~G~fg~Vy~a~~~--~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~--~~~l~IV~E 309 (488)
.++||+|+||+||+|.+. .++..||+|.+..... .....+|+.+++.+ +||||+++++++.. +..+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEe
Confidence 467999999999999865 4678999999864321 23467899999999 99999999998854 456899999
Q ss_pred cCCCCchhhhh----------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-----CCeEEEEeecCce
Q 011331 310 LCDHSLSDKKA----------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-----NGVYKLGDFGRAT 374 (488)
Q Consensus 310 ~~~~~l~~~~~----------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-----~g~vkL~DFGlA~ 374 (488)
|+++++..... ...+++..++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||+|+
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 81 YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred ccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 99887654321 12488999999999999999999999999999999999992 3689999999998
Q ss_pred ecCCCC------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh------------hhhhhc-
Q 011331 375 LLNKSL------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ------------FLNLRD- 435 (488)
Q Consensus 375 ~~~~~~------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------------~~~i~~- 435 (488)
...... ....||+.|+|||++.+...++.++|||||||++|||++|.+||..... +..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 764321 2346899999999987654577899999999999999999999864221 000000
Q ss_pred -C-----------CCC-------------------------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 436 -G-----------KLP-------------------------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 436 -~-----------~~~-------------------------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
+ ..+ .....+.++.+||.+||++||.+|||++|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 000 001224568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=350.01 Aligned_cols=243 Identities=25% Similarity=0.325 Sum_probs=198.7
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhC--CCCCeeEeeeeecccceEEEEEecCCC
Q 011331 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALG--SHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 237 LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~--~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
||+|+||+||+|.+..+|..||||++.... ...........|..++..+. +||||+.+++.+.+.+.+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999985431 12233345566777777665 799999999999999999999999987
Q ss_pred Cch-h-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCCCCCCC
Q 011331 314 SLS-D-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPIEEGDA 387 (488)
Q Consensus 314 ~l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~~~Gt~ 387 (488)
+.+ . ......+++..++.++.||+.||+|||++||+||||||+|||+ .++.++|+|||++..... ......||.
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 533 3 3344569999999999999999999999999999999999999 678999999999875422 223456999
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCC-CCcHHHHHHHHHcccCCCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLP-GHSLQFQNLLKVMVDPDPVQR 463 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~-~~s~~l~~lI~k~L~~dP~~R 463 (488)
.|+|||++.+...++.++|||||||++|+|++|..||..... ...+..+....+. .++.++.+||.+||..||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence 999999987654577899999999999999999999876543 2233444444443 468999999999999999999
Q ss_pred C----CHHHHHhChhhhhhH
Q 011331 464 P----SAKELVENPIFDKIQ 479 (488)
Q Consensus 464 p----Ta~elL~HP~f~~i~ 479 (488)
| ++.++++||||....
T Consensus 241 ~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 241 LGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCCCHHHHhcCccccCCC
Confidence 8 799999999998653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=344.15 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=200.9
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccC-CCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ-LHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~-~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++++.||+|+||+||+|.+..+++.||||++.+. .........+..|+.++..+ +|+||+.+++++.+++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence 3689999999999999999999999999999998642 12223345567788888887 999999999999999999999
Q ss_pred EecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---
Q 011331 308 MELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL--- 380 (488)
Q Consensus 308 ~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~--- 380 (488)
|||+.++ |..... ...+++..+..++.||+.||+|||++||+||||||+|||+ .++.++|+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 9999775 433322 3468999999999999999999999999999999999999 67899999999997654322
Q ss_pred -CCCCCCCCccChhhhcc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhc--CCCC---CCCCCcHH
Q 011331 381 -PIEEGDARYMPQEILNE----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRD--GKLP---LLPGHSLQ 447 (488)
Q Consensus 381 -~~~~Gt~~Y~APEvl~~----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~--~~~~---~~~~~s~~ 447 (488)
....||+.|+|||++.. ...++.++|||||||++|||++|..||...... ..+.. .... ..+.++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 22458999999999863 224567999999999999999999998765332 22222 1122 22346899
Q ss_pred HHHHHHHcccCCCCC--CCCHHHHHhChhhhhhHH
Q 011331 448 FQNLLKVMVDPDPVQ--RPSAKELVENPIFDKIQK 480 (488)
Q Consensus 448 l~~lI~k~L~~dP~~--RpTa~elL~HP~f~~i~~ 480 (488)
++++|.+||..++.+ |++++++++||||..+.+
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 999999998765544 889999999999987643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=335.14 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=203.7
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
|++.+.||+|+||+||+|.+..+++.||||.+....... .....+..|+.++..+ +|+||+.+++.+.+++.+|+|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEEE
Confidence 678899999999999999999999999999886543222 2234567899999998 99999999999999999999999
Q ss_pred cCCCCch-hhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CCC
Q 011331 310 LCDHSLS-DKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LPI 382 (488)
Q Consensus 310 ~~~~~l~-~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~~ 382 (488)
|+.++.+ ... ....+++..+..++.|++.||.|||++||+|+||||+||++ .++.++|+|||++...... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 9987543 322 22358999999999999999999999999999999999999 6789999999999765432 223
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh------hhhh-hcCCCCCCCCCcHHHHHHHHHc
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ------FLNL-RDGKLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------~~~i-~~~~~~~~~~~s~~l~~lI~k~ 455 (488)
..|+..|+|||++... .++.++|||||||++|+|++|..||..... ...+ .......+...+.++.+||.+|
T Consensus 161 ~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 161 RVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239 (285)
T ss_pred CCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHH
Confidence 4689999999998765 577899999999999999999999875321 1111 1112234456788999999999
Q ss_pred ccCCCCCCCC-----HHHHHhChhhhhhHH
Q 011331 456 VDPDPVQRPS-----AKELVENPIFDKIQK 480 (488)
Q Consensus 456 L~~dP~~RpT-----a~elL~HP~f~~i~~ 480 (488)
|+.||++||| ++|+++||||+++..
T Consensus 240 l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 240 LCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred hhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 9999999999 999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=341.64 Aligned_cols=248 Identities=28% Similarity=0.385 Sum_probs=202.7
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++.+.||.|+||+||+|.+..+|..||+|++.... .......+.+|++++..+ +|+||++++++|..++.+||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEEEEE
Confidence 47899999999999999999999999999999886542 334456788999999999 8999999999999999999999
Q ss_pred ecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-CCCC
Q 011331 309 ELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEK-GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-LPIE 383 (488)
Q Consensus 309 E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~-gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-~~~~ 383 (488)
||+.++ |... .....+++..+..++.||+.||.|||+. +|+|+||||+|||+ .++.+||+|||++...... ....
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 162 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccC
Confidence 999875 4332 3345688999999999999999999975 79999999999999 6789999999999765332 2344
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh--hhh----------------------------
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF--LNL---------------------------- 433 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~--~~i---------------------------- 433 (488)
.|+..|+|||++.+. .++.++|||||||++|+|++|..||...... ...
T Consensus 163 ~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (333)
T cd06650 163 VGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSY 241 (333)
T ss_pred CCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhh
Confidence 689999999998765 5777999999999999999999887643210 000
Q ss_pred -----------------hcCCCC-CC-CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 434 -----------------RDGKLP-LL-PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 434 -----------------~~~~~~-~~-~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.....+ .+ ...+.++.+||.+||++||++|||+.|++.||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 242 GPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 000001 11 12567899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=331.74 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=213.5
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-----Cc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-----HH-DAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-----~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
++..|..-+.||+|..++|.+|.++.+|..+|+|++.... .+ ...++.-..|+.||+++..||+|+.+.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 4456777888999999999999999999999999985321 11 12245677899999999999999999999999
Q ss_pred cceEEEEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC
Q 011331 301 NEQLYIQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN 377 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~ 377 (488)
+..+++|+|+|..+ |.+ ....-.+++.+.+.+|+|++.|++|||.++||||||||+|||+ ++-+++|+|||+|+.+.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999765 433 3334469999999999999999999999999999999999999 66799999999999886
Q ss_pred CC--CCCCCCCCCccChhhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCCC----CCCC
Q 011331 378 KS--LPIEEGDARYMPQEILNE-----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKLP----LLPG 443 (488)
Q Consensus 378 ~~--~~~~~Gt~~Y~APEvl~~-----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~~----~~~~ 443 (488)
.. ....+||++|+|||.+.. ...|+..+|+|++||++|.|+.|.+||-...++. .++.|.+. -+..
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWad 254 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWAD 254 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhh
Confidence 54 344689999999999853 2357779999999999999999999987655533 44566554 3446
Q ss_pred CcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHh
Q 011331 444 HSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481 (488)
Q Consensus 444 ~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~ 481 (488)
.+....+||.+||+.||.+|.|++|+|.||||..+-..
T Consensus 255 is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 255 ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 78899999999999999999999999999999776543
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=358.35 Aligned_cols=249 Identities=25% Similarity=0.352 Sum_probs=207.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc-----
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE----- 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~----- 302 (488)
..+|++.+.||+|+||+||+|.+..+|+.||||++............+..|+..+..+ +|+||++++..+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCcc
Confidence 3578999999999999999999999999999999876555556667788899999998 9999999988765432
Q ss_pred ---eEEEEEecCCCC-chhhh-----hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecC
Q 011331 303 ---QLYIQMELCDHS-LSDKK-----ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGR 372 (488)
Q Consensus 303 ---~l~IV~E~~~~~-l~~~~-----~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGl 372 (488)
.+++||||+.++ |.... ....+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 368999999875 43322 12468999999999999999999999999999999999999 678999999999
Q ss_pred ceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhc-CCCCCCCC
Q 011331 373 ATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRD-GKLPLLPG 443 (488)
Q Consensus 373 A~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~-~~~~~~~~ 443 (488)
++..... .....||+.|+|||++... .++.++|||||||+||||++|..||...... ..+.. ...+.++.
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS 268 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 9765422 2345699999999999765 5778999999999999999999998765432 22222 23356677
Q ss_pred CcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 444 HSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 444 ~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
++.++.++|.+||..||.+||++.++++|||++..
T Consensus 269 ~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 89999999999999999999999999999998754
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=331.62 Aligned_cols=245 Identities=30% Similarity=0.457 Sum_probs=201.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++++.||+|+||.||+|.+..+|+.||+|++..........+.+..|+.+++.+ +|+||+++++++.....+++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEEEe
Confidence 68999999999999999999998999999998864432222334577899999998 89999999999999999999999
Q ss_pred cCCCCchhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---CCC
Q 011331 310 LCDHSLSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---PIE 383 (488)
Q Consensus 310 ~~~~~l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---~~~ 383 (488)
|++++++... ....+++..++.++.||+.||.|||+.||+|+||||+||++ .++.++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence 9998866633 23458999999999999999999999999999999999999 67899999999998764432 233
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hc---------------------CCCC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RD---------------------GKLP 439 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~---------------------~~~~ 439 (488)
.++..|+|||++.+...++.++|||||||++|+|++|.+||........+ .. ...+
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence 57889999999866445677999999999999999999998654321111 00 0001
Q ss_pred ----------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 440 ----------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 440 ----------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
..+.++..+.+||.+||+.+|++|||+.|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=363.11 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=211.6
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
-|.++..||.|+||.||+|.++.++-..|.|++.. ....+..+++.||.||+.+ +||+||+|++.|...+.+||..|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceEEEEe
Confidence 36788999999999999999999999999998863 3567788999999999999 89999999999999999999999
Q ss_pred cCCCCchh---hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCC
Q 011331 310 LCDHSLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPI 382 (488)
Q Consensus 310 ~~~~~l~~---~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~ 382 (488)
||+|+-.+ ......+.+.++..+++|++.||.|||+++|||||||..|||+ -+|.++|+|||.+..... ....
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence 99987444 3334679999999999999999999999999999999999999 699999999998754422 2345
Q ss_pred CCCCCCccChhhhcc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc---CCC---CCCCCCcHHHHHHH
Q 011331 383 EEGDARYMPQEILNE----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD---GKL---PLLPGHSLQFQNLL 452 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~---~~~---~~~~~~s~~l~~lI 452 (488)
..||++|||||++.. ...|.+++||||||++|.||..+.+|.....++..+.. ... ..|..++..|.+|+
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfL 269 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFL 269 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHH
Confidence 679999999999753 23455699999999999999999999887776655443 222 24456788999999
Q ss_pred HHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 453 KVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.+||.+||..||++.+||+||||+.+.
T Consensus 270 k~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 270 KRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHHhcCCccCCCHHHHhhCcccccCC
Confidence 999999999999999999999998654
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=325.17 Aligned_cols=245 Identities=27% Similarity=0.342 Sum_probs=203.7
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc---hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH---DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~---~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
++|.+.+.||.|++|.||+|.+..++..||+|.+...... ......+.+|+.++.++ +||||+++++++..++.+|
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEE
Confidence 3588999999999999999999999999999988643222 12345678899999998 9999999999999999999
Q ss_pred EEEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 306 IQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 306 IV~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
++|||+.++.+. ......+++..+..++.||+.||.|||+.||+|+||+|+||++ .++.++|+|||+++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 999999875433 2234568899999999999999999999999999999999999 66899999999997653211
Q ss_pred ----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---h--cCCCCCCCCCcHHHHHH
Q 011331 381 ----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---R--DGKLPLLPGHSLQFQNL 451 (488)
Q Consensus 381 ----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~--~~~~~~~~~~s~~l~~l 451 (488)
....|+..|+|||++.+. .++.++||||||+++|||++|..||......... . ......+..++..+.++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239 (263)
T ss_pred cccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHH
Confidence 234578899999998776 4778999999999999999999998765443222 1 12334556778999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhh
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f 475 (488)
|.+||..+|.+|||+.++++||||
T Consensus 240 i~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 240 LRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=355.88 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=205.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCC-CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRID-GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+..|+.++..+ +|||||+++++|..++.+||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEEEEE
Confidence 489999999999999999998877 788999976432 233345577899999998 9999999999999999999999
Q ss_pred ecCCCCchh-h-----hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--
Q 011331 309 ELCDHSLSD-K-----KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 309 E~~~~~l~~-~-----~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-- 379 (488)
||++++.+. . .....+++.++..++.||+.||.|||++||+||||||+|||| .++.+||+|||+++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999876443 1 123458899999999999999999999999999999999999 6789999999999876433
Q ss_pred ---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCC-CCCCCCCcHHHHHHH
Q 011331 380 ---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGK-LPLLPGHSLQFQNLL 452 (488)
Q Consensus 380 ---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~-~~~~~~~s~~l~~lI 452 (488)
....+||+.|+|||++... .++.++|||||||++|||++|..||..... +..+..+. .+.+..++.++.++|
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 303 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL 303 (478)
T ss_pred cccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHH
Confidence 2234699999999998765 577899999999999999999999876543 22333333 345557899999999
Q ss_pred HHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 453 KVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.+||..||++||++.+++.|||++.+.
T Consensus 304 ~~~L~~dP~~Rps~~~~l~~~~~~~~~ 330 (478)
T PTZ00267 304 DPLLSKNPALRPTTQQLLHTEFLKYVA 330 (478)
T ss_pred HHHhccChhhCcCHHHHHhCHHHHHHH
Confidence 999999999999999999999997653
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=344.13 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=208.8
Q ss_pred ccceeeCCCCccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeE
Q 011331 214 LFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293 (488)
Q Consensus 214 ~~p~~~g~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~ 293 (488)
++|+..|+. ...+..+|++++.||+|+||+||+|.+..+|..||||++............+.+|+.++..+ +|+||++
T Consensus 2 ~~~~~~~~~-~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~ 79 (353)
T cd07850 2 FYSVEVGDS-TFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIG 79 (353)
T ss_pred ceeecccch-hhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcc
Confidence 445555432 33456789999999999999999999999999999999865444444456677899999998 9999999
Q ss_pred eeeeeccc------ceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEE
Q 011331 294 YYSSWFEN------EQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYK 366 (488)
Q Consensus 294 l~~~~~~~------~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vk 366 (488)
++++|... ...|+||||+.+++....... +++..+..++.||+.||+|||++||+|+||||+||++ .++.++
T Consensus 80 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~k 158 (353)
T cd07850 80 LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 158 (353)
T ss_pred eeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEE
Confidence 99988644 357999999998776654433 8999999999999999999999999999999999999 678999
Q ss_pred EEeecCceecCCCC--CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhh-------
Q 011331 367 LGDFGRATLLNKSL--PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLR------- 434 (488)
Q Consensus 367 L~DFGlA~~~~~~~--~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~------- 434 (488)
|+|||++....... ....++..|+|||.+.+. .++.++|||||||++|+|++|..||...+... .+.
T Consensus 159 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 159 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred EccCccceeCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99999998765432 234578899999998765 57789999999999999999999886543211 000
Q ss_pred ---------------cCC-----CC---------C-------CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 435 ---------------DGK-----LP---------L-------LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 435 ---------------~~~-----~~---------~-------~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
... .+ . ....+.++.++|.+||+.||++|||+.|+|.||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 000 00 0 11245678999999999999999999999999999854
Q ss_pred H
Q 011331 479 Q 479 (488)
Q Consensus 479 ~ 479 (488)
.
T Consensus 318 ~ 318 (353)
T cd07850 318 Y 318 (353)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=331.40 Aligned_cols=250 Identities=25% Similarity=0.398 Sum_probs=214.0
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++.+.||.|+||.||+|.+..+++.||+|++..... .......+..|++++.++ +||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEE
Confidence 368999999999999999999999999999999864322 223345688899999999 799999999999999999999
Q ss_pred EecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCC
Q 011331 308 MELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE 384 (488)
Q Consensus 308 ~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~ 384 (488)
|||++++ +... .....+++..+..++.||+.||.|||+.||+|+||+|+||+| .++.++|+|||++...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 159 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC 159 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCC
Confidence 9999654 4442 234568999999999999999999999999999999999999 678999999999987766555567
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCC
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPV 461 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~ 461 (488)
|++.|+|||.+... ..+.++||||||+++|+|++|..||..... ...+..+..+.+...+..+.++|.+||..||.
T Consensus 160 ~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 238 (290)
T cd05580 160 GTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLT 238 (290)
T ss_pred CCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHH
Confidence 89999999998665 567799999999999999999999876543 23445566677777899999999999999999
Q ss_pred CCC-----CHHHHHhChhhhhhHH
Q 011331 462 QRP-----SAKELVENPIFDKIQK 480 (488)
Q Consensus 462 ~Rp-----Ta~elL~HP~f~~i~~ 480 (488)
+|+ +++|+++||||+.+.+
T Consensus 239 ~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 239 KRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred HccCcccCCHHHHHcCcccccCCH
Confidence 999 9999999999987754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.13 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=204.3
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++++.||+|+||+||+|.+..++..||+|++.... .......+..|+.++.++ +||||+++++.+...+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEEe
Confidence 5788999999999999999999999999999986542 233455688899999998 89999999999999999999999
Q ss_pred cCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC-CCCCCCCCC
Q 011331 310 LCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK-SLPIEEGDA 387 (488)
Q Consensus 310 ~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~-~~~~~~Gt~ 387 (488)
|++++.+... ..+++..+..++.||+.||.|||+.||+|+||||+|||+ .++.++|+|||++..... ......|+.
T Consensus 80 ~~~~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (279)
T cd06619 80 FMDGGSLDVY--RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTN 157 (279)
T ss_pred cCCCCChHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCCCh
Confidence 9998765433 357888999999999999999999999999999999999 678999999999976543 234457899
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----------hhhhhcCCCC--CCCCCcHHHHHHHHHc
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----------FLNLRDGKLP--LLPGHSLQFQNLLKVM 455 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----------~~~i~~~~~~--~~~~~s~~l~~lI~k~ 455 (488)
.|+|||++... .++.++|||||||++|+|++|..||..... ...+.....+ .....+.++.++|.+|
T Consensus 158 ~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (279)
T cd06619 158 AYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQC 236 (279)
T ss_pred hhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHH
Confidence 99999998765 577899999999999999999999864211 0111111111 1234678999999999
Q ss_pred ccCCCCCCCCHHHHHhChhhhhhH
Q 011331 456 VDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 456 L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
|+.+|++||+++|++.||||+...
T Consensus 237 l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 237 MRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred hhCChhhCCCHHHHhcCccccccc
Confidence 999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=346.89 Aligned_cols=239 Identities=22% Similarity=0.333 Sum_probs=192.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++++.||+|+||+||+|.+..++..||+|+.... ....|+.++..+ +|+||+++++++...+..++|||
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhC-CCCCCcChhheEEeCCeeEEEEE
Confidence 689999999999999999999999999999975432 134588899998 89999999999999999999999
Q ss_pred cCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC--CCCCCC
Q 011331 310 LCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK--SLPIEE 384 (488)
Q Consensus 310 ~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~--~~~~~~ 384 (488)
++.+.+..... ...+++..++.++.||+.||.|||++|||||||||+|||+ .++.++|+|||+++.... ......
T Consensus 138 ~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred ccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccccc
Confidence 99887766432 3468999999999999999999999999999999999999 678999999999975432 223346
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCC-CCchh------------hhhhhc--C----CCC------
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLS-ESGPQ------------FLNLRD--G----KLP------ 439 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~-~~~~~------------~~~i~~--~----~~~------ 439 (488)
||..|+|||++... .++.++|||||||++|||+++..++ ..... +..+.. + ..+
T Consensus 218 gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 218 GTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296 (357)
T ss_pred ccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence 89999999998765 5778999999999999999865443 22100 000000 0 000
Q ss_pred ---------------C-------CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 440 ---------------L-------LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 440 ---------------~-------~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
. ....+.++.+||.+||+.||.+|||+.|||+||||+.+
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 0 01345567789999999999999999999999999864
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=329.83 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=206.1
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
|+..+.||.|+||+||+|.+..+++.||+|++....... .....+..|+.++..+ +|+||+.+++.+..++.+|++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEE
Confidence 678899999999999999999999999999986542222 2234567899999998 99999999999999999999999
Q ss_pred cCCCCchh-hh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CCC
Q 011331 310 LCDHSLSD-KK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LPI 382 (488)
Q Consensus 310 ~~~~~l~~-~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~~ 382 (488)
|+.++.+. .. ....+++..+..++.||+.||.|||+.||+|+||||+||++ +++.++|+|||++...... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 99876443 22 22358999999999999999999999999999999999999 6789999999999765432 223
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh-------hhhhcCCCCCCCCCcHHHHHHHHHc
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF-------LNLRDGKLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~-------~~i~~~~~~~~~~~s~~l~~lI~k~ 455 (488)
..|+..|+|||++... .++.++|||||||++|+|++|..||...... ..+.......+...+.++.+|+.+|
T Consensus 161 ~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 161 RVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 4689999999998765 5778999999999999999999998764331 1122333445567889999999999
Q ss_pred ccCCCCCCCC-----HHHHHhChhhhhhHH
Q 011331 456 VDPDPVQRPS-----AKELVENPIFDKIQK 480 (488)
Q Consensus 456 L~~dP~~RpT-----a~elL~HP~f~~i~~ 480 (488)
|+.||++||+ ++++++||||.....
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 9999999999 999999999998744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=328.20 Aligned_cols=252 Identities=29% Similarity=0.429 Sum_probs=204.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||.||+|.+..+|..||||++....... ....+..|+.++.+..+||||+++++++..++.+|++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 36899999999999999999999999999999987653332 33456667777666669999999999999999999999
Q ss_pred ecCCCCchhhh-----hcccCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-
Q 011331 309 ELCDHSLSDKK-----ASQFFAEGEVLKALHQIAQALQFIHEK-GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL- 380 (488)
Q Consensus 309 E~~~~~l~~~~-----~~~~l~~~~~~~i~~qI~~gL~yLH~~-gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~- 380 (488)
||+++++.... ....+++..++.++.||+.||.|||++ +++|+||||+||++ .++.+||+|||++.......
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 80 EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred hhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99998754422 224689999999999999999999997 99999999999999 67899999999998664322
Q ss_pred -CCCCCCCCccChhhhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcCCCC-CC-CCCcHHHHH
Q 011331 381 -PIEEGDARYMPQEILNED---YDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDGKLP-LL-PGHSLQFQN 450 (488)
Q Consensus 381 -~~~~Gt~~Y~APEvl~~~---~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~~~~-~~-~~~s~~l~~ 450 (488)
....|+..|+|||++... ..++.++|+|||||++|+|++|..|+..... .........+ .+ ..++.++.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQD 239 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 234688899999988542 2356799999999999999999999865321 2222222222 22 246889999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhhHHh
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~ 481 (488)
+|.+||..+|.+|||++++++||||+...+.
T Consensus 240 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 240 FVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 9999999999999999999999999886654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.67 Aligned_cols=242 Identities=21% Similarity=0.340 Sum_probs=196.0
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCCc
Q 011331 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSL 315 (488)
Q Consensus 237 LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~l 315 (488)
||+|+||+||++.+..+|+.||+|++...... .........|++++..+ +||||+++++++..+..+|+||||+.++.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 79999999999999999999999998643221 12234456799999999 99999999999999999999999998764
Q ss_pred hh-hh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--CCCCCCCC
Q 011331 316 SD-KK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL--PIEEGDAR 388 (488)
Q Consensus 316 ~~-~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~--~~~~Gt~~ 388 (488)
+. .. ....+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++....... ....|+..
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence 43 22 22348888999999999999999999999999999999999 67899999999997664322 23468999
Q ss_pred ccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-------hhhhhcCCCCC-CCCCcHHHHHHHHHcccCCC
Q 011331 389 YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-------FLNLRDGKLPL-LPGHSLQFQNLLKVMVDPDP 460 (488)
Q Consensus 389 Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~~~i~~~~~~~-~~~~s~~l~~lI~k~L~~dP 460 (488)
|+|||++... .++.++|||||||++|||++|..||..... .........+. ...++.++.++|.+||+.||
T Consensus 160 y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P 238 (277)
T cd05607 160 YMAPEILKEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKP 238 (277)
T ss_pred ccCHHHHccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCH
Confidence 9999998766 477899999999999999999999865321 11111222222 23578999999999999999
Q ss_pred CCCCCH----HHHHhChhhhhhHH
Q 011331 461 VQRPSA----KELVENPIFDKIQK 480 (488)
Q Consensus 461 ~~RpTa----~elL~HP~f~~i~~ 480 (488)
++||++ ++++.||||+.+..
T Consensus 239 ~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 239 EDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred hhCCCCccchhhhhcChhhcCCCH
Confidence 999999 77889999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=341.19 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=200.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++++.||+|+||+||++.+..+++.||+|++.+.. ........+..|+.++..+ +|+||+.+++.+.+.+.+|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEE
Confidence 36899999999999999999999999999999985421 1222234466777788777 999999999999999999999
Q ss_pred EecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----
Q 011331 308 MELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---- 379 (488)
Q Consensus 308 ~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---- 379 (488)
|||+.++ |..... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++.++|+|||++......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 9999775 433332 3468999999999999999999999999999999999999 6789999999998765322
Q ss_pred CCCCCCCCCccChhhhcc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcC--CCCC---CCCCcHH
Q 011331 380 LPIEEGDARYMPQEILNE----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDG--KLPL---LPGHSLQ 447 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~--~~~~---~~~~s~~ 447 (488)
.....||+.|+|||++.. ...++.++|||||||++|||++|..||....... .+... ..+. ...++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 123469999999999852 2246679999999999999999999997654322 22221 1222 2357899
Q ss_pred HHHHHHHcccCCCCC--CCCHHHHHhChhhhhhHH
Q 011331 448 FQNLLKVMVDPDPVQ--RPSAKELVENPIFDKIQK 480 (488)
Q Consensus 448 l~~lI~k~L~~dP~~--RpTa~elL~HP~f~~i~~ 480 (488)
+.+||.+||..++.+ |++++|+++||||+.+..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 999999999765554 789999999999998753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=341.47 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=201.4
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++++.||+|+||+||+|.+..+++.||+|++.+.. ........+..|+.++..+ +|+||+.+++++.+.+.+|||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 36899999999999999999999999999999986421 1223334466777777777 999999999999999999999
Q ss_pred EecCCCCchh-hhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---
Q 011331 308 MELCDHSLSD-KKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL--- 380 (488)
Q Consensus 308 ~E~~~~~l~~-~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~--- 380 (488)
|||+.++.+. ... ...+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 9999876443 322 3468999999999999999999999999999999999999 67899999999998764322
Q ss_pred -CCCCCCCCccChhhhccc----CCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhc--CCCCCC---CCCcHH
Q 011331 381 -PIEEGDARYMPQEILNED----YDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRD--GKLPLL---PGHSLQ 447 (488)
Q Consensus 381 -~~~~Gt~~Y~APEvl~~~----~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~--~~~~~~---~~~s~~ 447 (488)
....||+.|+|||++... ..++.++|||||||+||||++|..||...... ..+.. ...+.+ ..++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 234699999999998641 24567999999999999999999999765432 22222 122222 346899
Q ss_pred HHHHHHHcccCCCCC--CCCHHHHHhChhhhhhHH
Q 011331 448 FQNLLKVMVDPDPVQ--RPSAKELVENPIFDKIQK 480 (488)
Q Consensus 448 l~~lI~k~L~~dP~~--RpTa~elL~HP~f~~i~~ 480 (488)
+.++|.+||..++.+ |++++++++||||+.+.+
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence 999999999876654 579999999999988643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=332.11 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=200.0
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce-----E
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ-----L 304 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~-----l 304 (488)
+|++.+.||.|+||+||+|.+..+|..||||++............+..|+.++..+.+|+||+++++++...+. +
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 68999999999999999999999999999998765432222335677899999999778999999998887665 8
Q ss_pred EEEEecCCCCchhhhh------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--CCeEEEEeecCceec
Q 011331 305 YIQMELCDHSLSDKKA------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDFGRATLL 376 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~~------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~g~vkL~DFGlA~~~ 376 (488)
|++|||+++++..... ...+++..++.++.||+.||.|||++||+|+||+|+||+++ ++.++|+|||++...
T Consensus 82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence 9999999987655221 23579999999999999999999999999999999999994 679999999999765
Q ss_pred CCC---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc-------C----------
Q 011331 377 NKS---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD-------G---------- 436 (488)
Q Consensus 377 ~~~---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~-------~---------- 436 (488)
... .....+++.|+|||++.+...++.++||||||+++|+|++|.+||........+.. .
T Consensus 162 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T cd07837 162 SIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK 241 (295)
T ss_pred CCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhh
Confidence 322 12235688899999886554567899999999999999999998865433221100 0
Q ss_pred -----CCC---------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhh
Q 011331 437 -----KLP---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFD 476 (488)
Q Consensus 437 -----~~~---------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~ 476 (488)
..+ ..+..+.++.+||.+||..||.+|||++|++.||||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 242 LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred ccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000 1235788899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=331.19 Aligned_cols=245 Identities=27% Similarity=0.382 Sum_probs=200.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++++.||.|++|.||+|.+..+|..||||++............+..|+++++++ +||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEee
Confidence 47899999999999999999999999999998865433333345678899999999 89999999999999999999999
Q ss_pred cCCCCchhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 310 LCDHSLSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 310 ~~~~~l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
|+.+++.... ....+++..++.++.||+.||+|||+.|++|+||+|+||++ .++.++|+|||++...... ...
T Consensus 80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 9987655432 23468999999999999999999999999999999999999 6789999999998765432 223
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hc-C-------------------C--
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RD-G-------------------K-- 437 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~-~-------------------~-- 437 (488)
..++..|+|||++.+...++.++|||||||++|||++|..||........+ .. . .
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 357889999998866544677999999999999999999988654321111 00 0 0
Q ss_pred -------CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 438 -------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 438 -------~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
....+.++.++.++|.+||+.||.+|||++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.50 Aligned_cols=238 Identities=23% Similarity=0.348 Sum_probs=186.4
Q ss_pred EEEEecccCcEEEEEEEEcC--CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec--ccceEEEEE
Q 011331 233 EIEQIGAGNFSHVFKVLKRI--DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF--ENEQLYIQM 308 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~--~~~~l~IV~ 308 (488)
...+||+|+||+||+|.... ++..||+|.+..... ...+.+|+.++..+ +||||+++++++. .+..+|+||
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEE
Confidence 34689999999999998654 568999998864321 23467899999998 8999999999885 456789999
Q ss_pred ecCCCCchhhhh----------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-----CCeEEEEeecCc
Q 011331 309 ELCDHSLSDKKA----------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-----NGVYKLGDFGRA 373 (488)
Q Consensus 309 E~~~~~l~~~~~----------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-----~g~vkL~DFGlA 373 (488)
||+++++..... ...+++..++.++.||+.||.|||+.||+||||||+|||+. ++.+||+|||++
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 80 DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 999987654321 12478889999999999999999999999999999999992 368999999999
Q ss_pred eecCCCC------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh------------hhhh-
Q 011331 374 TLLNKSL------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF------------LNLR- 434 (488)
Q Consensus 374 ~~~~~~~------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~------------~~i~- 434 (488)
+...... ....||+.|+|||++.+...++.++|||||||++|||++|.+||...... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 8764322 23457899999999876545778999999999999999999998643210 0000
Q ss_pred --c-------------------------CCC----------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 435 --D-------------------------GKL----------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 435 --~-------------------------~~~----------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
. ... ......+..+.++|.+||..||.+|||+.|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000 0011234568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.10 Aligned_cols=247 Identities=20% Similarity=0.296 Sum_probs=195.3
Q ss_pred EEEEeccc--CcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEec
Q 011331 233 EIEQIGAG--NFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMEL 310 (488)
Q Consensus 233 ~~~~LG~G--~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~ 310 (488)
+++.||+| +|++||++.+..+|+.||||++............+..|+.+++.+ +||||++++++|..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEec
Confidence 46789999 789999999999999999999875544444445677788888888 999999999999999999999999
Q ss_pred CCCCchh-hhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC-------
Q 011331 311 CDHSLSD-KKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK------- 378 (488)
Q Consensus 311 ~~~~l~~-~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~------- 378 (488)
++++.+. ... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++.++++|||.+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9876443 221 2358999999999999999999999999999999999999 678999999986543211
Q ss_pred ---CCCCCCCCCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCC-------------
Q 011331 379 ---SLPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKL------------- 438 (488)
Q Consensus 379 ---~~~~~~Gt~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~------------- 438 (488)
......++..|+|||++... ..++.++|||||||++|||++|..||....... ....+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 01223467789999998753 346789999999999999999999986432111 0000000
Q ss_pred ---------------------------------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 439 ---------------------------------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 439 ---------------------------------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+....++.++.+||.+||++||++|||++||++||||+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~ 315 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 315 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence 011134678999999999999999999999999999988754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=352.47 Aligned_cols=238 Identities=26% Similarity=0.328 Sum_probs=197.7
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
...+++++.||+|.||+||+|.+. ....||+|.++.... ....+++|+++|++| +|+|||++++++...+.+|||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m---~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSM---SPEAFLREAQIMKKL-RHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecccc---ChhHHHHHHHHHHhC-cccCeEEEEEEEecCCceEEE
Confidence 345677899999999999999985 445899999876533 235578999999999 999999999999999999999
Q ss_pred EecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC-
Q 011331 308 MELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP- 381 (488)
Q Consensus 308 ~E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~- 381 (488)
|||+..+ |+.... ...+...+++.++.|||+|++||+++++|||||.+.|||| +++.+||+|||||+...+..-
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 9999765 555333 3568899999999999999999999999999999999999 678999999999996544322
Q ss_pred C---CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcC-CCCCCCchhhh---hh-hcCCCCCCCCCcHHHHHHHH
Q 011331 382 I---EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQFL---NL-RDGKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 382 ~---~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG-~~p~~~~~~~~---~i-~~~~~~~~~~~s~~l~~lI~ 453 (488)
. ...+..|.|||.+... .++.++|||||||+||||+|- +.|+....... .+ ++..+|.|+.+++++.++|.
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~ 438 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMK 438 (468)
T ss_pred ecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHH
Confidence 1 2246789999999877 578899999999999999995 45555443322 23 34578899999999999999
Q ss_pred HcccCCCCCCCCHHHHHh
Q 011331 454 VMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~ 471 (488)
.||..+|++|||++.+..
T Consensus 439 ~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 439 SCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HHhhCCcccCCCHHHHHH
Confidence 999999999999997664
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=331.60 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=208.4
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
+|++.+.||+|+||+||+|.+..++..||||.+....... .....+..|++++..+ +|+||+++++.+.+.+..|++|
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEEE
Confidence 6899999999999999999999899999999987553332 3456688899999999 8999999999999999999999
Q ss_pred ecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---
Q 011331 309 ELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL--- 380 (488)
Q Consensus 309 E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~--- 380 (488)
||+.++ +..... ...+++..++.++.||+.||.|||+.|++|+||||+||+| .++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999875 433222 2458999999999999999999999999999999999999 67899999999986542211
Q ss_pred -----------------------------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh--
Q 011331 381 -----------------------------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-- 429 (488)
Q Consensus 381 -----------------------------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-- 429 (488)
....|+..|+|||++.+. .++.++||||||+++|+|++|..||.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 123578899999998765 567899999999999999999999875543
Q ss_pred -hhhhhcCCCCCCC--CCcHHHHHHHHHcccCCCCCCCC----HHHHHhChhhhhhHHhhhh
Q 011331 430 -FLNLRDGKLPLLP--GHSLQFQNLLKVMVDPDPVQRPS----AKELVENPIFDKIQKHRKT 484 (488)
Q Consensus 430 -~~~i~~~~~~~~~--~~s~~l~~lI~k~L~~dP~~RpT----a~elL~HP~f~~i~~~~~~ 484 (488)
+..+.......+. ..+.++.++|.+||..||++||| ++|++.||||+.+.+...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~ 301 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIR 301 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcc
Confidence 2233333333332 36899999999999999999999 9999999999987665543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=318.39 Aligned_cols=244 Identities=30% Similarity=0.500 Sum_probs=202.6
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-cceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE-NEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-~~~l~IV~ 308 (488)
+|++++.||.|++|.||++.+..+++.||+|.+............+..|+.+++++ +|+||+++++.+.. +..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEEe
Confidence 47899999999999999999999999999999875544455566788899999998 89999999988764 44689999
Q ss_pred ecCCCCch-hhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---C
Q 011331 309 ELCDHSLS-DKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---L 380 (488)
Q Consensus 309 E~~~~~l~-~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~ 380 (488)
||+.++.+ ... ....+++.+++.++.||+.||.+||+.||+|+||||+||++ .++.++|+|||++...... .
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 99987533 322 23458999999999999999999999999999999999999 5789999999999866432 2
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCC-CCCCCCcHHHHHHHHHcc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKL-PLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~-~~~~~~s~~l~~lI~k~L 456 (488)
....|++.|+|||++... .++.++|||||||++|+|++|..||...... ..+..+.. +.+...+.++.++|.+||
T Consensus 160 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd08223 160 STLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATML 238 (257)
T ss_pred ccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHh
Confidence 234588999999998765 5677999999999999999999988754321 22333333 344567899999999999
Q ss_pred cCCCCCCCCHHHHHhChhh
Q 011331 457 DPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 457 ~~dP~~RpTa~elL~HP~f 475 (488)
+.||++|||+.++++||||
T Consensus 239 ~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 239 SKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ccCcccCCCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=327.49 Aligned_cols=244 Identities=30% Similarity=0.455 Sum_probs=199.7
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc--ceEEEEE
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN--EQLYIQM 308 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~--~~l~IV~ 308 (488)
|++++.||+|+||.||+|.+..++..||+|+++..... ........|+.++.++.+|+||+++++++.++ +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC-chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 57899999999999999999999999999998654322 22334567999999987799999999999987 8899999
Q ss_pred ecCCCCchhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCceecCCCC--CCCC
Q 011331 309 ELCDHSLSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSL--PIEE 384 (488)
Q Consensus 309 E~~~~~l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~~~~~~--~~~~ 384 (488)
||+++++...... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++++.++|+|||++....... ....
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~~~~~ 159 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYI 159 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCeEEEecccccccccCCCcCCCC
Confidence 9999887764432 46899999999999999999999999999999999999966999999999998764322 2345
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hh---c---------------CCC-----
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LR---D---------------GKL----- 438 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~---~---------------~~~----- 438 (488)
++..|+|||++.....++.++|||||||++|||++|.+||........ +. . ...
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd07831 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSK 239 (282)
T ss_pred CCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCccc
Confidence 788999999875543466799999999999999999998865432110 00 0 000
Q ss_pred ------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 439 ------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 439 ------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
...+..+.++.++|.+||.++|++|||++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 240 KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1123567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=338.05 Aligned_cols=246 Identities=21% Similarity=0.311 Sum_probs=194.2
Q ss_pred cceeEEEEecccCcEEEEEEEEc-----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc-c
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN-E 302 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~-~ 302 (488)
++|++++.||+|+||.||+|.+. .++..||||++... ........+..|+.++..+.+||||+++++++... +
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 47899999999999999999752 34678999998754 23344567889999999998899999999988764 4
Q ss_pred eEEEEEecCCCCchh-hhh-------------------------------------------------------------
Q 011331 303 QLYIQMELCDHSLSD-KKA------------------------------------------------------------- 320 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~-~~~------------------------------------------------------------- 320 (488)
.+|++|||++++.+. ...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999875332 111
Q ss_pred --cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-----CCCCCCCCCccCh
Q 011331 321 --SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-----LPIEEGDARYMPQ 392 (488)
Q Consensus 321 --~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~AP 392 (488)
...+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++..... .....++..|+||
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 1237778899999999999999999999999999999999 5789999999999865321 1123356789999
Q ss_pred hhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---h-hhhhcC-CCCCCCCCcHHHHHHHHHcccCCCCCCCCH
Q 011331 393 EILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---F-LNLRDG-KLPLLPGHSLQFQNLLKVMVDPDPVQRPSA 466 (488)
Q Consensus 393 Evl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~-~~i~~~-~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa 466 (488)
|++... .++.++|||||||+||||++ |..||..... + ..+..+ ....+...+.++.++|.+||+.||++|||+
T Consensus 246 E~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 324 (338)
T cd05102 246 ESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTF 324 (338)
T ss_pred HHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence 998765 57789999999999999997 8888875332 1 222222 233455678999999999999999999999
Q ss_pred HHHHhChhhhhh
Q 011331 467 KELVENPIFDKI 478 (488)
Q Consensus 467 ~elL~HP~f~~i 478 (488)
.|+++. |+.+
T Consensus 325 ~el~~~--l~~~ 334 (338)
T cd05102 325 SALVEI--LGDL 334 (338)
T ss_pred HHHHHH--HHHH
Confidence 999873 4443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=317.72 Aligned_cols=244 Identities=30% Similarity=0.474 Sum_probs=205.6
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|.+.+.||+|++|.||+|.+..+|..|++|.+............+..|+.+++.+ +||||+++++++..++..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEEE
Confidence 47889999999999999999999999999999875544566677888999999998 89999999999999999999999
Q ss_pred cCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---C
Q 011331 310 LCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---P 381 (488)
Q Consensus 310 ~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---~ 381 (488)
|+.++ +..... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++....... .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 99765 333221 2468899999999999999999999999999999999999 56899999999998764332 2
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCC-CCCCCcHHHHHHHHHccc
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLP-LLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~-~~~~~s~~l~~lI~k~L~ 457 (488)
...|+..|+|||++... .++.++|||||||++|+|++|..||...... ..+..+..+ .+..++.++.++|.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08529 160 TIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238 (256)
T ss_pred ccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 34588899999998765 4677999999999999999999998765432 222333333 333678899999999999
Q ss_pred CCCCCCCCHHHHHhChhh
Q 011331 458 PDPVQRPSAKELVENPIF 475 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f 475 (488)
.+|++||++.++++|||+
T Consensus 239 ~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 239 KDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCcccCcCHHHHhhCCCC
Confidence 999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=327.71 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=203.5
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++.+.||.|++|+||+|.+..+|..||+|++............+..|+.+++.+ +|+||+++++++...+..|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEEE
Confidence 578999999999999999999999999999998865433333345677899999999 8999999999999999999999
Q ss_pred ecCCCCchhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--CCeEEEEeecCceecCCC---C
Q 011331 309 ELCDHSLSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDFGRATLLNKS---L 380 (488)
Q Consensus 309 E~~~~~l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~g~vkL~DFGlA~~~~~~---~ 380 (488)
||+++++...... ..+++..++.++.||+.||.|||++|++|+||+|+||+++ ++.+||+|||++...... .
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 9998876553322 2257888999999999999999999999999999999995 457999999999765322 2
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc------C-----------------C
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD------G-----------------K 437 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~------~-----------------~ 437 (488)
....+++.|+|||++.+...++.++|||||||++|+|++|.+||........+.. . .
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA 240 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence 2345788999999987654567799999999999999999999875433211110 0 0
Q ss_pred CC---------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 438 LP---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 438 ~~---------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.+ ..+..+.++.++|.+||+.+|++||++.++++||||..+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 00 1245688899999999999999999999999999998764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=340.54 Aligned_cols=247 Identities=21% Similarity=0.315 Sum_probs=214.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..+|++.+.||+|.||+|-+|.....|+.||||.+++... ...+.....+|++|+..| +||||+.+|++|+..+.+.|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceEEE
Confidence 4478999999999999999999989999999999877643 344566788999999999 99999999999999999999
Q ss_pred EEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC--CCC
Q 011331 307 QMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK--SLP 381 (488)
Q Consensus 307 V~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~--~~~ 381 (488)
||||..++-+. ....+.+++.+++.+++||+.|+.|+|+++++|||||.+|||+ .++++||+|||++..+.. -..
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence 99999876333 4445679999999999999999999999999999999999999 678999999999987743 346
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccC
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~ 458 (488)
+.+|++-|.+||++++...-++.+|-|||||+||.|+.|..||++.+. ...+..+.+.-+ ..+..+.-||++||..
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP-~~PSdA~gLIRwmLmV 289 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP-ETPSDASGLIRWMLMV 289 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC-CCCchHHHHHHHHHhc
Confidence 789999999999999876667899999999999999999999988655 234555555443 3566788999999999
Q ss_pred CCCCCCCHHHHHhChhhh
Q 011331 459 DPVQRPSAKELVENPIFD 476 (488)
Q Consensus 459 dP~~RpTa~elL~HP~f~ 476 (488)
+|++|.|+.++-.|.|+.
T Consensus 290 NP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 290 NPERRATIEDIASHWWVN 307 (668)
T ss_pred CcccchhHHHHhhhheee
Confidence 999999999999999974
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=332.69 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=201.7
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc--ceE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN--EQL 304 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~--~~l 304 (488)
...+|++.+.||.|+||+||+|.+..+|..||+|++...............|+.++.++ +|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeE
Confidence 35679999999999999999999999999999999864432222233456799999998 899999999998754 568
Q ss_pred EEEEecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--
Q 011331 305 YIQMELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-- 379 (488)
|+||||+++++..... ...+++..++.++.||+.||.|||+.|++|+||||+||++ .++.++|+|||++......
T Consensus 84 ~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 84 FLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 9999999987655332 3568999999999999999999999999999999999999 6789999999999876532
Q ss_pred -CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hc-------------------C
Q 011331 380 -LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RD-------------------G 436 (488)
Q Consensus 380 -~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~-------------------~ 436 (488)
.....++..|+|||++.+...++.++|||||||++|||++|.+||........+ .. .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 222345778999999876545778999999999999999999998755432211 10 0
Q ss_pred CCCC-----------CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 437 KLPL-----------LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 437 ~~~~-----------~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.... ....+.++.++|.+||++||++|||+.+++.||||++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0000 12247889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=326.57 Aligned_cols=246 Identities=27% Similarity=0.405 Sum_probs=202.6
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++.+.||.|+||.||+|.+..+|..||+|++............+..|+.++..+ +|+||+++++++.....+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEec
Confidence 47899999999999999999998999999999876543344456788899999999 79999999999999999999999
Q ss_pred cCCCCchhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----CCC
Q 011331 310 LCDHSLSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----LPI 382 (488)
Q Consensus 310 ~~~~~l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----~~~ 382 (488)
|+.+++.... ....+++..++.++.||+.||.|||+.|++|+||||+||++ .++.++|+|||++...... ...
T Consensus 80 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 80 YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9955555533 23568999999999999999999999999999999999999 6789999999999876443 233
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---h---------------------cCCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---R---------------------DGKL 438 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~---------------------~~~~ 438 (488)
..|+..|+|||.+.....++.++|||||||++|||++|.+++........+ . ....
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 468899999999866545677999999999999999998777544321110 0 0000
Q ss_pred ---------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhh
Q 011331 439 ---------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFD 476 (488)
Q Consensus 439 ---------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~ 476 (488)
...+..+..+.++|.+||..+|++|||++++++||||.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 11234578899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=343.09 Aligned_cols=245 Identities=22% Similarity=0.277 Sum_probs=198.7
Q ss_pred ccceeEEEEecccCcEEEEEEEEc--CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKR--IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~--~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
..+|++++.||.|+||.||+|... .++..||+|.+... ....+|+.+++.+ +||||+++++++...+.+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTI-SHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhc-CCCCccceeeeEeeCCEEE
Confidence 347999999999999999999764 35688999987532 1245799999999 8999999999999999999
Q ss_pred EEEecCCCCchhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---
Q 011331 306 IQMELCDHSLSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL--- 380 (488)
Q Consensus 306 IV~E~~~~~l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~--- 380 (488)
++||++.+.+.... ....+++.+++.++.||+.||.|||++|||||||||+|||+ .++.++|+|||++.......
T Consensus 163 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 163 MVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred EEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 99999988776643 34569999999999999999999999999999999999999 67899999999997654321
Q ss_pred --CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh------hhhhhc-----------------
Q 011331 381 --PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ------FLNLRD----------------- 435 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------~~~i~~----------------- 435 (488)
....||+.|+|||++... .++.++|||||||++|||++|..||..... +..+..
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred cccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 234699999999998765 577799999999999999999988864321 111000
Q ss_pred ------------CCCCCC-----CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHh
Q 011331 436 ------------GKLPLL-----PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481 (488)
Q Consensus 436 ------------~~~~~~-----~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~ 481 (488)
.....+ ..++.++++||.+||..||++|||+.|+|.||||+.....
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence 000011 1346688999999999999999999999999999876543
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=327.64 Aligned_cols=246 Identities=28% Similarity=0.442 Sum_probs=202.0
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||.||+|.+..+++.||+|++............+..|+.++..+ +||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEEE
Confidence 368999999999999999999998999999998765433333345677899999998 8999999999999999999999
Q ss_pred ecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 309 ELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 309 E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
||++++++.... ...+++..++.++.||+.||.|||+.||+|+||+|+||++ .++.++|+|||++...... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 999987665332 2358999999999999999999999999999999999999 6789999999998765332 123
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hh---------------------cCCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LR---------------------DGKL 438 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~---------------------~~~~ 438 (488)
..++..|+|||++.+...++.++|||||||++|||++|.+||........ +. ....
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 45788999999986544566799999999999999999988864332110 00 0000
Q ss_pred ----------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 439 ----------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 439 ----------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
...+.++..+.+||.+||..+|++||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 1134568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=327.40 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=206.9
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
+.|++++.||.|+||.||+|.+..++..||+|++... .......+..|+.+++.+ +|+||+++++.+..++.+|+||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeEEEEE
Confidence 4589999999999999999999999999999998643 344566788899999998 8999999999999999999999
Q ss_pred ecCCCCchhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CC
Q 011331 309 ELCDHSLSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LP 381 (488)
Q Consensus 309 E~~~~~l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~ 381 (488)
||++++.+... ....+++..++.++.||+.||.|||+.|++|+||||+||++ .++.++|+|||++...... ..
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 99998765422 23468999999999999999999999999999999999999 5789999999998754322 22
Q ss_pred CCCCCCCccChhhhcc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCC---CCCCCCCcHHHHHH
Q 011331 382 IEEGDARYMPQEILNE----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGK---LPLLPGHSLQFQNL 451 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~---~~~~~~~s~~l~~l 451 (488)
...++..|+|||++.. ...++.++|||||||++|||++|.+|+....... .+.... ...+..++.++.++
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence 3458889999998842 2345678999999999999999999986543322 222222 22344678899999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhhHHhh
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKIQKHR 482 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i~~~~ 482 (488)
|.+||..+|++||+++++++||||..+...+
T Consensus 249 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 249 LKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred HHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 9999999999999999999999998775443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=343.03 Aligned_cols=252 Identities=24% Similarity=0.316 Sum_probs=215.7
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
+.|...+.||+||||.||-|..+.||+.||+|.+.+.... .....-++.|-++|.++ +.+.||.+-.+|++.+.+++|
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEEE
Confidence 4678889999999999999999999999999988544322 23345588899999999 889999999999999999999
Q ss_pred EecCCCCchh----hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 308 MELCDHSLSD----KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 308 ~E~~~~~l~~----~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
|..|+|+-+. ...+..+++..++.++.+|+.||++||+.+||+|||||+|||+ +.|+++|+|+|+|..+....
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 9999987554 2333579999999999999999999999999999999999999 66999999999999886543
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-------hhhhhcCCCCCCCCCcHHHHHHHH
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-------FLNLRDGKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~~~i~~~~~~~~~~~s~~l~~lI~ 453 (488)
...+||.+|||||++.++. |+...|+|||||+||||+.|+.||...-. ...+.......+...|++++++.+
T Consensus 344 ~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~ 422 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCE 422 (591)
T ss_pred ccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHH
Confidence 3457999999999998874 88899999999999999999999864321 122344555667888999999999
Q ss_pred HcccCCCCCCC-----CHHHHHhChhhhhhHHhh
Q 011331 454 VMVDPDPVQRP-----SAKELVENPIFDKIQKHR 482 (488)
Q Consensus 454 k~L~~dP~~Rp-----Ta~elL~HP~f~~i~~~~ 482 (488)
.+|++||++|. .++++.+||||+.+++.+
T Consensus 423 ~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 423 GLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred HHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 99999999996 488999999999998765
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.41 Aligned_cols=247 Identities=29% Similarity=0.393 Sum_probs=202.0
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++.+.||+|+||.||++.+..+|..||+|.+.... .......+..|++++.++ +||||+++++++..++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEEe
Confidence 36899999999999999999999999999999886542 334456688899999999 9999999999999999999999
Q ss_pred ecCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-CCCC
Q 011331 309 ELCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-LPIE 383 (488)
Q Consensus 309 E~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-~~~~ 383 (488)
||++++.+. . .....+++..+..++.||+.||.|||+ .+++|+||||+|||+ .++.++|+|||++...... ....
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 158 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccC
Confidence 999875443 2 234568999999999999999999997 699999999999999 6789999999998765332 2345
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh--hhhc--------------------------
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL--NLRD-------------------------- 435 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~--~i~~-------------------------- 435 (488)
.|+..|+|||++.+. .++.++|||||||++|+|++|..|+....... ....
T Consensus 159 ~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 159 VGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 688999999998654 46779999999999999999998875432211 0000
Q ss_pred -----------CCCCCC--CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 436 -----------GKLPLL--PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 436 -----------~~~~~~--~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
...+.. ..++.++.+||.+||..+|++|||+.++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000111 1257789999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=327.16 Aligned_cols=245 Identities=24% Similarity=0.339 Sum_probs=197.6
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||.||+|.+..+|..||+|++..... ......+.+|+.+++.+ +|+||+++++++..++..|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEEEE
Confidence 578999999999999999999999999999999864422 12223466799999998 8999999999999999999999
Q ss_pred ecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 309 ELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 309 E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
||+.+++..... ...+++..+..++.||+.||.|||+.||+|+||||+||++ .++.++|+|||+++..... ...
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence 999887665332 2457888899999999999999999999999999999999 6789999999998754321 233
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh----hh------------------c---CC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN----LR------------------D---GK 437 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~----i~------------------~---~~ 437 (488)
..++..|+|||.+.+...++.++|||||||++|||++|..||.......+ +. . ..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence 45788999999986544567799999999999999999999875432111 00 0 00
Q ss_pred CC-C-C---------CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 438 LP-L-L---------PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 438 ~~-~-~---------~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
.+ . + ...+.++.++|.+||..||.+|||++|++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 0 0 0125688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=332.67 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=223.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|..++.||+|.||+|.+|+.+.+|+.||||++++.... ..+...-+.|-.+|... +||.+..|-..|+.++++|+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEEE
Confidence 56889999999999999999999999999999999876433 34556778899999998 99999999999999999999
Q ss_pred EEecCCCC--chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceec---CCCC
Q 011331 307 QMELCDHS--LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL---NKSL 380 (488)
Q Consensus 307 V~E~~~~~--l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~---~~~~ 380 (488)
||||.+|+ +.+......+++..++.+-..|+.||.|||+++||+||||.+|+|+ .+|++||+|||+++.. +...
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccccee
Confidence 99999886 2335555679999999999999999999999999999999999999 7899999999999743 3445
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
.+.+||+.|+|||++... +|+.++|+|.+||++|||++|+.||+..+. +.-|....+.+|..+++++..|+..+|.
T Consensus 326 kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~ 404 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLK 404 (516)
T ss_pred ccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhh
Confidence 678999999999999776 788999999999999999999999987655 4455677888999999999999999999
Q ss_pred CCCCCCCC-----HHHHHhChhhhhhHH
Q 011331 458 PDPVQRPS-----AKELVENPIFDKIQK 480 (488)
Q Consensus 458 ~dP~~RpT-----a~elL~HP~f~~i~~ 480 (488)
+||.+|.. |.|+.+|+||..+.+
T Consensus 405 kdP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 405 KDPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred cChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 99999964 999999999999865
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=325.78 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=206.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||.|+||+||+|.+..++..||+|++... .......+..|+.+++.+ +|+||+++++++..+..+|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEEEEe
Confidence 4688999999999999999999889999999998643 334456788899999999 7999999999999999999999
Q ss_pred ecCCCCchhhh-h--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CC
Q 011331 309 ELCDHSLSDKK-A--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LP 381 (488)
Q Consensus 309 E~~~~~l~~~~-~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~ 381 (488)
||++++.+... . ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++...... ..
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 99988655422 2 2458999999999999999999999999999999999999 6789999999998655322 22
Q ss_pred CCCCCCCccChhhhccc----CCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCC---CCCCCCCcHHHHHH
Q 011331 382 IEEGDARYMPQEILNED----YDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGK---LPLLPGHSLQFQNL 451 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~----~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~---~~~~~~~s~~l~~l 451 (488)
...|+..|+|||++..+ ..++.++|||||||++|+|++|.+||....... .+..+. ...+..++.++.++
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF 241 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence 34588999999997522 235568999999999999999999987654322 222222 22345678999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhhHHh
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKIQKH 481 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i~~~ 481 (488)
|.+||+.+|.+||++.++++||||......
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 271 (280)
T cd06611 242 LKSCLVKDPDDRPTAAELLKHPFVSDQSDN 271 (280)
T ss_pred HHHHhccChhhCcCHHHHhcChhhcccchh
Confidence 999999999999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=327.03 Aligned_cols=250 Identities=29% Similarity=0.441 Sum_probs=203.9
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|+.++.||+|+||+||++.+..+|..||+|.+...... .....+..|+.++.++.+|+||+++++++...+..+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 567788999999999999999999999999998654322 4456688899999999669999999999999999999999
Q ss_pred cCCCCchhh------hhcccCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--
Q 011331 310 LCDHSLSDK------KASQFFAEGEVLKALHQIAQALQFIHEK-GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 310 ~~~~~l~~~------~~~~~l~~~~~~~i~~qI~~gL~yLH~~-gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-- 379 (488)
|+...+... .....+++..+..++.|++.||+|||+. ||+|+||||+||++ .++.++|+|||++......
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 998754331 1235689999999999999999999974 99999999999999 5789999999999765432
Q ss_pred CCCCCCCCCccChhhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCchhh-hh---hhcCCCCC-----CCCCcHHH
Q 011331 380 LPIEEGDARYMPQEILNED--YDHLDKVDIFSLGATMYELIKGSPLSESGPQF-LN---LRDGKLPL-----LPGHSLQF 448 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~--~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~-~~---i~~~~~~~-----~~~~s~~l 448 (488)
.....|+..|+|||++... ..++.++|||||||++|+|++|..||...... .. +..+..+. ...++.++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSF 243 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHH
Confidence 2234588999999998754 35677999999999999999999998654321 11 11122111 12368899
Q ss_pred HHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 449 QNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 449 ~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
.+||.+||..||++|||++++++||||+....
T Consensus 244 ~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~ 275 (288)
T cd06616 244 VNFINLCLIKDESKRPKYKELLEHPFIKDYEE 275 (288)
T ss_pred HHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence 99999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=328.26 Aligned_cols=249 Identities=26% Similarity=0.410 Sum_probs=197.5
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc---
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE--- 302 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~--- 302 (488)
...++|++++.||+|+||.||+|.+..++..||||++...............|+.+++++ +||||+++++++...+
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPY 87 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccc
Confidence 345678999999999999999999999999999998864332222234456799999999 9999999999876543
Q ss_pred -----eEEEEEecCCCCchhhhhcc--cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCce
Q 011331 303 -----QLYIQMELCDHSLSDKKASQ--FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRAT 374 (488)
Q Consensus 303 -----~l~IV~E~~~~~l~~~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~ 374 (488)
..|+||||+.+++....... .+++.+++.++.||+.||.|||++|++|+||||+||++ .++.++|+|||++.
T Consensus 88 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 88 NRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred cCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 45999999998766644333 68999999999999999999999999999999999999 67899999999997
Q ss_pred ecCCCC-------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hc--CC-----
Q 011331 375 LLNKSL-------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RD--GK----- 437 (488)
Q Consensus 375 ~~~~~~-------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~--~~----- 437 (488)
...... ....++..|+|||.+.+...++.++||||||+++|||++|.+|+......... .. +.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 653221 12347788999998866545677999999999999999999888654332110 00 00
Q ss_pred ------------CCC-------------CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 438 ------------LPL-------------LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 438 ------------~~~-------------~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
... ....+..+.+||.+||..||.+|||++|+|+||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 000 01125677899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=319.09 Aligned_cols=245 Identities=25% Similarity=0.375 Sum_probs=202.1
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++.+.||.|+||+||+|.+..++..||+|++....... ....+.+|+.++..+ +|+||+++++.+...+..|++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEEE
Confidence 36899999999999999999998899999999986543332 556788899999998 9999999999999999999999
Q ss_pred ecCCCCchh-hhh----cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 309 ELCDHSLSD-KKA----SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 309 E~~~~~l~~-~~~----~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
|++.++.+. ... ...+++..++.++.||+.||.|||+.||+|+||+|+||++ +++.++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999876433 222 1358999999999999999999999999999999999999 57899999999987654321
Q ss_pred -----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCCC---C---CCCCcH
Q 011331 381 -----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKLP---L---LPGHSL 446 (488)
Q Consensus 381 -----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~~---~---~~~~s~ 446 (488)
....|+..|+|||++.....++.++|+|||||++|+|++|..||....... .......+ . ...++.
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 223588999999998765456779999999999999999999987654322 22222111 1 125678
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 447 QFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
++.++|.+||..||++|||+.+|++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=367.27 Aligned_cols=252 Identities=28% Similarity=0.471 Sum_probs=206.3
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc--cce
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE--NEQ 303 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~--~~~ 303 (488)
....+|++++.||+|+||+||+|.+..++..||+|++............+..|+.++..+ +|||||+++++|.+ ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCE
Confidence 345689999999999999999999999999999999876545556667789999999999 89999999998854 457
Q ss_pred EEEEEecCCCC-chhhhh-----cccCCHHHHHHHHHHHHHHHHHHHHc-------CcccCCCCCCcEEEeC--------
Q 011331 304 LYIQMELCDHS-LSDKKA-----SQFFAEGEVLKALHQIAQALQFIHEK-------GIAHLDVKPDNIYVKN-------- 362 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~-------gIiHrDLKp~NILv~~-------- 362 (488)
+||||||+.++ |..... ...+++..++.|+.||+.||.|||+. +|||+||||+||||..
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 99999999875 433222 24699999999999999999999985 4999999999999942
Q ss_pred ----------CeEEEEeecCceecCCC--CCCCCCCCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCchh
Q 011331 363 ----------GVYKLGDFGRATLLNKS--LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQ 429 (488)
Q Consensus 363 ----------g~vkL~DFGlA~~~~~~--~~~~~Gt~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~ 429 (488)
+.+||+|||++...... .....||+.|+|||++... ..++.++|||||||+||||++|..||.....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 24899999999866432 2344699999999998542 3467799999999999999999999976543
Q ss_pred hhh----hhcCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 430 FLN----LRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 430 ~~~----i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+.. +...........+.++.+||..||..+|.+||++.|+|.||||+.+
T Consensus 249 ~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 249 FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 322 2222222334578999999999999999999999999999999865
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=322.49 Aligned_cols=243 Identities=24% Similarity=0.369 Sum_probs=196.6
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc------ce
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN------EQ 303 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~------~~ 303 (488)
.|++.+.||.|+||+||+|.+..+++.||+|++.... .....+..|+.++..+.+|+||+++++++... ..
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 5778889999999999999999999999999986432 22345778999999987899999999988753 46
Q ss_pred EEEEEecCCCCchh-hhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 304 LYIQMELCDHSLSD-KKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 304 l~IV~E~~~~~l~~-~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
+|++|||+.++.+. ... ...+++..+..++.||+.||.|||++||+|+||||+||++ .++.++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 89999999875333 222 2358999999999999999999999999999999999999 678999999999986543
Q ss_pred C---CCCCCCCCCccChhhhcc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hcC--CCCCCCCCcH
Q 011331 379 S---LPIEEGDARYMPQEILNE----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RDG--KLPLLPGHSL 446 (488)
Q Consensus 379 ~---~~~~~Gt~~Y~APEvl~~----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~~--~~~~~~~~s~ 446 (488)
. .....|+..|+|||++.. ...++.++|||||||++|||++|..|+......... ... ........+.
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 243 (272)
T ss_pred ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCH
Confidence 2 233468999999999852 224667999999999999999999998654332211 111 1122345688
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 447 QFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
++.+||.+||..+|.+|||+.++++||||
T Consensus 244 ~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 244 KFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=336.23 Aligned_cols=241 Identities=26% Similarity=0.437 Sum_probs=209.7
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEec
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMEL 310 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~ 310 (488)
|.++++||+|+||.||+|.++.+|..+|||.+. -+.+.++.+.|+.++.++ ..|+||++|+.+..+..+||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP----V~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP----VDTDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecC----ccchHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEeehhh
Confidence 568899999999999999999999999999874 345678899999999999 899999999999999999999999
Q ss_pred CCCC-chh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCC
Q 011331 311 CDHS-LSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIE 383 (488)
Q Consensus 311 ~~~~-l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~ 383 (488)
|+.+ ..+ ..++..+++.++..+++..+.||+|||...-||||||..|||+ ++|.+||+|||.|..+... ..+.
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcc
Confidence 9865 333 5566789999999999999999999999999999999999999 7999999999999877543 3456
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCCC------CCCCCcHHHHHHHHHccc
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLP------LLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~~------~~~~~s~~l~~lI~k~L~ 457 (488)
.||+.|||||++..- .|..++||||||++..||..|++|+..-.++..+...... -+...|.+|.+||++||.
T Consensus 190 IGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi 268 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI 268 (502)
T ss_pred ccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence 799999999999764 5667999999999999999999999876665444322211 233568899999999999
Q ss_pred CCCCCCCCHHHHHhChhhhh
Q 011331 458 PDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f~~ 477 (488)
+.|++|.||-+|++|||++.
T Consensus 269 K~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 269 KKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred CCHHHHHHHHHHhhhhhhcC
Confidence 99999999999999999975
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=346.52 Aligned_cols=239 Identities=24% Similarity=0.278 Sum_probs=193.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
..|.+.+.||+|+||.||+|.+..+++.||||.... .....|+++++++ +|+|||++++++..++..+|||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRL-SHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999999999999996421 2345799999999 9999999999999999999999
Q ss_pred ecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-----
Q 011331 309 ELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL----- 380 (488)
Q Consensus 309 E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~----- 380 (488)
|++.+++..... ...+++..++.++.||+.||.|||++|||||||||+|||| .++.++|+|||+++......
T Consensus 240 e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 240 PKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred EccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 999887766433 2358999999999999999999999999999999999999 67899999999998664321
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch----------hhhhh-hcCC-----CC-----
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP----------QFLNL-RDGK-----LP----- 439 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~----------~~~~i-~~~~-----~~----- 439 (488)
....||..|+|||++.+. .++.++|||||||+||||++|..++.... ...++ .... .+
T Consensus 320 ~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred cccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 124599999999998765 57789999999999999999875433211 11111 1100 00
Q ss_pred ---------------------C---CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 440 ---------------------L---LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 440 ---------------------~---~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
. ...++.++.+||.+||+.||.+|||+.|||+||||+.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 0123557899999999999999999999999999964
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=324.10 Aligned_cols=244 Identities=25% Similarity=0.393 Sum_probs=197.5
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc------cc
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE------NE 302 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~------~~ 302 (488)
+.|++.+.||.|+||+||+|.+..++..||+|++... ......+..|+.++.++.+|+||+++++++.. ..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 4678899999999999999999999999999987542 23445677899999998789999999998853 45
Q ss_pred eEEEEEecCCCC-chhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC
Q 011331 303 QLYIQMELCDHS-LSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN 377 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~ 377 (488)
.+|++|||+.++ +.... ....+++..++.++.||+.||.|||++||+|+||+|+||++ .++.++|+|||++....
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 789999999875 33322 23458888899999999999999999999999999999999 67899999999987653
Q ss_pred CC---CCCCCCCCCccChhhhcc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh---cCCC-C-CCCCCc
Q 011331 378 KS---LPIEEGDARYMPQEILNE----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR---DGKL-P-LLPGHS 445 (488)
Q Consensus 378 ~~---~~~~~Gt~~Y~APEvl~~----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~---~~~~-~-~~~~~s 445 (488)
.. .....|+..|+|||++.. ...++.++|||||||++|||++|..||........+. .... . ....++
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWS 252 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccC
Confidence 22 233568899999998752 2245678999999999999999999987654332221 1111 1 122468
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 446 LQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 446 ~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
.++.+||.+||..||.+|||+.||++||||
T Consensus 253 ~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.85 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=207.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
..+|++++.||.|+||.||+|.+..+|..||+|.+..... .....+..|+.++..+ +|+||+++++++...+..|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEEEEe
Confidence 4578999999999999999999999999999999864322 2335577889999888 999999999999999999999
Q ss_pred EecCCCCc-hhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 308 MELCDHSL-SDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 308 ~E~~~~~l-~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
|||++++. ........+++..+..++.|++.||.|||+.||+|+||||+|||+ .++.++|+|||++...... ...
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred ecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 99998754 444445678999999999999999999999999999999999999 6789999999998765432 223
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh----cC--CCCCCCCCcHHHHHHHHHcc
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR----DG--KLPLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~----~~--~~~~~~~~s~~l~~lI~k~L 456 (488)
..+++.|+|||.+.+. .++.++|||||||++|+|++|..||........+. .+ ....+...+..+.+||.+||
T Consensus 175 ~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (297)
T cd06656 175 MVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL 253 (297)
T ss_pred ccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHc
Confidence 4688899999998765 56789999999999999999999987654322211 11 11234456788999999999
Q ss_pred cCCCCCCCCHHHHHhChhhhhhHH
Q 011331 457 DPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 457 ~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
..+|++||+++++++||||+....
T Consensus 254 ~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 254 EMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred cCChhhCcCHHHHhcCchhccccc
Confidence 999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=325.51 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=205.2
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++++.||+|+||+||+|.+..+|..||+|.+... ........+.+|+.++.++ +|+||+++++.+..++.+|+|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEEEe
Confidence 688999999999999999999999999999988643 2344456788999999998 99999999999999999999999
Q ss_pred cCCCCchhh-hhc----ccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEE-eCCeEEEEeecCceecCC-CCC
Q 011331 310 LCDHSLSDK-KAS----QFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK-SLP 381 (488)
Q Consensus 310 ~~~~~l~~~-~~~----~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~-~~~ 381 (488)
|++++.+.. ... ..+++..+..++.||+.||.|||+ .||+|+||||+||++ .++.++|+|||++..... ...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence 998865442 222 268999999999999999999996 599999999999999 678999999999976533 233
Q ss_pred CCCCCCCccChhhhcccC-----CCCchhHHHHHHHHHHHHHcCCCCCCCchh---h---hhhhcC-CCCCCCCCcHHHH
Q 011331 382 IEEGDARYMPQEILNEDY-----DHLDKVDIFSLGATMYELIKGSPLSESGPQ---F---LNLRDG-KLPLLPGHSLQFQ 449 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~-----~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~---~~i~~~-~~~~~~~~s~~l~ 449 (488)
...|+..|+|||.+.... .++.++|||||||++|+|++|..||..... . ..+..+ ....++.++.++.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQ 239 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHH
Confidence 445888999999985431 346799999999999999999999865322 1 112222 2345566899999
Q ss_pred HHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 450 NLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+||.+||..+|++||+++++++||||....
T Consensus 240 ~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 240 DFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=335.92 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=203.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc-----ce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN-----EQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~-----~~ 303 (488)
++|++.+.||+|+||+||+|.+..+|..||||++... ........+..|+.++..+ +|+||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccce
Confidence 5799999999999999999999999999999998632 2223345677899999999 899999999876543 45
Q ss_pred EEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 304 LYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 304 l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
+|+++||+.+.+........+++..++.++.||+.||.|||+.||+|+||||+|||+ .++.++|+|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 83 VYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 899999999887776666789999999999999999999999999999999999999 67899999999997654321
Q ss_pred ----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh------------------hc---
Q 011331 381 ----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL------------------RD--- 435 (488)
Q Consensus 381 ----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i------------------~~--- 435 (488)
....|+..|+|||++.....++.++|||||||++|+|++|.+||......... ..
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhh
Confidence 22357899999998765445778999999999999999999988653221100 00
Q ss_pred ------C----CCC---CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 436 ------G----KLP---LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 436 ------~----~~~---~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
. ..+ ..+..+.++.++|.+||+.||++|||+.|+++||||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0 000 12346788999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=334.66 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=210.3
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc---
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE--- 302 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~--- 302 (488)
...++|++++.||+|+||+||+|.+..+|..||||++............+..|+.++..+ +|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCcccc
Confidence 345679999999999999999999999999999999865444444455688899999999 9999999999887654
Q ss_pred ---eEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 303 ---QLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 303 ---~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
.+++||||+++.+........+++..++.++.||+.||.|||+.||+|+||||+||++ .++.++|+|||++.....
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 91 RFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 3589999997777666666679999999999999999999999999999999999999 678999999999987765
Q ss_pred CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCC------------------
Q 011331 379 SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGK------------------ 437 (488)
Q Consensus 379 ~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~------------------ 437 (488)
......+++.|+|||.+.....++.++|+|||||++|+|++|.+||....... .+....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07880 171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250 (343)
T ss_pred CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHH
Confidence 55555688999999998764356779999999999999999999987543211 110000
Q ss_pred -------------CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 438 -------------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 438 -------------~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
....+.++.++.++|.+||..||.+|||+.++++||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0112456788999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=326.78 Aligned_cols=248 Identities=23% Similarity=0.385 Sum_probs=201.0
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc---hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH---DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~---~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
+|++.+.||.|+||.||+|.+..+|..||||.+...... ......+..|+.++..+ +|+||+++++++.+++.+|+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEE
Confidence 478899999999999999999989999999998754332 22344567899999999 89999999999999999999
Q ss_pred EEecCCCCchhhhhcc--cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---C
Q 011331 307 QMELCDHSLSDKKASQ--FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---L 380 (488)
Q Consensus 307 V~E~~~~~l~~~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~ 380 (488)
||||+.+.+....... .+++..++.++.||+.||.|||++||+|+||+|+||++ .++.++|+|||++...... .
T Consensus 80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999966565544333 58999999999999999999999999999999999999 6789999999999876543 2
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcC---------------------
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDG--------------------- 436 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~--------------------- 436 (488)
....++..|+|||.+.....++.++|||||||++|||++|.++|........ +...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 2334678899999986544567799999999999999999877654332111 1000
Q ss_pred -C-C-----CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 437 -K-L-----PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 437 -~-~-----~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
. . ......+.++.++|.+||.+||.+|||+.|+++||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 0 0 0113346789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=321.30 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=199.6
Q ss_pred ccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec----
Q 011331 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF---- 299 (488)
Q Consensus 224 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~---- 299 (488)
+....++|++++.||+|+||+||+|.+..++..||+|++.... .....+..|+.++..+.+|+||+++++++.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 3445678999999999999999999999999999999875421 122446678899999877999999999874
Q ss_pred -ccceEEEEEecCCCCchh-h-----hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeec
Q 011331 300 -ENEQLYIQMELCDHSLSD-K-----KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFG 371 (488)
Q Consensus 300 -~~~~l~IV~E~~~~~l~~-~-----~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFG 371 (488)
..+.+|+||||++++.+. . .....+++..++.++.||+.||.|||+.+|+|+||||+||++ .++.++|+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 456789999999876443 2 123458889999999999999999999999999999999999 67889999999
Q ss_pred CceecCCC---CCCCCCCCCccChhhhccc----CCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh---cCC---C
Q 011331 372 RATLLNKS---LPIEEGDARYMPQEILNED----YDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR---DGK---L 438 (488)
Q Consensus 372 lA~~~~~~---~~~~~Gt~~Y~APEvl~~~----~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~---~~~---~ 438 (488)
++...... .....|+..|+|||++... ..++.++|||||||++|||++|..|+........+. ... .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd06638 170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249 (286)
T ss_pred ceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcc
Confidence 99866432 2234589999999987532 235679999999999999999999987654432221 111 1
Q ss_pred CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 439 PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 439 ~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
..+...+.++.++|.+||+.||++|||+.||++|+||
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 1233457889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=327.41 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=200.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc--ceEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN--EQLY 305 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~--~~l~ 305 (488)
.++|++.+.||.|+||.||+|.+..++..||+|.++...........+.+|+.++..+ +||||+++++++... +.+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEE
Confidence 3578999999999999999999998999999999875433333334567899999999 799999999998877 8899
Q ss_pred EEEecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---
Q 011331 306 IQMELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 306 IV~E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--- 379 (488)
|||||+++++..... ...+++..++.++.||+.||.|||+.||+|+||||+||++ .++.++|+|||++......
T Consensus 83 lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 83 MVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred EEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 999999987655332 2358999999999999999999999999999999999999 6789999999999876543
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh---c---------------------
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR---D--------------------- 435 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~---~--------------------- 435 (488)
.....++..|+|||.+.+...++.++||||||+++|+|++|.+||........+. .
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 2234578899999998765456779999999999999999999887543221110 0
Q ss_pred C----------CCCCCCC-CcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 436 G----------KLPLLPG-HSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 436 ~----------~~~~~~~-~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
. ...++.. ++..+.++|.+||+.||++|||+.|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0 0011112 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=324.63 Aligned_cols=245 Identities=29% Similarity=0.440 Sum_probs=203.2
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++.+.||.|+||.||+|.+..++..||||+++...........+..|+++++.+ +|+||+++++++..++.+|++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEEEe
Confidence 68999999999999999999999999999999875444444456788899999999 79999999999999999999999
Q ss_pred cCCCCchhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC----CC
Q 011331 310 LCDHSLSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL----PI 382 (488)
Q Consensus 310 ~~~~~l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~----~~ 382 (488)
|++++++... ....+++..++.++.||+.||.|||+.|++|+||+|+||++ .++.++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 9998866532 23458999999999999999999999999999999999999 67899999999998765432 23
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hc--------------------C-CC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RD--------------------G-KL 438 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~--------------------~-~~ 438 (488)
..++..|+|||++.....++.++||||||+++|+|++|.+||........+ .. + ..
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence 457889999999876545778999999999999999999888643221100 00 0 00
Q ss_pred -----------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 439 -----------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 439 -----------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
..+..++.++.+||++||..+|++|||++++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0122347889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=323.39 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=195.4
Q ss_pred EecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-HHHHHHHHHHHHHHHh--CCCCCeeEeeeeecccceEEEEEecCC
Q 011331 236 QIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAAL--GSHENIVGYYSSWFENEQLYIQMELCD 312 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~iL~~l--~~HpnIv~l~~~~~~~~~l~IV~E~~~ 312 (488)
.||+|+||.||+|.+..+|..||+|.+.+..... ........|..++..+ .+|+||+.+++.+...+..|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999999999999999886543221 2222233444333332 379999999999999999999999998
Q ss_pred CCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-CCCCCCCCC
Q 011331 313 HSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-LPIEEGDAR 388 (488)
Q Consensus 313 ~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-~~~~~Gt~~ 388 (488)
++.+. ......+++..+..++.||+.||.|||++||+|+||||+|||+ .++.++|+|||++...... .....|+..
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 160 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 160 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCcC
Confidence 76544 2334569999999999999999999999999999999999999 6789999999999765432 223468999
Q ss_pred ccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh--hhhh----hcCCCCCCCCCcHHHHHHHHHcccCCCCC
Q 011331 389 YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ--FLNL----RDGKLPLLPGHSLQFQNLLKVMVDPDPVQ 462 (488)
Q Consensus 389 Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~--~~~i----~~~~~~~~~~~s~~l~~lI~k~L~~dP~~ 462 (488)
|+|||.+.....++.++|||||||++|+|++|..||..... ...+ .......++.++.++.++|.+||..||.+
T Consensus 161 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 240 (279)
T cd05633 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSK 240 (279)
T ss_pred ccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHH
Confidence 99999986544567799999999999999999999864321 1111 12233455678999999999999999999
Q ss_pred CC-----CHHHHHhChhhhhhHHhh
Q 011331 463 RP-----SAKELVENPIFDKIQKHR 482 (488)
Q Consensus 463 Rp-----Ta~elL~HP~f~~i~~~~ 482 (488)
|+ |++|+++||||+++....
T Consensus 241 R~~~~~~~~~~~~~h~~~~~~~~~~ 265 (279)
T cd05633 241 RLGCLGRGAQEVKEHVFFKGIDWQQ 265 (279)
T ss_pred hcCCCCCCHHHHHhCccccCCCHhH
Confidence 99 699999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=327.63 Aligned_cols=245 Identities=28% Similarity=0.417 Sum_probs=196.6
Q ss_pred ceeEEEEecccCcEEEEEEEEcC--CCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc--ceE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRI--DGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFEN--EQL 304 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~--~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~--~~l 304 (488)
+|++.+.||+|+||.||+|.+.. ++..||+|.+.... ...........|+.++..+ +||||+++++++.+. ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence 37899999999999999999988 89999999987532 1122234567899999998 899999999999988 789
Q ss_pred EEEEecCCCCchhhhh------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-e----CCeEEEEeecCc
Q 011331 305 YIQMELCDHSLSDKKA------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-K----NGVYKLGDFGRA 373 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~~------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~----~g~vkL~DFGlA 373 (488)
|+||||+++++..... ...+++..++.++.||+.||.|||+.||+|+||||+|||+ . ++.+||+|||++
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999999987654221 1368899999999999999999999999999999999999 5 689999999999
Q ss_pred eecCCCC------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh------------hhh-
Q 011331 374 TLLNKSL------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL------------NLR- 434 (488)
Q Consensus 374 ~~~~~~~------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~------------~i~- 434 (488)
....... ....++..|+|||++.+...++.++|||||||++|+|++|.+||....... .+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 8664322 123578899999988765456779999999999999999999886432110 000
Q ss_pred ------------------------cCCCCCCC------------CCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 435 ------------------------DGKLPLLP------------GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 435 ------------------------~~~~~~~~------------~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
.......+ ..+.++.++|.+||++||++|||+.|+++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00000111 456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=324.15 Aligned_cols=247 Identities=27% Similarity=0.417 Sum_probs=205.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
..+|++++.||+|+||.||+|.+..++..||+|.+...... ....+..|+.++..+ .|+||+++++.+......|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEEEe
Confidence 45789999999999999999999999999999988654322 235577899999888 999999999999999999999
Q ss_pred EecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 308 MELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 308 ~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
|||+.++ +........+++.++..++.||+.||.|||+.||+|+||||+|||+ .++.++|+|||++...... ...
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 9999875 4444445568999999999999999999999999999999999999 6789999999998765322 223
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh----hcC--CCCCCCCCcHHHHHHHHHcc
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL----RDG--KLPLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i----~~~--~~~~~~~~s~~l~~lI~k~L 456 (488)
..|++.|+|||.+... .++.++|||||||++|+|++|..||........+ ... ..+.+..++..+.++|.+||
T Consensus 176 ~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (296)
T cd06654 176 MVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (296)
T ss_pred ccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence 4688999999998765 4667999999999999999999998765432211 111 22334567889999999999
Q ss_pred cCCCCCCCCHHHHHhChhhhhh
Q 011331 457 DPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 457 ~~dP~~RpTa~elL~HP~f~~i 478 (488)
..+|++|||+.+++.||||...
T Consensus 255 ~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 255 DMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred cCCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=323.12 Aligned_cols=244 Identities=26% Similarity=0.412 Sum_probs=200.2
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++++.||.|++|+||+|.+..+|..||||++..... ......+..|+.+++.+ +|+||+++++++.+.+..+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEEe
Confidence 48899999999999999999999999999999875422 22234567899999999 89999999999999999999999
Q ss_pred cCCCCchhhhhc----ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CC
Q 011331 310 LCDHSLSDKKAS----QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LP 381 (488)
Q Consensus 310 ~~~~~l~~~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~ 381 (488)
|+++++...... ..+++..+..++.||+.||.|||+.|++|+||||+||++ +++.++|+|||++...... ..
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 79 YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred cCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 999876653322 358999999999999999999999999999999999999 6789999999999755322 22
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hh---------------c-----CCC
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LR---------------D-----GKL 438 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~---------------~-----~~~ 438 (488)
...++..|++||++.+...++.++|||||||++|+|++|.+||........ +. . ...
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 345788999999986654567799999999999999999998875432111 00 0 000
Q ss_pred C---------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 439 P---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 439 ~---------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
+ ..+..+.++.++|.+||+.||.+||++.|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 123457789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=315.69 Aligned_cols=244 Identities=32% Similarity=0.535 Sum_probs=204.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++++.||+|+||+||++.+..+|+.||+|.+............+..|+.+++.+ +|+||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEEe
Confidence 47899999999999999999999999999999865434445566788999999999 89999999999999999999999
Q ss_pred cCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---C
Q 011331 310 LCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---P 381 (488)
Q Consensus 310 ~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---~ 381 (488)
|+.++ +..... ...+++..++.++.||+.||.|||++|++|+||+|+|||+ .++.++|+|||++....... .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 99764 433222 2257899999999999999999999999999999999999 57899999999997664321 2
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCC-CCCCCCCcHHHHHHHHHccc
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGK-LPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~-~~~~~~~s~~l~~lI~k~L~ 457 (488)
...|+..|+|||++.+. ..+.++|+|||||++|+|++|..|+...... ..+..+. .+.+...+.++.++|.+||.
T Consensus 160 ~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 160 TCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred hccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhh
Confidence 23588899999998765 5677999999999999999999998755432 2222333 33455678999999999999
Q ss_pred CCCCCCCCHHHHHhChhh
Q 011331 458 PDPVQRPSAKELVENPIF 475 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f 475 (488)
.+|++||++.++++||||
T Consensus 239 ~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 239 RNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CChhhCcCHHHHhhCcCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=318.79 Aligned_cols=243 Identities=26% Similarity=0.367 Sum_probs=198.2
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.+|++++.||+|+||.||+|.+..+|..||+|++..... .....+..|+.++..+ +||||+++++++..++.+|+||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEE
Confidence 478999999999999999999999999999999864322 2234567899999998 9999999999999999999999
Q ss_pred ecCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 309 ELCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 309 E~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
||++++.+. . .....+++..+..++.||+.||.|||+.||+|+||+|+||++ .++.++|+|||++...... ...
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS 165 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence 999875443 2 234568999999999999999999999999999999999999 6788999999999866432 223
Q ss_pred CCCCCCccChhhhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hcCC--C---CCCCCCcHHHHHHH
Q 011331 383 EEGDARYMPQEILNE--DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RDGK--L---PLLPGHSLQFQNLL 452 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~--~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~~~--~---~~~~~~s~~l~~lI 452 (488)
..|+..|+|||.+.. ...++.++|||||||++|||++|..|+......... .... . .....++..+.+||
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFV 245 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHH
Confidence 458889999998742 223567999999999999999999988654332211 1111 1 11234678999999
Q ss_pred HHcccCCCCCCCCHHHHHhChh
Q 011331 453 KVMVDPDPVQRPSAKELVENPI 474 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~ 474 (488)
.+||..+|++|||++++++|+|
T Consensus 246 ~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 246 KISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHhhCChhhCcCHHHHhcCCC
Confidence 9999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=324.69 Aligned_cols=246 Identities=23% Similarity=0.368 Sum_probs=197.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++.+.||.|++|+||+|.+..++..||||.+...... .....+..|+.+++.+ +|+||+++++++.+++..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEE
Confidence 35789999999999999999999989999999998643221 1223456799999999 899999999999999999999
Q ss_pred EecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CC
Q 011331 308 MELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LP 381 (488)
Q Consensus 308 ~E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~ 381 (488)
|||+.+.+..... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||+++..... ..
T Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (291)
T cd07844 82 FEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS 161 (291)
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccc
Confidence 9999987655332 2468899999999999999999999999999999999999 6789999999998754321 12
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh----hhhh---c------------------C
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF----LNLR---D------------------G 436 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~----~~i~---~------------------~ 436 (488)
...++..|+|||++.+...++.++|||||||++|+|++|.+||...... ..+. . .
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY 241 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence 2346788999999876545778999999999999999999988644310 0000 0 0
Q ss_pred CC---------CCCCCCc--HHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 437 KL---------PLLPGHS--LQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 437 ~~---------~~~~~~s--~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
.. ...+..+ .++.++|.+||..+|.+|||+.|++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0011233 788899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=322.97 Aligned_cols=245 Identities=24% Similarity=0.383 Sum_probs=202.8
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEec
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMEL 310 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~ 310 (488)
|++++.||.|+||.||+|.+..++..+|+|.+... .......+..|+.++..+ +|+||+++++++...+..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEEEEe
Confidence 57889999999999999999999999999998643 234456688899999998 899999999999999999999999
Q ss_pred CCCCchhh-h--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCC
Q 011331 311 CDHSLSDK-K--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIE 383 (488)
Q Consensus 311 ~~~~l~~~-~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~ 383 (488)
+.++.+.. . ....+++..++.++.||+.||.|||+.||+|+||||+|||+ .++.++|+|||++...... ....
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 163 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence 98865542 2 23568999999999999999999999999999999999999 6789999999998755322 2234
Q ss_pred CCCCCccChhhhcc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcC---CCCCCCCCcHHHHHHHH
Q 011331 384 EGDARYMPQEILNE----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDG---KLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~---~~~~~~~~s~~l~~lI~ 453 (488)
.|+..|+|||++.. ...++.++|||||||++|||++|.+||....... .+... ....+..++.++.+||.
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK 243 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence 58899999999742 2245679999999999999999999987644322 22222 22334457889999999
Q ss_pred HcccCCCCCCCCHHHHHhChhhhhh
Q 011331 454 VMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+||..||.+||++.++++||||...
T Consensus 244 ~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 244 KCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHccCChhhCcCHHHHhcCCCEecc
Confidence 9999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=320.82 Aligned_cols=247 Identities=29% Similarity=0.439 Sum_probs=206.8
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++.+.||.|+||.||+|.+..+|..||+|++.... .......+..|+.+++.+ +|+||+++++++.+...+|+|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEEEE
Confidence 6788999999999999999999999999999986542 233445677899999999 79999999999999999999999
Q ss_pred cCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCCC
Q 011331 310 LCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIEE 384 (488)
Q Consensus 310 ~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~~ 384 (488)
|+.++ +........+++..++.++.||+.||.|||+.|++|+||+|+||++ .++.++|+|||+++..... .....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (274)
T cd06609 80 YCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV 159 (274)
T ss_pred eeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccccc
Confidence 99875 4444444578999999999999999999999999999999999999 6789999999999877543 23345
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCCC-CCCC-CcHHHHHHHHHcccCC
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKLP-LLPG-HSLQFQNLLKVMVDPD 459 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~~-~~~~-~s~~l~~lI~k~L~~d 459 (488)
|+..|+|||.+.+. .++.++|||||||++|+|++|..|+....... .+.....+ .... ++..+.++|.+||..+
T Consensus 160 ~~~~y~~PE~~~~~-~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~ 238 (274)
T cd06609 160 GTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKD 238 (274)
T ss_pred CCccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCC
Confidence 88899999998776 47789999999999999999999987544322 22222222 2223 6889999999999999
Q ss_pred CCCCCCHHHHHhChhhhhhH
Q 011331 460 PVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 460 P~~RpTa~elL~HP~f~~i~ 479 (488)
|++|||++++++||||+...
T Consensus 239 p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 239 PKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred hhhCcCHHHHhhChhhcCCC
Confidence 99999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=334.96 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=206.4
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc---
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE--- 302 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~--- 302 (488)
+...+|.+.+.||+|+||.||+|.+..+|..||||++............+.+|+.+++.+ +|+||+++++++....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCC
Confidence 445689999999999999999999998999999999875433333345678899999998 9999999999887543
Q ss_pred ---eEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 303 ---QLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 303 ---~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
.+|+||||+...+... ....+++..+..++.||+.||.|||+.||+||||||+||++ .++.++|+|||++.....
T Consensus 91 ~~~~~~lv~e~~~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 91 EFQDFYLVMPYMQTDLQKI-MGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred CCceEEEEecccccCHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 4699999998755443 23468999999999999999999999999999999999999 678999999999987655
Q ss_pred CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hc--------------------
Q 011331 379 SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RD-------------------- 435 (488)
Q Consensus 379 ~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~-------------------- 435 (488)
......++..|+|||.+.....++.++|||||||++|||++|+.||........+ ..
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (342)
T cd07879 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS 249 (342)
T ss_pred CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHH
Confidence 4444567889999999876445677999999999999999999998765422111 00
Q ss_pred -----CCC------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 436 -----GKL------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 436 -----~~~------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
... ...+..+.++.+||.+||+.||++||++++++.||||+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 012346778999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=323.54 Aligned_cols=244 Identities=27% Similarity=0.406 Sum_probs=199.7
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEec
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMEL 310 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~ 310 (488)
|++.+.||.|++|+||+|.+..+|..||+|++............+..|+.+++.+ +|+||+++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEec
Confidence 5678999999999999999999999999999865432223334577899999999 899999999999999999999999
Q ss_pred CCCCchhhhhcc---cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCC
Q 011331 311 CDHSLSDKKASQ---FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIE 383 (488)
Q Consensus 311 ~~~~l~~~~~~~---~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~ 383 (488)
+++.+....... .+++..++.++.||+.||.|||++|++|+||+|+||++ .++.++|+|||++...... ....
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 987766543322 58999999999999999999999999999999999999 6789999999999765322 2233
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc----------------------------
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD---------------------------- 435 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~---------------------------- 435 (488)
.++..|+|||++.....++.++||||||+++|+|++|.+||........+..
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence 5688999999886654567799999999999999999998865433211100
Q ss_pred CC----CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 436 GK----LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 436 ~~----~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
.. ....+.++.++.++|.+||+.||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00 01234567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=317.39 Aligned_cols=243 Identities=27% Similarity=0.395 Sum_probs=200.7
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-------HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-------AERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-------~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
|.+...||.|+||.||+|.+..++..||+|.+....... .....+.+|+.++.++ +||||+++++++...+.
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDADH 80 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCc
Confidence 677889999999999999998899999999886542221 1224577899999999 99999999999999999
Q ss_pred EEEEEecCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 304 LYIQMELCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 304 l~IV~E~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
.+++|||+.++.+. . .....+++..+..++.||+.||.|||+.|++|+||+|+||++ +++.++|+|||+++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999875443 2 223568899999999999999999999999999999999999 6789999999998766421
Q ss_pred --------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hcC-CCCCCCCCcHH
Q 011331 380 --------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RDG-KLPLLPGHSLQ 447 (488)
Q Consensus 380 --------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~~-~~~~~~~~s~~ 447 (488)
.....|+..|+|||.+... .++.++|||||||++|+|++|..||........+ ... ....+...+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1123578899999998765 5677999999999999999999998765443322 222 23344567899
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
+.++|.+||+.||.+||++.|+++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=313.22 Aligned_cols=244 Identities=31% Similarity=0.519 Sum_probs=205.9
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|+.++.||.|+||.||.+.+..++..|++|.+............+..|+.+++++ +|+||+++++++.+.+.++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEEE
Confidence 47899999999999999999999999999999875544556667788999999998 99999999999999999999999
Q ss_pred cCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---C
Q 011331 310 LCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---P 381 (488)
Q Consensus 310 ~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---~ 381 (488)
|+.++ +..... ...+++..+..++.|++.||.|||+.|++|+||+|+||++ .++.+||+|||++....... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 99875 433222 2358899999999999999999999999999999999999 67899999999998764332 3
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCC-CCCCCCcHHHHHHHHHccc
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKL-PLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~-~~~~~~s~~l~~lI~k~L~ 457 (488)
...|+..|+|||.+.+. .++.++||||||+++|||++|..||....... .+..+.. +.....+.++.++|.+||.
T Consensus 160 ~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08221 160 TVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQ 238 (256)
T ss_pred ccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 34689999999998765 46679999999999999999999987654322 2333322 3345678999999999999
Q ss_pred CCCCCCCCHHHHHhChhh
Q 011331 458 PDPVQRPSAKELVENPIF 475 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f 475 (488)
.+|.+||++.++++|||+
T Consensus 239 ~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 239 QDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cCcccCCCHHHHhhCcCC
Confidence 999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=313.44 Aligned_cols=244 Identities=28% Similarity=0.417 Sum_probs=204.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++.+.||+|+||.||+|.+..++..||||.+............+..|+.+++.+ +||||+++++.+...+.+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEEe
Confidence 47899999999999999999999999999999876544555667788999999999 89999999999999999999999
Q ss_pred cCCCCchh-hhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--CCeEEEEeecCceecCCCC--C
Q 011331 310 LCDHSLSD-KKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDFGRATLLNKSL--P 381 (488)
Q Consensus 310 ~~~~~l~~-~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~g~vkL~DFGlA~~~~~~~--~ 381 (488)
|++++.+. ... ...+++..++.++.|++.||.|||++||+|+||+|+||+++ ++.++|+|||++....... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 99875433 222 23489999999999999999999999999999999999994 3568999999998765332 2
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhh-cCCCCCCCCCcHHHHHHHHHccc
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLR-DGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~-~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
...|+..|+|||.+... .++.++||||||+++|+|++|..|+...... ..+. ....+.+...+.++.++|.+||.
T Consensus 160 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 238 (256)
T cd08220 160 TVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLN 238 (256)
T ss_pred ccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHcc
Confidence 34588899999998765 5677999999999999999999988765431 1222 22334555689999999999999
Q ss_pred CCCCCCCCHHHHHhChhh
Q 011331 458 PDPVQRPSAKELVENPIF 475 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f 475 (488)
.+|++|||+.|++.||||
T Consensus 239 ~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 239 LDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CChhhCCCHHHHhhCCCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=324.18 Aligned_cols=247 Identities=25% Similarity=0.393 Sum_probs=206.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.+|++++.||.|+||+||+|.+..+|+.||+|.+..... .....+..|+.+++.+ +|+||+.+++.+...+.+|+|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEEEE
Confidence 468999999999999999999999999999998864322 2345577899999998 8999999999999999999999
Q ss_pred ecCCCCchh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCC
Q 011331 309 ELCDHSLSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIE 383 (488)
Q Consensus 309 E~~~~~l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~ 383 (488)
||+.++.+. ......+++.++..++.||+.||.|||+.|++|+||||+||++ .++.++|+|||++...... ....
T Consensus 96 e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 175 (296)
T cd06655 96 EYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (296)
T ss_pred EecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence 999876444 4444568999999999999999999999999999999999999 6789999999998765332 2234
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcC---CCCCCCCCcHHHHHHHHHccc
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDG---KLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~---~~~~~~~~s~~l~~lI~k~L~ 457 (488)
.|+..|+|||.+... .++.++|||||||++|+|++|..||........ +... ....+..++..+.++|.+||.
T Consensus 176 ~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 254 (296)
T cd06655 176 VGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE 254 (296)
T ss_pred CCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhh
Confidence 688899999998765 567799999999999999999999876544222 2111 223445678899999999999
Q ss_pred CCCCCCCCHHHHHhChhhhhhH
Q 011331 458 PDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.||.+|||+.+++.||||+...
T Consensus 255 ~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 255 MDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred cChhhCCCHHHHhhChHhhhcc
Confidence 9999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=320.47 Aligned_cols=243 Identities=26% Similarity=0.409 Sum_probs=198.2
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++.+.||+|+||.||+|.+..++..||+|+++... ......+..|+.+++.+ +||||+++++.+...+.+|++|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEE
Confidence 46788999999999999999999999999999986542 23344577889999998 9999999999999999999999
Q ss_pred ecCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 309 ELCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 309 E~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
||++++.+. . ...+.+++..++.++.||+.||.|||+.||+|+||||+||++ .++.++|+|||++...... ...
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence 999875444 2 234569999999999999999999999999999999999999 6789999999998765432 223
Q ss_pred CCCCCCccChhhhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hcCCC--C---CCCCCcHHHHHHH
Q 011331 383 EEGDARYMPQEILNE--DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RDGKL--P---LLPGHSLQFQNLL 452 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~--~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~~~~--~---~~~~~s~~l~~lI 452 (488)
..|+..|+|||++.. ...++.++|||||||++|+|++|..|+........+ ..... + ....++..+.++|
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV 245 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHH
Confidence 468999999998742 224567999999999999999999887654332211 11111 1 1224678899999
Q ss_pred HHcccCCCCCCCCHHHHHhChh
Q 011331 453 KVMVDPDPVQRPSAKELVENPI 474 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~ 474 (488)
.+||..+|++|||++++++|||
T Consensus 246 ~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 246 KMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHccCCchhCcCHHHHhcCCC
Confidence 9999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=315.72 Aligned_cols=243 Identities=26% Similarity=0.399 Sum_probs=201.1
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++.+.||.|+||.||+|.+..++..+|+|++..... .....+..|+.+++.+ +||||+++++++...+.+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEEEE
Confidence 478999999999999999999998999999999875422 2456788899999999 9999999999999999999999
Q ss_pred ecCCCCchh-hh-h-cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CC
Q 011331 309 ELCDHSLSD-KK-A-SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LP 381 (488)
Q Consensus 309 E~~~~~l~~-~~-~-~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~ 381 (488)
||++++.+. .. . ...+++..++.++.||+.||.|||++||+|+||+|+||++ .++.++|+|||++...... ..
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 999876544 22 2 2569999999999999999999999999999999999999 6789999999999766432 23
Q ss_pred CCCCCCCccChhhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcCC-----CCCCCCCcHHHHHH
Q 011331 382 IEEGDARYMPQEILNED--YDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDGK-----LPLLPGHSLQFQNL 451 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~--~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~~-----~~~~~~~s~~l~~l 451 (488)
...++..|+|||.+... ..++.++|||||||++|+|++|.+|+........ +.... ......++.++.+|
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF 239 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence 34688899999988543 1456799999999999999999999876443221 21221 11223457789999
Q ss_pred HHHcccCCCCCCCCHHHHHhChh
Q 011331 452 LKVMVDPDPVQRPSAKELVENPI 474 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~ 474 (488)
|.+||..+|..|||+.+++.|||
T Consensus 240 i~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 240 IKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.64 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=204.0
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc-----ce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN-----EQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~-----~~ 303 (488)
.+|.+++.||+|+||+||+|.+..+|..||||.+............+..|+.++..+ +|+||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccCc
Confidence 468999999999999999999999999999999865433333445677899999998 899999999987654 35
Q ss_pred EEEEEecCCCCchhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--
Q 011331 304 LYIQMELCDHSLSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 304 l~IV~E~~~~~l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-- 379 (488)
+||+|||+++++.... ....+++..++.++.||+.||.|||++|++|+||||+||++ .++.++|+|||++......
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 163 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163 (337)
T ss_pred EEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence 8999999988776533 34568999999999999999999999999999999999999 6789999999999866432
Q ss_pred -CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh------hhhc-----------------
Q 011331 380 -LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL------NLRD----------------- 435 (488)
Q Consensus 380 -~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~------~i~~----------------- 435 (488)
.....++..|+|||.+.....++.++|||||||++|+|++|.+||....... ....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARR 243 (337)
T ss_pred cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhH
Confidence 2234578899999988654347779999999999999999999886432100 0000
Q ss_pred -------CC----CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 436 -------GK----LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 436 -------~~----~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
.. ....+.++.++.++|.+||+.+|++|||++|+++||||..++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 244 YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred HHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 00 0123457889999999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=334.80 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=210.4
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce--
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ-- 303 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~-- 303 (488)
.+.++|++.+.||.|+||+||+|.+..++..||||++............+..|+.+++.+ .|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhcccccc
Confidence 345679999999999999999999999999999999865433334445677899999998 99999999988876554
Q ss_pred ----EEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 304 ----LYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 304 ----l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
+|+|+||+++++........+++..++.++.||+.||.|||+.||+|+||||+||++ .++.++|+|||++.....
T Consensus 91 ~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 91 DFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 899999998887776666789999999999999999999999999999999999999 678999999999987765
Q ss_pred CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcCC------------------
Q 011331 379 SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDGK------------------ 437 (488)
Q Consensus 379 ~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~~------------------ 437 (488)
......++..|+|||.+.....++.++|||||||++|+|++|..||........ +....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07851 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARN 250 (343)
T ss_pred cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHH
Confidence 555567888999999986544567799999999999999999998865433211 11100
Q ss_pred ----C---------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 438 ----L---------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 438 ----~---------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
. ......+.++.+||.+||..||.+|||+.||++||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred HHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 0 011245889999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=320.07 Aligned_cols=251 Identities=27% Similarity=0.371 Sum_probs=201.8
Q ss_pred CccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc-
Q 011331 223 GLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN- 301 (488)
Q Consensus 223 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~- 301 (488)
.+....++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++.++.+||||+++++++...
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 34455678999999999999999999999999999999986432 22344667888999887899999999988753
Q ss_pred ----ceEEEEEecCCCCchh-hh-----hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEee
Q 011331 302 ----EQLYIQMELCDHSLSD-KK-----ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDF 370 (488)
Q Consensus 302 ----~~l~IV~E~~~~~l~~-~~-----~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DF 370 (488)
+.+|+||||++++.+. .. ....+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence 3689999999875433 21 23468999999999999999999999999999999999999 6788999999
Q ss_pred cCceecCCC---CCCCCCCCCccChhhhcccC----CCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcCC---
Q 011331 371 GRATLLNKS---LPIEEGDARYMPQEILNEDY----DHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDGK--- 437 (488)
Q Consensus 371 GlA~~~~~~---~~~~~Gt~~Y~APEvl~~~~----~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~~--- 437 (488)
|++...... .....|+..|+|||++.... .++.++|||||||++|||++|.+|+........ +....
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (291)
T cd06639 173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT 252 (291)
T ss_pred ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence 998765421 22346888999999975432 256799999999999999999999876544222 22221
Q ss_pred CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhh
Q 011331 438 LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFD 476 (488)
Q Consensus 438 ~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~ 476 (488)
...+...+..+.++|.+||+.+|++||++.|++.||||+
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 122345677899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=317.01 Aligned_cols=244 Identities=27% Similarity=0.363 Sum_probs=197.4
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc--cceE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH---HDAERRKALLEVQALAALGSHENIVGYYSSWFE--NEQL 304 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~---~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~--~~~l 304 (488)
+|++.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.+ +||||+++++++.+ ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCEE
Confidence 68899999999999999999999999999998864322 123345678899999999 89999999998865 4678
Q ss_pred EEEEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--
Q 011331 305 YIQMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-- 379 (488)
+++|||+.++ +... .....+++...+.++.||+.||+|||++||+|+||+|+||++ .++.++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 9999999875 4433 233468999999999999999999999999999999999999 6788999999998755321
Q ss_pred ----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc----C-CCCCCCCCcHHHHH
Q 011331 380 ----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD----G-KLPLLPGHSLQFQN 450 (488)
Q Consensus 380 ----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~----~-~~~~~~~~s~~l~~ 450 (488)
.....++..|+|||.+.+. .++.++|||||||++|||++|..||........+.. . ....+...+..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 1223588899999998764 577899999999999999999999876544333221 1 12233456788889
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhh
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFD 476 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~ 476 (488)
+| +||..+|++||+++|+++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 98 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=316.23 Aligned_cols=243 Identities=27% Similarity=0.379 Sum_probs=199.6
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH----DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~----~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
+|++.+.||.|+||+||+|.+. +|..+|||.+...... ......+.+|+++++.+ +|+||+++++++.+.+.+|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEE
Confidence 4678899999999999999874 8899999988643221 22335678899999999 8999999999999999999
Q ss_pred EEEecCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC----
Q 011331 306 IQMELCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---- 378 (488)
Q Consensus 306 IV~E~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---- 378 (488)
++|||+.++.+. . .....+++..+..++.||+.||+|||+.||+|+||+|+||++ .++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 999999875443 2 233568999999999999999999999999999999999999 688999999999875421
Q ss_pred -----CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hc---CCCCCCCCCcHH
Q 011331 379 -----SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RD---GKLPLLPGHSLQ 447 (488)
Q Consensus 379 -----~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~---~~~~~~~~~s~~ 447 (488)
......|+..|+|||++... .++.++|||||||++|+|++|..||......... .. .....+..++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred ccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 11234588899999998765 5677999999999999999999998764433221 11 122355567899
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
+.++|.+||..+|++||++.|+++||||
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=331.12 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=206.8
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc----
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN---- 301 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~---- 301 (488)
...++|++++.||+|+||.||+|.+..+|..||+|++............+.+|+.++.++ +|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeeccccc
Confidence 445689999999999999999999999999999999875433333445677899999999 899999999887533
Q ss_pred --ceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 302 --EQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 302 --~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
..+|++++++++.+........+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++.....
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 35789999998777665555679999999999999999999999999999999999999 678999999999987665
Q ss_pred CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc--C-----------------
Q 011331 379 SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD--G----------------- 436 (488)
Q Consensus 379 ~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~--~----------------- 436 (488)
......|+..|+|||++.+...++.++|||||||++|+|++|.+||........ +.. +
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (345)
T cd07877 173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 252 (345)
T ss_pred cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence 545557889999999986644567799999999999999999998864432111 000 0
Q ss_pred ------CCC------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 437 ------KLP------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 437 ------~~~------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
..+ .....+.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 000 0113577899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=314.10 Aligned_cols=241 Identities=28% Similarity=0.454 Sum_probs=202.1
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++.+.||.|+||.||+|.+..++..||+|.+... .....+..|+.+++.+ +|+||+++++.+.....+|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEEE
Confidence 4688999999999999999999988999999998643 2256788899999999 9999999999999999999999
Q ss_pred ecCCCCchh-hh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---C
Q 011331 309 ELCDHSLSD-KK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---P 381 (488)
Q Consensus 309 E~~~~~l~~-~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---~ 381 (488)
||+.++.+. .. ....+++..++.++.||+.||.|||+.|++|+||+|+||++ .++.++|+|||++....... .
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence 999876444 22 23568999999999999999999999999999999999999 67899999999998764322 2
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc------CCCCCCCCCcHHHHHHHHHc
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD------GKLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~------~~~~~~~~~s~~l~~lI~k~ 455 (488)
...|+..|+|||++.+. .++.++||||||+++|+|++|..|+........... .....+..++.++.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 158 TVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred cccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 34588899999998765 577899999999999999999999876543322211 11223334678999999999
Q ss_pred ccCCCCCCCCHHHHHhChhh
Q 011331 456 VDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 456 L~~dP~~RpTa~elL~HP~f 475 (488)
|+.||++|||+.|+|.||||
T Consensus 237 l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 237 LVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=317.81 Aligned_cols=249 Identities=29% Similarity=0.433 Sum_probs=205.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC--CCCCeeEeeeeecccceEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG--SHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~--~HpnIv~l~~~~~~~~~l~IV 307 (488)
.|++++.||.|+||.||+|.+..++..||+|.+.... .......+..|+.+++.+. .||||+++++++..+...|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 4678899999999999999999999999999986542 2334456778999999884 499999999999999999999
Q ss_pred EecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 308 MELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 308 ~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
|||+.++ +........+++..++.++.||+.||.|||+.||+|+||+|+||++ .++.++|+|||++...... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06917 81 MEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST 160 (277)
T ss_pred EecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccccc
Confidence 9999775 4444445578999999999999999999999999999999999999 6789999999999876432 223
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh---cCCCC-CCC-CCcHHHHHHHHHccc
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR---DGKLP-LLP-GHSLQFQNLLKVMVD 457 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~---~~~~~-~~~-~~s~~l~~lI~k~L~ 457 (488)
..|+..|+|||.+..+..++.++|+|||||++|+|++|..||........+. ....+ ... ..+.++.++|.+||.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 240 (277)
T cd06917 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLD 240 (277)
T ss_pred ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcC
Confidence 4588899999998765556779999999999999999999987654433221 11112 222 267899999999999
Q ss_pred CCCCCCCCHHHHHhChhhhhhH
Q 011331 458 PDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.||++||++.++++||||+...
T Consensus 241 ~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 241 EEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CCcccCcCHHHHhhChHhhccc
Confidence 9999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=321.37 Aligned_cols=240 Identities=20% Similarity=0.205 Sum_probs=189.2
Q ss_pred cceeEEEEecccCcEEEEEEEEcC----------------CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCee
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRI----------------DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIV 292 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~----------------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv 292 (488)
.+|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++.++ +||||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRL-KDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhc-CCCCee
Confidence 468899999999999999997532 34579999987542 334456788999999999 999999
Q ss_pred EeeeeecccceEEEEEecCCCCch-hhhhc--------------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccC
Q 011331 293 GYYSSWFENEQLYIQMELCDHSLS-DKKAS--------------------QFFAEGEVLKALHQIAQALQFIHEKGIAHL 351 (488)
Q Consensus 293 ~l~~~~~~~~~l~IV~E~~~~~l~-~~~~~--------------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHr 351 (488)
++++++.+.+..+|||||+.++.+ ..... ..+++..++.++.||+.||.|||++||+|+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999999999999999999977533 22111 236777899999999999999999999999
Q ss_pred CCCCCcEEE-eCCeEEEEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcC--CCC
Q 011331 352 DVKPDNIYV-KNGVYKLGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKG--SPL 423 (488)
Q Consensus 352 DLKp~NILv-~~g~vkL~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG--~~p 423 (488)
||||+|||+ .++.+||+|||+++...... ....++..|+|||++... .++.++|||||||++|||+++ ..|
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999 67899999999997653321 223457889999998765 577899999999999999874 456
Q ss_pred CCCchhhhh---h----h----cCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 424 SESGPQFLN---L----R----DGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 424 ~~~~~~~~~---i----~----~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
+........ . . ......++.++..+.++|.+||..||++|||+.+|..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 654322111 1 1 1112345567899999999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=311.04 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=207.8
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++.+.||.|++|.||+|.+..+|+.||||++...... .....+..|+..+..+ +|+||+++++++...+.++++||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEEEE
Confidence 688999999999999999999999999999998755332 4456788999999999 79999999999999999999999
Q ss_pred cCCCC-chhhh-hcccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC---C
Q 011331 310 LCDHS-LSDKK-ASQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP---I 382 (488)
Q Consensus 310 ~~~~~-l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~---~ 382 (488)
|++++ +.... ....+++..++.++.||+.||.|||+ .|++|+||+|+||++ .++.++|+|||++........ .
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 159 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence 99865 44433 23679999999999999999999999 999999999999999 678999999999987643322 3
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch--h----hhhhhc-CCCCCCCC-CcHHHHHHHHH
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP--Q----FLNLRD-GKLPLLPG-HSLQFQNLLKV 454 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~--~----~~~i~~-~~~~~~~~-~s~~l~~lI~k 454 (488)
..++..|+|||.+... .++.++|+||||+++|+|++|..|+.... . ...+.. ........ ++..+.++|.+
T Consensus 160 ~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (264)
T cd06623 160 FVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA 238 (264)
T ss_pred eeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHH
Confidence 3578899999998766 57779999999999999999999987653 2 122222 22333444 78899999999
Q ss_pred cccCCCCCCCCHHHHHhChhhhhhH
Q 011331 455 MVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
||..+|++|||+.|+++||||+.+.
T Consensus 239 ~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 239 CLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred HccCChhhCCCHHHHHhCHHHHhcc
Confidence 9999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=316.48 Aligned_cols=244 Identities=27% Similarity=0.411 Sum_probs=206.0
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
+|++.+.||.|+||.||+|.+..++..||+|++....... .....+..|+++++++ +||||+.+++.+.....+|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEE
Confidence 4789999999999999999999899999999986543222 4456788899999999 9999999999999999999999
Q ss_pred ecCCCCchh-hhh-cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CCCC
Q 011331 309 ELCDHSLSD-KKA-SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LPIE 383 (488)
Q Consensus 309 E~~~~~l~~-~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~~~ 383 (488)
||+.++.+. ... ...+++..+..++.||+.||.|||++|++|+||+|+||++ .++.++|+|||++...... ....
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 159 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence 999876443 332 2379999999999999999999999999999999999999 6789999999998766432 2334
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-----hhhhhc-CCCCCCCCCcHHHHHHHHHccc
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-----FLNLRD-GKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-----~~~i~~-~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
.|+..|+|||++... .++.++|+||||+++|+|++|..|+..... +..... .....++..+.++.++|.+||.
T Consensus 160 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (258)
T cd05578 160 SGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLE 238 (258)
T ss_pred CCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHcc
Confidence 588899999998765 467799999999999999999999876442 112222 4455666788999999999999
Q ss_pred CCCCCCCCH--HHHHhChhh
Q 011331 458 PDPVQRPSA--KELVENPIF 475 (488)
Q Consensus 458 ~dP~~RpTa--~elL~HP~f 475 (488)
.||.+||++ +|+++||||
T Consensus 239 ~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 239 RDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred CChhHcCCccHHHHhcCCCC
Confidence 999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=310.63 Aligned_cols=244 Identities=34% Similarity=0.506 Sum_probs=203.6
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec--ccceEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF--ENEQLYIQ 307 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~--~~~~l~IV 307 (488)
+|++++.||.|+||.||+|.+..+|..||+|++............+..|+++++.+ +|+||+++++.+. .+..+|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEE
Confidence 47899999999999999999999999999999876545556667788899999999 9999999998775 35568999
Q ss_pred EecCCCCch-hhhh-----cccCCHHHHHHHHHHHHHHHHHHH-----HcCcccCCCCCCcEEE-eCCeEEEEeecCcee
Q 011331 308 MELCDHSLS-DKKA-----SQFFAEGEVLKALHQIAQALQFIH-----EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATL 375 (488)
Q Consensus 308 ~E~~~~~l~-~~~~-----~~~l~~~~~~~i~~qI~~gL~yLH-----~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~ 375 (488)
|||++++.+ .... ...+++..++.++.||+.||.||| +.+|+|+||+|+||++ .++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999987533 3221 356899999999999999999999 8999999999999999 568999999999987
Q ss_pred cCCCC---CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCC-CCCCCCcHHH
Q 011331 376 LNKSL---PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKL-PLLPGHSLQF 448 (488)
Q Consensus 376 ~~~~~---~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~-~~~~~~s~~l 448 (488)
..... ....|++.|+|||++... .++.++|+||||+++|+|++|..|+..... ...+..+.. ..+...+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHH
Confidence 65432 234689999999998765 467799999999999999999999876532 122333333 3445678999
Q ss_pred HHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 449 QNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 449 ~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
.+++.+||..+|++|||++++++|||+
T Consensus 239 ~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 239 NEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=340.86 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=201.5
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
..|+++++||+||.+.||+++.. +...||+|.+...........-+..|+..|.+|.+|.+||+||++-..++.+||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 36899999999999999999876 45566666554433445556779999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhcc--cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCceecCCCCC-----
Q 011331 309 ELCDHSLSDKKASQ--FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSLP----- 381 (488)
Q Consensus 309 E~~~~~l~~~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~~~~~~~----- 381 (488)
|+-+..|....... .++...++.+.+|++.|+.++|+.||||.||||.|+|+-.|.+||+|||+|..+.....
T Consensus 440 E~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI~kd 519 (677)
T KOG0596|consen 440 ECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTSIVKD 519 (677)
T ss_pred ecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCccccceeec
Confidence 99888877743333 24445899999999999999999999999999999999999999999999988754432
Q ss_pred CCCCCCCccChhhhccc----------CCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcC--CCCCCCCC-
Q 011331 382 IEEGDARYMPQEILNED----------YDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDG--KLPLLPGH- 444 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~----------~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~--~~~~~~~~- 444 (488)
..+||+.||+||.+... ...+.++|||||||+||+|+.|++||..-.. +..+.+. .++++..-
T Consensus 520 sQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~ 599 (677)
T KOG0596|consen 520 SQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE 599 (677)
T ss_pred cccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC
Confidence 34699999999998532 1245689999999999999999999986543 2333332 22333222
Q ss_pred cHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 445 SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 445 s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
..++.++++.||++||.+|||+.|||.|||++-
T Consensus 600 ~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 600 NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 234999999999999999999999999999986
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=331.12 Aligned_cols=248 Identities=23% Similarity=0.384 Sum_probs=201.9
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc-------
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN------- 301 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~------- 301 (488)
.+|.+.+.||.|+||+||+|.+..+|..||+|++..... .....+..|+.+++.+ +||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhc-CCCcchhhHhhhcccccccccc
Confidence 578999999999999999999999999999998864422 3345677899999999 999999999776644
Q ss_pred -------ceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--CCeEEEEeecC
Q 011331 302 -------EQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDFGR 372 (488)
Q Consensus 302 -------~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~g~vkL~DFGl 372 (488)
..+|+||||+++++........+++..++.++.||+.||.|||+.||+|+||||+||+++ ++.++|+|||+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 82 VGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred cccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence 357999999998776665566799999999999999999999999999999999999994 45789999999
Q ss_pred ceecCCCC------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh---c--------
Q 011331 373 ATLLNKSL------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR---D-------- 435 (488)
Q Consensus 373 A~~~~~~~------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~---~-------- 435 (488)
+...+... ....|+..|+|||.+.....++.++|||||||++|+|++|..||.......... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 97654321 123578899999987655457779999999999999999999987543211110 0
Q ss_pred ----------------CCC------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 436 ----------------GKL------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 436 ----------------~~~------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
... ...+..+.++.+||.+||..||.+|||+.|++.||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 000 11245678899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=316.77 Aligned_cols=244 Identities=27% Similarity=0.418 Sum_probs=200.9
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc--ceEEEEE
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN--EQLYIQM 308 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~--~~l~IV~ 308 (488)
|++++.||.|+||.||+|.+..+|..||+|++............+..|+.++..+ +|+||+++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEe
Confidence 6789999999999999999998999999999976543334445678899999999 799999999999888 8899999
Q ss_pred ecCCCCchhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----CC
Q 011331 309 ELCDHSLSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----LP 381 (488)
Q Consensus 309 E~~~~~l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----~~ 381 (488)
||+++++...... ..+++..++.++.||+.||+|||+.|++|+||+|+||++ +++.++|+|||++...... ..
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 80 EYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred ccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 9999877664433 368999999999999999999999999999999999999 6789999999999877543 22
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcC-------CC-------------
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDG-------KL------------- 438 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~-------~~------------- 438 (488)
...++..|+|||.+.+...++.++||||||+++|||++|..||........ +... ..
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 345678899999876554577899999999999999999999875433111 1000 00
Q ss_pred ----------CCCCC-CcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 439 ----------PLLPG-HSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 439 ----------~~~~~-~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
..... ++..+.++|.+||..+|.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00112 27889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=317.05 Aligned_cols=246 Identities=33% Similarity=0.468 Sum_probs=203.6
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|+..+.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.+ +||||+++++.+...+.+++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEEEE
Confidence 57788899999999999999999999999999876532 34556788999999998 79999999999999999999999
Q ss_pred cCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-CCCC
Q 011331 310 LCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-LPIE 383 (488)
Q Consensus 310 ~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-~~~~ 383 (488)
|+.+. +..... ...+++..+..++.||+.||.|||+ .|++|+||||+||++ .++.++|+|||.+...... ....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF 159 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcc
Confidence 99964 443322 2568999999999999999999999 999999999999999 6789999999998765321 1225
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch----h----hhhhhcCCCC-CCCC-CcHHHHHHHH
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP----Q----FLNLRDGKLP-LLPG-HSLQFQNLLK 453 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~----~----~~~i~~~~~~-~~~~-~s~~l~~lI~ 453 (488)
.++..|+|||.+.+. .++.++||||||+++|+|++|..|+.... . ...+.....+ .+.. ++.++.++|.
T Consensus 160 ~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (265)
T cd06605 160 VGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN 238 (265)
T ss_pred cCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHH
Confidence 688899999998765 67789999999999999999999886541 1 1122222222 2223 6889999999
Q ss_pred HcccCCCCCCCCHHHHHhChhhhhh
Q 011331 454 VMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+||..||++|||+.+++.||||+.-
T Consensus 239 ~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 239 LCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=316.83 Aligned_cols=247 Identities=28% Similarity=0.402 Sum_probs=205.6
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
.|+.++.||.|+||.||+|.+..++..||||++.... .......+..|+.++..+ +|+||+++++++.++...|||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEe
Confidence 4778899999999999999999899999999986432 234456788899999998 89999999999999999999999
Q ss_pred cCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCCC
Q 011331 310 LCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIEE 384 (488)
Q Consensus 310 ~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~~ 384 (488)
|++++ +........+++..+..++.|++.||.|||+.|++|+||+|+||++ .++.++|+|||++...... .....
T Consensus 83 ~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06640 83 YLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred cCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccccc
Confidence 99875 4444555678999999999999999999999999999999999999 6789999999999765432 12335
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hcC-CCCCCCCCcHHHHHHHHHcccCCC
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RDG-KLPLLPGHSLQFQNLLKVMVDPDP 460 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~~-~~~~~~~~s~~l~~lI~k~L~~dP 460 (488)
++..|+|||++... ..+.++|+|||||++|||++|..|+......... ... ........+..+.++|.+||..+|
T Consensus 163 ~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06640 163 GTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDP 241 (277)
T ss_pred CcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCc
Confidence 78899999998765 4677999999999999999999998754432211 111 222333567889999999999999
Q ss_pred CCCCCHHHHHhChhhhhhH
Q 011331 461 VQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 461 ~~RpTa~elL~HP~f~~i~ 479 (488)
++||++.+++.||||....
T Consensus 242 ~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 242 SFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred ccCcCHHHHHhChHhhhcc
Confidence 9999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=366.53 Aligned_cols=249 Identities=36% Similarity=0.629 Sum_probs=205.6
Q ss_pred CccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc-
Q 011331 223 GLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN- 301 (488)
Q Consensus 223 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~- 301 (488)
..+||.++|++++.||+||||.||+|+++.+|+.||||++.... .+....+..+|+..|+++ +|||||++|..|.+.
T Consensus 473 ~~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 473 QFSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARL-NHPNVVRYYSAWVEST 550 (1351)
T ss_pred chhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccC
Confidence 34799999999999999999999999999999999999997654 566677899999999999 999999999766521
Q ss_pred --------------------------------------------------------------------------------
Q 011331 302 -------------------------------------------------------------------------------- 301 (488)
Q Consensus 302 -------------------------------------------------------------------------------- 301 (488)
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence
Q ss_pred --------------------------------------ceEEEEEecCCCCchhhhh-cccC--CHHHHHHHHHHHHHHH
Q 011331 302 --------------------------------------EQLYIQMELCDHSLSDKKA-SQFF--AEGEVLKALHQIAQAL 340 (488)
Q Consensus 302 --------------------------------------~~l~IV~E~~~~~l~~~~~-~~~l--~~~~~~~i~~qI~~gL 340 (488)
-.+||.||||+..++.... ...+ ....+|+++++|+.||
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHH
Confidence 0268999999987766332 2223 3678999999999999
Q ss_pred HHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---------------------CCCCCCCCCCCccChhhhccc
Q 011331 341 QFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---------------------KSLPIEEGDARYMPQEILNED 398 (488)
Q Consensus 341 ~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---------------------~~~~~~~Gt~~Y~APEvl~~~ 398 (488)
.|+|+.|||||||||.||++ .++.|||+|||+|+... ...+..+||.-|+|||++.+.
T Consensus 711 aYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 711 AYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99999999999999999999 67899999999998721 012345699999999999765
Q ss_pred C--CCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcCCCCCCCCC----cHHHHHHHHHcccCCCCCCCCHHH
Q 011331 399 Y--DHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDGKLPLLPGH----SLQFQNLLKVMVDPDPVQRPSAKE 468 (488)
Q Consensus 399 ~--~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~~~~~~~~~----s~~l~~lI~k~L~~dP~~RpTa~e 468 (488)
. .|+.|+||||||++|+||+. ||....+ +..++.+.+|.++.. -..-.++|++||+.||++||||.|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 4 57889999999999999985 4655544 445667777766322 234568999999999999999999
Q ss_pred HHhChhhh
Q 011331 469 LVENPIFD 476 (488)
Q Consensus 469 lL~HP~f~ 476 (488)
||++.||.
T Consensus 868 LL~s~llp 875 (1351)
T KOG1035|consen 868 LLNSELLP 875 (1351)
T ss_pred HhhccCCC
Confidence 99999997
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=347.27 Aligned_cols=245 Identities=25% Similarity=0.392 Sum_probs=208.7
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccC-CCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ-LHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~-~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
|.-++.||.|+||.||-|++..+.+.||||.+.-. .......++++.|+..|.++ .|||+|.+-++|......|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeeccchHHHHHH
Confidence 55677899999999999999999999999998543 23345568899999999999 99999999999999999999999
Q ss_pred cCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCCCC
Q 011331 310 LCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGD 386 (488)
Q Consensus 310 ~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~Gt 386 (488)
||-|+-.+ .....++.+.++..|+.+.+.||+|||+.+.||||||..|||+ +.|.|||+|||.|.... .....+||
T Consensus 107 YClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-PAnsFvGT 185 (948)
T KOG0577|consen 107 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-PANSFVGT 185 (948)
T ss_pred HHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-chhcccCC
Confidence 99886333 3344679999999999999999999999999999999999999 67999999999998654 35567999
Q ss_pred CCccChhhhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcCCCCC--CCCCcHHHHHHHHHcccCC
Q 011331 387 ARYMPQEILNE--DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDGKLPL--LPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 387 ~~Y~APEvl~~--~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~~~~~--~~~~s~~l~~lI~k~L~~d 459 (488)
|+|||||++.. ...|+-++||||||++..||...+||..+...+.. |-....|. .+.+++.|++||..||++=
T Consensus 186 PywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKi 265 (948)
T KOG0577|consen 186 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKI 265 (948)
T ss_pred ccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhC
Confidence 99999999852 33566799999999999999999999877655433 33333332 3456899999999999999
Q ss_pred CCCCCCHHHHHhChhhhh
Q 011331 460 PVQRPSAKELVENPIFDK 477 (488)
Q Consensus 460 P~~RpTa~elL~HP~f~~ 477 (488)
|.+|||.+++|.|+|+..
T Consensus 266 pqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 266 PQERPTSEELLKHRFVLR 283 (948)
T ss_pred cccCCcHHHHhhcchhcc
Confidence 999999999999999864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=323.57 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=211.6
Q ss_pred ceeE-EEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHE-IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~-~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
-|++ .+.||+|+|+.|--|....+|..||||++.+. ....+...++|++++.+...|+||+.|+++|+++..+||||
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 3444 36799999999999999999999999999875 34556789999999999999999999999999999999999
Q ss_pred ecCCCC-c-hhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--C--CeEEEEeecCceecC--C--
Q 011331 309 ELCDHS-L-SDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--N--GVYKLGDFGRATLLN--K-- 378 (488)
Q Consensus 309 E~~~~~-l-~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~--g~vkL~DFGlA~~~~--~-- 378 (488)
|-|.|+ + ........+++.++..+.++|+.||.|||.+||.||||||+|||.. + ..+|||||.++.... .
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999876 3 3355567799999999999999999999999999999999999993 2 469999999885431 1
Q ss_pred ------CCCCCCCCCCccChhhhc----ccCCCCchhHHHHHHHHHHHHHcCCCCCCCc------------------hhh
Q 011331 379 ------SLPIEEGDARYMPQEILN----EDYDHLDKVDIFSLGATMYELIKGSPLSESG------------------PQF 430 (488)
Q Consensus 379 ------~~~~~~Gt~~Y~APEvl~----~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~------------------~~~ 430 (488)
...+.+|+..|||||++. ....|..++|.|||||+||-|+.|.+||.+. ..+
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 123456999999999863 2234567999999999999999999999742 226
Q ss_pred hhhhcCCCCCCCC----CcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 431 LNLRDGKLPLLPG----HSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 431 ~~i~~~~~~~~~~----~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
..|.+|.+.+|.. +|.+..++|..+|..|+.+|.++.++++|||++....
T Consensus 316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 6788888887763 5889999999999999999999999999999987654
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=331.55 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=203.2
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc----cceE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE----NEQL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~----~~~l 304 (488)
.+|++.+.||.|+||.||+|.+..+|..||+|++............+..|+.++..+ +||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCceE
Confidence 468999999999999999999999999999999875433334455677899999999 79999999988763 4568
Q ss_pred EEEEecCCCCchhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 305 YIQMELCDHSLSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
|+||||+.+++.... ....+++..++.++.||+.||.|||++||+|+||||+||++ .++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 999999988766643 34558999999999999999999999999999999999999 67899999999997653211
Q ss_pred -----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh----------------------
Q 011331 381 -----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---------------------- 433 (488)
Q Consensus 381 -----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---------------------- 433 (488)
....|+..|+|||.+.....++.++|||||||++|||++|.+||........+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 22368889999999865445778999999999999999999998654321100
Q ss_pred ----h---cCCCC-----CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 434 ----R---DGKLP-----LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 434 ----~---~~~~~-----~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
. ....+ ..+..+.++.++|.+||+.+|.+|||+.+++.||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 0 00001 1245688999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=313.75 Aligned_cols=244 Identities=26% Similarity=0.377 Sum_probs=198.0
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc------
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE------ 302 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~------ 302 (488)
++|++.+.||.|+||+||+|.+..++..|++|++.... .....+..|+.++.++.+|+||+++++++....
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 57899999999999999999999899999999986432 234567889999999878999999999987544
Q ss_pred eEEEEEecCCCCchh-hh---h--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCcee
Q 011331 303 QLYIQMELCDHSLSD-KK---A--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATL 375 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~-~~---~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~ 375 (488)
.+|+||||++++.+. .. . ...+++..++.++.||+.||.|||+.|++|+||+|+||++ .++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 489999999875332 21 1 3568999999999999999999999999999999999999 678999999999876
Q ss_pred cCCC---CCCCCCCCCccChhhhccc----CCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCC---CCCC
Q 011331 376 LNKS---LPIEEGDARYMPQEILNED----YDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKL---PLLP 442 (488)
Q Consensus 376 ~~~~---~~~~~Gt~~Y~APEvl~~~----~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~---~~~~ 442 (488)
.... .....|+..|+|||++... ..++.++|||||||++|+|++|..||....... .+..... ..+.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPE 242 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchh
Confidence 5432 2234588899999987532 245668999999999999999999987543221 2222211 1222
Q ss_pred CCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 443 GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 443 ~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
..+.++.+||.+||..||++|||+.++++|||+
T Consensus 243 ~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 243 NWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=322.74 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=201.1
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc----
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE---- 302 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~---- 302 (488)
..++|++.+.||.|+||+||+|.+..+|..||||+++...........+..|+.+++.+ +||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999999999999999865433333334567799999999 8999999999887654
Q ss_pred ------eEEEEEecCCCCchhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCc
Q 011331 303 ------QLYIQMELCDHSLSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRA 373 (488)
Q Consensus 303 ------~l~IV~E~~~~~l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA 373 (488)
.+|+||||+++++...... ..+++..++.++.||+.||.|||+.||+|+||||+||++ .++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 7999999999876654332 358999999999999999999999999999999999999 6789999999999
Q ss_pred eecCCCC----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---h---cCCC-----
Q 011331 374 TLLNKSL----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---R---DGKL----- 438 (488)
Q Consensus 374 ~~~~~~~----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~---~~~~----- 438 (488)
....... ....++..|+|||.+.....++.++|||||||++|||++|.+||........+ . ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 8664322 22345778999998865545677999999999999999999988754332211 0 0000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 439 ----------------------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 439 ----------------------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
.....++..+.++|.+||..||.+|||+.++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0122457899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=320.24 Aligned_cols=248 Identities=27% Similarity=0.386 Sum_probs=204.6
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
.|+.++.||.|+||.||+|.+..++..||+|.+.... .......+..|+.++..+ +|+||+++++.+..++.+|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEEEEE
Confidence 4667788999999999999999899999999886442 233456788899999998 89999999999999999999999
Q ss_pred cCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---CCCC
Q 011331 310 LCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---PIEE 384 (488)
Q Consensus 310 ~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---~~~~ 384 (488)
|++++ +........+++..++.++.||+.||.|||++|++|+||+|+||++ .++.++|+|||++....... ....
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06642 83 YLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred ccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhccc
Confidence 99875 4444445668999999999999999999999999999999999999 67899999999997654321 2235
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCC-CCCCCCcHHHHHHHHHcccCCC
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKL-PLLPGHSLQFQNLLKVMVDPDP 460 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~-~~~~~~s~~l~~lI~k~L~~dP 460 (488)
|+..|+|||.+... .++.++|||||||++|||++|..|+....... .+..... ......+.++.++|.+||..+|
T Consensus 163 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06642 163 GTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDP 241 (277)
T ss_pred CcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCc
Confidence 78899999998765 57779999999999999999999886543322 1222222 2333467889999999999999
Q ss_pred CCCCCHHHHHhChhhhhhHH
Q 011331 461 VQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 461 ~~RpTa~elL~HP~f~~i~~ 480 (488)
++|||+.+++.||||.....
T Consensus 242 ~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06642 242 RFRPTAKELLKHKFITRYTK 261 (277)
T ss_pred ccCcCHHHHHHhHHHHHHhh
Confidence 99999999999999986543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=310.62 Aligned_cols=245 Identities=29% Similarity=0.388 Sum_probs=202.4
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH---HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~---~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
+|+..+.||+|+||+||+|.+..++..|++|.+..... .......+..|+.+++.+ +|+||+++++++.....+|+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEE
Confidence 36777899999999999999988999999998864321 123456788899999999 99999999999999999999
Q ss_pred EEecCCCCchh-hh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CC
Q 011331 307 QMELCDHSLSD-KK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LP 381 (488)
Q Consensus 307 V~E~~~~~l~~-~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~ 381 (488)
+|||++++.+. .. ....+++..++.++.||+.||.|||+.||+|+||+|+||++ .++.+||+|||++...... ..
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence 99999875433 22 23458899999999999999999999999999999999999 6789999999998766432 23
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hc--CCCCCCCCCcHHHHHHHHHcc
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RD--GKLPLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~--~~~~~~~~~s~~l~~lI~k~L 456 (488)
...|+..|+|||.+.....++.++|+|||||++|+|++|..||......... .. .....++.++..+.++|.+||
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence 4568899999999866533677999999999999999999998765432221 11 122344567899999999999
Q ss_pred cCCCCCCCCHHHHHhChhh
Q 011331 457 DPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 457 ~~dP~~RpTa~elL~HP~f 475 (488)
..+|++||++.+++.||||
T Consensus 240 ~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 240 QRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hcCcccCcCHHHHhcCCCC
Confidence 9999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=314.21 Aligned_cols=245 Identities=21% Similarity=0.349 Sum_probs=200.4
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH----DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~----~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
+|+..+.||+|+||.||+|.+..++..||+|++...... ......+..|+.+++++ +|+||+++++++.+.+.++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEE
Confidence 367889999999999999999999999999998643221 12346788899999998 9999999999999999999
Q ss_pred EEEecCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC-eEEEEeecCceecCCCC-
Q 011331 306 IQMELCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG-VYKLGDFGRATLLNKSL- 380 (488)
Q Consensus 306 IV~E~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g-~vkL~DFGlA~~~~~~~- 380 (488)
+||||+.++.+. . .....+++..++.++.||+.||.|||++|++|+||+|+||+++ ++ .++|+|||.+.......
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 999999876443 2 2335689999999999999999999999999999999999993 44 69999999987654321
Q ss_pred ------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhh-----hcCCCCCCCCCcH
Q 011331 381 ------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNL-----RDGKLPLLPGHSL 446 (488)
Q Consensus 381 ------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i-----~~~~~~~~~~~s~ 446 (488)
....|+..|+|||.+... .++.++|||||||++|+|++|..||..... ...+ .......++..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred cCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 123578899999998765 567799999999999999999998864321 1111 1122334456788
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHhChhhh
Q 011331 447 QFQNLLKVMVDPDPVQRPSAKELVENPIFD 476 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~RpTa~elL~HP~f~ 476 (488)
++.++|.+||..+|++|||+.++++||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=319.52 Aligned_cols=248 Identities=21% Similarity=0.298 Sum_probs=201.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
+|++++.||+|+||.||++.+..+++.||+|.+...... ......+..|+.++..+ +||||+++++.+..++.+|+||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEEE
Confidence 689999999999999999999999999999988654221 23345677899999988 8999999999999999999999
Q ss_pred ecCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC------
Q 011331 309 ELCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS------ 379 (488)
Q Consensus 309 E~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~------ 379 (488)
||++++.+. . .....+++..+..++.||+.||.|||++|++|+||||+||++ .++.++|+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999876444 2 234568999999999999999999999999999999999999 6789999999998642110
Q ss_pred ------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCCC---C
Q 011331 380 ------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLPL---L 441 (488)
Q Consensus 380 ------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~~---~ 441 (488)
.....|+..|+|||.+... .++.++|||||||++|||++|..||.+.... .......... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 1123478889999998765 5678999999999999999999998754332 2222222222 2
Q ss_pred CCCcHHHHHHHHHcccCCCCCCCC---HHHHHhChhhhhhH
Q 011331 442 PGHSLQFQNLLKVMVDPDPVQRPS---AKELVENPIFDKIQ 479 (488)
Q Consensus 442 ~~~s~~l~~lI~k~L~~dP~~RpT---a~elL~HP~f~~i~ 479 (488)
...+.++.++|.+||+.||++||+ +.++++||||....
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 256889999999999999999998 89999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=311.83 Aligned_cols=245 Identities=27% Similarity=0.355 Sum_probs=198.4
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc--ce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL---HHDAERRKALLEVQALAALGSHENIVGYYSSWFEN--EQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~---~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~--~~ 303 (488)
++|++.+.||+|+||.||+|.+..+|..||||.+.... ........+.+|+.++.++ .||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence 46899999999999999999999999999999875321 1223455678899999999 999999999988763 56
Q ss_pred EEEEEecCCCC-chhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC--
Q 011331 304 LYIQMELCDHS-LSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK-- 378 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~-- 378 (488)
++++|||+.++ +.... ....+++..+..++.||+.||.|||++||+|+||||+||++ .++.++|+|||++.....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 88999999875 43332 33458899999999999999999999999999999999999 678999999999875432
Q ss_pred ----CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc----C-CCCCCCCCcHHHH
Q 011331 379 ----SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD----G-KLPLLPGHSLQFQ 449 (488)
Q Consensus 379 ----~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~----~-~~~~~~~~s~~l~ 449 (488)
......|+..|+|||++.+. .++.++|||||||++|||++|+.||........+.. . ....++..+..+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239 (265)
T ss_pred ccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 12234588899999998764 567899999999999999999999876543322211 1 1223445678899
Q ss_pred HHHHHcccCCCCCCCCHHHHHhChhhh
Q 011331 450 NLLKVMVDPDPVQRPSAKELVENPIFD 476 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~HP~f~ 476 (488)
++|.+||. +|++||+++|++.|||+.
T Consensus 240 ~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 240 DFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 99999994 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=326.31 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=208.6
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-cceEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE-NEQLY 305 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-~~~l~ 305 (488)
..++|++++.||.|+||.||+|.+..+|..||||++............+..|+.++..+ +||||++++++|.. .+..|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCcEE
Confidence 45679999999999999999999999999999998865433344456677899999999 89999999998865 56789
Q ss_pred EEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCC
Q 011331 306 IQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE 384 (488)
Q Consensus 306 IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~ 384 (488)
++|||+++++........+++..+..++.||+.||.|||+.||+|+||+|+||++ .++.++|+|||++...........
T Consensus 87 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 166 (328)
T cd07856 87 FVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV 166 (328)
T ss_pred EEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCcCCCc
Confidence 9999998877666666678899999999999999999999999999999999999 678999999999987655444556
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh------hh------------------------h
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL------NL------------------------R 434 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~------~i------------------------~ 434 (488)
++..|+|||++.....++.++|||||||++|+|++|.+||....... +. .
T Consensus 167 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (328)
T cd07856 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLP 246 (328)
T ss_pred ccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhcc
Confidence 88899999988664457789999999999999999998886543210 00 0
Q ss_pred c-CCCC---CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 435 D-GKLP---LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 435 ~-~~~~---~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
. ...+ ..+.++.++.++|.+||+.+|++|||+++++.||||...+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 247 KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 0 0011 12356789999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=312.67 Aligned_cols=241 Identities=25% Similarity=0.387 Sum_probs=201.3
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCC-
Q 011331 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHS- 314 (488)
Q Consensus 237 LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~- 314 (488)
||.|+||.||+|.+..++..||+|++...... ......+..|+.++..+ +||||+++++.+.++..+|++|||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 69999999999999989999999998654322 23445688899999998 8999999999999999999999999765
Q ss_pred chhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CCCCCCCCCcc
Q 011331 315 LSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LPIEEGDARYM 390 (488)
Q Consensus 315 l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~~~~Gt~~Y~ 390 (488)
+.... ....+++..+..++.||+.||.|||++|++|+||+|+||++ .++.++|+|||++...... .....|+..|+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV 159 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence 43332 33458999999999999999999999999999999999999 6789999999999876543 22345888999
Q ss_pred ChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch--h---hhhhh--cCCCCCCCCCcHHHHHHHHHcccCCCCCC
Q 011331 391 PQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP--Q---FLNLR--DGKLPLLPGHSLQFQNLLKVMVDPDPVQR 463 (488)
Q Consensus 391 APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~--~---~~~i~--~~~~~~~~~~s~~l~~lI~k~L~~dP~~R 463 (488)
|||.+... .++.++|+||||+++|+|++|..|+.... . ...+. ......+...+.++.++|.+||..+|++|
T Consensus 160 ~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 238 (262)
T cd05572 160 APEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238 (262)
T ss_pred ChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhC
Confidence 99998654 56779999999999999999999987654 2 22222 33445555668999999999999999999
Q ss_pred CC-----HHHHHhChhhhhhH
Q 011331 464 PS-----AKELVENPIFDKIQ 479 (488)
Q Consensus 464 pT-----a~elL~HP~f~~i~ 479 (488)
|+ ++|+++||||++..
T Consensus 239 ~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 239 LGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred cCCcccCHHHHhcChhhhCCC
Confidence 99 99999999998763
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=367.61 Aligned_cols=255 Identities=24% Similarity=0.312 Sum_probs=209.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..+|.+++.||+|+||.|.+++.+.+++.||+|++.+-. ....+...|..|-.+|..- +.+.|+.++.+|+++.++|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEE
Confidence 458999999999999999999999999999999986521 2223334455566666655 89999999999999999999
Q ss_pred EEecCCCC-chhhhhcc-cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----
Q 011331 307 QMELCDHS-LSDKKASQ-FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---- 379 (488)
Q Consensus 307 V~E~~~~~-l~~~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---- 379 (488)
||||+.|| ++.+...- .+++.+++.|+..|+.||.-||+.|+|||||||+|||| ..|++||+|||.+-.++..
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~ 232 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR 232 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE
Confidence 99999776 44443333 59999999999999999999999999999999999999 6899999999998777533
Q ss_pred CCCCCCCCCccChhhhcc---c-CCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcC--CCCCC--CCCcHHH
Q 011331 380 LPIEEGDARYMPQEILNE---D-YDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDG--KLPLL--PGHSLQF 448 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~---~-~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~--~~~~~--~~~s~~l 448 (488)
..+.+|||.|++||+|.. + ..|+..+|+||+||++|||+.|..||+.... +-.|++- .+.+| ..+|.++
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeea 312 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEA 312 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHH
Confidence 234579999999999842 2 4678899999999999999999999987543 3344432 34444 5689999
Q ss_pred HHHHHHcccCCCCCCCC---HHHHHhChhhhhhHHhhhh
Q 011331 449 QNLLKVMVDPDPVQRPS---AKELVENPIFDKIQKHRKT 484 (488)
Q Consensus 449 ~~lI~k~L~~dP~~RpT---a~elL~HP~f~~i~~~~~~ 484 (488)
++||.+++. +|+.|.. ++++..||||.++.+..+.
T Consensus 313 kdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR 350 (1317)
T KOG0612|consen 313 KDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIR 350 (1317)
T ss_pred HHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhh
Confidence 999998876 5778877 9999999999999775543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=315.11 Aligned_cols=246 Identities=27% Similarity=0.432 Sum_probs=207.4
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++.+.||+|+||.||+|.+..+|..||+|++.... ........+..|+.++.++.+|+||+++++++..++.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36899999999999999999999999999999986532 22334466788999999984499999999999999999999
Q ss_pred EecCCC-Cchhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC----
Q 011331 308 MELCDH-SLSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---- 380 (488)
Q Consensus 308 ~E~~~~-~l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---- 380 (488)
||++.+ .+.... ....+++..++.++.||+.||.|||+.|++|+||+|+||++ .++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999965 454433 33469999999999999999999999999999999999999 67899999999987654321
Q ss_pred -------------------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCC
Q 011331 381 -------------------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKL 438 (488)
Q Consensus 381 -------------------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~ 438 (488)
....|+..|+|||++... .++.++||||||++++++++|..|+..... +..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 123478899999988765 477799999999999999999999876544 233445566
Q ss_pred CCCCCCcHHHHHHHHHcccCCCCCCCCH----HHHHhChhh
Q 011331 439 PLLPGHSLQFQNLLKVMVDPDPVQRPSA----KELVENPIF 475 (488)
Q Consensus 439 ~~~~~~s~~l~~lI~k~L~~dP~~RpTa----~elL~HP~f 475 (488)
..+..++..+.+||.+||..+|++|||+ +++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 6777889999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=326.58 Aligned_cols=247 Identities=21% Similarity=0.335 Sum_probs=193.8
Q ss_pred Eeccc--CcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 236 QIGAG--NFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 236 ~LG~G--~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
.||+| +||+||+|.+..+|+.||||++..........+.+.+|+.++..+ +||||++++++|..++.+|+||||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEecccC
Confidence 46666 999999999999999999999876544455556777888888877 899999999999999999999999987
Q ss_pred Cchh-hhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---------
Q 011331 314 SLSD-KKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--------- 379 (488)
Q Consensus 314 ~l~~-~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--------- 379 (488)
+.+. ... ...+++..+..++.||+.||+|||++||+||||||+|||+ .++.++++|||.+......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 5333 222 2358899999999999999999999999999999999999 6789999999865322110
Q ss_pred -CCCCCCCCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcC------------------
Q 011331 380 -LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDG------------------ 436 (488)
Q Consensus 380 -~~~~~Gt~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~------------------ 436 (488)
.....++..|+|||++... ..++.++|||||||++|||++|.+||........ ....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 0112345679999998654 3467899999999999999999999875432111 1000
Q ss_pred -----------------------------CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhhh
Q 011331 437 -----------------------------KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRK 483 (488)
Q Consensus 437 -----------------------------~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~~ 483 (488)
..+....++.++.+||.+||..||++|||++|+|+||||+.+.+..+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~~ 319 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQ 319 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhcc
Confidence 00111235678999999999999999999999999999999877543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=318.62 Aligned_cols=235 Identities=17% Similarity=0.182 Sum_probs=193.0
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHH-HHHHHHHHHHHHHhCCCCCeeEeeeeecc----cceEEEEEe
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE-RRKALLEVQALAALGSHENIVGYYSSWFE----NEQLYIQME 309 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~-~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~----~~~l~IV~E 309 (488)
..||+|++|.||+|.. +|+.||||++......... ...+.+|+.++.++ +||||+++++++.+ ...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5699999999999987 7999999998754332222 35677999999999 99999999999876 457899999
Q ss_pred cCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCCC
Q 011331 310 LCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEK-GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEG 385 (488)
Q Consensus 310 ~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~-gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~G 385 (488)
|++++.+. . .....+++...+.++.|++.||.|||+. +++||||||+|||+ .++.+||+|||+++..........|
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 182 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccccC
Confidence 99986444 2 2335688899999999999999999985 99999999999999 6789999999999876554445678
Q ss_pred CCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhh--hcCCCCCCCCCcHHHHHHHHHcccCC
Q 011331 386 DARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNL--RDGKLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 386 t~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i--~~~~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
+..|+|||++.+. ..++.++|||||||++|||++|..||...... ..+ .....+.+...+.++.+||.+||+.|
T Consensus 183 ~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~d 262 (283)
T PHA02988 183 FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHD 262 (283)
T ss_pred cccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCC
Confidence 9999999998652 25678999999999999999999999765431 222 12334455578999999999999999
Q ss_pred CCCCCCHHHHHhC
Q 011331 460 PVQRPSAKELVEN 472 (488)
Q Consensus 460 P~~RpTa~elL~H 472 (488)
|++|||++|+++.
T Consensus 263 p~~Rps~~ell~~ 275 (283)
T PHA02988 263 SIKRPNIKEILYN 275 (283)
T ss_pred cccCcCHHHHHHH
Confidence 9999999999863
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.65 Aligned_cols=247 Identities=26% Similarity=0.378 Sum_probs=204.1
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
..|.+.+.||+|+||+||+|.+..+|..||+|++.... ........+..|+.++..+ +||||+++++++.+++..|+|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCeEEEE
Confidence 35788999999999999999999899999999885432 2233446688899999999 899999999999999999999
Q ss_pred EecCCCCchhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCC
Q 011331 308 MELCDHSLSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE 384 (488)
Q Consensus 308 ~E~~~~~l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~ 384 (488)
|||+.+++.... ....+++..+..++.||+.||.|||+.||+|+||+|+||++ .++.++|+|||++...... ....
T Consensus 94 ~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-~~~~ 172 (307)
T cd06607 94 MEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-NSFV 172 (307)
T ss_pred HHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-CCcc
Confidence 999998766533 23468999999999999999999999999999999999999 6789999999999765432 3456
Q ss_pred CCCCccChhhhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcCCCC-C-CCCCcHHHHHHHHHccc
Q 011331 385 GDARYMPQEILNE--DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDGKLP-L-LPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 385 Gt~~Y~APEvl~~--~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~~~~-~-~~~~s~~l~~lI~k~L~ 457 (488)
|+..|+|||++.. ...++.++||||||+++|||++|.+|+........ +.....+ . ....+.++.++|.+||.
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 252 (307)
T cd06607 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQ 252 (307)
T ss_pred CCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc
Confidence 8889999998742 23466799999999999999999998876543222 2222212 1 23467899999999999
Q ss_pred CCCCCCCCHHHHHhChhhhh
Q 011331 458 PDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f~~ 477 (488)
.+|++||++.+++.||||..
T Consensus 253 ~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 253 KIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred CChhhCcCHHHHhcChhhcc
Confidence 99999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=316.91 Aligned_cols=245 Identities=24% Similarity=0.321 Sum_probs=194.5
Q ss_pred EecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-HHHHHHHHHHHHHHHh--CCCCCeeEeeeeecccceEEEEEecCC
Q 011331 236 QIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAAL--GSHENIVGYYSSWFENEQLYIQMELCD 312 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~iL~~l--~~HpnIv~l~~~~~~~~~l~IV~E~~~ 312 (488)
.||+|+||.||+|.+..+|+.||+|++.+..... ........|..++..+ ..||||+.+++++...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999999899999999986542221 1112233333332222 379999999999999999999999998
Q ss_pred CCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC-CCCCCCCCCC
Q 011331 313 HSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK-SLPIEEGDAR 388 (488)
Q Consensus 313 ~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~-~~~~~~Gt~~ 388 (488)
++.+. ......+++..++.++.|++.||.|||+.+|+|+||||+||++ .++.++|+|||++..... ......|+..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 160 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 160 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcC
Confidence 76443 2334568999999999999999999999999999999999999 678999999999876533 2234568999
Q ss_pred ccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-----hh-hhhcCCCCCCCCCcHHHHHHHHHcccCCCCC
Q 011331 389 YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-----FL-NLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQ 462 (488)
Q Consensus 389 Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-----~~-~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~ 462 (488)
|+|||++.....++.++||||+||++|||++|..||..... .. .........+...+.++.++|.+||..+|.+
T Consensus 161 y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~ 240 (278)
T cd05606 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNR 240 (278)
T ss_pred CcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHh
Confidence 99999987544567799999999999999999999875421 11 1122234455567899999999999999999
Q ss_pred CC-----CHHHHHhChhhhhhHH
Q 011331 463 RP-----SAKELVENPIFDKIQK 480 (488)
Q Consensus 463 Rp-----Ta~elL~HP~f~~i~~ 480 (488)
|| ++.++++||||+.+..
T Consensus 241 R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 241 RLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred ccCCCCCCHHHHHhCccccCCCc
Confidence 99 9999999999988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=312.00 Aligned_cols=244 Identities=22% Similarity=0.315 Sum_probs=196.7
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+.||.|+||.||+|.+..+|+.||||++.+... ..........|..++....+|+||+++++++..++.+|++|||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 569999999999999999999999999864322 1222334555666666555899999999999999999999999987
Q ss_pred Cchh-hh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCCCCCCcc
Q 011331 314 SLSD-KK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM 390 (488)
Q Consensus 314 ~l~~-~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~ 390 (488)
+.+. .. ....+++..+..++.||+.||.|||+.|++|+||+|+||++ .++.++|+|||++..... .....|+..|+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~y~ 160 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-NKKFVGTPDYL 160 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-cccCCCCcCcc
Confidence 6444 22 23568999999999999999999999999999999999999 678999999999876543 23446889999
Q ss_pred ChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCC----CCCCCCcHHHHHHHHHcccCCCCCC
Q 011331 391 PQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKL----PLLPGHSLQFQNLLKVMVDPDPVQR 463 (488)
Q Consensus 391 APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~----~~~~~~s~~l~~lI~k~L~~dP~~R 463 (488)
|||.+.+. .++.++||||||+++|+|++|..||....... .+..+.. .....++.++.++|.+||..+|++|
T Consensus 161 ~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 239 (260)
T cd05611 161 APETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239 (260)
T ss_pred ChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHc
Confidence 99998766 36789999999999999999999987544321 2222222 2333578999999999999999999
Q ss_pred C---CHHHHHhChhhhhhHH
Q 011331 464 P---SAKELVENPIFDKIQK 480 (488)
Q Consensus 464 p---Ta~elL~HP~f~~i~~ 480 (488)
| +++|+++||||..+++
T Consensus 240 ~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 240 LGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred cCCCcHHHHHcChHhhcCCC
Confidence 9 4589999999987753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=314.22 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=201.0
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc--cceEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE--NEQLYIQ 307 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~--~~~l~IV 307 (488)
+|...+.||.|++|.||+|.+..++..||+|++..... ......+.+|++++..+ +||||+++++++.. .+.+|+|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEE
Confidence 68899999999999999999998999999999875422 24456788999999998 89999999998864 4478999
Q ss_pred EecCCCCchh-h-----hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 308 MELCDHSLSD-K-----KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 308 ~E~~~~~l~~-~-----~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
|||++++.+. . .....+++..+..++.||+.||.|||+.|++|+||+|+||++ .++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 9999875332 1 123458899999999999999999999999999999999999 6789999999998755432
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-------h-hhhhcCCCCCC-------CCC
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-------F-LNLRDGKLPLL-------PGH 444 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~-~~i~~~~~~~~-------~~~ 444 (488)
.....++..|+|||.+... .++.++|||||||++|+|++|..|+..... . ..+.....+.. ...
T Consensus 160 ~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd06621 160 AGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238 (287)
T ss_pred cccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCch
Confidence 2234578899999998765 567799999999999999999998875411 1 11111111111 124
Q ss_pred cHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhh
Q 011331 445 SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHR 482 (488)
Q Consensus 445 s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~ 482 (488)
+..+.+||.+||..+|++|||+.|++.||||+...+.+
T Consensus 239 ~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~ 276 (287)
T cd06621 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK 276 (287)
T ss_pred HHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccch
Confidence 67899999999999999999999999999997766544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=326.66 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=206.3
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc-----eE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE-----QL 304 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~-----~l 304 (488)
+|++.+.||.|+||.||+|.+..+|..||||++............+..|+.+++.+ +|+||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence 47899999999999999999998899999999875443344556788899999999 8999999999988775 78
Q ss_pred EEEEecCCCCchhhhh-cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 305 YIQMELCDHSLSDKKA-SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
|++|||+.+++..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.++|+|||++.......
T Consensus 80 ~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 80 YIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999999976655333 3468999999999999999999999999999999999999 67899999999998765432
Q ss_pred ----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc--C---------------
Q 011331 381 ----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD--G--------------- 436 (488)
Q Consensus 381 ----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~--~--------------- 436 (488)
....++..|+|||++.+...++.++||||||+++|+|++|.+||........ +.. +
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 2335788999999987654677899999999999999999999865432110 000 0
Q ss_pred -----------C---CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 437 -----------K---LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 437 -----------~---~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
. ....+..+.++.++|.+||+++|++|||+++++.||||+.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0 0012346788999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=312.73 Aligned_cols=245 Identities=26% Similarity=0.403 Sum_probs=203.7
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEec
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMEL 310 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~ 310 (488)
|++++.||.|+||.||+|.+..++..||||++.... .......+..|+.++.++ +||||+++++.+..++..|+||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEEEEe
Confidence 678899999999999999998899999999876432 233456688899999998 899999999999999999999999
Q ss_pred CCCCch-hhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCCCC
Q 011331 311 CDHSLS-DKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIEEG 385 (488)
Q Consensus 311 ~~~~l~-~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~~G 385 (488)
++++.+ .......+++..+..++.||+.||.|||+.|++|+||+|+||++ .++.++|+|||++...... .....|
T Consensus 84 ~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 163 (277)
T cd06641 84 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 163 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccC
Confidence 987544 34445678999999999999999999999999999999999999 6789999999998765432 123457
Q ss_pred CCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcC-CCCCCCCCcHHHHHHHHHcccCCCC
Q 011331 386 DARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDG-KLPLLPGHSLQFQNLLKVMVDPDPV 461 (488)
Q Consensus 386 t~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~-~~~~~~~~s~~l~~lI~k~L~~dP~ 461 (488)
+..|+|||.+... ..+.++|+|||||++|+|++|..|+....... .+... .......++.++.++|.+||+.+|.
T Consensus 164 ~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 242 (277)
T cd06641 164 TPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS 242 (277)
T ss_pred CccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 8899999998654 56679999999999999999999886544322 12222 2224446788999999999999999
Q ss_pred CCCCHHHHHhChhhhhh
Q 011331 462 QRPSAKELVENPIFDKI 478 (488)
Q Consensus 462 ~RpTa~elL~HP~f~~i 478 (488)
+||++.++++||||...
T Consensus 243 ~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 243 FRPTAKELLKHKFIVRF 259 (277)
T ss_pred hCcCHHHHHhCHHHhhh
Confidence 99999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=316.64 Aligned_cols=244 Identities=29% Similarity=0.452 Sum_probs=202.8
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEec
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMEL 310 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~ 310 (488)
|++.+.||.|++|.||+|.+..+|..+|+|.+............+..|+.+++.+ +|+||+++++++..++.++++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEec
Confidence 5678899999999999999998999999999876544434456788899999999 799999999999999999999999
Q ss_pred CCCCchhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---CCCC
Q 011331 311 CDHSLSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---PIEE 384 (488)
Q Consensus 311 ~~~~l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---~~~~ 384 (488)
+++++...... ..+++..++.++.||+.||.|||+.||+|+||+|+||++ .++.++|+|||.+....... ....
T Consensus 80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 99877664333 478999999999999999999999999999999999999 57899999999997765432 2245
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc------C----------------------
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD------G---------------------- 436 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~------~---------------------- 436 (488)
++..|+|||.+.....++.++||||||+++|+|++|.++|........+.. .
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence 788899999987654577899999999999999999988865443211100 0
Q ss_pred -C----CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 437 -K----LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 437 -~----~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
. ....+.++.++.+||.+||.+||.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0 00123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.66 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=201.1
Q ss_pred ceeEEEEecccCcEEEEEEEEcCC--CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc----cce
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRID--GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE----NEQ 303 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~----~~~ 303 (488)
+|++.+.||.|+||.||+|.+..+ +..||||++............+..|+.++.++.+|+||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 478999999999999999999888 89999999865433333456678899999999779999999986542 245
Q ss_pred EEEEEecCCCCchhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--
Q 011331 304 LYIQMELCDHSLSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 304 l~IV~E~~~~~l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-- 379 (488)
+|+++|++++++.... ....+++..++.++.||+.||.|||+.||+|+||||+|||+ .++.++|+|||++......
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 160 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence 8999999988776643 34568999999999999999999999999999999999999 6789999999999765421
Q ss_pred -----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh--------------------
Q 011331 380 -----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR-------------------- 434 (488)
Q Consensus 380 -----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~-------------------- 434 (488)
.....|+..|+|||++.....++.++|||||||++|+|++|.+||........+.
T Consensus 161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd07857 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP 240 (332)
T ss_pred cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhh
Confidence 1223588999999987654457789999999999999999999886543210000
Q ss_pred ----------cC-CC---CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 435 ----------DG-KL---PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 435 ----------~~-~~---~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.. .. ...+..+..+.+||.+||+.||.+|||+.+++.||||+..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 241 KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 00 00 12234578899999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=322.27 Aligned_cols=247 Identities=25% Similarity=0.368 Sum_probs=197.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc------
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN------ 301 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~------ 301 (488)
.++|++++.||.|+||.||+|.+..++..||||++......+.......+|+++++.+ +|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccc
Confidence 4689999999999999999999999999999998865433333334567899999999 899999999877543
Q ss_pred --ceEEEEEecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceec
Q 011331 302 --EQLYIQMELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL 376 (488)
Q Consensus 302 --~~l~IV~E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~ 376 (488)
..+|+||||+++.+..... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++...
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 3479999999987665433 3469999999999999999999999999999999999999 6789999999999765
Q ss_pred CCCC--------------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh------cC
Q 011331 377 NKSL--------------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR------DG 436 (488)
Q Consensus 377 ~~~~--------------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~------~~ 436 (488)
.... ....|++.|+|||.+.+...++.++|||||||++|||++|.+||.......... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 3211 112467889999988665456779999999999999999999887543321100 00
Q ss_pred --------------------CCC-------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 437 --------------------KLP-------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 437 --------------------~~~-------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
... .....+..+.+||.+||..||.+|||+.|+++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 012344678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=327.70 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=205.5
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc--ce
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN--EQ 303 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~--~~ 303 (488)
.+.++|++.+.||+|+||.||+|.+..+|..||||++............+..|+.++.++.+|+||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 3456789999999999999999999989999999988654333344556778999999987899999999988653 36
Q ss_pred EEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---
Q 011331 304 LYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 304 l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--- 379 (488)
+|+||||+++.+........+++..++.++.||+.||.|||+.||+|+||||+||++ .++.++|+|||++......
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 84 IYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 899999999877665555578899999999999999999999999999999999999 6789999999999765321
Q ss_pred -----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---h------------------
Q 011331 380 -----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---L------------------ 433 (488)
Q Consensus 380 -----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i------------------ 433 (488)
.....|+..|+|||++.....++.++|||||||++|+|++|.+||........ +
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 11235888999999876544566799999999999999999988864322110 0
Q ss_pred ---------hcCC----CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 434 ---------RDGK----LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 434 ---------~~~~----~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.... ....+.++.++.++|.+||+.||++|||+.++++||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0000 012234688999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=308.67 Aligned_cols=245 Identities=29% Similarity=0.482 Sum_probs=202.2
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++.+.||+|+||.||+|.+..++..||+|++............+..|+.++..+ +|+||+++++.+...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEEe
Confidence 47899999999999999999988999999999876544444667789999999999 99999999999999999999999
Q ss_pred cCCCCchhh-h-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC-----
Q 011331 310 LCDHSLSDK-K-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP----- 381 (488)
Q Consensus 310 ~~~~~l~~~-~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~----- 381 (488)
|+.++.+.. . ....+++..++.++.||+.||.|||+.||+|+||+|+||++ .++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 998764442 2 22348899999999999999999999999999999999999 678999999999977643211
Q ss_pred --CCCCCCCccChhhhcccC--CCCchhHHHHHHHHHHHHHcCCCCCCCchhh----hhhhcCC-CCCCC--CCcHHHHH
Q 011331 382 --IEEGDARYMPQEILNEDY--DHLDKVDIFSLGATMYELIKGSPLSESGPQF----LNLRDGK-LPLLP--GHSLQFQN 450 (488)
Q Consensus 382 --~~~Gt~~Y~APEvl~~~~--~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~----~~i~~~~-~~~~~--~~s~~l~~ 450 (488)
...++..|+|||++.... ..+.++||||||+++|+|++|..||...... ..+.... ...+. .++..+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 235788999999987542 3667999999999999999999998654221 1112222 22223 34889999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhh
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
+|.+||+.+|.+|||+.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=308.90 Aligned_cols=244 Identities=31% Similarity=0.505 Sum_probs=201.2
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++.+.||.|+||.||+|.+..+|..||+|.+........+...+..|+++++.+ +|+||+++++.+...+..|+++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEEe
Confidence 47899999999999999999999999999999865433334455677899999999 89999999999999999999999
Q ss_pred cCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC-eEEEEeecCceecCCCC---
Q 011331 310 LCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG-VYKLGDFGRATLLNKSL--- 380 (488)
Q Consensus 310 ~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g-~vkL~DFGlA~~~~~~~--- 380 (488)
|+.++ +..... ...+++..+..++.||+.||.|||+.+++|+||||+||+++ ++ .++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 99775 333221 22478999999999999999999999999999999999994 43 57999999997664432
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhc-CCCCCCCCCcHHHHHHHHHcc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRD-GKLPLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~-~~~~~~~~~s~~l~~lI~k~L 456 (488)
....|+..|+|||++... .++.++|+||||+++|||++|..|+....... .+.. ...+..+..+.++.++|.+||
T Consensus 160 ~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 238 (257)
T cd08225 160 YTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238 (257)
T ss_pred cccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHh
Confidence 223588899999988654 56779999999999999999999987543322 2222 223345567899999999999
Q ss_pred cCCCCCCCCHHHHHhChhh
Q 011331 457 DPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 457 ~~dP~~RpTa~elL~HP~f 475 (488)
..+|++|||+.+++.||||
T Consensus 239 ~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 239 KVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ccChhhCcCHHHHhhCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=311.51 Aligned_cols=256 Identities=28% Similarity=0.434 Sum_probs=211.9
Q ss_pred CCCccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 221 GDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 221 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
|.....-.++.+.+..||.|..|+||+++.+.+|..+|||.+.+. .+..+..+.++.+.++....++|+||+.+++|..
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 433333456788899999999999999999999999999999765 4556677889999998888779999999999999
Q ss_pred cceEEEEEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHH-HcCcccCCCCCCcEEE-eCCeEEEEeecCceec
Q 011331 301 NEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIH-EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL 376 (488)
Q Consensus 301 ~~~l~IV~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH-~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~ 376 (488)
+..++|.||.|...... .+..+.++|..+-++..-++.||.||. ++||||||+||+|||+ ..|++||||||++..+
T Consensus 163 n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 163 NTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred CchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence 99999999998765333 344567999999999999999999997 5699999999999999 5699999999999776
Q ss_pred CCC--CCCCCCCCCccChhhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcCCCCCCC---CCc
Q 011331 377 NKS--LPIEEGDARYMPQEILNED--YDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDGKLPLLP---GHS 445 (488)
Q Consensus 377 ~~~--~~~~~Gt~~Y~APEvl~~~--~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~~~~~~~---~~s 445 (488)
-++ .....|-+.|||||.+... ..|.-.+||||||++|+||.||..||..... +..+.+...|..+ +.|
T Consensus 243 vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFS 322 (391)
T KOG0983|consen 243 VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFS 322 (391)
T ss_pred ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcC
Confidence 443 3345699999999998532 3455599999999999999999999987433 2234444445444 469
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 446 LQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 446 ~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
.+|++|+..||.+|+.+||...+||+|||+..
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 99999999999999999999999999998754
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.22 Aligned_cols=242 Identities=25% Similarity=0.353 Sum_probs=198.4
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCCc
Q 011331 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSL 315 (488)
Q Consensus 237 LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~l 315 (488)
||+|+||+||+|.+..+|+.||+|++...... ......+..|+.++..+ +||||+++++.+...+.+|+||||++++.
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 68999999999999999999999998643222 22344567899999999 79999999999999999999999998753
Q ss_pred hh-hh-hcc--cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CCCCCCCCC
Q 011331 316 SD-KK-ASQ--FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LPIEEGDAR 388 (488)
Q Consensus 316 ~~-~~-~~~--~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~~~~Gt~~ 388 (488)
+. .. ... .+++..++.++.||+.||.|||++|++|+||+|+||++ .++.++|+|||++...... .....++..
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence 33 22 222 58999999999999999999999999999999999999 6789999999998765422 223457889
Q ss_pred ccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhh----hhcCCCCCCCCCcHHHHHHHHHcccCCCC
Q 011331 389 YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLN----LRDGKLPLLPGHSLQFQNLLKVMVDPDPV 461 (488)
Q Consensus 389 Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~----i~~~~~~~~~~~s~~l~~lI~k~L~~dP~ 461 (488)
|+|||.+.+. .++.++|||||||++|+|++|..||..... ... ........++..+.++.++|.+||+.||.
T Consensus 160 y~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (277)
T cd05577 160 YMAPEVLQGE-VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE 238 (277)
T ss_pred cCCHHHhcCC-CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChh
Confidence 9999998765 477799999999999999999999865432 111 12233445566799999999999999999
Q ss_pred CCC-----CHHHHHhChhhhhhHH
Q 011331 462 QRP-----SAKELVENPIFDKIQK 480 (488)
Q Consensus 462 ~Rp-----Ta~elL~HP~f~~i~~ 480 (488)
+|| ++.++++||||..+..
T Consensus 239 ~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 239 KRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred HccCCCcccHHHHHhChhhhcCCh
Confidence 999 8999999999988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=320.92 Aligned_cols=245 Identities=26% Similarity=0.412 Sum_probs=202.3
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEec
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMEL 310 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~ 310 (488)
|.....||.|+||.||++.+..++..||||.+... .......+..|+.++..+ +|+||+++++.+...+..|+||||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeEEEEEeC
Confidence 34456799999999999999989999999988643 234455688899999998 899999999999999999999999
Q ss_pred CCCCchh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCCCC
Q 011331 311 CDHSLSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIEEG 385 (488)
Q Consensus 311 ~~~~l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~~G 385 (488)
++++.+. ......+++.+++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++...... .....|
T Consensus 101 ~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 180 (292)
T cd06658 101 LEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVG 180 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeec
Confidence 9876443 4445568999999999999999999999999999999999999 5789999999998754322 123458
Q ss_pred CCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc---CCCCCCCCCcHHHHHHHHHcccCC
Q 011331 386 DARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD---GKLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 386 t~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~---~~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
+..|+|||.+... .++.++||||||+++|||++|..||........ +.. ...+.....+..+.++|.+||..|
T Consensus 181 ~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 259 (292)
T cd06658 181 TPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259 (292)
T ss_pred CccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCC
Confidence 8999999998664 567799999999999999999999876544322 211 122233356889999999999999
Q ss_pred CCCCCCHHHHHhChhhhhhH
Q 011331 460 PVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 460 P~~RpTa~elL~HP~f~~i~ 479 (488)
|.+|||++|+++||||....
T Consensus 260 P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 260 PSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred hhHCcCHHHHhhChhhhccC
Confidence 99999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=347.21 Aligned_cols=252 Identities=25% Similarity=0.318 Sum_probs=188.8
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCC-CeEEEEEE--------------eccC-CCchHHHHHHHHHHHHHHHhCCCC
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRID-GCFYAVKH--------------SKRQ-LHHDAERRKALLEVQALAALGSHE 289 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAvK~--------------l~~~-~~~~~~~~~~~~Ei~iL~~l~~Hp 289 (488)
.+..+|++++.||+|+||+||+|..+.. +..+++|. +.+. .........+.+|+.++..+ +|+
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCC
Confidence 3456899999999999999999876433 22222221 1110 11222345678899999999 999
Q ss_pred CeeEeeeeecccceEEEEEecCCCCchhhhhcc------cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eC
Q 011331 290 NIVGYYSSWFENEQLYIQMELCDHSLSDKKASQ------FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KN 362 (488)
Q Consensus 290 nIv~l~~~~~~~~~l~IV~E~~~~~l~~~~~~~------~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~ 362 (488)
||+++++++...+..|+++|++.+.+....... ......++.++.||+.||.|||++|||||||||+|||| .+
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 999999999999999999999988766533222 23356688899999999999999999999999999999 67
Q ss_pred CeEEEEeecCceecCCCC----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC-c--h---hhhh
Q 011331 363 GVYKLGDFGRATLLNKSL----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSES-G--P---QFLN 432 (488)
Q Consensus 363 g~vkL~DFGlA~~~~~~~----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~-~--~---~~~~ 432 (488)
+.+||+|||+++.+.... ....||..|+|||++.+. .++.++|||||||+||||++|..++.. . . .+..
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 899999999998764322 234699999999998765 577899999999999999998754322 1 1 1111
Q ss_pred hhc------CCCC--------------------------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 433 LRD------GKLP--------------------------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 433 i~~------~~~~--------------------------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+.. ...+ .....+.++.++|.+||.+||.+|||+.|+|.||||....
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 100 0000 0012456788889999999999999999999999998643
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=319.69 Aligned_cols=242 Identities=26% Similarity=0.363 Sum_probs=203.0
Q ss_pred cceeEE-EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc----cce
Q 011331 229 TDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE----NEQ 303 (488)
Q Consensus 229 ~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~----~~~ 303 (488)
++|.+- +.||-|-.|.|..|.++.||+.+|+|++.. ..++.+|++.......|||||.++++|.. ...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 455553 579999999999999999999999998742 34567788888888899999999998864 445
Q ss_pred EEEEEecCCCC-chh---hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecCcee
Q 011331 304 LYIQMELCDHS-LSD---KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGRATL 375 (488)
Q Consensus 304 l~IV~E~~~~~-l~~---~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGlA~~ 375 (488)
+.||||.++|+ |.. ......++|.++..|++||+.|+.|||+.+|.||||||+|+|.. |-.+||+|||+|+.
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 78999999887 333 23334599999999999999999999999999999999999993 45799999999987
Q ss_pred cC--CCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-------hhhhhcCCCCCCC----
Q 011331 376 LN--KSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-------FLNLRDGKLPLLP---- 442 (488)
Q Consensus 376 ~~--~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~~~i~~~~~~~~~---- 442 (488)
.. ....+.+.|++|.|||++... .|...+|+||+||++|-|++|.+||++... -.+|+.+.+.+|.
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg~e-KydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs 292 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS 292 (400)
T ss_pred cCCCccccCCcccccccCHHHhCch-hcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh
Confidence 75 345567899999999999876 477799999999999999999999987533 2356667666654
Q ss_pred CCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 443 GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 443 ~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.+|+...++|+++|..+|.+|.|+.|+++|||+..-
T Consensus 293 ~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 293 CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred HHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 358889999999999999999999999999999754
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=348.13 Aligned_cols=240 Identities=27% Similarity=0.434 Sum_probs=199.1
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec----ccc---
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF----ENE--- 302 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~----~~~--- 302 (488)
++++.+.|.+|||+.||+|.+...|..||+|++... .....+...+||.+++.|.+|+|||.|++... .++
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 678999999999999999999988899999987643 45566788999999999999999999999322 122
Q ss_pred eEEEEEecCC-CCchh---hhhcccCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEE-eCCeEEEEeecCcee
Q 011331 303 QLYIQMELCD-HSLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKG--IAHLDVKPDNIYV-KNGVYKLGDFGRATL 375 (488)
Q Consensus 303 ~l~IV~E~~~-~~l~~---~~~~~~l~~~~~~~i~~qI~~gL~yLH~~g--IiHrDLKp~NILv-~~g~vkL~DFGlA~~ 375 (488)
.++|.||||. ++|.+ .+....|++.++++|+.|+|.|+++||..+ |||||||.+|||| .+|.+||||||.|+-
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 4689999998 46665 333456999999999999999999999997 9999999999999 788999999999974
Q ss_pred cCCCCC------------CCCCCCCccChhhhc--ccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCC--C
Q 011331 376 LNKSLP------------IEEGDARYMPQEILN--EDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKL--P 439 (488)
Q Consensus 376 ~~~~~~------------~~~Gt~~Y~APEvl~--~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~--~ 439 (488)
.-.... ....|+.|+|||.+. .+...++|+|||+|||+||.|+....||+....+ .|.++.+ |
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-aIlng~Y~~P 274 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-AILNGNYSFP 274 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-eEEeccccCC
Confidence 422111 123789999999874 3446778999999999999999999999876443 4454444 4
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 440 LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 440 ~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
..+.++..+.+||+.||+.||.+||++-+++++
T Consensus 275 ~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 275 PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred CCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 556899999999999999999999999999986
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=313.00 Aligned_cols=240 Identities=19% Similarity=0.297 Sum_probs=192.8
Q ss_pred ccceeEEEEe--cccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 228 YTDFHEIEQI--GAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 228 ~~~y~~~~~L--G~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.++|.+.+.+ |.|+||.||++.+..++..+|+|++........ |+.....+.+|+||+++++.+...+.+|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 3455666665 999999999999999999999999864322211 2222222337999999999999999999
Q ss_pred EEEecCCCC-chhhhh-cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCC-eEEEEeecCceecCCCCC
Q 011331 306 IQMELCDHS-LSDKKA-SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNG-VYKLGDFGRATLLNKSLP 381 (488)
Q Consensus 306 IV~E~~~~~-l~~~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g-~vkL~DFGlA~~~~~~~~ 381 (488)
+||||+.++ |..... ...+++..++.++.||+.||.|||+.|++|+||||+||++ .++ .++|+|||++...... .
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-~ 164 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-S 164 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-c
Confidence 999999764 444333 3379999999999999999999999999999999999999 455 8999999999876543 3
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-------hhhhhcCCCCCCCCCcHHHHHHHHH
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-------FLNLRDGKLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~~~i~~~~~~~~~~~s~~l~~lI~k 454 (488)
...|+..|+|||++... .++.++|||||||++|+|++|..||..... .........+.++..+..+.+||.+
T Consensus 165 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 243 (267)
T PHA03390 165 CYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQS 243 (267)
T ss_pred cCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHH
Confidence 34689999999998765 567799999999999999999999864321 1112233445556789999999999
Q ss_pred cccCCCCCCCC-HHHHHhChhhh
Q 011331 455 MVDPDPVQRPS-AKELVENPIFD 476 (488)
Q Consensus 455 ~L~~dP~~RpT-a~elL~HP~f~ 476 (488)
||+.+|.+||+ ++|+|+||||+
T Consensus 244 ~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 244 MLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HhccChhhCCchHHHHhcCCccc
Confidence 99999999996 69999999996
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=311.22 Aligned_cols=240 Identities=18% Similarity=0.246 Sum_probs=195.2
Q ss_pred cceeEEEEecccCcEEEEEEEEc---CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKR---IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
++|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+..|+.++..+ +||||+++++++..++.++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCcE
Confidence 46899999999999999999765 356799999987542 334456788999999998 9999999999999999999
Q ss_pred EEEecCCCCchhh-hh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-
Q 011331 306 IQMELCDHSLSDK-KA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL- 380 (488)
Q Consensus 306 IV~E~~~~~l~~~-~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~- 380 (488)
|||||++++.+.. .. ...+++..++.++.||+.||+|||++|++|+||||+|||+ .++.++++|||.+.......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 9999998875542 22 2468999999999999999999999999999999999999 67899999999876542211
Q ss_pred ---CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC-CCCCCCCCcHHHHHHH
Q 011331 381 ---PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG-KLPLLPGHSLQFQNLL 452 (488)
Q Consensus 381 ---~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~-~~~~~~~~s~~l~~lI 452 (488)
....++..|+|||++... .++.++|||||||++|||++ |..||...... ..+..+ ..+.+..++..+.+++
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLM 241 (266)
T ss_pred hcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 112356789999998665 57789999999999999775 98888654332 223332 3455667789999999
Q ss_pred HHcccCCCCCCCCHHHHHh
Q 011331 453 KVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~ 471 (488)
.+||+.+|.+|||++++++
T Consensus 242 ~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 242 LDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHcCCCchhCCCHHHHHH
Confidence 9999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=308.65 Aligned_cols=240 Identities=26% Similarity=0.334 Sum_probs=195.1
Q ss_pred EEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCC
Q 011331 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCD 312 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~ 312 (488)
....||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.++..+ +|+||+++++++..++.++++|||+.
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEecCC
Confidence 445799999999999999989999999988643 233456788899999998 99999999999999999999999998
Q ss_pred CCchh-hhhc--ccC--CHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--CCeEEEEeecCceecCCC---CCC
Q 011331 313 HSLSD-KKAS--QFF--AEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 313 ~~l~~-~~~~--~~l--~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
++.+. .... ..+ ++..+..++.||+.||.|||++||+|+||||+||+++ ++.++|+|||++...... ...
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 168 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET 168 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcccc
Confidence 75443 2222 334 7788899999999999999999999999999999994 579999999998765322 223
Q ss_pred CCCCCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh----hh--hcCCCCCCCCCcHHHHHHHHHc
Q 011331 383 EEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQFL----NL--RDGKLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~----~i--~~~~~~~~~~~s~~l~~lI~k~ 455 (488)
..|+..|+|||.+... ..++.++||||||+++|+|++|.+|+....... .. .......+..++.++.+||.+|
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 248 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRC 248 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHH
Confidence 4588999999998543 346679999999999999999999986532211 11 1122234556788999999999
Q ss_pred ccCCCCCCCCHHHHHhChhh
Q 011331 456 VDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 456 L~~dP~~RpTa~elL~HP~f 475 (488)
|+.+|.+|||+.|++.||||
T Consensus 249 l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 249 FEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred cCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=310.83 Aligned_cols=245 Identities=26% Similarity=0.357 Sum_probs=197.9
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc--------hHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH--------DAERRKALLEVQALAALGSHENIVGYYSSWFEN 301 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~--------~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~ 301 (488)
+|.+.+.||.|+||.||+|.+..+|..||+|.++..... ....+.+..|+.++..+ +|+||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccC
Confidence 478889999999999999999989999999987532110 01123567799999998 899999999999999
Q ss_pred ceEEEEEecCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 302 EQLYIQMELCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 302 ~~l~IV~E~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
+.+++||||+.++.+. . .....+++..+..++.||+.||.|||+.|++|+||+|+||++ .++.++|+|||++.....
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 9999999999876443 2 233568899999999999999999999999999999999999 678999999999976532
Q ss_pred C-----CCCCCCCCCccChhhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh---cC--CCCC----CCC
Q 011331 379 S-----LPIEEGDARYMPQEILNEDY-DHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR---DG--KLPL----LPG 443 (488)
Q Consensus 379 ~-----~~~~~Gt~~Y~APEvl~~~~-~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~---~~--~~~~----~~~ 443 (488)
. .....|+..|+|||.+.... .++.++|+||||+++|+|++|..|+........+. .. .... .+.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN 240 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccccc
Confidence 2 12235888999999986542 46779999999999999999999986544322221 11 1122 234
Q ss_pred CcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 444 HSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 444 ~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
++.++.++|.+||..+|++|||+++++.||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 241 LSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 58899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.01 Aligned_cols=243 Identities=22% Similarity=0.282 Sum_probs=193.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCC-----eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDG-----CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||.||+|.+...| ..||||++.... .......+..|+.+++.+.+|+||+++++++...+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 457899999999999999999865443 579999987543 23345668889999999878999999999999999
Q ss_pred eEEEEEecCCCCchh-hhh-------------------------------------------------------------
Q 011331 303 QLYIQMELCDHSLSD-KKA------------------------------------------------------------- 320 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~-~~~------------------------------------------------------------- 320 (488)
.+|+|||||.++.+. ...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 999999999765322 111
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC-----CCC
Q 011331 321 ----------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP-----IEE 384 (488)
Q Consensus 321 ----------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~-----~~~ 384 (488)
...+++..++.++.||+.||.|||++||+||||||+|||+ .++.++|+|||+++....... ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 1236788899999999999999999999999999999999 568899999999986543211 123
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhh-hcC-CCCCCCCCcHHHHHHHHHcccC
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNL-RDG-KLPLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i-~~~-~~~~~~~~s~~l~~lI~k~L~~ 458 (488)
++..|+|||++... .++.++|||||||++|||++ |..||..... .... ..+ ....+...+.++.++|.+||+.
T Consensus 276 ~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 354 (374)
T cd05106 276 LPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNL 354 (374)
T ss_pred CccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCC
Confidence 45679999998765 57789999999999999997 9988865432 1122 222 2334445689999999999999
Q ss_pred CCCCCCCHHHHHhC
Q 011331 459 DPVQRPSAKELVEN 472 (488)
Q Consensus 459 dP~~RpTa~elL~H 472 (488)
||.+|||+.++++.
T Consensus 355 dp~~RPs~~~l~~~ 368 (374)
T cd05106 355 EPTERPTFSQISQL 368 (374)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=306.76 Aligned_cols=240 Identities=32% Similarity=0.485 Sum_probs=200.3
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++.+.||.|+||.||++.+..++..||+|.++... .......+..|+.+++.+ +|+||+++++.+.+++.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEe
Confidence 4789999999999999999999999999999986432 234456677899999998 89999999999999999999999
Q ss_pred cCCCC-chhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---C
Q 011331 310 LCDHS-LSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---P 381 (488)
Q Consensus 310 ~~~~~-l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---~ 381 (488)
|++++ +.... ....+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++....... .
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 99875 43322 23457899999999999999999999999999999999999 67899999999997664321 2
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCC-CCCCCCCcHHHHHHHHHccc
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGK-LPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~-~~~~~~~s~~l~~lI~k~L~ 457 (488)
...|+..|+|||++... .++.++|+||||+++|+|++|..||...... ..+..+. .+.+..++..+.++|.+||.
T Consensus 159 ~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (255)
T cd08219 159 TYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK 237 (255)
T ss_pred cccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHh
Confidence 34588899999998665 5778999999999999999999998765432 2233333 34556678899999999999
Q ss_pred CCCCCCCCHHHHHhC
Q 011331 458 PDPVQRPSAKELVEN 472 (488)
Q Consensus 458 ~dP~~RpTa~elL~H 472 (488)
.||++|||+.+++.-
T Consensus 238 ~~P~~Rp~~~~il~~ 252 (255)
T cd08219 238 RNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCCCHHHHhhc
Confidence 999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=316.20 Aligned_cols=247 Identities=25% Similarity=0.328 Sum_probs=202.9
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.+|++++.||+|+||+||+|.+..+|..||+|++.... .......+..|++++..+ +||||+++++.+...+.+|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEEE
Confidence 46889999999999999999999999999999886432 233456788999999998 8999999999999999999999
Q ss_pred ecCCCCchhh--hhcccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEE-eCCeEEEEeecCceecCC-CCCCC
Q 011331 309 ELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK-SLPIE 383 (488)
Q Consensus 309 E~~~~~l~~~--~~~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~-~~~~~ 383 (488)
||++++.+.. ...+.+++..+..++.+|+.||.|||+ .|++|+||+|+||++ .++.++|+|||++..... .....
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~ 162 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF 162 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCcc
Confidence 9998865542 223468999999999999999999997 699999999999999 678999999999875532 22345
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh--------------hhhhcCC-CCCCC-CCcHH
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF--------------LNLRDGK-LPLLP-GHSLQ 447 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~--------------~~i~~~~-~~~~~-~~s~~ 447 (488)
.|+..|+|||++... .++.++|||||||++|+|++|..||...... ..+.... ...+. ..+.+
T Consensus 163 ~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd06620 163 VGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED 241 (284)
T ss_pred ccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHH
Confidence 689999999998765 5777999999999999999999998753321 1111111 11222 26788
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+.+||.+||..||++|||+.|+++||||..-
T Consensus 242 ~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 242 LRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 9999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=314.84 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=204.9
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
-.++|++.+.||+|+||+||+|.+..+|..||||.+..... .........|+.++..+..|+||+++++++.+...+|+
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 34678999999999999999999998899999999875422 23345567788878777679999999999999999999
Q ss_pred EEecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--C
Q 011331 307 QMELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--L 380 (488)
Q Consensus 307 V~E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~ 380 (488)
+|||+.+.+..... ...+++..+..++.||+.||.|||+ .||+|+||+|+||++ .++.++|+|||++...... .
T Consensus 92 v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~ 171 (296)
T cd06618 92 CMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171 (296)
T ss_pred EeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence 99999876544222 3468899999999999999999997 699999999999999 6789999999998765432 2
Q ss_pred CCCCCCCCccChhhhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcCCC---CCCCCCcHHHHH
Q 011331 381 PIEEGDARYMPQEILNED---YDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDGKL---PLLPGHSLQFQN 450 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~---~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~~~---~~~~~~s~~l~~ 450 (488)
....++..|+|||.+... ..++.++||||||+++|+|++|+.||..... ...+..... +....++.++.+
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCS 251 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Confidence 233478899999998643 2356799999999999999999999876322 112222222 222246889999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhhHHhh
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQKHR 482 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~ 482 (488)
||.+||..||.+||++++++.||||+.....+
T Consensus 252 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 283 (296)
T cd06618 252 FVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283 (296)
T ss_pred HHHHHccCChhhCCCHHHHhcChhhhccchhH
Confidence 99999999999999999999999998765433
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=301.49 Aligned_cols=244 Identities=29% Similarity=0.426 Sum_probs=205.0
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc--ceEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN--EQLYIQ 307 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~--~~l~IV 307 (488)
+|++.+.||+|++|.||+|.+..++..|++|++............+..|+.+++++ +|+||+++++.+... ..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEE
Confidence 47889999999999999999998999999999876544345567788999999999 799999999999988 889999
Q ss_pred EecCCCC-chhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-----
Q 011331 308 MELCDHS-LSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----- 379 (488)
Q Consensus 308 ~E~~~~~-l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----- 379 (488)
+||++++ +.... ....+++..++.++.|++.||.|||+.|++|+||+|+||++ .++.++|+|||.+......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 9999664 44432 22378999999999999999999999999999999999999 5689999999999877543
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhh--cCCCCCCCCCcHHHHHHHH
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLR--DGKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~--~~~~~~~~~~s~~l~~lI~ 453 (488)
.....++..|+|||.+... ..+.++||||||+++|+|++|..|+..... ...+. ......+...+..+.+||.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 2345688899999998765 467799999999999999999999876541 11222 1223345566899999999
Q ss_pred HcccCCCCCCCCHHHHHhChhh
Q 011331 454 VMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~HP~f 475 (488)
+||..+|++||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=316.15 Aligned_cols=249 Identities=27% Similarity=0.429 Sum_probs=205.2
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
...+|.+++.||.|+||+||++.+..++..||+|.+... .......+..|+.++..+ +||||+++++.+...+..|+
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMREN-KHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEE
Confidence 346789999999999999999999889999999998543 223345678899999998 89999999999999999999
Q ss_pred EEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CC
Q 011331 307 QMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LP 381 (488)
Q Consensus 307 V~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~ 381 (488)
|+||++++ +........+++..+..++.||+.||.|||++|++|+||+|+||++ .++.++|+|||++...... ..
T Consensus 94 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred EEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence 99999875 4444444568899999999999999999999999999999999999 6789999999988755322 22
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh----cC--CCCCCCCCcHHHHHHHHHc
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR----DG--KLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~----~~--~~~~~~~~s~~l~~lI~k~ 455 (488)
...|+..|+|||.+... .++.++|||||||++|+|++|..||........+. .+ ....+..++..+.++|.+|
T Consensus 174 ~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (293)
T cd06647 174 TMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252 (293)
T ss_pred cccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHH
Confidence 34588899999998765 56779999999999999999999987654422211 11 1122334578899999999
Q ss_pred ccCCCCCCCCHHHHHhChhhhhhH
Q 011331 456 VDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 456 L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
|..+|++||++.+++.||||+..+
T Consensus 253 l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 253 LEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=303.91 Aligned_cols=244 Identities=34% Similarity=0.559 Sum_probs=205.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++.+.||.|+||.||+|.+..++..||+|++............+..|+++++.+ +|+|++++++.+...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEEE
Confidence 47899999999999999999998999999999876544445667788999999999 79999999999999999999999
Q ss_pred cCCCC-chhhhh-----cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 310 LCDHS-LSDKKA-----SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 310 ~~~~~-l~~~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
+++++ +..... ...+++..++.++.+|+.||.|||+.|++|+||+|+||++ .++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 99875 433222 2568999999999999999999999999999999999999 56899999999998764432
Q ss_pred -CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhc-CCCCCCCCCcHHHHHHHHHc
Q 011331 381 -PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRD-GKLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 381 -~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~-~~~~~~~~~s~~l~~lI~k~ 455 (488)
....|++.|+|||.+... .++.++|+||+|+++|+|++|..|+...... ..+.. ...+.+...+.++.++|.+|
T Consensus 160 ~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSL 238 (258)
T ss_pred ecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 234588899999988665 4677999999999999999999998665321 12222 23344456789999999999
Q ss_pred ccCCCCCCCCHHHHHhChhh
Q 011331 456 VDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 456 L~~dP~~RpTa~elL~HP~f 475 (488)
|..+|++|||+.|+|+||||
T Consensus 239 l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 239 LQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred cCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=329.40 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=223.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..+|..+..||+|+||+|.+|..+.+.+.||||++++.. .++.+.+.-+.|-.+|+....-|.++.++..|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 458999999999999999999999999999999998773 3445566677788888888788999999999999999999
Q ss_pred EEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceec---CCCC
Q 011331 307 QMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL---NKSL 380 (488)
Q Consensus 307 V~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~---~~~~ 380 (488)
||||++|+-+. ...-+.+.|..+..++..|+-||-+||++|||+||||.+|||+ .+|++||+|||+++.. +...
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TT 507 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTT 507 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcce
Confidence 99999886333 4445679999999999999999999999999999999999999 7899999999999743 2334
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
.+.+||+.|+|||++... .|+.++|+||+||+||||+.|.+||++.++ +..|.+.....|..+|.++.++++.+|.
T Consensus 508 kTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~lt 586 (683)
T KOG0696|consen 508 KTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLT 586 (683)
T ss_pred eeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhh
Confidence 567899999999999876 688899999999999999999999988765 5677888888999999999999999999
Q ss_pred CCCCCCCC-----HHHHHhChhhhhhHHhhh
Q 011331 458 PDPVQRPS-----AKELVENPIFDKIQKHRK 483 (488)
Q Consensus 458 ~dP~~RpT-----a~elL~HP~f~~i~~~~~ 483 (488)
+.|.+|.. -.++-+||||+.|.+.|.
T Consensus 587 K~P~kRLGcg~~ge~di~~H~FFR~iDWek~ 617 (683)
T KOG0696|consen 587 KHPGKRLGCGPEGERDIREHPFFRRIDWEKL 617 (683)
T ss_pred cCCccccCCCCccccchhhCcchhhccHHHH
Confidence 99999964 578999999999976653
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=312.10 Aligned_cols=241 Identities=20% Similarity=0.270 Sum_probs=196.0
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCC-----eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDG-----CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
.+|++++.||+|+||.||+|.....+ ..||+|.+... ........+.+|+.++..+ +||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCCc
Confidence 46899999999999999999876555 78999988643 2334455688899999998 89999999999999999
Q ss_pred EEEEEecCCCC-chhhhhc-----------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCe
Q 011331 304 LYIQMELCDHS-LSDKKAS-----------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGV 364 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~~~~-----------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~ 364 (488)
.|++|||++++ +...... ..+++..++.++.||+.||.|||++|++|+||||+||++ +++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence 99999999865 3332211 457888999999999999999999999999999999999 6688
Q ss_pred EEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc
Q 011331 365 YKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD 435 (488)
Q Consensus 365 vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~ 435 (488)
++|+|||++...... .....++..|+|||.+... .++.++|||||||++|||++ |..||.+... ...+..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999765322 1223467889999988665 57789999999999999998 8888765332 222333
Q ss_pred CC-CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 436 GK-LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 436 ~~-~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
+. .+.+..++.++.+++.+||+.||.+||++.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 242 RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 33 34456789999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=302.22 Aligned_cols=244 Identities=32% Similarity=0.473 Sum_probs=207.2
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++.+.||+|++|.||++.+..++..||+|.+............+..|++++.++ +|+||+++++++...+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEe
Confidence 47889999999999999999998999999999876654445667788999999999 89999999999999999999999
Q ss_pred cCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC---CC
Q 011331 310 LCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP---IE 383 (488)
Q Consensus 310 ~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~---~~ 383 (488)
|+++..+. . .....+++..++.++.|++.||.|||+.||+|+||+|+||++ .++.++|+|||++........ ..
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 99875433 2 233568999999999999999999999999999999999999 568999999999987754332 34
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hh-hcCCCCCCCCCcHHHHHHHHHcccCC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NL-RDGKLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i-~~~~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
.++..|+|||.+... .++.++||||||+++|+|++|..|+....... .. .....+.+..++..+.++|.+||..+
T Consensus 160 ~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 160 VGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred ccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence 588899999998765 36779999999999999999999887544322 11 23334455677899999999999999
Q ss_pred CCCCCCHHHHHhChhh
Q 011331 460 PVQRPSAKELVENPIF 475 (488)
Q Consensus 460 P~~RpTa~elL~HP~f 475 (488)
|++|||+.+++.||||
T Consensus 239 p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 239 PNLRPTAKQLLKHPWI 254 (254)
T ss_pred hhhCcCHHHHhcCCCC
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.84 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=199.0
Q ss_pred cee-EEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHH------------HHHHHHHHHHHHHhCCCCCeeEeee
Q 011331 230 DFH-EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE------------RRKALLEVQALAALGSHENIVGYYS 296 (488)
Q Consensus 230 ~y~-~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~------------~~~~~~Ei~iL~~l~~HpnIv~l~~ 296 (488)
+|. +.+.||.|+||+||+|.+..+++.||||++......... ...+..|+.++..+ +|+||+++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 87 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMGLVD 87 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceeeeeE
Confidence 454 456799999999999999999999999998643221100 12467899999999 8999999999
Q ss_pred eecccceEEEEEecCCCCchhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCce
Q 011331 297 SWFENEQLYIQMELCDHSLSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRAT 374 (488)
Q Consensus 297 ~~~~~~~l~IV~E~~~~~l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~ 374 (488)
++...+.+|++|||+++++.... ....+++..+..++.||+.||.|||+.||+|+||+|+||++ .++.++|+|||++.
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 88 VYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred EEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcccee
Confidence 99999999999999998776643 33468999999999999999999999999999999999999 67899999999997
Q ss_pred ecCC-----------------CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---h
Q 011331 375 LLNK-----------------SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---R 434 (488)
Q Consensus 375 ~~~~-----------------~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~ 434 (488)
.... ......++..|+|||.+.+...++.++|||||||++|||++|.+||........+ .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 6541 1112346788999999876545678999999999999999999988765432111 0
Q ss_pred c---CC----C---------------------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 435 D---GK----L---------------------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 435 ~---~~----~---------------------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
. .. . ...+..+.++.++|.+||..+|++|||++|+|.||||+.-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 0 00 0 0123457889999999999999999999999999999864
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=306.34 Aligned_cols=242 Identities=27% Similarity=0.422 Sum_probs=197.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++.+.||+|+||.||+|.+..++..||||.+.... ........+..|+.+++.+ +||||+++++++...+..+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEE
Confidence 47899999999999999999999999999999875432 2334455688899999999 899999999999999999999
Q ss_pred EecCCCCchh-hh-----hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 308 MELCDHSLSD-KK-----ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 308 ~E~~~~~l~~-~~-----~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
|||++++.+. .. ....+++..++.++.||+.||.|||++|++|+||||+||++ .++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 9999875333 21 23458899999999999999999999999999999999999 67889999999998764322
Q ss_pred ---CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-----hhhhhcCCCC-CC-CCCcHHHHH
Q 011331 381 ---PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-----FLNLRDGKLP-LL-PGHSLQFQN 450 (488)
Q Consensus 381 ---~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-----~~~i~~~~~~-~~-~~~s~~l~~ 450 (488)
....|+..|+|||.+.+. .++.++||||||+++|||++|..|+..... ...+.....+ .+ ...+..+.+
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred HHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 234588899999998765 467799999999999999999998864321 1222222222 22 246788999
Q ss_pred HHHHcccCCCCCCCCHHHHHhC
Q 011331 451 LLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~H 472 (488)
+|.+||..+|++||++.++++.
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHH
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=312.72 Aligned_cols=244 Identities=31% Similarity=0.444 Sum_probs=198.0
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEec
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMEL 310 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~ 310 (488)
|++.+.||.|+||+||+|....+++.||||.+...... .......+|+..+.++.+|+||+++++++..++..|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 57889999999999999999989999999998654332 23334567899999994499999999999999999999999
Q ss_pred CCCCchhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CCCCC
Q 011331 311 CDHSLSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LPIEE 384 (488)
Q Consensus 311 ~~~~l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~~~~ 384 (488)
+++++...... ..+++..++.++.||+.||.|||++|++|+||+|+||++ .++.++|+|||++...... .....
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (283)
T cd07830 80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV 159 (283)
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCC
Confidence 97776653332 368999999999999999999999999999999999999 5689999999999876542 22345
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---h---------------------cCCC--
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---R---------------------DGKL-- 438 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~---------------------~~~~-- 438 (488)
++..|+|||++.....++.++|+||||+++|||++|.+||........+ . ....
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07830 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQ 239 (283)
T ss_pred CcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccc
Confidence 8889999998865555778999999999999999999888543221110 0 0000
Q ss_pred -------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 439 -------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 439 -------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
...+..+..+.++|.+||+.||++|||++|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 240 FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0112336789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.01 Aligned_cols=243 Identities=23% Similarity=0.305 Sum_probs=192.8
Q ss_pred ccceeEEEEecccCcEEEEEEEE-----cCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLK-----RIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++.+.||+|+||+||+|.+ ..++..||||+++... .......+.+|+.++..+.+||||+++++++...+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 34789999999999999999964 3457799999986542 23345678889999999988999999999999999
Q ss_pred eEEEEEecCCCC-chhhhh-------------------------------------------------------------
Q 011331 303 QLYIQMELCDHS-LSDKKA------------------------------------------------------------- 320 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~~------------------------------------------------------------- 320 (488)
..|+|||||+++ |.....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 999999999765 322111
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC---
Q 011331 321 ---------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP--- 381 (488)
Q Consensus 321 ---------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~--- 381 (488)
...+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 1136788899999999999999999999999999999999 567899999999986643211
Q ss_pred --CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh----hhhhhcCC-CCCCCCCcHHHHHHHH
Q 011331 382 --IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ----FLNLRDGK-LPLLPGHSLQFQNLLK 453 (488)
Q Consensus 382 --~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~----~~~i~~~~-~~~~~~~s~~l~~lI~ 453 (488)
...++..|+|||++... .++.++|||||||++|||++ |..||..... ...+..+. ...+...+.++.+||.
T Consensus 273 ~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 351 (375)
T cd05104 273 KGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMK 351 (375)
T ss_pred cCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHH
Confidence 12345679999998765 57789999999999999998 7777754321 12222222 2234456889999999
Q ss_pred HcccCCCCCCCCHHHHHhC
Q 011331 454 VMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~H 472 (488)
+||+.||++|||+.|+++.
T Consensus 352 ~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 352 SCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHccCChhHCcCHHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=318.54 Aligned_cols=249 Identities=23% Similarity=0.405 Sum_probs=201.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCC----eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-cce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDG----CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE-NEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-~~~ 303 (488)
..|+.++.||+|.||.||+|....++ ..||||.++-......-...+.+|+..++.+ +||||+.|..+|.. +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhccCce
Confidence 35789999999999999999665543 3799999875533334446688999999999 99999999999987 778
Q ss_pred EEEEEecCCCCchhhhh------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eC----CeEEEEeecC
Q 011331 304 LYIQMELCDHSLSDKKA------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KN----GVYKLGDFGR 372 (488)
Q Consensus 304 l~IV~E~~~~~l~~~~~------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~----g~vkL~DFGl 372 (488)
+|+++||.++.|++... ...++...+..++.||+.|+.|||++.|+||||||.|||| .+ |.+||+|||+
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 99999999999877322 2458899999999999999999999999999999999999 55 8999999999
Q ss_pred ceecCCCCCC------CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh------------hhhhh
Q 011331 373 ATLLNKSLPI------EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ------------FLNLR 434 (488)
Q Consensus 373 A~~~~~~~~~------~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------------~~~i~ 434 (488)
|+.+.+.... .+-|++|+|||++.+...|+.++|||++||++.||++-.++|.+... +.+|.
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 9988764322 34689999999999988999999999999999999999988865321 11111
Q ss_pred c--C-----CCCC---C---------------------------CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 435 D--G-----KLPL---L---------------------------PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 435 ~--~-----~~~~---~---------------------------~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
+ | ..|. . ..-++...+|+.+||.+||-+|+|++++|+|+||..
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 1 0 0010 0 012334789999999999999999999999999975
Q ss_pred h
Q 011331 478 I 478 (488)
Q Consensus 478 i 478 (488)
-
T Consensus 343 d 343 (438)
T KOG0666|consen 343 D 343 (438)
T ss_pred C
Confidence 3
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.46 Aligned_cols=241 Identities=27% Similarity=0.375 Sum_probs=203.0
Q ss_pred EecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCCc
Q 011331 236 QIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSL 315 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~l 315 (488)
.||+|.||+||.|++..+...+|||.+... ...+.+-+..||...+++ +|.|||+++|.+.+++.+-|.||-++|+.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTL-RHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHH-hhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 599999999999999999999999998643 334556688899888888 99999999999999999999999998864
Q ss_pred hh-hhh--cccC--CHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--CCeEEEEeecCceecCCC---CCCCCC
Q 011331 316 SD-KKA--SQFF--AEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDFGRATLLNKS---LPIEEG 385 (488)
Q Consensus 316 ~~-~~~--~~~l--~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~g~vkL~DFGlA~~~~~~---~~~~~G 385 (488)
+. ... =+++ .|..+-.+.+||+.||.|||++.|||||||-+||||+ .|.+||+|||.++.+..- ..+..|
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 43 222 2456 7788899999999999999999999999999999994 699999999998776433 345669
Q ss_pred CCCccChhhhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCch--hhhhhh----cCCCCCCCCCcHHHHHHHHHcccC
Q 011331 386 DARYMPQEILNE-DYDHLDKVDIFSLGATMYELIKGSPLSESGP--QFLNLR----DGKLPLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 386 t~~Y~APEvl~~-~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~--~~~~i~----~~~~~~~~~~s~~l~~lI~k~L~~ 458 (488)
|..|||||++.. ...|+.++|||||||++.||.||+|||.... +..... +...+.|..++.++++||.+|+.+
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep 818 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP 818 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence 999999999964 4678889999999999999999999987532 211122 234566777899999999999999
Q ss_pred CCCCCCCHHHHHhChhhhhhH
Q 011331 459 DPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 459 dP~~RpTa~elL~HP~f~~i~ 479 (488)
||..||+|.+||.+||++.-+
T Consensus 819 d~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 819 DPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred CcccCccHHHhccCcccccCC
Confidence 999999999999999998763
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=324.39 Aligned_cols=271 Identities=22% Similarity=0.330 Sum_probs=212.9
Q ss_pred cccccccccCCccceeeCCCCccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHH
Q 011331 203 RFGNQWAKCAGLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQAL 282 (488)
Q Consensus 203 ~~~~~~~~~~~~~p~~~g~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL 282 (488)
..+...+...|++|+..|..... .+|.++++||+|.|++||+|.+..+.+.||+|+.+. .....+.++.||.+|
T Consensus 55 qE~~~dY~kGGYHpV~IGD~F~~---gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL 128 (590)
T KOG1290|consen 55 QEDPEDYRKGGYHPVRIGDVFNG---GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKLL 128 (590)
T ss_pred ccChhhhhcCCCceeeccccccC---ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHH
Confidence 33444567789999999865431 478999999999999999999999999999999863 334456789999999
Q ss_pred HHhCCCC-------CeeEeeeeecc----cceEEEEEecCCCCchhhhh---cccCCHHHHHHHHHHHHHHHHHHHH-cC
Q 011331 283 AALGSHE-------NIVGYYSSWFE----NEQLYIQMELCDHSLSDKKA---SQFFAEGEVLKALHQIAQALQFIHE-KG 347 (488)
Q Consensus 283 ~~l~~Hp-------nIv~l~~~~~~----~~~l~IV~E~~~~~l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~-~g 347 (488)
.++..+. +||+|++.|.. +.++|||+|+++..|+.... .+.++...+..|++||+.||.|||+ +|
T Consensus 129 ~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg 208 (590)
T KOG1290|consen 129 QQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG 208 (590)
T ss_pred HHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC
Confidence 9985433 69999999985 45899999999999887433 3569999999999999999999995 59
Q ss_pred cccCCCCCCcEEEe-C----------------------------------------------------------------
Q 011331 348 IAHLDVKPDNIYVK-N---------------------------------------------------------------- 362 (488)
Q Consensus 348 IiHrDLKp~NILv~-~---------------------------------------------------------------- 362 (488)
|||.||||+|||+. +
T Consensus 209 IIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l 288 (590)
T KOG1290|consen 209 IIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASL 288 (590)
T ss_pred ccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhh
Confidence 99999999999982 0
Q ss_pred -------------------------------------------------C------------------------------
Q 011331 363 -------------------------------------------------G------------------------------ 363 (488)
Q Consensus 363 -------------------------------------------------g------------------------------ 363 (488)
.
T Consensus 289 ~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~ 368 (590)
T KOG1290|consen 289 AGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSP 368 (590)
T ss_pred cccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCc
Confidence 0
Q ss_pred -----------------------eEEEEeecCceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcC
Q 011331 364 -----------------------VYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKG 420 (488)
Q Consensus 364 -----------------------~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG 420 (488)
.|||+|||.|+......+....|..|+|||++.+. .|++.+||||++|++|||+||
T Consensus 369 ~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGs-gY~~~ADiWS~AC~~FELaTG 447 (590)
T KOG1290|consen 369 SSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGS-GYSTSADIWSTACMAFELATG 447 (590)
T ss_pred CCccccccccccCCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecC-CCCCchhHHHHHHHHHHhhcC
Confidence 14666777776666666666678889999999887 688899999999999999999
Q ss_pred CCCCCCc---------hhhh---hhh---------cC-----------C------CC-------------CCCCCcHHHH
Q 011331 421 SPLSESG---------PQFL---NLR---------DG-----------K------LP-------------LLPGHSLQFQ 449 (488)
Q Consensus 421 ~~p~~~~---------~~~~---~i~---------~~-----------~------~~-------------~~~~~s~~l~ 449 (488)
..+|+.. +.+. ++. .| . +. ++.....++.
T Consensus 448 DyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fs 527 (590)
T KOG1290|consen 448 DYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFS 527 (590)
T ss_pred ceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHH
Confidence 9887632 1111 111 11 1 11 1112234689
Q ss_pred HHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 450 NLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+||.-||+.+|++||||.++|+|||+..+..
T Consensus 528 dFL~PmLef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 528 DFLSPMLEFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred HHHHHHHhcCccccccHHHHhcCccccCCCC
Confidence 9999999999999999999999999987654
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=298.92 Aligned_cols=241 Identities=32% Similarity=0.513 Sum_probs=201.4
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++.+.||+|++|.||++.+..++..|++|++..... .....+..|+.++..+ +|+||+++++.+..++..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEe
Confidence 47889999999999999999998999999999875432 3556788899999999 79999999999999999999999
Q ss_pred cCCCC-chhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--CCC
Q 011331 310 LCDHS-LSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL--PIE 383 (488)
Q Consensus 310 ~~~~~-l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~--~~~ 383 (488)
|+++. +...... ..+++..++.++.||+.||.|||++|++|+||+|+||++ .++.++|+|||.+....... ...
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence 99864 4443333 368999999999999999999999999999999999999 57899999999998775443 455
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcC-CCCCC--CCCcHHHHHHHHHccc
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDG-KLPLL--PGHSLQFQNLLKVMVD 457 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~-~~~~~--~~~s~~l~~lI~k~L~ 457 (488)
.|+..|+|||.+... ..+.++||||||+++|+|++|..|+........ .... ....+ ..++.++.++|.+||.
T Consensus 158 ~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (253)
T cd05122 158 VGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236 (253)
T ss_pred ecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHcc
Confidence 688999999998765 467799999999999999999999876532211 1111 11122 2237899999999999
Q ss_pred CCCCCCCCHHHHHhChh
Q 011331 458 PDPVQRPSAKELVENPI 474 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~ 474 (488)
.||++|||+.++++|||
T Consensus 237 ~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 237 KNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CChhhCCCHHHHhcCCC
Confidence 99999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=312.57 Aligned_cols=244 Identities=29% Similarity=0.451 Sum_probs=200.6
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEec
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMEL 310 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~ 310 (488)
|++.+.||+|++|.||+|.+..++..||+|++............+..|+.+++.+ +|+||+++++++...+..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEecC
Confidence 5678899999999999999999999999999876543333345677899999998 899999999999999999999999
Q ss_pred CCCCchhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---CCCC
Q 011331 311 CDHSLSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---PIEE 384 (488)
Q Consensus 311 ~~~~l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---~~~~ 384 (488)
+++++...... ..+++..++.++.||+.||.|||++||+|+||+|+||++ +++.++|+|||++....... ....
T Consensus 80 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred cCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 99877664443 369999999999999999999999999999999999999 66899999999997664322 2334
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh-----------------------cCCC---
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR-----------------------DGKL--- 438 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~-----------------------~~~~--- 438 (488)
++..|+|||.+.....++.++|||||||++|||++|.+||........+. ....
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF 239 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence 67789999998765467779999999999999999998886543211100 0000
Q ss_pred ------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 439 ------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 439 ------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
...+..+..+.++|.+||..||++||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1123347789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=307.09 Aligned_cols=241 Identities=29% Similarity=0.428 Sum_probs=198.7
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCC-
Q 011331 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHS- 314 (488)
Q Consensus 237 LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~- 314 (488)
||.|+||.||+|.+..+|+.||+|++..... .......+..|+.++.++ +|+||+++++.+..+..+|++|||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 6899999999999998899999999865422 123456688899999999 7999999999999999999999999875
Q ss_pred chhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-----------CC
Q 011331 315 LSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-----------LP 381 (488)
Q Consensus 315 l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-----------~~ 381 (488)
+.... ....+++..++.++.||+.||.|||+.|++|+||+|+||++ .++.++|+|||++...... ..
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 159 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence 43322 23468999999999999999999999999999999999999 6789999999998754322 12
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCCCCCCC--cHHHHHHHHHcc
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLPLLPGH--SLQFQNLLKVMV 456 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~~~~~~--s~~l~~lI~k~L 456 (488)
...++..|+|||.+... ..+.++||||||+++|+|++|..||...... ..+..+....+... +..+.++|.+||
T Consensus 160 ~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 238 (265)
T cd05579 160 RIVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLL 238 (265)
T ss_pred CcccCccccCHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHh
Confidence 33578899999998765 4677999999999999999999998755432 23333444444444 899999999999
Q ss_pred cCCCCCCCCH---HHHHhChhhhhhH
Q 011331 457 DPDPVQRPSA---KELVENPIFDKIQ 479 (488)
Q Consensus 457 ~~dP~~RpTa---~elL~HP~f~~i~ 479 (488)
+.+|.+|||+ .++|+||||.++.
T Consensus 239 ~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 239 VPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred cCCHhhcCCCccHHHHhcCccccCCC
Confidence 9999999999 9999999998763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=315.41 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=198.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeE--EEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCF--YAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.++|++.+.||+|+||+||+|.+..+|.. +|+|.+... ........+..|+.++.++.+|+||+++++++...+.+|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 35789999999999999999998877754 577766532 233445667889999999988999999999999999999
Q ss_pred EEEecCCCC-chhhhh-----------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEE
Q 011331 306 IQMELCDHS-LSDKKA-----------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYK 366 (488)
Q Consensus 306 IV~E~~~~~-l~~~~~-----------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vk 366 (488)
+||||+.++ +..... ...+++..++.++.||+.||+|||++||+||||||+|||+ .++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence 999999765 333221 1257889999999999999999999999999999999999 678999
Q ss_pred EEeecCceecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC-CCC
Q 011331 367 LGDFGRATLLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG-KLP 439 (488)
Q Consensus 367 L~DFGlA~~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~-~~~ 439 (488)
|+|||++...... .....++..|+|||.+... .++.++|||||||++|||++ |..||...... ..+..+ ...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd05088 165 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 243 (303)
T ss_pred eCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCC
Confidence 9999998643221 1122345679999988665 46789999999999999998 88888654322 122222 223
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhhhh
Q 011331 440 LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKT 484 (488)
Q Consensus 440 ~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~~~ 484 (488)
.+...+.++.++|.+||+.+|++||++++++.+ +..+...++.
T Consensus 244 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~--l~~~~~~~~~ 286 (303)
T cd05088 244 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS--LNRMLEERKT 286 (303)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHHhhhh
Confidence 344578899999999999999999999999987 4555554443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=316.61 Aligned_cols=240 Identities=22% Similarity=0.317 Sum_probs=193.4
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeE----EEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCF----YAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.+|++++.||+|+||+||+|.+..+|.. ||||++... ......+.+..|+.++..+ +||||+++++++... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-Cc
Confidence 4789999999999999999988766654 899988643 2334456788899999998 999999999998765 57
Q ss_pred EEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 305 YIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
++++||+.++ +..... ...+++..++.++.||+.||+|||++||+||||||+|||+ .++.+||+|||+++......
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 7899999765 433222 2358888999999999999999999999999999999999 67899999999998764322
Q ss_pred C-----CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh--hhhhh--cCCCCCCCCCcHHHHH
Q 011331 381 P-----IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ--FLNLR--DGKLPLLPGHSLQFQN 450 (488)
Q Consensus 381 ~-----~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~--~~~i~--~~~~~~~~~~s~~l~~ 450 (488)
. ...++..|+|||.+... .++.++|||||||++|||++ |..|+.+... ...+. ....+.++.++.++.+
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 242 (316)
T ss_pred cceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 1 12245679999998765 57789999999999999998 8888875432 22222 2334556678899999
Q ss_pred HHHHcccCCCCCCCCHHHHHhC
Q 011331 451 LLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~H 472 (488)
+|.+||..+|++|||+.+++.+
T Consensus 243 li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 243 IMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=317.63 Aligned_cols=243 Identities=26% Similarity=0.402 Sum_probs=200.8
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecC
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELC 311 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~ 311 (488)
.....||.|+||.||+|.+..++..||+|++..... .....+..|+.++..+ +||||+++++.+..++..|++|||+
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEEEecC
Confidence 344579999999999999998999999999864322 2345678899999998 8999999999999999999999999
Q ss_pred CCCchh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCCCCC
Q 011331 312 DHSLSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIEEGD 386 (488)
Q Consensus 312 ~~~l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~~Gt 386 (488)
+++.+. ......+++..++.++.||+.||.|||+.||+|+||||+||++ .++.++|+|||++...... .....|+
T Consensus 101 ~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~ 180 (297)
T cd06659 101 QGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT 180 (297)
T ss_pred CCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecC
Confidence 876444 4444568999999999999999999999999999999999999 6789999999998755332 2234588
Q ss_pred CCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcCC---CCCCCCCcHHHHHHHHHcccCCC
Q 011331 387 ARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDGK---LPLLPGHSLQFQNLLKVMVDPDP 460 (488)
Q Consensus 387 ~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~~---~~~~~~~s~~l~~lI~k~L~~dP 460 (488)
..|+|||++... .++.++|||||||++|||++|..||........ +.... .......+..+.++|.+||+.+|
T Consensus 181 ~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P 259 (297)
T cd06659 181 PYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREP 259 (297)
T ss_pred ccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCc
Confidence 999999998765 567899999999999999999999875543222 22211 22234568899999999999999
Q ss_pred CCCCCHHHHHhChhhhhh
Q 011331 461 VQRPSAKELVENPIFDKI 478 (488)
Q Consensus 461 ~~RpTa~elL~HP~f~~i 478 (488)
.+||++.+++.||||...
T Consensus 260 ~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 260 QERATAQELLDHPFLLQT 277 (297)
T ss_pred ccCcCHHHHhhChhhccC
Confidence 999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=309.64 Aligned_cols=244 Identities=26% Similarity=0.392 Sum_probs=195.3
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC--CCCCeeEeeeeecccce-----
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG--SHENIVGYYSSWFENEQ----- 303 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~--~HpnIv~l~~~~~~~~~----- 303 (488)
|++++.||.|+||.||+|.+..++..||+|++............+..|+.++.++. +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67899999999999999999888999999998754433333445667777777663 69999999999988776
Q ss_pred EEEEEecCCCCchhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 304 LYIQMELCDHSLSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 304 l~IV~E~~~~~l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
++++|||+.+.+..... ...+++..++.++.||+.||.|||+.|++|+||+|+||++ .++.++|+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 99999999887654322 2358999999999999999999999999999999999999 6789999999999876433
Q ss_pred C--CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcC------------------
Q 011331 380 L--PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDG------------------ 436 (488)
Q Consensus 380 ~--~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~------------------ 436 (488)
. ....++..|+|||++... .++.++|||||||++|||++|.+|+....... .+...
T Consensus 161 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07838 161 MALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239 (287)
T ss_pred cccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence 2 223478889999998765 46779999999999999999998876543211 11000
Q ss_pred C---------CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 437 K---------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 437 ~---------~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
. ....+..+..+.++|.+||+.||.+||++++++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 00112346778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=311.60 Aligned_cols=247 Identities=28% Similarity=0.444 Sum_probs=203.2
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
.|...+.||.|++|.||++.+..++..||+|++... .......+.+|+.++..+ +|+||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEEEe
Confidence 345567999999999999999889999999987532 223345678899999998 89999999999999999999999
Q ss_pred cCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---CCCC
Q 011331 310 LCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---PIEE 384 (488)
Q Consensus 310 ~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---~~~~ 384 (488)
|+.++ +........+++..+..++.||+.||+|||++||+|+||+|+||++ .++.++|+|||++....... ....
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 99765 4444444678999999999999999999999999999999999999 67899999999887553321 2345
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCCC---CCCCCcHHHHHHHHHcccC
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKLP---LLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~~---~~~~~s~~l~~lI~k~L~~ 458 (488)
|+..|+|||.+... .++.++|||||||++|+|++|..||....... .+.....+ .+..++..+.+||.+||..
T Consensus 177 ~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 255 (285)
T cd06648 177 GTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR 255 (285)
T ss_pred CCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence 88999999998765 46779999999999999999999987654322 22222222 2233678999999999999
Q ss_pred CCCCCCCHHHHHhChhhhhhHH
Q 011331 459 DPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 459 dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+|++|||+.++++||||+....
T Consensus 256 ~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 256 DPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ChhhCcCHHHHccCcccccCCC
Confidence 9999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=308.71 Aligned_cols=248 Identities=20% Similarity=0.264 Sum_probs=195.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcC-----CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRI-----DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.... .+..||+|.+.... .......+..|+.+++.+ +|+||+++++++...+
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCC
Confidence 3578999999999999999997642 35689999876442 223345677899999998 8999999999999999
Q ss_pred eEEEEEecCCCCchh-hhhc-----------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEe
Q 011331 303 QLYIQMELCDHSLSD-KKAS-----------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGD 369 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~-~~~~-----------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~D 369 (488)
..|+||||+.++.+. .... ..+....++.++.||+.||.|||++||+|+||||+||++ .++.++|+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 999999999765333 2211 224567889999999999999999999999999999999 678999999
Q ss_pred ecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCC
Q 011331 370 FGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLP 439 (488)
Q Consensus 370 FGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~ 439 (488)
||+++...... ....++..|+|||.+... .++.++|||||||++|||++ |..|+...... ..+.. ....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99987553221 122356789999998765 56779999999999999998 67777543321 12222 2334
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHh------Chhhhhh
Q 011331 440 LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE------NPIFDKI 478 (488)
Q Consensus 440 ~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~------HP~f~~i 478 (488)
.+...+..+.++|.+||+.||++|||+.++++ ||||.++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 45566889999999999999999999999997 9998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.98 Aligned_cols=241 Identities=19% Similarity=0.254 Sum_probs=194.3
Q ss_pred cceeEEEEecccCcEEEEEEEEc----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKR----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.+|++.+.||+|+||+||+|.+. .++..||+|.+... ........+..|+.+++.+ +||||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCce
Confidence 46899999999999999999853 35678999998643 2334446678899999999 899999999999999999
Q ss_pred EEEEecCCCCchh-hhh------------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCe
Q 011331 305 YIQMELCDHSLSD-KKA------------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGV 364 (488)
Q Consensus 305 ~IV~E~~~~~l~~-~~~------------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~ 364 (488)
|++|||+.++.+. ... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 9999999875332 221 2247888899999999999999999999999999999999 5678
Q ss_pred EEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc
Q 011331 365 YKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD 435 (488)
Q Consensus 365 vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~ 435 (488)
++|+|||+++..... .....++..|+|||.+... .++.++|||||||++|||++ |..||...... ..+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999765321 2233456789999998655 57789999999999999998 88887653321 12222
Q ss_pred -CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 436 -GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 436 -~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
...+.+..++..+.++|.+||+.||.+||++.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 242 RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 2344556778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=303.20 Aligned_cols=237 Identities=20% Similarity=0.309 Sum_probs=192.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||.||++.+. .+..+|+|.+.... .....+..|+.+++.+ +||||+++++++...+.+|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---MSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---ccHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEEE
Confidence 46899999999999999999875 56689999876432 2234678899999999 8999999999999999999999
Q ss_pred ecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC----
Q 011331 309 ELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---- 380 (488)
Q Consensus 309 E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---- 380 (488)
||+.++ +..... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||+++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999865 443222 2358899999999999999999999999999999999999 67899999999987653221
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcCC-CCCCCCCcHHHHHHHHHc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDGK-LPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~~-~~~~~~~s~~l~~lI~k~ 455 (488)
....++..|+|||++... .++.++||||||+++|||++ |..||..... ...+..+. ...+...+.++.++|.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSC 237 (256)
T ss_pred CCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 112345689999998755 57779999999999999999 8888865543 22333333 233445688999999999
Q ss_pred ccCCCCCCCCHHHHHh
Q 011331 456 VDPDPVQRPSAKELVE 471 (488)
Q Consensus 456 L~~dP~~RpTa~elL~ 471 (488)
|+.+|.+|||+++++.
T Consensus 238 ~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 238 WHEKPEGRPTFAELLR 253 (256)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=304.39 Aligned_cols=239 Identities=21% Similarity=0.274 Sum_probs=196.5
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.+|.+.+.||.|+||.||+|.+..++..||+|++... ......+..|+.++..+ +|+||+++++++...+.++++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEEEE
Confidence 4689999999999999999999999999999998643 23345688899999998 8999999999999999999999
Q ss_pred ecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC--
Q 011331 309 ELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP-- 381 (488)
Q Consensus 309 E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~-- 381 (488)
||++++ +..... ...+++..++.++.||+.||+|||++|++|+||||+||++ .++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999765 433222 2358889999999999999999999999999999999999 678999999999976643221
Q ss_pred --CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCCCCCCCcHHHHHHHHH
Q 011331 382 --IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 382 --~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~~~~~~s~~l~~lI~k 454 (488)
...++..|+|||.+... .++.++|||||||++|||++ |..|+...... ..+.. .....+...+.++.++|.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA 240 (263)
T ss_pred cCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 12245679999988665 57779999999999999998 88887654321 22222 2344556788999999999
Q ss_pred cccCCCCCCCCHHHHHhC
Q 011331 455 MVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~H 472 (488)
||..||++|||+.++++.
T Consensus 241 cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 241 CWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HccCCcccCCCHHHHHHH
Confidence 999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=314.15 Aligned_cols=242 Identities=22% Similarity=0.325 Sum_probs=190.7
Q ss_pred CcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCCchh-hh
Q 011331 241 NFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSLSD-KK 319 (488)
Q Consensus 241 ~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~l~~-~~ 319 (488)
++|.||.++...+|..||||++............+..|+.++..+ +|+||+++++++..++..|++|||+.++.+. ..
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 445666666777999999999876534455567788999999999 8999999999999999999999999876443 22
Q ss_pred h---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----------CCCCCC
Q 011331 320 A---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----------LPIEEG 385 (488)
Q Consensus 320 ~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----------~~~~~G 385 (488)
. ...+++..+..++.||+.||.|||++||+|+||||+||++ .++.++|+|||.+...... .....+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 2 2358899999999999999999999999999999999999 5799999999988655321 122346
Q ss_pred CCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh----hhcC------------------------
Q 011331 386 DARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN----LRDG------------------------ 436 (488)
Q Consensus 386 t~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~----i~~~------------------------ 436 (488)
+..|+|||++... ..++.++|||||||++|||++|..||........ +...
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 7789999998653 3467799999999999999999999875433211 1100
Q ss_pred ---------CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhhh
Q 011331 437 ---------KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRK 483 (488)
Q Consensus 437 ---------~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~~ 483 (488)
.......++.++.+||.+||.+||++|||++++|+||||+.+...++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~ 306 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNT 306 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccch
Confidence 00011123567899999999999999999999999999998865443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=306.57 Aligned_cols=241 Identities=21% Similarity=0.313 Sum_probs=194.4
Q ss_pred cceeEEEEecccCcEEEEEEEEcC-----CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRI-----DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
++|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+..|+.+++.+ +|+||+++++++.+.+.
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCC
Confidence 468999999999999999999987 7889999987643 2334446688899999999 89999999999999999
Q ss_pred EEEEEecCCCC-chhhhhc--------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC---eEEEEee
Q 011331 304 LYIQMELCDHS-LSDKKAS--------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG---VYKLGDF 370 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~~~~--------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g---~vkL~DF 370 (488)
.++||||+.++ +...... ..+++..++.++.||+.||.|||++|++|+||||+||+++ ++ .+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 99999999765 3332211 2488899999999999999999999999999999999994 33 5999999
Q ss_pred cCceecCCCCC-----CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh--hh-hh-hcCCCCC
Q 011331 371 GRATLLNKSLP-----IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ--FL-NL-RDGKLPL 440 (488)
Q Consensus 371 GlA~~~~~~~~-----~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~--~~-~i-~~~~~~~ 440 (488)
|+++....... ....+..|+|||++... .++.++|||||||++|||++ |..||..... .. .+ .......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDP 242 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 99986632211 12235679999998665 57789999999999999997 8888765432 11 11 1233445
Q ss_pred CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 441 LPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 441 ~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
+..++..+.++|.+||+.+|++|||+.+|++|
T Consensus 243 ~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 243 PKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 56788999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=312.73 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=201.7
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
|...+.||.|+||+||+|.+..+|..||+|++..... .......+..|+.++..+ +|+||+++++++.+....|+|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEEEe
Confidence 5667889999999999999999999999999864322 233345678899999999 89999999999999999999999
Q ss_pred cCCCCchhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCCCC
Q 011331 310 LCDHSLSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGD 386 (488)
Q Consensus 310 ~~~~~l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~Gt 386 (488)
|+.+++.... ....+++.+++.++.||+.||.|||++||+|+||+|+||++ .++.++|+|||++.... ......|+
T Consensus 102 ~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-~~~~~~~~ 180 (313)
T cd06633 102 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-PANSFVGT 180 (313)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-CCCCcccc
Confidence 9988766533 23458999999999999999999999999999999999999 67899999999986532 23345688
Q ss_pred CCccChhhhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCCC--CCCCCcHHHHHHHHHcccCC
Q 011331 387 ARYMPQEILNE--DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKLP--LLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 387 ~~Y~APEvl~~--~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~~--~~~~~s~~l~~lI~k~L~~d 459 (488)
..|+|||++.. ...++.++|||||||++|+|++|.+|+....... .+.....+ ..+..+..+.+||.+||+.+
T Consensus 181 ~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 260 (313)
T cd06633 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKI 260 (313)
T ss_pred ccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCC
Confidence 99999999742 2246679999999999999999999987654322 22222222 22346778999999999999
Q ss_pred CCCCCCHHHHHhChhhhhh
Q 011331 460 PVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 460 P~~RpTa~elL~HP~f~~i 478 (488)
|.+||++.+++.||||...
T Consensus 261 P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 261 PQERPASAELLRHDFVRRD 279 (313)
T ss_pred hhhCcCHHHHhcCcccCCC
Confidence 9999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=309.41 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=203.1
Q ss_pred ceeEEEEecccCcEEEEEEEEc---CCCeEEEEEEeccCCCc--hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKR---IDGCFYAVKHSKRQLHH--DAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~l~~~~~~--~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
+|++.+.||.|+||.||+|.+. .+|..||+|++...... ......+..|+.++..+.+|+||+.+++.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4789999999999999999875 47899999998643211 122355678999999997899999999999999999
Q ss_pred EEEEecCCCCch-h-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-
Q 011331 305 YIQMELCDHSLS-D-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL- 380 (488)
Q Consensus 305 ~IV~E~~~~~l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~- 380 (488)
|+||||+.++.+ . ......+++..+..++.||+.||.|||+.|++|+||+|+|||+ .++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 999999987533 3 2334568899999999999999999999999999999999999 67899999999997654321
Q ss_pred ---CCCCCCCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCchh-------hhhhhcCCCCCCCCCcHHHH
Q 011331 381 ---PIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQ-------FLNLRDGKLPLLPGHSLQFQ 449 (488)
Q Consensus 381 ---~~~~Gt~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~~~i~~~~~~~~~~~s~~l~ 449 (488)
....|+..|+|||.+... ..++.++||||||+++|+|++|..|+..... ...+.....+.+..++..+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence 223588999999998643 2356789999999999999999988853211 11223344455667889999
Q ss_pred HHHHHcccCCCCCCC-----CHHHHHhChhhhhhH
Q 011331 450 NLLKVMVDPDPVQRP-----SAKELVENPIFDKIQ 479 (488)
Q Consensus 450 ~lI~k~L~~dP~~Rp-----Ta~elL~HP~f~~i~ 479 (488)
++|.+||..||++|| +++++++||||+.+.
T Consensus 241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 999999999999997 899999999999876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=310.19 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=193.7
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCe--EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGC--FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~--~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
++|++.+.||+|+||+||+|....++. .+++|.++.. ......+.+..|+.++.++.+||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 578999999999999999999877765 4688877632 2334456688899999999789999999999999999999
Q ss_pred EEecCCCC-chhhhhc-----------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEE
Q 011331 307 QMELCDHS-LSDKKAS-----------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKL 367 (488)
Q Consensus 307 V~E~~~~~-l~~~~~~-----------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL 367 (488)
+|||+.++ +...... ..+++..++.++.||+.||+|||++||+|+||||+|||+ .++.+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 99999764 4332211 247888999999999999999999999999999999999 6789999
Q ss_pred EeecCceecCCCCCC--CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCC
Q 011331 368 GDFGRATLLNKSLPI--EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPL 440 (488)
Q Consensus 368 ~DFGlA~~~~~~~~~--~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~ 440 (488)
+|||++......... ...+..|+|||++... .++.++|||||||++|||++ |..||..... ...+..+ ..+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK 239 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 999998644322111 1235579999998765 46789999999999999997 8888865433 2222222 2334
Q ss_pred CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 441 LPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 441 ~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
+..++..+.+||.+||..+|.+|||++++++.
T Consensus 240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 45678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=304.01 Aligned_cols=240 Identities=20% Similarity=0.264 Sum_probs=193.1
Q ss_pred eeEEEEecccCcEEEEEEEEcCC---CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce----
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRID---GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ---- 303 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~---- 303 (488)
|++++.||+|+||.||+|....+ +..||||+++...........+..|+..++.+ +|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence 56889999999999999987654 48899999876545555567789999999998 89999999998766554
Q ss_pred --EEEEEecCCCCchh-hh-------hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecC
Q 011331 304 --LYIQMELCDHSLSD-KK-------ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGR 372 (488)
Q Consensus 304 --l~IV~E~~~~~l~~-~~-------~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGl 372 (488)
.+++|||+.++.+. .. ....+++..++.++.||+.||.|||++||+|+||||+||++ +++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999875433 11 12358899999999999999999999999999999999999 678999999999
Q ss_pred ceecCCCCC-----CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCCCCC
Q 011331 373 ATLLNKSLP-----IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLPLLP 442 (488)
Q Consensus 373 A~~~~~~~~-----~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~~~~ 442 (488)
++....... ...++..|+|||.+... .++.++|||||||++|||++ |.+|+...... ..+.. .....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 986643211 12356789999998654 57789999999999999999 77777654331 22222 3344566
Q ss_pred CCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 443 GHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 443 ~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
..+.++.++|.+||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=312.26 Aligned_cols=246 Identities=24% Similarity=0.354 Sum_probs=202.4
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.|...+.||+|+||+||+|.+..+|..||+|++.... ........+..|+++++.+ +|+|++++++++..+...|+||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCeEEEEE
Confidence 3778899999999999999999899999999986432 2233445688899999999 8999999999999999999999
Q ss_pred ecCCCCchhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCCC
Q 011331 309 ELCDHSLSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEG 385 (488)
Q Consensus 309 E~~~~~l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~G 385 (488)
||+.+.+.... ....+++..+..++.||+.||.|||++||+|+||+|+||++ .++.++|+|||++..... .....|
T Consensus 105 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~ 183 (317)
T cd06635 105 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-ANSFVG 183 (317)
T ss_pred eCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-cccccC
Confidence 99998766533 23558999999999999999999999999999999999999 678999999999875543 234468
Q ss_pred CCCccChhhhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCC--CCCCCCcHHHHHHHHHcccC
Q 011331 386 DARYMPQEILNE--DYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKL--PLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 386 t~~Y~APEvl~~--~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~--~~~~~~s~~l~~lI~k~L~~ 458 (488)
+..|+|||.+.. ...++.++|||||||++|||++|..|+...... ..+..... ......+..+.++|.+||+.
T Consensus 184 ~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 263 (317)
T cd06635 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQK 263 (317)
T ss_pred CccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccC
Confidence 899999998742 224667999999999999999999988654332 12222222 22335678899999999999
Q ss_pred CCCCCCCHHHHHhChhhhh
Q 011331 459 DPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 459 dP~~RpTa~elL~HP~f~~ 477 (488)
+|.+||++.++++|+|+..
T Consensus 264 ~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 264 IPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CcccCcCHHHHHhChhhhc
Confidence 9999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=301.65 Aligned_cols=233 Identities=24% Similarity=0.298 Sum_probs=188.7
Q ss_pred EecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCCc
Q 011331 236 QIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSL 315 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~l 315 (488)
.||+|+||+||+|.+..+|..||+|.+.... .......+..|+.+++.+ +||||+++++++...+.+|+||||+.++.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 5899999999999999999999999876543 233446688899999998 89999999999999999999999997754
Q ss_pred hh-hhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCC-----CCCC
Q 011331 316 SD-KKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPI-----EEGD 386 (488)
Q Consensus 316 ~~-~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~-----~~Gt 386 (488)
+. ... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.++|+|||++......... ..++
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 33 322 2358899999999999999999999999999999999999 6788999999998765432111 1234
Q ss_pred CCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhh-cCCCCCCCCCcHHHHHHHHHcccCCCC
Q 011331 387 ARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLR-DGKLPLLPGHSLQFQNLLKVMVDPDPV 461 (488)
Q Consensus 387 ~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~-~~~~~~~~~~s~~l~~lI~k~L~~dP~ 461 (488)
..|+|||.+... .++.++|||||||++|||++ |..|+...... ..+. ....+.+...+.++.++|.+||+.+|+
T Consensus 160 ~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (252)
T cd05084 160 VKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPG 238 (252)
T ss_pred eeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChh
Confidence 569999998765 46779999999999999997 77777543321 1122 223445556789999999999999999
Q ss_pred CCCCHHHHHh
Q 011331 462 QRPSAKELVE 471 (488)
Q Consensus 462 ~RpTa~elL~ 471 (488)
+|||+.+++.
T Consensus 239 ~Rps~~~~~~ 248 (252)
T cd05084 239 QRPSFSTVHQ 248 (252)
T ss_pred hCcCHHHHHH
Confidence 9999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=299.91 Aligned_cols=244 Identities=30% Similarity=0.509 Sum_probs=204.2
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++.+.||.|+||.||++.+..++..||+|.+............+..|+.+++.+ +|+||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEeh
Confidence 47899999999999999999999999999999876544555566788899999999 79999999999999999999999
Q ss_pred cCCCCchh-hhh-----cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-CC
Q 011331 310 LCDHSLSD-KKA-----SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-LP 381 (488)
Q Consensus 310 ~~~~~l~~-~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-~~ 381 (488)
|+.+..+. ... ...+++..++.++.||+.||.|||+.|++|+||+|+||++ .++.++|+|||++...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 159 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK 159 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence 99775333 221 2458899999999999999999999999999999999999 6688999999999766433 22
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCC-CCCCCCCcHHHHHHHHHccc
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGK-LPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~-~~~~~~~s~~l~~lI~k~L~ 457 (488)
...|+..|+|||.+... .++.++|+||||+++|+|++|..|+...... ..+..+. .+.+...+.++.++|.+||.
T Consensus 160 ~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08530 160 TQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238 (256)
T ss_pred cccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcC
Confidence 34588899999998665 5667999999999999999999998765432 1222233 23445678899999999999
Q ss_pred CCCCCCCCHHHHHhChhh
Q 011331 458 PDPVQRPSAKELVENPIF 475 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f 475 (488)
.+|++|||+.+++.||++
T Consensus 239 ~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 239 VKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCcccCCCHHHHhcCCCC
Confidence 999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=323.38 Aligned_cols=243 Identities=23% Similarity=0.290 Sum_probs=201.4
Q ss_pred ccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 224 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
|..-.+++.+...||+|.||+||+|++- ..||||+++.....+...+.|..|+.++++- +|.||+-+.|++...+.
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPPL 462 (678)
T ss_pred cccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCce
Confidence 3444556788899999999999999884 5799999998888888889999999999998 99999999999988777
Q ss_pred EEEEEecCCCCchh---hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC--
Q 011331 304 LYIQMELCDHSLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN-- 377 (488)
Q Consensus 304 l~IV~E~~~~~l~~---~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~-- 377 (488)
.||+.+|+|..+. ......|.....+.|++||+.|+.|||.++|||+|||..|||+ +++.|||+|||+++.-.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 9999999997555 2223458888999999999999999999999999999999999 55999999999997542
Q ss_pred ---CCCCCCCCCCCccChhhhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hcCC-----CCCCCCC
Q 011331 378 ---KSLPIEEGDARYMPQEILNE--DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RDGK-----LPLLPGH 444 (488)
Q Consensus 378 ---~~~~~~~Gt~~Y~APEvl~~--~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~~~-----~~~~~~~ 444 (488)
.......|...|||||++.. ...|++.+|||||||++|||++|..||.......-| -.|. .......
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~ 621 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNC 621 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccC
Confidence 23344558888999999863 356788999999999999999999999844332211 1221 1223345
Q ss_pred cHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 445 SLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 445 s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
+.++.+|+..||..++++||.+.+||.
T Consensus 622 pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 622 PKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 779999999999999999999999987
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=304.74 Aligned_cols=242 Identities=17% Similarity=0.224 Sum_probs=192.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEc-----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++.+.||+|+||+||+|.+. .++..||||++... ........+..|+.++..+ +|+||+++++++..++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCC
Confidence 357899999999999999999764 24678999988643 2234456688899999998 8999999999999999
Q ss_pred eEEEEEecCCCCchh-hhhc-----------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEe
Q 011331 303 QLYIQMELCDHSLSD-KKAS-----------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGD 369 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~-~~~~-----------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~D 369 (488)
..++||||+.++.+. .... ..++...++.++.||+.||.|||+.|++|+||||+||++ .++.++|+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 999999999875333 2111 225667889999999999999999999999999999999 678999999
Q ss_pred ecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhhh---hhhc-CCCC
Q 011331 370 FGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQFL---NLRD-GKLP 439 (488)
Q Consensus 370 FGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~~---~i~~-~~~~ 439 (488)
||+++...... ....++..|+|||++... .++.++|||||||++|||++ |..||....... .+.. ....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD 241 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 99987553221 123457789999998765 57789999999999999999 677776543321 1222 2334
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 440 LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 440 ~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
.+...+..+.++|.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 455678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=331.22 Aligned_cols=252 Identities=26% Similarity=0.352 Sum_probs=222.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
...|.+.+.||+|.|++|.+|.+..+|..||||++.+...+...++.+.+|++++..+ +|||||+++.+......+|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeEEE
Confidence 4568999999999999999999999999999999998877777778899999999999 999999999999999999999
Q ss_pred EecCCCC-c-hhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CCeEEEEeecCceecCCC--CCC
Q 011331 308 MELCDHS-L-SDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKS--LPI 382 (488)
Q Consensus 308 ~E~~~~~-l-~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g~vkL~DFGlA~~~~~~--~~~ 382 (488)
|||+.++ + .....++.+.+..+..++.|+++|++|||+++|+|||||++|||++ +-++||+|||++..+... ..+
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt 213 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQT 213 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccc
Confidence 9999775 2 3367778899999999999999999999999999999999999995 456999999999887643 456
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
.+|++.|+|||++.+....++.+|+||+|++||.|+.|..||++... ......+.+.++--++.++.++|+++|..+
T Consensus 214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~ 293 (596)
T KOG0586|consen 214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLN 293 (596)
T ss_pred cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHhhccC
Confidence 78999999999998876677899999999999999999999986533 223344566666678999999999999999
Q ss_pred CCCCCCHHHHHhChhhhhhHH
Q 011331 460 PVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 460 P~~RpTa~elL~HP~f~~i~~ 480 (488)
|.+|++.+++++|.|......
T Consensus 294 Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 294 PSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred ccccCCHHHhhhhcccchhhh
Confidence 999999999999999976543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=331.04 Aligned_cols=242 Identities=22% Similarity=0.309 Sum_probs=210.6
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHS 314 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~ 314 (488)
+.||+|.||+||-|+++.+|+.||||++.+..........+..|++||..+ .||.||.+...|+..+.+++|||-+.|.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecCCceEEEEehhhcch
Confidence 689999999999999999999999999977655555567788999999999 9999999999999999999999999998
Q ss_pred chhh---hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeC----CeEEEEeecCceecCCC--CCCCCC
Q 011331 315 LSDK---KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKN----GVYKLGDFGRATLLNKS--LPIEEG 385 (488)
Q Consensus 315 l~~~---~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~----g~vkL~DFGlA~~~~~~--~~~~~G 385 (488)
+++. ...+++++.....++.||+.||.|||-+||+|+||||+|||+.+ -.+||||||+|+++++. ....+|
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG 728 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG 728 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence 7763 23467999999999999999999999999999999999999933 37999999999998753 345679
Q ss_pred CCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh-hhhcCCCC----CCCCCcHHHHHHHHHcccCCC
Q 011331 386 DARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL-NLRDGKLP----LLPGHSLQFQNLLKVMVDPDP 460 (488)
Q Consensus 386 t~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~-~i~~~~~~----~~~~~s~~l~~lI~k~L~~dP 460 (488)
|+.|+|||++..+ .|...-|+||.||++|--+.|..||....... .+.+..+- .+.+++.++.+||..+|+..-
T Consensus 729 TPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm 807 (888)
T KOG4236|consen 729 TPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKM 807 (888)
T ss_pred CccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHH
Confidence 9999999999876 57778999999999999999999998765543 34443332 334678999999999999999
Q ss_pred CCCCCHHHHHhChhhhhh
Q 011331 461 VQRPSAKELVENPIFDKI 478 (488)
Q Consensus 461 ~~RpTa~elL~HP~f~~i 478 (488)
.+|-|.+..|.|||+++-
T Consensus 808 ~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 808 RKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHhcchHhhccchhhhcc
Confidence 999999999999999863
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=332.45 Aligned_cols=234 Identities=24% Similarity=0.347 Sum_probs=200.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++....++.||.|+.|.||+|+. .++.||||+++. .-..+|..|++| +||||+.+.++|....-+|||
T Consensus 123 Fe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~e---------lkETdIKHLRkL-kH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRE---------LKETDIKHLRKL-KHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred HHHhhhhhhhccCcccceeeeec--cCceehhHHHhh---------hhhhhHHHHHhc-cCcceeeEeeeecCCceeEEe
Confidence 34445678999999999999987 489999998642 123478889999 999999999999999999999
Q ss_pred EecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CCC
Q 011331 308 MELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LPI 382 (488)
Q Consensus 308 ~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~~ 382 (488)
||||..+-+. ++....+....+..|.++|+.|+.|||.+.|||||||.=|||| .+..|||+|||.++....- .-.
T Consensus 191 MEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMS 270 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMS 270 (904)
T ss_pred eeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhh
Confidence 9999877444 4445678999999999999999999999999999999999999 7899999999998876543 223
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh-----cCCCCCCCCCcHHHHHHHHHccc
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR-----DGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~-----~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
..||..|||||++... ..+.|+|||||||+||||+||..||.+.+...-|- ...++.|..+++.|.=||+.||.
T Consensus 271 FaGTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred hhhhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence 5699999999999877 68899999999999999999999998766544332 23567888899999999999999
Q ss_pred CCCCCCCCHHHHHhChh
Q 011331 458 PDPVQRPSAKELVENPI 474 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~ 474 (488)
-.|..||++.++|.|-=
T Consensus 350 sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLHLD 366 (904)
T ss_pred cCCCCCccHHHHHHHHh
Confidence 99999999999999843
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.66 Aligned_cols=244 Identities=29% Similarity=0.437 Sum_probs=198.6
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL---HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~---~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
+|.+.+.||+|+||+||++.+..++..+++|+++... ........+..|+.+++.+ +||||+++++++.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEE
Confidence 4789999999999999999998887777777765321 1223344567788999998 89999999999999999999
Q ss_pred EEecCCCCchh-h-----hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCceecCCC-
Q 011331 307 QMELCDHSLSD-K-----KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 307 V~E~~~~~l~~-~-----~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~~~~~- 379 (488)
||||+.++.+. . .....+++..++.++.||+.||.|||+.|++|+||+|+||+++++.++|+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeecCCCc
Confidence 99999875433 1 1234689999999999999999999999999999999999998889999999998765332
Q ss_pred --CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCC-CCCCCCcHHHHHHHH
Q 011331 380 --LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKL-PLLPGHSLQFQNLLK 453 (488)
Q Consensus 380 --~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~-~~~~~~s~~l~~lI~ 453 (488)
.....|+..|+|||.+... .++.++|+||||+++|+|++|..|+....... .+..+.. ..+..++.++.++|.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence 1234578899999988654 46679999999999999999999987544322 2222333 334567889999999
Q ss_pred HcccCCCCCCCCHHHHHhChhh
Q 011331 454 VMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~HP~f 475 (488)
+||..+|++||++.|+++||||
T Consensus 239 ~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=303.41 Aligned_cols=241 Identities=20% Similarity=0.241 Sum_probs=195.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCC-----CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRID-----GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.++..+ +|+||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCCC
Confidence 45789999999999999999987643 4899999986442 334456688899999998 8999999999999999
Q ss_pred eEEEEEecCCCCchh-hhh-----------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEe
Q 011331 303 QLYIQMELCDHSLSD-KKA-----------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGD 369 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~-~~~-----------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~D 369 (488)
..|+||||+.++.+. ... ...+++..++.++.||+.||.|||+.||+|+||||+|||+ .++.++|+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 999999999765333 221 1236778899999999999999999999999999999999 679999999
Q ss_pred ecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCC
Q 011331 370 FGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLP 439 (488)
Q Consensus 370 FGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~ 439 (488)
||+++..... .....++..|+|||.+... .++.++|||||||++|||++ |..|+...... ..+.. ....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 9998765322 1233467889999998765 47779999999999999998 88887654321 12222 2344
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 440 LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 440 ~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
.+...+.++.++|.+||+.+|++|||+.++++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 56667899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=306.41 Aligned_cols=240 Identities=22% Similarity=0.279 Sum_probs=194.9
Q ss_pred cceeEEEEecccCcEEEEEEEEcC-----CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRI-----DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
.+|.+.+.||+|+||.||+|.+.. ++..||||++..... ......+.+|++++..+ +|+||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNF-QHENIVKFYGVCTEGDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhc-CCCCchheeeEEecCCC
Confidence 367889999999999999998753 468899999875432 33456788999999999 89999999999999999
Q ss_pred EEEEEecCCCCchh-hhh---------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEE
Q 011331 304 LYIQMELCDHSLSD-KKA---------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYK 366 (488)
Q Consensus 304 l~IV~E~~~~~l~~-~~~---------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vk 366 (488)
.|++|||+.++.+. ... ...+++..+..++.||+.||.|||++|++|+||||+||++ .++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence 99999999875433 111 2347888999999999999999999999999999999999 679999
Q ss_pred EEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcCC
Q 011331 367 LGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDGK 437 (488)
Q Consensus 367 L~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~~ 437 (488)
|+|||++....... ....++..|+|||++... .++.++|||||||++|||++ |..||..... ...+..+.
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 99999997653221 223356789999998765 57789999999999999998 9988765433 22233333
Q ss_pred C-CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 438 L-PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 438 ~-~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
. ..+...+..+.++|.+||..||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 242 LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3 334567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=303.26 Aligned_cols=239 Identities=21% Similarity=0.278 Sum_probs=191.2
Q ss_pred eEEEEecccCcEEEEEEEEcCCCe--EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc------ce
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGC--FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN------EQ 303 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~--~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~------~~ 303 (488)
.+.+.||+|+||.||+|.+..++. .||+|.++...........+..|+.++..+ +|+||+++++++... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCC
Confidence 467889999999999999877765 699999876555556677888999999998 899999999876432 24
Q ss_pred EEEEEecCCCCchh-hh-------hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCce
Q 011331 304 LYIQMELCDHSLSD-KK-------ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRAT 374 (488)
Q Consensus 304 l~IV~E~~~~~l~~-~~-------~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~ 374 (488)
.+++|||+.++.+. .. ....+++..++.++.||+.||.|||++||+|+||||+|||+ .++.++|+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 68999999865332 11 12347899999999999999999999999999999999999 67899999999998
Q ss_pred ecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCCCCCC
Q 011331 375 LLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPLLPGH 444 (488)
Q Consensus 375 ~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~~~~~ 444 (488)
...... ....+++.|+|||.+... .++.++|||||||++|||++ |..||..... ...+..+ ..+.++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC 239 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 764321 122356789999998765 57789999999999999999 7777754322 1223332 33455678
Q ss_pred cHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 445 SLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 445 s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
+..+.++|.+||+.||++|||+.+|+++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 240 LDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=300.87 Aligned_cols=238 Identities=21% Similarity=0.310 Sum_probs=193.7
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|+++++||+|+||.||+|... ++..||+|.+... ......+..|+.+++.+ +|+||+++++.+...+..|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEE
Confidence 457999999999999999999865 6678999987643 22346688899999998 899999999999999999999
Q ss_pred EecCCCC-chhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 308 MELCDHS-LSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 308 ~E~~~~~-l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
|||+.++ +.... ....+++..++.++.||+.||+|||+.|++|+||||+||++ .++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999764 44322 23457888999999999999999999999999999999999 67899999999998764322
Q ss_pred --CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHHHHHH
Q 011331 381 --PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~~lI~ 453 (488)
....++..|+|||.+... .++.++|||||||++|+|++ |..||..... ...+.. ...+....++.++.++|.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMK 238 (261)
T ss_pred ccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 122356789999998765 56779999999999999998 8888765322 222222 233445567899999999
Q ss_pred HcccCCCCCCCCHHHHHh
Q 011331 454 VMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~ 471 (488)
+||..+|++|||++++++
T Consensus 239 ~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 239 TCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=302.40 Aligned_cols=241 Identities=22% Similarity=0.286 Sum_probs=196.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcCC---CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRID---GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
++|++.+.||+|+||+||+|.+..+ ...||||++.... .......+..|+.++..+ +|+||+++++.+..++..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCceE
Confidence 4689999999999999999988654 4689999886542 344456788899999999 8999999999999999999
Q ss_pred EEEecCCCCchh-hh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-
Q 011331 306 IQMELCDHSLSD-KK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL- 380 (488)
Q Consensus 306 IV~E~~~~~l~~-~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~- 380 (488)
++|||+.++.+. .. ....+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++.......
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999875443 22 12368999999999999999999999999999999999999 57889999999998764211
Q ss_pred --C--CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC-CCCCCCCCcHHHHHH
Q 011331 381 --P--IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG-KLPLLPGHSLQFQNL 451 (488)
Q Consensus 381 --~--~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~-~~~~~~~~s~~l~~l 451 (488)
. ...++..|+|||.+... .++.++||||||+++|+|++ |..||...... ..+... ..+.+..++..+.++
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL 240 (266)
T ss_pred ceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1 12345789999998765 57779999999999999998 88887654321 222222 335556779999999
Q ss_pred HHHcccCCCCCCCCHHHHHhC
Q 011331 452 LKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~H 472 (488)
+.+||+.+|++||++.|++++
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=306.78 Aligned_cols=243 Identities=22% Similarity=0.332 Sum_probs=196.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCC-----CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRID-----GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||++.+... ...||+|.+... ........+..|+.++..+.+|+||+++++++..++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC-CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 45789999999999999999987643 378999998754 233445668889999999878999999999999999
Q ss_pred eEEEEEecCCCCchh-hh-----------------hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCC
Q 011331 303 QLYIQMELCDHSLSD-KK-----------------ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNG 363 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~-~~-----------------~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g 363 (488)
.++++|||+.++.+. .. ....+++..++.++.||+.||.|||+.||+|+||||+|||+ .++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC
Confidence 999999999765332 21 12458889999999999999999999999999999999999 678
Q ss_pred eEEEEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhh
Q 011331 364 VYKLGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLR 434 (488)
Q Consensus 364 ~vkL~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~ 434 (488)
.++|+|||+++...... ....++..|+|||++... .++.++|||||||++|||++ |..|+..... +..+.
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 248 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 99999999998654321 112345679999988665 56779999999999999997 8887765432 22222
Q ss_pred cC-CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 435 DG-KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 435 ~~-~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
.+ ....+...+.++.+|+.+||..||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 249 EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 22 234455678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=298.75 Aligned_cols=241 Identities=30% Similarity=0.478 Sum_probs=197.6
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++.+.||.|+||.||+|.+..+|..||+|.++..... ......+.+|+.+++++ +|+||+++++.+...+..+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEE
Confidence 4789999999999999999999999999999988643222 33356788999999999 999999999999999999999
Q ss_pred EecCCCC-chhhh-----hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 308 MELCDHS-LSDKK-----ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 308 ~E~~~~~-l~~~~-----~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
|||++++ +.... ....+++..++.++.||+.||.|||+.||+|+||+|+||++ .++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 9999875 33322 12448899999999999999999999999999999999999 6789999999998765432
Q ss_pred --CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-----hhhhhcCCCC-CCC-CCcHHHHH
Q 011331 380 --LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-----FLNLRDGKLP-LLP-GHSLQFQN 450 (488)
Q Consensus 380 --~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-----~~~i~~~~~~-~~~-~~s~~l~~ 450 (488)
.....|+..|+|||.+.+. .++.++|||||||++|+|++|..|+..... ...+..+..+ .+. ..+..+.+
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239 (267)
T ss_pred cccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHH
Confidence 2234588899999998755 567799999999999999999998854321 1122223222 232 56789999
Q ss_pred HHHHcccCCCCCCCCHHHHHh
Q 011331 451 LLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~ 471 (488)
+|.+||..+|++|||+.+|++
T Consensus 240 ~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 240 LVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=299.50 Aligned_cols=244 Identities=27% Similarity=0.394 Sum_probs=199.5
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce--
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ-- 303 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~-- 303 (488)
...++|++.+.||.|||+-||++....++..||+|++.... ..+.+..++|+...+++ +||||++++++...+..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccC
Confidence 34568999999999999999999999999999999987543 45667899999999999 89999999988765444
Q ss_pred ---EEEEEecCCCC-chh-----hhhcccCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEE-eCCeEEEEeec
Q 011331 304 ---LYIQMELCDHS-LSD-----KKASQFFAEGEVLKALHQIAQALQFIHEKG--IAHLDVKPDNIYV-KNGVYKLGDFG 371 (488)
Q Consensus 304 ---l~IV~E~~~~~-l~~-----~~~~~~l~~~~~~~i~~qI~~gL~yLH~~g--IiHrDLKp~NILv-~~g~vkL~DFG 371 (488)
.||++.|...+ +.+ ......+++.+++.|+.+|++||.+||+.. ++||||||.|||+ +++.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 89999998655 554 223346999999999999999999999998 9999999999999 55999999999
Q ss_pred CceecCCC------------CCCCCCCCCccChhhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCchh-----hhh
Q 011331 372 RATLLNKS------------LPIEEGDARYMPQEILNED--YDHLDKVDIFSLGATMYELIKGSPLSESGPQ-----FLN 432 (488)
Q Consensus 372 lA~~~~~~------------~~~~~Gt~~Y~APEvl~~~--~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-----~~~ 432 (488)
.++...-. .....-|..|+|||.+.-+ ...+.++|||||||+||+|+.|..||+..-. ...
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA 254 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA 254 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence 99765311 1122368899999998643 3456799999999999999999999874322 112
Q ss_pred hhcCC--CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 433 LRDGK--LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 433 i~~~~--~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
+..+. .|..+.+|+.+.++|++||+.||.+||++.+|+.+
T Consensus 255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 22333 34445689999999999999999999999999975
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=302.07 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=198.9
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc--ce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL---HHDAERRKALLEVQALAALGSHENIVGYYSSWFEN--EQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~---~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~--~~ 303 (488)
.+|++.+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+++.+ +|+||+++++.+.+. +.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence 36899999999999999999999999999999874321 1223456788899999999 899999999988764 46
Q ss_pred EEEEEecCCCC-chhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 304 LYIQMELCDHS-LSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
++++|||+.++ +.... ....+++..++.++.||+.||.|||+.|++|+||||+||++ .++.++|+|||+++.....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 89999999875 44332 23468899999999999999999999999999999999999 6788999999999765321
Q ss_pred -----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc----C-CCCCCCCCcHHHH
Q 011331 380 -----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD----G-KLPLLPGHSLQFQ 449 (488)
Q Consensus 380 -----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~----~-~~~~~~~~s~~l~ 449 (488)
.....|+..|+|||.+... .++.++|||||||++|+|++|.+||........+.. . ....+..++.++.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 239 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR 239 (264)
T ss_pred ccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHH
Confidence 1223588899999998765 567799999999999999999999876544332221 1 2234567789999
Q ss_pred HHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 450 NLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
++|.+||. +|..||++.++++|||.
T Consensus 240 ~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 240 DFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=305.62 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=198.4
Q ss_pred cceeEEEEecccCcEEEEEEEE-----cCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLK-----RIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
.+|.+.+.||.|+||+||++.+ ..++..||+|.+... .......+..|+.++.++ +|+||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCc
Confidence 4689999999999999999975 235677999988643 334456788999999999 89999999999999999
Q ss_pred EEEEEecCCCCchh-hhhc--------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEE
Q 011331 304 LYIQMELCDHSLSD-KKAS--------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKL 367 (488)
Q Consensus 304 l~IV~E~~~~~l~~-~~~~--------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL 367 (488)
+|+||||+.++.+. .... ..+++..++.++.||+.||+|||++|++||||||+|||+ +++.++|
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 99999999875433 2211 238999999999999999999999999999999999999 6789999
Q ss_pred EeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcCC-
Q 011331 368 GDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDGK- 437 (488)
Q Consensus 368 ~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~~- 437 (488)
+|||+++...... ....++..|+|||++... .++.++|||||||++|+|++ |.+||..... ...+..+.
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~ 240 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999997653221 122356789999998765 57789999999999999998 8888765432 22333333
Q ss_pred CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHh
Q 011331 438 LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481 (488)
Q Consensus 438 ~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~ 481 (488)
...+...+.++.+|+.+||+.||.+|||+.+++. +|+.+.+.
T Consensus 241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~--~l~~~~~~ 282 (288)
T cd05093 241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS--LLQNLAKA 282 (288)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH--HHHHHHHh
Confidence 2334457889999999999999999999999966 47766543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=308.45 Aligned_cols=251 Identities=21% Similarity=0.330 Sum_probs=199.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcC-------CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRI-------DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+..|+.++..+.+|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3578999999999999999998643 23579999987542 334456788899999999789999999999999
Q ss_pred cceEEEEEecCCCC-chhhhhc-----------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-e
Q 011331 301 NEQLYIQMELCDHS-LSDKKAS-----------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-K 361 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~~~~~-----------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~ 361 (488)
.+.+|+||||+.++ |...... ..++...++.++.||+.||+|||++|++|+||||+||++ .
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 99999999999875 3332211 247888999999999999999999999999999999999 6
Q ss_pred CCeEEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhh
Q 011331 362 NGVYKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLN 432 (488)
Q Consensus 362 ~g~vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~ 432 (488)
++.++|+|||+++..... .....++..|+|||++.+. .++.++|||||||++|||++ |.+|+..... ...
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 789999999999765321 1112245689999998765 57789999999999999998 7777765432 112
Q ss_pred hhcCC-CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhh
Q 011331 433 LRDGK-LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHR 482 (488)
Q Consensus 433 i~~~~-~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~ 482 (488)
+.... ...+...+.++.++|.+||..+|.+|||+.+++++ |+.+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~--l~~~~~~~ 303 (307)
T cd05098 255 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRILALT 303 (307)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH--HHHHHHHh
Confidence 22222 34556678999999999999999999999999986 66655443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=300.58 Aligned_cols=233 Identities=20% Similarity=0.261 Sum_probs=188.7
Q ss_pred EecccCcEEEEEEEE--cCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 236 QIGAGNFSHVFKVLK--RIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~--~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
.||+|+||.||+|.+ ..++..||+|+++...........+..|+.++..+ +|+||+++++++. .+..++||||+.+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999964 45689999999876544445567788999999998 9999999998875 4567999999987
Q ss_pred Cch-hhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC------CCCC
Q 011331 314 SLS-DKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL------PIEE 384 (488)
Q Consensus 314 ~l~-~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~------~~~~ 384 (488)
+.+ ... ....+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++....... ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 643 322 33468999999999999999999999999999999999999 67889999999998664322 1123
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCCCCCCcHHHHHHHHHcccCC
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
++..|+|||.+... .++.++|||||||++|||++ |..||..... ...+..+ ..+.+..++.++.++|.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 45789999988654 56679999999999999998 8888875432 2223332 34556678999999999999999
Q ss_pred CCCCCCHHHHHh
Q 011331 460 PVQRPSAKELVE 471 (488)
Q Consensus 460 P~~RpTa~elL~ 471 (488)
|++||++++|.+
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=307.71 Aligned_cols=241 Identities=20% Similarity=0.224 Sum_probs=192.1
Q ss_pred cceeEEEEecccCcEEEEEEEEcCC-----CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRID-----GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
.+|++++.||.|+||+||+|.+..+ +..||||++.... .......+..|+.++..+ +||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCCc
Confidence 3578889999999999999987543 5789999987542 233345677888888888 89999999999999999
Q ss_pred EEEEEecCCCCchh-hh-----------------hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCe
Q 011331 304 LYIQMELCDHSLSD-KK-----------------ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGV 364 (488)
Q Consensus 304 l~IV~E~~~~~l~~-~~-----------------~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~ 364 (488)
+++++||+.++.+. .. ....+++..++.++.||+.||.|||++||+||||||+|||+ +++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence 99999999765332 21 12347888899999999999999999999999999999999 6789
Q ss_pred EEEEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc
Q 011331 365 YKLGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD 435 (488)
Q Consensus 365 vkL~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~ 435 (488)
+||+|||+++...... ....+++.|+|||.+... .++.++|||||||++|||++ |..|+..... ...+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999987653221 122356789999998655 46779999999999999998 7777655332 222333
Q ss_pred CC-CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 436 GK-LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 436 ~~-~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
+. .+.+..++.++.+++.+||+.+|.+||++++++..
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 32 34556789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=303.83 Aligned_cols=243 Identities=25% Similarity=0.365 Sum_probs=191.9
Q ss_pred eeEEEEecccCcEEEEEEE----EcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc--cceE
Q 011331 231 FHEIEQIGAGNFSHVFKVL----KRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE--NEQL 304 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~--~~~l 304 (488)
|++++.||+|+||+||++. ...++..||+|++.... .......+..|+.++..+ +||||+++++++.. ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCceE
Confidence 3889999999999998864 33468899999986542 233456678899999999 99999999998765 3468
Q ss_pred EEEEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 305 YIQMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
|++|||+.++ +........+++..++.++.||+.||.|||++||+|+||||+|||+ .++.++|+|||+++......
T Consensus 84 ~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred EEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 9999999876 4444445579999999999999999999999999999999999999 67899999999998664321
Q ss_pred ----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-hhhhh------------------cCC
Q 011331 381 ----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-FLNLR------------------DGK 437 (488)
Q Consensus 381 ----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-~~~i~------------------~~~ 437 (488)
....++..|+|||.+... .++.++|||||||++|||++|..|+..... +.... ...
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence 112356679999998654 567799999999999999999988754321 11000 112
Q ss_pred CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 438 LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 438 ~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.+.+...+.++.+++.+||+.+|++|||++++++ +|+.+
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~--~l~~~ 281 (283)
T cd05080 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP--ILKEM 281 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH--HHHHh
Confidence 2334567899999999999999999999999997 45544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=298.58 Aligned_cols=237 Identities=28% Similarity=0.416 Sum_probs=200.2
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC-C
Q 011331 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-S 314 (488)
Q Consensus 237 LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~-~ 314 (488)
||.|+||.||++.+..++..||+|++....... .....+..|+.+++.+ +|+||+++++.+..+..+|++|||+.+ .
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999998889999999987543322 2345678899999998 899999999999999999999999955 4
Q ss_pred chhhhh-cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCCCCCCCc
Q 011331 315 LSDKKA-SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIEEGDARY 389 (488)
Q Consensus 315 l~~~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~~Gt~~Y 389 (488)
+..... ...+++..++.++.||+.||.|||+.|++|+||+|+||++ .++.++|+|||++...... .....++..|
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence 544332 3368999999999999999999999999999999999999 6789999999999876442 3345688899
Q ss_pred cChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCCCH
Q 011331 390 MPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSA 466 (488)
Q Consensus 390 ~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa 466 (488)
+|||.+... ..+.++|+||||+++|+|++|..||..... ...+.....+.+...+..+.++|.+||..||++||++
T Consensus 160 ~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~ 238 (250)
T cd05123 160 LAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGS 238 (250)
T ss_pred cChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCc
Confidence 999998765 466799999999999999999999876543 2233445666777779999999999999999999999
Q ss_pred ---HHHHhChhh
Q 011331 467 ---KELVENPIF 475 (488)
Q Consensus 467 ---~elL~HP~f 475 (488)
+++++||||
T Consensus 239 ~~~~~l~~~~~f 250 (250)
T cd05123 239 GGAEEIKAHPFF 250 (250)
T ss_pred ccHHHHHhCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.84 Aligned_cols=242 Identities=21% Similarity=0.295 Sum_probs=192.0
Q ss_pred cceeEEEEecccCcEEEEEEEEcC-----CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-cc
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRI-----DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE-NE 302 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-~~ 302 (488)
++|++++.||.|+||.||+|.... +++.||+|++.... .......+..|+.++.++.+|+||+++++++.. ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 368999999999999999997543 45789999986543 234456688899999999889999999998764 45
Q ss_pred eEEEEEecCCCCchh-hhh-------------------------------------------------------------
Q 011331 303 QLYIQMELCDHSLSD-KKA------------------------------------------------------------- 320 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~-~~~------------------------------------------------------------- 320 (488)
.++++|||+.++.+. ...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 789999999875332 111
Q ss_pred -cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-----CCCCCCCCCccChh
Q 011331 321 -SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-----LPIEEGDARYMPQE 393 (488)
Q Consensus 321 -~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APE 393 (488)
...+++..+..++.||+.||.|||++||+||||||+|||+ .++.++|+|||++..+... .....++..|+|||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 1257888999999999999999999999999999999999 5789999999999865321 11234567899999
Q ss_pred hhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hh-hhhcCC-CCCCCCCcHHHHHHHHHcccCCCCCCCCHH
Q 011331 394 ILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FL-NLRDGK-LPLLPGHSLQFQNLLKVMVDPDPVQRPSAK 467 (488)
Q Consensus 394 vl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~-~i~~~~-~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~ 467 (488)
++... .++.++|||||||+||||++ |..||..... +. .+..+. ...+...+.++.+++.+||+.+|++||++.
T Consensus 246 ~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 324 (337)
T cd05054 246 SIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFS 324 (337)
T ss_pred HhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 98765 57789999999999999997 8888864321 11 222222 233456788999999999999999999999
Q ss_pred HHHhC
Q 011331 468 ELVEN 472 (488)
Q Consensus 468 elL~H 472 (488)
|+++|
T Consensus 325 ell~~ 329 (337)
T cd05054 325 ELVEI 329 (337)
T ss_pred HHHHH
Confidence 99986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=302.79 Aligned_cols=240 Identities=22% Similarity=0.306 Sum_probs=192.5
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCe----EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGC----FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.+|++++.||.|+||+||+|.+..+|. .||+|++... ........+..|+.++..+ +|+||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT-STV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC-CCc
Confidence 478999999999999999999877776 4899988654 2334456788899999988 89999999998875 457
Q ss_pred EEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 305 YIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
+++|||++++ +..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ +++.+||+|||+++......
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 8899999765 444332 3458999999999999999999999999999999999999 67889999999998764322
Q ss_pred C-----CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh--h-hhhc-CCCCCCCCCcHHHHH
Q 011331 381 P-----IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF--L-NLRD-GKLPLLPGHSLQFQN 450 (488)
Q Consensus 381 ~-----~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~--~-~i~~-~~~~~~~~~s~~l~~ 450 (488)
. ...++..|+|||.+... .++.++|||||||++|||++ |..|+...... . .+.. ...+.++..+.++.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred ceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHH
Confidence 1 12346789999998665 57779999999999999998 88887653321 1 1222 234455678899999
Q ss_pred HHHHcccCCCCCCCCHHHHHhC
Q 011331 451 LLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~H 472 (488)
+|.+||..||++||++.++++.
T Consensus 243 li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 243 IMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=297.52 Aligned_cols=235 Identities=26% Similarity=0.347 Sum_probs=195.2
Q ss_pred EEecccCcEEEEEEEEcCC---CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecC
Q 011331 235 EQIGAGNFSHVFKVLKRID---GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELC 311 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~ 311 (488)
+.||+|+||.||+|.+... +..||+|++....... ....+..|+..+..+ +|+||+++++++.....++++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEec
Confidence 3689999999999999866 8999999987654333 467788999999999 6999999999999999999999999
Q ss_pred CCC-chhhhh----------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 312 DHS-LSDKKA----------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 312 ~~~-l~~~~~----------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
.++ +..... ...+++..++.++.||+.||+|||++||+|+||+|+||++ .++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 654 444322 2568999999999999999999999999999999999999 5699999999999876542
Q ss_pred -----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhh-cCCCCCCCCCcHHHH
Q 011331 380 -----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLR-DGKLPLLPGHSLQFQ 449 (488)
Q Consensus 380 -----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~-~~~~~~~~~~s~~l~ 449 (488)
.....++..|+|||.+... .++.++|||||||++|+|++ |..||...... ..+. ......+..++.++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 2234578899999998765 57789999999999999999 57887654331 2222 233455667799999
Q ss_pred HHHHHcccCCCCCCCCHHHHHhC
Q 011331 450 NLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~H 472 (488)
++|.+||..+|.+|||+.|++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=311.50 Aligned_cols=246 Identities=25% Similarity=0.394 Sum_probs=202.5
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccC-CCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ-LHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~-~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.|...+.||.|+||.||+|.+..++..||+|.+... .........+..|+.+++.+ +|+|++++++++......|+||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeEEEE
Confidence 467788999999999999999999999999988643 22334445678899999998 8999999999999999999999
Q ss_pred ecCCCCchhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCCC
Q 011331 309 ELCDHSLSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEG 385 (488)
Q Consensus 309 E~~~~~l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~G 385 (488)
||+.+++.... ....+++..+..++.||+.||.|||++|++|+||+|+||++ .++.++|+|||++...... ....|
T Consensus 95 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~ 173 (308)
T cd06634 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-NXFVG 173 (308)
T ss_pred EccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-ccccC
Confidence 99988765533 23458999999999999999999999999999999999999 6789999999998765432 34568
Q ss_pred CCCccChhhhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCCC--CCCCcHHHHHHHHHcccC
Q 011331 386 DARYMPQEILNE--DYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLPL--LPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 386 t~~Y~APEvl~~--~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~~--~~~~s~~l~~lI~k~L~~ 458 (488)
+..|+|||.+.. ...++.++|||||||++|+|++|..|+...... ..+.....+. ....+..+.++|.+||..
T Consensus 174 ~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 253 (308)
T cd06634 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253 (308)
T ss_pred CccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhC
Confidence 899999999742 224567999999999999999999887654332 2222222222 335788899999999999
Q ss_pred CCCCCCCHHHHHhChhhhh
Q 011331 459 DPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 459 dP~~RpTa~elL~HP~f~~ 477 (488)
+|++||++.++++|||+..
T Consensus 254 ~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 254 IPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CcccCCCHHHHhhCccccc
Confidence 9999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=302.03 Aligned_cols=241 Identities=29% Similarity=0.479 Sum_probs=196.1
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.+|++.+.||+|+||.||+|.+..+|..||||.+.... ........+..|+.++..+ +|+||+++++++..++.++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEE
Confidence 46888999999999999999999999999999875432 2233456788899999998 899999999999999999999
Q ss_pred EecCCCC-chhhh-----hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 308 MELCDHS-LSDKK-----ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 308 ~E~~~~~-l~~~~-----~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
|||+.++ +.... ....+++..++.++.||+.||.|||++|++|+||||+||++ .++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 9999875 33322 13458999999999999999999999999999999999999 67899999999987664322
Q ss_pred ---CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-----hhhhhcCCCC-CC-CCCcHHHHH
Q 011331 381 ---PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-----FLNLRDGKLP-LL-PGHSLQFQN 450 (488)
Q Consensus 381 ---~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-----~~~i~~~~~~-~~-~~~s~~l~~ 450 (488)
....|+..|+|||.+... .++.++||||||+++|+|++|..||..... ...+.....+ .+ ...+.++.+
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred cccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 234688999999998665 566799999999999999999998864322 1122222222 22 246889999
Q ss_pred HHHHcccCCCCCCCCHHHHHh
Q 011331 451 LLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~ 471 (488)
+|.+||..||++|||+.+|++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHH
Confidence 999999999999999998876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=305.89 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=202.5
Q ss_pred ceeEEEEecccCcEEEEEEEEc---CCCeEEEEEEeccCCCc--hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKR---IDGCFYAVKHSKRQLHH--DAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~l~~~~~~--~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
+|++.+.||.|+||.||+|.+. .++..||||++.+.... ......+..|+.++.++.+|+||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4789999999999999999864 46789999998643211 223345778999999997899999999999999999
Q ss_pred EEEEecCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-
Q 011331 305 YIQMELCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL- 380 (488)
Q Consensus 305 ~IV~E~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~- 380 (488)
|+||||+.++.+. . .....+++..++.++.|++.||.|||+.|++|+||+|+||++ .++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 9999999875433 2 223568899999999999999999999999999999999999 67899999999987653321
Q ss_pred ---CCCCCCCCccChhhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCchh-------hhhhhcCCCCCCCCCcHHHH
Q 011331 381 ---PIEEGDARYMPQEILNEDY-DHLDKVDIFSLGATMYELIKGSPLSESGPQ-------FLNLRDGKLPLLPGHSLQFQ 449 (488)
Q Consensus 381 ---~~~~Gt~~Y~APEvl~~~~-~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~~~i~~~~~~~~~~~s~~l~ 449 (488)
....|+..|+|||.+.... ..+.++||||||+++|||++|..|+..... ...+.....+.+...+..+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence 1235788999999986542 356799999999999999999988853211 11223344556667789999
Q ss_pred HHHHHcccCCCCCCCC---HHHHHhChhhhhhHH
Q 011331 450 NLLKVMVDPDPVQRPS---AKELVENPIFDKIQK 480 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpT---a~elL~HP~f~~i~~ 480 (488)
++|.+||+.||++||| +.++|+||||+.+.+
T Consensus 241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred HHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 9999999999999998 678899999998765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=306.44 Aligned_cols=247 Identities=30% Similarity=0.476 Sum_probs=204.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.+.|.+.+.||.|+||.||+|.+..++..||+|++..... ....+..|+..+..+ +|+||+++++.+...+..|++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDC-KHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEEEEE
Confidence 3457888999999999999999998899999999875422 455678899999998 899999999999999999999
Q ss_pred EecCCC-Cchhhhhcc--cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---C
Q 011331 308 MELCDH-SLSDKKASQ--FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---L 380 (488)
Q Consensus 308 ~E~~~~-~l~~~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~ 380 (488)
+||+++ +|....... .+++..++.++.||+.||.|||+.||+|+||+|+||++ .++.++|+|||++...... .
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence 999985 454443333 69999999999999999999999999999999999999 5789999999988655432 1
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCC---CCCCCCcHHHHHHHHH
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKL---PLLPGHSLQFQNLLKV 454 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~---~~~~~~s~~l~~lI~k 454 (488)
....++..|+|||.+... .++.++|+|||||++|+|++|..|+....... .+..... .....++.++.++|.+
T Consensus 174 ~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK 252 (286)
T ss_pred ccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHH
Confidence 233578899999998765 56789999999999999999999987654422 1222221 1222368899999999
Q ss_pred cccCCCCCCCCHHHHHhChhhhhhH
Q 011331 455 MVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
||+.+|.+|||+.++++||||+...
T Consensus 253 ~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 253 CLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HhccChhhCcCHHHHhhChHhhccC
Confidence 9999999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=319.14 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=204.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCC-----CeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE-----NIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hp-----nIv~l~~~~~~~~ 302 (488)
.++|.++..+|+|.||.|-.|.+..++..||||+++. -..-++.+..|+++|.++..+. -+|.+.++|...+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 5678999999999999999999999999999999863 3455677889999999995443 2778888999999
Q ss_pred eEEEEEecCCCCchhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-e-----------------
Q 011331 303 QLYIQMELCDHSLSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-K----------------- 361 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~----------------- 361 (488)
++|||+|.++-++.+.... ..++...++.+.+|++.+++|||+.+++|.||||+|||+ +
T Consensus 165 hiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 165 HICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred ceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 9999999999776554333 358889999999999999999999999999999999998 2
Q ss_pred ---CCeEEEEeecCceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh------hhh
Q 011331 362 ---NGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ------FLN 432 (488)
Q Consensus 362 ---~g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------~~~ 432 (488)
+-.++|+|||.|+.........+.|..|+|||++.+= .++.++||||+||+|+||.+|..+|...+. +..
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgL-GwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMer 323 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGL-GWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMER 323 (415)
T ss_pred cCCCcceEEEecCCcceeccCcceeeeccccCCchheecc-CcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHH
Confidence 1247999999999888888888999999999999874 688899999999999999999988875442 111
Q ss_pred hhcCCCC-------------------CCCC-------------------------CcHHHHHHHHHcccCCCCCCCCHHH
Q 011331 433 LRDGKLP-------------------LLPG-------------------------HSLQFQNLLKVMVDPDPVQRPSAKE 468 (488)
Q Consensus 433 i~~~~~~-------------------~~~~-------------------------~s~~l~~lI~k~L~~dP~~RpTa~e 468 (488)
+. |.+| ++.. .-.++.+||++||..||.+|+|+.|
T Consensus 324 Il-Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~E 402 (415)
T KOG0671|consen 324 IL-GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLRE 402 (415)
T ss_pred hh-CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHH
Confidence 11 1111 0100 0125889999999999999999999
Q ss_pred HHhChhhhhhH
Q 011331 469 LVENPIFDKIQ 479 (488)
Q Consensus 469 lL~HP~f~~i~ 479 (488)
+|.||||+.+.
T Consensus 403 AL~HpFF~~~~ 413 (415)
T KOG0671|consen 403 ALSHPFFARLT 413 (415)
T ss_pred HhcCHHhhcCC
Confidence 99999998764
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=306.82 Aligned_cols=243 Identities=27% Similarity=0.419 Sum_probs=201.3
Q ss_pred EEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCC
Q 011331 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCD 312 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~ 312 (488)
....||+|+||.||++....+|..||||++... .......+..|+.+++.+ +|+||+++++.+...+..|++|||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEEEecCC
Confidence 346799999999999999999999999987532 234456688899999998 89999999999999999999999998
Q ss_pred CCchh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCCCCCC
Q 011331 313 HSLSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIEEGDA 387 (488)
Q Consensus 313 ~~l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~~Gt~ 387 (488)
++.+. ......+++..++.++.||+.||+|||+.|++|+||+|+||++ .++.++|+|||++...... .....|+.
T Consensus 101 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 180 (292)
T cd06657 101 GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180 (292)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCc
Confidence 76444 4444568999999999999999999999999999999999999 5789999999998765432 22345889
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc---CCCCCCCCCcHHHHHHHHHcccCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD---GKLPLLPGHSLQFQNLLKVMVDPDPV 461 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~---~~~~~~~~~s~~l~~lI~k~L~~dP~ 461 (488)
.|+|||.+... .++.++|+||||+++|+|++|..||........ +.. ........++..+.++|.+||..+|.
T Consensus 181 ~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~ 259 (292)
T cd06657 181 YWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA 259 (292)
T ss_pred cccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcc
Confidence 99999988654 567799999999999999999999876543321 111 12223345688999999999999999
Q ss_pred CCCCHHHHHhChhhhhhH
Q 011331 462 QRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 462 ~RpTa~elL~HP~f~~i~ 479 (488)
+||++.++++||||....
T Consensus 260 ~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 260 QRATAAELLKHPFLAKAG 277 (292)
T ss_pred cCcCHHHHhcChHHhccC
Confidence 999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.84 Aligned_cols=249 Identities=28% Similarity=0.436 Sum_probs=205.7
Q ss_pred CCccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEecc--CCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec
Q 011331 222 DGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKR--QLHHDAERRKALLEVQALAALGSHENIVGYYSSWF 299 (488)
Q Consensus 222 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~--~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~ 299 (488)
+.-+|| .+....||+|+|-+||+|.+..+|..||.-.++. -.......+.+..|+.+|+.| +|||||++|++|.
T Consensus 36 ~p~gRy---~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~ 111 (632)
T KOG0584|consen 36 DPTGRY---LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWV 111 (632)
T ss_pred CCCCce---eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeehee
Confidence 344555 2455679999999999999999999999754432 223345568899999999999 9999999999999
Q ss_pred ccce--EEEEEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHc--CcccCCCCCCcEEE--eCCeEEEEeec
Q 011331 300 ENEQ--LYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEK--GIAHLDVKPDNIYV--KNGVYKLGDFG 371 (488)
Q Consensus 300 ~~~~--l~IV~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--gIiHrDLKp~NILv--~~g~vkL~DFG 371 (488)
+... +.+|+|++..|.+. .+..+.+....+..|++||+.||.|||++ .|||||||-+|||| ..|.|||+|+|
T Consensus 112 d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 112 DTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred cCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchh
Confidence 7655 88999999766444 55667799999999999999999999998 59999999999999 45999999999
Q ss_pred CceecCCCCCC-CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCc----hhhhhhhcCCCCC--CCCC
Q 011331 372 RATLLNKSLPI-EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESG----PQFLNLRDGKLPL--LPGH 444 (488)
Q Consensus 372 lA~~~~~~~~~-~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~----~~~~~i~~~~~~~--~~~~ 444 (488)
||+....+... ..|||.|||||++... |...+||||||+++.||+|+..||..= .-+.++..|..|. ..--
T Consensus 192 LAtl~r~s~aksvIGTPEFMAPEmYEE~--YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 192 LATLLRKSHAKSVIGTPEFMAPEMYEEN--YNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred HHHHhhccccceeccCccccChHHHhhh--cchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC
Confidence 99988765544 4799999999999865 567999999999999999999998642 2244555555442 2223
Q ss_pred cHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 445 SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 445 s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
.+++++||.+||.. .++|+|+.|||+||||+.
T Consensus 270 dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 270 DPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred CHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 78999999999999 999999999999999986
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=299.65 Aligned_cols=238 Identities=21% Similarity=0.292 Sum_probs=191.5
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.+|++++.||+|+||+||+|.+. .+..||||.+..... ....+..|+.++..+ +||||+++++++.....+|++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc---cHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEEE
Confidence 46899999999999999999775 355699998864322 234578899999999 8999999999999999999999
Q ss_pred ecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-C--
Q 011331 309 ELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-P-- 381 (488)
Q Consensus 309 E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-~-- 381 (488)
||+.++ +..... ...+++..++.++.||+.||.|||+.|++|+||||+||++ .++.+||+|||+++...... .
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999775 433222 2358999999999999999999999999999999999999 67899999999987653321 1
Q ss_pred -CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcCC-CCCCCCCcHHHHHHHHHc
Q 011331 382 -IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDGK-LPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 382 -~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~~-~~~~~~~s~~l~~lI~k~ 455 (488)
...++..|+|||.+... .++.++|||||||++|+|++ |..|+..... ...+..+. ...+...+..+.+++.+|
T Consensus 159 ~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSC 237 (256)
T ss_pred CCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 12345679999998754 46679999999999999998 8888764322 22333332 233445688999999999
Q ss_pred ccCCCCCCCCHHHHHhC
Q 011331 456 VDPDPVQRPSAKELVEN 472 (488)
Q Consensus 456 L~~dP~~RpTa~elL~H 472 (488)
|..+|.+|||+.+|+++
T Consensus 238 l~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 238 WHEKAEERPTFQQLLSS 254 (256)
T ss_pred cCCCcccCCCHHHHHHh
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=321.28 Aligned_cols=243 Identities=19% Similarity=0.249 Sum_probs=193.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCC-----CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRID-----GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
..+|++++.||+|+||+||+|.+... +..||||++... ......+.+.+|+.++.++..||||++++++|...+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45789999999999999999987433 457999998654 233445678999999999966999999999999999
Q ss_pred eEEEEEecCCCCchh-hhh-------------------------------------------------------------
Q 011331 303 QLYIQMELCDHSLSD-KKA------------------------------------------------------------- 320 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~-~~~------------------------------------------------------------- 320 (488)
.+|||||||.++.+. ...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999765322 100
Q ss_pred ------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCC
Q 011331 321 ------------------------------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNG 363 (488)
Q Consensus 321 ------------------------------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g 363 (488)
...+++..++.++.||+.||.|||+.||+|+||||+|||+ .++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 1236778889999999999999999999999999999999 567
Q ss_pred eEEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh----hhhh
Q 011331 364 VYKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ----FLNL 433 (488)
Q Consensus 364 ~vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~----~~~i 433 (488)
.+||+|||+++..... .....++..|+|||++... .++.++|||||||++|||++ |..||..... ...+
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~ 353 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI 353 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH
Confidence 8999999999865322 1123467789999998765 57789999999999999997 8888765322 1222
Q ss_pred hcC-CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 434 RDG-KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 434 ~~~-~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
..+ ..+.+..++.++.++|.+||..||++|||+.+|.+.
T Consensus 354 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 354 KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 222 344556778999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=288.62 Aligned_cols=248 Identities=26% Similarity=0.420 Sum_probs=205.8
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|..+++||+|.||+||+|+++.+++.||+|.++.....+.--..+++|+-+|+.+ .|.|||+++++...+..+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhccCceeEEeHH
Confidence 45677899999999999999999999999999875543333346689999999999 99999999999999999999999
Q ss_pred cCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---CCC
Q 011331 310 LCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---PIE 383 (488)
Q Consensus 310 ~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---~~~ 383 (488)
||+..+.. ...++.+....++.++.|++.||.|+|++++.||||||.|+|| .+|.+||+|||+|+..+-.. ...
T Consensus 82 ~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae 161 (292)
T KOG0662|consen 82 FCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161 (292)
T ss_pred HhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence 99987665 3345779999999999999999999999999999999999999 79999999999999876443 345
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhh---c----CC------------CC-
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLR---D----GK------------LP- 439 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~---~----~~------------~~- 439 (488)
+-|.+|++|.++.+..-|++..|+||.||++.|+.. |.++|.+.+.. .++. . .. +|
T Consensus 162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ 241 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI 241 (292)
T ss_pred eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence 679999999999887788899999999999999986 55666654332 2221 0 00 11
Q ss_pred ---------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 440 ---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 440 ---------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+.|..+..-+++++++|.-+|.+|++|+++|+||||.+.
T Consensus 242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 112334457899999999999999999999999999764
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=298.73 Aligned_cols=237 Identities=22% Similarity=0.355 Sum_probs=193.0
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++.+.||+|++|.||+|.+. ++..||||.++.... ....+..|+.++.++ +|+||+++++++...+.+|++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHC-CCCCccceeEEEecCCCeeeee
Confidence 46899999999999999999875 567899999865322 245578899999999 8999999999999999999999
Q ss_pred ecCCC-Cchhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-CC
Q 011331 309 ELCDH-SLSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-PI 382 (488)
Q Consensus 309 E~~~~-~l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-~~ 382 (488)
||+.+ ++...... ..+++..+..++.||+.||.|||+.||+|+||||+||++ .++.++|+|||++....... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 99965 45443322 358899999999999999999999999999999999999 67899999999998765321 11
Q ss_pred CCC---CCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCCCCCCCcHHHHHHHHH
Q 011331 383 EEG---DARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 383 ~~G---t~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~~~~~~s~~l~~lI~k 454 (488)
..| +..|+|||.+... .++.++||||||+++|||++ |..||...... ..+.. ...+.+...+..+.+++.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 161 REGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLD 239 (261)
T ss_pred cCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 222 3579999988765 57789999999999999999 88887654332 22222 2344556778999999999
Q ss_pred cccCCCCCCCCHHHHHh
Q 011331 455 MVDPDPVQRPSAKELVE 471 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~ 471 (488)
||..+|.+||++.+|+.
T Consensus 240 ~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 240 CWKEDPDDRPTFETLQW 256 (261)
T ss_pred HhhcCcccCCCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=304.42 Aligned_cols=240 Identities=23% Similarity=0.265 Sum_probs=191.7
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCC----------------eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCee
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDG----------------CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIV 292 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g----------------~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv 292 (488)
++|++++.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|++++..+ +||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRL-SDPNIA 82 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhc-CCCCEe
Confidence 47899999999999999999876543 568999987543 234456788899999999 899999
Q ss_pred EeeeeecccceEEEEEecCCCC-chhhhhc-c-----------cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEE
Q 011331 293 GYYSSWFENEQLYIQMELCDHS-LSDKKAS-Q-----------FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIY 359 (488)
Q Consensus 293 ~l~~~~~~~~~l~IV~E~~~~~-l~~~~~~-~-----------~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NIL 359 (488)
++++++..++.++++||++.++ +...... . .+++..++.++.||+.||.|||++||+|+||||+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 9999999999999999999865 3332211 1 5889999999999999999999999999999999999
Q ss_pred E-eCCeEEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc--CCCCCCCchhhh
Q 011331 360 V-KNGVYKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK--GSPLSESGPQFL 431 (488)
Q Consensus 360 v-~~g~vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt--G~~p~~~~~~~~ 431 (488)
+ .++.++|+|||+++..... .....++..|+|||.+... .++.++|||||||++|||++ |..|+.......
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 9 6689999999998765322 1223467789999998765 47789999999999999998 556665432211
Q ss_pred ---hhhc--------CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 432 ---NLRD--------GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 432 ---~i~~--------~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
.+.. ...+.++..+.++.++|.+||+.||.+|||+.||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 1111 112344566789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=332.21 Aligned_cols=242 Identities=25% Similarity=0.347 Sum_probs=206.8
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
+...|.+...+|.|+||.|-.|.+..++..+++|++.+. ..+...|+.++....+||||+.+++.+.++.++|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeecceecCCceeee
Confidence 466788889999999999999999999999999998754 22344577788888899999999999999999999
Q ss_pred EEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE--eCCeEEEEeecCceecCCCCCCC
Q 011331 307 QMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV--KNGVYKLGDFGRATLLNKSLPIE 383 (488)
Q Consensus 307 V~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv--~~g~vkL~DFGlA~~~~~~~~~~ 383 (488)
|||++.++ ++...........++..|+.+|+.|+.|||++|+|||||||+|||+ +.|+++|+|||.++.......+.
T Consensus 394 v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp 473 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTP 473 (612)
T ss_pred eehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhccc
Confidence 99999886 4444444444447888999999999999999999999999999999 45889999999999887775566
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc--CCCCCCCCCcHHHHHHHHHcccCCCC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD--GKLPLLPGHSLQFQNLLKVMVDPDPV 461 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~--~~~~~~~~~s~~l~~lI~k~L~~dP~ 461 (488)
+-|..|.|||++... .++.+|||||||++||+|++|..|+...+.-.++.. +..++...+|.++++||.+||+.||.
T Consensus 474 ~~t~~y~APEvl~~~-~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~ 552 (612)
T KOG0603|consen 474 ALTLQYVAPEVLAIQ-EYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPA 552 (612)
T ss_pred chhhcccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCChh
Confidence 788999999999854 788999999999999999999999887655433332 22333467899999999999999999
Q ss_pred CCCCHHHHHhChhh
Q 011331 462 QRPSAKELVENPIF 475 (488)
Q Consensus 462 ~RpTa~elL~HP~f 475 (488)
+|+++.+++.||||
T Consensus 553 ~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 553 LRLGADEIGAHPWF 566 (612)
T ss_pred hCcChhhhccCcch
Confidence 99999999999999
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=302.79 Aligned_cols=252 Identities=22% Similarity=0.289 Sum_probs=199.9
Q ss_pred cceeEEEEecccCcEEEEEEEEc-----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+... .......+.+|+.+++++ +|+||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNL-QHEHIVKFYGVCGDGDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCc
Confidence 36889999999999999999754 34567999987643 233445688899999998 89999999999999999
Q ss_pred EEEEEecCCCCchh-hhh-----------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCe
Q 011331 304 LYIQMELCDHSLSD-KKA-----------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGV 364 (488)
Q Consensus 304 l~IV~E~~~~~l~~-~~~-----------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~ 364 (488)
.++||||++++.+. ... ...+++..++.++.||+.||+|||++||+|+||||+|||+ .++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 99999999765333 221 1237889999999999999999999999999999999999 6789
Q ss_pred EEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc
Q 011331 365 YKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD 435 (488)
Q Consensus 365 vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~ 435 (488)
++|+|||++...... .....++..|+|||.+... .++.++|||||||++|||++ |..||...... ..+..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 240 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence 999999999765332 1223467889999998765 57779999999999999999 88887654332 22233
Q ss_pred CCC-CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhhhhcC
Q 011331 436 GKL-PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYM 486 (488)
Q Consensus 436 ~~~-~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~~~~~ 486 (488)
+.. ..+...+..+.++|.+||+.+|++|||+.++++ .++.+.+...+++
T Consensus 241 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~--~l~~~~~~~~~~~ 290 (291)
T cd05094 241 GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK--ILHALGKATPIYL 290 (291)
T ss_pred CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH--HHHHHHhhcCccc
Confidence 333 233456889999999999999999999999988 4777766554443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.21 Aligned_cols=243 Identities=23% Similarity=0.351 Sum_probs=194.5
Q ss_pred ccceeEEEEecccCcEEEEEEEE-----cCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLK-----RIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++.+.||+|+||.||+|.+ ..++..||||.++... .......+..|+.+++++.+|+||+++++++...+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 34789999999999999999975 3356789999886542 23445678889999999978999999999999999
Q ss_pred eEEEEEecCCCC-chhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC
Q 011331 303 QLYIQMELCDHS-LSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN 377 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~ 377 (488)
.+|++|||+.++ +...... ..+++..++.++.||+.||.|||++||+|+||||+|||+ .++.++|+|||++....
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 999999999865 4332221 238999999999999999999999999999999999999 66789999999997653
Q ss_pred CCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhh-hcC-CCCCCCCCcH
Q 011331 378 KSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNL-RDG-KLPLLPGHSL 446 (488)
Q Consensus 378 ~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i-~~~-~~~~~~~~s~ 446 (488)
... ....++..|+|||.+... .++.++|||||||++|||++ |..|+..... +... ..+ ....+...+.
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPA 271 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCH
Confidence 321 122356789999998765 46779999999999999998 8888765332 2122 222 2233445689
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 447 QFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
++.++|.+||..+|++|||+.|++..
T Consensus 272 ~~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 272 EIYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=300.91 Aligned_cols=233 Identities=18% Similarity=0.250 Sum_probs=183.3
Q ss_pred EecccCcEEEEEEEEcC------------CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 236 QIGAGNFSHVFKVLKRI------------DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~------------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
.||+|+||+||+|.... ....||+|++... .......+..|+.++..+ +||||+++++++..+..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQV-SHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCC
Confidence 68999999999997532 2346889987543 223344577788888888 99999999999999999
Q ss_pred EEEEEecCCCCchhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC-------eEEEEeecC
Q 011331 304 LYIQMELCDHSLSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG-------VYKLGDFGR 372 (488)
Q Consensus 304 l~IV~E~~~~~l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g-------~vkL~DFGl 372 (488)
.+++|||++++.+... ....+++..++.++.||+.||+|||++||+||||||+|||+. ++ .++++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 9999999998755422 234589999999999999999999999999999999999994 33 389999999
Q ss_pred ceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHH-cCCCCCCCchh--hhhhhcCCCCCCCCCcHHHH
Q 011331 373 ATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELI-KGSPLSESGPQ--FLNLRDGKLPLLPGHSLQFQ 449 (488)
Q Consensus 373 A~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLl-tG~~p~~~~~~--~~~i~~~~~~~~~~~s~~l~ 449 (488)
+...... ....++..|+|||++.....++.++|||||||++|||+ +|..|+..... ...............+.++.
T Consensus 159 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd05077 159 PITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELA 237 (262)
T ss_pred CccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCChHHHH
Confidence 8755332 23457889999999875446778999999999999998 57777654322 12223333444444578899
Q ss_pred HHHHHcccCCCCCCCCHHHHHhC
Q 011331 450 NLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~H 472 (488)
+||.+||+.||.+||++.+|+++
T Consensus 238 ~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 238 DLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHcCCChhhCcCHHHHHHh
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.62 Aligned_cols=244 Identities=20% Similarity=0.307 Sum_probs=193.9
Q ss_pred ceeEEEEecccCcEEEEEEEEcC-----CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRI-----DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
+|++.+.||+|+||+||+|.+.. ....+|+|.+.... .......+..|+.++..+ +||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCCc
Confidence 47889999999999999998753 23679999876442 334456788999999998 899999999999999999
Q ss_pred EEEEecCCCCchhhh-h-------------------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcE
Q 011331 305 YIQMELCDHSLSDKK-A-------------------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNI 358 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~-~-------------------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NI 358 (488)
|++|||+.++.+... . ...+++..++.++.||+.||.|||+.||+|+||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 999999986543311 1 12477889999999999999999999999999999999
Q ss_pred EE-eCCeEEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh--
Q 011331 359 YV-KNGVYKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ-- 429 (488)
Q Consensus 359 Lv-~~g~vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~-- 429 (488)
|+ +++.++|+|||+++..... .....++..|+|||.+... .++.++||||||+++|||++ |..||.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99 6789999999999765321 1222456789999988655 57789999999999999998 8888765432
Q ss_pred hhhh-hc-CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 430 FLNL-RD-GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 430 ~~~i-~~-~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.... .. ...+.+..++.++.+||.+||+.+|++||+++|+++. |+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~--l~~~ 286 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE--LEKM 286 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH--HHHH
Confidence 1122 11 2334455678999999999999999999999999873 5443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=298.85 Aligned_cols=237 Identities=20% Similarity=0.300 Sum_probs=191.8
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|++.+.||+|+||.||+|.+. ++..+|+|++...... ...+..|+.+++.+ +|+||+++++++...+..|+|||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEEEe
Confidence 5789999999999999999886 5778999998654322 23577799999998 89999999999999999999999
Q ss_pred cCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC-CC-
Q 011331 310 LCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP-IE- 383 (488)
Q Consensus 310 ~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~-~~- 383 (488)
|++++ +..... ...+++..++.++.||+.||.|||+.||+|+||||+||++ .++.+||+|||+++....... ..
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99775 443222 2368899999999999999999999999999999999999 678999999999976543211 11
Q ss_pred --CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC-CCCCCCCCcHHHHHHHHHcc
Q 011331 384 --EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG-KLPLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 384 --~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~-~~~~~~~~s~~l~~lI~k~L 456 (488)
.++..|+|||.+... .++.++||||||+++|+|++ |..||...... ..+... ....+...+.++.+++.+||
T Consensus 160 ~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 238 (256)
T cd05059 160 GTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCW 238 (256)
T ss_pred CCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence 234579999998765 56779999999999999999 77887654321 222222 33445567999999999999
Q ss_pred cCCCCCCCCHHHHHhC
Q 011331 457 DPDPVQRPSAKELVEN 472 (488)
Q Consensus 457 ~~dP~~RpTa~elL~H 472 (488)
..+|++|||+.|+++.
T Consensus 239 ~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 239 HEKPEDRPAFKKLLSQ 254 (256)
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=294.65 Aligned_cols=236 Identities=24% Similarity=0.324 Sum_probs=194.9
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++.+.||.|+||.||+|... |+.||||.+..... ....+..|+.++..+ +|+||+++++++...+..|+||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEEEE
Confidence 47899999999999999999874 89999999875422 456788899999999 8999999999999999999999
Q ss_pred ecCCCC-chhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCC
Q 011331 309 ELCDHS-LSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIE 383 (488)
Q Consensus 309 E~~~~~-l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~ 383 (488)
||+.++ +...... ..+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||.+..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~ 159 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG 159 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccccC
Confidence 999864 4443222 258999999999999999999999999999999999999 57899999999998775444444
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCCCCCCCcHHHHHHHHHcccC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLPLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~~~~~~s~~l~~lI~k~L~~ 458 (488)
.++..|+|||.+... .++.++||||||+++|||++ |..||...... ..+.. .....+...+.++.++|.+||..
T Consensus 160 ~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (256)
T cd05039 160 KLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWEL 238 (256)
T ss_pred CCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhcc
Confidence 456789999998655 56679999999999999997 88887654321 11222 23334556789999999999999
Q ss_pred CCCCCCCHHHHHh
Q 011331 459 DPVQRPSAKELVE 471 (488)
Q Consensus 459 dP~~RpTa~elL~ 471 (488)
+|++|||+.|+++
T Consensus 239 ~p~~Rp~~~~l~~ 251 (256)
T cd05039 239 DPAKRPTFKQLRE 251 (256)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999987
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=301.55 Aligned_cols=239 Identities=23% Similarity=0.292 Sum_probs=192.9
Q ss_pred cceeEEEEecccCcEEEEEEEEc-----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
.+|...+.||+|+||.||+|... .++..+|+|.+... .......+..|++++..+ +|+||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVL-QHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCCc
Confidence 36788999999999999999643 35778999987643 344556788999999999 99999999999999999
Q ss_pred EEEEEecCCCCchh-hhhc----------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeE
Q 011331 304 LYIQMELCDHSLSD-KKAS----------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVY 365 (488)
Q Consensus 304 l~IV~E~~~~~l~~-~~~~----------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~v 365 (488)
.+++|||+.++.+. .... ..+++..++.++.||+.||+|||++||+|+||||+|||+ +++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence 99999999865333 2211 247889999999999999999999999999999999999 67899
Q ss_pred EEEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC
Q 011331 366 KLGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG 436 (488)
Q Consensus 366 kL~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~ 436 (488)
+|+|||++....... ....+++.|+|||.+... .++.++|||||||++|||++ |.+||...... ..+..+
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence 999999997653221 122356789999988765 57789999999999999998 88887654332 222222
Q ss_pred -CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 437 -KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 437 -~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
....+..++..+.++|.+||+.||.+||++++|++
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 241 RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 33445567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=301.28 Aligned_cols=240 Identities=22% Similarity=0.293 Sum_probs=192.7
Q ss_pred cceeEEEEecccCcEEEEEEEEc-----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
++|++++.||.|+||.||+|.+. .++..||+|++.... .......+..|+.++..+ +||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEF-DHPNIVKLLGVCAVGKP 82 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCc
Confidence 47899999999999999999874 367899999986542 233446688899999999 89999999999999999
Q ss_pred EEEEEecCCCC-chhhhhc-----------------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEE
Q 011331 304 LYIQMELCDHS-LSDKKAS-----------------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIY 359 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~~~~-----------------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NIL 359 (488)
+|++|||+.++ +...... ..+++..++.++.||+.||.|||++|++|+||||+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 99999999875 3332211 23678889999999999999999999999999999999
Q ss_pred E-eCCeEEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh--
Q 011331 360 V-KNGVYKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF-- 430 (488)
Q Consensus 360 v-~~g~vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~-- 430 (488)
+ .++.++|+|||++...... ......+..|+|||.+... .++.++|||||||++|||++ |..||......
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~ 241 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9 7789999999998765322 1122346679999998765 57789999999999999997 77777543321
Q ss_pred -hhhhcCC-CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 431 -LNLRDGK-LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 431 -~~i~~~~-~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
..+..+. .+.+...+.++.+||.+||+.+|++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 242 IYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 2222232 2345567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=296.55 Aligned_cols=236 Identities=24% Similarity=0.335 Sum_probs=191.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec-ccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF-ENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~-~~~~l~I 306 (488)
..+|++.+.||+|+||.||++.. .|..||+|.+... .....+..|+.+++.+ +|+||+++++++. .++..|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEE
Confidence 34789999999999999999976 4889999988643 2345678899999999 8999999998754 5667999
Q ss_pred EEecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC
Q 011331 307 QMELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP 381 (488)
Q Consensus 307 V~E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~ 381 (488)
+|||++++ +..... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.+||+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 157 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence 99999875 443222 2247889999999999999999999999999999999999 678999999999987654444
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCCCCCCcHHHHHHHHHcc
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~~~~~s~~l~~lI~k~L 456 (488)
...++..|+|||++... .++.++|||||||++|||++ |..|+..... ...+..+ ....++.++..+.++|.+||
T Consensus 158 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05082 158 TGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCW 236 (256)
T ss_pred CCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHh
Confidence 44566789999998765 57779999999999999997 8888764332 1122222 23345677899999999999
Q ss_pred cCCCCCCCCHHHHHh
Q 011331 457 DPDPVQRPSAKELVE 471 (488)
Q Consensus 457 ~~dP~~RpTa~elL~ 471 (488)
..+|++|||+.++++
T Consensus 237 ~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 237 HLDAATRPSFLQLRE 251 (256)
T ss_pred cCChhhCcCHHHHHH
Confidence 999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=339.59 Aligned_cols=242 Identities=21% Similarity=0.285 Sum_probs=193.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++++.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..+ +||||+++++++.+++..|++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEE
Confidence 4789999999999999999999999999999998754322 33456688999999999 899999999999999999999
Q ss_pred EecCCCCchh-hhh------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCc
Q 011331 308 MELCDHSLSD-KKA------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRA 373 (488)
Q Consensus 308 ~E~~~~~l~~-~~~------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA 373 (488)
|||++++.+. ... ...++...++.++.||+.||+|||++||+||||||+|||+ .+|.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999876433 111 1234566788999999999999999999999999999999 6789999999999
Q ss_pred eecCCC---------------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh
Q 011331 374 TLLNKS---------------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN 432 (488)
Q Consensus 374 ~~~~~~---------------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~ 432 (488)
+..... .....||+.|+|||++.+. .++.++|||||||++|||++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 765210 0123589999999998765 577899999999999999999999876433211
Q ss_pred hhcC----C--CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 433 LRDG----K--LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 433 i~~~----~--~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
.... . ......++..+.+++.+||..||++|++..+.+.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1111 1 11123578899999999999999999876665544
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=300.90 Aligned_cols=237 Identities=31% Similarity=0.481 Sum_probs=187.8
Q ss_pred eEEEEecccCcEEEEEEEEc----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 232 HEIEQIGAGNFSHVFKVLKR----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.+.+.||.|.||.||+|... ..+..|+||++... ........+..|++.+.++ +||||+++++++...+.+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccc-ccccccccccccccccccccc
Confidence 46789999999999999887 45788999999543 3444577899999999999 999999999999988889999
Q ss_pred EecCCCC-chhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---
Q 011331 308 MELCDHS-LSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 308 ~E~~~~~-l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--- 379 (488)
|||+.++ |...... ..+++..++.++.||+.||.|||+++++|++|+++||++ .++.+||+|||++......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999865 4443332 469999999999999999999999999999999999999 5789999999999877321
Q ss_pred --CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC-CCCCCCCCcHHHHHHH
Q 011331 380 --LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG-KLPLLPGHSLQFQNLL 452 (488)
Q Consensus 380 --~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~-~~~~~~~~s~~l~~lI 452 (488)
.....+...|+|||.+... .++.++||||||+++|||++ |..|+...... ..+..+ ..+.+..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 1223466789999998765 47789999999999999999 66777654332 223333 3445567899999999
Q ss_pred HHcccCCCCCCCCHHHHHh
Q 011331 453 KVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~ 471 (488)
..||..||++|||+.++++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=295.91 Aligned_cols=240 Identities=22% Similarity=0.306 Sum_probs=194.5
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCe---EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGC---FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
++|+..+.||+|+||.||+|.+..++. .+|+|.+.... .......+..|+.++..+ +|+||+++++++...+..|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCcE
Confidence 367889999999999999999876654 79999886542 334456788899999998 8999999999999999999
Q ss_pred EEEecCCCCchh-hh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC
Q 011331 306 IQMELCDHSLSD-KK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP 381 (488)
Q Consensus 306 IV~E~~~~~l~~-~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~ 381 (488)
+||||++++.+. .. ....+++..+..++.|++.||.|||+.|++|+||||+||++ .++.++|+|||++........
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999876544 22 23468999999999999999999999999999999999999 678999999999976643211
Q ss_pred C------CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHHH
Q 011331 382 I------EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQN 450 (488)
Q Consensus 382 ~------~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~~ 450 (488)
. ...+..|+|||++... .++.++|||||||++|||++ |..||..... ...+.. ...+.+...+.++.+
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 241 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQ 241 (268)
T ss_pred cceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 1 1134579999998765 56789999999999999997 8988865432 222222 233445567899999
Q ss_pred HHHHcccCCCCCCCCHHHHHh
Q 011331 451 LLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~ 471 (488)
++.+||..+|++||++.++++
T Consensus 242 li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 242 LMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=298.91 Aligned_cols=239 Identities=23% Similarity=0.336 Sum_probs=196.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
..+|++++.||.|+||.||+|.+.. +..+|+|++.... ......+..|+.+++.+ +|+||+++++++...+.+++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEEE
Confidence 3578999999999999999999986 9999999986532 22345678899999999 899999999999999999999
Q ss_pred EecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 308 MELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 308 ~E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
|||++++ +..... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999874 444322 2458899999999999999999999999999999999999 67899999999997664321
Q ss_pred -CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHHHHHHH
Q 011331 381 -PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 381 -~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~~lI~k 454 (488)
....++..|+|||.+... .++.++||||||+++|+|++ |..|+..... +..+.. ...+.+...+..+.++|.+
T Consensus 161 ~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLE 239 (261)
T ss_pred ccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHH
Confidence 122356789999998765 57779999999999999998 7888765432 222222 2345566789999999999
Q ss_pred cccCCCCCCCCHHHHHh
Q 011331 455 MVDPDPVQRPSAKELVE 471 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~ 471 (488)
||..||.+|||+.++++
T Consensus 240 ~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 240 CWAAEPEDRPSFKALRE 256 (261)
T ss_pred HcCCCchhCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=303.05 Aligned_cols=248 Identities=21% Similarity=0.352 Sum_probs=195.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEc-------CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKR-------IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
..+|++.+.||+|+||.||+|.+. .++..||+|.+... ........+..|+.++..+.+||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 347899999999999999999753 23568999988643 2334456788999999998789999999999999
Q ss_pred cceEEEEEecCCCC-chhhhh-----------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-e
Q 011331 301 NEQLYIQMELCDHS-LSDKKA-----------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-K 361 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~~~~-----------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~ 361 (488)
...+|++|||+.++ |..... ...++...++.++.||+.||.|||++||+|+||||+||++ .
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~ 172 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE 172 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC
Confidence 99999999999875 333211 1247778899999999999999999999999999999999 6
Q ss_pred CCeEEEEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhh
Q 011331 362 NGVYKLGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLN 432 (488)
Q Consensus 362 ~g~vkL~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~ 432 (488)
++.++|+|||+++...... ....++..|+|||++... .++.++||||||+++|+|++ |..|+..... ...
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 251 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 7899999999998764321 122356789999998765 46779999999999999998 6666654322 112
Q ss_pred hhcC-CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 433 LRDG-KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 433 i~~~-~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+... ....+...+.++.+||.+||..+|.+|||+.|++.. ++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~--l~~~~ 297 (304)
T cd05101 252 LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED--LDRIL 297 (304)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH--HHHHH
Confidence 2222 223445678999999999999999999999999985 55443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=299.91 Aligned_cols=246 Identities=20% Similarity=0.292 Sum_probs=191.6
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCe----EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGC----FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.+|++++.||.|+||+||+|.+..+|. .|++|.+... ........+..|+.++..+ +||||+++++++. ....
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSL-DHAYIVRLLGICP-GASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcC-CCCCcceEEEEEC-CCcc
Confidence 478999999999999999999987776 4677776432 1223345677788888888 8999999999875 4557
Q ss_pred EEEEecCCCC-chhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 305 YIQMELCDHS-LSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
++++||+.++ +.... ....+++..++.++.||+.||.|||++|++|+||||+|||+ .++.+||+|||+++.....
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 8899999765 44432 23468999999999999999999999999999999999999 5788999999999865322
Q ss_pred ----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh--hh-hhcCC-CCCCCCCcHHHHH
Q 011331 380 ----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF--LN-LRDGK-LPLLPGHSLQFQN 450 (488)
Q Consensus 380 ----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~--~~-i~~~~-~~~~~~~s~~l~~ 450 (488)
.....++..|+|||.+... .++.++|||||||++|||++ |..|+...... .. +..+. .+.+...+..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYM 242 (279)
T ss_pred cccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHH
Confidence 1223467789999998765 57789999999999999998 88888654322 22 22222 3334456788999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
++.+||..||++|||+.|+++. |..+.+
T Consensus 243 li~~c~~~~p~~Rps~~el~~~--l~~~~~ 270 (279)
T cd05111 243 VMVKCWMIDENVRPTFKELANE--FTRMAR 270 (279)
T ss_pred HHHHHcCCCcccCcCHHHHHHH--HHHHHh
Confidence 9999999999999999999884 555443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=296.37 Aligned_cols=237 Identities=23% Similarity=0.326 Sum_probs=191.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||.||+|... ++..||+|.+..... ....+..|+.+++++ +|+||+++++++. .+..|++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQL-QHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhc-CCcCeeeEEEEEc-cCCcEEE
Confidence 457899999999999999999865 678899999875432 234678899999999 8999999998864 5678999
Q ss_pred EecCCCC-chhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 308 MELCDHS-LSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 308 ~E~~~~~-l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
|||+.++ +.... ....+++..++.++.||+.||+|||+.|++|+||||+||++ .++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999765 44322 22358889999999999999999999999999999999999 67899999999997765221
Q ss_pred --CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC-CCCCCCCCcHHHHHHHH
Q 011331 381 --PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG-KLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~-~~~~~~~~s~~l~~lI~ 453 (488)
....++..|+|||++... .++.++||||||+++|||++ |.+||...... ..+..+ ..+.+...+.++.++|.
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMR 237 (260)
T ss_pred cccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 123456789999998765 46779999999999999998 88888654331 122222 33455567889999999
Q ss_pred HcccCCCCCCCCHHHHHh
Q 011331 454 VMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~ 471 (488)
+||..+|++|||++++++
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 238 LCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHccCChhhCCCHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.02 Aligned_cols=246 Identities=21% Similarity=0.304 Sum_probs=192.4
Q ss_pred cceeEEEEecccCcEEEEEEEE-----cCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-cc
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLK-----RIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE-NE 302 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-~~ 302 (488)
++|++++.||+|+||+||+|.+ ..+++.||||+++... .......+..|+.++.++.+|+||+++++++.. +.
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 4689999999999999999984 3467899999987543 233456788899999999889999999998765 45
Q ss_pred eEEEEEecCCCCchh-hhh-------------------------------------------------------------
Q 011331 303 QLYIQMELCDHSLSD-KKA------------------------------------------------------------- 320 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~-~~~------------------------------------------------------------- 320 (488)
.++++||||+++.+. ...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 689999999875332 111
Q ss_pred -------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-----CCCCCCC
Q 011331 321 -------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-----PIEEGDA 387 (488)
Q Consensus 321 -------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-----~~~~Gt~ 387 (488)
...++...+..++.||+.||.|||++||+||||||+|||+ .++.++|+|||++....... ....++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 1236777889999999999999999999999999999999 67899999999997653211 1223567
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh----hhhhhcC-CCCCCCCCcHHHHHHHHHcccCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ----FLNLRDG-KLPLLPGHSLQFQNLLKVMVDPDPV 461 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~----~~~i~~~-~~~~~~~~s~~l~~lI~k~L~~dP~ 461 (488)
.|+|||++... .++.++|||||||++|+|++ |..|+..... ...+..+ ..+.+...+.++.+++.+||+.||+
T Consensus 246 ~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~ 324 (343)
T cd05103 246 KWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 324 (343)
T ss_pred ceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 79999998665 57789999999999999996 8877754321 1122222 2334445678999999999999999
Q ss_pred CCCCHHHHHhChhhhhh
Q 011331 462 QRPSAKELVENPIFDKI 478 (488)
Q Consensus 462 ~RpTa~elL~HP~f~~i 478 (488)
+|||+.||++| ++.+
T Consensus 325 ~Rps~~eil~~--l~~~ 339 (343)
T cd05103 325 QRPTFSELVEH--LGNL 339 (343)
T ss_pred hCcCHHHHHHH--HHHH
Confidence 99999999987 5544
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.40 Aligned_cols=240 Identities=18% Similarity=0.211 Sum_probs=188.9
Q ss_pred cceeEEEEecccCcEEEEEEEEcCC--------------CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEe
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRID--------------GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGY 294 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~--------------g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l 294 (488)
.+|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|++++.++ +|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l-~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRL-KNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCCcCeE
Confidence 4789999999999999999987543 2359999987542 334456788999999999 99999999
Q ss_pred eeeecccceEEEEEecCCCCchh-hhhc-------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE
Q 011331 295 YSSWFENEQLYIQMELCDHSLSD-KKAS-------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV 360 (488)
Q Consensus 295 ~~~~~~~~~l~IV~E~~~~~l~~-~~~~-------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv 360 (488)
++++...+..++||||+.++.+. .... ..+++..++.++.||+.||.|||++|++|+||||+||++
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 99999999999999999875333 2111 136788899999999999999999999999999999999
Q ss_pred -eCCeEEEEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc--CCCCCCCchhhh-
Q 011331 361 -KNGVYKLGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK--GSPLSESGPQFL- 431 (488)
Q Consensus 361 -~~g~vkL~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt--G~~p~~~~~~~~- 431 (488)
+++.+||+|||++....... ....++..|+|||++... .++.++|||||||++|+|++ |..||.......
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 67799999999997653221 122356789999998765 57789999999999999998 556665432211
Q ss_pred --hh--------hcCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 432 --NL--------RDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 432 --~i--------~~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
.+ .......++..+..+.+||.+||+.||++|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11 01112334557889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=295.77 Aligned_cols=237 Identities=22% Similarity=0.285 Sum_probs=190.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||.||+|.+. .+..||+|.+...... ...+.+|+.+++++ +|+||+++++++. .+..|++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKL-RHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhc-CCCceEEEEeEEC-CCCcEEE
Confidence 357899999999999999999876 6677999998754332 34578899999999 8999999998875 4568999
Q ss_pred EecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC-
Q 011331 308 MELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP- 381 (488)
Q Consensus 308 ~E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~- 381 (488)
|||+.++ +..... ...+++..++.++.||+.||.|||++||+|+||||+||++ +++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999875 433322 2348899999999999999999999999999999999999 567899999999986643221
Q ss_pred ---CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHHHHHH
Q 011331 382 ---IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 382 ---~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~~lI~ 453 (488)
...++..|+|||.+... .++.++||||||+++|+|++ |.+||..... ...+.. ...+.+...+..+.+||.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML 237 (260)
T ss_pred cccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 12355679999988654 57789999999999999999 7788765332 222222 244456677899999999
Q ss_pred HcccCCCCCCCCHHHHHh
Q 011331 454 VMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~ 471 (488)
+||..+|.+|||++++++
T Consensus 238 ~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 238 QCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHcccCcccCcCHHHHHH
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=297.02 Aligned_cols=226 Identities=20% Similarity=0.290 Sum_probs=183.5
Q ss_pred cCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCCch-hh
Q 011331 240 GNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSLS-DK 318 (488)
Q Consensus 240 G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~l~-~~ 318 (488)
|.+|.||+|++..+|+.||+|.+.... ....|...+... .||||+++++++.+.+..|++|||+.++.+ ..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999986432 122334444444 699999999999999999999999987543 32
Q ss_pred -hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCCCCCCccChhhhc
Q 011331 319 -KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILN 396 (488)
Q Consensus 319 -~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~ 396 (488)
.....+++..+..++.||+.||.|||++||+|+||||+||++ .++.++++|||++...........++..|+|||.+.
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGG 155 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccC
Confidence 333468999999999999999999999999999999999999 678999999998876655544556777899999886
Q ss_pred ccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCCCH-----HHHHh
Q 011331 397 EDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSA-----KELVE 471 (488)
Q Consensus 397 ~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa-----~elL~ 471 (488)
.. .++.++||||+||++|||++|..++....... ........++.++.++.++|.+||+.||++||++ +++++
T Consensus 156 ~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 233 (237)
T cd05576 156 IS-EETEACDWWSLGAILFELLTGKTLVECHPSGI-NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKS 233 (237)
T ss_pred CC-CCCchhhHHHHHHHHHHHHHCcchhhcCchhc-ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHc
Confidence 54 46779999999999999999997765332211 1111233556678999999999999999999985 99999
Q ss_pred Chhh
Q 011331 472 NPIF 475 (488)
Q Consensus 472 HP~f 475 (488)
||||
T Consensus 234 h~~~ 237 (237)
T cd05576 234 HPFF 237 (237)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=303.17 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=196.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcC-------CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRI-------DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
..+|.+++.||+|+||.||+|.+.. .+..||+|.+.... .......+..|+.++..+.+||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3478999999999999999997632 35679999886532 344456788899999998779999999999999
Q ss_pred cceEEEEEecCCCCchh-hhh-----------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-e
Q 011331 301 NEQLYIQMELCDHSLSD-KKA-----------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-K 361 (488)
Q Consensus 301 ~~~l~IV~E~~~~~l~~-~~~-----------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~ 361 (488)
++.+|++|||+.++.+. ... ...++...+..++.||+.||.|||++||+|+||||+|||+ .
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 99999999999875333 221 1347888999999999999999999999999999999999 6
Q ss_pred CCeEEEEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhh
Q 011331 362 NGVYKLGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLN 432 (488)
Q Consensus 362 ~g~vkL~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~ 432 (488)
++.+||+|||+++...... ....++..|+|||++... .++.++|||||||++|||++ |..||..... +..
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 7899999999997654211 112244679999998765 57779999999999999999 7777765432 222
Q ss_pred hhcCC-CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 433 LRDGK-LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 433 i~~~~-~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+..+. ...+..++.++.++|.+||..+|++|||+.++++. ++.+.
T Consensus 249 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~--l~~~~ 294 (314)
T cd05099 249 LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA--LDKVL 294 (314)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH--HHHHH
Confidence 22222 33455678899999999999999999999999973 55544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=295.71 Aligned_cols=236 Identities=22% Similarity=0.275 Sum_probs=188.7
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.+|++.+.||+|+||+||+|.+..+ ..||+|++...... ...+..|++++..+ +|+||+++++.+. ....|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~ 79 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYIVT 79 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhC-CCCCcceEEEEEC-CCCcEEEE
Confidence 4689999999999999999988655 46999998753322 24578899999998 8999999998875 45689999
Q ss_pred ecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC--
Q 011331 309 ELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP-- 381 (488)
Q Consensus 309 E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~-- 381 (488)
||+.++ +..... ...+++..++.++.||+.||.|||+.||+|+||||+||++ .++.++|+|||+++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999875 443322 2347889999999999999999999999999999999999 678999999999986643221
Q ss_pred --CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHHHHHHH
Q 011331 382 --IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 382 --~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~~lI~k 454 (488)
...++..|+|||++... .++.++|||||||++|||++ |..||..... ...+.. ...+....++..+.++|.+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred ccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 22356789999988655 56789999999999999999 7777765432 112222 2344556788999999999
Q ss_pred cccCCCCCCCCHHHHHh
Q 011331 455 MVDPDPVQRPSAKELVE 471 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~ 471 (488)
||+.||++|||+.++++
T Consensus 239 ~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 239 CWRKEPEERPTFEYLQA 255 (262)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=301.67 Aligned_cols=240 Identities=19% Similarity=0.239 Sum_probs=189.4
Q ss_pred cceeEEEEecccCcEEEEEEEEcC----------------CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCee
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRI----------------DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIV 292 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~----------------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv 292 (488)
++|++.+.||+|+||+||+|.+.. ++..||+|++.... .......+..|+.+++.+ +|+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l-~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRL-KDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhC-CCCCcc
Confidence 468999999999999999986432 34579999986542 234456788999999999 899999
Q ss_pred EeeeeecccceEEEEEecCCCC-chhhhhc------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEE
Q 011331 293 GYYSSWFENEQLYIQMELCDHS-LSDKKAS------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIY 359 (488)
Q Consensus 293 ~l~~~~~~~~~l~IV~E~~~~~-l~~~~~~------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NIL 359 (488)
++++++...+..|++|||+.++ +...... ..+++..++.++.||+.||+|||++||+|+||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 9999999999999999999765 3332211 23667789999999999999999999999999999999
Q ss_pred E-eCCeEEEEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc--CCCCCCCchhhh
Q 011331 360 V-KNGVYKLGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK--GSPLSESGPQFL 431 (488)
Q Consensus 360 v-~~g~vkL~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt--G~~p~~~~~~~~ 431 (488)
+ .++.++|+|||+++.+.... ....++..|+|||+.... .++.++|||||||++|||++ |..|+.......
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9 67899999999997653221 122346789999987655 57789999999999999998 667775432211
Q ss_pred hh-----------hcCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 432 NL-----------RDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 432 ~i-----------~~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
.+ .....+.+..++..+.+||.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11 11223445567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=300.63 Aligned_cols=233 Identities=16% Similarity=0.199 Sum_probs=182.7
Q ss_pred EecccCcEEEEEEEEcCC------------------------CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCe
Q 011331 236 QIGAGNFSHVFKVLKRID------------------------GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENI 291 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~~------------------------g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnI 291 (488)
+||+|+||.||+|....+ ...||+|++... .......+..|+.++..+ +||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l-~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQV-SHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcC-CCCCe
Confidence 599999999999975322 245889987532 222345577788888887 89999
Q ss_pred eEeeeeecccceEEEEEecCCCCchhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeC------
Q 011331 292 VGYYSSWFENEQLYIQMELCDHSLSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKN------ 362 (488)
Q Consensus 292 v~l~~~~~~~~~l~IV~E~~~~~l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~------ 362 (488)
+++++++..+...|+||||++++.+... ..+.+++.++..++.||+.||+|||++||+||||||+|||++.
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999998755422 2356899999999999999999999999999999999999942
Q ss_pred --CeEEEEeecCceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHH-cCCCCCCCchhh--hhhhcCC
Q 011331 363 --GVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELI-KGSPLSESGPQF--LNLRDGK 437 (488)
Q Consensus 363 --g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLl-tG~~p~~~~~~~--~~i~~~~ 437 (488)
..++++|||++...... ....++..|+|||.+.....++.++|||||||++|||+ +|..|+...... .......
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 237 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKK 237 (274)
T ss_pred ccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhc
Confidence 24899999988654322 23457888999998876545778999999999999984 688887654322 1222233
Q ss_pred CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 438 LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 438 ~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
...+...+.++.++|.+||+.+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 238 HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 34444566789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=306.91 Aligned_cols=246 Identities=21% Similarity=0.336 Sum_probs=194.9
Q ss_pred cceeEEEEecccCcEEEEEEEEcCC-------CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRID-------GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN 301 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~ 301 (488)
.+|++++.||+|+||.||+|.+... +..||+|++... ........+..|+.++.++.+|+||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3689999999999999999986432 347899987643 23445567889999999997899999999999999
Q ss_pred ceEEEEEecCCCC-chhhhh-----------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eC
Q 011331 302 EQLYIQMELCDHS-LSDKKA-----------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KN 362 (488)
Q Consensus 302 ~~l~IV~E~~~~~-l~~~~~-----------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~ 362 (488)
+.+|++|||+.++ |..... ...++...+..++.||+.||.|||++||+|+||||+|||+ .+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 9999999999775 333221 1236778889999999999999999999999999999999 67
Q ss_pred CeEEEEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhh
Q 011331 363 GVYKLGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNL 433 (488)
Q Consensus 363 g~vkL~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i 433 (488)
+.++|+|||+++...... ....++..|+|||++... .++.++|||||||++|||++ |..||..... ...+
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 249 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 249 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 899999999998664321 112245679999998765 56779999999999999998 7777754332 1122
Q ss_pred hc-CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 434 RD-GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 434 ~~-~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.. .....+...+.++.++|.+||+.+|.+|||+.|++++ |+.+
T Consensus 250 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~--l~~~ 293 (334)
T cd05100 250 KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED--LDRV 293 (334)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH--HHHH
Confidence 22 2334455678899999999999999999999999987 4444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=295.97 Aligned_cols=240 Identities=22% Similarity=0.310 Sum_probs=194.2
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCC---eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDG---CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.+|++++.||+|+||.||+|.+..++ ..||+|.++... .......+..|+.++..+ +||||+++++++..++..|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccE
Confidence 36889999999999999999886544 379999886543 344556788899999998 8999999999999999999
Q ss_pred EEEecCCCCchh-hhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC
Q 011331 306 IQMELCDHSLSD-KKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP 381 (488)
Q Consensus 306 IV~E~~~~~l~~-~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~ 381 (488)
+||||++++.+. ... ...+++..++.++.||+.||.|||+.|++|+||||+|||+ .++.++|+|||++........
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999876443 222 2357899999999999999999999999999999999999 678999999999976543211
Q ss_pred ------CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCCCCCCcHHHHH
Q 011331 382 ------IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPLLPGHSLQFQN 450 (488)
Q Consensus 382 ------~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~~~~~s~~l~~ 450 (488)
...++..|+|||.+... .++.++|+|||||++||+++ |..||..... ...+.++ ..+.+..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ 240 (267)
T ss_pred eeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHH
Confidence 11234679999998765 46789999999999999886 9988865432 2223322 33455567899999
Q ss_pred HHHHcccCCCCCCCCHHHHHh
Q 011331 451 LLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~ 471 (488)
++.+||+.+|.+||++.++++
T Consensus 241 li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 241 LMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHcccCchhCCCHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=295.88 Aligned_cols=241 Identities=23% Similarity=0.301 Sum_probs=195.7
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCe---EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGC---FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.+|++.+.||+|+||.||+|.+..++. .||||++.... .......+..|+.++..+ +||||+++++++..++.++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCceE
Confidence 468999999999999999999887665 69999986542 344567788999999998 9999999999999999999
Q ss_pred EEEecCCCCchh-hh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC
Q 011331 306 IQMELCDHSLSD-KK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP 381 (488)
Q Consensus 306 IV~E~~~~~l~~-~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~ 381 (488)
+||||++++.+. .. ..+.+++..++.++.|++.||.|||++|++|+||||+||++ .++.++|+|||++........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999876443 22 23458899999999999999999999999999999999999 668999999999876533211
Q ss_pred --C----CC--CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhh-cCCCCCCCCCcHHH
Q 011331 382 --I----EE--GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLR-DGKLPLLPGHSLQF 448 (488)
Q Consensus 382 --~----~~--Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~-~~~~~~~~~~s~~l 448 (488)
. .. .+..|+|||.+... .++.++|||||||++|||++ |..||...... ..+. ....+.++.++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 240 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTAL 240 (269)
T ss_pred ccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHH
Confidence 1 11 13479999998765 57789999999999999886 88888654332 1222 22445566788999
Q ss_pred HHHHHHcccCCCCCCCCHHHHHhC
Q 011331 449 QNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 449 ~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
.+++.+||..+|.+||++++++..
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 241 HQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=300.72 Aligned_cols=239 Identities=23% Similarity=0.296 Sum_probs=190.1
Q ss_pred eeEEEEecccCcEEEEEEEE----cCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc--ceE
Q 011331 231 FHEIEQIGAGNFSHVFKVLK----RIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN--EQL 304 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~----~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~--~~l 304 (488)
|++++.||+|+||.||+|.. ..++..||+|.+... ........+.+|+.+++.+ +|+||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCce
Confidence 68999999999999999974 456889999998644 2334456788999999999 999999999988775 568
Q ss_pred EEEEecCCCCchh-hhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 305 YIQMELCDHSLSD-KKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 305 ~IV~E~~~~~l~~-~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
++||||++++.+. ... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||+++......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999776444 222 2358899999999999999999999999999999999999 67899999999998664321
Q ss_pred ------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-----------------h-hhhh-c
Q 011331 381 ------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-----------------F-LNLR-D 435 (488)
Q Consensus 381 ------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-----------------~-~~i~-~ 435 (488)
....++..|+|||++.+. .++.++|||||||++|||+++..+...... . ..+. .
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 123467789999998765 577799999999999999998755322110 0 0011 1
Q ss_pred CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 436 GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 436 ~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
...+.+..++..+.+||.+||+.+|.+|||+++++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2234456678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=300.52 Aligned_cols=233 Identities=21% Similarity=0.314 Sum_probs=184.2
Q ss_pred EecccCcEEEEEEEEcCCCeE-------EEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 236 QIGAGNFSHVFKVLKRIDGCF-------YAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~~g~~-------vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.||.|+||+||+|.+...+.. ||+|.+... .......+..|+.++..+ +||||+++++++..+...++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEEEE
Confidence 589999999999988665543 888876532 123334577788888887 8999999999999999999999
Q ss_pred ecCCCCchh-hhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC--------eEEEEeecCceec
Q 011331 309 ELCDHSLSD-KKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG--------VYKLGDFGRATLL 376 (488)
Q Consensus 309 E~~~~~l~~-~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g--------~vkL~DFGlA~~~ 376 (488)
||++++.+. ... ...+++..++.++.||+.||+|||++||+||||||+||+++ ++ .++++|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 999886544 222 23588999999999999999999999999999999999993 33 2799999998755
Q ss_pred CCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCC-CCCCCchhh--hhhhcCCCCCCCCCcHHHHHHHH
Q 011331 377 NKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQF--LNLRDGKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 377 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~-~p~~~~~~~--~~i~~~~~~~~~~~s~~l~~lI~ 453 (488)
.. .....++..|+|||++.....++.++|||||||++|||++|. +|+...... ..+.......+...+.++.++|.
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (258)
T cd05078 159 LP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLIN 237 (258)
T ss_pred CC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHHHHH
Confidence 33 233468889999999976545677999999999999999995 554443332 22233344555567789999999
Q ss_pred HcccCCCCCCCCHHHHHhC
Q 011331 454 VMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~H 472 (488)
+||+.||++|||++++++.
T Consensus 238 ~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 238 QCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHhccChhhCCCHHHHHHh
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=291.98 Aligned_cols=238 Identities=24% Similarity=0.312 Sum_probs=194.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++.+.||.|+||+||+|.+. .+..||||.+..... ....+..|+.+++.+ +|+||+++++++......+++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCceEEE
Confidence 457899999999999999999876 567899999874332 235578899999998 899999999999998999999
Q ss_pred EecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 308 MELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 308 ~E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
|||++++ +..... ...+++..+..++.||+.||.|||++|++|+||||+||++ +++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999875 443322 2358899999999999999999999999999999999999 67899999999998764321
Q ss_pred --CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHHHHHH
Q 011331 381 --PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~~lI~ 453 (488)
....++..|+|||.+.+. ..+.++|||||||++|+|++ |..||..... ...+.. ...+.+...+.++.+++.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLML 238 (261)
T ss_pred hhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 112245689999998765 57789999999999999998 8888765433 222222 234556677899999999
Q ss_pred HcccCCCCCCCCHHHHHh
Q 011331 454 VMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~ 471 (488)
+||..+|++||+++++++
T Consensus 239 ~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 239 QCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHcccCcccCCCHHHHHH
Confidence 999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=296.45 Aligned_cols=240 Identities=29% Similarity=0.401 Sum_probs=188.6
Q ss_pred cceeEEEEecccCcEEEEEEE----EcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc--cc
Q 011331 229 TDFHEIEQIGAGNFSHVFKVL----KRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE--NE 302 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~--~~ 302 (488)
.+|++++.||+|+||+||+|. +..++..||||.+... .......+..|++++..+ +||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCC
Confidence 368899999999999999997 3457899999998643 334456688899999998 89999999987653 45
Q ss_pred eEEEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 303 QLYIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
.+++||||+.++ |..... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999765 443322 2358899999999999999999999999999999999999 678999999999987643
Q ss_pred CCC------CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh------------------hhhh
Q 011331 379 SLP------IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF------------------LNLR 434 (488)
Q Consensus 379 ~~~------~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~------------------~~i~ 434 (488)
... ...++..|+|||++.+. .++.++|||||||++|||++|..++...... ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 221 11234569999998765 5778999999999999999987654322110 0111
Q ss_pred --cCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 435 --DGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 435 --~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
....+.+...+.++.+||.+||..+|++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 12234455678899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=293.67 Aligned_cols=233 Identities=19% Similarity=0.241 Sum_probs=185.5
Q ss_pred EecccCcEEEEEEEEc--CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 236 QIGAGNFSHVFKVLKR--IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~--~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
.||+|+||.||+|.+. ..+..||+|++.... .......+.+|+.+++++ +|+||+++++++. ...+++||||+.+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQL-DNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999999765 446679999986542 233445688999999998 9999999999875 4578999999987
Q ss_pred Cchh-hh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC------CCC
Q 011331 314 SLSD-KK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL------PIE 383 (488)
Q Consensus 314 ~l~~-~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~------~~~ 383 (488)
+.+. .. ....+++..++.++.||+.||.|||++|++|+||||+||++ .++.++|+|||++....... ...
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 6444 22 23468999999999999999999999999999999999999 67889999999997553221 112
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCCCCCCCcHHHHHHHHHcccC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLPLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~~~~~~s~~l~~lI~k~L~~ 458 (488)
.++..|+|||.+... .++.++|||||||++|||++ |..||...... ..+.. .....++..+.++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 235689999998765 46779999999999999996 88888754331 12222 23445567799999999999999
Q ss_pred CCCCCCCHHHHHhC
Q 011331 459 DPVQRPSAKELVEN 472 (488)
Q Consensus 459 dP~~RpTa~elL~H 472 (488)
+|++||++.++++.
T Consensus 238 ~~~~Rp~~~~i~~~ 251 (257)
T cd05115 238 KWEDRPNFAKVEER 251 (257)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=335.47 Aligned_cols=240 Identities=25% Similarity=0.315 Sum_probs=197.9
Q ss_pred cceeEEEEecccCcEEEEEEEEcC-----CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRI-----DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
.+....+.||+|.||+||+|+... +...||||.++.. .....+++|.+|+..++.+ +|||||+|+|+|..++.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAEL-QHPNIVRLLGVCREGDP 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCCe
Confidence 356678899999999999996643 3468999999765 3445678999999999999 99999999999999999
Q ss_pred EEEEEecCCCCchh-hh-----------hcc----cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEE
Q 011331 304 LYIQMELCDHSLSD-KK-----------ASQ----FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYK 366 (488)
Q Consensus 304 l~IV~E~~~~~l~~-~~-----------~~~----~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vk 366 (488)
+|+|+|||.++.+. .. ... .++..+.+.++.||+.|+.||-++.+|||||-.+|+|| .+-.||
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence 99999999876443 11 112 28889999999999999999999999999999999999 556899
Q ss_pred EEeecCceecCCCCCCC-----CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhhh---hhhcC-
Q 011331 367 LGDFGRATLLNKSLPIE-----EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQFL---NLRDG- 436 (488)
Q Consensus 367 L~DFGlA~~~~~~~~~~-----~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~~---~i~~~- 436 (488)
|+|||+++.+=...-.. .-+.+|||||.+..+ .+++++|||||||+|||+++ |..|+++-.... .+..+
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 99999998653322222 236799999999887 68899999999999999998 667776544332 23333
Q ss_pred CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 437 KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 437 ~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
.++.|..++.++++||..||+.+|.+||++.||-.
T Consensus 723 lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 723 LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 46778899999999999999999999999999853
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=290.44 Aligned_cols=237 Identities=26% Similarity=0.331 Sum_probs=192.9
Q ss_pred eEEEEecccCcEEEEEEEEcCCC----eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDG----CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g----~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++.+.||.|+||.||+|.+..++ ..||+|++..... ......+..|+..+..+ +|+||+++++++.+.+..|++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEEE
Confidence 56788999999999999998766 8999999865432 22556788899999999 999999999999999999999
Q ss_pred EecCCCC-chhhhhc-cc--CCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC-
Q 011331 308 MELCDHS-LSDKKAS-QF--FAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP- 381 (488)
Q Consensus 308 ~E~~~~~-l~~~~~~-~~--l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~- 381 (488)
|||+.++ +...... .. +++..++.++.||+.||+|||+.|++|+||||+||++ .++.++|+|||++........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999775 4333222 22 8999999999999999999999999999999999999 567899999999986653311
Q ss_pred ---CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHHHHHH
Q 011331 382 ---IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 382 ---~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~~lI~ 453 (488)
...++..|+|||.+... .++.++||||||+++|+|++ |.+|+..... ...+.. .....+...+.++.+++.
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLML 238 (258)
T ss_pred ccccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence 12367899999998554 56789999999999999998 6777764322 122222 233445567899999999
Q ss_pred HcccCCCCCCCCHHHHHh
Q 011331 454 VMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~ 471 (488)
+||..||++|||+.|+++
T Consensus 239 ~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 239 QCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHCcCChhhCcCHHHHHh
Confidence 999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=304.65 Aligned_cols=247 Identities=27% Similarity=0.431 Sum_probs=201.6
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc--------c
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE--------N 301 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~--------~ 301 (488)
.|.-+.+||+|.||+||+|+...+|+.||+|++.........-..+++|+.+|..+ .|+|++.++++|.. .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCccccc
Confidence 46678899999999999999999999999997643322333346688999999999 99999999988763 3
Q ss_pred ceEEEEEecCCCCchhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 302 EQLYIQMELCDHSLSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 302 ~~l~IV~E~~~~~l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
..+|+||.+|++.|.....+ ..++..++.+++++++.||.|+|+..|+|||+||+|+|| .+|.+||+|||+|+.+..
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 35899999999987765444 358999999999999999999999999999999999999 679999999999987643
Q ss_pred C-------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hc--C-----C----
Q 011331 379 S-------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RD--G-----K---- 437 (488)
Q Consensus 379 ~-------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~--~-----~---- 437 (488)
+ .+..+-|.+|++||.+.+...++++.|||..||++.||++|.+.+.++...+.+ +. | .
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 2 223446899999999999889999999999999999999999998876543322 10 0 0
Q ss_pred -----------CCCCC-------------CCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 438 -----------LPLLP-------------GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 438 -----------~~~~~-------------~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
.|++. .-.++..+++.+||..||.+|++++++++|.||..
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 01111 11346789999999999999999999999999964
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=292.79 Aligned_cols=233 Identities=23% Similarity=0.299 Sum_probs=187.1
Q ss_pred EEecccCcEEEEEEEEcCCC---eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecC
Q 011331 235 EQIGAGNFSHVFKVLKRIDG---CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELC 311 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g---~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~ 311 (488)
+.||+|+||.||+|....++ ..||+|.+...... .....+..|+.++..+ .|+||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQL-DHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhc-CCCCeeeEEEEEc-CCceEEEEEeC
Confidence 36999999999999876655 79999998755433 3456788899999998 8999999999876 45689999999
Q ss_pred CCC-chhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCC------
Q 011331 312 DHS-LSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPI------ 382 (488)
Q Consensus 312 ~~~-l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~------ 382 (488)
.++ +.... ....+++..++.++.||+.||.|||.+|++|+||||+|||+ .++.++|+|||+++........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 765 44433 33458999999999999999999999999999999999999 6789999999999866432211
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCCCCCCCcHHHHHHHHHccc
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
..++..|+|||.+... .++.++|||||||++|+|++ |.+||...... ..+.. ...+.+..++..+.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 1234679999998655 57779999999999999998 88888654331 12222 2335556778999999999999
Q ss_pred CCCCCCCCHHHHHh
Q 011331 458 PDPVQRPSAKELVE 471 (488)
Q Consensus 458 ~dP~~RpTa~elL~ 471 (488)
.+|++|||+.+++.
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=333.06 Aligned_cols=145 Identities=30% Similarity=0.436 Sum_probs=125.7
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++++.||+|+||+||+|.+..+++.||||++.... ........+..|+.++..+ +|+||+++++++...+.+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999986532 2333446678888888888 999999999999999999999
Q ss_pred EecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCce
Q 011331 308 MELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRAT 374 (488)
Q Consensus 308 ~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~ 374 (488)
|||+.++ |... .....+++..++.++.||+.||.|||++|||||||||+|||| .++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999765 4332 233568899999999999999999999999999999999999 67899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=290.47 Aligned_cols=238 Identities=20% Similarity=0.304 Sum_probs=192.1
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.+|++.+.||.|+||.||+|.+. .+..+|+|++...... ...+..|++++..+ +||||+++++++......|++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEEE
Confidence 36889999999999999999875 5778999988654322 23577899999998 8999999999999999999999
Q ss_pred ecCCCCchh-hhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC----
Q 011331 309 ELCDHSLSD-KKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---- 380 (488)
Q Consensus 309 E~~~~~l~~-~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---- 380 (488)
||+.++.+. ... ...+++..++.++.|++.||+|||++|++|+||||+||++ .++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999876444 222 2458899999999999999999999999999999999999 57889999999987653321
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCCCCCCcHHHHHHHHHc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~~~~~s~~l~~lI~k~ 455 (488)
....++..|+|||.+... .++.++||||||+++|||++ |..||..... ...+..+ ....+...+..+.+|+.+|
T Consensus 159 ~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC 237 (256)
T ss_pred CCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 112345689999998765 57779999999999999998 8888765432 2223332 2223445689999999999
Q ss_pred ccCCCCCCCCHHHHHhC
Q 011331 456 VDPDPVQRPSAKELVEN 472 (488)
Q Consensus 456 L~~dP~~RpTa~elL~H 472 (488)
|..+|++|||+.+++++
T Consensus 238 l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 238 WKERPEDRPSFSLLLHQ 254 (256)
T ss_pred cccChhhCCCHHHHHHh
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=288.45 Aligned_cols=233 Identities=23% Similarity=0.296 Sum_probs=188.3
Q ss_pred EecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCCc
Q 011331 236 QIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSL 315 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~l 315 (488)
.||+|+||.||+|... ++..||+|++.... .......+..|+.++..+ +||||+++++++...+..++||||+.++.
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 6899999999999865 78899999987543 233445688899999998 99999999999999999999999998764
Q ss_pred hh-hh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC----CCCCCC
Q 011331 316 SD-KK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP----IEEGDA 387 (488)
Q Consensus 316 ~~-~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~----~~~Gt~ 387 (488)
+. .. ....+.+..++.++.||+.||.|||++|++|+||||+||++ .++.++|+|||++........ ...++.
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 33 22 22357899999999999999999999999999999999999 678999999999976543221 223456
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC-CCCCCCCCcHHHHHHHHHcccCCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG-KLPLLPGHSLQFQNLLKVMVDPDPVQ 462 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~-~~~~~~~~s~~l~~lI~k~L~~dP~~ 462 (488)
.|+|||++... .++.++||||||+++|+|++ |..||...... ..+..+ ....+..++..+.+++.+||..+|++
T Consensus 159 ~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (250)
T cd05085 159 KWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPEN 237 (250)
T ss_pred cccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCccc
Confidence 79999998765 57779999999999999998 88887654321 122222 23445567899999999999999999
Q ss_pred CCCHHHHHhC
Q 011331 463 RPSAKELVEN 472 (488)
Q Consensus 463 RpTa~elL~H 472 (488)
||++.|+++.
T Consensus 238 Rp~~~~l~~~ 247 (250)
T cd05085 238 RPKFSELQKE 247 (250)
T ss_pred CCCHHHHHHH
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=291.31 Aligned_cols=236 Identities=22% Similarity=0.282 Sum_probs=188.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.+|.+.+.||.|+||.||+|.+..+ ..||+|++..... ....+..|+.+++.+ +|+||+++++++. .+..|++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKL-RHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhC-CCCCeeeEEEEEc-CCCcEEEE
Confidence 4688999999999999999987644 4699998764322 234577899999998 8999999998875 45689999
Q ss_pred ecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC--
Q 011331 309 ELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP-- 381 (488)
Q Consensus 309 E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~-- 381 (488)
||+.++ +..... ...+++..+..++.||+.||.|||+.||+|+||||+||++ +++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999874 544332 2247888999999999999999999999999999999999 678999999999986643211
Q ss_pred --CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCCCCCCCcHHHHHHHHH
Q 011331 382 --IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 382 --~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~~~~~~s~~l~~lI~k 454 (488)
...++..|+|||.+... .++.++|||||||++|||++ |..||...... ..+.. ...+.+...+..+.++|.+
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKL 238 (260)
T ss_pred cCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence 12356789999988655 57789999999999999999 88887654321 22222 2334556678999999999
Q ss_pred cccCCCCCCCCHHHHHh
Q 011331 455 MVDPDPVQRPSAKELVE 471 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~ 471 (488)
||.+||++||+++++++
T Consensus 239 ~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 239 CWKKDPDERPTFEYIQS 255 (260)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=352.87 Aligned_cols=250 Identities=27% Similarity=0.366 Sum_probs=208.0
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..-+|+-...||.|.||.||-|.+..+|+..|+|.++-............+|..++..+ +|||+|++|++-.+.+.++|
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecHHHHHH
Confidence 34467888999999999999999999999999998865433333345577889999999 99999999999999999999
Q ss_pred EEecCCCCchh-hhhcc-cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---
Q 011331 307 QMELCDHSLSD-KKASQ-FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL--- 380 (488)
Q Consensus 307 V~E~~~~~l~~-~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~--- 380 (488)
.||||+++.+. ....+ ..++.....+..|++.|++|||+.|||||||||+||++ .+|.+|++|||.|..+....
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 99999887555 33333 36666777888999999999999999999999999999 68899999999998875543
Q ss_pred ----CCCCCCCCccChhhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh----h-cCCCCCCCCCcHHHH
Q 011331 381 ----PIEEGDARYMPQEILNED--YDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL----R-DGKLPLLPGHSLQFQ 449 (488)
Q Consensus 381 ----~~~~Gt~~Y~APEvl~~~--~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i----~-~~~~~~~~~~s~~l~ 449 (488)
....||+.|||||++.+. ..+.-++|||||||++.||+||+.||..-+....| - ....+.|..++.+-+
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGR 1471 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHH
Confidence 124599999999999653 24556999999999999999999999765543332 2 344556667899999
Q ss_pred HHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 450 NLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
+||..||..||..|-++.||++|.|-+.
T Consensus 1472 dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 9999999999999999999999988654
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=313.58 Aligned_cols=243 Identities=20% Similarity=0.269 Sum_probs=193.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEc-----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|.+.+.||+|+||.||+|.+. .++..||||+++... .......+..|+.++.++..||||+++++++...+
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 456888999999999999999864 346789999997543 23334568899999999955999999999999999
Q ss_pred eEEEEEecCCCCch-hhhh-------------------------------------------------------------
Q 011331 303 QLYIQMELCDHSLS-DKKA------------------------------------------------------------- 320 (488)
Q Consensus 303 ~l~IV~E~~~~~l~-~~~~------------------------------------------------------------- 320 (488)
.++||||||.++.+ ....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999986532 2110
Q ss_pred --------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-e
Q 011331 321 --------------------------------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-K 361 (488)
Q Consensus 321 --------------------------------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~ 361 (488)
...+++..++.++.||+.||.|||+.||+|+||||+|||+ .
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE 274 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC
Confidence 0135677788999999999999999999999999999999 5
Q ss_pred CCeEEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh----h
Q 011331 362 NGVYKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF----L 431 (488)
Q Consensus 362 ~g~vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~----~ 431 (488)
++.++|+|||+++..... .....++..|+|||.+... .++.++|||||||++|||++ |..|+...... .
T Consensus 275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 688999999999865321 1223467889999998765 57789999999999999998 77777543221 1
Q ss_pred hhhcC-CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 432 NLRDG-KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 432 ~i~~~-~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
.+..+ ..+.+..++.++.++|.+||..+|.+||++++|++.
T Consensus 354 ~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 354 AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 12222 334555678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=295.22 Aligned_cols=235 Identities=25% Similarity=0.362 Sum_probs=186.2
Q ss_pred EecccCcEEEEEEEEcCCCe--EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 236 QIGAGNFSHVFKVLKRIDGC--FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~~g~--~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
.||+|+||.||+|.+..+|. .+|+|.+... ........+..|+.++.++.+||||+++++++...+.+|++|||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 58999999999999987775 4688877632 22344557888999999998899999999999999999999999976
Q ss_pred C-chhhhhc-----------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCce
Q 011331 314 S-LSDKKAS-----------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRAT 374 (488)
Q Consensus 314 ~-l~~~~~~-----------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~ 374 (488)
+ +...... ..+++..++.++.||+.||+|||++|++|+||||+||++ .++.++|+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 5 4332211 247889999999999999999999999999999999999 67899999999986
Q ss_pred ecCCCC--CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCCCCCCcHH
Q 011331 375 LLNKSL--PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPLLPGHSLQ 447 (488)
Q Consensus 375 ~~~~~~--~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~~~~~s~~ 447 (488)
...... .....+..|+|||++... .++.++|||||||++|||++ |..||..... ...+..+ ....+...+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05047 161 GQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDE 239 (270)
T ss_pred ccchhhhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHH
Confidence 432211 112245679999998665 56779999999999999997 8888865432 2222222 23344567889
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
+.+++.+||..+|.+|||+.+++..
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 240 VYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHH
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=338.76 Aligned_cols=241 Identities=22% Similarity=0.306 Sum_probs=201.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCC-C----eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRID-G----CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-g----~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
....+..+.||+|.||.||.|..... | ..||||.+.+. ....+..+|++|..+++.+ +|||||+++|++.+.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCC
Confidence 34578889999999999999977643 3 24999988764 4567788999999999999 9999999999999999
Q ss_pred eEEEEEecCCCCch-hhhh--------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecC
Q 011331 303 QLYIQMELCDHSLS-DKKA--------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGR 372 (488)
Q Consensus 303 ~l~IV~E~~~~~l~-~~~~--------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGl 372 (488)
..+|++|||.++.+ ...+ ...++..+++.++.|||.|+.||+++++|||||..+|+|+ ....+||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 99999999988643 3222 2358899999999999999999999999999999999999 568999999999
Q ss_pred ceec-CCCCCCCC----CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcC-CCCCCCchhhh----hhhcCCCCCCC
Q 011331 373 ATLL-NKSLPIEE----GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQFL----NLRDGKLPLLP 442 (488)
Q Consensus 373 A~~~-~~~~~~~~----Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG-~~p~~~~~~~~----~i~~~~~~~~~ 442 (488)
|+.+ +....... -+..|||||.+... .++.++|||||||+|||+++- ..||.+...+. .+.++.++.|+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~ 927 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS 927 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC
Confidence 9944 32222222 23589999999875 788999999999999999985 45665544432 34578899999
Q ss_pred CCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 443 GHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 443 ~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
.+++.++++|..||+.+|++||++..|++
T Consensus 928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999999999999999999998
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=294.24 Aligned_cols=246 Identities=25% Similarity=0.333 Sum_probs=196.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCe----EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGC----FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.+|++++.||+|+||+||+|.+..+|. .||+|.+.... .......+.+|+.++..+ +|+||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-Cce
Confidence 468999999999999999999876665 68999876542 234456788899999999 89999999999887 789
Q ss_pred EEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 305 YIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
++||||+.++ +..... ...+++..++.++.||+.||+|||++||+|+||||+||++ .++.++|+|||+++......
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999765 443222 2358999999999999999999999999999999999999 67899999999998664321
Q ss_pred C-----CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCCCCCCCcHHHHH
Q 011331 381 P-----IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLPLLPGHSLQFQN 450 (488)
Q Consensus 381 ~-----~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~~~~~~s~~l~~ 450 (488)
. ...++..|+|||.+... .++.++|||||||++|||++ |..||...... ..+.. ...+.+...+.++.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred cceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 1 11235679999988654 56779999999999999998 99988764321 12222 234555567889999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
++.+||..+|+.|||+.++++ .|..+.+
T Consensus 243 ~~~~~l~~~p~~Rp~~~~l~~--~l~~~~~ 270 (279)
T cd05057 243 VLVKCWMIDAESRPTFKELIN--EFSKMAR 270 (279)
T ss_pred HHHHHcCCChhhCCCHHHHHH--HHHHHHh
Confidence 999999999999999999987 3655543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=298.20 Aligned_cols=240 Identities=18% Similarity=0.218 Sum_probs=180.0
Q ss_pred cceeEEEEecccCcEEEEEEEEcCC---CeEEEEEEeccCCCchH-H--------HHHHHHHHHHHHHhCCCCCeeEeee
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRID---GCFYAVKHSKRQLHHDA-E--------RRKALLEVQALAALGSHENIVGYYS 296 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~l~~~~~~~~-~--------~~~~~~Ei~iL~~l~~HpnIv~l~~ 296 (488)
++|++.+.||+|+||+||+|.+..+ +..+|+|+......... + ......+...+..+ .|+||+.+++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~ 90 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKYYG 90 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcEEE
Confidence 5799999999999999999998877 67788886432211100 0 01112223334444 8999999998
Q ss_pred eecccc----eEEEEEecCCCCchhhhhc-ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEee
Q 011331 297 SWFENE----QLYIQMELCDHSLSDKKAS-QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDF 370 (488)
Q Consensus 297 ~~~~~~----~l~IV~E~~~~~l~~~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DF 370 (488)
.+.... ..++++|++...+...... ...++..+..++.||+.||.|||++||+||||||+|||+ .++.++|+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 765443 3478888876665443222 236788899999999999999999999999999999999 5789999999
Q ss_pred cCceecCC----------CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-----------
Q 011331 371 GRATLLNK----------SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----------- 429 (488)
Q Consensus 371 GlA~~~~~----------~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----------- 429 (488)
|+|+.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.....
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~ 249 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD 249 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence 99976531 11234599999999998765 578899999999999999999999975421
Q ss_pred -hhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 430 -FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 430 -~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
...+..+.. ..+..+.++.+++..|+..+|++||++.++++
T Consensus 250 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 250 FIKRLHEGKI-KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhhhhhh-ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111222222 23456889999999999999999999999986
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=292.03 Aligned_cols=245 Identities=23% Similarity=0.319 Sum_probs=194.6
Q ss_pred cceeEEEEecccCcEEEEEEEEcCC---CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRID---GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.+|.+.+.||+|+||.||+|.+... ...||||...... .....+.+..|+.++..+ +|+||+++++++.+ +..|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC-CCcE
Confidence 3688999999999999999987544 4579999876442 234456788899999999 89999999998875 5578
Q ss_pred EEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-
Q 011331 306 IQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL- 380 (488)
Q Consensus 306 IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~- 380 (488)
+||||+.++ +..... ...+++..++.++.||+.||.|||++|++|+||||+||++ .++.++|+|||++.......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999865 433322 2358999999999999999999999999999999999999 66899999999998664321
Q ss_pred ---CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHHHHH
Q 011331 381 ---PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQNLL 452 (488)
Q Consensus 381 ---~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~~lI 452 (488)
....++..|+|||.+... .++.++|||||||++|||++ |.+||..... ...+.. ...+.++..+.++.++|
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 241 (270)
T ss_pred eecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence 112245679999988655 57789999999999999986 9988865433 222333 33456677899999999
Q ss_pred HHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 453 KVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.+||..+|++|||+.+++.. +..+.
T Consensus 242 ~~~l~~~P~~Rpt~~~~~~~--l~~~~ 266 (270)
T cd05056 242 TKCWAYDPSKRPRFTELKAQ--LSDIL 266 (270)
T ss_pred HHHcCCChhhCcCHHHHHHH--HHHHH
Confidence 99999999999999999875 55443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=290.34 Aligned_cols=233 Identities=21% Similarity=0.278 Sum_probs=188.2
Q ss_pred EEecccCcEEEEEEEEcC-CC--eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecC
Q 011331 235 EQIGAGNFSHVFKVLKRI-DG--CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELC 311 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~-~g--~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~ 311 (488)
+.||+|++|+||+|.+.. .+ ..||||.+...... .....+..|+.++.++ +|+||+++++.+.. ..++++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEec
Confidence 358999999999998865 33 36999998765432 4566788999999999 89999999999988 8899999999
Q ss_pred CCC-chhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC------C
Q 011331 312 DHS-LSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS------L 380 (488)
Q Consensus 312 ~~~-l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~------~ 380 (488)
+++ +...... ..+++..++.++.||+.||.|||++|++|+||||+||++ .++.+||+|||++...... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 765 4443222 358899999999999999999999999999999999999 6789999999999876432 1
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhhh---hhh--cCCCCCCCCCcHHHHHHHHH
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQFL---NLR--DGKLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~~---~i~--~~~~~~~~~~s~~l~~lI~k 454 (488)
....++..|+|||.+... .++.++|||||||++|||++ |..|+....... .+. ....+.+...+..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 223467889999998765 57779999999999999998 998886443221 111 22233445668899999999
Q ss_pred cccCCCCCCCCHHHHHh
Q 011331 455 MVDPDPVQRPSAKELVE 471 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~ 471 (488)
||..+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=290.86 Aligned_cols=235 Identities=24% Similarity=0.346 Sum_probs=189.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++.+.||+|+||.||++.. +++.||+|++... .....+..|+.++..+ +||||+++++++..+ ..+++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD----VTAQAFLEETAVMTKL-HHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc----chHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC-CcEEEE
Confidence 5689999999999999999864 7889999998643 2335678899999998 999999999988765 479999
Q ss_pred ecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCC
Q 011331 309 ELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIE 383 (488)
Q Consensus 309 E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~ 383 (488)
||+.++ +..... ...+++..++.++.||+.||.|||++|++|+||||+||++ .++.++|+|||++..........
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS 157 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCCCC
Confidence 999864 443222 2347889999999999999999999999999999999999 57899999999998654433334
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC-CCCCCCCCcHHHHHHHHHcccC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG-KLPLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~-~~~~~~~~s~~l~~lI~k~L~~ 458 (488)
..+..|+|||.+... .++.++|+|||||++|||++ |.+||...... ..+..+ ....+..++..+.++|.+||..
T Consensus 158 ~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (254)
T cd05083 158 KLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWET 236 (254)
T ss_pred CCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCC
Confidence 456789999988655 57789999999999999997 88887654321 122222 2334456789999999999999
Q ss_pred CCCCCCCHHHHHhC
Q 011331 459 DPVQRPSAKELVEN 472 (488)
Q Consensus 459 dP~~RpTa~elL~H 472 (488)
+|+.||+++++++.
T Consensus 237 ~p~~Rp~~~~l~~~ 250 (254)
T cd05083 237 EPKKRPSFHKLREK 250 (254)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=300.61 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=221.1
Q ss_pred ccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHH-HHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRK-ALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 224 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~-~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
++.-..+|.+++.||+|+|++|.+++.+.|.+.||+|++++...++.+..+ ...|-.+..+..+||.+|.++..|+...
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 444577999999999999999999999999999999999888766655443 5567888888889999999999999999
Q ss_pred eEEEEEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceec---
Q 011331 303 QLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL--- 376 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~--- 376 (488)
.+++|.||++|+-+. ......++++.++.+...|+.||.|||++|||+||||.+|||+ .+|++||.|+|+++..
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 999999999887333 4445679999999999999999999999999999999999999 6899999999999754
Q ss_pred CCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCc-----------hhhhhhhcCCCCCCCCCc
Q 011331 377 NKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESG-----------PQFLNLRDGKLPLLPGHS 445 (488)
Q Consensus 377 ~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~-----------~~~~~i~~~~~~~~~~~s 445 (488)
+....+.+||+.|+|||++.+. +|+..+|+|+|||+++||+.|+.||+.. -.++.+....+..|..+|
T Consensus 405 gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsls 483 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLS 483 (593)
T ss_pred CcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceee
Confidence 2345678899999999999886 7888999999999999999999998731 114456667777777888
Q ss_pred HHHHHHHHHcccCCCCCCC------CHHHHHhChhhhhhHH
Q 011331 446 LQFQNLLKVMVDPDPVQRP------SAKELVENPIFDKIQK 480 (488)
Q Consensus 446 ~~l~~lI~k~L~~dP~~Rp------Ta~elL~HP~f~~i~~ 480 (488)
-.+..+++..|.+||.+|. .+.++..||||+.+.+
T Consensus 484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 8889999999999999985 3899999999998754
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=293.28 Aligned_cols=246 Identities=20% Similarity=0.233 Sum_probs=196.0
Q ss_pred cceeEEEEecccCcEEEEEEEEcC----CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-cce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRI----DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE-NEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-~~~ 303 (488)
++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+..|+.+++.+ +|+||+++++++.. +..
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDGEP 83 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCC
Confidence 478999999999999999999875 3688999987643 3445566788999999999 99999999998765 567
Q ss_pred EEEEEecCCCCchh-hhhc---------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecC
Q 011331 304 LYIQMELCDHSLSD-KKAS---------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGR 372 (488)
Q Consensus 304 l~IV~E~~~~~l~~-~~~~---------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGl 372 (488)
.++++||+.++.+. .... ..+++..++.++.||+.||.|||++|++|+||||+||++ +++.+||+|||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 89999999764333 2111 358899999999999999999999999999999999999 678999999999
Q ss_pred ceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhhh---hhhc-CCCCCCC
Q 011331 373 ATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQFL---NLRD-GKLPLLP 442 (488)
Q Consensus 373 A~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~~---~i~~-~~~~~~~ 442 (488)
++.+.... ....++..|+|||++... .++.++|||||||++||+++ |..||....... .+.. ...+.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPI 242 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCC
Confidence 98653211 123456789999998665 57789999999999999998 888887543321 1222 2233445
Q ss_pred CCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 443 GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 443 ~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.++.++.++|.+||..||++|||+.++++. |+.+.
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~--l~~~~ 277 (280)
T cd05043 243 NCPDELFAVMACCWALDPEERPSFSQLVQC--LTDFH 277 (280)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHH--HHHHH
Confidence 678999999999999999999999999973 55544
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=288.49 Aligned_cols=233 Identities=24% Similarity=0.325 Sum_probs=188.9
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHS 314 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~ 314 (488)
+.||.|+||.||+|.+.. ++.||+|++...... .....+..|+.+++.+ +|+||+++++++...+..|+||||+.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 368999999999999876 999999988654332 3456788899999998 8999999999999999999999999765
Q ss_pred -chhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-----CCCCC
Q 011331 315 -LSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-----PIEEG 385 (488)
Q Consensus 315 -l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-----~~~~G 385 (488)
+.... ....+++..+..++.+++.||.|||++|++|+||+|+||++ .++.++|+|||++....... ....+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 43322 23457889999999999999999999999999999999999 67899999999997654211 11223
Q ss_pred CCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHHHHHHHcccCCC
Q 011331 386 DARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQNLLKVMVDPDP 460 (488)
Q Consensus 386 t~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~~lI~k~L~~dP 460 (488)
+..|+|||.+... .++.++|||||||++|||++ |..|+..... ...+.. ...+.+...+.++.++|.+||..+|
T Consensus 158 ~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 5679999998765 57789999999999999999 7777755432 122222 2334455678999999999999999
Q ss_pred CCCCCHHHHHh
Q 011331 461 VQRPSAKELVE 471 (488)
Q Consensus 461 ~~RpTa~elL~ 471 (488)
.+|||+.|+++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999987
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=293.05 Aligned_cols=241 Identities=23% Similarity=0.305 Sum_probs=192.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcC-----CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRI-----DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
++|++++.||.|+||+||+|.... +...||+|.+.... .......+..|+.++.++ +|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCCc
Confidence 478999999999999999998754 35689999876432 222456688899999999 99999999999999999
Q ss_pred EEEEEecCCCCchh-hhh-cc---------cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeec
Q 011331 304 LYIQMELCDHSLSD-KKA-SQ---------FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFG 371 (488)
Q Consensus 304 l~IV~E~~~~~l~~-~~~-~~---------~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFG 371 (488)
.|+||||++++.+. ... .. .+++..+..++.||+.||.|||+.||+|+||||+||++ .++.++|+|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 99999999865333 222 12 58999999999999999999999999999999999999 67899999999
Q ss_pred CceecCCC----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcCC--CCCC
Q 011331 372 RATLLNKS----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDGK--LPLL 441 (488)
Q Consensus 372 lA~~~~~~----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~~--~~~~ 441 (488)
++...... .....++..|+|||.+... ..+.++||||||+++|+|++ |..||..... ...+..+. .+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 98654321 1223467789999988654 46679999999999999998 6677754322 12222222 3344
Q ss_pred CCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 442 PGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 442 ~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
..++..+.++|.+||..+|++|||+.|++.+
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 5678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=288.86 Aligned_cols=237 Identities=21% Similarity=0.270 Sum_probs=190.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++.+.||+|+||.||+|.+. .+..||+|.+... ......+.+|+.+++.+ +|+||+++++.+.. ...|++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeEEE
Confidence 457899999999999999999764 5667999987643 23345688899999998 89999999999887 788999
Q ss_pred EecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC-
Q 011331 308 MELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP- 381 (488)
Q Consensus 308 ~E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~- 381 (488)
|||++++ +..... ...++...+..++.||+.||.|||+.|++|+||||+||++ .++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999764 444322 2347888899999999999999999999999999999999 678999999999976643211
Q ss_pred ---CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCCCCCCCcHHHHHHHH
Q 011331 382 ---IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 382 ---~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~~~~~~s~~l~~lI~ 453 (488)
...++..|+|||++... .++.++|||||||++|+|++ |..||...... ..+.. ...+.+...+.++.+++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 237 (260)
T ss_pred cccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHH
Confidence 12356679999998765 56779999999999999998 88887654321 12222 233455677899999999
Q ss_pred HcccCCCCCCCCHHHHHh
Q 011331 454 VMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~ 471 (488)
+||+.+|++||++.++++
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 238 RCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHcccCcccCcCHHHHHH
Confidence 999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=301.71 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=209.9
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++++-+..||.|+||+|++-.++.+|+..|||.++... ...+.++++.|.....+-.++||||++||+...++..||.|
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 45677889999999999999999999999999997543 35677889999999999889999999999999999999999
Q ss_pred ecCCCCchh------hhhcccCCHHHHHHHHHHHHHHHHHHH-HcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 309 ELCDHSLSD------KKASQFFAEGEVLKALHQIAQALQFIH-EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 309 E~~~~~l~~------~~~~~~l~~~~~~~i~~qI~~gL~yLH-~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
|+|+-++.. ......++|..+-.+...++.||.||- +..||||||||+|||+ ..|.+||||||++..+.++.
T Consensus 143 ELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 143 ELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred HHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 999987554 233456999999999999999999997 4599999999999999 67999999999998775543
Q ss_pred --CCCCCCCCccChhhhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCchhhh----hhhcCCCCCCC------CCcHH
Q 011331 381 --PIEEGDARYMPQEILNEDY-DHLDKVDIFSLGATMYELIKGSPLSESGPQFL----NLRDGKLPLLP------GHSLQ 447 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~~~-~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~----~i~~~~~~~~~------~~s~~ 447 (488)
+...|-..|||||.+.... .|.-++|+||||++|||+.||..|+..++... .+..+..|... .++..
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~ 302 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFS 302 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHH
Confidence 3456889999999986432 35569999999999999999999999887632 23344444221 26888
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
+..||.-||.+|-+.||...+|+++||++.
T Consensus 303 ~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 303 MVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred HHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 999999999999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.90 Aligned_cols=267 Identities=24% Similarity=0.363 Sum_probs=216.2
Q ss_pred cccccccccCCccceeeCCCCccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHH
Q 011331 203 RFGNQWAKCAGLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQAL 282 (488)
Q Consensus 203 ~~~~~~~~~~~~~p~~~g~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL 282 (488)
.+.++|....|+|-+..|+..-. +|.+....|+|-||+|..|.+...|..||||+|. .++......+.|+++|
T Consensus 410 ~L~DNWdDaEGYYrv~igE~LD~----RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIR---nNE~M~KtGl~EleiL 482 (752)
T KOG0670|consen 410 GLQDNWDDAEGYYRVRIGELLDS----RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIR---NNEVMHKTGLKELEIL 482 (752)
T ss_pred ccccCcccccceEEEehhhhhcc----eeEEEeccccceeeeeeeccccCCCCeeEEEEee---cchHHhhhhhHHHHHH
Confidence 34578999999999999876444 5699999999999999999999999999999997 4566677899999999
Q ss_pred HHhCC-----CCCeeEeeeeecccceEEEEEecCCCCchhhhh----cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCC
Q 011331 283 AALGS-----HENIVGYYSSWFENEQLYIQMELCDHSLSDKKA----SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDV 353 (488)
Q Consensus 283 ~~l~~-----HpnIv~l~~~~~~~~~l~IV~E~~~~~l~~~~~----~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDL 353 (488)
.+|.. --|+++|+..|.+.+++|||||-+..+|..... +-.|....+..|++|++.||..|-.+||+|.||
T Consensus 483 kKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDI 562 (752)
T KOG0670|consen 483 KKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADI 562 (752)
T ss_pred HHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeeccc
Confidence 99952 347999999999999999999999988777433 234777889999999999999999999999999
Q ss_pred CCCcEEEeC--CeEEEEeecCceecCCC-CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-
Q 011331 354 KPDNIYVKN--GVYKLGDFGRATLLNKS-LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ- 429 (488)
Q Consensus 354 Kp~NILv~~--g~vkL~DFGlA~~~~~~-~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~- 429 (488)
||+||||.+ ..+||||||.|...+.. .+...-+..|.|||++.+- .|....|+||+||+||||.||+.+|.+...
T Consensus 563 KPDNiLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~-~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 563 KPDNILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGL-PYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred CccceEeccCcceeeeccCccccccccccccHHHHHHhccCcceeecC-cccCCccceeeceeeEEeeccceecCCCCcH
Confidence 999999954 57999999999877543 2223345679999998775 566699999999999999999988876422
Q ss_pred -hhhh---hcCCCC---------------------------------------CCC------------CC-------cHH
Q 011331 430 -FLNL---RDGKLP---------------------------------------LLP------------GH-------SLQ 447 (488)
Q Consensus 430 -~~~i---~~~~~~---------------------------------------~~~------------~~-------s~~ 447 (488)
+..+ ..|.+| ..| .+ -.+
T Consensus 642 ~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~ 721 (752)
T KOG0670|consen 642 QMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQ 721 (752)
T ss_pred HHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHH
Confidence 1111 011111 000 01 236
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
|++||.+||..||++|.|..++|.||||+.
T Consensus 722 ~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 722 LRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 899999999999999999999999999974
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=289.54 Aligned_cols=231 Identities=19% Similarity=0.245 Sum_probs=180.7
Q ss_pred EEecccCcEEEEEEEEcCCC----------eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 235 EQIGAGNFSHVFKVLKRIDG----------CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g----------~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
+.||+|+||.||+|.+..++ ..|++|++.... .....+.+|+.+++.+ +||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQL-SHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcC-CCcchhheeeEEec-CCc
Confidence 36899999999999998776 457888765332 1156678899999998 89999999999888 778
Q ss_pred EEEEecCCCCchh-hhh-cc-cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC-------eEEEEeecCc
Q 011331 305 YIQMELCDHSLSD-KKA-SQ-FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG-------VYKLGDFGRA 373 (488)
Q Consensus 305 ~IV~E~~~~~l~~-~~~-~~-~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g-------~vkL~DFGlA 373 (488)
++||||+.++.+. ... .. .++...+..++.||+.||.|||++||+|+||||+|||++ ++ .++|+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999876544 222 22 588999999999999999999999999999999999994 44 6999999999
Q ss_pred eecCCCCCCCCCCCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcC-CCCCCCchhhh--hhhcCCCCCCCCCcHHHH
Q 011331 374 TLLNKSLPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIKG-SPLSESGPQFL--NLRDGKLPLLPGHSLQFQ 449 (488)
Q Consensus 374 ~~~~~~~~~~~Gt~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG-~~p~~~~~~~~--~i~~~~~~~~~~~s~~l~ 449 (488)
..... .....++..|+|||++... ..++.++|||||||++|||++| ..|+....... .........+......+.
T Consensus 156 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (259)
T cd05037 156 ITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELA 234 (259)
T ss_pred ccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCCchHHH
Confidence 87644 2344577889999998654 3567799999999999999995 55665442211 111111112222347899
Q ss_pred HHHHHcccCCCCCCCCHHHHHh
Q 011331 450 NLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~ 471 (488)
++|.+||..+|.+|||+.++++
T Consensus 235 ~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 235 NLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=288.30 Aligned_cols=234 Identities=21% Similarity=0.253 Sum_probs=180.7
Q ss_pred EecccCcEEEEEEEEcC---CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec-ccceEEEEEecC
Q 011331 236 QIGAGNFSHVFKVLKRI---DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF-ENEQLYIQMELC 311 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~-~~~~l~IV~E~~ 311 (488)
.||+|+||+||+|.+.. .+..||||.+... ........+..|+.+++.+ +||||+++++++. .++..+++|||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEecC
Confidence 58999999999998653 3468999987532 2334456778899999888 9999999999765 455689999999
Q ss_pred CCCchh-hhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-------C
Q 011331 312 DHSLSD-KKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-------L 380 (488)
Q Consensus 312 ~~~l~~-~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-------~ 380 (488)
.++.+. ... ...+++..+..++.||+.||.|||+.||+|+||||+|||+ .++.+||+|||+++..... .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 875443 222 2346777888999999999999999999999999999999 6789999999999755321 1
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCC-CCCCCchhh---hhhhcC-CCCCCCCCcHHHHHHHHHc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQF---LNLRDG-KLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~-~p~~~~~~~---~~i~~~-~~~~~~~~s~~l~~lI~k~ 455 (488)
....++..|+|||.+... .++.++|||||||++|||++|. +|+...... ..+..+ ..+.+...+..+.+++.+|
T Consensus 160 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 238 (262)
T cd05058 160 TGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSC 238 (262)
T ss_pred ccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHH
Confidence 122456789999988654 5778999999999999999965 455433221 122222 2333445688999999999
Q ss_pred ccCCCCCCCCHHHHHhC
Q 011331 456 VDPDPVQRPSAKELVEN 472 (488)
Q Consensus 456 L~~dP~~RpTa~elL~H 472 (488)
|..+|++||++.++++.
T Consensus 239 l~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 239 WHPKPEMRPTFSELVSR 255 (262)
T ss_pred cCCChhhCCCHHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=290.69 Aligned_cols=234 Identities=23% Similarity=0.282 Sum_probs=178.0
Q ss_pred EecccCcEEEEEEEEcC--CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 236 QIGAGNFSHVFKVLKRI--DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
.||+|+||+||+|.... ....+|+|.+... ........+.+|+.+++.+ +|+||+++++.+.+...+|+||||+.+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeCCC
Confidence 58999999999996432 4567888877543 2334445678899999988 899999999999999999999999987
Q ss_pred Cchh-hhhc------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-----C
Q 011331 314 SLSD-KKAS------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-----L 380 (488)
Q Consensus 314 ~l~~-~~~~------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-----~ 380 (488)
+.+. .... ...++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++...... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 5443 2211 224567788999999999999999999999999999999 6789999999998653211 1
Q ss_pred CCCCCCCCccChhhhcc------cCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhhh---h-hhcCCCC-----CCCCC
Q 011331 381 PIEEGDARYMPQEILNE------DYDHLDKVDIFSLGATMYELIK-GSPLSESGPQFL---N-LRDGKLP-----LLPGH 444 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~------~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~~---~-i~~~~~~-----~~~~~ 444 (488)
....++..|+|||++.. ...++.++|||||||++|||++ |..||....... . +...... .....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY 239 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence 22345678999998743 2245679999999999999999 667765543221 1 1222211 23356
Q ss_pred cHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 445 SLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 445 s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
+..+.+++..|+ .||++|||+++|++-
T Consensus 240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 240 SDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred CHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 788899999998 599999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=289.37 Aligned_cols=242 Identities=26% Similarity=0.439 Sum_probs=195.6
Q ss_pred ceeEEEEecccCcEEEEEEEEcC-CCeEEEEEEeccCC--------CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRI-DGCFYAVKHSKRQL--------HHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAvK~l~~~~--------~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
+|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .......++..|+.++.+..+|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37888999999999999999987 68899999875321 2233445677888888876699999999999999
Q ss_pred cceEEEEEecCCCC-chhh-----hhcccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEE-eCCeEEEEeecC
Q 011331 301 NEQLYIQMELCDHS-LSDK-----KASQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYV-KNGVYKLGDFGR 372 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~~-----~~~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv-~~g~vkL~DFGl 372 (488)
++..|++|||+.++ +... .....+++..++.++.||+.||.|||+ .|++|+||+|+||++ .++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999875 3322 123458999999999999999999996 789999999999999 678999999999
Q ss_pred ceecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCC-CCCC-CCc
Q 011331 373 ATLLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKL-PLLP-GHS 445 (488)
Q Consensus 373 A~~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~-~~~~-~~s 445 (488)
+...... .....|+..|+|||.+... .++.++||||||+++|+|++|.+|+....... .+..... +... .++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 9876443 2344588899999998765 47789999999999999999999987654322 2222222 2222 468
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 446 LQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 446 ~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
.++.++|.+||+.||++||++.|+..+
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=289.95 Aligned_cols=233 Identities=24% Similarity=0.269 Sum_probs=179.2
Q ss_pred EecccCcEEEEEEEEc--CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 236 QIGAGNFSHVFKVLKR--IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~--~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
.||+|+||.||+|... .++..+|+|.++... .......+..|+.++..+ +||||+++++++.+...+++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 5899999999999764 346789999886543 233445688899999999 899999999999999999999999986
Q ss_pred Cchh-hhh------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-----C
Q 011331 314 SLSD-KKA------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-----L 380 (488)
Q Consensus 314 ~l~~-~~~------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-----~ 380 (488)
+.+. ... ....++..+..++.||+.||.|||++|++|+||||+||++ .++.++|+|||++...... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 5433 221 1235567788999999999999999999999999999999 6789999999998754322 1
Q ss_pred CCCCCCCCccChhhhccc------CCCCchhHHHHHHHHHHHHHc-CCCCCCCchhhhh----hhcCCC--C---CCCCC
Q 011331 381 PIEEGDARYMPQEILNED------YDHLDKVDIFSLGATMYELIK-GSPLSESGPQFLN----LRDGKL--P---LLPGH 444 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~------~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~~~----i~~~~~--~---~~~~~ 444 (488)
....++..|+|||++... ..++.++|||||||++|||++ |..||........ +..... + .....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence 123467889999998532 134679999999999999996 9988865432211 111111 1 12246
Q ss_pred cHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 445 SLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 445 s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
+..+.++|.+|+ .+|++|||++||+.
T Consensus 240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 240 SDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 788999999998 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=296.23 Aligned_cols=244 Identities=22% Similarity=0.330 Sum_probs=192.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCe----EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGC----FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
++|+.++.||+|+||.||+|.+..+|. .||+|.+.... .......+..|+.++..+ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-Cc
Confidence 468899999999999999999887775 57888876432 233344678899999998 999999999988754 46
Q ss_pred EEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 305 YIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
++++||+.++ +..... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.+||+|||+++......
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 7899999865 444322 2357889999999999999999999999999999999999 67899999999998654321
Q ss_pred -----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh--hhhhh--cCCCCCCCCCcHHHHH
Q 011331 381 -----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ--FLNLR--DGKLPLLPGHSLQFQN 450 (488)
Q Consensus 381 -----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~--~~~i~--~~~~~~~~~~s~~l~~ 450 (488)
....++..|+|||.+... .++.++|||||||++|||++ |..|+.+... ...+. ....+.++..+..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYM 242 (303)
T ss_pred cccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 122356789999998654 57789999999999999997 8788765322 22222 2234455667889999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+|.+||..+|++||++++++.. |..+
T Consensus 243 li~~c~~~~p~~Rp~~~~l~~~--l~~~ 268 (303)
T cd05110 243 VMVKCWMIDADSRPKFKELAAE--FSRM 268 (303)
T ss_pred HHHHHcCCChhhCcCHHHHHHH--HHHH
Confidence 9999999999999999999885 4443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=309.30 Aligned_cols=240 Identities=27% Similarity=0.385 Sum_probs=187.9
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc-eE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE-QL 304 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~-~l 304 (488)
...++|.....||+|+||.||+|... +|..||||.+....... ..++..|+.++.++ +|||||+|+|+|.+.+ ..
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRL-RHPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcC-CCcCcccEEEEEecCCceE
Confidence 34567888899999999999999876 56999999886543332 34599999999999 7999999999999999 59
Q ss_pred EEEEecCCCCch-hhhhc--c-cCCHHHHHHHHHHHHHHHHHHHHc---CcccCCCCCCcEEE-eCCeEEEEeecCceec
Q 011331 305 YIQMELCDHSLS-DKKAS--Q-FFAEGEVLKALHQIAQALQFIHEK---GIAHLDVKPDNIYV-KNGVYKLGDFGRATLL 376 (488)
Q Consensus 305 ~IV~E~~~~~l~-~~~~~--~-~l~~~~~~~i~~qI~~gL~yLH~~---gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~ 376 (488)
+||+||+..+.+ +.... . .+++....+|+.++|.||+|||.. .|||||||++|||+ .+..+||+|||+|+..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 999999986544 32211 1 789999999999999999999985 39999999999999 5789999999999766
Q ss_pred CC-CCCC--C-CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch---h--hh-------------hhh
Q 011331 377 NK-SLPI--E-EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP---Q--FL-------------NLR 434 (488)
Q Consensus 377 ~~-~~~~--~-~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~---~--~~-------------~i~ 434 (488)
.. .... . .||.+|+|||.+..+ ..+.++|||||||+|.||++|+.+.+... . +. ++.
T Consensus 228 ~~~~~~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 228 PEGDTSVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred CccccceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 54 3222 2 799999999998764 57789999999999999999997665321 0 11 111
Q ss_pred cCCCCCCCCCc-----HHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 435 DGKLPLLPGHS-----LQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 435 ~~~~~~~~~~s-----~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
+..+.. .... ..+..+..+|++.+|..||++.|+++
T Consensus 307 D~~l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 307 DPRLKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111110 1222 23567788999999999999999854
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=290.02 Aligned_cols=240 Identities=18% Similarity=0.237 Sum_probs=189.8
Q ss_pred eeEEEEecccCcEEEEEEEEcC---CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc-----
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRI---DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE----- 302 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~----- 302 (488)
|++.+.||+|+||+||+|.+.. ++..||||++............+..|+.+++.+ +||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence 5678899999999999998653 578999999876555555667788999999999 8999999999876432
Q ss_pred -eEEEEEecCCCCchh-hhh-------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecC
Q 011331 303 -QLYIQMELCDHSLSD-KKA-------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGR 372 (488)
Q Consensus 303 -~l~IV~E~~~~~l~~-~~~-------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGl 372 (488)
..++++||+.++.+. ... ...++...++.++.||+.||+|||++||+|+||||+||++ .++.++|+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247889999765432 111 1247888999999999999999999999999999999999 578999999999
Q ss_pred ceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhhh---hhhc-CCCCCCC
Q 011331 373 ATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQFL---NLRD-GKLPLLP 442 (488)
Q Consensus 373 A~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~~---~i~~-~~~~~~~ 442 (488)
++...... ....++..|++||.+... .++.++|||||||++|||++ |.+|+....... .+.. .....++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 98653221 122355789999998765 56779999999999999999 777776543321 1222 2334456
Q ss_pred CCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 443 GHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 443 ~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
..+..+.+++.+||..+|++|||+.|++.+
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=315.75 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=204.7
Q ss_pred ccccccceeEEEEecccCcEEEEEEEEcCCCe---E-EEEEEecc-CCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeee
Q 011331 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGC---F-YAVKHSKR-QLHHDAERRKALLEVQALAALGSHENIVGYYSSW 298 (488)
Q Consensus 224 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~-vAvK~l~~-~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~ 298 (488)
|.-..++-.+.++||+|+||+||+|.....+. . ||||..+. .........+++.|+++++.+ +|||||++||+.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa 230 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVA 230 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE
Confidence 44445566777999999999999997765432 3 89998874 224556678899999999998 999999999999
Q ss_pred cccceEEEEEecCCCCchh--hhhcc-cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeC-CeEEEEeecCce
Q 011331 299 FENEQLYIQMELCDHSLSD--KKASQ-FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKN-GVYKLGDFGRAT 374 (488)
Q Consensus 299 ~~~~~l~IV~E~~~~~l~~--~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~-g~vkL~DFGlA~ 374 (488)
.....+|||||+|.|+.+. ....+ .++..+...++.+.+.||+|||++++|||||-.+|+|++. +.+||+|||+++
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999886444 23333 4999999999999999999999999999999999999955 677999999998
Q ss_pred ecCCC---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhh-h-cCCCCCCCCCc
Q 011331 375 LLNKS---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNL-R-DGKLPLLPGHS 445 (488)
Q Consensus 375 ~~~~~---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i-~-~~~~~~~~~~s 445 (488)
....- .....-+..|+|||.+... .++.++|||||||++||+++ |..|+.+.... ..+ . ....+.+...+
T Consensus 311 ~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p 389 (474)
T KOG0194|consen 311 AGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTP 389 (474)
T ss_pred CCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCH
Confidence 66411 1122356789999999877 78889999999999999999 77777765432 223 2 33455666788
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHh
Q 011331 446 LQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481 (488)
Q Consensus 446 ~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~ 481 (488)
.++..++.+||..+|++|||+.++.+ +++.+...
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~--~l~~~~~~ 423 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKK--KLEALEKK 423 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHH--HHHHHHhc
Confidence 99999999999999999999999987 56665543
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=289.58 Aligned_cols=233 Identities=25% Similarity=0.335 Sum_probs=185.5
Q ss_pred EecccCcEEEEEEEEcCCC------eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 236 QIGAGNFSHVFKVLKRIDG------CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~~g------~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
.||+|+||.||+|.+...+ ..||||.+.... .......+..|+.+++.+ +||||+++++++...+..+++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEEEe
Confidence 5899999999999876443 789999876432 223456688899999999 99999999999999999999999
Q ss_pred cCCCC-chhhhh--------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC-----eEEEEeecCce
Q 011331 310 LCDHS-LSDKKA--------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG-----VYKLGDFGRAT 374 (488)
Q Consensus 310 ~~~~~-l~~~~~--------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g-----~vkL~DFGlA~ 374 (488)
|+.++ +..... ...+++..++.++.||+.||.|||+.+++|+||||+||+++ ++ .++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99865 333221 13478889999999999999999999999999999999994 44 79999999987
Q ss_pred ecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhhh---hhh-cCCCCCCCCC
Q 011331 375 LLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQFL---NLR-DGKLPLLPGH 444 (488)
Q Consensus 375 ~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~~---~i~-~~~~~~~~~~ 444 (488)
...... ....++..|+|||++... .++.++|||||||++|||++ |..||....... .+. ......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC 238 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence 553221 122456789999998765 57789999999999999998 888876443221 222 2334455667
Q ss_pred cHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 445 SLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 445 s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
+..+.++|.+||..+|.+||+++++++
T Consensus 239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 239 PDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred hHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 899999999999999999999999876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=313.65 Aligned_cols=248 Identities=25% Similarity=0.348 Sum_probs=200.3
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccC-CCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ-LHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~-~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
-|-.++.||-|+||+|.++....|...||+|.+++. ............|..||+.. +.+.||+||..|++++.+|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEE
Confidence 488899999999999999999999999999998654 22222234455688888887 8999999999999999999999
Q ss_pred ecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CC---
Q 011331 309 ELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KS--- 379 (488)
Q Consensus 309 E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~--- 379 (488)
+|+.|+-.. +..-+.++|..++.++..+.+|+++.|+.|+|||||||+|||| .+|+|||.||||++-+. ++
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 999886332 4455679999999999999999999999999999999999999 68999999999996431 00
Q ss_pred ---------------------------------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcC
Q 011331 380 ---------------------------------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKG 420 (488)
Q Consensus 380 ---------------------------------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG 420 (488)
.-..+||+.|+|||++... .++..||+||.||+||||+.|
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHhhHHHHHHhhC
Confidence 0012499999999999876 678899999999999999999
Q ss_pred CCCCCCchhhh---hhhc----CCCCCCCCCcHHHHHHHHHcccCCCCCCCC---HHHHHhChhhhhhHH
Q 011331 421 SPLSESGPQFL---NLRD----GKLPLLPGHSLQFQNLLKVMVDPDPVQRPS---AKELVENPIFDKIQK 480 (488)
Q Consensus 421 ~~p~~~~~~~~---~i~~----~~~~~~~~~s~~l~~lI~k~L~~dP~~RpT---a~elL~HP~f~~i~~ 480 (488)
.+||....+.. ++.+ ..++.-..++.++.++|.+++ -+++.|.. ++||..||||+.|..
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccch
Confidence 99997654321 2221 223444567999999999865 45667754 888999999998754
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=290.68 Aligned_cols=239 Identities=27% Similarity=0.368 Sum_probs=191.0
Q ss_pred ceeEEEEecccCcEEEEEEEEcC----CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc--cce
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRI----DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE--NEQ 303 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~--~~~ 303 (488)
+|++.+.||+|+||.||+|.... ++..||||++...... .....+..|+.+++.+ .|+||+++++++.. ...
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCCc
Confidence 57888999999999999998643 4889999998754332 3456788999999998 99999999998877 557
Q ss_pred EEEEEecCCCC-chhhhhcc--cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 304 LYIQMELCDHS-LSDKKASQ--FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
.+++|||+.++ +....... .+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 89999999764 44433222 48999999999999999999999999999999999999 6789999999999876522
Q ss_pred CC------CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-h----------------hhhh--
Q 011331 380 LP------IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-F----------------LNLR-- 434 (488)
Q Consensus 380 ~~------~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-~----------------~~i~-- 434 (488)
.. ...++..|+|||.+... .++.++|||||||++|||++|..|+..... . ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 11 12345679999988665 567799999999999999999987654211 1 1111
Q ss_pred cCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 435 DGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 435 ~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
....+.+..++.++.+++.+||..+|.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1223344566789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.01 Aligned_cols=245 Identities=25% Similarity=0.365 Sum_probs=205.8
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-----cceE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE-----NEQL 304 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-----~~~l 304 (488)
-|.+.+.||.|.+|.||+++++.+|...|+|+.......+ ++...|..+|+.+..|||++.+|++|.. ++.+
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 4789999999999999999999999999999987543333 3455688999999999999999998873 5679
Q ss_pred EEEEecCCCCchh----hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 305 YIQMELCDHSLSD----KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 305 ~IV~E~~~~~l~~----~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
|||||||+++.-. ......+.|..+..|++.++.||.+||.+.+||||||-.|||+ ++|.+||+|||.+..++..
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 9999999886332 2335679999999999999999999999999999999999999 7899999999999887643
Q ss_pred ---CCCCCCCCCccChhhhccc----CCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCCCC------CCCCcH
Q 011331 380 ---LPIEEGDARYMPQEILNED----YDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPL------LPGHSL 446 (488)
Q Consensus 380 ---~~~~~Gt~~Y~APEvl~~~----~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~~~------~~~~s~ 446 (488)
..+..||+.|||||++... +.|...+|+||||++..||..|.+|+....++..+....... +...+.
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~ 256 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSK 256 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHH
Confidence 3466799999999998642 445568999999999999999999988766654443322222 334578
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 447 QFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
+|.+||..||.+|-++||+..++|+|||+++
T Consensus 257 ~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 257 KFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 9999999999999999999999999999974
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=316.20 Aligned_cols=259 Identities=23% Similarity=0.380 Sum_probs=218.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..+++.+..||-|+||.|=++........+|+|++++.. ......+....|-.++..+ +.|+||++|..|.++..+|+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccchhhhh
Confidence 457788999999999999999876555569999987653 3334455678899999998 79999999999999999999
Q ss_pred EEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC--
Q 011331 307 QMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP-- 381 (488)
Q Consensus 307 V~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~-- 381 (488)
.||-|-|+ ++. ....+.+.+..+..++..++.|++|||++|||+|||||+|+|+ .+|-+||.|||+|+.+.....
T Consensus 498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTw 577 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTW 577 (732)
T ss_pred hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCcee
Confidence 99999665 444 4556779999999999999999999999999999999999999 689999999999998876544
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcC--CCCCCCCCcHHHHHHHHHcc
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDG--KLPLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~--~~~~~~~~s~~l~~lI~k~L 456 (488)
+.+||+.|.|||++.++ .+..++|.||||+++|||++|.+||.+.+++.. +..+ .+.+|..++....++|+++.
T Consensus 578 TFcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LC 656 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLC 656 (732)
T ss_pred eecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHH
Confidence 46899999999998776 566799999999999999999999999887653 3332 35567788999999999999
Q ss_pred cCCCCCCCC-----HHHHHhChhhhhhHH--hhhhcCCC
Q 011331 457 DPDPVQRPS-----AKELVENPIFDKIQK--HRKTYMKP 488 (488)
Q Consensus 457 ~~dP~~RpT-----a~elL~HP~f~~i~~--~~~~~~~~ 488 (488)
..+|.+|.. +.++-+|-||.++.+ .++..|.|
T Consensus 657 r~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~p 695 (732)
T KOG0614|consen 657 RDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPP 695 (732)
T ss_pred hcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCC
Confidence 999999976 999999999998864 44444443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=283.93 Aligned_cols=252 Identities=20% Similarity=0.285 Sum_probs=203.5
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc--eE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE--QL 304 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~--~l 304 (488)
..++|++++++|+|.+++||.|.+..+++.++||+++. ...++..+|+.||..|..||||++++++..+.. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 35689999999999999999999999999999999863 445678899999999988999999999988654 46
Q ss_pred EEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--CCeEEEEeecCceecCCC--C
Q 011331 305 YIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDFGRATLLNKS--L 380 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~g~vkL~DFGlA~~~~~~--~ 380 (488)
.+++||+++.-.... .+.++..++..++.+++.||.|+|++||+|||+||.|+||+ ...++|+|+|+|...... .
T Consensus 111 aLiFE~v~n~Dfk~l-y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQL-YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred hhHhhhhccccHHHH-hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence 799999987643322 25688889999999999999999999999999999999994 578999999999887543 3
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch----hhhhhh-------------cCCCCC---
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP----QFLNLR-------------DGKLPL--- 440 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~----~~~~i~-------------~~~~~~--- 440 (488)
...+.+.+|--||.+..-..+..+-|+|||||+|..|+..+.||..+. ++..+. .-.+.+
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~ 269 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQ 269 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChh
Confidence 445577789999998654345568999999999999999987765431 111110 000000
Q ss_pred ---------------------CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhhhh
Q 011331 441 ---------------------LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKT 484 (488)
Q Consensus 441 ---------------------~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~~~ 484 (488)
-.-+++++.+|+.++|..|..+|+||+|++.||||..+.....+
T Consensus 270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~ 334 (338)
T KOG0668|consen 270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESS 334 (338)
T ss_pred HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhc
Confidence 01246899999999999999999999999999999988765544
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=284.14 Aligned_cols=233 Identities=19% Similarity=0.235 Sum_probs=176.0
Q ss_pred EecccCcEEEEEEEEcCC--CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 236 QIGAGNFSHVFKVLKRID--GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~~--g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
.||+|+||+||++..... ...+++|.+... ........+.+|+.++..+ +||||+++++.+......|+||||+.+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCCC
Confidence 599999999999975433 345667766543 2234456788899999988 999999999999999999999999987
Q ss_pred Cch-hhhh-----cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC-----CCC
Q 011331 314 SLS-DKKA-----SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK-----SLP 381 (488)
Q Consensus 314 ~l~-~~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~-----~~~ 381 (488)
+.+ .... ...+++..++.++.||+.||.|||+.+++|+||||+|||+ .++.++|+|||++..... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 533 3221 1235667788999999999999999999999999999999 678999999999864321 112
Q ss_pred CCCCCCCccChhhhccc------CCCCchhHHHHHHHHHHHHHcC-CCCCCCchhh---hhh-hcCC-----CCCCCCCc
Q 011331 382 IEEGDARYMPQEILNED------YDHLDKVDIFSLGATMYELIKG-SPLSESGPQF---LNL-RDGK-----LPLLPGHS 445 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~------~~~~~ksDIwSlGvlL~eLltG-~~p~~~~~~~---~~i-~~~~-----~~~~~~~s 445 (488)
...|+..|+|||++... ..++.++|||||||++|||+++ ..|+...... ..+ .... ......++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS 239 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence 34578899999987431 2346689999999999999975 5566543321 111 1111 12234578
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 446 LQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 446 ~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
..+.++|..|| .+|++||+++++++
T Consensus 240 ~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 240 ERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 89999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=304.10 Aligned_cols=249 Identities=23% Similarity=0.375 Sum_probs=207.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccC-CCchH----HHHHHHHHHHHHHHhCCCCCeeEeeeeec-cc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ-LHHDA----ERRKALLEVQALAALGSHENIVGYYSSWF-EN 301 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~-~~~~~----~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~-~~ 301 (488)
.++|-++..||+|||++||+|.+....+.||||+.... .+.+. ..+.+.+|..|.+.| +||.||++|++|. +.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLDT 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeecc
Confidence 34677889999999999999999999999999986422 12222 234577899999998 9999999999997 56
Q ss_pred ceEEEEEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHc--CcccCCCCCCcEEEeC----CeEEEEeecCc
Q 011331 302 EQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEK--GIAHLDVKPDNIYVKN----GVYKLGDFGRA 373 (488)
Q Consensus 302 ~~l~IV~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--gIiHrDLKp~NILv~~----g~vkL~DFGlA 373 (488)
+.+|-|+|||+|+-++ +..+..+++.+++.|+.||+.||.||.+. .|||.||||.|||+-+ |.+||.|||++
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 6789999999998665 45566799999999999999999999976 5999999999999943 68999999999
Q ss_pred eecCCCC----------CCCCCCCCccChhhhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh------
Q 011331 374 TLLNKSL----------PIEEGDARYMPQEILNE---DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR------ 434 (488)
Q Consensus 374 ~~~~~~~----------~~~~Gt~~Y~APEvl~~---~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~------ 434 (488)
++++... ....||.+|++||.+.- ....+.++||||+||++|.++.|+.||........+.
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 9885421 12359999999998642 3456679999999999999999999998776544432
Q ss_pred ---cCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 435 ---DGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 435 ---~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
.-.+|..|.++.++..||++||++.-++|....+|-.||+|..
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 2345667788999999999999999999999999999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.69 Aligned_cols=245 Identities=24% Similarity=0.233 Sum_probs=167.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCC----CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeee------
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRID----GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSS------ 297 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~------ 297 (488)
.++|.+.+.||+|+||+||+|.+..+ +..||||++..... .+....+ .+... .+.+++.+...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~-~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRA-CPNSCADFVYGFLEPVS 203 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhh-chhhHHHHHHhhhcccc
Confidence 56899999999999999999999988 99999998754211 1111111 11121 22222222221
Q ss_pred ecccceEEEEEecCCCCchh-hhhccc---------------------CCHHHHHHHHHHHHHHHHHHHHcCcccCCCCC
Q 011331 298 WFENEQLYIQMELCDHSLSD-KKASQF---------------------FAEGEVLKALHQIAQALQFIHEKGIAHLDVKP 355 (488)
Q Consensus 298 ~~~~~~l~IV~E~~~~~l~~-~~~~~~---------------------l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp 355 (488)
......++|||||++++.+. ...... .....+..++.||+.||.|||++||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 24566799999999876332 221111 12334668999999999999999999999999
Q ss_pred CcEEEe--CCeEEEEeecCceecCCC----CCCCCCCCCccChhhhccc---------------------CCCCchhHHH
Q 011331 356 DNIYVK--NGVYKLGDFGRATLLNKS----LPIEEGDARYMPQEILNED---------------------YDHLDKVDIF 408 (488)
Q Consensus 356 ~NILv~--~g~vkL~DFGlA~~~~~~----~~~~~Gt~~Y~APEvl~~~---------------------~~~~~ksDIw 408 (488)
+|||++ ++.+||+|||+|+.+... .....|++.|+|||.+... ..+..++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 999995 478999999999865322 2345689999999976321 1233467999
Q ss_pred HHHHHHHHHHcCCCCCCCchh-hhh-hhcCCC---------------------CCCCCCcHHHHHHHHHcccCCCCCCCC
Q 011331 409 SLGATMYELIKGSPLSESGPQ-FLN-LRDGKL---------------------PLLPGHSLQFQNLLKVMVDPDPVQRPS 465 (488)
Q Consensus 409 SlGvlL~eLltG~~p~~~~~~-~~~-i~~~~~---------------------~~~~~~s~~l~~lI~k~L~~dP~~RpT 465 (488)
||||+||||+++..+...... +.. +..... ..........++||.+||++||.+|||
T Consensus 364 SlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 999999999997655443211 111 110000 001111234568999999999999999
Q ss_pred HHHHHhChhhhhhH
Q 011331 466 AKELVENPIFDKIQ 479 (488)
Q Consensus 466 a~elL~HP~f~~i~ 479 (488)
++|+|+||||+...
T Consensus 444 a~e~L~Hpff~~~~ 457 (566)
T PLN03225 444 AKAALAHPYFDREG 457 (566)
T ss_pred HHHHhCCcCcCCCC
Confidence 99999999998643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=269.78 Aligned_cols=232 Identities=33% Similarity=0.544 Sum_probs=191.9
Q ss_pred CcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC-Cchhhh
Q 011331 241 NFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSDKK 319 (488)
Q Consensus 241 ~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~-~l~~~~ 319 (488)
+||.||+|.+..+|..||+|++........ ...+..|++.+.++ +|+||+++++.+......+++||++++ .+....
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999998899999999875433222 56788899999999 999999999999999999999999988 454433
Q ss_pred hcc-cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CCCCCCCCCccChhhh
Q 011331 320 ASQ-FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LPIEEGDARYMPQEIL 395 (488)
Q Consensus 320 ~~~-~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~~~~Gt~~Y~APEvl 395 (488)
... .++...++.++.+++.+|.|||+.|++|+||+|+||++ .++.++|+|||.+...... .....++..|++||.+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 322 38899999999999999999999999999999999999 5689999999999877552 3445688899999998
Q ss_pred cccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcCCCCCCCC---CcHHHHHHHHHcccCCCCCCCCHHH
Q 011331 396 NEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDGKLPLLPG---HSLQFQNLLKVMVDPDPVQRPSAKE 468 (488)
Q Consensus 396 ~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~~~~~~~~---~s~~l~~lI~k~L~~dP~~RpTa~e 468 (488)
... .++.++||||||+++|+|++|..|+..... ...+.......... ++.++.+++.+||..+|++||++.+
T Consensus 159 ~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 237 (244)
T smart00220 159 LGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEE 237 (244)
T ss_pred ccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHH
Confidence 754 466799999999999999999998866222 11222233322222 7889999999999999999999999
Q ss_pred HHhChhh
Q 011331 469 LVENPIF 475 (488)
Q Consensus 469 lL~HP~f 475 (488)
+++||||
T Consensus 238 ~~~~~~~ 244 (244)
T smart00220 238 ALQHPFF 244 (244)
T ss_pred HhhCCCC
Confidence 9999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.12 Aligned_cols=243 Identities=20% Similarity=0.256 Sum_probs=199.7
Q ss_pred ccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 224 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
|.--..+.....+||-|.||.||.|.|+.-...||||.++.. ..+.++|+.|+.+++.+ .|||+|+|+++|.....
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCC
Confidence 333345667788999999999999999999999999998754 35677899999999999 99999999999999999
Q ss_pred EEEEEecCC-CCchhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 304 LYIQMELCD-HSLSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 304 l~IV~E~~~-~~l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
+|||+|||. |+|++.. ....++.-.++.++.||..|++||..+++|||||...|+|| .+..+||+||||++.+..
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 999999985 4555522 22347777888999999999999999999999999999999 677899999999998854
Q ss_pred CC-CCC---CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcC-CCCCCCchhh--hh-hh-cCCCCCCCCCcHHHH
Q 011331 379 SL-PIE---EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQF--LN-LR-DGKLPLLPGHSLQFQ 449 (488)
Q Consensus 379 ~~-~~~---~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG-~~p~~~~~~~--~~-i~-~~~~~~~~~~s~~l~ 449 (488)
.. +.. ..++.|.|||-|..+ .++-|+|||+|||+|||+.|- ..|+.+-+.- .. +. ......+.++++.++
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVY 496 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVY 496 (1157)
T ss_pred CceecccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHH
Confidence 32 222 346789999998765 567799999999999999984 4565544331 12 22 234567889999999
Q ss_pred HHHHHcccCCCCCCCCHHHHHh
Q 011331 450 NLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~ 471 (488)
+||+.||+|+|.+||++.|+-.
T Consensus 497 eLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 497 ELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHhcCCcccCccHHHHHH
Confidence 9999999999999999988743
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=310.46 Aligned_cols=232 Identities=27% Similarity=0.392 Sum_probs=185.3
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc------eE
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE------QL 304 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~------~l 304 (488)
|..-+.||+|+||.||+++++.+|+.||||.++... +...+..+.+|+++|+++ +|+|||+++++-.+.. ..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccccc
Confidence 456678999999999999999999999999987643 445567789999999999 6999999998766544 35
Q ss_pred EEEEecCCCCchhhhh-----cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe---CC--eEEEEeecCce
Q 011331 305 YIQMELCDHSLSDKKA-----SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK---NG--VYKLGDFGRAT 374 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~---~g--~vkL~DFGlA~ 374 (488)
.+|||||.++.+.... ...+++.+++.++..++.||.|||++|||||||||.||++- +| ..||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 7999999887555322 34599999999999999999999999999999999999992 34 47999999999
Q ss_pred ecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh-------hhhh-----------
Q 011331 375 LLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF-------LNLR----------- 434 (488)
Q Consensus 375 ~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~-------~~i~----------- 434 (488)
.+++. .....||..|.+||++.....|+..+|.|||||++|+++||..||...... ..+.
T Consensus 173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~ 252 (732)
T KOG4250|consen 173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA 252 (732)
T ss_pred cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence 88654 345679999999999985446778999999999999999999887532111 1111
Q ss_pred ----c------CCCCCCCCCc----HHHHHHHHHcccCCCCCCC
Q 011331 435 ----D------GKLPLLPGHS----LQFQNLLKVMVDPDPVQRP 464 (488)
Q Consensus 435 ----~------~~~~~~~~~s----~~l~~lI~k~L~~dP~~Rp 464 (488)
+ ..+|.+...+ ..+-.++..+|.++|.+|-
T Consensus 253 ~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 253 QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1 1123322222 3467889999999999997
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.39 Aligned_cols=240 Identities=20% Similarity=0.198 Sum_probs=193.0
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
..+.++++||+|.||+|.+|.-. .+.+||||+++.. .+...+.++.+|+.+|.++ +|||||+++++|..++.+++++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPD-ATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcc-cchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHHHH
Confidence 35678999999999999999764 4699999999865 3445578899999999999 9999999999999999999999
Q ss_pred ecCCCCchh-hhhcc---cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC--
Q 011331 309 ELCDHSLSD-KKASQ---FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP-- 381 (488)
Q Consensus 309 E~~~~~l~~-~~~~~---~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~-- 381 (488)
||++.+-+. ..... .+.-.....++.||+.||+||.+.++|||||.+.|+|+ .++++||+|||+++.+-....
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999876443 22221 22344567799999999999999999999999999999 689999999999986533221
Q ss_pred ---CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcC--CCCCCCchhhhhhhc-----------CCCCCCCCCc
Q 011331 382 ---IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKG--SPLSESGPQFLNLRD-----------GKLPLLPGHS 445 (488)
Q Consensus 382 ---~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG--~~p~~~~~~~~~i~~-----------~~~~~~~~~s 445 (488)
..+-+.+|||||.+..+ .+++++|+|+||++|||+++- ..||........+.+ -.++.|+-++
T Consensus 695 vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp 773 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP 773 (807)
T ss_pred eecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence 22346799999987765 578899999999999998764 467765433222211 1234566789
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 446 LQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 446 ~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
.+++++|.+||..|.++|||+++|..|
T Consensus 774 ~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 774 QGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred HHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 999999999999999999999998764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=283.42 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=201.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc-----
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE----- 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~----- 302 (488)
..+|.-+..+|.|.- .|..|-+...++.||+|.+-....+....+.+.+|...+..+ +|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHHH
Confidence 457788899999999 888899999999999998866666666678899999999999 9999999999987433
Q ss_pred -eEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 303 -QLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 303 -~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
.+|+|||+++.++..... ..+....+..++.|+++|+.|||+.||+||||||+||++ .+..+||+|||+|+..+..
T Consensus 94 ~e~y~v~e~m~~nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~ 172 (369)
T KOG0665|consen 94 QEVYLVMELMDANLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF 172 (369)
T ss_pred HhHHHHHHhhhhHHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCccc
Confidence 579999999998877544 457788899999999999999999999999999999999 7889999999999866543
Q ss_pred -CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hh---------------------
Q 011331 380 -LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LR--------------------- 434 (488)
Q Consensus 380 -~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~--------------------- 434 (488)
.+..+.|..|+|||++.+- .+...+||||+||++.||++|+.+|.+.+.... +.
T Consensus 173 ~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y 251 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY 251 (369)
T ss_pred ccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence 2334688899999998765 377799999999999999999988876533111 00
Q ss_pred --c----CCCC---------------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhh
Q 011331 435 --D----GKLP---------------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFD 476 (488)
Q Consensus 435 --~----~~~~---------------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~ 476 (488)
. .... ..+.-...+++++.+||..||++|.+++++|+||||+
T Consensus 252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 0000 1112245689999999999999999999999999997
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.19 Aligned_cols=238 Identities=22% Similarity=0.317 Sum_probs=194.3
Q ss_pred ceeEEEEecccCcEEEEEEEEcCC----CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRID----GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
...+.++||.|.||.||.|..... ..-||||..+... .....+.++.|..+++.+ +|||||+++|+|.+ ...|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnf-dHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhC-CCcchhheeeeeec-ccee
Confidence 345567899999999999965432 3458999887643 334478899999999999 99999999999875 4689
Q ss_pred EEEecCCCC-chh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC
Q 011331 306 IQMELCDHS-LSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP 381 (488)
Q Consensus 306 IV~E~~~~~-l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~ 381 (488)
||||++..+ |.. ......++...+..++.||+.||+|||+..+|||||...|||| +..-+||+|||+++.+....-
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 999999765 433 2334468999999999999999999999999999999999999 667899999999998876432
Q ss_pred C----CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHHHHH
Q 011331 382 I----EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQNLL 452 (488)
Q Consensus 382 ~----~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~~lI 452 (488)
. ..-+..|||||.++-. .++.++|||-|||++||++. |..||.+... ...+.+ ..+|.|+.+++.++.++
T Consensus 547 YkaS~~kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslm 625 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLM 625 (974)
T ss_pred hhccccccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHH
Confidence 2 2245689999998765 68889999999999999776 6778775433 233444 46789999999999999
Q ss_pred HHcccCCCCCCCCHHHHHh
Q 011331 453 KVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~ 471 (488)
.+||++||.+||++.|+..
T Consensus 626 skcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 626 SKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHhccCcccCCcHHHHHH
Confidence 9999999999999988764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=303.45 Aligned_cols=246 Identities=22% Similarity=0.311 Sum_probs=206.7
Q ss_pred eeEEEEecccCcEEEEEEEEcCCC---eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDG---CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
..+.+.||.|.||+|++|+.+..| ..||||.++.. ..+..+.+|+.|+.|+-++ +||||++|.++......+.||
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeEEE
Confidence 578899999999999999988776 47999999865 4567788999999999999 999999999999999999999
Q ss_pred EecCCCCchh---hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCC-
Q 011331 308 MELCDHSLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPI- 382 (488)
Q Consensus 308 ~E~~~~~l~~---~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~- 382 (488)
+|||+.+.++ +...+.+...++..+++.|+.|+.||-++|+|||||...|||| .+-.+||+|||+++.+.+..+.
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 9999877555 2333558888999999999999999999999999999999999 6779999999999988543321
Q ss_pred ---CCC--CCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhhh---hhh-cCCCCCCCCCcHHHHHHH
Q 011331 383 ---EEG--DARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQFL---NLR-DGKLPLLPGHSLQFQNLL 452 (488)
Q Consensus 383 ---~~G--t~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~~---~i~-~~~~~~~~~~s~~l~~lI 452 (488)
.-| +.+|.|||.+... .++.++||||||++|||.+. |..|+-+..... .+. +..+|.|.+++..+..||
T Consensus 789 ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLM 867 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLM 867 (996)
T ss_pred ccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHH
Confidence 112 5689999999765 57889999999999999654 777765544432 333 346788889999999999
Q ss_pred HHcccCCCCCCCCHHHHHhChhhhhhHHh
Q 011331 453 KVMVDPDPVQRPSAKELVENPIFDKIQKH 481 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~f~~i~~~ 481 (488)
..||++|-.+||.+.||+.+ |.++.+.
T Consensus 868 ldCWqkdR~~RP~F~qiV~~--lDklIrn 894 (996)
T KOG0196|consen 868 LDCWQKDRNRRPKFAQIVST--LDKLIRN 894 (996)
T ss_pred HHHHHHHhhcCCCHHHHHHH--HHHHhcC
Confidence 99999999999999999986 6665543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.48 Aligned_cols=244 Identities=19% Similarity=0.255 Sum_probs=200.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCC---eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDG---CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
+..+.++||+|.||+|++|.|...+ ..||||.++...... ...+|++|+.++.++ +|+|+++||++..+ ..+.|
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L-~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKL-QHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhc-cCcceeEEeeeecc-chhhH
Confidence 4456789999999999999887543 468999997664433 567899999999999 99999999999887 77899
Q ss_pred EEecCCCC-chhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC
Q 011331 307 QMELCDHS-LSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP 381 (488)
Q Consensus 307 V~E~~~~~-l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~ 381 (488)
|||++..+ |++.. ....|....+..|+.||+.||.||..+++|||||...|||+ +...||||||||.+.+.....
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999865 54432 23457888999999999999999999999999999999999 778999999999998865433
Q ss_pred CC------CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCC-CCCCCchh---hhhhh-cCCCCCCCCCcHHHHH
Q 011331 382 IE------EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLR-DGKLPLLPGHSLQFQN 450 (488)
Q Consensus 382 ~~------~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~-~p~~~~~~---~~~i~-~~~~~~~~~~s~~l~~ 450 (488)
.. .-.+.|+|||.|... .++.++|||+|||+||||+++. -||-+-.. ++.+. ...++.++.+++.+++
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~ 346 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQ 346 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHH
Confidence 32 246679999999875 5778999999999999999964 67765433 22333 3456778889999999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
+++.||..+|++|||+..|.+.-++..
T Consensus 347 imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 347 IMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred HHHHhccCCccccccHHHHHHhHHHHh
Confidence 999999999999999999987655544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=292.30 Aligned_cols=249 Identities=19% Similarity=0.239 Sum_probs=176.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEc----------------CCCeEEEEEEeccCCCchH------------HHHHHHHHH
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKR----------------IDGCFYAVKHSKRQLHHDA------------ERRKALLEV 279 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~----------------~~g~~vAvK~l~~~~~~~~------------~~~~~~~Ei 279 (488)
.++|.+.++||+|+||+||+|... ..++.||||.+........ ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999652 2456899999864311100 112244567
Q ss_pred HHHHHhCCCCCe-----eEeeeeecc--------cceEEEEEecCCCCchh-hhh-------------------------
Q 011331 280 QALAALGSHENI-----VGYYSSWFE--------NEQLYIQMELCDHSLSD-KKA------------------------- 320 (488)
Q Consensus 280 ~iL~~l~~HpnI-----v~l~~~~~~--------~~~l~IV~E~~~~~l~~-~~~------------------------- 320 (488)
.++.++ .|.++ +.++++|.. .+..||||||+.++.+. ...
T Consensus 224 ~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 224 YMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777 44443 566666543 35689999999865332 111
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC----CCCCCCCccChhhh
Q 011331 321 SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP----IEEGDARYMPQEIL 395 (488)
Q Consensus 321 ~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~----~~~Gt~~Y~APEvl 395 (488)
...+++..++.++.||+.||.|||+.+|+||||||+|||+ .++.+||+|||++........ ...+++.|+|||++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 1123556788999999999999999999999999999999 678999999999976533211 12347899999987
Q ss_pred ccc---------------------CCCCchhHHHHHHHHHHHHHcCCC-CCCCchhh----h----------hhh--cCC
Q 011331 396 NED---------------------YDHLDKVDIFSLGATMYELIKGSP-LSESGPQF----L----------NLR--DGK 437 (488)
Q Consensus 396 ~~~---------------------~~~~~ksDIwSlGvlL~eLltG~~-p~~~~~~~----~----------~i~--~~~ 437 (488)
... +....+.||||+||++|+|++|.. |+.....+ . ... ...
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 532 112235799999999999999975 44321111 0 011 112
Q ss_pred CCCCCCCcHHHHHHHHHcccCCC---CCCCCHHHHHhChhhhh
Q 011331 438 LPLLPGHSLQFQNLLKVMVDPDP---VQRPSAKELVENPIFDK 477 (488)
Q Consensus 438 ~~~~~~~s~~l~~lI~k~L~~dP---~~RpTa~elL~HP~f~~ 477 (488)
.+.....+...++||.+||..+| .+|+|++|+|+||||..
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 33445678899999999999876 68999999999999953
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=257.88 Aligned_cols=210 Identities=30% Similarity=0.423 Sum_probs=179.2
Q ss_pred ccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 224 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
+..--+++..+..||+|++|.|-+.++..+|...|+|.+.... +..+..+.++|+.+..+...+|++|.+|+.....+.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 3333456677889999999999999999999999999997764 456677899999999998899999999999999999
Q ss_pred EEEEEecCCCCchh-----hhhcccCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEE-eCCeEEEEeecCceec
Q 011331 304 LYIQMELCDHSLSD-----KKASQFFAEGEVLKALHQIAQALQFIHEK-GIAHLDVKPDNIYV-KNGVYKLGDFGRATLL 376 (488)
Q Consensus 304 l~IV~E~~~~~l~~-----~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~ 376 (488)
+||.||.|+.++.. ....+.++|..+-+++.-|+.||.|||++ .+||||+||+|||| .+|.+|+||||.+..+
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 99999999988665 23446799999999999999999999976 89999999999999 6899999999999888
Q ss_pred CCCCC--CCCCCCCccChhhhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCCch-hhhhhh
Q 011331 377 NKSLP--IEEGDARYMPQEILNED---YDHLDKVDIFSLGATMYELIKGSPLSESGP-QFLNLR 434 (488)
Q Consensus 377 ~~~~~--~~~Gt~~Y~APEvl~~~---~~~~~ksDIwSlGvlL~eLltG~~p~~~~~-~~~~i~ 434 (488)
.++.. ...|...|||||.+..+ ..|+-++||||||+++.||.+++.|++.+- ++..+.
T Consensus 200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLk 263 (282)
T KOG0984|consen 200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLK 263 (282)
T ss_pred hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHH
Confidence 66543 24688899999998532 356779999999999999999999998874 344443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.94 Aligned_cols=235 Identities=33% Similarity=0.476 Sum_probs=188.8
Q ss_pred EEEecccCcEE-EEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCC
Q 011331 234 IEQIGAGNFSH-VFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCD 312 (488)
Q Consensus 234 ~~~LG~G~fg~-Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~ 312 (488)
-+.+|.|.-|+ ||+|.. .|+.||||.+-. ....-+.+|++.|..-..|||||++|+.-.+...+||+.|+|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 35689999875 689987 589999997642 3344578999999999999999999999999999999999999
Q ss_pred CCchhhhhcc-----cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----C--CeEEEEeecCceecCCC--
Q 011331 313 HSLSDKKASQ-----FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----N--GVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 313 ~~l~~~~~~~-----~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~--g~vkL~DFGlA~~~~~~-- 379 (488)
.+|.+..... .......+.++.|++.||++||+.+||||||||.||||. + ..++|+|||+++.+...
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 9877744331 112245788999999999999999999999999999993 2 37899999999887532
Q ss_pred ----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcC-CCCCCCchh-hhhhhcCCCCCC---CCCcHHHHH
Q 011331 380 ----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ-FLNLRDGKLPLL---PGHSLQFQN 450 (488)
Q Consensus 380 ----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG-~~p~~~~~~-~~~i~~~~~~~~---~~~s~~l~~ 450 (488)
.....||-+|+|||++... ..+.++||+||||++|..++| .+||...-. ..+|..+...+. +....++.+
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~eA~d 745 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCEAKD 745 (903)
T ss_pred hhhcccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHHHHH
Confidence 2334599999999999876 345699999999999999998 688876543 345555443321 112228999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhh
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFD 476 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~ 476 (488)
||.+|+.++|..||+|.+||+||+|=
T Consensus 746 LI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 746 LISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred HHHHhcCCCcccCCCHHHHhCCCccC
Confidence 99999999999999999999999993
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=274.94 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=198.7
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc-----eEEE
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE-----QLYI 306 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~-----~l~I 306 (488)
+-.+.||.|.||+||.+.+..+|+.||+|++..-..+-..-+.+++|+.+|... +|.|++..+++..-.. .+|+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHH
Confidence 345679999999999999999999999998865444455567899999999998 9999999888765432 4688
Q ss_pred EEecCCCCchhhhh-cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----C
Q 011331 307 QMELCDHSLSDKKA-SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----L 380 (488)
Q Consensus 307 V~E~~~~~l~~~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----~ 380 (488)
++|++...|..... -+.++...+.-+++||+.||.|||+.||.||||||.|+|| ++-.+||||||+|+..+.. .
T Consensus 135 ~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 135 LTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 99999887766333 3468888999999999999999999999999999999999 6779999999999876432 2
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---------------------------
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL--------------------------- 433 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i--------------------------- 433 (488)
+.++-|.+|+|||++.+...|+.++||||.||++.||+..+.+|....+...+
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L 294 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL 294 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence 33457889999999999888999999999999999999888877654332111
Q ss_pred hcC-CCC---------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 434 RDG-KLP---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 434 ~~~-~~~---------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+.+ +.| .+.....+...++.++|..||.+|++..+++.|+++.+.+
T Consensus 295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 100 011 1112345678899999999999999999999999987653
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=294.25 Aligned_cols=246 Identities=25% Similarity=0.345 Sum_probs=198.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcC-------CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRI-------DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
.+++.+.+.||.|.||+|++|.-.. ....||||.++..... .+...+..|+.++..++.|+||+.+++++..
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 4455677799999999999985331 1567999998776554 7778899999999999999999999999999
Q ss_pred cceEEEEEecCCCC-chhhhhccc-----------------CCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-e
Q 011331 301 NEQLYIQMELCDHS-LSDKKASQF-----------------FAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-K 361 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~~~~~~~-----------------l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~ 361 (488)
.+.+++|+||+..+ |+....... ++..+++.++.||+.|++||++.++|||||-.+|||| .
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 99999999999765 444333333 8889999999999999999999999999999999999 5
Q ss_pred CCeEEEEeecCceecCCCCCCC----CC--CCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCC-CCCCCc---hh-h
Q 011331 362 NGVYKLGDFGRATLLNKSLPIE----EG--DARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGS-PLSESG---PQ-F 430 (488)
Q Consensus 362 ~g~vkL~DFGlA~~~~~~~~~~----~G--t~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~-~p~~~~---~~-~ 430 (488)
+..+||+|||+|+......... .| +..|||||.+.. ..++.++|||||||+||||++.. .|+.+. .. .
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 6699999999998653322211 12 456999999987 47888999999999999999955 555542 12 2
Q ss_pred hhhhcCCC-CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 431 LNLRDGKL-PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 431 ~~i~~~~~-~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
..++.|.. ..|..++.+++++|+.||..+|++||++.++.+ +|..
T Consensus 533 ~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~~ 578 (609)
T KOG0200|consen 533 EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE--FFEK 578 (609)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH--HHHH
Confidence 33555544 566677999999999999999999999999987 3554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=312.19 Aligned_cols=239 Identities=19% Similarity=0.257 Sum_probs=182.1
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
..|...+.||+|+||+||+|.+..+|..||||++...... ...|++++.++ +|||||++++++.+.+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKL-QHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhC-CCCCcceEEEEEEcCCCCEEEE
Confidence 3566778899999999999999889999999988643211 12357788888 9999999999999999999999
Q ss_pred ecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHH---HcCcccCCCCCCcEEEe-CCeEEEEeecCceecCCCCCCCC
Q 011331 309 ELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIH---EKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE 384 (488)
Q Consensus 309 E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH---~~gIiHrDLKp~NILv~-~g~vkL~DFGlA~~~~~~~~~~~ 384 (488)
||++++.+..... .+++..+..++.||+.||+||| +.+|+||||||+||+++ ++..+++ ||.+...... ....
T Consensus 763 Ey~~~g~L~~~l~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-~~~~ 839 (968)
T PLN00113 763 EYIEGKNLSEVLR-NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-TKCF 839 (968)
T ss_pred eCCCCCcHHHHHh-cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-CCcc
Confidence 9998765443332 4888999999999999999999 66999999999999994 4556654 6665543222 2336
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhh---h----------hcCCC----CCCCC
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLN---L----------RDGKL----PLLPG 443 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~---i----------~~~~~----~~~~~ 443 (488)
|+..|+|||++... .++.++|||||||++|||++|+.|++.... ... . .+... +....
T Consensus 840 ~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (968)
T PLN00113 840 ISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918 (968)
T ss_pred ccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHH
Confidence 88999999998765 577899999999999999999999753211 000 0 00001 11111
Q ss_pred CcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 444 HSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 444 ~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
...++.+++.+||+.||++|||+.|+++. ++.+.+
T Consensus 919 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~~ 953 (968)
T PLN00113 919 EIVEVMNLALHCTATDPTARPCANDVLKT--LESASR 953 (968)
T ss_pred HHHHHHHHHHhhCcCCchhCcCHHHHHHH--HHHhhc
Confidence 23357789999999999999999999985 555543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=272.08 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=198.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcC---CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRI---DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.+.|.++++||.|.|++||++.+.. ..+.||+|.+.... .......|++.|..+..+.||+++.+++..++..
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 4468999999999999999998887 78999999886432 2234788999999999999999999999999999
Q ss_pred EEEEecCCCCch-hhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE--eCCeEEEEeecCceecCC---
Q 011331 305 YIQMELCDHSLS-DKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV--KNGVYKLGDFGRATLLNK--- 378 (488)
Q Consensus 305 ~IV~E~~~~~l~-~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv--~~g~vkL~DFGlA~~~~~--- 378 (488)
.+||||+++.-. ... ..++..++..+++.++.||.++|.+|||||||||.|+|. ..+.-.|+|||+|.....
T Consensus 111 ~ivlp~~~H~~f~~l~--~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLY--RSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred EEEecccCccCHHHHH--hcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 999999998533 333 237788999999999999999999999999999999999 468899999999972100
Q ss_pred -----C---------------------------------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHH
Q 011331 379 -----S---------------------------------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATM 414 (488)
Q Consensus 379 -----~---------------------------------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL 414 (488)
. .....||++|+|||++.....-++++||||.||++
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 00123999999999998766777899999999999
Q ss_pred HHHHcCCCCCCCchh----hhh---h------h-----cCC-------------------------------C------C
Q 011331 415 YELIKGSPLSESGPQ----FLN---L------R-----DGK-------------------------------L------P 439 (488)
Q Consensus 415 ~eLltG~~p~~~~~~----~~~---i------~-----~~~-------------------------------~------~ 439 (488)
..++++..||..... ..+ + + .+. . .
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 999999988763210 000 0 0 000 0 0
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhhh
Q 011331 440 LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRK 483 (488)
Q Consensus 440 ~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~~ 483 (488)
.....+..+.+|+.+||..||.+|+||+++|.||||....+...
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~~ 392 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTER 392 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhhh
Confidence 00112446889999999999999999999999999998765443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=287.87 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=205.7
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
..+|.++..+|.|.||.||++++..+++..|+|+++... .....-...|+-+++.. +|||||.+++.+.....+||.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc-~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecC-CCcChHHHHhhhhhhcCcEEE
Confidence 347899999999999999999999999999999987542 33345567788888888 999999999999999999999
Q ss_pred EecCCCCchhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CC
Q 011331 308 MELCDHSLSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LP 381 (488)
Q Consensus 308 ~E~~~~~l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~ 381 (488)
||||+++.++.. ..+.+++.++...++..+.||+|||+.|-+|||||-.||++ +.|.+|++|||.+..+... ..
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK 170 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence 999998766633 34568999999999999999999999999999999999999 7799999999988766432 23
Q ss_pred CCCCCCCccChhhhc--ccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh--hcCC------CCCCCCCcHHHHHH
Q 011331 382 IEEGDARYMPQEILN--EDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL--RDGK------LPLLPGHSLQFQNL 451 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~--~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i--~~~~------~~~~~~~s~~l~~l 451 (488)
...||++|||||+.. ....|...+|||++|+...|+-.-.+|.....++..+ +... +......++-|.+|
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f 250 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF 250 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence 457999999999852 2335777999999999999999888876665554332 2111 12233467889999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
++.+|.++|.+|||++.+|.|||+..
T Consensus 251 vK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 251 VKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHhcCCCccCCChhhheeceeecc
Confidence 99999999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=269.78 Aligned_cols=235 Identities=23% Similarity=0.330 Sum_probs=182.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHh-CCCCCeeEeeeeecccc----e
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAAL-GSHENIVGYYSSWFENE----Q 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l-~~HpnIv~l~~~~~~~~----~ 303 (488)
...++++.||+|.||.||+|.. +++.||||++. ..+.+.+..|-.|.+.. ..|+||++++++-.... .
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 4567889999999999999976 57999999974 35567788888887753 38999999998766555 7
Q ss_pred EEEEEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHc---------CcccCCCCCCcEEE-eCCeEEEEeecC
Q 011331 304 LYIQMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEK---------GIAHLDVKPDNIYV-KNGVYKLGDFGR 372 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~---------gIiHrDLKp~NILv-~~g~vkL~DFGl 372 (488)
++||+||.+.+ |.+......+++.++.+++.-++.||+|||+- .|+|||||..|||| +|+.+.|+|||+
T Consensus 283 ywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 89999999764 66666777899999999999999999999963 59999999999999 789999999999
Q ss_pred ceecCCC-----CCCCCCCCCccChhhhcccCCCC-----chhHHHHHHHHHHHHHcCCCCC------------CCc---
Q 011331 373 ATLLNKS-----LPIEEGDARYMPQEILNEDYDHL-----DKVDIFSLGATMYELIKGSPLS------------ESG--- 427 (488)
Q Consensus 373 A~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~-----~ksDIwSlGvlL~eLltG~~p~------------~~~--- 427 (488)
|..+... ....+||.+|||||+|.+.-++. .+.||||+|.+||||++..... +..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9887532 22357999999999997643333 3789999999999999854222 100
Q ss_pred ------hhhhhhhcCCCCCCCCC------cHHHHHHHHHcccCCCCCCCCHHHHH
Q 011331 428 ------PQFLNLRDGKLPLLPGH------SLQFQNLLKVMVDPDPVQRPSAKELV 470 (488)
Q Consensus 428 ------~~~~~i~~~~~~~~~~~------s~~l~~lI~k~L~~dP~~RpTa~elL 470 (488)
.....+++...|..+.. ...+.+.|..||+.|++.|.||.=+-
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 01112334444444322 34688999999999999999975443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=263.19 Aligned_cols=236 Identities=26% Similarity=0.368 Sum_probs=181.5
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHH-hCCCCCeeEeeeeecccc----e
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAA-LGSHENIVGYYSSWFENE----Q 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~-l~~HpnIv~l~~~~~~~~----~ 303 (488)
.+..+++.||+|.||+||+|+++ |+.||||++. ..+...+++|.+|... +.+|+||+.+++.=..++ .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~-----srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFS-----SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEec-----ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 35789999999999999999995 9999999974 3456678899999886 359999999987644332 5
Q ss_pred EEEEEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHc--------CcccCCCCCCcEEE-eCCeEEEEeecCc
Q 011331 304 LYIQMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEK--------GIAHLDVKPDNIYV-KNGVYKLGDFGRA 373 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--------gIiHrDLKp~NILv-~~g~vkL~DFGlA 373 (488)
+|||++|.+.+ |.+......++....++++.-++.||+|||-. .|+|||||..|||| .+|.+.|+|+|||
T Consensus 284 LwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 89999999865 55566667899999999999999999999953 49999999999999 8999999999999
Q ss_pred eecCCC-------CCCCCCCCCccChhhhccc-----CCCCchhHHHHHHHHHHHHHcC----------CCCCCCch---
Q 011331 374 TLLNKS-------LPIEEGDARYMPQEILNED-----YDHLDKVDIFSLGATMYELIKG----------SPLSESGP--- 428 (488)
Q Consensus 374 ~~~~~~-------~~~~~Gt~~Y~APEvl~~~-----~~~~~ksDIwSlGvlL~eLltG----------~~p~~~~~--- 428 (488)
...... ....+||.+|||||+|.+. ++.-..+||||||.++||++.. .+||++..
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 765432 3456799999999998643 1222479999999999998753 24555431
Q ss_pred -hhhhhh------cCCCCCCCCC-c----HHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 429 -QFLNLR------DGKLPLLPGH-S----LQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 429 -~~~~i~------~~~~~~~~~~-s----~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
.+.+.+ ....+.++.. + ..+-++|+.||..+|.-|.||-.+-+
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 222222 1222223222 2 24678899999999999999866554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=232.46 Aligned_cols=207 Identities=37% Similarity=0.602 Sum_probs=178.3
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC-Cc
Q 011331 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SL 315 (488)
Q Consensus 237 LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~-~l 315 (488)
||.|++|.||++....+|..+++|++....... ....+.+|++.+..+ .|++|+++++++......+++||++++ .+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987543221 346788999999999 889999999999999999999999995 44
Q ss_pred hhhhhcc--cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--CCeEEEEeecCceecCCC---CCCCCCCCC
Q 011331 316 SDKKASQ--FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDFGRATLLNKS---LPIEEGDAR 388 (488)
Q Consensus 316 ~~~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~g~vkL~DFGlA~~~~~~---~~~~~Gt~~ 388 (488)
....... .++...++.++.+++.+|.+||+.|++|+||+|.||+++ ++.++|+|||.+...... .....+...
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 4443332 589999999999999999999999999999999999995 589999999999877554 334557889
Q ss_pred ccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHH
Q 011331 389 YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKE 468 (488)
Q Consensus 389 Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~e 468 (488)
|++||.+......+.+.|+|++|+++++| ..+.+++.+|+..+|++||++.+
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------~~~~~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------PELKDLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------HHHHHHHHHHhhCCcccCcCHHH
Confidence 99999986643466799999999999999 78899999999999999999999
Q ss_pred HHhCh
Q 011331 469 LVENP 473 (488)
Q Consensus 469 lL~HP 473 (488)
+++|+
T Consensus 211 l~~~~ 215 (215)
T cd00180 211 ILEHL 215 (215)
T ss_pred HhhCC
Confidence 99985
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=273.95 Aligned_cols=199 Identities=24% Similarity=0.394 Sum_probs=169.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchH-----HHHHHHHHHHHHHHhC--CCCCeeEeeeeec
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDA-----ERRKALLEVQALAALG--SHENIVGYYSSWF 299 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~-----~~~~~~~Ei~iL~~l~--~HpnIv~l~~~~~ 299 (488)
..+|..++.+|.|+||.|++|.++.....|+||.+.+.. .-+. ..-..-.||+||..+. .|+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 457999999999999999999999999999999886542 1111 1223557999999983 3999999999999
Q ss_pred ccceEEEEEecCCCCc--hh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCcee
Q 011331 300 ENEQLYIQMELCDHSL--SD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATL 375 (488)
Q Consensus 300 ~~~~l~IV~E~~~~~l--~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~ 375 (488)
+++.+||+||--+.++ .. ...+..|.|.++..+++||+.|+++||+.||||||||-+||.+ .+|-+||+|||.|..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 9999999999886652 22 3345679999999999999999999999999999999999999 789999999999876
Q ss_pred cC-CCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 011331 376 LN-KSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSES 426 (488)
Q Consensus 376 ~~-~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~ 426 (488)
.. ....+.+||..|+|||++.+....+..-|||+||++||.++....||++
T Consensus 720 ~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 63 4566778999999999999887777889999999999999988888764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=271.83 Aligned_cols=238 Identities=23% Similarity=0.321 Sum_probs=192.1
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCe----EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGC----FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
++..+.||+|+||+||+|.+.-.|+ +||||++... ........++.|+-++.++ +||||++|++++.... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-HHH
Confidence 4556889999999999998876554 6888887643 3334456789999999999 9999999999998776 889
Q ss_pred EEecCCCC-chh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 307 QMELCDHS-LSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 307 V~E~~~~~-l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
|++|+..+ |++ +..+..+.....+.|+.||++||.|||+++++||||-.+|||| +-+.+||.|||+|+.+....
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999876 444 3344568889999999999999999999999999999999999 66899999999999875321
Q ss_pred -CC--CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh--hhhh--hcCCCCCCCCCcHHHHHHH
Q 011331 381 -PI--EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ--FLNL--RDGKLPLLPGHSLQFQNLL 452 (488)
Q Consensus 381 -~~--~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~--~~~i--~~~~~~~~~~~s~~l~~lI 452 (488)
.. ..-.+.|||=|.+... .|+.++|||||||++||++| |..|+++... ...+ ....++.||..+.+++-+|
T Consensus 855 y~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 11 2235678888888765 67889999999999999998 4456554322 2222 1245888999999999999
Q ss_pred HHcccCCCCCCCCHHHHHhC
Q 011331 453 KVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~H 472 (488)
.+||..|+..||+|+++.+-
T Consensus 934 vkCwmid~~~rp~fkel~~~ 953 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAEE 953 (1177)
T ss_pred HHHhccCcccCccHHHHHHH
Confidence 99999999999999998763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=242.36 Aligned_cols=250 Identities=20% Similarity=0.252 Sum_probs=200.3
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeee-eecccceEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYS-SWFENEQLY 305 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~-~~~~~~~l~ 305 (488)
+.+.|.+.+.||.|.||.+-+|.++.++..+++|.+.+.. ...+++.+|..---.|..|.||+.-|+ .|+..+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 3456889999999999999999999999999999987553 345678888887777888999997765 577788888
Q ss_pred EEEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE---eCCeEEEEeecCceecCCCCC
Q 011331 306 IQMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV---KNGVYKLGDFGRATLLNKSLP 381 (488)
Q Consensus 306 IV~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv---~~g~vkL~DFGlA~~~~~~~~ 381 (488)
+++||++.+ |........+.|.....++.|+++||.|||++++||||||.+|||| +.-.+||||||+.+..+....
T Consensus 99 F~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred EeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 999999865 4444555678889999999999999999999999999999999999 345899999999988776665
Q ss_pred CCCCCCCccChhhhc----ccCCCCchhHHHHHHHHHHHHHcCCCCCCCch----h---hhhhhcCCCC----CCCCCcH
Q 011331 382 IEEGDARYMPQEILN----EDYDHLDKVDIFSLGATMYELIKGSPLSESGP----Q---FLNLRDGKLP----LLPGHSL 446 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~----~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~----~---~~~i~~~~~~----~~~~~s~ 446 (488)
....+..|.+||++. +.+...+.+|||.||+++|.++||.+||.... . +....++..+ .....++
T Consensus 179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~ 258 (378)
T KOG1345|consen 179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSE 258 (378)
T ss_pred hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCH
Confidence 566777899999864 34555668999999999999999999997431 1 2222333332 2234688
Q ss_pred HHHHHHHHcccCCCCCC---CCHHHHHhChhhhhhH
Q 011331 447 QFQNLLKVMVDPDPVQR---PSAKELVENPIFDKIQ 479 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~R---pTa~elL~HP~f~~i~ 479 (488)
.+..+.++-|..++++| -+++.....-|.....
T Consensus 259 ~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i 294 (378)
T KOG1345|consen 259 KALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLI 294 (378)
T ss_pred HHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhh
Confidence 99999999999999999 6677777777776543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=223.74 Aligned_cols=194 Identities=34% Similarity=0.529 Sum_probs=165.1
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEec
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMEL 310 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~ 310 (488)
|.+.+.||.|++|+||+|....++..+|+|.+...... .....+..|+..+..+ +|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEec
Confidence 56788999999999999999988999999998754332 2456788899999999 899999999999999999999999
Q ss_pred CCC-Cchhhhhc-cc-CCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC----CC
Q 011331 311 CDH-SLSDKKAS-QF-FAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL----PI 382 (488)
Q Consensus 311 ~~~-~l~~~~~~-~~-l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~----~~ 382 (488)
+++ .+...... .. +++..++.++.+++.+|.+||++|++|+||+|.||++ .++.++|+|||.+....... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 988 44443332 23 8899999999999999999999999999999999999 56899999999998775432 44
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSES 426 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~ 426 (488)
..++..|++||.+.....++.++|||+||+++++|++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 56788899999984333566799999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=280.06 Aligned_cols=189 Identities=19% Similarity=0.243 Sum_probs=141.6
Q ss_pred CCeeEeeeee-------cccceEEEEEecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEE
Q 011331 289 ENIVGYYSSW-------FENEQLYIQMELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIY 359 (488)
Q Consensus 289 pnIv~l~~~~-------~~~~~l~IV~E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NIL 359 (488)
+||+.++++| .+...++++||++++.|..... ...+++.+++.++.||+.||.|||++|||||||||+|||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiL 112 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFV 112 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEE
Confidence 5777777776 2344678889999888776543 345899999999999999999999999999999999999
Q ss_pred E-eC-------------------CeEEEEeecCceecCCC-------------------CCCCCCCCCccChhhhcccCC
Q 011331 360 V-KN-------------------GVYKLGDFGRATLLNKS-------------------LPIEEGDARYMPQEILNEDYD 400 (488)
Q Consensus 360 v-~~-------------------g~vkL~DFGlA~~~~~~-------------------~~~~~Gt~~Y~APEvl~~~~~ 400 (488)
| .. +.+||+|||+++..... .....||++|||||++.+. .
T Consensus 113 l~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~ 191 (793)
T PLN00181 113 MSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS-S 191 (793)
T ss_pred EcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccC-C
Confidence 9 32 34566677766532110 0113578899999998765 5
Q ss_pred CCchhHHHHHHHHHHHHHcCCCCCCCchh-hhhhhcCCCC-CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 401 HLDKVDIFSLGATMYELIKGSPLSESGPQ-FLNLRDGKLP-LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 401 ~~~ksDIwSlGvlL~eLltG~~p~~~~~~-~~~i~~~~~~-~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
++.++|||||||+||||++|.+|+..... +..+.....+ .......+...++.+||+++|.+||++.|+++||||...
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 77899999999999999999887654322 2222222221 111234567789999999999999999999999999764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=250.62 Aligned_cols=460 Identities=33% Similarity=0.339 Sum_probs=346.4
Q ss_pred hHHhhcccchhhhh----hhhccccceeec-cCCCCCCChHHHhhhhhcccCC----c-------cccccCCCCCCceee
Q 011331 13 REESQMKGTLARHF----QVQLGYSSSIQH-QSFSSTSSSSRLQNHLESVSQD----A-------TLSAADVDDKDLILT 76 (488)
Q Consensus 13 ~~~~~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~----~-------~~~~~~~~~~~~~~~ 76 (488)
++-.+++....||. ..+.++.+..+. .++++++.++-+++...+++.. . +..++...+++++..
T Consensus 26 sp~~p~~~~~~r~~~~~~s~k~~~~s~ss~~~~p~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 105 (524)
T KOG0601|consen 26 SPHSPLELYDERISESSSSHKKGQSSKSSRFLPPSPTARSPSPSGRALSEANSSTTVSQPIEEDSDGPGCESLSSPIYGA 105 (524)
T ss_pred CCCCCCcchhhcccCCccccccccccccccCCCCCCcccCCCCCcccccccccccccCCceeecCCCCccccccccccCC
Confidence 44567888889998 778888777766 6666665555677776666655 2 122234667789999
Q ss_pred cccccCCCccCCCCCCCcC--CCCCCCCCCCC--CCCCccccccccccccccCCCCCCCCCCC-----CCCccccccccC
Q 011331 77 QDFFCTPDYITPVNQNSMS--GFDCNRENIPC--PKSPEKLNTVKSKKLRQDGFLVNPLDPTS-----YDYQDTVDLAKD 147 (488)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 147 (488)
++|+|..|+++|.....+. |.+...-...| ..+|.+....|+|+|.+....+..---++ .+-+ ...++ +
T Consensus 106 S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~-~~~v~-~ 183 (524)
T KOG0601|consen 106 SPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSH-ENPVR-D 183 (524)
T ss_pred CCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCcc-ccccc-c
Confidence 9999999999999999999 99999988899 99999999889999988532221100001 0111 11111 1
Q ss_pred CCCchhhhhccccCccccCCCCcccCcccccccccCCCCCCCCCcCCCCC----ccccccccccccccCCccceeeCCCC
Q 011331 148 SFSTDEVQLTKTIGYTTQKTHNYVPQSAVALRCRVMPPPCIKNPYQKDAS----EMDIDRFGNQWAKCAGLFPVITGGDG 223 (488)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~p~~~g~~~ 223 (488)
+.-|++ ...-+......+.+.+......|..+|.++..+.+..... +............+.....+...++.
T Consensus 184 ~~~~e~----~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 184 SPAWEG----SGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW 259 (524)
T ss_pred Cccccc----CCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc
Confidence 111221 1112222222335666666667777777776654433322 22222222222333333445566666
Q ss_pred ccccccceeEEEEecccCcEEEEEEEEc-CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKR-IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 224 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
..++..+|.++..||.|.|+.|+.+..+ .++..|++|.+.+...........+.|+.+...+..|.++++++..|....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 7889999999999999999999998766 689999999998887777777888899999999999999999999999999
Q ss_pred eEEEEEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeC--CeEEEEeecCceecCC
Q 011331 303 QLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKN--GVYKLGDFGRATLLNK 378 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~--g~vkL~DFGlA~~~~~ 378 (488)
+.||-.|||++.... ......+.+...+.+..|++.++.++|+..++|+|+||+||++.+ +..++.|||+++.+.-
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 999999999876444 233456888899999999999999999999999999999999954 8899999999875433
Q ss_pred CCCCCCCCCCcc-ChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 379 SLPIEEGDARYM-PQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 379 ~~~~~~Gt~~Y~-APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
......+.-++. ..|++...+.+..+.|++|||..+.+.++|.+..........++.+..+..++...+++.+.+.++.
T Consensus 420 ~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~p~~~~~~~~~q~~~kv~~~ 499 (524)
T KOG0601|consen 420 SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGDTPNLPGLKLQLQVLLKVMIN 499 (524)
T ss_pred ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeecccccCCCchHHhhhhhhhhhcC
Confidence 333444445555 3777878888889999999999999999999999898999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHhChhhhhh
Q 011331 458 PDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f~~i 478 (488)
.++..||.+.++..|+-|...
T Consensus 500 ~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 500 PDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred Cccccchhhhhhcccchhhhh
Confidence 999999999999999877654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-26 Score=209.22 Aligned_cols=145 Identities=23% Similarity=0.302 Sum_probs=117.2
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCCCCCCccChhhhcccCC
Q 011331 322 QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYD 400 (488)
Q Consensus 322 ~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~~~ 400 (488)
..+++..++.++.||+.||.|||+++ ||+|||+ .++.+++ ||++....... ..||+.|||||++.+. .
T Consensus 12 ~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--~~g~~~y~aPE~~~~~-~ 80 (176)
T smart00750 12 RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--SRVDPYFMAPEVIQGQ-S 80 (176)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc--CCCcccccChHHhcCC-C
Confidence 45999999999999999999999999 9999999 6788888 99998765432 3689999999999765 5
Q ss_pred CCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcCCCCC-------CCCCcH--HHHHHHHHcccCCCCCCCCHH
Q 011331 401 HLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDGKLPL-------LPGHSL--QFQNLLKVMVDPDPVQRPSAK 467 (488)
Q Consensus 401 ~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~~~~~-------~~~~s~--~l~~lI~k~L~~dP~~RpTa~ 467 (488)
++.++|||||||++|||++|..||..... ...+.....+. +...+. ++.++|.+||..+|.+|||+.
T Consensus 81 ~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~ 160 (176)
T smart00750 81 YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAAN 160 (176)
T ss_pred CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHH
Confidence 77899999999999999999999865432 12222211111 112233 699999999999999999999
Q ss_pred HHHhChhhhh
Q 011331 468 ELVENPIFDK 477 (488)
Q Consensus 468 elL~HP~f~~ 477 (488)
|+++|+|+..
T Consensus 161 ~ll~~~~~~~ 170 (176)
T smart00750 161 HYLAHCRALF 170 (176)
T ss_pred HHHHHHHHHH
Confidence 9999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=224.41 Aligned_cols=243 Identities=19% Similarity=0.169 Sum_probs=187.1
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCC-----eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDG-----CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
.+..+++....+-+|.||.||.|.++... +.|-+|.++.. .+......++.|...+..+ .|||+..+.++..+
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcC-cCCCccceeEEEee
Confidence 34556888889999999999999887532 33556655433 3344556677787777787 79999999988765
Q ss_pred -cceEEEEEecCCCCchh-hh---------hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CCeEEEE
Q 011331 301 -NEQLYIQMELCDHSLSD-KK---------ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NGVYKLG 368 (488)
Q Consensus 301 -~~~l~IV~E~~~~~l~~-~~---------~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g~vkL~ 368 (488)
....++++.+++-+-+. .. ..+.++..++..++.||+.|++|||++|+||.||...|.+|+ .-.+||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 44567777777644222 11 123467778889999999999999999999999999999995 5799999
Q ss_pred eecCceecCCCCCCCC-----CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhhh---hhhc-CCC
Q 011331 369 DFGRATLLNKSLPIEE-----GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQFL---NLRD-GKL 438 (488)
Q Consensus 369 DFGlA~~~~~~~~~~~-----Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~~---~i~~-~~~ 438 (488)
|=.+++.+-...-... -+..||+||.+... .++.++|+|||||+||||+| |+.|+..-+++. -+.+ ..+
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL 517 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence 9999987643322222 35689999999876 67889999999999999988 567776665543 2333 356
Q ss_pred CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 439 PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 439 ~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
..|-.+++++..+|..||+.+|++||+++|+..
T Consensus 518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 677789999999999999999999999999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-24 Score=205.56 Aligned_cols=245 Identities=32% Similarity=0.463 Sum_probs=194.5
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchH-HHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDA-ERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~-~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
|.+.+.||.|+||.||++.+. ..+|+|.+........ ....+.+|+.++..+..|++|+.+++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 678899999999999999887 8899999876654443 567788999999999444489999999988888899999
Q ss_pred cCCCCchh-hhhcc----cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC-eEEEEeecCceecCCC---
Q 011331 310 LCDHSLSD-KKASQ----FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG-VYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 310 ~~~~~l~~-~~~~~----~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g-~vkL~DFGlA~~~~~~--- 379 (488)
++.+..+. ..... .+.+.....++.|++.++.|+|+.|++||||||+||+++ .+ .++++|||.+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99876444 22222 689999999999999999999999999999999999994 45 7999999999865432
Q ss_pred ------CCCCCCCCCccChhhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCchh------h-hhhhcCCCC-CCCC
Q 011331 380 ------LPIEEGDARYMPQEILNED--YDHLDKVDIFSLGATMYELIKGSPLSESGPQ------F-LNLRDGKLP-LLPG 443 (488)
Q Consensus 380 ------~~~~~Gt~~Y~APEvl~~~--~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------~-~~i~~~~~~-~~~~ 443 (488)
.....|+..|+|||.+... .......|+||+|++++++++|..|+..... . ..+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2455799999999998763 3566799999999999999999988765532 1 111222222 1111
Q ss_pred C--------cHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 444 H--------SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 444 ~--------s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
. ...+.+++.+++..+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 1 2578999999999999999999999999776543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-26 Score=250.31 Aligned_cols=247 Identities=22% Similarity=0.274 Sum_probs=190.8
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEecc---CCCchHHHHH-HHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKR---QLHHDAERRK-ALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~---~~~~~~~~~~-~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.....+|.|++|.|+.+........++.|.... .......... ...|.-+-..+ .|+|++..+..+.+....+-+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccchhh
Confidence 456789999999999988887777777775542 1122222222 44455555555 899999888887777766666
Q ss_pred EecCCCCchhhhhcc-cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-----
Q 011331 308 MELCDHSLSDKKASQ-FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL----- 380 (488)
Q Consensus 308 ~E~~~~~l~~~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~----- 380 (488)
||||...+....... .+...++--+++|++.||.|||+.||.|||||++|+++ .+|.+||+|||.+.......
T Consensus 400 mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred hhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 999999555544444 79999999999999999999999999999999999999 57799999999998764322
Q ss_pred --CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh------------hhhcCCCCCCCCCcH
Q 011331 381 --PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL------------NLRDGKLPLLPGHSL 446 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~------------~i~~~~~~~~~~~s~ 446 (488)
...+|+..|+|||++..........||||.|++++.|++|+.||....... ++..+...+...++.
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~ 559 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR 559 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence 234589999999998766444468999999999999999998886543221 112233334445678
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 447 QFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+.+.+|.+||++||.+|.|+++|++.+||+.+.
T Consensus 560 ~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 560 ETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 899999999999999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-26 Score=240.89 Aligned_cols=240 Identities=25% Similarity=0.341 Sum_probs=202.6
Q ss_pred ecccCcEEEEEEEEc---CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 237 IGAGNFSHVFKVLKR---IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 237 LG~G~fg~Vy~a~~~---~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
+|.|.||.|++++.. ..|..||+|++++.............|..++..+.+||.+|+++..|+....+++++++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 789999999987543 35788999998765444333335566888888887799999999999999999999999987
Q ss_pred Cchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCCCCCCcc
Q 011331 314 SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM 390 (488)
Q Consensus 314 ~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~ 390 (488)
+.+- ......+.+.....+...++.+++++|+.||||+|+|++||++ .+|++++.|||+.+..-..... +||..||
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-cgt~eym 160 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-CGTYEYR 160 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-ccchhhh
Confidence 5332 3444557788889999999999999999999999999999999 7899999999999876443222 8999999
Q ss_pred ChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCCC-----
Q 011331 391 PQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPS----- 465 (488)
Q Consensus 391 APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpT----- 465 (488)
|||+++ .+..++|+||||++++||++|..||.. .....|.......+...+..+++++..++..+|..|.-
T Consensus 161 ApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~-~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~ 236 (612)
T KOG0603|consen 161 APEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG-DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDG 236 (612)
T ss_pred hhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch-HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcch
Confidence 999997 245589999999999999999999877 66667778888899999999999999999999999965
Q ss_pred HHHHHhChhhhhhHHh
Q 011331 466 AKELVENPIFDKIQKH 481 (488)
Q Consensus 466 a~elL~HP~f~~i~~~ 481 (488)
+.|+++|+||+.|.+.
T Consensus 237 ~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 237 VDEIKQHEFFQSIDWN 252 (612)
T ss_pred hHHHhccchheeeeHh
Confidence 6899999999998654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-23 Score=208.75 Aligned_cols=240 Identities=25% Similarity=0.267 Sum_probs=185.2
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCC-eEEEEEEeccCCCchHHHHHHHHHHHHHHHhC---CCCCeeEeeeee-cccceE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDG-CFYAVKHSKRQLHHDAERRKALLEVQALAALG---SHENIVGYYSSW-FENEQL 304 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~---~HpnIv~l~~~~-~~~~~l 304 (488)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+-........ ..+..|+.++..+. ...++..+++.+ ..+..-
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 7899999999999999999998774 6889997653211111 14666888888885 246899999888 577788
Q ss_pred EEEEecCCCCchhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--C----CeEEEEeecCce-
Q 011331 305 YIQMELCDHSLSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--N----GVYKLGDFGRAT- 374 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~----g~vkL~DFGlA~- 374 (488)
||||+.++.+|.+... .+.++...+..++.|++.+|++||+.|+|||||||+|+++. + ..+.|.|||+|+
T Consensus 97 ~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 97 FIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 9999999998887442 35699999999999999999999999999999999999993 2 469999999998
Q ss_pred -ecC-CC----------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhh---cC
Q 011331 375 -LLN-KS----------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLR---DG 436 (488)
Q Consensus 375 -~~~-~~----------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~---~~ 436 (488)
... .. .....||..|+++.+..+. ..+.+.|+||++.++.|++.|..||..... ...+. ..
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 321 11 1123499999999987654 678899999999999999999988865432 11111 11
Q ss_pred -CCC-CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 437 -KLP-LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 437 -~~~-~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
... .....+.++..++..+-..+...+|....+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 111 233456788888888888999999998888765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=216.09 Aligned_cols=161 Identities=19% Similarity=0.149 Sum_probs=125.3
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcC-CCeEEEEEEeccCCC---chHHHHHHHHHHHHHHHhCCCCCeeE-eeeeecc
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRI-DGCFYAVKHSKRQLH---HDAERRKALLEVQALAALGSHENIVG-YYSSWFE 300 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAvK~l~~~~~---~~~~~~~~~~Ei~iL~~l~~HpnIv~-l~~~~~~ 300 (488)
....+|.+.+.||+|+||+||+|.+.. ++..||||++..... .......+.+|+.+|..+ +|+||+. +++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~~--- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLAT--- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEEc---
Confidence 345579999999999999999998876 688889998653211 233456688999999999 8999884 5432
Q ss_pred cceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCC-CCCcEEE-eCCeEEEEeecCceecCC
Q 011331 301 NEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDV-KPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 301 ~~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDL-Kp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
+..|||||||++..+.... ... ...++.|++.||.|||++||+|||| ||+|||+ .++.++|+|||+|+.+..
T Consensus 91 -~~~~LVmE~~~G~~L~~~~--~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLAR--PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred -CCcEEEEEccCCCCHHHhC--ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 4589999999887554221 111 2568899999999999999999999 9999999 568999999999986643
Q ss_pred CC-----------CCCCCCCCccChhhhc
Q 011331 379 SL-----------PIEEGDARYMPQEILN 396 (488)
Q Consensus 379 ~~-----------~~~~Gt~~Y~APEvl~ 396 (488)
.. ....+++.|+|||.+.
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 21 2234788899999874
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=192.99 Aligned_cols=234 Identities=21% Similarity=0.247 Sum_probs=186.1
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
+.|.++++||.|+||.+|+|.....|+.||||+=... ...-++..|..+...|.....|..+..++.+...-.+||
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeeccc----CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 4689999999999999999999999999999974322 223346778888888877788999888888888999999
Q ss_pred ecCCCCchhh--hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecCceecCCC---
Q 011331 309 ELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 309 E~~~~~l~~~--~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGlA~~~~~~--- 379 (488)
++++-+|.+. ..+..++...++-++-|++.-++|+|.+++|||||||+|+|.. -..+.|+|||+|+.+.+.
T Consensus 91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 9999887763 3456688899999999999999999999999999999999993 367999999999876432
Q ss_pred -------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh------hhhhhcCCCCCC-----
Q 011331 380 -------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ------FLNLRDGKLPLL----- 441 (488)
Q Consensus 380 -------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------~~~i~~~~~~~~----- 441 (488)
.....||.+|++=....+. .-+...|+=|+|.+|..+..|..||.+-.. +..+.+.+...+
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC 249 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLC 249 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHh
Confidence 1234599999886654432 345588999999999999999999986432 344444444433
Q ss_pred CCCcHHHHHHHHHcccCCCCCCCCHH
Q 011331 442 PGHSLQFQNLLKVMVDPDPVQRPSAK 467 (488)
Q Consensus 442 ~~~s~~l~~lI~k~L~~dP~~RpTa~ 467 (488)
.+.+.+|.-.|..|=..-=++-|...
T Consensus 250 ~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 250 KGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred CCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 46788888888888777767777643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=196.19 Aligned_cols=236 Identities=23% Similarity=0.298 Sum_probs=186.1
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
.|+++++||.|+||+++.|.+..+++.||||.=... .+.-++..|....+.|...++|..+|.+..++.+-.||||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 589999999999999999999999999999953221 2234566788888888899999999988888888899999
Q ss_pred cCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe------CCeEEEEeecCceecCCCC-
Q 011331 310 LCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK------NGVYKLGDFGRATLLNKSL- 380 (488)
Q Consensus 310 ~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~------~g~vkL~DFGlA~~~~~~~- 380 (488)
+++.+|.+ ......++...+.-++.|++.-++|+|++.+|+|||||+|+||. ...+.|+|||+|+.+.+..
T Consensus 105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 99998776 34456799999999999999999999999999999999999992 3579999999998774432
Q ss_pred ---------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCc------hhhhhhhcCCCC-----C
Q 011331 381 ---------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESG------PQFLNLRDGKLP-----L 440 (488)
Q Consensus 381 ---------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~------~~~~~i~~~~~~-----~ 440 (488)
....||.+||+=.-..+. .-+...|+=|||.+++..+.|..||.+. ..+.+|-+.+.. +
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGr-EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~L 263 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVL 263 (449)
T ss_pred cccCccccccccccceeeeEeeccccc-hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHH
Confidence 234599999996654443 5567899999999999999999999863 223344332222 2
Q ss_pred CCCCcHHHHHHHHHcccCCCCCCCCHHHHH
Q 011331 441 LPGHSLQFQNLLKVMVDPDPVQRPSAKELV 470 (488)
Q Consensus 441 ~~~~s~~l~~lI~k~L~~dP~~RpTa~elL 470 (488)
-.+.+.+|..-|...=..+-.+-|..+-+.
T Consensus 264 c~g~P~efa~Yl~yvR~L~F~E~PDYdylr 293 (449)
T KOG1165|consen 264 CEGFPEEFATYLRYVRRLDFFETPDYDYLR 293 (449)
T ss_pred HhcCHHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 235677777777766666666777755443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-22 Score=188.01 Aligned_cols=140 Identities=16% Similarity=0.157 Sum_probs=107.6
Q ss_pred EEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHH------------------------HHHHHHHHHHHHHhCCCC
Q 011331 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE------------------------RRKALLEVQALAALGSHE 289 (488)
Q Consensus 234 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~------------------------~~~~~~Ei~iL~~l~~Hp 289 (488)
.+.||+|+||+||+|.+. +|+.||||+++........ ......|+..+..+ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence 357999999999999987 8999999998754211110 11234588999998 666
Q ss_pred CeeEeeeeecccceEEEEEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHH-HHcCcccCCCCCCcEEEeCCeEE
Q 011331 290 NIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFI-HEKGIAHLDVKPDNIYVKNGVYK 366 (488)
Q Consensus 290 nIv~l~~~~~~~~~l~IV~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yL-H~~gIiHrDLKp~NILv~~g~vk 366 (488)
++........ . ..+|||||++++.+. ......+++..+..++.||+.+|.+| |+.||+||||||+|||++++.++
T Consensus 80 ~v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~~~v~ 157 (190)
T cd05147 80 GIPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHDGKLY 157 (190)
T ss_pred CCCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEECCcEE
Confidence 6643332222 2 238999999886432 23345789999999999999999999 79999999999999999889999
Q ss_pred EEeecCceecC
Q 011331 367 LGDFGRATLLN 377 (488)
Q Consensus 367 L~DFGlA~~~~ 377 (488)
|+|||+|...+
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=192.68 Aligned_cols=233 Identities=21% Similarity=0.200 Sum_probs=145.9
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCC---------CCCeeEeeeeec
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGS---------HENIVGYYSSWF 299 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~---------HpnIv~l~~~~~ 299 (488)
.+...+.||.|+++.||.+.+..||+.+|||++...... ....+.+.+|...+..+.. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 356788999999999999999999999999987543222 2233444444433333211 212222222211
Q ss_pred ---------cc---c-----eEEEEEecCCCCchhhhh----cc----cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCC
Q 011331 300 ---------EN---E-----QLYIQMELCDHSLSDKKA----SQ----FFAEGEVLKALHQIAQALQFIHEKGIAHLDVK 354 (488)
Q Consensus 300 ---------~~---~-----~l~IV~E~~~~~l~~~~~----~~----~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLK 354 (488)
.. . +.+++|.-+.++|..... .. .+.....+.+..|++..+++||..|++|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 11 1 235677777666544211 11 12222234555899999999999999999999
Q ss_pred CCcEEE-eCCeEEEEeecCceecCCCCCCCCCCCCccChhhhccc-------CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 011331 355 PDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNED-------YDHLDKVDIFSLGATMYELIKGSPLSES 426 (488)
Q Consensus 355 p~NILv-~~g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~-------~~~~~ksDIwSlGvlL~eLltG~~p~~~ 426 (488)
|+|+++ .+|.++|+||+.....+........+..|.|||..... ..++.+.|.|+||+++|.|++|..||..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 999999 78999999999887766544334566789999987442 2456799999999999999999999875
Q ss_pred chhhhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCC
Q 011331 427 GPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQR 463 (488)
Q Consensus 427 ~~~~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~R 463 (488)
......... .+..-..+++.++.||..+|+++|.+|
T Consensus 253 ~~~~~~~~~-~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 253 SSPEADPEW-DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CGGGSTSGG-GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCccccccc-cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 433221111 111112678999999999999999987
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-21 Score=193.94 Aligned_cols=186 Identities=25% Similarity=0.352 Sum_probs=144.6
Q ss_pred hCCCCCeeEeeeeecc---------------------------cceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHH
Q 011331 285 LGSHENIVGYYSSWFE---------------------------NEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIA 337 (488)
Q Consensus 285 l~~HpnIv~l~~~~~~---------------------------~~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~ 337 (488)
+..|||||++..+|.+ +..+|+||....++|.+.......+.....-++.|++
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLL 351 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHH
Confidence 3579999999987753 2358999999899888877778889999999999999
Q ss_pred HHHHHHHHcCcccCCCCCCcEEE--eC-C--eEEEEeecCceecCC---CCC------CCCCCCCccChhhhccc-----
Q 011331 338 QALQFIHEKGIAHLDVKPDNIYV--KN-G--VYKLGDFGRATLLNK---SLP------IEEGDARYMPQEILNED----- 398 (488)
Q Consensus 338 ~gL~yLH~~gIiHrDLKp~NILv--~~-g--~vkL~DFGlA~~~~~---~~~------~~~Gt~~Y~APEvl~~~----- 398 (488)
+|+.|||++||.|||+|.+|||| ++ + .+.|+|||++-.... ..+ ...|...-||||+...-
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999999 33 3 689999998743222 111 12377789999997532
Q ss_pred -CCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcCCC-CCCCCCcHHHHHHHHHcccCCCCCCCC---HHHH
Q 011331 399 -YDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDGKL-PLLPGHSLQFQNLLKVMVDPDPVQRPS---AKEL 469 (488)
Q Consensus 399 -~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~~~-~~~~~~s~~l~~lI~k~L~~dP~~RpT---a~el 469 (488)
.+| .++|.|+.|.+.||++....||+..-. .....+..+ +.+..++..+++++..+|+.||++|++ |..+
T Consensus 432 vvny-~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 432 VVNY-EKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred eecc-chhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhH
Confidence 122 389999999999999999988886322 112333344 455678999999999999999999998 4555
Q ss_pred Hh
Q 011331 470 VE 471 (488)
Q Consensus 470 L~ 471 (488)
|+
T Consensus 511 l~ 512 (598)
T KOG4158|consen 511 LN 512 (598)
T ss_pred HH
Confidence 54
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-21 Score=180.26 Aligned_cols=141 Identities=19% Similarity=0.144 Sum_probs=109.8
Q ss_pred EEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchH------------------------HHHHHHHHHHHHHHhCCCC
Q 011331 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDA------------------------ERRKALLEVQALAALGSHE 289 (488)
Q Consensus 234 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~------------------------~~~~~~~Ei~iL~~l~~Hp 289 (488)
.+.||+|+||+||+|.+. +|+.||||+++....... .......|...+.++ .|+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence 467999999999999987 899999999875421100 012235688889988 788
Q ss_pred CeeEeeeeecccceEEEEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEeCCeEE
Q 011331 290 NIVGYYSSWFENEQLYIQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYVKNGVYK 366 (488)
Q Consensus 290 nIv~l~~~~~~~~~l~IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv~~g~vk 366 (488)
+|.....+.... .||||||+++. +.. ......++...+..++.|++.+|.+||+ .||+||||||+|||++++.++
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~~~~~~ 157 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYHDGKPY 157 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEECCCEE
Confidence 875444333322 48999999886 222 2334567888999999999999999999 999999999999999989999
Q ss_pred EEeecCceecCC
Q 011331 367 LGDFGRATLLNK 378 (488)
Q Consensus 367 L~DFGlA~~~~~ 378 (488)
|+|||+|+....
T Consensus 158 liDFG~a~~~~~ 169 (190)
T cd05145 158 IIDVSQAVELDH 169 (190)
T ss_pred EEEcccceecCC
Confidence 999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-22 Score=210.33 Aligned_cols=148 Identities=32% Similarity=0.517 Sum_probs=120.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---------CCCCCCCCccChh
Q 011331 324 FAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---------PIEEGDARYMPQE 393 (488)
Q Consensus 324 l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---------~~~~Gt~~Y~APE 393 (488)
.+....+.++.|++.|++| +|.+|+|+||.||++ .++.+||.|||+.+...... +...||..||+||
T Consensus 356 ~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPE 432 (516)
T KOG1033|consen 356 RSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPE 432 (516)
T ss_pred cchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHH
Confidence 4445678889999999999 999999999999999 67789999999998764332 3456999999999
Q ss_pred hhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhhhhhhcCCCC--CCCCCcHHHHHHHHHcccCCCCCCCCHHHHH
Q 011331 394 ILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQFLNLRDGKLP--LLPGHSLQFQNLLKVMVDPDPVQRPSAKELV 470 (488)
Q Consensus 394 vl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~~~i~~~~~~--~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL 470 (488)
.+.+. .|+.++||||||++|+||+. -...++....+..++++.+| +...++ +-..|+.+|+...|.+||++.+.-
T Consensus 433 Qi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 433 QIRGQ-QYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred HHhhh-hhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHHHh
Confidence 99876 68889999999999999998 33445555556677888877 333333 445899999999999999998888
Q ss_pred hChhhh
Q 011331 471 ENPIFD 476 (488)
Q Consensus 471 ~HP~f~ 476 (488)
-|+|.+
T Consensus 511 ~~~~~~ 516 (516)
T KOG1033|consen 511 LHEFLQ 516 (516)
T ss_pred hhhhcC
Confidence 888753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.8e-21 Score=183.86 Aligned_cols=172 Identities=12% Similarity=0.065 Sum_probs=125.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHH-HH------HHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAER-RK------ALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~-~~------~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
.++|++++.||.|+||.||++.. ++..+|||++.......... .. +.+|++.+.++ .|++|..+.+++..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~ 106 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLL 106 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeee
Confidence 45799999999999999999654 57789999997654333222 22 46888899999 99999999887664
Q ss_pred c--------ceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecC
Q 011331 301 N--------EQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGR 372 (488)
Q Consensus 301 ~--------~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGl 372 (488)
. +..+|+|||++|..+... ..+++ ..+.+|+.+|..||+.|++|+|++|+||+++++.++|+|||.
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~--~~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~gi~liDfg~ 180 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDM--PEISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNGLRIIDLSG 180 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHh--hhccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCCEEEEECCC
Confidence 3 357899999998644322 12332 346699999999999999999999999999543399999998
Q ss_pred ceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHH
Q 011331 373 ATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELI 418 (488)
Q Consensus 373 A~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLl 418 (488)
.+........ ..++.. ..+..++||||||+++.-+.
T Consensus 181 ~~~~~e~~a~---------d~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 181 KRCTAQRKAK---------DRIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cccccchhhH---------HHHHHH-hHhcccccccceeEeehHHH
Confidence 8655322111 012222 23446899999999987643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=215.32 Aligned_cols=238 Identities=25% Similarity=0.315 Sum_probs=178.5
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL--HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~--~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
+|+..+.||++.|=+|.+|++. .| .|+||++-+.. ..-....+.+.|++ ..+.++||++.+--+...+...|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHHHHHH
Confidence 6788999999999999999885 44 49999985542 23344555666666 3445899999998887788888999
Q ss_pred EecCCCCchhhhhcc-cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceec--CCCCCC-
Q 011331 308 MELCDHSLSDKKASQ-FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL--NKSLPI- 382 (488)
Q Consensus 308 ~E~~~~~l~~~~~~~-~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~--~~~~~~- 382 (488)
-+|..++|.++...+ .+...+.+.|+.||+.||.-+|+.||+|+|||.+|||| +-+.+.|+||..-+.. ....+.
T Consensus 100 RqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 999999988865544 47788889999999999999999999999999999999 5688999999876432 221111
Q ss_pred ---CC----CCCCccChhhhccc----------CCCCchhHHHHHHHHHHHHHcC-CCCCCCchhhhhhhcCCCCC----
Q 011331 383 ---EE----GDARYMPQEILNED----------YDHLDKVDIFSLGATMYELIKG-SPLSESGPQFLNLRDGKLPL---- 440 (488)
Q Consensus 383 ---~~----Gt~~Y~APEvl~~~----------~~~~~ksDIwSlGvlL~eLltG-~~p~~~~~~~~~i~~~~~~~---- 440 (488)
.. --..|+|||.+... ...+++.||||+||+++||++- .++|. -.++...+.+..-.
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-LSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-HHHHHhHhccCccCHHHH
Confidence 11 22359999987431 1145689999999999999986 55554 44444443332110
Q ss_pred CC-CCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 441 LP-GHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 441 ~~-~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
.. -.+..++++|..|++.||++|.+|++.|+.
T Consensus 259 Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 01 124478999999999999999999999976
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-21 Score=212.11 Aligned_cols=213 Identities=23% Similarity=0.325 Sum_probs=156.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.+|..++.|-.|+||.||+++++.+...+|+|+ ++.. . .++. ++... ..|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~----l---ilRn--ilt~a-~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN----L---ILRN--ILTFA-GNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccc----h---hhhc--ccccc-CCccee----------------
Confidence 468899999999999999999999999999964 2211 0 1111 22222 445444
Q ss_pred ecCCCCchhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-------
Q 011331 309 ELCDHSLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS------- 379 (488)
Q Consensus 309 E~~~~~l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~------- 379 (488)
+.-... ..-+.++.. ++.+++|||+.||+|||+||+|++| .-|++|+.|||+.+.....
T Consensus 136 ----gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred ----chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 111111 111223322 2889999999999999999999999 5799999999998654221
Q ss_pred -----------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCC---C
Q 011331 380 -----------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLL---P 442 (488)
Q Consensus 380 -----------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~---~ 442 (488)
....+||+.|+|||++... .|+..+|||++|+++||.+.|..||++..+ +..+....+.++ .
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~de 282 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDE 282 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCc
Confidence 1224699999999998775 688899999999999999999999887643 223333333333 3
Q ss_pred CCcHHHHHHHHHcccCCCCCC---CCHHHHHhChhhhhhHHh
Q 011331 443 GHSLQFQNLLKVMVDPDPVQR---PSAKELVENPIFDKIQKH 481 (488)
Q Consensus 443 ~~s~~l~~lI~k~L~~dP~~R---pTa~elL~HP~f~~i~~~ 481 (488)
..+.+++++|.++|+.+|..| ..+-++.+|+||+.+.+.
T Consensus 283 a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 283 ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 457899999999999999999 468899999999988654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-19 Score=172.94 Aligned_cols=183 Identities=16% Similarity=0.081 Sum_probs=135.8
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH--HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~--~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
.+...|++|+||+|+++.. .+..++.+.+..... .......+.+|+++|.++.+|++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4677899999999997755 678888776653322 111223577899999999777889999875 45799999
Q ss_pred cCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCC-CCCcEEE-eCCeEEEEeecCceecCCCCCC-----
Q 011331 310 LCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDV-KPDNIYV-KNGVYKLGDFGRATLLNKSLPI----- 382 (488)
Q Consensus 310 ~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDL-Kp~NILv-~~g~vkL~DFGlA~~~~~~~~~----- 382 (488)
|+.|..+.... +.. ...++.|++.+|.++|++||+|||| ||+|||+ .+|.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~----~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~ 153 (218)
T PRK12274 79 YLAGAAMYQRP----PRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLA 153 (218)
T ss_pred eecCccHHhhh----hhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHH
Confidence 99887554221 111 2467899999999999999999999 7999999 5789999999999865433210
Q ss_pred -----------CCCCCCccChhhhcccCCCC-chhHHHHHHHHHHHHHcCCCCCC
Q 011331 383 -----------EEGDARYMPQEILNEDYDHL-DKVDIFSLGATMYELIKGSPLSE 425 (488)
Q Consensus 383 -----------~~Gt~~Y~APEvl~~~~~~~-~ksDIwSlGvlL~eLltG~~p~~ 425 (488)
...++.|+.|+.-.--...+ ...++++.|+.+|.++|+..+.-
T Consensus 154 ~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 154 REDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 12677888888542211122 47899999999999999987653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-20 Score=180.10 Aligned_cols=235 Identities=16% Similarity=0.190 Sum_probs=183.6
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.++.++.+|.....|+.|+|++. |..+++|++..........+++..|.-.|+.. .||||+.+++.|....++.++.
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccCCCCceEee
Confidence 45677888999999999999995 66778888876655555567788888888887 9999999999999999999999
Q ss_pred ecCCCCchhhhh----cccCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEEeCC---eEEEEeecCceecCCC
Q 011331 309 ELCDHSLSDKKA----SQFFAEGEVLKALHQIAQALQFIHEKG--IAHLDVKPDNIYVKNG---VYKLGDFGRATLLNKS 379 (488)
Q Consensus 309 E~~~~~l~~~~~----~~~l~~~~~~~i~~qI~~gL~yLH~~g--IiHrDLKp~NILv~~g---~vkL~DFGlA~~~~~~ 379 (488)
.|+..+.+.... .-.....++.+++.+|+.|++|||+.. |.-.-|....|+|++. .+-.+|--++-.
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq---- 342 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---- 342 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee----
Confidence 999876444222 223667889999999999999999874 4445688899999543 344445333322
Q ss_pred CCCCCCCCCccChhhhcccCCC--CchhHHHHHHHHHHHHHcCCCCCCCchhhh-----hhhcCCCCCCCCCcHHHHHHH
Q 011331 380 LPIEEGDARYMPQEILNEDYDH--LDKVDIFSLGATMYELIKGSPLSESGPQFL-----NLRDGKLPLLPGHSLQFQNLL 452 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~--~~ksDIwSlGvlL~eLltG~~p~~~~~~~~-----~i~~~~~~~~~~~s~~l~~lI 452 (488)
.......+.||+||.+...... ..++|+|||+++||||.|...||....++. .+.......||+.+....++|
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm 422 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLM 422 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHH
Confidence 1223456789999999754322 248999999999999999999998876643 234456678999999999999
Q ss_pred HHcccCCCCCCCCHHHHH
Q 011331 453 KVMVDPDPVQRPSAKELV 470 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL 470 (488)
.-|+..||.+||.++.++
T Consensus 423 ~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHhcCCCCcCCCcceeh
Confidence 999999999999998765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5e-18 Score=163.18 Aligned_cols=135 Identities=17% Similarity=0.269 Sum_probs=102.7
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC----CCCCeeEeeeeecccc---eE
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG----SHENIVGYYSSWFENE---QL 304 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~----~HpnIv~l~~~~~~~~---~l 304 (488)
.-.+.||+|+||.||. +..++.. +||++..... .......+|+.++..+. .||||+++++++.++. .+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 3456899999999995 7667666 6998864322 23456889999999984 4799999999999874 43
Q ss_pred E-EEEecCC--C-CchhhhhcccCCHHHHHHHHHHHHHHH-HHHHHcCcccCCCCCCcEEEe-----CCeEEEEeecCc
Q 011331 305 Y-IQMELCD--H-SLSDKKASQFFAEGEVLKALHQIAQAL-QFIHEKGIAHLDVKPDNIYVK-----NGVYKLGDFGRA 373 (488)
Q Consensus 305 ~-IV~E~~~--~-~l~~~~~~~~l~~~~~~~i~~qI~~gL-~yLH~~gIiHrDLKp~NILv~-----~g~vkL~DFGlA 373 (488)
+ +||||++ + +|.+......+++. ..++.|++.++ +|||+++||||||||+|||++ ++.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 7899954 3 56555554456555 46688888888 999999999999999999993 137999995544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.8e-18 Score=167.10 Aligned_cols=143 Identities=19% Similarity=0.100 Sum_probs=109.1
Q ss_pred eeEEEEecccCcEEEEEEE-EcCCCeEEEEEEeccCCCch----------------------HHHHHHHHHHHHHHHhCC
Q 011331 231 FHEIEQIGAGNFSHVFKVL-KRIDGCFYAVKHSKRQLHHD----------------------AERRKALLEVQALAALGS 287 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~-~~~~g~~vAvK~l~~~~~~~----------------------~~~~~~~~Ei~iL~~l~~ 287 (488)
|.+.+.||+|+||.||+|. +..+|+.||||+++...... .....+..|+..+.++ .
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L-~ 108 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL-Y 108 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-H
Confidence 6788999999999999998 66789999999986432100 0112356799999998 4
Q ss_pred CC--CeeEeeeeecccceEEEEEecCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHcC-cccCCCCCCcEEEeC
Q 011331 288 HE--NIVGYYSSWFENEQLYIQMELCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEKG-IAHLDVKPDNIYVKN 362 (488)
Q Consensus 288 Hp--nIv~l~~~~~~~~~l~IV~E~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~g-IiHrDLKp~NILv~~ 362 (488)
+. .+..++.. ...+|||||+++..+. . .....+....+..++.||+.+|.+||+.| |+|+||||+||++++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~~ 184 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVHD 184 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEEC
Confidence 32 33444432 2358999999985432 1 22344666678899999999999999999 999999999999998
Q ss_pred CeEEEEeecCceecCC
Q 011331 363 GVYKLGDFGRATLLNK 378 (488)
Q Consensus 363 g~vkL~DFGlA~~~~~ 378 (488)
+.++|+|||+|...+.
T Consensus 185 ~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 185 GKVVIIDVSQSVELDH 200 (237)
T ss_pred CCEEEEEChhhhccCC
Confidence 8999999999875443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.2e-17 Score=157.18 Aligned_cols=136 Identities=18% Similarity=0.187 Sum_probs=108.5
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch------HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD------AERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~------~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
+.||+|++|.||+|.+ .|..|++|+........ .....+..|+.++..+ .|++|+....++...+..+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEEE
Confidence 5799999999999987 68889999865432211 1234577899999998 7888877776777778889999
Q ss_pred ecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCcee
Q 011331 309 ELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATL 375 (488)
Q Consensus 309 E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~ 375 (488)
||++|..+...... ... ....++.+|+.+|.+||+.|++|+|++|.|||++++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~-~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINS-NGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHh-ccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEECCCEEEEECCcccC
Confidence 99988644422221 122 788999999999999999999999999999999989999999998865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-17 Score=176.03 Aligned_cols=260 Identities=30% Similarity=0.411 Sum_probs=209.3
Q ss_pred eeeCCCCccccccceeEEEEecc--cCcEEEEEEEE--cCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCee
Q 011331 217 VITGGDGLSRYYTDFHEIEQIGA--GNFSHVFKVLK--RIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIV 292 (488)
Q Consensus 217 ~~~g~~~~~~~~~~y~~~~~LG~--G~fg~Vy~a~~--~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv 292 (488)
...+....+.+...|.+...+|. |.+|.||.+.. ..++..+|+|.-+...........-.+|+....++..|+|.+
T Consensus 102 ~~~~S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v 181 (524)
T KOG0601|consen 102 IYGASPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPV 181 (524)
T ss_pred ccCCCCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCcccccc
Confidence 33333444445556788899999 99999999988 889999999985443333333444566777888888999999
Q ss_pred EeeeeecccceEEEEEecCCCCchhh--hhcccCCHHHHHHHHHHHHH----HHHHHHHcCcccCCCCCCcEEE-eC-Ce
Q 011331 293 GYYSSWFENEQLYIQMELCDHSLSDK--KASQFFAEGEVLKALHQIAQ----ALQFIHEKGIAHLDVKPDNIYV-KN-GV 364 (488)
Q Consensus 293 ~l~~~~~~~~~l~IV~E~~~~~l~~~--~~~~~l~~~~~~~i~~qI~~----gL~yLH~~gIiHrDLKp~NILv-~~-g~ 364 (488)
+.+..|...+.+||.+|+|+..+... .....++...++..+.+... ||.++|..+|+|-|+||+||++ .+ ..
T Consensus 182 ~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 182 RDSPAWEGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred ccCcccccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccce
Confidence 99999999999999999999876652 23345888999999999999 9999999999999999999999 66 78
Q ss_pred EEEEeecCceecCCCCC--------CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCc--hhhhhhh
Q 011331 365 YKLGDFGRATLLNKSLP--------IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESG--PQFLNLR 434 (488)
Q Consensus 365 vkL~DFGlA~~~~~~~~--------~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~--~~~~~i~ 434 (488)
++++|||+...+....- ...|...|++||++++- ++...|||++|.++.+..+|..++..+ ..+..++
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 99999999988754321 11477889999998765 556999999999999999998777665 5566666
Q ss_pred cCCCC--CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 435 DGKLP--LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 435 ~~~~~--~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
++.++ +..+.+..+...+..|++.+|-.|++++.+++|+++...
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 65543 344567788889999999999999999999999999753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5e-17 Score=182.80 Aligned_cols=193 Identities=21% Similarity=0.226 Sum_probs=147.9
Q ss_pred ccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC--CCCCeeEeeeeeccc
Q 011331 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG--SHENIVGYYSSWFEN 301 (488)
Q Consensus 224 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~--~HpnIv~l~~~~~~~ 301 (488)
+......|.|-+.||+|+||+||+|.... |+.||+|+-+.... .+ +..-.+++.+|. --+-|..+..++.-.
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~--WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP--WE---FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc--ee---eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 34445578999999999999999999875 99999998654322 11 222223333431 124466666666777
Q ss_pred ceEEEEEecCCCC-chhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeC--------CeEEEEeec
Q 011331 302 EQLYIQMELCDHS-LSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKN--------GVYKLGDFG 371 (488)
Q Consensus 302 ~~l~IV~E~~~~~-l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~--------g~vkL~DFG 371 (488)
+.-+||+||.+.+ |++.. ..+.|.+..+..+..|++.-+++||..+|||+||||+|.||.. -.++|+|||
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 7788999999764 55533 3456999999999999999999999999999999999999932 369999999
Q ss_pred CceecC---C--CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCC
Q 011331 372 RATLLN---K--SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPL 423 (488)
Q Consensus 372 lA~~~~---~--~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p 423 (488)
.+-.+. + .....++|-.+-.+|.+.+. .+++.+|.|.|+.+++-|+.|+..
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHHHH
Confidence 885442 2 22334578888999988765 799999999999999999999754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=151.60 Aligned_cols=137 Identities=23% Similarity=0.156 Sum_probs=103.3
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch--------------------HHHHHHHHHHHHHHHhCCCC-
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD--------------------AERRKALLEVQALAALGSHE- 289 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~--------------------~~~~~~~~Ei~iL~~l~~Hp- 289 (488)
|.+.+.||.|+||.||+|.+. +|+.||||++....... ........|..++..+ .|.
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcC
Confidence 577889999999999999875 89999999875432100 1112356788888888 566
Q ss_pred -CeeEeeeeecccceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEE
Q 011331 290 -NIVGYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKL 367 (488)
Q Consensus 290 -nIv~l~~~~~~~~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL 367 (488)
.++.+++ ....+++|||+++..+..... ......++.+|+.++.++|+.||+|+||||+||++ .++.++|
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV----LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc----cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 3444443 245689999998864432211 13567889999999999999999999999999999 5789999
Q ss_pred EeecCceecC
Q 011331 368 GDFGRATLLN 377 (488)
Q Consensus 368 ~DFGlA~~~~ 377 (488)
+|||++....
T Consensus 167 iDfg~~~~~~ 176 (198)
T cd05144 167 IDWPQMVSTD 176 (198)
T ss_pred EECCccccCC
Confidence 9999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=148.90 Aligned_cols=139 Identities=20% Similarity=0.171 Sum_probs=97.4
Q ss_pred EEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHH----------------------HHHHHHHHHHhCCC-CC
Q 011331 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRK----------------------ALLEVQALAALGSH-EN 290 (488)
Q Consensus 234 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~----------------------~~~Ei~iL~~l~~H-pn 290 (488)
.+.||+|+||+||+|.+. +|..||||++............ ...|...+..+..+ -.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 457999999999999886 8999999998654222111111 13455556665222 22
Q ss_pred eeEeeeeecccceEEEEEecCCCCchh-hhhcccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEeCCeEEEE
Q 011331 291 IVGYYSSWFENEQLYIQMELCDHSLSD-KKASQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYVKNGVYKLG 368 (488)
Q Consensus 291 Iv~l~~~~~~~~~l~IV~E~~~~~l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv~~g~vkL~ 368 (488)
+.++++. ...++||||++++... ...........+..++.+++.++.++|. .||+|+||||+||+++++.++|+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~~~~~~li 156 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVDDGKVYII 156 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEECCcEEEE
Confidence 4444433 2358999999883211 0000111116788999999999999999 99999999999999999999999
Q ss_pred eecCceecC
Q 011331 369 DFGRATLLN 377 (488)
Q Consensus 369 DFGlA~~~~ 377 (488)
|||.+....
T Consensus 157 Dfg~a~~~~ 165 (187)
T cd05119 157 DVPQAVEID 165 (187)
T ss_pred ECccccccc
Confidence 999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=149.86 Aligned_cols=133 Identities=19% Similarity=0.180 Sum_probs=101.1
Q ss_pred EecccCcEEEEEEEEcCCCeEEEEEEeccCCCc------hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 236 QIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH------DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~------~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
.||+|+||+||+|.. +|..|++|+....... ......+..|+.++..+ .|+++.....++...+..+++||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEE
Confidence 389999999999984 6889999986432111 11235567899999998 67765544445556667799999
Q ss_pred cCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCceec
Q 011331 310 LCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLL 376 (488)
Q Consensus 310 ~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~~ 376 (488)
|+++..+...... ... .++.+|+.+|.+||+.|++|+|++|.||+++++.++|+|||++...
T Consensus 78 ~~~g~~l~~~~~~----~~~-~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEE----GND-ELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhh----cHH-HHHHHHHHHHHHHHHCCeecCCCCcceEEEECCcEEEEECCCCcCC
Confidence 9987644322111 011 7899999999999999999999999999999899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.1e-16 Score=170.78 Aligned_cols=137 Identities=17% Similarity=0.116 Sum_probs=106.6
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-C-----chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-H-----HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~-----~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
|...+.||+|+||+||++.+. +..+++|+..... . .......+.+|+.++..+ .|++|+.+..++......
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeCCCC
Confidence 456789999999999999875 3344444322111 1 112234578899999999 899998877777777788
Q ss_pred EEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCceec
Q 011331 305 YIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLL 376 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~~ 376 (488)
++||||+++..+..... ....++.+|+.+|.+||+.|++||||||+|||++++.++|+|||+++..
T Consensus 412 ~lv~E~~~g~~L~~~l~------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEECCcEEEEeCcccccC
Confidence 99999998865442221 4578899999999999999999999999999999899999999999764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.8e-18 Score=187.09 Aligned_cols=248 Identities=21% Similarity=0.245 Sum_probs=193.2
Q ss_pred ceeEEEEecccCcEEEEEEEEcC-CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRI-DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.|.+.+.||+|+|+.|-++.... ....+|+|.+...............|..+-..+..|.|++.+++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 56788889999999999887743 45567777665432222233344456666667756999999999999999999999
Q ss_pred ecCCCCchh-hh--hcc-cCCHHHHHHHHHHHHHHHHHHH-HcCcccCCCCCCcEEE-eCC-eEEEEeecCceecCC-C-
Q 011331 309 ELCDHSLSD-KK--ASQ-FFAEGEVLKALHQIAQALQFIH-EKGIAHLDVKPDNIYV-KNG-VYKLGDFGRATLLNK-S- 379 (488)
Q Consensus 309 E~~~~~l~~-~~--~~~-~l~~~~~~~i~~qI~~gL~yLH-~~gIiHrDLKp~NILv-~~g-~vkL~DFGlA~~~~~-~- 379 (488)
++.+++.+. .. ... .++...+..++.|+..++.|+| ..++.|+||||+|.++ ..+ .++++|||+|+.+.. .
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g 180 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG 180 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence 998775333 22 122 4677789999999999999999 9999999999999999 556 899999999987754 2
Q ss_pred ----CCCCCC-CCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh----hhhhcC----CCCCCCCCcH
Q 011331 380 ----LPIEEG-DARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF----LNLRDG----KLPLLPGHSL 446 (488)
Q Consensus 380 ----~~~~~G-t~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~----~~i~~~----~~~~~~~~s~ 446 (488)
....+| ++.|+|||...+........|+||.|+++..+++|..|+...... ...... ....+...+.
T Consensus 181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (601)
T KOG0590|consen 181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISD 260 (601)
T ss_pred cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCCh
Confidence 123458 999999999877434456899999999999999999887654321 111111 3455667788
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 447 QFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
...+++.+++..+|+.|.+.+++..+||+..
T Consensus 261 ~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 261 QAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred hhhhcccccccCCchhccccccccccccccc
Confidence 9999999999999999999999999999987
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.6e-15 Score=128.97 Aligned_cols=132 Identities=21% Similarity=0.218 Sum_probs=108.1
Q ss_pred EEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCC-CCeeEeeeeecccceEEEEEecC
Q 011331 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH-ENIVGYYSSWFENEQLYIQMELC 311 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~H-pnIv~l~~~~~~~~~l~IV~E~~ 311 (488)
+++.||.|.++.||++... +..+++|....... ...+..|+.++..+..+ .++++++.+....+..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 4678999999999999874 47899998765432 45677899999998444 68889988888888899999999
Q ss_pred CCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHc---CcccCCCCCCcEEEeC-CeEEEEeecCcee
Q 011331 312 DHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEK---GIAHLDVKPDNIYVKN-GVYKLGDFGRATL 375 (488)
Q Consensus 312 ~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~---gIiHrDLKp~NILv~~-g~vkL~DFGlA~~ 375 (488)
.+...... +......++.+++.+|.+||.. +++|+||+|+||++++ +.++++|||.++.
T Consensus 76 ~g~~~~~~-----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV-----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC-----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 87644321 4556778899999999999985 7999999999999954 8999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-14 Score=141.17 Aligned_cols=134 Identities=23% Similarity=0.305 Sum_probs=98.3
Q ss_pred EEec-ccCcEEEEEEEEcCCCeEEEEEEeccCCC-----------chHHHHHHHHHHHHHHHhCCCCCe--eEeeeeecc
Q 011331 235 EQIG-AGNFSHVFKVLKRIDGCFYAVKHSKRQLH-----------HDAERRKALLEVQALAALGSHENI--VGYYSSWFE 300 (488)
Q Consensus 235 ~~LG-~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-----------~~~~~~~~~~Ei~iL~~l~~HpnI--v~l~~~~~~ 300 (488)
..|| .||.|+||.+.. .+..++||.+..... .......+.+|+.++..+ .|++| +.++++...
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence 4577 888889998876 378899998754210 112335678899999999 77774 666665443
Q ss_pred cce----EEEEEecCCC--CchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCc
Q 011331 301 NEQ----LYIQMELCDH--SLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRA 373 (488)
Q Consensus 301 ~~~----l~IV~E~~~~--~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA 373 (488)
... .+||||++++ .+........+++. .+.+|+.+|.+||++||+|+||||+|||+ .++.++|+|||.+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 222 3599999986 34444333445543 36789999999999999999999999999 4678999999988
Q ss_pred ee
Q 011331 374 TL 375 (488)
Q Consensus 374 ~~ 375 (488)
+.
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 75
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.8e-15 Score=157.70 Aligned_cols=185 Identities=23% Similarity=0.339 Sum_probs=140.0
Q ss_pred CCCCeeEeeeeecccceEEEEEecCCCC-chhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCc-ccCCCCCCcEEEe-
Q 011331 287 SHENIVGYYSSWFENEQLYIQMELCDHS-LSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGI-AHLDVKPDNIYVK- 361 (488)
Q Consensus 287 ~HpnIv~l~~~~~~~~~l~IV~E~~~~~-l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gI-iHrDLKp~NILv~- 361 (488)
.|.|+.++++.+.+...+++|.+||..+ +.+.... ..+..--...++++|+.||.|||.-.| .|+.++..|.+++
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~ 84 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDS 84 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeee
Confidence 8999999999999999999999999875 4443333 346666677889999999999998765 9999999999994
Q ss_pred CCeEEEEeecCceecCCC-----CCCCCCCCCccChhhhccc--CC----CCchhHHHHHHHHHHHHHcCCCCCCCchh-
Q 011331 362 NGVYKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNED--YD----HLDKVDIFSLGATMYELIKGSPLSESGPQ- 429 (488)
Q Consensus 362 ~g~vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~--~~----~~~ksDIwSlGvlL~eLltG~~p~~~~~~- 429 (488)
.-.+||.|||+....... .....-..-|.|||.+... .. .+.+.||||||++++|+++...||.....
T Consensus 85 ~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~ 164 (484)
T KOG1023|consen 85 RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLV 164 (484)
T ss_pred eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccccccc
Confidence 568999999998776421 1111123459999998653 11 35579999999999999999988875321
Q ss_pred ------hhhhhc-CCCCCCC------CCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 430 ------FLNLRD-GKLPLLP------GHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 430 ------~~~i~~-~~~~~~~------~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
...+.+ +..++.| ...+++..++..||..+|+.||+++++-.
T Consensus 165 ~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 165 EDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred CChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 112233 3333333 33457899999999999999999988765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.2e-13 Score=125.53 Aligned_cols=139 Identities=17% Similarity=0.091 Sum_probs=101.4
Q ss_pred EEecccCcEEEEEEEEcC------CCeEEEEEEeccCCC----------------------ch--HHHHHHHHHHHHHHH
Q 011331 235 EQIGAGNFSHVFKVLKRI------DGCFYAVKHSKRQLH----------------------HD--AERRKALLEVQALAA 284 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~------~g~~vAvK~l~~~~~----------------------~~--~~~~~~~~Ei~iL~~ 284 (488)
..||.|.-+.||.|.... .+..+|||+++.... +. .....+.+|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 357999998652110 00 111224478999998
Q ss_pred hCCC-CCeeEeeeeecccceEEEEEecCCCCch-h-hhhcccCCHHHHHHHHHHHHHHHHHH-HHcCcccCCCCCCcEEE
Q 011331 285 LGSH-ENIVGYYSSWFENEQLYIQMELCDHSLS-D-KKASQFFAEGEVLKALHQIAQALQFI-HEKGIAHLDVKPDNIYV 360 (488)
Q Consensus 285 l~~H-pnIv~l~~~~~~~~~l~IV~E~~~~~l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yL-H~~gIiHrDLKp~NILv 360 (488)
+... -++..++.+ ..-+|||||+++... . ......+++..+..++.+++.+|..| |+.||||+||++.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 8433 456666653 456889999986421 1 22223455667788899999999999 89999999999999999
Q ss_pred eCCeEEEEeecCceecC
Q 011331 361 KNGVYKLGDFGRATLLN 377 (488)
Q Consensus 361 ~~g~vkL~DFGlA~~~~ 377 (488)
.++.+.|+|||.|....
T Consensus 159 ~~~~v~iIDF~qav~~~ 175 (197)
T cd05146 159 HDGKVWFIDVSQSVEPT 175 (197)
T ss_pred ECCcEEEEECCCceeCC
Confidence 98999999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.1e-12 Score=118.21 Aligned_cols=129 Identities=18% Similarity=0.107 Sum_probs=94.0
Q ss_pred EEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCC
Q 011331 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 234 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
++.|+.|.++.||++... |..|++|+...... .......|+.++..+.....+.+++.... ..-++|||++++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 567899999999999864 88999998754321 12235568888888743333445554433 335799999998
Q ss_pred CchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCc-----ccCCCCCCcEEEeCCeEEEEeecCcee
Q 011331 314 SLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGI-----AHLDVKPDNIYVKNGVYKLGDFGRATL 375 (488)
Q Consensus 314 ~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gI-----iHrDLKp~NILv~~g~vkL~DFGlA~~ 375 (488)
...... ......++.+++.+|..||..++ +|+|++|.||+++++.++|+|||.+..
T Consensus 76 ~~l~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEEEEecccccC
Confidence 643321 01123467899999999999985 999999999999988999999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.8e-12 Score=137.90 Aligned_cols=142 Identities=21% Similarity=0.224 Sum_probs=93.7
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHH--------------------------------------HHHHH
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE--------------------------------------RRKAL 276 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~--------------------------------------~~~~~ 276 (488)
+.||.|++|+||+|... +|+.||||+.+........ ..++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999875 8999999998654211100 01234
Q ss_pred HHHHHHHHhC----CCCCeeEeeeeecccceEEEEEecCCCCchh-hhhcccCCHHHHHHHHHHHHH-HHHHHHHcCccc
Q 011331 277 LEVQALAALG----SHENIVGYYSSWFENEQLYIQMELCDHSLSD-KKASQFFAEGEVLKALHQIAQ-ALQFIHEKGIAH 350 (488)
Q Consensus 277 ~Ei~iL~~l~----~HpnIv~l~~~~~~~~~l~IV~E~~~~~l~~-~~~~~~l~~~~~~~i~~qI~~-gL~yLH~~gIiH 350 (488)
.|...+.++. ++++|.-..-++...+..+|||||++|..+. ......... ....++..++. .+..+|..|++|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~H 280 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFFH 280 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCcee
Confidence 4555555442 3444443332333345579999999885333 211110110 23345555555 478889999999
Q ss_pred CCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 351 LDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 351 rDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
+|++|.||++ .+|.++|+|||++..++.
T Consensus 281 ~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 281 ADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999 678999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.9e-14 Score=156.08 Aligned_cols=251 Identities=21% Similarity=0.271 Sum_probs=184.7
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchH-HHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDA-ERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~-~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
...+.+.+.+-+|.++.++.+.-..+|-..++|+......... ..+....+-.++... .+|.++...-.+......+|
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcch
Confidence 3467888899999999999998887886677765432210000 011122222222222 45777766666667788999
Q ss_pred EEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC-----
Q 011331 307 QMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK----- 378 (488)
Q Consensus 307 V~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~----- 378 (488)
+++|++++ +..+ ...+..++.-++.++..+..+++|||...++|+|++|.|+++ .+|..++.|||+....+-
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 99999764 3222 223346777788888999999999999999999999999999 789999999985432210
Q ss_pred -C----------------------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh
Q 011331 379 -S----------------------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ 429 (488)
Q Consensus 379 -~----------------------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~ 429 (488)
. .....||+.|.+||.+.+. .+...+|+|++|++++|.++|.+||.....
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-RHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-cCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0 0012489999999998876 567799999999999999999999987554
Q ss_pred ---hhhhhcCCCCCCC---CCcHHHHHHHHHcccCCCCCCCCHH---HHHhChhhhhhHH
Q 011331 430 ---FLNLRDGKLPLLP---GHSLQFQNLLKVMVDPDPVQRPSAK---ELVENPIFDKIQK 480 (488)
Q Consensus 430 ---~~~i~~~~~~~~~---~~s~~l~~lI~k~L~~dP~~RpTa~---elL~HP~f~~i~~ 480 (488)
+.++..+..+++. ..+.+.++++..++..+|.+|..+. ++-.||||+.+.+
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 4455556666554 3588999999999999999999877 9999999998754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.3e-12 Score=141.22 Aligned_cols=145 Identities=20% Similarity=0.227 Sum_probs=91.5
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch--------------------------------HHH-
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD--------------------------------AER- 272 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~--------------------------------~~~- 272 (488)
..+.+|.. +.||+|++|+||+|....+|+.||||+.++..... ...
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34556676 78999999999999998779999999997542110 001
Q ss_pred -----HHHHHHHHHHHHhC---CCCCeeEeeeee-cccceEEEEEecCCCCchhh----hhcc----cCCHHHHHHHHHH
Q 011331 273 -----RKALLEVQALAALG---SHENIVGYYSSW-FENEQLYIQMELCDHSLSDK----KASQ----FFAEGEVLKALHQ 335 (488)
Q Consensus 273 -----~~~~~Ei~iL~~l~---~HpnIv~l~~~~-~~~~~l~IV~E~~~~~l~~~----~~~~----~l~~~~~~~i~~q 335 (488)
-++.+|+..+.++. .+.+.+.+-.++ .-....+|||||++|.-... ...+ .+.+..+..++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 12333444444331 122222222222 22445679999999853321 1111 1333344444455
Q ss_pred HHHHHHHHHHcCcccCCCCCCcEEE-eCC----eEEEEeecCceecCC
Q 011331 336 IAQALQFIHEKGIAHLDVKPDNIYV-KNG----VYKLGDFGRATLLNK 378 (488)
Q Consensus 336 I~~gL~yLH~~gIiHrDLKp~NILv-~~g----~vkL~DFGlA~~~~~ 378 (488)
| ...|++|+|++|.||+| .+| .++++|||++..++.
T Consensus 276 i-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 V-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 46899999999999999 455 899999999987653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.3e-12 Score=126.22 Aligned_cols=230 Identities=18% Similarity=0.267 Sum_probs=148.4
Q ss_pred EEEEEEEcCCCeEEEEEEeccC----C-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc-----eEEEEEecCCC
Q 011331 244 HVFKVLKRIDGCFYAVKHSKRQ----L-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENE-----QLYIQMELCDH 313 (488)
Q Consensus 244 ~Vy~a~~~~~g~~vAvK~l~~~----~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~-----~l~IV~E~~~~ 313 (488)
.||++.+...|..|....+... . .....++.. ...|..+ .|.|||+++.+|.+.. ...++.||+..
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~v---Fdnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymss 156 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAV---FDNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSS 156 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHH---HHHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccc
Confidence 4677777767766654322111 0 111111111 2234455 6999999999998644 46788999976
Q ss_pred Cchh------hhhcccCCHHHHHHHHHHHHHHHHHHHHc--CcccCCCCCCcEEE-eCCeEEEEeecCceec-------C
Q 011331 314 SLSD------KKASQFFAEGEVLKALHQIAQALQFIHEK--GIAHLDVKPDNIYV-KNGVYKLGDFGRATLL-------N 377 (488)
Q Consensus 314 ~l~~------~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~-------~ 377 (488)
+.+. .+....+......+|+.||+.||.|||++ -|+|+++..+-|++ .+|-+|++--.-.... .
T Consensus 157 gs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~ 236 (458)
T KOG1266|consen 157 GSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTRE 236 (458)
T ss_pred hhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhH
Confidence 5332 22234578888899999999999999998 49999999999999 6788887421111100 0
Q ss_pred CCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-h---hhhhcCCCCCCCCCcHHHHHHHH
Q 011331 378 KSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-F---LNLRDGKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 378 ~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-~---~~i~~~~~~~~~~~s~~l~~lI~ 453 (488)
.......|-++|.+||.=... ..+.++|||+||....||..|..-...... . ..+..-.+.+ ...--+.+|.
T Consensus 237 ~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~ 312 (458)
T KOG1266|consen 237 AEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL---ENGLQRGSIT 312 (458)
T ss_pred hhhhccccCCccccCCcCccc-ccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec---cCccccCcCc
Confidence 111233477899999964332 344589999999999999988754332211 1 1111111111 1122346899
Q ss_pred HcccCCCCCCCCHHHHHhChhhhhhHHh
Q 011331 454 VMVDPDPVQRPSAKELVENPIFDKIQKH 481 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~HP~f~~i~~~ 481 (488)
+|++..|..||++.+++.||.+=.++-.
T Consensus 313 kcl~~eP~~rp~ar~llfHpllfeVhsl 340 (458)
T KOG1266|consen 313 KCLEGEPNGRPDARLLLFHPLLFEVHSL 340 (458)
T ss_pred ccccCCCCCCcchhhhhcCceeeecchH
Confidence 9999999999999999999987655543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.1e-11 Score=128.25 Aligned_cols=165 Identities=24% Similarity=0.282 Sum_probs=122.8
Q ss_pred EEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCCchhhhhcccCCH
Q 011331 247 KVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQFFAE 326 (488)
Q Consensus 247 ~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~l~~~~~~~~l~~ 326 (488)
.|..+.++.+|.|.+++.... .......+.+..|+.+ +||||+++++.++..+.+|||+|-+.---... ..+..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~l---k~l~~ 103 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVTERVRPLETVL---KELGK 103 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEeeccccHHHHH---HHhHH
Confidence 355566888898888775432 3344566777888888 99999999999999999999999875421111 11335
Q ss_pred HHHHHHHHHHHHHHHHHH-HcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC---CCCCCCCccChhhhcccCCC
Q 011331 327 GEVLKALHQIAQALQFIH-EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP---IEEGDARYMPQEILNEDYDH 401 (488)
Q Consensus 327 ~~~~~i~~qI~~gL~yLH-~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~---~~~Gt~~Y~APEvl~~~~~~ 401 (488)
..+..-+.||+.||.||| +++++|++|.-+.|+| ..|.-||++|.++........ ...--..|..|+.+... .+
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s-~~ 182 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS-EW 182 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc-cc
Confidence 677788999999999997 6789999999999999 689999999998865433221 11112246677655333 22
Q ss_pred CchhHHHHHHHHHHHHHcC
Q 011331 402 LDKVDIFSLGATMYELIKG 420 (488)
Q Consensus 402 ~~ksDIwSlGvlL~eLltG 420 (488)
..|.|-|||+++|++.|
T Consensus 183 --s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 --SIDSWGLGCLIEELFNG 199 (690)
T ss_pred --chhhhhHHHHHHHHhCc
Confidence 57999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.9e-10 Score=105.94 Aligned_cols=132 Identities=20% Similarity=0.211 Sum_probs=97.8
Q ss_pred EecccCcEEEEEEEEcCCCeEEEEEEe-ccC-----CCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 236 QIGAGNFSHVFKVLKRIDGCFYAVKHS-KRQ-----LHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~~g~~vAvK~l-~~~-----~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
.+++|+-+.+|.+.+ -|..+.+|.= .+. +..........+|+.++.++ .--.|....-+..+.....|+||
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEEE
Confidence 478899999999866 3556777742 222 11122345677899999988 44455554445667777789999
Q ss_pred cCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCcee
Q 011331 310 LCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATL 375 (488)
Q Consensus 310 ~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~ 375 (488)
|++|.++....... ...++..|-.-+.-||..||||+||.++||++.++.+.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~-----~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCcEEEEECCcccc
Confidence 99998765222211 35778888889999999999999999999999998899999999974
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.2e-10 Score=104.45 Aligned_cols=129 Identities=24% Similarity=0.200 Sum_probs=84.9
Q ss_pred EEEEEEEcCCCeEEEEEEeccCC------------------------CchHHHHHHHHHHHHHHHhCCC-CCeeEeeeee
Q 011331 244 HVFKVLKRIDGCFYAVKHSKRQL------------------------HHDAERRKALLEVQALAALGSH-ENIVGYYSSW 298 (488)
Q Consensus 244 ~Vy~a~~~~~g~~vAvK~l~~~~------------------------~~~~~~~~~~~Ei~iL~~l~~H-pnIv~l~~~~ 298 (488)
.||.|... .|..+|||+.+... ..........+|...|.++... -++.+++.+.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38888874 78899999875321 1112235577899999998443 2566666442
Q ss_pred cccceEEEEEecCC--CCchhhhhcccCCHHHHHHHHHHHHHHHHH-HHHcCcccCCCCCCcEEEeCCeEEEEeecCcee
Q 011331 299 FENEQLYIQMELCD--HSLSDKKASQFFAEGEVLKALHQIAQALQF-IHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATL 375 (488)
Q Consensus 299 ~~~~~l~IV~E~~~--~~l~~~~~~~~l~~~~~~~i~~qI~~gL~y-LH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~ 375 (488)
.-+|||||++ |..+.......++......++.+++..+.. +|+.||||+||.+.|||+.++.+.|+|||.|..
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~~~iIDf~qav~ 155 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGKVYIIDFGQAVD 155 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTCEEE--GTTEEE
T ss_pred ----CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecceEEEEecCccee
Confidence 3469999998 644443333333345677888888886666 579999999999999999988999999999876
Q ss_pred cC
Q 011331 376 LN 377 (488)
Q Consensus 376 ~~ 377 (488)
..
T Consensus 156 ~~ 157 (188)
T PF01163_consen 156 SS 157 (188)
T ss_dssp TT
T ss_pred cC
Confidence 54
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.6e-09 Score=101.53 Aligned_cols=140 Identities=16% Similarity=0.180 Sum_probs=99.9
Q ss_pred EEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCC-CCeeEeeeeeccc---ceEEEEEe
Q 011331 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH-ENIVGYYSSWFEN---EQLYIQME 309 (488)
Q Consensus 234 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~H-pnIv~l~~~~~~~---~~l~IV~E 309 (488)
++.||.|.++.||++... +|..|++|+....... ........|+.++..+..+ .++.+++.+.... +..+++||
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 367899999999999774 3689999987543221 1234577888898888432 3456666666553 36789999
Q ss_pred cCCCCchhhhh-cccCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 011331 310 LCDHSLSDKKA-SQFFAEGEVLKALHQIAQALQFIHE------------------------------------------- 345 (488)
Q Consensus 310 ~~~~~l~~~~~-~~~l~~~~~~~i~~qI~~gL~yLH~------------------------------------------- 345 (488)
|+++....... ...+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 81 RVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred EeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99886433221 1346677777788888888888874
Q ss_pred -------------cCcccCCCCCCcEEEeC---CeEEEEeecCcee
Q 011331 346 -------------KGIAHLDVKPDNIYVKN---GVYKLGDFGRATL 375 (488)
Q Consensus 346 -------------~gIiHrDLKp~NILv~~---g~vkL~DFGlA~~ 375 (488)
..++|+|+.+.||++++ +.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23599999999999954 5689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.2e-09 Score=96.89 Aligned_cols=140 Identities=20% Similarity=0.220 Sum_probs=100.5
Q ss_pred EEEEecccCcEEEEEEEEcCCCeEEEEEEe-ccC-----CCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHS-KRQ-----LHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l-~~~-----~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.+..|-+|+-+.|+++.+ .|+.+.||.= .+. +.....+.....|+..|.++ .--.|...--+|.+...-.|
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCCeE
Confidence 567888999999999987 5888888842 111 22233456678899999987 33355544445667777788
Q ss_pred EEecCCCC--chhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eC-C--eEEEEeecCcee
Q 011331 307 QMELCDHS--LSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KN-G--VYKLGDFGRATL 375 (488)
Q Consensus 307 V~E~~~~~--l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~-g--~vkL~DFGlA~~ 375 (488)
+|||+++. +.... ............++++|-..+.-||..+|||+||..+||++ .+ + .+.++|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99999983 22211 11222233347899999999999999999999999999999 33 3 358999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.84 E-value=7.2e-08 Score=101.62 Aligned_cols=211 Identities=18% Similarity=0.228 Sum_probs=148.2
Q ss_pred CcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec----ccceEEEEEecCCCC--
Q 011331 241 NFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF----ENEQLYIQMELCDHS-- 314 (488)
Q Consensus 241 ~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~----~~~~l~IV~E~~~~~-- 314 (488)
.-.+.|+|....+|..|++|.++....... .....-+++++++ .|.|||.+.++|. .+..+++|++|.++.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 346789999999999999999842211111 1222346778888 9999999999887 355689999998753
Q ss_pred chhh----------------hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCC-eEEEEeecCceecC
Q 011331 315 LSDK----------------KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNG-VYKLGDFGRATLLN 377 (488)
Q Consensus 315 l~~~----------------~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g-~vkL~DFGlA~~~~ 377 (488)
|.+. ......+|..+|.++.|+..||.++|+.|...+-|.|.+|++... +++|...|....+.
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 3321 112347789999999999999999999999999999999999655 88888877766554
Q ss_pred CCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 378 KSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 378 ~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
... .+| +... .+-|.=-||.++..|.||..-.-..+..+... ...+-+.++.+++++|..+..
T Consensus 445 ~d~---------~~~--le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~--~~~I~~~yS~D~rn~v~yl~s 507 (655)
T KOG3741|consen 445 EDP---------TEP--LESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSH--LTRITTTYSTDLRNVVEYLES 507 (655)
T ss_pred CCC---------Ccc--hhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHH--HHHhhhhhhHHHHHHHHHHHh
Confidence 321 111 2221 26788899999999999953211111111110 111234578999999999999
Q ss_pred CCCCCCCCHHHHHhC
Q 011331 458 PDPVQRPSAKELVEN 472 (488)
Q Consensus 458 ~dP~~RpTa~elL~H 472 (488)
.++.+ -++.+++-|
T Consensus 508 ~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 508 LNFRE-KSIQDLLPM 521 (655)
T ss_pred cCccc-ccHHHHHHH
Confidence 99886 677777654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.5e-09 Score=117.55 Aligned_cols=151 Identities=21% Similarity=0.382 Sum_probs=112.3
Q ss_pred HHHHHHHHHHHc-CcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCC------------CCCCCCccChhhhcccCC
Q 011331 335 QIAQALQFIHEK-GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPI------------EEGDARYMPQEILNEDYD 400 (488)
Q Consensus 335 qI~~gL~yLH~~-gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~------------~~Gt~~Y~APEvl~~~~~ 400 (488)
+++.||.|+|.. ++||+.|.|++|.+ .+|..||+.|+++......... ..-...|.|||.+... .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-T 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-c
Confidence 355999999965 89999999999999 6789999999988655432111 1134569999999874 5
Q ss_pred CCchhHHHHHHHHHHHHH-cCCCCCCCch--hhhhhh-----cCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 401 HLDKVDIFSLGATMYELI-KGSPLSESGP--QFLNLR-----DGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 401 ~~~ksDIwSlGvlL~eLl-tG~~p~~~~~--~~~~i~-----~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
.+.++|+||+||++|.+. .|+..+.... ...... .+..-....++.++++-|.+++..++.-||++.+++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 667999999999999999 5555544331 111111 12223345678999999999999999999999999999
Q ss_pred hhhhhhHHhhhhcC
Q 011331 473 PIFDKIQKHRKTYM 486 (488)
Q Consensus 473 P~f~~i~~~~~~~~ 486 (488)
|||++..-....||
T Consensus 266 ~ff~D~~~~aLrfL 279 (700)
T KOG2137|consen 266 PFFSDPGLKALRFL 279 (700)
T ss_pred cccCCchhhhhhhc
Confidence 99987554444444
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.1e-07 Score=95.01 Aligned_cols=132 Identities=16% Similarity=0.057 Sum_probs=87.4
Q ss_pred CcEEEEEEEEcCCCeEEEEEEeccCCCchHH---------HHHHHHHHHHHHHhCCCCCe--eEeeeeecc-----cceE
Q 011331 241 NFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE---------RRKALLEVQALAALGSHENI--VGYYSSWFE-----NEQL 304 (488)
Q Consensus 241 ~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~---------~~~~~~Ei~iL~~l~~HpnI--v~l~~~~~~-----~~~l 304 (488)
....|+++.. .|+.|.||..........- ...+.+|...+.++. ..+| +.+..++.. ...-
T Consensus 34 ~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s 110 (268)
T PRK15123 34 EGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTS 110 (268)
T ss_pred CCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCcccee
Confidence 3334556543 6788999976433211100 013667888777762 2222 222333322 2346
Q ss_pred EEEEecCCCC--chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--------CCeEEEEeec
Q 011331 305 YIQMELCDHS--LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--------NGVYKLGDFG 371 (488)
Q Consensus 305 ~IV~E~~~~~--l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--------~g~vkL~DFG 371 (488)
+||||++++. +..... ....+......++.+|+..+.-||..||+|+|+++.|||++ +..+.|+||+
T Consensus 111 ~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 111 FIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 8999999885 333321 23455667789999999999999999999999999999995 2579999999
Q ss_pred Ccee
Q 011331 372 RATL 375 (488)
Q Consensus 372 lA~~ 375 (488)
.+..
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.4e-08 Score=96.40 Aligned_cols=138 Identities=21% Similarity=0.165 Sum_probs=102.6
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccC--------------------CCchHHHHHHHHHHHHHHHhCCC-CC
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ--------------------LHHDAERRKALLEVQALAALGSH-EN 290 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~--------------------~~~~~~~~~~~~Ei~iL~~l~~H-pn 290 (488)
.+...||-|.-|.||.|.+. .|.++|||.-+.. .+....+..+.+|.++|.+|..+ -.
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 46789999999999999886 7999999964321 11123456788999999998433 25
Q ss_pred eeEeeeeecccceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEe
Q 011331 291 IVGYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGD 369 (488)
Q Consensus 291 Iv~l~~~~~~~~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~D 369 (488)
|.+.+ +.+.-.+|||+++|..+.... +....+..++..|+.-+.-+=..||||+|+++-||+| .+|.+.++|
T Consensus 173 VP~P~----~~nRHaVvMe~ieG~eL~~~r---~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vID 245 (304)
T COG0478 173 VPKPI----AWNRHAVVMEYIEGVELYRLR---LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVID 245 (304)
T ss_pred CCCcc----ccccceeeeehcccceeeccc---CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEe
Confidence 66655 346678999999996443222 2345566667777777776669999999999999999 678999999
Q ss_pred ecCceecC
Q 011331 370 FGRATLLN 377 (488)
Q Consensus 370 FGlA~~~~ 377 (488)
|--+...+
T Consensus 246 wPQ~v~~~ 253 (304)
T COG0478 246 WPQAVPIS 253 (304)
T ss_pred CcccccCC
Confidence 99776543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=8e-07 Score=91.85 Aligned_cols=227 Identities=17% Similarity=0.195 Sum_probs=144.4
Q ss_pred EEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec-------c-cceE
Q 011331 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF-------E-NEQL 304 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~-------~-~~~l 304 (488)
..+.||+|+.+.+|-.-.. + ..+.|++..... .... ..+..|.....||-+-. --+|. + ...+
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Ppp--a~~a---qk~a~la~~p~~p~~~~-rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPP--AAQA---QKVAELAATPDAPLLNY-RVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchh--h-chhheeecCCCc--hHHH---HHHHHhccCCCCcchhh-hhcccHHHhhCCCcccee
Confidence 3467999999999965322 2 234477654322 1111 22344555556664332 11221 2 2236
Q ss_pred EEEEecCCCC-----chh----hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCce
Q 011331 305 YIQMELCDHS-----LSD----KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRAT 374 (488)
Q Consensus 305 ~IV~E~~~~~-----l~~----~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~ 374 (488)
.+.|..+.+. +.. ........+.-+++..+.|+.+.+-||..|.+-+|++++|+|| +++.+.|.|-..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 7778877652 111 1222336677889999999999999999999999999999999 67889998755433
Q ss_pred ecCCC--CCCCCCCCCccChhhhc----ccCCCCchhHHHHHHHHHHHHHcC-CCCCCCchh-------hh-hhhcC---
Q 011331 375 LLNKS--LPIEEGDARYMPQEILN----EDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ-------FL-NLRDG--- 436 (488)
Q Consensus 375 ~~~~~--~~~~~Gt~~Y~APEvl~----~~~~~~~ksDIwSlGvlL~eLltG-~~p~~~~~~-------~~-~i~~~--- 436 (488)
+..+. ....+|...|.+||.-. .+.+-+...|.|.||+++++++.| .+||.+-.. .. .|-.+
T Consensus 166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 33222 23456899999999754 223445578999999999999988 788764311 11 22211
Q ss_pred --------CCCCC-----CCCcHHHHHHHHHcccCC--CCCCCCHHH
Q 011331 437 --------KLPLL-----PGHSLQFQNLLKVMVDPD--PVQRPSAKE 468 (488)
Q Consensus 437 --------~~~~~-----~~~s~~l~~lI~k~L~~d--P~~RpTa~e 468 (488)
..+.+ .-++..++.+..+|+..- +.-|||++-
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 11111 124678999999999643 567999763
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.9e-07 Score=91.00 Aligned_cols=141 Identities=17% Similarity=0.136 Sum_probs=95.6
Q ss_pred EEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHH----------------------HHHHHHHHHHHHHhCC-CC
Q 011331 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE----------------------RRKALLEVQALAALGS-HE 289 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~----------------------~~~~~~Ei~iL~~l~~-Hp 289 (488)
+...|..|..+.||+|.. .++..||||+++.....-.. ..-...|...|.++.+ +=
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 455899999999999976 37899999998643211110 0123345556665521 12
Q ss_pred CeeEeeeeecccceEEEEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEeCCeEE
Q 011331 290 NIVGYYSSWFENEQLYIQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYVKNGVYK 366 (488)
Q Consensus 290 nIv~l~~~~~~~~~l~IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv~~g~vk 366 (488)
.+.+.+.+. .-.|||||++.. .-. ....-.+...++..+..+++..+.-|=. .|+||+||+.-|||+.+|.+.
T Consensus 131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~~p~ 206 (268)
T COG1718 131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDGEPY 206 (268)
T ss_pred CCCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECCeEE
Confidence 223333221 236899999764 111 2222234445788899999999998865 899999999999999999999
Q ss_pred EEeecCceecCC
Q 011331 367 LGDFGRATLLNK 378 (488)
Q Consensus 367 L~DFGlA~~~~~ 378 (488)
|+|||-|.....
T Consensus 207 iID~~QaV~~~h 218 (268)
T COG1718 207 IIDVSQAVTIDH 218 (268)
T ss_pred EEECccccccCC
Confidence 999998876553
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.7e-08 Score=106.92 Aligned_cols=232 Identities=18% Similarity=0.210 Sum_probs=164.6
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCC-eeEeeeeecccceEEEEEec
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN-IVGYYSSWFENEQLYIQMEL 310 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hpn-Iv~l~~~~~~~~~l~IV~E~ 310 (488)
.....+++|+++++++.+...+...+ .+.+... .....+++.|.++ +||| .+..++.+..+...+|+|++
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKV-NNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHc-cCCCCcccccccCCcccccchhhhh
Confidence 33456789999999998876555444 5554321 2344578889998 8999 77888888888889999999
Q ss_pred CCCC--chh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCceecCCC--CCCCC
Q 011331 311 CDHS--LSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKS--LPIEE 384 (488)
Q Consensus 311 ~~~~--l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~~~~~--~~~~~ 384 (488)
+.++ ... ....-.+.+.+...++..-+++|+++|+-.-+|+| ||+..++..+..||+.+..+... ..+..
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~~~~~~~~v~~~L~~~~~~~t~~ 391 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEEVKLLDFAVPPQLTRTMKPRTAI 391 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccccccccccCCcccCcccccccCC
Confidence 9775 111 11122344555667777788899999998878988 99999999999999999877655 45567
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh-hhhcCC-CC-CCC--CCcHHHH-HHHHHcccC
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL-NLRDGK-LP-LLP--GHSLQFQ-NLLKVMVDP 458 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~-~i~~~~-~~-~~~--~~s~~l~-~lI~k~L~~ 458 (488)
+++.++|||+...+ .+....|.|++|+-..+|.-|.+|........ .+..+. .+ +.. ..+..+. ++...|+..
T Consensus 392 ~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g 470 (829)
T KOG0576|consen 392 GTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNG 470 (829)
T ss_pred CCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCCCccccCCCCCCCCccccchhhhcCcccccCCcccccCC
Confidence 99999999988766 34458999999988778888876654422111 111111 00 000 0112223 377889999
Q ss_pred CCCCCCCHHHHHhChhhhh
Q 011331 459 DPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 459 dP~~RpTa~elL~HP~f~~ 477 (488)
.|..|+...+++.|.+|.+
T Consensus 471 ~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 471 LPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred CCCCCcchhhHHHHHHhcc
Confidence 9999999999999999975
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=1e-06 Score=84.40 Aligned_cols=104 Identities=21% Similarity=0.205 Sum_probs=73.0
Q ss_pred HHHHHHHHHHHHhCC-CCCeeEeeeeeccc----ceEEEEEecCCCC--chhhhhc-ccCCHHHHHHHHHHHHHHHHHHH
Q 011331 273 RKALLEVQALAALGS-HENIVGYYSSWFEN----EQLYIQMELCDHS--LSDKKAS-QFFAEGEVLKALHQIAQALQFIH 344 (488)
Q Consensus 273 ~~~~~Ei~iL~~l~~-HpnIv~l~~~~~~~----~~l~IV~E~~~~~--l~~~~~~-~~l~~~~~~~i~~qI~~gL~yLH 344 (488)
..+.+|...+..+.. .=.+..++.+.... ..-+||+|++++. +...... ..++......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 456677777666621 11233444444332 2358999999874 3333222 22566778899999999999999
Q ss_pred HcCcccCCCCCCcEEEeCC----eEEEEeecCceec
Q 011331 345 EKGIAHLDVKPDNIYVKNG----VYKLGDFGRATLL 376 (488)
Q Consensus 345 ~~gIiHrDLKp~NILv~~g----~vkL~DFGlA~~~ 376 (488)
+.||+|+|+++.||||..+ .+.|+||+.++..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999543 6999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.8e-06 Score=91.89 Aligned_cols=141 Identities=23% Similarity=0.256 Sum_probs=92.0
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchH--------------------------------------HHHHHH
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDA--------------------------------------ERRKAL 276 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~--------------------------------------~~~~~~ 276 (488)
+.|+.++-|+||+|... +|+.||||+.++...... ..-++.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67999999999999886 699999999875421110 011233
Q ss_pred HHHHHHHHh----CCCCCeeEeeeeecccceEEEEEecCCCC-chh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 011331 277 LEVQALAAL----GSHENIVGYYSSWFENEQLYIQMELCDHS-LSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIA 349 (488)
Q Consensus 277 ~Ei~iL~~l----~~HpnIv~l~~~~~~~~~l~IV~E~~~~~-l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIi 349 (488)
+|...+.++ .+.++|.-..=+|.-.+.-.|+|||++|. +.+ ......++...+.....++ .+..+-..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCcc
Confidence 344433333 24555554444566667778999999985 222 1223445533333333332 23334458999
Q ss_pred cCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 350 HLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 350 HrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
|.|..|.||+| .+|.+.+.|||+...++.
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999 678999999999876654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.3e-05 Score=77.41 Aligned_cols=138 Identities=17% Similarity=0.197 Sum_probs=86.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHH-H------HHHHHHHHHHHhC--CCCCeeEeeeeec
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAER-R------KALLEVQALAALG--SHENIVGYYSSWF 299 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~-~------~~~~Ei~iL~~l~--~HpnIv~l~~~~~ 299 (488)
++|.+.+.+-......|.+.. .+|..+.+|..+......... . ...+.+..+.++. ....+..++.+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 468888888888877777654 378999999875432111100 0 1122223233321 2222333222222
Q ss_pred -----ccceEEEEEecCCCCch-hhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCc
Q 011331 300 -----ENEQLYIQMELCDHSLS-DKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRA 373 (488)
Q Consensus 300 -----~~~~l~IV~E~~~~~l~-~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA 373 (488)
--...+|+|||++|.-+ +.. .+.+ .+...|..++.-||+.|+.|+|..|.|++++++.++++||+..
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~---~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~i~iID~~~k 181 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIE---DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNGIRIIDTQGK 181 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccch---hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCcEEEEECccc
Confidence 22345689999998532 211 1222 2446677889999999999999999999999999999999976
Q ss_pred ee
Q 011331 374 TL 375 (488)
Q Consensus 374 ~~ 375 (488)
+.
T Consensus 182 ~~ 183 (229)
T PF06176_consen 182 RM 183 (229)
T ss_pred cc
Confidence 53
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.7e-05 Score=75.51 Aligned_cols=136 Identities=22% Similarity=0.211 Sum_probs=77.3
Q ss_pred EEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCC-CCeeEeeeee---cccceEEEEEe
Q 011331 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH-ENIVGYYSSW---FENEQLYIQME 309 (488)
Q Consensus 234 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~H-pnIv~l~~~~---~~~~~l~IV~E 309 (488)
++.|+.|..+.||++.... ..+++|..... ........|..++..+..+ ..+.+++... ......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5789999999999998753 59999986532 3445566788887777443 2355666533 23345789999
Q ss_pred cCCCCchhh--------------------hhcc-----cCCHHH---------HHHH------------HHHHHH-HHHH
Q 011331 310 LCDHSLSDK--------------------KASQ-----FFAEGE---------VLKA------------LHQIAQ-ALQF 342 (488)
Q Consensus 310 ~~~~~l~~~--------------------~~~~-----~l~~~~---------~~~i------------~~qI~~-gL~y 342 (488)
++++..... .... .+.... .... ...+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 998752221 0000 000000 0000 111222 3333
Q ss_pred HHH-------cCcccCCCCCCcEEEe--CCeEEEEeecCcee
Q 011331 343 IHE-------KGIAHLDVKPDNIYVK--NGVYKLGDFGRATL 375 (488)
Q Consensus 343 LH~-------~gIiHrDLKp~NILv~--~g~vkL~DFGlA~~ 375 (488)
+++ ..++|+|+.|.|||++ ++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 332 3599999999999997 67778999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.30 E-value=8.7e-06 Score=78.23 Aligned_cols=135 Identities=20% Similarity=0.146 Sum_probs=92.0
Q ss_pred cccCcEEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHHHHHhCCCCC--eeEeeeeecc----cceEEEE
Q 011331 238 GAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH----DAERRKALLEVQALAALGSHEN--IVGYYSSWFE----NEQLYIQ 307 (488)
Q Consensus 238 G~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~----~~~~~~~~~Ei~iL~~l~~Hpn--Iv~l~~~~~~----~~~l~IV 307 (488)
|+||.|-|+.... .|..|-+|.-...... ..-+..+.+|...|..+. ..+ +.++...... .-.-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~-~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELE-RAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHH-HcCCCCCccceeeeeccCCceEEEEE
Confidence 5688888988654 3557888865321100 123466888988888873 222 3344311111 1236899
Q ss_pred EecCCC--Cchhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CCe--EEEEeecCcee
Q 011331 308 MELCDH--SLSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NGV--YKLGDFGRATL 375 (488)
Q Consensus 308 ~E~~~~--~l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g~--vkL~DFGlA~~ 375 (488)
+|-+++ +|...... ...+......++.+|+..+.-||+.|+.|+|+.+.||+++ +|. +.++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998885 44333322 2346666789999999999999999999999999999994 666 99999997654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.4e-05 Score=77.80 Aligned_cols=72 Identities=14% Similarity=0.057 Sum_probs=51.8
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCC-CeeEeeeeecccceEEEEEecCCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE-NIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hp-nIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
..||.|..+.||+. .|..+++|...... ......+|.+++..+.... .+.+++.+....+...++||+++|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 57899999999984 25567889875432 1223567888888874332 256777777778888999999988
Q ss_pred C
Q 011331 314 S 314 (488)
Q Consensus 314 ~ 314 (488)
.
T Consensus 79 ~ 79 (226)
T TIGR02172 79 K 79 (226)
T ss_pred c
Confidence 4
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=5.9e-06 Score=76.91 Aligned_cols=128 Identities=25% Similarity=0.255 Sum_probs=90.0
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecC
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELC 311 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~ 311 (488)
++.+.||+|.+|.||++.+. |..+|+|+-+. +..+..+..|+++|..+..----.++|.+.. .++.|||+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i 94 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI 94 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence 56788999999999999884 77999998543 3456678889999998843333345554432 34559999
Q ss_pred CCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCC-C-CcEEEeCCeEEEEeecCcee
Q 011331 312 DHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVK-P-DNIYVKNGVYKLGDFGRATL 375 (488)
Q Consensus 312 ~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLK-p-~NILv~~g~vkL~DFGlA~~ 375 (488)
+|- |....... -.+.+..++..---|-..||-|..|. | .||++.++.+.|+||..|+.
T Consensus 95 ~G~~L~~~~~~~------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 984 33221110 13444556666556677899999998 3 56677888999999999974
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.9e-05 Score=87.40 Aligned_cols=81 Identities=20% Similarity=0.235 Sum_probs=55.3
Q ss_pred EEEEecccCcEEEEEEEEcCCC--eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCe--eEeeeeeccc---ceEE
Q 011331 233 EIEQIGAGNFSHVFKVLKRIDG--CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENI--VGYYSSWFEN---EQLY 305 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~g--~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnI--v~l~~~~~~~---~~l~ 305 (488)
.++.|+.|.++.+|+......+ ..+++|+...... ......+.+|..++..+..|.+| .+++.++.+. +..|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 3677899999999998765332 4677776533211 11234577899999998556654 6777776654 4678
Q ss_pred EEEecCCCC
Q 011331 306 IQMELCDHS 314 (488)
Q Consensus 306 IV~E~~~~~ 314 (488)
+||||+++.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999999874
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.99 E-value=6.2e-05 Score=73.43 Aligned_cols=71 Identities=8% Similarity=0.004 Sum_probs=49.6
Q ss_pred ecccCc-EEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCC
Q 011331 237 IGAGNF-SHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHS 314 (488)
Q Consensus 237 LG~G~f-g~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~ 314 (488)
|-.|.. +.||++.. .+..+.||+..... ......|+.++..+..+--+.+++.+....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444555 78999865 34678888764321 2345678888888866655667887777667789999999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.8e-05 Score=87.24 Aligned_cols=236 Identities=19% Similarity=0.234 Sum_probs=144.1
Q ss_pred ecccCcEEEEEEEEcCC----CeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE----E
Q 011331 237 IGAGNFSHVFKVLKRID----GCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI----Q 307 (488)
Q Consensus 237 LG~G~fg~Vy~a~~~~~----g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I----V 307 (488)
|---.+|++++..+... -..+-++.-..... ...+......|...+..+ .|+|++.++.+........+ .
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~ 264 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVL 264 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHH
Confidence 55556777777655321 11122221111111 123444555677777777 89999999887765444333 3
Q ss_pred EecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc---EEE-eCCeEEEE--eecCceecCCC
Q 011331 308 MELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDN---IYV-KNGVYKLG--DFGRATLLNKS 379 (488)
Q Consensus 308 ~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~N---ILv-~~g~vkL~--DFGlA~~~~~~ 379 (488)
.|+|..- +.. .......+...++.+..++.+||.|+|+....|.-|...- .-+ .++.+.+. ||+....+...
T Consensus 265 ~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~ 344 (1351)
T KOG1035|consen 265 QEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN 344 (1351)
T ss_pred HhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCc
Confidence 4566542 222 3334568888999999999999999999854444333331 111 23455555 78777655432
Q ss_pred C--CCCCCCCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCCCCCCCCcH-HHHHHHHHc
Q 011331 380 L--PIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSL-QFQNLLKVM 455 (488)
Q Consensus 380 ~--~~~~Gt~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~~~~~~~s~-~l~~lI~k~ 455 (488)
. ....-+..|.++|.+..+ +......|+|.+|.++..+..|..+.........+ .+..+. ....++.+|
T Consensus 345 ~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~~~-------l~~~~~~~~~d~~~~~ 417 (1351)
T KOG1035|consen 345 EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPVSL-------LDVLSTSELLDALPKC 417 (1351)
T ss_pred ccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchhhh-------hccccchhhhhhhhhh
Confidence 1 122244567778776543 22223469999999999999987654432221111 111221 677889999
Q ss_pred ccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 456 VDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 456 L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+.-++++|+++.+++.|||...-..
T Consensus 418 ~~~~~~~Rl~~~~ll~~~f~~~~~~ 442 (1351)
T KOG1035|consen 418 LDEDSEERLSALELLTHPFLRFPTD 442 (1351)
T ss_pred cchhhhhccchhhhhhchhcccccc
Confidence 9999999999999999999875443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00023 Score=68.06 Aligned_cols=128 Identities=26% Similarity=0.291 Sum_probs=89.7
Q ss_pred cceeEEEEecccCc-EEEEEEEEcCCCeEEEEEEecc---CC-------Cc--h-------HHHHHHHHHHHHHHHhC--
Q 011331 229 TDFHEIEQIGAGNF-SHVFKVLKRIDGCFYAVKHSKR---QL-------HH--D-------AERRKALLEVQALAALG-- 286 (488)
Q Consensus 229 ~~y~~~~~LG~G~f-g~Vy~a~~~~~g~~vAvK~l~~---~~-------~~--~-------~~~~~~~~Ei~iL~~l~-- 286 (488)
.+++.++.||.|.- |.||++.. .|..||+|+++. .. .. + .....+..|.++..+|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57899999999999 99999976 689999999321 00 00 0 11234677887777763
Q ss_pred CCCCe--eEeeeeeccc------------------ceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHc
Q 011331 287 SHENI--VGYYSSWFEN------------------EQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEK 346 (488)
Q Consensus 287 ~HpnI--v~l~~~~~~~------------------~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~ 346 (488)
++.++ |+++++..-. ...-||.||+.... .....-+.+|.+-|..+|+.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~~~~~~~dl~~~~k~ 183 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRDIPQMLRDLKILHKL 183 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhHHHHHHHHHHHHHHC
Confidence 34455 8888876311 01357778765543 11233466788888999999
Q ss_pred CcccCCCCCCcEEEeCCeEEEEeecCc
Q 011331 347 GIAHLDVKPDNIYVKNGVYKLGDFGRA 373 (488)
Q Consensus 347 gIiHrDLKp~NILv~~g~vkL~DFGlA 373 (488)
||+-+|+++.|.. .-+|+|||.+
T Consensus 184 gI~~~Dv~~~ny~----~G~lvDfs~~ 206 (207)
T PF13095_consen 184 GIVPRDVKPRNYR----GGKLVDFSSS 206 (207)
T ss_pred CeeeccCcccccc----CCEEEecccC
Confidence 9999999999988 5688999864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00013 Score=75.05 Aligned_cols=140 Identities=16% Similarity=0.190 Sum_probs=98.7
Q ss_pred EEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC----------------------CchHH--HHHHHHHHHHHHHhCCC
Q 011331 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL----------------------HHDAE--RRKALLEVQALAALGSH 288 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~----------------------~~~~~--~~~~~~Ei~iL~~l~~H 288 (488)
+-.+|..|.-+.||.|... +|..+|||+++-.. .+... ..-+..|...|.++ +.
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~~ 225 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-NN 225 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-Hh
Confidence 4568999999999999765 89999999875321 11111 12345677777777 33
Q ss_pred CCeeEeeeeecccceEEEEEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHH-HHcCcccCCCCCCcEEEeCCeE
Q 011331 289 ENIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFI-HEKGIAHLDVKPDNIYVKNGVY 365 (488)
Q Consensus 289 pnIv~l~~~~~~~~~l~IV~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yL-H~~gIiHrDLKp~NILv~~g~v 365 (488)
..|...--+.. ..-.|||+|++..-.- ....-.++...+..+..|++.-+.-| |.+++||.||.-=|+|+.+|.+
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~l 303 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGKL 303 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCEE
Confidence 33332211111 1246899999753221 34445688888999999999988888 7889999999999999999999
Q ss_pred EEEeecCceec
Q 011331 366 KLGDFGRATLL 376 (488)
Q Consensus 366 kL~DFGlA~~~ 376 (488)
.|+|-+-+...
T Consensus 304 yiIDVSQSVE~ 314 (520)
T KOG2270|consen 304 YIIDVSQSVEH 314 (520)
T ss_pred EEEEccccccC
Confidence 99998876544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00018 Score=78.10 Aligned_cols=139 Identities=20% Similarity=0.217 Sum_probs=87.6
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchH-----------------------------------HHHHHHHHH
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDA-----------------------------------ERRKALLEV 279 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~-----------------------------------~~~~~~~Ei 279 (488)
+.||..+.|+|++|+.+ +|+.||||+-++...... ..-++..|.
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 57999999999999887 599999998765431110 011122333
Q ss_pred HHHHHhC---CCCC------eeEeeeeecccceEEEEEecCCCC---chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcC
Q 011331 280 QALAALG---SHEN------IVGYYSSWFENEQLYIQMELCDHS---LSDKKASQFFAEGEVLKALHQIAQALQFIHEKG 347 (488)
Q Consensus 280 ~iL~~l~---~Hpn------Iv~l~~~~~~~~~l~IV~E~~~~~---l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~g 347 (488)
+...+.. .|-+ |.++ +|.-...-.|+||||+|. -.+......++...+...+.+... .-|-..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~V--y~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKV--YWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCee--hhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 3222221 2333 3333 244455678999999984 222344445666654444433222 2334668
Q ss_pred cccCCCCCCcEEEe-----CCeEEEEeecCceecCC
Q 011331 348 IAHLDVKPDNIYVK-----NGVYKLGDFGRATLLNK 378 (488)
Q Consensus 348 IiHrDLKp~NILv~-----~g~vkL~DFGlA~~~~~ 378 (488)
++|+|-.|.||+|. ++.+.+.|||+...+..
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999995 46899999999876643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00035 Score=66.78 Aligned_cols=129 Identities=19% Similarity=0.221 Sum_probs=86.7
Q ss_pred EEEecccCcEEEEEEEEcCCCeEEEEEEeccCC--------------CchHHHHHHHHHHHHHHHhC-----CCCCeeEe
Q 011331 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL--------------HHDAERRKALLEVQALAALG-----SHENIVGY 294 (488)
Q Consensus 234 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~--------------~~~~~~~~~~~Ei~iL~~l~-----~HpnIv~l 294 (488)
...||+|+.-.||.- . ..-...||++.... .......+..+|+.....+. .+.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999999973 2 33456678776543 00112344555555555542 47789999
Q ss_pred eeeecccceEEEEEecCC---CC----chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe---CC-
Q 011331 295 YSSWFENEQLYIQMELCD---HS----LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK---NG- 363 (488)
Q Consensus 295 ~~~~~~~~~l~IV~E~~~---~~----l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~---~g- 363 (488)
+|+.+++..+.+|+|.+. |. |.+......+++ .+...+-.-..||-+.+|+.+||+|.||++. ++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999999872 32 344444555555 3344444556688899999999999999992 23
Q ss_pred -eEEEEe
Q 011331 364 -VYKLGD 369 (488)
Q Consensus 364 -~vkL~D 369 (488)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00036 Score=67.51 Aligned_cols=74 Identities=14% Similarity=0.082 Sum_probs=46.8
Q ss_pred EEEecccCcEEEEEEEEcC-CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCC
Q 011331 234 IEQIGAGNFSHVFKVLKRI-DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCD 312 (488)
Q Consensus 234 ~~~LG~G~fg~Vy~a~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~ 312 (488)
++.|..|-...||++.... .+..|++|+....... ......|+.++..+..+.-.++++..+. + .++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeC
Confidence 5678888899999986542 2578889976533111 1223357778877754444555654433 2 37999997
Q ss_pred CC
Q 011331 313 HS 314 (488)
Q Consensus 313 ~~ 314 (488)
|.
T Consensus 76 G~ 77 (235)
T cd05157 76 GR 77 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00023 Score=69.21 Aligned_cols=71 Identities=13% Similarity=0.080 Sum_probs=42.7
Q ss_pred EEecccCcE-EEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCC--CeeEeeeeeccc---ceEEEEE
Q 011331 235 EQIGAGNFS-HVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE--NIVGYYSSWFEN---EQLYIQM 308 (488)
Q Consensus 235 ~~LG~G~fg-~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hp--nIv~l~~~~~~~---~~l~IV~ 308 (488)
+.|+.|+.. .||++ +..+.+|+.... ........|..++..+..+- .+..+++..... +..|++|
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 457767776 58876 235777865431 12345778999988874431 244444443332 2348899
Q ss_pred ecCCCC
Q 011331 309 ELCDHS 314 (488)
Q Consensus 309 E~~~~~ 314 (488)
++++|.
T Consensus 74 ~~i~G~ 79 (235)
T cd05155 74 RWLEGE 79 (235)
T ss_pred EeecCC
Confidence 999773
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00051 Score=72.40 Aligned_cols=79 Identities=23% Similarity=0.249 Sum_probs=52.5
Q ss_pred EEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC---c--hHHHHHHHHHHHHHHHhCCC--CCeeEeeeeecccceEE
Q 011331 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH---H--DAERRKALLEVQALAALGSH--ENIVGYYSSWFENEQLY 305 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~---~--~~~~~~~~~Ei~iL~~l~~H--pnIv~l~~~~~~~~~l~ 305 (488)
..+.||.|.+..||++.....++.|.||.-..... . .........|...|..+..+ .++++++.+ +.+..+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 35679999999999999863336899997431100 0 11234456677777776433 456777755 446678
Q ss_pred EEEecCCC
Q 011331 306 IQMELCDH 313 (488)
Q Consensus 306 IV~E~~~~ 313 (488)
+|||++++
T Consensus 108 lVME~L~~ 115 (401)
T PRK09550 108 TVMEDLSD 115 (401)
T ss_pred EEEecCCC
Confidence 99999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00058 Score=67.24 Aligned_cols=132 Identities=16% Similarity=0.054 Sum_probs=71.9
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCCch
Q 011331 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSLS 316 (488)
Q Consensus 237 LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~l~ 316 (488)
+..|-.+.+|++. .+|..+++|+...... ........|..++..+..+.-..+++.... -++||||++|...
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~--~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~ 75 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK--ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVI 75 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccc--cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccc
Confidence 4567778888876 3577888887543211 000124557778887744422234443322 2689999987421
Q ss_pred hh------------------hhc-----ccCCH-HHHHHHHHHH---------HHHHHHHHH--------cCcccCCCCC
Q 011331 317 DK------------------KAS-----QFFAE-GEVLKALHQI---------AQALQFIHE--------KGIAHLDVKP 355 (488)
Q Consensus 317 ~~------------------~~~-----~~l~~-~~~~~i~~qI---------~~gL~yLH~--------~gIiHrDLKp 355 (488)
.. ... ..+.. ..+..+..++ ...+..+-. ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 10 000 00111 1112222111 111222222 1489999999
Q ss_pred CcEEEeCCeEEEEeecCceec
Q 011331 356 DNIYVKNGVYKLGDFGRATLL 376 (488)
Q Consensus 356 ~NILv~~g~vkL~DFGlA~~~ 376 (488)
.||+++++.+.|+||+.|...
T Consensus 156 ~Nil~~~~~~~lIDwE~a~~g 176 (256)
T TIGR02721 156 YNLVVTPQGLKLIDWEYASDG 176 (256)
T ss_pred CcEEEeCCCCEEEeccccCcC
Confidence 999996656899999988653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0002 Score=72.59 Aligned_cols=136 Identities=18% Similarity=0.134 Sum_probs=96.8
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccC--------------------CCchHHHHHHHHHHHHHHHhCCCCC
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ--------------------LHHDAERRKALLEVQALAALGSHEN 290 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~--------------------~~~~~~~~~~~~Ei~iL~~l~~Hpn 290 (488)
+.++++||-|.-+-||.+.+. .|...++|..+.. .+.-..+..+.+|...++.|..|-.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 467889999999999999885 7889998853311 1112234557788888888855443
Q ss_pred -eeEeeeeecccceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEE
Q 011331 291 -IVGYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLG 368 (488)
Q Consensus 291 -Iv~l~~~~~~~~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~ 368 (488)
|.+.+ +.+..++|||++++--+..... ...+..+...++.-+--|-.+|+||+|.+-=|||| +++.++++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~----v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vI 244 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRH----VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVI 244 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeee----cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEe
Confidence 33333 4567789999998853332111 12345566677777778889999999999999999 57889999
Q ss_pred eecCcee
Q 011331 369 DFGRATL 375 (488)
Q Consensus 369 DFGlA~~ 375 (488)
||--...
T Consensus 245 DFPQmvS 251 (465)
T KOG2268|consen 245 DFPQMVS 251 (465)
T ss_pred echHhhc
Confidence 9986543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.002 Score=64.52 Aligned_cols=136 Identities=16% Similarity=0.093 Sum_probs=78.4
Q ss_pred EEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCC-CeeEeeee------ecccceEE
Q 011331 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE-NIVGYYSS------WFENEQLY 305 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hp-nIv~l~~~------~~~~~~l~ 305 (488)
-++.|..|....+|++.. .+..+++|+.... . ......|+.++..+..+- .+.+++.. ...++..+
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 466788888889999865 3457888987531 1 223455666666663221 24454432 12345678
Q ss_pred EEEecCCCCchhh---------------hh--cccCC--------HHHHHH------------HHHHHHHHHHHHHH---
Q 011331 306 IQMELCDHSLSDK---------------KA--SQFFA--------EGEVLK------------ALHQIAQALQFIHE--- 345 (488)
Q Consensus 306 IV~E~~~~~l~~~---------------~~--~~~l~--------~~~~~~------------i~~qI~~gL~yLH~--- 345 (488)
+++++++|..... .. ...+. ...... ....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999998742110 00 00000 000000 11123344555543
Q ss_pred ----cCcccCCCCCCcEEEeCCe-EEEEeecCcee
Q 011331 346 ----KGIAHLDVKPDNIYVKNGV-YKLGDFGRATL 375 (488)
Q Consensus 346 ----~gIiHrDLKp~NILv~~g~-vkL~DFGlA~~ 375 (488)
.+++|+|+.|.||+++++. +.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999996655 57999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.003 Score=63.68 Aligned_cols=74 Identities=15% Similarity=0.039 Sum_probs=44.2
Q ss_pred EEEecccCcEEEEEEEEcC------CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 234 IEQIGAGNFSHVFKVLKRI------DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 234 ~~~LG~G~fg~Vy~a~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++.|..|-...||++.... .++.|++|+...... .......|..++..+..+--..+++..+. + .+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v 75 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI 75 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence 4556677777888886542 257899998754321 12334567777777744333345555443 2 257
Q ss_pred EecCCCC
Q 011331 308 MELCDHS 314 (488)
Q Consensus 308 ~E~~~~~ 314 (488)
+||++|.
T Consensus 76 ~e~i~G~ 82 (302)
T cd05156 76 EEFIPSR 82 (302)
T ss_pred hheeCCC
Confidence 8887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.009 Score=60.66 Aligned_cols=29 Identities=28% Similarity=0.314 Sum_probs=25.3
Q ss_pred CcccCCCCCCcEEEeCCeE-EEEeecCcee
Q 011331 347 GIAHLDVKPDNIYVKNGVY-KLGDFGRATL 375 (488)
Q Consensus 347 gIiHrDLKp~NILv~~g~v-kL~DFGlA~~ 375 (488)
|+||+|+.|.||+++++.+ -|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 8999999999999976665 7999998864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0046 Score=62.63 Aligned_cols=138 Identities=15% Similarity=0.133 Sum_probs=76.3
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCC-CCeeEeeee------ecccceE
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH-ENIVGYYSS------WFENEQL 304 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~H-pnIv~l~~~------~~~~~~l 304 (488)
..++.++.|....+|++.. ++..+.+|+..... .. .....|+.++..|..+ -.+.+++.. ...++..
T Consensus 25 ~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~-~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRV-KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred eeccccCCccccceEEEEe--CCCcEEEEEecCCC-CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 3466778888889998864 24467789865421 11 1233455666655221 124444432 1234567
Q ss_pred EEEEecCCCCchh---------------h--hhcccC--------C-HHHH---H-----------HHHHHHHHHHHHHH
Q 011331 305 YIQMELCDHSLSD---------------K--KASQFF--------A-EGEV---L-----------KALHQIAQALQFIH 344 (488)
Q Consensus 305 ~IV~E~~~~~l~~---------------~--~~~~~l--------~-~~~~---~-----------~i~~qI~~gL~yLH 344 (488)
+++|||++|.... . .....+ . ..+. . .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999773110 0 000001 0 0000 0 00112334555554
Q ss_pred H-------cCcccCCCCCCcEEEeC-CeEEEEeecCcee
Q 011331 345 E-------KGIAHLDVKPDNIYVKN-GVYKLGDFGRATL 375 (488)
Q Consensus 345 ~-------~gIiHrDLKp~NILv~~-g~vkL~DFGlA~~ 375 (488)
. .+++|+|+.+.||++++ +.+.|+||+.+..
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 3 58999999999999955 4468999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.002 Score=60.96 Aligned_cols=96 Identities=21% Similarity=0.090 Sum_probs=73.3
Q ss_pred HHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCC-chh----hhhcccCCHHHHHHHHHHHHHHHHHHHH---cCc
Q 011331 277 LEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHS-LSD----KKASQFFAEGEVLKALHQIAQALQFIHE---KGI 348 (488)
Q Consensus 277 ~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~-l~~----~~~~~~l~~~~~~~i~~qI~~gL~yLH~---~gI 348 (488)
.|.-++..+...+++++++|+|- .++|.||...+ +.. ...-...++....+++.+++..+.+|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 36667777755579999999983 35688998854 221 1111236788899999999999999987 346
Q ss_pred ccCCCCCCcEEE-eCCeEEEEeecCceec
Q 011331 349 AHLDVKPDNIYV-KNGVYKLGDFGRATLL 376 (488)
Q Consensus 349 iHrDLKp~NILv-~~g~vkL~DFGlA~~~ 376 (488)
.-.|++++|+-| ++|.+|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 678999999999 5689999999987554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0064 Score=63.97 Aligned_cols=77 Identities=19% Similarity=0.207 Sum_probs=50.4
Q ss_pred EEEecccCcEEEEEEEEcCCCeEEEEEEecc----CCCchHHHHHHHHHHHHHHHhCCC-C-CeeEeeeeecccceEEEE
Q 011331 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKR----QLHHDAERRKALLEVQALAALGSH-E-NIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 234 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~----~~~~~~~~~~~~~Ei~iL~~l~~H-p-nIv~l~~~~~~~~~l~IV 307 (488)
++.||.|.-.-||++.+...++.|+||.-.. ...-.....+...|..+|+.+... | +++++| +.+.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhHH
Confidence 6789999999999998843467899996421 111112234556677777776432 3 466665 4466667788
Q ss_pred EecCC
Q 011331 308 MELCD 312 (488)
Q Consensus 308 ~E~~~ 312 (488)
||+++
T Consensus 112 MEdL~ 116 (409)
T PRK12396 112 MEDLS 116 (409)
T ss_pred HHhCc
Confidence 99885
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0053 Score=63.80 Aligned_cols=75 Identities=24% Similarity=0.274 Sum_probs=47.7
Q ss_pred EecccCcEEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHHHHHhCCC-C-CeeEeeeeecccceEEEEE
Q 011331 236 QIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ-----LHHDAERRKALLEVQALAALGSH-E-NIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 236 ~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~-----~~~~~~~~~~~~Ei~iL~~l~~H-p-nIv~l~~~~~~~~~l~IV~ 308 (488)
.||.|....||++.....++.|+||.-..- ..-.....+...|...|...... | .++++| +.+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 579999999999997543478999964211 01112223455677777776443 2 355664 44566667899
Q ss_pred ecCC
Q 011331 309 ELCD 312 (488)
Q Consensus 309 E~~~ 312 (488)
|+++
T Consensus 80 EdL~ 83 (370)
T TIGR01767 80 EDLS 83 (370)
T ss_pred hhCc
Confidence 9985
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.017 Score=60.99 Aligned_cols=77 Identities=19% Similarity=0.328 Sum_probs=49.9
Q ss_pred EEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC--Cch---HHHHHHHHHHHHHHHhCCC--CCeeEeeeeecccceEE
Q 011331 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL--HHD---AERRKALLEVQALAALGSH--ENIVGYYSSWFENEQLY 305 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~--~~~---~~~~~~~~Ei~iL~~l~~H--pnIv~l~~~~~~~~~l~ 305 (488)
..+.||.|....||++.+. +..|+||.-.... ... ........|...|..+..+ .++.+++.++. +.-+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4778999999999998873 4568899753111 111 1233345567777665322 46778877665 4467
Q ss_pred EEEecCCC
Q 011331 306 IQMELCDH 313 (488)
Q Consensus 306 IV~E~~~~ 313 (488)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 78999965
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0051 Score=65.95 Aligned_cols=160 Identities=24% Similarity=0.236 Sum_probs=98.9
Q ss_pred HHHHHHHHHHHHHhCCCCCeeEeeeeecc-cceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 011331 272 RRKALLEVQALAALGSHENIVGYYSSWFE-NEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAH 350 (488)
Q Consensus 272 ~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-~~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiH 350 (488)
..+.+-..+.++.+ .|+|+..++.+-.. .....+|||+++.++.+....+.+...... .+|+.|
T Consensus 26 s~~ilgr~~~lktl-~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~l~~~s~~--------------~~~~~~ 90 (725)
T KOG1093|consen 26 SIQILGRFQYLKSL-QHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGNLKDESLL--------------AHGVLH 90 (725)
T ss_pred HHHHhhhhHHHHhh-cCccceeeEeeecCccceEEEEehhhccchHHHHHhcccchhhhc--------------ccccce
Confidence 45567778888888 89999999876553 345788999999988775443332211111 122222
Q ss_pred CCCCCCcEEEeCCeEEEEeecCceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh
Q 011331 351 LDVKPDNIYVKNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF 430 (488)
Q Consensus 351 rDLKp~NILv~~g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~ 430 (488)
-|| ++++| -+++. | |-.+ .+|+||||+|.++.|+..|...+......
T Consensus 91 -----~~~------~~~td-~~~t~-------------~--~~~~------~pKsdVwsl~~i~~el~L~~~l~~~~~~s 137 (725)
T KOG1093|consen 91 -----LNI------IYITD-HFLTK-------------Y--PSPI------GPKSDVWSLGFIILELYLGISLEAELTES 137 (725)
T ss_pred -----ehh------hhccc-ccccc-------------C--CCCC------CcchhhhhHHHHHHHHHHhhHHHHHHHHH
Confidence 122 22233 11111 1 1111 13899999999999999997665443221
Q ss_pred hh--hhcC--CCC-----------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 431 LN--LRDG--KLP-----------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 431 ~~--i~~~--~~~-----------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.. +... ..+ ..-.++..+..+..+|+-..|..||...++.+++.|.+.-
T Consensus 138 ~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~ 201 (725)
T KOG1093|consen 138 EYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY 201 (725)
T ss_pred HHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence 11 1110 000 0112355677889999999999999999999999998763
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.025 Score=58.64 Aligned_cols=137 Identities=12% Similarity=0.097 Sum_probs=76.3
Q ss_pred eEEEEecccCcEEEEEEEEcC----CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 232 HEIEQIGAGNFSHVFKVLKRI----DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.-+..|-.|-...+|++.... .++.|.+|+....... ......|..++..+..+.--.++++.+.. + .|
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~---~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v 111 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL---FFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RV 111 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe---eechHHHHHHHHHHHHcCCCCceEEEECC-c---eE
Confidence 345566668888999986432 2468999987543211 12234577777777544444455655533 2 46
Q ss_pred EecCCCCchh-h-----------------hhcc-------cCCHHHHHHHHHHH-----------------HHHHHHHH-
Q 011331 308 MELCDHSLSD-K-----------------KASQ-------FFAEGEVLKALHQI-----------------AQALQFIH- 344 (488)
Q Consensus 308 ~E~~~~~l~~-~-----------------~~~~-------~l~~~~~~~i~~qI-----------------~~gL~yLH- 344 (488)
.||+++..+. . .... ......+..++.++ ...+..|.
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 8888653111 0 0000 00112222322111 11122221
Q ss_pred -------HcCcccCCCCCCcEEEe--CCeEEEEeecCcee
Q 011331 345 -------EKGIAHLDVKPDNIYVK--NGVYKLGDFGRATL 375 (488)
Q Consensus 345 -------~~gIiHrDLKp~NILv~--~g~vkL~DFGlA~~ 375 (488)
...++|+|+++.|||++ ++.+.|+||..|..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12589999999999995 36799999998864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.041 Score=55.22 Aligned_cols=30 Identities=23% Similarity=0.315 Sum_probs=25.0
Q ss_pred CcccCCCCCCcEEEeC-Ce-EEEEeecCceec
Q 011331 347 GIAHLDVKPDNIYVKN-GV-YKLGDFGRATLL 376 (488)
Q Consensus 347 gIiHrDLKp~NILv~~-g~-vkL~DFGlA~~~ 376 (488)
.++|+|+.|.|||+++ +. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999965 65 569999988754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.00081 Score=79.28 Aligned_cols=203 Identities=15% Similarity=-0.005 Sum_probs=125.8
Q ss_pred HHHHHHHHHHHHHhCCCCCeeEeeeeecc--cceEEEEEecCCCCchh------hhhcccCCHHHHHHHHHHHHHHHHHH
Q 011331 272 RRKALLEVQALAALGSHENIVGYYSSWFE--NEQLYIQMELCDHSLSD------KKASQFFAEGEVLKALHQIAQALQFI 343 (488)
Q Consensus 272 ~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~--~~~l~IV~E~~~~~l~~------~~~~~~l~~~~~~~i~~qI~~gL~yL 343 (488)
.+-.+.|...++.. .|+++...+.-... +...|++++|+..+... ......+.+.-+....++.+.+..-+
T Consensus 1273 kemll~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1273 KEMLLSERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred HHhhhhhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence 33344454445555 78888877654443 34468888888765222 11222344444444445547777777
Q ss_pred HHc-C----cccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHH
Q 011331 344 HEK-G----IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATM 414 (488)
Q Consensus 344 H~~-g----IiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL 414 (488)
|+. + -+|+++|+-|.+| .+..++++++|++++.+.. .....+++.|+.|++.+.- .++.++|+|..|+.+
T Consensus 1352 ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~i-k~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEI-KFTKRSDILRRSLSL 1430 (2724)
T ss_pred hhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHH-hhhhHHHHHHHHHHH
Confidence 755 2 6899999999999 7889999999999954432 3445688889999987654 455569999999999
Q ss_pred HHHHcCCCCCCCchh--hhh-hhcCCCC-CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhh
Q 011331 415 YELIKGSPLSESGPQ--FLN-LRDGKLP-LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFD 476 (488)
Q Consensus 415 ~eLltG~~p~~~~~~--~~~-i~~~~~~-~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~ 476 (488)
|+.-.|..++-.-.. ... +.++..- .....+.+.-.....+|-+.-..||.-...+.-+.|.
T Consensus 1431 y~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 999988765432111 111 1111111 1111233333444445555566788877777776664
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.074 Score=54.71 Aligned_cols=75 Identities=15% Similarity=0.068 Sum_probs=43.4
Q ss_pred EEEEecccCcEEEEEEEEcCC---CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 233 EIEQIGAGNFSHVFKVLKRID---GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
.++.|..|-...+|++..... +..|.+|+...... .......|..++..+..+.--.++++++. ++ +|.+
T Consensus 18 ~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~ 90 (330)
T PLN02421 18 SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS 90 (330)
T ss_pred EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence 345566688888998865422 23788998754321 12233457777777744333345555542 32 4788
Q ss_pred cCCCC
Q 011331 310 LCDHS 314 (488)
Q Consensus 310 ~~~~~ 314 (488)
|+++.
T Consensus 91 fi~g~ 95 (330)
T PLN02421 91 FINAR 95 (330)
T ss_pred hhcCC
Confidence 88653
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.12 Score=52.88 Aligned_cols=143 Identities=15% Similarity=0.145 Sum_probs=77.2
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCC-CCeeEeeeeecccc--eEEEEE
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH-ENIVGYYSSWFENE--QLYIQM 308 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~H-pnIv~l~~~~~~~~--~l~IV~ 308 (488)
.+++.+-.|.-..+|..... ++.+++. ............+..+|..++..+..- --+...++.|.++. ..|.||
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 34555544444455555443 7777777 221112223345566788888887432 22334455555544 669999
Q ss_pred ecCCCCchhh-hhcccC---------------------------------CHHHHHHHHH--------------HHHHHH
Q 011331 309 ELCDHSLSDK-KASQFF---------------------------------AEGEVLKALH--------------QIAQAL 340 (488)
Q Consensus 309 E~~~~~l~~~-~~~~~l---------------------------------~~~~~~~i~~--------------qI~~gL 340 (488)
++++|..... ...... ...++..+.. ....-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 9998731110 000000 0001111111 122233
Q ss_pred HHHHHc--------CcccCCCCCCcEEEe-CCeEEEEeecCceecC
Q 011331 341 QFIHEK--------GIAHLDVKPDNIYVK-NGVYKLGDFGRATLLN 377 (488)
Q Consensus 341 ~yLH~~--------gIiHrDLKp~NILv~-~g~vkL~DFGlA~~~~ 377 (488)
.+|+.+ .++|+|+.+.||+|+ ++.+=|+||+++...+
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 444432 479999999999994 4568899999997654
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.12 Score=54.45 Aligned_cols=75 Identities=13% Similarity=0.093 Sum_probs=45.0
Q ss_pred EEEEecccCcEEEEEEEEcCC-Ce-----EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 233 EIEQIGAGNFSHVFKVLKRID-GC-----FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~-g~-----~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++.|..|-...+|++..... +. .|.+.+.... .....+..+|++++..+..+..-.++++.+.. ++
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~ 126 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT 126 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence 455676788899999865432 12 2444432211 11122345578888888665556677766643 58
Q ss_pred EEecCCCC
Q 011331 307 QMELCDHS 314 (488)
Q Consensus 307 V~E~~~~~ 314 (488)
+.||++|.
T Consensus 127 l~efIeGr 134 (383)
T PTZ00384 127 IQEWVEGN 134 (383)
T ss_pred EEEEeccc
Confidence 89999764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.067 Score=54.09 Aligned_cols=76 Identities=18% Similarity=0.253 Sum_probs=46.2
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC--CCCCeeEeeeeecccceEEEEEe
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG--SHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~--~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+..+.|+.|....+|+.. .++..+.||+-... ....+..|..-|+.|. ..-.+.+++.+...++.-||+||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 456788999999999987 57889999986421 1223556777777762 34457788888877777799999
Q ss_pred cCCCC
Q 011331 310 LCDHS 314 (488)
Q Consensus 310 ~~~~~ 314 (488)
|++..
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 98643
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.12 Score=52.40 Aligned_cols=106 Identities=12% Similarity=0.049 Sum_probs=70.7
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCC--CCeeEeeeeecc---cceEEE
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH--ENIVGYYSSWFE---NEQLYI 306 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~H--pnIv~l~~~~~~---~~~l~I 306 (488)
...+.||.|..+.||..... ++ .+.+|..+.. .....+..|...|+.+..+ -.+.++++++.. .+.-+|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMARSF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEeccc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 45778999999999998643 23 5677764321 0123467788888888554 357788876654 466899
Q ss_pred EEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHc
Q 011331 307 QMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEK 346 (488)
Q Consensus 307 V~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~ 346 (488)
|||++++...... .........+..+++.+|.-||+.
T Consensus 91 VmE~i~G~~~~~~---~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 91 LLERLRGVSVEAP---ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EEeccCCEecCCC---CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9999988533221 123344556667778888888874
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.029 Score=53.50 Aligned_cols=29 Identities=41% Similarity=0.566 Sum_probs=20.7
Q ss_pred CcccCCCCCCcEEE--eCCeEEEEeecCcee
Q 011331 347 GIAHLDVKPDNIYV--KNGVYKLGDFGRATL 375 (488)
Q Consensus 347 gIiHrDLKp~NILv--~~g~vkL~DFGlA~~ 375 (488)
-+.|.||.+.|||+ .++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 789999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.06 Score=55.06 Aligned_cols=135 Identities=18% Similarity=0.126 Sum_probs=91.4
Q ss_pred EEEEecccCcEEEEEEEEc-------C---CCeEEEEEEeccCCC----------------------ch--HHHHHHHHH
Q 011331 233 EIEQIGAGNFSHVFKVLKR-------I---DGCFYAVKHSKRQLH----------------------HD--AERRKALLE 278 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~-------~---~g~~vAvK~l~~~~~----------------------~~--~~~~~~~~E 278 (488)
+-..|..|.-+.|+-|.-- . ....+|||+++-.+. +. ....-+.+|
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE 335 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE 335 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence 4457888999988877321 0 134578887642110 00 011123344
Q ss_pred HHHHHHhC----CCCCeeEeeeeecccceEEEEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHH-HHcCcccC
Q 011331 279 VQALAALG----SHENIVGYYSSWFENEQLYIQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFI-HEKGIAHL 351 (488)
Q Consensus 279 i~iL~~l~----~HpnIv~l~~~~~~~~~l~IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yL-H~~gIiHr 351 (488)
...|.++. .+|-+|.+- ...|||-|++.. +.. ....-.++..+......||..++.-| |++-+||.
T Consensus 336 mhNL~RMq~~GlpcP~vV~lk-------khvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHA 408 (531)
T KOG2269|consen 336 MHNLSRMQKHGLPCPQVVKLK-------KHVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHA 408 (531)
T ss_pred HHHHHHHHhcCCCCCceeeee-------cceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeec
Confidence 44455442 456677664 356899999753 222 33444588889999999999999888 89999999
Q ss_pred CCCCCcEEEeCCeEEEEeecCce
Q 011331 352 DVKPDNIYVKNGVYKLGDFGRAT 374 (488)
Q Consensus 352 DLKp~NILv~~g~vkL~DFGlA~ 374 (488)
|+.--|+|...|.+.++|-.-+.
T Consensus 409 DlSEyN~Lw~~gKvw~IDVsQsv 431 (531)
T KOG2269|consen 409 DLSEYNLLWTPGKVWVIDVSQSV 431 (531)
T ss_pred chhhhhheecCCceEEEechhcc
Confidence 99999999999999999977654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.21 Score=50.57 Aligned_cols=29 Identities=10% Similarity=0.102 Sum_probs=25.7
Q ss_pred CcccCCCCCCcEEE-eCCeEEEEeecCcee
Q 011331 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATL 375 (488)
Q Consensus 347 gIiHrDLKp~NILv-~~g~vkL~DFGlA~~ 375 (488)
+++|+|+.++|||+ .++.+.|+||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 79999999999999 567899999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.15 Score=52.96 Aligned_cols=73 Identities=23% Similarity=0.275 Sum_probs=56.1
Q ss_pred ccceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEeCCeEEEEeecCcee
Q 011331 300 ENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEK-GIAHLDVKPDNIYVKNGVYKLGDFGRATL 375 (488)
Q Consensus 300 ~~~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-gIiHrDLKp~NILv~~g~vkL~DFGlA~~ 375 (488)
+....|++|++-++.+... ..-...++..++.+-+..+.-+... ..=|||+..+||||++|.+-|+||-+++.
T Consensus 297 e~~y~yl~~kdhgt~is~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDHGTPISII---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILIDEGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecCCceeeee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeeecCceEEEEeeeeec
Confidence 3445678888877665432 2234567888888877777777654 78999999999999999999999999984
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.86 E-value=1.3 Score=45.51 Aligned_cols=28 Identities=25% Similarity=0.195 Sum_probs=24.1
Q ss_pred cCcccCCCCCCcEEEeCCeEEEEeecCce
Q 011331 346 KGIAHLDVKPDNIYVKNGVYKLGDFGRAT 374 (488)
Q Consensus 346 ~gIiHrDLKp~NILv~~g~vkL~DFGlA~ 374 (488)
.++||+|+.+.|||+++ .+.|+||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWRD-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhccccC-CcEEEeCCCCC
Confidence 36899999999999964 67899999775
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.68 E-value=0.13 Score=51.70 Aligned_cols=29 Identities=31% Similarity=0.418 Sum_probs=25.9
Q ss_pred cCcccCCCCCCcEEEeCCeEEEEeecCce
Q 011331 346 KGIAHLDVKPDNIYVKNGVYKLGDFGRAT 374 (488)
Q Consensus 346 ~gIiHrDLKp~NILv~~g~vkL~DFGlA~ 374 (488)
.+++|+|+.+.||+++++.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDNEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeCCcEEEEECcccc
Confidence 47999999999999977889999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.54 E-value=1.5 Score=45.36 Aligned_cols=133 Identities=18% Similarity=0.176 Sum_probs=74.3
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCC-----eeEeeee--ecccc--eEE
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN-----IVGYYSS--WFENE--QLY 305 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hpn-----Iv~l~~~--~~~~~--~l~ 305 (488)
..|.+ .-..||++... +|+. ++|+.... ... .+...|+..+..+..+.- |..+-|- ..-.+ ..+
T Consensus 32 ~~l~s-~eN~~f~~~~~-~g~~-iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 32 RGLNS-EENSNFRVQTE-DGRY-ILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred ccccc-ccCceEEEEec-CCCe-EEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 34444 56678988764 3433 99988765 333 334556666666643322 1222221 11233 677
Q ss_pred EEEecCCCCchhh------------------hhcccC-----------CHH----H---------HHHHHHHHHHHHHHH
Q 011331 306 IQMELCDHSLSDK------------------KASQFF-----------AEG----E---------VLKALHQIAQALQFI 343 (488)
Q Consensus 306 IV~E~~~~~l~~~------------------~~~~~l-----------~~~----~---------~~~i~~qI~~gL~yL 343 (488)
-+++|++|..... .....+ .+. . -.....++...+..+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8899998753220 000001 110 0 011223455555555
Q ss_pred HHc--------C--cccCCCCCCcEEEeCC--eEEEEeecCce
Q 011331 344 HEK--------G--IAHLDVKPDNIYVKNG--VYKLGDFGRAT 374 (488)
Q Consensus 344 H~~--------g--IiHrDLKp~NILv~~g--~vkL~DFGlA~ 374 (488)
.+. + +||+|+.|+||+++++ .+.++|||-+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 542 4 9999999999999665 48999999775
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=93.43 E-value=0.64 Score=46.46 Aligned_cols=28 Identities=36% Similarity=0.393 Sum_probs=23.6
Q ss_pred cccCCCCCCcEEEe---CC---eEEEEeecCcee
Q 011331 348 IAHLDVKPDNIYVK---NG---VYKLGDFGRATL 375 (488)
Q Consensus 348 IiHrDLKp~NILv~---~g---~vkL~DFGlA~~ 375 (488)
++|+|++.+|||+. +| .++++||-+++.
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeeccccccC
Confidence 89999999999992 33 689999998764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=92.46 E-value=0.56 Score=46.03 Aligned_cols=72 Identities=13% Similarity=0.188 Sum_probs=46.0
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC--CCCCeeEeeeeecccceEEEEEecCC
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG--SHENIVGYYSSWFENEQLYIQMELCD 312 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~--~HpnIv~l~~~~~~~~~l~IV~E~~~ 312 (488)
+.+--|---+.|.+.+ ....|-||+- .......+..|+.-|..+. +.-.|.+++.+....++.|+||||++
T Consensus 22 ~~v~gG~inea~~v~d--g~~~~FvK~n-----~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~ 94 (286)
T COG3001 22 EEVSGGDINEAWRLRD--GTDPFFVKCN-----QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP 94 (286)
T ss_pred cccCCccccceeEeec--CCcceEEEec-----chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence 3344444444555443 3457788852 2333445666776666653 23467788889999999999999996
Q ss_pred C
Q 011331 313 H 313 (488)
Q Consensus 313 ~ 313 (488)
.
T Consensus 95 ~ 95 (286)
T COG3001 95 T 95 (286)
T ss_pred C
Confidence 4
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.83 E-value=3.2 Score=49.32 Aligned_cols=30 Identities=33% Similarity=0.367 Sum_probs=24.3
Q ss_pred cCcccCCCCCCcEEEeCC---eEE-EEeecCcee
Q 011331 346 KGIAHLDVKPDNIYVKNG---VYK-LGDFGRATL 375 (488)
Q Consensus 346 ~gIiHrDLKp~NILv~~g---~vk-L~DFGlA~~ 375 (488)
.++||+|+.+.|||++.+ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 479999999999999543 454 999998753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 488 | ||||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-54 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-54 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-54 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-54 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-33 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-31 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-27 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-27 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-27 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-25 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-25 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-24 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-23 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-19 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-17 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-15 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-13 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-13 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-13 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-13 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-12 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-04 |
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-106
Identities = 111/289 (38%), Positives = 169/289 (58%), Gaps = 29/289 (10%)
Query: 220 GGDGL-SRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLE 278
G G+ SRY T+FHE+E+IG+G F VFK +KR+DGC YA+K SK+ L + + AL E
Sbjct: 1 GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 279 VQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSD-----KKASQFFAEGEVLKA 332
V A A LG H ++V Y+S+W E++ + IQ E C+ SL+D + +F E E+
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 333 LHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGV-------------------YKLGDFGR 372
L Q+ + L++IH + H+D+KP NI++ + + +K+GD G
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 373 ATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN 432
T ++ S +EEGD+R++ E+L E+Y HL K DIF+L T+ PL +G Q+
Sbjct: 181 VTRIS-SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239
Query: 433 LRDGKLPLLPGH-SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
+R G+LP +P S +F LLKVM+ PDP +RPSA LV++ + +
Sbjct: 240 IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 303 bits (778), Expect = e-100
Identities = 90/269 (33%), Positives = 129/269 (47%), Gaps = 9/269 (3%)
Query: 216 PVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKA 275
P S + F + ++G G++ VFKV + DG YAVK S +R +
Sbjct: 44 PGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARK 103
Query: 276 LLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKAL 333
L EV + +G H V +W E LY+Q ELC SL + E +V L
Sbjct: 104 LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYL 163
Query: 334 HQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPI--EEGDARYM 390
AL +H +G+ HLDVKP NI++ G KLGDFG L + +EGD RYM
Sbjct: 164 RDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYM 223
Query: 391 PQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLP--LLPGHSLQF 448
E+L Y D+FSLG T+ E+ L G + LR G LP G S +
Sbjct: 224 APELLQGSYGT--AADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSEL 281
Query: 449 QNLLKVMVDPDPVQRPSAKELVENPIFDK 477
+++L +M++PDP R +A+ L+ P+ +
Sbjct: 282 RSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 3e-77
Identities = 94/298 (31%), Positives = 145/298 (48%), Gaps = 40/298 (13%)
Query: 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAAL 285
RY TDF I+ +G G F VF+ ++D C YA+K + + + R K + EV+ALA L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKL 60
Query: 286 GSHENIVGYYSSWFENEQ------------LYIQMELCDH-SLSD----KKASQFFAEGE 328
H IV Y+++W E LYIQM+LC +L D + +
Sbjct: 61 -EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 329 VLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE--- 384
L QIA+A++F+H KG+ H D+KP NI+ + V K+GDFG T +++ +
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 385 ------------GDARYMPQEIL-NEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQF 430
G YM E + Y H KVDIFSLG ++EL+ S E
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSH--KVDIFSLGLILFELLYPFSTQMERVRTL 237
Query: 431 LNLRDGKLPLLPGH-SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMK 487
++R+ K P L +++ M+ P P++RP A ++EN +F+ + KT ++
Sbjct: 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLR 295
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-68
Identities = 88/287 (30%), Positives = 131/287 (45%), Gaps = 41/287 (14%)
Query: 225 SRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAA 284
R+ DF EIE IG+G F VFK RIDG Y +K K KA EV+ALA
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY------NNEKAEREVKALAK 60
Query: 285 LGSHENIVGYYSSWFE----------------NEQLYIQMELCDH-SLSD---KKASQFF 324
L H NIV Y W + L+IQME CD +L K+ +
Sbjct: 61 L-DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 325 AEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIE 383
+ L+ QI + + +IH K + + D+KP NI++ K+GDFG T L
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 384 E--GDARYMPQEIL-NEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQFLNLRDGKLP 439
G RYM E + ++DY +VD+++LG + EL+ E+ F +LRDG +
Sbjct: 180 RSKGTLRYMSPEQISSQDYGK--EVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIIS 237
Query: 440 LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF-----DKIQKH 481
+ + LL+ ++ P RP+ E++ +K ++H
Sbjct: 238 --DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERH 282
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 3e-59
Identities = 82/272 (30%), Positives = 130/272 (47%), Gaps = 19/272 (6%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+ +++IG G+F V DG Y +K ER ++ EV LA + H
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHP 83
Query: 290 NIVGYYSSWFENEQLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIAQALQFIHE 345
NIV Y S+ EN LYI M+ C+ L + F E ++L QI AL+ +H+
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEIL-NEDYD 400
+ I H D+K NI++ K+G +LGDFG A +LN ++ + G Y+ EI N+ Y+
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN 203
Query: 401 HLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKLPLLPGH-SLQFQNLLKVMV 456
+ K DI++LG +YEL + S L + G P + H S ++L+ +
Sbjct: 204 N--KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261
Query: 457 DPDPVQRPSAKELVENPIFDKIQKHRKTYMKP 488
+P RPS ++E I K + ++ P
Sbjct: 262 KRNPRDRPSVNSILEKGF---IAKRIEKFLSP 290
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 6e-58
Identities = 83/297 (27%), Positives = 137/297 (46%), Gaps = 47/297 (15%)
Query: 225 SRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAA 284
RY +DF EI +G G F V K +D +YA+K + + + L EV LA+
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLAS 58
Query: 285 LGSHENIVGYYSSWFENEQ-------------LYIQMELCD-HSLSD--KKASQFFAEGE 328
L +H+ +V YY++W E L+IQME C+ +L D + E
Sbjct: 59 L-NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 329 VLKALHQIAQALQFIHEKGIAHLDVKPDNI-YVKNGVYKLGDFGRATLLNKSLPIEEGDA 387
+ QI +AL +IH +GI H D+KP NI ++ K+GDFG A +++SL I + D+
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 388 R-----------------YMPQEILNE--DYDHLDKVDIFSLGATMYELIKG-SPLSESG 427
+ Y+ E+L+ Y+ K+D++SLG +E+I S E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE--KIDMYSLGIIFFEMIYPFSTGMERV 235
Query: 428 PQFLNLRDGKLPLLPGH----SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
LR + P + ++++++D DP +RP A+ L+ + +
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-56
Identities = 73/263 (27%), Positives = 117/263 (44%), Gaps = 22/263 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
+F ++IG G FS V++ +DG A+K L R + E+ L L +H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 91
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSD-----KKASQFFAEGEVLKALHQIAQALQF 342
N++ YY+S+ E+ +L I +EL D LS KK + E V K Q+ AL+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEIL-NE 397
+H + + H D+KP N+++ GV KLGD G + G YM E +
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 398 DYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ---FLNLRDGKLPLLPGH--SLQFQN 450
Y+ K DI+SLG +YE+ + + P LP S + +
Sbjct: 212 GYNF--KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269
Query: 451 LLKVMVDPDPVQRPSAKELVENP 473
L+ + ++PDP +RP + +
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVA 292
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-56
Identities = 82/278 (29%), Positives = 129/278 (46%), Gaps = 28/278 (10%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
D+ + IG G++ K+ ++ DG K +AE++ + EV L L H
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHP 65
Query: 290 NIVGYYSSWFE--NEQLYIQMELCDH-SLSD-----KKASQFFAEGEVLKALHQIAQALQ 341
NIV YY + N LYI ME C+ L+ K Q+ E VL+ + Q+ AL+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 342 FIHEKG-----IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQ 392
H + + H D+KP N+++ KLGDFG A +LN + G YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 393 EIL-NEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKLPLLPGH-SLQ 447
E + Y+ K DI+SLG +YEL P + S + +R+GK +P S +
Sbjct: 186 EQMNRMSYNE--KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTY 485
++ M++ RPS +E++ENP+ I +H +
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEILENPL---ILEHHHHH 278
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-50
Identities = 69/275 (25%), Positives = 114/275 (41%), Gaps = 34/275 (12%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+ I+++G G FS+V V DG FYA+K + H +R +A E H
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALK--RILCHEQQDREEAQREADMHRLFN-HP 86
Query: 290 NIVGYYSSWFE----NEQLYIQMELCDH-SLSD-----KKASQFFAEGEVLKALHQIAQA 339
NI+ + + ++ + +L + K F E ++L L I +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 340 LQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN-------KSLPIEEGDAR--- 388
L+ IH KG AH D+KP NI + G L D G ++L +++ A+
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 389 --YMPQEILN-EDYDHLD-KVDIFSLGATMYELIKGSP----LSESGPQFLNLRDGKL-- 438
Y E+ + + + +D + D++SLG +Y ++ G + + G +L
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 439 PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENP 473
P P HS LL M+ DP QRP L+
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 170 bits (431), Expect = 6e-49
Identities = 86/334 (25%), Positives = 136/334 (40%), Gaps = 83/334 (24%)
Query: 225 SRYYTDFHEIEQIGAGNFSHVFK----------VLKRID--------------------- 253
SRY TDF I+ +G G F VF+ +KRI
Sbjct: 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 254 -------------------------GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+ + + L + ++++ + S
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPF-ST 120
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSD----KKASQFFAEGEVLKALHQIAQALQFI 343
+N VG LYIQM+LC +L D + + + G L QIA+A++F+
Sbjct: 121 KNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---------------GDA 387
H KG+ H D+KP NI+ + V K+GDFG T +++ + G
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 388 RYMPQEIL-NEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQFLNLRDGKLPLLPGH- 444
YM E + +Y H KVDIFSLG ++EL+ S E ++R+ K PLL
Sbjct: 241 LYMSPEQIHGNNYSH--KVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQK 298
Query: 445 SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478
Q +++ M+ P P +RP A +++EN IF+ +
Sbjct: 299 YPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-43
Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 45/281 (16%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSHE 289
+ G F+ V++ G YA+K R L ++ E+ +A++ EV + L H
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALK---RLLSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 290 NIVGYYSSWF--------ENEQLYIQMELCDHSLSD----KKASQFFAEGEVLKALHQIA 337
NIV + S+ + + ELC L + ++ + VLK +Q
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 338 QALQFIHEKG--IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP----------IEE 384
+A+Q +H + I H D+K +N+ + G KL DFG AT ++ +EE
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 385 GDAR-----YMPQEIL----NEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQFLNLR 434
R Y EI+ N K DI++LG +Y L P + L +
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGE--KQDIWALGCILYLLCFRQHPFEDGAK--LRIV 262
Query: 435 DGK--LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENP 473
+GK +P F +L++ M+ +P +R S E+V
Sbjct: 263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-43
Identities = 67/260 (25%), Positives = 110/260 (42%), Gaps = 20/260 (7%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGY 294
+IG G+F V+K L A + + +ER++ E + L L H NIV +
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRF 90
Query: 295 YSSWF----ENEQLYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKG- 347
Y SW + + + EL +L K + + QI + LQF+H +
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 348 -IAHLDVKPDNIYV--KNGVYKLGDFGRATLLNKSLPIEE-GDARYMPQEILNEDYDHLD 403
I H D+K DNI++ G K+GD G ATL S G +M E+ E YD
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDE-- 208
Query: 404 KVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGKLPLLPGH--SLQFQNLLKVMVD 457
VD+++ G M E+ P SE + + G P + + +++ +
Sbjct: 209 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268
Query: 458 PDPVQRPSAKELVENPIFDK 477
+ +R S K+L+ + F +
Sbjct: 269 QNKDERYSIKDLLNHAFFQE 288
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-41
Identities = 65/271 (23%), Positives = 111/271 (40%), Gaps = 24/271 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAAL-GSH 288
+ ++QIG+G S VF+VL YA+K+ + + E+ L L
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKG 347
+ I+ Y ++ +Y+ ME + L+ K + E + +A+ IH+ G
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 348 IAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSLPIEEGDAR-----YMPQEILNEDYDHL 402
I H D+KP N + +G+ KL DFG A + D++ YMP E + +
Sbjct: 129 IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 403 D----------KVDIFSLGATMYELIKGSP----LSESGPQFLNLRDGKLPL-LPGH-SL 446
+ K D++SLG +Y + G + + + D + P
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 248
Query: 447 QFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
Q++LK + DP QR S EL+ +P
Sbjct: 249 DLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-41
Identities = 65/271 (23%), Positives = 111/271 (40%), Gaps = 24/271 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAAL-GSH 288
+ ++QIG+G S VF+VL YA+K+ + + E+ L L
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKG 347
+ I+ Y ++ +Y+ ME + L+ K + E + +A+ IH+ G
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 348 IAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSLPIEEGDAR-----YMPQEILNEDYDHL 402
I H D+KP N + +G+ KL DFG A + D++ YMP E + +
Sbjct: 148 IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 403 D----------KVDIFSLGATMYELIKGSP----LSESGPQFLNLRDGKLPL-LPGH-SL 446
+ K D++SLG +Y + G + + + D + P
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 267
Query: 447 QFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
Q++LK + DP QR S EL+ +P
Sbjct: 268 DLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 78/277 (28%), Positives = 123/277 (44%), Gaps = 23/277 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
D + ++G+G V+K+ R G AVK +R + E ++ L+++ +
Sbjct: 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCP 84
Query: 290 NIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEK- 346
IV + ++ N ++I MEL K+ E + K I +AL ++ EK
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP--IEEGDARYM------PQEILNE 397
G+ H DVKP NI + + G KL DFG + L G A YM P +
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 398 DYDHLDKVDIFSLGATMYELIKGS-PLSESGPQFLNLR---DGKLPLLPGH---SLQFQN 450
DYD + D++SLG ++ EL G P F L + PLLPGH S FQ+
Sbjct: 205 DYDI--RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQS 262
Query: 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMK 487
+K + D +RP +L+E+ F K + + +
Sbjct: 263 FVKDCLTKDHRKRPKYNKLLEHS-FIKRYETLEVDVA 298
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 7e-40
Identities = 65/271 (23%), Positives = 109/271 (40%), Gaps = 24/271 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAAL-GSH 288
+ ++QIG+G S VF+VL YA+K+ + + E+ L L
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKG 347
+ I+ Y ++ +Y+ ME + L+ K + E + +A+ IH+ G
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 348 IAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSLPIEE-----GDARYMPQEILNEDYDHL 402
I H D+KP N + +G+ KL DFG A + G YMP E + +
Sbjct: 176 IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 403 D----------KVDIFSLGATMYELIKGSP----LSESGPQFLNLRDGKLPL-LPGH-SL 446
+ K D++SLG +Y + G + + + D + P
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 295
Query: 447 QFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
Q++LK + DP QR S EL+ +P
Sbjct: 296 DLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 70/276 (25%), Positives = 113/276 (40%), Gaps = 33/276 (11%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
F + +G G + D AVK + A+R EVQ L H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFADR-----EVQLLRESDEHP 78
Query: 290 NIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKG 347
N++ Y+ + + + YI +ELC +L + ++ E + L Q L +H
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 348 IAHLDVKPDNIYVKNG------VYKLGDFGRATLLN------KSLPIEEGDARYMPQEIL 395
I H D+KP NI + + DFG L G ++ E+L
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 396 NED----YDHLDKVDIFSLGATMYELI-KGS-PLSESGPQFLNLRDGKLPL-----LPGH 444
+ED + VDIFS G Y +I +GS P +S + N+ G L
Sbjct: 199 SEDCKENPTY--TVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256
Query: 445 SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
+ + L++ M+ DP +RPSAK ++++P F ++K
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 77/294 (26%), Positives = 120/294 (40%), Gaps = 30/294 (10%)
Query: 218 ITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL 277
I+ D ++ +IG G + V K++ + G AVK + D + +K LL
Sbjct: 11 ISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLL 68
Query: 278 -EVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSLSD------KKASQFFAEGEVL 330
++ + IV +Y + F +I MEL S E +
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 331 KALHQIAQALQFIHEKG-IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP--IEEGD 386
K +AL + E I H D+KP NI + ++G KL DFG + L S+ + G
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGC 188
Query: 387 ARYM-P----QEILNEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQFLNLR---DGK 437
YM P + YD + D++SLG T+YEL G P + F L G
Sbjct: 189 RPYMAPERIDPSASRQGYDV--RSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246
Query: 438 LPLLPGH-----SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYM 486
P L S F N + + + D +RP KEL+++P F + + R +
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP-FILMYEERAVEV 299
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 76/278 (27%), Positives = 119/278 (42%), Gaps = 26/278 (9%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSH 288
D I ++G G + V K+ G AVK + +++ +K LL ++
Sbjct: 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDC 65
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLSD-----KKASQFFAEGEVLKALHQIAQALQFI 343
V +Y + F ++I MEL D SL Q E + K I +AL+ +
Sbjct: 66 PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 344 HEKG-IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE--GDARYM-PQEILNED 398
H K + H DVKP N+ + G K+ DFG + L + + G YM P+ I E
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL 185
Query: 399 ----YDHLDKVDIFSLGATMYELIKGS-PLSESGPQFLNLR---DGKLPLLPGH--SLQF 448
Y K DI+SLG TM EL P G F L+ + P LP S +F
Sbjct: 186 NQKGYSV--KSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEF 243
Query: 449 QNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYM 486
+ + + +RP+ EL+++P F + + + T +
Sbjct: 244 VDFTSQCLKKNSKERPTYPELMQHP-FFTLHESKGTDV 280
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-38
Identities = 75/278 (26%), Positives = 119/278 (42%), Gaps = 22/278 (7%)
Query: 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALG 286
Y + + +G G + V+ + A+K + D+ + L E+ L
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHL- 76
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQF--FAEGEVLKAL--HQIAQALQ 341
H+NIV Y S+ EN + I ME SLS S++ + E QI + L+
Sbjct: 77 KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLK 136
Query: 342 FIHEKGIAHLDVKPDNIYV--KNGVYKLGDFGRATLLNKSLPIEE---GDARYM-PQEIL 395
++H+ I H D+K DN+ + +GV K+ DFG + L P E G +YM P+ I
Sbjct: 137 YLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196
Query: 396 NEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQ----FLNLRDGKLPLLPGH-SLQFQ 449
+ DI+SLG T+ E+ G P E G F P +P S + +
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 256
Query: 450 NLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMK 487
+ +PDP +R A +L+ + K +KT K
Sbjct: 257 AFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 64/265 (24%), Positives = 105/265 (39%), Gaps = 30/265 (11%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGY 294
++G G+F V ++ + G AVK + + E+ A A L S IV
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE---VFRVE----ELVACAGL-SSPRIVPL 115
Query: 295 YSSWFENEQLYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLD 352
Y + E + I MEL + SL K E L L Q + L+++H + I H D
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175
Query: 353 VKPDNIYV-KNGVY-KLGDFGRATLLNKSLPIEEGDAR--------YM-PQEILNEDYDH 401
VK DN+ + +G L DFG A L + +M P+ ++ + D
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235
Query: 402 LDKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGK-LPLLPGH-SLQFQNLLKVM 455
KVDI+S M ++ G P ++ + + +P + ++
Sbjct: 236 --KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 293
Query: 456 VDPDPVQRPSAKELVENPIFDKIQK 480
+ +PV R SA EL +Q+
Sbjct: 294 LRKEPVHRASAMELRRKV-GKALQE 317
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 17/271 (6%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
F ++E+IG G+F VFK + A+K + D E E+ L+
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIEDIQQEITVLSQC-DS 79
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIHEKG 347
+ YY S+ ++ +L+I ME S D E ++ L +I + L ++H +
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYM-PQEILNEDYDHL 402
H D+K N+ + ++G KL DFG A L + G +M P+ I YD
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS- 198
Query: 403 DKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGKLPLLPGH-SLQFQNLLKVMVD 457
K DI+SLG T EL +G P SE P FL ++ P L G+ S + ++ ++
Sbjct: 199 -KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACLN 256
Query: 458 PDPVQRPSAKELVENPIFDKIQKHRKTYMKP 488
+P RP+AKEL+++ F + +Y+
Sbjct: 257 KEPSFRPTAKELLKHK-FILRNAKKTSYLTE 286
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 69/269 (25%), Positives = 117/269 (43%), Gaps = 22/269 (8%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+ E+IG G V+ + G A++ L ++ + E+ + +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMREN-KN 76
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIHEKG 347
NIV Y S+ ++L++ ME SL+D EG++ + QAL+F+H
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYM-PQEILNEDYDHL 402
+ H D+K DNI + +G KL DFG + G +M P+ + + Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP- 195
Query: 403 DKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGKLPLLPG---HSLQFQNLLKVM 455
KVDI+SLG E+I+G P P +L + P L S F++ L
Sbjct: 196 -KVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 456 VDPDPVQRPSAKELVENPIFDKIQKHRKT 484
++ D +R SAKEL+++ F ++ +
Sbjct: 254 LEMDVEKRGSAKELLQHQ-F--LKIAKPL 279
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 72/258 (27%), Positives = 117/258 (45%), Gaps = 19/258 (7%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+IG G+ V ++ G AVK L R EV + H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDY-QH 101
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIHEKG 347
N+V Y S+ E+L++ ME +L+D + E ++ + QAL ++H +G
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYM-PQEILNEDYDHL 402
+ H D+K D+I + +G KL DFG ++K +P + G +M P+ I Y
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYAT- 220
Query: 403 DKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGKLPLLPG---HSLQFQNLLKVM 455
+VDI+SLG + E++ G P P LRD P L S ++ L+ M
Sbjct: 221 -EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNSHKVSPVLRDFLERM 278
Query: 456 VDPDPVQRPSAKELVENP 473
+ DP +R +A+EL+++P
Sbjct: 279 LVRDPQERATAQELLDHP 296
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-36
Identities = 71/286 (24%), Positives = 121/286 (42%), Gaps = 40/286 (13%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSH 288
D+ E IG+G + V A+K L LL E+QA++ H
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQTSMDELLKEIQAMSQC-HH 72
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSD---------KKASQFFAEGEVLKALHQIAQ 338
NIV YY+S+ ++L++ M+L S+ D + S E + L ++ +
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 339 ALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR--------Y 389
L+++H+ G H DVK NI + ++G ++ DFG + L I R +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 390 MPQEILNED--YDHLDKVDIFSLGATMYELIKGSP-------------LSESGPQFLNLR 434
M E++ + YD K DI+S G T EL G+ ++ P L
Sbjct: 193 MAPEVMEQVRGYDF--KADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250
Query: 435 DGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
+L + F+ ++ + + DP +RP+A EL+ + F K +
Sbjct: 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-36
Identities = 74/292 (25%), Positives = 131/292 (44%), Gaps = 25/292 (8%)
Query: 218 ITGGDGLSRYYTDFHEI----EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAER 272
T G + F + +G G+F V +I G AVK SKRQ+ ++
Sbjct: 11 ATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK 70
Query: 273 RKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCD-HSLSDK-KASQFFAEGEVL 330
L EVQ L L H NI+ Y + + Y+ E+ L D+ + + F+E +
Sbjct: 71 ESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 129
Query: 331 KALHQIAQALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLLNKSLPIEE-- 384
+ + Q+ + ++H+ I H D+KP+N+ + K+ ++ DFG +T S +++
Sbjct: 130 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 189
Query: 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSP----LSESGPQFLNLRDGKL-- 438
G A Y+ E+L+ YD K D++S G +Y L+ G P +E + GK
Sbjct: 190 GTAYYIAPEVLHGTYDE--KCDVWSTGVILYILLSGCPPFNGANEYDI-LKKVEKGKYTF 246
Query: 439 --PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMKP 488
P S ++L++ M+ P R SA++ +++ K + + P
Sbjct: 247 ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 20/269 (7%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGS 287
F ++ +IG G+F V+ + A+K E+ + ++ EV+ L L
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-R 112
Query: 288 HENIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHE 345
H N + Y + ++ ME C S SD + + E E+ H Q L ++H
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM-PQEILNED---YD 400
+ H DVK NI + + G+ KLGDFG A+++ + G +M P+ IL D YD
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-VGTPYWMAPEVILAMDEGQYD 231
Query: 401 HLDKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGKLPLLPGH-SLQFQNLLKVM 455
KVD++SLG T EL + PL + ++ L GH S F+N +
Sbjct: 232 G--KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 289
Query: 456 VDPDPVQRPSAKELVENPIFDKIQKHRKT 484
+ P RP+++ L+++ F + + R
Sbjct: 290 LQKIPQDRPTSEVLLKHR-F--VLRERPP 315
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 45/306 (14%), Positives = 82/306 (26%), Gaps = 48/306 (15%)
Query: 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALA 283
LS+ +E + G+ S VF V +A+K + + L E A
Sbjct: 57 LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAA 116
Query: 284 ALGSHENIVGYYSSW--------------------------FENEQLYIQMELCDHSLSD 317
A E+ + + M L
Sbjct: 117 ARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLEL 176
Query: 318 --------KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLG 368
+ Q+ + + KG+ H PDN+++ +G LG
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLG 236
Query: 369 DFGRATLLNKSLPIEEGDARYMPQEILN-EDYDHLDKVDIFSLGATMYELIKGSP----- 422
D + P Y P+E LN ++ + LG ++Y +
Sbjct: 237 DVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 423 -------LSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
+ + L+ ++ D +R E +E P F
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356
Query: 476 DKIQKH 481
++Q
Sbjct: 357 LQLQNE 362
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 67/288 (23%), Positives = 129/288 (44%), Gaps = 26/288 (9%)
Query: 218 ITGGDGLSRYYTDFHEI----EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAER 272
T G ++ E+ +++G+G + V ++ A+K K + +
Sbjct: 22 ATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSN 80
Query: 273 RKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCD-HSLSDK-KASQFFAEGEVL 330
K L EV L L H NI+ Y + + Y+ ME L D+ F E +
Sbjct: 81 SKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA 139
Query: 331 KALHQIAQALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLLNKSLPIEE-- 384
+ Q+ + ++H+ I H D+KP+N+ + K+ + K+ DFG + + ++E
Sbjct: 140 VIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL 199
Query: 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPL----SESGPQFLNLRDGKL-- 438
G A Y+ E+L + YD K D++S+G ++ L+ G P ++ + GK
Sbjct: 200 GTAYYIAPEVLRKKYDE--KCDVWSIGVILFILLAGYPPFGGQTDQEI-LRKVEKGKYTF 256
Query: 439 --PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKT 484
P S ++L+K M+ D +R SA++ +E+P ++ +++
Sbjct: 257 DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKES 304
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 70/271 (25%), Positives = 127/271 (46%), Gaps = 26/271 (9%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
F +E++G G++ V+K + + G A+K Q+ +++ ++ + E+ +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK----QVPVESDLQEIIKEISIMQQC-DS 83
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHE 345
++V YY S+F+N L+I ME C S+SD + ++ E E+ L + L+++H
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYM-PQEILNEDYD 400
H D+K NI + G KL DFG A L ++ G +M P+ I Y+
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 203
Query: 401 HLDKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGKLPLLPG---HSLQFQNLLK 453
DI+SLG T E+ +G P ++ P F+ + P S F + +K
Sbjct: 204 C--VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-PTFRKPELWSDNFTDFVK 260
Query: 454 VMVDPDPVQRPSAKELVENPIFDKIQKHRKT 484
+ P QR +A +L+++P F ++ +
Sbjct: 261 QCLVKSPEQRATATQLLQHP-F--VRSAKGV 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 71/271 (26%), Positives = 128/271 (47%), Gaps = 24/271 (8%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ + ++G G F V+K + G A K + + E ++E++ LA H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATC-DHPY 77
Query: 291 IVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKG 347
IV +++ + +L+I +E C ++ + + E ++ Q+ +AL F+H K
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYM-PQEILNE----- 397
I H D+K N+ + G +L DFG + K+L + G +M P+ ++ E
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 398 DYDHLDKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGKLPLLPGH--SLQFQNL 451
YD+ K DI+SLG T+ E+ + P E P + LL S++F++
Sbjct: 198 PYDY--KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255
Query: 452 LKVMVDPDPVQRPSAKELVENPIFDKIQKHR 482
LK+ +D +P RPSA +L+E+P I ++
Sbjct: 256 LKIALDKNPETRPSAAQLLEHPFVSSITSNK 286
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 26/287 (9%)
Query: 219 TGGDGLSRYYTDFHEI----EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERR 273
+ G + F E +G G+F V K RI YAVK +K + +
Sbjct: 8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTS 66
Query: 274 KALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCD-HSLSDK-KASQFFAEGEVLK 331
L EV+ L L H NI+ + ++ YI EL L D+ + F+E + +
Sbjct: 67 TILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR 125
Query: 332 ALHQIAQALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLLNKSLPIEE--G 385
+ Q+ + ++H+ I H D+KP+NI + K+ K+ DFG +T ++ +++ G
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 386 DARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSP----LSESGPQFLNLRDGKL--- 438
A Y+ E+L YD K D++S G +Y L+ G+P +E + GK
Sbjct: 186 TAYYIAPEVLRGTYDE--KCDVWSAGVILYILLSGTPPFYGKNEYDI-LKRVETGKYAFD 242
Query: 439 -PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKT 484
P S ++L++ M+ P R +A + +E+P K T
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPT 289
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 67/291 (23%), Positives = 111/291 (38%), Gaps = 62/291 (21%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGY 294
+ +G G+ V G AVK A E++ L H N++ Y
Sbjct: 21 KILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALM-----EIKLLTESDDHPNVIRY 74
Query: 295 YSSWFENEQ-LYIQMELCDHSLSD--------KKASQFFAEGEVLKALHQIAQALQFIHE 345
Y S ++ LYI +ELC+ +L D + + E + L QIA + +H
Sbjct: 75 YCS-ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 346 KGIAHLDVKPDNI--------------YVKNGVYKLGDFGRATLLN-------KSLPIEE 384
I H D+KP NI +N + DFG L+ +L
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 385 GDARYMPQEILNEDYDHLD------KVDIFSLGATMYELIKGSPLSESGPQF-------- 430
G + + E+L E + +DIFS+G Y + LS+ F
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI-----LSKGKHPFGDKYSRES 248
Query: 431 ------LNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
+L + K + +L+ M+D DP++RP+A +++ +P+F
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 80/314 (25%), Positives = 124/314 (39%), Gaps = 64/314 (20%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSH 288
DF +I ++GAGN VFKV + G A K L R ++ E+Q L +
Sbjct: 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARK--LIHLEIKPAIRNQIIRELQVLHEC-NS 90
Query: 289 ENIVGYYSSWFENEQLYIQMELCD-HSLSD-KKASQFFAEGEVLKALHQIAQALQFIHEK 346
IVG+Y +++ + ++ I ME D SL K + E + K + + L ++ EK
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 347 G-IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP---IEEGDARYM-PQEILNEDYD 400
I H DVKP NI V G KL DFG + L S+ + G YM P+ + Y
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGTHYS 208
Query: 401 HLDKVDIFSLGATMYELIKGS-PLSESGPQFLNLRDGKL--------------------- 438
+ DI+S+G ++ E+ G P+ + L L G
Sbjct: 209 V--QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 439 -----------------------PLLPGH--SLQFQNLLKVMVDPDPVQRPSAKELVENP 473
P LP SL+FQ+ + + +P +R K+L+ +
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326
Query: 474 IFDKIQKHRKTYMK 487
F K +
Sbjct: 327 -FIKRSDAEEVDFA 339
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-33
Identities = 67/266 (25%), Positives = 129/266 (48%), Gaps = 28/266 (10%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALAALGSH 288
+ +G G F+ F++ +A K K L +R K +E+ +L +H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH 74
Query: 289 ENIVGYYSSWFENEQ-LYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHE 345
+++VG++ +FE+ +++ +ELC SL + K + E E L QI Q++H
Sbjct: 75 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR--------YMPQEILN 396
+ H D+K N+++ ++ K+GDFG AT + +G+ + Y+ E+L+
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-----DGERKKVLCGTPNYIAPEVLS 188
Query: 397 E-DYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGH-SLQFQNL 451
+ + +VD++S+G MY L+ G P E+ +L ++ + +P H + +L
Sbjct: 189 KKGHSF--EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-IPKHINPVAASL 245
Query: 452 LKVMVDPDPVQRPSAKELVENPIFDK 477
++ M+ DP RP+ EL+ + F
Sbjct: 246 IQKMLQTDPTARPTINELLNDEFFTS 271
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 62/302 (20%), Positives = 118/302 (39%), Gaps = 35/302 (11%)
Query: 218 ITGGDGLSRYYTDFHEI----EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAER 272
I G + + E ++G+G + V ++ A+K K Q
Sbjct: 21 INPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYS 80
Query: 273 RKALL----------EVQALAALGSHENIVGYYSSWFENEQLYIQMELCD-HSLSDK-KA 320
E+ L +L H NI+ + + + + Y+ E + L ++
Sbjct: 81 DDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN 139
Query: 321 SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNI-YV---KNGVYKLGDFGRATLL 376
F E + + QI + ++H+ I H D+KP+NI K+ DFG ++
Sbjct: 140 RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 377 NKSLPIEE--GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSP----LSESGPQF 430
+K + + G A Y+ E+L + Y+ K D++S G MY L+ G P ++
Sbjct: 200 SKDYKLRDRLGTAYYIAPEVLKKKYNE--KCDVWSCGVIMYILLCGYPPFGGQNDQDI-I 256
Query: 431 LNLRDGKL----PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYM 486
+ GK S + + L+K+M+ D +R +A+E + + K +
Sbjct: 257 KKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSD 316
Query: 487 KP 488
+
Sbjct: 317 QK 318
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 34/281 (12%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
F +E +G G + V+K G A+K + D E + E+ L H
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGD-EEEEIKQEINMLKKYSHH 80
Query: 289 ENIVGYYSSWF------ENEQLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIAQ 338
NI YY ++ ++QL++ ME C S++D E + +I +
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140
Query: 339 ALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP-----IEEGDARYM-P 391
L +H+ + H D+K N+ + +N KL DFG + L++++ I G +M P
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAP 198
Query: 392 QEILNED-----YDHLDKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGKLPLLP 442
+ I ++ YD K D++SLG T E+ +G+ PL + P FL R+ L
Sbjct: 199 EVIACDENPDATYDF--KSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 256
Query: 443 GH-SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHR 482
S +FQ+ ++ + + QRP+ ++L+++P R
Sbjct: 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER 297
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-32
Identities = 60/319 (18%), Positives = 110/319 (34%), Gaps = 72/319 (22%)
Query: 224 LSRYYTDFHEI----EQIGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDA--ERRKAL 276
+ + IG G++ V ++ A+K +K ++ + +
Sbjct: 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK 76
Query: 277 LEVQALAALGSHENIVGYYSSWFENEQLYIQMELC------------------------- 311
EV+ + L H NI Y + + + + + MELC
Sbjct: 77 TEVRLMKKL-HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 312 -----------------DHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVK 354
+ E + + QI AL ++H +GI H D+K
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIK 195
Query: 355 PDNIYV---KNGVYKLGDFGRATLLNKSLPIEE-------GDARYMPQEILN---EDYDH 401
P+N K+ KL DFG + K E G ++ E+LN E Y
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255
Query: 402 LDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL----PLLPGHSLQFQNLLKV 454
K D +S G ++ L+ G+ + + + KL P S ++LL
Sbjct: 256 --KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSN 313
Query: 455 MVDPDPVQRPSAKELVENP 473
+++ + +R A +++P
Sbjct: 314 LLNRNVDERFDAMRALQHP 332
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 67/266 (25%), Positives = 129/266 (48%), Gaps = 28/266 (10%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALAALGSH 288
+ +G G F+ F++ +A K K L +R K +E+ +L +H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH 100
Query: 289 ENIVGYYSSWFENEQ-LYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHE 345
+++VG++ +FE+ +++ +ELC SL + K + E E L QI Q++H
Sbjct: 101 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR--------YMPQEILN 396
+ H D+K N+++ ++ K+GDFG AT + +G+ + Y+ E+L+
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-----DGERKKVLCGTPNYIAPEVLS 214
Query: 397 E-DYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGH-SLQFQNL 451
+ + +VD++S+G MY L+ G P E+ +L ++ + +P H + +L
Sbjct: 215 KKGHSF--EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-IPKHINPVAASL 271
Query: 452 LKVMVDPDPVQRPSAKELVENPIFDK 477
++ M+ DP RP+ EL+ + F
Sbjct: 272 IQKMLQTDPTARPTINELLNDEFFTS 297
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 61/310 (19%), Positives = 102/310 (32%), Gaps = 64/310 (20%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
+ + +G G ++VF+ + G +A+K + + + E + L L +H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR--EFEVLKKL-NH 66
Query: 289 ENIVGYYSSWFE--NEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIAQALQ 341
+NIV ++ E + ME C L + + E E L L + +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 342 FIHEKGIAHLDVKPDNIYV-----KNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEI 394
+ E GI H ++KP NI VYKL DFG A L G Y+ ++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 395 L---------NEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-----FLNLRDGKL 438
+ Y VD++S+G T Y GS GP+ + GK
Sbjct: 187 YERAVLRKDHQKKYGA--TVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 439 P-------------------------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENP 473
L G + +L +++ D + +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 474 IFDKIQKHRK 483
HR
Sbjct: 305 ---SDILHRG 311
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 36/281 (12%)
Query: 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGS 287
Y + E +G G F V K R A+K Q+ ++ER+ ++E++ L+ + +
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIK----QIESESERKAFIVELRQLSRV-N 59
Query: 288 HENIVGYYSSWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIAQALQF 342
H NIV Y + + + ME + + L + ++ + Q +Q + +
Sbjct: 60 HPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 343 IHE---KGIAHLDVKPDNIYV--KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEIL-N 396
+H K + H D+KP N+ + V K+ DFG A + + +G A +M E+
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEG 177
Query: 397 EDYDHLDKVDIFSLGATMYELIKGS-PLSE-SGPQFL-------NLRDGKLPLLPGHSLQ 447
+Y K D+FS G ++E+I P E GP F R PL+
Sbjct: 178 SNYSE--KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---PPLIKNLPKP 232
Query: 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMKP 488
++L+ DP QRPS +E+V+ I + ++ +P
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVK--IMTHLMRYFPGADEP 271
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 28/278 (10%)
Query: 219 TGGDGLSRYYTDFHEI----EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERR 273
+ G + ++ ++G+G F V V +R G +K +K + E+
Sbjct: 8 SSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI 67
Query: 274 KALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELC------DHSLSDKKASQFFAEG 327
+A E++ L +L H NI+ + + + +YI ME C + +S + + +EG
Sbjct: 68 EA--EIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124
Query: 328 EVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLLNKSLPIE 383
V + + Q+ AL + H + + H D+KP+NI + K+ DFG A L
Sbjct: 125 YVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184
Query: 384 E--GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL 438
G A YM E+ D K DI+S G MY L+ G S + +
Sbjct: 185 NAAGTALYMAPEVFKRDVTF--KCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242
Query: 439 --PLLPGH-SLQFQNLLKVMVDPDPVQRPSAKELVENP 473
+ + Q +LLK M+ DP +RPSA +++ +
Sbjct: 243 NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 73/273 (26%), Positives = 113/273 (41%), Gaps = 38/273 (13%)
Query: 229 TDFHEI--EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAAL 285
TD +++ + +G G V + R G A+K A + EV
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQ-----EVDHHWQA 78
Query: 286 GSHENIVG----YYSSWFENEQLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIA 337
+IV Y + L I ME + L ++ Q F E E + + I
Sbjct: 79 SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 338 QALQFIHEKGIAHLDVKPDNI-YV---KNGVYKLGDFGRATLL-NKSLPIEEGDARYMPQ 392
A+QF+H IAH DVKP+N+ Y K+ V KL DFG A +L Y+
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAP 198
Query: 393 EILN-EDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-----FLNLRDGKL----PL 440
E+L E YD D++SLG MY L+ G P S +G +R G+ P
Sbjct: 199 EVLGPEKYDK--SCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256
Query: 441 LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENP 473
S + L+++++ DP +R + + + +P
Sbjct: 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 60/291 (20%), Positives = 112/291 (38%), Gaps = 43/291 (14%)
Query: 230 DFHEI---EQIGAGNFSHVFKVLKRIDGCFY---AVKHSKRQLHHDAERRKALLEVQALA 283
F ++ E IG G F V+ G ++ A++ + ++ + + EV A
Sbjct: 31 PFEQLEIGELIGKGRFGQVYH------GRWHGEVAIRLIDIERDNEDQLKAFKREVMAYR 84
Query: 284 ALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQAL 340
HEN+V + + L I LC +L + A + + +I + +
Sbjct: 85 QT-RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGM 143
Query: 341 QFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLL--------NKSLPIEEGDARYMPQ 392
++H KGI H D+K N++ NG + DFG ++ L I+ G ++
Sbjct: 144 GYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 393 EIL----------NEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQ--FLNLRDGKLP 439
EI+ + D+F+LG YEL P + + G P
Sbjct: 204 EIIRQLSPDTEEDKLPFSK--HSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261
Query: 440 LLP--GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMKP 488
L G + ++L + +RP+ +L++ + +K+ K + P
Sbjct: 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNRRLSHP 310
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 61/267 (22%), Positives = 121/267 (45%), Gaps = 29/267 (10%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALAALGSH 288
DF +G G+F+ V++ G A+K K+ ++ ++ EV+ L H
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KH 70
Query: 289 ENIVGYYSSWFENEQ-LYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIH 344
+I+ Y+ +FE+ +Y+ +E+C + ++ K + F+E E +HQI + ++H
Sbjct: 71 PSILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR---------YMPQEI 394
GI H D+ N+ + +N K+ DFG AT L + + Y+ EI
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL------KMPHEKHYTLCGTPNYISPEI 183
Query: 395 LNEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKLPLLPGH-SLQFQN 450
H + D++SLG Y L+ G P +++ + +P S++ ++
Sbjct: 184 ATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE-MPSFLSIEAKD 241
Query: 451 LLKVMVDPDPVQRPSAKELVENPIFDK 477
L+ ++ +P R S ++++P +
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFMSR 268
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 63/275 (22%), Positives = 119/275 (43%), Gaps = 33/275 (12%)
Query: 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALA 283
++Y + + +G G+FS K + + +AVK +++ + ++ E+ AL
Sbjct: 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK-----EITALK 60
Query: 284 ALGSHENIVGYYSSWFENEQ-LYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQAL 340
H NIV + F ++ ++ MEL + L ++ K + F+E E + ++ A+
Sbjct: 61 LCEGHPNIVKLHE-VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAV 119
Query: 341 QFIHEKGIAHLDVKPDNI-YV---KNGVYKLGDFGRATLL---NKSLPIEEGDARYMPQE 393
+H+ G+ H D+KP+N+ + N K+ DFG A L N+ L Y E
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179
Query: 394 ILN-EDYDHLDKVDIFSLGATMYELIKGSP---------LSESGPQ-FLNLRDGKLPLLP 442
+LN YD D++SLG +Y ++ G S + ++ G
Sbjct: 180 LLNQNGYDE--SCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237
Query: 443 GH----SLQFQNLLKVMVDPDPVQRPSAKELVENP 473
S + ++L++ ++ DP +R L N
Sbjct: 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 59/299 (19%), Positives = 100/299 (33%), Gaps = 61/299 (20%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
+ + +G G ++VF+ + G +A+K + + + E + L L +H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR--EFEVLKKL-NH 66
Query: 289 ENIVGYYSSWFE--NEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIAQALQ 341
+NIV ++ E + ME C L + + E E L L + +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 342 FIHEKGIAHLDVKPDNIYV-----KNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEI 394
+ E GI H ++KP NI VYKL DFG A L G Y+ ++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 395 L---------NEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-----FLNLRDGKL 438
+ Y VD++S+G T Y GS GP+ + GK
Sbjct: 187 YERAVLRKDHQKKYGA--TVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 439 P-------------------------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472
L G + +L +++ D + +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 68/271 (25%), Positives = 109/271 (40%), Gaps = 54/271 (19%)
Query: 229 TDFHEI--EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAAL 285
D +++ + +G G V ++ + +A+K A R EV+
Sbjct: 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP---KARR-----EVELHWRA 67
Query: 286 GSHENIVG----YYSSWFENEQLYIQMELCDHS-LSDK---KASQFFAEGEVLKALHQIA 337
+IV Y + + + L I ME D L + + Q F E E + + I
Sbjct: 68 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 338 QALQFIHEKGIAHLDVKPDNI-YV---KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQE 393
+A+Q++H IAH DVKP+N+ Y N + KL DFG A E
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------------E 169
Query: 394 ILNEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-----FLNLRDGKL----PLLP 442
E YD D++SLG MY L+ G P S G +R G+ P
Sbjct: 170 TTGEKYDK--SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227
Query: 443 GHSLQFQNLLKVMVDPDPVQRPSAKELVENP 473
S + + L++ ++ +P QR + E + +P
Sbjct: 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-30
Identities = 69/255 (27%), Positives = 120/255 (47%), Gaps = 20/255 (7%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
+G G+F V K RI YAVK +K + + L EV+ L L H NI+
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKL-DHPNIMK 85
Query: 294 YYSSWFENEQLYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
+ ++ YI EL L D+ + F+E + + + Q+ + ++H+ I H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHR 145
Query: 352 DVKPDNIYV----KNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEILNEDYDHLDKV 405
D+KP+NI + K+ K+ DFG +T ++ +++ G A Y+ E+L YD K
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE--KC 203
Query: 406 DIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL----PLLPGHSLQFQNLLKVMVDP 458
D++S G +Y L+ G+P ++ + GK P S ++L++ M+
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263
Query: 459 DPVQRPSAKELVENP 473
P R +A + +E+P
Sbjct: 264 HPSLRITATQCLEHP 278
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 59/263 (22%), Positives = 115/263 (43%), Gaps = 25/263 (9%)
Query: 229 TDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALG 286
++ + IG G++ V +++ A K K + + + E++ + +L
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSL- 63
Query: 287 SHENIVGYYSSWFENEQ-LYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFI 343
H NI+ Y FE+ +Y+ MELC L ++ + F E + + + + A+ +
Sbjct: 64 DHPNIIRLYE-TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 344 HEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEILNE 397
H+ +AH D+KP+N + KL DFG A + G Y+ ++L
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG 182
Query: 398 DYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL----PLLPGHSLQFQN 450
Y + D +S G MY L+ G P + + + L +R+G S Q ++
Sbjct: 183 LYGP--ECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240
Query: 451 LLKVMVDPDPVQRPSAKELVENP 473
L++ ++ P QR ++ + +E+
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHE 263
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 5e-30
Identities = 41/367 (11%), Positives = 92/367 (25%), Gaps = 60/367 (16%)
Query: 165 QKTHNYVP-QSAVALRCRVMPPPCIKNPYQKDASEMDIDRFGNQWAKCAGLFP---VITG 220
Q P + +P ++ + S D L+
Sbjct: 17 QGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAAD-------SLVSTSLWNTGQPFRV 69
Query: 221 GDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK----------HSKRQLHHDA 270
L +G + + + G + V ++ +Q+ +
Sbjct: 70 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 129
Query: 271 ERRKALLEVQALAALGSHENI-----------------VGYYSSWFENEQLYIQMELCDH 313
R + L ++ H V +
Sbjct: 130 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 189
Query: 314 SLSD--------KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGV 364
+L + L+ Q+ + L +H G+ H ++P +I + + G
Sbjct: 190 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG 249
Query: 365 YKLGDFGRATLLNKSLPIEEGDARYMPQEIL---------NEDYDHLDKVDIFSLGATMY 415
L F S G + P E + D ++LG +Y
Sbjct: 250 VFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308
Query: 416 ELIKG-SPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPI 474
+ P ++ + + LL+ + R + +E P
Sbjct: 309 WIWCADLPNTDDAALGGSEWI--FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366
Query: 475 FDKIQKH 481
+++++
Sbjct: 367 YEQLRTE 373
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 8e-30
Identities = 33/305 (10%), Positives = 81/305 (26%), Gaps = 50/305 (16%)
Query: 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK----------HSKRQLHHDAERR 273
L +G + + + G + V ++ +Q+ + R
Sbjct: 68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 127
Query: 274 KALLEVQALAALGSHENI-----------------VGYYSSWFENEQLYIQMELCDHSLS 316
+ L ++ H V + +L
Sbjct: 128 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 187
Query: 317 D--------KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKL 367
+ L+ Q+ + L +H G+ H ++P +I + + G L
Sbjct: 188 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 247
Query: 368 GDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLD----------KVDIFSLGATMYEL 417
F + + P E+ D ++LG +Y +
Sbjct: 248 TGFEHLVRDGARVVS-SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 418 IKGS-PLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFD 476
P+++ + + + LL+ + R + +E P ++
Sbjct: 307 WCADLPITKDAALGGSEWIFRSC--KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364
Query: 477 KIQKH 481
+++
Sbjct: 365 QLRTE 369
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 50/340 (14%), Positives = 115/340 (33%), Gaps = 42/340 (12%)
Query: 184 PPPCIKNPYQKDASEMDIDRFGNQWAKCAGLF------PVITGGDGLSRYYTDFHEIEQI 237
P + NP+ + + F P I + +
Sbjct: 14 PNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLL 73
Query: 238 GAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIV 292
G G F+ V++ + + + +K K + L+E + +
Sbjct: 74 GEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS---MQHMFM 130
Query: 293 GYYSSWFENEQLYIQMELCDH-SLSD------KKASQFFAEGEVLKALHQIAQALQFIHE 345
+YS+ + EL + +L + + +G V+ ++ ++ +H+
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 346 KGIAHLDVKPDNIYVKNGVY------------KLGDFGRATLLNKSLPIEE-----GDAR 388
I H D+KPDN + NG L D G++ + +
Sbjct: 191 CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSG 250
Query: 389 YMPQEILN-EDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQ 447
+ E+L+ + +++ ++D F + AT+Y ++ G+ + +G LP +
Sbjct: 251 FQCVEMLSNKPWNY--QIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDM- 307
Query: 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMK 487
+ VM++ + +L+ + Q+H ++
Sbjct: 308 WNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIR 347
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 68/276 (24%), Positives = 111/276 (40%), Gaps = 43/276 (15%)
Query: 229 TDFHEI--EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAAL 285
D +++ + +G G V ++ + +A+K A R EV+
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP---KARR-----EVELHWRA 111
Query: 286 GSHENIVG----YYSSWFENEQLYIQMELC------DHSLSDKKASQFFAEGEVLKALHQ 335
+IV Y + + + L I ME + Q F E E + +
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKS 169
Query: 336 IAQALQFIHEKGIAHLDVKPDNI-YV---KNGVYKLGDFGRATLLNKSLPIEE--GDARY 389
I +A+Q++H IAH DVKP+N+ Y N + KL DFG A + Y
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 229
Query: 390 MPQEILN-EDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-----FLNLRDGKL--- 438
+ E+L E YD D++SLG MY L+ G P S G +R G+
Sbjct: 230 VAPEVLGPEKYDK--SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287
Query: 439 -PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENP 473
P S + + L++ ++ +P QR + E + +P
Sbjct: 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 71/277 (25%), Positives = 121/277 (43%), Gaps = 37/277 (13%)
Query: 224 LSRYYTDFHEI----EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLE 278
L R F + E IG G++S + + + +AVK K + D E
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--DPTE-----E 65
Query: 279 VQALAALGSHENIVGYYSSWFENEQ-LYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQ 335
++ L G H NI+ +++ + +Y+ EL L DK +FF+E E L
Sbjct: 66 IEILLRYGQHPNIITLKD-VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT 124
Query: 336 IAQALQFIHEKGIAHLDVKPDNIYVKN-----GVYKLGDFGRATLL---NKSLPIEEGDA 387
I + ++++H +G+ H D+KP NI + ++ DFG A L N L A
Sbjct: 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA 184
Query: 388 RYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSP-----LSESGPQ-FLNLRDGKLPL 440
++ E+L YD DI+SLG +Y ++ G ++ + + GK L
Sbjct: 185 NFVAPEVLERQGYDA--ACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242
Query: 441 LPGH----SLQFQNLLKVMVDPDPVQRPSAKELVENP 473
G+ S ++L+ M+ DP QR +A ++ +P
Sbjct: 243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 64/265 (24%), Positives = 118/265 (44%), Gaps = 30/265 (11%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALL-----EVQALAALGSH 288
+ +G+G V +R A++ SKR+ + R E++ L L +H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NH 199
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEK 346
I+ + F+ E YI +EL + L DK ++ E +Q+ A+Q++HE
Sbjct: 200 PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 258
Query: 347 GIAHLDVKPDNIYV----KNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEILNED-- 398
GI H D+KP+N+ + ++ + K+ DFG + +L ++ + G Y+ E+L
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGT 318
Query: 399 --YDHLDKVDIFSLGATMYELIKGSP--LSESGPQ--FLNLRDGKLPLLPGH----SLQF 448
Y+ VD +SLG ++ + G P + GK +P S +
Sbjct: 319 AGYNR--AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKA 376
Query: 449 QNLLKVMVDPDPVQRPSAKELVENP 473
+L+K ++ DP R + +E + +P
Sbjct: 377 LDLVKKLLVVDPKARFTTEEALRHP 401
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 71/293 (24%), Positives = 115/293 (39%), Gaps = 54/293 (18%)
Query: 229 TDFHEI--EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAAL 285
D +++ + +G G + V + I YAVK K+ H R + EV+ L
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQC 67
Query: 286 GSHENIVGYYSSWFENEQ-LYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQF 342
H N++ +FE E Y+ E S+ + F E E + +A AL F
Sbjct: 68 QGHRNVLELIE-FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDF 126
Query: 343 IHEKGIAHLDVKPDNI-YV---KNGVYKLGDFGRATLLNKSLPIEE----------GDAR 388
+H KGIAH D+KP+NI + K+ DF + + + G A
Sbjct: 127 LHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 389 YMPQEILN------EDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQFLNLRDGKLPL 440
YM E++ YD + D++SLG +Y L+ G P + G R P
Sbjct: 187 YMAPEVVEAFSEEASIYDK--RCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 441 ---------LPGH-----------SLQFQNLLKVMVDPDPVQRPSAKELVENP 473
G S ++L+ ++ D QR SA +++++P
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 67/267 (25%), Positives = 117/267 (43%), Gaps = 25/267 (9%)
Query: 229 TDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQL---HHDAERRKALLEVQALA 283
D +E+ E++G+G F+ V K ++ G YA K KR+L R + EV L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 284 ALGSHENIVGYYSSWFENEQLYIQMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQ 341
+ H NI+ + + + + +EL L D + E E + L QI +
Sbjct: 64 EI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122
Query: 342 FIHEKGIAHLDVKPDNI-----YVKNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEI 394
++H K IAH D+KP+NI V N KL DFG A + + G ++ EI
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 395 LNED-YDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL----PLLPGHSL 446
+N + + D++S+G Y L+ G+ L E+ + N+ S
Sbjct: 183 VNYEPLGL--EADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240
Query: 447 QFQNLLKVMVDPDPVQRPSAKELVENP 473
++ ++ ++ DP +R + + +E+
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHS 267
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 56/329 (17%), Positives = 103/329 (31%), Gaps = 72/329 (21%)
Query: 229 TDFHEIEQIGAG--NFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG 286
+ + IG G + V + G + V+ + + E+
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF- 83
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIAQALQF 342
+H NIV Y +++ + +L++ + S D E + L + +AL +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARY----------MP 391
IH G H VK +I + +G L + + + +
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 392 QEILNED---YDHLDKVDIFSLGATMYELIKGSP-------------------------- 422
E+L ++ YD K DI+S+G T EL G
Sbjct: 204 PEVLQQNLQGYDA--KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261
Query: 423 -----------------------LSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPD 459
L+ S P+ N P S F + ++ + +
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321
Query: 460 PVQRPSAKELVENPIFDKIQKHRKTYMKP 488
P RPSA L+ + F +I++ +
Sbjct: 322 PDARPSASTLLNHSFFKQIKRRASEALPE 350
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 55/265 (20%), Positives = 121/265 (45%), Gaps = 22/265 (8%)
Query: 229 TDFHEI--EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG 286
+F+ + +++G G F+ V + + + G YA K K++ R + L E+ L
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDHS-LSDK---KASQFFAEGEVLKALHQIAQALQF 342
S ++ + + ++ + +E + + ++ +E +V++ + QI + + +
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 343 IHEKGIAHLDVKPDNI----YVKNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEILN 396
+H+ I HLD+KP NI G K+ DFG + + + + E G Y+ EILN
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 397 EDYDHLDK-VDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL----PLLPGHSLQF 448
YD + D++++G Y L+ + + E + +LN+ + S
Sbjct: 207 --YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA 264
Query: 449 QNLLKVMVDPDPVQRPSAKELVENP 473
+ ++ ++ +P +RP+A+ + +
Sbjct: 265 TDFIQSLLVKNPEKRPTAEICLSHS 289
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 64/267 (23%), Positives = 119/267 (44%), Gaps = 25/267 (9%)
Query: 229 TDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQL---HHDAERRKALLEVQALA 283
DF++I E++G+G F+ V K ++ G YA K KRQ R + EV L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 284 ALGSHENIVGYYSSWFENEQLYIQMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQ 341
+ H N++ + + + + +EL L D + +E E + QI +
Sbjct: 71 QV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 342 FIHEKGIAHLDVKPDNIYVKN-----GVYKLGDFGRATLLNKSLPIEE--GDARYMPQEI 394
++H K IAH D+KP+NI + + KL DFG A + + + G ++ EI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 395 LNEDYDHLDK-VDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL----PLLPGHSL 446
+N Y+ L D++S+G Y L+ G+ L ++ + N+ S
Sbjct: 190 VN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247
Query: 447 QFQNLLKVMVDPDPVQRPSAKELVENP 473
++ ++ ++ + +R + +E + +P
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHP 274
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 64/296 (21%), Positives = 114/296 (38%), Gaps = 49/296 (16%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+ E++G G F +V + + + G A+K +++L R + LE+Q + L +H
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKL-NHP 72
Query: 290 NIVGYY------SSWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIAQ 338
N+V N+ + ME C+ L+ + EG + L I+
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 339 ALQFIHEKGIAHLDVKPDNI----YVKNGVYKLGDFGRATLLNKSLPIEE--GDARYM-P 391
AL+++HE I H D+KP+NI + ++K+ D G A L++ E G +Y+ P
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 392 QEILNEDYDHLDKVDIFSLGATMYELIKGSP--LSESGP-QFLNLRDGKLP--------- 439
+ + + Y VD +S G +E I G L P Q+ K
Sbjct: 193 ELLEQKKYTV--TVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250
Query: 440 ---------------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
L + + + L+ M+ QR + + F +
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 66/283 (23%), Positives = 110/283 (38%), Gaps = 37/283 (13%)
Query: 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALG 286
+D E +G G F KV R G +K R D E ++ L EV+ + L
Sbjct: 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCL- 64
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFI 343
H N++ + +++++L E +L K + + + IA + ++
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE-----------------G 385
H I H D+ N V +N + DFG A L+ E G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 386 DARYM-PQEILNEDYDHLDKVDIFSLGATMYELI-KGSPLSESGPQF----LNLRDGKLP 439
+ +M P+ I YD KVD+FS G + E+I + + + P+ LN+R
Sbjct: 185 NPYWMAPEMINGRSYDE--KVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242
Query: 440 LLPGH-SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481
P + F + D DP +RPS +L + ++ H
Sbjct: 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRMH 283
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 60/267 (22%), Positives = 116/267 (43%), Gaps = 25/267 (9%)
Query: 229 TDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQL---HHDAERRKALLEVQALA 283
D+++ E++G+G F+ V K ++ G YA K KR+ R EV L
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 284 ALGSHENIVGYYSSWFENEQLYIQMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQ 341
+ H N++ + + + + +EL L D + E E + L QI +
Sbjct: 70 EI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 342 FIHEKGIAHLDVKPDNI-----YVKNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEI 394
++H IAH D+KP+NI V K+ DFG A ++ + G ++ EI
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 395 LNED-YDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL----PLLPGHSL 446
+N + + D++S+G Y L+ G+ L ++ + N+ S
Sbjct: 189 VNYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 447 QFQNLLKVMVDPDPVQRPSAKELVENP 473
++ ++ ++ DP +R + ++ +++P
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHP 273
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 64/269 (23%), Positives = 107/269 (39%), Gaps = 27/269 (10%)
Query: 229 TDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALL--EVQALAA 284
D +E+ E IG G FS V + + R G +AVK + L E
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 285 LGSHENIVGYYSSWFENEQLYIQMELC------DHSLSDKKASQFFAEGEVLKALHQIAQ 338
L H +IV ++ + LY+ E + A ++E + QI +
Sbjct: 83 L-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 339 ALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLLNKSLPIEE---GDARYMP 391
AL++ H+ I H DVKP + + + KLG FG A L +S + G +M
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201
Query: 392 QEILNED-YDHLDKVDIFSLGATMYELIKGSP--LSESGPQFLNLRDGKL----PLLPGH 444
E++ + Y VD++ G ++ L+ G F + GK
Sbjct: 202 PEVVKREPYGK--PVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHI 259
Query: 445 SLQFQNLLKVMVDPDPVQRPSAKELVENP 473
S ++L++ M+ DP +R + E + +P
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHP 288
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 65/267 (24%), Positives = 118/267 (44%), Gaps = 25/267 (9%)
Query: 229 TDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQL---HHDAERRKALLEVQALA 283
DF++I E++G+G F+ V K ++ G YA K KRQ R + EV L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 284 ALGSHENIVGYYSSWFENEQLYIQMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQ 341
+ H NI+ + + + + +EL L D + +E E + QI +
Sbjct: 71 QV-LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 342 FIHEKGIAHLDVKPDNI-----YVKNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEI 394
++H K IAH D+KP+NI + KL DFG A + + + G ++ EI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 395 LNEDYDHLDK-VDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL----PLLPGHSL 446
+N Y+ L D++S+G Y L+ G+ L ++ + N+ S
Sbjct: 190 VN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247
Query: 447 QFQNLLKVMVDPDPVQRPSAKELVENP 473
++ ++ ++ + +R + +E + +P
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHP 274
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 56/271 (20%), Positives = 99/271 (36%), Gaps = 33/271 (12%)
Query: 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-----EVQAL 282
+ +QIG G F V K D A+K EV +
Sbjct: 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 283 AALGSHENIVGYY-SSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQ 338
+ L +H NIV Y + ME L + L+ + IA
Sbjct: 78 SNL-NHPNIVKLYGLMH---NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 339 ALQFIHEKG--IAHLDVKPDNIYV------KNGVYKLGDFGRATLLNKSLPIEEGDARYM 390
++++ + I H D++ NI++ K+ DFG + S+ G+ ++M
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWM 193
Query: 391 PQEIL---NEDYDHLDKVDIFSLGATMYELIKGSP----LSESGPQFLN--LRDGKLPLL 441
E + E Y K D +S +Y ++ G S +F+N +G P +
Sbjct: 194 APETIGAEEESYTE--KADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 442 PGH-SLQFQNLLKVMVDPDPVQRPSAKELVE 471
P + +N++++ DP +RP +V+
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 62/257 (24%), Positives = 115/257 (44%), Gaps = 12/257 (4%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
DF +G G F +V+ ++ A+K K QL + EV+ + L H
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 68
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHEK 346
NI+ Y + + ++Y+ +E ++ + + F E + ++A AL + H K
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE-GDARYMPQEIL-NEDYDHLD 403
+ H D+KP+N+ + G K+ DFG + S + G Y+P E++ +D
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDE-- 186
Query: 404 KVDIFSLGATMYELIKGS-PLSESGPQFL--NLRDGKLPLLPGHSLQFQNLLKVMVDPDP 460
KVD++SLG YE + G P + Q + + + ++L+ ++ +P
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 246
Query: 461 VQRPSAKELVENPIFDK 477
QRP +E++E+P
Sbjct: 247 SQRPMLREVLEHPWITA 263
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 64/266 (24%), Positives = 112/266 (42%), Gaps = 24/266 (9%)
Query: 216 PVITGGDGLS-RYYTDFHEI-EQIGAGNFSHVFKVL-KRIDGCFYAVKHSKRQLHHDAER 272
P + GD ++ +Y E+ I G ++ L + ++G +K +A+
Sbjct: 70 PQLNPGDIVAGQY-----EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQA 124
Query: 273 RKALLEVQALAALGSHENIVGYY-----SSWFENEQLYIQMELCD-HSLSDKKASQFFAE 326
A+ E Q LA + H +IV + + + YI ME SL K +
Sbjct: 125 M-AMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKL-PV 181
Query: 327 GEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSLPIEEGD 386
E + L +I AL ++H G+ + D+KP+NI + KL D G + +N + G
Sbjct: 182 AEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFGYL-YGT 240
Query: 387 ARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSL 446
+ EI+ DI+++G T+ L P + +G L + +
Sbjct: 241 PGFQAPEIVRTGPT--VATDIYTVGRTLAALTLDLP-TRNGRYVDGLPE--DDPVLKTYD 295
Query: 447 QFQNLLKVMVDPDPVQRP-SAKELVE 471
+ LL+ +DPDP QR +A+E+
Sbjct: 296 SYGRLLRRAIDPDPRQRFTTAEEMSA 321
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 55/275 (20%), Positives = 111/275 (40%), Gaps = 40/275 (14%)
Query: 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQAL 282
++ +Y + E +G G F V K + G A K R + ++ + E+ +
Sbjct: 85 VNSFY-TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVM 140
Query: 283 AALGSHENIVGYYSSWFENEQLYIQMELC------------DHSLSDKKASQFFAEGEVL 330
L H N++ Y ++ + + ME ++L++ F
Sbjct: 141 NQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF------- 192
Query: 331 KALHQIAQALQFIHEKGIAHLDVKPDNIYVKN---GVYKLGDFGRATLLNKSLPIEE--G 385
+ QI + ++ +H+ I HLD+KP+NI N K+ DFG A ++ G
Sbjct: 193 --MKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250
Query: 386 DARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL---- 438
++ E++N D+ D++S+G Y L+ G L ++ + N+ +
Sbjct: 251 TPEFLAPEVVNYDFVSF-PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED 309
Query: 439 PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENP 473
S + + + ++ + R SA E +++P
Sbjct: 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKHP 344
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 57/265 (21%), Positives = 111/265 (41%), Gaps = 29/265 (10%)
Query: 229 TDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALG 286
+ + I E +G G F V + ++ Y K + ++ E+ L
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK----EISILNIAR 59
Query: 287 SHENIVGYYSSWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIAQALQ 341
H NI+ + S+ E+L + E ++ E E++ +HQ+ +ALQ
Sbjct: 60 -HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQ 116
Query: 342 FIHEKGIAHLDVKPDNI-YV--KNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEILN 396
F+H I H D++P+NI Y ++ K+ +FG+A L Y E+
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 397 EDYDHLDK-VDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL----PLLPGHSLQF 448
+D + D++SLG +Y L+ G L+E+ Q N+ + + S++
Sbjct: 177 --HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 449 QNLLKVMVDPDPVQRPSAKELVENP 473
+ + ++ + R +A E +++P
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHP 259
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 62/263 (23%), Positives = 104/263 (39%), Gaps = 24/263 (9%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAE------RRKALLEVQALAALGS 287
E +G G S V + + + YAVK + R L EV L +
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 288 HENIVGYYSSWFENEQLYIQMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHE 345
H NI+ ++ N ++ +L L D +E E K + + + + +H+
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 346 KGIAHLDVKPDNI-YVKNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEILNEDYDHL 402
I H D+KP+NI + KL DFG + L+ + E G Y+ EI+ +
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 202
Query: 403 DK-----VDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL----PLLPGHSLQFQN 450
VD++S G MY L+ GSP + G P +S ++
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 262
Query: 451 LLKVMVDPDPVQRPSAKELVENP 473
L+ + P +R +A+E + +P
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHP 285
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 66/256 (25%), Positives = 120/256 (46%), Gaps = 21/256 (8%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSHENIVG 293
E++G G FS V + + + G +A K + ++L + +K E + L H NIV
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKL-QHPNIVR 69
Query: 294 YYSSWFENEQLYIQMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
+ S E Y+ +L L + A +F++E + + QI +++ + H GI H
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHR 129
Query: 352 DVKPDNIYV----KNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEILNED-YDHLDK 404
++KP+N+ + K KL DFG A +N S G Y+ E+L +D Y
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK--P 187
Query: 405 VDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL----PLLPGHSLQFQNLLKVMVD 457
VDI++ G +Y L+ G P E + + ++ G P + + ++L+ M+
Sbjct: 188 VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLT 247
Query: 458 PDPVQRPSAKELVENP 473
+P +R +A + ++ P
Sbjct: 248 VNPKKRITADQALKVP 263
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 63/275 (22%), Positives = 121/275 (44%), Gaps = 29/275 (10%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALAALGSH 288
DF +G G F +V+ ++ + A+K K QL + + E++ + L H
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RH 73
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHEK 346
NI+ Y+ + + +++Y+ +E L + + F E + ++A AL + HE+
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR--------YMPQEIL-N 396
+ H D+KP+N+ + G K+ DFG + R Y+P E++
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVH-------APSLRRRTMCGTLDYLPPEMIEG 186
Query: 397 EDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKLPLLPGHSLQFQNLLK 453
+ +D KVD++ G YE + G P S S + + + L P S ++L+
Sbjct: 187 KTHDE--KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLIS 244
Query: 454 VMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMKP 488
++ P QR K ++E+P + + + + P
Sbjct: 245 KLLRYHPPQRLPLKGVMEHPWV---KANSRRVLPP 276
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 52/272 (19%), Positives = 117/272 (43%), Gaps = 42/272 (15%)
Query: 229 TDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALG 286
D+++I E++G+G F V + +++ G + K + ++ E+ + L
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQL- 105
Query: 287 SHENIVGYYSSWFENEQLYIQMELC------------DHSLSDKKASQFFAEGEVLKALH 334
H ++ + ++ + ++ + +E D+ +S+ + + +
Sbjct: 106 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY---------MR 156
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYV---KNGVYKLGDFGRATLLNKSLPIEE--GDARY 389
Q + L+ +HE I HLD+KP+NI K K+ DFG AT LN ++ A +
Sbjct: 157 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 216
Query: 390 MPQEILNEDYDHLDK-VDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL----PLL 441
EI++ + + D++++G Y L+ G E + N++
Sbjct: 217 AAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 274
Query: 442 PGHSLQFQNLLKVMVDPDPVQRPSAKELVENP 473
S + ++ +K ++ +P +R + + +E+P
Sbjct: 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 68/265 (25%), Positives = 124/265 (46%), Gaps = 29/265 (10%)
Query: 229 TDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALG 286
+DF E+ ++G G S V++ ++ YA+K K E+ L L
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT-----EIGVLLRL- 105
Query: 287 SHENIVGYYSSWFENEQ-LYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFI 343
SH NI+ FE + + +EL L D+ +++E + A+ QI +A+ ++
Sbjct: 106 SHPNIIKLKE-IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYL 164
Query: 344 HEKGIAHLDVKPDNI-YV---KNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEILNE 397
HE GI H D+KP+N+ Y + K+ DFG + ++ + ++ G Y EIL
Sbjct: 165 HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG 224
Query: 398 D-YDHLDKVDIFSLGATMYELIKGSP--LSESGPQFL--NLRDGKL----PLLPGHSLQF 448
Y +VD++S+G Y L+ G E G QF+ + + + P SL
Sbjct: 225 CAYGP--EVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA 282
Query: 449 QNLLKVMVDPDPVQRPSAKELVENP 473
++L++ ++ DP +R + + +++P
Sbjct: 283 KDLVRKLIVLDPKKRLTTFQALQHP 307
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 66/270 (24%), Positives = 120/270 (44%), Gaps = 28/270 (10%)
Query: 225 SRYYTDFHEI----EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEV 279
S T+ + E +G+G FS VF V +R+ G +A+K K D+ E+
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EI 57
Query: 280 QALAALGSHENIVGYYSSWFENEQ-LYIQMELCDHS-LSDK-KASQFFAEGEVLKALHQI 336
L + HENIV +E+ Y+ M+L L D+ + E + + Q+
Sbjct: 58 AVLKKI-KHENIVTLED-IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV 115
Query: 337 AQALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLLNKSLPIEE-GDARYMP 391
A++++HE GI H D+KP+N+ +N + DFG + + + G Y+
Sbjct: 116 LSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVA 175
Query: 392 QEILNED-YDHLDKVDIFSLGATMYELIKGSP--LSESGPQFLNL-RDGKL----PLLPG 443
E+L + Y VD +S+G Y L+ G P E+ + ++G P
Sbjct: 176 PEVLAQKPYSK--AVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDD 233
Query: 444 HSLQFQNLLKVMVDPDPVQRPSAKELVENP 473
S ++ + +++ DP +R + ++ + +P
Sbjct: 234 ISESAKDFICHLLEKDPNERYTCEKALSHP 263
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 69/276 (25%), Positives = 126/276 (45%), Gaps = 25/276 (9%)
Query: 219 TGGDGLSRYYTDFHEI----EQIGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERR 273
G + + T F + E++G G FS V + + + G +A K + ++L + +
Sbjct: 15 RGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQ 73
Query: 274 KALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHS-LSDK-KASQFFAEGEVLK 331
K E + L H NIV + S E Y+ +L L + A +F++E +
Sbjct: 74 KLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 132
Query: 332 ALHQIAQALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLLNKSLPIEE--G 385
+ QI +++ + H GI H ++KP+N+ + K KL DFG A +N S G
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192
Query: 386 DARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL--- 438
Y+ E+L +D Y VDI++ G +Y L+ G P E + + ++ G
Sbjct: 193 TPGYLSPEVLKKDPYSK--PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 250
Query: 439 -PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENP 473
P + + ++L+ M+ +P +R +A + ++ P
Sbjct: 251 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 65/289 (22%), Positives = 121/289 (41%), Gaps = 52/289 (17%)
Query: 224 LSRYYTDFHEI----EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALL- 277
+S Y + + +G+G V +R A+K SKR+ + R
Sbjct: 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 278 ----EVQALAALGSHENIVGYYSSWFENEQLYIQMELCD-----------HSLSDKKASQ 322
E++ L L +H I+ + +F+ E YI +EL + L +
Sbjct: 61 NVETEIEILKKL-NHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 323 FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLLNK 378
+F +Q+ A+Q++HE GI H D+KP+N+ + ++ + K+ DFG + +L +
Sbjct: 119 YF---------YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 379 SLPIEE--GDARYMPQEILNED----YDHLDKVDIFSLGATMYELIKGSP--LSESGPQ- 429
+ + G Y+ E+L Y+ VD +SLG ++ + G P
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNR--AVDCWSLGVILFICLSGYPPFSEHRTQVS 227
Query: 430 -FLNLRDGKLPLLPGH----SLQFQNLLKVMVDPDPVQRPSAKELVENP 473
+ GK +P S + +L+K ++ DP R + +E + +P
Sbjct: 228 LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 276
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-27
Identities = 56/277 (20%), Positives = 112/277 (40%), Gaps = 36/277 (12%)
Query: 230 DFHEI---EQIGAGNFSHVFKVLKRIDGCFY---AVKHSKRQLHHDAERRKALLEVQALA 283
+I ++IG+G+F V+K G ++ AVK + + EV L
Sbjct: 22 PDGQITVGQRIGSGSFGTVYK------GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 75
Query: 284 ALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQAL 340
H NI+ + QL I + C+ SL + F +++ Q A+ +
Sbjct: 76 KT-RHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 341 QFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATL-----LNKSLPIEEGDARYMPQEI 394
++H K I H D+K +NI++ ++ K+GDFG AT + G +M E+
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 395 L-NEDYDHLD-KVDIFSLGATMYELIKG-------SPLSE--SGPQFLNLRDGKLPLLPG 443
+ +D + + D+++ G +YEL+ G + + +L +
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253
Query: 444 HSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
+ + L+ + +RPS ++ +++ +
Sbjct: 254 CPKRMKRLMAECLKKKRDERPSFPRILA--EIEELAR 288
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 63/264 (23%), Positives = 106/264 (40%), Gaps = 28/264 (10%)
Query: 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGS 287
+ D + E+IGAG+F V + G AVK Q H + L EV + L
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRL-R 92
Query: 288 HENIVGYYSSWFENEQLYIQMELCDHS-----LSDKKASQFFAEGEVLKALHQIAQALQF 342
H NIV + + + L I E L A + E L + +A+ + +
Sbjct: 93 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 343 IHEKG--IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDA---RYMPQEIL- 395
+H + I H ++K N+ V K K+ DFG + L + + A +M E+L
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 396 NEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQ-------FLNLRDGKLPLLPGHSLQ 447
+E + K D++S G ++EL P P F R L + + Q
Sbjct: 213 DEPSNE--KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR---LEIPRNLNPQ 267
Query: 448 FQNLLKVMVDPDPVQRPSAKELVE 471
+++ +P +RPS +++
Sbjct: 268 VAAIIEGCWTNEPWKRPSFATIMD 291
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 69/328 (21%), Positives = 122/328 (37%), Gaps = 29/328 (8%)
Query: 173 QSAVALRCRVMPPPCIKNPYQKDASEMDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDFH 232
Q +R P N + D G + + P D +F+
Sbjct: 36 QRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDW--AAAKEFY 93
Query: 233 EI----EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLH-----HDAERRKALLEVQAL 282
+ + IG G S V + + R G +AVK + R E L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 283 AALGSHENIVGYYSSWFENEQLYIQMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQAL 340
+ H +I+ S+ + +++ +L L D +E E + + +A+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 341 QFIHEKGIAHLDVKPDNI-YVKNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEILNE 397
F+H I H D+KP+NI N +L DFG + L + E G Y+ EIL
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKC 273
Query: 398 DYDHLDK-----VDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL----PLLPGHS 445
D VD+++ G ++ L+ GSP + +G+ P S
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 333
Query: 446 LQFQNLLKVMVDPDPVQRPSAKELVENP 473
++L+ ++ DP R +A++ +++P
Sbjct: 334 STVKDLISRLLQVDPEARLTAEQALQHP 361
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 56/266 (21%), Positives = 114/266 (42%), Gaps = 28/266 (10%)
Query: 228 YTDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAAL 285
D ++I E++G G F V +V +R G +A K +++ E+Q ++ L
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVL 211
Query: 286 GSHENIVGYYSSWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIAQAL 340
H +V + ++ ++ ++ + E ++D+ +E E ++ + Q+ + L
Sbjct: 212 -RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGL 268
Query: 341 QFIHEKGIAHLDVKPDNIYVKN---GVYKLGDFGRATLLNKSLPIEE--GDARYMPQEIL 395
+HE HLD+KP+NI KL DFG L+ ++ G A + E+
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 396 NEDYDHLDK-VDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL----PLLPGHSLQ 447
+ D++S+G Y L+ G E+ + N++ G S
Sbjct: 329 E--GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386
Query: 448 FQNLLKVMVDPDPVQRPSAKELVENP 473
++ ++ ++ DP R + + +E+P
Sbjct: 387 GKDFIRKLLLADPNTRMTIHQALEHP 412
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 69/313 (22%), Positives = 109/313 (34%), Gaps = 71/313 (22%)
Query: 225 SRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRK-----ALLEV 279
S + + + +IG G + V+K G F A+K ++ + + EV
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK--SVRVPNGGGGGGGLPISTVREV 62
Query: 280 QALAAL--GSHENIVG-----YYSSWFENEQLYIQMELCDHSLS---DKKASQFFAEGEV 329
L L H N+V S ++ + E D L DK +
Sbjct: 63 ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI 122
Query: 330 LKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFG--RATLLNKSLPIEEGD 386
+ Q + L F+H I H D+KP+NI V G KL DFG R S +
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI----YSYQM---- 174
Query: 387 ARYMPQ---------EIL-NEDYDHLDKVDIFSLGATMYELIKGSPL----SESG----- 427
P E+L Y VD++S+G E+ + PL SE+
Sbjct: 175 -ALTPVVVTLWYRAPEVLLQSTYAT--PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231
Query: 428 ------------PQFLNLRDGKLPLLPGHSLQFQ---------NLLKVMVDPDPVQRPSA 466
P+ ++L G P +Q LL M+ +P +R SA
Sbjct: 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA 291
Query: 467 KELVENPIFDKIQ 479
+++ K +
Sbjct: 292 FRALQHSYLHKDE 304
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 63/289 (21%), Positives = 109/289 (37%), Gaps = 57/289 (19%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
+E +G G + V++ G AVK + R E+ L HENI+G
Sbjct: 13 LECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRET---ELYNTVML-RHENILG 66
Query: 294 YY----SSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIHEK-- 346
+ +S + QL++ + SL D L+ + IA L +H +
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 347 ------GIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE-------GDARYMPQ 392
IAH D+K NI VK NG + D G A + ++S + G RYM
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 393 EILN-----EDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF----------------- 430
E+L+ + +D +VDI++ G ++E+ + + +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 431 --LNLRDGKLPLLPGHSLQFQ---NLLKVMV---DPDPVQRPSAKELVE 471
+ D + P +P +L K+M +P R +A + +
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 61/312 (19%), Positives = 110/312 (35%), Gaps = 62/312 (19%)
Query: 229 TDFHEI---EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAAL 285
T I E IG G F V++ + G AVK + R E+ L
Sbjct: 39 TIARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREA---EIYQTVML 93
Query: 286 GSHENIVGYYSSWFENE----QLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQAL 340
HENI+G+ ++ ++ QL++ + +H SL D ++K A L
Sbjct: 94 -RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 152
Query: 341 QFIHEK--------GIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE------- 384
+H + IAH D+K NI VK NG + D G A + + +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 385 GDARYMPQEILNE-----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN------- 432
G RYM E+L++ ++ + DI+++G +E+ + + +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272
Query: 433 ------------LRDGKLPLLPGHSLQ---FQNLLKVMV---DPDPVQRPSAKELVENPI 474
P +P + + K+M + R +A + +
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK--T 330
Query: 475 FDKIQKHRKTYM 486
++ + M
Sbjct: 331 LSQLSQQEGIKM 342
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 66/268 (24%), Positives = 123/268 (45%), Gaps = 28/268 (10%)
Query: 229 TDFHEI----EQIGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALA 283
T F E E++G G FS V + +K + G YA + ++L + +K E +
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR-DHQKLEREARICR 65
Query: 284 ALGSHENIVGYYSSWFENEQ-LYIQMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQAL 340
L H NIV + E Y+ +L L + A ++++E + + QI +A+
Sbjct: 66 LL-KHPNIVRLHD-SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV 123
Query: 341 QFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLL---NKSLPIEEGDARYMPQE 393
H+ G+ H ++KP+N+ + K KL DFG A + ++ G Y+ E
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183
Query: 394 ILNED-YDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKL----PLLPGHS 445
+L +D Y VD+++ G +Y L+ G P E + + ++ G P +
Sbjct: 184 VLRKDPYGK--PVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 241
Query: 446 LQFQNLLKVMVDPDPVQRPSAKELVENP 473
+ ++L+ M+ +P +R +A E +++P
Sbjct: 242 PEAKDLINKMLTINPSKRITAAEALKHP 269
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 57/220 (25%), Positives = 85/220 (38%), Gaps = 34/220 (15%)
Query: 221 GDGLSRYYTDFHEI-EQIGAGNFSHVFK----VLKRIDGCFYAVKHSKRQLHHDAE-RRK 274
G Y + +G G V++ V +RI A+K L D R +
Sbjct: 30 GTQFGPY-----RLRRLVGRGGMGDVYEAEDTVRERIV----ALKLMSETLSSDPVFRTR 80
Query: 275 ALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCD-HSLSDKKASQF-FAEGEVLKA 332
E + L ++V + + QLY+ M L + L+ Q A +
Sbjct: 81 MQREARTAGRL-QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAI 139
Query: 333 LHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFG--RA------TLLNKSLPIE 383
+ QI AL H G H DVKP+NI V + L DFG A T L ++
Sbjct: 140 VRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV--- 196
Query: 384 EGDARYM-PQEILNEDYDHLDKVDIFSLGATMYELIKGSP 422
G YM P+ + + DI++L +YE + GSP
Sbjct: 197 -GTLYYMAPERFSESHATY--RADIYALTCVLYECLTGSP 233
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 69/323 (21%), Positives = 114/323 (35%), Gaps = 69/323 (21%)
Query: 222 DGLSRYYTDFHEIEQIGAGNFSHVFKVL-KRIDGCFYAVKHSKRQLHHDAER--RKALLE 278
DGL R + + +IG G + VFK + G F A+K + ++ E + E
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALK--RVRVQTGEEGMPLSTIRE 61
Query: 279 VQALAAL--GSHENIVG-----YYSSWFENEQLYIQMELCDHSLS---DKKASQFFAEGE 328
V L L H N+V S +L + E D L+ DK
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121
Query: 329 VLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFG--RATLLNKSLPIEEG 385
+ + Q+ + L F+H + H D+KP NI V +G KL DFG R S +
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI----YSFQM--- 174
Query: 386 DARYMPQ---------EIL-NEDYDHLDKVDIFSLGATMYELIKGSPL----SESG---- 427
E+L Y VD++S+G E+ + PL S+
Sbjct: 175 --ALTSVVVTLWYRAPEVLLQSSYAT--PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 230
Query: 428 -------------PQFLNLRDGKLPLLPGHSLQFQ---------NLLKVMVDPDPVQRPS 465
P+ + L ++ +LL + +P +R S
Sbjct: 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290
Query: 466 AKELVENPIFDKIQKHRKTYMKP 488
A + +P F +++ ++
Sbjct: 291 AYSALSHPYFQDLERCKENLDSH 313
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 60/263 (22%), Positives = 108/263 (41%), Gaps = 35/263 (13%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE-RRKALLEVQALAALGSHENIV 292
++++G G S V+ I A+K E ++ EV + L SH+NIV
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIV 74
Query: 293 GYYSSWFENEQLYIQMELCD-HSLSDKKASQF-FAEGEVLKALHQIAQALQFIHEKGIAH 350
E++ Y+ ME + +LS+ S + + +QI ++ H+ I H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVH 134
Query: 351 LDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE-----GDARYM-PQEILNEDYDHLD 403
D+KP NI + N K+ DFG A L+++ + + G +Y P++ E D
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEATDE-- 191
Query: 404 KVDIFSLGATMYELIKGSP--------------LSESGPQFLNLRDGKLPLLPGHSLQFQ 449
DI+S+G +YE++ G P + +S P +P
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP------QSLS 245
Query: 450 NLLKVMVDPDPVQRP-SAKELVE 471
N++ + D R + +E+ +
Sbjct: 246 NVILRATEKDKANRYKTIQEMKD 268
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 77/301 (25%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+ +I +IG G++ VFK R G A+K ++ AL E++ L L H
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHP 62
Query: 290 NIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKG 347
N+V + +L++ E CDH++ + + E V Q QA+ F H+
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPI--EEGDAR-YMPQEIL--NEDYDH 401
H DVKP+NI + K+ V KL DFG A LL +E R Y E+L + Y
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG- 181
Query: 402 LDKVDIFSLGATMYELIKGSPL---------------------SESGPQFLNLRD---GK 437
VD++++G EL+ G PL F + K
Sbjct: 182 -PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 438 LP----------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMK 487
+P P S LLK + DP +R + ++L+ +P F+ I++ +
Sbjct: 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKE 300
Query: 488 P 488
Sbjct: 301 H 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 62/293 (21%), Positives = 104/293 (35%), Gaps = 57/293 (19%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+E G F V+K ++ + AVK Q + EV +L + HE
Sbjct: 25 PLQLLEVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQSWQNEY---EVYSLPGM-KHE 78
Query: 290 NIVGYY----SSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIH 344
NI+ + + L++ + SLSD + + E+ +A+ L ++H
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH 138
Query: 345 EK----------GIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE-----GDAR 388
E I+H D+K N+ +K N + DFG A + G R
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 389 YMPQEIL----NEDYDHLDKVDIFSLGATMYELIKG------------SPLSESGPQFLN 432
YM E+L N D ++D++++G ++EL P E Q +
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258
Query: 433 L--------RDGKLPLLPGHSL------QFQNLLKVMVDPDPVQRPSAKELVE 471
L K P+L + ++ D D R SA + E
Sbjct: 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 62/270 (22%), Positives = 107/270 (39%), Gaps = 36/270 (13%)
Query: 230 DFHEI---EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKA--LLEVQALAA 284
DF E+ E IG G F V++ G AVK ++ D + E + A
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 285 LGSHENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFI 343
L H NI+ + L + ME L+ + + ++ QIA+ + ++
Sbjct: 63 L-KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYL 121
Query: 344 HEKG---IAHLDVKPDNIYV---------KNGVYKLGDFGRATLLNKSLPI-EEGDARYM 390
H++ I H D+K NI + N + K+ DFG A +++ + G +M
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWM 181
Query: 391 PQEIL-NEDYDHLDKVDIFSLGATMYELIKGS-PLSE-SGPQ------FLNLRDGKLPLL 441
E++ + D++S G ++EL+ G P G L LP+
Sbjct: 182 APEVIRASMFSK--GSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA---LPIP 236
Query: 442 PGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471
F L++ +PDP RPS +++
Sbjct: 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILD 266
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 62/297 (20%), Positives = 99/297 (33%), Gaps = 60/297 (20%)
Query: 229 TDFHEI---EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAAL 285
T +I +QIG G + V+ + G AVK R E+ +
Sbjct: 34 TIAKQIQMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEASWFRET---EIYQTVLM 88
Query: 286 GSHENIVGYY----SSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQAL 340
HENI+G+ QLY+ + ++ SL D S +LK + L
Sbjct: 89 -RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGL 147
Query: 341 QFIHEK--------GIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE------- 384
+H + IAH D+K NI VK NG + D G A +
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 385 GDARYMPQEILNEDYDHLD-----KVDIFSLGATMYELIKGSPLSESGPQF--------- 430
G RYMP E+L+E + D++S G ++E+ + ++
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 431 ----------LNLRDGKLPLLPGHSL------QFQNLLKVMVDPDPVQRPSAKELVE 471
+ P P Q L+ +P R +A + +
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 73/289 (25%), Positives = 114/289 (39%), Gaps = 45/289 (15%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE--RRKALLEVQALAALGS 287
+ + +G G++ V K + G A+K K D + ++ A+ E++ L L
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIK--KFLESDDDKMVKKIAMREIKLLKQL-R 82
Query: 288 HENIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHE 345
HEN+V + ++ Y+ E DH++ D + V K L QI + F H
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPI--EEGDAR-YMPQEILNEDYDH 401
I H D+KP+NI V ++GV KL DFG A L + +E R Y E+L D +
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 402 LDKVDIFSLGATMYELIKGSPL---------------------SESGPQFLNLRDGK--- 437
VD++++G + E+ G PL F
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 438 LP----------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFD 476
LP P S +L K + DP +RP EL+ + F
Sbjct: 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 62/255 (24%), Positives = 107/255 (41%), Gaps = 26/255 (10%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKAL---LEVQALAAL---GSHE 289
+G G F VF + D A+K + ++ + ++ LEV L + G H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 290 NIVGYYSSWFENEQ-LYIQMELCDHS--LSDK-KASQFFAEGEVLKALHQIAQALQFIHE 345
++ WFE ++ + +E + L D EG Q+ A+Q H
Sbjct: 99 GVIRLLD-WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157
Query: 346 KGIAHLDVKPDNIYV--KNGVYKLGDFGRATLLNKS-LPIEEGDARYMPQEILNEDYDHL 402
+G+ H D+K +NI + + G KL DFG LL+ +G Y P E ++ H
Sbjct: 158 RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHA 217
Query: 403 DKVDIFSLGATMYELIKGS-PLSESGPQFLNLR---DGKLPLLPGHSLQFQNLLKVMVDP 458
++SLG +Y+++ G P F + + +L S L++ + P
Sbjct: 218 LPATVWSLGILLYDMVCGDIP-------FERDQEILEAELHFPAHVSPDCCALIRRCLAP 270
Query: 459 DPVQRPSAKELVENP 473
P RPS +E++ +P
Sbjct: 271 KPSSRPSLEEILLDP 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 44/280 (15%), Positives = 101/280 (36%), Gaps = 33/280 (11%)
Query: 224 LSRY----YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEV 279
++++ + + + ++ + ++K R G VK K + + R E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 280 QALAALGSHENIVGYY--SSWFENEQLYIQMELCDH-SLSD---KKASQFFAEGEVLKAL 333
L SH N++ + + SL + + + + + +K
Sbjct: 59 PRLRIF-SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 334 HQIAQALQFIHEKG--IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM 390
+A+ + F+H I + ++ + ++ ++ + ++
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM--YAPAWV 175
Query: 391 PQEIL-NEDYDHLD-KVDIFSLGATMYELIKGS-PLSE-SGPQ------FLNLRDGKLPL 440
E L + D D++S ++EL+ P ++ S + LR +
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR---PTI 232
Query: 441 LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
PG S L+K+ ++ DP +RP +V PI +K+Q
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIV--PILEKMQD 270
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 64/301 (21%), Positives = 111/301 (36%), Gaps = 55/301 (18%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALL----------- 277
D+ I + G F+ + L D FYA+K K L + K+
Sbjct: 32 DYRIIRTLNQGKFNKII--LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 278 ---EVQALAALGSHENIVGYYSSWFENEQLYIQME----------LCDHSLSDKKASQFF 324
E+Q + + +E + +++YI E + DK + F
Sbjct: 90 FKNELQIITDI-KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 325 AEGEVLKALHQIAQALQFIH-EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL-NKSLP 381
+ + + + +IH EK I H DVKP NI + KNG KL DFG + + +K +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 382 IEEGDARYMPQEIL-NEDYDHLDKVDIFSLGATMYELIKGS------------------- 421
G +MP E NE + KVDI+SLG +Y +
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268
Query: 422 ----PLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
PL + + S + + LK+ + +P +R ++++ +++
Sbjct: 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328
Query: 478 I 478
Sbjct: 329 T 329
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 32/250 (12%), Positives = 64/250 (25%), Gaps = 48/250 (19%)
Query: 234 IEQIGAGNFSHVFK----VLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSH 288
+ G ++ L R A+ Q + + L L+ +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQ----VALTFVDPQGVLPDDVLQETLSRTLRLSRI-DK 90
Query: 289 ENIVGYYSSWFENEQLYIQMELCD-HSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKG 347
+ + E SL + + ++A+ +A A H G
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV-GAIRAMQSLAAAADAAHRAG 149
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVD 406
+A P + V +G L + + + + D
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA---------TMPDANPQ----------------DD 184
Query: 407 IFSLGATMYELIKGSP--LSESGPQFLNLR----DGKLP----LLPGHSLQFQNLLKVMV 456
I +GA++Y L+ L G+ + Q + V
Sbjct: 185 IRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSV 244
Query: 457 DPDPVQRPSA 466
D R ++
Sbjct: 245 QGDGGIRSAS 254
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 54/306 (17%), Positives = 102/306 (33%), Gaps = 68/306 (22%)
Query: 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGS 287
+ +E IG G + V+K +D AVK + K + + +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQNFINEK---NIYRVPLM-E 65
Query: 288 HENIVGYY-----SSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQ 341
H+NI + + + + ME + SL + + H + + L
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLA 125
Query: 342 FIHE---------KGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEEGDA---- 387
++H I+H D+ N+ VK +G + DFG + L + + G+
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 388 -------RYMPQEILNEDYD------HLDKVDIFSLGATMYELIKGSPLSESG------- 427
RYM E+L + L +VD+++LG +E+ G
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245
Query: 428 ----------PQFLNLRD-----GKLPLLPGHSLQFQNLLKVM-------VDPDPVQRPS 465
P F +++ + P P + ++ + D D R +
Sbjct: 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305
Query: 466 AKELVE 471
A+ E
Sbjct: 306 AQXAEE 311
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 58/253 (22%), Positives = 102/253 (40%), Gaps = 18/253 (7%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKAL---LEVQALAALGS-H 288
+G+G F V+ ++ D A+KH K ++ E +EV L + S
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 289 ENIVGYYSSWFENEQ-LYIQMELCDHS--LSDK-KASQFFAEGEVLKALHQIAQALQFIH 344
++ WFE + +E + L D E Q+ +A++ H
Sbjct: 108 SGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 345 EKGIAHLDVKPDNIYV--KNGVYKLGDFGRATLLNKS-LPIEEGDARYMPQEILNEDYDH 401
G+ H D+K +NI + G KL DFG LL + +G Y P E + H
Sbjct: 167 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 226
Query: 402 LDKVDIFSLGATMYELIKGS-PLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDP 460
++SLG +Y+++ G P + G++ S + Q+L++ + P
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPFEHD----EEIIRGQVFFRQRVSSECQHLIRWCLALRP 282
Query: 461 VQRPSAKELVENP 473
RP+ +E+ +P
Sbjct: 283 SDRPTFEEIQNHP 295
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 62/209 (29%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE-----RRKALLEVQALAALGSH 288
E +G G S V D AVK + L D RR E Q AAL +H
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRR----EAQNAAAL-NH 71
Query: 289 ENIVGYYSSWFENEQL----YIQMELCD-HSLSDKKASQF-FAEGEVLKALHQIAQALQF 342
IV Y + YI ME D +L D ++ ++ + QAL F
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFG--RATLLNKSLPIEE-----GDARYM-PQE 393
H+ GI H DVKP NI + K+ DFG RA + + + + G A+Y+ P++
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARA-IADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 394 ILNEDYDHLDKVDIFSLGATMYELIKGSP 422
+ D + D++SLG +YE++ G P
Sbjct: 191 ARGDSVDA--RSDVYSLGCVLYEVLTGEP 217
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 73/300 (24%), Positives = 118/300 (39%), Gaps = 64/300 (21%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAER--RKALLEVQALAALGS 287
+ I ++G G + V+K + + A+K + +L H+ E A+ EV L L
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIK--RIRLEHEEEGVPGTAIREVSLLKEL-Q 91
Query: 288 HENIVGYYSSWFENEQLYIQMELCDHSLSDKK---ASQFFAEGEVLKALHQIAQALQFIH 344
H NI+ S N +L++ E ++ L KK + + + L+Q+ + F H
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAENDL--KKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 345 EKGIAHLDVKPDNI------YVKNGVYKLGDFG--RATLLNKSLPIEEGDAR-----YMP 391
+ H D+KP N+ + V K+GDFG RA +PI + Y P
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA----FGIPIRQFTHEIITLWYRP 205
Query: 392 QEIL--NEDYDHLDKVDIFSLGATMYELIKGSPL---------------------SESGP 428
EIL + Y VDI+S+ E++ +PL + P
Sbjct: 206 PEILLGSRHYST--SVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263
Query: 429 QFLNLRDGKLPLLPGHSLQFQNLLKVMVDP------------DPVQRPSAKELVENPIFD 476
L D K + +L ++D DPV+R SAK +E+P F
Sbjct: 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 9e-23
Identities = 76/294 (25%), Positives = 122/294 (41%), Gaps = 56/294 (19%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAER--RKALLEVQALAALGS 287
+ ++E+IG G + VFK R A+K + +L D E AL E+ L L
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK--RVRLDDDDEGVPSSALREICLLKEL-K 59
Query: 288 HENIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHE 345
H+NIV + +++L + E CD L + V L Q+ + L F H
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFG--RATLLNKSLPIEEGDAR-----YMPQEIL-- 395
+ + H D+KP N+ + +NG KL +FG RA +P+ A Y P ++L
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARA----FGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 396 NEDYDHLDKVDIFSLGATMYELIK----------------------GSPLSESGPQFLNL 433
+ Y +D++S G EL G+P E P L
Sbjct: 176 AKLYST--SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 434 RD--------GKLPL---LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFD 476
D L +P + ++LL+ ++ +PVQR SA+E +++P F
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 1e-22
Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 56/293 (19%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAER--RKALLEVQALAALGS 287
+H +E+IG G + V+K G +A+K K +L + E + E+ L L
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNY-GETFALK--KIRLEKEDEGIPSTTIREISILKEL-K 58
Query: 288 HENIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHE 345
H NIV Y ++L + E D L L Q+ + + H+
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFG--RATLLNKSLPIEEGDAR-----YMPQEIL-- 395
+ + H D+KP N+ + + G K+ DFG RA +P+ + Y ++L
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARA----FGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 396 NEDYDHLDKVDIFSLGATMYELIKGSPL---------------------SESGPQFLNLR 434
++ Y +DI+S+G E++ G+PL S++ P L
Sbjct: 175 SKKYST--TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 435 DGK--LPLLPGHSLQFQ---------NLLKVMVDPDPVQRPSAKELVENPIFD 476
+ + +LL M+ DP QR +AK+ +E+ F
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 65/299 (21%), Positives = 111/299 (37%), Gaps = 57/299 (19%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAER--RKALLEVQALAALGS 287
+ ++E++G G + V+K G A+K + +L + E A+ E+ L L
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALK--RIRLDAEDEGIPSTAIREISLLKEL-H 77
Query: 288 HENIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHE 345
H NIV L + E + L + + ++ L+Q+ + + H+
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFG--RATLLNKSLPIEEGDAR-----YMPQEIL-- 395
I H D+KP N+ + +G KL DFG RA +P+ Y ++L
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARA----FGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 396 NEDYDHLDKVDIFSLGATMYELIKGSPL---------------------SESGPQFLNLR 434
++ Y VDI+S+G E+I G PL PQ L
Sbjct: 194 SKKYST--SVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251
Query: 435 D---GKLPLLPGHSLQFQ---------NLLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481
+ +LL M+ DP +R SA++ + +P F +
Sbjct: 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ 310
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 59/295 (20%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAER---RKALLEVQALAALG 286
+ +++++G G ++ V+K ++ A+K ++ + E A+ EV L L
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDL- 57
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIH 344
H NIV + + L + E D L V L Q+ + L + H
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFG--RATLLNKSLPIEEGDAR-----YMPQEIL- 395
+ + H D+KP N+ + + G KL DFG RA KS+P + D Y P +IL
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARA----KSIPTKTYDNEVVTLWYRPPDILL 173
Query: 396 -NEDYDHLDKVDIFSLGATMYELIKGSPL---------------------SESGPQFLNL 433
+ DY ++D++ +G YE+ G PL E+ P L+
Sbjct: 174 GSTDYS--TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231
Query: 434 RD---GKLPLLPGHSLQFQ---------NLLKVMVDPDPVQRPSAKELVENPIFD 476
+ P +L +LL ++ + R SA++ +++P F
Sbjct: 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 64/295 (21%), Positives = 116/295 (39%), Gaps = 57/295 (19%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRK-----ALLEVQALAA 284
+ +++ +G G F+ V+K + A+K K +L H +E + AL E++ L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIK--KIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 285 LGSHENIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQF 342
L SH NI+G ++ + + + + L K S + + Q L++
Sbjct: 69 L-SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFG--RATLLNKSLPIEEGDAR-----YMPQEI 394
+H+ I H D+KP+N+ + +NGV KL DFG ++ P + Y E+
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS----FGSPNRAYTHQVVTRWYRAPEL 183
Query: 395 L--NEDYDHLDKVDIFSLGATMYELIKGSPL---------------------SESGPQFL 431
L Y VD++++G + EL+ P E P
Sbjct: 184 LFGARMYGV--GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241
Query: 432 NLRDGK-LPLLPGHSLQFQ---------NLLKVMVDPDPVQRPSAKELVENPIFD 476
+L D PG L +L++ + +P R +A + ++ F
Sbjct: 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 22/260 (8%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAE-RRKALLEVQALAALGSHENIVGY 294
+G G++ V +VL C AVK K++L E+Q L L H+N++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQL 71
Query: 295 YSSWF--ENEQLYIQMELC---DHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIA 349
+ E +++Y+ ME C + D + F + Q+ L+++H +GI
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 350 HLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE-----GDARYMPQEILN--EDYDH 401
H D+KP N+ + G K+ G A L+ + G + P EI N + +
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSG 191
Query: 402 LDKVDIFSLGATMYELIKGS-PLSESGPQ--FLNLRDGKLPLLPGH-SLQFQNLLKVMVD 457
KVDI+S G T+Y + G P F N+ G +PG +LLK M++
Sbjct: 192 F-KVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA-IPGDCGPPLSDLLKGMLE 249
Query: 458 PDPVQRPSAKELVENPIFDK 477
+P +R S +++ ++ F K
Sbjct: 250 YEPAKRFSIRQIRQHSWFRK 269
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-22
Identities = 60/267 (22%), Positives = 107/267 (40%), Gaps = 46/267 (17%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALL-----EVQALAALGS 287
+ +G+G F V+ + + VK K ++ D L E+ L+ +
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-E 87
Query: 288 HENIVGYYSSWFENEQ-LYIQMELC-------DH-----SLSDKKASQFFAEGEVLKALH 334
H NI+ FEN+ + ME L + AS F
Sbjct: 88 HANIIKVLD-IFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF---------R 137
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE--GDARYM- 390
Q+ A+ ++ K I H D+K +NI + ++ KL DFG A L + G Y
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCA 197
Query: 391 PQEILNEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQFLNLR---DGKLPLLPGHSL 446
P+ ++ Y +++++SLG T+Y L+ P F L + + S
Sbjct: 198 PEVLMGNPYRGP-ELEMWSLGVTLYTLVFEENP-------FCELEETVEAAIHPPYLVSK 249
Query: 447 QFQNLLKVMVDPDPVQRPSAKELVENP 473
+ +L+ ++ P P +R + ++LV +P
Sbjct: 250 ELMSLVSGLLQPVPERRTTLEKLVTDP 276
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 6e-22
Identities = 74/316 (23%), Positives = 119/316 (37%), Gaps = 68/316 (21%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAER---RKALLEVQALAALG 286
F ++E++G G ++ V+K L + G + A+K ++ D+E A+ E+ + L
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALK----EVKLDSEEGTPSTAIREISLMKEL- 60
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDHSL-------SDKKASQFFAEGEVLKALHQIAQA 339
HENIV Y +L + E D+ L + + V Q+ Q
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 340 LQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFG--RATLLNKSLPIEEGDAR-----YMP 391
L F HE I H D+KP N+ + K G KLGDFG RA +P+ + Y
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA----FGIPVNTFSSEVVTLWYRA 176
Query: 392 QEIL--NEDYDHLDKVDIFSLGATMYELIKGSPL---------------------SESGP 428
++L + Y +DI+S G + E+I G PL P
Sbjct: 177 PDVLMGSRTYS--TSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234
Query: 429 QFLNLRDGK--LPLLPGHSLQFQ--------------NLLKVMVDPDPVQRPSAKELVEN 472
L + P L+ + L ++ +P R SAK+ + +
Sbjct: 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294
Query: 473 PIFDKIQKHRKTYMKP 488
P F + H
Sbjct: 295 PWFAEYYHHASMGGSR 310
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 65/250 (26%), Positives = 113/250 (45%), Gaps = 11/250 (4%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYS 296
IG GNF+ V + G A+K + + +K EV+ + L +H NIV +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFE 81
Query: 297 SWFENEQLYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVK 354
+ LY+ ME + D A E E QI A+Q+ H+K I H D+K
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 141
Query: 355 PDNIYV-KNGVYKLGDFGRATLLNKSLPIEE--GDARYM-PQEILNEDYDHLDKVDIFSL 410
+N+ + + K+ DFG + ++ G Y P+ + YD +VD++SL
Sbjct: 142 AENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP-EVDVWSL 200
Query: 411 GATMYELIKGS-PLSESGPQFL--NLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAK 467
G +Y L+ GS P + L + GK + S +NLLK + +P++R + +
Sbjct: 201 GVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLE 260
Query: 468 ELVENPIFDK 477
+++++ +
Sbjct: 261 QIMKDRWINA 270
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 68/310 (21%), Positives = 114/310 (36%), Gaps = 68/310 (21%)
Query: 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE--RRKALLEVQALA 283
+ + ++ +IG G F VFK R G A+K K + ++ E AL E++ L
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQ 71
Query: 284 ALGSHENIVG--------YYSSWFENEQLYIQMELCDH---SLSDKKASQFFAEGEVLKA 332
L HEN+V +Y+ + C+H L +F E+ +
Sbjct: 72 LL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRV 129
Query: 333 LHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMP 391
+ + L +IH I H D+K N+ + ++GV KL DFG A SL RY
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF--SLAKNSQPNRYTN 187
Query: 392 Q---------EIL--NEDYDHLDKVDIFSLGATMYELIKGSPL----SESG--------- 427
+ E+L DY +D++ G M E+ SP+ +E
Sbjct: 188 RVVTLWYRPPELLLGERDYG--PPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245
Query: 428 --------PQFLNLRD---GKLPLLPGHSL--QFQN---------LLKVMVDPDPVQRPS 465
P N +L + + + L+ ++ DP QR
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305
Query: 466 AKELVENPIF 475
+ + + + F
Sbjct: 306 SDDALNHDFF 315
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 56/287 (19%), Positives = 110/287 (38%), Gaps = 49/287 (17%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALAALGS----- 287
++IG G++ V D +YA+K SK++L A + A G
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 288 -----------------HENIVGYYSSWF--ENEQLYIQMELCDH-SLSDKKASQFFAEG 327
H N+V + LY+ EL + + + + +E
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 328 EVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGD 386
+ + + ++++H + I H D+KP N+ V ++G K+ DFG + + D
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF------KGSD 191
Query: 387 AR---------YMPQEILNEDYDHLD--KVDIFSLGATMYELIKGS-PLSESGPQ--FLN 432
A +M E L+E +D++++G T+Y + G P +
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK 251
Query: 433 LRDG--KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
++ + P P + ++L+ M+D +P R E+ +P +
Sbjct: 252 IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 63/263 (23%), Positives = 113/263 (42%), Gaps = 17/263 (6%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
+G G F V ++ G AVK +++++ K E+Q L H +I+ Y
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLY 77
Query: 296 SSWFENEQLYIQMELCDHS-LSDKKAS-QFFAEGEVLKALHQIAQALQFIHEKGIAHLDV 353
++ ME L D E E + QI A+ + H + H D+
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDL 137
Query: 354 KPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE--GDARYM-PQEILNEDYDHLDKVDIFS 409
KP+N+ + + K+ DFG + +++ + G Y P+ I Y +VDI+S
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP-EVDIWS 196
Query: 410 LGATMYELIKGS-PLSESGPQ--FLNLRDGKLPLLPGH-SLQFQNLLKVMVDPDPVQRPS 465
G +Y L+ G+ P + F +R G +P + + LL M+ DP++R +
Sbjct: 197 CGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY-IPEYLNRSVATLLMHMLQVDPLKRAT 255
Query: 466 AKELVENPIFDKIQKHRKTYMKP 488
K++ E+ F ++ +Y+ P
Sbjct: 256 IKDIREHEWF---KQDLPSYLFP 275
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 5e-21
Identities = 57/278 (20%), Positives = 103/278 (37%), Gaps = 43/278 (15%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
+G G + V + R+ AVK ++ E K E+ L +HEN+V +Y
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKML-NHENVVKFY 71
Query: 296 SSWFENEQLYIQMELC------DHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIA 349
E Y+ +E C D D E + + HQ+ + ++H GI
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 350 HLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM------------PQEILN 396
H D+KP+N+ + + K+ DFG AT+ + + P+ +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATV------FRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 397 EDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQFLNLRD---GKLPLLPGH--SLQFQN 450
++ VD++S G + ++ G P + D K L P
Sbjct: 182 REFHAE-PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMKP 488
LL ++ +P R + ++ ++ + K K K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWY---NKPLKKGAKR 275
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 7e-21
Identities = 69/268 (25%), Positives = 117/268 (43%), Gaps = 24/268 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
F + IG G+F V V K YA+K+ +K++ E R E+Q + L H
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EH 74
Query: 289 ENIVGYYSSWFENEQLYIQMELCD------HSLSDKKASQFFAEGEVLKALHQIAQALQF 342
+V + S+ + E +++ ++L H L F E V + ++ AL +
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYH-LQQNVH---FKEETVKLFICELVMALDY 130
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEILNEDY 399
+ + I H D+KPDNI + ++G + DF A +L + I G YM E+ +
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 400 D--HLDKVDIFSLGATMYELIKGSP-----LSESGPQ-FLNLRDGKLPLLPGHSLQFQNL 451
+ VD +SLG T YEL++G S S + + S + +L
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSL 250
Query: 452 LKVMVDPDPVQR-PSAKELVENPIFDKI 478
LK +++P+P QR ++ P + I
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 61/262 (23%), Positives = 111/262 (42%), Gaps = 16/262 (6%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
+G G+F V A+K S++ L + E+ L L H +I+ Y
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLY 75
Query: 296 SSWFENEQLYIQMELCDHSLSDKKAS-QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVK 354
+ + +E L D + E E + QI A+++ H I H D+K
Sbjct: 76 DVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLK 135
Query: 355 PDNIYV-KNGVYKLGDFGRATLLNKSLPIEE--GDARYM-PQEILNEDYDHLDKVDIFSL 410
P+N+ + N K+ DFG + ++ ++ G Y P+ I + Y +VD++S
Sbjct: 136 PENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAG-PEVDVWSC 194
Query: 411 GATMYELIKGS-PLSESGPQ--FLNLRDGKLPLLPGH-SLQFQNLLKVMVDPDPVQRPSA 466
G +Y ++ G P + F + +P S Q+L++ M+ DP+QR +
Sbjct: 195 GIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV-MPDFLSPGAQSLIRRMIVADPMQRITI 253
Query: 467 KELVENPIFDKIQKHRKTYMKP 488
+E+ +P F + Y++P
Sbjct: 254 QEIRRDPWF---NVNLPDYLRP 272
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 73/342 (21%), Positives = 128/342 (37%), Gaps = 62/342 (18%)
Query: 184 PPPCIKNPYQKDASEMDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDFHEIEQIGAGNFS 243
++ P + ++ D+ G++ G + + + IG G+F
Sbjct: 13 SCKPVQQPSAFGSMKVSRDKDGSKVTT----VVATPGQGPDRPQEVSYTDTKVIGNGSFG 68
Query: 244 HVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG----YYSS-- 297
V++ G A+K ++ D E+Q + L H NIV +YSS
Sbjct: 69 VVYQAKLCDSGELVAIK----KVLQDKRF--KNRELQIMRKL-DHCNIVRLRYFFYSSGE 121
Query: 298 WFENEQLYIQMELCDHSL-----SDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLD 352
+ L + ++ ++ +A Q V ++Q+ ++L +IH GI H D
Sbjct: 122 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 181
Query: 353 VKPDNIYV--KNGVYKLGDFGRATLLNKSLP-IEEGDARY--MPQEILN-EDYDHLDKVD 406
+KP N+ + V KL DFG A L + P + +RY P+ I DY +D
Sbjct: 182 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS--SID 239
Query: 407 IFSLGATMYELIKGSPL--SESGPQFLNL--------------------RDGKLPLLPGH 444
++S G + EL+ G P+ +SG L + K P + H
Sbjct: 240 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 299
Query: 445 SLQ--FQ--------NLLKVMVDPDPVQRPSAKELVENPIFD 476
F+ L +++ P R + E + FD
Sbjct: 300 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 5e-20
Identities = 62/274 (22%), Positives = 118/274 (43%), Gaps = 32/274 (11%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
DF IG G F V+ K G YA+K K+++ AL E L+ + +
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 289 EN--IVGYYSSWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIAQALQ 341
+ IV ++ ++L ++L + + LS F+E ++ +I L+
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLE 306
Query: 342 FIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR-----YMPQEIL 395
+H + + + D+KP NI + ++G ++ D G L ++ A YM E+L
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTHGYMAPEVL 362
Query: 396 NEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ-----FLNLRDGKLPLLPGHSLQFQ 449
+ + D FSLG +++L++G SP + + + L S + +
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 450 NLLKVMVDPDPVQR-----PSAKELVENPIFDKI 478
+LL+ ++ D +R A+E+ E+P F +
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 9e-20
Identities = 58/267 (21%), Positives = 107/267 (40%), Gaps = 54/267 (20%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK--------HSKRQLHHDAERRKALLEVQ 280
DF + +G G+FS V + YA+K + + ER
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD------- 82
Query: 281 ALAALGSHENIVGYYSSWFENEQLYIQMELC-----------DHSLSDKKASQFFAEGEV 329
++ L H V Y ++ ++E+LY + S + +F+
Sbjct: 83 VMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTA--- 137
Query: 330 LKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR 388
+I AL+++H KGI H D+KP+NI + ++ ++ DFG A K L E AR
Sbjct: 138 -----EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA----KVLSPESKQAR 188
Query: 389 ---------YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDG 436
Y+ E+L E D+++LG +Y+L+ G P + + F +
Sbjct: 189 ANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 247
Query: 437 KLPLLPGHSLQFQNLLKVMVDPDPVQR 463
+ + ++L++ ++ D +R
Sbjct: 248 EYDFPEKFFPKARDLVEKLLVLDATKR 274
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 59/309 (19%)
Query: 217 VITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKAL 276
+ + G + + + IG G+F VF+ A+K ++ D
Sbjct: 28 LASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEV-AIK----KVLQDKRF--KN 80
Query: 277 LEVQALAALGSHENIVG-----YYSSWFENEQ-LYIQMELCDHSL-----SDKKASQFFA 325
E+Q + + H N+V Y + ++E L + +E ++ K Q
Sbjct: 81 RELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMP 139
Query: 326 EGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV--KNGVYKLGDFGRATLLNKSLP-I 382
+ ++Q+ ++L +IH GI H D+KP N+ + +GV KL DFG A +L P +
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199
Query: 383 EEGDARY--MPQEILN-EDYDHLDKVDIFSLGATMYELIKGSPL--SESGPQFLNL---- 433
+RY P+ I +Y +DI+S G M EL++G PL ESG L
Sbjct: 200 SYICSRYYRAPELIFGATNYTT--NIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257
Query: 434 ----------------RDGKLPLLPGHSLQ--FQ--------NLLKVMVDPDPVQRPSAK 467
+ K P + H F+ +L+ +++ P R +A
Sbjct: 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317
Query: 468 ELVENPIFD 476
E + +P FD
Sbjct: 318 EALCHPFFD 326
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 9e-20
Identities = 62/277 (22%), Positives = 114/277 (41%), Gaps = 35/277 (12%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
F + +G G F VF + G YA K +K++L + A++E + LA +
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HS 244
Query: 289 ENIVGYYSSWFENEQLYIQMELCD------HSLSDKKASQFFAEGEVLKALHQIAQALQF 342
IV ++ L + M + + H + + + F E + QI L+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR-------YMPQEI 394
+H++ I + D+KP+N+ + +G ++ D G L L + + +M E+
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLG----LAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 395 L-NEDYDHLDKVDIFSLGATMYELIKGSP-------LSESGPQFLNLRDGKLPLLPGHSL 446
L E+YD VD F+LG T+YE+I E+ + + + S
Sbjct: 361 LLGEEYDF--SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418
Query: 447 QFQNLLKVMVDPDPVQR-----PSAKELVENPIFDKI 478
++ + ++ DP +R S L +P+F I
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 57/278 (20%), Positives = 103/278 (37%), Gaps = 43/278 (15%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
+G G + V + R+ AVK ++ E K E+ L +HEN+V +Y
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKML-NHENVVKFY 71
Query: 296 SSWFENEQLYIQMELC------DHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIA 349
E Y+ +E C D D E + + HQ+ + ++H GI
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 350 HLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM------------PQEILN 396
H D+KP+N+ + + K+ DFG AT+ + + P+ +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATV------FRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 397 EDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQFLNLRD---GKLPLLPGH--SLQFQN 450
++ VD++S G + ++ G P + D K L P
Sbjct: 182 REFHAE-PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMKP 488
LL ++ +P R + ++ ++ + K K K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWY---NKPLKKGAKR 275
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 7e-19
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE---- 289
++ IG G+F V K A+K + + R+A E++ L L +
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 290 -NIVGYYSSWFENEQLYIQMELCDHSLSDK-KASQF--FAEGEVLKALHQIAQALQFIHE 345
N++ ++ + + EL +L + K ++F F+ V K H I Q L +H+
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 346 KGIAHLDVKPDNIYVKNGVY---KLGDFGRATLLNKSLPIEEGDARYM-------PQEIL 395
I H D+KP+NI +K K+ DFG + ++ + Y+ P+ IL
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV------YTYIQSRFYRAPEVIL 272
Query: 396 NEDYDHLDKVDIFSLGATMYELIKGSPL 423
Y +D++SLG + EL+ G PL
Sbjct: 273 GARYGM--PIDMWSLGCILAELLTGYPL 298
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 34/227 (14%)
Query: 217 VITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKAL 276
++ G+ Y IG G+F V K R++ + A+K K A +A
Sbjct: 45 IVKNGEKWMDRY---EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQ 98
Query: 277 LEVQALAALGSHE-----NIVGYYSSWFENEQLYIQMELCDHSLSDK-KASQF--FAEGE 328
+EV+ L + H+ IV + L + E+ ++L D + + F +
Sbjct: 99 IEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNL 158
Query: 329 VLKALHQIAQALQFIHEK--GIAHLDVKPDNIYVKNGVY---KLGDFGRATLLNKSLPIE 383
K Q+ AL F+ I H D+KP+NI + N K+ DFG + L + +
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI--- 215
Query: 384 EGDARYM-------PQEILNEDYDHLDKVDIFSLGATMYELIKGSPL 423
+Y+ P+ +L YD +D++SLG + E+ G PL
Sbjct: 216 ---YQYIQSRFYRSPEVLLGMPYDL--AIDMWSLGCILVEMHTGEPL 257
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 64/275 (23%), Positives = 114/275 (41%), Gaps = 34/275 (12%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
F + +G G F V R G YA K K+++ AL E Q L + +
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NS 243
Query: 289 ENIVGYYSSWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIAQALQFI 343
+V ++ + L + + L + + F E + +I L+ +
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE------GDARYMPQEIL- 395
H + I + D+KP+NI + +G ++ D G L +P + G YM E++
Sbjct: 303 HRERIVYRDLKPENILLDDHGHIRISDLG----LAVHVPEGQTIKGRVGTVGYMAPEVVK 358
Query: 396 NEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ------FLNLRDGKLPLLPGHSLQF 448
NE Y D ++LG +YE+I G SP + + +++ S Q
Sbjct: 359 NERYTF--SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416
Query: 449 QNLLKVMVDPDPVQR-----PSAKELVENPIFDKI 478
++L ++ DP +R SA+E+ E+P+F K+
Sbjct: 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 5e-18
Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 17/263 (6%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
+G G F V + G AVK +++++ K E+Q L H +I+ Y
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLY 82
Query: 296 SSWFENEQLYIQMELCDHS-LSDKKAS-QFFAEGEVLKALHQIAQALQFIHEKGIAHLDV 353
+++ ME L D E E + QI + + H + H D+
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142
Query: 354 KPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE--GDARYM-PQEILNEDYDHLDKVDIFS 409
KP+N+ + + K+ DFG + +++ + G Y P+ I Y +VDI+S
Sbjct: 143 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP-EVDIWS 201
Query: 410 LGATMYELIKGS-PLSESGPQ--FLNLRDGKLPLLPGH-SLQFQNLLKVMVDPDPVQRPS 465
G +Y L+ G+ P + F + DG P + + +LLK M+ DP++R +
Sbjct: 202 SGVILYALLCGTLPFDDDHVPTLFKKICDGIFY-TPQYLNPSVISLLKHMLQVDPMKRAT 260
Query: 466 AKELVENPIFDKIQKHRKTYMKP 488
K++ E+ F ++ Y+ P
Sbjct: 261 IKDIREHEWF---KQDLPKYLFP 280
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
DF ++ IG G F V V + +A+K +K ++ AE E L G
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDS 133
Query: 289 ENIVGYYSSWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIAQALQFI 343
+ I + ++ ++ LY+ M+ LS K E L ++ A+ +
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS--KFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR---------YMPQE 393
H+ H D+KPDNI + NG +L DFG L +E+G + Y+ E
Sbjct: 192 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL-----MEDGTVQSSVAVGTPDYISPE 246
Query: 394 ILNEDYDHLDK----VDIFSLGATMYELIKGSP 422
IL + D +SLG MYE++ G
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 74/318 (23%), Positives = 115/318 (36%), Gaps = 64/318 (20%)
Query: 216 PVITGGDGLSRYYTD-FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSK-RQLHHDAERR 273
D SR D F G G F V ++ G A+K K Q R
Sbjct: 9 NAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK--KVIQDPRFRNR- 65
Query: 274 KALLEVQALAALGSHENIVG----YYSSWFENEQ---LYIQMELCDHSL-----SDKKAS 321
L +Q LA L H NIV +Y+ + + L + ME +L + +
Sbjct: 66 -ELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQ 123
Query: 322 QFFAEGEVLKALHQIAQALQFIHEK--GIAHLDVKPDNIYV--KNGVYKLGDFGRATLLN 377
+ L Q+ +++ +H + H D+KP N+ V +G KL DFG A L+
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 378 KSLP-IEEGDARY--MPQEILN-EDYDHLDKVDIFSLGATMYELIKGSPL--SESGPQFL 431
S P + +RY P+ I + Y VDI+S+G E++ G P+ ++ L
Sbjct: 184 PSEPNVAYICSRYYRAPELIFGNQHYTT--AVDIWSVGCIFAEMMLGEPIFRGDNSAGQL 241
Query: 432 NL--------------------RDGKLPLLPGHSLQ--FQN-----------LLKVMVDP 458
+ D L G F + LL ++
Sbjct: 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQY 301
Query: 459 DPVQRPSAKELVENPIFD 476
P +R E + +P FD
Sbjct: 302 LPEERMKPYEALCHPYFD 319
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 72/279 (25%), Positives = 123/279 (44%), Gaps = 45/279 (16%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGS 287
+DFH ++ IG G+F V + + FYAVK K+ + E + + E L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 288 HENIVGYYSSWFENEQLYIQMELC-----------DHSLSDKKASQFFAEGEVLKALHQI 336
H +VG + S+ ++LY ++ + + +A +F+A +I
Sbjct: 98 HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-RFYAA--------EI 148
Query: 337 AQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDA-------- 387
A AL ++H I + D+KP+NI + G L DFG L K IE
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG----LCK-ENIEHNSTTSTFCGTP 203
Query: 388 RYMPQEILNE-DYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKLPLLPG 443
Y+ E+L++ YD VD + LGA +YE++ G P S + + + N+ + L L P
Sbjct: 204 EYLAPEVLHKQPYDRT--VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN 261
Query: 444 HSLQFQNLLKVMVDPDPVQR----PSAKELVENPIFDKI 478
+ ++LL+ ++ D +R E+ + F I
Sbjct: 262 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 64/280 (22%), Positives = 110/280 (39%), Gaps = 42/280 (15%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-------HSKRQLHHDAERRKALLEVQAL 282
D+ ++ IG G F V V + YA+K + E R +
Sbjct: 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM------ 123
Query: 283 AALGSHENIVGYYSSWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIA 337
A + +V + ++ ++ LY+ ME + +S+ E ++
Sbjct: 124 -AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVV 178
Query: 338 QALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE----GDARYMPQ 392
AL IH G H DVKPDN+ + K+G KL DFG +NK + G Y+
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 393 EILN---EDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKLPL-LPGH- 444
E+L D + + D +S+G +YE++ G ++S + + + K L P
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298
Query: 445 --SLQFQNLLKVMVDPDPVQR---PSAKELVENPIFDKIQ 479
S + +NL+ + D R +E+ + F Q
Sbjct: 299 DISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQ 337
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 8e-17
Identities = 68/270 (25%), Positives = 115/270 (42%), Gaps = 52/270 (19%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGS 287
DF + IG G+++ V V + YA+K K ++ D + E +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 288 HENIVGYYSSWFENEQ-LYIQMELC-----------DHSLSDKKASQFFAEGEVLKALHQ 335
H +VG +S F+ E L+ +E L ++ A + AE
Sbjct: 69 HPFLVGLHSC-FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE--------- 118
Query: 336 IAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDA------- 387
I+ AL ++HE+GI + D+K DN+ + G KL D+G + K + GD
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG----MCK-EGLRPGDTTSTFCGT 173
Query: 388 -RYMPQEILN-EDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ-----------FLNL 433
Y+ EIL EDY VD ++LG M+E++ G SP G F +
Sbjct: 174 PNYIAPEILRGEDYGF--SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231
Query: 434 RDGKLPLLPGHSLQFQNLLKVMVDPDPVQR 463
+ ++ + S++ ++LK ++ DP +R
Sbjct: 232 LEKQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 63/280 (22%), Positives = 111/280 (39%), Gaps = 46/280 (16%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGS 287
TDF+ + +G G+F V ++ YAVK K + D + ++E + LA G
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 288 HENIVGYYSSWFENEQLYIQMELC-----------DHSLSDKKASQFFAEGEVLKALHQI 336
+ +S + ++LY ME + A + AE I
Sbjct: 80 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE---------I 130
Query: 337 AQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDA-------- 387
A L F+ KGI + D+K DN+ + G K+ DFG + K I +G
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG----MCK-ENIWDGVTTKTFCGTP 185
Query: 388 RYMPQEILN-EDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKLPLLPG 443
Y+ EI+ + Y VD ++ G +YE++ G E + F ++ + +
Sbjct: 186 DYIAPEIIAYQPYGK--SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS 243
Query: 444 HSLQFQNLLKVMVDPDPVQR-----PSAKELVENPIFDKI 478
S + + K ++ P +R +++ E+ F I
Sbjct: 244 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.0 bits (202), Expect = 1e-16
Identities = 62/274 (22%), Positives = 112/274 (40%), Gaps = 34/274 (12%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGS 287
TDF+ + +G G+F V ++ YAVK K + D + ++E + LA G
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 288 HENIVGYYSSWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKALHQIAQALQF 342
+ +S + ++LY ME + + + F E + +IA L F
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFF 457
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDA--------RYMPQE 393
+ KGI + D+K DN+ + G K+ DFG + K I +G Y+ E
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFG----MCK-ENIWDGVTTKTFCGTPDYIAPE 512
Query: 394 ILNE-DYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKLPLLPGHSLQFQ 449
I+ Y VD ++ G +YE++ G E + F ++ + + S +
Sbjct: 513 IIAYQPYGK--SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 570
Query: 450 NLLKVMVDPDPVQR-----PSAKELVENPIFDKI 478
+ K ++ P +R +++ E+ F I
Sbjct: 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 57/257 (22%), Positives = 105/257 (40%), Gaps = 39/257 (15%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-------SKRQLHHDAERRKALLEVQA 281
F I+ +G G+F V V + G YA+K +Q+ H ++ L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-- 98
Query: 282 LAALGSHENIVGYYSSWFENEQLYIQMELCD-----HSLSDKK-----ASQFFAEGEVLK 331
+ +V S+ +N LY+ ME L ++F+A
Sbjct: 99 -----NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA----- 148
Query: 332 ALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM 390
QI +++H + + D+KP+N+ + + G ++ DFG A + G +
Sbjct: 149 ---QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEAL 205
Query: 391 PQEIL-NEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ--FLNLRDGKLPLLPGHSL 446
EI+ ++ Y+ VD ++LG +YE+ G P P + + GK+ S
Sbjct: 206 APEIILSKGYNK--AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSS 263
Query: 447 QFQNLLKVMVDPDPVQR 463
++LL+ ++ D +R
Sbjct: 264 DLKDLLRNLLQVDLTKR 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 55/222 (24%), Positives = 80/222 (36%), Gaps = 44/222 (19%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
DF ++ IG G FS V V + G YA+K +K + E E L G
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-GDR 120
Query: 289 ENIVGYYSSWFENEQLYIQMELC------------DHSLSDKKASQFFAEGEVLKALHQI 336
I + ++ + LY+ ME + + A + AE I
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE---------I 171
Query: 337 AQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR------- 388
A+ +H G H D+KPDNI + + G +L DFG L +G R
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR-----ADGTVRSLVAVGT 226
Query: 389 --YMPQEILNEDYDHLDK------VDIFSLGATMYELIKGSP 422
Y+ EIL D ++LG YE+ G
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 64/293 (21%), Positives = 110/293 (37%), Gaps = 52/293 (17%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ + +G+G + V G AVK R ++ E++ L + HEN
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHEN 89
Query: 291 IVGYY------SSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIH 344
++G S E +Y+ L L++ Q + V ++QI + L++IH
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR-YMPQEILNEDYDHL 402
I H D+KP N+ V ++ K+ DFG A + R Y EI+ +
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-GYVATRWYRAPEIMLNWMHYN 208
Query: 403 DKVDIFSLGATMYELIKGSPL-----------------------------SESGPQFLNL 433
VDI+S+G M EL+ G L SES ++
Sbjct: 209 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ- 267
Query: 434 RDGKLP---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
L + G + +LL+ M+ D +R +A + + + F +
Sbjct: 268 ---SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 67/276 (24%), Positives = 116/276 (42%), Gaps = 42/276 (15%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGS 287
DF + +G G+F VF + F+A+K K + D + ++E + L+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 288 HENIVGYYSSWFENEQLYIQMELC-----------DHSLSDKKASQFFAEGEVLKALHQI 336
H + + ++ E L+ ME H +A+ + AE I
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE---------I 127
Query: 337 AQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDA-------- 387
LQF+H KGI + D+K DNI + K+G K+ DFG + K +
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG----MCK-ENMLGDAKTNTFCGTP 182
Query: 388 RYMPQEILNE-DYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ--FLNLRDGKLPLLPG 443
Y+ EIL Y+H VD +S G +YE++ G SP + F ++R
Sbjct: 183 DYIAPEILLGQKYNH--SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 240
Query: 444 HSLQFQNLLKVMVDPDPVQR-PSAKELVENPIFDKI 478
+ ++LL + +P +R ++ ++P+F +I
Sbjct: 241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 67/270 (24%), Positives = 115/270 (42%), Gaps = 52/270 (19%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGS 287
DF + IG G+++ V V + YA++ K ++ D + E +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 288 HENIVGYYSSWFENEQ-LYIQMELC-----------DHSLSDKKASQFFAEGEVLKALHQ 335
H +VG +S F+ E L+ +E L ++ A + AE
Sbjct: 112 HPFLVGLHSC-FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE--------- 161
Query: 336 IAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDA------- 387
I+ AL ++HE+GI + D+K DN+ + G KL D+G + K + GD
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG----MCK-EGLRPGDTTSTFCGT 216
Query: 388 -RYMPQEILN-EDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ-----------FLNL 433
Y+ EIL EDY VD ++LG M+E++ G SP G F +
Sbjct: 217 PNYIAPEILRGEDYGF--SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274
Query: 434 RDGKLPLLPGHSLQFQNLLKVMVDPDPVQR 463
+ ++ + S++ ++LK ++ DP +R
Sbjct: 275 LEKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 55/223 (24%), Positives = 90/223 (40%), Gaps = 36/223 (16%)
Query: 230 DFHEIE--QIGAGNFSHVFKVLKR--IDGCFYAVKHSKRQLHHDAERRKALLEVQALAAL 285
D E E ++G G + HV+K ++ D YA+K Q+ A E+ L L
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK----QIEGTGISMSACREIALLREL 75
Query: 286 GSHENIVGYYS--SWFENEQLYIQMELCDHSL----------SDKKASQFFAEGEVLKAL 333
H N++ + ++++ + +H L K G V L
Sbjct: 76 -KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 334 HQIAQALQFIHEKGIAHLDVKPDNIYV-----KNGVYKLGDFGRATLLNKSL-PIEEGDA 387
+QI + ++H + H D+KP NI V + G K+ D G A L N L P+ + D
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 388 R-----YMPQEIL--NEDYDHLDKVDIFSLGATMYELIKGSPL 423
Y E+L Y +DI+++G EL+ P+
Sbjct: 195 VVVTFWYRAPELLLGARHYT--KAIDIWAIGCIFAELLTSEPI 235
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 67/293 (22%), Positives = 115/293 (39%), Gaps = 48/293 (16%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+ +++ +G+G + V + G A+K R + ++A E++ L + H
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RH 83
Query: 289 ENIVGYY------SSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQF 342
EN++G + + Y+ M L + E + ++Q+ + L++
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR-YMPQEIL--NED 398
IH GI H D+KP N+ V ++ K+ DFG A + + R Y E++
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-GYVVTRWYRAPEVILNWMR 202
Query: 399 YDHLDKVDIFSLGATMYELIKGSPL--------------------SESGPQFLNLRDGK- 437
Y VDI+S+G M E+I G L Q L + K
Sbjct: 203 YTQ--TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 260
Query: 438 ----LP---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
LP +L S NLL+ M+ D QR +A E + +P F+
Sbjct: 261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 5e-16
Identities = 62/261 (23%), Positives = 102/261 (39%), Gaps = 43/261 (16%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGS 287
+F I +G G+F V + G YAVK K + D + + E + L+ +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 288 HENIVGYYSSWFENEQ-LYIQMELC-----------DHSLSDKKASQFFAEGEVLKALHQ 335
H + + F+ L+ ME + +A + AE
Sbjct: 83 HPFLTQLFCC-FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------- 132
Query: 336 IAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDA------- 387
I AL F+H+KGI + D+K DN+ + G KL DFG + K I G
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG----MCK-EGICNGVTTATFCGT 187
Query: 388 -RYMPQEILNE-DYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKLPLLP 442
Y+ EIL E Y VD +++G +YE++ G +E+ F + + ++
Sbjct: 188 PDYIAPEILQEMLYGP--AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 245
Query: 443 GHSLQFQNLLKVMVDPDPVQR 463
+LK + +P R
Sbjct: 246 WLHEDATGILKSFMTKNPTMR 266
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 63/303 (20%), Positives = 115/303 (37%), Gaps = 69/303 (22%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+ +G+G + V + + G A+K R + ++A E+ L + H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QH 82
Query: 289 ENIVGYY------SSWFENEQLYIQMELCD--------HSLSDKKASQFFAEGEVLKALH 334
EN++G SS Y+ M S++K Q+ ++
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKI-QYL--------VY 133
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEEGDAR-YMPQ 392
Q+ + L++IH G+ H D+KP N+ V + K+ DFG A + + R Y
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-GYVVTRWYRAP 192
Query: 393 EILNEDYDHLDKVDIFSLGATMYELIKGSPL----------------------------- 423
E++ + VDI+S+G M E++ G L
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252
Query: 424 SESGPQFLNLRDGKLP---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPI 474
++ ++ LP L P S Q +LL+ M++ D +R +A + + +P
Sbjct: 253 DKAAKSYIQ----SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308
Query: 475 FDK 477
F+
Sbjct: 309 FEP 311
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 44/244 (18%), Positives = 83/244 (34%), Gaps = 48/244 (19%)
Query: 213 GLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAER 272
G P G Y + ++G G+FS V+ ++ A+K +
Sbjct: 6 GYHPAFKGEPYKDARY---ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYT 59
Query: 273 RKALLEVQALAALGS----------HENIVGYYSSWFE-----NEQLYIQMELCDHSLSD 317
A E++ L + +I+ F + + E+ +L
Sbjct: 60 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD-HFNHKGPNGVHVVMVFEVLGENLLA 118
Query: 318 -KKASQF--FAEGEVLKALHQIAQALQFIHEK-GIAHLDVKPDNIYVKNGVY-------K 366
K + V + Q+ L ++H + GI H D+KP+N+ ++ K
Sbjct: 119 LIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 178
Query: 367 LGDFGRATLLNKSLPIEEGDARYM-------PQEILNEDYDHLDKVDIFSLGATMYELIK 419
+ D G A ++ + P+ +L + DI+S ++ELI
Sbjct: 179 IADLGNACWYDEHY------TNSIQTREYRSPEVLLGAPWGC--GADIWSTACLIFELIT 230
Query: 420 GSPL 423
G L
Sbjct: 231 GDFL 234
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 58/308 (18%), Positives = 112/308 (36%), Gaps = 73/308 (23%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
D+ + ++G G +S VF+ + + VK K +++K E++ L L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGP 91
Query: 290 NIVGYY---SSWFENEQLYIQMEL--CD-----HSLSDKKASQFFAEGEVLKALHQIAQA 339
NI+ + + D +L+D +F+ +++I +A
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI-RFY--------MYEILKA 142
Query: 340 LQFIHEKGIAHLDVKPDNIYV--KNGVYKLGDFG--RATLLNKSLPIEEGDARYMPQEIL 395
L + H GI H DVKP N+ + ++ +L D+G + + + E+L
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 202
Query: 396 --NEDYDHLDKVDIFSLGATMYELIK----------------------GSPLSESGPQFL 431
+ YD+ +D++SLG + +I G+
Sbjct: 203 VDYQMYDY--SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260
Query: 432 NLRDGK--LPLLPGHSLQ-----FQNLLKVMVDP------------DPVQRPSAKELVEN 472
N+ +L HS + + + +V P D R +A+E +E+
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320
Query: 473 PIFDKIQK 480
P F + K
Sbjct: 321 PYFYTVVK 328
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 9e-16
Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 51/283 (18%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRID---GCFYAVK-------HSKRQLHHDAERRKALLE 278
+ F ++ +G G+F VF V K YA+K + ++ ER L+E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD-ILVE 82
Query: 279 VQALAALGSHENIVGYYSSWFENEQLYIQMELCD-----HSLSDKKASQFFAEGEVLKAL 333
V +H IV + ++ +LY+ ++ LS + F E +V L
Sbjct: 83 V-------NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYL 132
Query: 334 HQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGD------ 386
++A AL +H GI + D+KP+NI + + G KL DFG L+K I+
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG----LSK-ESIDHEKKAYSFC 187
Query: 387 --ARYMPQEILNE-DYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKLPL 440
YM E++N + D +S G M+E++ G+ + + + KL +
Sbjct: 188 GTVEYMAPEVVNRRGHTQS--ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM 245
Query: 441 LPGHSLQFQNLLKVMVDPDPVQR-----PSAKELVENPIFDKI 478
S + Q+LL+++ +P R +E+ + F I
Sbjct: 246 PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 66/280 (23%), Positives = 121/280 (43%), Gaps = 47/280 (16%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGS 287
DF ++ +G G F V V ++ G +YA+K K + E + E + L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-R 63
Query: 288 HENIVGYYSSWFENEQLYIQMELC-----------DHSLSDKKASQFFAEGEVLKALHQI 336
H + ++ +++L ME + ++++A + AE I
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE---------I 114
Query: 337 AQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDA-------- 387
AL+++H + + + D+K +N+ + K+G K+ DFG L K I +G
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG----LCK-EGISDGATMKTFCGTP 169
Query: 388 RYMPQEILNE-DYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKLPLLPG 443
Y+ E+L + DY VD + LG MYE++ G ++ + F + ++
Sbjct: 170 EYLAPEVLEDNDYGR--AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 227
Query: 444 HSLQFQNLLKVMVDPDPVQR-----PSAKELVENPIFDKI 478
S + ++LL ++ DP QR AKE++E+ F I
Sbjct: 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 72/338 (21%), Positives = 125/338 (36%), Gaps = 93/338 (27%)
Query: 220 GGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEV 279
G + S+ Y+ + +G G+F V +V G +A+K ++ D E+
Sbjct: 1 GLETSSKKYSL---GKTLGTGSFGIVCEVFDIESGKRFALK----KVLQDPRY--KNREL 51
Query: 280 QALAALGSHENIVG----YYSSWFENEQ-------------------------------- 303
+ L H NI+ +Y++ E +
Sbjct: 52 DIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN 110
Query: 304 --LYIQMELCDHSL-----SDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPD 356
L + ME +L S ++ + + ++Q+ +A+ FIH GI H D+KP
Sbjct: 111 KYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQ 170
Query: 357 NIYV--KNGVYKLGDFGRATLLNKSLP-IEEGDARY--MPQEILN-EDYDHLDKVDIFSL 410
N+ V K+ KL DFG A L S P + +R+ P+ +L +Y +D++S+
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTP--SIDLWSI 228
Query: 411 GATMYELIKGSPL--SESGPQFLNL--------------------RDGKLPLLPGHSLQ- 447
G ELI G PL E+ L + + P L +
Sbjct: 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK 288
Query: 448 -FQN--------LLKVMVDPDPVQRPSAKELVENPIFD 476
LL+ ++ +P R + E + +P FD
Sbjct: 289 ILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFD 326
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 58/262 (22%), Positives = 102/262 (38%), Gaps = 30/262 (11%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSHENIVGYY 295
IG+GNF + ++ AVK+ + + +R E+ +L H NIV +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSL-RHPNIVRFK 82
Query: 296 SSWFENEQLYIQMELCDH-SLSDKKASQ-FFAEGEVLKALHQIAQALQFIHEKGIAHLDV 353
L I ME L ++ + F+E E Q+ + + H I H D+
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDL 142
Query: 354 KPDNIYV---KNGVYKLGDFGRATLLNKSLPIEE-----GDARYM-PQEILNEDYDHLDK 404
K +N + K+ DFG S+ + G Y+ P+ +L ++YD
Sbjct: 143 KLENTLLDGSPAPRLKICDFG---YSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK-I 198
Query: 405 VDIFSLGATMYELIKGS-PLSESGPQ--FLNLRDG------KLPLLPGHSLQFQNLLKVM 455
D++S G T+Y ++ G+ P + + +P S + +L+ +
Sbjct: 199 ADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRI 258
Query: 456 VDPDPVQRPSAKELVENPIFDK 477
DP R S E+ + F K
Sbjct: 259 FVADPATRISIPEIKTHSWFLK 280
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 70/291 (24%), Positives = 108/291 (37%), Gaps = 58/291 (19%)
Query: 234 IEQIGAGNFSHVFK----VLKRIDGCFYAVKHSKRQLHHDAERRKA--LLEVQALAALGS 287
++Q+G GNF V L+ G AVK +L H E E++ L +L
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK----KLQHSTEEHLRDFEREIEILKSL-Q 69
Query: 288 HENIVGYY--SSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQF 342
H+NIV Y L + ME + SL D +K + ++L+ QI + +++
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-----------LPIEEGDARYM 390
+ K H D+ NI V K+GDFG +L + PI +
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI-----FWY 184
Query: 391 PQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQ 449
E L E + D++S G +YEL S+S P G
Sbjct: 185 APESLTESKFSV--ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 450 NLLK-----------------VMVD---PDPVQRPSAKELVENPIFDKIQK 480
LLK +M + + QRPS ++L D+I+
Sbjct: 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL--RVDQIRD 291
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ ++ IG+G V I A+K R + ++A E+ + + H+N
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKN 85
Query: 291 IVGYY------SSWFENEQLYIQMELCDHSLS-------DKKASQFFAEGEVLKALHQIA 337
I+G S E + +YI MEL D +L D + + L+Q+
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL--------LYQML 137
Query: 338 QALQFIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEEGDA-RY--MPQE 393
++ +H GI H D+KP NI VK + K+ DFG A S + RY P+
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 394 ILNEDYDHLDKVDIFSLGATMYELIKGSPL 423
IL Y + VDI+S+G M E+IKG L
Sbjct: 198 ILGMGYK--ENVDIWSVGCIMGEMIKGGVL 225
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 70/291 (24%), Positives = 108/291 (37%), Gaps = 58/291 (19%)
Query: 234 IEQIGAGNFSHVFK----VLKRIDGCFYAVKHSKRQLHHDA--ERRKALLEVQALAALGS 287
++Q+G GNF V L+ G AVK +L H R E++ L +L
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK----KLQHSTEEHLRDFEREIEILKSL-Q 100
Query: 288 HENIVGYY--SSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQF 342
H+NIV Y L + ME + SL D +K + ++L+ QI + +++
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-----------LPIEEGDARYM 390
+ K H D+ NI V K+GDFG +L + PI +
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI-----FWY 215
Query: 391 PQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQ 449
E L E + D++S G +YEL S+S P G
Sbjct: 216 APESLTESKFSV--ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273
Query: 450 NLLK-----------------VMVD---PDPVQRPSAKELVENPIFDKIQK 480
LLK +M + + QRPS ++L D+I+
Sbjct: 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL--RVDQIRD 322
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 4e-15
Identities = 59/268 (22%), Positives = 116/268 (43%), Gaps = 61/268 (22%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-------SKRQLHH-DAERRKALLEVQ 280
DF + +G G+F V + R +G +YA+K +Q+ H + ER
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL------- 58
Query: 281 ALAALGSHENIVGYYSSWFENEQLYIQMELC-----------DHSLSDKKASQFFAEGEV 329
L+ + +H I+ + ++ + +Q+++ M+ + A +F+A
Sbjct: 59 MLSIV-THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-KFYAA--- 113
Query: 330 LKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR 388
++ AL+++H K I + D+KP+NI + KNG K+ DFG K
Sbjct: 114 -----EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG----FAK-----YVPDV 159
Query: 389 ---------YMPQEIL-NEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ--FLNLRD 435
Y+ E++ + Y+ +D +S G +YE++ G +P +S + + +
Sbjct: 160 TYTLCGTPDYIAPEVVSTKPYNK--SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217
Query: 436 GKLPLLPGHSLQFQNLLKVMVDPDPVQR 463
+L P + ++LL ++ D QR
Sbjct: 218 AELRFPPFFNEDVKDLLSRLITRDLSQR 245
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 66/333 (19%), Positives = 117/333 (35%), Gaps = 102/333 (30%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE---- 289
I ++G G F V + +YAVK + + R A +E L + + +
Sbjct: 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVR---NIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 290 NIVGYYSSWFE-NEQLYIQMELCDHSLSD-KKASQF--FAEGEVLKALHQIAQALQFIHE 345
NIV Y+ F + + + E SL + + + F ++ +I +AL ++ +
Sbjct: 97 NIVKYHG-KFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK 155
Query: 346 KGIAHLDVKPDNIYVKNGVY--------------------------KLGDFGRATLLNKS 379
+ H D+KP+NI + + + KL DFG AT +
Sbjct: 156 MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY 215
Query: 380 LPIEEGDARYM-------PQEILNEDYDHLDKVDIFSLGATMYELIKGSPL--------- 423
+ P+ ILN +D D++S G + EL GS L
Sbjct: 216 HG------SIINTRQYRAPEVILNLGWDV--SSDMWSFGCVLAELYTGSLLFRTHEHMEH 267
Query: 424 --------------------SESGPQFLNLRDGKLP----------------LLPGHSL- 446
+G +++N + KL LP + +
Sbjct: 268 LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII 327
Query: 447 ---QFQNLLKVMVDPDPVQRPSAKELVENPIFD 476
F + L ++ DP RPS EL+++ +
Sbjct: 328 KHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 46/280 (16%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGS 287
+F ++ +G G F V V ++ G +YA+K K + E L E + L
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-R 206
Query: 288 HENIVGYYSSWFENEQLYIQMELC-----------DHSLSDKKASQFFAEGEVLKALHQI 336
H + S+ +++L ME + S+ +A + AE I
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE---------I 257
Query: 337 AQALQFIH-EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDA------- 387
AL ++H EK + + D+K +N+ + K+G K+ DFG L K I++G
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFG----LCK-EGIKDGATMKTFCGT 312
Query: 388 -RYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNLRDGKLPLLPG 443
Y+ E+L ED D+ VD + LG MYE++ G ++ + F + ++
Sbjct: 313 PEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT 371
Query: 444 HSLQFQNLLKVMVDPDPVQR----PS-AKELVENPIFDKI 478
+ ++LL ++ DP QR AKE++++ F I
Sbjct: 372 LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 68/296 (22%), Positives = 117/296 (39%), Gaps = 67/296 (22%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRID---GCFYAVK---------HSKRQLHHDAERRKAL 276
+F ++ +G G + VF V K G YA+K +K H ER+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ--- 110
Query: 277 LEVQALAALGSHENIVGYYSSWFENEQLYIQMELC-----------DHSLSDKKASQFFA 325
L + +V + ++ +L++ ++ ++ + +
Sbjct: 111 ----VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG 166
Query: 326 EGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE 384
E I AL+ +H+ GI + D+K +NI + NG L DFG L+K + +
Sbjct: 167 E---------IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG----LSK-EFVAD 212
Query: 385 GDAR---------YMPQEIL-NEDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ---- 429
R YM +I+ D H VD +SLG MYEL+ G SP + G +
Sbjct: 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 272
Query: 430 --FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQR-----PSAKELVENPIFDKI 478
+ + P S ++L++ ++ DP +R A E+ E+ F KI
Sbjct: 273 EISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 28/210 (13%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ ++ IG+G V + A+K R + ++A E+ + + H+N
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKN 122
Query: 291 IVGYY------SSWFENEQLYIQMELCDHSLS-------DKKASQFFAEGEVLKALHQIA 337
I+ + E + +Y+ MEL D +L D + + L+Q+
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL--------LYQML 174
Query: 338 QALQFIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRA-TLLNKSLPIEEGDARY--MPQE 393
++ +H GI H D+KP NI VK + K+ DFG A T + RY P+
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 394 ILNEDYDHLDKVDIFSLGATMYELIKGSPL 423
IL Y VDI+S+G M E+++ L
Sbjct: 235 ILGMGYKE--NVDIWSVGCIMGEMVRHKIL 262
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 53/227 (23%), Positives = 86/227 (37%), Gaps = 49/227 (21%)
Query: 234 IEQIGAGNFSHVFKVL-KRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE--- 289
++ +G G F V + + + G AVK K + D A E+Q L L + +
Sbjct: 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 290 --NIVGYYSSWFENEQ-LYIQMELCDHSLSD-KKASQF--FAEGEVLKALHQIAQALQFI 343
V WFE+ + I EL S D K + F F + K +QI +++ F+
Sbjct: 76 TFRCVQMLE-WFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 344 HEKGIAHLDVKPDNIYVKNGVY--------------------KLGDFGRATLLNKSLPIE 383
H + H D+KP+NI Y K+ DFG AT ++
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHS-- 192
Query: 384 EGDARYM-------PQEILNEDYDHLDKVDIFSLGATMYELIKGSPL 423
+ P+ IL + D++S+G + E G +
Sbjct: 193 ----TLVSTRHYRAPEVILALGWSQ--PCDVWSIGCILIEYYLGFTV 233
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 77/290 (26%), Positives = 120/290 (41%), Gaps = 65/290 (22%)
Query: 230 DFHEIEQIGAGNFSHVF---KVLKRIDGCFYAVK---------HSKRQLHHDAERRKALL 277
F + +G G + VF KV G +A+K ++K H AER +L
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN--IL 75
Query: 278 EVQALAALGSHENIVGYYSSWFENEQLYIQMELC-----------DHSLSDKKASQFFAE 326
E H IV ++ +LY+ +E + + A + AE
Sbjct: 76 E------EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129
Query: 327 GEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEG 385
I+ AL +H+KGI + D+KP+NI + G KL DFG L K I +G
Sbjct: 130 ---------ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG----LCK-ESIHDG 175
Query: 386 DA--------RYMPQEILNE-DYDHLDKVDIFSLGATMYELIKGSP--LSESGPQ-FLNL 433
YM EIL ++ VD +SLGA MY+++ G+P E+ + +
Sbjct: 176 TVTHTFCGTIEYMAPEILMRSGHNRA--VDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233
Query: 434 RDGKLPLLPGHSLQFQNLLKVMVDPDPVQR-----PSAKELVENPIFDKI 478
KL L P + + ++LLK ++ + R A E+ +P F I
Sbjct: 234 LKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 51/212 (24%), Positives = 83/212 (39%), Gaps = 35/212 (16%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
+IG G+F +F+ ++ A+K R ++ + E + L I
Sbjct: 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR----RSDAPQLRDEYRTYKLLAGCTGIPN 70
Query: 294 YYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
Y E + ++L SL D + F+ V A Q+ +Q IHEK + +
Sbjct: 71 VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR 130
Query: 352 DVKPDNIYV-------KNGVYKLGDFGRATL-----LNKSLPIEE-----GDARYMPQEI 394
D+KPDN + N +Y + DFG + +P E G ARYM
Sbjct: 131 DIKPDNFLIGRPNSKNANMIY-VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS--- 186
Query: 395 LNEDYDHLDKV-----DIFSLGATMYELIKGS 421
+N HL + D+ +LG ++GS
Sbjct: 187 IN---THLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 61/338 (18%), Positives = 111/338 (32%), Gaps = 94/338 (27%)
Query: 234 IEQIGAGNFSHVFKVLKRIDG-CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE--- 289
+ +G G F V + L G A+K + + R A LE+ L + +
Sbjct: 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIR---NVGKYREAARLEINVLKKIKEKDKEN 80
Query: 290 --NIVGYYSSWFENEQLYIQMELCDHSLSD-KKASQF--FAEGEVLKALHQIAQALQFIH 344
V + + + I EL + + K + F + V +Q+ AL+F+H
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140
Query: 345 EKGIAHLDVKPDNIYVKNGVY--------------------KLGDFGRATLLNKSLPIEE 384
E + H D+KP+NI N + ++ DFG AT ++
Sbjct: 141 ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT--- 197
Query: 385 GDARYM-------PQEILNEDYDHLDKVDIFSLGATMYELIKGSPL-------------- 423
+ P+ IL + D++S+G ++E +G L
Sbjct: 198 ---TIVATRHYRPPEVILELGWAQ--PCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252
Query: 424 ---------------------SESGPQFLNLRDGKLPLLPGHSL------------QFQN 450
N DG+ L Q +
Sbjct: 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312
Query: 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMKP 488
L++ M++ DP QR + E + +P F + +++
Sbjct: 313 LMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTS 350
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 46/214 (21%), Positives = 89/214 (41%), Gaps = 28/214 (13%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKR-QLHHDAERRKALLEVQALAALGS 287
+ + IG G + V ++ A+K + +R L E++ L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR--TLREIKILLRF-R 83
Query: 288 HENIVGYY-----SSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQF 342
HENI+G + + + +YI +L + L +Q + + L+QI + L++
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM----------- 390
IH + H D+KP N+ + K+ DFG L + + ++
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFG----LARVADPDHDHTGFLTEYVATRWYRA 199
Query: 391 PQEILN-EDYDHLDKVDIFSLGATMYELIKGSPL 423
P+ +LN + Y +DI+S+G + E++ P+
Sbjct: 200 PEIMLNSKGYTK--SIDIWSVGCILAEMLSNRPI 231
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 59/291 (20%), Positives = 97/291 (33%), Gaps = 52/291 (17%)
Query: 229 TDFHEIEQIGAGNFSHVFK----VLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAA 284
I +G G+F V G AVK K + E++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRN 79
Query: 285 LGSHENIVGYY--SSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQA 339
L HENIV Y + + + ME SL + K + LK QI +
Sbjct: 80 L-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 340 LQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFG--RATLLNKS---------LPIEEGDA 387
+ ++ + H D+ N+ V K+GDFG +A +K P+
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV----- 193
Query: 388 RYMPQEILNED-YDHLDKVDIFSLGATMYELI-KGSPLSESGPQFLNLRDGKLPLLPGHS 445
+ E L + + D++S G T++EL+ S FL + +
Sbjct: 194 FWYAPECLMQSKFYI--ASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 446 LQFQ---------------NLLKVMVD---PDPVQRPSAKELVENPIFDKI 478
L + ++M P R S + L+E F+ +
Sbjct: 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE--GFEAL 300
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 66/270 (24%), Positives = 103/270 (38%), Gaps = 31/270 (11%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
EQIG GNF VF R D AVK + L + K L E + L SH NIV
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQY-SHPNIVR 176
Query: 294 YYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAH 350
+ + +YI MEL + +L+ + A ++++ K H
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236
Query: 351 LDVKPDNIYV-KNGVYKLGDFGRATLL----------NKSLPIEEGDARYMPQEILNED- 398
D+ N V + V K+ DFG + + +P+ ++ E LN
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV-----KWTAPEALNYGR 291
Query: 399 YDHLDKVDIFSLGATMYELI-KG-SPLSE-SGPQFLNL--RDGKLPLLPGHSLQFQNLLK 453
Y + D++S G ++E G SP S Q + G+LP L++
Sbjct: 292 YSS--ESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLME 349
Query: 454 VMVDPDPVQRPSAKELVENPIFDKIQKHRK 483
+P QRPS + + I+K +
Sbjct: 350 QCWAYEPGQRPSFSTIYQ--ELQSIRKRHR 377
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 62/283 (21%), Positives = 108/283 (38%), Gaps = 55/283 (19%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY----AVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+ +GAG F V + + AVK K H ER + E++ L+ LG+H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNH 86
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH--------------SLSDKKASQFFAEGEVLKAL- 333
NIV + + E C + S + + L
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 334 -----HQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-------- 379
+Q+A+ + F+ K H D+ NI + + K+ DFG A +
Sbjct: 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 380 --LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELI-KGS---PLSESGPQFLN 432
LP+ ++M E + Y + D++S G ++EL GS P +F
Sbjct: 207 ARLPV-----KWMAPESIFNCVYTF--ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 433 -LRDGKLPLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
+++G L P H+ + +M DP++RP+ K++V+
Sbjct: 260 MIKEGFRMLSPEHAP--AEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 65/313 (20%), Positives = 115/313 (36%), Gaps = 80/313 (25%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAERRKALLEVQALAALGSHE 289
F +G G + V + G A+K A R L E++ L HE
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR--TLREIKILKHF-KHE 69
Query: 290 NIVGYY-----SSWFENEQLYIQMELCD---------HSLSDKKASQFFAEGEVLKALHQ 335
NI+ + S+ ++YI EL LSD Q+F ++Q
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-QYF--------IYQ 120
Query: 336 IAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQ-- 392
+A++ +H + H D+KP N+ + N K+ DFG A ++++S
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 393 -----------EIL--NEDYDHLDKVDIFSLGATMYELIK-------------------- 419
E++ + Y +D++S G + EL
Sbjct: 181 EFVATRWYRAPEVMLTSAKYS--RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238
Query: 420 -GSPLSESGPQFLNLRDGK-----LP---------LLPGHSLQFQNLLKVMVDPDPVQRP 464
G+P S++ + + + LP + P + + +LL+ M+ DP +R
Sbjct: 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI 298
Query: 465 SAKELVENPIFDK 477
+AKE +E+P
Sbjct: 299 TAKEALEHPYLQT 311
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 53/210 (25%), Positives = 80/210 (38%), Gaps = 33/210 (15%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
+IG+G+F ++ G A+K + + +E + + I
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECV----KTKHPQLHIESKIYKMMQGGVGIPT 69
Query: 294 YYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
E + + MEL SL D S+ F+ VL Q+ +++IH K H
Sbjct: 70 IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR 129
Query: 352 DVKPDNIYV-----KNGVYKLGDFGRATLL-----NKSLPIEE-----GDARYMPQEILN 396
DVKPDN + N VY + DFG A ++ +P E G ARY +N
Sbjct: 130 DVKPDNFLMGLGKKGNLVY-IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS---IN 185
Query: 397 EDYDHLDKV-----DIFSLGATMYELIKGS 421
HL D+ SLG + GS
Sbjct: 186 ---THLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 56/313 (17%), Positives = 101/313 (32%), Gaps = 80/313 (25%)
Query: 231 FHEIEQIGAGNFSHVFKV---------LKRIDGCFYAVKHSKR-QLHHDAERRKALLEVQ 280
+ I +G++ V +KR+ + +R L E++
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR--VLREIR 81
Query: 281 ALAALGSHENIVGYY-----SSWFENEQLYIQMELCD-----------HSLSDKKASQFF 324
L H NI+G +LY+ EL +S + Q+F
Sbjct: 82 LLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI-QYF 139
Query: 325 AEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIE 383
++ I L +HE G+ H D+ P NI + N + DF A
Sbjct: 140 --------MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT 191
Query: 384 EGDA-R-YMPQEIL--NEDYDHLDKVDIFSLGATMYELIKGSPL---------------- 423
R Y E++ + + VD++S G M E+ L
Sbjct: 192 HYVTHRWYRAPELVMQFKGFT--KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249
Query: 424 -------------SESGPQFLNLRDGKLP------LLPGHSLQFQNLLKVMVDPDPVQRP 464
S S +L +P ++P +L+ M++ +P +R
Sbjct: 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309
Query: 465 SAKELVENPIFDK 477
S ++ + +P F+
Sbjct: 310 STEQALRHPYFES 322
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 44/228 (19%), Positives = 89/228 (39%), Gaps = 51/228 (22%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ +++ +G G VF + A+K + AL E++ + L H+N
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH--ALREIKIIRRL-DHDN 69
Query: 291 IVG--------------YYSSWFENEQLYIQMELCD---------HSLSDKKASQFFAEG 327
IV S E +YI E + L ++ A + F
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA-RLF--- 125
Query: 328 EVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV--KNGVYKLGDFGRATLLNKSLPIEEG 385
++Q+ + L++IH + H D+KP N+++ ++ V K+GDFG L + +
Sbjct: 126 -----MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG----LARIMDPHYS 176
Query: 386 DARYMPQ----------EILNEDYDHLDKVDIFSLGATMYELIKGSPL 423
++ + +L ++ +D+++ G E++ G L
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 51/210 (24%), Positives = 80/210 (38%), Gaps = 33/210 (15%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
+IG+G+F ++ A+K + + L E + L I
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENV----KTKHPQLLYESKIYRILQGGTGIPN 67
Query: 294 YYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
E + + M+L SL D S+ + VL Q+ ++F+H K H
Sbjct: 68 VRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
Query: 352 DVKPDNIYV-----KNGVYKLGDFGRATL-----LNKSLPIEE-----GDARYMPQEILN 396
D+KPDN + N VY + DFG A ++ +P E G ARY +N
Sbjct: 128 DIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS---VN 183
Query: 397 EDYDHLDKV-----DIFSLGATMYELIKGS 421
HL D+ SLG + ++GS
Sbjct: 184 ---THLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 58/287 (20%), Positives = 98/287 (34%), Gaps = 52/287 (18%)
Query: 234 IEQIGAGNFSHVFK----VLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSH 288
I +G G+F V G AVK K + R E+ L L H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA--DAGPQHRSGWKQEIDILRTL-YH 92
Query: 289 ENIVGYY--SSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIHE 345
E+I+ Y L + ME SL D ++L QI + + ++H
Sbjct: 93 EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 346 KGIAHLDVKPDNIYVKNG-VYKLGDFGRATLLNKS-----------LPIEEGDARYMPQE 393
+ H D+ N+ + N + K+GDFG A + + P+ + E
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-----FWYAPE 207
Query: 394 ILNED-YDHLDKVDIFSLGATMYELI-KGSPLSESGPQFLNLRDGKLPLLPGHSLQFQ-- 449
L E + + D++S G T+YEL+ +FL L + L
Sbjct: 208 CLKEYKFYY--ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 450 -------------NLLKVMVD---PDPVQRPSAKELVENPIFDKIQK 480
+ +M + + RP+ + L+ I + +
Sbjct: 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTVHE 310
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 60/279 (21%), Positives = 109/279 (39%), Gaps = 51/279 (18%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDG----CFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+ +GAG F V + + AVK K H E+ + E++ ++ LG H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSELKIMSHLGQH 109
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSD---------------KKASQFFAEGEVLKA 332
ENIV + + + E C + L + A+ + ++L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 333 LHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----------LP 381
Q+AQ + F+ K H DV N+ + V K+GDFG A + LP
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 382 IEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELI-KGS---PLSESGPQFLN-LRD 435
+ ++M E + + Y + D++S G ++E+ G P +F ++D
Sbjct: 230 V-----KWMAPESIFDCVYTV--QSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 436 GKLPLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
G P + +N+ +M +P RP+ +++
Sbjct: 283 GYQMAQPAFAP--KNIYSIMQACWALEPTHRPTFQQICS 319
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 47/233 (20%), Positives = 91/233 (39%), Gaps = 53/233 (22%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH--DAERRKALLEVQALAALGSH 288
+ ++++G G + V+K + R G AVK + DA+R E+ L L H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQR--TFREIMILTELSGH 68
Query: 289 ENIVG----YYSSWFENEQLYIQMELCD---------HSLSDKKASQFFAEGEVLKALHQ 335
ENIV + +Y+ + + + L Q+ ++Q
Sbjct: 69 ENIVNLLNVLRADNDR--DVYLVFDYMETDLHAVIRANILEPVHK-QYV--------VYQ 117
Query: 336 IAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFG--RATLLNKSLPIEEGDARYMPQ 392
+ + ++++H G+ H D+KP NI + K+ DFG R+ + + + +
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 393 EILNEDYDHL----------------------DKVDIFSLGATMYELIKGSPL 423
E ++D L +D++SLG + E++ G P+
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 65/288 (22%), Positives = 103/288 (35%), Gaps = 57/288 (19%)
Query: 234 IEQIGAGNFSHVFK----VLKRIDGCFYAVKHSKRQLHHDA-ERRKALL-EVQALAALGS 287
I Q+G GNF V L G AVK QL H ++++ E+Q L AL
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK----QLQHSGPDQQRDFQREIQILKAL-H 82
Query: 288 HENIVGYY--SSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQF 342
+ IV Y S + L + ME L D ++ +L QI + +++
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 343 IHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKS-----------LPIEEGDARYM 390
+ + H D+ NI V+ K+ DFG A LL PI +
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI-----FWY 197
Query: 391 PQEILNED-YDHLDKVDIFSLGATMYELI-KGSPLSESGPQFLNLRDGKLPLLPGHSLQF 448
E L+++ + + D++S G +YEL +FL + + + L
Sbjct: 198 APESLSDNIFSR--QSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255
Query: 449 Q---------------NLLKVMVD---PDPVQRPSAKELVENPIFDKI 478
+ ++M P P RPS L D +
Sbjct: 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP--QLDML 301
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 50/212 (23%), Positives = 83/212 (39%), Gaps = 35/212 (16%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
++IG GNF + + A+K + + LE + LGS + I
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIK----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 69
Query: 294 YYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
Y + + +EL SL D + F+ VL Q+ ++++H K + +
Sbjct: 70 VYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYR 129
Query: 352 DVKPDNIYV-------KNGVYKLGDFGRATL-----LNKSLPIEE-----GDARYMPQEI 394
DVKP+N + + ++ + DF A K +P E G ARYM
Sbjct: 130 DVKPENFLIGRPGNKTQQVIH-IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS--- 185
Query: 395 LNEDYDHLDKV-----DIFSLGATMYELIKGS 421
+N HL K D+ +LG ++GS
Sbjct: 186 IN---THLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 64/289 (22%), Positives = 107/289 (37%), Gaps = 62/289 (21%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY----AVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+ +G+G F V I AVK K + +ER + E++ + LGSH
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQLGSH 108
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH----------------SLSDKKASQFFAEGEVLKA 332
ENIV + + +Y+ E C + + + + E E L
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 333 L---------HQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--- 379
L +Q+A+ ++F+ K H D+ N+ V V K+ DFG A +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 380 -------LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELI-KGS---PLSESG 427
LP+ ++M E L E Y K D++S G ++E+ G P
Sbjct: 229 VVRGNARLPV-----KWMAPESLFEGIYTI--KSDVWSYGILLWEIFSLGVNPYPGIPVD 281
Query: 428 PQFLN-LRDGKLPLLPGH-SLQFQNLLKVMVD---PDPVQRPSAKELVE 471
F +++G P + + + + M D +RPS L
Sbjct: 282 ANFYKLIQNGFKMDQPFYATEEIYII---MQSCWAFDSRKRPSFPNLTS 327
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 62/309 (20%), Positives = 113/309 (36%), Gaps = 64/309 (20%)
Query: 216 PVITGGDGLSRYYTDFHEI--------EQIGAGNFSHVFK-VLKRIDGCFY------AVK 260
P++ G E + +G G F V ID AVK
Sbjct: 14 PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 261 HSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH------- 313
+ + + + E++ + +G H+NI+ + ++ LY+ +E
Sbjct: 74 -MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 314 -----SLSDKKASQFFAEGEVLKALH------QIAQALQFIHEKGIAHLDVKPDNIYV-K 361
+ E + Q+A+ ++++ + H D+ N+ V +
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 362 NGVYKLGDFGRATLLNKS----------LPIEEGDARYMPQEILNED-YDHLDKVDIFSL 410
N V K+ DFG A +N LP+ ++M E L + Y H + D++S
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPV-----KWMAPEALFDRVYTH--QSDVWSF 245
Query: 411 GATMYELIK--GSPLSE-SGPQFLN-LRDGK-LPLLPGHSLQFQNLLKVMVD---PDPVQ 462
G M+E+ GSP + L++G + + + + M D P Q
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMM---MRDCWHAVPSQ 302
Query: 463 RPSAKELVE 471
RP+ K+LVE
Sbjct: 303 RPTFKQLVE 311
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 62/283 (21%), Positives = 110/283 (38%), Gaps = 56/283 (19%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY----AVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+ +G G F V + ID AVK K +E R + E++ L +G H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHH 90
Query: 289 ENIVGYYSSWFENEQ-LYIQMELCDH------------SLSDKKASQFFAEGEVLKALH- 334
N+V + + L + +E C K + + L H
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 335 -----QIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--------- 379
Q+A+ ++F+ + H D+ NI + + V K+ DFG A + K
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 380 -LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELI-KGS---PLSESGPQFLN- 432
LP+ ++M E + + Y + D++S G ++E+ G+ P + +F
Sbjct: 211 RLPL-----KWMAPETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 433 LRDGK-LPLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
L++G + + + M+D +P QRP+ ELVE
Sbjct: 264 LKEGTRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVE 303
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 55/261 (21%), Positives = 98/261 (37%), Gaps = 62/261 (23%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH--DAERRKALLEVQALAALGSH 288
+ IG G++ HV + +++ A+K R D +R L E+ L L +H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR--ILREIAILNRL-NH 111
Query: 289 ENIVGYY-----SSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALH------QIA 337
+++V + ++LY+ +E+ D + F L LH +
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFK-----KLFRTPVYLTELHIKTLLYNLL 166
Query: 338 QALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRA--------------------TLL 376
++++H GI H D+KP N V ++ K+ DFG A +
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 377 NKSLPIEEGDARYMPQ----------EIL--NEDYDHLDKVDIFSLGATMYELIKGSPLS 424
+ P + R + E++ E+Y + +D++S+G EL L+
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT--EAIDVWSIGCIFAEL-----LN 279
Query: 425 ESGPQFLNLRDGKLPLLPGHS 445
D PL PG S
Sbjct: 280 MIKENVAYHADRG-PLFPGSS 299
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 56/256 (21%), Positives = 91/256 (35%), Gaps = 57/256 (22%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH--DAERRKALLEVQALAALGSH 288
+ IG G++ +V+ + A+K R D +R L E+ L L
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR--ILREITILNRL-KS 84
Query: 289 ENIVGYY-----SSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALH------QIA 337
+ I+ Y + ++LYI +E+ D L + F L H +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLK-----KLFKTPIFLTEEHIKTILYNLL 139
Query: 338 QALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRA---------------TLLNKSLP 381
FIHE GI H D+KP N + ++ K+ DFG A + P
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 382 IEEGDARYMPQ----------EIL--NEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ 429
+ + + E++ E+Y +DI+S G EL+ + P
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYT--KSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 430 FLNLRDGKLPLLPGHS 445
+ PL PG S
Sbjct: 258 ------NRFPLFPGSS 267
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 58/277 (20%), Positives = 113/277 (40%), Gaps = 42/277 (15%)
Query: 229 TDFHEIEQIGAGNFSHVFK-VLKRIDGCFY---AVKHSKRQLHHDAERRKALLEVQALAA 284
T+F +I+ +G+G F V+K + A+K + ++ L E +A+
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMAS 73
Query: 285 LGSHENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQ 341
+ + ++ + + +L L D ++ +L QIA+ +
Sbjct: 74 V-DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 342 FIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKS----------LPIEEGDARYM 390
++ ++ + H D+ N+ VK K+ DFG A LL +PI ++M
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 186
Query: 391 PQE-ILNEDYDHLDKVDIFSLGATMYELIK--GSPLSE-SGPQFLNL--RDGKLPLLPGH 444
E IL+ Y H + D++S G T++EL+ P + ++ + +LP P
Sbjct: 187 ALESILHRIYTH--QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 244
Query: 445 SLQFQNLLKVMVD---PDPVQRPSAKELVENPIFDKI 478
+ ++ +M D RP +EL+ F K+
Sbjct: 245 T---IDVYMIMRKCWMIDADSRPKFRELII--EFSKM 276
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 51/263 (19%), Positives = 103/263 (39%), Gaps = 29/263 (11%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSHENIV 292
++G G + V++ + + AVK L D + L E + + H N+V
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVK----TLKEDTMEVEEFLKEAAVMKEI-KHPNLV 279
Query: 293 GYYSSWFENEQLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKGI 348
YI E + +L D + Q + +L QI+ A++++ +K
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339
Query: 349 AHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM-----PQEILNEDYDHL 402
H ++ N V +N + K+ DFG + L+ A++ P+ + +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI- 398
Query: 403 DKVDIFSLGATMYELI-------KGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVM 455
K D+++ G ++E+ G LS+ +D ++ G + L++
Sbjct: 399 -KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--EKDYRMERPEGCPEKVYELMRAC 455
Query: 456 VDPDPVQRPSAKELVENPIFDKI 478
+P RPS E+ + F+ +
Sbjct: 456 WQWNPSDRPSFAEIHQ--AFETM 476
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 58/283 (20%), Positives = 111/283 (39%), Gaps = 56/283 (19%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY------AVKHSKRQLHHDAERRKALLEVQALAALG 286
+ +G G F V +D AVK K + + + E++ + +G
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMIG 132
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDH------------SLSDKKASQFFAEGEVLKALH 334
H+NI+ + ++ LY+ +E + + E L +
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 335 ------QIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-------- 379
Q+A+ ++++ K H D+ N+ V ++ V K+ DFG A ++
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 380 --LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIK--GSPLSE-SGPQFLN- 432
LP+ ++M E L + Y H + D++S G ++E+ GSP +
Sbjct: 253 GRLPV-----KWMAPEALFDRIYTH--QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 433 LRDG-KLPLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
L++G ++ + + + M D P QRP+ K+LVE
Sbjct: 306 LKEGHRMDKPSNCTNELYMM---MRDCWHAVPSQRPTFKQLVE 345
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 60/283 (21%), Positives = 108/283 (38%), Gaps = 56/283 (19%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY------AVKHSKRQLHHDAERRKALLEVQALAALG 286
+ +G G F V ID AVK K + + + E++ + +G
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIG 144
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDH------------SLSDKKASQFFAEGEVLKALH 334
H+NI+ + ++ LY+ +E + E +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 335 ------QIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-------- 379
Q+A+ ++++ + H D+ N+ V +N V K+ DFG A +N
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 380 --LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIK--GSPL-SESGPQFLN- 432
LP+ ++M E L + Y H + D++S G M+E+ GSP +
Sbjct: 265 GRLPV-----KWMAPEALFDRVYTH--QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317
Query: 433 LRDGK-LPLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
L++G + + + + M D P QRP+ K+LVE
Sbjct: 318 LKEGHRMDKPANCTNELYMM---MRDCWHAVPSQRPTFKQLVE 357
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 56/275 (20%), Positives = 101/275 (36%), Gaps = 47/275 (17%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY--AVKHSKRQLHHDA---ERRKALLEVQALAALGS 287
+ IG+G+ V L+ A+K L +RR L E +
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIK----ALKAGYTERQRRDFLSEASIMGQF-D 108
Query: 288 HENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIH 344
H NI+ I E ++ SL + F +++ L + ++++
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-----------LPIEEGDARYMPQ 392
+ G H D+ N+ V N V K+ DFG + +L +PI R+
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI-----RWTAP 223
Query: 393 EILNED-YDHLDKVDIFSLGATMYELI-KG-SPLSE-SGPQFLNL--RDGKLPLLPGHSL 446
E + + D++S G M+E++ G P + ++ +LP G
Sbjct: 224 EAIAFRTFSS--ASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP- 280
Query: 447 QFQNLLKVMVD---PDPVQRPSAKELVENPIFDKI 478
L ++M+D D QRP ++V + D +
Sbjct: 281 --HALHQLMLDCWHKDRAQRPRFSQIVS--VLDAL 311
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 63/285 (22%), Positives = 103/285 (36%), Gaps = 38/285 (13%)
Query: 216 PVITGGDGLSRYYTDFHEI--------EQIGAGNFSHVFK-VLKRIDGCFY--AVKHSKR 264
+I D + T +EI IG G F V + + + A+K + +
Sbjct: 369 EIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-TCK 427
Query: 265 QLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKAS 321
D+ R K L E + H +IV ++I MELC L +
Sbjct: 428 NCTSDSVREKFLQEALTMRQF-DHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK 485
Query: 322 QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379
++ +Q++ AL ++ K H D+ N+ V N KLGDFG + + S
Sbjct: 486 FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
Query: 380 --------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK--GSPLSE-SGP 428
LPI ++M E +N D++ G M+E++ P
Sbjct: 546 YYKASKGKLPI-----KWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599
Query: 429 QFLNL--RDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471
+ +LP+ P +L+ DP +RP EL
Sbjct: 600 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 9e-11
Identities = 68/291 (23%), Positives = 118/291 (40%), Gaps = 69/291 (23%)
Query: 230 DFHEIEQIGAGNFSHVFK-VLKRIDGCFYAVKHSKRQLHHDAER--RKALLEVQALAALG 286
+F IG G F V+K VL+ DG A+K + ++ + + E++ L+
Sbjct: 40 NFDHKFLIGHGVFGKVYKGVLR--DGAKVALK----RRTPESSQGIEEFETEIETLSFC- 92
Query: 287 SHENIV---GYYSSWFENEQL---YIQME---LCDHSLSDKKASQFFAEGEV-LKALHQI 336
H ++V G+ E ++ Y ME L H L E L+
Sbjct: 93 RHPHLVSLIGFCD---ERNEMILIYKYMENGNLKRH-LYGSDLPTMSMSWEQRLEICIGA 148
Query: 337 AQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---------GD 386
A+ L ++H + I H DVK NI + +N V K+ DFG ++K + G
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFG----ISKKGTELDQTHLSTVVKGT 204
Query: 387 ARYMPQEILNEDY---DHL-DKVDIFSLGATMYELIKG-SPLSESGP-QFLNL------- 433
Y+ E Y L +K D++S G ++E++ S + +S P + +NL
Sbjct: 205 LGYIDPE-----YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 434 -RDGKL-----PLLPGHSLQFQNLLKVM------VDPDPVQRPSAKELVEN 472
+G+L P L ++ ++L K + RPS +++
Sbjct: 260 HNNGQLEQIVDPNLADK-IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 38/226 (16%), Positives = 67/226 (29%), Gaps = 48/226 (21%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVK------HSKRQLHHDA--ERRKALLEVQALAAL 285
++IG+G F ++ A L + +R A +
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 286 GSHENIVG-----YYSSWFENEQLY--IQMELCDHSLSDK-KASQFFAEGEVLKALHQIA 337
+ +G + Y + ME L + F + VL+ ++
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRML 161
Query: 338 QALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATL-------------LNKSL 380
L++IHE H D+K N+ + + VY L D+G + K
Sbjct: 162 DVLEYIHENEYVHGDIKAANLLLGYKNPDQVY-LADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 381 PIEEGDARYMPQEILNEDYDHLDKV-----DIFSLGATMYELIKGS 421
G + L+ H D+ LG M + G
Sbjct: 221 ---NGTIEFTS---LD---AHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 63/291 (21%), Positives = 112/291 (38%), Gaps = 52/291 (17%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY-AVKHSKRQLHHDAERRKALLEVQALAALGSHENI 291
+ IG GNF V K +K+ A+K K + + R E++ L LG H NI
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 292 VGYYSSWFENEQLYIQMELCDH------------------SLSDKKASQFFAEGEVLKAL 333
+ + LY+ +E H + + ++L
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 334 HQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFG--------RATLLNKSLPIEE 384
+A+ + ++ +K H D+ NI V +N V K+ DFG + + LP+
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR-LPV-- 205
Query: 385 GDARYMPQEILNED-YDHLDKVDIFSLGATMYELIK--GSPLSE-SGPQFLN-LRDGK-L 438
R+M E LN Y D++S G ++E++ G+P + + L G L
Sbjct: 206 ---RWMAIESLNYSVYTT--NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 260
Query: 439 PLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVENPIFDKIQKHRKTYM 486
+ +M P +RPS +++ +++ + RKTY+
Sbjct: 261 EKPLNCD---DEVYDLMRQCWREKPYERPSFAQILV--SLNRMLEERKTYV 306
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 38/227 (16%), Positives = 77/227 (33%), Gaps = 47/227 (20%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCF--------YAVK--HSKRQLHHDA---ERRKALLEVQ 280
N +++ +++K +L ++ +R L+V
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 281 ALAALGSHENIVG----YYSSWFENEQLYIQMELCDHSLSD---KKASQFFAEGEVLKAL 333
L S ++ +++ ++ + SL +E VL+
Sbjct: 107 KWKKLYS-TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVA 165
Query: 334 HQIAQALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLL---NKSLPIEE-- 384
++ AL+F+HE H +V +NI+V ++ V L +G A K + E
Sbjct: 166 CRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVT-LAGYGFAFRYCPSGKHVAYVEGS 224
Query: 385 -----GDARYMPQEILNEDYDHLDKV-----DIFSLGATMYELIKGS 421
GD ++ ++ H D+ SLG M + + G
Sbjct: 225 RSPHEGDLEFIS---MD---LHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 51/273 (18%), Positives = 96/273 (35%), Gaps = 45/273 (16%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY--AVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ +G G F V + LK+ DG AVK K E + L E + SH N
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPN 97
Query: 291 IVGYY-----SSWFENEQLYIQMELCDH--------SLSDKKASQFFAEGEVLKALHQIA 337
++ S + + + + + + +LK + IA
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 338 QALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----------LPIEEGD 386
++++ + H D+ N + + + DFG + + +P+
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---- 213
Query: 387 ARYMPQEILNED-YDHLDKVDIFSLGATMYELIK--GSPLSE-SGPQFLN-LRDGKLPLL 441
+++ E L + Y K D+++ G TM+E+ +P + + L G
Sbjct: 214 -KWIAIESLADRVYTS--KSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ 270
Query: 442 PGHSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
P L L ++M DP+ RP+ L
Sbjct: 271 PEDCLD--ELYEIMYSCWRTDPLDRPTFSVLRL 301
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 63/282 (22%), Positives = 109/282 (38%), Gaps = 47/282 (16%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY--AVKHSKRQLHHDA---ERRKALLEVQALAALGS 287
+ +GAG F V LK A+K L +RR L E +
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIK----TLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 288 HENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIH 344
H NI+ +++ + I E ++ SL +K F +++ L IA ++++
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-----------LPIEEGDARYMPQ 392
+ G H D+ NI + N V K+ DFG +L +PI R+
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI-----RWTSP 219
Query: 393 EILNEDYDHL-DKVDIFSLGATMYELI-KG-SPLSE-SGPQFLNL--RDGKLPLLPGHSL 446
E + Y D++S G ++E++ G P E S + +LP
Sbjct: 220 EAIA--YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP- 276
Query: 447 QFQNLLKVMVD---PDPVQRPSAKELVENPIFDKIQKHRKTY 485
L ++M+D D RP +++V I DK+ ++ +
Sbjct: 277 --AALYQLMLDCWQKDRNNRPKFEQIVS--ILDKLIRNPGSL 314
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 63/283 (22%), Positives = 110/283 (38%), Gaps = 49/283 (17%)
Query: 229 TDFHEIEQIGAGNFSHVFK-VLKRIDGCFY--AVKHSKRQLHHDAERRKALL-EVQALAA 284
D +E++G G+F V + G AVK K + E + EV A+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 285 LGSHENIVGYY---SSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQ 338
L H N++ Y + + + EL SL D +K F G + + Q+A+
Sbjct: 78 L-DHRNLIRLYGVVLT----PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 132
Query: 339 ALQFIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKS-----------LPIEEGD 386
+ ++ K H D+ N+ + + K+GDFG L ++ +P
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---- 188
Query: 387 ARYMPQE-ILNEDYDHLDKVDIFSLGATMYELI-KG-SPLSE-SGPQFLNL--RDG-KLP 439
+ E + + H D + G T++E+ G P +G Q L+ ++G +LP
Sbjct: 189 -AWCAPESLKTRTFSH--ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 440 LLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVENPIFDKIQ 479
Q++ VMV P RP+ L + + Q
Sbjct: 246 RPEDCP---QDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQ 283
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 3e-10
Identities = 48/198 (24%), Positives = 79/198 (39%), Gaps = 28/198 (14%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIV 292
++ IG G F V + G AVK + +DA + L E + L H N+V
Sbjct: 26 LQTIGKGEFGDVMLGDYR---GNKVAVK----CIKNDATAQAFLAEASVMTQL-RHSNLV 77
Query: 293 GYYSSWFENE-QLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKG 347
E + LYI E SL D + +LK + +A++++
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRA-----TLLNKSLPIEEGDARYMPQEILNED-YD 400
H D+ N+ V ++ V K+ DFG T LP+ ++ E L E +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFS 192
Query: 401 HLDKVDIFSLGATMYELI 418
K D++S G ++E+
Sbjct: 193 T--KSDVWSFGILLWEIY 208
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 36/229 (15%), Positives = 70/229 (30%), Gaps = 51/229 (22%)
Query: 234 IEQIGAGNFSHVFKVLKRI-----DGCFYAVKHSKR---QLHHDAERRKALLEVQALAAL 285
IG G F ++ VK L + + + + + +
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 286 GSHENIVG-------YYSSWFENEQLY--IQMELCDHSLSD--KKASQFFAEGEVLKALH 334
+ +N + Y + M+ L + ++ F+ VL+
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLL-------------N 377
+I L++IHE H D+K N+ + + VY L D+G A
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY-LVDYGLAYRYCPEGVHKAYAADPK 218
Query: 378 KSLPIEEGDARYMPQEILNEDYDHLDKV-----DIFSLGATMYELIKGS 421
+ +G + ++ H D+ LG M + + G
Sbjct: 219 RCH---DGTIEFTS---ID---AHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 61/263 (23%), Positives = 100/263 (38%), Gaps = 38/263 (14%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY--AVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
IG G F V + + + A+K + + D+ R K L E + H +
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCTSDSVREKFLQEALTMRQF-DHPH 77
Query: 291 IVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKG 347
IV ++I MELC L + ++ +Q++ AL ++ K
Sbjct: 78 IVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---------LPIEEGDARYMPQEILNE 397
H D+ N+ V N KLGDFG + + S LPI ++M E +N
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI-----KWMAPESINF 191
Query: 398 D-YDHLDKVDIFSLGATMYELI-KG-SPLSE-SGPQFLN-LRDG-KLPLLPGHSLQFQNL 451
+ D++ G M+E++ G P + + +G +LP+ P L
Sbjct: 192 RRFTS--ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP---PTL 246
Query: 452 LKVMVD---PDPVQRPSAKELVE 471
+M DP +RP EL
Sbjct: 247 YSLMTKCWAYDPSRRPRFTELKA 269
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 44/206 (21%), Positives = 82/206 (39%), Gaps = 28/206 (13%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGS 287
TD ++G G + V++ + + AVK L D + L E + +
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK----TLKEDTMEVEEFLKEAAVMKEI-K 67
Query: 288 HENIVGYYSSWFENEQLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIAQALQFI 343
H N+V YI E + +L D + Q + +L QI+ A++++
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---------LPIEEGDARYMPQE 393
+K H D+ N V +N + K+ DFG + L+ PI ++ E
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-----KWTAPE 182
Query: 394 ILNED-YDHLDKVDIFSLGATMYELI 418
L + + K D+++ G ++E+
Sbjct: 183 SLAYNKFSI--KSDVWAFGVLLWEIA 206
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 61/280 (21%), Positives = 102/280 (36%), Gaps = 45/280 (16%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSHENI 291
++G G F V+ A+K L +A L E Q + L HE +
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRV--AIK----TLKPGTMSPEAFLQEAQVMKKL-RHEKL 241
Query: 292 VGYYSSWFENEQLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKG 347
V Y+ E E +YI E SL D + ++ +++ QIA + ++
Sbjct: 242 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---------KSLPIEEGDARYMPQEILNE 397
H D++ NI V +N V K+ DFG A L+ PI ++ E
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-----KWTAPEAALY 355
Query: 398 D-YDHLDKVDIFSLGATMYELI-------KGSPLSESGPQFLNLRDG-KLPLLPGHSLQF 448
+ K D++S G + EL G E Q + G ++P P
Sbjct: 356 GRFTI--KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERGYRMPCPPECPESL 410
Query: 449 QNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMKP 488
+L+ +P +RP+ + L + + +P
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQA--FLEDYFTSTEPQYQP 448
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 64/296 (21%), Positives = 103/296 (34%), Gaps = 53/296 (17%)
Query: 216 PVITGGDGLSRYYTDFHEI--------EQIGAGNFSHVFK-VLKRIDGCFYAVKHSKRQL 266
T D EI ++G G F V+ A+K L
Sbjct: 246 VCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV--AIK----TL 299
Query: 267 HHDAERRKALL-EVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSD---KKAS 321
+A L E Q + L HE +V Y+ E E +YI E SL D +
Sbjct: 300 KPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG 357
Query: 322 QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN--- 377
++ +++ QIA + ++ H D++ NI V +N V K+ DFG A L+
Sbjct: 358 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
Query: 378 ------KSLPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELI-------KGSPL 423
PI ++ E + K D++S G + EL G
Sbjct: 418 YTARQGAKFPI-----KWTAPEAALYGRFTI--KSDVWSFGILLTELTTKGRVPYPGMVN 470
Query: 424 SESGPQFLNLRDG-KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478
E Q + G ++P P +L+ +P +RP+ + L +
Sbjct: 471 REVLDQ---VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA--FLEDY 521
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 62/286 (21%), Positives = 108/286 (37%), Gaps = 46/286 (16%)
Query: 229 TDFHEIEQIGAGNFSHVFK-VLKRIDGCFY---AVKHSKRQLHHDAERRKALLEVQALAA 284
T+ +++ +G+G F V K V +K + + A+ +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK-VIEDKSGRQSFQAVTDHMLAIGS 71
Query: 285 LGSHENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQ 341
L H +IV L + + SL D ++ +L QIA+ +
Sbjct: 72 L-DHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 342 FIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKS----------LPIEEGDARYM 390
++ E G+ H ++ N+ +K ++ DFG A LL PI ++M
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI-----KWM 184
Query: 391 PQE-ILNEDYDHLDKVDIFSLGATMYELI-------KGSPLSESGPQFLNLRDGKLPLLP 442
E I Y H + D++S G T++EL+ G L+E P L + +L
Sbjct: 185 ALESIHFGKYTH--QSDVWSYGVTVWELMTFGAEPYAGLRLAEV-PDLLE-KGERLAQPQ 240
Query: 443 GHSLQFQNLLKVMVD---PDPVQRPSAKELVENPIFDKIQKHRKTY 485
+ ++ VMV D RP+ KEL F ++ + Y
Sbjct: 241 ICT---IDVYMVMVKCWMIDENIRPTFKELAN--EFTRMARDPPRY 281
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 6e-10
Identities = 44/206 (21%), Positives = 81/206 (39%), Gaps = 30/206 (14%)
Query: 229 TDFHEIEQIGAGNFSHVFK-VLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALG 286
++ +++IG+G F V D A+K + A + + E + + L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV--AIK----TIREGAMSEEDFIEEAEVMMKL- 60
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFI 343
SH +V Y E + + E +H LSD + FA +L + + + ++
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---------LPIEEGDARYMPQE 393
E + H D+ N V +N V K+ DFG + P+ ++ E
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-----KWASPE 175
Query: 394 ILNED-YDHLDKVDIFSLGATMYELI 418
+ + Y K D++S G M+E+
Sbjct: 176 VFSFSRYSS--KSDVWSFGVLMWEVF 199
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 6e-10
Identities = 44/271 (16%), Positives = 97/271 (35%), Gaps = 49/271 (18%)
Query: 229 TDFHEIEQIGAGNFSHVFK-VLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALG 286
+ ++++G+G F V K AVK + + E Q + L
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV--AVK----MIKEGSMSEDEFFQEAQTMMKL- 60
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFI 343
SH +V +Y + +YI E + L + + + ++L+ + + + + F+
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---------LPIEEGDARYMPQE 393
H D+ N V ++ K+ DFG + P+ ++ E
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV-----KWSAPE 175
Query: 394 ILNEDYDHLDKV-----DIFSLGATMYELI-KG-SPLSE-SGPQFLNL--RDGKLPLLPG 443
+ + D+++ G M+E+ G P + + + + +L
Sbjct: 176 VFH------YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHL 229
Query: 444 HSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
S + ++M P +RP+ ++L+
Sbjct: 230 AS---DTIYQIMYSCWHELPEKRPTFQQLLS 257
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 7e-10
Identities = 58/263 (22%), Positives = 95/263 (36%), Gaps = 38/263 (14%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY--AVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+G G F V++ V G AVK + ++ + K + E + L H +
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVK-TCKKDCTLDNKEKFMSEAVIMKNL-DHPH 74
Query: 291 IVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKG 347
IV E E +I MEL + L ++ ++ QI +A+ ++
Sbjct: 75 IVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---------LPIEEGDARYMPQEILNE 397
H D+ NI V KLGDFG + + LPI ++M E +N
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI-----KWMSPESINF 188
Query: 398 D-YDHLDKVDIFSLGATMYELI-KG-SPLSE-SGPQFLNL--RDGKLPLLPGHSLQFQNL 451
+ D++ M+E++ G P + + + +LP L
Sbjct: 189 RRFTT--ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCP---PVL 243
Query: 452 LKVMVD---PDPVQRPSAKELVE 471
+M DP RP ELV
Sbjct: 244 YTLMTRCWDYDPSDRPRFTELVC 266
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 48/274 (17%), Positives = 98/274 (35%), Gaps = 46/274 (16%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY--AVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+G G F V + LK+ DG F AVK K + ++ + L E + H +
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPH 86
Query: 291 IVGYY------SSWFENEQLYIQMELCDH--------SLSDKKASQFFAEGEVLKALHQI 336
+ + + + H + + +++ + I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 337 AQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----------LPIEEG 385
A ++++ + H D+ N + ++ + DFG + + LP+
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV--- 203
Query: 386 DARYMPQEILNED-YDHLDKVDIFSLGATMYELIK--GSPLSE-SGPQFLN-LRDGKLPL 440
+++ E L ++ Y D+++ G TM+E++ +P + + N L G
Sbjct: 204 --KWLALESLADNLYTV--HSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259
Query: 441 LPGHSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
P + + + +M DP QRPS L
Sbjct: 260 QPPECM--EEVYDLMYQCWSADPKQRPSFTCLRM 291
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 58/284 (20%), Positives = 115/284 (40%), Gaps = 42/284 (14%)
Query: 229 TDFHEIEQIGAGNFSHVFK-VLKRIDGCFY---AVKHSKRQLHHDAERRKALLEVQALAA 284
T+F +I+ +G+G F V+K + A+K + ++ L E +A+
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMAS 73
Query: 285 LGSHENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQ 341
+ + ++ + + +L L D ++ +L QIA+ +
Sbjct: 74 V-DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 342 FIHEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKS----------LPIEEGDARYM 390
++ ++ + H D+ N+ VK K+ DFG A LL +PI ++M
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 186
Query: 391 PQEILNED-YDHLDKVDIFSLGATMYELIK--GSPLSE-SGPQFLNL--RDGKLPLLPGH 444
E + Y H + D++S G T++EL+ P + ++ + +LP P
Sbjct: 187 ALESILHRIYTH--QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 244
Query: 445 SLQFQNLLKVMVD---PDPVQRPSAKELVENPIFDKIQKHRKTY 485
+ ++ +MV D RP +EL+ F K+ + + Y
Sbjct: 245 T---IDVYMIMVKCWMIDADSRPKFRELII--EFSKMARDPQRY 283
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 9e-10
Identities = 51/274 (18%), Positives = 105/274 (38%), Gaps = 47/274 (17%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY----AVKHSKRQLHHDAERRKALLEVQALAALGSH 288
++G G+F V++ V K + A+K + + ER + L E +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK-TVNEAASMRERIEFLNEASVMKEFN-C 87
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH------------SLSDKKASQFFAEGEVLKALHQI 336
++V + + + MEL ++++ + ++++ +I
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 337 AQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----------LPIEEG 385
A + +++ H D+ N V ++ K+GDFG + ++ LP+
Sbjct: 148 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV--- 204
Query: 386 DARYMPQEILNED-YDHLDKVDIFSLGATMYELIK--GSPLSE-SGPQFLN-LRDGKLPL 440
R+M E L + + D++S G ++E+ P S Q L + +G L
Sbjct: 205 --RWMSPESLKDGVFTT--YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 260
Query: 441 LPGHSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
P + L ++M +P RPS E++
Sbjct: 261 KPDNCPD--MLFELMRMCWQYNPKMRPSFLEIIS 292
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 48/208 (23%), Positives = 85/208 (40%), Gaps = 35/208 (16%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY---AVKHSKRQLHHDA---ERRKALLEVQALAALG 286
+ IGAG F V+K +LK G A+K L +R L E +
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK----TLKAGYTEKQRVDFLGEAGIMGQF- 103
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFI 343
SH NI+ + + + I E ++ +L ++ F+ +++ L IA ++++
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-----------LPIEEGDARYMP 391
H D+ NI V N V K+ DFG + +L +PI R+
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI-----RWTA 218
Query: 392 QEILNED-YDHLDKVDIFSLGATMYELI 418
E ++ + D++S G M+E++
Sbjct: 219 PEAISYRKFTS--ASDVWSFGIVMWEVM 244
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 60/300 (20%), Positives = 106/300 (35%), Gaps = 64/300 (21%)
Query: 223 GLSRYYTDFHEI--------EQIGAGNFSHVFK-VLKRIDGCFY----AVKHSKRQLHHD 269
G I ++G G F VF + AVK K
Sbjct: 1 GAMHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTL 58
Query: 270 AERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH---------------- 313
A R+ E + L L HE+IV +Y + + L + E H
Sbjct: 59 AARKDFQREAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMI 117
Query: 314 --SLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDF 370
++A ++L QIA + ++ + H D+ N V N + K+GDF
Sbjct: 118 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF 177
Query: 371 GRATLLNKS----------LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIK 419
G + + + LPI R+MP E + + + D++S G ++E+
Sbjct: 178 GMSRDVYSTDYYRVGGHTMLPI-----RWMPPESIMYRKFTT--ESDVWSFGVILWEIFT 230
Query: 420 --GSPLSE-SGPQFLN-LRDGK-LPLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
P + S + + + G+ L + ++ M+ +P QR + KE+ +
Sbjct: 231 YGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDV---MLGCWQREPQQRLNIKEIYK 287
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 44/219 (20%), Positives = 77/219 (35%), Gaps = 39/219 (17%)
Query: 231 FHEI--------EQIGAGNFSHVFK-VLKRIDGCFY------AVKHSKRQLHHDAERRKA 275
FH+I E +G G F+ +FK V + + +K + H
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESF 59
Query: 276 LLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKA 332
++ L SH+++V Y ++ + E SL KK L+
Sbjct: 60 FEAASMMSKL-SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118
Query: 333 LHQIAQALQFIHEKGIAHLDVKPDNIYV---------KNGVYKLGDFGRATLLNKS---- 379
Q+A A+ F+ E + H +V NI + KL D G + +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELI 418
I ++P E + + D +S G T++E+
Sbjct: 179 ERI-----PWVPPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 55/298 (18%), Positives = 103/298 (34%), Gaps = 57/298 (19%)
Query: 219 TGGDGLSRYYTDFHEI--------EQIGAGNFSHVFK-VLKRIDGCFY----AVKHSKRQ 265
G + +D E+ +G G F V++ + + AVK + +
Sbjct: 53 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPE 111
Query: 266 LHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH---------SLS 316
+ + + L+E ++ +H+NIV ++ +I +EL +
Sbjct: 112 VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 170
Query: 317 DKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGR 372
A ++L IA Q++ E H D+ N + V K+GDFG
Sbjct: 171 RPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230
Query: 373 ATLLNKS----------LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIK-- 419
A + ++ LP+ ++MP E E + K D +S G ++E+
Sbjct: 231 ARDIYRAGYYRKGGCAMLPV-----KWMPPEAFMEGIFTS--KTDTWSFGVLLWEIFSLG 283
Query: 420 GSPLSE-SGPQFLN-LRDGK-LPLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
P S + L + G + + M P RP+ ++E
Sbjct: 284 YMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAIILE 338
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 42/206 (20%), Positives = 82/206 (39%), Gaps = 30/206 (14%)
Query: 229 TDFHEIEQIGAGNFSHVFK-VLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALG 286
D ++++G G F V + A+K + + + E + + L
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV--AIK----MIKEGSMSEDEFIEEAKVMMNL- 76
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFI 343
SHE +V Y + ++I E + L + ++ F ++L+ + +A++++
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---------LPIEEGDARYMPQE 393
K H D+ N V GV K+ DFG + + P+ R+ P E
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-----RWSPPE 191
Query: 394 ILNED-YDHLDKVDIFSLGATMYELI 418
+L + K DI++ G M+E+
Sbjct: 192 VLMYSKFSS--KSDIWAFGVLMWEIY 215
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 56/296 (18%), Positives = 103/296 (34%), Gaps = 57/296 (19%)
Query: 222 DGLSRYYTDFHEI--------EQIGAGNFSHVFK-VLKRIDGCFY----AVKHSKRQLHH 268
G + +D E+ +G G F V++ + + AVK + ++
Sbjct: 15 AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCS 73
Query: 269 DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH---------SLSDKK 319
+ + L+E ++ +H+NIV ++ +I MEL +
Sbjct: 74 EQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS 132
Query: 320 ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATL 375
A ++L IA Q++ E H D+ N + V K+GDFG A
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
Query: 376 LNKS----------LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIK--GSP 422
+ ++ LP+ ++MP E E + K D +S G ++E+ P
Sbjct: 193 IYRASYYRKGGCAMLPV-----KWMPPEAFMEGIFTS--KTDTWSFGVLLWEIFSLGYMP 245
Query: 423 LSE-SGPQFLN-LRDGK-LPLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVEN 472
S + L + G + + M P RP+ ++E
Sbjct: 246 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAIILER 298
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 71/388 (18%), Positives = 114/388 (29%), Gaps = 140/388 (36%)
Query: 213 GLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAER 272
G V G RY H I ++G G+FS V+ F A+K K H+
Sbjct: 25 GYHLVKIGDLFNGRY----HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY---T 77
Query: 273 RKALLEVQALAALGS-------HENIVGYYSSWFENEQLYIQ----------MELCDHSL 315
AL E++ L ++ + E +V F+ I E+ H L
Sbjct: 78 ETALDEIRLLKSVRNSDPNDPNREMVVQLLDD-FK-----ISGVNGTHICMVFEVLGHHL 131
Query: 316 SD-KKASQF--FAEGEVLKALHQIAQALQFIHEK-GIAHLDVKPDNI------------- 358
S + V K + Q+ Q L ++H K I H D+KP+NI
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191
Query: 359 -------------------------------------YVKNGVYKLGDFGRATLLNKSLP 381
+ K+ D G A ++K
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT 251
Query: 382 IEEGDARYMPQE-ILNEDYDHLDKVDIFSLGATMYELIKGSPL----------------- 423
+ +Y E ++ Y+ DI+S +EL G L
Sbjct: 252 EDIQTRQYRSLEVLIGSGYNT--PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIA 309
Query: 424 ----------------SESGPQFLNLRDGKL---PLLPGHSL----------------QF 448
+ +F + G L L L F
Sbjct: 310 LIIELLGKVPRKLIVAGKYSKEFFT-KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGF 368
Query: 449 QNLLKVMVDPDPVQRPSAKELVENPIFD 476
+ L M++ P +R +A E + +P +
Sbjct: 369 TDFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 60/269 (22%), Positives = 103/269 (38%), Gaps = 41/269 (15%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIV 292
++ IG G F V + G AVK + +DA + L E + L H N+V
Sbjct: 198 LQTIGKGEFGDVMLGDYR---GNKVAVK----CIKNDATAQAFLAEASVMTQL-RHSNLV 249
Query: 293 GYYSSWFENE-QLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKG 347
E + LYI E SL D + +LK + +A++++
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNED-YD 400
H D+ N+ V ++ V K+ DFG + + LP+ ++ E L E +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFS 364
Query: 401 HLDKVDIFSLGATMYELI-------KGSPLSESGPQFLNLRDG-KLPLLPGHSLQFQNLL 452
K D++S G ++E+ PL + + G K+ G +++
Sbjct: 365 T--KSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEKGYKMDAPDGCPPAVYDVM 419
Query: 453 KVMVDPDPVQRPSAKELVENPIFDKIQKH 481
K D RP+ +L E + I+ H
Sbjct: 420 KNCWHLDAATRPTFLQLRE--QLEHIRTH 446
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 61/327 (18%), Positives = 116/327 (35%), Gaps = 73/327 (22%)
Query: 216 PVITGGDGLSRYYTDFHEI--------EQIGAGNFSHVFK-VLKRIDGCFY----AVKHS 262
P+ D E + +G G F V K + G AVK
Sbjct: 2 PLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML 61
Query: 263 KRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH--------- 313
K + +E R L E L + H +++ Y + ++ L + +E +
Sbjct: 62 K-ENASPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRE 119
Query: 314 -----------SLSDKKASQFFAEGEVLKALH------QIAQALQFIHEKGIAHLDVKPD 356
S +S + L QI+Q +Q++ E + H D+
Sbjct: 120 SRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179
Query: 357 NIYV-KNGVYKLGDFGRATLLNKS----------LPIEEGDARYMPQEILNED-YDHLDK 404
NI V + K+ DFG + + + +P+ ++M E L + Y +
Sbjct: 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPV-----KWMAIESLFDHIYTT--Q 232
Query: 405 VDIFSLGATMYELIK--GSPL-SESGPQFLN-LRDGK-LPLLPGHSLQFQNLLKVMVD-- 457
D++S G ++E++ G+P + N L+ G + S + L M+
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRL---MLQCW 289
Query: 458 -PDPVQRPSAKELVENPIFDKIQKHRK 483
+P +RP ++ + +K+ R+
Sbjct: 290 KQEPDKRPVFADISK--DLEKMMVKRR 314
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 53/262 (20%), Positives = 98/262 (37%), Gaps = 39/262 (14%)
Query: 236 QIGAGNFSHVFK-VLKRIDGCFY-AVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
++G GNF V + V + A+K +Q A+ + + E Q + L + IV
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIK-VLKQGTEKADTEEMMREAQIMHQL-DNPYIVR 74
Query: 294 YYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAH 350
+ E L + ME+ L + V + LHQ++ ++++ EK H
Sbjct: 75 LIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 351 LDVKPDNIYV-KNGVYKLGDFGRATLLNKS-----------LPIEEGDARYMPQE-ILNE 397
D+ N+ + K+ DFG + L P+ ++ E I
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL-----KWYAPECINFR 188
Query: 398 DYDHLDKVDIFSLGATMYELI-KG-SPLSE-SGPQFLNL--RDGKLPLLPGHSLQFQNLL 452
+ + D++S G TM+E + G P + GP+ + + ++ P L
Sbjct: 189 KFSS--RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP---PELY 243
Query: 453 KVMVD---PDPVQRPSAKELVE 471
+M D RP + +
Sbjct: 244 ALMSDCWIYKWEDRPDFLTVEQ 265
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 57/266 (21%), Positives = 104/266 (39%), Gaps = 37/266 (13%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIV 292
+++GAG F V+ + AVK K L E + L H+ +V
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKV--AVKTMKP---GSMSVEAFLAEANVMKTL-QHDKLV 246
Query: 293 GYYSSWFENEQLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKGI 348
++ + E +YI E SL D +++ QIA+ + FI ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 349 AHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---------LPIEEGDARYMPQEILNED 398
H D++ NI V + V K+ DFG A ++ + PI ++ E +N
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI-----KWTAPEAIN-- 358
Query: 399 YDHLD-KVDIFSLGATMYELI-KG-SPLSE-SGPQFLNL--RDGKLPLLPGHSLQFQNLL 452
+ K D++S G + E++ G P S P+ + R ++P + N++
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 418
Query: 453 KVMVDPDPVQRPSAKELVENPIFDKI 478
P +RP+ + + + D
Sbjct: 419 MRCWKNRPEERPTFEYIQS--VLDDF 442
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 8e-09
Identities = 45/202 (22%), Positives = 87/202 (43%), Gaps = 24/202 (11%)
Query: 233 EIEQIGAGNFSHVFK-VLKRIDGCFY-AVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
E +++G+GNF V K + AVK K + + A + + L E + L +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPY 79
Query: 291 IVGYYSSWFENEQLYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGI 348
IV E E + ME+ + L+ + ++ + +++ +HQ++ ++++ E
Sbjct: 80 IVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 349 AHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR-----------YMPQEILN 396
H D+ N+ + K+ DFG L+K+L +E + Y P+ I
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFG----LSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 397 EDYDHLDKVDIFSLGATMYELI 418
+ K D++S G M+E
Sbjct: 195 YKFSS--KSDVWSFGVLMWEAF 214
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 59/266 (22%), Positives = 102/266 (38%), Gaps = 39/266 (14%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY--AVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
E IG G+F V+ L DG AVK S ++ E + L E + SH N
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK-SLNRITDIGEVSQFLTEGIIMKDF-SHPN 87
Query: 291 IVGYYSSWFENE-QLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEK 346
++ +E + + H L + + + +++ Q+A+ ++++ K
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS------------LPIEEGDARYMPQE 393
H D+ N + + K+ DFG A + LP+ ++M E
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-----KWMALE 202
Query: 394 ILNED-YDHLDKVDIFSLGATMYELIK--GSPLSESGPQ--FLNLRDGKLPLLPGHSLQF 448
L + K D++S G ++EL+ P + + L G+ L P +
Sbjct: 203 SLQTQKFTT--KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP-- 258
Query: 449 QNLLKVMVD---PDPVQRPSAKELVE 471
L +VM+ P RPS ELV
Sbjct: 259 DPLYEVMLKCWHPKAEMRPSFSELVS 284
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 44/200 (22%), Positives = 82/200 (41%), Gaps = 26/200 (13%)
Query: 236 QIGAGNFSHVFK-VLKRIDGCFY-AVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
++G GNF V + V + A+K K+ A+ + + E Q + L + IV
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQL-DNPYIVR 400
Query: 294 YYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAH 350
+ E L + ME+ L + V + LHQ++ ++++ EK H
Sbjct: 401 LIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 351 LDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR-----------YMPQEILNED 398
++ N+ + K+ DFG L+K+L ++ Y P+ I
Sbjct: 460 RNLAARNVLLVNRHYAKISDFG----LSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 399 YDHLDKVDIFSLGATMYELI 418
+ + D++S G TM+E +
Sbjct: 516 FSS--RSDVWSYGVTMWEAL 533
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 56/280 (20%), Positives = 102/280 (36%), Gaps = 55/280 (19%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY----AVKHSKRQLHHDAERRKALLEVQALAALGSH 288
++G G F VF + AVK K ++ R+ E + L L H
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTML-QH 102
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-----------------SLSDKKASQFFAEGEVLK 331
++IV ++ E L + E H + + A G++L
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 332 ALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----------L 380
Q+A + ++ H D+ N V + V K+GDFG + + + L
Sbjct: 163 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 381 PIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIK--GSPLSE-SGPQFLN-LRD 435
PI R+MP E + + + D++S G ++E+ P + S + ++ +
Sbjct: 223 PI-----RWMPPESILYRKFTT--ESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275
Query: 436 GK-LPLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
G+ L + + M +P QR S K++
Sbjct: 276 GRELERPRACPPEVYAI---MRGCWQREPQQRHSIKDVHA 312
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 60/266 (22%), Positives = 102/266 (38%), Gaps = 39/266 (14%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY--AVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
E IG G+F V+ L DG AVK S ++ E + L E + SH N
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK-SLNRITDIGEVSQFLTEGIIMKDF-SHPN 151
Query: 291 IVGYYSSWFENE-QLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEK 346
++ +E + + H L + + + +++ Q+A+ ++F+ K
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS------------LPIEEGDARYMPQE 393
H D+ N + + K+ DFG A + LP+ ++M E
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-----KWMALE 266
Query: 394 ILNED-YDHLDKVDIFSLGATMYELIK--GSPLSE-SGPQFLN-LRDGKLPLLPGHSLQF 448
L + K D++S G ++EL+ P + + L G+ L P +
Sbjct: 267 SLQTQKFTT--KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP-- 322
Query: 449 QNLLKVMVD---PDPVQRPSAKELVE 471
L +VM+ P RPS ELV
Sbjct: 323 DPLYEVMLKCWHPKAEMRPSFSELVS 348
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 3e-08
Identities = 51/281 (18%), Positives = 95/281 (33%), Gaps = 55/281 (19%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY----AVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+E++G F V+K L A+K + + R + E A L H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK-TLKDKAEGPLREEFRHEAMLRARL-QH 71
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH------------------SLSDKKASQFFAEGEVL 330
N+V +++ L + C H + D+ + +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 331 KALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---------- 379
+ QIA ++++ + H D+ N+ V K+ D G + +
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 380 LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIK--GSPLSE-SGPQFLN-LR 434
LPI R+M E + + DI+S G ++E+ P S + +R
Sbjct: 192 LPI-----RWMAPEAIMYGKFSI--DSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 244
Query: 435 DGK-LPLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
+ + LP L M++ P +RP K++
Sbjct: 245 NRQVLPCPDDCPAWVYAL---MIECWNEFPSRRPRFKDIHS 282
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 32/207 (15%)
Query: 229 TDFHEIEQIGAGNFSHVFK-VLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALG 286
+E++GAG F V+ AVK L + A L E + L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV--AVK----SLKQGSMSPDAFLAEANLMKQL- 65
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIAQALQF 342
H+ +V Y+ + E +YI E ++ SL D + ++L QIA+ + F
Sbjct: 66 QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---------LPIEEGDARYMPQ 392
I E+ H D++ NI V K+ DFG A L+ + PI ++
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-----KWTAP 179
Query: 393 EILNED-YDHLDKVDIFSLGATMYELI 418
E +N + K D++S G + E++
Sbjct: 180 EAINYGTFTI--KSDVWSFGILLTEIV 204
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 7e-08
Identities = 31/183 (16%), Positives = 53/183 (28%), Gaps = 48/183 (26%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH------SKRQLHHDAERRKALLEVQALA 283
E+IG G F VF+ D A+K H + L E+
Sbjct: 21 KLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 284 ALG--------SHENIVGYYSSW------------------------------FENEQLY 305
L E +G S F+++QL+
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 306 IQMELCDHSLS-DKKASQFFAEGEVLKALHQIAQALQFIHEK-GIAHLDVKPDNIYVKNG 363
I +E + ++ ++ + LHQ+ +L H D+ N+ +K
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198
Query: 364 VYK 366
K
Sbjct: 199 SLK 201
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 51/269 (18%), Positives = 97/269 (36%), Gaps = 41/269 (15%)
Query: 232 HEIEQIGAGNFSHVFK-VLKRIDGCFY--AVKHSKRQLHHDAERRKALLEVQALAALGSH 288
H IG G+F V+ A+K S ++ + L E + L +H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK-SLSRITEMQQVEAFLREGLLMRGL-NH 81
Query: 289 ENIVGYYS-SWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIH 344
N++ ++ + H L + + +++ Q+A+ ++++
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS------------LPIEEGDARYMP 391
E+ H D+ N + ++ K+ DFG A + LP+ ++
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV-----KWTA 196
Query: 392 QEILNED-YDHLDKVDIFSLGATMYELIK--GSPLSE-SGPQFLN-LRDGK-LPLLPGHS 445
E L + K D++S G ++EL+ P + L G+ LP
Sbjct: 197 LESLQTYRFTT--KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCP 254
Query: 446 LQFQNLLKVMVD---PDPVQRPSAKELVE 471
+L +VM DP RP+ + LV
Sbjct: 255 ---DSLYQVMQQCWEADPAVRPTFRVLVG 280
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 52/303 (17%), Positives = 101/303 (33%), Gaps = 63/303 (20%)
Query: 234 IEQIGAGNFSHVFK-VLKRIDGCFY----AVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+ IG G F VF+ + AVK ++ + E +A +
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQREAALMAEF-DN 109
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH--------------------------SLSDKKASQ 322
NIV + + + E + +
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 323 FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-- 379
+ E L Q+A + ++ E+ H D+ N V +N V K+ DFG + + +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 380 --------LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIK--GSP-LSESG 427
+PI R+MP E + + Y + D+++ G ++E+ P +
Sbjct: 230 YKADGNDAIPI-----RWMPPESIFYNRYTT--ESDVWAYGVVLWEIFSYGLQPYYGMAH 282
Query: 428 PQFLN-LRDGKLPLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVENPIFDKIQKHRK 483
+ + +RDG + P + L +M P RPS + I ++ + +
Sbjct: 283 EEVIYYVRDGNILACPENCP--LELYNLMRLCWSKLPADRPSFCSIHR--ILQRMCERAE 338
Query: 484 TYM 486
+
Sbjct: 339 GTV 341
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 57/259 (22%), Positives = 93/259 (35%), Gaps = 71/259 (27%)
Query: 237 IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAER------RKALLEVQALAALGSHEN 290
+G G F V+K ++ AVK +L + ++ E++ +A HEN
Sbjct: 39 MGEGGFGVVYK--GYVNNTTVAVK----KLAAMVDITTEELKQQFDQEIKVMAKC-QHEN 91
Query: 291 IV---GYYSSWFENEQL---YIQME---LCDHSLSDKKASQFF--------AEGEVLKAL 333
+V G+ S + + L Y+ M L D LS + A+G
Sbjct: 92 LVELLGFSS---DGDDLCLVYVYMPNGSLLDR-LSCLDGTPPLSWHMRCKIAQG------ 141
Query: 334 HQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE-------- 384
A + F+HE H D+K NI + + K+ DFG L ++
Sbjct: 142 --AANGINFLHENHHIHRDIKSANILLDEAFTAKISDFG----LARASEKFAQTVMTSRI 195
Query: 385 -GDARYMPQEILNEDY--DHL-DKVDIFSLGATMYELIKG-SPLSESGPQFLNLRDGKLP 439
G YM E + K DI+S G + E+I G + E L D K
Sbjct: 196 VGTTAYMAPE-----ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDIKEE 249
Query: 440 LLPGHSLQFQNLLKVMVDP 458
+ + ++ +D
Sbjct: 250 IEDE-----EKTIEDYIDK 263
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 68/298 (22%), Positives = 109/298 (36%), Gaps = 80/298 (26%)
Query: 230 DFHEIEQIGAGNFSHVFK-VLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
+F +G G F V+K L DG AVK K + E + EV+ ++ H
Sbjct: 31 NFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQGGEL-QFQTEVEMISMA-VH 86
Query: 289 ENIV---GYYSSWFENEQL--YIQMELCDHSLSDKKASQFFAEGEVLKAL-----HQI-- 336
N++ G+ + E+L Y M S+ AS E L +I
Sbjct: 87 RNLLRLRGFCMT--PTERLLVYPYMAN--GSV----ASCLRERPESQPPLDWPKRQRIAL 138
Query: 337 --AQALQFIHEKG---IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDAR-- 388
A+ L ++H+ I H DVK NI + + +GDFG A L+ + D
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM------DYKDTHVT 192
Query: 389 --------YMPQE-----ILNEDYDHLDKVDIFSLGATMYELIKG-SPLSESGP---QFL 431
++ E +E K D+F G + ELI G + +
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSE------KTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 432 NL--------RDGKL-----PLLPGH--SLQFQNLLKVM---VDPDPVQRPSAKELVE 471
L ++ KL L G+ + + L++V P++RP E+V
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 27/156 (17%)
Query: 335 QIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----------LPIE 383
Q+A+ ++F+ + H D+ NI + + V K+ DFG A + K LP+
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL- 259
Query: 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GS---PLSESGPQFLN-LRDGKL 438
++M E + D + + D++S G ++E+ G+ P + +F L++G
Sbjct: 260 ----KWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 314
Query: 439 PLLPGHSLQFQNLLKVMVD---PDPVQRPSAKELVE 471
P ++ + + M+D +P QRP+ ELVE
Sbjct: 315 MRAPDYTT--PEMYQTMLDCWHGEPSQRPTFSELVE 348
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 1e-04
Identities = 56/392 (14%), Positives = 117/392 (29%), Gaps = 122/392 (31%)
Query: 8 QKKSKREESQMKGTLARH----FQVQLGYSSSIQHQSFSSTSSSSRLQNH---------L 54
S +M L + + +SS+I+ + S + RL L
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL 250
Query: 55 ESVSQDATLSAADVDDKDLILTQD----FFCTPDYITPVNQNSMS-GFDCNRENIPCPKS 109
+V +A ++ K L+ T+ F + T ++ + S
Sbjct: 251 LNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT----------P 300
Query: 110 PEKLN------TVKSKKLRQDGFLVNPL-----------DPTSYDYQDTVDLAKDSFSTD 152
E + + + L ++ NP ++D V+ K
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK------ 354
Query: 153 EVQLTKTIGYTTQKTHNYVPQSAVALRCRVMPPPCIKNPYQKDASEMDIDRFGNQWAKCA 212
LT I +S++ V+ P + + + +
Sbjct: 355 ---LTTII------------ESSLN----VLEPAEYRKMFD----------------RLS 379
Query: 213 GLFPV---ITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-- 267
+FP I LS + D + + + N H + +++ K K
Sbjct: 380 -VFPPSAHIP-TILLSLIWFDVIKSDVMVVVNKLHKYSLVE---------KQPKESTISI 428
Query: 268 HDAERRKALLEVQALAALGSHENIVGYYSSW--FENEQL-------YIQMELCDHSLSDK 318
++++ AL H +IV +Y+ F+++ L Y + H L +
Sbjct: 429 PSIYLEL-KVKLENEYAL--HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHH-LKNI 484
Query: 319 KASQFFAEGEVLKALHQIAQALQFIHEKGIAH 350
+ + + +F+ +K I H
Sbjct: 485 EHPERMTL------FRMVFLDFRFLEQK-IRH 509
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 1e-04
Identities = 58/415 (13%), Positives = 119/415 (28%), Gaps = 120/415 (28%)
Query: 136 YDYQDTVDLAKDSFSTD----EVQ-LTKTIGYTTQKTHNYVPQSAVALRCRVM------- 183
Y Y+D + + +D+F + +VQ + K+I + ++ + + +
Sbjct: 16 YQYKDILSVFEDAFVDNFDCKDVQDMPKSI-LSKEEIDHIIMSKDAVSGTLRLFWTLLSK 74
Query: 184 PPPCIKNPYQK---DASEMDIDRFGNQWAKCAGLFPVITGGDGLSRYYTDFHEIEQIGAG 240
+ QK + ++ + ++R Y + +
Sbjct: 75 Q----EEMVQKFVEEVLRINYKFLMSPIKT------EQRQPSMMTRMYIEQRDRLY---- 120
Query: 241 NFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQ------------------AL 282
N + VF K++ +L + R+ALLE++ AL
Sbjct: 121 NDNQVFA------------KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVAL 168
Query: 283 AALGSHE-------NI----VGYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLK 331
S++ I + +S L + +L + + + L+
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNS--PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR 226
Query: 332 ALHQIAQALQ-FIHEKGIAH-LDVKPDNIYVKNGVYKLGDFGRATLL---NKSLPIEEGD 386
+H I L+ + K + L V N+ + + LL K + +
Sbjct: 227 -IHSIQAELRRLLKSKPYENCLLVL-LNVQNAK-AWNAFNLSCKILLTTRFKQV-TDFLS 282
Query: 387 ARYMPQEILNEDYDHLDK---VDIFS--LGATMYEL----IKGSPLSES--GPQFLNLRD 435
A L+ L + L +L + +P S ++RD
Sbjct: 283 AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIA---ESIRD 339
Query: 436 GKLPLLPGHSLQFQNLLKVMVDP------------DPV-QRPSAKELVENPIFDK 477
G + N V D +P R L +F
Sbjct: 340 GL--------ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS---VFPP 383
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 488 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.74 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.57 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.49 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.2 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.19 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.13 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.02 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.85 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.76 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.57 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.55 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.42 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.35 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.25 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.11 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.07 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.0 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.92 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.82 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.79 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.54 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.31 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.45 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-58 Score=457.66 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=205.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.+..... .....+.+|+.+++.+ +|||||++++++.+++.+||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEE
Confidence 357899999999999999999999999999999997653332 2345688999999999 89999999999999999999
Q ss_pred EEecCCCCchhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CCC
Q 011331 307 QMELCDHSLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LPI 382 (488)
Q Consensus 307 V~E~~~~~l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~~ 382 (488)
|||||++++... ...+.+++.+++.++.||+.||+|||++|||||||||+|||+ .+|.+||+|||+|+..... ...
T Consensus 91 vmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 170 (275)
T 3hyh_A 91 VIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 170 (275)
T ss_dssp EEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence 999998877663 445679999999999999999999999999999999999999 6789999999999876432 345
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
.+||+.|||||++.+...++.++|||||||+||||++|.+||.+... +..+..+..+++..++.++.+||.+||++|
T Consensus 171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 250 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 250 (275)
T ss_dssp ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSS
T ss_pred eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCC
Confidence 67999999999998764456799999999999999999999976543 345667788888889999999999999999
Q ss_pred CCCCCCHHHHHhChhhhh
Q 011331 460 PVQRPSAKELVENPIFDK 477 (488)
Q Consensus 460 P~~RpTa~elL~HP~f~~ 477 (488)
|++|||++|+++||||+.
T Consensus 251 P~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 251 PLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp GGGSCCHHHHHHCHHHHT
T ss_pred hhHCcCHHHHHcCccccc
Confidence 999999999999999973
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=468.45 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=222.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.+ +|||||+++++|.+++.+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEE
Confidence 479999999999999999999999999999999865321 122345688999999999 899999999999999999999
Q ss_pred EecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-----
Q 011331 308 MELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----- 379 (488)
Q Consensus 308 ~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----- 379 (488)
||||+++ |.. ....+.+++.+++.++.||+.||+|||++|||||||||+|||| .+|.+||+|||+|+.+...
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~ 190 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence 9999886 444 3344679999999999999999999999999999999999999 6799999999999987422
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcc
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L 456 (488)
..+.+||+.|||||++.+. .++.++|||||||+||||++|.+||..... +..+..+...++..++.++++||.+||
T Consensus 191 ~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL 269 (311)
T 4aw0_A 191 ANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLL 269 (311)
T ss_dssp BCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHS
T ss_pred ccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHc
Confidence 2345799999999999876 578899999999999999999999986543 345667788888899999999999999
Q ss_pred cCCCCCCCCHHH------HHhChhhhhhHHhhhhcCCC
Q 011331 457 DPDPVQRPSAKE------LVENPIFDKIQKHRKTYMKP 488 (488)
Q Consensus 457 ~~dP~~RpTa~e------lL~HP~f~~i~~~~~~~~~~ 488 (488)
++||++|||++| |++||||+++.+.+....+|
T Consensus 270 ~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~p 307 (311)
T 4aw0_A 270 VLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307 (311)
T ss_dssp CSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCC
T ss_pred cCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCC
Confidence 999999999887 68999999987655444443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=468.35 Aligned_cols=248 Identities=31% Similarity=0.526 Sum_probs=211.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|++..+|+.||||++..........+.+.+|+.+++++ +|||||+++++|.+++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999987766677778899999999999 899999999999999999999
Q ss_pred EecCCCC-chhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---
Q 011331 308 MELCDHS-LSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 308 ~E~~~~~-l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--- 379 (488)
||||+++ |.+.. ....+++.+++.++.||+.||.|||++|||||||||+|||| .+|.+||+|||+|+.....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 9999875 44433 22357999999999999999999999999999999999999 6799999999999877532
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCC-CCCCCCcHHHHHHHHHc
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKL-PLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~-~~~~~~s~~l~~lI~k~ 455 (488)
....+||+.|||||++.+. .|+.++|||||||+||||++|.+||..... +..+..+.. +.+..++.++.+||.+|
T Consensus 182 ~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~ 260 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHH
Confidence 1234699999999999875 678899999999999999999999987644 334444444 45667899999999999
Q ss_pred ccCCCCCCCCHHHHHhChhhhh
Q 011331 456 VDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 456 L~~dP~~RpTa~elL~HP~f~~ 477 (488)
|++||++|||++|+|+||||++
T Consensus 261 L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 261 FKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp TCSSGGGSCCHHHHHTSHHHHT
T ss_pred ccCChhHCcCHHHHhcCHHhhc
Confidence 9999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=464.85 Aligned_cols=247 Identities=28% Similarity=0.427 Sum_probs=213.7
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
...|+++++||+|+||+||+|.++.+|+.||||++...... ..+.+.+|+.+|+.+ +|||||+++++|.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEE
Confidence 34689999999999999999999999999999998654222 234578899999999 999999999999999999999
Q ss_pred EecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 308 MELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 308 ~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
||||+++ |........+++.+++.++.||+.||+|||++|||||||||+|||| .+|.+||+|||+|+.+... ...
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 9999886 4445556789999999999999999999999999999999999999 6799999999999887543 345
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCC---CCCCCCCcHHHHHHHHHcc
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGK---LPLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~---~~~~~~~s~~l~~lI~k~L 456 (488)
.+||+.|||||++... .|+.++|||||||+||||++|.+||.+.... ..+.... .+.+..++.++.+||.+||
T Consensus 230 ~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L 308 (346)
T 4fih_A 230 LVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLL 308 (346)
T ss_dssp CCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHS
T ss_pred cccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHc
Confidence 6899999999999765 5788999999999999999999999876443 2333332 3344568999999999999
Q ss_pred cCCCCCCCCHHHHHhChhhhhh
Q 011331 457 DPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 457 ~~dP~~RpTa~elL~HP~f~~i 478 (488)
++||++|||++|+|+||||+..
T Consensus 309 ~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 309 VRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp CSSTTTSCCHHHHTTCGGGGGC
T ss_pred CCChhHCcCHHHHhcCHhhcCC
Confidence 9999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=457.57 Aligned_cols=251 Identities=26% Similarity=0.389 Sum_probs=210.7
Q ss_pred cceeEEEEecccCcEEEEEEEEc---CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKR---IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
++|++++.||+|+||+||+|++. .+++.||||++.+..........+.+|+.+++++ +|||||+++++|.+++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEE
Confidence 47999999999999999999884 4688999999875433333334577899999998 9999999999999999999
Q ss_pred EEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---C
Q 011331 306 IQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---S 379 (488)
Q Consensus 306 IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~ 379 (488)
||||||+++ |.. ....+.+++.+++.++.||+.||+|||++|||||||||+|||+ .+|.+||+|||+|+.... .
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 182 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence 999999875 444 3344679999999999999999999999999999999999999 679999999999986532 2
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcc
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L 456 (488)
....+||+.|||||++.+. .++.++|||||||+||||++|.+||.+... +..+..+..+.+..+|.++.+||.+||
T Consensus 183 ~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 261 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLF 261 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHc
Confidence 3456799999999999766 577899999999999999999999987544 345667778888899999999999999
Q ss_pred cCCCCCCCC-----HHHHHhChhhhhhHHh
Q 011331 457 DPDPVQRPS-----AKELVENPIFDKIQKH 481 (488)
Q Consensus 457 ~~dP~~RpT-----a~elL~HP~f~~i~~~ 481 (488)
++||++||| ++|+++||||+.+.+.
T Consensus 262 ~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 262 KRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp CSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 999999998 5899999999988543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-56 Score=466.69 Aligned_cols=247 Identities=28% Similarity=0.433 Sum_probs=214.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.+.|++++.||+|+||+||+|.++.+|+.||||++...... ..+.+.+|+.+|+.+ +|||||+++++|.+++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEEEE
Confidence 35689999999999999999999999999999999654322 234578999999999 999999999999999999999
Q ss_pred EecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 308 MELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 308 ~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
||||+++ |........+++.+++.++.||+.||+|||++|||||||||+|||| .+|.+||+|||+|+.+... ...
T Consensus 227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 9999886 4445556779999999999999999999999999999999999999 6799999999999887543 335
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcC---CCCCCCCCcHHHHHHHHHcc
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDG---KLPLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~---~~~~~~~~s~~l~~lI~k~L 456 (488)
.+||+.|||||++... .|+.++|||||||+||||++|.+||.+.... ..+... ..+.+..++.++.+||.+||
T Consensus 307 ~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L 385 (423)
T 4fie_A 307 LVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLL 385 (423)
T ss_dssp CEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHS
T ss_pred cccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHc
Confidence 6799999999999765 5788999999999999999999999876443 233333 33455678999999999999
Q ss_pred cCCCCCCCCHHHHHhChhhhhh
Q 011331 457 DPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 457 ~~dP~~RpTa~elL~HP~f~~i 478 (488)
++||++|||++|+|+||||+..
T Consensus 386 ~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 386 VRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp CSSTTTSCCHHHHTTCGGGGGC
T ss_pred CCChhHCcCHHHHhcCHHhcCC
Confidence 9999999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-56 Score=444.38 Aligned_cols=244 Identities=25% Similarity=0.351 Sum_probs=206.8
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc----cceEEE
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE----NEQLYI 306 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~----~~~l~I 306 (488)
|++.++||+|+||+||+|.+..++..||||++..........+.+.+|+.+++++ +|||||+++++|.+ ++.+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEEE
Confidence 4677889999999999999999999999999976655666778899999999999 99999999999865 456899
Q ss_pred EEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEEe--CCeEEEEeecCceecCCC-
Q 011331 307 QMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKG--IAHLDVKPDNIYVK--NGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 307 V~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~g--IiHrDLKp~NILv~--~g~vkL~DFGlA~~~~~~- 379 (488)
|||||+++.+. ......+++..++.++.||+.||+|||++| ||||||||+||||+ +|.+||+|||+|+.....
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~ 186 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc
Confidence 99999876444 334467999999999999999999999998 99999999999994 689999999999865433
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh----hhhhcCCCC--CCCCCcHHHHHHHH
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF----LNLRDGKLP--LLPGHSLQFQNLLK 453 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~----~~i~~~~~~--~~~~~s~~l~~lI~ 453 (488)
....+||+.|||||++.+. ++.++|||||||+||||+||.+||...... ..+..+..+ .+...++++.+||.
T Consensus 187 ~~~~~GTp~YmAPE~~~~~--y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~ 264 (290)
T 3fpq_A 187 AKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264 (290)
T ss_dssp BEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred cCCcccCccccCHHHcCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHH
Confidence 2345799999999998764 677999999999999999999999754332 223333332 34457889999999
Q ss_pred HcccCCCCCCCCHHHHHhChhhhh
Q 011331 454 VMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
+||++||++|||++|+|+||||++
T Consensus 265 ~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 265 GCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHccCChhHCcCHHHHhcCccccC
Confidence 999999999999999999999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=453.27 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=212.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec------ccc
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF------ENE 302 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~------~~~ 302 (488)
++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+.+|+.+ +|||||++++++. +.+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccccCC
Confidence 479999999999999999999999999999999987666666677889999999999 8999999999875 346
Q ss_pred eEEEEEecCCCCchhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC--
Q 011331 303 QLYIQMELCDHSLSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK-- 378 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~-- 378 (488)
.+|||||||+++|.... ..+.+++.+++.+++||+.||.|||++|||||||||+|||+ .+|.+||+|||+|+.+..
T Consensus 133 ~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp CEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 79999999998876643 45679999999999999999999999999999999999999 678999999999986532
Q ss_pred -----CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhc--CCC----------
Q 011331 379 -----SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRD--GKL---------- 438 (488)
Q Consensus 379 -----~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~--~~~---------- 438 (488)
.....+||+.|||||++.+...++.++||||+||++|||++|.+||.+..... .+.. +..
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~ 292 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC----
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence 23356899999999998775567889999999999999999999997654322 1110 000
Q ss_pred ----------C---------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 439 ----------P---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 439 ----------~---------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+ ..+.++.++.+||.+||.+||++|||++|+|+||||+..+
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp -CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 0 1245789999999999999999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=437.52 Aligned_cols=249 Identities=35% Similarity=0.613 Sum_probs=195.6
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc---
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE--- 302 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~--- 302 (488)
||.++|++++.||+|+||+||+|.++.+|+.||||++.... .....+.+.+|+.+++++ +|||||+++++|.+.+
T Consensus 2 R~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC---
T ss_pred CcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccc
Confidence 67789999999999999999999999999999999987542 345566789999999999 8999999999987544
Q ss_pred ---------eEEEEEecCCCCchh-hhhc----ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEE
Q 011331 303 ---------QLYIQMELCDHSLSD-KKAS----QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKL 367 (488)
Q Consensus 303 ---------~l~IV~E~~~~~l~~-~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL 367 (488)
.+|||||||+++.+. .... ....+..++.++.||+.||+|||++|||||||||+|||| .+|.+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 479999999876443 2221 224556789999999999999999999999999999999 6799999
Q ss_pred EeecCceecCCCC---------------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---
Q 011331 368 GDFGRATLLNKSL---------------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ--- 429 (488)
Q Consensus 368 ~DFGlA~~~~~~~---------------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~--- 429 (488)
+|||+|+..+... ...+||+.|||||++.+. .++.++|||||||+||||++ ||.....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 9999998764321 224699999999999875 67889999999999999996 5655432
Q ss_pred -hhhhhcCCCC-CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 430 -FLNLRDGKLP-LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 430 -~~~i~~~~~~-~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
...+.....| .++..++.+.+||.+||++||++|||+.|+|+||||+++..
T Consensus 236 ~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 1223333332 22234667889999999999999999999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=443.77 Aligned_cols=242 Identities=26% Similarity=0.329 Sum_probs=205.2
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
..|.+.++||+|+||+||+|+++.+|+.||||+++..... .+|+.+++.+ +|||||+++++|.+++.+||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l-~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGL-SSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEE
Confidence 4689999999999999999999999999999999754322 3589999998 9999999999999999999999
Q ss_pred ecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCC-eEEEEeecCceecCCC-----
Q 011331 309 ELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNG-VYKLGDFGRATLLNKS----- 379 (488)
Q Consensus 309 E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g-~vkL~DFGlA~~~~~~----- 379 (488)
|||+++ |... ...+.+++.+++.++.||+.||+|||++|||||||||+|||| .+| .+||+|||+|+.+...
T Consensus 130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 999876 4443 334679999999999999999999999999999999999999 456 6999999999876432
Q ss_pred ---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCC---CCCCCCcHHHHH
Q 011331 380 ---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKL---PLLPGHSLQFQN 450 (488)
Q Consensus 380 ---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~---~~~~~~s~~l~~ 450 (488)
....+||+.|||||++.+. .++.++|||||||+||||++|.+||..... +..+..... ..++.++.++.+
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 288 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ 288 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHH
T ss_pred eecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHH
Confidence 1234699999999999875 578899999999999999999999976433 333444433 356788999999
Q ss_pred HHHHcccCCCCCCCCHHHH-------------HhChhhhhhH
Q 011331 451 LLKVMVDPDPVQRPSAKEL-------------VENPIFDKIQ 479 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~el-------------L~HP~f~~i~ 479 (488)
||.+||++||.+|||+.|| |+|||+.+.+
T Consensus 289 li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 289 AIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 9999999999999999998 5799997754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=436.73 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=202.3
Q ss_pred cccceeEEEEecccCcEEEEEEEEc---CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKR---IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
..++|++++.||+|+||+||+|.++ .+++.||||++.... ......+|+++|..+.+|||||+++++|.+++.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 4457999999999999999999875 368899999986532 234577899999999889999999999999999
Q ss_pred EEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-C-CeEEEEeecCceecCCC--
Q 011331 304 LYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-N-GVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 304 l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~-g~vkL~DFGlA~~~~~~-- 379 (488)
+|||||||+++.+.... +.+++.+++.++.||+.||+|||++|||||||||+|||++ + +.+||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~-~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL-NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EEEEEECCCCCCHHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred EEEEEeCCCcccHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 99999999876444332 4599999999999999999999999999999999999994 3 79999999999865321
Q ss_pred -----------------------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-
Q 011331 380 -----------------------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ- 429 (488)
Q Consensus 380 -----------------------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~- 429 (488)
....+||+.|||||++.+...++.++||||+||++|||++|.+||..+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 12346999999999997765678899999999999999999998854321
Q ss_pred h---hhhh--------------------------------------c----------------CCCCCCCCCcHHHHHHH
Q 011331 430 F---LNLR--------------------------------------D----------------GKLPLLPGHSLQFQNLL 452 (488)
Q Consensus 430 ~---~~i~--------------------------------------~----------------~~~~~~~~~s~~l~~lI 452 (488)
. ..+. . ........+++++.+||
T Consensus 254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl 333 (361)
T 4f9c_A 254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL 333 (361)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence 0 0000 0 00112345789999999
Q ss_pred HHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 453 KVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.+||++||++|||++|+|+||||+++.
T Consensus 334 ~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 334 DKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-53 Score=423.45 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=209.5
Q ss_pred cceeEEEEecccCcEEEEEEEEc-----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
++|.+.+.||+|+||+||+|.+. .+|..||||+++.. .....+.+.+|+.+++++ +|||||+++++|.+++.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCE
Confidence 57899999999999999999875 35889999999753 455567899999999999 99999999999999999
Q ss_pred EEEEEecCCCCchh-hhh--------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEE
Q 011331 304 LYIQMELCDHSLSD-KKA--------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKL 367 (488)
Q Consensus 304 l~IV~E~~~~~l~~-~~~--------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL 367 (488)
+|||||||+++.+. ... ...+++.+++.++.||+.||.|||+++||||||||+|||| .++.+||
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence 99999999876443 221 1358999999999999999999999999999999999999 6789999
Q ss_pred EeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-C
Q 011331 368 GDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-K 437 (488)
Q Consensus 368 ~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~ 437 (488)
+|||+|+..... .....||+.|||||++... .++.++|||||||+||||+| |..||..... ...+..+ .
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~ 248 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 248 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999865432 1223589999999999776 68889999999999999998 8999876543 2234444 3
Q ss_pred CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhhhhcC
Q 011331 438 LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYM 486 (488)
Q Consensus 438 ~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~~~~~ 486 (488)
.+.+..++.++.+||.+||+.||++|||++|| |+|++.+.+....++
T Consensus 249 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~~~~p~~l 295 (299)
T 4asz_A 249 LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLAKASPVYL 295 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHHHHSCCCS
T ss_pred CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHHhcCCccc
Confidence 56677889999999999999999999999999 569998877655444
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=456.78 Aligned_cols=254 Identities=22% Similarity=0.298 Sum_probs=212.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchH-HHHHHHHH---HHHHHHhCCCCCeeEeeeeecccce
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDA-ERRKALLE---VQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~-~~~~~~~E---i~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...... .......| +.++..+ +|||||+++++|.+.+.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCE
Confidence 4689999999999999999999999999999999864321111 11223333 3344444 89999999999999999
Q ss_pred EEEEEecCCCCch-h-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 304 LYIQMELCDHSLS-D-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 304 l~IV~E~~~~~l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
+|||||||+|+-+ . ....+.+++..++.|+.||+.||.|||++|||||||||+|||| .+|.+||+|||+|+.+...
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~ 346 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence 9999999987643 3 3345679999999999999999999999999999999999999 6799999999999887543
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh------hhhhhcCCCCCCCCCcHHHHHHHH
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ------FLNLRDGKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------~~~i~~~~~~~~~~~s~~l~~lI~ 453 (488)
..+.+||+.|||||++..+..|+.++|||||||+||||++|.+||.+... ...+.......+..+|.++++||.
T Consensus 347 ~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~ 426 (689)
T 3v5w_A 347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426 (689)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHHH
Confidence 34568999999999997554677899999999999999999999975321 223456677788899999999999
Q ss_pred HcccCCCCCCCC-----HHHHHhChhhhhhHHhh
Q 011331 454 VMVDPDPVQRPS-----AKELVENPIFDKIQKHR 482 (488)
Q Consensus 454 k~L~~dP~~RpT-----a~elL~HP~f~~i~~~~ 482 (488)
+||++||.+|++ ++||++||||+++.+..
T Consensus 427 ~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 427 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp HHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred HHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 999999999998 89999999999986644
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=419.26 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=203.8
Q ss_pred cceeEEEEecccCcEEEEEEEEc-----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
.+|.+.++||+|+||+||+|.+. .++..||||+++.. .....+.+.+|+.+|.++ +|||||+++++|.+.+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTML-QHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE
Confidence 57899999999999999999865 36899999999753 455667899999999999 99999999999999999
Q ss_pred EEEEEecCCCCchhh-hh----------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeE
Q 011331 304 LYIQMELCDHSLSDK-KA----------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVY 365 (488)
Q Consensus 304 l~IV~E~~~~~l~~~-~~----------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~v 365 (488)
+|||||||+++.+.. .. ...+++.+++.++.||+.||.|||+++||||||||+|||| .++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 999999998764442 11 2358999999999999999999999999999999999999 56899
Q ss_pred EEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-
Q 011331 366 KLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD- 435 (488)
Q Consensus 366 kL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~- 435 (488)
||+|||+|+..... .....||+.|||||++... .++.++|||||||+||||+| |..||..... ...+..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999866332 2234699999999999876 68889999999999999999 8999876543 223333
Q ss_pred CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhhhhcC
Q 011331 436 GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYM 486 (488)
Q Consensus 436 ~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~~~~~ 486 (488)
...+.+..+++++.+||.+||+.||++|||++||+++ ++.+.+....++
T Consensus 277 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~--L~~l~~~pp~~l 325 (329)
T 4aoj_A 277 RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR--LQALAQAPPVYL 325 (329)
T ss_dssp CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH--HHHHHHSCC---
T ss_pred CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH--HHHHhhCCcccc
Confidence 3466777899999999999999999999999999874 777766544443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=413.82 Aligned_cols=241 Identities=19% Similarity=0.224 Sum_probs=201.4
Q ss_pred cceeEEEEecccCcEEEEEEEEc-----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
.+++++++||+|+||+||+|... .+++.||||+++... .....+.+.+|+.++.++ +|||||++++++.+.+.
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECCE
Confidence 46789999999999999999863 367899999987543 233456789999999999 99999999999999999
Q ss_pred EEEEEecCCCCchh-hhh-----------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCe
Q 011331 304 LYIQMELCDHSLSD-KKA-----------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGV 364 (488)
Q Consensus 304 l~IV~E~~~~~l~~-~~~-----------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~ 364 (488)
+|||||||+++.+. ... ...+++.+++.++.||+.||.|||+++||||||||+|||| +++.
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC
Confidence 99999999876443 221 2358999999999999999999999999999999999999 6789
Q ss_pred EEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc
Q 011331 365 YKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD 435 (488)
Q Consensus 365 vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~ 435 (488)
+||+|||+|+..... .....||+.|||||++... .++.++|||||||+||||+| |..||.+... ...+..
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~ 262 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 262 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999866321 2345699999999999776 68889999999999999998 8888876543 223333
Q ss_pred -CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 436 -GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 436 -~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
...+.++.++.++.+||.+||+.||++|||+.||+++
T Consensus 263 ~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 263 RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3456777899999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=411.05 Aligned_cols=240 Identities=23% Similarity=0.297 Sum_probs=195.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.+++++.+.||+|+||+||+|.+. ..||||+++.........+.+.+|+.+++++ +|||||++++++.+ +.+|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC-CeEEEE
Confidence 467899999999999999999754 3599999976655666678899999999999 99999999998764 568999
Q ss_pred EecCCCCchh-hh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC-----
Q 011331 308 MELCDHSLSD-KK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK----- 378 (488)
Q Consensus 308 ~E~~~~~l~~-~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~----- 378 (488)
||||+++.+. .. ....+++.++..++.||+.||+|||++|||||||||+|||| .++.+||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999876443 32 23569999999999999999999999999999999999999 567999999999986642
Q ss_pred CCCCCCCCCCccChhhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---h-hhhcC-CC----CCCCCCcHH
Q 011331 379 SLPIEEGDARYMPQEILNED--YDHLDKVDIFSLGATMYELIKGSPLSESGPQF---L-NLRDG-KL----PLLPGHSLQ 447 (488)
Q Consensus 379 ~~~~~~Gt~~Y~APEvl~~~--~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~-~i~~~-~~----~~~~~~s~~ 447 (488)
.....+||+.|||||++... ..++.++|||||||+||||+||..||...... . .+..+ .. ..++.++.+
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 269 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA 269 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence 12345799999999998642 24778999999999999999999999764321 1 12222 11 234567999
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
+.+||.+||+.||++|||+.||+++
T Consensus 270 l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 270 MKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999998765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=440.99 Aligned_cols=248 Identities=22% Similarity=0.387 Sum_probs=214.3
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..++|++++.||+|+||+||+|.++.+|+.||||++... .......+.+|+.+|+.+ +|||||+++++|.+++.+||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEE
Confidence 456899999999999999999999999999999998754 344556788999999999 99999999999999999999
Q ss_pred EEecCCCC-chhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe---CCeEEEEeecCceecCCCC
Q 011331 307 QMELCDHS-LSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK---NGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 307 V~E~~~~~-l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~---~g~vkL~DFGlA~~~~~~~ 380 (488)
|||||+++ |.... ....+++.++..++.||+.||.|||++||+||||||+|||++ .+.+||+|||+|+.+....
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999875 44433 235699999999999999999999999999999999999993 3799999999999875432
Q ss_pred --CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCC----CCCCcHHHHHH
Q 011331 381 --PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPL----LPGHSLQFQNL 451 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~----~~~~s~~l~~l 451 (488)
...+||+.|||||++.+. .++.++|||||||+||||++|.+||.+... +..+......+ ++.++.++.+|
T Consensus 312 ~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred ceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 345799999999999876 678899999999999999999999987544 33444444333 35689999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
|.+||++||.+|||+.|+|+||||+..
T Consensus 391 i~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=412.04 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=205.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCC-----CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-c
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRID-----GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE-N 301 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-~ 301 (488)
.++|++++.||+|+||+||+|.+..+ ++.||||++.... ...+.+.+.+|+.+|.++.+|||||+++++|.+ +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 46899999999999999999987654 4789999997653 345567799999999999667999999999876 4
Q ss_pred ceEEEEEecCCCCchh-hhh-----------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eC
Q 011331 302 EQLYIQMELCDHSLSD-KKA-----------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KN 362 (488)
Q Consensus 302 ~~l~IV~E~~~~~l~~-~~~-----------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~ 362 (488)
+.+|||||||+++.+. ... ...+++..++.++.||+.||.|||+++||||||||+|||+ .+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence 6799999999886443 211 2348899999999999999999999999999999999999 67
Q ss_pred CeEEEEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---h-hh
Q 011331 363 GVYKLGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---F-LN 432 (488)
Q Consensus 363 g~vkL~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~-~~ 432 (488)
+.+||+|||+|+.+.... ....||+.|||||++.+. .++.++|||||||+||||+| |..||.+... + ..
T Consensus 222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~ 300 (353)
T 4ase_A 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 300 (353)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 899999999998764332 234589999999999876 68889999999999999998 8999876432 2 22
Q ss_pred hhcC-CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 433 LRDG-KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 433 i~~~-~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+..+ ..+.+..+++++.++|.+||+.||++|||+.||++| ++.+
T Consensus 301 i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~--L~~l 345 (353)
T 4ase_A 301 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNL 345 (353)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH--HHHH
Confidence 3333 456677889999999999999999999999999998 5444
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=397.13 Aligned_cols=251 Identities=25% Similarity=0.344 Sum_probs=219.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+++.+ +||||+++++++...+.+|+|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999999976655666677889999999999 899999999999999999999
Q ss_pred EecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CCC
Q 011331 308 MELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LPI 382 (488)
Q Consensus 308 ~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~~ 382 (488)
|||++++ +.. ....+.+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++...... ...
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 172 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence 9999765 444 3345679999999999999999999999999999999999999 6789999999999765432 334
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
.+||+.|+|||++.+....+.++|||||||++|+|++|..||..... ...+..+....+..++.++.+||.+||..|
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 252 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLN 252 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSS
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCC
Confidence 57999999999998764445799999999999999999999976543 334556777777889999999999999999
Q ss_pred CCCCCCHHHHHhChhhhhhH
Q 011331 460 PVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 460 P~~RpTa~elL~HP~f~~i~ 479 (488)
|.+|||++|+++||||+...
T Consensus 253 P~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 253 PIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp TTTSCCHHHHTTCTTTTTTC
T ss_pred hhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999998654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=385.39 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=210.6
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.++..+ +||||+++++++.+++.+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEEE
Confidence 579999999999999999999999999999999976655555567788999999999 8999999999999999999999
Q ss_pred ecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 309 ELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 309 E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
||+++++..... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++..... ...
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence 999988766332 4679999999999999999999999999999999999999 6789999999999876532 334
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh----hhhhc-----------------------
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF----LNLRD----------------------- 435 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~----~~i~~----------------------- 435 (488)
..||+.|+|||++.+...++.++|||||||++|||++|..|+...... ..+..
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence 568999999999977645788999999999999999988775433221 11100
Q ss_pred ------CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 436 ------GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 436 ------~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
......+.++.++.+||.+||+.||++|||++|+|+||||+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 0111234578999999999999999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=388.70 Aligned_cols=261 Identities=34% Similarity=0.581 Sum_probs=220.7
Q ss_pred cCCccceeeCCCCccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCC
Q 011331 211 CAGLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290 (488)
Q Consensus 211 ~~~~~p~~~g~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hpn 290 (488)
..+++|...|. .+.++|++++.||+|+||+||+|.+..+|+.||||++...............|+..+..+.+|||
T Consensus 43 ~~~~~p~~~~~----~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~ 118 (311)
T 3p1a_A 43 SPGYDPSRPES----FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118 (311)
T ss_dssp CTTCCTTSSSC----HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCCCCCCCccc----hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCc
Confidence 34455554432 34467999999999999999999999999999999987665566667778888888888889999
Q ss_pred eeEeeeeecccceEEEEEecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEE
Q 011331 291 IVGYYSSWFENEQLYIQMELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKL 367 (488)
Q Consensus 291 Iv~l~~~~~~~~~l~IV~E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL 367 (488)
|++++++|.+.+.+||||||+++++..... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||
T Consensus 119 iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl 198 (311)
T 3p1a_A 119 CVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKL 198 (311)
T ss_dssp BCCEEEEEEETTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEE
T ss_pred EEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999888766332 3459999999999999999999999999999999999999 6789999
Q ss_pred EeecCceecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCCC--CCCC
Q 011331 368 GDFGRATLLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLP--LLPG 443 (488)
Q Consensus 368 ~DFGlA~~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~~--~~~~ 443 (488)
+|||++...... .....||+.|+|||++.+ .++.++|||||||++|||++|..++........+..+..+ .+..
T Consensus 199 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (311)
T 3p1a_A 199 GDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAG 276 (311)
T ss_dssp CCCTTCEECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTT
T ss_pred ccceeeeecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccC
Confidence 999999877543 234469999999999876 4677999999999999999998888777666666554443 3456
Q ss_pred CcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 444 HSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 444 ~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
++.++.+||.+||++||++|||++|+|+||||+.
T Consensus 277 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 277 LSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 8999999999999999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=400.03 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=214.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.+... ..........|+.++..+.+||||+++++++.+.+.+||
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 4689999999999999999999999999999999865321 222345677899999988789999999999999999999
Q ss_pred EEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CC
Q 011331 307 QMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SL 380 (488)
Q Consensus 307 V~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~ 380 (488)
|||||+++.+. ......+++..++.++.||+.||.|||++||+||||||+|||| .+|.+||+|||+|+.... ..
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 181 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT 181 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccc
Confidence 99999875443 3334679999999999999999999999999999999999999 679999999999985422 23
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
...+||+.|+|||++.+. .++.++|||||||++|||++|.+||..... +..+.......+..++.++.+||.+||.
T Consensus 182 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~ 260 (353)
T 3txo_A 182 ATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMT 260 (353)
T ss_dssp ----CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 345799999999998765 577899999999999999999999976544 4456677778888899999999999999
Q ss_pred CCCCCCCCH------HHHHhChhhhhhHHh
Q 011331 458 PDPVQRPSA------KELVENPIFDKIQKH 481 (488)
Q Consensus 458 ~dP~~RpTa------~elL~HP~f~~i~~~ 481 (488)
+||.+||++ +|+++||||+.+.+.
T Consensus 261 ~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 261 KNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp SSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred hCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 999999998 999999999988543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=390.10 Aligned_cols=253 Identities=24% Similarity=0.385 Sum_probs=207.9
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.+.++|++++.||+|+||+||+|.+. +|+.||||++............+.+|+.++..+ +||||+++++++.+.+.+|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCSSCEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccCCEEE
Confidence 44578999999999999999999985 699999999875543333456788999999999 8999999999999999999
Q ss_pred EEEecCCCCchhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---
Q 011331 306 IQMELCDHSLSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 306 IV~E~~~~~l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--- 379 (488)
|||||+++++...... ..+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.....
T Consensus 96 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp EEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 9999999877664332 349999999999999999999999999999999999999 6789999999999876532
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhh---cCC----------------
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLR---DGK---------------- 437 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~---~~~---------------- 437 (488)
.....||+.|+|||++.+...++.++|||||||++|+|++|.+||....... .+. ...
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 2345689999999998765567889999999999999999999987543211 110 000
Q ss_pred --C---------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 438 --L---------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 438 --~---------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
. ...+.++.++.+||.+||++||++|||++|+|+||||+++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 0 012456789999999999999999999999999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=401.82 Aligned_cols=254 Identities=20% Similarity=0.353 Sum_probs=206.3
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc--e
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE--Q 303 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~--~ 303 (488)
...++|++++.||+|+||+||+|.+..+|+.||||++..............+|+.++..+.+||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34568999999999999999999999999999999997666666777889999999999966999999999987543 7
Q ss_pred EEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---
Q 011331 304 LYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 304 l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--- 379 (488)
+|||||||++++........+++..+..++.||+.||.|||++||+||||||+|||| .++.+||+|||+|+.....
T Consensus 86 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 999999999888777767789999999999999999999999999999999999999 6789999999999865321
Q ss_pred ---------------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hc
Q 011331 380 ---------------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RD 435 (488)
Q Consensus 380 ---------------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~ 435 (488)
....+||+.|+|||++.+...++.++|||||||++|||++|.+||.+......+ ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 123469999999999977556788999999999999999999999765432211 10
Q ss_pred --CC---------------------------------------------CCCCCCCcHHHHHHHHHcccCCCCCCCCHHH
Q 011331 436 --GK---------------------------------------------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKE 468 (488)
Q Consensus 436 --~~---------------------------------------------~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~e 468 (488)
+. .......+.++.+||.+||..||++|||++|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 00 0012257889999999999999999999999
Q ss_pred HHhChhhhhhH
Q 011331 469 LVENPIFDKIQ 479 (488)
Q Consensus 469 lL~HP~f~~i~ 479 (488)
+|+||||+.++
T Consensus 326 ~l~Hp~~~~~~ 336 (388)
T 3oz6_A 326 ALKHPFVSIFH 336 (388)
T ss_dssp HTTSTTTTTTC
T ss_pred HhCCHHHHHhc
Confidence 99999998654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=399.88 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=216.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|++..+++.||||++++..... .....+..|..++.++.+||||++++++|.+.+.+||
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999999999999999997653332 3334577899999988899999999999999999999
Q ss_pred EEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCC
Q 011331 307 QMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSL 380 (488)
Q Consensus 307 V~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~ 380 (488)
||||++++.+. ......+++..++.++.||+.||.|||++||+||||||+|||| .+|.+||+|||+|+... ...
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~ 210 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 210 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCcc
Confidence 99999886443 3334679999999999999999999999999999999999999 67999999999998632 233
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch------------hhhhhhcCCCCCCCCCcHHH
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP------------QFLNLRDGKLPLLPGHSLQF 448 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~------------~~~~i~~~~~~~~~~~s~~l 448 (488)
...+||+.|+|||++.+. .++.++|||||||++|||++|.+||.... ....+.......+..++.++
T Consensus 211 ~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~ 289 (396)
T 4dc2_A 211 STFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 289 (396)
T ss_dssp CCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred ccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHH
Confidence 456799999999999775 67889999999999999999999996321 13345567778888899999
Q ss_pred HHHHHHcccCCCCCCCCH------HHHHhChhhhhhHHh
Q 011331 449 QNLLKVMVDPDPVQRPSA------KELVENPIFDKIQKH 481 (488)
Q Consensus 449 ~~lI~k~L~~dP~~RpTa------~elL~HP~f~~i~~~ 481 (488)
.+||.+||+.||.+||++ +|+++||||+.+.+.
T Consensus 290 ~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp HHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred HHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence 999999999999999984 899999999988543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=389.52 Aligned_cols=252 Identities=23% Similarity=0.393 Sum_probs=218.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.+.... ......+..|+.++..+ +||||+++++++.+.+.+|+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEE
Confidence 45799999999999999999999999999999998643211 11234567788899888 99999999999999999999
Q ss_pred EEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCC
Q 011331 307 QMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIE 383 (488)
Q Consensus 307 V~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~ 383 (488)
||||++++ |... .....+++..++.++.||+.||.|||++||+||||||+|||+ .+|.+||+|||+++.........
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~ 163 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL 163 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCC
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCccccc
Confidence 99999875 4443 334569999999999999999999999999999999999999 67999999999999887666667
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDP 460 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP 460 (488)
+||+.|+|||++... .++.++|||||||++|||++|.+||..... +..+.......++.++.++.++|.+||..||
T Consensus 164 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp 242 (318)
T 1fot_A 164 CGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL 242 (318)
T ss_dssp CSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCT
T ss_pred cCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCH
Confidence 899999999998765 577899999999999999999999976543 3455667777888899999999999999999
Q ss_pred CCCC-----CHHHHHhChhhhhhHHh
Q 011331 461 VQRP-----SAKELVENPIFDKIQKH 481 (488)
Q Consensus 461 ~~Rp-----Ta~elL~HP~f~~i~~~ 481 (488)
.+|| +++|+++||||+.+.+.
T Consensus 243 ~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 243 SQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp TTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred HHcCCCcCCCHHHHhcCccccCCCHH
Confidence 9999 99999999999987543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=391.99 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=215.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.+... .......+..|+.++..+ +||||+++++++.+.+.+||
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEE
Confidence 3579999999999999999999999999999999864311 112345678899999998 89999999999999999999
Q ss_pred EEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CC
Q 011331 307 QMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SL 380 (488)
Q Consensus 307 V~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~ 380 (488)
||||++++.+. ......+++..++.++.||+.||.|||++||+||||||+|||+ .+|.+||+|||+++.... ..
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 162 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence 99999876443 2334569999999999999999999999999999999999999 679999999999986422 23
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
...+||+.|+|||++.+. .++.++|||||||++|||++|.+||..... ...+.......+..++.++.+||.+||+
T Consensus 163 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~ 241 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241 (337)
T ss_dssp CCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 345699999999998765 577899999999999999999999976543 3345556677778899999999999999
Q ss_pred CCCCCCC-----CHHHHHhChhhhhhHHh
Q 011331 458 PDPVQRP-----SAKELVENPIFDKIQKH 481 (488)
Q Consensus 458 ~dP~~Rp-----Ta~elL~HP~f~~i~~~ 481 (488)
.||.+|| +++|+++||||+.+.+.
T Consensus 242 ~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp SSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred cCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 9999999 99999999999987543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=388.14 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=215.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.+... .......+..|+.++..+.+||||+++++++.+.+.+||
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 4579999999999999999999999999999999976533 334456688899999988789999999999999999999
Q ss_pred EEecCCCCch-h-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCC
Q 011331 307 QMELCDHSLS-D-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSL 380 (488)
Q Consensus 307 V~E~~~~~l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~ 380 (488)
||||++++.+ . ......+++..++.++.||+.||.|||++||+||||||+|||| .+|.+||+|||+++... ...
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~ 167 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCB
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcc
Confidence 9999987543 3 2334579999999999999999999999999999999999999 67999999999998642 223
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCc------------hhhhhhhcCCCCCCCCCcHHH
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESG------------PQFLNLRDGKLPLLPGHSLQF 448 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~------------~~~~~i~~~~~~~~~~~s~~l 448 (488)
...+||+.|+|||++.+. .++.++|||||||++|||++|.+||... .....+.......+..++.++
T Consensus 168 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~ 246 (345)
T 3a8x_A 168 STFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 246 (345)
T ss_dssp CCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHH
Confidence 445799999999999765 5778999999999999999999998641 112344566677788899999
Q ss_pred HHHHHHcccCCCCCCCCH------HHHHhChhhhhhHH
Q 011331 449 QNLLKVMVDPDPVQRPSA------KELVENPIFDKIQK 480 (488)
Q Consensus 449 ~~lI~k~L~~dP~~RpTa------~elL~HP~f~~i~~ 480 (488)
.+||.+||..||.+||++ +|+++||||+.+.+
T Consensus 247 ~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp HHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred HHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 999999999999999995 89999999998754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=373.51 Aligned_cols=254 Identities=42% Similarity=0.799 Sum_probs=217.9
Q ss_pred cccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 225 SRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 225 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.++.++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+..+..+.+||||+++++++.+.+.+
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 35667899999999999999999999999999999999876555666778899999999988999999999999999999
Q ss_pred EEEEecCCC-Cchhhhhc-----ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-C---------------
Q 011331 305 YIQMELCDH-SLSDKKAS-----QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-N--------------- 362 (488)
Q Consensus 305 ~IV~E~~~~-~l~~~~~~-----~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~--------------- 362 (488)
||||||+++ +|...... ..+++..++.++.||+.||.|||++||+|+||||+|||++ +
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999987 44443222 5589999999999999999999999999999999999994 2
Q ss_pred ----CeEEEEeecCceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCC
Q 011331 363 ----GVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKL 438 (488)
Q Consensus 363 ----g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~ 438 (488)
..++|+|||++...... ....||+.|+|||++.....++.++|||||||++|+|++|.+++........+..+..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~ 245 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP-QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRL 245 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS-CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHTTCC
T ss_pred cCCceEEEEcccccccccCCc-cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHcCCC
Confidence 26999999999877553 3456999999999998765666799999999999999999988877777666666555
Q ss_pred C-CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 439 P-LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 439 ~-~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+ .+..++.++.++|.+||+.||++|||+.|+++||||+...
T Consensus 246 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 246 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 4 4557899999999999999999999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=380.99 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=204.2
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||+||+|.+ .+|+.||||++............+.+|+.++..+ +||||+++++++.+.+.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEEE
Confidence 5789999999999999999998 5899999999865433333345677899999999 8999999999999999999999
Q ss_pred ecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 309 ELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 309 E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
||+++++..... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++..... ...
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence 999987666433 3569999999999999999999999999999999999999 6789999999999766432 233
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc--CC------------------C-
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD--GK------------------L- 438 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~--~~------------------~- 438 (488)
..||+.|+|||++.+...++.++|||||||++|||++|.+||........ +.. +. .
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccc
Confidence 46899999999997654577899999999999999999999876433211 100 00 0
Q ss_pred --------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 439 --------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 439 --------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.....++.++.+||.+||+.||++|||++|+++||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 1124578999999999999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=404.04 Aligned_cols=252 Identities=22% Similarity=0.370 Sum_probs=196.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-----cc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE-----NE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-----~~ 302 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+|..+ +||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCc
Confidence 4579999999999999999999999999999999977656666677899999999999 89999999999843 35
Q ss_pred eEEEEEecCCCCchhhhhc-ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 303 QLYIQMELCDHSLSDKKAS-QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
.+||||||+++++...... ..+++..++.++.||+.||.|||++|||||||||+|||| .++.+||+|||+|+.....
T Consensus 131 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 131 ELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp CEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred eEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 7999999999887764443 469999999999999999999999999999999999999 6789999999999876421
Q ss_pred -----------------------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-----------
Q 011331 380 -----------------------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK----------- 419 (488)
Q Consensus 380 -----------------------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt----------- 419 (488)
....+||+.|+|||++.....++.++|||||||+||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 1234689999999987555468889999999999999999
Q ss_pred CCCCCCCchhh-----------------------hhh---hc-------------------C---------CCCCCCCCc
Q 011331 420 GSPLSESGPQF-----------------------LNL---RD-------------------G---------KLPLLPGHS 445 (488)
Q Consensus 420 G~~p~~~~~~~-----------------------~~i---~~-------------------~---------~~~~~~~~s 445 (488)
|.++|.+...+ ..+ .. . .....+..+
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 56666442210 000 00 0 001234568
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 446 LQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 446 ~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
.++.+||.+||.+||++|||++|+|+||||+.++.
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 99999999999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=378.40 Aligned_cols=248 Identities=26% Similarity=0.393 Sum_probs=211.5
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..++|++++.||+|+||+||+|.+..+|+.||||++....... ...+.+|+.++..+ +||||+++++++...+.+|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMREN-KNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEEE
Confidence 3457899999999999999999999999999999986443222 34578899999998 99999999999999999999
Q ss_pred EEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CC
Q 011331 307 QMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LP 381 (488)
Q Consensus 307 V~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~ 381 (488)
||||++++ |........+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++...... ..
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 99999765 5455555679999999999999999999999999999999999999 6789999999999876533 23
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---h---cCCCCCCCCCcHHHHHHHHHc
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---R---DGKLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~---~~~~~~~~~~s~~l~~lI~k~ 455 (488)
...||+.|+|||++... .++.++|||||||++|||++|..||........+ . ......+..++..+.+||.+|
T Consensus 175 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 253 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (297)
T ss_dssp CCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred CccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence 45699999999998765 5778999999999999999999999765443221 1 223344567899999999999
Q ss_pred ccCCCCCCCCHHHHHhChhhhhh
Q 011331 456 VDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 456 L~~dP~~RpTa~elL~HP~f~~i 478 (488)
|+.||++|||+.|+++||||+..
T Consensus 254 l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 254 LEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ccCChhHCcCHHHHhhChhhccc
Confidence 99999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=391.91 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=213.0
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
+..++|.+++.||+|+||+||+|.+..+|..||||++....... .....+.+|+.++..+ +||||+++++++.+.+.+
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEE
Confidence 34568999999999999999999999999999999986432111 1124577899999998 899999999999999999
Q ss_pred EEEEecCCCCchh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--C
Q 011331 305 YIQMELCDHSLSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--L 380 (488)
Q Consensus 305 ~IV~E~~~~~l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~ 380 (488)
||||||+++++.. ......+++.+++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++...... .
T Consensus 85 ~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 85 VMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred EEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence 9999999877666 3345679999999999999999999999999999999999999 5689999999999866432 3
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
...+||+.|+|||++.+....+.++|||||||++|+|++|..||..... ...+..+....+..++.++.+||.+||.
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 244 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIV 244 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSC
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcC
Confidence 4557999999999997764446799999999999999999999876432 2233444556677789999999999999
Q ss_pred CCCCCCCCHHHHHhChhhhh
Q 011331 458 PDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f~~ 477 (488)
.||.+|||++|+++||||+.
T Consensus 245 ~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 245 ADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp SSGGGSCCHHHHTTCHHHHT
T ss_pred CChhHCcCHHHHHhChhhcc
Confidence 99999999999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=390.80 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=218.7
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.+... .......+.+|+.++..+ +||||+++++++.+.+.+||
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEE
Confidence 4589999999999999999999999999999999864311 112235678899999998 99999999999999999999
Q ss_pred EEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCC
Q 011331 307 QMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIE 383 (488)
Q Consensus 307 V~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~ 383 (488)
||||++++ |... .....+++..++.++.||+.||.|||++||+||||||+|||+ .+|.+||+|||+++.........
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~ 198 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL 198 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCC
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCcccc
Confidence 99999765 4442 334579999999999999999999999999999999999999 67899999999999887666667
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDP 460 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP 460 (488)
.||+.|+|||++... .++.++|||||||++|||++|.+||..... +..+..+....+..++.++.++|.+||+.||
T Consensus 199 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp 277 (350)
T 1rdq_E 199 CGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277 (350)
T ss_dssp EECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCT
T ss_pred cCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 899999999998765 577899999999999999999999976543 3455667778888899999999999999999
Q ss_pred CCCCC-----HHHHHhChhhhhhHH
Q 011331 461 VQRPS-----AKELVENPIFDKIQK 480 (488)
Q Consensus 461 ~~RpT-----a~elL~HP~f~~i~~ 480 (488)
.+||+ ++|+++||||+.+.+
T Consensus 278 ~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 278 TKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp TTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HhccCCccCCHHHHHhCcCcCCCCH
Confidence 99998 999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=390.97 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=215.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++++... ..........|..++..+.+||||+++++++.+.+.+||
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 4589999999999999999999999999999999865311 112234577889999887799999999999999999999
Q ss_pred EEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCC
Q 011331 307 QMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSL 380 (488)
Q Consensus 307 V~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~ 380 (488)
||||++++ |... .....+++..++.++.||+.||.|||++||+||||||+|||+ .+|.+||+|||+++... ...
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 175 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcc
Confidence 99999875 4332 234579999999999999999999999999999999999999 67999999999998642 223
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
...+||+.|+|||++.+. .++.++|||||||++|||++|.+||..... +..+.......+..++.++.+||.+||.
T Consensus 176 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~ 254 (345)
T 1xjd_A 176 NTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 254 (345)
T ss_dssp CCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSC
T ss_pred cCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHhc
Confidence 455799999999999765 577899999999999999999999976543 3345566667777899999999999999
Q ss_pred CCCCCCCCHH-HHHhChhhhhhHHh
Q 011331 458 PDPVQRPSAK-ELVENPIFDKIQKH 481 (488)
Q Consensus 458 ~dP~~RpTa~-elL~HP~f~~i~~~ 481 (488)
.||++||++. ++++||||+.+.+.
T Consensus 255 ~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 255 REPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp SSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred CCHhHcCCChHHHHcCccccCCCHH
Confidence 9999999998 99999999988543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=390.58 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=216.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.+... ..........|..++..+.+||||+++++++.+.+.+||
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4689999999999999999999999999999999865321 112245577889999888789999999999999999999
Q ss_pred EEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCC
Q 011331 307 QMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSL 380 (488)
Q Consensus 307 V~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~ 380 (488)
||||++++ |... .....+++..++.++.||+.||.|||++||+||||||+|||+ .+|.+||+|||+++... ...
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 178 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCccc
Confidence 99999875 4433 334579999999999999999999999999999999999999 67999999999998642 223
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
...+||+.|+|||++... .++.++|||||||++|||++|.+||..... +..+.......+..++.++.+||.+||.
T Consensus 179 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~ 257 (353)
T 2i0e_A 179 KTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 257 (353)
T ss_dssp CCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhh
Confidence 455799999999999765 577899999999999999999999976543 3455667777888899999999999999
Q ss_pred CCCCCCC-----CHHHHHhChhhhhhHHh
Q 011331 458 PDPVQRP-----SAKELVENPIFDKIQKH 481 (488)
Q Consensus 458 ~dP~~Rp-----Ta~elL~HP~f~~i~~~ 481 (488)
.||.+|| +++++++||||+.+.+.
T Consensus 258 ~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 258 KHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp SCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred cCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 9999999 47999999999987543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=388.56 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=211.8
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch----HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD----AERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~----~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
+.++|++++.||+|+||+||+|.+..+|..||||++....... .....+.+|+.++..+ +||||++++++|.+.+
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENRT 88 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSS
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEeCC
Confidence 4457999999999999999999999999999999987543221 1245688899999999 8999999999999999
Q ss_pred eEEEEEecCCCC-chhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCC----eEEEEeecCcee
Q 011331 303 QLYIQMELCDHS-LSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNG----VYKLGDFGRATL 375 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g----~vkL~DFGlA~~ 375 (488)
.+||||||+.++ |.... ....+++..++.++.||+.||.|||++||+||||||+|||+ .++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 999999999765 44432 34569999999999999999999999999999999999999 444 799999999987
Q ss_pred cCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCC----CCCcH
Q 011331 376 LNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLL----PGHSL 446 (488)
Q Consensus 376 ~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~----~~~s~ 446 (488)
.... .....||+.|+|||++... .++.++|||||||++|+|++|.+||.+... +..+..+...++ ..++.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 247 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 7543 3445799999999999765 577899999999999999999999976543 334444444433 56799
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 447 QFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
++.+||.+||..||.+|||+.|+|+||||+.+
T Consensus 248 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 99999999999999999999999999999865
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=375.12 Aligned_cols=249 Identities=21% Similarity=0.377 Sum_probs=204.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch------------------------HHHHHHHHHHHHHH
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD------------------------AERRKALLEVQALA 283 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~------------------------~~~~~~~~Ei~iL~ 283 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++....... .....+.+|+.++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999999999999999986542111 12345788999999
Q ss_pred HhCCCCCeeEeeeeecc--cceEEEEEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE
Q 011331 284 ALGSHENIVGYYSSWFE--NEQLYIQMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV 360 (488)
Q Consensus 284 ~l~~HpnIv~l~~~~~~--~~~l~IV~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv 360 (488)
.+ +||||+++++++.+ .+.+||||||++++ +........+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 99 89999999999986 66899999999875 4444445679999999999999999999999999999999999999
Q ss_pred -eCCeEEEEeecCceecCCCC---CCCCCCCCccChhhhcccCC--CCchhHHHHHHHHHHHHHcCCCCCCCchhh---h
Q 011331 361 -KNGVYKLGDFGRATLLNKSL---PIEEGDARYMPQEILNEDYD--HLDKVDIFSLGATMYELIKGSPLSESGPQF---L 431 (488)
Q Consensus 361 -~~g~vkL~DFGlA~~~~~~~---~~~~Gt~~Y~APEvl~~~~~--~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~ 431 (488)
.++.+||+|||+++...... ....||+.|+|||++..... ++.++|||||||++|+|++|..||...... .
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 250 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH
Confidence 67899999999998765432 34569999999999876422 356899999999999999999998765432 2
Q ss_pred hhhcCC--CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 432 NLRDGK--LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 432 ~i~~~~--~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
.+.... .+..+.++.++.+||.+||+.||++|||+.|+++||||++
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 222332 3344578999999999999999999999999999999964
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=398.26 Aligned_cols=252 Identities=24% Similarity=0.390 Sum_probs=214.5
Q ss_pred cccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 225 SRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 225 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.++.++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSSEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECCEE
Confidence 3556789999999999999999999999999999999977655556667789999999999 999999999999999999
Q ss_pred EEEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecCceecCC
Q 011331 305 YIQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGRATLLNK 378 (488)
Q Consensus 305 ~IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGlA~~~~~ 378 (488)
|||||||.++ |.. ......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|.....
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 9999999875 433 33456799999999999999999999999999999999999994 47899999999987654
Q ss_pred CC---CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCC----CCCCCcHHH
Q 011331 379 SL---PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLP----LLPGHSLQF 448 (488)
Q Consensus 379 ~~---~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~----~~~~~s~~l 448 (488)
.. ....||+.|+|||++... .++.++|||||||++|+|++|.+||..... ...+..+... ..+.++.++
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 32 335799999999999765 577899999999999999999999876543 2334444333 234679999
Q ss_pred HHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 449 QNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 449 ~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999999999999999999999999754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=386.83 Aligned_cols=244 Identities=22% Similarity=0.338 Sum_probs=186.2
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc----eE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE----QL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~----~l 304 (488)
.+|.+.+.||+|+||+||+|.+ +|+.||||++... .........|+..+..+ +|||||++++++.+.+ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEE
Confidence 3578999999999999999987 6999999998643 12222233455555566 8999999999998654 58
Q ss_pred EEEEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHc--------CcccCCCCCCcEEE-eCCeEEEEeecCce
Q 011331 305 YIQMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEK--------GIAHLDVKPDNIYV-KNGVYKLGDFGRAT 374 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--------gIiHrDLKp~NILv-~~g~vkL~DFGlA~ 374 (488)
|||||||+++ |........+++..+..++.||+.||+|||++ +||||||||+|||| .++.+||+|||+|+
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999865 55555667799999999999999999999987 99999999999999 67899999999998
Q ss_pred ecCCCC-------CCCCCCCCccChhhhcccC-----CCCchhHHHHHHHHHHHHHcCCCCCCCchh-------------
Q 011331 375 LLNKSL-------PIEEGDARYMPQEILNEDY-----DHLDKVDIFSLGATMYELIKGSPLSESGPQ------------- 429 (488)
Q Consensus 375 ~~~~~~-------~~~~Gt~~Y~APEvl~~~~-----~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------------- 429 (488)
...... ...+||+.|||||++.+.. .++.++|||||||+||||+||.+|+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 764322 2346999999999986542 245689999999999999999776532110
Q ss_pred ----hhh-hh-cCCCCCCC-C-----CcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 430 ----FLN-LR-DGKLPLLP-G-----HSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 430 ----~~~-i~-~~~~~~~~-~-----~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
... +. ....|..| . .+..+.+||.+||+.||++|||+.||++. ++.+.+
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~--L~~l~~ 297 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLSQ 297 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH--HHHHHH
Confidence 111 11 11122222 1 23578899999999999999999999985 666544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=389.20 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=211.0
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc----
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE---- 302 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~---- 302 (488)
..++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.++..+ +||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCcccc
Confidence 45679999999999999999999999999999999976655566677889999999999 8999999999988653
Q ss_pred --eEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 303 --QLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 303 --~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
.+||||||+++++........+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+++.....
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (367)
T 1cm8_A 102 FTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181 (367)
T ss_dssp CCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred CceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc
Confidence 4699999997777776666789999999999999999999999999999999999999 6789999999999988766
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc--CC-----------------
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD--GK----------------- 437 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~--~~----------------- 437 (488)
.....||+.|+|||++.+...++.++|||||||++|||++|.+||.+...... +.. +.
T Consensus 182 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~ 261 (367)
T 1cm8_A 182 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261 (367)
T ss_dssp CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHH
T ss_pred cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHH
Confidence 66678999999999987744678899999999999999999999976543211 100 00
Q ss_pred ------------CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 438 ------------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 438 ------------~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
....+..+.++.+||.+||..||.+|||++|+|+||||+.++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 0123567899999999999999999999999999999987643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=373.71 Aligned_cols=252 Identities=31% Similarity=0.460 Sum_probs=207.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.++..+ +||||+++++++.+.+.+++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEEE
Confidence 4579999999999999999999999999999999876655555567788999999999 899999999999999999999
Q ss_pred EecCCCCchhh--hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CC
Q 011331 308 MELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LP 381 (488)
Q Consensus 308 ~E~~~~~l~~~--~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~ 381 (488)
|||++++++.. .....+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||++...... ..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence 99999876552 234569999999999999999999999999999999999999 5789999999999876532 23
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---h---------------------cCC
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---R---------------------DGK 437 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~---------------------~~~ 437 (488)
...||+.|+|||++.+...++.++|||||||++|+|++|.+||........+ . ...
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence 4468999999999976556788999999999999999999998765432111 0 011
Q ss_pred CCC----------CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 438 LPL----------LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 438 ~~~----------~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
.+. .+.++.++.+||.+||+.||.+|||++|+++||||+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 111 1457889999999999999999999999999999998753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=393.11 Aligned_cols=253 Identities=24% Similarity=0.361 Sum_probs=207.7
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc-----
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN----- 301 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~----- 301 (488)
..++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.++..+ +||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcC
Confidence 34689999999999999999999999999999999987655666677899999999999 899999999999876
Q ss_pred ceEEEEEecCCCCchhhhhc-ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 302 EQLYIQMELCDHSLSDKKAS-QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 302 ~~l~IV~E~~~~~l~~~~~~-~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
+.+||||||++++|...... ..+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+|+.....
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 103 DELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred CeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 57999999999877765443 459999999999999999999999999999999999999 6789999999999876432
Q ss_pred -------------------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCC-----------CC
Q 011331 380 -------------------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGS-----------PL 423 (488)
Q Consensus 380 -------------------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~-----------~p 423 (488)
....+||+.|+|||++.....++.++|||||||++|||++|. ++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~ 262 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence 244579999999999755556888999999999999999853 33
Q ss_pred CCCchh--------------------hhhh------------------------hcC--CCC-----CCCCCcHHHHHHH
Q 011331 424 SESGPQ--------------------FLNL------------------------RDG--KLP-----LLPGHSLQFQNLL 452 (488)
Q Consensus 424 ~~~~~~--------------------~~~i------------------------~~~--~~~-----~~~~~s~~l~~lI 452 (488)
|.+... +..+ ... ..+ ..+.++.++.+||
T Consensus 263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 342 (432)
T 3n9x_A 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL 342 (432)
T ss_dssp CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence 332210 0000 000 000 1246799999999
Q ss_pred HHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 453 KVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
.+||..||.+|||++|+|+||||+.++.
T Consensus 343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 343 ESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 9999999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=382.82 Aligned_cols=249 Identities=28% Similarity=0.414 Sum_probs=194.6
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.++..+ +||||+++++++.+.+.+||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEEE
Confidence 47899999999999999999999999999999986542 222234577899999999 8999999999999999999999
Q ss_pred ecCCCCchhhhhc-------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 309 ELCDHSLSDKKAS-------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 309 E~~~~~l~~~~~~-------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
||+++++...... ..+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.....
T Consensus 83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 9999876653322 348999999999999999999999999999999999999 6789999999999876532
Q ss_pred --CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhc--CC---------------
Q 011331 380 --LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRD--GK--------------- 437 (488)
Q Consensus 380 --~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~--~~--------------- 437 (488)
.....||+.|+|||++.+...++.++|||||||++|||++|.+||....... .+.. +.
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence 2345689999999999765467789999999999999999999987653321 1100 00
Q ss_pred -----------------CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 438 -----------------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 438 -----------------~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
......++.++.+||.+||+.||++|||++|+|+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 001224688999999999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=385.02 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=214.2
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.+.++|++++.||+|+||+||+|.+..+|..||||++............+.+|+.++..+ +||||+++++++.+.+..|
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEE
Confidence 345679999999999999999999999999999999976655666677889999999999 8999999999999999999
Q ss_pred EEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-C---CeEEEEeecCceecCCC
Q 011331 306 IQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-N---GVYKLGDFGRATLLNKS 379 (488)
Q Consensus 306 IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~---g~vkL~DFGlA~~~~~~ 379 (488)
+||||+.++ +.. ......+++..++.++.||+.||.|||++||+||||||+|||++ + +.+||+|||++......
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 999999875 433 33345689999999999999999999999999999999999993 2 46999999999877543
Q ss_pred C--CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCC----CCCcHHHHH
Q 011331 380 L--PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLL----PGHSLQFQN 450 (488)
Q Consensus 380 ~--~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~----~~~s~~l~~ 450 (488)
. ....||+.|+|||++... .++.++|||||||++|+|++|.+||..... ...+..+....+ ..++.++.+
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 263 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred cccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2 345799999999999765 577899999999999999999999876543 233444443332 357899999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
||.+||..||++|||+.|+|+||||+..
T Consensus 264 li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 264 LIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=377.71 Aligned_cols=247 Identities=22% Similarity=0.353 Sum_probs=210.9
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
+.++|++++.||+|+||+||+|.+..+|+.||+|++... ......+.+|+.++..+ +||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEEEE
Confidence 456899999999999999999999999999999998643 34455688899999998 89999999999999999999
Q ss_pred EEecCCCC-chhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe---CCeEEEEeecCceecCCCC
Q 011331 307 QMELCDHS-LSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK---NGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 307 V~E~~~~~-l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~---~g~vkL~DFGlA~~~~~~~ 380 (488)
|||||+++ |...... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999875 4443332 3599999999999999999999999999999999999994 6899999999998775432
Q ss_pred --CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCC----CCCcHHHHHH
Q 011331 381 --PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLL----PGHSLQFQNL 451 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~----~~~s~~l~~l 451 (488)
....||+.|+|||++... .++.++|||||||++|+|++|.+||..... ...+..+....+ +.++.++.+|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred ccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 234589999999999765 467899999999999999999999976543 233444444433 4689999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
|.+||..||.+|||+.|+|+||||+..
T Consensus 238 i~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 238 VDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=385.37 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=207.0
Q ss_pred ccceeEEEEeccc--CcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 228 YTDFHEIEQIGAG--NFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 228 ~~~y~~~~~LG~G--~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.++|++++.||+| +||+||+|.+..+|+.||||++............+.+|+.+++.+ +|||||++++++.+.+.+|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEEE
Confidence 3479999999999 999999999999999999999977655566667788899999999 8999999999999999999
Q ss_pred EEEecCCCCchh-hhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC--
Q 011331 306 IQMELCDHSLSD-KKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK-- 378 (488)
Q Consensus 306 IV~E~~~~~l~~-~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~-- 378 (488)
||||||+++.+. ... ...+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999875443 222 2569999999999999999999999999999999999999 589999999998865421
Q ss_pred --------CCCCCCCCCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcCC---------
Q 011331 379 --------SLPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDGK--------- 437 (488)
Q Consensus 379 --------~~~~~~Gt~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~~--------- 437 (488)
......||+.|+|||++... ..++.++|||||||++|||++|.+||........ +..+.
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 12234689999999999763 3577899999999999999999999875432111 11111
Q ss_pred -------------------------------------CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 438 -------------------------------------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 438 -------------------------------------~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
.+.+..++.++.+||.+||++||++|||+.|+|+||||+.+.+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence 1233457889999999999999999999999999999998764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=401.66 Aligned_cols=261 Identities=23% Similarity=0.354 Sum_probs=208.1
Q ss_pred ccceeeCCCCccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeE
Q 011331 214 LFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293 (488)
Q Consensus 214 ~~p~~~g~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~ 293 (488)
++++..|+. .....++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+++.+ +||||++
T Consensus 48 ~~~~~~~~~-~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~ 125 (464)
T 3ttj_A 48 FYSVEVGDS-TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIS 125 (464)
T ss_dssp EEEEEC--C-EEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCC
T ss_pred ceeeecCCc-ceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCc
Confidence 444444432 33456789999999999999999999999999999999976655666677889999999999 9999999
Q ss_pred eeeeeccc------ceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEE
Q 011331 294 YYSSWFEN------EQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYK 366 (488)
Q Consensus 294 l~~~~~~~------~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vk 366 (488)
+++++... ..+||||||+++++..... ..+++..++.++.||+.||.|||++||+||||||+|||| .++.+|
T Consensus 126 l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 126 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp CSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEEccCCccccCCeEEEEEeCCCCCHHHHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEE
Confidence 99998654 4679999999998766544 359999999999999999999999999999999999999 578999
Q ss_pred EEeecCceecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc--C---
Q 011331 367 LGDFGRATLLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD--G--- 436 (488)
Q Consensus 367 L~DFGlA~~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~--~--- 436 (488)
|+|||+|+..... .....||+.|+|||++.+. .++.++|||||||+||||++|.+||.+...... +.. +
T Consensus 205 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 205 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283 (464)
T ss_dssp ECCCCCC-----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred EEEEEeeeecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999999877543 3345799999999999775 678899999999999999999999986543211 100 0
Q ss_pred ----------------CCCC---------CCC------------CcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 437 ----------------KLPL---------LPG------------HSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 437 ----------------~~~~---------~~~------------~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
..+. .+. .+.++.+||.+||.+||++|||++|+|+||||+..
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 0000 000 15679999999999999999999999999999854
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=382.18 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=201.8
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.++..+ +||||+++++++.+++.+||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEETTEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCEEEE
Confidence 35679999999999999999999999999999999976544444456678899999999 89999999999999999999
Q ss_pred EEecCCCCchhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-C-----CeEEEEeecCceecCCC
Q 011331 307 QMELCDHSLSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-N-----GVYKLGDFGRATLLNKS 379 (488)
Q Consensus 307 V~E~~~~~l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~-----g~vkL~DFGlA~~~~~~ 379 (488)
||||+++++.... ....+++..++.++.||+.||.|||++||+||||||+||||+ + +.+||+|||+++.....
T Consensus 111 v~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 111 IFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp EEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 9999998776643 345699999999999999999999999999999999999993 2 35999999999866432
Q ss_pred ---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hc--CCCC------------
Q 011331 380 ---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RD--GKLP------------ 439 (488)
Q Consensus 380 ---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~--~~~~------------ 439 (488)
.....||+.|+|||++.+...++.++|||||||++|||++|.+||........+ .. +..+
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD 270 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhh
Confidence 334468999999999977555788999999999999999999999765442211 10 0000
Q ss_pred ----C------------CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 440 ----L------------LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 440 ----~------------~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
. ...++.++.+||.+||++||.+|||++|+|+||||+...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 0 011578999999999999999999999999999998763
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=390.39 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=215.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.++..+ +|||||+++++|.+.+.+|+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEE
Confidence 467999999999999999999999999999999986432 1112245688899999999 99999999999999999999
Q ss_pred EEecCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CC
Q 011331 307 QMELCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LP 381 (488)
Q Consensus 307 V~E~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~ 381 (488)
||||+.++.+. . .....+++..++.++.||+.||.|||++||+||||||+|||| .+|.+||+|||+|+..... ..
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 172 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172 (384)
T ss_dssp EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBC
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCcee
Confidence 99999876443 2 334569999999999999999999999999999999999999 6799999999999876433 34
Q ss_pred CCCCCCCccChhhhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCchh------hhhhhcCCCCCCCCCcHHHHHHHH
Q 011331 382 IEEGDARYMPQEILNE--DYDHLDKVDIFSLGATMYELIKGSPLSESGPQ------FLNLRDGKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~--~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------~~~i~~~~~~~~~~~s~~l~~lI~ 453 (488)
...||+.|+|||++.. ...++.++|||||||++|||++|..||..... ...+.......+..++.++.+||.
T Consensus 173 ~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~ 252 (384)
T 4fr4_A 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLK 252 (384)
T ss_dssp CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHH
Confidence 5679999999999864 23467799999999999999999999874321 233445667778889999999999
Q ss_pred HcccCCCCCCCC-HHHHHhChhhhhhHH
Q 011331 454 VMVDPDPVQRPS-AKELVENPIFDKIQK 480 (488)
Q Consensus 454 k~L~~dP~~RpT-a~elL~HP~f~~i~~ 480 (488)
+||..||.+||+ ++++++||||+.+.+
T Consensus 253 ~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 253 KLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp HHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred HHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 999999999998 999999999998865
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=382.84 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=208.5
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH---HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~---~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
+.++|++++.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.++..+ +||||+++++++.+.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGM 100 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCE
Confidence 34579999999999999999999999999999999853210 111245688899999999 89999999999999999
Q ss_pred EEEEEecCCCC-chhhhh-----cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC---eEEEEeecCc
Q 011331 304 LYIQMELCDHS-LSDKKA-----SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG---VYKLGDFGRA 373 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g---~vkL~DFGlA 373 (488)
+|||||||+++ |..... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999865 433221 12489999999999999999999999999999999999994 33 4999999999
Q ss_pred eecCCC---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh--hhhhhcCCCCCC----CCC
Q 011331 374 TLLNKS---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ--FLNLRDGKLPLL----PGH 444 (488)
Q Consensus 374 ~~~~~~---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~--~~~i~~~~~~~~----~~~ 444 (488)
...... .....||+.|+|||++... .++.++|||||||++|+|++|..||..... +..+..+..... +.+
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHI 259 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccccC
Confidence 877543 2345699999999999765 577899999999999999999999976543 233444444433 467
Q ss_pred cHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 445 SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 445 s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+.++.+||.+||..||++|||+.|+|+||||+...
T Consensus 260 s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 99999999999999999999999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=363.83 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=214.8
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.+.++|++++.||+|+||+||+|.+..+|..||+|++............+.+|+.++..+ +||||+++++++...+..|
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCEEE
Confidence 345789999999999999999999999999999999976655666677888999999999 8999999999999999999
Q ss_pred EEEecCCCCch-h-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-C---CeEEEEeecCceecCCC
Q 011331 306 IQMELCDHSLS-D-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-N---GVYKLGDFGRATLLNKS 379 (488)
Q Consensus 306 IV~E~~~~~l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~---g~vkL~DFGlA~~~~~~ 379 (488)
+||||+.++.+ . ......+++..++.++.||+.||.|||++||+|+||||+||+++ + +.+||+|||++......
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999987533 3 33445699999999999999999999999999999999999993 3 34999999999877543
Q ss_pred C--CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCC----CCCCCCcHHHHH
Q 011331 380 L--PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKL----PLLPGHSLQFQN 450 (488)
Q Consensus 380 ~--~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~----~~~~~~s~~l~~ 450 (488)
. ....||+.|+|||++... .++.++||||||+++|+|++|..||...... ..+..+.. +....++.++.+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred ccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 2 335699999999998765 5778999999999999999999998765432 22333332 233467999999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
||.+||+.||++|||+.|+++||||+...+
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 999999999999999999999999987644
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=376.75 Aligned_cols=251 Identities=28% Similarity=0.390 Sum_probs=205.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEc---CCCeEEEEEEeccCCC--chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKR---IDGCFYAVKHSKRQLH--HDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~l~~~~~--~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|.+. .+|+.||||++.+... .......+.+|+.++..+ +||||+++++++...+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTGG 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcCC
Confidence 357999999999999999999985 5899999999976432 123345577899999999 8999999999999999
Q ss_pred eEEEEEecCCCCch-h-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC-
Q 011331 303 QLYIQMELCDHSLS-D-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK- 378 (488)
Q Consensus 303 ~l~IV~E~~~~~l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~- 378 (488)
.+||||||++++.+ . ......+++..++.++.||+.||.|||++||+||||||+|||| .+|.+||+|||+++....
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 99999999987543 3 2334568999999999999999999999999999999999999 678999999999975432
Q ss_pred --CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHH
Q 011331 379 --SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 379 --~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~ 453 (488)
......||+.|+|||++... .++.++|||||||++|||++|..||..... ...+.......++.++.++.+||.
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 253 (327)
T 3a62_A 175 GTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred CccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 22345799999999998765 577899999999999999999999976543 334556677788889999999999
Q ss_pred HcccCCCCCCC-----CHHHHHhChhhhhhHH
Q 011331 454 VMVDPDPVQRP-----SAKELVENPIFDKIQK 480 (488)
Q Consensus 454 k~L~~dP~~Rp-----Ta~elL~HP~f~~i~~ 480 (488)
+||..||.+|| ++.|+++||||+.+.+
T Consensus 254 ~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 254 KLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp HHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred HHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 99999999999 8999999999998743
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=381.83 Aligned_cols=246 Identities=24% Similarity=0.323 Sum_probs=206.1
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC----CCCCeeEeeeeecccc
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG----SHENIVGYYSSWFENE 302 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~----~HpnIv~l~~~~~~~~ 302 (488)
..++|++++.||+|+||+||+|.+..+|+.||||++.. ..........|+.++..+. +||||+++++++...+
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 34689999999999999999999999999999999863 2344556778999999984 4999999999999999
Q ss_pred eEEEEEecCCCCchhhhhcc---cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe------------------
Q 011331 303 QLYIQMELCDHSLSDKKASQ---FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK------------------ 361 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~~~~~~---~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~------------------ 361 (488)
.+||||||++++|....... .+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 110 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 110 HMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred eeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 99999999977776644332 499999999999999999999999999999999999994
Q ss_pred --------CCeEEEEeecCceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh-
Q 011331 362 --------NGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN- 432 (488)
Q Consensus 362 --------~g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~- 432 (488)
++.+||+|||+|+..........||+.|+|||++.+. .++.++|||||||++|+|++|..||........
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 268 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence 6789999999999877766677899999999999765 578899999999999999999999876433111
Q ss_pred --hhcCCCC--------------------------CC--------------------CCCcHHHHHHHHHcccCCCCCCC
Q 011331 433 --LRDGKLP--------------------------LL--------------------PGHSLQFQNLLKVMVDPDPVQRP 464 (488)
Q Consensus 433 --i~~~~~~--------------------------~~--------------------~~~s~~l~~lI~k~L~~dP~~Rp 464 (488)
+.....+ .+ ...+..+.+||.+||++||++||
T Consensus 269 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 348 (360)
T 3llt_A 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP 348 (360)
T ss_dssp HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC
Confidence 1100000 00 01236788999999999999999
Q ss_pred CHHHHHhChhhh
Q 011331 465 SAKELVENPIFD 476 (488)
Q Consensus 465 Ta~elL~HP~f~ 476 (488)
|++|+|+||||+
T Consensus 349 ta~elL~hp~f~ 360 (360)
T 3llt_A 349 SPAELLKHKFLE 360 (360)
T ss_dssp CHHHHTTSGGGC
T ss_pred CHHHHhcCcccC
Confidence 999999999996
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=386.40 Aligned_cols=263 Identities=25% Similarity=0.331 Sum_probs=210.9
Q ss_pred cccccCCccceeeCCCCccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC
Q 011331 207 QWAKCAGLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG 286 (488)
Q Consensus 207 ~~~~~~~~~p~~~g~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~ 286 (488)
..+...+++|...|. .+.++|++++.||+|+||+||+|.+..+|+.||||++... ......+.+|+.++..+.
T Consensus 19 ~~~~~~~~~~~~~g~----~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~ 91 (397)
T 1wak_A 19 NDYCKGGYHLVKIGD----LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVR 91 (397)
T ss_dssp ---CC--CCSSCTTC----EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHH
T ss_pred ccCCCCCceEEehhh----hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHh
Confidence 334445666665553 3346799999999999999999999999999999998643 344567888999999884
Q ss_pred -------CCCCeeEeeeeec----ccceEEEEEecCCCCchhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHc-CcccC
Q 011331 287 -------SHENIVGYYSSWF----ENEQLYIQMELCDHSLSDKKAS---QFFAEGEVLKALHQIAQALQFIHEK-GIAHL 351 (488)
Q Consensus 287 -------~HpnIv~l~~~~~----~~~~l~IV~E~~~~~l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~-gIiHr 351 (488)
+|+||+++++++. ....+||||||++++++..... ..+++..++.++.||+.||.|||++ ||+||
T Consensus 92 ~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHr 171 (397)
T 1wak_A 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHT 171 (397)
T ss_dssp HSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECC
T ss_pred hcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 2888999999987 6678999999998887764332 4599999999999999999999998 99999
Q ss_pred CCCCCcEEEe-CC-------------------------------------------------eEEEEeecCceecCCCCC
Q 011331 352 DVKPDNIYVK-NG-------------------------------------------------VYKLGDFGRATLLNKSLP 381 (488)
Q Consensus 352 DLKp~NILv~-~g-------------------------------------------------~vkL~DFGlA~~~~~~~~ 381 (488)
||||+||||+ ++ .+||+|||+|+.......
T Consensus 172 Dikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~ 251 (397)
T 1wak_A 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT 251 (397)
T ss_dssp CCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSC
T ss_pred CCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCc
Confidence 9999999994 33 799999999998877666
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---------hhhhh--cCC-------------
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---------FLNLR--DGK------------- 437 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---------~~~i~--~~~------------- 437 (488)
...||+.|+|||++.+. .++.++|||||||+||||++|..||..... ...+. .+.
T Consensus 252 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 330 (397)
T 1wak_A 252 EDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330 (397)
T ss_dssp SCCSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG
T ss_pred cCCCCCcccCChhhcCC-CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc
Confidence 77899999999999775 577899999999999999999999864321 00000 000
Q ss_pred ---------------------------CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 438 ---------------------------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 438 ---------------------------~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
...+...+.++.+||.+||+.||++|||++|+|+||||+.
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp GTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0112233567899999999999999999999999999973
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=379.12 Aligned_cols=250 Identities=22% Similarity=0.361 Sum_probs=206.0
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
+.++|++++.||+|+||+||+|.+..+++.||||++..... ......+.+|+.++..+ +||||+++++++.+.+..||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEE
Confidence 45689999999999999999999999999999999864422 22235578899999998 89999999999999999999
Q ss_pred EEecCCCC-chhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----
Q 011331 307 QMELCDHS-LSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---- 379 (488)
Q Consensus 307 V~E~~~~~-l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---- 379 (488)
||||++++ +.... ....+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999875 43432 23469999999999999999999999999999999999999 5689999999999865321
Q ss_pred -CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcC--CCCCCCCCcHHHHHHH
Q 011331 380 -LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDG--KLPLLPGHSLQFQNLL 452 (488)
Q Consensus 380 -~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~--~~~~~~~~s~~l~~lI 452 (488)
.....||+.|+|||++.....++.++|||||||++|+|++|..||..... ....... ..+....++.++.+||
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 23457999999999997654446789999999999999999999875432 1222222 2233356799999999
Q ss_pred HHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 453 KVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.+||..||++|||++|+++||||+..
T Consensus 243 ~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 243 HKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHccCChhhCcCHHHHhhChhhccc
Confidence 99999999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=387.82 Aligned_cols=253 Identities=26% Similarity=0.368 Sum_probs=207.7
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|++..++..||||++.+.... .........|..++.+..+||||++++++|.+.+.+||
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 45899999999999999999999999999999999765322 23345566777775444499999999999999999999
Q ss_pred EEecCCCCch-h-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCC
Q 011331 307 QMELCDHSLS-D-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSL 380 (488)
Q Consensus 307 V~E~~~~~l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~ 380 (488)
||||++++.+ . ......+++..++.++.||+.||.|||++||+||||||+|||| .+|.+||+|||+++... ...
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~ 196 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCcc
Confidence 9999987543 3 3334569999999999999999999999999999999999999 67999999999997642 233
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
...+||+.|+|||++.+. .++.++|||||||++|||++|.+||..... +..+.......++.++.++.+||.+||+
T Consensus 197 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL~ 275 (373)
T 2r5t_A 197 STFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQ 275 (373)
T ss_dssp CSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHTC
T ss_pred ccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHcc
Confidence 456799999999999765 577899999999999999999999976543 3455666777788899999999999999
Q ss_pred CCCCCCCCH----HHHHhChhhhhhHHh
Q 011331 458 PDPVQRPSA----KELVENPIFDKIQKH 481 (488)
Q Consensus 458 ~dP~~RpTa----~elL~HP~f~~i~~~ 481 (488)
.||.+||++ .++++||||+.+.+.
T Consensus 276 ~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 276 KDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp SSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred cCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 999999986 799999999988543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=376.61 Aligned_cols=249 Identities=26% Similarity=0.375 Sum_probs=206.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCC-CCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH-ENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~H-pnIv~l~~~~~~~~~l~I 306 (488)
..+|++++.||+|+||+||+|.+. ++..||||++............+.+|+.++..+..| +||+++++++.+.+.+||
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 346999999999999999999885 799999999976655566667889999999999433 999999999999999999
Q ss_pred EEecCCCCchhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCceecCCCC-----
Q 011331 307 QMELCDHSLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSL----- 380 (488)
Q Consensus 307 V~E~~~~~l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~~~~~~----- 380 (488)
|||+.++++... .....+++.+++.++.||+.||.|||++||+||||||+||||+++.+||+|||+++......
T Consensus 87 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~ 166 (343)
T 3dbq_A 87 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVK 166 (343)
T ss_dssp EECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC---------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCcccccccC
Confidence 999777766663 33456999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCCCCCCccChhhhcc----------cCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhh--cCCCCCCCCC
Q 011331 381 PIEEGDARYMPQEILNE----------DYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLR--DGKLPLLPGH 444 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~----------~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~--~~~~~~~~~~ 444 (488)
....||+.|+|||++.. ...++.++|||||||++|||++|..||..... ...+. ......+...
T Consensus 167 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T 3dbq_A 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246 (343)
T ss_dssp ---CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCS
T ss_pred CCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccC
Confidence 23469999999999854 13567799999999999999999999875322 11222 2334456667
Q ss_pred cHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 445 SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 445 s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
+.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 247 ~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 247 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 889999999999999999999999999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=395.84 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=207.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.... ........+..|+.++..+ +||||++++++|.+.+.+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCEEEE
Confidence 457999999999999999999999999999999986532 1223345677888888888 89999999999999999999
Q ss_pred EEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---C
Q 011331 307 QMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---S 379 (488)
Q Consensus 307 V~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~ 379 (488)
||||++++.+. ......+++..++.++.||+.||.|||+ +|||||||||+|||| .++.+||+|||+|+.... .
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 305 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 305 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcc
Confidence 99999886443 3334579999999999999999999998 999999999999999 678999999999975422 2
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcc
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L 456 (488)
.....||+.|+|||++... .++.++|||||||+||||++|..||..... ...+.......+..++.++.+||.+||
T Consensus 306 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 384 (446)
T 4ejn_A 306 MKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 384 (446)
T ss_dssp -CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHc
Confidence 3456799999999998765 578899999999999999999999976543 334455667777889999999999999
Q ss_pred cCCCCCCC-----CHHHHHhChhhhhhHH
Q 011331 457 DPDPVQRP-----SAKELVENPIFDKIQK 480 (488)
Q Consensus 457 ~~dP~~Rp-----Ta~elL~HP~f~~i~~ 480 (488)
+.||.+|| |++|+++||||+.+.+
T Consensus 385 ~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 385 KKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 99999999 9999999999998854
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=383.27 Aligned_cols=252 Identities=24% Similarity=0.391 Sum_probs=210.1
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE-
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL- 304 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l- 304 (488)
...++|.+++.||+|+||+||+|.+..+|+.||||++............+.+|+.++..+ +||||+++++++...+..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSST
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCcc
Confidence 345689999999999999999999999999999999987655666677889999999999 899999999999877765
Q ss_pred -----EEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 305 -----YIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 305 -----~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
|+||||+++++.... ...+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+++....
T Consensus 118 ~~~~~~lv~e~~~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 118 NFYDFYLVMPFMQTDLQKIM-GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp TCCCCEEEEECCCEEHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred cceeEEEEEccccccHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 999999998765544 3459999999999999999999999999999999999999 578999999999988776
Q ss_pred CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc-----C-----------------
Q 011331 379 SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD-----G----------------- 436 (488)
Q Consensus 379 ~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~-----~----------------- 436 (488)
......||+.|+|||++.+...++.++|||||||++|+|++|..||........+.. +
T Consensus 197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 276 (371)
T 4exu_A 197 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 276 (371)
T ss_dssp ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHH
T ss_pred CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhh
Confidence 666678999999999987744678899999999999999999999986543211100 0
Q ss_pred ------CC------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 437 ------KL------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 437 ------~~------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.. ..++.++.++.+||.+||+.||++|||+.|+|+||||+.+.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 00 12345789999999999999999999999999999998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=380.39 Aligned_cols=250 Identities=24% Similarity=0.418 Sum_probs=205.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-------
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE------- 300 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~------- 300 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.++..+ +||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeecccccccc
Confidence 4578999999999999999999999999999999865544433345677899999999 89999999999876
Q ss_pred -cceEEEEEecCCCCchhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceec
Q 011331 301 -NEQLYIQMELCDHSLSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL 376 (488)
Q Consensus 301 -~~~l~IV~E~~~~~l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~ 376 (488)
.+.+||||||+++++...... ..+++.+++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+|+..
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 456899999999877664333 469999999999999999999999999999999999999 5789999999999876
Q ss_pred CC-------CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc--CCC--CCCC
Q 011331 377 NK-------SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD--GKL--PLLP 442 (488)
Q Consensus 377 ~~-------~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~--~~~--~~~~ 442 (488)
.. ......||+.|+|||++.+...++.++|||||||++|||++|.+||........ +.. +.. ...+
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 42 123346899999999987655678899999999999999999999886543211 111 111 1111
Q ss_pred C----------------------------CcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 443 G----------------------------HSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 443 ~----------------------------~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
. .+.++.+||.+||+.||++|||++|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 1 26679999999999999999999999999999763
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=386.43 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=196.4
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc-----
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN----- 301 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~----- 301 (488)
..++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.++..+ +||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCcccc
Confidence 34689999999999999999999999999999999976655566677888999999999 899999999998654
Q ss_pred -ceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 302 -EQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 302 -~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
..+|+|||+++++|........+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+++.....
T Consensus 106 ~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 106 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp CCCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred CCeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 56899999998777776666789999999999999999999999999999999999999 6789999999999887666
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc--C------------------
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD--G------------------ 436 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~--~------------------ 436 (488)
.....||+.|+|||++.+...++.++|||||||++|||++|.+||.+...... +.. +
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 265 (367)
T 2fst_X 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265 (367)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHH
T ss_pred CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHH
Confidence 56678999999999987744678899999999999999999999976543211 100 0
Q ss_pred -----CCC------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 437 -----KLP------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 437 -----~~~------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
..+ ..+..+.++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 266 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 000 1235688999999999999999999999999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=373.78 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=209.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch----HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD----AERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~----~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
.++|++++.||+|+||+||+|.+..+|..||||++....... .....+.+|+.++..+ +||||+++++++.+.+.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCE
Confidence 456899999999999999999999999999999986543221 1245688899999999 89999999999999999
Q ss_pred EEEEEecCCCC-chhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCC----eEEEEeecCceec
Q 011331 304 LYIQMELCDHS-LSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNG----VYKLGDFGRATLL 376 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g----~vkL~DFGlA~~~ 376 (488)
+|+||||++++ |.... ....+++..++.++.||+.||.|||++||+||||||+|||+ .++ .+||+|||+++..
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 99999999765 44432 34569999999999999999999999999999999999999 445 7999999999877
Q ss_pred CC--CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCCC----CCCCcHH
Q 011331 377 NK--SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLPL----LPGHSLQ 447 (488)
Q Consensus 377 ~~--~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~~----~~~~s~~ 447 (488)
.. ......||+.|+|||++... .++.++|||||||++|+|++|..||...... ..+....... ++.++..
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHH
Confidence 43 23445799999999998765 5778999999999999999999998765432 2333333332 2467899
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 248 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 9999999999999999999999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=380.51 Aligned_cols=246 Identities=23% Similarity=0.283 Sum_probs=195.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++....... ..+.+|+.+++.+ +||||+++++++.+.+.+|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEEEE
Confidence 457999999999999999999999999999999987543222 4467899999999 899999999999999999999
Q ss_pred EecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC--eEEEEeecCceecC--CCC
Q 011331 308 MELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG--VYKLGDFGRATLLN--KSL 380 (488)
Q Consensus 308 ~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g--~vkL~DFGlA~~~~--~~~ 380 (488)
|||++++ |... ...+.+++..++.++.||+.||.|||++||+||||||+||||+ ++ .+||+|||+++... ...
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence 9999775 4332 3345799999999999999999999999999999999999994 34 49999999997442 223
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-------hhhhhcCCC--CCCCCCcHHHHHH
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-------FLNLRDGKL--PLLPGHSLQFQNL 451 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~~~i~~~~~--~~~~~~s~~l~~l 451 (488)
....||+.|+|||++.+....+.++|||||||++|+|++|..||..... ...+..... +....++.++.+|
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 254 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHH
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHH
Confidence 3456999999999987663334459999999999999999999976432 122233333 3334679999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
|.+||..||.+|||+.|+++||||..
T Consensus 255 i~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 255 ISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp HHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred HHHHccCChhHCcCHHHHHhCcchhc
Confidence 99999999999999999999999954
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=381.10 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=205.2
Q ss_pred ccceeeCCCCccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeE
Q 011331 214 LFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293 (488)
Q Consensus 214 ~~p~~~g~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~ 293 (488)
++++..|+. .....++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+++.+ +||||++
T Consensus 11 ~~~~~~~~~-~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~ 88 (371)
T 2xrw_A 11 FYSVEIGDS-TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIG 88 (371)
T ss_dssp EEEEEETTE-EEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCC
T ss_pred ceEeecCCc-ccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccc
Confidence 444444432 22345789999999999999999999999999999999976655566667788999999999 8999999
Q ss_pred eeeeecccc------eEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEE
Q 011331 294 YYSSWFENE------QLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYK 366 (488)
Q Consensus 294 l~~~~~~~~------~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vk 366 (488)
+++++...+ .+||||||+++++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ .++.+|
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 89 LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp EEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred eEEeeccccccccccceEEEEEcCCCCHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEE
Confidence 999987655 789999999988766543 569999999999999999999999999999999999999 578999
Q ss_pred EEeecCceecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCC----
Q 011331 367 LGDFGRATLLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGK---- 437 (488)
Q Consensus 367 L~DFGlA~~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~---- 437 (488)
|+|||+++..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..... .+....
T Consensus 168 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 246 (371)
T 2xrw_A 168 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246 (371)
T ss_dssp ECCCCC----------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCC
T ss_pred EEEeecccccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999999876543 2345699999999999765 57789999999999999999999997654321 111100
Q ss_pred -----------------CCC---------------CC------CCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 438 -----------------LPL---------------LP------GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 438 -----------------~~~---------------~~------~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.+. +. ..+.++.+||.+||..||.+|||++|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 000 00 015679999999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=376.74 Aligned_cols=251 Identities=36% Similarity=0.634 Sum_probs=201.9
Q ss_pred cccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc--
Q 011331 225 SRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE-- 302 (488)
Q Consensus 225 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~-- 302 (488)
+++.++|++++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.++..+ +||||++++++|.+..
T Consensus 2 s~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp CHHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSC
T ss_pred chhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccc
Confidence 466788999999999999999999999999999999987543 333456788999999999 8999999999886543
Q ss_pred -------------------------------------------------------eEEEEEecCCCCchh-hhhc----c
Q 011331 303 -------------------------------------------------------QLYIQMELCDHSLSD-KKAS----Q 322 (488)
Q Consensus 303 -------------------------------------------------------~l~IV~E~~~~~l~~-~~~~----~ 322 (488)
.+|+|||||+++.+. .... .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 389999999886443 2221 2
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---------------CCCCCCC
Q 011331 323 FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---------------LPIEEGD 386 (488)
Q Consensus 323 ~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---------------~~~~~Gt 386 (488)
...+..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+++..... .....||
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 35666789999999999999999999999999999999 5789999999999877543 1234699
Q ss_pred CCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh-hhhhcCCCCC-CCCCcHHHHHHHHHcccCCCCCCC
Q 011331 387 ARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF-LNLRDGKLPL-LPGHSLQFQNLLKVMVDPDPVQRP 464 (488)
Q Consensus 387 ~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~-~~i~~~~~~~-~~~~s~~l~~lI~k~L~~dP~~Rp 464 (488)
+.|+|||++.+. .++.++|||||||++|||++|..++...... ..+.....+. ....+.++.+||.+||+.||.+||
T Consensus 240 ~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 318 (332)
T 3qd2_B 240 KLYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP 318 (332)
T ss_dssp GGGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred cCccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence 999999998765 5788999999999999999997665433222 2223333221 224567889999999999999999
Q ss_pred CHHHHHhChhhhhh
Q 011331 465 SAKELVENPIFDKI 478 (488)
Q Consensus 465 Ta~elL~HP~f~~i 478 (488)
|+.|+|+||||+.+
T Consensus 319 s~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 319 EATDIIENAIFENL 332 (332)
T ss_dssp CHHHHHHSTTCCCC
T ss_pred CHHHHhhchhhhcC
Confidence 99999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=378.60 Aligned_cols=246 Identities=26% Similarity=0.435 Sum_probs=206.1
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.+.++|++++.||+|+||+||+|.+..+|+.||||++..... ....|++++.++.+||||+++++++.+.+.+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 345679999999999999999999999999999999975432 23458888888878999999999999999999
Q ss_pred EEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--CC---eEEEEeecCceecCC
Q 011331 306 IQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NG---VYKLGDFGRATLLNK 378 (488)
Q Consensus 306 IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~g---~vkL~DFGlA~~~~~ 378 (488)
||||||+++ +.. ......+++..++.++.||+.||.|||++||+||||||+|||+. ++ .+||+|||+++....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999875 444 33445699999999999999999999999999999999999993 22 599999999987643
Q ss_pred C---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch------hhhhhhcCCCCC----CCCCc
Q 011331 379 S---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP------QFLNLRDGKLPL----LPGHS 445 (488)
Q Consensus 379 ~---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~------~~~~i~~~~~~~----~~~~s 445 (488)
. .....||+.|+|||++... .++.++|||||||++|||++|.+||.... .+..+..+.... ++.++
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence 2 2345789999999998764 46679999999999999999999987532 123344444443 35689
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 446 LQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 446 ~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.++.+||.+||..||++|||+.|+++||||...
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 999999999999999999999999999999764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=382.97 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=201.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.++..+ +||||+++++++.+.+.+||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEEe
Confidence 57999999999999999999999999999999986432 111122355799999998 8999999999999999999999
Q ss_pred ecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 309 ELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 309 E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
||+++++..... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++..... ...
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 80 EYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred cccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence 999987766433 3458999999999999999999999999999999999999 6789999999999865432 233
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hh---cCC-------------------
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LR---DGK------------------- 437 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~---~~~------------------- 437 (488)
..||+.|+|||++.+...++.++|||||||++|+|++|.+||........ +. ...
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence 46899999999987755678899999999999999999999976543211 10 000
Q ss_pred --------CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 438 --------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 438 --------~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
....+.++.++.+||.+||++||.+|||++|+|+||||..+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 0112356889999999999999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=382.94 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=207.1
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCC-CCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGS-HENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~-HpnIv~l~~~~~~~~~l~IV 307 (488)
.+|++++.||+|+||+||+|.+. +|..||||++............+.+|+.++..+.. ||||+++++++...+.+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 46999999999999999999986 49999999997665555667789999999999954 69999999999999999999
Q ss_pred EecCCCCchhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCceecCCC-----CC
Q 011331 308 MELCDHSLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKS-----LP 381 (488)
Q Consensus 308 ~E~~~~~l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~~~~~-----~~ 381 (488)
||+.+++|... .....+++.+++.++.||+.||.|||++||+||||||+||||+++.+||+|||+++..... ..
T Consensus 135 ~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~ 214 (390)
T 2zmd_A 135 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKD 214 (390)
T ss_dssp EECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC---------C
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCccccCC
Confidence 99766666553 3345689999999999999999999999999999999999998899999999999876432 23
Q ss_pred CCCCCCCccChhhhcc----------cCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhc--CCCCCCCCCc
Q 011331 382 IEEGDARYMPQEILNE----------DYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRD--GKLPLLPGHS 445 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~----------~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~--~~~~~~~~~s 445 (488)
...||+.|+|||++.. ...++.++|||||||+||||++|.+||..... +..+.. .....+...+
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (390)
T 2zmd_A 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 294 (390)
T ss_dssp CSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSC
T ss_pred CCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccch
Confidence 4569999999999864 12467799999999999999999999975422 222222 2334556678
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 446 LQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 446 ~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 295 ~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 295 KDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 999999999999999999999999999999753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=364.67 Aligned_cols=252 Identities=27% Similarity=0.364 Sum_probs=195.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++..... .........|+..+.+..+||||+++++++.+.+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4579999999999999999999999999999999876533 333444555555555555999999999999999999999
Q ss_pred EecCCCCchhhh-----hcccCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 308 MELCDHSLSDKK-----ASQFFAEGEVLKALHQIAQALQFIHEK-GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 308 ~E~~~~~l~~~~-----~~~~l~~~~~~~i~~qI~~gL~yLH~~-gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
|||+++++.... ....+++..++.++.||+.||.|||++ ||+|+||||+|||+ .++.+||+|||+++......
T Consensus 85 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 164 (290)
T 3fme_A 85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164 (290)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred EehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence 999998764422 235799999999999999999999998 99999999999999 56899999999998764432
Q ss_pred --CCCCCCCCccChhhhc---ccCCCCchhHHHHHHHHHHHHHcCCCCCCCch-h---hhhhh-cCCCC-CCCCCcHHHH
Q 011331 381 --PIEEGDARYMPQEILN---EDYDHLDKVDIFSLGATMYELIKGSPLSESGP-Q---FLNLR-DGKLP-LLPGHSLQFQ 449 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~---~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~-~---~~~i~-~~~~~-~~~~~s~~l~ 449 (488)
....||+.|+|||++. ....++.++|||||||++|+|++|..||.... . ..... ..... ....++.++.
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (290)
T 3fme_A 165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFV 244 (290)
T ss_dssp -----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHH
T ss_pred cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHH
Confidence 2346999999999973 33457789999999999999999999987532 2 11222 22222 2346799999
Q ss_pred HHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 450 NLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
++|.+||+.||++|||+.|+++||||+....
T Consensus 245 ~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~ 275 (290)
T 3fme_A 245 DFTSQCLKKNSKERPTYPELMQHPFFTLHES 275 (290)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence 9999999999999999999999999986543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=393.61 Aligned_cols=251 Identities=24% Similarity=0.303 Sum_probs=211.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.+... .......+..|+.++..+ +||||++++++|.+.+.+||
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEE
Confidence 4689999999999999999999999999999999864211 001122366788999888 99999999999999999999
Q ss_pred EEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----C
Q 011331 307 QMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----L 380 (488)
Q Consensus 307 V~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----~ 380 (488)
|||||+++ |........+++..++.++.||+.||.|||++|||||||||+|||| .+|.+||+|||+|+..... .
T Consensus 147 V~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 226 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226 (410)
T ss_dssp EECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEEC
T ss_pred EEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccc
Confidence 99999775 5555555679999999999999999999999999999999999999 6799999999999876543 2
Q ss_pred CCCCCCCCccChhhhcccC---CCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhc----CCCCCCCCCcHHHHH
Q 011331 381 PIEEGDARYMPQEILNEDY---DHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRD----GKLPLLPGHSLQFQN 450 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~---~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~----~~~~~~~~~s~~l~~ 450 (488)
...+||+.|+|||++.... .++.++|||||||+||||++|.+||...... ..+.. ...+....++.++.+
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~ 306 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 306 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHH
T ss_pred cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHH
Confidence 3567999999999987542 1567999999999999999999999865432 23322 344555678999999
Q ss_pred HHHHcccCCCCC--CCCHHHHHhChhhhhhH
Q 011331 451 LLKVMVDPDPVQ--RPSAKELVENPIFDKIQ 479 (488)
Q Consensus 451 lI~k~L~~dP~~--RpTa~elL~HP~f~~i~ 479 (488)
||.+||..+|.+ ||+++|+++||||+.+.
T Consensus 307 li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 307 LICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp HHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred HHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 999999999988 99999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=378.99 Aligned_cols=250 Identities=23% Similarity=0.377 Sum_probs=211.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc-----c
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN-----E 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~-----~ 302 (488)
..+|++++.||+|+||+||+|.+..++..||||++... ........+.+|+.++..+ +||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccc
Confidence 35799999999999999999999999999999998753 3344557788999999999 899999999998654 4
Q ss_pred eEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--
Q 011331 303 QLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-- 379 (488)
.+|+||||+++++........+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||++......
T Consensus 104 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 104 DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp CEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred eEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 6899999999988877777789999999999999999999999999999999999999 6789999999999876432
Q ss_pred ----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hc--C--------------
Q 011331 380 ----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RD--G-------------- 436 (488)
Q Consensus 380 ----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~--~-------------- 436 (488)
.....||+.|+|||++.....++.++|||||||++|+|++|.+||........+ .. +
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 263 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 233479999999999866556788999999999999999999999765332111 00 0
Q ss_pred ------------CC---CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 437 ------------KL---PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 437 ------------~~---~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.. ...+.++.++.+||.+||++||.+|||+.|+|+||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 00 01246789999999999999999999999999999998763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=383.37 Aligned_cols=247 Identities=24% Similarity=0.365 Sum_probs=203.0
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc------
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE------ 300 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~------ 300 (488)
...+|++++.||+|+||+||+|.+..+|+.||||++..... ...+|+.+++.+ +||||++++++|..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTC-CCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHc-CCCCccchhheeeecCcccc
Confidence 34679999999999999999999999999999999864321 123589999998 99999999998843
Q ss_pred --------------------------------cceEEEEEecCCCCchhh-----hhcccCCHHHHHHHHHHHHHHHHHH
Q 011331 301 --------------------------------NEQLYIQMELCDHSLSDK-----KASQFFAEGEVLKALHQIAQALQFI 343 (488)
Q Consensus 301 --------------------------------~~~l~IV~E~~~~~l~~~-----~~~~~l~~~~~~~i~~qI~~gL~yL 343 (488)
...++|||||+++++... .....+++..++.++.||+.||.||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp --------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 344899999999875542 2245799999999999999999999
Q ss_pred HHcCcccCCCCCCcEEEe--CCeEEEEeecCceecCC--CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc
Q 011331 344 HEKGIAHLDVKPDNIYVK--NGVYKLGDFGRATLLNK--SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK 419 (488)
Q Consensus 344 H~~gIiHrDLKp~NILv~--~g~vkL~DFGlA~~~~~--~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt 419 (488)
|++||+||||||+|||++ ++.+||+|||+|+.... ......||+.|+|||++.+...++.++|||||||++|||++
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999999999995 68999999999987643 23345689999999998776567889999999999999999
Q ss_pred CCCCCCCchhhhh---hhc-------------------CCCC----------CCCCCcHHHHHHHHHcccCCCCCCCCHH
Q 011331 420 GSPLSESGPQFLN---LRD-------------------GKLP----------LLPGHSLQFQNLLKVMVDPDPVQRPSAK 467 (488)
Q Consensus 420 G~~p~~~~~~~~~---i~~-------------------~~~~----------~~~~~s~~l~~lI~k~L~~dP~~RpTa~ 467 (488)
|.+||........ +.. ...+ .+...+.++.+||.+||++||.+|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 9999986543211 110 0011 3445788999999999999999999999
Q ss_pred HHHhChhhhhhHH
Q 011331 468 ELVENPIFDKIQK 480 (488)
Q Consensus 468 elL~HP~f~~i~~ 480 (488)
|+|+||||+.+..
T Consensus 318 e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 318 EAMAHPFFDHLRN 330 (383)
T ss_dssp HHHTSGGGHHHHH
T ss_pred HHhcCHHHHHHHh
Confidence 9999999998865
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=363.18 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=210.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchH-HHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDA-ERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~-~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..++..||||++........ ....+.+|+.++..+ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEEE
Confidence 4689999999999999999999999999999999864321111 134577899999998 89999999999999999999
Q ss_pred EEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-CCC
Q 011331 307 QMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-LPI 382 (488)
Q Consensus 307 V~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-~~~ 382 (488)
||||++++.+. ......+++..++.++.||+.||.|||++||+|+||||+|||+ .++.++|+|||++...... ...
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 166 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD 166 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcccccc
Confidence 99999875433 2334569999999999999999999999999999999999999 6789999999998655432 234
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
..|++.|+|||++.+. .++.++||||||+++|+|++|..||..... ...+.......+..++.++.+||.+||+.|
T Consensus 167 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 245 (279)
T 3fdn_A 167 LCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245 (279)
T ss_dssp -CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSS
T ss_pred cCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccC
Confidence 5699999999998765 567799999999999999999999886543 334555666777788999999999999999
Q ss_pred CCCCCCHHHHHhChhhhhhH
Q 011331 460 PVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 460 P~~RpTa~elL~HP~f~~i~ 479 (488)
|.+|||+.|+++||||+...
T Consensus 246 p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 246 PSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp GGGSCCHHHHHHCHHHHHHC
T ss_pred hhhCCCHHHHhhCccccCCc
Confidence 99999999999999998754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=367.94 Aligned_cols=247 Identities=21% Similarity=0.264 Sum_probs=204.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc--cceEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE--NEQLY 305 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~--~~~l~ 305 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.... ...+.+|+.++..+.+||||+++++++.+ ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 468999999999999999999999999999999986432 34578899999999669999999999987 67799
Q ss_pred EEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC-eEEEEeecCceecCCC--CC
Q 011331 306 IQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG-VYKLGDFGRATLLNKS--LP 381 (488)
Q Consensus 306 IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g-~vkL~DFGlA~~~~~~--~~ 381 (488)
+||||++++.+.... ..+++..++.++.||+.||.|||++||+||||||+||||+ ++ .+||+|||+|+..... ..
T Consensus 110 lv~e~~~~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~ 188 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLY-QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 188 (330)
T ss_dssp EEEECCCCCCHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred EEEeccCchhHHHHH-HhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccc
Confidence 999999887555333 3589999999999999999999999999999999999995 55 8999999999876432 34
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh----h-------------hhhcCCCC-----
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF----L-------------NLRDGKLP----- 439 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~----~-------------~i~~~~~~----- 439 (488)
...|+..|+|||++.....++.++|||||||++|+|++|..||...... . .+......
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (330)
T 3nsz_A 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 268 (330)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence 4568999999999876446788999999999999999999988543110 0 00111111
Q ss_pred -------------------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 440 -------------------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 440 -------------------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
....++.++.+||.+||++||.+|||++|+|+||||+.+.+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 11226899999999999999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=365.31 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=198.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc---hHHHHHHHHHHHHHHHhC--CCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH---DAERRKALLEVQALAALG--SHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~---~~~~~~~~~Ei~iL~~l~--~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++...... ........+|+.++..+. +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 45789999999999999999999999999999998643211 111233456666666653 5999999999987654
Q ss_pred -----eEEEEEecCCCCchhhhhcc---cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCc
Q 011331 303 -----QLYIQMELCDHSLSDKKASQ---FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRA 373 (488)
Q Consensus 303 -----~l~IV~E~~~~~l~~~~~~~---~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA 373 (488)
.+++||||+++++....... .+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 58999999998776644332 38999999999999999999999999999999999999 6789999999999
Q ss_pred eecCCCC--CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc--CCC--------
Q 011331 374 TLLNKSL--PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD--GKL-------- 438 (488)
Q Consensus 374 ~~~~~~~--~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~--~~~-------- 438 (488)
+...... ....||+.|+|||++... .++.++|||||||++|||++|.+||........ +.. +..
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (308)
T 3g33_A 168 RIYSYQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246 (308)
T ss_dssp TTSTTCCCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSS
T ss_pred cccCCCcccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccch
Confidence 8665332 334689999999998765 577899999999999999999999976543221 110 000
Q ss_pred -----------------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 439 -----------------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 439 -----------------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
...+.++.++.+||.+||++||++|||+.|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 01245788999999999999999999999999999998653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=358.78 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=211.7
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.+.++|++.+.||+|+||+||+|.+..++..||+|++....... ...+.+|+.++..+ +||||+++++++.+.+.+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeEE
Confidence 34567999999999999999999999999999999987543322 45678899999999 9999999999999999999
Q ss_pred EEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE---e-CCeEEEEeecCceecCCC
Q 011331 306 IQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV---K-NGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 306 IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv---~-~g~vkL~DFGlA~~~~~~ 379 (488)
+||||++++ +.. ......+++..++.++.||+.||.|||++||+|+||||+|||+ + ++.++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999875 433 3344568999999999999999999999999999999999999 2 478999999999876533
Q ss_pred --CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCC----CCcHHHHH
Q 011331 380 --LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLP----GHSLQFQN 450 (488)
Q Consensus 380 --~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~----~~s~~l~~ 450 (488)
.....||+.|+|||++.+. ++.++||||||+++|+|++|..||..... ...+..+....+. .++.++.+
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred cchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence 2345699999999998764 66799999999999999999999876543 2334444444443 67899999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+|.+||+.||.+|||+.|+|+||||+....
T Consensus 241 li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 999999999999999999999999987654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=369.52 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=202.8
Q ss_pred cccccceeEE-EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 225 SRYYTDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 225 ~~~~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
+++.+.|++. +.||+|+||+||+|.+..+|+.||||++..... .....+.+|+.++.++.+||||+++++++.+.+.
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 3566678885 789999999999999999999999999875422 2345688899999997789999999999999999
Q ss_pred EEEEEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CCe---EEEEeecCceecC
Q 011331 304 LYIQMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NGV---YKLGDFGRATLLN 377 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g~---vkL~DFGlA~~~~ 377 (488)
+||||||++++ +... .....+++..++.++.||+.||.|||++||+||||||+|||++ ++. +||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999865 4443 2345699999999999999999999999999999999999994 443 9999999987653
Q ss_pred CC----------CCCCCCCCCccChhhhcc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCch---------------
Q 011331 378 KS----------LPIEEGDARYMPQEILNE----DYDHLDKVDIFSLGATMYELIKGSPLSESGP--------------- 428 (488)
Q Consensus 378 ~~----------~~~~~Gt~~Y~APEvl~~----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~--------------- 428 (488)
.. .....||+.|+|||++.. ...++.++|||||||++|||++|.+||....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 11 123359999999999864 1135669999999999999999999987532
Q ss_pred ---hhhhhhcCCCCCC----CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 429 ---QFLNLRDGKLPLL----PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 429 ---~~~~i~~~~~~~~----~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
....+..+....+ ..++.++.+||.+||..||.+|||+.|+++||||+...
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 1233444444443 35789999999999999999999999999999998764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=372.53 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=208.4
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce---
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ--- 303 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~--- 303 (488)
...+|.+.+.||+|+||+||+|.+..+|+.||||++............+.+|+.++..+ +||||+++++++...+.
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEeccccccc
Confidence 34679999999999999999999999999999999976655566667889999999999 89999999999987654
Q ss_pred ---EEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 304 ---LYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 304 ---l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
+|+||||+++++.... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||+++.....
T Consensus 101 ~~~~~lv~e~~~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 101 FYDFYLVMPFMQTDLQKIM-GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CCCCEEEEECCSEEGGGTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred ceeEEEEeccccCCHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 4999999998666543 3459999999999999999999999999999999999999 5789999999999877665
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hh----------------------
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LR---------------------- 434 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~---------------------- 434 (488)
.....||+.|+|||++.....++.++|||||||++|+|++|..||........ +.
T Consensus 180 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 259 (353)
T 3coi_A 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 259 (353)
T ss_dssp ----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHH
T ss_pred ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHH
Confidence 55667999999999987644677899999999999999999999876432111 00
Q ss_pred -----c----CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 435 -----D----GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 435 -----~----~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
. ......+.++.++.+||.+||..||++|||+.|+++||||+.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 260 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0 01123456799999999999999999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=391.77 Aligned_cols=255 Identities=22% Similarity=0.285 Sum_probs=209.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+++.||||++.+.... ......+..|+.++..+ +||||++++++|.+.+.+||
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEEE
Confidence 46899999999999999999999999999999998642111 11122367788899888 99999999999999999999
Q ss_pred EEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 307 QMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 307 V~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
|||||.++ |..... ...+++..++.++.||+.||.|||++|||||||||+|||| .+|.+||+|||+|+......
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 99999775 444332 3579999999999999999999999999999999999999 67999999999998764322
Q ss_pred --CCCCCCCCccChhhhcc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhc----CCCC-CCCCCcH
Q 011331 381 --PIEEGDARYMPQEILNE----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRD----GKLP-LLPGHSL 446 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~----~~~~-~~~~~s~ 446 (488)
...+||+.|+|||++.. ...++.++|||||||++|||++|.+||...... ..+.. ...+ ....++.
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 311 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCH
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCH
Confidence 23579999999999862 234677999999999999999999999875432 22221 1222 2245899
Q ss_pred HHHHHHHHcccCCCCC--CCCHHHHHhChhhhhhHHhhh
Q 011331 447 QFQNLLKVMVDPDPVQ--RPSAKELVENPIFDKIQKHRK 483 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~--RpTa~elL~HP~f~~i~~~~~ 483 (488)
++.+||.+||..+|++ |++++|+++||||+++.+...
T Consensus 312 ~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 312 NAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp HHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred HHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 9999999999998888 999999999999998865443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=381.82 Aligned_cols=256 Identities=16% Similarity=0.115 Sum_probs=194.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhC-CCCCeeEeeeee-------c
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALG-SHENIVGYYSSW-------F 299 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~-~HpnIv~l~~~~-------~ 299 (488)
.+|++++.||+|+||+||+|.+..+|+.||||++..... .......+..|+.++..+. +||||++++..+ .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 358999999999999999999999999999999986543 3344556677766666664 599988865333 2
Q ss_pred cc-----------------ceEEEEEecCCCCchhhhh--cccCCHHHH------HHHHHHHHHHHHHHHHcCcccCCCC
Q 011331 300 EN-----------------EQLYIQMELCDHSLSDKKA--SQFFAEGEV------LKALHQIAQALQFIHEKGIAHLDVK 354 (488)
Q Consensus 300 ~~-----------------~~l~IV~E~~~~~l~~~~~--~~~l~~~~~------~~i~~qI~~gL~yLH~~gIiHrDLK 354 (488)
.. ..+|||||||+++|..... ...+.+... +.++.||+.||+|||++||||||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 21 4489999999977666433 223444445 6777999999999999999999999
Q ss_pred CCcEEE-eCCeEEEEeecCceecCCCCCCCCCCCCccChhhhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh-
Q 011331 355 PDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNE-DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL- 431 (488)
Q Consensus 355 p~NILv-~~g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~-~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~- 431 (488)
|+|||| .+|.+||+|||+|+..+.......+|+.|+|||++.. ...++.++|||||||+||||++|..||.......
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~ 301 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT
T ss_pred HHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc
Confidence 999999 6789999999999987654435567799999999975 1257789999999999999999999987653211
Q ss_pred ----h---h--h--cCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhhhh
Q 011331 432 ----N---L--R--DGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKT 484 (488)
Q Consensus 432 ----~---i--~--~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~~~ 484 (488)
. . . ....+..+.++.++.+||.+||+.||++|||+.|+|+||||+.+.....+
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 365 (371)
T 3q60_A 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISS 365 (371)
T ss_dssp TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHHHH
T ss_pred cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHHhh
Confidence 0 0 0 11223345789999999999999999999999999999999999875544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=374.13 Aligned_cols=251 Identities=28% Similarity=0.406 Sum_probs=208.7
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.++..+ +||||+++++++.+.+.+||
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEE
Confidence 35689999999999999999999999999999999876655555566788999999999 89999999999999999999
Q ss_pred EEecCCCCchhh--hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---C
Q 011331 307 QMELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---L 380 (488)
Q Consensus 307 V~E~~~~~l~~~--~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~ 380 (488)
||||++++++.. .....+++..++.++.||+.||.|||++||+|+||||+|||| .++.+||+|||++...... .
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 181 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcccc
Confidence 999999876653 234569999999999999999999999999999999999999 6789999999999765432 2
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh------------------------cC
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR------------------------DG 436 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~------------------------~~ 436 (488)
....||+.|+|||++.+...++.++|||||||++|+|++|.+||........+. ..
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 345689999999999776567889999999999999999999987654321110 00
Q ss_pred CCC----------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 437 KLP----------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 437 ~~~----------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
..+ ..+.++.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 111 123578999999999999999999999999999999865
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=409.34 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=218.7
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+++.||||++++... ..........|..++..+.+||||+.++++|.+.+.+||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 5689999999999999999999999999999999864311 122345677899999988889999999999999999999
Q ss_pred EEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCC
Q 011331 307 QMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSL 380 (488)
Q Consensus 307 V~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~ 380 (488)
||||++++.+. ......+++..++.++.||+.||.|||++|||||||||+|||| .+|.+||+|||+|+... ...
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~ 499 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 499 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCB
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCccc
Confidence 99999876443 2333679999999999999999999999999999999999999 67999999999998642 223
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
...+||+.|+|||++... .++.++|||||||+||||++|.+||..... +..+......++..++.++.+||.+||+
T Consensus 500 ~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~ 578 (674)
T 3pfq_A 500 KTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 578 (674)
T ss_dssp CCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSC
T ss_pred ccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 456799999999999765 678899999999999999999999987543 4456677788888999999999999999
Q ss_pred CCCCCCCCH-----HHHHhChhhhhhHHh
Q 011331 458 PDPVQRPSA-----KELVENPIFDKIQKH 481 (488)
Q Consensus 458 ~dP~~RpTa-----~elL~HP~f~~i~~~ 481 (488)
+||++||++ +||++||||+.+.+.
T Consensus 579 ~dP~~R~~~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 579 KHPGKRLGCGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp SSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred CCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence 999999997 999999999988653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=373.27 Aligned_cols=247 Identities=25% Similarity=0.386 Sum_probs=209.6
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
..|++++.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..+ +||||+++++++...+..|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeEEEE
Confidence 4589999999999999999999999999999998754332 34456788999999999 899999999999999999999
Q ss_pred EecCCCCchhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCC
Q 011331 308 MELCDHSLSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE 384 (488)
Q Consensus 308 ~E~~~~~l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~ 384 (488)
|||+.+++.... ....+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||++...... ....
T Consensus 133 ~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-~~~~ 211 (348)
T 1u5q_A 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-NSFV 211 (348)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-CCCC
T ss_pred EecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-Cccc
Confidence 999998766633 34569999999999999999999999999999999999999 5689999999999876543 3457
Q ss_pred CCCCccChhhhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCCC--CCCCCcHHHHHHHHHccc
Q 011331 385 GDARYMPQEILNE--DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKLP--LLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 385 Gt~~Y~APEvl~~--~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~~--~~~~~s~~l~~lI~k~L~ 457 (488)
||+.|+|||++.. ...++.++|||||||++|||++|.+||....... .+.....+ ....++..+.+||.+||+
T Consensus 212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 291 (348)
T 1u5q_A 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 291 (348)
T ss_dssp SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTC
T ss_pred CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 9999999999852 3356779999999999999999999987654322 22222222 334679999999999999
Q ss_pred CCCCCCCCHHHHHhChhhhh
Q 011331 458 PDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f~~ 477 (488)
.||++|||++++++||||..
T Consensus 292 ~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 292 KIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp SSGGGSCCHHHHTTCHHHHS
T ss_pred cChhhCcCHHHHhhChhhhc
Confidence 99999999999999999965
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=373.65 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=206.3
Q ss_pred ccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL---HHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 224 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~---~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
+..+.++|++++.||+|+||+||+|.+..++..||||++.... ........+.+|+.++..+ +||||+++++++.+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 99 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYED 99 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhcc
Confidence 4455678999999999999999999999999999999986431 1223456788999999999 89999999999999
Q ss_pred cceEEEEEecCCCCchh-hhh-----------------------------------------cccCCHHHHHHHHHHHHH
Q 011331 301 NEQLYIQMELCDHSLSD-KKA-----------------------------------------SQFFAEGEVLKALHQIAQ 338 (488)
Q Consensus 301 ~~~l~IV~E~~~~~l~~-~~~-----------------------------------------~~~l~~~~~~~i~~qI~~ 338 (488)
.+.+|||||||+++.+. ... ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999775433 221 122467788999999999
Q ss_pred HHHHHHHcCcccCCCCCCcEEEe-CC--eEEEEeecCceecCCC-------CCCCCCCCCccChhhhcc-cCCCCchhHH
Q 011331 339 ALQFIHEKGIAHLDVKPDNIYVK-NG--VYKLGDFGRATLLNKS-------LPIEEGDARYMPQEILNE-DYDHLDKVDI 407 (488)
Q Consensus 339 gL~yLH~~gIiHrDLKp~NILv~-~g--~vkL~DFGlA~~~~~~-------~~~~~Gt~~Y~APEvl~~-~~~~~~ksDI 407 (488)
||.|||++||+|+||||+||||+ ++ .+||+|||++...... .....||+.|+|||++.. ...++.++||
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999999999999999999994 44 8999999999876321 234569999999999864 2457789999
Q ss_pred HHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCCC----CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 408 FSLGATMYELIKGSPLSESGPQF---LNLRDGKLPL----LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 408 wSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~~----~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
|||||++|||++|..||...... ..+....... ...++.++.+||.+||+.||.+|||+.|+|+||||+.+.
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999999765442 2233333222 224789999999999999999999999999999998864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=380.54 Aligned_cols=245 Identities=26% Similarity=0.358 Sum_probs=198.2
Q ss_pred ccccceeEE-EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc----
Q 011331 226 RYYTDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE---- 300 (488)
Q Consensus 226 ~~~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~---- 300 (488)
...++|.++ +.||+|+||+||+|.+..+|+.||||++... ....+|+.++.++.+||||++++++|..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 345678887 6899999999999999999999999998632 2356788888777799999999998875
Q ss_pred cceEEEEEecCCCC-chhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecC
Q 011331 301 NEQLYIQMELCDHS-LSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGR 372 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGl 372 (488)
.+.+|||||||+++ |...... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 67799999999875 4443322 3499999999999999999999999999999999999994 68899999999
Q ss_pred ceecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-------hhhhhcCCCCC---
Q 011331 373 ATLLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-------FLNLRDGKLPL--- 440 (488)
Q Consensus 373 A~~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~~~i~~~~~~~--- 440 (488)
++..... ....+||+.|+|||++... .++.++|||||||++|||++|..||..... ...+..+....
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp CEECC-----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred ccccCCCCccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 9876532 3455789999999998765 577899999999999999999999875432 22333333332
Q ss_pred -CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 441 -LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 441 -~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
...++.++.+||.+||..||++|||+.|+++||||...
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 25689999999999999999999999999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=385.24 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=205.9
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC-----CCCCeeEeeeeeccc
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG-----SHENIVGYYSSWFEN 301 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~-----~HpnIv~l~~~~~~~ 301 (488)
...+|++++.||+|+||+||+|.+..+++.||||++... ......+..|+.++..+. +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 345799999999999999999999999999999998642 344556778888888773 577999999999999
Q ss_pred ceEEEEEecCCCCchhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCe--EEEEeecCcee
Q 011331 302 EQLYIQMELCDHSLSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGV--YKLGDFGRATL 375 (488)
Q Consensus 302 ~~l~IV~E~~~~~l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~--vkL~DFGlA~~ 375 (488)
+.+||||||+++++...... ..+++..++.++.||+.||.|||++|||||||||+|||| .++. +||+|||+|+.
T Consensus 172 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 99999999999887764333 348999999999999999999999999999999999999 4555 99999999988
Q ss_pred cCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hc--C--------------
Q 011331 376 LNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RD--G-------------- 436 (488)
Q Consensus 376 ~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~--~-------------- 436 (488)
.........||+.|+|||++.+. .++.++|||||||+||||++|.+||........+ .. +
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~ 330 (429)
T 3kvw_A 252 EHQRVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAK 330 (429)
T ss_dssp TTCCCCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHH
T ss_pred cCCcccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhh
Confidence 87776777899999999998776 5788999999999999999999998765331110 00 0
Q ss_pred ------CC-----------------------------C--------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhCh
Q 011331 437 ------KL-----------------------------P--------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENP 473 (488)
Q Consensus 437 ------~~-----------------------------~--------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP 473 (488)
.. + +....+.++.+||.+||++||++|||++|+|+||
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hp 410 (429)
T 3kvw_A 331 NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHP 410 (429)
T ss_dssp HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred hccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCCh
Confidence 00 0 0112367899999999999999999999999999
Q ss_pred hhhhhH
Q 011331 474 IFDKIQ 479 (488)
Q Consensus 474 ~f~~i~ 479 (488)
||+...
T Consensus 411 w~~~~~ 416 (429)
T 3kvw_A 411 WLRRRL 416 (429)
T ss_dssp TTC---
T ss_pred hhccCC
Confidence 998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=376.85 Aligned_cols=248 Identities=21% Similarity=0.294 Sum_probs=209.9
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch------HHHHHHHHHHHHHHHhCCCCCeeEeeeeec
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD------AERRKALLEVQALAALGSHENIVGYYSSWF 299 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~------~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~ 299 (488)
.+.++|++++.||+|+||+||+|.+..+|+.||||++....... .....+.+|+.++..+ +||||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFE 99 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence 45678999999999999999999999999999999987543211 1233566799999999 8999999999999
Q ss_pred ccceEEEEEecCCCC--chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCcee
Q 011331 300 ENEQLYIQMELCDHS--LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATL 375 (488)
Q Consensus 300 ~~~~l~IV~E~~~~~--l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~ 375 (488)
+.+.+++||||+..+ +... .....+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++..
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999999664 3332 334469999999999999999999999999999999999999 678999999999987
Q ss_pred cCCCC--CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCCCCCCCCcHHHHHHHH
Q 011331 376 LNKSL--PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 376 ~~~~~--~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~~~~~~~s~~l~~lI~ 453 (488)
..... ....||+.|+|||++.+....+.++|||||||++|+|++|..||..... ........+..++.++.+||.
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~l~~li~ 256 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---TVEAAIHPPYLVSKELMSLVS 256 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---GTTTCCCCSSCCCHHHHHHHH
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---HHhhccCCCcccCHHHHHHHH
Confidence 75432 2346999999999997764447799999999999999999999976433 233344555668999999999
Q ss_pred HcccCCCCCCCCHHHHHhChhhhh
Q 011331 454 VMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
+||+.||.+|||+.|+++||||+.
T Consensus 257 ~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 257 GLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp HHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred HHccCChhhCcCHHHHhcCccccC
Confidence 999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=392.24 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=210.8
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.+.++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.++..+ +||||+++++++.+.+.+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEEE
Confidence 556789999999999999999999999999999999864322223356688999999999 9999999999999999999
Q ss_pred EEEecCCCCch-h-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecCceecCCC
Q 011331 306 IQMELCDHSLS-D-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 306 IV~E~~~~~l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGlA~~~~~~ 379 (488)
+|||||.++.+ . ......+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.....
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999987533 3 33446799999999999999999999999999999999999993 357999999999766433
Q ss_pred --CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCC----CCCCCcHHHHH
Q 011331 380 --LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLP----LLPGHSLQFQN 450 (488)
Q Consensus 380 --~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~----~~~~~s~~l~~ 450 (488)
.....||+.|+|||++.+. ++.++|||||||++|+|++|.+||...... ..+..+... .+..++.++.+
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 255 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (486)
T ss_dssp ----CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred CccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence 2345699999999999764 677999999999999999999999775442 233444332 23467899999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
||.+||+.||.+|||+.|+|+||||+..
T Consensus 256 li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 256 LIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred HHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 9999999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=389.75 Aligned_cols=252 Identities=23% Similarity=0.398 Sum_probs=207.8
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.+.++|++++.||+|+||+||+|.+..++..||||++............+.+|+.+++.+ +||||++++++|.+.+.+|
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEE
Confidence 445679999999999999999999999999999999876533333356688899999998 8999999999999999999
Q ss_pred EEEecCCCCch-h-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecCceecCCC
Q 011331 306 IQMELCDHSLS-D-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 306 IV~E~~~~~l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGlA~~~~~~ 379 (488)
||||||.++.+ . ......+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+|......
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999987533 3 33445799999999999999999999999999999999999993 356999999999877543
Q ss_pred --CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCCC----CCCCcHHHHH
Q 011331 380 --LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLPL----LPGHSLQFQN 450 (488)
Q Consensus 380 --~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~~----~~~~s~~l~~ 450 (488)
.....||+.|+|||++... ++.++|||||||++|+|++|.+||...... ..+..+.... +..++.++.+
T Consensus 193 ~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLRKK--YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHTTC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred ccccccCCCcCeeCHHHHccc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 2345699999999998754 667999999999999999999999865442 2334443332 3467999999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
||.+||+.||.+|||+.|+|+||||+....
T Consensus 271 li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 271 LIKQMLQFDSQRRISAQQALEHPWIKEMCS 300 (494)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred HHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence 999999999999999999999999987643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=370.10 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=209.9
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc-----
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN----- 301 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~----- 301 (488)
..++|++++.||+|+||+||+|.+..+|+.||||++... ........+.+|+.++..+ +||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCcc
Confidence 456899999999999999999999999999999998643 3344556788999999999 899999999987654
Q ss_pred ceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 302 EQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 302 ~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
...|+||||+++++........+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++......
T Consensus 87 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 87 NEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp CCEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ceEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 67999999999887776666789999999999999999999999999999999999999 6789999999999876432
Q ss_pred ------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh------c------
Q 011331 380 ------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR------D------ 435 (488)
Q Consensus 380 ------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~------~------ 435 (488)
.....||+.|+|||++.....++.++|||||||++|+|++|.+||........+. .
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 1123689999999998665567889999999999999999999987654211100 0
Q ss_pred ---------------C--CCC------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 436 ---------------G--KLP------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 436 ---------------~--~~~------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
. ..+ ..+.++.++.+||.+||..||++|||+.|+++||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0 000 1246789999999999999999999999999999998764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=386.37 Aligned_cols=255 Identities=12% Similarity=0.077 Sum_probs=200.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhC--CCCCeeEee-------ee
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALG--SHENIVGYY-------SS 297 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~--~HpnIv~l~-------~~ 297 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.++..+. +|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 457999999999999999999998899999999986432 23344567888995554443 799999998 44
Q ss_pred ecccc-----------------eEEEEEecCCCCchhhhhc-ccCCH-------HHHHHHHHHHHHHHHHHHHcCcccCC
Q 011331 298 WFENE-----------------QLYIQMELCDHSLSDKKAS-QFFAE-------GEVLKALHQIAQALQFIHEKGIAHLD 352 (488)
Q Consensus 298 ~~~~~-----------------~l~IV~E~~~~~l~~~~~~-~~l~~-------~~~~~i~~qI~~gL~yLH~~gIiHrD 352 (488)
+.+.+ ..||||||++++|...... ..+++ ..++.++.||+.||+|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 44443 3889999998776653322 23444 78888999999999999999999999
Q ss_pred CCCCcEEE-eCCeEEEEeecCceecCCCCCCCCCCCCccChhhhccc----------CCCCchhHHHHHHHHHHHHHcCC
Q 011331 353 VKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNED----------YDHLDKVDIFSLGATMYELIKGS 421 (488)
Q Consensus 353 LKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~----------~~~~~ksDIwSlGvlL~eLltG~ 421 (488)
|||+|||| .++.+||+|||+|+..+.......| +.|+|||++... ..++.++|||||||+||||++|.
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~ 310 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence 99999999 6789999999999976655555678 999999998764 24678999999999999999999
Q ss_pred CCCCCchhhhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhhhh
Q 011331 422 PLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKT 484 (488)
Q Consensus 422 ~p~~~~~~~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~~~ 484 (488)
.||......... .......+.++.++.+||.+||+.||++|||+.|+++||||+.+...-++
T Consensus 311 ~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~ 372 (377)
T 3byv_A 311 LPITKDAALGGS-EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSA 372 (377)
T ss_dssp CCC------CCS-GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHHHH
T ss_pred CCCcccccccch-hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHHHH
Confidence 998765432211 11223346789999999999999999999999999999999998765443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=391.07 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=213.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|.+++.||+|+||+||+|.+..+|+.||||++....... .....+.+|+.+++.+ +||||+++++++.+.+.+||
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEE
Confidence 457899999999999999999999999999999986432111 1235678899999998 89999999999999999999
Q ss_pred EEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CC
Q 011331 307 QMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LP 381 (488)
Q Consensus 307 V~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~ 381 (488)
||||++++ |... .....+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++...... ..
T Consensus 94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 173 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 173 (476)
T ss_dssp EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccccc
Confidence 99999775 4332 234569999999999999999999999999999999999999 6789999999999877543 33
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccC
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~ 458 (488)
..+||+.|+|||++.+....+.++|||||||++|+|++|..||..... ...+..+....+..++.++.+||.+||..
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 253 (476)
T 2y94_A 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQV 253 (476)
T ss_dssp CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTCS
T ss_pred ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcCC
Confidence 557999999999998764456799999999999999999999876432 34556667777778899999999999999
Q ss_pred CCCCCCCHHHHHhChhhhh
Q 011331 459 DPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 459 dP~~RpTa~elL~HP~f~~ 477 (488)
||.+|||++|+++||||+.
T Consensus 254 dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 254 DPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp STTTSCCHHHHHTCHHHHT
T ss_pred CchhCcCHHHHHhCHHhhh
Confidence 9999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=386.45 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=206.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|++..+|+.||||++.+... .......+..|+.++..+ +||||++++++|.+.+.+||
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEE
Confidence 4689999999999999999999999999999999864211 111223467788999888 99999999999999999999
Q ss_pred EEecCCCC-chhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 307 QMELCDHS-LSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 307 V~E~~~~~-l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
||||+.++ |...... ..+++..++.++.||+.||.|||++|||||||||+|||| .+|.+||+|||+++......
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 99999765 4443322 369999999999999999999999999999999999999 57999999999998765432
Q ss_pred --CCCCCCCCccChhhhcc------cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhc----CCCC-CCCCC
Q 011331 381 --PIEEGDARYMPQEILNE------DYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRD----GKLP-LLPGH 444 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~------~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~----~~~~-~~~~~ 444 (488)
...+||+.|+|||++.. ...++.++|||||||++|||++|.+||...... ..+.. ...+ ....+
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 298 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CC
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCC
Confidence 23579999999999863 224677999999999999999999999765432 22322 2222 23578
Q ss_pred cHHHHHHHHHcccCCCCCC---CCHHHHHhChhhhhhHHhh
Q 011331 445 SLQFQNLLKVMVDPDPVQR---PSAKELVENPIFDKIQKHR 482 (488)
Q Consensus 445 s~~l~~lI~k~L~~dP~~R---pTa~elL~HP~f~~i~~~~ 482 (488)
+.++++||.+||. +|.+| |+++|+++||||+.+.+..
T Consensus 299 s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~ 338 (412)
T 2vd5_A 299 PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG 338 (412)
T ss_dssp CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 9999999999999 99998 5999999999999886544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=364.04 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=205.8
Q ss_pred cccceeEEEEecccCcEEEEEEEE-cCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCC------CeeEeeeeec
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLK-RIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE------NIVGYYSSWF 299 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hp------nIv~l~~~~~ 299 (488)
+.++|++++.||+|+||+||+|.+ ..+|+.||||++... ......+.+|+.++..+ +|+ +|+++++++.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHh-hhcCCCCceeeEeeecccc
Confidence 345799999999999999999998 568999999998642 34456678899988887 444 5999999999
Q ss_pred ccceEEEEEecCCCCchhhhhcc---cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe---------------
Q 011331 300 ENEQLYIQMELCDHSLSDKKASQ---FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--------------- 361 (488)
Q Consensus 300 ~~~~l~IV~E~~~~~l~~~~~~~---~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--------------- 361 (488)
+.+.+||||||+++++....... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 88 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 88 HHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred cCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999999987777644332 588999999999999999999999999999999999993
Q ss_pred -----CCeEEEEeecCceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---h
Q 011331 362 -----NGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---L 433 (488)
Q Consensus 362 -----~g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i 433 (488)
++.+||+|||+++..........||+.|+|||++.+. .++.++|||||||++|||++|..||........ +
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 246 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred cccccCCCceEeeCcccccCccccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 5579999999999877766677899999999998765 577899999999999999999999876432111 0
Q ss_pred h--cCCC------------------------------------------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHH
Q 011331 434 R--DGKL------------------------------------------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKEL 469 (488)
Q Consensus 434 ~--~~~~------------------------------------------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~el 469 (488)
. .+.. ......+.++.+||.+||+.||.+|||+.|+
T Consensus 247 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 326 (339)
T 1z57_A 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA 326 (339)
T ss_dssp HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence 0 0000 1112235789999999999999999999999
Q ss_pred HhChhhhhhHH
Q 011331 470 VENPIFDKIQK 480 (488)
Q Consensus 470 L~HP~f~~i~~ 480 (488)
++||||+.+.+
T Consensus 327 l~hp~f~~~~~ 337 (339)
T 1z57_A 327 LKHPFFDLLKK 337 (339)
T ss_dssp TTSGGGGGGGC
T ss_pred hcCHHHHHHhc
Confidence 99999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=364.71 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=210.0
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch----HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD----AERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~----~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
..++|++++.||+|+||+||+|.+..+|..||||++....... .....+.+|+.++..+ +||||+++++++.+.+
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYENRT 88 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Confidence 3457899999999999999999999999999999986543221 1245688899999999 8999999999999999
Q ss_pred eEEEEEecCCCC-chhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCC----eEEEEeecCcee
Q 011331 303 QLYIQMELCDHS-LSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNG----VYKLGDFGRATL 375 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g----~vkL~DFGlA~~ 375 (488)
.+|+||||++++ |.... ....+++..++.++.||+.||.|||++||+|+||||+|||+ .++ .++|+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 999999999764 44432 34568999999999999999999999999999999999999 445 799999999987
Q ss_pred cCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCC----CCCcH
Q 011331 376 LNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLL----PGHSL 446 (488)
Q Consensus 376 ~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~----~~~s~ 446 (488)
.... .....||+.|+|||++... .++.++|||||||++|+|++|..||..... ...+.......+ ..++.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred cCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence 7543 2345699999999998765 577899999999999999999999876543 223333333332 46789
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 447 QFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.+.+||.+||..||++|||+.|+++||||+.+.
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 999999999999999999999999999998653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=372.99 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=188.7
Q ss_pred ccceeEE---EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 228 YTDFHEI---EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 228 ~~~y~~~---~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
..+|.+. +.||+|+||+||+|.+..+|+.||||++... ......+|+.++..+.+||||+++++++.+.+.+
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 3456664 7899999999999999999999999998643 2345678999999996799999999999999999
Q ss_pred EEEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC---eEEEEeecCceecCC
Q 011331 305 YIQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG---VYKLGDFGRATLLNK 378 (488)
Q Consensus 305 ~IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g---~vkL~DFGlA~~~~~ 378 (488)
||||||++++ |.. ......+++.+++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 9999999875 444 33345699999999999999999999999999999999999994 33 799999999986643
Q ss_pred C---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----------hhhhhcCCCCCC----
Q 011331 379 S---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----------FLNLRDGKLPLL---- 441 (488)
Q Consensus 379 ~---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----------~~~i~~~~~~~~---- 441 (488)
. .....||+.|+|||++... .++.++|||||||++|+|++|..||..... ...+..+.....
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (325)
T 3kn6_A 162 DNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW 240 (325)
T ss_dssp ----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHH
T ss_pred CCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccc
Confidence 2 2345689999999998765 578899999999999999999999875422 233444444443
Q ss_pred CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 442 PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 442 ~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
..++.++.+||.+||..||.+|||+.|+++||||+..
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 2578999999999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=359.33 Aligned_cols=250 Identities=23% Similarity=0.402 Sum_probs=212.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..++..||||++...... ......+.+|+.++..+ +||||+++++++.+.+.+|+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEEEE
Confidence 45799999999999999999999999999999998543111 11135678899999999 89999999999999999999
Q ss_pred EEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-CCC
Q 011331 307 QMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-LPI 382 (488)
Q Consensus 307 V~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-~~~ 382 (488)
||||++++ +... .....+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++...... ...
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT 171 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCC
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccccccc
Confidence 99999874 4442 334569999999999999999999999999999999999999 6789999999999766432 334
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
..|++.|+|||++.+. .++.++||||||+++|+|++|..||..... ...+.......++.++.++.++|.+||..|
T Consensus 172 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 250 (284)
T 2vgo_A 172 MCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYH 250 (284)
T ss_dssp CCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSS
T ss_pred ccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhcC
Confidence 5699999999998765 567899999999999999999999876543 234455666777889999999999999999
Q ss_pred CCCCCCHHHHHhChhhhhhH
Q 011331 460 PVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 460 P~~RpTa~elL~HP~f~~i~ 479 (488)
|.+|||++|+++||||+...
T Consensus 251 p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 251 PPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp GGGSCCHHHHHTCHHHHHHC
T ss_pred HhhCCCHHHHhhCHHHHhhc
Confidence 99999999999999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=371.54 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=194.8
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
...++|++.+.||+|+||+||+|.+..+++.||||++.... ....+.+|+.++..+ +||||+++++++.+.+.+|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhC-CCCCCcceeeeEecCCeEE
Confidence 34467999999999999999999999999999999987532 334577899999999 8999999999999999999
Q ss_pred EEEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecCceecCCC
Q 011331 306 IQMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 306 IV~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGlA~~~~~~ 379 (488)
|||||++++ +... .....+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 999999865 4342 3345689999999999999999999999999999999999994 689999999999876443
Q ss_pred --CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcCCC----CCCCCCcHHHH
Q 011331 380 --LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDGKL----PLLPGHSLQFQ 449 (488)
Q Consensus 380 --~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~~~----~~~~~~s~~l~ 449 (488)
.....||+.|+|||++.+. .++.++|||||||++|||++|..||..... +..+..... +..+.++.++.
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 283 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283 (349)
T ss_dssp --------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred cccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence 2345699999999998765 577899999999999999999999865432 223333332 23356899999
Q ss_pred HHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 450 NLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+||.+||..||++|||+.|+|+||||+..
T Consensus 284 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 284 DLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=368.93 Aligned_cols=253 Identities=20% Similarity=0.345 Sum_probs=209.5
Q ss_pred ccccceeEE-EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 226 RYYTDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 226 ~~~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.+.++|.+. +.||+|+||+||+|.+..+|+.||||++............+.+|+.++..+..||||+++++++.+.+.+
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 344567887 8999999999999999999999999998765444444567889999999998889999999999999999
Q ss_pred EEEEecCCCC-chhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecCceec
Q 011331 305 YIQMELCDHS-LSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGRATLL 376 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGlA~~~ 376 (488)
|+||||+.++ +.... ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++..
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999885 33332 235699999999999999999999999999999999999994 489999999999877
Q ss_pred CCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcC----CCCCCCCCcHH
Q 011331 377 NKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDG----KLPLLPGHSLQ 447 (488)
Q Consensus 377 ~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~----~~~~~~~~s~~ 447 (488)
... .....||+.|+|||++... .++.++|||||||++|+|++|..||....... .+... ..+....++..
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 263 (327)
T 3lm5_A 185 GHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263 (327)
T ss_dssp ---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred CCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHH
Confidence 543 2345699999999998765 57789999999999999999999987654322 22222 22334568999
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+.+||.+||+.||.+|||++|+|+||||+.+.
T Consensus 264 ~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 99999999999999999999999999998764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=387.79 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=208.2
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-----------HHHHHHHHHHHHHHHhCCCCCeeEe
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-----------AERRKALLEVQALAALGSHENIVGY 294 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-----------~~~~~~~~Ei~iL~~l~~HpnIv~l 294 (488)
.+.++|++++.||+|+||+||+|.+..++..||||++....... .....+.+|+.++..+ +||||+++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~ 111 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKL 111 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeE
Confidence 34567999999999999999999999999999999987543221 2245688899999999 89999999
Q ss_pred eeeecccceEEEEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC---eEEEE
Q 011331 295 YSSWFENEQLYIQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG---VYKLG 368 (488)
Q Consensus 295 ~~~~~~~~~l~IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g---~vkL~ 368 (488)
++++.+.+.+|||||||+++ |.. ......+++..++.++.||+.||.|||++||+||||||+|||++ ++ .+||+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 99999999999999999875 433 33446799999999999999999999999999999999999994 33 69999
Q ss_pred eecCceecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCC--
Q 011331 369 DFGRATLLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLL-- 441 (488)
Q Consensus 369 DFGlA~~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~-- 441 (488)
|||+++..... .....||+.|+|||++... ++.++|||||||++|+|++|.+||..... ...+..+.....
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhccC--CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 99999877543 3345699999999998754 67799999999999999999999976543 234444544433
Q ss_pred --CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 442 --PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 442 --~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
..++.++.+||.+||++||.+|||++|+|+||||+..
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 5689999999999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=364.96 Aligned_cols=245 Identities=27% Similarity=0.387 Sum_probs=207.6
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
.|...+.||+|+||+||+|.+..+|+.||||++...... ....+.+|+.++..+ +||||+++++++...+.+|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEe
Confidence 477888999999999999999999999999998754322 245578899999998 89999999999999999999999
Q ss_pred cCCCCch-hhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCCC
Q 011331 310 LCDHSLS-DKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIEE 384 (488)
Q Consensus 310 ~~~~~l~-~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~~ 384 (488)
|++++.+ .......+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++...... .....
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccccc
Confidence 9987644 44555679999999999999999999999999999999999999 5789999999999876543 23456
Q ss_pred CCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCC---CCCCCCcHHHHHHHHHcccC
Q 011331 385 GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKL---PLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 385 Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~---~~~~~~s~~l~~lI~k~L~~ 458 (488)
||+.|+|||++... .++.++|||||||++|||++|..||...... ..+..... .....++.++.++|.+||+.
T Consensus 203 gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 281 (321)
T 2c30_A 203 GTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR 281 (321)
T ss_dssp SCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCS
T ss_pred CCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccC
Confidence 99999999999765 5778999999999999999999998765432 22333322 22345789999999999999
Q ss_pred CCCCCCCHHHHHhChhhhhh
Q 011331 459 DPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 459 dP~~RpTa~elL~HP~f~~i 478 (488)
||++|||+.|+++||||...
T Consensus 282 dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 282 DPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp STTTSCCHHHHHTSGGGGGC
T ss_pred ChhhCcCHHHHhcChhhccC
Confidence 99999999999999999754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=357.69 Aligned_cols=249 Identities=25% Similarity=0.445 Sum_probs=214.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..+|.+++.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.++..+ +||||+++++++.+.+.+|+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEEEE
Confidence 457899999999999999999999999999999986543 2344556788899999999 99999999999999999999
Q ss_pred EEecCCCCch-hh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CC
Q 011331 307 QMELCDHSLS-DK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SL 380 (488)
Q Consensus 307 V~E~~~~~l~-~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~ 380 (488)
||||++++.+ .. .....+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||++..... ..
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 172 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence 9999987543 32 233569999999999999999999999999999999999999 578999999999987642 22
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
....||+.|+|||++... .++.++||||||+++|+|++|..||..... ...+.......+..++.++.++|.+||+
T Consensus 173 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 251 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 251 (294)
T ss_dssp CCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHcc
Confidence 345689999999998765 567899999999999999999999876533 3344556667777889999999999999
Q ss_pred CCCCCCCCHHHHHhChhhhhh
Q 011331 458 PDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f~~i 478 (488)
.||++|||++|+++||||+..
T Consensus 252 ~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 252 TDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp SSGGGSCCGGGGGGSHHHHTS
T ss_pred cChhhCcCHHHHhhChheecC
Confidence 999999999999999999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=356.42 Aligned_cols=257 Identities=25% Similarity=0.343 Sum_probs=210.9
Q ss_pred ccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC---c----hHHHHHHHHHHHHHHHhCCCCCeeEeee
Q 011331 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH---H----DAERRKALLEVQALAALGSHENIVGYYS 296 (488)
Q Consensus 224 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~---~----~~~~~~~~~Ei~iL~~l~~HpnIv~l~~ 296 (488)
...+.++|++++.||+|+||+||+|.+..+|+.||||++..... . ......+.+|+.++.++.+||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 44567889999999999999999999999999999999864321 1 1234567899999999967999999999
Q ss_pred eecccceEEEEEecCCCC-chhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCc
Q 011331 297 SWFENEQLYIQMELCDHS-LSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRA 373 (488)
Q Consensus 297 ~~~~~~~l~IV~E~~~~~-l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA 373 (488)
++...+.+|+||||++++ +.... ....+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 999999999999999864 44432 33569999999999999999999999999999999999999 6789999999999
Q ss_pred eecCCC--CCCCCCCCCccChhhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCC----
Q 011331 374 TLLNKS--LPIEEGDARYMPQEILNE-----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLP---- 439 (488)
Q Consensus 374 ~~~~~~--~~~~~Gt~~Y~APEvl~~-----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~---- 439 (488)
...... .....|++.|+|||++.. ...++.++||||||+++|+|++|..||...... ..+..+...
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 876543 234468999999999852 234677999999999999999999998765432 223333322
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 440 LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 440 ~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
....++.++.++|.+||..||.+|||+.|+++||||+....
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 22457899999999999999999999999999999987653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=359.03 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=202.0
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.+.++|.+.+.||+|+||+||+|.+..+|..||+|++..... ......+.+|+.++..+ +||||+++++++.+.+.+|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeEE
Confidence 345679999999999999999999999999999999865432 22345688899999999 8999999999999999999
Q ss_pred EEEecCCCC-chhhh-----hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecCcee
Q 011331 306 IQMELCDHS-LSDKK-----ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGRATL 375 (488)
Q Consensus 306 IV~E~~~~~-l~~~~-----~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGlA~~ 375 (488)
+||||++++ +.... ....+++..++.++.||+.||.|||++||+|+||||+|||++ ++.+||+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999875 43322 235699999999999999999999999999999999999993 36799999999976
Q ss_pred cCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCCC---CCCCCcHH
Q 011331 376 LNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKLP---LLPGHSLQ 447 (488)
Q Consensus 376 ~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~~---~~~~~s~~ 447 (488)
.... .....||+.|+|||++... ++.++|||||||++|+|++|..||....... ........ ....++.+
T Consensus 177 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (285)
T 3is5_A 177 FKSDEHSTNAAGTALYMAPEVFKRD--VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ 254 (285)
T ss_dssp ----------CTTGGGCCHHHHTTC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred cCCcccCcCcccccCcCChHHhccC--CCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHH
Confidence 5432 3345699999999998654 6679999999999999999999997654321 11112211 22347899
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=363.38 Aligned_cols=249 Identities=22% Similarity=0.366 Sum_probs=202.9
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec-------
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF------- 299 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~------- 299 (488)
+.++|++++.||+|+||+||+|.+..+|+.||||++... .......+.+|+.++..+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhc-CCCCeeEEEEeccccccccc
Confidence 345799999999999999999999999999999998643 345567788999999999 8999999998873
Q ss_pred -------ccceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--CCeEEEEee
Q 011331 300 -------ENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDF 370 (488)
Q Consensus 300 -------~~~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~g~vkL~DF 370 (488)
+.+.+|+||||+++++........+++..++.++.||+.||.|||++||+|+||||+|||++ ++.+||+||
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp C----CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 45688999999998877776677899999999999999999999999999999999999994 469999999
Q ss_pred cCceecCCC------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcC-----
Q 011331 371 GRATLLNKS------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDG----- 436 (488)
Q Consensus 371 GlA~~~~~~------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~----- 436 (488)
|+++..... .....+|..|+|||++.....++.++|||||||++|||++|..||........ +...
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 999866421 22345789999999987644678899999999999999999999976543211 1100
Q ss_pred -------------------CC------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 437 -------------------KL------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 437 -------------------~~------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.. ...+.++.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 00 0224678999999999999999999999999999999865
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=373.23 Aligned_cols=262 Identities=20% Similarity=0.292 Sum_probs=208.4
Q ss_pred cCCccceeeCCCCccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC----
Q 011331 211 CAGLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG---- 286 (488)
Q Consensus 211 ~~~~~p~~~g~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~---- 286 (488)
..+++|...|+.. ...+|++++.||+|+||+||+|.+..+|+.||||++... ......+..|+.++..+.
T Consensus 4 ~~~~~p~~~~~~~---~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~ 77 (373)
T 1q8y_A 4 PGGYHPAFKGEPY---KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADN 77 (373)
T ss_dssp ---CCCCCTTCEE---TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCC
T ss_pred CCCceeeecCCcc---cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccc
Confidence 3456666555321 235799999999999999999999999999999998642 344556778998888873
Q ss_pred ------CCCCeeEeeeeecccc----eEEEEEecCCCCchhhhh---cccCCHHHHHHHHHHHHHHHHHHHHc-CcccCC
Q 011331 287 ------SHENIVGYYSSWFENE----QLYIQMELCDHSLSDKKA---SQFFAEGEVLKALHQIAQALQFIHEK-GIAHLD 352 (488)
Q Consensus 287 ------~HpnIv~l~~~~~~~~----~l~IV~E~~~~~l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~-gIiHrD 352 (488)
.|+||+++++++...+ .+++|||++++++..... ...+++..++.++.||+.||.|||++ ||+|||
T Consensus 78 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~D 157 (373)
T 1q8y_A 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTD 157 (373)
T ss_dssp SHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSC
T ss_pred cchhccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecC
Confidence 2899999999988654 789999999766666433 34599999999999999999999998 999999
Q ss_pred CCCCcEEEe-C------CeEEEEeecCceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 011331 353 VKPDNIYVK-N------GVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSE 425 (488)
Q Consensus 353 LKp~NILv~-~------g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~ 425 (488)
|||+||||+ + +.+||+|||++...........||+.|+|||++.+. .++.++|||||||++|||++|..||.
T Consensus 158 ikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp CSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CChHHeEEeccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 999999993 2 279999999999887776677899999999999765 57789999999999999999999987
Q ss_pred Cchh---------hhhhh------------------------------------------cCCCCCCCCCcHHHHHHHHH
Q 011331 426 SGPQ---------FLNLR------------------------------------------DGKLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 426 ~~~~---------~~~i~------------------------------------------~~~~~~~~~~s~~l~~lI~k 454 (488)
.... ...+. ......+...+.++.+||.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 316 (373)
T 1q8y_A 237 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316 (373)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHH
Confidence 4321 00100 01112333456789999999
Q ss_pred cccCCCCCCCCHHHHHhChhhhhhH
Q 011331 455 MVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
||+.||.+|||++|+|+||||+...
T Consensus 317 ~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 317 MLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp GGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HhccCccccCCHHHHhhChhhhccc
Confidence 9999999999999999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=377.14 Aligned_cols=249 Identities=21% Similarity=0.389 Sum_probs=210.2
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
...++|++++.||+|+||+||+|.+..+|+.||+|++.... ......+.+|+.++..+ +||||+++++++.+.+.+|
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEEE
Confidence 34568999999999999999999999999999999987542 34455788999999998 8999999999999999999
Q ss_pred EEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe---CCeEEEEeecCceecCCC
Q 011331 306 IQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK---NGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 306 IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~---~g~vkL~DFGlA~~~~~~ 379 (488)
|||||+.++ |..... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999875 434332 23689999999999999999999999999999999999994 367999999999877543
Q ss_pred C--CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCC----CCCCCCcHHHHH
Q 011331 380 L--PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKL----PLLPGHSLQFQN 450 (488)
Q Consensus 380 ~--~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~----~~~~~~s~~l~~ 450 (488)
. ....||+.|+|||++... .++.++|||||||++|||++|..||...... ..+..... .....++.++.+
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 283 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred cceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 2 234699999999999765 5778999999999999999999999865432 22333332 233467999999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
||.+||..||.+|||+.|+|+||||+..
T Consensus 284 li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 284 FIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 9999999999999999999999999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=356.30 Aligned_cols=252 Identities=22% Similarity=0.359 Sum_probs=209.1
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
+.++|++++.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.++..+ +||||+++++++.+.+..|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEEE
Confidence 34679999999999999999999999999999999864422 23346678899999998 89999999999999999999
Q ss_pred EEecCCCC-chhhhh-cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----
Q 011331 307 QMELCDHS-LSDKKA-SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---- 379 (488)
Q Consensus 307 V~E~~~~~-l~~~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---- 379 (488)
||||++++ +..... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999874 444322 3469999999999999999999999999999999999999 5789999999999865321
Q ss_pred -CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcC--CCCCCCCCcHHHHHHH
Q 011331 380 -LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDG--KLPLLPGHSLQFQNLL 452 (488)
Q Consensus 380 -~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~--~~~~~~~~s~~l~~lI 452 (488)
.....|++.|+|||++.....++.++|||||||++|+|++|..||..... ...+... ..+....++..+.++|
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 23456899999999987653346689999999999999999999875432 2222222 2223346789999999
Q ss_pred HHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 453 KVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
.+||..||.+|||++|+++||||+...+
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHCCCCchhCCCHHHHhcCccccChhh
Confidence 9999999999999999999999987654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=366.02 Aligned_cols=249 Identities=25% Similarity=0.446 Sum_probs=214.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..+|.+++.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.++..+ +||||+++++++.+.+.+||
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEE
Confidence 457899999999999999999999999999999986543 2344566788899999998 99999999999999999999
Q ss_pred EEecCCCCch-hh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---C
Q 011331 307 QMELCDHSLS-DK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---L 380 (488)
Q Consensus 307 V~E~~~~~l~-~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~ 380 (488)
||||++++.+ .. .....+++.+++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||++...... .
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence 9999987543 32 233569999999999999999999999999999999999999 6789999999999876422 2
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
....||+.|+|||++... .++.++|||||||++|+|++|..||..... ...+.......+..++.++.+||.+||+
T Consensus 199 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 277 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 277 (335)
T ss_dssp CCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcc
Confidence 345699999999998765 567899999999999999999999876533 3344556667777889999999999999
Q ss_pred CCCCCCCCHHHHHhChhhhhh
Q 011331 458 PDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f~~i 478 (488)
.||++|||++|+++||||...
T Consensus 278 ~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 278 TDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp SSGGGSCCGGGGGGSHHHHTS
T ss_pred CChhHCcCHHHHhcCccccCC
Confidence 999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=370.46 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=201.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch---HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD---AERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~---~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++....... .....+.+|+.++..+ +||||+++++++.+.+.+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCce
Confidence 457899999999999999999999999999999986432221 1124577899999999 899999999999999999
Q ss_pred EEEEecCCCCchhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--
Q 011331 305 YIQMELCDHSLSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-- 379 (488)
|+||||+++++...... ..+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.....
T Consensus 88 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 88 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 99999999876664433 358899999999999999999999999999999999999 6789999999999876432
Q ss_pred -CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc--CCC---------------
Q 011331 380 -LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD--GKL--------------- 438 (488)
Q Consensus 380 -~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~--~~~--------------- 438 (488)
.....||+.|+|||++.+...++.++|||||||++|||++|.+||........ +.. +..
T Consensus 168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 247 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence 23456899999999997654577899999999999999999998876543221 110 000
Q ss_pred -----C------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 439 -----P------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 439 -----~------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+ ....++.++.+||.+||..||++|||+.|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 0 014567899999999999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=381.81 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=200.9
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc------cc
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE------NE 302 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~------~~ 302 (488)
.+|++++.||+|+||+||+|.+..+|+.||||++..... ...+|+++++.+ +|||||+++++|.. ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHc-CCCCccceeeEEeccCCCCcce
Confidence 368999999999999999999999999999999864321 133689999998 89999999998853 23
Q ss_pred eEEEEEecCCCCchhhh-----hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-C-CeEEEEeecCcee
Q 011331 303 QLYIQMELCDHSLSDKK-----ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-N-GVYKLGDFGRATL 375 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~~~-----~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~-g~vkL~DFGlA~~ 375 (488)
.+++||||+++++.... ....+++..++.++.||+.||.|||++||+||||||+||||+ + +.+||+|||+|+.
T Consensus 127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 47899999998765422 245699999999999999999999999999999999999995 4 5789999999987
Q ss_pred cCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhc---------------
Q 011331 376 LNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRD--------------- 435 (488)
Q Consensus 376 ~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~--------------- 435 (488)
.... .....||+.|+|||++.+...++.++|||||||+||||++|.+||.+..... .+..
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 6432 3345789999999998765467889999999999999999999997654321 1110
Q ss_pred ----CCCC----------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 436 ----GKLP----------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 436 ----~~~~----------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
...+ +.+..+.++.+||.+||.+||.+|||+.|+++||||+.+..
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 0111 23456899999999999999999999999999999988753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=354.02 Aligned_cols=252 Identities=24% Similarity=0.359 Sum_probs=208.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch----HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD----AERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~----~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
++|++++.||+|+||+||+|.+..+|+.||+|++....... .....+.+|+.++..+ +||||+++++++.+.+..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCCeE
Confidence 57899999999999999999999999999999986543221 1245688899999999 899999999999999999
Q ss_pred EEEEecCCCC-chhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCC----eEEEEeecCceecC
Q 011331 305 YIQMELCDHS-LSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNG----VYKLGDFGRATLLN 377 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g----~vkL~DFGlA~~~~ 377 (488)
|+||||++++ +.... ....+++..++.++.||+.||.|||++||+|+||||+||++ .++ .++|+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 9999999764 44432 34569999999999999999999999999999999999999 444 79999999998764
Q ss_pred CC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCCC----CCCCcHHH
Q 011331 378 KS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLPL----LPGHSLQF 448 (488)
Q Consensus 378 ~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~~----~~~~s~~l 448 (488)
.. .....|++.|+|||++... .++.++||||||+++|+|++|..||...... ..+....... .+.++..+
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 242 (283)
T ss_dssp --------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred CCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHH
Confidence 32 2334689999999998765 5778999999999999999999998765432 2233333322 24678999
Q ss_pred HHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhh
Q 011331 449 QNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHR 482 (488)
Q Consensus 449 ~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~ 482 (488)
.+||.+||..||++|||+.|+++||||+.+.+..
T Consensus 243 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 243 KDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred HHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 9999999999999999999999999999987643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=364.54 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=206.4
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCC-eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCC------eeEeeeeec
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDG-CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN------IVGYYSSWF 299 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hpn------Iv~l~~~~~ 299 (488)
+.++|++++.||+|+||+||+|.+..++ ..||||++... ......+..|+.++..+ .|++ ++.+++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeee
Confidence 3568999999999999999999998777 79999998642 34456677899999888 5544 899999999
Q ss_pred ccceEEEEEecCCCCchhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE----------------
Q 011331 300 ENEQLYIQMELCDHSLSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV---------------- 360 (488)
Q Consensus 300 ~~~~l~IV~E~~~~~l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv---------------- 360 (488)
..+.+||||||++++++..... ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 93 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 93 FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred eCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 9999999999998887764332 359999999999999999999999999999999999999
Q ss_pred ----eCCeEEEEeecCceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---h
Q 011331 361 ----KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---L 433 (488)
Q Consensus 361 ----~~g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i 433 (488)
.++.+||+|||+++..........||+.|+|||++.+. .++.++|||||||++|||++|..||........ +
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 25789999999999877766677899999999999765 577899999999999999999999976433111 1
Q ss_pred h--cCCCC------------------------------------------CCCCCcHHHHHHHHHcccCCCCCCCCHHHH
Q 011331 434 R--DGKLP------------------------------------------LLPGHSLQFQNLLKVMVDPDPVQRPSAKEL 469 (488)
Q Consensus 434 ~--~~~~~------------------------------------------~~~~~s~~l~~lI~k~L~~dP~~RpTa~el 469 (488)
. .+..+ .....+.++.+||.+||+.||++|||+.|+
T Consensus 252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331 (355)
T ss_dssp HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence 0 01100 111224589999999999999999999999
Q ss_pred HhChhhhhhHH
Q 011331 470 VENPIFDKIQK 480 (488)
Q Consensus 470 L~HP~f~~i~~ 480 (488)
|+||||+.+..
T Consensus 332 l~hp~f~~~~~ 342 (355)
T 2eu9_A 332 LLHPFFAGLTP 342 (355)
T ss_dssp TTSGGGGGCCH
T ss_pred hcChhhcCCCh
Confidence 99999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=372.80 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=201.8
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEec
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMEL 310 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~ 310 (488)
+...+.||+|+||+||+|.+..+|..||||++.... ......+.+|+.++..+ +||||+++++++.+.+.+||||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeC
Confidence 344778999999999999999999999999987542 34456788999999999 899999999999999999999999
Q ss_pred CCCC-chhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe---CCeEEEEeecCceecCCC--CCC
Q 011331 311 CDHS-LSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK---NGVYKLGDFGRATLLNKS--LPI 382 (488)
Q Consensus 311 ~~~~-l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~---~g~vkL~DFGlA~~~~~~--~~~ 382 (488)
++++ |.... ....+++..++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||+++..... ...
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 9875 44422 234599999999999999999999999999999999999992 468999999999877543 234
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCCC----CCCCcHHHHHHHHHc
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLPL----LPGHSLQFQNLLKVM 455 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~~----~~~~s~~l~~lI~k~ 455 (488)
..||+.|+|||++... .++.++|||||||++|||++|..||...... ..+....... .+.++.++.+||.+|
T Consensus 248 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 326 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326 (373)
T ss_dssp CCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTT
T ss_pred ccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHH
Confidence 5699999999998765 5778999999999999999999999765432 3333333332 246799999999999
Q ss_pred ccCCCCCCCCHHHHHhChhhhhhH
Q 011331 456 VDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 456 L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
|+.||.+|||+.|+|+||||+...
T Consensus 327 L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 327 LIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp SCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred cCCChhhCCCHHHHhcCcCcCCCc
Confidence 999999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=389.34 Aligned_cols=252 Identities=24% Similarity=0.404 Sum_probs=212.4
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.+.++|++++.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..+ +||||+++++++.+.+.+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEE
Confidence 3456799999999999999999999999999999998654322 33456688999999999 899999999999999999
Q ss_pred EEEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecCceecCC
Q 011331 305 YIQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGRATLLNK 378 (488)
Q Consensus 305 ~IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGlA~~~~~ 378 (488)
|+|||||.++ +.. ......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999875 433 33456799999999999999999999999999999999999992 57899999999987654
Q ss_pred CC--CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCC----CCCCCcHHHH
Q 011331 379 SL--PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLP----LLPGHSLQFQ 449 (488)
Q Consensus 379 ~~--~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~----~~~~~s~~l~ 449 (488)
.. ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||...... ..+..+... .+..++.++.
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred ccccccCCCCccccCceeecCC--CCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 32 234699999999999764 667999999999999999999999876543 233444332 2346799999
Q ss_pred HHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 450 NLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+||.+||++||.+|||+.|+|+||||+....
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 9999999999999999999999999987643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=396.04 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=213.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.+... .......+..|+.++..+ +||||+++++++.+.+.+||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEEE
Confidence 3578999999999999999999999999999999864311 112234578899999999 89999999999999999999
Q ss_pred EEecCCCCchh-hhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-
Q 011331 307 QMELCDHSLSD-KKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL- 380 (488)
Q Consensus 307 V~E~~~~~l~~-~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~- 380 (488)
||||++++.+. .... ..+++..++.++.||+.||.|||++|||||||||+|||| .+|.+||+|||+|+......
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 99999875443 2222 249999999999999999999999999999999999999 67999999999998775432
Q ss_pred -CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-------hhhhhcCCCCCCCCCcHHHHHHH
Q 011331 381 -PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-------FLNLRDGKLPLLPGHSLQFQNLL 452 (488)
Q Consensus 381 -~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~~~i~~~~~~~~~~~s~~l~~lI 452 (488)
...+||+.|+|||++.+. .++.++|||||||++|||++|.+||..... ...+.......+..++.++.+||
T Consensus 342 ~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI 420 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420 (576)
T ss_dssp EECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 345799999999999765 577899999999999999999999976421 22344555667778999999999
Q ss_pred HHcccCCCCCCC-----CHHHHHhChhhhhhHHh
Q 011331 453 KVMVDPDPVQRP-----SAKELVENPIFDKIQKH 481 (488)
Q Consensus 453 ~k~L~~dP~~Rp-----Ta~elL~HP~f~~i~~~ 481 (488)
.+||+.||.+|| +++|+++||||+.+.+.
T Consensus 421 ~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp HHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred HHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 999999999999 89999999999987543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=364.81 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=206.9
Q ss_pred ccccccceeEEEEecccCcEEEEEEEEc-CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC--CCCCeeEeeeeec-
Q 011331 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKR-IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG--SHENIVGYYSSWF- 299 (488)
Q Consensus 224 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~--~HpnIv~l~~~~~- 299 (488)
+.+..++|++++.||+|+||+||+|.+. .+|+.||||++............+.+|+.++..+. .||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred ccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 4455678999999999999999999995 67899999998643322222223556776666653 8999999999987
Q ss_pred ----ccceEEEEEecCCCCchhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeec
Q 011331 300 ----ENEQLYIQMELCDHSLSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFG 371 (488)
Q Consensus 300 ----~~~~l~IV~E~~~~~l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFG 371 (488)
....+++||||+++++...... ..+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 5678999999999876664332 348999999999999999999999999999999999999 67899999999
Q ss_pred CceecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc--C--------
Q 011331 372 RATLLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD--G-------- 436 (488)
Q Consensus 372 lA~~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~--~-------- 436 (488)
+++..... .....||..|+|||++... .++.++|||||||++|+|++|.+||........ +.. +
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 166 LARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred ccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 99866432 2345689999999998765 577899999999999999999999976543211 110 0
Q ss_pred -----------------CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHh
Q 011331 437 -----------------KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481 (488)
Q Consensus 437 -----------------~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~ 481 (488)
.....+.++.++.+||.+||..||.+|||+.|+++||||+.+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 001235678999999999999999999999999999999987653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=354.49 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=204.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..+ +||||+++++++.+.+.+|+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCeEEE
Confidence 45789999999999999999999999999999998643111 11234678899999998 89999999999999999999
Q ss_pred EEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--CC
Q 011331 307 QMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--LP 381 (488)
Q Consensus 307 V~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--~~ 381 (488)
||||++++ +... .....+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++...... ..
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 168 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCccee
Confidence 99999764 4443 234568999999999999999999999999999999999999 5789999999999876432 23
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccC
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~ 458 (488)
...|++.|+|||++......+.++||||||+++|+|++|..||..... ...+..+....+..++.++.++|.+||+.
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 248 (276)
T 2h6d_A 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQV 248 (276)
T ss_dssp --------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccC
Confidence 446899999999987764445799999999999999999999876433 33445566667778899999999999999
Q ss_pred CCCCCCCHHHHHhChhhhhh
Q 011331 459 DPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 459 dP~~RpTa~elL~HP~f~~i 478 (488)
||.+|||+.|+++||||+..
T Consensus 249 ~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 249 DPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp SGGGSCCHHHHHHSHHHHTT
T ss_pred ChhhCCCHHHHHhChhhccC
Confidence 99999999999999999754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=378.48 Aligned_cols=245 Identities=24% Similarity=0.364 Sum_probs=199.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc-----
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE----- 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~----- 302 (488)
..+|++++.||+|+||+||+|.+..++. ||+|++..... ...+|+.+++.+ +||||++++++|...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCc
Confidence 4579999999999999999999986665 88887643211 122588999998 8999999999986443
Q ss_pred -eEEEEEecCCCCchhhh-----hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--CCeEEEEeecCce
Q 011331 303 -QLYIQMELCDHSLSDKK-----ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDFGRAT 374 (488)
Q Consensus 303 -~l~IV~E~~~~~l~~~~-----~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~g~vkL~DFGlA~ 374 (488)
.+|+||||+++++.... ....+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+|+
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 38899999998765522 246799999999999999999999999999999999999995 6899999999998
Q ss_pred ecCC--CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhh---------------
Q 011331 375 LLNK--SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLR--------------- 434 (488)
Q Consensus 375 ~~~~--~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~--------------- 434 (488)
.... ......||+.|+|||++.+...++.++|||||||++|||++|.+||.+..... .+.
T Consensus 191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 7643 23345689999999998765567889999999999999999999997654321 111
Q ss_pred ----cCCCC----------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 435 ----DGKLP----------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 435 ----~~~~~----------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
....+ +.+.++.++.+||.+||++||.+|||+.|+++||||+.+..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 01111 23457899999999999999999999999999999998754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=357.98 Aligned_cols=251 Identities=23% Similarity=0.381 Sum_probs=189.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch-HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD-AERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~-~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++....... .....+.+|+.++..+ +||||+++++++.+.+..|+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEE
Confidence 457999999999999999999999999999999986431111 1135678899999998 89999999999999999999
Q ss_pred EEecCCCCchh-hhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---
Q 011331 307 QMELCDHSLSD-KKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 307 V~E~~~~~l~~-~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--- 379 (488)
||||++++.+. .... ..+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 99999875443 3222 468999999999999999999999999999999999999 6789999999999876432
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCCCCCCCcHHHHHHHHHcc
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLPLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~~~~~~s~~l~~lI~k~L 456 (488)
.....||+.|+|||++... .++.++|||||||++|+|++|..||...... ..+.......+..++.++.++|.+||
T Consensus 169 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 247 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLL 247 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHS
T ss_pred ceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHc
Confidence 2234689999999998765 5677999999999999999999998754322 22223344556678999999999999
Q ss_pred cCCCCCCCCHHHHHhChhhhhhHH
Q 011331 457 DPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 457 ~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
..||++|||++++++||||.....
T Consensus 248 ~~dp~~Rps~~~~l~h~~~~~~~~ 271 (278)
T 3cok_A 248 RRNPADRLSLSSVLDHPFMSRNSS 271 (278)
T ss_dssp CSSGGGSCCHHHHTTSTTTC----
T ss_pred ccCHhhCCCHHHHhcCccccCCCC
Confidence 999999999999999999986543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=392.49 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=213.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|.+++.||+|+||+||+|.+..+|+.||||++.+.... ......+..|+.++..+ +||||++++++|.+.+.+||
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEE
Confidence 35789999999999999999999999999999998643211 12235678899999999 99999999999999999999
Q ss_pred EEecCCCCchh-hhh-----cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 307 QMELCDHSLSD-KKA-----SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 307 V~E~~~~~l~~-~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
||||++++.+. ... ...+++..++.++.||+.||.|||++||+||||||+|||| .+|.+||+|||+++.....
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 99999876443 222 2359999999999999999999999999999999999999 6789999999999877543
Q ss_pred C---CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch-------hhhhhhcCCCCCCCCCcHHHH
Q 011331 380 L---PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP-------QFLNLRDGKLPLLPGHSLQFQ 449 (488)
Q Consensus 380 ~---~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~-------~~~~i~~~~~~~~~~~s~~l~ 449 (488)
. ...+||+.|+|||++.+. .++.++|||||||++|||++|.+||.... ....+.......+..++.++.
T Consensus 343 ~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 421 (543)
T 3c4z_A 343 QTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421 (543)
T ss_dssp CCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHH
Confidence 2 234799999999999775 67789999999999999999999997642 123445566777788999999
Q ss_pred HHHHHcccCCCCCCCC-----HHHHHhChhhhhhHHh
Q 011331 450 NLLKVMVDPDPVQRPS-----AKELVENPIFDKIQKH 481 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpT-----a~elL~HP~f~~i~~~ 481 (488)
+||.+||+.||.+||+ ++++++||||+.+.+.
T Consensus 422 ~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp HHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred HHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 9999999999999996 5999999999987543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=367.30 Aligned_cols=252 Identities=24% Similarity=0.411 Sum_probs=209.6
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc------hHHHHHHHHHHHHHHHhCCCCCeeEeeeeec
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH------DAERRKALLEVQALAALGSHENIVGYYSSWF 299 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~------~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~ 299 (488)
.+..+|++.+.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..+.+||||++++++|.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 3456799999999999999999999989999999998654311 1224567889999999978999999999999
Q ss_pred ccceEEEEEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceec
Q 011331 300 ENEQLYIQMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL 376 (488)
Q Consensus 300 ~~~~l~IV~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~ 376 (488)
..+..|+||||++++ +... .....+++..++.++.||+.||.|||+.||+|+||||+|||| .+|.++|+|||++..+
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 999999999999875 4432 233569999999999999999999999999999999999999 6789999999999877
Q ss_pred CCC--CCCCCCCCCccChhhhccc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCCC----CC
Q 011331 377 NKS--LPIEEGDARYMPQEILNED-----YDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLPL----LP 442 (488)
Q Consensus 377 ~~~--~~~~~Gt~~Y~APEvl~~~-----~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~~----~~ 442 (488)
... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||...... ..+..+.... +.
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 330 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 543 2345799999999998632 24667999999999999999999998765432 2233333332 24
Q ss_pred CCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 443 GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 443 ~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
..+.++.+||.+||+.||++|||+.|+|+||||++
T Consensus 331 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 67889999999999999999999999999999973
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=355.39 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=204.9
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc----cceEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE----NEQLY 305 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~----~~~l~ 305 (488)
.|++.+.||+|+||+||+|.+..++..||+|++............+.+|+.++..+ +||||+++++++.. ...+|
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCceEE
Confidence 47899999999999999999999999999999976655666677889999999999 89999999998765 45689
Q ss_pred EEEecCCCC-chhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEEe--CCeEEEEeecCceecCCC
Q 011331 306 IQMELCDHS-LSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKG--IAHLDVKPDNIYVK--NGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 306 IV~E~~~~~-l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~g--IiHrDLKp~NILv~--~g~vkL~DFGlA~~~~~~ 379 (488)
+||||++++ |.... ....+++..++.++.||+.||.|||++| |+|+||||+|||++ ++.+||+|||++......
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 999999775 44433 2367999999999999999999999999 99999999999994 689999999999765443
Q ss_pred C-CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh----hhhcCCC--CCCCCCcHHHHHHH
Q 011331 380 L-PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL----NLRDGKL--PLLPGHSLQFQNLL 452 (488)
Q Consensus 380 ~-~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~----~i~~~~~--~~~~~~s~~l~~lI 452 (488)
. ....||+.|+|||++.+. ++.++|||||||++|+|++|..||....... .+..+.. ......+.++.+||
T Consensus 186 ~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 263 (290)
T 1t4h_A 186 FAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp SBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred ccccccCCcCcCCHHHHhcc--CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHH
Confidence 2 234699999999998754 6779999999999999999999987643322 2222222 23345678999999
Q ss_pred HHcccCCCCCCCCHHHHHhChhhhh
Q 011331 453 KVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
.+||+.||.+|||+.|+++||||++
T Consensus 264 ~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 264 EGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=361.09 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=209.3
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc--hHHHHHHHHHHHHHHHhCCCCCeeEeeeee--cccc
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH--DAERRKALLEVQALAALGSHENIVGYYSSW--FENE 302 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~--~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~--~~~~ 302 (488)
..++|++++.||+|+||.||+|.+..++..||||++...... ......+.+|+.++..+ +||||+++++++ .+.+
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCC
Confidence 456789999999999999999999999999999998643111 12346688999999999 899999999998 4556
Q ss_pred eEEEEEecCCCCchhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 303 QLYIQMELCDHSLSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
.+||||||+++++.... ....+++..++.++.||+.||.|||++||+|+||||+|||+ .++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999998855532 24569999999999999999999999999999999999999 678999999999987642
Q ss_pred C-----CCCCCCCCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHH
Q 011331 379 S-----LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQ 449 (488)
Q Consensus 379 ~-----~~~~~Gt~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~ 449 (488)
. .....||+.|+|||++... ..++.++|||||||++|||++|..||..... ...+..+....+..++.++.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence 2 1234589999999998653 2235699999999999999999999886543 23455666777788999999
Q ss_pred HHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 450 NLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+||.+||..||.+|||+.|+++||||+...
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 999999999999999999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=366.84 Aligned_cols=250 Identities=28% Similarity=0.375 Sum_probs=206.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+..+|..||+|++.... .......+.+|+.++..+ +||||+++++++.+.+.+|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECCEEEEE
Confidence 357999999999999999999999999999999987652 445567788999999999 899999999999999999999
Q ss_pred EecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEE-eCCeEEEEeecCceecCC-CCCC
Q 011331 308 MELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEK-GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK-SLPI 382 (488)
Q Consensus 308 ~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~-gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~-~~~~ 382 (488)
|||++++ |... .....+++..++.++.||+.||.|||+. ||+|+||||+|||| .++.++|+|||++..... ....
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 189 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 189 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccC
Confidence 9999874 4443 2334699999999999999999999986 99999999999999 678999999999975532 2334
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh-------------------------------
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL------------------------------- 431 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~------------------------------- 431 (488)
..||+.|+|||++.+. .++.++|||||||++|+|++|..||.......
T Consensus 190 ~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (360)
T 3eqc_A 190 FVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268 (360)
T ss_dssp -CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred CCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence 5799999999998765 67889999999999999999999986532210
Q ss_pred --------------hhhcCCCCC--CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 432 --------------NLRDGKLPL--LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 432 --------------~i~~~~~~~--~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
.+.....+. ...++.++.+||.+||+.||++|||++|+|+||||+....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp -----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred cCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 011111111 1246889999999999999999999999999999987654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=369.03 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=193.9
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce--
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ-- 303 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~-- 303 (488)
...++|++++.||+|+||+||+|.+..+|..||||++..... .......++..+..+ +||||++++++|...+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhc-CCCCcccHHHhhhcccccc
Confidence 345689999999999999999999999999999998854321 123355677778888 89999999999865433
Q ss_pred -----EEEEEecCCCCchhh-----hhcccCCHHHHHHHHHHHHHHHHHHH--HcCcccCCCCCCcEEEe--CCeEEEEe
Q 011331 304 -----LYIQMELCDHSLSDK-----KASQFFAEGEVLKALHQIAQALQFIH--EKGIAHLDVKPDNIYVK--NGVYKLGD 369 (488)
Q Consensus 304 -----l~IV~E~~~~~l~~~-----~~~~~l~~~~~~~i~~qI~~gL~yLH--~~gIiHrDLKp~NILv~--~g~vkL~D 369 (488)
++|||||+++++... .....+++..++.++.||+.||.||| ++||+||||||+||||+ ++.+||+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 899999999986542 23456899999999999999999999 99999999999999994 68999999
Q ss_pred ecCceecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhc--C------
Q 011331 370 FGRATLLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRD--G------ 436 (488)
Q Consensus 370 FGlA~~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~--~------ 436 (488)
||+++..... .....||+.|+|||++.+...++.++|||||||++|+|++|.+||....... .+.. +
T Consensus 176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp CTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 9999876543 2345689999999998765457889999999999999999999997654321 1100 0
Q ss_pred ------------------------CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 437 ------------------------KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 437 ------------------------~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
........+.++.+||.+||+.||.+|||+.|+|+||||+.+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 00112235789999999999999999999999999999998764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=376.53 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=200.6
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc------hHHHHHHHHHHHHHHHhCCCCCeeEeeeeec
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH------DAERRKALLEVQALAALGSHENIVGYYSSWF 299 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~------~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~ 299 (488)
.+.++|.+++.||+|+||+||+|.+..+++.||||++...... ......+.+|+.++.++ +||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence 3456899999999999999999999999999999998653211 11223477899999999 9999999999875
Q ss_pred ccceEEEEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-C---CeEEEEeecCc
Q 011331 300 ENEQLYIQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-N---GVYKLGDFGRA 373 (488)
Q Consensus 300 ~~~~l~IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~---g~vkL~DFGlA 373 (488)
.+.+||||||+.++ |.. ......+++..++.++.||+.||.|||++||+||||||+|||++ + +.+||+|||+|
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred -cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 45589999999875 433 23345699999999999999999999999999999999999993 2 35999999999
Q ss_pred eecCCC--CCCCCCCCCccChhhhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcCCCCCC----
Q 011331 374 TLLNKS--LPIEEGDARYMPQEILNE--DYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDGKLPLL---- 441 (488)
Q Consensus 374 ~~~~~~--~~~~~Gt~~Y~APEvl~~--~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~~~~~~---- 441 (488)
+..... .....||+.|+|||++.. ...++.++|||||||++|+|++|.+||..... ...+..+.....
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 876543 234569999999999853 23566799999999999999999999875432 223344444333
Q ss_pred CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHh
Q 011331 442 PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481 (488)
Q Consensus 442 ~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~ 481 (488)
..++.++.+||.+||+.||.+|||++|+|+||||+.....
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 409 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHH
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHH
Confidence 4578999999999999999999999999999999876543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=371.06 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=205.3
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCC-----eeEeeeeecc
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN-----IVGYYSSWFE 300 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hpn-----Iv~l~~~~~~ 300 (488)
.+.++|++++.||+|+||+||+|.+..+|+.||||++... ......+..|+.++..+..|++ |+.+++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 4567899999999999999999999999999999998742 3445567788888888855664 9999999999
Q ss_pred cceEEEEEecCCCCchhhhhc---ccCCHHHHHHHHHHHHHHHHHHH--HcCcccCCCCCCcEEEe---CCeEEEEeecC
Q 011331 301 NEQLYIQMELCDHSLSDKKAS---QFFAEGEVLKALHQIAQALQFIH--EKGIAHLDVKPDNIYVK---NGVYKLGDFGR 372 (488)
Q Consensus 301 ~~~l~IV~E~~~~~l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH--~~gIiHrDLKp~NILv~---~g~vkL~DFGl 372 (488)
.+.+||||||+++++...... ..+++..++.++.||+.||.||| +.|||||||||+||||. ++.+||+|||+
T Consensus 128 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 128 RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999999999887764433 35899999999999999999999 57999999999999993 46899999999
Q ss_pred ceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc--CCC---------
Q 011331 373 ATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD--GKL--------- 438 (488)
Q Consensus 373 A~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~--~~~--------- 438 (488)
|+..........||+.|+|||++.+. .++.++|||||||++|||++|.+||........ +.. +..
T Consensus 208 a~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (382)
T 2vx3_A 208 SCQLGQRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP 286 (382)
T ss_dssp CEETTCCCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT
T ss_pred ceecccccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH
Confidence 99887766677899999999999775 577899999999999999999999986433111 100 000
Q ss_pred ------------------------CC-CCC----------------------------CcHHHHHHHHHcccCCCCCCCC
Q 011331 439 ------------------------PL-LPG----------------------------HSLQFQNLLKVMVDPDPVQRPS 465 (488)
Q Consensus 439 ------------------------~~-~~~----------------------------~s~~l~~lI~k~L~~dP~~RpT 465 (488)
.. ++. .+.++.+||.+||++||++|||
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt 366 (382)
T 2vx3_A 287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ 366 (382)
T ss_dssp THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence 00 000 0147899999999999999999
Q ss_pred HHHHHhChhhhhhH
Q 011331 466 AKELVENPIFDKIQ 479 (488)
Q Consensus 466 a~elL~HP~f~~i~ 479 (488)
++|+|+||||+...
T Consensus 367 a~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 367 PYYALQHSFFKKTA 380 (382)
T ss_dssp HHHHTTSGGGCC--
T ss_pred HHHHhcCcccccCC
Confidence 99999999998653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=370.69 Aligned_cols=253 Identities=26% Similarity=0.341 Sum_probs=208.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEc---CCCeEEEEEEeccCCC--chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKR---IDGCFYAVKHSKRQLH--HDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~l~~~~~--~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|.+. .+|+.||||+++.... .......+..|+.++..+.+||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 457999999999999999999985 4899999999864321 11223346678999999878999999999999999
Q ss_pred eEEEEEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 303 QLYIQMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
.+||||||++++ |... .....+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+++.....
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 999999999875 4332 334569999999999999999999999999999999999999 6789999999999865321
Q ss_pred ----CCCCCCCCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCchh-------hhhhhcCCCCCCCCCcHH
Q 011331 380 ----LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQ-------FLNLRDGKLPLLPGHSLQ 447 (488)
Q Consensus 380 ----~~~~~Gt~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~~~i~~~~~~~~~~~s~~ 447 (488)
.....||+.|+|||++.+. ..++.++|||||||+||||++|..||..... ...+.....+.+..++..
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 292 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHH
Confidence 2234699999999998753 3467799999999999999999999864321 123344566677889999
Q ss_pred HHHHHHHcccCCCCCCC-----CHHHHHhChhhhhhHH
Q 011331 448 FQNLLKVMVDPDPVQRP-----SAKELVENPIFDKIQK 480 (488)
Q Consensus 448 l~~lI~k~L~~dP~~Rp-----Ta~elL~HP~f~~i~~ 480 (488)
+.+||.+||..||.+|| |++|+++||||+.+.+
T Consensus 293 ~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 99999999999999999 9999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=356.38 Aligned_cols=246 Identities=24% Similarity=0.322 Sum_probs=199.7
Q ss_pred CCccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc
Q 011331 222 DGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN 301 (488)
Q Consensus 222 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~ 301 (488)
..+.....+|++++.||+|+||+||+|.+ +|..||||++............+.+|+.++.++ +||||+++++++.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQP 106 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECST
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC
Confidence 33444467899999999999999999977 689999999977655666667889999999999 899999999999999
Q ss_pred ceEEEEEecCCCC-chhhhhc----ccCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEE-eCCeEEEEeecCc
Q 011331 302 EQLYIQMELCDHS-LSDKKAS----QFFAEGEVLKALHQIAQALQFIHEKG--IAHLDVKPDNIYV-KNGVYKLGDFGRA 373 (488)
Q Consensus 302 ~~l~IV~E~~~~~-l~~~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~g--IiHrDLKp~NILv-~~g~vkL~DFGlA 373 (488)
+.+|+||||++++ |...... ..+++..++.++.||+.||.|||++| |+||||||+|||+ .++.+||+|||++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 9999999999875 4333222 23999999999999999999999999 9999999999999 5689999999999
Q ss_pred eecCCC---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---h--hcCCCCCCCCCc
Q 011331 374 TLLNKS---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---L--RDGKLPLLPGHS 445 (488)
Q Consensus 374 ~~~~~~---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i--~~~~~~~~~~~s 445 (488)
+..... .....||+.|+|||++.+. .++.++|||||||++|||++|..||........ + .......+..++
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN 265 (309)
T ss_dssp ---------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred ccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence 765433 2345699999999999765 567899999999999999999999986544221 1 234556677889
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 446 LQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 446 ~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
.++.+||.+||..||.+|||+.++++
T Consensus 266 ~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 266 PQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999998
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=355.22 Aligned_cols=248 Identities=25% Similarity=0.447 Sum_probs=206.2
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
+.++|.+++.||+|+||+||+|.+..+|+.||||++.... ......+.+|+.++..+ +||||+++++++.+.+.+|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKI-KHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhC-CCCCeeehhhhcccCCEEEE
Confidence 3457999999999999999999999999999999987532 22335577899999999 89999999999999999999
Q ss_pred EEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE----eCCeEEEEeecCceecCCC-
Q 011331 307 QMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 307 V~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv----~~g~vkL~DFGlA~~~~~~- 379 (488)
||||++++ +... .....+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 99999764 4442 334568999999999999999999999999999999999999 3578999999999765432
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCC----CCCCCCcHHHHHHH
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKL----PLLPGHSLQFQNLL 452 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~----~~~~~~s~~l~~lI 452 (488)
.....||+.|+|||++... .++.++|||||||++|+|++|..||..... ...+..+.. +....++.++.+||
T Consensus 164 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 242 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFI 242 (304)
T ss_dssp THHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred cccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHH
Confidence 2223589999999998765 577899999999999999999999876543 223333332 33456899999999
Q ss_pred HHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 453 KVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.+||..||++|||+.|+++||||+..
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 243 CHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHcCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.37 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=210.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
..|++++.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.++..+ +||||+++++++.+.+.+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEE
Confidence 468999999999999999999999999999999865432 23356788999999998 9999999999999999999999
Q ss_pred ecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCC
Q 011331 309 ELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIE 383 (488)
Q Consensus 309 E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~ 383 (488)
||++++ +........+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++...... ....
T Consensus 100 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 179 (303)
T 3a7i_A 100 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 179 (303)
T ss_dssp ECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCC
T ss_pred EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCcc
Confidence 999875 4445556679999999999999999999999999999999999999 6789999999999876542 2345
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhc-CCCCCCCCCcHHHHHHHHHcccCC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRD-GKLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~-~~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
.|++.|+|||++... .++.++|||||||++|+|++|..||....... .+.. ........++..+.+||.+||..|
T Consensus 180 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 258 (303)
T 3a7i_A 180 VGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 258 (303)
T ss_dssp CSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSS
T ss_pred CCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCC
Confidence 689999999998765 56779999999999999999999987654322 2222 233455678999999999999999
Q ss_pred CCCCCCHHHHHhChhhhhh
Q 011331 460 PVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 460 P~~RpTa~elL~HP~f~~i 478 (488)
|.+|||+.|+++||||...
T Consensus 259 p~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 259 PSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp GGGSCCHHHHTTCHHHHHH
T ss_pred hhhCcCHHHHhhChhhhcC
Confidence 9999999999999999653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=376.99 Aligned_cols=245 Identities=23% Similarity=0.352 Sum_probs=185.7
Q ss_pred cceeE-EEEecccCcEEEEEEEEc--CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec--ccce
Q 011331 229 TDFHE-IEQIGAGNFSHVFKVLKR--IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF--ENEQ 303 (488)
Q Consensus 229 ~~y~~-~~~LG~G~fg~Vy~a~~~--~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~--~~~~ 303 (488)
+.|.+ .++||+|+||+||+|.+. .++..||||++...... ..+.+|+.+++.+ +||||+++++++. ....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLREL-KHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCe
Confidence 34565 457999999999999976 56899999998754322 3467899999999 8999999999994 5778
Q ss_pred EEEEEecCCCCchhhhhc----------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-----CCeEEEE
Q 011331 304 LYIQMELCDHSLSDKKAS----------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-----NGVYKLG 368 (488)
Q Consensus 304 l~IV~E~~~~~l~~~~~~----------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-----~g~vkL~ 368 (488)
+||||||+++++...... ..+++..++.++.||+.||.|||++||+||||||+||||. ++.+||+
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999999999886653321 1399999999999999999999999999999999999992 3789999
Q ss_pred eecCceecCCC------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh------------h
Q 011331 369 DFGRATLLNKS------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ------------F 430 (488)
Q Consensus 369 DFGlA~~~~~~------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------------~ 430 (488)
|||+|+..... .....||+.|+|||++.+...++.++|||||||+||||++|.+||..... +
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 99999876432 23356899999999997754578899999999999999999999864321 1
Q ss_pred hhhhc--CCC------------------------------------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 431 LNLRD--GKL------------------------------------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 431 ~~i~~--~~~------------------------------------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
..+.. +.. ......+.++.+||.+||.+||.+|||++|+|+|
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11100 000 0011226788999999999999999999999999
Q ss_pred hhhhhh
Q 011331 473 PIFDKI 478 (488)
Q Consensus 473 P~f~~i 478 (488)
|||+..
T Consensus 335 p~f~~~ 340 (405)
T 3rgf_A 335 PYFLED 340 (405)
T ss_dssp GGGTSS
T ss_pred hhhccC
Confidence 999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=354.41 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=206.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCC-CCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGS-HENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~-HpnIv~l~~~~~~~~~l~I 306 (488)
..+|++++.||+|+||+||+|.+. +|..||||++............+.+|+.++..+.. |+||+++++++...+.+||
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 346999999999999999999886 69999999997655556667788999999999954 6999999999999999999
Q ss_pred EEecCCCCchhhh-hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCceecCCCC-----
Q 011331 307 QMELCDHSLSDKK-ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSL----- 380 (488)
Q Consensus 307 V~E~~~~~l~~~~-~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~~~~~~----- 380 (488)
|||+.+++|.... ....+++..++.++.||+.||.|||++||+|+||||+|||++++.+||+|||++.......
T Consensus 106 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~~~~ 185 (313)
T 3cek_A 106 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVK 185 (313)
T ss_dssp EECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC----------
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccccccccCccccccc
Confidence 9997776666533 3456899999999999999999999999999999999999999999999999998764322
Q ss_pred CCCCCCCCccChhhhccc----------CCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhc--CCCCCCCCC
Q 011331 381 PIEEGDARYMPQEILNED----------YDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRD--GKLPLLPGH 444 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~----------~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~--~~~~~~~~~ 444 (488)
....|++.|+|||++... ..++.++|||||||++|+|++|..||..... ...+.. .....+...
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
T 3cek_A 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265 (313)
T ss_dssp ----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCS
T ss_pred cCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccc
Confidence 234689999999998641 2467799999999999999999999875422 112222 233455667
Q ss_pred cHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 445 SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 445 s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+.++.++|.+||..||.+|||+.|+++||||+...
T Consensus 266 ~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 266 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred hHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 89999999999999999999999999999998643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=353.90 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=191.5
Q ss_pred cccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 225 SRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 225 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
..-.++|++++.||+|+||+||+|.+..+|+.||||++...... ........|+..+.+..+||||+++++++.+.+.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 33456899999999999999999999999999999999765333 33344555555544444999999999999999999
Q ss_pred EEEEecCCCCchhhh--hcccCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 305 YIQMELCDHSLSDKK--ASQFFAEGEVLKALHQIAQALQFIHEK-GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~-gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
||||||++..+.... ....+++..++.++.||+.||.|||+. ||+|+||||+|||+ .++.+||+|||++......
T Consensus 100 ~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 100 FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp EEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999999954433322 245799999999999999999999995 99999999999999 6789999999999766432
Q ss_pred -CCCCCCCCCccChhhhcc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcCCCC---CCCCCcHH
Q 011331 380 -LPIEEGDARYMPQEILNE----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDGKLP---LLPGHSLQ 447 (488)
Q Consensus 380 -~~~~~Gt~~Y~APEvl~~----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~~~~---~~~~~s~~ 447 (488)
.....|++.|+|||++.. ...++.++|||||||++|+|++|..||..... ...+.....+ ....++.+
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD 259 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHH
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHH
Confidence 233468999999999852 23567799999999999999999999875321 2233333332 23357899
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+.+||.+||..||.+|||++|+++||||+...
T Consensus 260 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 260 FQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 99999999999999999999999999998764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=367.01 Aligned_cols=252 Identities=20% Similarity=0.297 Sum_probs=199.5
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC---------chHHHHHHHHHHHHHHHhCCCCCeeEeee
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH---------HDAERRKALLEVQALAALGSHENIVGYYS 296 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~---------~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~ 296 (488)
...++|++++.||+|+||+||+|.+. +|..||||++..... .......+.+|+.++..+ +||||+++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 96 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRD 96 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSE
T ss_pred HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceee
Confidence 34568999999999999999999986 599999999854321 223346789999999999 8999999999
Q ss_pred eec-----ccceEEEEEecCCCCchhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEE
Q 011331 297 SWF-----ENEQLYIQMELCDHSLSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLG 368 (488)
Q Consensus 297 ~~~-----~~~~l~IV~E~~~~~l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~ 368 (488)
++. ....+|+||||+++++...... ..+++..++.++.||+.||.|||++||+|+||||+|||| .++.+||+
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 984 3447899999999887774443 358999999999999999999999999999999999999 57899999
Q ss_pred eecCceecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---h---------
Q 011331 369 DFGRATLLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---R--------- 434 (488)
Q Consensus 369 DFGlA~~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~--------- 434 (488)
|||++...... .....||+.|+|||++.+...++.++|||||||++|+|++|..||........+ .
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 99999755332 234568999999999876446788999999999999999999999765321110 0
Q ss_pred ---------------cCCC--------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 435 ---------------DGKL--------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 435 ---------------~~~~--------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.... ...+..+..+.+||.+||+.||.+|||+.|+|+||||+.+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 0000 12345688899999999999999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=357.36 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=202.0
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC------chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH------HDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~------~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
+.++|++++.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.++..+ +||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEES
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcC
Confidence 34579999999999999999999999999999999865321 112234577899999999 99999999999876
Q ss_pred cceEEEEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC---eEEEEeecCce
Q 011331 301 NEQLYIQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG---VYKLGDFGRAT 374 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g---~vkL~DFGlA~ 374 (488)
+. .|+||||++++ +.. ......+++..++.++.||+.||.|||++||+|+||||+|||++ ++ .+||+|||++.
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 55 89999999874 444 33345699999999999999999999999999999999999994 33 49999999998
Q ss_pred ecCCCC--CCCCCCCCccChhhhc--ccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcCCCCCC----C
Q 011331 375 LLNKSL--PIEEGDARYMPQEILN--EDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDGKLPLL----P 442 (488)
Q Consensus 375 ~~~~~~--~~~~Gt~~Y~APEvl~--~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~~~~~~----~ 442 (488)
...... ....||+.|+|||++. ....++.++|||||||++|+|++|..||..... ...+..+..... .
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence 765431 1235899999999974 233567799999999999999999999875432 122333443332 4
Q ss_pred CCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 443 GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 443 ~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.++.++.+||.+||..||++|||+.|+|+||||+...
T Consensus 246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred hcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 6789999999999999999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=357.96 Aligned_cols=252 Identities=26% Similarity=0.412 Sum_probs=190.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.... .......+..|+..+.+..+||||+++++++...+..|||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 457899999999999999999999999999999997543 3344556777777666656999999999999999999999
Q ss_pred EecCCCCchhhhh------cccCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 308 MELCDHSLSDKKA------SQFFAEGEVLKALHQIAQALQFIHEK-GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 308 ~E~~~~~l~~~~~------~~~l~~~~~~~i~~qI~~gL~yLH~~-gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
|||+++++..... ...+++..++.++.||+.||.|||+. ||+|+||||+|||+ .++.+||+|||+++.....
T Consensus 100 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 100 MELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp ECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred EeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 9999987655332 46789999999999999999999999 99999999999999 6789999999999876433
Q ss_pred C--CCCCCCCCccChhhhc---ccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh----hhhhcCCCCC-----CCCCc
Q 011331 380 L--PIEEGDARYMPQEILN---EDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF----LNLRDGKLPL-----LPGHS 445 (488)
Q Consensus 380 ~--~~~~Gt~~Y~APEvl~---~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~----~~i~~~~~~~-----~~~~s 445 (488)
. ....||+.|+|||++. ....++.++|||||||++|+|++|..||...... ..+..+..+. ...++
T Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3aln_A 180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFS 259 (327)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCC
T ss_pred cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCC
Confidence 2 2336999999999984 2235678999999999999999999998764332 1222222221 23578
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 446 LQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 446 ~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
.++.+||.+||..||.+|||+.|+++||||.....
T Consensus 260 ~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 260 PSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 99999999999999999999999999999987543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=355.37 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=201.1
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc------
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE------ 300 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~------ 300 (488)
..++|++++.||+|+||+||+|.+..+|+.||||++..... ....+.+|+.++.++.+||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 35679999999999999999999999999999999865422 234577899999999889999999999876
Q ss_pred cceEEEEEecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCcee
Q 011331 301 NEQLYIQMELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATL 375 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~ 375 (488)
.+.+||||||++++ |..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||++..
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 56899999999884 443322 2569999999999999999999999999999999999999 578999999999987
Q ss_pred cCCC---CCCCCCCCCccChhhhcc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCC--CCCCC
Q 011331 376 LNKS---LPIEEGDARYMPQEILNE----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKL--PLLPG 443 (488)
Q Consensus 376 ~~~~---~~~~~Gt~~Y~APEvl~~----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~--~~~~~ 443 (488)
.... .....|++.|+|||++.. ...++.++|||||||++|+|++|..||....... .+..... .....
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 2x7f_A 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 258 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSC
T ss_pred cCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccc
Confidence 6432 234468999999999862 2356779999999999999999999987654322 2222222 22456
Q ss_pred CcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 444 HSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 444 ~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 259 ~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 259 WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred cCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 789999999999999999999999999999998753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=352.23 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=209.4
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.+.++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.++.++ +||||+++++++.+.+.+|
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCeEE
Confidence 445689999999999999999999999999999999865543334456788999999999 9999999999999999999
Q ss_pred EEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecCceecCCC
Q 011331 306 IQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 306 IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGlA~~~~~~ 379 (488)
+||||+.++ +.. ......+++..++.++.||+.||.|||++||+|+||||+||+|+ ++.+||+|||++......
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 999999765 433 33345799999999999999999999999999999999999993 247999999999866433
Q ss_pred C--CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCC----CCCCCcHHHHH
Q 011331 380 L--PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLP----LLPGHSLQFQN 450 (488)
Q Consensus 380 ~--~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~----~~~~~s~~l~~ 450 (488)
. ....|++.|+|||++.+. ++.++||||||+++|+|++|..||...... ..+..+... ....++.++.+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred CccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence 2 233478899999998765 667999999999999999999998765432 233333332 22567999999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+|.+||..||.+|||+.|+++||||++.
T Consensus 256 li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999865
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=354.73 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=203.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+..+|..||+|++.... ......+..|+.++..+ +||||+++++++...+.+|+|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCeEEEE
Confidence 357899999999999999999999999999999986432 22345688899999999 899999999999999999999
Q ss_pred EecCCCCchhh---hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC---CCC
Q 011331 308 MELCDHSLSDK---KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN---KSL 380 (488)
Q Consensus 308 ~E~~~~~l~~~---~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~---~~~ 380 (488)
|||++++.+.. .....+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||++.... ...
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence 99998865542 223569999999999999999999999999999999999999 57899999999875432 122
Q ss_pred CCCCCCCCccChhhhc----ccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCC---CCCCCCcHHHHH
Q 011331 381 PIEEGDARYMPQEILN----EDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKL---PLLPGHSLQFQN 450 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~----~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~---~~~~~~s~~l~~ 450 (488)
....||+.|+|||++. ....++.++|||||||++|+|++|..|+....... .+..... ..+..++.++.+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD 254 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHH
Confidence 3456999999999984 23356779999999999999999999987654322 2222222 234567899999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+|.+||..||.+|||+.++++||||+.+..
T Consensus 255 li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 255 FLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp HHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred HHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 999999999999999999999999987653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=349.04 Aligned_cols=249 Identities=31% Similarity=0.484 Sum_probs=208.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec--ccceEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF--ENEQLY 305 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~--~~~~l~ 305 (488)
.++|++++.||+|+||+||+|.+..+|+.||+|++............+..|+.++..+ +||||+++++++. ..+.+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEE
Confidence 4579999999999999999999999999999999976655666677899999999999 8999999999874 467899
Q ss_pred EEEecCCCC-chhhhh-----cccCCHHHHHHHHHHHHHHHHHHHHcC-----cccCCCCCCcEEE-eCCeEEEEeecCc
Q 011331 306 IQMELCDHS-LSDKKA-----SQFFAEGEVLKALHQIAQALQFIHEKG-----IAHLDVKPDNIYV-KNGVYKLGDFGRA 373 (488)
Q Consensus 306 IV~E~~~~~-l~~~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~g-----IiHrDLKp~NILv-~~g~vkL~DFGlA 373 (488)
+||||++++ |..... ...+++..++.++.||+.||.|||+.| |+|+||||+|||+ .++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999874 444222 123999999999999999999999999 9999999999999 5789999999999
Q ss_pred eecCCCCC---CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCC-CCCCCCcH
Q 011331 374 TLLNKSLP---IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKL-PLLPGHSL 446 (488)
Q Consensus 374 ~~~~~~~~---~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~-~~~~~~s~ 446 (488)
........ ...|++.|+|||++... .++.++|||||||++|+|++|..||..... ...+..+.. ..+..++.
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (279)
T 2w5a_A 164 RILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242 (279)
T ss_dssp HHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred eeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCH
Confidence 76643321 23589999999998765 577899999999999999999999876543 223334443 45567899
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 447 QFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
++.++|.+||..||.+|||+.||++|+|+.+-
T Consensus 243 ~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 243 ELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 99999999999999999999999999999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=353.56 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=204.9
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|.+++.||+|+||+||+|.+..+|..||+|++.. ........+.+|+.++..+ +||||+++++++.+.+.+++||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEEEE
Confidence 578999999999999999999999999999998854 3445567789999999999 8999999999999999999999
Q ss_pred ecCCCCch-hhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC---
Q 011331 309 ELCDHSLS-DKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP--- 381 (488)
Q Consensus 309 E~~~~~l~-~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~--- 381 (488)
||++++.+ .... ...+++..++.++.||+.||.|||++||+|+||||+|||| .++.+||+|||+++.......
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99987544 3332 3569999999999999999999999999999999999999 678999999999987643211
Q ss_pred --------------CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh-----hh-cCCCCCC
Q 011331 382 --------------IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN-----LR-DGKLPLL 441 (488)
Q Consensus 382 --------------~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~-----i~-~~~~~~~ 441 (488)
...||+.|+|||++.+. .++.++|||||||++|||++|..|+........ .. ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCC
T ss_pred ccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCC
Confidence 34699999999999765 677899999999999999999988764322110 00 0011235
Q ss_pred CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 442 PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 442 ~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+.++.++.++|.+||+.||++|||+.++++ |++.+..
T Consensus 246 ~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~ 282 (310)
T 3s95_A 246 PNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRM 282 (310)
T ss_dssp TTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence 677889999999999999999999999998 7877764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=357.77 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=202.1
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce-
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQ- 303 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~- 303 (488)
.+.++|++++.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..+ +||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETT
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCC
Confidence 3456899999999999999999999999999999999765333 34456688899999998 89999999999876553
Q ss_pred ---EEEEEecCCCCch-hh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC
Q 011331 304 ---LYIQMELCDHSLS-DK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN 377 (488)
Q Consensus 304 ---l~IV~E~~~~~l~-~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~ 377 (488)
.||||||++++.+ .. .....+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||+++...
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 4999999987544 32 234569999999999999999999999999999999999999 67899999999998664
Q ss_pred CC------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh----hhcCCCC---CCCCC
Q 011331 378 KS------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN----LRDGKLP---LLPGH 444 (488)
Q Consensus 378 ~~------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~----i~~~~~~---~~~~~ 444 (488)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|..||........ +.....+ ....+
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp --------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred ccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 32 1234589999999999765 577899999999999999999999976544221 2222222 23468
Q ss_pred cHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 445 SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 445 s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+.++.++|.+||+.||.+||++.+++.|+|++..
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 9999999999999999999999999999999754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=360.11 Aligned_cols=250 Identities=21% Similarity=0.344 Sum_probs=210.1
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch----HHHHHHHHHHHHHHHhC-CCCCeeEeeeeeccc
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD----AERRKALLEVQALAALG-SHENIVGYYSSWFEN 301 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~----~~~~~~~~Ei~iL~~l~-~HpnIv~l~~~~~~~ 301 (488)
..++|++++.||+|+||+||+|.+..+|+.||||++....... .....+..|+.++..+. .|+||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 4567999999999999999999999999999999986542211 11234567899999985 379999999999999
Q ss_pred ceEEEEEecCCC--Cchhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--CCeEEEEeecCceec
Q 011331 302 EQLYIQMELCDH--SLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDFGRATLL 376 (488)
Q Consensus 302 ~~l~IV~E~~~~--~l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~g~vkL~DFGlA~~~ 376 (488)
+.+++|||++.+ .+... .....+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++..
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 999999999974 44443 3345799999999999999999999999999999999999995 589999999999877
Q ss_pred CCC-CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCCCCCCCCcHHHHHHHHHc
Q 011331 377 NKS-LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 377 ~~~-~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~~~~~~~s~~l~~lI~k~ 455 (488)
... .....||+.|+|||++......+.++|||||||++|||++|..||..... +..........++.++.+||.+|
T Consensus 201 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~li~~~ 277 (320)
T 3a99_A 201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---IIRGQVFFRQRVSSECQHLIRWC 277 (320)
T ss_dssp CSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---HHHCCCCCSSCCCHHHHHHHHHH
T ss_pred ccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---hhcccccccccCCHHHHHHHHHH
Confidence 543 23456999999999987654446789999999999999999999976543 33445556678899999999999
Q ss_pred ccCCCCCCCCHHHHHhChhhhhhH
Q 011331 456 VDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 456 L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
|+.||.+|||++|+++||||+...
T Consensus 278 l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 278 LALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp TCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ccCChhhCcCHHHHhcCHhhcCcc
Confidence 999999999999999999998763
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=362.31 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=208.9
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch---------------HHHHHHHHHHHHHHHhCCCCC
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD---------------AERRKALLEVQALAALGSHEN 290 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~---------------~~~~~~~~Ei~iL~~l~~Hpn 290 (488)
.+.++|++++.||+|+||+||+|.+ +|+.||||++....... .....+.+|+.++..+ +|||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 104 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEY 104 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTT
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCC
Confidence 3456899999999999999999998 89999999986431111 0116688899999999 8999
Q ss_pred eeEeeeeecccceEEEEEecCCCC-chhh------hh---cccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEE
Q 011331 291 IVGYYSSWFENEQLYIQMELCDHS-LSDK------KA---SQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIY 359 (488)
Q Consensus 291 Iv~l~~~~~~~~~l~IV~E~~~~~-l~~~------~~---~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NIL 359 (488)
|+++++++.+.+.+|+||||++++ |... .. ...+++..++.++.||+.||.|||+ +||+|+||||+|||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 999999999999999999999874 4332 22 4569999999999999999999999 99999999999999
Q ss_pred E-eCCeEEEEeecCceecCC-CCCCCCCCCCccChhhhcccCCCCc-hhHHHHHHHHHHHHHcCCCCCCCchh----hhh
Q 011331 360 V-KNGVYKLGDFGRATLLNK-SLPIEEGDARYMPQEILNEDYDHLD-KVDIFSLGATMYELIKGSPLSESGPQ----FLN 432 (488)
Q Consensus 360 v-~~g~vkL~DFGlA~~~~~-~~~~~~Gt~~Y~APEvl~~~~~~~~-ksDIwSlGvlL~eLltG~~p~~~~~~----~~~ 432 (488)
+ .++.++|+|||++..... ......|+..|+|||++.....++. ++|||||||++|||++|..||..... ...
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred EcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 9 678999999999987643 2344569999999999976534444 89999999999999999999876433 233
Q ss_pred hhcCCCCCC-------------------CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 433 LRDGKLPLL-------------------PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 433 i~~~~~~~~-------------------~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+..+....+ ..++.++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 444444444 568999999999999999999999999999999987653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=351.91 Aligned_cols=246 Identities=25% Similarity=0.403 Sum_probs=203.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.... ....+.+|+.++..+ +||||+++++++...+.+|+|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEE
Confidence 457899999999999999999999999999999986532 234578899999999 999999999999999999999
Q ss_pred EecCCCCchh-hh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---C
Q 011331 308 MELCDHSLSD-KK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---L 380 (488)
Q Consensus 308 ~E~~~~~l~~-~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~ 380 (488)
|||++++.+. .. ....+++..++.++.||+.||.|||+.||+|+||||+||++ .++.++|+|||++...... .
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence 9999885443 32 24579999999999999999999999999999999999999 6789999999999876543 2
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcC---CCCCCCCCcHHHHHHHHH
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDG---KLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~---~~~~~~~~s~~l~~lI~k 454 (488)
....|++.|+|||++... .++.++|||||||++|+|++|..||........ +... ....+..++.++.+||.+
T Consensus 183 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 261 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261 (314)
T ss_dssp CCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred CccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHH
Confidence 344689999999998765 577899999999999999999999876543222 1122 222344578999999999
Q ss_pred cccCCCCCCCCHHHHHhChhhhhhH
Q 011331 455 MVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
||..||.+|||+.++++||||+...
T Consensus 262 ~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 262 CLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HccCChhhCcCHHHHHhCHHHhcCC
Confidence 9999999999999999999998753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=355.17 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=200.4
Q ss_pred cccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch----HHHHHHHHHHHHHHHhC---CCCCeeEeeee
Q 011331 225 SRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD----AERRKALLEVQALAALG---SHENIVGYYSS 297 (488)
Q Consensus 225 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~----~~~~~~~~Ei~iL~~l~---~HpnIv~l~~~ 297 (488)
..+.++|++++.||+|+||+||+|.+..+|+.||||++....... .....+..|+.++.++. +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 345568999999999999999999999999999999986543222 12334567888888875 79999999999
Q ss_pred ecccceEEEEEec-CCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--CCeEEEEeecC
Q 011331 298 WFENEQLYIQMEL-CDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDFGR 372 (488)
Q Consensus 298 ~~~~~~l~IV~E~-~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~g~vkL~DFGl 372 (488)
+...+..++|||+ +.++ +... .....+++..++.++.||+.||.|||++||+|+||||+||+++ ++.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 5554 4442 2345699999999999999999999999999999999999995 68999999999
Q ss_pred ceecCCC-CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCCCCCCCCcHHHHHH
Q 011331 373 ATLLNKS-LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNL 451 (488)
Q Consensus 373 A~~~~~~-~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~~~~~~~s~~l~~l 451 (488)
+...... .....|+..|+|||++......+.++|||||||++|+|++|..||..... +.......+..++.++.+|
T Consensus 187 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~l 263 (312)
T 2iwi_A 187 GALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---ILEAELHFPAHVSPDCCAL 263 (312)
T ss_dssp CEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---HHHTCCCCCTTSCHHHHHH
T ss_pred hhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---HhhhccCCcccCCHHHHHH
Confidence 9877543 33456899999999987653344589999999999999999999976543 3344556677889999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
|.+||+.||++|||++|+++||||+....
T Consensus 264 i~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 264 IRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp HHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred HHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 99999999999999999999999987643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=348.40 Aligned_cols=246 Identities=33% Similarity=0.582 Sum_probs=196.9
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-----
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE----- 300 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~----- 300 (488)
++.++|++++.||+|+||+||+|.+..+|+.||||++.. .......+.+|+.++..+ +||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCC
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchh
Confidence 455689999999999999999999999999999999863 334556788999999999 89999999998754
Q ss_pred --------cceEEEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEE
Q 011331 301 --------NEQLYIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLG 368 (488)
Q Consensus 301 --------~~~l~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~ 368 (488)
.+.+|+||||++++ |..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe
Confidence 46789999999874 444332 3457889999999999999999999999999999999999 67899999
Q ss_pred eecCceecCCC-----------------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh--
Q 011331 369 DFGRATLLNKS-----------------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-- 429 (488)
Q Consensus 369 DFGlA~~~~~~-----------------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-- 429 (488)
|||++...... .....||+.|+|||++.+...++.++|||||||++|+|++ |+.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 99999765421 1234589999999999765457789999999999999998 4433222
Q ss_pred --hhhhhcCCCC----CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 430 --FLNLRDGKLP----LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 430 --~~~i~~~~~~----~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
...+...... .....+..+.++|.+||+.||.+|||+.++++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 2223333222 334567789999999999999999999999999999754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=355.66 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=184.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.++..+ +||||+++++++...+..|+|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCC-CCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCcEEE
Confidence 4578999999999999999999988999999998864321 23345678899999988 899999999999999999999
Q ss_pred EecCCCC-chhhhh---------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceec
Q 011331 308 MELCDHS-LSDKKA---------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL 376 (488)
Q Consensus 308 ~E~~~~~-l~~~~~---------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~ 376 (488)
|||++++ +..... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++...
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 9999765 433221 3458999999999999999999999999999999999999 6789999999998765
Q ss_pred CCC--------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhcCC--------
Q 011331 377 NKS--------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRDGK-------- 437 (488)
Q Consensus 377 ~~~--------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~~~-------- 437 (488)
... .....||+.|+|||++.....++.++|||||||++|+|++|..||........ .....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccc
Confidence 321 12346899999999986533467799999999999999999999876543221 11111
Q ss_pred --CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 438 --LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 438 --~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
......++.++.++|.+||+.||.+|||+.|+++||||+....
T Consensus 252 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp ---CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 1233467899999999999999999999999999999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=348.60 Aligned_cols=252 Identities=24% Similarity=0.306 Sum_probs=200.9
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|.....||+|+||+||+|.+..++..||||++.... ......+.+|+.++..+ +||||+++++++...+.+++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEE
Confidence 3444558999999999999999999999999986542 33456688899999998 99999999999999999999999
Q ss_pred cCCCCchh-hhhc----ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--CCeEEEEeecCceecCCC---
Q 011331 310 LCDHSLSD-KKAS----QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK--NGVYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 310 ~~~~~l~~-~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~--~g~vkL~DFGlA~~~~~~--- 379 (488)
|++++.+. .... ..+++..++.++.||+.||.|||++||+|+||||+||+++ ++.++|+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 99765433 2222 2467889999999999999999999999999999999994 789999999999876432
Q ss_pred CCCCCCCCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCchhh----h--hhhcCCCCCCCCCcHHHHHHH
Q 011331 380 LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQF----L--NLRDGKLPLLPGHSLQFQNLL 452 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~----~--~i~~~~~~~~~~~s~~l~~lI 452 (488)
.....|++.|+|||++... ..++.++|||||||++|+|++|..||...... . .........+..++.++.++|
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence 2345689999999998653 23677999999999999999999998643221 1 112233455667899999999
Q ss_pred HHcccCCCCCCCCHHHHHhChhhhhhHHhhhh
Q 011331 453 KVMVDPDPVQRPSAKELVENPIFDKIQKHRKT 484 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~f~~i~~~~~~ 484 (488)
.+||+.||++|||+.|+++||||+...+.+++
T Consensus 260 ~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~ 291 (295)
T 2clq_A 260 LKCFEPDPDKRACANDLLVDEFLKVSSKKKKT 291 (295)
T ss_dssp HHTTCSSTTTSCCHHHHHTSGGGCC-------
T ss_pred HHHccCChhhCCCHHHHhcChhhhhccccCCC
Confidence 99999999999999999999999987765543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=352.57 Aligned_cols=250 Identities=16% Similarity=0.206 Sum_probs=186.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCe---EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGC---FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.++|++++.||+|+||+||+|.+..++. .||||++............+.+|+.++..+ +||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccccc
Confidence 3578999999999999999999887765 899999876554556677899999999999 999999999999877655
Q ss_pred ------EEEEecCCCCchh-hhhc-------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEe
Q 011331 305 ------YIQMELCDHSLSD-KKAS-------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGD 369 (488)
Q Consensus 305 ------~IV~E~~~~~l~~-~~~~-------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~D 369 (488)
++||||+.++.+. .... ..+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEee
Confidence 9999999885433 2211 148999999999999999999999999999999999999 578999999
Q ss_pred ecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhh-cCCCC
Q 011331 370 FGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLR-DGKLP 439 (488)
Q Consensus 370 FGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~-~~~~~ 439 (488)
||+++...... ....+++.|+|||++... .++.++|||||||++|||++ |..||...... ..+. ....+
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 259 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred ccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC
Confidence 99998664322 123467789999998765 57789999999999999999 88888754332 2222 33456
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCC-------HHHHHhChhhhhhH
Q 011331 440 LLPGHSLQFQNLLKVMVDPDPVQRPS-------AKELVENPIFDKIQ 479 (488)
Q Consensus 440 ~~~~~s~~l~~lI~k~L~~dP~~RpT-------a~elL~HP~f~~i~ 479 (488)
.++.++.++.+||.+||+.||.+||| ++++++|||+....
T Consensus 260 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 260 QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 67788999999999999999999999 88999999997643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=353.88 Aligned_cols=245 Identities=23% Similarity=0.332 Sum_probs=195.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc--eEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE--QLY 305 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~--~l~ 305 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.++..+ +||||+++++++...+ .+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEE
Confidence 3578999999999999999999999999999999875321 22245577899999999 8999999999987655 789
Q ss_pred EEEecCCCC-chhhhhc----ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE----e-CCeEEEEeecCcee
Q 011331 306 IQMELCDHS-LSDKKAS----QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV----K-NGVYKLGDFGRATL 375 (488)
Q Consensus 306 IV~E~~~~~-l~~~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv----~-~g~vkL~DFGlA~~ 375 (488)
|||||++++ |...... ..+++..++.++.||+.||.|||++||+||||||+|||| + ++.+||+|||+++.
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 999999865 4332222 228999999999999999999999999999999999998 2 34699999999987
Q ss_pred cCCCC--CCCCCCCCccChhhhcc-------cCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-------hhhhhcCC--
Q 011331 376 LNKSL--PIEEGDARYMPQEILNE-------DYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-------FLNLRDGK-- 437 (488)
Q Consensus 376 ~~~~~--~~~~Gt~~Y~APEvl~~-------~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~~~i~~~~-- 437 (488)
..... ....||+.|+|||++.. ...++.++|||||||++|||++|..||..... ...+..+.
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~ 245 (319)
T 4euu_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (319)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred cCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence 75432 34569999999999852 23577899999999999999999999853211 11111111
Q ss_pred -------------------CCC----CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChh
Q 011331 438 -------------------LPL----LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPI 474 (488)
Q Consensus 438 -------------------~~~----~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~ 474 (488)
.+. ...++..+.++|.+||++||++|||++|+|+||-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 111 1234567899999999999999999999999984
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=359.07 Aligned_cols=248 Identities=22% Similarity=0.357 Sum_probs=205.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEc-------CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKR-------IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
.++|++++.||+|+||+||+|.+. .++..||||+++.. ........+.+|+.++..+.+||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 457999999999999999999875 35678999998754 3445567799999999999789999999999999
Q ss_pred cceEEEEEecCCCC-chhhhhc-----------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-e
Q 011331 301 NEQLYIQMELCDHS-LSDKKAS-----------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-K 361 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~~~~~-----------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~ 361 (488)
.+.+||||||++++ |...... ..+++.+++.++.||+.||.|||++||+||||||+|||| .
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence 99999999999875 4332221 247899999999999999999999999999999999999 6
Q ss_pred CCeEEEEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhh
Q 011331 362 NGVYKLGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLN 432 (488)
Q Consensus 362 ~g~vkL~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~ 432 (488)
++.+||+|||+++...... ....+|+.|+|||++.+. .++.++|||||||++|||++ |..||..... ...
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~ 317 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 7899999999998765321 223467889999998765 57889999999999999999 8888865433 222
Q ss_pred hhcC-CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 433 LRDG-KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 433 i~~~-~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+..+ ....+..++.++.++|.+||+.||.+|||+.|++++ |+.+.
T Consensus 318 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~--L~~il 363 (370)
T 2psq_A 318 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIL 363 (370)
T ss_dssp HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHH
Confidence 3333 344566789999999999999999999999999986 65543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=356.80 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=203.2
Q ss_pred ccceeEEEEecccCcEEEEEEE-----EcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVL-----KRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|. +..+++.||||++... ........+.+|+.++.++.+||||+++++++.+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 4579999999999999999998 4556799999999754 334456778999999999988999999999988755
Q ss_pred e-EEEEEecCCCCchh-hhhc-----------------------------------------------------------
Q 011331 303 Q-LYIQMELCDHSLSD-KKAS----------------------------------------------------------- 321 (488)
Q Consensus 303 ~-l~IV~E~~~~~l~~-~~~~----------------------------------------------------------- 321 (488)
. +++|||||+++.+. ....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 4 89999999875333 2211
Q ss_pred --------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-----CCCCCCCC
Q 011331 322 --------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-----LPIEEGDA 387 (488)
Q Consensus 322 --------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-----~~~~~Gt~ 387 (488)
..+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+++..... .....||+
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 259 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence 118899999999999999999999999999999999999 6789999999999866332 12345788
Q ss_pred CccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh----hhhhh-cCCCCCCCCCcHHHHHHHHHcccCCCC
Q 011331 388 RYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ----FLNLR-DGKLPLLPGHSLQFQNLLKVMVDPDPV 461 (488)
Q Consensus 388 ~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~----~~~i~-~~~~~~~~~~s~~l~~lI~k~L~~dP~ 461 (488)
.|+|||++... .++.++|||||||++|||++ |..||..... ...+. ......+..++.++.++|.+||+.||.
T Consensus 260 ~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 338 (359)
T 3vhe_A 260 KWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 338 (359)
T ss_dssp GGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred eeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 99999998765 57789999999999999998 9988875432 11222 234556667899999999999999999
Q ss_pred CCCCHHHHHhChhhhhhH
Q 011331 462 QRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 462 ~RpTa~elL~HP~f~~i~ 479 (488)
+|||+.|+++| |+.+.
T Consensus 339 ~Rps~~ell~~--L~~~~ 354 (359)
T 3vhe_A 339 QRPTFSELVEH--LGNLL 354 (359)
T ss_dssp GSCCHHHHHHH--HHHHH
T ss_pred hCCCHHHHHHH--HHHHH
Confidence 99999999997 66554
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=347.25 Aligned_cols=250 Identities=21% Similarity=0.321 Sum_probs=202.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL-HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~-~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+..++..||||++.... ........+.+|+.++..+ +||||+++++++.+.+.+|+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECSSEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeCCeEEE
Confidence 457999999999999999999999999999999985442 3344456788999999999 89999999999999999999
Q ss_pred EEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----
Q 011331 307 QMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---- 379 (488)
Q Consensus 307 V~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---- 379 (488)
||||++++ |... .....+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++......
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 99999875 4432 334569999999999999999999999999999999999999 6789999999999766432
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhhcCCCC-----CCCCCcHHHHHH
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLRDGKLP-----LLPGHSLQFQNL 451 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~~~~~~-----~~~~~s~~l~~l 451 (488)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||....... .......+ ..+.++..+.++
T Consensus 169 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 247 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV 247 (294)
T ss_dssp ------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHH
T ss_pred cCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHH
Confidence 2234599999999998775 56789999999999999999999998754422 12222222 345688999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
|.+||+.||.+||+..+.+.+.|..-+.
T Consensus 248 i~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 248 ILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred HHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 9999999999999666666666665443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=351.36 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=204.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCC---eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDG---CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.++|++++.||+|+||+||+|.+..+| ..||||++.... .......+.+|+.++..+ +||||+++++++.+.+.+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCcc
Confidence 357899999999999999999998654 459999997542 445567789999999999 899999999999999999
Q ss_pred EEEEecCCCC-chhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 305 YIQMELCDHS-LSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
||||||++++ |.... ....+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+++......
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999875 44433 23469999999999999999999999999999999999999 67899999999998764321
Q ss_pred ------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhh-cCCCCCCCCCcHHHH
Q 011331 381 ------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLR-DGKLPLLPGHSLQFQ 449 (488)
Q Consensus 381 ------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~-~~~~~~~~~~s~~l~ 449 (488)
....+|+.|+|||++... .++.++|||||||++|||++ |..||...... ..+. ....+.+..++.++.
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 284 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH 284 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHH
Confidence 122367789999998765 57789999999999999999 99888765432 2222 235566778899999
Q ss_pred HHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 450 NLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
++|.+||..||.+|||+.|+++. ++.+.+
T Consensus 285 ~li~~~l~~dp~~Rps~~eil~~--L~~l~~ 313 (325)
T 3kul_A 285 QLMLDCWHKDRAQRPRFSQIVSV--LDALIR 313 (325)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH--HHHHHh
Confidence 99999999999999999999983 666543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=337.51 Aligned_cols=244 Identities=20% Similarity=0.303 Sum_probs=203.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+. ++..||||++...... ...+.+|+.++.++ +||||+++++++.+.+.+|+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhC-CCCCEeeEEEEEecCCceEEE
Confidence 458999999999999999999987 6888999999765333 24578899999999 899999999999999999999
Q ss_pred EecCCCCchh-hh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC----C
Q 011331 308 MELCDHSLSD-KK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK----S 379 (488)
Q Consensus 308 ~E~~~~~l~~-~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~----~ 379 (488)
|||++++.+. .. ....+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++..... .
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999876443 32 23458999999999999999999999999999999999999 678999999999976532 2
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC-CCCCCCCCcHHHHHHHHH
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG-KLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~-~~~~~~~~s~~l~~lI~k 454 (488)
.....+|+.|+|||++... .++.++|||||||++|+|++ |..||...... ..+..+ ....+...+.++.++|.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 242 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 242 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred ccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHH
Confidence 2334577889999998765 57789999999999999999 88888765432 223333 344455679999999999
Q ss_pred cccCCCCCCCCHHHHHhChhhhhhH
Q 011331 455 MVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
||+.||++|||+.|+++| ++.+.
T Consensus 243 ~l~~~p~~Rps~~~ll~~--l~~l~ 265 (269)
T 4hcu_A 243 CWRERPEDRPAFSRLLRQ--LAEIA 265 (269)
T ss_dssp HTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HccCCcccCcCHHHHHHH--HHHHH
Confidence 999999999999999997 65554
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=358.71 Aligned_cols=247 Identities=21% Similarity=0.270 Sum_probs=202.5
Q ss_pred ccceeEEEEecccCcEEEEEEE-----EcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVL-----KRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|. +..++..||||++... ........+.+|+.++..+ +||||+++++++.+.+
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecCC
Confidence 4578999999999999999999 4557889999998643 3445556788999999999 8999999999999999
Q ss_pred eEEEEEecCCCC-chhhhhc--------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC---eEEEEe
Q 011331 303 QLYIQMELCDHS-LSDKKAS--------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG---VYKLGD 369 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~~~--------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g---~vkL~D 369 (488)
..||||||++++ |...... ..+++..++.++.||+.||.|||++||+||||||+||||+ +| .+||+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999775 4443222 2489999999999999999999999999999999999994 33 599999
Q ss_pred ecCceecCC-----CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCC
Q 011331 370 FGRATLLNK-----SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLP 439 (488)
Q Consensus 370 FGlA~~~~~-----~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~ 439 (488)
||+|+.... ......||+.|+|||++... .++.++|||||||++|||++ |..||...... ..+.. ....
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~ 306 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 306 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999975421 22334578999999998765 57889999999999999998 88888765432 22222 3345
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 440 LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 440 ~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
.+..++..+.+||.+||+.||.+|||+.+|++|.++..
T Consensus 307 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 56678999999999999999999999999999977643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=342.03 Aligned_cols=246 Identities=26% Similarity=0.348 Sum_probs=199.4
Q ss_pred ccceeEEEEecccCcEEEEEEE----EcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc--c
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVL----KRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE--N 301 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~--~ 301 (488)
..+|++++.||+|+||+||+|. +..+|+.||||++... .......+.+|+.++..+ +||||+++++++.. .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCC
Confidence 4579999999999999999998 5668999999998743 345556788999999999 89999999998865 4
Q ss_pred ceEEEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC
Q 011331 302 EQLYIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN 377 (488)
Q Consensus 302 ~~l~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~ 377 (488)
..+++||||++++ |..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||++....
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 5689999999774 444322 2349999999999999999999999999999999999999 68999999999998764
Q ss_pred CCC------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh-------------------hh
Q 011331 378 KSL------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF-------------------LN 432 (488)
Q Consensus 378 ~~~------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~-------------------~~ 432 (488)
... ....++..|+|||++... .++.++|||||||++|||++|..|+...... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 321 223467789999998765 5788999999999999999999887654221 01
Q ss_pred -hhcCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 433 -LRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 433 -i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
......+.+..++.++.++|.+||+.||++|||+.|+++. ++.+.
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~--L~~l~ 290 (295)
T 3ugc_A 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR--VDQIR 290 (295)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH--HHHHH
Confidence 1233556677889999999999999999999999999974 55543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=353.20 Aligned_cols=244 Identities=27% Similarity=0.372 Sum_probs=177.1
Q ss_pred cccceeEEE-EecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc----c
Q 011331 227 YYTDFHEIE-QIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE----N 301 (488)
Q Consensus 227 ~~~~y~~~~-~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~----~ 301 (488)
+.++|++++ .||+|+||+||+|.+..+|+.||||++... . ....|+..+.++.+||||+++++++.. +
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P----KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 345789966 599999999999999999999999998642 1 223455555555599999999999876 5
Q ss_pred ceEEEEEecCCCC-chhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecCc
Q 011331 302 EQLYIQMELCDHS-LSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGRA 373 (488)
Q Consensus 302 ~~l~IV~E~~~~~-l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGlA 373 (488)
..+||||||++++ |...... ..+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 5689999999885 4443322 3599999999999999999999999999999999999994 356999999999
Q ss_pred eecCCC-CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh-------hhhcCC----CCCC
Q 011331 374 TLLNKS-LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL-------NLRDGK----LPLL 441 (488)
Q Consensus 374 ~~~~~~-~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~-------~i~~~~----~~~~ 441 (488)
+..... .....||+.|+|||++... .++.++|||||||++|+|++|..||....... .+.... .+..
T Consensus 179 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T 3fhr_A 179 KETTQNALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257 (336)
T ss_dssp EEC----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred eeccccccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence 876533 3345689999999998654 56679999999999999999999986543211 111111 2233
Q ss_pred CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 442 PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 442 ~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
..++.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 5679999999999999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=344.12 Aligned_cols=248 Identities=21% Similarity=0.314 Sum_probs=204.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEc-----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
..+|.+.+.||+|+||+||+|.+. .++..||||++... ........+.+|+.++..+ +||||+++++++.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecCC
Confidence 457999999999999999999883 45689999998754 3445567788999999999 8999999999999999
Q ss_pred eEEEEEecCCCC-chhhhhc-------------------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCC
Q 011331 303 QLYIQMELCDHS-LSDKKAS-------------------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPD 356 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~~~-------------------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~ 356 (488)
.+|+||||++++ |...... ..+++..++.++.||+.||.|||++||+|+||||+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 179 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence 999999999865 4332221 23889999999999999999999999999999999
Q ss_pred cEEE-eCCeEEEEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh
Q 011331 357 NIYV-KNGVYKLGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ 429 (488)
Q Consensus 357 NILv-~~g~vkL~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~ 429 (488)
|||+ .++.+||+|||++....... ....+++.|+|||++.+. .++.++|||||||++|||++ |..||.....
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999 57899999999998764321 233477889999998765 56789999999999999999 9888876433
Q ss_pred ---hhhhhcC-CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 430 ---FLNLRDG-KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 430 ---~~~i~~~-~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
...+..+ ....+..++.++.++|.+||+.||++|||+.|++++ |+.+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~--l~~~~~ 311 (314)
T 2ivs_A 259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD--LEKMMV 311 (314)
T ss_dssp GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHh
Confidence 1222222 344566789999999999999999999999999987 666544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=334.62 Aligned_cols=244 Identities=18% Similarity=0.256 Sum_probs=201.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+. ++..||||++...... ...+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhC-CCCCEeeEEEEEccCCceEEE
Confidence 457999999999999999999876 6888999999754333 24578899999999 899999999999999999999
Q ss_pred EecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---
Q 011331 308 MELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL--- 380 (488)
Q Consensus 308 ~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~--- 380 (488)
|||++++ +..... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999876 443222 2359999999999999999999999999999999999999 67899999999998764332
Q ss_pred -CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC-CCCCCCCCcHHHHHHHHH
Q 011331 381 -PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG-KLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 381 -~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~-~~~~~~~~s~~l~~lI~k 454 (488)
....+|+.|+|||++... .++.++||||||+++|+|++ |..||...... ..+..+ ....+...+.++.++|.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYS 240 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHH
Confidence 223467789999998764 46779999999999999999 88888754432 223333 334455679999999999
Q ss_pred cccCCCCCCCCHHHHHhChhhhhhH
Q 011331 455 MVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
||+.||++|||+.|+++| ++.+.
T Consensus 241 ~l~~~p~~Rps~~~ll~~--L~~l~ 263 (268)
T 3sxs_A 241 CWHELPEKRPTFQQLLSS--IEPLR 263 (268)
T ss_dssp TTCSSGGGSCCHHHHHHH--HGGGC
T ss_pred HcCCChhhCcCHHHHHHH--HHHhh
Confidence 999999999999999997 66654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=336.17 Aligned_cols=241 Identities=23% Similarity=0.364 Sum_probs=191.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch--HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD--AERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~--~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.++|++.+.||+|+||+||+|.+ +|..||||++....... .....+.+|+.++..+ +||||+++++++.+.+.+|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CE
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceE
Confidence 45789999999999999999997 48999999986542222 2235678899999999 8999999999999999999
Q ss_pred EEEecCCCCch-hhhhcccCCHHHHHHHHHHHHHHHHHHHHcC---cccCCCCCCcEEEe---------CCeEEEEeecC
Q 011331 306 IQMELCDHSLS-DKKASQFFAEGEVLKALHQIAQALQFIHEKG---IAHLDVKPDNIYVK---------NGVYKLGDFGR 372 (488)
Q Consensus 306 IV~E~~~~~l~-~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~g---IiHrDLKp~NILv~---------~g~vkL~DFGl 372 (488)
+||||++++.+ .......+++..++.++.||+.||.|||++| |+|+||||+|||++ ++.++|+|||+
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999987644 4555667999999999999999999999999 99999999999994 57899999999
Q ss_pred ceecCCC-CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---h--hcCCCCCCCCCcH
Q 011331 373 ATLLNKS-LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---L--RDGKLPLLPGHSL 446 (488)
Q Consensus 373 A~~~~~~-~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i--~~~~~~~~~~~s~ 446 (488)
+...... .....||+.|+|||++... .++.++||||||+++|+|++|..||........ + .....+.+..++.
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (271)
T 3dtc_A 163 AREWHRTTKMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE 241 (271)
T ss_dssp -------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred ccccccccccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCH
Confidence 9866433 2345699999999998765 577899999999999999999999976543221 1 2233456677899
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 447 QFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
++.++|.+||+.||.+|||+.|+++|
T Consensus 242 ~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 242 PFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 99999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=346.66 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=187.2
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeee--------cc
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSW--------FE 300 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~--------~~ 300 (488)
.+|++++.||+|+||+||+|.+..+|+.||||++... .......+.+|+.++.++.+||||+++++++ ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 4789999999999999999999999999999988543 3445567889999999996699999999988 34
Q ss_pred cceEEEEEecCCCCchhhh----hcccCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEE-eCCeEEEEeecCc
Q 011331 301 NEQLYIQMELCDHSLSDKK----ASQFFAEGEVLKALHQIAQALQFIHEKG--IAHLDVKPDNIYV-KNGVYKLGDFGRA 373 (488)
Q Consensus 301 ~~~l~IV~E~~~~~l~~~~----~~~~l~~~~~~~i~~qI~~gL~yLH~~g--IiHrDLKp~NILv-~~g~vkL~DFGlA 373 (488)
...++++|||+++++.... ....+++..++.++.||+.||.|||++| |+|+||||+|||| .++.+||+|||++
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 5568999999998766533 2356999999999999999999999999 9999999999999 5689999999999
Q ss_pred eecCCCCC---------------CCCCCCCccChhhhc--ccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhc-
Q 011331 374 TLLNKSLP---------------IEEGDARYMPQEILN--EDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD- 435 (488)
Q Consensus 374 ~~~~~~~~---------------~~~Gt~~Y~APEvl~--~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~- 435 (488)
+....... ...||+.|+|||++. ....++.++|||||||++|+|++|..||........+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 265 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc
Confidence 87643211 335899999999983 233577899999999999999999999976544332222
Q ss_pred CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 436 GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 436 ~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
...+.....+..+.+||.+||+.||.+|||+.|+++| |+.+.
T Consensus 266 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~--l~~~~ 307 (337)
T 3ll6_A 266 YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ--LQEIA 307 (337)
T ss_dssp CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH--HHHHH
T ss_pred ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH--HHHHH
Confidence 2233445667889999999999999999999999997 44443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=352.58 Aligned_cols=248 Identities=20% Similarity=0.322 Sum_probs=206.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcC-------CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRI-------DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
.++|.+++.||+|+||+||+|.+.. .+..||||++... ........+.+|+.++..+.+||||+++++++.+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4589999999999999999999753 3468999998765 3445567889999999999899999999999999
Q ss_pred cceEEEEEecCCCC-chhhhhc-----------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-e
Q 011331 301 NEQLYIQMELCDHS-LSDKKAS-----------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-K 361 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~~~~~-----------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~ 361 (488)
.+.+||||||++++ |...... ..+++..++.++.||+.||.|||++||+||||||+|||| .
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence 99999999999875 4443322 248999999999999999999999999999999999999 5
Q ss_pred CCeEEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hh
Q 011331 362 NGVYKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LN 432 (488)
Q Consensus 362 ~g~vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~ 432 (488)
++.+||+|||+|+..... .....||+.|+|||++.+. .++.++|||||||++|||++ |..||...... ..
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~ 305 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 789999999999876432 2233477889999998765 57889999999999999999 88888764332 22
Q ss_pred hhc-CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 433 LRD-GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 433 i~~-~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+.. .....+..++.++.+||.+||+.||++|||+.|++++ ++.+.
T Consensus 306 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~~ 351 (382)
T 3tt0_A 306 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIV 351 (382)
T ss_dssp HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHH
Confidence 222 2445566789999999999999999999999999996 65553
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=336.51 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=194.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCC---CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRID---GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.++|++++.||+|+||+||+|.+..+ +..||+|++... ........+.+|+.++..+ +||||+++++++. .+..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhC-CCCccceEEEEEc-cCcc
Confidence 45799999999999999999998653 567999998654 3345567788999999999 8999999999874 5678
Q ss_pred EEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 305 YIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
|+||||++++ +..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||+++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999875 433322 2358999999999999999999999999999999999999 68999999999998764322
Q ss_pred ----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHHHH
Q 011331 381 ----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQNL 451 (488)
Q Consensus 381 ----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~~l 451 (488)
....+++.|+|||++... .++.++|||||||++|||++ |.+||..... ...+.. ...+.++.++.++.++
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 249 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 249 (281)
T ss_dssp --------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 223467889999998765 57789999999999999997 8888875433 222333 3456677889999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhhHHh
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKIQKH 481 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i~~~ 481 (488)
|.+||..||++|||+.|++++ |+.+...
T Consensus 250 i~~~l~~~p~~Rps~~~l~~~--l~~~~~~ 277 (281)
T 1mp8_A 250 MTKCWAYDPSRRPRFTELKAQ--LSTILEE 277 (281)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH--HHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH--HHHHHHH
Confidence 999999999999999999986 6666543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=356.64 Aligned_cols=248 Identities=24% Similarity=0.316 Sum_probs=205.7
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|.+++.||+|+||+||+|.+..+|..||||+++.. ........+.+|+.++..+ +||||+++++++...+.+|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEEE
Confidence 45799999999999999999999999999999998754 2334456788999999999 899999999999999999999
Q ss_pred EecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---
Q 011331 308 MELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL--- 380 (488)
Q Consensus 308 ~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~--- 380 (488)
|||++++ +..... ...+++..++.++.||+.||+|||++||+||||||+|||| .++.+||+|||+++......
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999865 444222 2359999999999999999999999999999999999999 57899999999998654321
Q ss_pred --CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhh-cCCCCCCCCCcHHHHHHHH
Q 011331 381 --PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLR-DGKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~-~~~~~~~~~~s~~l~~lI~ 453 (488)
....++..|+|||++... .++.++|||||||++|||++ |..||...... ..+. ....+.+..++.++.++|.
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 349 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLME 349 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 122356779999998765 57789999999999999998 88888764332 1222 3345667778999999999
Q ss_pred HcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 454 VMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+||+.||++|||+.++++. ++.+.+
T Consensus 350 ~cl~~dP~~Rps~~~i~~~--L~~i~~ 374 (377)
T 3cbl_A 350 QCWAYEPGQRPSFSTIYQE--LQSIRK 374 (377)
T ss_dssp HHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HHcCCCchhCcCHHHHHHH--HHHHHh
Confidence 9999999999999999974 666643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=347.44 Aligned_cols=247 Identities=21% Similarity=0.281 Sum_probs=204.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEc-----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|.+. .++..||||++.... .......+.+|+.++..+ +||||+++++++.+.+
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEF-DNPNIVKLLGVCAVGK 123 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSS
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEccCC
Confidence 457899999999999999999987 456999999987543 344556788999999999 8999999999999999
Q ss_pred eEEEEEecCCCC-chhhhhc-------------------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCC
Q 011331 303 QLYIQMELCDHS-LSDKKAS-------------------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPD 356 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~~~-------------------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~ 356 (488)
.+||||||++++ |...... ..+++.+++.++.||+.||.|||++||+|+||||+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 999999999874 4432222 46899999999999999999999999999999999
Q ss_pred cEEE-eCCeEEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh
Q 011331 357 NIYV-KNGVYKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ 429 (488)
Q Consensus 357 NILv-~~g~vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~ 429 (488)
|||| .++.+||+|||+++..... .....||+.|+|||++... .++.++|||||||++|||++ |..||.....
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 9999 6789999999999765322 2234578899999998765 57789999999999999999 8888876543
Q ss_pred h---hhhhcCC-CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 430 F---LNLRDGK-LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 430 ~---~~i~~~~-~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
. ..+..+. ...+..++.++.++|.+||+.||.+|||+.+++++ |+.+.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~--L~~~~ 334 (343)
T 1luf_A 283 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI--LQRMC 334 (343)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHTT
T ss_pred HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH--HHHHH
Confidence 2 2233333 34566789999999999999999999999999985 66654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=338.31 Aligned_cols=242 Identities=20% Similarity=0.276 Sum_probs=199.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchH-HH----HHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDA-ER----RKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~-~~----~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++.+.||+|+||+||+|.+..+++.||||++........ .. +.+.+|+.++..+ +||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNPP 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTTT
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCCC
Confidence 3578999999999999999999999999999999865432221 11 5688899999999 8999999999987765
Q ss_pred eEEEEEecCCCC-chhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEE-eCCe-----EEEEeec
Q 011331 303 QLYIQMELCDHS-LSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKG--IAHLDVKPDNIYV-KNGV-----YKLGDFG 371 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~g--IiHrDLKp~NILv-~~g~-----vkL~DFG 371 (488)
++||||++++ +.... ....+++..++.++.||+.||.|||++| |+|+||||+|||+ .++. +||+|||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 7999999864 44433 3346999999999999999999999999 9999999999999 4454 9999999
Q ss_pred CceecCCCCCCCCCCCCccChhhhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-----hhhh--hcCCCCCCCC
Q 011331 372 RATLLNKSLPIEEGDARYMPQEILNE-DYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-----FLNL--RDGKLPLLPG 443 (488)
Q Consensus 372 lA~~~~~~~~~~~Gt~~Y~APEvl~~-~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-----~~~i--~~~~~~~~~~ 443 (488)
+++..........||+.|+|||++.. ...++.++|||||||++|||++|..||..... ...+ .......+..
T Consensus 175 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 4f0f_A 175 LSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254 (287)
T ss_dssp TCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTT
T ss_pred ccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcc
Confidence 99877665556779999999999842 33467799999999999999999999875422 1111 1233456667
Q ss_pred CcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 444 HSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 444 ~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
++.++.++|.+||+.||.+|||+.|+++.
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 255 CPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 89999999999999999999999999873
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=350.09 Aligned_cols=243 Identities=21% Similarity=0.260 Sum_probs=199.1
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||+||+|.+..+|+.||||++..... ...+..|+.++..+.+||||+++++++...+..||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 579999999999999999999999999999999864322 2346789999999989999999999999999999999
Q ss_pred ecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCe-----EEEEeecCceecCCCC
Q 011331 309 ELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGV-----YKLGDFGRATLLNKSL 380 (488)
Q Consensus 309 E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~-----vkL~DFGlA~~~~~~~ 380 (488)
||++++|..... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++. +||+|||+++......
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 85 ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred EeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 999666665433 4579999999999999999999999999999999999999 4455 9999999998764321
Q ss_pred ----------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh------hhhhhcCCCCC----
Q 011331 381 ----------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ------FLNLRDGKLPL---- 440 (488)
Q Consensus 381 ----------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------~~~i~~~~~~~---- 440 (488)
....||+.|+|||++.+. .++.++|||||||++|||++|..||..... +..+.....+.
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 243 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV 243 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred CCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH
Confidence 345699999999998775 578899999999999999999999976321 11221111111
Q ss_pred -CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 441 -LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 441 -~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
....+ ++.++|..||..||.+||++++|++ .|+.+.
T Consensus 244 ~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~--~l~~~~ 280 (330)
T 2izr_A 244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK--LFTDLF 280 (330)
T ss_dssp HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH--HHHHHH
T ss_pred HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH--HHHHHH
Confidence 12345 9999999999999999999999988 455443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=342.25 Aligned_cols=245 Identities=20% Similarity=0.296 Sum_probs=199.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCC-------eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDG-------CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
.++|++.+.||+|+||+||+|.+..++ ..||+|++.... ......+.+|+.++..+ +||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKL-SHKHLVLNYGVCVC 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTS-CCTTBCCEEEEECC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEe
Confidence 357999999999999999999998777 579999986532 23346688999999999 89999999999999
Q ss_pred cceEEEEEecCCCC-chhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCe--------EEEE
Q 011331 301 NEQLYIQMELCDHS-LSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGV--------YKLG 368 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~--------vkL~ 368 (488)
.+..||||||++++ |...... ..+++..++.++.||+.||.|||++||+||||||+|||+ .++. +||+
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999864 4443222 339999999999999999999999999999999999999 4554 9999
Q ss_pred eecCceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCc-hh--hhhhhcCCCCCCCCCc
Q 011331 369 DFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESG-PQ--FLNLRDGKLPLLPGHS 445 (488)
Q Consensus 369 DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~-~~--~~~i~~~~~~~~~~~s 445 (488)
|||++...... ....||+.|+|||++.....++.++|||||||++|||++|..++... .. ...........+...+
T Consensus 164 Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (289)
T 4fvq_A 164 DPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKA 242 (289)
T ss_dssp CCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCSS
T ss_pred cCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCCCCC
Confidence 99998654322 22347889999999976446788999999999999999966554433 22 2223344555666778
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 446 LQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 446 ~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.++.++|.+||+.||.+|||+.|+++| |+.+
T Consensus 243 ~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l 273 (289)
T 4fvq_A 243 AELANLINNCMDYEPDHRPSFRAIIRD--LNSL 273 (289)
T ss_dssp CTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHH--HHHh
Confidence 899999999999999999999999986 5544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=334.08 Aligned_cols=243 Identities=22% Similarity=0.294 Sum_probs=199.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+. ++..||||++...... ...+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcC-CCCCEeeEEEEEecCCCeEEE
Confidence 468999999999999999999886 7889999999765333 24578899999999 899999999999999999999
Q ss_pred EecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC----C
Q 011331 308 MELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK----S 379 (488)
Q Consensus 308 ~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~----~ 379 (488)
|||++++ +..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.++|+|||+++.... .
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999765 444332 3569999999999999999999999999999999999999 678999999999976532 1
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCCCCCCcHHHHHHHHH
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~~~~~s~~l~~lI~k 454 (488)
.....+|+.|+|||++... .++.++||||||+++|+|++ |..||..... ...+..+ ....+...+..+.++|.+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 256 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 256 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHH
Confidence 2334577889999998765 57789999999999999998 9988876443 2233333 334455678999999999
Q ss_pred cccCCCCCCCCHHHHHhChhhhhh
Q 011331 455 MVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
||+.||.+|||+.|+++| ++.+
T Consensus 257 ~l~~~p~~Rps~~~ll~~--L~~~ 278 (283)
T 3gen_A 257 CWHEKADERPTFKILLSN--ILDV 278 (283)
T ss_dssp TTCSSGGGSCCHHHHHHH--HHHH
T ss_pred HccCChhHCcCHHHHHHH--HHHH
Confidence 999999999999999987 4444
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=339.72 Aligned_cols=248 Identities=23% Similarity=0.307 Sum_probs=204.3
Q ss_pred ccceeEEEEecccCcEEEEEEEE-----cCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLK-----RIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|.+ ..++..||||++.... .......+.+|+.++.++.+||||+++++++.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 45789999999999999999985 4568899999997543 33456778899999999988999999999999999
Q ss_pred eEEEEEecCCCC-chhhhhcc-------------------cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-e
Q 011331 303 QLYIQMELCDHS-LSDKKASQ-------------------FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-K 361 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~~~~-------------------~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~ 361 (488)
..++||||++++ |....... .+++..++.++.||+.||.|||++||+|+||||+|||+ .
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence 999999999874 44422221 38999999999999999999999999999999999999 5
Q ss_pred CCeEEEEeecCceecCCCCC-----CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhh
Q 011331 362 NGVYKLGDFGRATLLNKSLP-----IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLN 432 (488)
Q Consensus 362 ~g~vkL~DFGlA~~~~~~~~-----~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~ 432 (488)
++.+||+|||++........ ...||+.|+|||++... .++.++|||||||++|+|++ |..||..... ...
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 259 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence 78999999999987654322 23467789999998765 57789999999999999999 8888865432 111
Q ss_pred -hhc-CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 433 -LRD-GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 433 -i~~-~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+.. .....+..++.++.++|.+||..||.+|||+.|++++ |+.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~~~ 306 (313)
T 1t46_A 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL--IEKQI 306 (313)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH--HHHHH
Confidence 222 2334456789999999999999999999999999986 65544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=346.17 Aligned_cols=245 Identities=22% Similarity=0.326 Sum_probs=193.2
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEE----EEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFY----AVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~v----AvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
++|++++.||+|+||+||+|.+..+|..+ |+|.+... ........+.+|+.++..+ +||||+++++++.+.. .
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESSS-E
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCC-e
Confidence 47999999999999999999998777654 77766432 2223346788999999999 8999999999998765 7
Q ss_pred EEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 305 YIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
++++||+.++ +..... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+|+......
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 7888888765 444222 3569999999999999999999999999999999999999 67999999999998764322
Q ss_pred -----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh--hh-hhh-cCCCCCCCCCcHHHHH
Q 011331 381 -----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ--FL-NLR-DGKLPLLPGHSLQFQN 450 (488)
Q Consensus 381 -----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~--~~-~i~-~~~~~~~~~~s~~l~~ 450 (488)
....||+.|+|||++.+. .++.++|||||||++|||++ |..||..... .. .+. ....+.++.++.++.+
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250 (327)
T ss_dssp C-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHH
T ss_pred ccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 123467899999998765 67889999999999999999 9988876433 11 222 2345667788999999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+|.+||+.||.+|||+.|++++ |+.+.
T Consensus 251 li~~~l~~~p~~Rps~~ell~~--l~~~~ 277 (327)
T 3poz_A 251 IMVKCWMIDADSRPKFRELIIE--FSKMA 277 (327)
T ss_dssp HHHHHTCSCGGGSCCHHHHHHH--HHHHH
T ss_pred HHHHHcCCChhhCCCHHHHHHH--HHHHH
Confidence 9999999999999999999987 55443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=336.35 Aligned_cols=246 Identities=21% Similarity=0.243 Sum_probs=202.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+|+.++..+.+|+||+++++++......|+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 3579999999999999999999999999999999864321 234677999999998899999999999999999999
Q ss_pred EecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCe-----EEEEeecCceecCCC
Q 011331 308 MELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGV-----YKLGDFGRATLLNKS 379 (488)
Q Consensus 308 ~E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~-----vkL~DFGlA~~~~~~ 379 (488)
|||++++|..... ...+++..++.++.||+.||.|||++||+||||||+|||| .++. +||+|||+++.....
T Consensus 85 ~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 85 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred EEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 9999666666433 3459999999999999999999999999999999999999 4444 999999999876532
Q ss_pred ----------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh------hhhhhcC-----CC
Q 011331 380 ----------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ------FLNLRDG-----KL 438 (488)
Q Consensus 380 ----------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------~~~i~~~-----~~ 438 (488)
.....||+.|+|||++.+. .++.++|||||||++|||++|..||..... ...+... ..
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred cccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 2334699999999998765 578899999999999999999999876321 1111111 11
Q ss_pred CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 439 PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 439 ~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
...+.++.++.++|.+||+.||++|||+++|++. |+.+.+
T Consensus 244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~--l~~~~~ 283 (298)
T 1csn_A 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL--FSKVLE 283 (298)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH--HHHHHH
T ss_pred HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH--HHHHHH
Confidence 1234688999999999999999999999999884 666543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=346.23 Aligned_cols=243 Identities=23% Similarity=0.282 Sum_probs=197.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEc-----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|.+. .++..||||++.... .......+.+|+.++.++.+||||+++++++...+
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 357899999999999999999973 367799999987542 23345678899999999988999999999999999
Q ss_pred eEEEEEecCCCC-chhhhhc------------------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 011331 303 QLYIQMELCDHS-LSDKKAS------------------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDN 357 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~~~------------------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~N 357 (488)
.+||||||++++ |...... ..+++..++.++.||+.||.|||++||+|+||||+|
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 202 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 202 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence 999999999774 4442221 237899999999999999999999999999999999
Q ss_pred EEE-eCCeEEEEeecCceecCCCCC-----CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh-
Q 011331 358 IYV-KNGVYKLGDFGRATLLNKSLP-----IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ- 429 (488)
Q Consensus 358 ILv-~~g~vkL~DFGlA~~~~~~~~-----~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~- 429 (488)
||| .++.+||+|||++........ ...||+.|+|||++... .++.++|||||||++|+|++ |..||.....
T Consensus 203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 999 578999999999986643321 23467889999998765 57789999999999999998 9888876432
Q ss_pred --hhh-hhc-CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 430 --FLN-LRD-GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 430 --~~~-i~~-~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
... +.. ...+.+..++.++.+||.+||..||.+|||+.|+++|
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 282 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 222 222 2344566789999999999999999999999999997
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=334.77 Aligned_cols=242 Identities=35% Similarity=0.549 Sum_probs=201.8
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-----
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE----- 300 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~----- 300 (488)
++..+|++++.||+|+||+||+|.+..+|+.||||++.... ..+.+|+.++..+ +||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKL-DHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC-
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhC-CCCCEEEEeeeEeccccCc
Confidence 45568999999999999999999999999999999986432 2356799999999 89999999998754
Q ss_pred -----------cceEEEEEecCCCC-chhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCe
Q 011331 301 -----------NEQLYIQMELCDHS-LSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGV 364 (488)
Q Consensus 301 -----------~~~l~IV~E~~~~~-l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~ 364 (488)
...+|+||||++++ |.... ....+++..++.++.||+.||.|||++||+|+||||+|||+ .++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence 45689999999874 44432 23469999999999999999999999999999999999999 6889
Q ss_pred EEEEeecCceecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh-hhhhcCCCCCC
Q 011331 365 YKLGDFGRATLLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF-LNLRDGKLPLL 441 (488)
Q Consensus 365 vkL~DFGlA~~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~-~~i~~~~~~~~ 441 (488)
+||+|||++...... .....|++.|+|||++... .++.++|||||||++|+|++|..|+...... ..+.... .+
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~--~~ 237 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI--IS 237 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTC--CC
T ss_pred EEECcchhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhccc--cc
Confidence 999999999877543 2345699999999998765 5778999999999999999999887544332 2233332 34
Q ss_pred CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 442 PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 442 ~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
..++.++.++|.+||..||.+|||+.|+++|.|.-.
T Consensus 238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 567899999999999999999999999999977643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=341.51 Aligned_cols=250 Identities=18% Similarity=0.243 Sum_probs=204.7
Q ss_pred ccccceeEEEEecccCcEEEEEEEEc-----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
...++|++.+.||+|+||+||+|.+. .++..||||++... ........+.+|+.++..+ +||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEcc
Confidence 34567999999999999999999876 36789999998754 3345566788999999999 89999999999999
Q ss_pred cceEEEEEecCCCC-chhhhhc-----------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEE
Q 011331 301 NEQLYIQMELCDHS-LSDKKAS-----------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKL 367 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~~~~~-----------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL 367 (488)
.+..|+||||++++ |...... ..+++..++.++.||+.||.|||++||+||||||+|||| .++.+||
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence 99999999999874 4432221 346899999999999999999999999999999999999 6789999
Q ss_pred EeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CC
Q 011331 368 GDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GK 437 (488)
Q Consensus 368 ~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~ 437 (488)
+|||++....... ....||+.|+|||++... .++.++|||||||++|+|++ |..||...... ..+.. ..
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 258 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence 9999997654321 223468889999998765 57789999999999999999 77887654332 22222 33
Q ss_pred CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC------hhhhhh
Q 011331 438 LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN------PIFDKI 478 (488)
Q Consensus 438 ~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H------P~f~~i 478 (488)
...+..++.++.++|.+||+.||.+|||+.|+++| ++|+.+
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~ 305 (322)
T 1p4o_A 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305 (322)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence 45566789999999999999999999999999987 555554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.41 Aligned_cols=249 Identities=21% Similarity=0.305 Sum_probs=203.0
Q ss_pred ccceeEEEEecccCcEEEEEEEE-----cCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLK-----RIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|.+ ..+++.||||++.... .......+.+|+.++..+.+||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 45799999999999999999985 3567999999997653 34455678999999999988999999999987654
Q ss_pred -eEEEEEecCCCC-chhhhhcc-----------------cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eC
Q 011331 303 -QLYIQMELCDHS-LSDKKASQ-----------------FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KN 362 (488)
Q Consensus 303 -~l~IV~E~~~~~-l~~~~~~~-----------------~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~ 362 (488)
.+|+||||++++ |....... .+++..++.++.||+.||.|||++||+|+||||+|||+ .+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence 599999999875 43322221 27899999999999999999999999999999999999 67
Q ss_pred CeEEEEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh----hhh
Q 011331 363 GVYKLGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ----FLN 432 (488)
Q Consensus 363 g~vkL~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~----~~~ 432 (488)
+.+||+|||+++...... ....||+.|+|||++... .++.++|||||||++|+|++ |..||..... ...
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 263 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence 899999999998664322 123478899999998765 57789999999999999998 8888865332 122
Q ss_pred hhc-CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 433 LRD-GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 433 i~~-~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+.. .....+..++.++.++|.+||+.||.+|||+.|+++| |+.+..
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~~~~ 310 (316)
T 2xir_A 264 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLLQ 310 (316)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred hccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHh
Confidence 222 3345566789999999999999999999999999997 665543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=333.07 Aligned_cols=246 Identities=22% Similarity=0.242 Sum_probs=198.7
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCC-eeEeeeeecccceEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN-IVGYYSSWFENEQLY 305 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hpn-Iv~l~~~~~~~~~l~ 305 (488)
..++|++++.||+|+||+||+|.+..+|+.||||++...... ..+.+|+.++..+ .|++ |..+..++...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMM-QGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHH-TTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHh-hcCCCCCccccccCCCCceE
Confidence 346799999999999999999999999999999998654322 2477899999999 5555 555555556778889
Q ss_pred EEEecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE----eCCeEEEEeecCceecCCC
Q 011331 306 IQMELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 306 IV~E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv----~~g~vkL~DFGlA~~~~~~ 379 (488)
+||||+++++..... ...+++..++.++.||+.||.|||++||+|+||||+|||| .++.+||+|||++......
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 82 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 999999666666433 4569999999999999999999999999999999999999 4689999999999876543
Q ss_pred C----------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh------hhhhhcCCCC----
Q 011331 380 L----------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ------FLNLRDGKLP---- 439 (488)
Q Consensus 380 ~----------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------~~~i~~~~~~---- 439 (488)
. ....||+.|+|||++.+. .++.++|||||||++|||++|..||..... ...+......
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 2 344699999999998775 577899999999999999999999875321 1122221111
Q ss_pred -CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 440 -LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 440 -~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
....++.++.++|.+||+.||.+|||+.++++ .|+.+..
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~l~~~~~ 280 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRNLFH 280 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH--HHHHHHH
Confidence 23568899999999999999999999999998 4766654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.17 Aligned_cols=255 Identities=25% Similarity=0.374 Sum_probs=205.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEE--EEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFY--AVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~v--AvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.++|++.+.||+|+||+||+|.+..+|..+ |||.+... ........+.+|+.++.++.+||||+++++++.+.+.+|
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 357899999999999999999999898866 99988643 233345668889999999988999999999999999999
Q ss_pred EEEecCCCC-chhhhhc-----------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEE
Q 011331 306 IQMELCDHS-LSDKKAS-----------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYK 366 (488)
Q Consensus 306 IV~E~~~~~-l~~~~~~-----------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vk 366 (488)
|||||++++ |...... ..+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+|
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEE
Confidence 999999774 4443222 258999999999999999999999999999999999999 678999
Q ss_pred EEeecCceecCC--CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC-CCC
Q 011331 367 LGDFGRATLLNK--SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG-KLP 439 (488)
Q Consensus 367 L~DFGlA~~~~~--~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~-~~~ 439 (488)
|+|||+++.... ......+++.|+|||++... .++.++|||||||++|||++ |..||...... ..+..+ ...
T Consensus 183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 261 (327)
T 1fvr_A 183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 261 (327)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC
T ss_pred EcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCC
Confidence 999999975432 22334578899999998765 56789999999999999998 99998765432 223333 345
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhhhhcC
Q 011331 440 LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYM 486 (488)
Q Consensus 440 ~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~~~~~ 486 (488)
.+..++.++.+||.+||..||.+|||+.|++++ ++.+...+++++
T Consensus 262 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~~~~~~~~~~ 306 (327)
T 1fvr_A 262 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS--LNRMLEERKTYV 306 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHSSSCSB
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHHhhcCcc
Confidence 566789999999999999999999999999997 776665555443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=329.97 Aligned_cols=244 Identities=15% Similarity=0.203 Sum_probs=202.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc--ceEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN--EQLY 305 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~--~~l~ 305 (488)
.++|++++.||+|+||+||+|.+. |..||||++............+.+|+.++..+ +||||+++++++.+. +.++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeE
Confidence 457899999999999999999984 99999999987655666677899999999998 899999999999877 7889
Q ss_pred EEEecCCC-Cchhhhhcc---cCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 306 IQMELCDH-SLSDKKASQ---FFAEGEVLKALHQIAQALQFIHEKG--IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 306 IV~E~~~~-~l~~~~~~~---~l~~~~~~~i~~qI~~gL~yLH~~g--IiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
+||||+++ +|....... .+++..++.++.||+.||.|||++| |+|+||||+|||+ .++.++|+|||++....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 99999987 454433332 4899999999999999999999999 9999999999999 57799999999876433
Q ss_pred CCCCCCCCCCccChhhhcccC--CCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hh--hcCCCCCCCCCcHHHHHH
Q 011331 379 SLPIEEGDARYMPQEILNEDY--DHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NL--RDGKLPLLPGHSLQFQNL 451 (488)
Q Consensus 379 ~~~~~~Gt~~Y~APEvl~~~~--~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i--~~~~~~~~~~~s~~l~~l 451 (488)
.....||+.|+|||++.+.. .++.++|||||||++|||++|..||....... .+ .......+..++.++.++
T Consensus 165 -~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (271)
T 3kmu_A 165 -SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKL 243 (271)
T ss_dssp -CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHH
T ss_pred -ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 23456899999999987542 22337999999999999999999987654322 11 223445667789999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
|.+||+.||++|||++|+++. ++.+
T Consensus 244 i~~~l~~~p~~Rps~~~il~~--L~~l 268 (271)
T 3kmu_A 244 MKICMNEDPAKRPKFDMIVPI--LEKM 268 (271)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH--HHHh
Confidence 999999999999999999973 5544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.93 Aligned_cols=246 Identities=22% Similarity=0.238 Sum_probs=195.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++.... ....+..|+.++..+.+|++|..+..++...+..+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 457999999999999999999999999999999865432 2234677999999994444455555555778889999
Q ss_pred EecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE----eCCeEEEEeecCceecCCCC-
Q 011331 308 MELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLLNKSL- 380 (488)
Q Consensus 308 ~E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv----~~g~vkL~DFGlA~~~~~~~- 380 (488)
|||+++++..... ...+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+++......
T Consensus 84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 84 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp EECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred EEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 9999766666443 4569999999999999999999999999999999999999 45789999999998765432
Q ss_pred ---------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh------hhhhhcCCCC-----C
Q 011331 381 ---------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ------FLNLRDGKLP-----L 440 (488)
Q Consensus 381 ---------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------~~~i~~~~~~-----~ 440 (488)
....||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ...+...... .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred CccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 234689999999998775 578899999999999999999999875321 1112111111 2
Q ss_pred CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 441 LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 441 ~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
...++.++.++|.+||+.||++|||+.++++ .|+.+..
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~~~~ 280 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRNLFH 280 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHHHHH
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHH--HHHHHHH
Confidence 2567899999999999999999999999998 4766654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=363.33 Aligned_cols=245 Identities=28% Similarity=0.375 Sum_probs=191.1
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
+|.+.+.||+|+||+||. ....+|+.||||++...... .+.+|+.++..+.+|||||++++++.+.+.+|||||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 689999999999999764 34458999999998653222 245789999998789999999999999999999999
Q ss_pred cCCCCchhhhhcc--cCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CC--eEEEEeecCceecCCC--
Q 011331 310 LCDHSLSDKKASQ--FFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NG--VYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 310 ~~~~~l~~~~~~~--~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g--~vkL~DFGlA~~~~~~-- 379 (488)
||++++....... .+.+..++.++.||+.||.|||++||+||||||+||||+ ++ .+||+|||+|+.....
T Consensus 99 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 99 LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp CCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 9998777644433 345556789999999999999999999999999999993 23 5889999999876432
Q ss_pred ----CCCCCCCCCccChhhhcc--cCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh-hhhhcCC--CC---CCCCCcH
Q 011331 380 ----LPIEEGDARYMPQEILNE--DYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF-LNLRDGK--LP---LLPGHSL 446 (488)
Q Consensus 380 ----~~~~~Gt~~Y~APEvl~~--~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~-~~i~~~~--~~---~~~~~s~ 446 (488)
.....||+.|+|||++.. ...++.++|||||||++|||++ |.+||...... ..+.... .. .....+.
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDV 258 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHH
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccH
Confidence 233569999999999874 2356679999999999999999 88887543321 1111111 11 1122356
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 447 QFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
.+.+||.+||+.||.+|||+.|+++||||..+.+
T Consensus 259 ~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~ 292 (432)
T 3p23_A 259 IARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292 (432)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred HHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence 6899999999999999999999999999987654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=330.66 Aligned_cols=251 Identities=22% Similarity=0.253 Sum_probs=201.8
Q ss_pred ccccccceeEEEEecccCcEEEEEEEEcC---CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRI---DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 224 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
+....++|.+.+.||+|+||+||+|.+.. ++..||||++.... .......+.+|+.++..+ +||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC
Confidence 33445689999999999999999998654 34579999987542 344567788999999999 89999999998865
Q ss_pred cceEEEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceec
Q 011331 301 NEQLYIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL 376 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~ 376 (488)
+..|+||||+.++ +..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||++...
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4578999999875 433222 2458999999999999999999999999999999999999 6899999999999866
Q ss_pred CCC----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhh-cCCCCCCCCCcHH
Q 011331 377 NKS----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLR-DGKLPLLPGHSLQ 447 (488)
Q Consensus 377 ~~~----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~-~~~~~~~~~~s~~ 447 (488)
... .....+++.|+|||++... .++.++|||||||++|+|++ |..||..... ...+. ....+.+..++..
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV 242 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHH
T ss_pred ccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHH
Confidence 432 1234578889999998765 57789999999999999998 9998864322 22222 2345566678999
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+.++|.+||..||++|||+.|++++ ++.+..
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~--L~~~~~ 273 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCS--LSDVYQ 273 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHH--HHHHHH
Confidence 9999999999999999999999986 666543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=345.24 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=194.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc----e
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE----Q 303 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~----~ 303 (488)
.++|++++.||+|+||+||+|.+. ++.||||++... .........|+.++.++ +||||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCce
Confidence 457999999999999999999875 899999998643 33444566688888888 8999999999998744 4
Q ss_pred EEEEEecCCC-CchhhhhcccCCHHHHHHHHHHHHHHHHHHHHc----------CcccCCCCCCcEEE-eCCeEEEEeec
Q 011331 304 LYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIHEK----------GIAHLDVKPDNIYV-KNGVYKLGDFG 371 (488)
Q Consensus 304 l~IV~E~~~~-~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~----------gIiHrDLKp~NILv-~~g~vkL~DFG 371 (488)
+|+||||+++ +|........+++..++.++.||+.||.|||+. ||+||||||+|||+ .++.+||+|||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 7999999977 565566667799999999999999999999999 99999999999999 67899999999
Q ss_pred CceecCCCC-----CCCCCCCCccChhhhcccC----CCCchhHHHHHHHHHHHHHcCCCCCCCchh-------------
Q 011331 372 RATLLNKSL-----PIEEGDARYMPQEILNEDY----DHLDKVDIFSLGATMYELIKGSPLSESGPQ------------- 429 (488)
Q Consensus 372 lA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~----~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------------- 429 (488)
+|+...... ....||+.|+|||++.+.. .++.++|||||||++|||++|..||.....
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 998764322 2346899999999987531 334588999999999999999998864311
Q ss_pred -----hhh--hhcCCCCCCCC------CcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 430 -----FLN--LRDGKLPLLPG------HSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 430 -----~~~--i~~~~~~~~~~------~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
... ......+..+. .+.++.+||.+||+.||++|||+.|+++. ++.+.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~--L~~l~~ 318 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER--ITQMQR 318 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHHH
Confidence 000 11111222111 24569999999999999999999999984 666654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.30 Aligned_cols=243 Identities=28% Similarity=0.386 Sum_probs=188.7
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
.|.+.+.||+|+||+||.+. ..+|+.||||++.... ...+.+|+.++..+.+||||+++++++.+.+.+|||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 35667899999999998764 4589999999986431 23467899999987789999999999999999999999
Q ss_pred cCCCCchhhhhcccC--------CHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeC--------------CeEEE
Q 011331 310 LCDHSLSDKKASQFF--------AEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKN--------------GVYKL 367 (488)
Q Consensus 310 ~~~~~l~~~~~~~~l--------~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~--------------g~vkL 367 (488)
||+++|......... ++..++.++.||+.||.|||++||+||||||+||||+. +.+||
T Consensus 90 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp CCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred cCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 998876664433221 22345789999999999999999999999999999942 38999
Q ss_pred EeecCceecCCCC-------CCCCCCCCccChhhhcc------cCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh-hhh
Q 011331 368 GDFGRATLLNKSL-------PIEEGDARYMPQEILNE------DYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ-FLN 432 (488)
Q Consensus 368 ~DFGlA~~~~~~~-------~~~~Gt~~Y~APEvl~~------~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~-~~~ 432 (488)
+|||+++...... ....||+.|+|||++.+ ...++.++|||||||++|||++ |.+||..... ...
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~ 249 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHH
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHH
Confidence 9999998775422 23469999999999865 2357789999999999999999 8888865422 222
Q ss_pred hhcCCCCCC-------CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 433 LRDGKLPLL-------PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 433 i~~~~~~~~-------~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+..+..... ..++.++.+||.+||+.||.+|||+.|+++||||...
T Consensus 250 i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 250 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 322222211 1245789999999999999999999999999999654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=339.50 Aligned_cols=248 Identities=21% Similarity=0.337 Sum_probs=203.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEc-------CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKR-------IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
.++|++++.||+|+||+||+|.+. .++..||||++... ........+.+|+.++..+.+||||+++++++.+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 457999999999999999999986 46789999998754 3445567788999999999889999999999999
Q ss_pred cceEEEEEecCCCC-chhhhhc-----------------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-e
Q 011331 301 NEQLYIQMELCDHS-LSDKKAS-----------------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-K 361 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~~~~~-----------------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~ 361 (488)
.+.+|+||||++++ |...... ..+++..++.++.||+.||.|||++||+|+||||+|||| .
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence 99999999999874 4433221 238899999999999999999999999999999999999 6
Q ss_pred CCeEEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hh
Q 011331 362 NGVYKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LN 432 (488)
Q Consensus 362 ~g~vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~ 432 (488)
++.+||+|||+++..... .....+|+.|+|||++... .++.++|||||||++|||++ |..||...... ..
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 271 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence 789999999999876542 2233577889999998765 57789999999999999999 88888764331 12
Q ss_pred hhc-CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 433 LRD-GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 433 i~~-~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+.. .....+..++.++.++|.+||..||.+|||+.|++++ ++.+.
T Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~l~ 317 (334)
T 2pvf_A 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED--LDRIL 317 (334)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH--HHHHH
Confidence 222 2345566789999999999999999999999999986 65553
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=334.08 Aligned_cols=244 Identities=22% Similarity=0.294 Sum_probs=203.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
..+|++.+.||+|+||+||+|.+..++..||||++... ......+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCEEEE
Confidence 45799999999999999999999999999999998743 23456788999999999 899999999999999999999
Q ss_pred EecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 308 MELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 308 ~E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
|||++++ +..... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++.......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 9999864 444322 3458999999999999999999999999999999999999 67899999999998665332
Q ss_pred --CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhh-cCCCCCCCCCcHHHHHHHH
Q 011331 381 --PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLR-DGKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~-~~~~~~~~~~s~~l~~lI~ 453 (488)
....+|+.|+|||++... .++.++||||||+++|+|++ |.+||...... ..+. ......+..++.++.+||.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246 (288)
T ss_dssp EETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 123367789999998765 57789999999999999999 88888654331 1222 2244566778999999999
Q ss_pred HcccCCCCCCCCHHHHHhChhhhhh
Q 011331 454 VMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+||..||.+|||+.|+++. |+.+
T Consensus 247 ~~l~~dp~~Rps~~~~~~~--l~~~ 269 (288)
T 3kfa_A 247 ACWQWNPSDRPSFAEIHQA--FETM 269 (288)
T ss_dssp HHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred HHhCCChhhCcCHHHHHHH--HHHH
Confidence 9999999999999999873 4443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=335.52 Aligned_cols=240 Identities=23% Similarity=0.291 Sum_probs=195.8
Q ss_pred cceeEEEEecccCcEEEEEEE----EcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc--c
Q 011331 229 TDFHEIEQIGAGNFSHVFKVL----KRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN--E 302 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~--~ 302 (488)
..|++++.||+|+||+||+|. +..+|+.||||++.... .......+.+|+.++..+ +||||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCc
Confidence 358999999999999999998 56789999999987542 222346688899999999 899999999999876 6
Q ss_pred eEEEEEecCCCC-chhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 303 QLYIQMELCDHS-LSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
.+|+||||++++ |.... ....+++..++.++.||+.||.|||++||+|+||||+|||+ .++.++|+|||++.....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 789999999875 44432 23469999999999999999999999999999999999999 789999999999987754
Q ss_pred C------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh--------------h----hhh-
Q 011331 379 S------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ--------------F----LNL- 433 (488)
Q Consensus 379 ~------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~--------------~----~~i- 433 (488)
. .....||..|+|||++... .++.++|||||||++|+|++|..|+..... . ..+
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 3 2234588889999998765 566799999999999999999887543211 1 111
Q ss_pred hcCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 434 RDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 434 ~~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
.....+.++.++.++.+||.+||+.||.+|||+.++++
T Consensus 258 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 12345567788999999999999999999999999997
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=330.77 Aligned_cols=245 Identities=19% Similarity=0.266 Sum_probs=201.3
Q ss_pred cceeEEE-EecccCcEEEEEEEEc--CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 229 TDFHEIE-QIGAGNFSHVFKVLKR--IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 229 ~~y~~~~-~LG~G~fg~Vy~a~~~--~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
++|.+++ .||+|+||+||+|.+. .++..||||++... ........+.+|+.++..+ +||||+++++++ ..+.+|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESSSEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCCCcE
Confidence 4677777 9999999999999864 46889999999764 3445567789999999999 899999999998 556799
Q ss_pred EEEecCCCCchh-hh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--
Q 011331 306 IQMELCDHSLSD-KK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 306 IV~E~~~~~l~~-~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-- 379 (488)
+||||++++.+. .. ....+++..++.++.||+.||.|||++||+|+||||+|||+ .++.++|+|||++......
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 999999885444 22 23459999999999999999999999999999999999999 7899999999999876432
Q ss_pred ----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCCCCCCcHHHHH
Q 011331 380 ----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPLLPGHSLQFQN 450 (488)
Q Consensus 380 ----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~~~~~s~~l~~ 450 (488)
.....||+.|+|||++... .++.++|||||||++|||++ |..||..... ...+..+ ..+.++.++.++.+
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 244 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 244 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHH
Confidence 1233468899999998754 56779999999999999998 9999875433 2223333 34566788999999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+|.+||..||++|||+.++++| ++.+.
T Consensus 245 li~~~l~~~p~~Rps~~~l~~~--l~~~~ 271 (287)
T 1u59_A 245 LMSDCWIYKWEDRPDFLTVEQR--MRACY 271 (287)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH--HHHHH
Confidence 9999999999999999999997 44443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=345.72 Aligned_cols=245 Identities=20% Similarity=0.243 Sum_probs=196.0
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeE----EEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCF----YAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
++|++++.||+|+||+||+|.+..+|.. ||+|++.... .......+.+|+.++..+ +||||+++++++. .+..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-BSSE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-CCcc
Confidence 5799999999999999999999888775 7777764331 112223466788899998 8999999999886 5678
Q ss_pred EEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 305 YIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
++||||+.++ +..... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++......
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999864 444332 3468999999999999999999999999999999999999 67899999999998764322
Q ss_pred -----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHHH
Q 011331 381 -----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQN 450 (488)
Q Consensus 381 -----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~~ 450 (488)
....|+..|+|||++... .++.++|||||||++|+|++ |..||..... ...+.. .....+..++.++.+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYM 248 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTH
T ss_pred ccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHH
Confidence 234578899999999765 57789999999999999999 9999876432 122222 244555667889999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+|.+||..||.+|||+.|+++| |+.+.
T Consensus 249 li~~~l~~dp~~Rps~~el~~~--l~~~~ 275 (325)
T 3kex_A 249 VMVKCWMIDENIRPTFKELANE--FTRMA 275 (325)
T ss_dssp HHHHHTCSCTTTSCCHHHHHHH--HHHHT
T ss_pred HHHHHcCCChhhCcCHHHHHHH--HHHHH
Confidence 9999999999999999999997 55543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=332.49 Aligned_cols=245 Identities=19% Similarity=0.267 Sum_probs=198.2
Q ss_pred cceeEEE-EecccCcEEEEEEEE--cCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 229 TDFHEIE-QIGAGNFSHVFKVLK--RIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 229 ~~y~~~~-~LG~G~fg~Vy~a~~--~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.+|++.+ .||+|+||+||+|.+ ..++..||||++............+.+|+.++..+ +||||+++++++ ..+.+|
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSSEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCCcE
Confidence 4788988 999999999999954 55689999999976544444567788999999999 899999999998 667899
Q ss_pred EEEecCCCCch-hh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 306 IQMELCDHSLS-DK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 306 IV~E~~~~~l~-~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
+||||++++.+ .. .....+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||++.......
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 99999987543 32 233459999999999999999999999999999999999999 78999999999998764332
Q ss_pred ----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC-CCCCCCCCcHHHHHH
Q 011331 381 ----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG-KLPLLPGHSLQFQNL 451 (488)
Q Consensus 381 ----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~-~~~~~~~~s~~l~~l 451 (488)
....+++.|+|||++... .++.++||||||+++|+|++ |..||...... ..+..+ ....+..++.++.++
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 252 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 223467889999998654 46779999999999999999 99998764432 222222 345567789999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
|.+||..||.+|||+.++++ .|+.+
T Consensus 253 i~~~l~~dp~~Rps~~~l~~--~L~~~ 277 (291)
T 1xbb_A 253 MNLCWTYDVENRPGFAAVEL--RLRNY 277 (291)
T ss_dssp HHHHTCSSTTTSCCHHHHHH--HHHHH
T ss_pred HHHHcCCChhhCcCHHHHHH--HHHHH
Confidence 99999999999999999987 35544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=333.30 Aligned_cols=251 Identities=27% Similarity=0.465 Sum_probs=196.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccC-CCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQ-LHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~-~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..+|++++.||+|+||+||+|.+..+|..||||++... .........+.+|+.++..+ +||||+++++++...+.+++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCcEEE
Confidence 45789999999999999999999999999999998753 23345567788999999999 89999999999999999999
Q ss_pred EEecCCCC-chhhh-----hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 307 QMELCDHS-LSDKK-----ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 307 V~E~~~~~-l~~~~-----~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
||||++++ +.... ....+++..++.++.||+.||.|||++||+|+||||+|||+ .++.++|+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 99999875 43322 23458999999999999999999999999999999999999 5789999999999766432
Q ss_pred ---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-----hhhhhcCCCCC--CCCCcHHHH
Q 011331 380 ---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-----FLNLRDGKLPL--LPGHSLQFQ 449 (488)
Q Consensus 380 ---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-----~~~i~~~~~~~--~~~~s~~l~ 449 (488)
.....|++.|+|||++... .++.++|||||||++|+|++|..||..... ...+.....+. ...++.++.
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 268 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 268 (310)
T ss_dssp ---------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHH
T ss_pred CccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHH
Confidence 2234689999999998765 577899999999999999999999865321 12233333322 246799999
Q ss_pred HHHHHcccCCCCCCCCHHHHHhChhhhhhHHhh
Q 011331 450 NLLKVMVDPDPVQRPSAKELVENPIFDKIQKHR 482 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~ 482 (488)
++|.+||..||.+|||+.+++++ ++.+....
T Consensus 269 ~li~~~l~~dp~~Rps~~~il~~--l~~l~~~~ 299 (310)
T 2wqm_A 269 QLVNMCINPDPEKRPDVTYVYDV--AKRMHACT 299 (310)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH--HHHHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHHHH--HHHHHHhh
Confidence 99999999999999999999984 77766443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=341.05 Aligned_cols=247 Identities=21% Similarity=0.265 Sum_probs=199.0
Q ss_pred ccceeEEEEecccCcEEEEEEE-----EcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVL-----KRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|. +..++..||||++... ........+.+|+.++..+ +||||+++++++.+.+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCCC
Confidence 3578999999999999999998 5567889999998643 3445566788999999999 9999999999999999
Q ss_pred eEEEEEecCCCC-chhhhhc--------ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEe
Q 011331 303 QLYIQMELCDHS-LSDKKAS--------QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGD 369 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~~~--------~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~D 369 (488)
..||||||++++ |...... ..+++..++.++.||+.||.|||++||+|+||||+||||+ +..++|+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence 999999999764 4443222 2488999999999999999999999999999999999994 24699999
Q ss_pred ecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCC
Q 011331 370 FGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLP 439 (488)
Q Consensus 370 FGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~ 439 (488)
||++...... .....|++.|+|||++... .++.++|||||||++|+|++ |..||...... ..+.. ....
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 265 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 265 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC
Confidence 9999754322 2234578899999998765 57789999999999999998 88888754332 22222 3445
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 440 LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 440 ~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
.+..++..+.++|.+||..||.+|||+.++++|.|+-.
T Consensus 266 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 56678999999999999999999999999999988753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=354.40 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=199.9
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc-eE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE-QL 304 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~-~l 304 (488)
...++|++++.||+|+||+||+|.+. |..||||+++... ..+.+.+|+.++.++ +||||+++++++...+ .+
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCce
Confidence 34568999999999999999999874 8899999997542 345688999999999 9999999999977655 79
Q ss_pred EEEEecCCCC-chhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 305 YIQMELCDHS-LSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
||||||++++ |...... ..+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+++.....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 9999999875 4443222 237899999999999999999999999999999999999 5789999999999876554
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHHHHHHH
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~~lI~k 454 (488)
.....++..|+|||++... .++.++|||||||+||||++ |..||..... ...+.. ...+.+..++.++.++|.+
T Consensus 343 ~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 421 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKN 421 (450)
T ss_dssp ----CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 4455688999999999765 57889999999999999998 9888875432 223333 3456677889999999999
Q ss_pred cccCCCCCCCCHHHHHhChhhhhhH
Q 011331 455 MVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
||..||++|||+.++++. ++.+.
T Consensus 422 cl~~dp~~Rpt~~~l~~~--L~~i~ 444 (450)
T 1k9a_A 422 CWHLDAATRPTFLQLREQ--LEHIR 444 (450)
T ss_dssp HTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HcCCChhHCcCHHHHHHH--HHHHH
Confidence 999999999999999873 55544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=325.10 Aligned_cols=245 Identities=21% Similarity=0.318 Sum_probs=203.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+. ++..||+|++...... ...+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEE
Confidence 357899999999999999999986 7889999999765333 24678899999999 899999999999999999999
Q ss_pred EecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC----C
Q 011331 308 MELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK----S 379 (488)
Q Consensus 308 ~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~----~ 379 (488)
|||++++ +..... ...+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++..... .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999875 444332 2458999999999999999999999999999999999999 678999999999976532 1
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC-CCCCCCCCcHHHHHHHHH
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG-KLPLLPGHSLQFQNLLKV 454 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~-~~~~~~~~s~~l~~lI~k 454 (488)
.....++..|+|||++... .++.++||||||+++|+|++ |.+||...... ..+..+ ....+...+.++.++|.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 240 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 240 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred cccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHH
Confidence 2334578889999998765 57789999999999999999 88888764332 223333 334455679999999999
Q ss_pred cccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 455 MVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 455 ~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
||..||++|||+.+++++ ++.+..
T Consensus 241 ~l~~~p~~Rps~~~ll~~--L~~l~~ 264 (267)
T 3t9t_A 241 CWRERPEDRPAFSRLLRQ--LAEIAE 264 (267)
T ss_dssp HTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred HccCChhhCcCHHHHHHH--HHHHHh
Confidence 999999999999999986 665543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=339.35 Aligned_cols=248 Identities=21% Similarity=0.287 Sum_probs=203.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCe-----EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGC-----FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~-----~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++.+.||+|+||+||+|.+..++. .||+|++.... .......+.+|+.++..+.+||||+++++++.+.+
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 4579999999999999999999976654 89999987543 34456778899999999988999999999999999
Q ss_pred eEEEEEecCCCC-chhhhh---------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeE
Q 011331 303 QLYIQMELCDHS-LSDKKA---------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVY 365 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~~---------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~v 365 (488)
.+|+||||++++ |..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEE
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeE
Confidence 999999999874 433221 2357999999999999999999999999999999999999 57899
Q ss_pred EEEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhh-h-
Q 011331 366 KLGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNL-R- 434 (488)
Q Consensus 366 kL~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i-~- 434 (488)
||+|||++....... ....||+.|+|||++... .++.++|||||||++|||++ |..||..... ...+ .
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 282 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence 999999998664322 223467889999998765 57789999999999999998 8888865422 1122 2
Q ss_pred cCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 435 DGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 435 ~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
......+...+.++.++|.+||+.||.+|||+.|+++ +++.+.
T Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~L~~~~ 325 (333)
T 2i1m_A 283 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS--FLQEQA 325 (333)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH--HHHHHH
Confidence 2234455667999999999999999999999999998 476654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=343.62 Aligned_cols=249 Identities=20% Similarity=0.267 Sum_probs=198.9
Q ss_pred cccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 225 SRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 225 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
....++|++.+.||+|+||+||+|.+. +|..||||++..... .....+.+|+.++..+ +||||+++++++.+.+.+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS--QGIEEFETEIETLSFC-RHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS--SHHHHHHHHHHGGGSC-CCTTBCCEEEECCCTTCC
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh--HHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCeE
Confidence 344567899999999999999999864 799999998865432 3356688999999998 899999999999999999
Q ss_pred EEEEecCCCC-chhhhhc-----ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC
Q 011331 305 YIQMELCDHS-LSDKKAS-----QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN 377 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~~-----~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~ 377 (488)
|+||||++++ |...... ..+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||+++...
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999999875 4433222 248999999999999999999999999999999999999 67899999999998654
Q ss_pred CCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh----------hhhcCC-----
Q 011331 378 KSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL----------NLRDGK----- 437 (488)
Q Consensus 378 ~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~----------~i~~~~----- 437 (488)
... ....||+.|+|||++... .++.++|||||||++|||++|..||....... ....+.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred cccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence 321 223489999999998765 57789999999999999999999886532210 000111
Q ss_pred -----CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 438 -----LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 438 -----~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
....+..+.++.++|.+||+.||++|||+.|+++| ++.+.+
T Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~l~ 315 (321)
T 2qkw_B 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK--LEYALR 315 (321)
T ss_dssp SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH--HHHHhh
Confidence 11223346789999999999999999999999987 444433
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=337.55 Aligned_cols=245 Identities=26% Similarity=0.341 Sum_probs=202.2
Q ss_pred cceeEEEEecccCcEEEEEEE----EcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec--ccc
Q 011331 229 TDFHEIEQIGAGNFSHVFKVL----KRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF--ENE 302 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~--~~~ 302 (488)
.+|++++.||+|+||+||+|. +..++..||||++... .......+.+|+.++..+ +||||+++++++. +..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCc
Confidence 479999999999999999998 4678999999998753 344556788999999999 9999999999876 556
Q ss_pred eEEEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 303 QLYIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 303 ~l~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
.+||||||++++ |..... ...+++..++.++.||+.||.|||++||+|+||||+|||| .++.+||+|||++.....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 799999999765 443222 3459999999999999999999999999999999999999 789999999999987643
Q ss_pred CC------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh------------------hhh-
Q 011331 379 SL------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF------------------LNL- 433 (488)
Q Consensus 379 ~~------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~------------------~~i- 433 (488)
.. ....||..|+|||++.+. .++.++|||||||++|+|++|..||...... ..+
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 22 234578889999998765 5677999999999999999999887654321 011
Q ss_pred hcCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 434 RDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 434 ~~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.....+.++.++.++.+||.+||+.||.+|||+.|++++ ++.+.
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~~ 302 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ--LDMLW 302 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHC-
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHH
Confidence 123445667889999999999999999999999999876 66554
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=340.80 Aligned_cols=246 Identities=22% Similarity=0.328 Sum_probs=194.4
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEE----EEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFY----AVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~v----AvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
++|++++.||+|+||+||+|.+..++..| |+|.+.... .......+.+|+.++..+ +||||+++++++.... .
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS-E
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC-c
Confidence 57999999999999999999998887755 666664332 223356688899999999 8999999999998765 7
Q ss_pred EEEEecCCCC-chhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 305 YIQMELCDHS-LSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
++++|++.++ +.... ....+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+++......
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 7888888765 44432 23569999999999999999999999999999999999999 67999999999998764321
Q ss_pred -----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhh-cCCCCCCCCCcHHHHH
Q 011331 381 -----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLR-DGKLPLLPGHSLQFQN 450 (488)
Q Consensus 381 -----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~-~~~~~~~~~~s~~l~~ 450 (488)
....||+.|+|||++.+. .++.++|||||||++|||++ |..||...... ..+. ....+.++.++.++.+
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 250 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250 (327)
T ss_dssp --------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHH
T ss_pred ccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 223467889999998765 57889999999999999999 99998764331 1222 3345667778999999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+|.+||..||.+|||+.|+++. |+.+..
T Consensus 251 li~~~l~~dp~~Rps~~ell~~--L~~~~~ 278 (327)
T 3lzb_A 251 IMRKCWMIDADSRPKFRELIIE--FSKMAR 278 (327)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH--HHHHHT
T ss_pred HHHHHcCCChhHCcCHHHHHHH--HHHHHh
Confidence 9999999999999999999984 666543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=332.13 Aligned_cols=238 Identities=26% Similarity=0.379 Sum_probs=188.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHh-CCCCCeeEeeeeecc----cc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAAL-GSHENIVGYYSSWFE----NE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l-~~HpnIv~l~~~~~~----~~ 302 (488)
.++|++++.||+|+||+||+|.+ +|+.||||++... ....+..|.+++... .+||||+++++++.. ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 45799999999999999999987 6999999998642 233455677777663 389999999988653 45
Q ss_pred eEEEEEecCCC-CchhhhhcccCCHHHHHHHHHHHHHHHHHHH--------HcCcccCCCCCCcEEE-eCCeEEEEeecC
Q 011331 303 QLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIH--------EKGIAHLDVKPDNIYV-KNGVYKLGDFGR 372 (488)
Q Consensus 303 ~l~IV~E~~~~-~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH--------~~gIiHrDLKp~NILv-~~g~vkL~DFGl 372 (488)
.+|+||||+++ +|........+++..++.++.||+.||.||| ++||+||||||+|||+ .++.+||+|||+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred eeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 68999999987 4555666677999999999999999999999 9999999999999999 678999999999
Q ss_pred ceecCCCC-------CCCCCCCCccChhhhcccCC-----CCchhHHHHHHHHHHHHHcC----------CCCCCCchh-
Q 011331 373 ATLLNKSL-------PIEEGDARYMPQEILNEDYD-----HLDKVDIFSLGATMYELIKG----------SPLSESGPQ- 429 (488)
Q Consensus 373 A~~~~~~~-------~~~~Gt~~Y~APEvl~~~~~-----~~~ksDIwSlGvlL~eLltG----------~~p~~~~~~- 429 (488)
|+...... ....||+.|+|||++..... ++.++|||||||++|||++| ..||.....
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 97664332 23479999999999876532 33589999999999999999 777754211
Q ss_pred ------hhhh--hcCCCCCCC------CCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 430 ------FLNL--RDGKLPLLP------GHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 430 ------~~~i--~~~~~~~~~------~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
.... .....+..+ ..+.++.+||.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 1111 112222222 245789999999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=335.08 Aligned_cols=248 Identities=17% Similarity=0.213 Sum_probs=194.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcC---CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc--
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRI---DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE-- 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~-- 302 (488)
.++|.+.+.||+|+||+||+|.+.. ++..||||++............+.+|+.++..+ +||||+++++++.+.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeecccc
Confidence 3578999999999999999998765 566899999876655666677889999999999 8999999999988755
Q ss_pred ---eEEEEEecCCCCchh-hh-------hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEee
Q 011331 303 ---QLYIQMELCDHSLSD-KK-------ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDF 370 (488)
Q Consensus 303 ---~l~IV~E~~~~~l~~-~~-------~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DF 370 (488)
..|+||||+.++.+. .. ....+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 359999999875433 22 23459999999999999999999999999999999999999 5789999999
Q ss_pred cCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCCC
Q 011331 371 GRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLPL 440 (488)
Q Consensus 371 GlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~~ 440 (488)
|++...... .....+++.|+|||++... .++.++|||||||++|+|++ |.+||...... ..+.. .....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 270 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ 270 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC
T ss_pred CcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCC
Confidence 999866432 1233478899999998765 57789999999999999999 77787654332 22222 34456
Q ss_pred CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 441 LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 441 ~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+..++.++.++|.+||..||.+|||+.+++++ |+.+.
T Consensus 271 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~--L~~l~ 307 (313)
T 3brb_A 271 PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ--LEKLL 307 (313)
T ss_dssp BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred CccccHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHH
Confidence 67789999999999999999999999999986 55543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=337.55 Aligned_cols=246 Identities=25% Similarity=0.384 Sum_probs=197.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec----ccce
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF----ENEQ 303 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~----~~~~ 303 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++... .......+.+|+.++..+ +||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCce
Confidence 35799999999999999999999999999999988643 345566788999999998 9999999999987 3557
Q ss_pred EEEEEecCCCC-chhhhh-----cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceec
Q 011331 304 LYIQMELCDHS-LSDKKA-----SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL 376 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~ 376 (488)
.|+||||+.++ |..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.++|+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 89999999885 433222 3569999999999999999999999999999999999999 6789999999998765
Q ss_pred CCCC------------CCCCCCCCccChhhhcccC--CCCchhHHHHHHHHHHHHHcCCCCCCCch----hhh-hh-hcC
Q 011331 377 NKSL------------PIEEGDARYMPQEILNEDY--DHLDKVDIFSLGATMYELIKGSPLSESGP----QFL-NL-RDG 436 (488)
Q Consensus 377 ~~~~------------~~~~Gt~~Y~APEvl~~~~--~~~~ksDIwSlGvlL~eLltG~~p~~~~~----~~~-~i-~~~ 436 (488)
.... ....||+.|+|||++.... .++.++|||||||++|+|++|..||.... ... .+ ...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 3211 1124799999999986431 25679999999999999999999985321 111 11 123
Q ss_pred CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 437 KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 437 ~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
..+..+.++.++.++|.+||+.||.+|||+.+++++ |+.+
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~ 304 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ--LEAL 304 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHT
T ss_pred CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH--hhhc
Confidence 345556789999999999999999999999999996 5544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=332.26 Aligned_cols=228 Identities=27% Similarity=0.364 Sum_probs=186.1
Q ss_pred ccccceeEE-EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc----
Q 011331 226 RYYTDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE---- 300 (488)
Q Consensus 226 ~~~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~---- 300 (488)
.+.++|.++ +.||+|+||+||+|.+..+|+.||||++... ....+|+.++.++.+||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 445678888 7899999999999999999999999998632 2456788888777799999999999876
Q ss_pred cceEEEEEecCCC-Cchhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecC
Q 011331 301 NEQLYIQMELCDH-SLSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGR 372 (488)
Q Consensus 301 ~~~l~IV~E~~~~-~l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGl 372 (488)
...+||||||+++ +|...... ..+++..++.++.||+.||.|||++||+|+||||+|||++ ++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 7789999999987 45443322 2599999999999999999999999999999999999994 68899999999
Q ss_pred ceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh-------hhhcCCCCCC----
Q 011331 373 ATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL-------NLRDGKLPLL---- 441 (488)
Q Consensus 373 A~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~-------~i~~~~~~~~---- 441 (488)
+..... ..++.++|||||||++|||++|..||....... .+.......+
T Consensus 167 a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (299)
T 3m2w_A 167 AKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226 (299)
T ss_dssp CEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHH
T ss_pred cccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhc
Confidence 976432 134569999999999999999999987654321 1112222223
Q ss_pred CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 442 PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 442 ~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
..++.++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 227 ~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred ccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 467999999999999999999999999999999987643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=337.16 Aligned_cols=247 Identities=22% Similarity=0.300 Sum_probs=197.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCC----eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDG----CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
..+|.+.+.||+|+||+||+|.+..++ ..||||++.... .......+.+|+.++..+ +||||+++++++.+.+.
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKP 120 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCC
Confidence 347899999999999999999887553 469999987543 445566788999999999 89999999999999999
Q ss_pred EEEEEecCCCCchh-hhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 304 LYIQMELCDHSLSD-KKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 304 l~IV~E~~~~~l~~-~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
+||||||++++.+. ... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||+++.....
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999885443 322 2469999999999999999999999999999999999999 6789999999999876432
Q ss_pred C------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCCCCCCcHHH
Q 011331 380 L------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPLLPGHSLQF 448 (488)
Q Consensus 380 ~------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~~~~~s~~l 448 (488)
. ....+|+.|+|||++... .++.++|||||||++|||++ |..||..... ...+..+ ..+.+..++.++
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l 279 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 279 (333)
T ss_dssp ----------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred cccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHH
Confidence 1 122357789999998765 57789999999999999999 9988865433 2223333 455667789999
Q ss_pred HHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 449 QNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 449 ~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.++|.+||+.||.+||++.+++++ ++.+.
T Consensus 280 ~~li~~~l~~~p~~Rps~~~l~~~--L~~~~ 308 (333)
T 1mqb_A 280 YQLMMQCWQQERARRPKFADIVSI--LDKLI 308 (333)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHH--HHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH--HHHHH
Confidence 999999999999999999999985 55544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.48 Aligned_cols=239 Identities=24% Similarity=0.436 Sum_probs=188.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++.+.||+|+||+||+|.+ .++.||||++... .....+.+|+.++.++ +||||+++++++.+ ..|+|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE----SERKAFIVELRQLSRV-NHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST----THHHHHHHHHHHHHHC-CCTTBCCEEEBCTT--TTEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh----hHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC--CcEEE
Confidence 35789999999999999999987 4899999998532 3456788999999999 89999999998874 48999
Q ss_pred EecCCCC-chhhhhc----ccCCHHHHHHHHHHHHHHHHHHHH---cCcccCCCCCCcEEEe-CCe-EEEEeecCceecC
Q 011331 308 MELCDHS-LSDKKAS----QFFAEGEVLKALHQIAQALQFIHE---KGIAHLDVKPDNIYVK-NGV-YKLGDFGRATLLN 377 (488)
Q Consensus 308 ~E~~~~~-l~~~~~~----~~l~~~~~~~i~~qI~~gL~yLH~---~gIiHrDLKp~NILv~-~g~-vkL~DFGlA~~~~ 377 (488)
|||++++ |...... ..+++..++.++.||+.||.|||+ +||+||||||+|||++ ++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 9999875 4433222 237889999999999999999999 8999999999999994 454 8999999998776
Q ss_pred CCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-----hhhh-hcCCCCCCCCCcHHHHHH
Q 011331 378 KSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-----FLNL-RDGKLPLLPGHSLQFQNL 451 (488)
Q Consensus 378 ~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-----~~~i-~~~~~~~~~~~s~~l~~l 451 (488)
.......||+.|+|||++.+. .++.++|||||||++|||++|..||..... ...+ .....+.+..++..+.++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (307)
T 2eva_A 158 THMTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 236 (307)
T ss_dssp -------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHH
T ss_pred cccccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHH
Confidence 555556799999999998765 577899999999999999999999874321 1112 223445566789999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
|.+||..||.+|||++|++++ ++.+
T Consensus 237 i~~~l~~dp~~Rps~~ell~~--L~~~ 261 (307)
T 2eva_A 237 MTRCWSKDPSQRPSMEEIVKI--MTHL 261 (307)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred HHHHhcCChhhCcCHHHHHHH--HHHH
Confidence 999999999999999999984 4444
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=328.41 Aligned_cols=248 Identities=19% Similarity=0.216 Sum_probs=199.1
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCe---EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGC---FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
....|++.+.||+|+||+||+|.+..++. .||+|++... ........+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEG 96 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSS
T ss_pred cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCC
Confidence 33467889999999999999998765544 8999998753 3445567788999999999 89999999999987666
Q ss_pred E-EEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 304 L-YIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 304 l-~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
. +++|||+.++ +..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||+++....
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 5 9999999765 444333 3568999999999999999999999999999999999999 567999999999975532
Q ss_pred -------CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCC-Cchhh---hhhh-cCCCCCCCCCcH
Q 011331 379 -------SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSE-SGPQF---LNLR-DGKLPLLPGHSL 446 (488)
Q Consensus 379 -------~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~-~~~~~---~~i~-~~~~~~~~~~s~ 446 (488)
......+++.|+|||++... .++.++|||||||++|+|++|..|+. ..... ..+. ....+.+..++.
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPD 255 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred CcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchH
Confidence 12334578899999998765 67789999999999999999665543 32221 1222 233455667899
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 447 QFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
++.++|.+||+.||.+|||+.++++. ++.+.
T Consensus 256 ~l~~li~~~l~~~p~~Rps~~~ll~~--l~~~~ 286 (298)
T 3pls_A 256 SLYQVMQQCWEADPAVRPTFRVLVGE--VEQIV 286 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH--HHHHH
Confidence 99999999999999999999999984 66554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=348.92 Aligned_cols=246 Identities=22% Similarity=0.300 Sum_probs=192.4
Q ss_pred cceeEEEEecccCcEEEEEEEEc---CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKR---IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.+|.+.+.||+|+||+||+|.+. .++..||||+++... .....+.+.+|+.++.++ +||||+++++++.+.+.+|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCceE
Confidence 47899999999999999999886 467889999987542 445567799999999999 8999999999999999999
Q ss_pred EEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC
Q 011331 306 IQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP 381 (488)
Q Consensus 306 IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~ 381 (488)
|||||++++ |..... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.......
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 999999765 444332 2359999999999999999999999999999999999999 678999999999987643211
Q ss_pred ------CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC-CCCCCCCCcHHHHH
Q 011331 382 ------IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG-KLPLLPGHSLQFQN 450 (488)
Q Consensus 382 ------~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~-~~~~~~~~s~~l~~ 450 (488)
...+++.|+|||++... .++.++|||||||++|||++ |..||...... ..+..+ ..+.+..++.++.+
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 281 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 281 (373)
T ss_dssp -----------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHH
T ss_pred cceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHH
Confidence 12356789999998765 57789999999999999998 99888654332 122222 34556678999999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+|.+||+.||.+|||+.++++ .++.+.
T Consensus 282 li~~cl~~dp~~RPs~~~i~~--~L~~~~ 308 (373)
T 2qol_A 282 LMLDCWQKDRNNRPKFEQIVS--ILDKLI 308 (373)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred HHHHHhCcChhhCcCHHHHHH--HHHHHH
Confidence 999999999999999999987 355554
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=330.55 Aligned_cols=240 Identities=22% Similarity=0.301 Sum_probs=187.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++.+.||+|+||+||+|.+. ..||||+++...........+.+|+.++..+ +||||+++++++ ..+.+++|
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSSSCEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-cCCccEEE
Confidence 457899999999999999999764 3599999987666667777899999999998 899999999854 56678999
Q ss_pred EecCCCCchh-hh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC-----
Q 011331 308 MELCDHSLSD-KK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK----- 378 (488)
Q Consensus 308 ~E~~~~~l~~-~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~----- 378 (488)
|||++++.+. .. ....+++..++.++.||+.||.|||++||+|+||||+|||+ .++.++|+|||++.....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 9999876443 22 23468999999999999999999999999999999999999 678999999999976532
Q ss_pred CCCCCCCCCCccChhhhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh----hhhcCCC-----CCCCCCcHH
Q 011331 379 SLPIEEGDARYMPQEILNE--DYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL----NLRDGKL-----PLLPGHSLQ 447 (488)
Q Consensus 379 ~~~~~~Gt~~Y~APEvl~~--~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~----~i~~~~~-----~~~~~~s~~ 447 (488)
......||+.|+|||++.. ...++.++|||||||++|+|++|..||....... .+..+.. .....++.+
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHH
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHH
Confidence 1223468999999999862 3356779999999999999999999987643221 1122221 233467899
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
+.+||.+||..||.+|||+.|+++.
T Consensus 258 l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 258 MKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHH
Confidence 9999999999999999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=355.55 Aligned_cols=251 Identities=13% Similarity=0.105 Sum_probs=193.5
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCC-CCeeE-------------
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSH-ENIVG------------- 293 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~H-pnIv~------------- 293 (488)
..|...+.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.++..+ .| .|+..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchhh
Confidence 357899999999999999999999999999999873322 222245677888888877 44 32211
Q ss_pred --------eeeeecc-----cceEEEEEecCCCCchhhhh--------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCC
Q 011331 294 --------YYSSWFE-----NEQLYIQMELCDHSLSDKKA--------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLD 352 (488)
Q Consensus 294 --------l~~~~~~-----~~~l~IV~E~~~~~l~~~~~--------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrD 352 (488)
+..++.. ...++++|+++.+++..... ...+++..++.++.||+.||.|||++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 1111111 22468889988877665332 34577888999999999999999999999999
Q ss_pred CCCCcEEE-eCCeEEEEeecCceecCCCCCCCCCCCCccChhhhc---------ccCCCCchhHHHHHHHHHHHHHcCCC
Q 011331 353 VKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILN---------EDYDHLDKVDIFSLGATMYELIKGSP 422 (488)
Q Consensus 353 LKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~---------~~~~~~~ksDIwSlGvlL~eLltG~~ 422 (488)
|||+|||| .++.+||+|||+++..+.......| +.|+|||++. ....++.++|||||||++|||++|..
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~ 315 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSC
T ss_pred cccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999 6789999999999887766566678 9999999983 22246679999999999999999999
Q ss_pred CCCCchhhhhhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhh
Q 011331 423 LSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHR 482 (488)
Q Consensus 423 p~~~~~~~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~ 482 (488)
||........ ..........++.++.+||.+||+.||++|||+.++++||||+.+....
T Consensus 316 Pf~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~ 374 (413)
T 3dzo_A 316 PNTDDAALGG-SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 374 (413)
T ss_dssp CCCTTGGGSC-SGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHHH
T ss_pred CCCCcchhhh-HHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHHH
Confidence 9976543221 1112223346789999999999999999999999999999999886543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=334.93 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=193.4
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
..++|++++.||+|+||+||+|.+..+++.||||++...... ......+.+|+.++..+ +||||+++++++...+.+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEE
Confidence 356899999999999999999999999999999998755333 33346788899999998 8999999999999999999
Q ss_pred EEEecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---
Q 011331 306 IQMELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 306 IV~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--- 379 (488)
+||||++++ |... .....+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 999999875 4443 233569999999999999999999999999999999999999 6789999999999766432
Q ss_pred -CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh--hhhcCCC----CCCCCCcHHHHHHH
Q 011331 380 -LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL--NLRDGKL----PLLPGHSLQFQNLL 452 (488)
Q Consensus 380 -~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~--~i~~~~~----~~~~~~s~~l~~lI 452 (488)
.....|++.|+|||++... .++.++||||||+++|+|++|..||....... ....... ..++.++.++.++|
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 269 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVI 269 (309)
T ss_dssp ------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHH
T ss_pred cccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHH
Confidence 2234689999999998765 56779999999999999999999997654321 1111211 24567899999999
Q ss_pred HHcccCCCCCCC-CHHHHHh
Q 011331 453 KVMVDPDPVQRP-SAKELVE 471 (488)
Q Consensus 453 ~k~L~~dP~~Rp-Ta~elL~ 471 (488)
.+||..||++|| |++++++
T Consensus 270 ~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 270 ARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHTCSSGGGSCSSHHHHHH
T ss_pred HHhccCCHHHHHHhHHHHHH
Confidence 999999999999 8888875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.31 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=202.6
Q ss_pred eeEEEEecccCcEEEEEEEE----cCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc--cceE
Q 011331 231 FHEIEQIGAGNFSHVFKVLK----RIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE--NEQL 304 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~----~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~--~~~l 304 (488)
|++++.||+|+||+||+|.. ..+|+.||||++... ........+.+|+.++..+ +||||+++++++.+ ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCceE
Confidence 49999999999999988754 447899999999765 3345567789999999999 89999999999987 4678
Q ss_pred EEEEecCCC-CchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 305 YIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 305 ~IV~E~~~~-~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
|+||||+++ +|........+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||++.......
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 190 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190 (318)
T ss_dssp EEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSE
T ss_pred EEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccc
Confidence 999999987 45555556679999999999999999999999999999999999999 67899999999998775432
Q ss_pred ----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh-----------------hh-h-hcCC
Q 011331 381 ----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF-----------------LN-L-RDGK 437 (488)
Q Consensus 381 ----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~-----------------~~-i-~~~~ 437 (488)
....||..|+|||++... .++.++|||||||++|+|++|..||...... .. + ....
T Consensus 191 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (318)
T 3lxp_A 191 YRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269 (318)
T ss_dssp EEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC
T ss_pred cccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC
Confidence 234578889999998764 5667999999999999999999888654221 01 1 1234
Q ss_pred CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHh
Q 011331 438 LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481 (488)
Q Consensus 438 ~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~ 481 (488)
.+.+..++.++.+||.+||+.||.+|||+.|+++ +|+.+...
T Consensus 270 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l~~~ 311 (318)
T 3lxp_A 270 LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTVHEK 311 (318)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHHHHh
Confidence 5566778999999999999999999999999996 67777543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=326.75 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=191.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-cceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE-NEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-~~~l~I 306 (488)
.++|++++.||+|+||+||+|.+ +|..||||++.... ..+.+.+|+.++..+ +||||+++++++.+ .+.+|+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceEE
Confidence 46899999999999999999987 48999999986432 345688899999999 89999999998655 457999
Q ss_pred EEecCCCC-chhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC
Q 011331 307 QMELCDHS-LSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP 381 (488)
Q Consensus 307 V~E~~~~~-l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~ 381 (488)
||||++++ |...... ..+++..++.++.||+.||.|||++||+|+||||+||++ .++.++|+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 172 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccccc
Confidence 99999874 4443222 238999999999999999999999999999999999999 578999999999987765555
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCCCCCCcHHHHHHHHHcc
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~~~~~s~~l~~lI~k~L 456 (488)
...+++.|+|||++... .++.++||||||+++|+|++ |..||..... ...+..+ ....+..++.++.++|.+||
T Consensus 173 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 251 (278)
T 1byg_A 173 TGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 251 (278)
T ss_dssp ---CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHh
Confidence 56788999999998765 57789999999999999998 8888875432 2222222 34556678999999999999
Q ss_pred cCCCCCCCCHHHHHhChhhhhhHH
Q 011331 457 DPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 457 ~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
..||.+|||+.|+++ .|+.+..
T Consensus 252 ~~~p~~Rps~~~l~~--~L~~i~~ 273 (278)
T 1byg_A 252 HLDAAMRPSFLQLRE--QLEHIKT 273 (278)
T ss_dssp CSSGGGSCCHHHHHH--HHHHHHH
T ss_pred cCChhhCCCHHHHHH--HHHHHHh
Confidence 999999999999998 3665543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=342.87 Aligned_cols=243 Identities=16% Similarity=0.170 Sum_probs=187.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcC---CCeEEEEEEeccCCCchHH---------HHHHHHHHHHHHHhCCCCCeeEee
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRI---DGCFYAVKHSKRQLHHDAE---------RRKALLEVQALAALGSHENIVGYY 295 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAvK~l~~~~~~~~~---------~~~~~~Ei~iL~~l~~HpnIv~l~ 295 (488)
.++|++++.||+|+||+||+|.+.. ++..||||++......... ...+.+|+..+..+ +||||++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~ 114 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFY 114 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceee
Confidence 3579999999999999999999987 7899999998654221111 12355677778887 999999999
Q ss_pred eeecc----cceEEEEEecCCCCchhhhh-cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC--eEEE
Q 011331 296 SSWFE----NEQLYIQMELCDHSLSDKKA-SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG--VYKL 367 (488)
Q Consensus 296 ~~~~~----~~~l~IV~E~~~~~l~~~~~-~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g--~vkL 367 (488)
+++.. ...+||||||++++|..... ...+++.+++.++.||+.||.|||++||+||||||+||||+ ++ .+||
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred cccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 99887 78899999999555555332 33799999999999999999999999999999999999994 45 9999
Q ss_pred EeecCceecCCCC----------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhh
Q 011331 368 GDFGRATLLNKSL----------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNL 433 (488)
Q Consensus 368 ~DFGlA~~~~~~~----------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i 433 (488)
+|||+|+.+.... ....||+.|+|||++.+. .++.++|||||||++|||++|..||..... ....
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 9999998763211 234699999999998765 578899999999999999999999954211 1111
Q ss_pred h---cCCCC-------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 434 R---DGKLP-------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 434 ~---~~~~~-------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
. ....+ ....++.++.++|.+||..||++|||+++|++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1 01111 112678999999999999999999999999873
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=335.67 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=190.6
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHh-CCCCCeeEeeeeeccc----
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAAL-GSHENIVGYYSSWFEN---- 301 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l-~~HpnIv~l~~~~~~~---- 301 (488)
..++|++++.||+|+||+||+|.+. |..||||++... .......|.+++..+ .+||||+++++++...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3457899999999999999999874 999999998532 122344455555443 3899999999998876
Q ss_pred ceEEEEEecCCC-CchhhhhcccCCHHHHHHHHHHHHHHHHHHHHc--------CcccCCCCCCcEEE-eCCeEEEEeec
Q 011331 302 EQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIHEK--------GIAHLDVKPDNIYV-KNGVYKLGDFG 371 (488)
Q Consensus 302 ~~l~IV~E~~~~-~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~--------gIiHrDLKp~NILv-~~g~vkL~DFG 371 (488)
..+|+||||+++ +|........+++..++.++.||+.||.|||++ ||+||||||+|||+ .++.+||+|||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 789999999987 565566666799999999999999999999998 99999999999999 67899999999
Q ss_pred CceecCCCC-------CCCCCCCCccChhhhcccCCCCc-----hhHHHHHHHHHHHHHcC----------CCCCCCchh
Q 011331 372 RATLLNKSL-------PIEEGDARYMPQEILNEDYDHLD-----KVDIFSLGATMYELIKG----------SPLSESGPQ 429 (488)
Q Consensus 372 lA~~~~~~~-------~~~~Gt~~Y~APEvl~~~~~~~~-----ksDIwSlGvlL~eLltG----------~~p~~~~~~ 429 (488)
+|+...... ....||+.|+|||++........ ++|||||||++|||++| ..||.....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 997664321 23469999999999876532221 49999999999999999 555543211
Q ss_pred -------hhhh---hcCCCCCCC-----CCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhh
Q 011331 430 -------FLNL---RDGKLPLLP-----GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHR 482 (488)
Q Consensus 430 -------~~~i---~~~~~~~~~-----~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~ 482 (488)
.... .......+. .++.++.+||.+||+.||.+|||+.|+++| |+.+....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~l~~~~ 333 (337)
T 3mdy_A 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT--LAKMSESQ 333 (337)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHHHHTT
T ss_pred CCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH--HHHHHhhc
Confidence 1111 111112221 346779999999999999999999999997 77766543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.73 Aligned_cols=240 Identities=21% Similarity=0.266 Sum_probs=201.8
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
-..+|++.+.||+|+||+||+|.+..++..||||++..... ....+.+|+.++.++ +||||+++++++.+.+.+||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcEEE
Confidence 35689999999999999999999998899999999875432 245688999999999 89999999999999999999
Q ss_pred EEecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--
Q 011331 307 QMELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 307 V~E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-- 379 (488)
||||+.++ |..... ...+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+++.....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999865 444332 2458999999999999999999999999999999999999 6789999999999876432
Q ss_pred --CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCCCCCCCcHHHHHHH
Q 011331 380 --LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLPLLPGHSLQFQNLL 452 (488)
Q Consensus 380 --~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~~~~~~s~~l~~lI 452 (488)
.....++..|+|||++... .++.++|||||||+||||++ |..||...... ..+.. ...+.+..++.++.+||
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 452 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 452 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 1223467789999998765 57789999999999999999 88888654321 12222 24456677899999999
Q ss_pred HHcccCCCCCCCCHHHHHh
Q 011331 453 KVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~ 471 (488)
.+||+.||++|||+.+|++
T Consensus 453 ~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 453 RACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCcChhHCcCHHHHHH
Confidence 9999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=349.65 Aligned_cols=245 Identities=21% Similarity=0.262 Sum_probs=201.5
Q ss_pred cccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 225 SRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 225 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
....++|++.+.||+|+||+||+|.+. .+..||||+++.... ..+.+.+|+.++..+ +||||+++++++. .+.+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTL-QHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSC
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCcc
Confidence 334568999999999999999999886 578899999975432 245688999999999 8999999999886 6679
Q ss_pred EEEEecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 305 YIQMELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
||||||+.++ |..... ...+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+++.....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999875 444322 2368899999999999999999999999999999999999 5789999999999866431
Q ss_pred ----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhh-cCCCCCCCCCcHHHHH
Q 011331 380 ----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLR-DGKLPLLPGHSLQFQN 450 (488)
Q Consensus 380 ----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~-~~~~~~~~~~s~~l~~ 450 (488)
.....++..|+|||++... .++.++|||||||+||||++ |..||...... ..+. ....+.+..++.++.+
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 416 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred ceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 2234467889999999765 57889999999999999999 99888764332 2222 3345667788999999
Q ss_pred HHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 451 LLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
||.+||..||++|||+++|++. |+.+
T Consensus 417 li~~cl~~dp~~RPt~~~i~~~--L~~~ 442 (454)
T 1qcf_A 417 IMMRCWKNRPEERPTFEYIQSV--LDDF 442 (454)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH--HHTS
T ss_pred HHHHHccCChhHCcCHHHHHHH--HHHH
Confidence 9999999999999999999862 5444
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=321.96 Aligned_cols=239 Identities=23% Similarity=0.316 Sum_probs=196.1
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
...++|++++.||+|+||+||+|.+. ++..||||++...... ...+.+|+.++..+ +||||+++++++. .+..|
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQL-QHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhC-CCcCcceEEEEEc-CCCcE
Confidence 34568999999999999999999975 6789999998754322 35678899999999 8999999999876 45689
Q ss_pred EEEecCCCC-chhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 306 IQMELCDHS-LSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 306 IV~E~~~~~-l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
+||||+.++ |...... ..+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||++.......
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 999999764 4443322 269999999999999999999999999999999999999 57899999999998765322
Q ss_pred ----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCCCCCCcHHHHHH
Q 011331 381 ----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPLLPGHSLQFQNL 451 (488)
Q Consensus 381 ----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~~~~~s~~l~~l 451 (488)
....++..|+|||++... .++.++|||||||++|||++ |..||..... ...+..+ ....+..++.++.++
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 242 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHH
Confidence 233467889999998754 56779999999999999999 8888865433 2222222 344556789999999
Q ss_pred HHHcccCCCCCCCCHHHHHh
Q 011331 452 LKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~ 471 (488)
|.+||..||++|||+.++++
T Consensus 243 i~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 243 MRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccChhhCCCHHHHHH
Confidence 99999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=343.55 Aligned_cols=247 Identities=17% Similarity=0.168 Sum_probs=189.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCC-----CeEEEEEEeccCCCchHHH---------HHHHHHHHHHHHhCCCCCeeE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRID-----GCFYAVKHSKRQLHHDAER---------RKALLEVQALAALGSHENIVG 293 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAvK~l~~~~~~~~~~---------~~~~~Ei~iL~~l~~HpnIv~ 293 (488)
.++|++++.||+|+||+||+|.+..+ ++.||||++.......... .....|+..+..+ +||||++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~ 112 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGVPK 112 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCSCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCCCe
Confidence 45799999999999999999998764 5889999986542111100 1122333344444 7999999
Q ss_pred eeeeeccc----ceEEEEEecCCCCchhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe---CCe
Q 011331 294 YYSSWFEN----EQLYIQMELCDHSLSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK---NGV 364 (488)
Q Consensus 294 l~~~~~~~----~~l~IV~E~~~~~l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~---~g~ 364 (488)
+++++... ..+||||||++++|...... ..+++..++.++.||+.||.|||++||+||||||+||||+ ++.
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 99998764 55899999995555553332 5699999999999999999999999999999999999994 589
Q ss_pred EEEEeecCceecCCC----------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---h
Q 011331 365 YKLGDFGRATLLNKS----------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---L 431 (488)
Q Consensus 365 vkL~DFGlA~~~~~~----------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~ 431 (488)
+||+|||+|+.+... .....||+.|+|||++.+. .++.++|||||||+||||++|..||...... .
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 999999999876421 1223499999999998765 5788999999999999999999999753211 0
Q ss_pred ------------hhhcCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 432 ------------NLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 432 ------------~i~~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.+....+ ....++.++.++|..||..||.+||++.+|++ .|+.+-
T Consensus 272 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~--~l~~~~ 328 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCF-PAANAPGEIAKYMETVKLLDYTEKPLYENLRD--ILLQGL 328 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHS-CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhc-ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH--HHHHHH
Confidence 0000011 12567899999999999999999999999987 455543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=326.88 Aligned_cols=247 Identities=21% Similarity=0.227 Sum_probs=195.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCC---CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeee-cccce
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRID---GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSW-FENEQ 303 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~-~~~~~ 303 (488)
..+|++.+.||+|+||+||+|.+..+ +..||+|.+... ........+.+|+.+++++ +||||+++++++ ..++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCCc
Confidence 34689999999999999999987543 346899998753 3445567788999999999 899999999985 45668
Q ss_pred EEEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 304 LYIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
.|+||||++++ |..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||+++.....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 89999999885 444332 3458999999999999999999999999999999999999 6789999999999865321
Q ss_pred -------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCC-CCCCCchh---hhhhhcC-CCCCCCCCcHH
Q 011331 380 -------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDG-KLPLLPGHSLQ 447 (488)
Q Consensus 380 -------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~-~p~~~~~~---~~~i~~~-~~~~~~~~s~~ 447 (488)
.....||+.|+|||++... .++.++|||||||++|+|++|. +|+..... ...+..+ ....+..++.+
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 260 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred chhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence 2233477889999998765 5778999999999999999954 55544322 1222233 33445667999
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+.++|.+||+.||.+|||+.|+++. ++.+.
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~~--L~~~~ 290 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVSR--ISAIF 290 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH--HHHHH
Confidence 9999999999999999999999984 55543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.35 Aligned_cols=240 Identities=17% Similarity=0.234 Sum_probs=188.6
Q ss_pred ccceeEEEEecccCcEEEEEE-----EEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC--CCCCeeEeeeeecc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKV-----LKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG--SHENIVGYYSSWFE 300 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a-----~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~--~HpnIv~l~~~~~~ 300 (488)
.++|++.+.||+|+||+||+| .+..+++.||||++.... ...+..|+.++..+. .|+||+.+++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 457999999999999999999 467789999999987532 234666777777772 28999999999999
Q ss_pred cceEEEEEecCCCC-chhhh------hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-e-----------
Q 011331 301 NEQLYIQMELCDHS-LSDKK------ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-K----------- 361 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~~~------~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~----------- 361 (488)
.+..|||||||+++ |.... ....+++..++.++.||+.||+|||++|||||||||+|||| .
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence 99999999999865 44332 23569999999999999999999999999999999999999 4
Q ss_pred CCeEEEEeecCceecCC-----CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcC
Q 011331 362 NGVYKLGDFGRATLLNK-----SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDG 436 (488)
Q Consensus 362 ~g~vkL~DFGlA~~~~~-----~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~ 436 (488)
++.+||+|||+|+.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||............
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 297 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEECS
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCCCceeech
Confidence 58999999999976531 22345699999999999776 5788999999999999999999998654332211111
Q ss_pred CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChh
Q 011331 437 KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPI 474 (488)
Q Consensus 437 ~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~ 474 (488)
..... ..++.+.+++..||..+|.+|++..+.+.+.+
T Consensus 298 ~~~~~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 298 LFRRL-PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp CCTTC-SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred hcccc-CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 12211 35788999999999999999965444444433
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=348.27 Aligned_cols=238 Identities=22% Similarity=0.271 Sum_probs=194.0
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..++|++.+.||+|+||+||+|.+. .+..||||+++..... ...+.+|+.+++++ +||||+++++++.+ +.+||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSC---HHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCCC---HHHHHHHHHHHHhC-CCCCEeeEEEEEcC-CceEE
Confidence 3567999999999999999999987 4577999998754322 34688999999999 89999999999876 77999
Q ss_pred EEecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-
Q 011331 307 QMELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL- 380 (488)
Q Consensus 307 V~E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~- 380 (488)
||||+.++ |..... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++......
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999875 444322 2458999999999999999999999999999999999999 67899999999998764321
Q ss_pred ---CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCCCCCCCcHHHHHHH
Q 011331 381 ---PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLPLLPGHSLQFQNLL 452 (488)
Q Consensus 381 ---~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~~~~~~s~~l~~lI 452 (488)
....++..|+|||++... .++.++|||||||+||||++ |..||...... ..+.. ...+.++.++..+.++|
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 414 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 414 (452)
T ss_dssp -------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred ecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 223467889999998765 57889999999999999999 88888764332 22222 34566778899999999
Q ss_pred HHcccCCCCCCCCHHHHHh
Q 011331 453 KVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~ 471 (488)
.+||+.||++|||+++|++
T Consensus 415 ~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 415 CQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHccCChhhCcCHHHHHH
Confidence 9999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=343.15 Aligned_cols=245 Identities=21% Similarity=0.269 Sum_probs=193.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++.+.||+|+||+||+|.+. +|..||||++..... ......+.+|+.++..+ +||||+++++++...+..++|
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 105 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERT-QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 105 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTC-CCTTBCCCCEEECCSSCCEEE
T ss_pred hhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccC-chHHHHHHHHHHHHHhc-cCCCccceEEEEecCCceEEE
Confidence 457889999999999999999754 799999999865421 11223578899999998 899999999999999999999
Q ss_pred EecCCCCch-hhhh-----cccCCHHHHHHHHHHHHHHHHHHHHc---CcccCCCCCCcEEE-eCCeEEEEeecCceecC
Q 011331 308 MELCDHSLS-DKKA-----SQFFAEGEVLKALHQIAQALQFIHEK---GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN 377 (488)
Q Consensus 308 ~E~~~~~l~-~~~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~---gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~ 377 (488)
|||++++.+ .... ...+++..++.++.||+.||.|||++ ||+|+||||+|||+ .++.+||+|||++....
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 185 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccC
Confidence 999987543 3222 22389999999999999999999999 99999999999999 56799999999998764
Q ss_pred CCC----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-------hhhhh-----cCC----
Q 011331 378 KSL----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-------FLNLR-----DGK---- 437 (488)
Q Consensus 378 ~~~----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-------~~~i~-----~~~---- 437 (488)
... ....||+.|+|||++... .++.++|||||||++|+|++|..||..... ..... ...
T Consensus 186 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (326)
T 3uim_A 186 YKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL 264 (326)
T ss_dssp SSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTS
T ss_pred cccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhh
Confidence 322 234589999999998665 477899999999999999999999862211 00000 000
Q ss_pred ------CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhh
Q 011331 438 ------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFD 476 (488)
Q Consensus 438 ------~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~ 476 (488)
....+..+.++.++|.+||+.||.+|||+.||++|-+-.
T Consensus 265 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 265 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred cChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 111223357899999999999999999999999985433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=347.17 Aligned_cols=243 Identities=23% Similarity=0.325 Sum_probs=192.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc--eEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE--QLY 305 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~--~l~ 305 (488)
..+|++.+.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.++..+ +||||+++++++...+ .+|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeE
Confidence 3578999999999999999999999999999999875321 22245577899999999 8999999999988655 789
Q ss_pred EEEecCCCCch-hhhhc----ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE----e-CCeEEEEeecCcee
Q 011331 306 IQMELCDHSLS-DKKAS----QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV----K-NGVYKLGDFGRATL 375 (488)
Q Consensus 306 IV~E~~~~~l~-~~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv----~-~g~vkL~DFGlA~~ 375 (488)
||||||+++.+ ..... ..+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||+++.
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999987533 32221 229999999999999999999999999999999999998 2 24699999999987
Q ss_pred cCCC--CCCCCCCCCccChhhhccc-------CCCCchhHHHHHHHHHHHHHcCCCCCCCch-------hhhhhhcCCC-
Q 011331 376 LNKS--LPIEEGDARYMPQEILNED-------YDHLDKVDIFSLGATMYELIKGSPLSESGP-------QFLNLRDGKL- 438 (488)
Q Consensus 376 ~~~~--~~~~~Gt~~Y~APEvl~~~-------~~~~~ksDIwSlGvlL~eLltG~~p~~~~~-------~~~~i~~~~~- 438 (488)
.... .....||+.|+|||++... ..++.++|||||||++|||++|..||.... .+..+..+..
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (396)
T ss_dssp CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred ccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence 6432 2345699999999998641 235569999999999999999999985321 1122222211
Q ss_pred --------------------CCC----CCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 439 --------------------PLL----PGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 439 --------------------~~~----~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
+.. ..++..+.++|.+||++||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 111 2245678999999999999999999998765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=347.73 Aligned_cols=237 Identities=18% Similarity=0.201 Sum_probs=186.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC------chHHHHHHHHHHHHHHHhC--------CCCCeeEe
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH------HDAERRKALLEVQALAALG--------SHENIVGY 294 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~------~~~~~~~~~~Ei~iL~~l~--------~HpnIv~l 294 (488)
++|++++.||+|+||+||+|.+ +|+.||||++..... .......+.+|+.+++.+. .||||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 4689999999999999999998 789999999875422 1222356788999988884 35555555
Q ss_pred e-----------------eeecc-------------cceEEEEEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHH
Q 011331 295 Y-----------------SSWFE-------------NEQLYIQMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFI 343 (488)
Q Consensus 295 ~-----------------~~~~~-------------~~~l~IV~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yL 343 (488)
+ ++|.+ .+.+|||||||.++ ++.......+++..++.++.||+.||.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 4 44443 78899999999775 66655557799999999999999999999
Q ss_pred H-HcCcccCCCCCCcEEE-eCC--------------------eEEEEeecCceecCCCCCCCCCCCCccChhhhcccCCC
Q 011331 344 H-EKGIAHLDVKPDNIYV-KNG--------------------VYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDH 401 (488)
Q Consensus 344 H-~~gIiHrDLKp~NILv-~~g--------------------~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~~~~ 401 (488)
| ++|||||||||+|||| .++ .+||+|||+|+..... ...||+.|+|||++.+..
T Consensus 178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~~g~~-- 253 (336)
T 2vuw_A 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLFTGDG-- 253 (336)
T ss_dssp HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGGCCCS--
T ss_pred HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccChhhhcCCC--
Confidence 9 9999999999999999 455 8999999999877643 457999999999998764
Q ss_pred CchhHHHHHHHH-HHHHHcCCCCCCCch----hhhhhh-cCCCC------CCCCCcHHHHHHHHHcccCCCCCCCCHHHH
Q 011331 402 LDKVDIFSLGAT-MYELIKGSPLSESGP----QFLNLR-DGKLP------LLPGHSLQFQNLLKVMVDPDPVQRPSAKEL 469 (488)
Q Consensus 402 ~~ksDIwSlGvl-L~eLltG~~p~~~~~----~~~~i~-~~~~~------~~~~~s~~l~~lI~k~L~~dP~~RpTa~el 469 (488)
+.++||||||++ .++++.|..||.... ....+. ..... .++.++.++.+||.+||++| |++|+
T Consensus 254 ~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~ 328 (336)
T 2vuw_A 254 DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDL 328 (336)
T ss_dssp SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHH
T ss_pred ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHH
Confidence 679999998777 778888988885421 111111 11111 12246789999999999987 99999
Q ss_pred H-hChhhh
Q 011331 470 V-ENPIFD 476 (488)
Q Consensus 470 L-~HP~f~ 476 (488)
| +||||+
T Consensus 329 l~~Hp~f~ 336 (336)
T 2vuw_A 329 LCQHSLFK 336 (336)
T ss_dssp HHHCGGGC
T ss_pred HhcCCCcC
Confidence 9 999995
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=330.30 Aligned_cols=247 Identities=26% Similarity=0.371 Sum_probs=201.1
Q ss_pred ccceeEEEEecccCcEEEEEEE----EcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc-
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVL----KRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE- 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~- 302 (488)
..+|++++.||+|+||+||+|. +..+|+.||||++... .......+.+|+.++..+ +||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCC
Confidence 3468999999999999999998 4568999999998753 344566788999999999 8999999999887654
Q ss_pred -eEEEEEecCCCC-chhhhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC
Q 011331 303 -QLYIQMELCDHS-LSDKKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN 377 (488)
Q Consensus 303 -~l~IV~E~~~~~-l~~~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~ 377 (488)
.+++||||++++ |...... ..+++..++.++.||+.||.|||++||+|+||||+|||| .++.+||+|||++....
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 789999999874 4443322 358999999999999999999999999999999999999 68999999999998775
Q ss_pred CCC------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh-h------------------hh
Q 011331 378 KSL------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ-F------------------LN 432 (488)
Q Consensus 378 ~~~------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~-~------------------~~ 432 (488)
... ....++..|+|||++... .++.++|||||||++|||++|..|+..... + ..
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 432 233477789999998765 467799999999999999999988764311 0 01
Q ss_pred hh-cCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 433 LR-DGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 433 i~-~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+. ....+.+..++.++.++|.+||..||++|||+.|+++. |+.+..
T Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~--L~~l~~ 322 (326)
T 2w1i_A 276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR--VDQIRD 322 (326)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH--HHHHHH
T ss_pred hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHHH
Confidence 11 23455677889999999999999999999999999973 665543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.41 Aligned_cols=241 Identities=17% Similarity=0.213 Sum_probs=192.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCC--------CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeE------
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRID--------GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG------ 293 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~--------g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~------ 293 (488)
.++|++++.||+|+||+||+|.+..+ ++.||||++... ..+.+|+.++..+ +||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRA-AKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHH-CCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHh-cccchhhhhhhhc
Confidence 35799999999999999999999874 889999998643 3467899999999 8999887
Q ss_pred ---------eeeeecc-cceEEEEEecCCCCchhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE
Q 011331 294 ---------YYSSWFE-NEQLYIQMELCDHSLSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV 360 (488)
Q Consensus 294 ---------l~~~~~~-~~~l~IV~E~~~~~l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv 360 (488)
+++++.. ++.+||||||++++|...... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 4555554 678999999995556553332 569999999999999999999999999999999999999
Q ss_pred e-CC--eEEEEeecCceecCCC----------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCc
Q 011331 361 K-NG--VYKLGDFGRATLLNKS----------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESG 427 (488)
Q Consensus 361 ~-~g--~vkL~DFGlA~~~~~~----------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~ 427 (488)
+ ++ .+||+|||+++..... .....||+.|+|||++.+. .++.++|||||||+||||++|..||...
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 5 44 8999999999765421 1234699999999998765 5788999999999999999999998764
Q ss_pred hh----hhh----hhcCCCCCC------CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 428 PQ----FLN----LRDGKLPLL------PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 428 ~~----~~~----i~~~~~~~~------~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.. ... +........ ..++.++.+||.+||..||.+|||++++++. |+.+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~--L~~~~ 335 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN--LEALL 335 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH--HHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH--HHHHH
Confidence 31 111 112222221 2468999999999999999999999999984 66654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=323.89 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=191.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcC-CC--eEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRI-DG--CFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~-~g--~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
.++|++++.||+|+||+||+|.+.. ++ ..||||++..... .......+.+|+.++..+ +||||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccCC-
Confidence 3579999999999999999998643 33 3699998865432 234556788999999999 8999999999988765
Q ss_pred EEEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 304 LYIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
.++||||+.++ +..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||++......
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 89999999864 444222 3569999999999999999999999999999999999999 7899999999999876433
Q ss_pred C------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhhh---hhh--cCCCCCCCCCcHH
Q 011331 380 L------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQFL---NLR--DGKLPLLPGHSLQ 447 (488)
Q Consensus 380 ~------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~~---~i~--~~~~~~~~~~s~~ 447 (488)
. ....+|..|+|||++... .++.++||||||+++|+|++ |..||....... .+. ....+.+..++.+
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred ccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHH
Confidence 2 233578889999998765 46779999999999999999 999987654322 222 2234556678999
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+.++|.+||..||.+|||+.++++ +|+.+.
T Consensus 254 l~~li~~~l~~~p~~Rps~~~l~~--~l~~~~ 283 (291)
T 1u46_A 254 IYNVMVQCWAHKPEDRPTFVALRD--FLLEAQ 283 (291)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH--HHHHHC
T ss_pred HHHHHHHHccCCcccCcCHHHHHH--HHHHhC
Confidence 999999999999999999999998 466553
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=333.52 Aligned_cols=236 Identities=22% Similarity=0.304 Sum_probs=179.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHH--HHHhCCCCCeeEeeeee-----cc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQA--LAALGSHENIVGYYSSW-----FE 300 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~i--L~~l~~HpnIv~l~~~~-----~~ 300 (488)
.++|++++.||+|+||+||+|.+ +++.||||++.... ...+..|..+ +..+ +||||+++++.+ ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADG 83 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTS
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhc-cCcchhhheecccccccCC
Confidence 46799999999999999999976 79999999986431 2223334333 3335 899999998743 23
Q ss_pred cceEEEEEecCCC-CchhhhhcccCCHHHHHHHHHHHHHHHHHHHHc---------CcccCCCCCCcEEE-eCCeEEEEe
Q 011331 301 NEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIHEK---------GIAHLDVKPDNIYV-KNGVYKLGD 369 (488)
Q Consensus 301 ~~~l~IV~E~~~~-~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~---------gIiHrDLKp~NILv-~~g~vkL~D 369 (488)
...+||||||+++ +|.........++..++.++.||+.||.|||+. ||+||||||+|||| .++.+||+|
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred CceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 4468999999976 555555566779999999999999999999999 99999999999999 568999999
Q ss_pred ecCceecCCC-----------CCCCCCCCCccChhhhccc------CCCCchhHHHHHHHHHHHHHcCCCCCCCchhh--
Q 011331 370 FGRATLLNKS-----------LPIEEGDARYMPQEILNED------YDHLDKVDIFSLGATMYELIKGSPLSESGPQF-- 430 (488)
Q Consensus 370 FGlA~~~~~~-----------~~~~~Gt~~Y~APEvl~~~------~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~-- 430 (488)
||+++..... .....||+.|+|||++.+. ..++.++|||||||++|||++|..|+......
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 9999876432 1234699999999998752 13446899999999999999997665432110
Q ss_pred ------------------hhh--hcC-CCCCCCC------CcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 431 ------------------LNL--RDG-KLPLLPG------HSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 431 ------------------~~i--~~~-~~~~~~~------~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
..+ ... ....+.. .+.++.+||.+||..||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 000 011 1112221 3457999999999999999999999976
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=340.22 Aligned_cols=246 Identities=22% Similarity=0.252 Sum_probs=189.6
Q ss_pred cceeEEEEecccCcEEEEEEEEcCC---CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeec-ccceE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRID---GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWF-ENEQL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~-~~~~l 304 (488)
..|++.+.||+|+||+||+|.+..+ +..||||.+... ........+.+|+.++..+ +||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCCe
Confidence 3588999999999999999987643 346899988653 3345567789999999999 8999999999865 45678
Q ss_pred EEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 305 YIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
|+||||++++ |..... ...+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+++.....
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999875 444332 2458889999999999999999999999999999999999 5789999999999865322
Q ss_pred ------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCCCCCCcHHH
Q 011331 380 ------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPLLPGHSLQF 448 (488)
Q Consensus 380 ------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~~~~~s~~l 448 (488)
.....+|+.|+|||++... .++.++|||||||++|||++ |.+||..... ...+..+ ....+..++..+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l 325 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 325 (373)
T ss_dssp -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 1223477889999998765 57789999999999999999 5666654322 2223333 344556789999
Q ss_pred HHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 449 QNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 449 ~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.++|.+||..||++|||+.|++++ ++.+.
T Consensus 326 ~~li~~cl~~dp~~RPs~~ell~~--L~~i~ 354 (373)
T 3c1x_A 326 YEVMLKCWHPKAEMRPSFSELVSR--ISAIF 354 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH--HHHHH
Confidence 999999999999999999999985 55543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=359.40 Aligned_cols=239 Identities=19% Similarity=0.258 Sum_probs=194.2
Q ss_pred eeE-EEEecccCcEEEEEEEE--cCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 231 FHE-IEQIGAGNFSHVFKVLK--RIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 231 y~~-~~~LG~G~fg~Vy~a~~--~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
+.+ .+.||+|+||+||+|.+ ..++..||||+++...........+.+|+.++..+ +|||||++++++. .+.++||
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-~~~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICE-AESWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEE-SSSEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCCEEEE
Confidence 444 34899999999999955 45678999999976544444567789999999999 8999999999886 4568999
Q ss_pred EecCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC----
Q 011331 308 MELCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---- 380 (488)
Q Consensus 308 ~E~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---- 380 (488)
|||+.++.+. . .....+++..++.++.||+.||.|||++|||||||||+|||| .++.+||+|||+|+.+....
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999876443 2 334569999999999999999999999999999999999999 78899999999998664321
Q ss_pred --CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCCCCCCCcHHHHHHHH
Q 011331 381 --PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~~~~~~s~~l~~lI~ 453 (488)
....||+.|+|||++... .++.++|||||||+||||++ |..||...... ..+.. ...+.+..++.++.+||.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp -------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 223467889999999765 67889999999999999998 99998765432 22333 345566788999999999
Q ss_pred HcccCCCCCCCCHHHHHhC
Q 011331 454 VMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~H 472 (488)
+||+.||++|||+.+|++.
T Consensus 607 ~cl~~dP~~RPs~~~l~~~ 625 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVELR 625 (635)
T ss_dssp HHTCSSTTTSCCHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.47 Aligned_cols=246 Identities=23% Similarity=0.331 Sum_probs=196.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHh-CCCCCeeEeeeeecccc----
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAAL-GSHENIVGYYSSWFENE---- 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l-~~HpnIv~l~~~~~~~~---- 302 (488)
.++|++++.||+|+||+||+|.+ +|+.||||++... ....+..|++++..+ .+||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 45789999999999999999988 5999999998632 234567788888873 38999999999998776
Q ss_pred eEEEEEecCCC-CchhhhhcccCCHHHHHHHHHHHHHHHHHHH--------HcCcccCCCCCCcEEE-eCCeEEEEeecC
Q 011331 303 QLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIH--------EKGIAHLDVKPDNIYV-KNGVYKLGDFGR 372 (488)
Q Consensus 303 ~l~IV~E~~~~-~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH--------~~gIiHrDLKp~NILv-~~g~vkL~DFGl 372 (488)
.+|+||||+++ +|........+++..++.++.||+.||.||| +.||+|+||||+|||| .++.+||+|||+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 79999999987 5555555667999999999999999999999 8999999999999999 678999999999
Q ss_pred ceecCCCC-------CCCCCCCCccChhhhcccCCC-----CchhHHHHHHHHHHHHHcC----------CCCCCCch--
Q 011331 373 ATLLNKSL-------PIEEGDARYMPQEILNEDYDH-----LDKVDIFSLGATMYELIKG----------SPLSESGP-- 428 (488)
Q Consensus 373 A~~~~~~~-------~~~~Gt~~Y~APEvl~~~~~~-----~~ksDIwSlGvlL~eLltG----------~~p~~~~~-- 428 (488)
+....... ....||+.|+|||++...... +.++|||||||++|||++| ..||....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 98765432 344699999999998764222 2589999999999999999 56665431
Q ss_pred -----hhhh-hhcC-CCCCCC------CCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhh
Q 011331 429 -----QFLN-LRDG-KLPLLP------GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHR 482 (488)
Q Consensus 429 -----~~~~-i~~~-~~~~~~------~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~ 482 (488)
.... +... ..+..+ ..+..+.++|.+||+.||++|||+.|+++| |+.+....
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~--L~~i~~~~ 338 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLSQQE 338 (342)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH--HHHHHHTT
T ss_pred cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH--HHHHHHHh
Confidence 1111 1111 112111 234679999999999999999999999997 77776543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=351.46 Aligned_cols=246 Identities=22% Similarity=0.268 Sum_probs=201.4
Q ss_pred ccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 224 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
+....++|++.+.||+|+||+||+|.+. .+..||||+++..... .+.+.+|+.+++.+ +|+||+++++++.+ +.
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHC-CCTTBCCEEEEECS-SS
T ss_pred eecchhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCCC---HHHHHHHHHHHHhC-CCCCEeeEEEEEee-cc
Confidence 3344568999999999999999999986 4577999999764322 34688999999999 89999999999876 77
Q ss_pred EEEEEecCCCC-chhhhh---cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 304 LYIQMELCDHS-LSDKKA---SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 304 l~IV~E~~~~~-l~~~~~---~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
+||||||+.++ |..... ...+++.+++.++.||+.||.|||++|||||||||+|||| .++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999875 444322 2458999999999999999999999999999999999999 678999999999986542
Q ss_pred C----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHH
Q 011331 379 S----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQ 449 (488)
Q Consensus 379 ~----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~ 449 (488)
. .....++..|+|||++... .++.++|||||||+||||++ |..||..... ...+.. ...+.+..++.++.
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 494 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 494 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 1 2234577889999998765 57889999999999999999 8888876433 222322 34566778899999
Q ss_pred HHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 450 NLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+||.+||+.||++|||+++|++. |+.+
T Consensus 495 ~li~~cl~~dP~~RPt~~~l~~~--L~~~ 521 (535)
T 2h8h_A 495 DLMCQCWRKEPEERPTFEYLQAF--LEDY 521 (535)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH--HHTS
T ss_pred HHHHHHcCCChhHCcCHHHHHHH--HHHH
Confidence 99999999999999999999873 4444
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=350.19 Aligned_cols=239 Identities=21% Similarity=0.228 Sum_probs=198.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++...... ..+..|+.++..+..|++|..+..++...+..|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 45799999999999999999999999999999987644322 23678999999996667788887788888899999
Q ss_pred EecCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE----eCCeEEEEeecCceecCCCCC
Q 011331 308 MELCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLLNKSLP 381 (488)
Q Consensus 308 ~E~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv----~~g~vkL~DFGlA~~~~~~~~ 381 (488)
|||+++.|..... ...+++..++.++.||+.||.|||++|||||||||+|||| .++.+||+|||+++.......
T Consensus 82 me~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred EECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 9999777666443 4579999999999999999999999999999999999999 468999999999987754321
Q ss_pred ----------CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh------hhhhhcC-----CCCC
Q 011331 382 ----------IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ------FLNLRDG-----KLPL 440 (488)
Q Consensus 382 ----------~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------~~~i~~~-----~~~~ 440 (488)
...||+.|+|||++.+. .++.++|||||||+||||++|..||..... +..+... ....
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred ccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 45699999999998775 578899999999999999999999875321 1111111 1122
Q ss_pred CCCCcHHHHHHHHHcccCCCCCCCCHHHHHh
Q 011331 441 LPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 441 ~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~ 471 (488)
...++.++.+||.+||..||++||++.+|++
T Consensus 241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3567899999999999999999999999887
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=356.43 Aligned_cols=239 Identities=19% Similarity=0.269 Sum_probs=193.5
Q ss_pred cceeEEE-EecccCcEEEEEEEEcC--CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 229 TDFHEIE-QIGAGNFSHVFKVLKRI--DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 229 ~~y~~~~-~LG~G~fg~Vy~a~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.++.+.+ .||+|+||+||+|.+.. ++..||||+++... .......+.+|+.++..+ +|||||++++++.. +.+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCeE
Confidence 3566666 89999999999998763 56789999997642 233456788999999999 99999999999876 5699
Q ss_pred EEEecCCCCchh-hh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-
Q 011331 306 IQMELCDHSLSD-KK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL- 380 (488)
Q Consensus 306 IV~E~~~~~l~~-~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~- 380 (488)
||||||.++.+. .. ....+++..++.++.||+.||.|||++|||||||||+|||| .++.+||+|||+++......
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999886444 22 23459999999999999999999999999999999999999 68999999999998664321
Q ss_pred -----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCCCCCCcHHHHH
Q 011331 381 -----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPLLPGHSLQFQN 450 (488)
Q Consensus 381 -----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~~~~~s~~l~~ 450 (488)
....+++.|+|||++... .++.++|||||||+||||++ |..||..... ...+..+ ..+.++.++.++.+
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp ----------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 122356889999999765 57889999999999999998 9999876433 2233333 45566789999999
Q ss_pred HHHHcccCCCCCCCCHHHHHh
Q 011331 451 LLKVMVDPDPVQRPSAKELVE 471 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~ 471 (488)
||.+||..||++|||+.+|++
T Consensus 571 li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=325.67 Aligned_cols=240 Identities=22% Similarity=0.292 Sum_probs=192.3
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL--HHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~--~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
...+.||+|+||+||+|.+ ++..||||++.... ........+.+|+.++..+ +||||+++++++.+.+..|+|||
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEecCCceEEEEE
Confidence 3457899999999999986 68999999986542 2233456788999999999 89999999999999999999999
Q ss_pred cCCCC-chhhhh----cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----
Q 011331 310 LCDHS-LSDKKA----SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---- 379 (488)
Q Consensus 310 ~~~~~-l~~~~~----~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---- 379 (488)
|++++ +..... ...+++..++.++.||+.||.|||++||+|+||||+|||+ .++.+||+|||++......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 99765 433222 3458999999999999999999999999999999999999 5789999999999876432
Q ss_pred -CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---h----hhc----------CCC-CC
Q 011331 380 -LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---N----LRD----------GKL-PL 440 (488)
Q Consensus 380 -~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~----i~~----------~~~-~~ 440 (488)
.....||+.|+|||++.+. ++.++|||||||++|+|++|.+||....... . +.. ... ..
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred cccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 1234689999999998765 5679999999999999999999987542211 1 111 111 12
Q ss_pred CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 441 LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 441 ~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+...+..+.++|.+||+.||.+|||+.+++++ |+.+
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~--L~~l 304 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL--LQEM 304 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH--HHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH--HHHH
Confidence 22346789999999999999999999999985 4443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=369.65 Aligned_cols=250 Identities=25% Similarity=0.334 Sum_probs=199.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc------c
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE------N 301 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~------~ 301 (488)
.++|++++.||+|+||+||+|.+..+|..||||++... ........+.+|+.++..+ +||||+++++++.. +
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCC
Confidence 35789999999999999999999999999999998754 3455567789999999999 89999999998765 6
Q ss_pred ceEEEEEecCCCC-chhhhhc----ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC---eEEEEeecC
Q 011331 302 EQLYIQMELCDHS-LSDKKAS----QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG---VYKLGDFGR 372 (488)
Q Consensus 302 ~~l~IV~E~~~~~-l~~~~~~----~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g---~vkL~DFGl 372 (488)
+..|||||||+++ |...... ..+++..++.++.||+.||.|||++||+|+||||+|||++ ++ .++|+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 7789999999775 4433222 2588999999999999999999999999999999999994 33 499999999
Q ss_pred ceecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh-----------------h
Q 011331 373 ATLLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN-----------------L 433 (488)
Q Consensus 373 A~~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~-----------------i 433 (488)
+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||........ .
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred ccccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 9876543 2345699999999998765 577899999999999999999999865322111 0
Q ss_pred hcCC------CC----CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 434 RDGK------LP----LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 434 ~~~~------~~----~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
..+. .+ ....++..+.+||.+||.+||++|||+.|+++||||+.+..
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 0111 11 12235789999999999999999999999999999998864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=334.61 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=194.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+.. .||+|++............+.+|+.++..+ +||||+++++++.+.+.+++|
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSCEEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCceEEE
Confidence 4578999999999999999998853 499999875433333334566788999998 899999999999999999999
Q ss_pred EecCCCCchh-hhhc--ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCceecCC------
Q 011331 308 MELCDHSLSD-KKAS--QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNK------ 378 (488)
Q Consensus 308 ~E~~~~~l~~-~~~~--~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~~~~------ 378 (488)
|||++++.+. .... ..+++..++.++.||+.||.|||++||+|+||||+|||++++.++|+|||+++....
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC----------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCcccccccccccc
Confidence 9999875443 3322 258999999999999999999999999999999999999999999999999875431
Q ss_pred --CCCCCCCCCCccChhhhcc--------cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCCC--CCC
Q 011331 379 --SLPIEEGDARYMPQEILNE--------DYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLPL--LPG 443 (488)
Q Consensus 379 --~~~~~~Gt~~Y~APEvl~~--------~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~~--~~~ 443 (488)
......|++.|+|||++.. ...++.++|||||||++|||++|..||...... ..+..+..+. ...
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIG 267 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSS
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCC
Confidence 1223458899999999864 234677999999999999999999998765432 2233333332 235
Q ss_pred CcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHh
Q 011331 444 HSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481 (488)
Q Consensus 444 ~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~ 481 (488)
++.++.++|.+||..||++|||+.++++ .|+.+.+.
T Consensus 268 ~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~ 303 (319)
T 2y4i_B 268 MGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKR 303 (319)
T ss_dssp CCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC---
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHh
Confidence 7889999999999999999999999998 47766543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=364.32 Aligned_cols=245 Identities=22% Similarity=0.284 Sum_probs=201.6
Q ss_pred cccceeEEEEecccCcEEEEEEEEcC-CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce--
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRI-DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQ-- 303 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~-- 303 (488)
..++|++++.||+|+||+||+|.+.. +|+.||||++... ........+..|+.++..+ +||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTS
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCC
Confidence 34689999999999999999999976 7999999998653 2334456788999999999 89999999999987665
Q ss_pred ---EEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCceecCCCC
Q 011331 304 ---LYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 304 ---l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~~~~~~ 380 (488)
.||||||++++.+.......+++..++.++.||+.||.|||++|||||||||+||||+++.+||+|||+++.....
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSF- 234 (681)
T ss_dssp CEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEETTCC-
T ss_pred CceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhcccC-
Confidence 7999999988655544445799999999999999999999999999999999999998889999999999887654
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCCCCCCCCcHHHHHHHHHcccCCC
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDP 460 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP 460 (488)
....||+.|+|||++... ++.++|||||||+||+|++|.+++...... .+. ........+..+.+||.+||+.||
T Consensus 235 ~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-~~~--~~~~~~~~~~~l~~li~~~l~~dP 309 (681)
T 2pzi_A 235 GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD-GLP--EDDPVLKTYDSYGRLLRRAIDPDP 309 (681)
T ss_dssp SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS-SCC--TTCHHHHHCHHHHHHHHHHTCSSG
T ss_pred CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc-ccc--ccccccccCHHHHHHHhhhccCCh
Confidence 456799999999998765 367999999999999999998877642110 000 000001235789999999999999
Q ss_pred CCCCCHHHHHhChhhhhhH
Q 011331 461 VQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 461 ~~RpTa~elL~HP~f~~i~ 479 (488)
.+||+..+.+.|+|+.-++
T Consensus 310 ~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 310 RQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp GGSCSSHHHHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHHHHHHH
Confidence 9999999999999997654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=349.18 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=200.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCC---CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRID---GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.++|++++.||+|+||+||+|.+..+ +..||||++... ........+..|+.++..+ +||||+++++++. .+.+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSC
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe-cCce
Confidence 46799999999999999999998653 568999998653 3445567789999999999 8999999999885 4668
Q ss_pred EEEEecCCCC-chhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 305 YIQMELCDHS-LSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
||||||++++ |..... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++......
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999865 443322 2358999999999999999999999999999999999999 68999999999998764332
Q ss_pred ----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCCCCCCCcHHHHHH
Q 011331 381 ----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLPLLPGHSLQFQNL 451 (488)
Q Consensus 381 ----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~~~~~~s~~l~~l 451 (488)
....+|+.|+|||++... .++.++|||||||++|||++ |.+||...... ..+.. ...+.++.++.++.++
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 624 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 624 (656)
T ss_dssp --------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred ceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHH
Confidence 123467899999998765 67889999999999999997 88888764332 22333 3456777889999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
|.+||..||++|||+.|+++. ++.+.
T Consensus 625 i~~~l~~dP~~RPs~~el~~~--L~~il 650 (656)
T 2j0j_A 625 MTKCWAYDPSRRPRFTELKAQ--LSTIL 650 (656)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH--HHHHH
Confidence 999999999999999999985 66554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=313.90 Aligned_cols=222 Identities=16% Similarity=0.104 Sum_probs=182.4
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++++.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..+ +||||+++++++.+.+.+|||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCcEEEE
Confidence 5789999999999999999999999999999999765433 44557788999999998 999999999999999999999
Q ss_pred EecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCCCC
Q 011331 308 MELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGD 386 (488)
Q Consensus 308 ~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~Gt 386 (488)
|||++++.+...........++..++.||+.||.|||++||+||||||+|||| .+|.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---------------
T ss_pred EEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---------------
Confidence 99998754443333345667899999999999999999999999999999999 57889987443
Q ss_pred CCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh------hcCCCC----CCCCCcHHHHHHHHHcc
Q 011331 387 ARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL------RDGKLP----LLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 387 ~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i------~~~~~~----~~~~~s~~l~~lI~k~L 456 (488)
|++| ++.++|||||||++|||++|..||........+ .....+ ..+.++.++.++|.+||
T Consensus 175 --~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 244 (286)
T 3uqc_A 175 --TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSV 244 (286)
T ss_dssp --CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHH
T ss_pred --ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHc
Confidence 4443 556999999999999999999999865442211 112111 23568999999999999
Q ss_pred cCCCCCCCCHHHHHhChhhhhhH
Q 011331 457 DPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 457 ~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+.||.+| |+.|+++. ++.+.
T Consensus 245 ~~dP~~R-s~~el~~~--L~~~~ 264 (286)
T 3uqc_A 245 QGDGGIR-SASTLLNL--MQQAT 264 (286)
T ss_dssp CTTSSCC-CHHHHHHH--HHHHH
T ss_pred ccCCccC-CHHHHHHH--HHHHh
Confidence 9999999 99999984 65543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-32 Score=294.82 Aligned_cols=182 Identities=16% Similarity=0.057 Sum_probs=127.7
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCC--------chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH--------HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~--------~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..++.|++|.+..++....|+.||||++.+... .....+.+.+|+++|+++..|+||+++++++++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 357788888888888888999999999865421 123456789999999999899999999999999999999
Q ss_pred EEecCCCCchh-h-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---
Q 011331 307 QMELCDHSLSD-K-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL--- 380 (488)
Q Consensus 307 V~E~~~~~l~~-~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~--- 380 (488)
|||||+|+.+. . ...+.+++. .++.||+.||+|||++|||||||||+|||| .+|.+||+|||+|+......
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence 99999986444 3 333456654 589999999999999999999999999999 68999999999998765432
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCC
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGS 421 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~ 421 (488)
...+||+.|||||++.+.+ ..++|+||+|+++++|.+|.
T Consensus 397 ~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred cCceechhhccHHHhCCCC--CCcccccccccchhhhcccc
Confidence 2346999999999998763 45899999999988876653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-26 Score=247.23 Aligned_cols=182 Identities=14% Similarity=0.087 Sum_probs=137.0
Q ss_pred EEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch------HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD------AERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~------~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..+.||+|+||+||+|. ..+..+|+|+........ ...+.+.+|+.++.++ +||||+.+..++...+..||
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccEE
Confidence 45689999999999993 468899999864432221 1234578999999999 99999966556667777899
Q ss_pred EEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCceecCCCC------
Q 011331 307 QMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSL------ 380 (488)
Q Consensus 307 V~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~~~~~~------ 380 (488)
||||++++.+...... +..++.||+.||.|||++||+||||||+|||+++ .+||+|||+|+......
T Consensus 417 VmE~~~ggsL~~~l~~------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-~~kL~DFGla~~~~~~~~~~~~~ 489 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-DLYIIDFGLGKISNLDEDKAVDL 489 (540)
T ss_dssp EEECCCSEEHHHHSTT------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-SEEECCCTTCEECCCHHHHHHHH
T ss_pred EEECCCCCCHHHHHHH------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-eEEEEECccCEECCCccccccch
Confidence 9999986544422222 6789999999999999999999999999999977 99999999999875421
Q ss_pred ----CCCCCCCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcCCCCC
Q 011331 381 ----PIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLS 424 (488)
Q Consensus 381 ----~~~~Gt~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG~~p~ 424 (488)
....||+.|||||++... ..|+..+|+||.++-..+.+.++..+
T Consensus 490 ~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 490 IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 234699999999998641 13556789999999988888776554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=208.90 Aligned_cols=146 Identities=22% Similarity=0.104 Sum_probs=115.4
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch----------------HHHHHHHHHHHHHHHhCCCCCeeE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD----------------AERRKALLEVQALAALGSHENIVG 293 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~----------------~~~~~~~~Ei~iL~~l~~HpnIv~ 293 (488)
-|.+++.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.++..+. | ++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~---~-~~ 165 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ---G-LA 165 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT---T-SS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc---C-CC
Confidence 356779999999999999999 789999999986432111 23566889999999994 4 55
Q ss_pred eeeeecccceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCc
Q 011331 294 YYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRA 373 (488)
Q Consensus 294 l~~~~~~~~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA 373 (488)
+++++. .+..|+||||++++.+... .......++.||+.||.|||++||+||||||+||||++|.+||+|||+|
T Consensus 166 v~~~~~-~~~~~lvmE~~~g~~L~~l-----~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~~~~vkl~DFG~a 239 (282)
T 1zar_A 166 VPKVYA-WEGNAVLMELIDAKELYRV-----RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQS 239 (282)
T ss_dssp SCCEEE-EETTEEEEECCCCEEGGGC-----CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCTTC
T ss_pred cCeEEe-ccceEEEEEecCCCcHHHc-----chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEECCcEEEEECCCC
Confidence 555443 4567999999988543322 2234668999999999999999999999999999999999999999999
Q ss_pred eecCCCCCCCCCCCCccChhhhc
Q 011331 374 TLLNKSLPIEEGDARYMPQEILN 396 (488)
Q Consensus 374 ~~~~~~~~~~~Gt~~Y~APEvl~ 396 (488)
+.. ..|+|||++.
T Consensus 240 ~~~----------~~~~a~e~l~ 252 (282)
T 1zar_A 240 VEV----------GEEGWREILE 252 (282)
T ss_dssp EET----------TSTTHHHHHH
T ss_pred eEC----------CCCCHHHHHH
Confidence 743 3578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.7e-20 Score=183.59 Aligned_cols=140 Identities=18% Similarity=0.126 Sum_probs=105.7
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeE--EEEEEeccCCCc----------------------hHHHHHHHHHHHHHHHhC
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCF--YAVKHSKRQLHH----------------------DAERRKALLEVQALAALG 286 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAvK~l~~~~~~----------------------~~~~~~~~~Ei~iL~~l~ 286 (488)
|.+.+.||+|+||.||+|.+..+|.. ||||+++..... ......+.+|+.++..+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 127 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA- 127 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH-
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH-
Confidence 67899999999999999999778999 999987543111 01123578899999998
Q ss_pred CCCCe--eEeeeeecccceEEEEEecCCC-C----chhhhhcccCCHHHHHHHHHHHHHHHHHHH-HcCcccCCCCCCcE
Q 011331 287 SHENI--VGYYSSWFENEQLYIQMELCDH-S----LSDKKASQFFAEGEVLKALHQIAQALQFIH-EKGIAHLDVKPDNI 358 (488)
Q Consensus 287 ~HpnI--v~l~~~~~~~~~l~IV~E~~~~-~----l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH-~~gIiHrDLKp~NI 358 (488)
.|++| +.++.. +..+|||||+++ + .+.... ...++..+..++.||+.||.||| ++|||||||||+||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELG-RELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHG-GGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHh-hccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 66654 333322 357899999952 2 222111 11335578899999999999999 99999999999999
Q ss_pred EEeCCeEEEEeecCceecC
Q 011331 359 YVKNGVYKLGDFGRATLLN 377 (488)
Q Consensus 359 Lv~~g~vkL~DFGlA~~~~ 377 (488)
|+++ .++|+|||+|....
T Consensus 203 Ll~~-~~~liDFG~a~~~~ 220 (258)
T 1zth_A 203 MYID-KVYFIDMGQAVTLR 220 (258)
T ss_dssp EESS-SEEECCCTTCEETT
T ss_pred EEcC-cEEEEECcccccCC
Confidence 9977 99999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=5.4e-18 Score=175.55 Aligned_cols=139 Identities=17% Similarity=0.145 Sum_probs=95.9
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc------------hH--------HHHHHHHHHHHHHHhCCCCC
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH------------DA--------ERRKALLEVQALAALGSHEN 290 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~------------~~--------~~~~~~~Ei~iL~~l~~Hpn 290 (488)
|.+.+.||.|+||.||+|.+. +|+.||||+++..... .. .+..+.+|...|.++ .+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTT
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcC
Confidence 799999999999999999985 7999999987532100 00 011233456666665 3333
Q ss_pred eeEeeeeecccceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC------
Q 011331 291 IVGYYSSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG------ 363 (488)
Q Consensus 291 Iv~l~~~~~~~~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g------ 363 (488)
+.... .+. ....+|||||+++..+.... ....+..++.||+.+|.+||++|||||||||.||||+ +|
T Consensus 175 v~vp~-p~~-~~~~~LVME~i~G~~L~~l~----~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~ 248 (397)
T 4gyi_A 175 FPVPE-PIA-QSRHTIVMSLVDALPMRQVS----SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPS 248 (397)
T ss_dssp CSCCC-EEE-EETTEEEEECCSCEEGGGCC----CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTT
T ss_pred CCCCe-eee-ccCceEEEEecCCccHhhhc----ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccc
Confidence 22111 111 12237999999886443221 2234667899999999999999999999999999994 33
Q ss_pred ----eEEEEeecCceecC
Q 011331 364 ----VYKLGDFGRATLLN 377 (488)
Q Consensus 364 ----~vkL~DFGlA~~~~ 377 (488)
.+.|+||+-+....
T Consensus 249 ~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 249 SITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SEEEEEEECCCTTCEETT
T ss_pred ccccceEEEEeCCcccCC
Confidence 38999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=5.5e-12 Score=122.13 Aligned_cols=142 Identities=15% Similarity=0.149 Sum_probs=109.9
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
....|.+...+|.|+.+.||++.. .|..+++|+........ ...+.+|+.++..+..+..+.++++++.+.+..|+
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 345688899999999999999864 37899999986421111 22477899999998667788899998888889999
Q ss_pred EEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 011331 307 QMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHE----------------------------------------- 345 (488)
Q Consensus 307 V~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~----------------------------------------- 345 (488)
|||+++|..+.... .+......++.+++.+|..||+
T Consensus 88 v~e~i~G~~l~~~~---~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 88 LMSEADGVLCSEEY---EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp EEECCSSEEHHHHC---CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred EEEecCCeehhhcc---CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 99999986544321 1122345788999999999998
Q ss_pred ------------------cCcccCCCCCCcEEEeCCeE-EEEeecCcee
Q 011331 346 ------------------KGIAHLDVKPDNIYVKNGVY-KLGDFGRATL 375 (488)
Q Consensus 346 ------------------~gIiHrDLKp~NILv~~g~v-kL~DFGlA~~ 375 (488)
..++|+|++|.|||++++.+ .|+||+.+..
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 45899999999999977665 5999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=4e-11 Score=114.79 Aligned_cols=138 Identities=17% Similarity=0.105 Sum_probs=97.9
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCC-eeEeeeeecccceE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN-IVGYYSSWFENEQL 304 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hpn-Iv~l~~~~~~~~~l 304 (488)
.+...+.+....+.|..+.||++.. .+|..|++|+..... ...+..|+.++..+..+.- +.+++.++...+..
T Consensus 17 ~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 17 ERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred HhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 3344555544334566699999954 467889999875431 1345678888888855522 55688888888889
Q ss_pred EEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcC-------------------------------------
Q 011331 305 YIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKG------------------------------------- 347 (488)
Q Consensus 305 ~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~g------------------------------------- 347 (488)
|+||||++|..+. . .... ...++.+++..|..||+..
T Consensus 91 ~~v~e~i~G~~l~-~--~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 91 WLLLGEVPGQDLL-S--SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEEEECCSSEETT-T--SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEEEecCCcccC-c--CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9999999986443 1 1122 2356778888888888643
Q ss_pred ---------------------cccCCCCCCcEEEeCCeE-EEEeecCcee
Q 011331 348 ---------------------IAHLDVKPDNIYVKNGVY-KLGDFGRATL 375 (488)
Q Consensus 348 ---------------------IiHrDLKp~NILv~~g~v-kL~DFGlA~~ 375 (488)
++|+|++|.|||++++.+ .|+|||.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 999999999999977665 5999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=6e-10 Score=113.12 Aligned_cols=141 Identities=17% Similarity=0.229 Sum_probs=103.0
Q ss_pred EEEEecccCcEEEEEEEEcCCCeEEEEEEec--cCCCchHHHHHHHHHHHHHHHhCC-CCCeeEeeeeeccc---ceEEE
Q 011331 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSK--RQLHHDAERRKALLEVQALAALGS-HENIVGYYSSWFEN---EQLYI 306 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~--~~~~~~~~~~~~~~Ei~iL~~l~~-HpnIv~l~~~~~~~---~~l~I 306 (488)
.++.|+.|.++.||++... +..+++|+.. .... ......+.+|+.++..+.. +..+++++.++.+. +..|+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 4678999999999998753 5678888764 2211 1123457789999998843 34577888877765 45899
Q ss_pred EEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 011331 307 QMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHE----------------------------------------- 345 (488)
Q Consensus 307 V~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~----------------------------------------- 345 (488)
||||++|.......-..++..+...++.+++..|..||+
T Consensus 119 vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp EEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 999999864432222347788889999999999999997
Q ss_pred -----------------cCcccCCCCCCcEEEe-CC--eEEEEeecCceec
Q 011331 346 -----------------KGIAHLDVKPDNIYVK-NG--VYKLGDFGRATLL 376 (488)
Q Consensus 346 -----------------~gIiHrDLKp~NILv~-~g--~vkL~DFGlA~~~ 376 (488)
.+++|+|+++.|||++ ++ .+.|+||+.+...
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 3589999999999995 33 3689999999764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=3.3e-09 Score=105.20 Aligned_cols=180 Identities=17% Similarity=0.139 Sum_probs=119.5
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCC--eeEeeeeecccc---eEEEEEe
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN--IVGYYSSWFENE---QLYIQME 309 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hpn--Iv~l~~~~~~~~---~l~IV~E 309 (488)
+.++.|..+.||++. ..+++|+... ......+..|..++..+..+.. +..++......+ ..|+|||
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 458999999999863 4588887542 2344567889999988854443 334444443333 3488999
Q ss_pred cCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 011331 310 LCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHE-------------------------------------------- 345 (488)
Q Consensus 310 ~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~-------------------------------------------- 345 (488)
+++|..+.......++..+...++.+++..|..||+
T Consensus 97 ~i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 97 KIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred ccCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 999864443223457888888899999999999996
Q ss_pred --------------cCcccCCCCCCcEEEeC--C-eEEEEeecCceecCCCCCCCCCCCCc---cChhhh---cccCCCC
Q 011331 346 --------------KGIAHLDVKPDNIYVKN--G-VYKLGDFGRATLLNKSLPIEEGDARY---MPQEIL---NEDYDHL 402 (488)
Q Consensus 346 --------------~gIiHrDLKp~NILv~~--g-~vkL~DFGlA~~~~~~~~~~~Gt~~Y---~APEvl---~~~~~~~ 402 (488)
..++|+|++|.||++++ + .+.|+||+.+...+..... .....+ ..|+.. ...|...
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-ISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-HTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-HHHHhhccccCHHHHHHHHHHcCCC
Confidence 13699999999999965 4 5789999998765321100 000111 233322 1111111
Q ss_pred ----------chhHHHHHHHHHHHHHcCCCCC
Q 011331 403 ----------DKVDIFSLGATMYELIKGSPLS 424 (488)
Q Consensus 403 ----------~ksDIwSlGvlL~eLltG~~p~ 424 (488)
...+.|++|.++|.+.+|..++
T Consensus 256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1368999999999999997554
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=9.9e-07 Score=87.78 Aligned_cols=135 Identities=16% Similarity=0.189 Sum_probs=93.7
Q ss_pred EEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCC--CeeEeeeeec-ccceEEEEEec
Q 011331 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE--NIVGYYSSWF-ENEQLYIQMEL 310 (488)
Q Consensus 234 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hp--nIv~l~~~~~-~~~~l~IV~E~ 310 (488)
++.++.|....||++ |..+++|+.. .......+..|..+|..+..+- .|.+++.+.. ..+..|+|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 456888999999988 5678888753 2233456888999999995542 2455555553 45667899999
Q ss_pred CCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHc--------------------------------------------
Q 011331 311 CDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEK-------------------------------------------- 346 (488)
Q Consensus 311 ~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~-------------------------------------------- 346 (488)
++|..+....-..++..+...++.++...|..||+.
T Consensus 95 i~G~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 95 VQGQILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp CCSEECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred cCCeECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 998644332223345555666666666666666642
Q ss_pred ----------------CcccCCCCCCcEEEeC----CeE-EEEeecCceecC
Q 011331 347 ----------------GIAHLDVKPDNIYVKN----GVY-KLGDFGRATLLN 377 (488)
Q Consensus 347 ----------------gIiHrDLKp~NILv~~----g~v-kL~DFGlA~~~~ 377 (488)
.++|+|+++.|||+++ +.+ .|+||+.+...+
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3489999999999954 554 899999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=1.5e-06 Score=83.98 Aligned_cols=132 Identities=14% Similarity=0.107 Sum_probs=90.7
Q ss_pred ecccCcE-EEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCCCCc
Q 011331 237 IGAGNFS-HVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDHSL 315 (488)
Q Consensus 237 LG~G~fg-~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~~~l 315 (488)
+..|..| .||+......+..+.+|+... .....+..|..+|+.+..+-.+.+++.++.+.+..|+|||++++..
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 4445444 689887776778899998542 2344577899999988665557788888888899999999998854
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHHHHHHHHc-------------------------------------------------
Q 011331 316 SDKKASQFFAEGEVLKALHQIAQALQFIHEK------------------------------------------------- 346 (488)
Q Consensus 316 ~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~------------------------------------------------- 346 (488)
....... .......+..++...|.-||..
T Consensus 107 ~~~~~~~--~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 107 AFQVLEE--YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHHHHHH--CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred ccccccC--CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 3211110 1112234455555555555531
Q ss_pred ---------CcccCCCCCCcEEEeCCeE-EEEeecCcee
Q 011331 347 ---------GIAHLDVKPDNIYVKNGVY-KLGDFGRATL 375 (488)
Q Consensus 347 ---------gIiHrDLKp~NILv~~g~v-kL~DFGlA~~ 375 (488)
.++|+|+.+.|||++++.+ -|+||+.+..
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1589999999999977654 5999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=4.1e-06 Score=85.97 Aligned_cols=79 Identities=23% Similarity=0.294 Sum_probs=48.7
Q ss_pred EEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC--ch---HHHHHHHHHHHHHHHhCCC-C-CeeEeeeeecccceEE
Q 011331 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH--HD---AERRKALLEVQALAALGSH-E-NIVGYYSSWFENEQLY 305 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~--~~---~~~~~~~~Ei~iL~~l~~H-p-nIv~l~~~~~~~~~l~ 305 (488)
.++.||.|.++.||++.....++.|+||....... .. ........|..++..+..+ + .+.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999997655678999998643211 00 0112356688888877443 3 34455543 344568
Q ss_pred EEEecCCC
Q 011331 306 IQMELCDH 313 (488)
Q Consensus 306 IV~E~~~~ 313 (488)
+|||++++
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=1.8e-05 Score=79.71 Aligned_cols=83 Identities=6% Similarity=-0.069 Sum_probs=52.4
Q ss_pred eEEEEe-cccCcEEEEEEEEc--C----CCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCC--CCeeEeeeeeccc
Q 011331 232 HEIEQI-GAGNFSHVFKVLKR--I----DGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSH--ENIVGYYSSWFEN 301 (488)
Q Consensus 232 ~~~~~L-G~G~fg~Vy~a~~~--~----~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~H--pnIv~l~~~~~~~ 301 (488)
..++.| +.|..+.+|++... . ++..+++|+...... ..........|+.++..+..+ -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 456778 88999999988653 1 167889997643210 000012355677777777444 3466777666554
Q ss_pred ---ceEEEEEecCCCC
Q 011331 302 ---EQLYIQMELCDHS 314 (488)
Q Consensus 302 ---~~l~IV~E~~~~~ 314 (488)
+..|+|||+++|.
T Consensus 103 ~~~g~~~~v~e~l~G~ 118 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGV 118 (357)
T ss_dssp TTTSSCEEEEECCCCB
T ss_pred CccCCceEEEEecCCC
Confidence 3568999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.85 E-value=0.0002 Score=70.79 Aligned_cols=30 Identities=17% Similarity=0.237 Sum_probs=26.6
Q ss_pred cCcccCCCCCCcEEE-eCCeEEEEeecCcee
Q 011331 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATL 375 (488)
Q Consensus 346 ~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~ 375 (488)
.+++|+|+++.|||+ .++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 479999999999999 577899999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.76 E-value=7.9e-05 Score=73.37 Aligned_cols=124 Identities=9% Similarity=-0.048 Sum_probs=72.6
Q ss_pred EEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecC-C
Q 011331 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELC-D 312 (488)
Q Consensus 234 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~-~ 312 (488)
++.|+.|....+|++ ..+++|+....... ......|+.++..+..+.-..+++... .+.-++++||+ +
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 677889999999998 45888887542111 111234666666653332224555443 33346889999 6
Q ss_pred CCchhhhhcccCCHHHH---HHHHHHHHHHHHHHHH--------------------------------------------
Q 011331 313 HSLSDKKASQFFAEGEV---LKALHQIAQALQFIHE-------------------------------------------- 345 (488)
Q Consensus 313 ~~l~~~~~~~~l~~~~~---~~i~~qI~~gL~yLH~-------------------------------------------- 345 (488)
+..+.. ... ..++.+++..|.-||+
T Consensus 92 g~~l~~--------~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 163 (301)
T 3dxq_A 92 AQTMSP--------EKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVR 163 (301)
T ss_dssp CEECCH--------HHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHH
T ss_pred CccCCH--------hhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHH
Confidence 532210 000 0122222222222222
Q ss_pred ---------cCcccCCCCCCcEEEeCCeEEEEeecCceec
Q 011331 346 ---------KGIAHLDVKPDNIYVKNGVYKLGDFGRATLL 376 (488)
Q Consensus 346 ---------~gIiHrDLKp~NILv~~g~vkL~DFGlA~~~ 376 (488)
..++|+|+.+.||+..++.+.|+||..+...
T Consensus 164 ~~l~~~~~~~~l~HgDl~~~Nil~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 164 SALAAHPLPLAACHCDPLCENFLDTGERMWIVDWEYSGMN 203 (301)
T ss_dssp HHHHSSCCCCEEECSCCCGGGEEECSSCEEECCCTTCEEE
T ss_pred HHHHhcCCCceeeccCCCcCCEEECCCCEEEEecccccCC
Confidence 1379999999999987888999999988754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00021 Score=73.86 Aligned_cols=76 Identities=11% Similarity=-0.017 Sum_probs=45.6
Q ss_pred HcCcccCCCCCCcEEEeCCeEEEEeecCceecCCCCC--CCC--CCCCccChhhhcccC--CCCchhHHHHHHHHHHHHH
Q 011331 345 EKGIAHLDVKPDNIYVKNGVYKLGDFGRATLLNKSLP--IEE--GDARYMPQEILNEDY--DHLDKVDIFSLGATMYELI 418 (488)
Q Consensus 345 ~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~~~~~~~--~~~--Gt~~Y~APEvl~~~~--~~~~ksDIwSlGvlL~eLl 418 (488)
...++|+|+++.|||++++.+.|+||+.+........ ... -...|++|+...... .......+..++..+|+.+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDSTQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CCEEECSCCSGGGEEECSSCEEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCCCEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4579999999999999665699999999876532100 000 012345555432110 0111345557777888777
Q ss_pred cC
Q 011331 419 KG 420 (488)
Q Consensus 419 tG 420 (488)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00061 Score=68.09 Aligned_cols=76 Identities=18% Similarity=0.183 Sum_probs=57.6
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCC--CCeeEeeeeecccceEEEEEe
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH--ENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~H--pnIv~l~~~~~~~~~l~IV~E 309 (488)
..++.|+.|....+|++.. ++..+++|+.... ....+..|...|+.+..+ ..+++++.+....+..|+|||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 3567899999999999864 4678889986532 234567788888877443 567788888777788999999
Q ss_pred cCCCC
Q 011331 310 LCDHS 314 (488)
Q Consensus 310 ~~~~~ 314 (488)
++++.
T Consensus 112 ~l~G~ 116 (312)
T 3jr1_A 112 ALNKS 116 (312)
T ss_dssp CCCCC
T ss_pred eccCC
Confidence 99864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00085 Score=66.17 Aligned_cols=138 Identities=11% Similarity=0.062 Sum_probs=76.1
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCC-CeeEeeee------ecccceE
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE-NIVGYYSS------WFENEQL 304 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hp-nIv~l~~~------~~~~~~l 304 (488)
..++.|+.|....||++... .| .+++|+..... .......|+.++..+..+. .+.+++.. ....+..
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 45677888999999998753 34 68899876421 1122345666666663331 13344321 1123567
Q ss_pred EEEEecCCCCchh------------------hhhcc---c----CCHHHHHHH---------------HHHHHHHHHHHH
Q 011331 305 YIQMELCDHSLSD------------------KKASQ---F----FAEGEVLKA---------------LHQIAQALQFIH 344 (488)
Q Consensus 305 ~IV~E~~~~~l~~------------------~~~~~---~----l~~~~~~~i---------------~~qI~~gL~yLH 344 (488)
+++|++++|.... ..... . ......... -..+...+..++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8999999874210 00000 0 010000000 011344555665
Q ss_pred H-------cCcccCCCCCCcEEEeCCeE-EEEeecCcee
Q 011331 345 E-------KGIAHLDVKPDNIYVKNGVY-KLGDFGRATL 375 (488)
Q Consensus 345 ~-------~gIiHrDLKp~NILv~~g~v-kL~DFGlA~~ 375 (488)
+ .+++|+|+.+.|||++++.+ .|+||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3 36999999999999977665 7999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0026 Score=61.90 Aligned_cols=76 Identities=18% Similarity=0.111 Sum_probs=51.4
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCC--CeeEeeeeecccceEEEEE
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE--NIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hp--nIv~l~~~~~~~~~l~IV~ 308 (488)
..-++.+|.|..+.||++... +|+.|.+|+........ ...+..|+..|+.+...- .+.+++.+ +.-++||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~ 89 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAM 89 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEE
T ss_pred eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEE
Confidence 456889999999999999764 79999999864332211 123556888888885432 23444443 2347889
Q ss_pred ecCCC
Q 011331 309 ELCDH 313 (488)
Q Consensus 309 E~~~~ 313 (488)
|++++
T Consensus 90 e~l~~ 94 (288)
T 3f7w_A 90 EWVDE 94 (288)
T ss_dssp ECCCC
T ss_pred Eeecc
Confidence 99865
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00089 Score=67.75 Aligned_cols=75 Identities=11% Similarity=0.005 Sum_probs=42.7
Q ss_pred EEEEecccCcEEEEEEEEcC--------CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 233 EIEQIGAGNFSHVFKVLKRI--------DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.++.|+.|....+|++.... .+..|++|+...... .......|..++..+..+.-+.++++.+. -
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~ 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---ELYNTISEFEVYKTMSKYKIAPQLLNTFN----G 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---GTSCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---ceecHHHHHHHHHHHHhcCCCCceEEecC----C
Confidence 45678889899999997643 136889998653211 11123457777777644433445655442 2
Q ss_pred EEEEecCCCC
Q 011331 305 YIQMELCDHS 314 (488)
Q Consensus 305 ~IV~E~~~~~ 314 (488)
++||||++|.
T Consensus 110 ~~v~e~i~G~ 119 (369)
T 3c5i_A 110 GRIEEWLYGD 119 (369)
T ss_dssp EEEEECCCSE
T ss_pred cEEEEEecCC
Confidence 6899999863
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0018 Score=66.41 Aligned_cols=136 Identities=15% Similarity=0.073 Sum_probs=78.8
Q ss_pred EEEecccCcEEEEEEEEcC-------CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 234 IEQIGAGNFSHVFKVLKRI-------DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 234 ~~~LG~G~fg~Vy~a~~~~-------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
++.|..|....+|++.... ++..|.+|+...... ......+|..+++.+..+.-..++++.+.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 4567778888899987642 357899998532211 133455788888877555444666666554 28
Q ss_pred EEecCCCCchhh------------------hhc------ccC--CHHHHHHHHHHHHH-------------------HHH
Q 011331 307 QMELCDHSLSDK------------------KAS------QFF--AEGEVLKALHQIAQ-------------------ALQ 341 (488)
Q Consensus 307 V~E~~~~~l~~~------------------~~~------~~l--~~~~~~~i~~qI~~-------------------gL~ 341 (488)
||||++|..+.. ... ... -...+..++.++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999998632110 000 001 12344555544322 233
Q ss_pred HHHH--------cCcccCCCCCCcEEEeC-----CeEEEEeecCceec
Q 011331 342 FIHE--------KGIAHLDVKPDNIYVKN-----GVYKLGDFGRATLL 376 (488)
Q Consensus 342 yLH~--------~gIiHrDLKp~NILv~~-----g~vkL~DFGlA~~~ 376 (488)
.|.+ ..++|+|+.+.|||+.+ +.+.|+||..|...
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 3332 25899999999999953 58999999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0036 Score=65.08 Aligned_cols=73 Identities=11% Similarity=-0.013 Sum_probs=49.4
Q ss_pred EEEEecccCcEEEEEEEEcC-------CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 233 EIEQIGAGNFSHVFKVLKRI-------DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~-------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.++.|+.|....||++.... .+..|.+|+.... .. ...+..|..++..+..+.-..++++.+.+ .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 46778999999999997642 2578999987431 11 12344688888887555444566665543 2
Q ss_pred EEEecCCC
Q 011331 306 IQMELCDH 313 (488)
Q Consensus 306 IV~E~~~~ 313 (488)
+|+||++|
T Consensus 149 ~v~e~l~G 156 (429)
T 1nw1_A 149 RLEEYIPS 156 (429)
T ss_dssp EEECCCCE
T ss_pred EEEEEeCC
Confidence 88999976
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0065 Score=57.59 Aligned_cols=128 Identities=15% Similarity=0.152 Sum_probs=83.8
Q ss_pred hhhcccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCCCCCCccChhhh
Q 011331 318 KKASQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEIL 395 (488)
Q Consensus 318 ~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl 395 (488)
.....+++|.++|.++.|.+.+|.-+-. +.-..+=+.|..|++ .+|.|.+.+ +.+. .....+.|||..
T Consensus 40 ~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------~~~~~~~~pe~~ 109 (229)
T 2yle_A 40 RLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------AGEPPPVAGKLG 109 (229)
T ss_dssp HHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C---------------------CCS
T ss_pred HHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------ccccCCCChhhc
Confidence 3445789999999999999999877622 221223344788998 788888764 2111 112245688876
Q ss_pred cccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCCCCCCCCcHHHHHHHHHcccC-----------------
Q 011331 396 NEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDP----------------- 458 (488)
Q Consensus 396 ~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~~~~~~~s~~l~~lI~k~L~~----------------- 458 (488)
.. ..+.+.=|||||++||..+-=..+... ...+|+++.+||..|..-
T Consensus 110 ~~--~~te~~~IysLG~tLY~ALDygL~e~e--------------E~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg 173 (229)
T 2yle_A 110 YS--QCMETEVIESLGIIIYKALDYGLKENE--------------ERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEG 173 (229)
T ss_dssp SS--SSCHHHHHHHHHHHHHHHHTTTCCTTE--------------EECCCHHHHHHHHHHTTCCC---------------
T ss_pred cc--cchHHHHHHHHHHHHHHHhhcCCCccc--------------chhhCHHHHHHHHHHHhcccccccccccccccccc
Confidence 32 345688999999999998865443322 234789999999999755
Q ss_pred --------CCCCCCCHHHHHh
Q 011331 459 --------DPVQRPSAKELVE 471 (488)
Q Consensus 459 --------dP~~RpTa~elL~ 471 (488)
.+..|.++++||+
T Consensus 174 ~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 174 LGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp -----CCSCCCCCCSHHHHHH
T ss_pred cccccccccccCcCCHHHHHH
Confidence 2467899999885
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.002 Score=63.71 Aligned_cols=136 Identities=13% Similarity=0.048 Sum_probs=75.8
Q ss_pred EEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCC-CeeEeeee-----ecccceEEEEE
Q 011331 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE-NIVGYYSS-----WFENEQLYIQM 308 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hp-nIv~l~~~-----~~~~~~l~IV~ 308 (488)
..|+ |....||++... +|..+++|+........ .....|..++..+..+. .+++++.. ....+..+++|
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 3466 888899987543 56679999986432222 23455777777664321 24444433 11245568899
Q ss_pred ecCCCCchh------------------hhhc-------ccCCHHHH----HHHH---------------HHHHHHHHHHH
Q 011331 309 ELCDHSLSD------------------KKAS-------QFFAEGEV----LKAL---------------HQIAQALQFIH 344 (488)
Q Consensus 309 E~~~~~l~~------------------~~~~-------~~l~~~~~----~~i~---------------~qI~~gL~yLH 344 (488)
++++|.... .... ........ ..++ ..+-..+..+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999873110 0000 01111110 0111 11111223332
Q ss_pred -------HcCcccCCCCCCcEEEeCCeEEEEeecCceec
Q 011331 345 -------EKGIAHLDVKPDNIYVKNGVYKLGDFGRATLL 376 (488)
Q Consensus 345 -------~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~~ 376 (488)
...++|+|+++.|||+++ .+.|+||+.+...
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWRD-GPMFVDLDDARNG 224 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEESS-SEEECCCTTCCEE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEcC-CCEEEECCCCCcC
Confidence 235899999999999985 8999999987654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.016 Score=60.77 Aligned_cols=75 Identities=16% Similarity=0.037 Sum_probs=48.4
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecC
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELC 311 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~ 311 (488)
-.++.|+.|....+|++.....+..|++|+........ .....|..++..+..+.-..++++.+. + .+||||+
T Consensus 111 ~~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I 183 (458)
T 2qg7_A 111 LEFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFM 183 (458)
T ss_dssp EEEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECC
T ss_pred eEEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEee
Confidence 35678999999999999875445889999874321111 112468888888855544457776663 2 2499999
Q ss_pred CC
Q 011331 312 DH 313 (488)
Q Consensus 312 ~~ 313 (488)
+|
T Consensus 184 ~G 185 (458)
T 2qg7_A 184 DG 185 (458)
T ss_dssp CS
T ss_pred CC
Confidence 76
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0024 Score=63.43 Aligned_cols=32 Identities=22% Similarity=0.159 Sum_probs=27.3
Q ss_pred cCcccCCCCCCcEEEeC-----CeEEEEeecCceecC
Q 011331 346 KGIAHLDVKPDNIYVKN-----GVYKLGDFGRATLLN 377 (488)
Q Consensus 346 ~gIiHrDLKp~NILv~~-----g~vkL~DFGlA~~~~ 377 (488)
..++|+|+.+.|||+++ +.+.|+||+.+....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 36999999999999954 679999999987653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.31 E-value=0.023 Score=56.84 Aligned_cols=31 Identities=19% Similarity=0.291 Sum_probs=27.0
Q ss_pred CcccCCCCCCcEEEe-CCeEEEEeecCceecC
Q 011331 347 GIAHLDVKPDNIYVK-NGVYKLGDFGRATLLN 377 (488)
Q Consensus 347 gIiHrDLKp~NILv~-~g~vkL~DFGlA~~~~ 377 (488)
.++|+|+.+.||+++ ++.+.|+||+.+....
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 699999999999995 5789999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.71 E-value=0.03 Score=58.18 Aligned_cols=75 Identities=13% Similarity=0.033 Sum_probs=46.6
Q ss_pred EEEEecccCcEEEEEEEEcCC-------CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 233 EIEQIGAGNFSHVFKVLKRID-------GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.++.|..|....+|++..... +..|++++....... ..+..+|..++..+..+.-..++++.+. -+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 466788888899999876521 578999986432111 1123457777776644433455555332 26
Q ss_pred EEEecCCCC
Q 011331 306 IQMELCDHS 314 (488)
Q Consensus 306 IV~E~~~~~ 314 (488)
+||||++|.
T Consensus 147 ~I~efI~G~ 155 (424)
T 3mes_A 147 RIEEFIDGE 155 (424)
T ss_dssp EEEECCCSE
T ss_pred EEEEEeCCc
Confidence 889999873
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.45 E-value=0.32 Score=49.68 Aligned_cols=29 Identities=24% Similarity=0.262 Sum_probs=24.5
Q ss_pred cccCCCCCCcEEEe-------CCeEEEEeecCceec
Q 011331 348 IAHLDVKPDNIYVK-------NGVYKLGDFGRATLL 376 (488)
Q Consensus 348 IiHrDLKp~NILv~-------~g~vkL~DFGlA~~~ 376 (488)
++|+|+.+.|||+. ++.+.|+||..|...
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 67999999999993 357999999999754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 488 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-43 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-42 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-40 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-38 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-38 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-37 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-37 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-33 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-32 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-31 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-15 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-51
Identities = 63/261 (24%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 226 RYYT--DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQAL 282
R + DF +G G F +V+ ++ A+K K QL + EV+
Sbjct: 1 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 283 AALGSHENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQF--FAEGEVLKALHQIAQAL 340
+ L H NI+ Y + + ++Y+ +E ++ + F E + ++A AL
Sbjct: 61 SHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 119
Query: 341 QFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-LPIEEGDARYMPQEIL-NE 397
+ H K + H D+KP+N+ + G K+ DFG + S G Y+P E++
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 179
Query: 398 DYDHLDKVDIFSLGATMYELIKGSPLSESGP---QFLNLRDGKLPLLPGHSLQFQNLLKV 454
+D KVD++SLG YE + G P E+ + + + + ++L+
Sbjct: 180 MHDE--KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 237
Query: 455 MVDPDPVQRPSAKELVENPIF 475
++ +P QRP +E++E+P
Sbjct: 238 LLKHNPSQRPMLREVLEHPWI 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 3e-51
Identities = 80/266 (30%), Positives = 123/266 (46%), Gaps = 25/266 (9%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
D+ + IG G++ K+ ++ DG K +AE++ + EV L L H
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHP 63
Query: 290 NIVGYYSSWFE--NEQLYIQMELCDH-SLSD-----KKASQFFAEGEVLKALHQIAQALQ 341
NIV YY + N LYI ME C+ L+ K Q+ E VL+ + Q+ AL+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 342 FIHEKG-----IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEG---DARYMPQ 392
H + + H D+KP N+++ KLGDFG A +LN + YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 393 EILN-EDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGH-SLQ 447
E +N Y+ K DI+SLG +YEL P + Q +R+GK +P S +
Sbjct: 184 EQMNRMSYNE--KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 241
Query: 448 FQNLLKVMVDPDPVQRPSAKELVENP 473
++ M++ RPS +E++ENP
Sbjct: 242 LNEIITRMLNLKDYHRPSVEEILENP 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 9e-51
Identities = 68/258 (26%), Positives = 116/258 (44%), Gaps = 13/258 (5%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSHE 289
F ++ +IG G+F V+ + A+K E+ + ++ EV+ L L H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHP 75
Query: 290 NIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKG 347
N + Y + ++ ME C S SD + + E E+ H Q L ++H
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM-PQEILNEDYDHLD-K 404
+ H DVK NI + + G+ KLGDFG A+++ + G +M P+ IL D D K
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-VGTPYWMAPEVILAMDEGQYDGK 194
Query: 405 VDIFSLGATMYELIKGSPL---SESGPQFLNLRDGKLPLLPGH--SLQFQNLLKVMVDPD 459
VD++SLG T EL + P + ++ + P L S F+N + +
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 254
Query: 460 PVQRPSAKELVENPIFDK 477
P RP+++ L+++ +
Sbjct: 255 PQDRPTSEVLLKHRFVLR 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 4e-49
Identities = 57/262 (21%), Positives = 111/262 (42%), Gaps = 16/262 (6%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
D+ ++ +G G + V + R+ AVK + D E+ L +HE
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICINKML-NHE 63
Query: 290 NIVGYYSSWFENEQLYIQMELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIHEKG 347
N+V +Y E Y+ +E C + E + + HQ+ + ++H G
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE-----GDARYMPQEILNEDYDH 401
I H D+KP+N+ + + K+ DFG AT+ + G Y+ E+L H
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 402 LDKVDIFSLGATMYELIKGSPL----SESGPQFLNLRDGKLPLLPGHSL--QFQNLLKVM 455
+ VD++S G + ++ G S+S ++ + ++ K L P + LL +
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 243
Query: 456 VDPDPVQRPSAKELVENPIFDK 477
+ +P R + ++ ++ ++K
Sbjct: 244 LVENPSARITIPDIKKDRWYNK 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 8e-49
Identities = 63/265 (23%), Positives = 114/265 (43%), Gaps = 21/265 (7%)
Query: 229 TDFHEI-EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGS 287
DF EI ++G G F V+K + A K + E ++E+ LA+
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK--VIDTKSEEELEDYMVEIDILASC-D 67
Query: 288 HENIVGYYSSWFENEQLYIQMELCDHSLSDK---KASQFFAEGEVLKALHQIAQALQFIH 344
H NIV +++ L+I +E C D + + E ++ Q AL ++H
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEIL----N 396
+ I H D+K NI +G KL DFG + +++ + G +M E++ +
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 397 EDYDHLDKVDIFSLGATMYELIKGSPLSESGP---QFLNLRDGKLPLLP---GHSLQFQN 450
+D + K D++SLG T+ E+ + P L + + P L S F++
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247
Query: 451 LLKVMVDPDPVQRPSAKELVENPIF 475
LK ++ + R + +L+++P
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-48
Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 21/271 (7%)
Query: 217 VITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKAL 276
+++ GD +Y E+IG G V+ + G A++ L ++ +
Sbjct: 12 IVSVGDPKKKY----TRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELII 65
Query: 277 LEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQ 335
E+ + + NIV Y S+ ++L++ ME SL+D EG++ +
Sbjct: 66 NEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE 124
Query: 336 IAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL---NKSLPIEEGDARYM- 390
QAL+F+H + H D+K DNI + +G KL DFG + G +M
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 391 PQEILNEDYDHLDKVDIFSLGATMYELIKGSPL----SESGPQFLNLRDG--KLPLLPGH 444
P+ + + Y KVDI+SLG E+I+G P + +L +G +L
Sbjct: 185 PEVVTRKAYGP--KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 445 SLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
S F++ L +D D +R SAKEL+++
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (421), Expect = 1e-47
Identities = 56/265 (21%), Positives = 114/265 (43%), Gaps = 21/265 (7%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+ E++G G F V +V +R G +A K H++++ E+Q ++ L H
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVL-RHP 83
Query: 290 NIVGYYSSWFENEQLYIQMELCDH-SLSDK--KASQFFAEGEVLKALHQIAQALQFIHEK 346
+V + ++ ++ ++ + E L +K +E E ++ + Q+ + L +HE
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 347 GIAHLDVKPDNIYV---KNGVYKLGDFGRATLLN--KSLPIEEGDARYMPQEIL-NEDYD 400
HLD+KP+NI ++ KL DFG L+ +S+ + G A + E+ +
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 401 HLDKVDIFSLGATMYELIKGSPL---SESGPQFLNLRDGKL----PLLPGHSLQFQNLLK 453
+ D++S+G Y L+ G N++ G S ++ ++
Sbjct: 204 Y--YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261
Query: 454 VMVDPDPVQRPSAKELVENPIFDKI 478
++ DP R + + +E+P
Sbjct: 262 KLLLADPNTRMTIHQALEHPWLTPG 286
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-47
Identities = 54/264 (20%), Positives = 99/264 (37%), Gaps = 23/264 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+ ++ IG G F V G AVK + +DA + L E + L H
Sbjct: 8 ELKLLQTIGKGEFGDVMLG--DYRGNKVAVK----CIKNDATAQAFLAEASVMTQL-RHS 60
Query: 290 NIVGYYSSWFE-NEQLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIAQALQFIH 344
N+V E LYI E SL D + +LK + +A++++
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM-PQEILNEDYDHL 402
H D+ N+ V ++ V K+ DFG + + + ++ P+ + + +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFST- 179
Query: 403 DKVDIFSLGATMYELIKGSPLSESGPQFLNL-----RDGKLPLLPGHSLQFQNLLKVMVD 457
K D++S G ++E+ + ++ + K+ G ++K
Sbjct: 180 -KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 238
Query: 458 PDPVQRPSAKELVENPIFDKIQKH 481
D RPS +L E + I+ H
Sbjct: 239 LDAAMRPSFLQLRE--QLEHIKTH 260
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (409), Expect = 7e-47
Identities = 65/275 (23%), Positives = 114/275 (41%), Gaps = 24/275 (8%)
Query: 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-------HSKRQLHHDAERRKALLEV 279
+Y ++ E +G G S V + + + YAVK S R L EV
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 280 QALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIA 337
L + H NI+ ++ N ++ +L L D +E E K + +
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 120
Query: 338 QALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEI 394
+ + +H+ I H D+KP+NI + + KL DFG + L+ + E G Y+ EI
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 395 L-----NEDYDHLDKVDIFSLGATMYELIKGSPL---SESGPQFLNLRDGKL----PLLP 442
+ + + +VD++S G MY L+ GSP + + G P
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 443 GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
+S ++L+ + P +R +A+E + +P F +
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 4e-46
Identities = 68/267 (25%), Positives = 111/267 (41%), Gaps = 23/267 (8%)
Query: 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAAL 285
R+ +IG G+F V+K L A + + +ER++ E + L L
Sbjct: 9 RFL---KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65
Query: 286 GSHENIVGYYSSWFE----NEQLYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQA 339
H NIV +Y SW + + + EL +L K + + QI +
Sbjct: 66 -QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKG 124
Query: 340 LQFIHEKG--IAHLDVKPDNIYV--KNGVYKLGDFGRATLLNKSLPIEE-GDARYMPQEI 394
LQF+H + I H D+K DNI++ G K+GD G ATL S G +M E+
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEM 184
Query: 395 LNEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDGKLPLL--PGHSLQF 448
E YD VD+++ G M E+ P SE + + G P +
Sbjct: 185 YEEKYDE--SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242
Query: 449 QNLLKVMVDPDPVQRPSAKELVENPIF 475
+ +++ + + +R S K+L+ + F
Sbjct: 243 KEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-45
Identities = 75/304 (24%), Positives = 119/304 (39%), Gaps = 57/304 (18%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
DF +I ++GAGN VFKV + G A K ++ A R + + E+Q L +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHEC-NSP 64
Query: 290 NIVGYYSSWFENEQLYIQMELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIHEK- 346
IVG+Y +++ + ++ I ME D D+ K + E + K + + L ++ EK
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE-GDARYMPQEILN-EDYDHLD 403
I H DVKP NI V G KL DFG + L S+ G YM E L Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV-- 182
Query: 404 KVDIFSLGATMYELIKG------------------------------------------- 420
+ DI+S+G ++ E+ G
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 421 --SPLSESGPQFLNLRDGKLPLLPGH--SLQFQNLLKVMVDPDPVQRPSAKELVENPIFD 476
P + + P LP SL+FQ+ + + +P +R K+L+ +
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
Query: 477 KIQK 480
+
Sbjct: 303 RSDA 306
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 5e-45
Identities = 63/277 (22%), Positives = 120/277 (43%), Gaps = 20/277 (7%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
DF + +G G+FS V + YA+K KR + + + E ++ L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 67
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLSDKKASQF--FAEGEVLKALHQIAQALQFIHEK 346
V Y ++ ++E+LY + + K + F E +I AL+++H K
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE-----GDARYMPQEILNEDYD 400
GI H D+KP+NI + ++ ++ DFG A +L+ G A+Y+ E+L E
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS- 186
Query: 401 HLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVD 457
D+++LG +Y+L+ G P +G + F + + + ++L++ ++
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 246
Query: 458 PDPVQRPSAKELV------ENPIFDKIQKHRKTYMKP 488
D +R +E+ +P F+ + P
Sbjct: 247 LDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 283
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 5e-44
Identities = 63/262 (24%), Positives = 111/262 (42%), Gaps = 14/262 (5%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
DF + +G G+F VF + F+A+K K + D + ++E + L+ H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHEK 346
+ + ++ E L+ ME + L ++ F +I LQF+H K
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 347 GIAHLDVKPDNI-YVKNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEIL-NEDYDH 401
GI + D+K DNI K+G K+ DFG G Y+ EIL + Y+H
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 182
Query: 402 LDKVDIFSLGATMYELIKGSPLSESGP---QFLNLRDGKLPLLPGHSLQFQNLLKVMVDP 458
VD +S G +YE++ G F ++R + ++LL +
Sbjct: 183 --SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 459 DPVQRPSAK-ELVENPIFDKIQ 479
+P +R + ++ ++P+F +I
Sbjct: 241 EPEKRLGVRGDIRQHPLFREIN 262
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 7e-44
Identities = 52/260 (20%), Positives = 104/260 (40%), Gaps = 14/260 (5%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD----AERRKALLEVQALAAL 285
+ +G+G F V+ ++ D A+KH ++ D + +EV L +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 286 GS-HENIVGYYSSWFENEQLYIQMELCDHSLSDK---KASQFFAEGEVLKALHQIAQALQ 341
S ++ + + + +E + E Q+ +A++
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 342 FIHEKGIAHLDVKPDNIYV--KNGVYKLGDFGRATLLNKSLPIE-EGDARYMPQEILNED 398
H G+ H D+K +NI + G KL DFG LL ++ + +G Y P E +
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 399 YDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVDP 458
H ++SLG +Y+++ G E + + G++ S + Q+L++ +
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR---GQVFFRQRVSSECQHLIRWCLAL 241
Query: 459 DPVQRPSAKELVENPIFDKI 478
P RP+ +E+ +P +
Sbjct: 242 RPSDRPTFEEIQNHPWMQDV 261
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 2e-43
Identities = 55/275 (20%), Positives = 112/275 (40%), Gaps = 20/275 (7%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+ + +G G FS V + A+K ++ E E+ L + H
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS-MENEIAVLHKI-KHP 67
Query: 290 NIVGYYSSWFENEQLYIQMELCDH-SLSDK-KASQFFAEGEVLKALHQIAQALQFIHEKG 347
NIV + LY+ M+L L D+ F+ E + + + Q+ A++++H+ G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 348 IAHLDVKPDNIYV----KNGVYKLGDFGRATLLNKSLPIEE--GDARYM-PQEILNEDYD 400
I H D+KP+N+ ++ + DFG + + + + G Y+ P+ + + Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 401 HLDKVDIFSLGATMYELIKGSPL---SESGPQFLNLRDGKL----PLLPGHSLQFQNLLK 453
VD +S+G Y L+ G P F + + P S ++ ++
Sbjct: 188 K--AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 245
Query: 454 VMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMKP 488
+++ DP +R + ++ +++P K +
Sbjct: 246 HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 280
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (389), Expect = 4e-43
Identities = 54/277 (19%), Positives = 116/277 (41%), Gaps = 21/277 (7%)
Query: 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGS 287
Y + +E++G+G F V + +++ G + K + ++ E+ + L
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQL-H 84
Query: 288 HENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIH 344
H ++ + ++ + ++ + +E L D +E EV+ + Q + L+ +H
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 345 EKGIAHLDVKPDNIYV---KNGVYKLGDFGRATLLNKS--LPIEEGDARYMPQEILN-ED 398
E I HLD+KP+NI K K+ DFG AT LN + + A + EI++ E
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 204
Query: 399 YDHLDKVDIFSLGATMYELIKGSPL---SESGPQFLNLRDGKL----PLLPGHSLQFQNL 451
D++++G Y L+ G + N++ S + ++
Sbjct: 205 VGF--YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262
Query: 452 LKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMKP 488
+K ++ +P +R + + +E+P + + +
Sbjct: 263 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 299
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-43
Identities = 57/262 (21%), Positives = 107/262 (40%), Gaps = 25/262 (9%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
++IG+G+F V+K D AVK + + EV L H
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHV 64
Query: 290 NIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEK 346
NI+ + + QL I + C+ SL F +++ Q AQ + ++H K
Sbjct: 65 NILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE-----GDARYMPQEILN-EDY 399
I H D+K +NI++ ++ K+GDFG AT+ ++ + G +M E++ +D
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 400 DHLD-KVDIFSLGATMYELIKGS-PLSESGPQFL-------NLRDGKLPLLPGH-SLQFQ 449
+ + D+++ G +YEL+ G P S + L + + +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 450 NLLKVMVDPDPVQRPSAKELVE 471
L+ + +RP +++
Sbjct: 244 RLMAECLKKKRDERPLFPQILA 265
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 151 bits (382), Expect = 1e-42
Identities = 59/262 (22%), Positives = 128/262 (48%), Gaps = 14/262 (5%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
DF + +G G+F V + R +G +YA+K K+++ ++ + + + + ++ +H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 290 NIVGYYSSWFENEQLYIQMELCD--HSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKG 347
I+ + ++ + +Q+++ M+ + S + SQ F ++ AL+++H K
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEIL-NEDYDHLDKV 405
I + D+KP+NI + KNG K+ DFG A + G Y+ E++ + Y+ +
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNK--SI 182
Query: 406 DIFSLGATMYELIKG-SPLSESGP--QFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPVQ 462
D +S G +YE++ G +P +S + + + +L P + ++LL ++ D Q
Sbjct: 183 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQ 242
Query: 463 R-----PSAKELVENPIFDKIQ 479
R +++ +P F ++
Sbjct: 243 RLGNLQNGTEDVKNHPWFKEVV 264
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-42
Identities = 55/266 (20%), Positives = 113/266 (42%), Gaps = 22/266 (8%)
Query: 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGS 287
Y + E +G G F V + ++ Y K K + ++ E+ L
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIA-R 59
Query: 288 HENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIH 344
H NI+ + S+ E+L + E + + ++ E E++ +HQ+ +ALQF+H
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 345 EKGIAHLDVKPDNIYV---KNGVYKLGDFGRATLLNKSLP---IEEGDARYMPQEILNED 398
I H D++P+NI ++ K+ +FG+A L + Y P+ ++
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 399 YDHLDKVDIFSLGATMYELIKGSPL--SESGPQFL-NLRDGKL----PLLPGHSLQFQNL 451
D++SLG +Y L+ G +E+ Q + N+ + + S++ +
Sbjct: 180 VST--ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 452 LKVMVDPDPVQRPSAKELVENPIFDK 477
+ ++ + R +A E +++P +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQ 263
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-42
Identities = 56/258 (21%), Positives = 97/258 (37%), Gaps = 25/258 (9%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSH 288
+E++GAG F V+ AVK L + A L E + L H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVK----SLKQGSMSPDAFLAEANLMKQL-QH 67
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLSD----KKASQFFAEGEVLKALHQIAQALQFIH 344
+ +V Y+ E +YI E ++ + ++L QIA+ + FI
Sbjct: 68 QRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 345 EKGIAHLDVKPDNIYVKN-GVYKLGDFGRATLLNKSLPIEE----GDARYM-PQEILNED 398
E+ H D++ NI V + K+ DFG A L+ + ++ P+ I
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 399 YDHLDKVDIFSLGATMYELIKGSPLSESGP----QFLNLRDGKLPLLPGH-SLQFQNLLK 453
+ K D++S G + E++ + G NL G + P + + L++
Sbjct: 187 FTI--KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244
Query: 454 VMVDPDPVQRPSAKELVE 471
+ P RP+ L
Sbjct: 245 LCWKERPEDRPTFDYLRS 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (369), Expect = 6e-41
Identities = 53/277 (19%), Positives = 104/277 (37%), Gaps = 31/277 (11%)
Query: 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALG 286
TD ++G G + V++ + + AVK L D + L E + +
Sbjct: 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK----TLKEDTMEVEEFLKEAAVMKEI- 70
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDHSLSD----KKASQFFAEGEVLKALHQIAQALQF 342
H N+V YI E + + Q + +L QI+ A+++
Sbjct: 71 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM-----PQEILN 396
+ +K H D+ N V +N + K+ DFG + L+ A++ P+ +
Sbjct: 131 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 397 EDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL-----RDGKLPLLPGHSLQFQNL 451
+ K D+++ G ++E+ G + +D ++ G + L
Sbjct: 191 NKFSI--KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 248
Query: 452 LKVMVDPDPVQRPSAKELV--------ENPIFDKIQK 480
++ +P RPS E+ E+ I D+++K
Sbjct: 249 MRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-40
Identities = 61/302 (20%), Positives = 116/302 (38%), Gaps = 38/302 (12%)
Query: 214 LFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVK-HSKRQLHHDAER 272
++PV+ + D + IG GNF V K + DG ++ +
Sbjct: 3 IYPVLD--------WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH 54
Query: 273 RKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSD-------------- 317
R E++ L LG H NI+ + LY+ +E H +L D
Sbjct: 55 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 114
Query: 318 ---KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRA 373
+ + ++L +A+ + ++ +K H D+ NI V +N V K+ DFG +
Sbjct: 115 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 174
Query: 374 TLLNKSLP--IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL 431
+ + R+M E LN + D++S G ++E++ G
Sbjct: 175 RGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 233
Query: 432 NL-----RDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYM 486
L + +L + +L++ P +RPS +++ +++ + RKTY+
Sbjct: 234 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV--SLNRMLEERKTYV 291
Query: 487 KP 488
Sbjct: 292 NT 293
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-40
Identities = 72/282 (25%), Positives = 117/282 (41%), Gaps = 36/282 (12%)
Query: 230 DFHEIEQ-IGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH 288
D+ Q +G G V ++ + +A+K + + KA EV+
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQC 64
Query: 289 ENIVGYY----SSWFENEQLYIQMELCDH-SLSD---KKASQFFAEGEVLKALHQIAQAL 340
+IV + + + L I ME D L + Q F E E + + I +A+
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 341 QFIHEKGIAHLDVKPDNIYV----KNGVYKLGDFGRATLL--NKSLPIEEGDARYMPQEI 394
Q++H IAH DVKP+N+ N + KL DFG A + SL Y+ E+
Sbjct: 125 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 184
Query: 395 LN-EDYDHLDKVDIFSLGATMYELIKG-------SPLSESGPQFLNLRDGKL----PLLP 442
L E YD D++SLG MY L+ G L+ S +R G+ P
Sbjct: 185 LGPEKYDK--SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 443 GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKT 484
S + + L++ ++ +P QR + E + +P + K +T
Sbjct: 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 284
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 146 bits (369), Expect = 3e-40
Identities = 62/268 (23%), Positives = 114/268 (42%), Gaps = 18/268 (6%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAAL--G 286
DF IG G F V+ K G YA+K K+++ AL E L+ + G
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIH 344
IV ++ ++L ++L + F+E ++ +I L+ +H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP-IEEGDARYMPQEILNEDYDHL 402
+ + + D+KP NI + ++G ++ D G A +K P G YM E+L + +
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 403 DKVDIFSLGATMYELIKGS-PLSESGPQ-----FLNLRDGKLPLLPGHSLQFQNLLKVMV 456
D FSLG +++L++G P + + + L S + ++LL+ ++
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244
Query: 457 DPDPVQRPS-----AKELVENPIFDKIQ 479
D +R A+E+ E+P F +
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFFRSLD 272
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-40
Identities = 59/282 (20%), Positives = 107/282 (37%), Gaps = 41/282 (14%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVK---HSKRQLHHDAERRKALLEVQALAALGSHEN 290
++ +G G F+ V+K + A+K R D R AL E++ L L SH N
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPN 61
Query: 291 IVGYYSSWFENEQLYIQMELCD--HSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGI 348
I+G ++ + + + + + K S + + Q L+++H+ I
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 349 AHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEILNEDYDHLDK 404
H D+KP+N+ + +NGV KL DFG A Y E+L +
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181
Query: 405 VDIFSLGATMYELI---------------------KGSPLSESGPQFLNLRDGKLP---- 439
VD++++G + EL+ G+P E P +L D
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241
Query: 440 ------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
+ +L++ + +P R +A + ++ F
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 6e-40
Identities = 71/290 (24%), Positives = 110/290 (37%), Gaps = 40/290 (13%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+F ++E+IG G + V+K ++ G A+K + + A+ E+ L L +H
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHP 61
Query: 290 NIVGYYSSWFENEQLYIQMELCDHSLS---DKKASQFFAEGEVLKALHQIAQALQFIHEK 346
NIV +LY+ E L D A + L Q+ Q L F H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE---GDARYMPQEILNEDYDHL 402
+ H D+KP N+ + G KL DFG A + Y EIL +
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 403 DKVDIFSLGATMYELI---------------------KGSPLSESGPQFLNLRDGKLP-- 439
VDI+SLG E++ G+P P ++ D K
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 440 ---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
++P ++LL M+ DP +R SAK + +P F + K
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-39
Identities = 49/257 (19%), Positives = 94/257 (36%), Gaps = 23/257 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSH 288
+ +++IG+G F V ++ A+K + A + + E + + L SH
Sbjct: 6 ELTFVQEIGSGQFGLVHLG-YWLNKDKVAIK----TIREGAMSEEDFIEEAEVMMKL-SH 59
Query: 289 ENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHE 345
+V Y E + + E +H LSD + FA +L + + + ++ E
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----LPIEEGDARYMPQEILN-EDY 399
+ H D+ N V +N V K+ DFG + + ++ E+ + Y
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 400 DHLDKVDIFSLGATMYELIKGSPLSESGP----QFLNLRDGKLPLLPGH-SLQFQNLLKV 454
K D++S G M+E+ + ++ G P S ++
Sbjct: 180 SS--KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237
Query: 455 MVDPDPVQRPSAKELVE 471
P RP+ L+
Sbjct: 238 CWKERPEDRPAFSRLLR 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-39
Identities = 62/266 (23%), Positives = 113/266 (42%), Gaps = 19/266 (7%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
DF ++ +G G F V V ++ G +YA+K K + E + E + L H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RH 64
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHS--LSDKKASQFFAEGEVLKALHQIAQALQFIHEK 346
+ ++ +++L ME + + F E +I AL+++H +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLL---NKSLPIEEGDARYMPQEIL-NEDYDH 401
+ + D+K +N+ + K+G K+ DFG ++ G Y+ E+L + DY
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 402 LDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDP 458
VD + LG MYE++ G + F + ++ S + ++LL ++
Sbjct: 185 --AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242
Query: 459 DPVQRPS-----AKELVENPIFDKIQ 479
DP QR AKE++E+ F I
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-38
Identities = 60/279 (21%), Positives = 109/279 (39%), Gaps = 39/279 (13%)
Query: 230 DFHEIEQIGAGNFSHVFKV-----LKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAA 284
+ +GAG F V + +K AVK K H ER + E++ L+
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSY 82
Query: 285 LGSHENIVGYYSSWFENEQLYIQMELCDH-SLSD-------------------KKASQFF 324
LG+H NIV + + E C + L + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 325 AEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP-- 381
++L +Q+A+ + F+ K H D+ NI + + K+ DFG A +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 382 ---IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELI-KGSPLSESGPQ----FLNL 433
++M E + + + D++S G ++EL GS P + +
Sbjct: 203 VKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 434 RDGKLPLLPGH-SLQFQNLLKVMVDPDPVQRPSAKELVE 471
++G L P H + +++K D DP++RP+ K++V+
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 5e-38
Identities = 53/258 (20%), Positives = 95/258 (36%), Gaps = 25/258 (9%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSH 288
++G G F V+ A+K L +A L E Q + L H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWN-GTTRVAIK----TLKPGTMSPEAFLQEAQVMKKL-RH 71
Query: 289 ENIVGYYSSWFENEQLYIQMELCDHSLSD----KKASQFFAEGEVLKALHQIAQALQFIH 344
E +V Y+ E +YI E + ++ +++ QIA + ++
Sbjct: 72 EKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----LPIEEGDARYM-PQEILNED 398
H D++ NI V +N V K+ DFG A L+ + + ++ P+ L
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 399 YDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL-----RDGKLPLLPGHSLQFQNLLK 453
+ K D++S G + EL + G + R ++P P +L+
Sbjct: 191 FTI--KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248
Query: 454 VMVDPDPVQRPSAKELVE 471
+P +RP+ + L
Sbjct: 249 QCWRKEPEERPTFEYLQA 266
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 137 bits (346), Expect = 9e-38
Identities = 61/286 (21%), Positives = 105/286 (36%), Gaps = 40/286 (13%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+H +E+IG G + V+K G +A+K + + + + E+ L L H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHS 60
Query: 290 NIVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKG 347
NIV Y ++L + E D L L Q+ + + H++
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEG---DARYMPQEILNEDYDHLD 403
+ H D+KP N+ + + G K+ DFG A + Y ++L +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 404 KVDIFSLGATMYELIKGSP-------------------------------LSESGPQFLN 432
+DI+S+G E++ G+P L + P F
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 433 LRDGKLP-LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
L G +LL M+ DP QR +AK+ +E+ F +
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (347), Expect = 9e-38
Identities = 56/273 (20%), Positives = 102/273 (37%), Gaps = 27/273 (9%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDG---CFYAVKHSKRQLHHDAERRKALLEVQALAALG 286
+ IGAG F V ++ G F A+K K + + +RR L E +
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQF- 84
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDHSLSD---KKASQFFAEGEVLKALHQIAQALQFI 343
H N++ ++ + I E ++ D ++ F +++ L IA ++++
Sbjct: 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE--------GDARYM-PQE 393
+ H D+ NI V N V K+ DFG + L R+ P+
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 394 ILNEDYDHLDKVDIFSLGATMYELI--KGSPLSESGPQFLN---LRDGKLPLLPGHSLQF 448
I + D++S G M+E++ P + Q + +D +LP
Sbjct: 205 IQYRKFTS--ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSAL 262
Query: 449 QNLLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481
L+ D RP ++V DK+ ++
Sbjct: 263 HQLMLDCWQKDRNHRPKFGQIVN--TLDKMIRN 293
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-37
Identities = 54/263 (20%), Positives = 97/263 (36%), Gaps = 25/263 (9%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRID---GCFYAVKHSKRQLHHDAERRKALL-EVQALAAL 285
D +E++G G+F V + AVK K + E + EV A+ +L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 286 GSHENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQF--FAEGEVLKALHQIAQALQF 342
H N++ Y + + EL SL D+ F G + + Q+A+ + +
Sbjct: 69 -DHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE------GDARYM-PQEI 394
+ K H D+ N+ + + K+GDFG L ++ + P+ +
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 395 LNEDYDHLDKVDIFSLGATMYELI-KGSPL--SESGPQFLNL---RDGKLPLLPGHSLQF 448
+ H D + G T++E+ G +G Q L+ +LP
Sbjct: 187 KTRTFSH--ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 449 QNLLKVMVDPDPVQRPSAKELVE 471
N++ P RP+ L +
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (346), Expect = 1e-37
Identities = 53/284 (18%), Positives = 98/284 (34%), Gaps = 45/284 (15%)
Query: 230 DFHEIEQIGAGNFSHVFKV-----LKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAA 284
+ + IG G F VF+ L AVK K + D + E +A
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAE 72
Query: 285 LGSHENIVGYYSSWFENEQLYIQMELCDH-SLSD-------------------------K 318
+ NIV + + + E + L++
Sbjct: 73 F-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 319 KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN 377
+ E L Q+A + ++ E+ H D+ N V +N V K+ DFG + +
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 378 KSLPIEE-----GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKG--SPLSESGPQ- 429
+ + R+MP E + + + D+++ G ++E+ P +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 430 -FLNLRDGKLPLLPGH-SLQFQNLLKVMVDPDPVQRPSAKELVE 471
+RDG + P + L+ NL+++ P RPS +
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 2e-37
Identities = 56/285 (19%), Positives = 102/285 (35%), Gaps = 46/285 (16%)
Query: 230 DFHEIEQIGAGNFSHVFKVL-----KRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAA 284
+ + +G+G F V K AVK K + +ER + E++ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQ 96
Query: 285 LGSHENIVGYYSSWFENEQLYIQMELCDH-------------------------SLSDKK 319
LGSHENIV + + +Y+ E C + L +++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 320 ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378
++L +Q+A+ ++F+ K H D+ N+ V V K+ DFG A +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 379 S-----LPIEEGDARYM-PQEILNEDYDHLDKVDIFSLGATMYELI-KGSPLSESGPQFL 431
++M P+ + Y K D++S G ++E+ G P
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYTI--KSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 432 NL-----RDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE 471
N K+ + + +++ D +RPS L
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-37
Identities = 63/290 (21%), Positives = 112/290 (38%), Gaps = 42/290 (14%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ +++ +G+G + V + G A+K R + ++A E++ L + HEN
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHEN 78
Query: 291 IVGYYSSWFENEQL------YIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIH 344
++G + +E L Y+ M L + E + ++Q+ + L++IH
Sbjct: 79 VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 138
Query: 345 EKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLD 403
GI H D+KP N+ V ++ K+ DFG A + + Y E++ +
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQ 198
Query: 404 KVDIFSLGATMYELIKGSPL---------------------------------SESGPQF 430
VDI+S+G M E+I G L
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258
Query: 431 LNLRDGKLP-LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479
L +L S NLL+ M+ D QR +A E + +P F+ +
Sbjct: 259 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-37
Identities = 63/299 (21%), Positives = 108/299 (36%), Gaps = 54/299 (18%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+ ++ +IG G F VFK R G A+K + + AL E++ L L HE
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHE 69
Query: 290 NIVGYYSSWFENE--------QLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQA 339
N+V +Y+ + C+H L+ F E+ + + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 340 LQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE-------GDARYMP 391
L +IH I H D+K N+ + ++GV KL DFG A + + + Y P
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 392 QEILNEDYDHLDKVDIFSLGATMYELIKGSPL---------------------SESGPQF 430
E+L + D+ +D++ G M E+ SP+ E P
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 431 LNLRDGKLPLLPGH--------------SLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
N + L +L+ ++ DP QR + + + + F
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-37
Identities = 54/273 (19%), Positives = 108/273 (39%), Gaps = 22/273 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAE----RRKALLEVQALAAL 285
+ E++G+G F+ V K ++ G YA K K++ + R EV L +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 286 GSHENIVGYYSSWFENEQLYIQMELCDHS--LSDKKASQFFAEGEVLKALHQIAQALQFI 343
H N++ + + + + +EL + E E + L QI + ++
Sbjct: 71 -QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 344 HEKGIAHLDVKPDNIYV-----KNGVYKLGDFGRATLLN--KSLPIEEGDARYMPQEILN 396
H IAH D+KP+NI + K+ DFG A ++ G ++ EI+N
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189
Query: 397 EDYDHLDKVDIFSLGATMYELIKGSPLSESGP---QFLNLRDGKL----PLLPGHSLQFQ 449
+ + D++S+G Y L+ G+ N+ S +
Sbjct: 190 YEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 450 NLLKVMVDPDPVQRPSAKELVENPIFDKIQKHR 482
+ ++ ++ DP +R + ++ +++P +
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-37
Identities = 52/257 (20%), Positives = 95/257 (36%), Gaps = 21/257 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
D ++++G G F V R A+K K + + E + + L SHE
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG---SMSEDEFIEEAKVMMNL-SHE 59
Query: 290 NIVGYYSSWFENEQLYIQMELCDHSLSDK---KASQFFAEGEVLKALHQIAQALQFIHEK 346
+V Y + ++I E + + F ++L+ + +A++++ K
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE----GDARYMPQEIL-NEDYD 400
H D+ N V GV K+ DFG + + R+ P E+L +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 401 HLDKVDIFSLGATMYELI-KGSPLSESGPQ---FLNLRDGKLPLLPGH-SLQFQNLLKVM 455
K DI++ G M+E+ G E ++ G P S + ++
Sbjct: 180 S--KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237
Query: 456 VDPDPVQRPSAKELVEN 472
+RP+ K L+ N
Sbjct: 238 WHEKADERPTFKILLSN 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-37
Identities = 66/303 (21%), Positives = 114/303 (37%), Gaps = 47/303 (15%)
Query: 223 GLSRYYTDFHEIEQIGAGNFSHVFKVL-KRIDGCFYAVKHSKRQLHHDAERRKALLEVQA 281
GL R + + +IG G + VFK + G F A+K + Q + + EV
Sbjct: 1 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV 60
Query: 282 LAALGS--HENIVGYYSSWFENE-----QLYIQMELCDH---SLSDKKASQFFAEGEVLK 331
L L + H N+V + + +L + E D + DK +
Sbjct: 61 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 120
Query: 332 ALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE--GDAR 388
+ Q+ + L F+H + H D+KP NI V +G KL DFG A + + + +
Sbjct: 121 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW 180
Query: 389 YM-PQEILNEDYDHLDKVDIFSLGATMYELIKGSPL---------------------SES 426
Y P+ +L Y VD++S+G E+ + PL E
Sbjct: 181 YRAPEVLLQSSYAT--PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 427 GPQFLNLRDGKLP---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
P+ + L + ++LL + +P +R SA + +P F
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
Query: 478 IQK 480
+++
Sbjct: 299 LER 301
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 4e-37
Identities = 69/287 (24%), Positives = 117/287 (40%), Gaps = 40/287 (13%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+ ++E+IG G + VFK R A+K + + AL E+ L L H+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHK 61
Query: 290 NIVGYYSSWFENEQLYIQMELCDHS--LSDKKASQFFAEGEVLKALHQIAQALQFIHEKG 347
NIV + +++L + E CD + V L Q+ + L F H +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 348 IAHLDVKPDNIYV-KNGVYKLGDFGRATLL---NKSLPIEEGDARYMPQEILNEDYDHLD 403
+ H D+KP N+ + +NG KL +FG A + E Y P ++L +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 404 KVDIFSLGATMYEL----------------------IKGSPLSESGPQFLNLRDGK---- 437
+D++S G EL + G+P E P L D K
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 438 -------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
+ ++P + ++LL+ ++ +PVQR SA+E +++P F
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-37
Identities = 51/267 (19%), Positives = 102/267 (38%), Gaps = 22/267 (8%)
Query: 233 EIEQIGAGNFSHVFKVLKRI--DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
E +++G+GNF V K ++ AVK K + + A + + L E + L +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPY 69
Query: 291 IVGYYSSWFENEQLYIQMELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIHEKGI 348
IV E E + ME+ + +K + ++ + +++ +HQ++ ++++ E
Sbjct: 70 IVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 349 AHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE------GDARYMPQEILNEDYDH 401
H D+ N+ + K+ DFG + L + ++ E +N
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 402 LDKVDIFSLGATMYELI--KGSPLSESGPQ--FLNLRDGKLPLLPGH-SLQFQNLLKVMV 456
K D++S G M+E P L G+ P + +L+ +
Sbjct: 189 S-KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 247
Query: 457 DPDPVQRPSAKELV---ENPIFDKIQK 480
D RP + N +D + +
Sbjct: 248 TYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-37
Identities = 57/270 (21%), Positives = 95/270 (35%), Gaps = 22/270 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRID---GCFYAVKHSKRQLHHDAERRKALLEVQALAALG 286
IG G F V + + A+K + + D+ R K L E +
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCTSDSVREKFLQEALTMRQF- 65
Query: 287 SHENIVGYYSSWFENEQLYIQMELCDH-SLSDKKASQF--FAEGEVLKALHQIAQALQFI 343
H +IV ++I MELC L + ++ +Q++ AL ++
Sbjct: 66 DHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE----GDARYMPQEILNED 398
K H D+ N+ V N KLGDFG + + S + ++M E +N
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 399 YDHLDKVDIFSLGATMYELI-KGSPLSESGPQ----FLNLRDGKLPLLPGHSLQFQNLLK 453
D++ G M+E++ G + +LP+ P +L+
Sbjct: 185 R-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243
Query: 454 VMVDPDPVQRPSAKELVENPIFDKIQKHRK 483
DP +RP EL I + K
Sbjct: 244 KCWAYDPSRRPRFTELKA--QLSTILEEEK 271
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-37
Identities = 58/293 (19%), Positives = 108/293 (36%), Gaps = 48/293 (16%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ + IG G + V ++ A+K H ++ L E++ L HEN
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-KISPFEHQTYCQRTLREIKILLRF-RHEN 67
Query: 291 IVGYY-----SSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHE 345
I+G + + + +Y+ L L +Q + + L+QI + L++IH
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 127
Query: 346 KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE------GDARYMPQEILNED 398
+ H D+KP N+ + K+ DFG A + + Y EI+
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 399 YDHLDKVDIFSLGATMYEL---------------------IKGSPLSESGPQFLNLRDGK 437
+ +DI+S+G + E+ I GSP E +NL+
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 438 LP-------------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
L P + +LL M+ +P +R ++ + +P ++
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 4e-37
Identities = 58/275 (21%), Positives = 113/275 (41%), Gaps = 22/275 (8%)
Query: 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDA---ERRKALLEVQALAAL 285
T+F +I+ +G+G F V+K L +G + + ++L ++ L E +A++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 286 GSHENIVGYYSSWFENEQLYIQMELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFI 343
+ ++ + I + L D + +L QIA+ + ++
Sbjct: 69 -DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-----LPIEEGDARYMPQE-ILN 396
++ + H D+ N+ V K+ DFG A LL + ++M E IL+
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 397 EDYDHLDKVDIFSLGATMYELI-KGSPLSESGPQ---FLNLRDGKLPLLPGH-SLQFQNL 451
Y H + D++S G T++EL+ GS + P L G+ P ++ +
Sbjct: 188 RIYTH--QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 245
Query: 452 LKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYM 486
+ D RP +EL+ F K+ + + Y+
Sbjct: 246 MVKCWMIDADSRPKFRELIIE--FSKMARDPQRYL 278
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-36
Identities = 54/266 (20%), Positives = 98/266 (36%), Gaps = 24/266 (9%)
Query: 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRI--DGCFYAVKHSKRQLHHDAERRKALLEVQA 281
L R +IE +G GNF V + + R+ A+K K+ + + + E Q
Sbjct: 5 LKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQI 62
Query: 282 LAALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQ 338
+ L + IV + E L + ME+ L + V + LHQ++
Sbjct: 63 MHQL-DNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 339 ALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE------GDARYM- 390
++++ EK H D+ N+ + K+ DFG + L ++
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 391 PQEILNEDYDHLDKVDIFSLGATMYELI-KGSPL--SESGPQFL-NLRDGKLPLLPGH-S 445
P+ I + + D++S G TM+E + G GP+ + + GK P
Sbjct: 181 PECINFRKFSS--RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 238
Query: 446 LQFQNLLKVMVDPDPVQRPSAKELVE 471
+ L+ RP + +
Sbjct: 239 PELYALMSDCWIYKWEDRPDFLTVEQ 264
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-36
Identities = 68/312 (21%), Positives = 120/312 (38%), Gaps = 55/312 (17%)
Query: 217 VITGGDGLSRYYT-DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKA 275
V T G G R + + + IG G+F V++ G A+K ++ D +
Sbjct: 7 VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNR 62
Query: 276 LLEVQALAALGSHENIVGYYSSWFENEQ------LYIQMELCDHS-----LSDKKASQFF 324
E+Q + L H NIV ++ + + L + ++ + +A Q
Sbjct: 63 --ELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 325 AEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV--KNGVYKLGDFGRATLLNKSLPI 382
V ++Q+ ++L +IH GI H D+KP N+ + V KL DFG A L + P
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 383 EE--GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPL--SESGPQFL------- 431
Y E++ D+ +D++S G + EL+ G P+ +SG L
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
Query: 432 -------------NLRDGKLPLLPGHSL----------QFQNLLKVMVDPDPVQRPSAKE 468
N + K P + H + L +++ P R + E
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299
Query: 469 LVENPIFDKIQK 480
+ FD+++
Sbjct: 300 ACAHSFFDELRD 311
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 5e-36
Identities = 53/279 (18%), Positives = 108/279 (38%), Gaps = 40/279 (14%)
Query: 230 DFHEIEQIGAGNFSHVFKV-------LKRIDGCFYAVKHSKRQLHHDAERRKALLEVQAL 282
+ +G G F V K AVK K + + E++ +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMM 72
Query: 283 AALGSHENIVGYYSSWFENEQLYIQMELCDH-SLSD-----------------KKASQFF 324
+G H+NI+ + ++ LY+ +E +L + +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 325 AEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---- 379
+ +++ +Q+A+ ++++ K H D+ N+ V ++ V K+ DFG A ++
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 380 -LPIEEGDARYMPQEIL-NEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNL 433
++M E L + Y H + D++S G ++E+ G F L
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTH--QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 434 RDGKLPLLPGH-SLQFQNLLKVMVDPDPVQRPSAKELVE 471
++G P + + + +++ P QRP+ K+LVE
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 6e-36
Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 25/275 (9%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRID---GCFYAVK--HSKRQLHHDAERRKALLEVQALAA 284
+F ++ +G G + VF V K G YA+K + E Q L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 285 LGSHENIVGYYSSWFENEQLYIQMELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQF 342
+ +V + ++ +L++ ++ + + F E EV + +I AL+
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL----NKSLPIEEGDARYMPQEIL-N 396
+H+ GI + D+K +NI + NG L DFG + + G YM +I+
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 397 EDYDHLDKVDIFSLGATMYELIKG-SPLSESGPQ------FLNLRDGKLPLLPGHSLQFQ 449
D H VD +SLG MYEL+ G SP + G + + + P S +
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 264
Query: 450 NLLKVMVDPDPVQRPS-----AKELVENPIFDKIQ 479
+L++ ++ DP +R A E+ E+ F KI
Sbjct: 265 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 6e-36
Identities = 55/271 (20%), Positives = 102/271 (37%), Gaps = 24/271 (8%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDG----CFYAVKHSKRQLHHDAERRKALLEVQALAAL 285
+ IGAG F V+K + + A+K K + + +R L E +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQF 66
Query: 286 GSHENIVGYYSSWFENEQLYIQMELCDHSLSDK---KASQFFAEGEVLKALHQIAQALQF 342
SH NI+ + + + I E ++ DK + F+ +++ L IA +++
Sbjct: 67 -SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN------KSLPIEEGDARYMPQEIL 395
+ H D+ NI V N V K+ DFG + +L + + R+ E +
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 396 NEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDG-KLPLLPGHSLQFQN 450
+ D++S G M+E++ + DG +LP
Sbjct: 186 SYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244
Query: 451 LLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481
L+ + +RP ++V I DK+ +
Sbjct: 245 LMMQCWQQERARRPKFADIVS--ILDKLIRA 273
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 131 bits (330), Expect = 1e-35
Identities = 66/265 (24%), Positives = 98/265 (36%), Gaps = 26/265 (9%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALL-EVQALAALGSH 288
+ E +G G S V AVK + L D E Q AAL +H
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NH 66
Query: 289 ENIVGYYSSWFENE----QLYIQMELCDHSLSDKKASQF--FAEGEVLKALHQIAQALQF 342
IV Y + YI ME D ++ + QAL F
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 343 IHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE------GDARYMPQEIL 395
H+ GI H DVKP NI + K+ DFG A + S G A+Y+ E
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 396 -NEDYDHLDKVDIFSLGATMYELIKGSPL----SESGPQFLNLRDGKLP---LLPGHSLQ 447
+ D + D++SLG +YE++ G P S + ++R+ +P G S
Sbjct: 187 RGDSVDA--RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244
Query: 448 FQNLLKVMVDPDPVQRP-SAKELVE 471
++ + +P R +A E+
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMRA 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (330), Expect = 2e-35
Identities = 53/266 (19%), Positives = 87/266 (32%), Gaps = 34/266 (12%)
Query: 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293
+IG+G+F ++ G A+K + + +E + + I
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIK----LECVKTKHPQLHIESKIYKMMQGGVGIPT 67
Query: 294 YYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHL 351
E + + MEL SL D S+ F+ VL Q+ +++IH K H
Sbjct: 68 IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR 127
Query: 352 DVKPDNIYV----KNGVYKLGDFGRATLLNKSLPIEE----------GDARYMPQE-ILN 396
DVKPDN + K + + DFG A + + G ARY L
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 397 EDYDHLDKVDIFSLGATMYELIKGSPLSESG-----------PQFLNLRDGKLPLLPGHS 445
+ + D+ SLG + GS + + L G+
Sbjct: 188 IEQSR--RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 446 LQFQNLLKVMVDPDPVQRPSAKELVE 471
+F L +P L +
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYLRQ 271
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (331), Expect = 5e-35
Identities = 57/263 (21%), Positives = 111/263 (42%), Gaps = 16/263 (6%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKH-SKRQLHHDAERRKALLEVQALAALGSH 288
F I+ +G G+F V V + G YA+K K+++ + L E + L A+ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NF 100
Query: 289 ENIVGYYSSWFENEQLY--IQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEK 346
+V S+ +N LY ++ S + F+E QI +++H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 347 GIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM-PQEILNEDYDHLDK 404
+ + D+KP+N+ + + G ++ DFG A + G + P+ IL++ Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNK--A 218
Query: 405 VDIFSLGATMYELIKGSPLSESGP---QFLNLRDGKLPLLPGHSLQFQNLLKVMVDPDPV 461
VD ++LG +YE+ G P + + + GK+ S ++LL+ ++ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 462 QR-----PSAKELVENPIFDKIQ 479
+R ++ + F
Sbjct: 279 KRFGNLKNGVNDIKNHKWFATTD 301
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 9e-35
Identities = 63/289 (21%), Positives = 108/289 (37%), Gaps = 42/289 (14%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+ + +G+G + V G AVK R ++ E++ L + HE
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHE 77
Query: 290 NIVGYY------SSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFI 343
N++G S E +Y+ L L++ Q + V ++QI + L++I
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 344 HEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHL 402
H I H D+KP N+ V ++ K+ DFG A + + Y EI+ +
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYN 197
Query: 403 DKVDIFSLGATMYELIKGSPL----SESGPQFLNLRDGKLP------------------- 439
VDI+S+G M EL+ G L L LR P
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257
Query: 440 -----------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477
+ G + +LL+ M+ D +R +A + + + F +
Sbjct: 258 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 128 bits (321), Expect = 4e-34
Identities = 52/284 (18%), Positives = 96/284 (33%), Gaps = 38/284 (13%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHEN 290
+ +IG G+F +F+ ++ A+K ++ + E + L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK----FEPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 291 IVGYYSSWFENEQLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGI 348
I Y E + ++L SL D + F+ V A Q+ +Q IHEK +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 349 AHLDVKPDNIYV------KNGVYKLGDFGRATLLNKSLPIEE----------GDARYMPQ 392
+ D+KPDN + + + DFG + + G ARYM
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 393 EILN-EDYDHLDKVDIFSLGATMYELIKGSPLSESGP------QFLNLRDGKLP-----L 440
+ + D+ +LG ++GS + ++ + + K L
Sbjct: 183 NTHLGREQSR--RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 441 LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKT 484
G +F + + P L +F K+ + T
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKVLERLNT 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 125 bits (314), Expect = 7e-33
Identities = 53/298 (17%), Positives = 109/298 (36%), Gaps = 53/298 (17%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
D+ + ++G G +S VF+ + + VK K +R E++ L L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR-----EIKILENLRGGP 90
Query: 290 NIVGYYSSWFE--NEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKG 347
NI+ + + + E +++ K+ Q + ++ +++I +AL + H G
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNT-DFKQLYQTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 348 IAHLDVKPDNIYV--KNGVYKLGDFGRATLL--NKSLPIEEGDARYMPQEILNEDYDHLD 403
I H DVKP N+ + ++ +L D+G A + + + E+L + +
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 209
Query: 404 KVDIFSLGATMYEL----------------------IKGSPLSESGPQFLNL-------- 433
+D++SLG + + + G+ N+
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269
Query: 434 -----------RDGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480
R S + + L ++ D R +A+E +E+P F + K
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-32
Identities = 53/284 (18%), Positives = 94/284 (33%), Gaps = 28/284 (9%)
Query: 224 LSRYYTDFHEIEQIGAGNFSHVFKVLKRID---GCFYAVKHSKRQLHHDAERRKALLEVQ 280
+ H E IG G+F V+ + AVK R + E + L E
Sbjct: 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGI 80
Query: 281 ALAALGSHENIVGYYSSWFENE-QLYIQMELCDHSLSDK---KASQFFAEGEVLKALHQI 336
+ SH N++ +E + + H + +++ Q+
Sbjct: 81 IMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 139
Query: 337 AQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE-------GDAR 388
A+ ++F+ K H D+ N + + K+ DFG A + +
Sbjct: 140 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 389 YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDGKLPLLPGH 444
+M E L K D++S G ++EL+ + L G+ L P +
Sbjct: 200 WMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258
Query: 445 -SLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYMK 487
++ P RPS ELV +I T++
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVS-----RISAIFSTFIG 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-31
Identities = 56/288 (19%), Positives = 102/288 (35%), Gaps = 57/288 (19%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGY 294
E IG G F V++ + G AVK + R E+ L HENI+G+
Sbjct: 9 ESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREA---EIYQTVML-RHENILGF 62
Query: 295 YSSWFENE----QLYIQMELCDH-SLSDKKASQFFAEGEVLKALHQIAQALQFIHE---- 345
++ ++ QL++ + +H SL D ++K A L +H
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 346 ----KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE-------GDARYMPQE 393
IAH D+K NI V KNG + D G A + + + G RYM E
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 394 ILNED-----YDHLDKVDIFSLGATMYELIKGSPLSESGPQF------------------ 430
+L++ ++ + DI+++G +E+ + + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 431 -LNLRDGKLPLLPGH------SLQFQNLLKVMVDPDPVQRPSAKELVE 471
+ P +P +++ + R +A + +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-31
Identities = 54/278 (19%), Positives = 101/278 (36%), Gaps = 38/278 (13%)
Query: 230 DFHEIEQIGAGNFSHVFK-----VLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAA 284
+ +G G F V + + K AVK K H E R + E++ L
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIH 72
Query: 285 LGSHENIVGYYSSWFE-NEQLYIQMELCDHS------------------LSDKKASQFFA 325
+G H N+V + + L + +E C + F
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 326 EGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEE 384
++ Q+A+ ++F+ + H D+ NI + + V K+ DFG A + K
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 385 -----GDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL-----NLR 434
++M E + + + + D++S G ++E+ G + L+
Sbjct: 193 KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 435 DGKLPLLPGH-SLQFQNLLKVMVDPDPVQRPSAKELVE 471
+G P + + + + +P QRP+ ELVE
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 9e-31
Identities = 43/271 (15%), Positives = 100/271 (36%), Gaps = 33/271 (12%)
Query: 230 DFHEIEQIGAGNFSHVFK-----VLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAA 284
++G G+F V++ V+K A+K ER + L E +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKE 79
Query: 285 LGSHENIVGYYSSWFENEQLYIQMELCDH------------SLSDKKASQFFAEGEVLKA 332
+ ++V + + + MEL ++++ + ++++
Sbjct: 80 F-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 333 LHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEGDARYM- 390
+IA + +++ H D+ N V ++ K+GDFG + ++ +G +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 391 -----PQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDGKLPLL 441
P+ + + + D++S G ++E+ + G + +G L
Sbjct: 199 VRWMSPESLKDGVFTT--YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256
Query: 442 PGH-SLQFQNLLKVMVDPDPVQRPSAKELVE 471
P + L+++ +P RPS E++
Sbjct: 257 PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-28
Identities = 62/302 (20%), Positives = 115/302 (38%), Gaps = 57/302 (18%)
Query: 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE 289
+ ++ IG+G V + A+K R + ++A E+ + + +H+
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHK 76
Query: 290 NIVGYYSSWF------ENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFI 343
NI+ + + E + +Y+ MEL D +L + L+Q+ ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-QMELDHERMSYLLYQMLCGIKHL 135
Query: 344 HEKGIAHLDVKPDNIYVK-NGVYKLGDFGRATLLNKSLPIEE--GDARYMPQEILNEDYD 400
H GI H D+KP NI VK + K+ DFG A S + Y E++
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-LGMG 194
Query: 401 HLDKVDIFSLGATMYELIKGSPL-----------------------------------SE 425
+ + VDI+S+G M E+++ L E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 426 SGPQFLNLRDGKL----------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIF 475
+ P++ L KL + Q ++LL M+ DP +R S + +++P
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 476 DK 477
+
Sbjct: 315 NV 316
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 91.2 bits (225), Expect = 9e-21
Identities = 52/318 (16%), Positives = 93/318 (29%), Gaps = 74/318 (23%)
Query: 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVK--HSKRQLHHDAERRKALL-----EVQALA 283
+ + ++G G+FS V+ ++ A+K + AE LL
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 284 ALGSHENIVGYYSSWFENEQLYIQMEL-------CDHSLSDKKASQFFAEGEVLKALHQI 336
+I+ + + + + +L K + V + Q+
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 337 AQALQFIHEK-GIAHLDVKPDNIYV-------KNGVYKLGDFGRATLLNKSLPIEEGDAR 388
L ++H + GI H D+KP+N+ + K+ D G A ++
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 389 YMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRD------------- 435
Y E+L DI+S ++ELI G L E +D
Sbjct: 195 YRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
Query: 436 --------------------------------------GKLPLLPGHSLQFQNLLKVMVD 457
K + + + L M+
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313
Query: 458 PDPVQRPSAKELVENPIF 475
DP +R A LV +P
Sbjct: 314 LDPRKRADAGGLVNHPWL 331
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 70.6 bits (172), Expect = 8e-15
Identities = 33/195 (16%), Positives = 57/195 (29%), Gaps = 22/195 (11%)
Query: 235 EQIGAGNFSHVFKVLKRIDGCFYAVK-------HSKRQLHHDAERRKALLEVQALAALGS 287
+ +G G S VF VK K+ + +A
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 288 HENIVGYYS----SWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFI 343
+ + E + MEL D K + L I + +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDA-----KELYRVRVENPDEVLDMILEEVAKF 119
Query: 344 HEKGIAHLDVKPDNIYVKNGVYKLGDFGRATLL--NKSLPIEEGDARYMPQEILNEDYDH 401
+ +GI H D+ N+ V + DF ++ + I E D R + + Y
Sbjct: 120 YHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGWREILERDVRNII-TYFSRTYRT 178
Query: 402 LDKVDIFSLGATMYE 416
+ DI S + +
Sbjct: 179 --EKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 488 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.35 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.99 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.79 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.73 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.91 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=439.55 Aligned_cols=248 Identities=24% Similarity=0.403 Sum_probs=215.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|.++.+|+.||||++.+.... ......+.+|+.+++.+ +|||||++++++.+++.+||
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999999999999999998643211 12245678899999999 99999999999999999999
Q ss_pred EEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-CCC
Q 011331 307 QMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-LPI 382 (488)
Q Consensus 307 V~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-~~~ 382 (488)
|||||+++.+. ......+++.+++.++.||+.||+|||++|||||||||+|||+ .+|.+||+|||+|+..... ...
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 163 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT 163 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEE
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCcccc
Confidence 99999876443 2344679999999999999999999999999999999999999 5789999999999876543 334
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCC
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPD 459 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~d 459 (488)
..||+.|||||++.+. .++.++|||||||+||||++|.+||..... +..+.......+..++.++.+||.+||+.|
T Consensus 164 ~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 242 (263)
T d2j4za1 164 LCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 242 (263)
T ss_dssp TTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCC
Confidence 5699999999999876 577899999999999999999999986543 344566777788889999999999999999
Q ss_pred CCCCCCHHHHHhChhhhh
Q 011331 460 PVQRPSAKELVENPIFDK 477 (488)
Q Consensus 460 P~~RpTa~elL~HP~f~~ 477 (488)
|++|||++|+|+||||+.
T Consensus 243 p~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 243 PSQRPMLREVLEHPWITA 260 (263)
T ss_dssp GGGSCCHHHHHTCHHHHH
T ss_pred HhHCcCHHHHHcCcCcCC
Confidence 999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-56 Score=440.88 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=206.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.++.+|+.||||++..... ....+.+.+|+.+++++ +|||||++++++.+++.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEEE
Confidence 4689999999999999999999999999999999875422 22345688999999999 999999999999999999999
Q ss_pred EecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-----
Q 011331 308 MELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----- 379 (488)
Q Consensus 308 ~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----- 379 (488)
||||+++ |... .....+++.+++.++.||+.||.|||++|||||||||+|||+ .++.+||+|||+|+.....
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 9999875 4443 334579999999999999999999999999999999999999 5789999999999876322
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcCC--CCCCCCCcHHHHHHHH
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDGK--LPLLPGHSLQFQNLLK 453 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~~--~~~~~~~s~~l~~lI~ 453 (488)
....+||+.|||||++.+...++.++|||||||+||||++|.+||..... +....... .+....++.++.+||.
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 241 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence 23457999999999997764456789999999999999999999865432 12222222 2233467999999999
Q ss_pred HcccCCCCCCCCHHHHHhChhhhh
Q 011331 454 VMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
+||+.||++|||++|+|+||||++
T Consensus 242 ~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 242 KILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHcCCChhHCcCHHHHhcCHhhCc
Confidence 999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-56 Score=440.85 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=219.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|++++.||+|+||+||+|.+..+|+.||||++.+... .......+.+|+.+++++ +|||||+++++|.+++.+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEE
Confidence 579999999999999999999999999999999864321 122345688999999999 999999999999999999999
Q ss_pred EecCCCCch-h-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-----
Q 011331 308 MELCDHSLS-D-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----- 379 (488)
Q Consensus 308 ~E~~~~~l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----- 379 (488)
||||+++.+ . ....+.+++..++.++.||+.||.|||++|||||||||+|||| .+|.+||+|||+|+.+...
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 999987643 3 3445679999999999999999999999999999999999999 6789999999999877432
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcc
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMV 456 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L 456 (488)
.....||+.|||||++.+. .++.++|||||||+||||++|.+||..... +..+..+...++..+++++.+||.+||
T Consensus 167 ~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 245 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 245 (288)
T ss_dssp ---CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTS
T ss_pred cccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence 2235699999999999776 578899999999999999999999987644 345667777788889999999999999
Q ss_pred cCCCCCCCCHHH------HHhChhhhhhHHhhhhcCCC
Q 011331 457 DPDPVQRPSAKE------LVENPIFDKIQKHRKTYMKP 488 (488)
Q Consensus 457 ~~dP~~RpTa~e------lL~HP~f~~i~~~~~~~~~~ 488 (488)
+.||++|||++| +++||||+.+.+.+....+|
T Consensus 246 ~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~p 283 (288)
T d1uu3a_ 246 VLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 283 (288)
T ss_dssp CSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCC
T ss_pred cCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCC
Confidence 999999999987 68999999987655444444
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=438.04 Aligned_cols=245 Identities=26% Similarity=0.410 Sum_probs=211.6
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.+|++++.||+|+||+||+|.+..+|+.||||++...... ..+.+.+|+.+++.+ +|||||+++++|.+++.+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEEEEE
Confidence 4689999999999999999999999999999998754322 245688999999999 9999999999999999999999
Q ss_pred ecCCCCch-hhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCC
Q 011331 309 ELCDHSLS-DKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIE 383 (488)
Q Consensus 309 E~~~~~l~-~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~ 383 (488)
|||+++.+ .......+++.+++.++.||+.||.|||++|||||||||+|||+ .+|.+||+|||+|+.+... ....
T Consensus 97 Ey~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 97 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp ECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred EecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence 99987644 45555679999999999999999999999999999999999999 6789999999999877432 3345
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---h-hcC--CCCCCCCCcHHHHHHHHHccc
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---L-RDG--KLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i-~~~--~~~~~~~~s~~l~~lI~k~L~ 457 (488)
.||+.|+|||++.+. .++.++|||||||++|||++|.+||.+...... + ... ..+.++.++.++++||.+||+
T Consensus 177 ~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 255 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255 (293)
T ss_dssp CSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred ccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence 699999999999875 577899999999999999999999976544221 2 222 334556789999999999999
Q ss_pred CCCCCCCCHHHHHhChhhhh
Q 011331 458 PDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f~~ 477 (488)
+||++|||++|+|+||||+.
T Consensus 256 ~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 256 MDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp SSTTTSCCHHHHTTCGGGGG
T ss_pred CChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-55 Score=441.12 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=221.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+++.+ +|||||++++++.+.+.+|+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeee
Confidence 3579999999999999999999999999999999864321 112245688899999998 99999999999999999999
Q ss_pred EEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCC
Q 011331 307 QMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIE 383 (488)
Q Consensus 307 V~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~ 383 (488)
|||||+++.+. ......+++..++.++.||+.||.|||++|||||||||+|||| .+|.+||+|||+|+.........
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 161 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL 161 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCC
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccccccc
Confidence 99999887554 3445568999999999999999999999999999999999999 67899999999999988777778
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDP 460 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP 460 (488)
+||+.|||||++.+. .++.++|||||||+||||++|..||.+... ...+..+....++.++.++.++|.+||.+||
T Consensus 162 ~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp 240 (316)
T d1fota_ 162 CGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL 240 (316)
T ss_dssp CSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCT
T ss_pred cCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCH
Confidence 899999999999765 577899999999999999999999987644 3456677788888999999999999999999
Q ss_pred CCCC-----CHHHHHhChhhhhhHH
Q 011331 461 VQRP-----SAKELVENPIFDKIQK 480 (488)
Q Consensus 461 ~~Rp-----Ta~elL~HP~f~~i~~ 480 (488)
.+|+ |++++++||||+++.+
T Consensus 241 ~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 241 SQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp TTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred HhccccchhhHHHHHcCcccccCCH
Confidence 9996 9999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-55 Score=429.14 Aligned_cols=245 Identities=32% Similarity=0.494 Sum_probs=202.2
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc--cceEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE--NEQLYI 306 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~--~~~l~I 306 (488)
++|++++.||+|+||+||+|+++.+|+.||||++......+...+.+.+|+++++++ +|||||++++++.+ ++.+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEE
Confidence 579999999999999999999999999999999987666667777899999999999 99999999999865 567899
Q ss_pred EEecCCCCchh-h-----hhcccCCHHHHHHHHHHHHHHHHHHHHcC-----cccCCCCCCcEEE-eCCeEEEEeecCce
Q 011331 307 QMELCDHSLSD-K-----KASQFFAEGEVLKALHQIAQALQFIHEKG-----IAHLDVKPDNIYV-KNGVYKLGDFGRAT 374 (488)
Q Consensus 307 V~E~~~~~l~~-~-----~~~~~l~~~~~~~i~~qI~~gL~yLH~~g-----IiHrDLKp~NILv-~~g~vkL~DFGlA~ 374 (488)
|||||+++.+. . .....+++..++.++.||+.||.|||++| ||||||||+|||| .++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999876443 2 12356999999999999999999999976 9999999999999 67899999999998
Q ss_pred ecCCC---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCC-CCCCCCcHH
Q 011331 375 LLNKS---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKL-PLLPGHSLQ 447 (488)
Q Consensus 375 ~~~~~---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~-~~~~~~s~~ 447 (488)
..... .....||+.|||||++.+. .++.++|||||||++|||++|.+||..... ...+..+.. +.+..++++
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 241 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 241 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred ecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 76432 2345799999999999765 578899999999999999999999976543 233444544 455678999
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhh
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIF 475 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f 475 (488)
+.+||.+||+.||.+|||++|+|+|||+
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=438.14 Aligned_cols=250 Identities=28% Similarity=0.370 Sum_probs=208.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+..+|+.||||+++... .......+.+|+.+|+.+ +|||||+++++|.+.+.+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999999999999999987653 334456788999999999 899999999999999999999
Q ss_pred EecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEE-eCCeEEEEeecCceecCC-CCCC
Q 011331 308 MELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK-SLPI 382 (488)
Q Consensus 308 ~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~-~~~~ 382 (488)
||||+++.+. ....+.+++..++.++.||+.||.|||+ +|||||||||+|||| .+|.+||+|||+|+.... ....
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~ 162 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 162 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC--
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcccc
Confidence 9999986444 2344579999999999999999999997 599999999999999 689999999999987643 2345
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh------------------------------
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN------------------------------ 432 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~------------------------------ 432 (488)
.+||+.|||||++.+. .++.++|||||||++|||++|..||........
T Consensus 163 ~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241 (322)
T ss_dssp -CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred ccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence 6899999999999876 578899999999999999999999865421100
Q ss_pred ---------------hhcCCCC-CC-CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 433 ---------------LRDGKLP-LL-PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 433 ---------------i~~~~~~-~~-~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+.....+ .+ ...+.++.+||.+||++||.+|||++|+|+||||+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 0000111 11 135789999999999999999999999999999987653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=432.37 Aligned_cols=245 Identities=24% Similarity=0.376 Sum_probs=209.2
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
.|++++.||+|+||+||+|.+..+|..||||++.... ....+.+.+|+.+++++ +|||||++++++.+.+.+|||||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEEEEe
Confidence 5899999999999999999999999999999987542 23345688999999999 89999999999999999999999
Q ss_pred cCCCCchhhh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCCC
Q 011331 310 LCDHSLSDKK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLPI 382 (488)
Q Consensus 310 ~~~~~l~~~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~~ 382 (488)
||+++.+... ....+++.++..++.||+.||.|||++|||||||||+|||| .+|.+||+|||+|+.... ....
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 9998755422 23569999999999999999999999999999999999999 678999999999986642 1235
Q ss_pred CCCCCCccChhhhcc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCC---CCCCCCCcHHHHHHH
Q 011331 383 EEGDARYMPQEILNE----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGK---LPLLPGHSLQFQNLL 452 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~---~~~~~~~s~~l~~lI 452 (488)
..||+.|+|||++.. ...++.++|||||||+||||++|.+||.+.... ..+..+. ...+..++.++.+||
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li 249 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence 679999999999842 234678999999999999999999999765442 2333333 334457899999999
Q ss_pred HHcccCCCCCCCCHHHHHhChhhhh
Q 011331 453 KVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
.+||+.||++|||++|+|+||||+.
T Consensus 250 ~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 250 KKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-54 Score=432.81 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=211.1
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
.|++++.||+|+||+||+|.+..+|+.||||++...... ....+.+.+|+.+++++ +|||||++++++.+++.+||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEEEEE
Confidence 489999999999999999999999999999998765433 34456789999999999 8999999999999999999999
Q ss_pred ecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCCCC
Q 011331 309 ELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIEEG 385 (488)
Q Consensus 309 E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~~G 385 (488)
|||.++.+. ......+++.+++.++.||+.||.|||++|||||||||+|||| .++.+||+|||+|+..... ....|
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~~~G 173 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-NSFVG 173 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-CCCCS
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-Ccccc
Confidence 999987655 3445679999999999999999999999999999999999999 5789999999999876543 45679
Q ss_pred CCCccChhhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCC--CCCCCcHHHHHHHHHcccC
Q 011331 386 DARYMPQEILNED--YDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLP--LLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 386 t~~Y~APEvl~~~--~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~--~~~~~s~~l~~lI~k~L~~ 458 (488)
|+.|||||++.+. ..++.++|||||||++|||++|.+||.+.... ..+..+..+ ....+++++.+||.+||+.
T Consensus 174 T~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 253 (309)
T d1u5ra_ 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253 (309)
T ss_dssp CGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCS
T ss_pred CccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcC
Confidence 9999999998532 24677999999999999999999998765443 233333332 3345799999999999999
Q ss_pred CCCCCCCHHHHHhChhhhh
Q 011331 459 DPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 459 dP~~RpTa~elL~HP~f~~ 477 (488)
||++|||++|+|+||||..
T Consensus 254 dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 254 IPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp SGGGSCCHHHHTTCHHHHS
T ss_pred ChhHCcCHHHHHhCHHhcC
Confidence 9999999999999999964
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=438.31 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=218.7
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.+ +|||||+++++|.+++.+||
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeecccccccc
Confidence 4589999999999999999999999999999999875421 122346688999999999 89999999999999999999
Q ss_pred EEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---C
Q 011331 307 QMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---L 380 (488)
Q Consensus 307 V~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~ 380 (488)
|||||+++.+. ......+++..++.++.||+.||+|||++|||||||||+|||+ .+|.+||+|||+|+..... .
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~ 162 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence 99999887544 3444679999999999999999999999999999999999999 6799999999999866432 2
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
...+||+.|+|||++.+. .++.++|||||||+||||++|.+||..... +..+..+...++..++.++.+||.+||+
T Consensus 163 ~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~ 241 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241 (337)
T ss_dssp CCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhcc
Confidence 345799999999999776 578899999999999999999999987654 3456677788888999999999999999
Q ss_pred CCCCCCCC-----HHHHHhChhhhhhHH
Q 011331 458 PDPVQRPS-----AKELVENPIFDKIQK 480 (488)
Q Consensus 458 ~dP~~RpT-----a~elL~HP~f~~i~~ 480 (488)
+||.+|++ ++|+++||||+++.+
T Consensus 242 ~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 242 KDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp SSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred CCchhhcccccccHHHHHcCcccccCCH
Confidence 99999994 999999999998753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=425.15 Aligned_cols=243 Identities=25% Similarity=0.349 Sum_probs=205.8
Q ss_pred eeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc----cceEEE
Q 011331 231 FHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE----NEQLYI 306 (488)
Q Consensus 231 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~----~~~l~I 306 (488)
|++.++||+|+||+||+|.+..++..||+|++..........+.+.+|+++++++ +|||||+++++|.+ +..+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEEEE
Confidence 4677889999999999999999999999999876655666677889999999999 89999999999864 456899
Q ss_pred EEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEE-e-CCeEEEEeecCceecCCC-
Q 011331 307 QMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKG--IAHLDVKPDNIYV-K-NGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 307 V~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~g--IiHrDLKp~NILv-~-~g~vkL~DFGlA~~~~~~- 379 (488)
|||||+++.+. ......+++..++.++.||+.||+|||++| ||||||||+|||| + ++.+||+|||+|+.....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence 99999886544 334467999999999999999999999998 9999999999999 3 589999999999865443
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh----hhhhcCCCC--CCCCCcHHHHHHHH
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF----LNLRDGKLP--LLPGHSLQFQNLLK 453 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~----~~i~~~~~~--~~~~~s~~l~~lI~ 453 (488)
.....||+.|||||++.+. ++.++|||||||+||||++|..||...... ..+..+..+ .+...++++.+||.
T Consensus 170 ~~~~~GT~~Y~aPE~~~~~--~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~ 247 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 247 (270)
T ss_dssp BEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred cCCcccCccccCHHHhCCC--CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHH
Confidence 2345799999999999765 667999999999999999999999754332 233333322 33457899999999
Q ss_pred HcccCCCCCCCCHHHHHhChhhh
Q 011331 454 VMVDPDPVQRPSAKELVENPIFD 476 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~HP~f~ 476 (488)
+||++||++|||++|+|+||||+
T Consensus 248 ~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 248 GCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHccCCHhHCcCHHHHhCCcccC
Confidence 99999999999999999999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-54 Score=439.77 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=220.8
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.+ +|||||++++++.+.+.+|+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccccccccc
Confidence 4689999999999999999999999999999999864321 112345688999999999 99999999999999999999
Q ss_pred EEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCCCC
Q 011331 307 QMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLPIE 383 (488)
Q Consensus 307 V~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~~~ 383 (488)
||||+.++.+. ....+.+++..++.++.||+.||.|||++|||||||||+|||| .+|.+||+|||+|+.........
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 198 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL 198 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCC
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccccccc
Confidence 99999886544 3344679999999999999999999999999999999999999 67899999999999887766677
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccCCC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDPDP 460 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~dP 460 (488)
.||+.|||||++.+. .++.++|||||||+||||++|.+||.+... +..+..+....+..++.++.+||.+||.+||
T Consensus 199 ~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 277 (350)
T d1rdqe_ 199 CGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277 (350)
T ss_dssp EECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCT
T ss_pred cCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCH
Confidence 899999999999875 577899999999999999999999987544 3455667778888899999999999999999
Q ss_pred CCCC-----CHHHHHhChhhhhhHH
Q 011331 461 VQRP-----SAKELVENPIFDKIQK 480 (488)
Q Consensus 461 ~~Rp-----Ta~elL~HP~f~~i~~ 480 (488)
.+|+ |++||++||||+.+.+
T Consensus 278 ~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 278 TKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp TTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HhccccccccHHHHHcCccccCCCH
Confidence 9994 9999999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-54 Score=431.48 Aligned_cols=247 Identities=22% Similarity=0.390 Sum_probs=196.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.+.|++++.||+|+||+||+|.++.+|+.||||++...... .....+.+|+.+++.+ +|||||++++++.+++.+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEE
Confidence 45699999999999999999999999999999998755332 2335577899999999 999999999999999999999
Q ss_pred EecCCCC-chhh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecCceecCCC--
Q 011331 308 MELCDHS-LSDK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 308 ~E~~~~~-l~~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGlA~~~~~~-- 379 (488)
||||+++ |... ...+.+++.++..++.||+.||.|||++|||||||||+|||+. ++.+||+|||+|+.....
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 9999865 5443 3455799999999999999999999999999999999999993 578999999999876433
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCC----CCCCCCcHHHHHHH
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKL----PLLPGHSLQFQNLL 452 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~----~~~~~~s~~l~~lI 452 (488)
....+||+.|||||++.+. .++.++|||||||+||||++|.+||.+... ...+..+.. +.++.++.++.+||
T Consensus 166 ~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 244 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244 (307)
T ss_dssp -------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred eeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHH
Confidence 3445799999999999775 578899999999999999999999976543 223443333 34457899999999
Q ss_pred HHcccCCCCCCCCHHHHHhChhhhh
Q 011331 453 KVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 453 ~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
.+||++||++|||++|+++||||+.
T Consensus 245 ~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 245 RHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHccCCHhHCcCHHHHhcCHhhCC
Confidence 9999999999999999999999973
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=423.49 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=211.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch----HHHHHHHHHHHHHHHhCCCCCeeEeeeeecccce
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD----AERRKALLEVQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~----~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
.++|++++.||+|+||+||+|.++.+|+.||||++.+..... ...+.+.+|+.+++++ +|||||+++++|.+.+.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE
Confidence 346999999999999999999999999999999986543221 2346788999999999 89999999999999999
Q ss_pred EEEEEecCCCCch-hh-hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCC----eEEEEeecCceec
Q 011331 304 LYIQMELCDHSLS-DK-KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNG----VYKLGDFGRATLL 376 (488)
Q Consensus 304 l~IV~E~~~~~l~-~~-~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g----~vkL~DFGlA~~~ 376 (488)
+|||||||+++.+ .. ...+.+++..++.++.||+.||+|||++|||||||||+|||+ .++ .+||+|||+|+..
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999987644 33 344579999999999999999999999999999999999999 333 5999999999887
Q ss_pred CCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCCC----CCCCcHH
Q 011331 377 NKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLPL----LPGHSLQ 447 (488)
Q Consensus 377 ~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~~----~~~~s~~ 447 (488)
... .....||+.|+|||++.+. .++.++|||||||+||||++|..||.+.... ..+..+.... ++.++.+
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred CCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHH
Confidence 533 3445799999999999875 5778999999999999999999999865442 3344444433 3568999
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+++||.+||+.||++|||++|+|+||||+....
T Consensus 247 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 999999999999999999999999999987654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.7e-53 Score=433.86 Aligned_cols=249 Identities=22% Similarity=0.388 Sum_probs=213.6
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..++|++++.||+|+||+||+|.++.+|+.||||++... .....+.+.+|+.+|.++ +|||||+++++|.+.+.+||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEE
Confidence 456899999999999999999999999999999998754 344556788999999999 89999999999999999999
Q ss_pred EEecCCCC-chhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe---CCeEEEEeecCceecCCCC
Q 011331 307 QMELCDHS-LSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK---NGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 307 V~E~~~~~-l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~---~g~vkL~DFGlA~~~~~~~ 380 (488)
|||||+++ |.... ..+.+++.+++.++.||+.||.|||++|||||||||+|||+. ++.+||+|||+|+.+....
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999875 44433 334699999999999999999999999999999999999993 4789999999999876433
Q ss_pred C--CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCC----CCCCcHHHHHH
Q 011331 381 P--IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPL----LPGHSLQFQNL 451 (488)
Q Consensus 381 ~--~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~----~~~~s~~l~~l 451 (488)
. ...||+.|||||++.+. .++.++|||||||++|||++|..||.+... +..+....... .+.++.++.+|
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred ccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 2 35799999999999765 577899999999999999999999976543 33444444332 24679999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
|.+||.+||++|||++|+|+||||+...
T Consensus 260 i~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999998653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-53 Score=434.84 Aligned_cols=248 Identities=21% Similarity=0.383 Sum_probs=213.1
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
..++|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+|+.+|+++ +|||||+++++|.+++.+||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEE
Confidence 3467999999999999999999999999999999987542 34456788899999999 99999999999999999999
Q ss_pred EEecCCCCch-hhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe---CCeEEEEeecCceecCCCC
Q 011331 307 QMELCDHSLS-DKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK---NGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 307 V~E~~~~~l~-~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~---~g~vkL~DFGlA~~~~~~~ 380 (488)
|||||+++.+ .... ...+++.+++.++.||+.||.|||++|||||||||+||||+ ++.+||+|||+|+......
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999987644 3222 33599999999999999999999999999999999999994 5799999999999876432
Q ss_pred --CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCCC----CCCCCcHHHHHH
Q 011331 381 --PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKLP----LLPGHSLQFQNL 451 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~~----~~~~~s~~l~~l 451 (488)
....||+.|+|||++.+. .++.++|||||||+||||++|.+||.+.... ..+..+... .++.++.++.+|
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred ceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 335799999999999775 5788999999999999999999999875442 334444433 335789999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
|.+||++||.+|||++|+|+||||+..
T Consensus 263 i~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.4e-53 Score=433.75 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=209.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchH-HHHHHHHH---HHHHHHhCCCCCeeEeeeeecccce
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDA-ERRKALLE---VQALAALGSHENIVGYYSSWFENEQ 303 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~-~~~~~~~E---i~iL~~l~~HpnIv~l~~~~~~~~~ 303 (488)
.++|++++.||+|+||+||+|++..+|+.||||++.+...... ....+.+| +.++..+ +|||||+++++|.+.+.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCE
Confidence 4689999999999999999999999999999999864321111 12223444 4444444 79999999999999999
Q ss_pred EEEEEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 304 LYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 304 l~IV~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
+|||||||+++.+. ......+++..++.++.||+.||.|||++|||||||||+|||| .+|.+||+|||+|+.....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 99999999876443 3345678999999999999999999999999999999999999 6799999999999977543
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh--h----hhhhcCCCCCCCCCcHHHHHHHH
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ--F----LNLRDGKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~--~----~~i~~~~~~~~~~~s~~l~~lI~ 453 (488)
.....||+.|+|||++..+..++.++|||||||+||||++|..||..... . ..........+..++.++.+||.
T Consensus 162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 241 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241 (364)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHH
T ss_pred ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHH
Confidence 34557999999999997655678899999999999999999999975432 1 12234455667789999999999
Q ss_pred HcccCCCCCCCC-----HHHHHhChhhhhhHH
Q 011331 454 VMVDPDPVQRPS-----AKELVENPIFDKIQK 480 (488)
Q Consensus 454 k~L~~dP~~RpT-----a~elL~HP~f~~i~~ 480 (488)
+||++||++||| |+|+++||||+.+.+
T Consensus 242 ~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp HHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred HHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 999999999999 899999999998754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-52 Score=414.06 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=211.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-------hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-------DAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-------~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
.++|++++.||+|+||+||+|++..+|+.||||++.+.... ......+.+|+.+++++..|||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 56899999999999999999999999999999998654322 12234688999999999669999999999999
Q ss_pred cceEEEEEecCCCC-chh-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecC
Q 011331 301 NEQLYIQMELCDHS-LSD-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLN 377 (488)
Q Consensus 301 ~~~l~IV~E~~~~~-l~~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~ 377 (488)
++.+|||||||+++ |.. ......+++.+++.++.||+.||+|||++|||||||||+|||| .++.+||+|||+|+..+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999875 443 3345679999999999999999999999999999999999999 67899999999998875
Q ss_pred CC--CCCCCCCCCccChhhhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh---hhhhcCCC----CCCCC
Q 011331 378 KS--LPIEEGDARYMPQEILNE-----DYDHLDKVDIFSLGATMYELIKGSPLSESGPQF---LNLRDGKL----PLLPG 443 (488)
Q Consensus 378 ~~--~~~~~Gt~~Y~APEvl~~-----~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~---~~i~~~~~----~~~~~ 443 (488)
.. .....||+.|+|||++.. ...++.++||||+||+||||++|.+||.+.... ..+..+.. +..+.
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 43 334569999999999853 234577999999999999999999999876542 23333332 23346
Q ss_pred CcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 444 HSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 444 ~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
+|+++++||.+||+.||++|||++|+|+||||++
T Consensus 242 ~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 8999999999999999999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=427.82 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=214.8
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
++|.+++.||+|+||+||+|.+..+|+.||||++.+... .......+..|+.++.+..+|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 579999999999999999999999999999999864321 1223456778888887655999999999999999999999
Q ss_pred EecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC---CCC
Q 011331 308 MELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK---SLP 381 (488)
Q Consensus 308 ~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~---~~~ 381 (488)
||||+++.+. ......+++.+++.++.||+.||.|||++|||||||||+|||+ .+|.+||+|||+|+.... ...
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~ 161 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 161 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccccc
Confidence 9999886444 3344679999999999999999999999999999999999999 678999999999986543 223
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCCCCCcHHHHHHHHHcccC
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~~~~s~~l~~lI~k~L~~ 458 (488)
...||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ...+..+....+..++.++.+||.+||++
T Consensus 162 ~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~ 240 (320)
T d1xjda_ 162 TFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240 (320)
T ss_dssp CCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCS
T ss_pred ccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhccc
Confidence 45699999999999876 577899999999999999999999986544 33456677777888999999999999999
Q ss_pred CCCCCCCHH-HHHhChhhhhhH
Q 011331 459 DPVQRPSAK-ELVENPIFDKIQ 479 (488)
Q Consensus 459 dP~~RpTa~-elL~HP~f~~i~ 479 (488)
||++|||+. |+++||||+++.
T Consensus 241 dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 241 EPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp SGGGSBTTBSCGGGSGGGTTCC
T ss_pred CCCCCcCHHHHHHhCchhccCC
Confidence 999999995 899999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=419.46 Aligned_cols=247 Identities=21% Similarity=0.348 Sum_probs=210.9
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCch----HHHHHHHHHHHHHHHhC-CCCCeeEeeeeecccce
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHD----AERRKALLEVQALAALG-SHENIVGYYSSWFENEQ 303 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~----~~~~~~~~Ei~iL~~l~-~HpnIv~l~~~~~~~~~ 303 (488)
++|++.+.||+|+||+||+|.+..+|+.||||++.+..... .....+.+|+.+++++. .|||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999999999999999986542221 11233567999999984 39999999999999999
Q ss_pred EEEEEecCCCC-ch-h-hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-C-CeEEEEeecCceecCC
Q 011331 304 LYIQMELCDHS-LS-D-KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-N-GVYKLGDFGRATLLNK 378 (488)
Q Consensus 304 l~IV~E~~~~~-l~-~-~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~-g~vkL~DFGlA~~~~~ 378 (488)
+|+||||+.++ .+ . ......+++.+++.++.||+.||.|||++|||||||||+|||++ + +.+||+|||+|+....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 99999999763 32 2 33456799999999999999999999999999999999999995 4 7999999999987654
Q ss_pred C-CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhhcCCCCCCCCCcHHHHHHHHHccc
Q 011331 379 S-LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLRDGKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 379 ~-~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~~~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
. .....||+.|+|||++.....++.++|||||||+||||++|..||.... .+..+....++.+|.++.+||.+||+
T Consensus 164 ~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~i~~~~~~~~~~~s~~~~~li~~~L~ 240 (273)
T d1xwsa_ 164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---EIIRGQVFFRQRVSSECQHLIRWCLA 240 (273)
T ss_dssp SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---HHHHCCCCCSSCCCHHHHHHHHHHTC
T ss_pred ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---HHhhcccCCCCCCCHHHHHHHHHHcc
Confidence 3 3456799999999998765445668999999999999999999998654 34556667778899999999999999
Q ss_pred CCCCCCCCHHHHHhChhhhhh
Q 011331 458 PDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f~~i 478 (488)
.||++|||++|+|+||||+++
T Consensus 241 ~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 241 LRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp SSGGGSCCHHHHHTSGGGSSC
T ss_pred CCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=426.58 Aligned_cols=265 Identities=24% Similarity=0.386 Sum_probs=219.9
Q ss_pred CccceeeCCCCccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCee
Q 011331 213 GLFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIV 292 (488)
Q Consensus 213 ~~~p~~~g~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv 292 (488)
|+++.-.+... ..+.++|++++.||+|+||+||+|.+..+|+.||||+++.........+.+.+|+.+|+.+ +|||||
T Consensus 3 ~~~~~~~~~~~-~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv 80 (346)
T d1cm8a_ 3 GFYRQEVTKTA-WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVI 80 (346)
T ss_dssp SBCCEECSSSE-ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBC
T ss_pred CcEEEeccCce-eecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCee
Confidence 45555444332 2356789999999999999999999999999999999987666667778899999999999 899999
Q ss_pred Eeeeeecccc------eEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeE
Q 011331 293 GYYSSWFENE------QLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVY 365 (488)
Q Consensus 293 ~l~~~~~~~~------~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~v 365 (488)
+++++|...+ .+|||||||+..+........+++..++.++.||+.||.|||++|||||||||+|||+ .++.+
T Consensus 81 ~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~ 160 (346)
T d1cm8a_ 81 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL 160 (346)
T ss_dssp CCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred EEEEEeccCccccccceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccc
Confidence 9999998655 5799999997777766667789999999999999999999999999999999999999 68899
Q ss_pred EEEeecCceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhhh-----cC----
Q 011331 366 KLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNLR-----DG---- 436 (488)
Q Consensus 366 kL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i~-----~~---- 436 (488)
||+|||+|+..........||+.|+|||++.+...++.++|||||||++|||++|.+||........+. .+
T Consensus 161 kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 161 KILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp EECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 999999999988877788899999999998765567789999999999999999999987653321110 00
Q ss_pred -------------------C------CCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 437 -------------------K------LPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 437 -------------------~------~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
. ....+..++++.+||.+||.+||.+|||++|+|+||||+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0 113356789999999999999999999999999999999865
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=424.23 Aligned_cols=251 Identities=28% Similarity=0.417 Sum_probs=208.2
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||+||+|.+..+|+.||||+++...........+.+|+.+++++ +|||||+++++|.+++.+||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEEE
Confidence 589999999999999999999999999999999975543333456788999999998 8999999999999999999999
Q ss_pred ecCCCCchh---hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CC
Q 011331 309 ELCDHSLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LP 381 (488)
Q Consensus 309 E~~~~~l~~---~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~ 381 (488)
|||++++.. ......+++.+++.++.||+.||.|||++|||||||||+|||+ .++.+||+|||+|+..... ..
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence 999987554 2334569999999999999999999999999999999999999 6789999999999876533 33
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---h------------------cCC--C
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---R------------------DGK--L 438 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~------------------~~~--~ 438 (488)
...||+.|+|||++.....++.++|||||||++|+|++|..||........+ . ... .
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccc
Confidence 4479999999999876655678999999999999999999999765332111 0 000 0
Q ss_pred C---------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 439 P---------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 439 ~---------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+ ..+.++.++.+||.+||.+||++|||++|||+||||+++.+
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 0 12356789999999999999999999999999999998743
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-53 Score=421.07 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=208.5
Q ss_pred cccccceeEEEEecccCcEEEEEEEEcCC-CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC--CCCCeeEeeeeec--
Q 011331 225 SRYYTDFHEIEQIGAGNFSHVFKVLKRID-GCFYAVKHSKRQLHHDAERRKALLEVQALAALG--SHENIVGYYSSWF-- 299 (488)
Q Consensus 225 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~--~HpnIv~l~~~~~-- 299 (488)
.+..++|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+++.+. +||||++++++|.
T Consensus 3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 35567899999999999999999999765 678999998654333333334567777776653 7999999999885
Q ss_pred ---ccceEEEEEecCCCCchh---hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecC
Q 011331 300 ---ENEQLYIQMELCDHSLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGR 372 (488)
Q Consensus 300 ---~~~~l~IV~E~~~~~l~~---~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGl 372 (488)
....+|++||||++++.. ......+++..++.++.||+.||+|||++|||||||||+|||+ .++.+||+|||+
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 345789999999987554 3344569999999999999999999999999999999999999 568999999999
Q ss_pred ceecCC--CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc------------
Q 011331 373 ATLLNK--SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD------------ 435 (488)
Q Consensus 373 A~~~~~--~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~------------ 435 (488)
++.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||........ +..
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 976542 23456799999999998765 678899999999999999999999976543211 100
Q ss_pred ---------------CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhhh
Q 011331 436 ---------------GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRK 483 (488)
Q Consensus 436 ---------------~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~~ 483 (488)
.........+..+.+||.+||++||++||||+|+|+||||+++.+-+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ke 304 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhCC
Confidence 001134457889999999999999999999999999999999876543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=421.90 Aligned_cols=246 Identities=23% Similarity=0.372 Sum_probs=201.7
Q ss_pred EEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchH---HHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEe
Q 011331 233 EIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDA---ERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQME 309 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~---~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E 309 (488)
.++.||+|+||+||+|++..+|+.||||+++....... ....+.+|+.+++.+ +|||||++++++.+++.+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhh
Confidence 47889999999999999999999999999865432221 134688999999999 89999999999999999999999
Q ss_pred cCCCCchhhhh--cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCCC
Q 011331 310 LCDHSLSDKKA--SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPIE 383 (488)
Q Consensus 310 ~~~~~l~~~~~--~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~~ 383 (488)
||.+++..... ...+++.++..+++||+.||+|||++|||||||||+|||+ .++.+||+|||+|+..... ....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~ 160 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence 99987655322 4569999999999999999999999999999999999999 6789999999999876542 2345
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc--C--------------------CC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD--G--------------------KL 438 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~--~--------------------~~ 438 (488)
+||+.|+|||++.....++.++|||||||++|||++|.+||........ +.. + ..
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240 (299)
T ss_dssp CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence 6999999999987665678899999999999999999999876543221 110 0 00
Q ss_pred C------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 439 P------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 439 ~------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+ ..+..+.++.+||.+||++||++||||+|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 0 1235688999999999999999999999999999998653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-52 Score=418.48 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=211.0
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEE
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~I 306 (488)
++++|++++.||+|+||+||+|.+..+|+.||||+++.. ..+...+.+|+.+|..+ +|||||+++++|.+++.+||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEE
Confidence 457899999999999999999999999999999999754 23445678999999998 89999999999999999999
Q ss_pred EEecCCCC-chhhhh-c-ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe---CCeEEEEeecCceecCCCC
Q 011331 307 QMELCDHS-LSDKKA-S-QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK---NGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 307 V~E~~~~~-l~~~~~-~-~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~---~g~vkL~DFGlA~~~~~~~ 380 (488)
|||||+++ |..... . ..+++.+++.++.||+.||.|||++||+||||||+|||++ .+.+||+|||+++......
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999875 444333 2 2589999999999999999999999999999999999994 3489999999998775432
Q ss_pred --CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh---hhhhhcCCCCCC----CCCcHHHHHH
Q 011331 381 --PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ---FLNLRDGKLPLL----PGHSLQFQNL 451 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~---~~~i~~~~~~~~----~~~s~~l~~l 451 (488)
....||+.|+|||++.+. .++.++|||||||++|+|++|.+||..... +..+..+...++ +.++.++.+|
T Consensus 159 ~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred cccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHH
Confidence 334689999999998765 577899999999999999999999987544 334555555443 3689999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
|.+||.+||++|||++|+|+||||+.
T Consensus 238 i~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcCHhhcc
Confidence 99999999999999999999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.9e-52 Score=410.65 Aligned_cols=247 Identities=24% Similarity=0.381 Sum_probs=206.7
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||+||+|++. +|+.||||++............+.+|+.+++++ +|||||+++++|.+.+.+|++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEEE
Confidence 57999999999999999999986 889999999976544444456788999999999 8999999999999999999999
Q ss_pred ecCCCCchhh--hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---CCC
Q 011331 309 ELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---LPI 382 (488)
Q Consensus 309 E~~~~~l~~~--~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---~~~ 382 (488)
|++.++++.. .....+++..++.++.||+.||+|||++|||||||||+|||| .++.+||+|||+|...... ...
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence 9999886652 334669999999999999999999999999999999999999 6799999999999876543 233
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hhh------------------cC-----
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NLR------------------DG----- 436 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i~------------------~~----- 436 (488)
..|++.|+|||++.....++.++|||||||++|||++|++||....... .+. ..
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence 4589999999999766567889999999999999999999997543211 100 00
Q ss_pred ------CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 437 ------KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 437 ------~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
.....+.++.++.+||.+||++||++|||++|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 00124457889999999999999999999999999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=415.33 Aligned_cols=243 Identities=27% Similarity=0.370 Sum_probs=201.6
Q ss_pred cccceeEEE-EecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc----c
Q 011331 227 YYTDFHEIE-QIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE----N 301 (488)
Q Consensus 227 ~~~~y~~~~-~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~----~ 301 (488)
..++|++++ .||+|+||+||+|.+..+|+.||||+++.. ....+|+.++.++.+|||||+++++|.+ +
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 356889886 599999999999999999999999998642 2356799998887799999999999865 5
Q ss_pred ceEEEEEecCCCC-chhhhhc---ccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecCc
Q 011331 302 EQLYIQMELCDHS-LSDKKAS---QFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGRA 373 (488)
Q Consensus 302 ~~l~IV~E~~~~~-l~~~~~~---~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGlA 373 (488)
..+|||||||+++ |...... ..+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 6799999999875 4443322 3699999999999999999999999999999999999994 357999999999
Q ss_pred eecCC--CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhh-------hhhhcCCCCCC---
Q 011331 374 TLLNK--SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQF-------LNLRDGKLPLL--- 441 (488)
Q Consensus 374 ~~~~~--~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~-------~~i~~~~~~~~--- 441 (488)
+.... ......||+.|||||++.+. .++.++|||||||+||+|++|.+||.+.... ..+..+...++
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 162 KETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp EECCCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred eeccCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 87643 33456799999999998765 5778999999999999999999999654321 12222333333
Q ss_pred -CCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 442 -PGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 442 -~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
+.++.++.+||.+||++||++|||+.|+|+||||+.
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 247889999999999999999999999999999964
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=399.26 Aligned_cols=249 Identities=26% Similarity=0.404 Sum_probs=211.2
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||+||+|.+..+|+.||||+++...........+.+|+.+++.+ +||||++++++|.+....+++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEEe
Confidence 579999999999999999999999999999999976655556677889999999998 9999999999999999999999
Q ss_pred ecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC---CC
Q 011331 309 ELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL---PI 382 (488)
Q Consensus 309 E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~---~~ 382 (488)
|++.++.+. ....+.+++..++.++.||+.||+|||++|||||||||+|||+ .++.+||+|||.|+...... ..
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence 999887554 3445679999999999999999999999999999999999999 67899999999998875432 23
Q ss_pred CCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh----hhh------------------------
Q 011331 383 EEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL----NLR------------------------ 434 (488)
Q Consensus 383 ~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~----~i~------------------------ 434 (488)
..++..|+|||++.....++.++|||||||++|||++|..||....... .+.
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence 4578899999998776567889999999999999999998865432211 110
Q ss_pred -----cCCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 435 -----DGKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 435 -----~~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.......+..+.++.+||.+||++||.+||||+|+|+||||+++
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 01112334568899999999999999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-50 Score=405.63 Aligned_cols=247 Identities=21% Similarity=0.262 Sum_probs=204.9
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc--cceEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE--NEQLY 305 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~--~~~l~ 305 (488)
.++|++++.||+|+||+||+|++..+|+.||||+++... ...+.+|+.+|..+.+||||++++++|.. ...+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 368999999999999999999999999999999986432 34578899999999779999999999874 45799
Q ss_pred EEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-C-CeEEEEeecCceecCC--CCC
Q 011331 306 IQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-N-GVYKLGDFGRATLLNK--SLP 381 (488)
Q Consensus 306 IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~-g~vkL~DFGlA~~~~~--~~~ 381 (488)
+|||||+++.+... .+.+++.+++.++.||+.||.|||++|||||||||+||||+ + +.+||+|||+|+.... ...
T Consensus 109 ~v~e~~~~~~L~~~-~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~ 187 (328)
T d3bqca1 109 LVFEHVNNTDFKQL-YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 187 (328)
T ss_dssp EEEECCCSCBGGGT-TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCC
T ss_pred EEEeecCCCcHHHH-hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCccc
Confidence 99999998765543 35699999999999999999999999999999999999994 3 4799999999987753 344
Q ss_pred CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh----hh---h--------------------
Q 011331 382 IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL----NL---R-------------------- 434 (488)
Q Consensus 382 ~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~----~i---~-------------------- 434 (488)
...||+.|+|||++.....++.++||||+||++|||++|..||....... .+ .
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 267 (328)
T d3bqca1 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267 (328)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGG
T ss_pred ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCccc
Confidence 55689999999998776567889999999999999999999886532110 00 0
Q ss_pred -c-------------CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 435 -D-------------GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 435 -~-------------~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
. ........++.++.+||.+||.+||++|||++|+|+||||+.+.+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred chhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 0 000111236789999999999999999999999999999998753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=405.78 Aligned_cols=249 Identities=25% Similarity=0.416 Sum_probs=201.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-------
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE------- 300 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~------- 300 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++......+.....+.+|+.+|+++ +||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence 3578999999999999999999999999999999865544444556788999999999 89999999998754
Q ss_pred -cceEEEEEecCCCCchhh--hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceec
Q 011331 301 -NEQLYIQMELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLL 376 (488)
Q Consensus 301 -~~~l~IV~E~~~~~l~~~--~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~ 376 (488)
++.+|+|||||.+++... .....+++..++.+++||+.||.|||++|||||||||+|||| .++.+||+|||+|+..
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 456899999999876653 334569999999999999999999999999999999999999 6899999999999766
Q ss_pred CC-------CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh---hc--CCCC-----
Q 011331 377 NK-------SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL---RD--GKLP----- 439 (488)
Q Consensus 377 ~~-------~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i---~~--~~~~----- 439 (488)
.. ......||+.|+|||++.....++.++|||||||++|||++|.+||.+......+ .. +..+
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 42 1233469999999999876656788999999999999999999999764432211 00 0000
Q ss_pred ------------CCC-------------CCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 440 ------------LLP-------------GHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 440 ------------~~~-------------~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
... ..+.++.+||.+||++||++||||+|+|+||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 000 12567889999999999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-50 Score=402.87 Aligned_cols=244 Identities=20% Similarity=0.267 Sum_probs=204.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++.+.||+|+||+||+|.+..+|+.||||+++.... ..+.+.+|+.+++++ +|||||+++++|.+++.+|||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhC-CCCCEecCCccEeeCCeeEEE
Confidence 4578999999999999999999999999999999875432 245688999999999 999999999999999999999
Q ss_pred EecCCCCchh-hh---hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCCC-
Q 011331 308 MELCDHSLSD-KK---ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSLP- 381 (488)
Q Consensus 308 ~E~~~~~l~~-~~---~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~~- 381 (488)
||||+++.+. .. ....+++..++.++.||+.||.|||++|||||||||+|||| .++.+||+|||+|+.......
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 9999876433 22 23468999999999999999999999999999999999999 678999999999987644321
Q ss_pred ---CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh----hhhc-CCCCCCCCCcHHHHHHHH
Q 011331 382 ---IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL----NLRD-GKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 382 ---~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~----~i~~-~~~~~~~~~s~~l~~lI~ 453 (488)
...|++.|+|||++... .++.++|||||||++|||++|..|+....... .+.. ...+.+..++.++.+||.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 250 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 250 (287)
T ss_dssp EETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHH
Confidence 23478899999998776 57889999999999999999776655433222 2222 345666788999999999
Q ss_pred HcccCCCCCCCCHHHHHhChhhhhh
Q 011331 454 VMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+||+.||++|||++||++ +|+.+
T Consensus 251 ~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 251 ACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp HHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred HHcCCCHhHCcCHHHHHH--HHHHH
Confidence 999999999999999976 45544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=409.80 Aligned_cols=244 Identities=23% Similarity=0.330 Sum_probs=201.9
Q ss_pred ceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc------cce
Q 011331 230 DFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE------NEQ 303 (488)
Q Consensus 230 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~------~~~ 303 (488)
+|+.++.||+|+||+||+|++..+|+.||||++..... ...+|+.+|+++ +||||++++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceE
Confidence 68999999999999999999999999999999865421 123689999999 99999999998853 335
Q ss_pred EEEEEecCCCCchhh-----hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-CC-eEEEEeecCceec
Q 011331 304 LYIQMELCDHSLSDK-----KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK-NG-VYKLGDFGRATLL 376 (488)
Q Consensus 304 l~IV~E~~~~~l~~~-----~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~-~g-~vkL~DFGlA~~~ 376 (488)
+|||||||++++... .....+++.+++.++.||+.||+|||++|||||||||+|||++ ++ .+||+|||+|+..
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 899999999875442 2344699999999999999999999999999999999999994 54 8999999999877
Q ss_pred CC--CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hh-----------------
Q 011331 377 NK--SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LR----------------- 434 (488)
Q Consensus 377 ~~--~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~----------------- 434 (488)
.. ......||..|+|||++.+...++.++|||||||++|||++|.+||........ +.
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 43 334557999999999987666788899999999999999999999876533211 10
Q ss_pred --cCCC----------CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 435 --DGKL----------PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 435 --~~~~----------~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
.... ...+..++++.+||.+||.+||++||||.|+|+||||+++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0011 123457889999999999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=395.87 Aligned_cols=243 Identities=23% Similarity=0.327 Sum_probs=201.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+. ++..||||+++..... .+.+.+|+.++.++ +|||||++++++.+ +.+|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhC-CCCCEeEEEeeecc-CCeEEE
Confidence 457999999999999999999976 6889999999754322 34688999999999 99999999998754 567999
Q ss_pred EecCCCCchh----hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC---
Q 011331 308 MELCDHSLSD----KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 308 ~E~~~~~l~~----~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~--- 379 (488)
||||+++.+. ......+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+|+.....
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999876543 2222359999999999999999999999999999999999999 5789999999999887542
Q ss_pred -CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch-h---hhhhhcC-CCCCCCCCcHHHHHHHH
Q 011331 380 -LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP-Q---FLNLRDG-KLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 380 -~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~-~---~~~i~~~-~~~~~~~~s~~l~~lI~ 453 (488)
.....||+.|||||++... .++.++|||||||+||||+||..|+.... . ...+..+ ..+.+..++.++.+||.
T Consensus 166 ~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 244 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHH
Confidence 2334689999999998765 57789999999999999999765544332 2 2233333 44556678999999999
Q ss_pred HcccCCCCCCCCHHHHHh--Chhhhh
Q 011331 454 VMVDPDPVQRPSAKELVE--NPIFDK 477 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~--HP~f~~ 477 (488)
+||+.||++|||++||++ |+||..
T Consensus 245 ~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 245 LCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999998 889865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=396.83 Aligned_cols=243 Identities=19% Similarity=0.287 Sum_probs=198.2
Q ss_pred EEecccCcEEEEEEEEc--CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEEecCC
Q 011331 235 EQIGAGNFSHVFKVLKR--IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQMELCD 312 (488)
Q Consensus 235 ~~LG~G~fg~Vy~a~~~--~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~E~~~ 312 (488)
++||+|+||+||+|.+. .+++.||||+++...........+.+|+.+++++ +|||||++++++.. +..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc-CCEEEEEEcCC
Confidence 57999999999999765 3568899999976544455567899999999999 99999999999864 56799999998
Q ss_pred CCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC------CCC
Q 011331 313 HSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL------PIE 383 (488)
Q Consensus 313 ~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~------~~~ 383 (488)
++.+. ......+++..++.++.||+.||.|||++|||||||||+|||| .++.+||+|||+|+...... ...
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 86444 3344569999999999999999999999999999999999999 78999999999998764322 234
Q ss_pred CCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhc-CCCCCCCCCcHHHHHHHHHcccC
Q 011331 384 EGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRD-GKLPLLPGHSLQFQNLLKVMVDP 458 (488)
Q Consensus 384 ~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~-~~~~~~~~~s~~l~~lI~k~L~~ 458 (488)
.||+.|||||++... .++.++|||||||++|||++ |.+||.+.... ..+.. ...+.+..++.++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 589999999998765 57789999999999999998 88998764332 23333 34566778899999999999999
Q ss_pred CCCCCCCHHHH---HhChhhhhhHH
Q 011331 459 DPVQRPSAKEL---VENPIFDKIQK 480 (488)
Q Consensus 459 dP~~RpTa~el---L~HP~f~~i~~ 480 (488)
||++|||+++| |+|+|++-++.
T Consensus 250 dp~~RPs~~~i~~~L~~~~~~~~~e 274 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYYDVVNE 274 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHhhcCCC
Confidence 99999999998 57777765543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-49 Score=398.52 Aligned_cols=245 Identities=22% Similarity=0.303 Sum_probs=195.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCe---EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGC---FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
++|++.+.||+|+||+||+|.++.+|+ .||||.+... ......+.+.+|+.+|+++ +|||||++++++.+++.+|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEE
Confidence 468999999999999999999987664 6899987654 3445567799999999999 9999999999999999999
Q ss_pred EEEecCCCCchhh-h--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC-
Q 011331 306 IQMELCDHSLSDK-K--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL- 380 (488)
Q Consensus 306 IV~E~~~~~l~~~-~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~- 380 (488)
||||||+++.+.. . ..+.+++.+++.++.||+.||.|||++|||||||||+|||| .++.+||+|||+|+......
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 9999999875542 2 23468999999999999999999999999999999999999 67899999999998764321
Q ss_pred -------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhh-cCCCCCCCCCcHHH
Q 011331 381 -------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLR-DGKLPLLPGHSLQF 448 (488)
Q Consensus 381 -------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~-~~~~~~~~~~s~~l 448 (488)
....||+.|||||++... .++.++|||||||+||||+| |.+||.+.... ..+. ....+.+..++.++
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 262 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSAL 262 (299)
T ss_dssp ------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHH
Confidence 113478999999998765 67889999999999999998 78888765432 2233 33456777889999
Q ss_pred HHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 449 QNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 449 ~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
.+||.+||+.||++|||+.||+++ ++.+
T Consensus 263 ~~li~~cl~~~P~~RPs~~ei~~~--L~~~ 290 (299)
T d1jpaa_ 263 HQLMLDCWQKDRNHRPKFGQIVNT--LDKM 290 (299)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHH--HHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHH--HHHH
Confidence 999999999999999999999986 4444
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=390.36 Aligned_cols=243 Identities=19% Similarity=0.301 Sum_probs=194.4
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||+||+|.+. ++..||||+++..... .+.+.+|+.+++++ +|||||++++++..++.+||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhc-CCCCcccccceeccCCceEEEE
Confidence 47899999999999999999986 6889999998754333 34688999999999 8999999999999999999999
Q ss_pred ecCCCCchh-hh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----C
Q 011331 309 ELCDHSLSD-KK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----L 380 (488)
Q Consensus 309 E~~~~~l~~-~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----~ 380 (488)
|||+++.+. .. ....+++..++.++.||+.||.|||+++|+||||||+|||| .++.+||+|||+|+..... .
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999876443 22 23558899999999999999999999999999999999999 5789999999999876432 2
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCC-CCCCCchh---hhhhhcC-CCCCCCCCcHHHHHHHHHc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRDG-KLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~-~p~~~~~~---~~~i~~~-~~~~~~~~s~~l~~lI~k~ 455 (488)
....||+.|+|||++... .++.++|||||||+||||+||. +|+..... ...+..+ ....+...+.++.+||.+|
T Consensus 160 ~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 238 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238 (263)
T ss_dssp -----CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred cceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHH
Confidence 234589999999999876 5788999999999999999964 44543322 2233333 3445567799999999999
Q ss_pred ccCCCCCCCCHHHHHhChhhhhhH
Q 011331 456 VDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 456 L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
|+.||++|||++|+++| |+++.
T Consensus 239 l~~~p~~Rps~~~il~~--L~~i~ 260 (263)
T d1sm2a_ 239 WKERPEDRPAFSRLLRQ--LAEIA 260 (263)
T ss_dssp TCSSGGGSCCHHHHHHH--HHHHH
T ss_pred ccCCHhHCcCHHHHHHH--HHHHH
Confidence 99999999999999997 66654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-50 Score=408.30 Aligned_cols=261 Identities=22% Similarity=0.320 Sum_probs=206.4
Q ss_pred ccceeeCCCCccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeE
Q 011331 214 LFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVG 293 (488)
Q Consensus 214 ~~p~~~g~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~ 293 (488)
++|+..|+..+ ...++|++++.||+|+||+||+|++..+|+.||||++............+.+|+.+++.+ +|||||+
T Consensus 3 ~~~~~~~~~~f-~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~ 80 (355)
T d2b1pa1 3 FYSVEVGDSTF-TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIS 80 (355)
T ss_dssp EEEEEETTEEE-EEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCC
T ss_pred CEEEEeCCcce-eecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeE
Confidence 56777765322 334689999999999999999999999999999999987766666677889999999999 8999999
Q ss_pred eeeeecc------cceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEE
Q 011331 294 YYSSWFE------NEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYK 366 (488)
Q Consensus 294 l~~~~~~------~~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vk 366 (488)
++++|.. ...+|+|||||.++++... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++.++
T Consensus 81 ~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~-~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~k 159 (355)
T d2b1pa1 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_dssp CSEEECSCCSTTTCCEEEEEEECCSEEHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred EEEEEecccccccCceeEEEEeccchHHHHhh-hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccccee
Confidence 9999863 4689999999998877654 3569999999999999999999999999999999999999 588999
Q ss_pred EEeecCceecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---h--------
Q 011331 367 LGDFGRATLLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---L-------- 433 (488)
Q Consensus 367 L~DFGlA~~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i-------- 433 (488)
++|||+++..... .....||+.|+|||++.+. .++.++||||+||++|||++|.+||.+...... +
T Consensus 160 l~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~ 238 (355)
T d2b1pa1 160 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_dssp ECCCCC---------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eechhhhhccccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCC
Confidence 9999998766432 3345699999999999775 678899999999999999999999865432110 0
Q ss_pred --------------hcCCCCC--------------------CCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 434 --------------RDGKLPL--------------------LPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 434 --------------~~~~~~~--------------------~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
....... ....+.++.+||.+||.+||++||||+|||+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0010000 01135678999999999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=404.95 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=205.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc-----
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE----- 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~----- 302 (488)
..+|++++.||+|+||+||+|.+..+|+.||||++.+. ........+++|+.+|+.+ +||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccc
Confidence 35799999999999999999999999999999999754 3445567789999999999 9999999999987543
Q ss_pred eEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--
Q 011331 303 QLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-- 379 (488)
.+||+|++++++|........+++..++.++.||+.||+|||++|||||||||+|||| .++.+||+|||+|+.....
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred eEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 4677777777777776667789999999999999999999999999999999999999 6789999999999876432
Q ss_pred ----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhhh------h---------------
Q 011331 380 ----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLNL------R--------------- 434 (488)
Q Consensus 380 ----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~i------~--------------- 434 (488)
.....||+.|+|||++.....++.++||||+||++|||++|.+||......... .
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 234569999999999876656788999999999999999999998754321000 0
Q ss_pred -------cC---CC---CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 435 -------DG---KL---PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 435 -------~~---~~---~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
.. .. ...+.++.++.+||.+||++||.+|||++|+|+||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 00 00 12346788999999999999999999999999999998653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-50 Score=403.51 Aligned_cols=243 Identities=23% Similarity=0.252 Sum_probs=199.3
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCC-----eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDG-----CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|.+..++ ..||+|++.... .......+.+|+.++.++.+|||||++++++.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 357999999999999999999987654 379999986542 23445678899999999988999999999999999
Q ss_pred eEEEEEecCCCCchh-hhh------------------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 011331 303 QLYIQMELCDHSLSD-KKA------------------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDN 357 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~-~~~------------------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~N 357 (488)
.+|||||||+++.+. ... ...+++..++.++.||+.||+|||++|||||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 999999999876443 221 1348899999999999999999999999999999999
Q ss_pred EEE-eCCeEEEEeecCceecCCCCC-----CCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh-
Q 011331 358 IYV-KNGVYKLGDFGRATLLNKSLP-----IEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ- 429 (488)
Q Consensus 358 ILv-~~g~vkL~DFGlA~~~~~~~~-----~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~- 429 (488)
||+ .++.+||+|||+|+....... ...||+.|||||++... .++.++|||||||+||||++ |.+||.+...
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999 678999999999987654322 33479999999998765 57889999999999999998 8888875432
Q ss_pred --hhhhh-c-CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhC
Q 011331 430 --FLNLR-D-GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 430 --~~~i~-~-~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~H 472 (488)
+..+. . ...+.+..+++++.+||.+||+.||++|||++||++|
T Consensus 274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22332 2 2445667889999999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=406.03 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=207.9
Q ss_pred cccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeeccc-----
Q 011331 227 YYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFEN----- 301 (488)
Q Consensus 227 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~----- 301 (488)
+-++|++++.||+|+||+||+|++..+|+.||||++.+..........+.+|+.+|+.+ +|||||++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTT
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeecccccc
Confidence 34689999999999999999999999999999999987666666777889999999999 899999999988532
Q ss_pred -ceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 302 -EQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 302 -~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
..+++++++++++|......+.+++.+++.++.||+.||+|||++|||||||||+|||+ .+|.+|++|||+|......
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred CceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence 33555555555566666666789999999999999999999999999999999999999 6789999999999888776
Q ss_pred CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhhh---hhc---------------------
Q 011331 380 LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFLN---LRD--------------------- 435 (488)
Q Consensus 380 ~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~~---i~~--------------------- 435 (488)
.....|++.|+|||++.....++.++|||||||++|+|++|.+||.+...... +..
T Consensus 175 ~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (348)
T d2gfsa1 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254 (348)
T ss_dssp GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence 67778999999999977665677899999999999999999999876432110 000
Q ss_pred ----CCCC------CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 436 ----GKLP------LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 436 ----~~~~------~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
...+ .....+.++.+||.+||..||.+||||+|+|+||||+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0000 1235788999999999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=391.51 Aligned_cols=244 Identities=19% Similarity=0.274 Sum_probs=202.3
Q ss_pred cceeEEE-EecccCcEEEEEEEEcC--CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 229 TDFHEIE-QIGAGNFSHVFKVLKRI--DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 229 ~~y~~~~-~LG~G~fg~Vy~a~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
++|.+.+ +||+|+||+||+|.++. ++..||||+++... .....+.+.+|+.++.++ +|||||++++++.. +.+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc-CeEE
Confidence 4677877 49999999999997754 45689999997653 445567899999999999 89999999999865 5689
Q ss_pred EEEecCCCCchh-hh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC--
Q 011331 306 IQMELCDHSLSD-KK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS-- 379 (488)
Q Consensus 306 IV~E~~~~~l~~-~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~-- 379 (488)
||||||+++.+. .. ....+++.+++.++.||+.||.|||++|||||||||+|||| .++.+||+|||+|+.....
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 999999986544 22 23569999999999999999999999999999999999999 6899999999999877432
Q ss_pred ----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCCCCCCcHHHHH
Q 011331 380 ----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPLLPGHSLQFQN 450 (488)
Q Consensus 380 ----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~~~~~s~~l~~ 450 (488)
.....||+.|+|||++... .++.++|||||||++|||+| |.+||..... ...+..+ ..+.++.++.++.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 2234589999999998765 57789999999999999998 8999875432 2334444 45667789999999
Q ss_pred HHHHcccCCCCCCCCHHHH---HhChhhh
Q 011331 451 LLKVMVDPDPVQRPSAKEL---VENPIFD 476 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~el---L~HP~f~ 476 (488)
||.+||+.||++|||+.++ |+|+|+.
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999888 6777774
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-50 Score=395.94 Aligned_cols=245 Identities=22% Similarity=0.292 Sum_probs=197.5
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|... ..||||+++.........+.+.+|+.++.++ +|||||++++++. .+.+|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~-~~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYST-APQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEe-ccEEEEE
Confidence 457889999999999999999753 4699999976655566677899999999999 9999999999875 4568999
Q ss_pred EecCCCC-chhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----
Q 011331 308 MELCDHS-LSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---- 379 (488)
Q Consensus 308 ~E~~~~~-l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---- 379 (488)
||||+++ |.... ....+++..+..++.||+.||+|||++|||||||||+|||| .++.+||+|||+|+.....
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999875 44432 23569999999999999999999999999999999999999 5789999999999776432
Q ss_pred -CCCCCCCCCccChhhhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh----hhhcCCC-----CCCCCCcHH
Q 011331 380 -LPIEEGDARYMPQEILNED--YDHLDKVDIFSLGATMYELIKGSPLSESGPQFL----NLRDGKL-----PLLPGHSLQ 447 (488)
Q Consensus 380 -~~~~~Gt~~Y~APEvl~~~--~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~----~i~~~~~-----~~~~~~s~~ 447 (488)
.....||+.|||||++... ..++.++|||||||+||||+||..||.+..... .+..+.. ..+..++.+
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 241 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence 2345699999999998642 246789999999999999999999997643321 2222221 234567899
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 448 FQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 448 l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+.+||.+||+.||++|||++||+++ ++.+.
T Consensus 242 l~~li~~cl~~dp~~RPt~~~il~~--Le~l~ 271 (276)
T d1uwha_ 242 MKRLMAECLKKKRDERPLFPQILAS--IELLA 271 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH--HHHHH
Confidence 9999999999999999999999987 44443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=386.62 Aligned_cols=247 Identities=22% Similarity=0.301 Sum_probs=197.7
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCC----eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDG----CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
+.|++.+.||+|+||+||+|.+..++ ..||||++... ........+.+|+.++.++ +|||||++++++.+.+.+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCce
Confidence 36889999999999999999887654 57999998754 3445556789999999999 899999999999999999
Q ss_pred EEEEecCCCCchhh---hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 305 YIQMELCDHSLSDK---KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 305 ~IV~E~~~~~l~~~---~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
++|||||.++.+.. .....+++.+++.++.||+.||.|||++|||||||||+|||| .++.+||+|||+|+.....
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 99999998875542 233569999999999999999999999999999999999999 6789999999999876432
Q ss_pred -----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhc-CCCCCCCCCcHHHH
Q 011331 380 -----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRD-GKLPLLPGHSLQFQ 449 (488)
Q Consensus 380 -----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~-~~~~~~~~~s~~l~ 449 (488)
.....||+.|||||++... .++.++|||||||+||||++|..|+..... +..+.. ...+.+..++.++.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 243 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243 (283)
T ss_dssp ---------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHH
T ss_pred ccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHH
Confidence 1123589999999998776 678899999999999999997655543322 222333 34566677899999
Q ss_pred HHHHHcccCCCCCCCCHHHHHhChhhhhhHH
Q 011331 450 NLLKVMVDPDPVQRPSAKELVENPIFDKIQK 480 (488)
Q Consensus 450 ~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~ 480 (488)
+||.+||+.||++|||+.||++ .++.+.+
T Consensus 244 ~li~~cl~~~p~~RPt~~eil~--~L~~l~~ 272 (283)
T d1mqba_ 244 QLMMQCWQQERARRPKFADIVS--ILDKLIR 272 (283)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH--HHHHHHH
T ss_pred HHHHHHCcCCHhHCcCHHHHHH--HHHHHhh
Confidence 9999999999999999999998 4555543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.4e-49 Score=388.06 Aligned_cols=247 Identities=25% Similarity=0.306 Sum_probs=198.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc----
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH-DAERRKALLEVQALAALGSHENIVGYYSSWFENE---- 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~-~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~---- 302 (488)
.++|++++.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.+++.+ +|||||++++++...+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCc
Confidence 45799999999999999999999999999999999765443 34456788999999998 9999999999987654
Q ss_pred eEEEEEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 303 QLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
.+|||||||+++.+. ....+.+++.+++.++.||+.||+|||++|||||||||+|||+ .++.++|+|||.+......
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 489999999976444 3345579999999999999999999999999999999999999 6789999999998765322
Q ss_pred ------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh---hh-hcCCC---CCCCCCcH
Q 011331 380 ------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL---NL-RDGKL---PLLPGHSL 446 (488)
Q Consensus 380 ------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~---~i-~~~~~---~~~~~~s~ 446 (488)
.....||+.|+|||++.+. .++.++|||||||+||||++|.+||....... .+ ..... ...+.+|.
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp --------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred cccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 2334699999999999765 57789999999999999999999998754422 22 22222 23457899
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHhChhhh
Q 011331 447 QFQNLLKVMVDPDPVQRPSAKELVENPIFD 476 (488)
Q Consensus 447 ~l~~lI~k~L~~dP~~RpTa~elL~HP~f~ 476 (488)
++.+||.+||++||++||+..+.|.|+|++
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 999999999999999999444444567764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=384.34 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=198.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCC---CeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRID---GCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
.++|++++.||+|+||+||+|.+..+ +..||||+++.. ..+.....+.+|+.+++++ +|||||++++++. ++.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCeE
Confidence 35799999999999999999988754 457999988654 3455567799999999999 9999999999986 5678
Q ss_pred EEEEecCCCCchh---hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC-
Q 011331 305 YIQMELCDHSLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 305 ~IV~E~~~~~l~~---~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~- 379 (488)
|||||||+++.+. ......+++..++.++.||+.||.|||++|||||||||+||++ .++.+||+|||+|+.....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999887544 2234468999999999999999999999999999999999999 7799999999999876432
Q ss_pred ---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhcC-CCCCCCCCcHHHHHH
Q 011331 380 ---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRDG-KLPLLPGHSLQFQNL 451 (488)
Q Consensus 380 ---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~~-~~~~~~~~s~~l~~l 451 (488)
.....||+.|+|||++... .++.++|||||||+||||++ |.+||..... ...+..+ ..+.++.++.++.+|
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 241 (273)
T ss_dssp --------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 2234589999999999766 57789999999999999998 7888875443 2233333 456778899999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhhHHhh
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKIQKHR 482 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i~~~~ 482 (488)
|.+||..||++|||+.||++| ++.+....
T Consensus 242 i~~cl~~dp~~Rps~~ei~~~--L~~i~~~~ 270 (273)
T d1mp8a_ 242 MTKCWAYDPSRRPRFTELKAQ--LSTILEEE 270 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH--HHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH--HHHHHHHh
Confidence 999999999999999999997 77765443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=384.34 Aligned_cols=238 Identities=22% Similarity=0.295 Sum_probs=202.3
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|+++++||+|+||+||+|+++ ++..||||+++..... ..++.+|+.++.++ +||||+++++++.+++.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEE
Confidence 46889999999999999999985 8889999999865433 34688999999999 8999999999999999999999
Q ss_pred ecCCCCchh---hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----C
Q 011331 309 ELCDHSLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS----L 380 (488)
Q Consensus 309 E~~~~~l~~---~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~----~ 380 (488)
||++++.+. ......+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+|+..... .
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999876543 2334568999999999999999999999999999999999999 5689999999999866432 2
Q ss_pred CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhhcC-CCCCCCCCcHHHHHHHHHc
Q 011331 381 PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLRDG-KLPLLPGHSLQFQNLLKVM 455 (488)
Q Consensus 381 ~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~~~-~~~~~~~~s~~l~~lI~k~ 455 (488)
....||+.|+|||++... .++.++|||||||++|||+| |+.||...... ..+..+ ..+.+...+.++.+||.+|
T Consensus 159 ~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 237 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237 (258)
T ss_dssp CCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred cccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHH
Confidence 234589999999999876 57889999999999999998 78888764432 223333 4456667899999999999
Q ss_pred ccCCCCCCCCHHHHHhC
Q 011331 456 VDPDPVQRPSAKELVEN 472 (488)
Q Consensus 456 L~~dP~~RpTa~elL~H 472 (488)
|+.||++|||++|+++|
T Consensus 238 l~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 238 WHEKADERPTFKILLSN 254 (258)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHH
Confidence 99999999999999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=386.21 Aligned_cols=245 Identities=21% Similarity=0.281 Sum_probs=199.0
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQ 307 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV 307 (488)
.++|++++.||+|+||+||+|.+. ++..||||+++..... .+.+.+|+.++.++ +|||||++++++.+ +.+|+|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l-~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSC---HHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccCC---HHHHHHHHHHHHhc-ccCCEeEEEEEEec-CCeEEE
Confidence 468999999999999999999987 4567999999755332 35688999999999 99999999999854 568999
Q ss_pred EecCCCCchh----hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC--
Q 011331 308 MELCDHSLSD----KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL-- 380 (488)
Q Consensus 308 ~E~~~~~l~~----~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~-- 380 (488)
||||.++.+. ......+++.+++.++.||+.||+|||++||+||||||+|||| +++.+||+|||+|+......
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999887433 2223469999999999999999999999999999999999999 57899999999998764322
Q ss_pred --CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhh-cCCCCCCCCCcHHHHHHHH
Q 011331 381 --PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLR-DGKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 381 --~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~-~~~~~~~~~~s~~l~~lI~ 453 (488)
....||+.|+|||++... .++.++|||||||+||||++|..|+..... +..+. ....+.++.++.++.+||.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 248 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248 (285)
T ss_dssp ------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred eeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHH
Confidence 234689999999999776 578899999999999999997666544332 22232 3355778889999999999
Q ss_pred HcccCCCCCCCCHHHHHh--ChhhhhhH
Q 011331 454 VMVDPDPVQRPSAKELVE--NPIFDKIQ 479 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~--HP~f~~i~ 479 (488)
+||+.||++|||+++|++ |+||..+.
T Consensus 249 ~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 249 QCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 999999999999999987 77886653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=396.45 Aligned_cols=255 Identities=25% Similarity=0.320 Sum_probs=210.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEc---CCCeEEEEEEeccCCC--chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKR---IDGCFYAVKHSKRQLH--HDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAvK~l~~~~~--~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|.+. .+|+.||||++++... .....+.+.+|+.+++++.+||||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 468999999999999999999874 4689999999865421 11223457789999999966689999999999999
Q ss_pred eEEEEEecCCCCchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC
Q 011331 303 QLYIQMELCDHSLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS 379 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~ 379 (488)
.+|++|||+.++.+. ......+++..++.++.||+.||.|||++|||||||||+|||+ .+|.+||+|||+|+.....
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 999999999876443 3445578999999999999999999999999999999999999 6789999999999876432
Q ss_pred ----CCCCCCCCCccChhhhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCchhh-------hhhhcCCCCCCCCCcHH
Q 011331 380 ----LPIEEGDARYMPQEILNED-YDHLDKVDIFSLGATMYELIKGSPLSESGPQF-------LNLRDGKLPLLPGHSLQ 447 (488)
Q Consensus 380 ----~~~~~Gt~~Y~APEvl~~~-~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~-------~~i~~~~~~~~~~~s~~ 447 (488)
.....|++.|+|||.+... ..++.++|||||||+||||++|..||...... ........+.+..++.+
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 262 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHH
Confidence 2345699999999998643 34667999999999999999999999764321 12234566677789999
Q ss_pred HHHHHHHcccCCCCCCC-----CHHHHHhChhhhhhHHhh
Q 011331 448 FQNLLKVMVDPDPVQRP-----SAKELVENPIFDKIQKHR 482 (488)
Q Consensus 448 l~~lI~k~L~~dP~~Rp-----Ta~elL~HP~f~~i~~~~ 482 (488)
+.+||.+||++||++|| |++|+++||||+.++...
T Consensus 263 ~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~ 302 (322)
T d1vzoa_ 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 302 (322)
T ss_dssp HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHH
Confidence 99999999999999999 599999999999876543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=388.84 Aligned_cols=240 Identities=22% Similarity=0.320 Sum_probs=192.7
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCe----EEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGC----FYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
++|++++.||+|+||+||+|.+..+|+ .||+|.++.. ......+.+.+|+.++.++ +|||||++++++.+++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~-~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-V 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESSS-E
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC-e
Confidence 479999999999999999999988876 5788877643 2223356789999999999 9999999999998755 5
Q ss_pred EEEEecCCC-Cchh--hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 305 YIQMELCDH-SLSD--KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 305 ~IV~E~~~~-~l~~--~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
+++||++.+ ++.. ......+++..++.++.||+.||.|||++|||||||||+|||| .++.+||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 666677654 4544 2334569999999999999999999999999999999999999 68899999999998764322
Q ss_pred -----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHHH
Q 011331 381 -----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQN 450 (488)
Q Consensus 381 -----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~~ 450 (488)
....||+.|+|||++.++ .++.++|||||||+||||+| |.+||..... ...+.. ...+.++.++.++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 223589999999998776 57889999999999999998 6777765432 223333 345677788999999
Q ss_pred HHHHcccCCCCCCCCHHHHHhC
Q 011331 451 LLKVMVDPDPVQRPSAKELVEN 472 (488)
Q Consensus 451 lI~k~L~~dP~~RpTa~elL~H 472 (488)
||.+||..||++|||+.|+++|
T Consensus 245 li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999998
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=381.89 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=193.5
Q ss_pred cceeEEEEecccCcEEEEEEEEcC-----CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-cc
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRI-----DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE-NE 302 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-~~ 302 (488)
++|++++.||+|+||+||+|.+.. +++.||||+++... .....+.+..|+.++.++.+|+||+.+++++.. ++
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 579999999999999999998754 45789999987543 344566788899999999889999999998765 45
Q ss_pred eEEEEEecCCCCchh-hhh-----------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCC
Q 011331 303 QLYIQMELCDHSLSD-KKA-----------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNG 363 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~-~~~-----------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g 363 (488)
.+++|||||+++.+. ... ...+++.+++.++.||+.||.|||++|||||||||+|||| .++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence 689999999876443 211 2348899999999999999999999999999999999999 678
Q ss_pred eEEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCC-CCCCCchh---h-hhh
Q 011331 364 VYKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQ---F-LNL 433 (488)
Q Consensus 364 ~vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~-~p~~~~~~---~-~~i 433 (488)
.+||+|||+|+..... .....||+.|+|||++.+. .++.++|||||||++|||++|. +||..... + ..+
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~ 250 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999866432 2234689999999999876 5788999999999999999975 45654322 1 223
Q ss_pred hcC-CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 434 RDG-KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 434 ~~~-~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
..+ ..+.+..+++++.++|.+||+.||++|||++|+++| ++.+-
T Consensus 251 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~--L~~il 295 (299)
T d1ywna1 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH--LGNLL 295 (299)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred hcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHHH
Confidence 333 445666789999999999999999999999999998 66553
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=376.21 Aligned_cols=245 Identities=22% Similarity=0.305 Sum_probs=194.9
Q ss_pred cccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-cce
Q 011331 225 SRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE-NEQ 303 (488)
Q Consensus 225 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-~~~ 303 (488)
....++|++++.||+|+||+||+|.+ .|..||||+++.. ...+.+.+|+.+++++ +||||+++++++.+ ++.
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~ 75 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGG 75 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--C
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH----HHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCc
Confidence 34466899999999999999999988 4889999998653 2345688999999999 99999999998865 567
Q ss_pred EEEEEecCCCCchh-h---hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCC
Q 011331 304 LYIQMELCDHSLSD-K---KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNK 378 (488)
Q Consensus 304 l~IV~E~~~~~l~~-~---~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~ 378 (488)
+||||||++++.+. . .....+++..++.++.||+.||.|||+++||||||||+|||+ .++.+||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 89999999886444 2 222358999999999999999999999999999999999999 689999999999998777
Q ss_pred CCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhhhhc-CCCCCCCCCcHHHHHHHH
Q 011331 379 SLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLNLRD-GKLPLLPGHSLQFQNLLK 453 (488)
Q Consensus 379 ~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~i~~-~~~~~~~~~s~~l~~lI~ 453 (488)
......+|..|+|||++.+. .++.++|||||||++|||+| |.+|+..... ...+.. ...+.++.++.++.+||.
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 234 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234 (262)
T ss_dssp ------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred CCccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 66667799999999999765 67889999999999999998 6777665432 223333 345667778999999999
Q ss_pred HcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 454 VMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 454 k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+||+.||.+|||+.+|+++ |+.+.
T Consensus 235 ~cl~~dP~~Rps~~~l~~~--L~~i~ 258 (262)
T d1byga_ 235 NCWHLDAAMRPSFLQLREQ--LEHIK 258 (262)
T ss_dssp HHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHcccCHhHCcCHHHHHHH--HHHHH
Confidence 9999999999999999984 66654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=384.80 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=205.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCCeE--EEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDGCF--YAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
+++|++.+.||+|+||+||+|.+..+|.. ||||.+.... .....+.+.+|+.+|.++.+|||||++++++.+++.+|
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 36889999999999999999999988875 6677765432 23345678999999999878999999999999999999
Q ss_pred EEEecCCCCchh-hh-----------------hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEE
Q 011331 306 IQMELCDHSLSD-KK-----------------ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYK 366 (488)
Q Consensus 306 IV~E~~~~~l~~-~~-----------------~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vk 366 (488)
|||||++++.+. .. ....+++..++.++.||+.||.|||++|||||||||+|||+ .++.+|
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceE
Confidence 999999876433 21 12468999999999999999999999999999999999999 678999
Q ss_pred EEeecCceecCCC--CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCC-CCCCchh---hhhhhc-CCCC
Q 011331 367 LGDFGRATLLNKS--LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSP-LSESGPQ---FLNLRD-GKLP 439 (488)
Q Consensus 367 L~DFGlA~~~~~~--~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~-p~~~~~~---~~~i~~-~~~~ 439 (488)
|+|||+|+..... .....||..|+|||.+... .++.++|||||||++|||++|.. ||..... ...+.. ...+
T Consensus 168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~ 246 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246 (309)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC
T ss_pred EccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9999999866432 2234689999999999765 57889999999999999999765 5554332 222333 3455
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHhhhhcC
Q 011331 440 LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKHRKTYM 486 (488)
Q Consensus 440 ~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~~~~~~ 486 (488)
.+..+++++.+||.+||+.||++|||+.||++| |+.+.+.+++++
T Consensus 247 ~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~--L~~i~~~~~~~~ 291 (309)
T d1fvra_ 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS--LNRMLEERKTYV 291 (309)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHSSSCSB
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHHHhcCcCCC
Confidence 667789999999999999999999999999998 777766555544
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=374.13 Aligned_cols=244 Identities=20% Similarity=0.272 Sum_probs=191.1
Q ss_pred cceeEEEEecccCcEEEEEEEEcCC---CeEEEEEEeccCCC-chHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRID---GCFYAVKHSKRQLH-HDAERRKALLEVQALAALGSHENIVGYYSSWFENEQL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAvK~l~~~~~-~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l 304 (488)
++|++++.||+|+||+||+|....+ +..||||++.+... .....+.+.+|+.+++++ +|||||++++++.+ +.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee-cch
Confidence 5799999999999999999986533 34789999875533 233456789999999999 99999999999975 578
Q ss_pred EEEEecCCCCchh---hhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCCC
Q 011331 305 YIQMELCDHSLSD---KKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKSL 380 (488)
Q Consensus 305 ~IV~E~~~~~l~~---~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~~ 380 (488)
++|||||+++.+. ......+++..++.++.||+.||.|||++||+||||||+|||| .++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 9999999875433 2334569999999999999999999999999999999999999 78999999999999874432
Q ss_pred ------CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hhhh-c-CCCCCCCCCcHHH
Q 011331 381 ------PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LNLR-D-GKLPLLPGHSLQF 448 (488)
Q Consensus 381 ------~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~i~-~-~~~~~~~~~s~~l 448 (488)
....|+..|+|||++... .++.++|||||||++|||++ |.+||...... ..+. . ...+.++.++.++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 233578899999999876 57789999999999999998 89998765432 2222 2 2445667889999
Q ss_pred HHHHHHcccCCCCCCCCHHHHHhChhhhh
Q 011331 449 QNLLKVMVDPDPVQRPSAKELVENPIFDK 477 (488)
Q Consensus 449 ~~lI~k~L~~dP~~RpTa~elL~HP~f~~ 477 (488)
.+||.+||..||++|||+.||++ +|++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~--~L~~ 271 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD--FLLE 271 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH--HHHh
Confidence 99999999999999999999974 5544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-46 Score=375.36 Aligned_cols=246 Identities=20% Similarity=0.264 Sum_probs=201.6
Q ss_pred ccceeEEEEecccCcEEEEEEEEc-----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|++. .++..||||+++... .......+.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEF-DNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhc-CCCCcccceeeeccCC
Confidence 457999999999999999999875 356899999987543 344567799999999999 9999999999999999
Q ss_pred eEEEEEecCCCCchh-hhh-------------------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCC
Q 011331 303 QLYIQMELCDHSLSD-KKA-------------------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPD 356 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~-~~~-------------------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~ 356 (488)
.++++|||+.++.+. ... ...+++..++.++.||+.||+|||++|||||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 999999999875333 221 123788999999999999999999999999999999
Q ss_pred cEEE-eCCeEEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCC-CCCCCchh
Q 011331 357 NIYV-KNGVYKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQ 429 (488)
Q Consensus 357 NILv-~~g~vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~-~p~~~~~~ 429 (488)
|||| .++.+||+|||+|+..... .....|++.|+|||++... .++.++|||||||+||||++|. +||.....
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 9999 6789999999999765321 2234688999999999875 6888999999999999999996 55655433
Q ss_pred h---hhhhcCCC-CCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 430 F---LNLRDGKL-PLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 430 ~---~~i~~~~~-~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
. ..+..+.. +.+..++.++.+||.+||+.||++|||+.||++ +|+++
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--~L~~i 299 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRM 299 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHh
Confidence 2 33444444 456678999999999999999999999999965 45544
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=374.08 Aligned_cols=247 Identities=20% Similarity=0.299 Sum_probs=200.2
Q ss_pred ccceeEEEEecccCcEEEEEEEEcCCC-------eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRIDG-------CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE 300 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g-------~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~ 300 (488)
.++|++++.||+|+||+||+|....++ ..||||+++... .......+..|+..+.++.+|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 468999999999999999999876544 479999987653 445567889999999999889999999999999
Q ss_pred cceEEEEEecCCCCchh-hhh-----------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-e
Q 011331 301 NEQLYIQMELCDHSLSD-KKA-----------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-K 361 (488)
Q Consensus 301 ~~~l~IV~E~~~~~l~~-~~~-----------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~ 361 (488)
++.+|+|||||+++.+. ... ...+++.+++.++.||+.||.|||++|||||||||+|||+ .
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 170 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence 99999999999876444 221 1348999999999999999999999999999999999999 6
Q ss_pred CCeEEEEeecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchhh---hh
Q 011331 362 NGVYKLGDFGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQF---LN 432 (488)
Q Consensus 362 ~g~vkL~DFGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~~---~~ 432 (488)
++.+||+|||+++..... .....||+.|+|||++.++ .++.++|||||||++|||++ |.+||...... ..
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 789999999999876432 2234688999999999775 68889999999999999998 57777654332 22
Q ss_pred hhc-CCCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 433 LRD-GKLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 433 i~~-~~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+.. ...+.+..++.++.+||.+||+.||++|||+.||++ .++.+
T Consensus 250 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~--~L~~i 294 (299)
T d1fgka_ 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE--DLDRI 294 (299)
T ss_dssp HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH--HHHHH
Confidence 233 345666778999999999999999999999999998 35444
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9e-46 Score=368.29 Aligned_cols=243 Identities=21% Similarity=0.202 Sum_probs=196.0
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||+||+|.+..+|+.||||++..... ...+..|+++++.+.+|++|+.++.++.+++..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 468999999999999999999999999999998865422 2246789999999955556667777778888999999
Q ss_pred ecCCCCchhh--hhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe----CCeEEEEeecCceecCCC---
Q 011331 309 ELCDHSLSDK--KASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK----NGVYKLGDFGRATLLNKS--- 379 (488)
Q Consensus 309 E~~~~~l~~~--~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~----~g~vkL~DFGlA~~~~~~--- 379 (488)
||+++++... .....+++..+..++.||+.||+|||++|||||||||+|||+. +..++|+|||+|+.....
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 83 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred EEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 9999887663 3345699999999999999999999999999999999999983 357999999999877432
Q ss_pred -------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchhhh------hhhc-----CCCCCC
Q 011331 380 -------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQFL------NLRD-----GKLPLL 441 (488)
Q Consensus 380 -------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~~~------~i~~-----~~~~~~ 441 (488)
.....||+.|||||++.+. .++.++|||||||++|||++|..||....... .... ......
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred cceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence 1234699999999998876 57889999999999999999999986532211 1111 111134
Q ss_pred CCCcHHHHHHHHHcccCCCCCCCCHHH---HHhChhhh
Q 011331 442 PGHSLQFQNLLKVMVDPDPVQRPSAKE---LVENPIFD 476 (488)
Q Consensus 442 ~~~s~~l~~lI~k~L~~dP~~RpTa~e---lL~HP~f~ 476 (488)
+.++.++.+||.+||..||++||++.+ +|+|+|.+
T Consensus 242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 578999999999999999999999875 46676653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=370.19 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=202.4
Q ss_pred ccceeEEEEecccCcEEEEEEEEc-----CCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKR-----IDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|.+. .+++.||||+++... .......+.+|+.++.++.+|||||++++++.+.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 358999999999999999999863 467899999997643 44556678999999999978999999999999999
Q ss_pred eEEEEEecCCCCchh-hh-------------------hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-e
Q 011331 303 QLYIQMELCDHSLSD-KK-------------------ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-K 361 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~-~~-------------------~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~ 361 (488)
.+|||||||+++.+. .. ....+++..++.++.||+.||.|||++|||||||||+|||+ .
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 999999999886433 11 11258899999999999999999999999999999999999 6
Q ss_pred CCeEEEEeecCceecCCCC-----CCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCchh---hhh
Q 011331 362 NGVYKLGDFGRATLLNKSL-----PIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIK-GSPLSESGPQ---FLN 432 (488)
Q Consensus 362 ~g~vkL~DFGlA~~~~~~~-----~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLlt-G~~p~~~~~~---~~~ 432 (488)
++.++|+|||+++...... ....||+.|+|||++... .++.++|||||||++|||+| |.+++..... +..
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 7899999999998765432 224589999999999766 57889999999999999999 5555544322 222
Q ss_pred h-hcC-CCCCCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 433 L-RDG-KLPLLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 433 i-~~~-~~~~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
+ ..+ ....+...+.++.+||.+||+.||.+|||+.||++ .|+++
T Consensus 260 ~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~--~L~~~ 305 (311)
T d1t46a_ 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ--LIEKQ 305 (311)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHh
Confidence 2 233 33445567999999999999999999999999997 45543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=372.23 Aligned_cols=249 Identities=17% Similarity=0.232 Sum_probs=205.1
Q ss_pred ccceeEEEEecccCcEEEEEEEEcC-----CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc
Q 011331 228 YTDFHEIEQIGAGNFSHVFKVLKRI-----DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE 302 (488)
Q Consensus 228 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~ 302 (488)
.++|++++.||+|+||+||+|.+.. ++..||||+++.. ........+.+|+.++.++ +|||||++++++..++
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecCC
Confidence 4689999999999999999998753 4678999999754 3445566789999999999 8999999999999999
Q ss_pred eEEEEEecCCCCchhhhh------------cccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEe
Q 011331 303 QLYIQMELCDHSLSDKKA------------SQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGD 369 (488)
Q Consensus 303 ~l~IV~E~~~~~l~~~~~------------~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~D 369 (488)
.+++|||||.++.+.... ...+++..+..++.||+.||.|||+++|+||||||+|||| .++.+||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence 999999999876443111 1236888999999999999999999999999999999999 578999999
Q ss_pred ecCceecCCC-----CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCC-CCCCCchh---hhhhhc-CCCC
Q 011331 370 FGRATLLNKS-----LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGS-PLSESGPQ---FLNLRD-GKLP 439 (488)
Q Consensus 370 FGlA~~~~~~-----~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~-~p~~~~~~---~~~i~~-~~~~ 439 (488)
||+|+..... .....||+.|+|||.+.+. .++.++|||||||+||||+||. +|+..... +..+.. ...+
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 9999866432 1223589999999999876 5778999999999999999995 55554433 223333 3445
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHh------ChhhhhhH
Q 011331 440 LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVE------NPIFDKIQ 479 (488)
Q Consensus 440 ~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~------HP~f~~i~ 479 (488)
.++.++..+.++|.+||+.||++|||+.||++ +|+|+++.
T Consensus 256 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~ 301 (308)
T d1p4oa_ 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301 (308)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCC
Confidence 66788999999999999999999999999998 77776543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=365.50 Aligned_cols=243 Identities=21% Similarity=0.236 Sum_probs=196.8
Q ss_pred eEEEEecccCcEEEEEEEEcCCC---eEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecc-cceEEEE
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDG---CFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFE-NEQLYIQ 307 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g---~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~-~~~l~IV 307 (488)
+..+.||+|+||+||+|.+..++ ..||||+++.. ........+.+|+.++.++ +|||||++++++.. ++.+++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEE
Confidence 33578999999999999986643 46999998643 4556678899999999999 89999999999875 5689999
Q ss_pred EecCCCCchhh-h--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-eCCeEEEEeecCceecCCC----
Q 011331 308 MELCDHSLSDK-K--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYV-KNGVYKLGDFGRATLLNKS---- 379 (488)
Q Consensus 308 ~E~~~~~l~~~-~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv-~~g~vkL~DFGlA~~~~~~---- 379 (488)
||||+++.+.. . ....+++..++.++.||+.||.|||+.||+||||||+|||| .++.+||+|||+++.....
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999875542 2 23347788899999999999999999999999999999999 5689999999999876432
Q ss_pred ---CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh----hhhhhcC-CCCCCCCCcHHHHHH
Q 011331 380 ---LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ----FLNLRDG-KLPLLPGHSLQFQNL 451 (488)
Q Consensus 380 ---~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~----~~~i~~~-~~~~~~~~s~~l~~l 451 (488)
.....||+.|+|||++... .++.++||||||++||||++|..||..... ...+..+ ....++.+++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 1223589999999998765 578899999999999999998777665432 2233333 344556779999999
Q ss_pred HHHcccCCCCCCCCHHHHHhChhhhhhH
Q 011331 452 LKVMVDPDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 452 I~k~L~~dP~~RpTa~elL~HP~f~~i~ 479 (488)
|.+||+.||++|||+.|+++| |+.+.
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~--L~~i~ 292 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR--ISAIF 292 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH--HHHHH
Confidence 999999999999999999997 66654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-44 Score=368.18 Aligned_cols=259 Identities=21% Similarity=0.283 Sum_probs=198.5
Q ss_pred ccceeeCCCCccccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhC-------
Q 011331 214 LFPVITGGDGLSRYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALG------- 286 (488)
Q Consensus 214 ~~p~~~g~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~------- 286 (488)
++|+..|+... .++|++++.||+|+||+||+|++..+|+.||||+++.. ........+|+.+++.+.
T Consensus 1 ~~p~~~g~~~~---~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~ 74 (362)
T d1q8ya_ 1 YHPAFKGEPYK---DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKE 74 (362)
T ss_dssp CCCCCTTCEET---TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHH
T ss_pred CCCCCCCCCcc---CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhh
Confidence 35666654211 13589999999999999999999999999999999753 233455677888887762
Q ss_pred ---CCCCeeEeeeeeccc--ceEEEEEecCCCC--chh---hhhcccCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCC
Q 011331 287 ---SHENIVGYYSSWFEN--EQLYIQMELCDHS--LSD---KKASQFFAEGEVLKALHQIAQALQFIHE-KGIAHLDVKP 355 (488)
Q Consensus 287 ---~HpnIv~l~~~~~~~--~~l~IV~E~~~~~--l~~---~~~~~~l~~~~~~~i~~qI~~gL~yLH~-~gIiHrDLKp 355 (488)
.|+||+++++++... ...+++|+++... ... ......+++..++.++.||+.||.|||+ .||+||||||
T Consensus 75 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp 154 (362)
T d1q8ya_ 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 154 (362)
T ss_dssp HHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSG
T ss_pred hhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCCh
Confidence 368899999888653 4556666666442 111 3344568999999999999999999998 8999999999
Q ss_pred CcEEEe-CC------eEEEEeecCceecCCCCCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCch
Q 011331 356 DNIYVK-NG------VYKLGDFGRATLLNKSLPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGP 428 (488)
Q Consensus 356 ~NILv~-~g------~vkL~DFGlA~~~~~~~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~ 428 (488)
+||||+ ++ .++|+|||.|...........||+.|+|||++... .++.++||||+||++++|++|+.||....
T Consensus 155 ~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 155 ENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp GGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred hHeeeeccCcccccceeeEeecccccccccccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 999993 32 59999999999887777777899999999998765 57789999999999999999999986421
Q ss_pred hh---------h---hhhc---------------------------------------CCCCCCCCCcHHHHHHHHHccc
Q 011331 429 QF---------L---NLRD---------------------------------------GKLPLLPGHSLQFQNLLKVMVD 457 (488)
Q Consensus 429 ~~---------~---~i~~---------------------------------------~~~~~~~~~s~~l~~lI~k~L~ 457 (488)
.. . .+.. .........+.++.+||.+||.
T Consensus 234 ~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~ 313 (362)
T d1q8ya_ 234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313 (362)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred cccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCC
Confidence 10 0 0000 0011122346789999999999
Q ss_pred CCCCCCCCHHHHHhChhhhhhH
Q 011331 458 PDPVQRPSAKELVENPIFDKIQ 479 (488)
Q Consensus 458 ~dP~~RpTa~elL~HP~f~~i~ 479 (488)
+||.+||||+|+|+||||++..
T Consensus 314 ~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 314 LDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp SSTTTCBCHHHHHTCGGGTTCT
T ss_pred CChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999998653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.5e-44 Score=355.35 Aligned_cols=243 Identities=21% Similarity=0.267 Sum_probs=199.7
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEEEEE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLYIQM 308 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~IV~ 308 (488)
++|++++.||+|+||+||+|.+..+|+.||||++..... ...+..|++++..+.+|+||+.+++++..+...|+||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 478999999999999999999999999999999864322 2235678889999977799999999999999999999
Q ss_pred ecCCCCchhhh--hcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe------CCeEEEEeecCceecCCC-
Q 011331 309 ELCDHSLSDKK--ASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVK------NGVYKLGDFGRATLLNKS- 379 (488)
Q Consensus 309 E~~~~~l~~~~--~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~------~g~vkL~DFGlA~~~~~~- 379 (488)
||+++++.... ....+++..+..++.|++.||+|||++|||||||||+||||+ ++.+||+|||+|+.....
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 81 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred EecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 99988876633 234699999999999999999999999999999999999994 468999999999876432
Q ss_pred ---------CCCCCCCCCccChhhhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCchh------hhhhhcCC-----CC
Q 011331 380 ---------LPIEEGDARYMPQEILNEDYDHLDKVDIFSLGATMYELIKGSPLSESGPQ------FLNLRDGK-----LP 439 (488)
Q Consensus 380 ---------~~~~~Gt~~Y~APEvl~~~~~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------~~~i~~~~-----~~ 439 (488)
.....||+.|||||++.+. .++.++|||||||++|||++|..||..... ...+.... ..
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence 2234699999999999875 688899999999999999999999964321 11111111 11
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhh
Q 011331 440 LLPGHSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKI 478 (488)
Q Consensus 440 ~~~~~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i 478 (488)
..+.++.++.++|..|+..+|++||+++.+.+ +|+++
T Consensus 240 l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~--~l~~~ 276 (293)
T d1csna_ 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKV 276 (293)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH--HHHHH
T ss_pred hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH--HHHHH
Confidence 23567899999999999999999999888765 45554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-44 Score=356.51 Aligned_cols=245 Identities=22% Similarity=0.332 Sum_probs=185.5
Q ss_pred cceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccc----eE
Q 011331 229 TDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENE----QL 304 (488)
Q Consensus 229 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~----~l 304 (488)
.+|.+.+.||+|+||+||+|+. +|+.||||++... .........|+..+..+ +|||||++++++.+.+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEE
Confidence 3678999999999999999986 6999999998643 12222222344444455 8999999999998654 68
Q ss_pred EEEEecCCCC-chhhhhcccCCHHHHHHHHHHHHHHHHHHHH--------cCcccCCCCCCcEEE-eCCeEEEEeecCce
Q 011331 305 YIQMELCDHS-LSDKKASQFFAEGEVLKALHQIAQALQFIHE--------KGIAHLDVKPDNIYV-KNGVYKLGDFGRAT 374 (488)
Q Consensus 305 ~IV~E~~~~~-l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~--------~gIiHrDLKp~NILv-~~g~vkL~DFGlA~ 374 (488)
|||||||+++ |........+++...+.++.||+.||.|||+ +|||||||||+|||| .++.+||+|||+++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 9999999875 5455555679999999999999999999996 599999999999999 67899999999998
Q ss_pred ecCCC-------CCCCCCCCCccChhhhcccC-----CCCchhHHHHHHHHHHHHHcCCCCCCCchh-------------
Q 011331 375 LLNKS-------LPIEEGDARYMPQEILNEDY-----DHLDKVDIFSLGATMYELIKGSPLSESGPQ------------- 429 (488)
Q Consensus 375 ~~~~~-------~~~~~Gt~~Y~APEvl~~~~-----~~~~ksDIwSlGvlL~eLltG~~p~~~~~~------------- 429 (488)
..... .....||+.|+|||++.... .++.++|||||||+||||+||.+|+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76432 22356999999999986542 145689999999999999999876642111
Q ss_pred ----hh-hhh-cCCCCCCCC------CcHHHHHHHHHcccCCCCCCCCHHHHHhChhhhhhHHh
Q 011331 430 ----FL-NLR-DGKLPLLPG------HSLQFQNLLKVMVDPDPVQRPSAKELVENPIFDKIQKH 481 (488)
Q Consensus 430 ----~~-~i~-~~~~~~~~~------~s~~l~~lI~k~L~~dP~~RpTa~elL~HP~f~~i~~~ 481 (488)
.. .+. ....|..+. ....+.++|.+||+.||++|||+.||+++ +..+.+.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~--L~~i~~~ 298 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH--HHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH--HHHHHHh
Confidence 00 011 111121111 23468899999999999999999999985 6666543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=9.8e-25 Score=201.96 Aligned_cols=165 Identities=19% Similarity=0.081 Sum_probs=121.1
Q ss_pred eEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCc----------------hHHHHHHHHHHHHHHHhCCCCCeeEee
Q 011331 232 HEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHH----------------DAERRKALLEVQALAALGSHENIVGYY 295 (488)
Q Consensus 232 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~----------------~~~~~~~~~Ei~iL~~l~~HpnIv~l~ 295 (488)
.+.++||+|+||+||+|.+. +|+.||||+++..... .........|...+.++ .|.+++..+
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~~ 80 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKVY 80 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceEE
Confidence 57899999999999999985 7999999987532110 11123455688888888 889998887
Q ss_pred eeecccceEEEEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEeCCeEEEEeecCcee
Q 011331 296 SSWFENEQLYIQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHEKGIAHLDVKPDNIYVKNGVYKLGDFGRATL 375 (488)
Q Consensus 296 ~~~~~~~~l~IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~~gIiHrDLKp~NILv~~g~vkL~DFGlA~~ 375 (488)
++.. .+++|||+++.... .++...+..++.||+.||.|||++||+||||||+|||++++.++|+|||+|..
T Consensus 81 ~~~~----~~lvme~~~~~~~~-----~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~liDFG~a~~ 151 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-----RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVE 151 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-----GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCTTCEE
T ss_pred EecC----CEEEEEeecccccc-----chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEEECCCccc
Confidence 6532 37999999986432 24555678899999999999999999999999999999988999999999987
Q ss_pred cCCCCCCCCCCCCccCh------hhhcccCCCCchhHHHHHHHHH
Q 011331 376 LNKSLPIEEGDARYMPQ------EILNEDYDHLDKVDIFSLGATM 414 (488)
Q Consensus 376 ~~~~~~~~~Gt~~Y~AP------Evl~~~~~~~~ksDIwSlGvlL 414 (488)
...... ..|... +.+... +..++|+||+.--+
T Consensus 152 ~~~~~~-----~~~l~rd~~~~~~~f~r~--y~~~~d~~s~~~~~ 189 (191)
T d1zara2 152 VGEEGW-----REILERDVRNIITYFSRT--YRTEKDINSAIDRI 189 (191)
T ss_dssp TTSTTH-----HHHHHHHHHHHHHHHHHH--HCCCCCHHHHHHHH
T ss_pred CCCCCc-----HHHHHHHHHHHHHHHcCC--CCCcccHHHHHHHH
Confidence 643211 112211 122223 44589999985443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.35 E-value=9.5e-07 Score=82.55 Aligned_cols=143 Identities=15% Similarity=0.153 Sum_probs=90.6
Q ss_pred ccccceeEEEEecccCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 226 RYYTDFHEIEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 226 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.....|+.++..+.++.+.||++.. .+..+.+|+........ .....+|...+..+..+-.+.+++.+..+++..|
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3345677777665566679998753 56677888765332111 2235568888887755545677777777888999
Q ss_pred EEEecCCCCchhhhhcccCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 011331 306 IQMELCDHSLSDKKASQFFAEGEVLKALHQIAQALQFIHE---------------------------------------- 345 (488)
Q Consensus 306 IV~E~~~~~l~~~~~~~~l~~~~~~~i~~qI~~gL~yLH~---------------------------------------- 345 (488)
+||++++|........... ....++.++...|..||+
T Consensus 87 lv~~~l~G~~~~~~~~~~~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEEEecccccccccccccc---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9999998854321111111 122233333333444442
Q ss_pred -------------c------CcccCCCCCCcEEEeCCeE-EEEeecCcee
Q 011331 346 -------------K------GIAHLDVKPDNIYVKNGVY-KLGDFGRATL 375 (488)
Q Consensus 346 -------------~------gIiHrDLKp~NILv~~g~v-kL~DFGlA~~ 375 (488)
. .++|+|+.|.|||++++.+ -|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 2689999999999987765 5999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.99 E-value=6.6e-06 Score=82.46 Aligned_cols=78 Identities=23% Similarity=0.276 Sum_probs=47.6
Q ss_pred EEEecccCcEEEEEEEEcCCCeEEEEEEeccCC--Cc---hHHHHHHHHHHHHHHHhCCC--CCeeEeeeeecccceEEE
Q 011331 234 IEQIGAGNFSHVFKVLKRIDGCFYAVKHSKRQL--HH---DAERRKALLEVQALAALGSH--ENIVGYYSSWFENEQLYI 306 (488)
Q Consensus 234 ~~~LG~G~fg~Vy~a~~~~~g~~vAvK~l~~~~--~~---~~~~~~~~~Ei~iL~~l~~H--pnIv~l~~~~~~~~~l~I 306 (488)
.+.||.|....||++.+..+|+.|+||...... .. .....+...|...|..+..+ ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 567999999999999887778899999653210 00 01112345677777776544 235556543 4455678
Q ss_pred EEecCCC
Q 011331 307 QMELCDH 313 (488)
Q Consensus 307 V~E~~~~ 313 (488)
|||++++
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.79 E-value=0.00011 Score=67.57 Aligned_cols=73 Identities=14% Similarity=0.038 Sum_probs=47.6
Q ss_pred EecccCc-EEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCC-CCeeEeeeeecccceEEEEEecCCC
Q 011331 236 QIGAGNF-SHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSH-ENIVGYYSSWFENEQLYIQMELCDH 313 (488)
Q Consensus 236 ~LG~G~f-g~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~H-pnIv~l~~~~~~~~~l~IV~E~~~~ 313 (488)
.+..|.. +.||++... .+..+.+|........ .+..|...++.+..+ -.+.+++.+..+.+..++||++++|
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~~-----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGALN-----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTTS-----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCHh-----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 3444543 678988653 5777888986543222 244566666665333 2356777777788889999999976
Q ss_pred C
Q 011331 314 S 314 (488)
Q Consensus 314 ~ 314 (488)
.
T Consensus 91 ~ 91 (255)
T d1nd4a_ 91 Q 91 (255)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.90 E-value=0.0018 Score=62.14 Aligned_cols=131 Identities=14% Similarity=0.075 Sum_probs=73.5
Q ss_pred cCcEEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCC-CeeEeee-----eecccceEEEEEecCCC
Q 011331 240 GNFSHVFKVLKRIDGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHE-NIVGYYS-----SWFENEQLYIQMELCDH 313 (488)
Q Consensus 240 G~fg~Vy~a~~~~~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~Hp-nIv~l~~-----~~~~~~~l~IV~E~~~~ 313 (488)
+-.-.||++.. .+|..|++|+.+....+.. ++..|+..+..|..+. .++.... .+...+..+.++++++|
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s~~---~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERWTAD---QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTSCHH---HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCCCCHH---HHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 33468999876 4788999999876544433 3555777777663221 1222211 22345667889999875
Q ss_pred Cchh------------------hh-hc------cc-------------------CCHHHHHHHHHHHHHHHHHHHH----
Q 011331 314 SLSD------------------KK-AS------QF-------------------FAEGEVLKALHQIAQALQFIHE---- 345 (488)
Q Consensus 314 ~l~~------------------~~-~~------~~-------------------l~~~~~~~i~~qI~~gL~yLH~---- 345 (488)
.... .. .. .. ++......+...+-..+..+..
T Consensus 109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 188 (325)
T d1zyla1 109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 188 (325)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred cCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccc
Confidence 3110 00 00 00 1111111122222233333322
Q ss_pred ---cCcccCCCCCCcEEEeCCeEEEEeecCcee
Q 011331 346 ---KGIAHLDVKPDNIYVKNGVYKLGDFGRATL 375 (488)
Q Consensus 346 ---~gIiHrDLKp~NILv~~g~vkL~DFGlA~~ 375 (488)
.++||+|+.+.|||++++. .++||+-++.
T Consensus 189 ~~p~~liHgDlh~~NvL~~~~~-~~IDFdd~~~ 220 (325)
T d1zyla1 189 DFTVLRLHGDCHAGNILWRDGP-MFVDLDDARN 220 (325)
T ss_dssp CSCCEECCSSCSGGGEEESSSE-EECCCTTCCE
T ss_pred cCCceeecCCCCcccEEEeCCc-eEEechhccc
Confidence 3689999999999997765 4789998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.73 E-value=0.002 Score=63.61 Aligned_cols=73 Identities=11% Similarity=-0.012 Sum_probs=50.1
Q ss_pred EEEEecccCcEEEEEEEEcC-------CCeEEEEEEeccCCCchHHHHHHHHHHHHHHHhCCCCCeeEeeeeecccceEE
Q 011331 233 EIEQIGAGNFSHVFKVLKRI-------DGCFYAVKHSKRQLHHDAERRKALLEVQALAALGSHENIVGYYSSWFENEQLY 305 (488)
Q Consensus 233 ~~~~LG~G~fg~Vy~a~~~~-------~g~~vAvK~l~~~~~~~~~~~~~~~Ei~iL~~l~~HpnIv~l~~~~~~~~~l~ 305 (488)
.++.|+.|..-.+|++.... .+..|.+++.-. .... ....+|..+++.+..+.-..++++++.+ +
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 45679999999999997653 346688887642 2222 2345688888888666545577777653 5
Q ss_pred EEEecCCC
Q 011331 306 IQMELCDH 313 (488)
Q Consensus 306 IV~E~~~~ 313 (488)
+||||+++
T Consensus 118 ~I~efi~g 125 (395)
T d1nw1a_ 118 RLEEYIPS 125 (395)
T ss_dssp EEECCCCE
T ss_pred eEEEEecc
Confidence 78999976
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.91 E-value=0.045 Score=51.27 Aligned_cols=30 Identities=30% Similarity=0.329 Sum_probs=25.5
Q ss_pred cCcccCCCCCCcEEEeCCe-EEEEeecCcee
Q 011331 346 KGIAHLDVKPDNIYVKNGV-YKLGDFGRATL 375 (488)
Q Consensus 346 ~gIiHrDLKp~NILv~~g~-vkL~DFGlA~~ 375 (488)
.|+||+|+.++||+++++. .-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3799999999999997665 47999998864
|